data_2k3t_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2k3t _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A 2427 ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.134 0 CA-C-O 121.049 0.249 . . . . 0.0 113.003 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A 2428 ' ' ASP . . . . . . . . . . . . . 13.4 t70 -150.4 135.48 9.91 Favored Pre-proline 0 CA--C 1.55 0.958 0 C-N-CA 124.471 1.108 . . . . 0.0 111.658 -174.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 2429 ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -67.16 -21.18 48.91 Favored 'Trans proline' 0 C--N 1.352 0.717 0 C-N-CA 123.44 2.76 . . . . 0.0 113.946 -175.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 2430 ' ' GLY . . . . . . . . . . . . . . . -80.48 -25.6 56.44 Favored Glycine 0 CA--C 1.532 1.115 0 CA-C-N 119.29 0.95 . . . . 0.0 113.021 174.319 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 2431 ' ' LEU . . . . . . . . . . . . . 4.4 mm? -80.61 -37.55 30.94 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 124.138 0.975 . . . . 0.0 111.058 171.218 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 2432 ' ' VAL . . . . . . . . . . . . . 74.7 t -63.5 137.62 24.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 CA-C-O 121.598 0.713 . . . . 0.0 110.607 170.333 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 2433 ' ' SER . . . . . . . . . . . . . 8.1 t -133.5 -171.4 2.7 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 125.224 1.41 . . . . 0.0 110.103 173.007 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 2434 ' ' ALA . . . . . . . . . . . . . . . -144.59 145.65 31.91 Favored 'General case' 0 CA--C 1.538 0.487 0 O-C-N 121.029 -1.044 . . . . 0.0 111.502 176.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 2435 ' ' TYR . . . . . . . . . . . . . 80.5 m-85 -145.72 154.42 42.05 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 125.454 1.501 . . . . 0.0 111.844 -174.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 2436 ' ' GLY . . . . . . . . . . . . . . . 113.64 162.28 14.7 Favored Glycine 0 N--CA 1.473 1.149 0 C-N-CA 125.167 1.365 . . . . 0.0 113.954 176.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 2437 ' ' ALA . . . . . . . . . . . . . . . -60.62 -27.3 67.66 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.322 1.449 . . . . 0.0 114.462 -170.19 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 2438 ' ' GLY . . . . . . . . . . . . . . . -64.83 -18.59 64.4 Favored Glycine 0 CA--C 1.531 1.033 0 CA-C-O 119.025 -0.875 . . . . 0.0 114.33 -179.081 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 2439 ' ' LEU . . . . . . . . . . . . . 87.2 mt -74.33 -24.43 59.19 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 118.576 1.188 . . . . 0.0 112.698 170.703 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 2440 ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -90.07 -28.0 19.31 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.844 1.258 . . . . 0.0 111.691 174.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 2441 ' ' GLY . . . . . . . . . . . . . . . 110.93 -137.1 14.08 Favored Glycine 0 CA--C 1.529 0.931 0 C-N-CA 125.83 1.681 . . . . 0.0 113.428 175.079 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 2442 ' ' GLY . . . . . . . . . . . . . . . 165.34 -136.31 4.13 Favored Glycine 0 N--CA 1.471 1.025 0 C-N-CA 124.032 0.825 . . . . 0.0 113.7 -172.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 2443 ' ' VAL . . . . . . . . . . . . . 73.8 t -130.2 149.3 33.45 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 125.921 1.688 . . . . 0.0 109.302 -178.104 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 2444 ' ' THR . . . . . . . . . . . . . 38.1 p -58.31 136.26 57.33 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.608 0.763 . . . . 0.0 112.005 176.566 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 2445 ' ' GLY . . . . . . . . . . . . . . . 77.67 -10.89 22.0 Favored Glycine 0 CA--C 1.538 1.484 0 C-N-CA 124.905 1.241 . . . . 0.0 114.805 -175.655 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 2446 ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -95.07 141.68 23.57 Favored Pre-proline 0 CA--C 1.553 1.079 0 C-N-CA 125.63 1.572 . . . . 0.0 110.981 177.588 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 2447 ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -74.18 134.74 19.73 Favored 'Trans proline' 0 C--N 1.35 0.649 0 C-N-CA 123.113 2.542 . . . . 0.0 111.437 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 2448 ' ' ALA . . . . . . . . . . . . . . . -116.65 119.98 37.21 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 126.688 1.995 . . . . 0.0 108.919 175.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 2449 ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -122.62 131.7 53.94 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 124.094 0.958 . . . . 0.0 111.94 -168.336 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 2450 ' ' PHE . . . . . . . . . . . . . 15.3 p90 -147.56 166.67 26.62 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 125.283 1.433 . . . . 0.0 111.107 174.307 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 2451 ' ' VAL . . . . . . . . . . . . . 15.0 p -122.42 135.47 62.42 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 C-N-CA 125.045 1.338 . . . . 0.0 110.987 176.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 2452 ' ' VAL . . . . . . . . . . . . . 56.9 t -85.08 107.09 15.64 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 N-CA-C 106.825 -1.546 . . . . 0.0 106.825 163.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 2453 ' ' ASN . . . . . . . . . . . . . 17.4 t-20 -92.7 119.77 32.43 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 123.389 0.676 . . . . 0.0 112.49 -168.088 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 2454 ' ' THR . . . . . . . . . . . . . 76.8 p -102.8 -1.17 30.29 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 125.739 1.615 . . . . 0.0 113.906 -178.126 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 2455 ' ' SER . . . . . . . . . . . . . 29.5 m -56.93 -29.63 63.29 Favored 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 114.478 1.288 . . . . 0.0 114.478 -174.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 2456 ' ' ASN . . . . . . . . . . . . . 86.8 m-20 -82.96 -18.42 40.02 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 124.321 1.048 . . . . 0.0 113.396 175.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 2457 ' ' ALA . . . . . . . . . . . . . . . -104.03 -36.03 7.88 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 125.533 1.533 . . . . 0.0 113.626 -172.48 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 2458 ' ' GLY . . . . . . . . . . . . . . . 105.99 -107.17 2.72 Favored Glycine 0 CA--C 1.529 0.958 0 C-N-CA 124.9 1.238 . . . . 0.0 111.167 -172.616 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 2459 ' ' ALA . . . . . . . . . . . . . . . -143.31 156.22 44.66 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.706 1.202 . . . . 0.0 112.905 -176.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 2460 ' ' GLY . . . . . . . . . . . . . . . 164.26 166.81 23.78 Favored Glycine 0 CA--C 1.532 1.136 0 C-N-CA 125.825 1.678 . . . . 0.0 112.772 -174.634 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 2461 ' ' ALA . . . . . . . . . . . . . . . -74.98 144.18 43.27 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 123.921 0.889 . . . . 0.0 112.363 -179.422 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 2462 ' ' LEU . . . . . . . . . . . . . 48.2 tp -124.83 141.73 51.92 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.291 1.436 . . . . 0.0 111.328 179.417 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 2463 ' ' SER . . . . . . . . . . . . . 15.8 t -123.71 160.42 27.27 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 125.005 1.322 . . . . 0.0 110.291 158.11 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 2464 ' ' VAL . . . . . . . . . . . . . 5.8 p -161.68 133.82 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 124.892 1.277 . . . . 0.0 110.634 -176.334 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 2465 ' ' THR . . . . . . . . . . . . . 94.2 m -137.84 138.5 39.2 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 126.048 1.739 . . . . 0.0 109.369 -177.407 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 2466 ' ' ILE . . . . . . . . . . . . . 45.3 mt -119.67 125.3 74.21 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 C-N-CA 124.39 1.076 . . . . 0.0 108.821 176.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 2467 ' ' ASP . . . . . . . . . . . . . 35.7 t70 -137.05 130.5 31.44 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 125.135 1.374 . . . . 0.0 111.296 -174.397 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 2468 ' ' GLY . . . . . . . . . . . . . . . -167.17 -142.43 3.45 Favored Glycine 0 CA--C 1.538 1.506 0 CA-C-O 118.524 -1.153 . . . . 0.0 113.883 -175.111 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 2469 ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo -68.61 -14.36 39.33 Favored 'Trans proline' 0 CA--C 1.539 0.759 0 C-N-CA 123.977 3.118 . . . . 0.0 113.58 -178.465 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 2470 ' ' SER . . . . . . . . . . . . . 7.5 t -157.73 -170.4 3.18 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 125.776 1.63 . . . . 0.0 110.356 170.625 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 2471 ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -77.48 171.39 14.96 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 124.245 1.018 . . . . 0.0 111.824 168.079 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 2472 ' ' VAL . . . . . . . . . . . . . 28.7 m -135.07 151.75 31.4 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 125.376 1.471 . . . . 0.0 110.389 175.097 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 2473 ' ' LYS . . . . . . . . . . . . . 99.7 mttt -93.59 118.51 31.46 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.811 0.845 . . . . 0.0 109.451 170.088 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 2474 ' ' MET . . . . . . . . . . . . . 77.2 mtp -111.13 137.34 48.93 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 125.282 1.433 . . . . 0.0 112.54 -175.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 2475 ' ' ASP . . . . . . . . . . . . . 25.8 t70 -113.59 94.89 5.06 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 126.364 1.866 . . . . 0.0 109.042 162.371 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 2476 ' ' CYS . . . . . . . . . . . . . 47.5 t -91.35 129.43 37.34 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.382 1.073 . . . . 0.0 110.123 173.374 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 2477 ' ' GLN . . . . . . . . . . . . . 70.1 mm-40 -142.33 140.17 32.04 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 124.571 1.148 . . . . 0.0 110.821 -175.527 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 2478 ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -82.22 148.1 28.61 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 123.63 0.772 . . . . 0.0 111.854 173.06 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 2479 ' ' CYS . . . . . . . . . . . . . 31.9 p -161.36 171.7 6.59 Favored Pre-proline 0 CA--C 1.553 1.086 0 C-N-CA 125.639 1.576 . . . . 0.0 111.863 -175.005 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 2480 ' ' PRO . . . . . . . . . . . . . 66.0 Cg_exo -58.42 -24.73 70.24 Favored 'Trans proline' 0 CA--C 1.539 0.772 0 C-N-CA 123.348 2.699 . . . . 0.0 114.341 174.137 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 2481 ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -81.69 -6.51 59.09 Favored 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 124.981 1.312 . . . . 0.0 113.047 177.374 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 2482 ' ' GLY . . . . . . . . . . . . . . . 120.43 -118.04 3.73 Favored Glycine 0 N--CA 1.469 0.883 0 C-N-CA 126.08 1.8 . . . . 0.0 111.987 -176.709 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 2483 ' ' TYR . . . . . . . . . . . . . 93.4 m-85 -124.14 111.78 16.32 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.211 1.004 . . . . 0.0 110.651 173.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 2484 ' ' ARG . . . . . . . . . . . . . 13.7 ttp-105 -78.07 139.52 39.08 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 123.871 0.869 . . . . 0.0 109.807 173.571 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 2485 ' ' VAL . . . . . . . . . . . . . 90.7 t -126.96 116.09 43.5 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 C-N-CA 125.202 1.401 . . . . 0.0 108.257 170.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 2486 ' ' THR . . . . . . . . . . . . . 87.2 m -103.44 133.61 48.2 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 107.478 -1.304 . . . . 0.0 107.478 164.403 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 2487 ' ' TYR . . . . . . . . . . . . . 27.5 p90 -139.14 155.13 48.09 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 113.166 0.802 . . . . 0.0 113.166 176.4 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 2488 ' ' THR . . . . . . . . . . . . . 93.0 m -120.1 116.97 32.33 Favored Pre-proline 0 N--CA 1.474 0.737 0 C-N-CA 124.205 1.002 . . . . 0.0 109.774 176.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 2489 ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -82.5 158.4 16.83 Favored 'Trans proline' 0 C--N 1.351 0.681 0 C-N-CA 123.97 3.113 . . . . 0.0 111.551 173.402 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 2490 ' ' MET . . . . . . . . . . . . . 25.3 ptm -132.78 7.71 4.09 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 114.612 1.338 . . . . 0.0 114.612 -176.218 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 2491 ' ' ALA . . . . . . . . . . . . . . . -144.83 143.83 22.3 Favored Pre-proline 0 CA--C 1.547 0.838 0 C-N-CA 125.357 1.463 . . . . 0.0 111.224 172.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 2492 ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -76.16 156.86 38.0 Favored 'Trans proline' 0 CA--C 1.536 0.616 0 C-N-CA 123.704 2.936 . . . . 0.0 111.138 175.47 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 2493 ' ' GLY . . . . . . . . . . . . . . . 130.47 -140.37 11.71 Favored Glycine 0 CA--C 1.528 0.89 0 C-N-CA 125.643 1.592 . . . . 0.0 111.181 -171.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 2494 ' ' SER . . . . . . . . . . . . . 54.4 p -140.93 138.59 33.95 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 113.333 0.864 . . . . 0.0 113.333 178.628 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 2495 ' ' TYR . . . . . . . . . . . . . 56.6 m-85 -111.13 131.48 55.06 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 126.215 1.806 . . . . 0.0 110.412 -178.666 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 2496 ' ' LEU . . . . . . . . . . . . . 86.2 mt -86.62 123.2 31.54 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 124.459 1.103 . . . . 0.0 109.33 169.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 2497 ' ' ILE . . . . . . . . . . . . . 49.7 mt -100.93 94.45 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 C-N-CA 125.641 1.576 . . . . 0.0 107.939 179.391 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 2498 ' ' SER . . . . . . . . . . . . . 67.1 m -88.71 119.3 29.06 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 125.594 1.557 . . . . 0.0 110.245 -178.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 2499 ' ' ILE . . . . . 0.686 ' H ' ' HG ' ' A' 2510 ' ' SER . 33.7 mt -127.09 121.4 57.76 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 C-N-CA 125.223 1.409 . . . . 0.0 108.088 -170.883 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 2500 ' ' LYS . . . . . . . . . . . . . 93.0 mttt -131.8 119.22 20.96 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 123.857 0.863 . . . . 0.0 112.063 -168.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 2501 ' ' TYR . . . . . . . . . . . . . 66.6 t80 -125.87 137.74 53.76 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.796 1.239 . . . . 0.0 112.507 -169.459 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 2502 ' ' GLY . . . . . . . . . . . . . . . 70.06 10.26 64.9 Favored Glycine 0 CA--C 1.537 1.444 0 C-N-CA 124.445 1.022 . . . . 0.0 114.318 -178.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 2503 ' ' GLY . . . . . . . . . . . . . . . 149.94 -176.3 28.66 Favored Glycine 0 CA--C 1.54 1.615 0 C-N-CA 126.094 1.806 . . . . 0.0 112.849 -171.454 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 2504 ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -81.45 34.57 0.55 Allowed 'Trans proline' 0 CA--C 1.546 1.111 0 C-N-CA 125.193 3.929 . . . . 0.0 113.346 -173.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 2505 ' ' TYR . . . . . . . . . . . . . 82.6 m-85 -122.53 135.63 54.69 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 125.026 1.33 . . . . 0.0 112.296 -174.355 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 2506 ' ' HIS . . . . . . . . . . . . . 94.8 m-70 -60.51 140.75 57.17 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 124.254 1.022 . . . . 0.0 113.676 -176.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 2507 ' ' ILE . . . . . . . . . . . . . 1.9 pp -75.98 167.85 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 C-N-CA 123.562 0.745 . . . . 0.0 112.505 172.277 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 2508 ' ' GLY . . . . . . . . . . . . . . . -58.33 112.4 3.93 Favored Glycine 0 CA--C 1.533 1.166 0 C-N-CA 124.003 0.811 . . . . 0.0 112.877 -174.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 2509 ' ' GLY . . . . . . . . . . . . . . . 95.47 -8.94 69.24 Favored Glycine 0 CA--C 1.536 1.37 0 C-N-CA 125.983 1.754 . . . . 0.0 115.004 -178.105 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 2510 ' ' SER . . . . . 0.686 ' HG ' ' H ' ' A' 2499 ' ' ILE . 13.3 t -84.78 145.82 44.94 Favored Pre-proline 0 CA--C 1.552 1.047 0 CA-C-N 119.195 1.498 . . . . 0.0 112.0 179.731 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 2511 ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -75.39 144.25 79.9 Favored 'Cis proline' 0 C--N 1.354 0.83 0 CA-C-N 120.217 1.113 . . . . 0.0 113.026 -0.57 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 2512 ' ' PHE . . . . . . . . . . . . . 94.9 m-85 -96.94 134.1 40.73 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.511 1.124 . . . . 0.0 110.519 175.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 2513 ' ' LYS . . . . . . . . . . . . . 59.6 pttt -89.54 105.56 17.88 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 123.686 0.794 . . . . 0.0 112.358 176.27 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 2514 ' ' ALA . . . . . . . . . . . . . . . -91.88 126.86 37.13 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 125.261 1.424 . . . . 0.0 110.374 174.522 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 2515 ' ' LYS . . . . . . . . . . . . . 30.6 mtpp -101.38 134.44 44.46 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 124.712 1.205 . . . . 0.0 111.123 -175.295 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 2516 ' ' VAL . . . . . . . . . . . . . 84.7 t -132.58 137.01 55.09 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 C-N-CA 124.493 1.117 . . . . 0.0 110.715 -169.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 2517 ' ' THR . . . . . . . . . . . . . 73.4 p -123.65 -177.27 3.68 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 125.741 1.616 . . . . 0.0 110.965 176.219 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 2518 ' ' GLY . . . . . . . . . . . . . . . 98.62 -176.52 29.98 Favored Glycine 0 CA--C 1.54 1.621 0 C-N-CA 124.749 1.166 . . . . 0.0 113.465 -176.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 2519 ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -71.1 151.08 61.11 Favored 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 123.814 3.009 . . . . 0.0 111.885 -176.263 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 2520 ' ' ARG . . . . . . . . . . . . . 21.5 ttt85 . . . . . 0 CA--C 1.539 0.542 0 C-N-CA 123.872 0.869 . . . . 0.0 110.896 176.144 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A 2427 ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.795 0 N-CA-C 112.594 -0.202 . . . . 0.0 112.594 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A 2428 ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -148.9 143.37 17.02 Favored Pre-proline 0 CA--C 1.545 0.765 0 C-N-CA 125.078 1.351 . . . . 0.0 111.643 178.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 2429 ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -65.32 -24.4 57.83 Favored 'Trans proline' 0 C--N 1.351 0.707 0 C-N-CA 123.215 2.61 . . . . 0.0 112.773 177.715 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 2430 ' ' GLY . . . . . . . . . . . . . . . -75.59 -23.28 73.38 Favored Glycine 0 CA--C 1.535 1.317 0 CA-C-N 119.065 0.848 . . . . 0.0 113.805 174.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 2431 ' ' LEU . . . . . . . . . . . . . 4.4 mm? -86.95 -33.16 19.76 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.492 1.117 . . . . 0.0 111.616 173.682 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 2432 ' ' VAL . . . . . . . . . . . . . 53.4 t -70.16 138.31 22.26 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 C-N-CA 124.166 0.987 . . . . 0.0 111.092 172.005 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 2433 ' ' SER . . . . . . . . . . . . . 58.5 m -139.13 146.96 41.28 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 125.705 1.602 . . . . 0.0 109.628 173.549 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 2434 ' ' ALA . . . . . . . . . . . . . . . -98.98 149.36 23.06 Favored 'General case' 0 CA--C 1.54 0.568 0 O-C-N 121.528 -0.733 . . . . 0.0 112.13 176.219 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 2435 ' ' TYR . . . . . . . . . . . . . 89.7 m-85 -142.67 145.18 33.17 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.831 1.652 . . . . 0.0 111.563 -178.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 2436 ' ' GLY . . . . . . . . . . . . . . . 126.93 160.4 10.52 Favored Glycine 0 N--CA 1.474 1.193 0 C-N-CA 125.325 1.44 . . . . 0.0 113.948 178.379 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 2437 ' ' ALA . . . . . . . . . . . . . . . -63.18 -28.83 70.32 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 114.283 1.216 . . . . 0.0 114.283 -171.186 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 2438 ' ' GLY . . . . . . . . . . . . . . . -66.95 -11.08 57.62 Favored Glycine 0 CA--C 1.531 1.093 0 C-N-CA 124.437 1.018 . . . . 0.0 114.501 -178.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 2439 ' ' LEU . . . . . . . . . . . . . 75.6 mt -78.68 -25.22 44.8 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 118.537 1.168 . . . . 0.0 112.594 170.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 2440 ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -94.46 -31.98 13.72 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.897 1.279 . . . . 0.0 112.361 -175.165 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 2441 ' ' GLY . . . . . . . . . . . . . . . 159.22 -155.08 26.15 Favored Glycine 0 CA--C 1.527 0.807 0 C-N-CA 124.45 1.024 . . . . 0.0 113.575 -176.225 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 2442 ' ' GLY . . . . . . . . . . . . . . . 168.01 -171.9 42.54 Favored Glycine 0 CA--C 1.529 0.93 0 C-N-CA 124.636 1.112 . . . . 0.0 113.498 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 2443 ' ' VAL . . . . . . . . . . . . . 95.4 t -117.6 137.55 51.17 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 125.379 1.471 . . . . 0.0 108.996 176.452 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 2444 ' ' THR . . . . . . . . . . . . . 21.5 p -57.99 136.62 57.13 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.18 0.992 . . . . 0.0 112.232 177.308 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 2445 ' ' GLY . . . . . . . . . . . . . . . 79.61 -12.53 27.53 Favored Glycine 0 CA--C 1.534 1.274 0 C-N-CA 124.624 1.107 . . . . 0.0 114.713 -178.644 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 2446 ' ' ASN . . . . . . . . . . . . . 80.5 m-20 -99.43 150.15 36.5 Favored Pre-proline 0 CA--C 1.547 0.843 0 C-N-CA 124.898 1.279 . . . . 0.0 110.825 173.266 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 2447 ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -70.75 142.51 43.76 Favored 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 122.756 2.304 . . . . 0.0 111.01 175.163 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 2448 ' ' ALA . . . . . . . . . . . . . . . -128.35 135.31 49.4 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 126.726 2.011 . . . . 0.0 108.618 171.209 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 2449 ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -142.11 154.04 44.59 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 114.324 1.231 . . . . 0.0 114.324 -163.12 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 2450 ' ' PHE . . . . . . . . . . . . . 54.3 p90 -158.56 155.28 28.04 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 126.118 1.767 . . . . 0.0 111.405 -179.225 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 2451 ' ' VAL . . . . . . . . . . . . . 59.6 t -111.39 129.29 67.0 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 C-N-CA 125.11 1.364 . . . . 0.0 108.914 173.361 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 2452 ' ' VAL . . . . . . . . . . . . . 39.0 t -84.19 101.4 8.71 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 N-CA-C 107.208 -1.405 . . . . 0.0 107.208 166.016 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 2453 ' ' ASN . . . . . . . . . . . . . 19.3 t-20 -83.11 124.74 30.77 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 123.478 0.711 . . . . 0.0 112.472 -169.356 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 2454 ' ' THR . . . . . . . . . . . . . 40.4 p -103.96 -1.25 27.86 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 125.696 1.598 . . . . 0.0 113.881 -179.001 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 2455 ' ' SER . . . . . . . . . . . . . 44.5 m -57.8 -29.13 64.64 Favored 'General case' 0 N--CA 1.48 1.047 0 CA-C-N 120.32 1.418 . . . . 0.0 114.441 -175.445 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 2456 ' ' ASN . . . . . . . . . . . . . 67.3 m-80 -86.86 -11.99 49.18 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 124.688 1.195 . . . . 0.0 113.557 176.152 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 2457 ' ' ALA . . . . . . . . . . . . . . . -112.54 -22.33 10.85 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 126.172 1.789 . . . . 0.0 113.851 -174.073 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 2458 ' ' GLY . . . . . . . . . . . . . . . 91.36 -85.89 1.28 Allowed Glycine 0 CA--C 1.529 0.943 0 C-N-CA 124.986 1.279 . . . . 0.0 111.338 -176.496 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 2459 ' ' ALA . . . . . . . . . . . . . . . -157.84 157.14 32.7 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 124.987 1.315 . . . . 0.0 112.617 -176.466 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 2460 ' ' GLY . . . . . . . . . . . . . . . 165.09 167.34 25.52 Favored Glycine 0 CA--C 1.532 1.126 0 C-N-CA 125.545 1.545 . . . . 0.0 113.008 -176.145 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 2461 ' ' ALA . . . . . . . . . . . . . . . -77.96 145.64 35.94 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.265 1.026 . . . . 0.0 112.572 -178.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 2462 ' ' LEU . . . . . . . . . . . . . 29.9 tp -121.21 141.6 50.7 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 125.336 1.455 . . . . 0.0 110.999 178.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 2463 ' ' SER . . . . . . . . . . . . . 29.7 t -102.24 -109.75 0.23 Allowed 'General case' 0 CA--C 1.552 1.02 0 C-N-CA 125.24 1.416 . . . . 0.0 110.014 171.119 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 2464 ' ' VAL . . . . . . . . . . . . . 48.3 t 105.31 123.57 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.247 0 C-N-CA 131.659 3.984 . . . . 0.0 109.702 172.647 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 2465 ' ' THR . . . . . . . . . . . . . 89.9 m -131.95 139.29 48.64 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 125.408 1.483 . . . . 0.0 109.076 174.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 2466 ' ' ILE . . . . . . . . . . . . . 35.8 mt -119.15 117.39 54.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 123.634 0.773 . . . . 0.0 109.649 175.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 2467 ' ' ASP . . . . . . . . . . . . . 34.8 t70 -95.17 162.34 13.74 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 125.776 1.631 . . . . 0.0 110.286 168.638 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 2468 ' ' GLY . . . . . . . . . . . . . . . 168.73 -166.78 39.9 Favored Glycine 0 CA--C 1.536 1.358 0 O-C-N 121.125 -0.985 . . . . 0.0 114.717 178.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 2469 ' ' PRO . . . . . . . . . . . . . 76.1 Cg_endo -70.94 -15.86 32.66 Favored 'Trans proline' 0 CA--C 1.541 0.853 0 C-N-CA 123.969 3.113 . . . . 0.0 113.088 177.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 2470 ' ' SER . . . . . . . . . . . . . 37.2 m -153.67 174.52 14.38 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 126.868 2.067 . . . . 0.0 110.343 175.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 2471 ' ' LYS . . . . . . . . . . . . . 67.9 mttm -68.32 167.54 14.3 Favored 'General case' 0 CA--C 1.549 0.918 0 O-C-N 121.252 -0.905 . . . . 0.0 112.181 168.611 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 2472 ' ' VAL . . . . . . . . . . . . . 14.3 m -133.35 144.9 34.84 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 125.468 1.507 . . . . 0.0 111.34 -179.583 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 2473 ' ' LYS . . . . . . . . . . . . . 14.5 mmmm -89.31 71.27 8.18 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.337 1.055 . . . . 0.0 111.588 -179.263 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 2474 ' ' MET . . . . . . . . . . . . . 92.0 mtp -69.77 140.74 53.43 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 124.494 1.118 . . . . 0.0 112.969 -178.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 2475 ' ' ASP . . . . . . . . . . . . . 30.5 t70 -133.4 125.15 28.46 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 126.97 2.108 . . . . 0.0 108.755 163.117 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 2476 ' ' CYS . . . . . . . . . . . . . 42.6 t -122.18 132.75 54.61 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.797 1.239 . . . . 0.0 110.956 -177.706 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 2477 ' ' GLN . . . . . . . . . . . . . 15.9 mm100 -142.02 151.86 42.85 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 125.454 1.502 . . . . 0.0 110.721 -178.622 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 2478 ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -79.88 151.75 30.01 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 123.412 0.685 . . . . 0.0 111.67 169.343 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 2479 ' ' CYS . . . . . . . . . . . . . 19.5 p -156.82 172.15 6.5 Favored Pre-proline 0 CA--C 1.553 1.096 0 C-N-CA 126.083 1.753 . . . . 0.0 111.505 -176.576 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 2480 ' ' PRO . . . . . . . . . . . . . 58.0 Cg_exo -59.02 -26.2 80.71 Favored 'Trans proline' 0 CA--C 1.539 0.75 0 C-N-CA 123.342 2.694 . . . . 0.0 114.584 176.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 2481 ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -88.37 -6.1 57.9 Favored 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 125.382 1.473 . . . . 0.0 113.154 -179.086 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 2482 ' ' GLY . . . . . . . . . . . . . . . 128.24 -132.21 7.26 Favored Glycine 0 N--CA 1.472 1.055 0 C-N-CA 125.335 1.445 . . . . 0.0 112.164 -176.324 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 2483 ' ' TYR . . . . . . . . . . . . . 95.1 m-85 -108.78 117.62 34.67 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 123.809 0.844 . . . . 0.0 110.854 173.551 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 2484 ' ' ARG . . . . . . . . . . . . . 57.5 ttt180 -92.43 130.55 38.07 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 124.117 0.967 . . . . 0.0 110.676 177.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 2485 ' ' VAL . . . . . . . . . . . . . 89.9 t -114.09 132.76 62.18 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 C-N-CA 125.863 1.665 . . . . 0.0 108.47 172.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 2486 ' ' THR . . . . . . . . . . . . . 95.4 m -125.6 137.22 53.89 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 125.11 1.364 . . . . 0.0 107.821 169.06 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 2487 ' ' TYR . . . . . . . . . . . . . 21.6 p90 -144.09 152.75 41.37 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 123.72 0.808 . . . . 0.0 112.604 177.415 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 2488 ' ' THR . . . . . . . . . . . . . 84.4 m -113.25 119.71 41.61 Favored Pre-proline 0 N--CA 1.474 0.753 0 CA-C-O 117.892 -1.051 . . . . 0.0 109.466 173.287 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 2489 ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -83.67 154.75 13.66 Favored 'Trans proline' 0 CA--C 1.537 0.634 0 C-N-CA 124.064 3.176 . . . . 0.0 111.209 171.298 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 2490 ' ' MET . . . . . . . . . . . . . 28.0 ptm -119.69 -2.37 10.44 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 114.892 1.441 . . . . 0.0 114.892 -174.211 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 2491 ' ' ALA . . . . . . . . . . . . . . . -147.25 148.23 31.14 Favored Pre-proline 0 CA--C 1.545 0.786 0 C-N-CA 125.687 1.595 . . . . 0.0 110.896 177.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 2492 ' ' PRO . . . . . . . . . . . . . 74.9 Cg_endo -72.18 153.91 56.9 Favored 'Trans proline' 0 CA--C 1.536 0.584 0 C-N-CA 123.043 2.495 . . . . 0.0 111.161 174.546 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 2493 ' ' GLY . . . . . . . . . . . . . . . 135.39 -170.12 23.12 Favored Glycine 0 CA--C 1.529 0.949 0 C-N-CA 125.363 1.459 . . . . 0.0 113.313 -177.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 2494 ' ' SER . . . . . 0.471 ' HG ' ' HE2' ' A' 2513 ' ' LYS . 70.3 m -95.54 121.07 36.85 Favored 'General case' 0 N--CA 1.471 0.61 0 O-C-N 121.839 -0.8 . . . . 0.0 111.818 179.303 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 2495 ' ' TYR . . . . . . . . . . . . . 63.5 m-85 -99.07 126.01 44.71 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 125.156 1.382 . . . . 0.0 109.706 171.43 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 2496 ' ' LEU . . . . . . . . . . . . . 26.1 tp -101.2 110.68 22.73 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.359 1.064 . . . . 0.0 109.44 -176.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 2497 ' ' ILE . . . . . . . . . . . . . 39.8 mt -96.56 96.48 5.54 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 C-N-CA 125.688 1.595 . . . . 0.0 108.618 -172.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 2498 ' ' SER . . . . . . . . . . . . . 68.9 m -80.86 83.54 6.58 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 125.409 1.484 . . . . 0.0 110.165 176.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 2499 ' ' ILE . . . . . . . . . . . . . 50.5 mt -79.91 114.53 20.9 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 C-N-CA 124.31 1.044 . . . . 0.0 109.227 177.025 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 2500 ' ' LYS . . . . . . . . . . . . . 83.7 mttt -127.52 133.33 49.83 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 125.03 1.332 . . . . 0.0 111.769 -175.165 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 2501 ' ' TYR . . . . . . . . . . . . . 64.4 t80 -141.83 143.09 33.22 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 125.465 1.506 . . . . 0.0 111.805 -170.332 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 2502 ' ' GLY . . . . . . . . . . . . . . . 69.26 11.86 65.01 Favored Glycine 0 CA--C 1.536 1.388 0 C-N-CA 124.443 1.02 . . . . 0.0 114.474 177.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 2503 ' ' GLY . . . . . . . . . . . . . . . 145.9 -165.6 28.05 Favored Glycine 0 CA--C 1.54 1.614 0 C-N-CA 125.731 1.634 . . . . 0.0 112.999 -170.487 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 2504 ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -82.28 13.72 2.46 Favored 'Trans proline' 0 CA--C 1.544 0.999 0 C-N-CA 124.762 3.641 . . . . 0.0 113.962 -174.318 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 2505 ' ' TYR . . . . . . . . . . . . . 84.0 m-85 -106.22 142.32 36.1 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.78 1.232 . . . . 0.0 113.452 -173.325 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 2506 ' ' HIS . . . . . . . . . . . . . 97.7 m-70 -65.03 143.89 57.64 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 124.762 1.225 . . . . 0.0 113.046 178.282 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 2507 ' ' ILE . . . . . . . . . . . . . 20.4 pt -73.65 175.6 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 N-CA-C 113.437 0.902 . . . . 0.0 113.437 173.583 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 2508 ' ' GLY . . . . . . . . . . . . . . . -58.95 119.53 18.34 Favored Glycine 0 CA--C 1.534 1.232 0 O-C-N 121.487 -0.758 . . . . 0.0 111.512 172.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 2509 ' ' GLY . . . . . . . . . . . . . . . 87.19 -6.76 82.76 Favored Glycine 0 CA--C 1.536 1.359 0 C-N-CA 125.616 1.579 . . . . 0.0 115.034 -176.733 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 2510 ' ' SER . . . . . . . . . . . . . 43.8 t -89.09 147.67 39.13 Favored Pre-proline 0 CA--C 1.549 0.938 0 CA-C-N 118.914 1.357 . . . . 0.0 112.043 -179.005 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 2511 ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -74.46 146.22 86.16 Favored 'Cis proline' 0 C--N 1.353 0.808 0 CA-C-N 119.671 0.918 . . . . 0.0 112.608 -1.036 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 2512 ' ' PHE . . . . . . . . . . . . . 94.7 m-85 -96.3 126.41 41.49 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.612 1.165 . . . . 0.0 110.797 179.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 2513 ' ' LYS . . . . . 0.471 ' HE2' ' HG ' ' A' 2494 ' ' SER . 85.0 tttt -94.5 100.16 12.2 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.025 0.93 . . . . 0.0 111.407 -179.03 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 2514 ' ' ALA . . . . . . . . . . . . . . . -89.02 115.46 26.6 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.355 1.462 . . . . 0.0 110.913 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 2515 ' ' LYS . . . . . . . . . . . . . 48.4 mtpt -94.04 98.64 11.14 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 124.099 0.959 . . . . 0.0 110.529 -174.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 2516 ' ' VAL . . . . . . . . . . . . . 63.7 t -90.96 140.74 15.49 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 125.673 1.589 . . . . 0.0 110.496 -173.39 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 2517 ' ' THR . . . . . . . . . . . . . 72.0 p -124.4 -177.33 3.76 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 125.582 1.553 . . . . 0.0 111.121 177.093 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 2518 ' ' GLY . . . . . . . . . . . . . . . 98.34 178.34 32.81 Favored Glycine 0 CA--C 1.539 1.558 0 C-N-CA 124.752 1.167 . . . . 0.0 113.561 -177.183 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 2519 ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -73.43 141.82 32.24 Favored 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 123.776 2.984 . . . . 0.0 111.932 -173.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 2520 ' ' ARG . . . . . . . . . . . . . 37.6 ttm180 . . . . . 0 CA--C 1.539 0.525 0 C-N-CA 122.959 0.503 . . . . 0.0 110.004 172.733 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A 2427 ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.055 0 CA-C-O 121.335 0.408 . . . . 0.0 113.166 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A 2428 ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -143.52 135.64 13.2 Favored Pre-proline 0 CA--C 1.544 0.738 0 C-N-CA 124.785 1.234 . . . . 0.0 111.204 178.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 2429 ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -67.94 -22.59 41.95 Favored 'Trans proline' 0 CA--C 1.537 0.648 0 C-N-CA 122.964 2.443 . . . . 0.0 113.003 -178.347 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 2430 ' ' GLY . . . . . . . . . . . . . . . -76.72 -23.12 70.64 Favored Glycine 0 CA--C 1.535 1.292 0 CA-C-N 118.864 0.756 . . . . 0.0 113.557 173.399 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 2431 ' ' LEU . . . . . . . . . . . . . 4.3 mm? -87.72 -35.46 17.93 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.514 1.126 . . . . 0.0 111.353 173.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 2432 ' ' VAL . . . . . . . . . . . . . 74.2 t -64.91 139.6 21.13 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 123.389 0.676 . . . . 0.0 110.473 169.639 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 2433 ' ' SER . . . . . . . . . . . . . 8.5 t -131.37 -176.21 3.95 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.942 1.297 . . . . 0.0 110.507 173.162 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 2434 ' ' ALA . . . . . . . . . . . . . . . -141.96 143.19 33.1 Favored 'General case' 0 CA--C 1.538 0.5 0 O-C-N 121.042 -1.036 . . . . 0.0 111.712 177.107 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 2435 ' ' TYR . . . . . . . . . . . . . 79.1 m-85 -143.65 157.5 44.36 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.536 1.534 . . . . 0.0 111.899 -175.111 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 2436 ' ' GLY . . . . . . . . . . . . . . . 108.05 159.75 20.37 Favored Glycine 0 N--CA 1.474 1.17 0 C-N-CA 125.244 1.402 . . . . 0.0 113.694 177.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 2437 ' ' ALA . . . . . . . . . . . . . . . -62.88 -27.42 69.34 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.075 1.35 . . . . 0.0 114.582 -169.294 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 2438 ' ' GLY . . . . . . . . . . . . . . . -66.27 -14.12 61.29 Favored Glycine 0 CA--C 1.532 1.114 0 C-N-CA 123.974 0.797 . . . . 0.0 114.683 -176.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 2439 ' ' LEU . . . . . . . . . . . . . 88.1 mt -72.07 -22.74 61.32 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 118.466 1.133 . . . . 0.0 112.761 170.233 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 2440 ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -94.48 -16.59 23.21 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 125.076 1.35 . . . . 0.0 112.82 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 2441 ' ' GLY . . . . . . . . . . . . . . . 102.92 -138.82 14.15 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 125.559 1.552 . . . . 0.0 112.39 -177.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 2442 ' ' GLY . . . . . . . . . . . . . . . 150.81 -140.72 8.1 Favored Glycine 0 CA--C 1.532 1.125 0 C-N-CA 124.007 0.813 . . . . 0.0 114.088 -177.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 2443 ' ' VAL . . . . . . . . . . . . . 99.2 t -113.08 139.15 39.77 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 C-N-CA 125.601 1.561 . . . . 0.0 110.115 -175.156 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 2444 ' ' THR . . . . . . . . . . . . . 30.1 p -61.72 142.9 56.95 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 124.302 1.041 . . . . 0.0 112.412 176.41 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 2445 ' ' GLY . . . . . . . . . . . . . . . 79.01 -10.61 32.65 Favored Glycine 0 CA--C 1.537 1.412 0 C-N-CA 124.462 1.03 . . . . 0.0 114.558 -177.118 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 2446 ' ' ASN . . . . . . . . . . . . . 79.7 m-20 -101.59 148.39 35.17 Favored Pre-proline 0 CA--C 1.548 0.87 0 C-N-CA 124.94 1.296 . . . . 0.0 111.117 174.159 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 2447 ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -73.75 129.88 14.02 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 123.176 2.584 . . . . 0.0 111.276 178.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 2448 ' ' ALA . . . . . . . . . . . . . . . -101.87 116.34 32.5 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 126.222 1.809 . . . . 0.0 109.031 170.485 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 2449 ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -111.96 132.79 54.55 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.389 1.076 . . . . 0.0 111.66 -172.319 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 2450 ' ' PHE . . . . . . . . . . . . . 37.8 p90 -147.59 168.56 21.68 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.48 1.512 . . . . 0.0 110.882 171.277 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 2451 ' ' VAL . . . . . . . . . . . . . 14.7 p -126.94 136.93 59.4 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 C-N-CA 124.609 1.164 . . . . 0.0 110.508 174.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 2452 ' ' VAL . . . . . . . . . . . . . 22.0 t -89.5 103.8 14.43 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 N-CA-C 106.797 -1.557 . . . . 0.0 106.797 164.669 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 2453 ' ' ASN . . . . . . . . . . . . . 18.6 t-20 -91.29 120.18 31.96 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 123.874 0.87 . . . . 0.0 112.271 -167.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 2454 ' ' THR . . . . . . . . . . . . . 75.1 p -104.24 2.62 31.84 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 125.958 1.703 . . . . 0.0 113.887 -175.397 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 2455 ' ' SER . . . . . . . . . . . . . 45.2 m -56.89 -27.5 60.72 Favored 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 114.782 1.401 . . . . 0.0 114.782 -173.482 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 2456 ' ' ASN . . . . . . . . . . . . . 70.1 m-80 -91.6 -12.22 34.93 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 124.537 1.135 . . . . 0.0 113.644 176.339 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 2457 ' ' ALA . . . . . . . . . . . . . . . -106.6 -33.43 7.66 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 125.575 1.55 . . . . 0.0 113.759 -174.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 2458 ' ' GLY . . . . . . . . . . . . . . . 87.28 -152.84 24.76 Favored Glycine 0 CA--C 1.533 1.171 0 C-N-CA 124.779 1.181 . . . . 0.0 112.202 -172.099 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 2459 ' ' ALA . . . . . . . . . . . . . . . -69.22 151.94 45.69 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 123.924 0.89 . . . . 0.0 112.6 178.127 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 2460 ' ' GLY . . . . . . . . . . . . . . . 159.86 157.62 8.72 Favored Glycine 0 CA--C 1.532 1.103 0 C-N-CA 125.302 1.43 . . . . 0.0 113.193 179.4 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 2461 ' ' ALA . . . . . . . . . . . . . . . -85.1 139.88 31.39 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.262 1.025 . . . . 0.0 113.346 -172.659 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 2462 ' ' LEU . . . . . . . . . . . . . 31.6 tp -106.4 146.55 30.34 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.778 1.631 . . . . 0.0 111.023 175.765 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 2463 ' ' SER . . . . . . . . . . . . . 4.0 t -137.62 42.13 2.34 Favored 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 125.885 1.674 . . . . 0.0 110.91 -178.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 2464 ' ' VAL . . . . . . . . . . . . . 11.0 p -63.98 135.34 27.94 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.975 0 C-N-CA 124.982 1.313 . . . . 0.0 112.017 -175.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 2465 ' ' THR . . . . . . . . . . . . . 96.3 m -136.41 145.17 44.98 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 125.925 1.69 . . . . 0.0 109.591 -179.16 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 2466 ' ' ILE . . . . . . . . . . . . . 40.6 mt -121.96 123.42 69.06 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 C-N-CA 123.748 0.819 . . . . 0.0 109.98 173.717 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 2467 ' ' ASP . . . . . . . . . . . . . 36.7 t70 -99.39 155.62 17.44 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 125.836 1.655 . . . . 0.0 110.179 166.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 2468 ' ' GLY . . . . . . . . . . . . . . . 177.17 -169.43 41.7 Favored Glycine 0 CA--C 1.537 1.44 0 O-C-N 121.043 -1.036 . . . . 0.0 115.562 -179.28 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 2469 ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -69.73 -17.49 37.69 Favored 'Trans proline' 0 CA--C 1.54 0.79 0 C-N-CA 124.322 3.348 . . . . 0.0 113.411 179.463 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 2470 ' ' SER . . . . . . . . . . . . . 35.0 m -153.92 176.09 12.58 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 127.165 2.186 . . . . 0.0 109.617 174.228 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 2471 ' ' LYS . . . . . . . . . . . . . 4.0 mppt? -66.84 162.96 20.47 Favored 'General case' 0 CA--C 1.551 0.989 0 O-C-N 121.03 -1.044 . . . . 0.0 111.455 168.432 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 2472 ' ' VAL . . . . . . . . . . . . . 33.0 m -118.84 145.87 24.26 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 C-N-CA 124.928 1.291 . . . . 0.0 110.954 175.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 2473 ' ' LYS . . . . . . . . . . . . . 99.0 mttt -86.04 90.9 8.24 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 123.678 0.791 . . . . 0.0 109.357 171.158 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 2474 ' ' MET . . . . . . . . . . . . . 60.5 ttm -89.9 143.38 26.84 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.546 1.139 . . . . 0.0 112.532 -175.068 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 2475 ' ' ASP . . . . . . . . . . . . . 35.8 t0 -133.94 82.04 1.95 Allowed 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 127.96 2.504 . . . . 0.0 108.559 171.637 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 2476 ' ' CYS . . . . . . . . . . . . . 52.6 t -88.01 134.43 33.74 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.841 1.256 . . . . 0.0 110.666 175.609 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 2477 ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -139.51 140.78 37.29 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.519 1.127 . . . . 0.0 111.394 -175.745 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 2478 ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -82.24 139.61 34.14 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.654 1.181 . . . . 0.0 110.304 172.54 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 2479 ' ' CYS . . . . . . . . . . . . . 30.7 p -158.95 169.23 10.91 Favored Pre-proline 0 CA--C 1.553 1.064 0 C-N-CA 125.293 1.437 . . . . 0.0 111.604 -171.558 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 2480 ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -65.91 -15.66 49.74 Favored 'Trans proline' 0 CA--C 1.543 0.943 0 C-N-CA 122.569 2.179 . . . . 0.0 113.427 173.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 2481 ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -77.51 -11.21 59.83 Favored 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 124.69 1.196 . . . . 0.0 112.953 172.133 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 2482 ' ' GLY . . . . . . . . . . . . . . . 117.36 -122.91 5.6 Favored Glycine 0 C--N 1.342 0.911 0 C-N-CA 126.439 1.971 . . . . 0.0 111.48 -172.167 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 2483 ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -117.18 110.4 18.11 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 123.91 0.884 . . . . 0.0 110.209 171.221 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 2484 ' ' ARG . . . . . . . . . . . . . 51.7 ttm-85 -86.37 128.56 34.95 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.741 0.816 . . . . 0.0 109.258 177.289 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 2485 ' ' VAL . . . . . . . . . . . . . 58.4 t -118.98 114.28 44.22 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 C-N-CA 125.331 1.452 . . . . 0.0 108.436 -177.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 2486 ' ' THR . . . . . . . . . . . . . 62.8 m -104.58 140.46 37.96 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 165.654 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 2487 ' ' TYR . . . . . . . . . . . . . 23.3 p90 -146.65 144.63 29.63 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 112.538 0.57 . . . . 0.0 112.538 171.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 2488 ' ' THR . . . . . . . . . . . . . 90.5 m -107.11 114.94 60.79 Favored Pre-proline 0 N--CA 1.473 0.685 0 CA-C-O 118.228 -0.892 . . . . 0.0 109.403 173.554 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 2489 ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -81.38 158.31 19.7 Favored 'Trans proline' 0 C--N 1.351 0.69 0 C-N-CA 124.075 3.184 . . . . 0.0 111.218 173.123 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 2490 ' ' MET . . . . . . . . . . . . . 28.9 ptm -128.77 3.31 5.44 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 115.153 1.538 . . . . 0.0 115.153 -171.198 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 2491 ' ' ALA . . . . . . . . . . . . . . . -152.04 150.33 25.51 Favored Pre-proline 0 CA--C 1.548 0.876 0 C-N-CA 125.505 1.522 . . . . 0.0 110.925 175.558 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 2492 ' ' PRO . . . . . . . . . . . . . 99.0 Cg_endo -74.45 151.21 42.16 Favored 'Trans proline' 0 CA--C 1.539 0.738 0 C-N-CA 123.24 2.627 . . . . 0.0 111.375 178.448 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 2493 ' ' GLY . . . . . . . . . . . . . . . 138.39 -173.66 22.39 Favored Glycine 0 CA--C 1.532 1.116 0 C-N-CA 125.55 1.548 . . . . 0.0 113.382 -177.068 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 2494 ' ' SER . . . . . . . . . . . . . 18.1 p -88.69 120.44 30.09 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.304 1.042 . . . . 0.0 111.55 175.085 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 2495 ' ' TYR . . . . . . . . . . . . . 68.8 m-85 -94.51 116.13 28.42 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 124.027 0.931 . . . . 0.0 109.652 168.539 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 2496 ' ' LEU . . . . . . . . . . . . . 22.8 tp -89.94 105.42 17.79 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 124.041 0.936 . . . . 0.0 109.561 -179.081 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 2497 ' ' ILE . . . . . . . . . . . . . 28.1 mt -88.33 103.1 13.39 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 C-N-CA 125.747 1.619 . . . . 0.0 108.335 -179.201 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 2498 ' ' SER . . . . . . . . . . . . . 73.7 m -90.14 95.98 10.46 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 124.819 1.248 . . . . 0.0 109.638 175.442 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 2499 ' ' ILE . . . . . . . . . . . . . 40.1 mt -91.29 92.52 3.94 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 C-N-CA 124.602 1.161 . . . . 0.0 108.566 -178.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 2500 ' ' LYS . . . . . . . . . . . . . 84.1 mttt -103.37 137.02 42.06 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 124.286 1.035 . . . . 0.0 111.721 -179.463 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 2501 ' ' TYR . . . . . . . . . . . . . 60.3 t80 -146.32 144.11 29.58 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.63 1.172 . . . . 0.0 112.357 -171.047 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 2502 ' ' GLY . . . . . . . . . . . . . . . 67.75 18.29 70.15 Favored Glycine 0 CA--C 1.535 1.314 0 C-N-CA 124.252 0.93 . . . . 0.0 113.673 179.209 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 2503 ' ' GLY . . . . . . . . . . . . . . . 134.44 -167.58 23.8 Favored Glycine 0 CA--C 1.54 1.636 0 C-N-CA 126.119 1.819 . . . . 0.0 112.43 -166.366 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 2504 ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -82.19 24.34 0.72 Allowed 'Trans proline' 0 CA--C 1.545 1.072 0 C-N-CA 124.903 3.735 . . . . 0.0 113.653 -173.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 2505 ' ' TYR . . . . . . . . . . . . . 73.9 m-85 -114.15 135.46 54.01 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.684 1.194 . . . . 0.0 113.022 -172.062 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 2506 ' ' HIS . . . . . . . . . . . . . 92.7 m-70 -63.33 142.85 58.23 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 125.359 1.464 . . . . 0.0 113.566 -179.246 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 2507 ' ' ILE . . . . . . . . . . . . . 1.7 pp -76.01 171.93 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 C-N-CA 123.716 0.806 . . . . 0.0 112.898 172.614 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 2508 ' ' GLY . . . . . . . . . . . . . . . -59.8 111.13 3.27 Favored Glycine 0 CA--C 1.534 1.235 0 C-N-CA 123.733 0.682 . . . . 0.0 112.609 -177.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 2509 ' ' GLY . . . . . . . . . . . . . . . 96.26 -8.22 66.97 Favored Glycine 0 CA--C 1.536 1.346 0 C-N-CA 125.835 1.683 . . . . 0.0 114.904 -177.262 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 2510 ' ' SER . . . . . . . . . . . . . 44.3 t -81.98 147.88 59.13 Favored Pre-proline 0 CA--C 1.55 0.962 0 CA-C-N 119.114 1.457 . . . . 0.0 111.841 177.577 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 2511 ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -79.29 155.71 90.42 Favored 'Cis proline' 0 C--N 1.354 0.817 0 CA-C-N 119.794 0.962 . . . . 0.0 113.333 -0.182 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 2512 ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -106.25 130.74 54.05 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.348 1.459 . . . . 0.0 110.466 177.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 2513 ' ' LYS . . . . . . . . . . . . . 19.7 ptpt -86.41 4.89 37.56 Favored 'General case' 0 N--CA 1.479 0.997 0 N-CA-C 116.488 2.032 . . . . 0.0 116.488 -167.664 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 2514 ' ' ALA . . . . . . . . . . . . . . . 3.17 93.19 0.01 OUTLIER 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 129.777 3.231 . . . . 0.0 116.188 -178.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 2515 ' ' LYS . . . . . . . . . . . . . 9.3 mtpm? -84.59 116.51 23.2 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 124.101 0.961 . . . . 0.0 111.364 -174.004 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 2516 ' ' VAL . . . . . . . . . . . . . 52.9 t -108.62 143.48 18.85 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 C-N-CA 125.958 1.703 . . . . 0.0 110.261 -174.5 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 2517 ' ' THR . . . . . . . . . . . . . 77.1 p -132.47 177.94 7.21 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 125.489 1.516 . . . . 0.0 111.438 178.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 2518 ' ' GLY . . . . . . . . . . . . . . . 104.5 -165.73 14.91 Favored Glycine 0 CA--C 1.54 1.643 0 C-N-CA 124.903 1.24 . . . . 0.0 113.424 -177.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 2519 ' ' PRO . . . . . . . . . . . . . 77.3 Cg_endo -70.94 176.53 7.54 Favored 'Trans proline' 0 CA--C 1.538 0.684 0 C-N-CA 124.17 3.247 . . . . 0.0 112.36 -178.302 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 2520 ' ' ARG . . . . . . . . . . . . . 50.9 ptt85 . . . . . 0 N--CA 1.47 0.556 0 C-N-CA 124.774 1.23 . . . . 0.0 111.683 177.769 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A 2427 ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.156 0 CA-C-O 121.312 0.396 . . . . 0.0 113.652 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A 2428 ' ' ASP . . . . . . . . . . . . . 13.8 t70 -106.86 136.52 19.43 Favored Pre-proline 0 CA--C 1.55 0.973 0 C-N-CA 124.958 1.303 . . . . 0.0 112.366 -172.181 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 2429 ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -64.58 -23.99 63.48 Favored 'Trans proline' 0 C--N 1.351 0.693 0 C-N-CA 123.222 2.615 . . . . 0.0 113.855 -178.275 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 2430 ' ' GLY . . . . . . . . . . . . . . . -75.43 -22.44 75.62 Favored Glycine 0 CA--C 1.533 1.209 0 CA-C-N 119.349 0.977 . . . . 0.0 113.345 175.267 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 2431 ' ' LEU . . . . . . . . . . . . . 4.3 mm? -83.96 -37.85 21.74 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.419 1.088 . . . . 0.0 111.197 170.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 2432 ' ' VAL . . . . . . . . . . . . . 69.5 t -61.85 136.8 24.82 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 123.775 0.83 . . . . 0.0 111.166 173.541 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 2433 ' ' SER . . . . . . . . . . . . . 68.5 m -128.72 163.11 25.85 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 125.867 1.667 . . . . 0.0 110.084 172.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 2434 ' ' ALA . . . . . . . . . . . . . . . -124.48 150.38 45.8 Favored 'General case' 0 CA--C 1.538 0.505 0 O-C-N 121.335 -0.853 . . . . 0.0 112.053 174.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 2435 ' ' TYR . . . . . . . . . . . . . 76.4 m-85 -143.24 161.61 37.83 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 126.063 1.745 . . . . 0.0 111.797 -175.183 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 2436 ' ' GLY . . . . . . . . . . . . . . . 106.43 159.75 22.11 Favored Glycine 0 N--CA 1.473 1.116 0 C-N-CA 125.131 1.348 . . . . 0.0 113.851 176.695 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 2437 ' ' ALA . . . . . . . . . . . . . . . -61.82 -28.55 69.55 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.005 1.322 . . . . 0.0 114.428 -169.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 2438 ' ' GLY . . . . . . . . . . . . . . . -66.48 -14.32 62.09 Favored Glycine 0 CA--C 1.532 1.154 0 C-N-CA 124.148 0.88 . . . . 0.0 114.581 -177.501 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 2439 ' ' LEU . . . . . . . . . . . . . 81.5 mt -74.4 -26.99 60.43 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 118.601 1.201 . . . . 0.0 112.338 169.31 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 2440 ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -93.67 -21.26 19.47 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 125.511 1.524 . . . . 0.0 112.255 177.39 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 2441 ' ' GLY . . . . . . . . . . . . . . . 110.65 -136.34 13.52 Favored Glycine 0 N--CA 1.47 0.945 0 C-N-CA 126.004 1.764 . . . . 0.0 113.181 177.234 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 2442 ' ' GLY . . . . . . . . . . . . . . . 156.52 -138.3 5.88 Favored Glycine 0 CA--C 1.53 1.022 0 C-N-CA 123.859 0.742 . . . . 0.0 114.227 -174.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 2443 ' ' VAL . . . . . . . . . . . . . 61.9 t -119.25 141.14 40.61 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 C-N-CA 125.369 1.468 . . . . 0.0 110.474 -173.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 2444 ' ' THR . . . . . . . . . . . . . 19.8 p -54.7 133.84 47.15 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 125.316 1.446 . . . . 0.0 112.29 174.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 2445 ' ' GLY . . . . . . . . . . . . . . . 81.68 -10.02 53.15 Favored Glycine 0 CA--C 1.535 1.314 0 C-N-CA 125.035 1.302 . . . . 0.0 114.844 178.67 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 2446 ' ' ASN . . . . . . . . . . . . . 91.0 m-20 -101.61 150.91 37.7 Favored Pre-proline 0 CA--C 1.548 0.876 0 C-N-CA 125.061 1.344 . . . . 0.0 111.257 175.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 2447 ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -72.68 130.9 16.46 Favored 'Trans proline' 0 C--N 1.35 0.656 0 C-N-CA 122.977 2.451 . . . . 0.0 111.538 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 2448 ' ' ALA . . . . . . . . . . . . . . . -99.82 118.2 35.77 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 126.417 1.887 . . . . 0.0 109.11 170.005 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 2449 ' ' GLU . . . . . . . . . . . . . 45.0 tt0 -115.88 131.8 56.83 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 124.994 1.317 . . . . 0.0 111.356 -169.459 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 2450 ' ' PHE . . . . . . . . . . . . . 40.4 p90 -148.02 165.7 29.96 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.096 1.358 . . . . 0.0 111.742 174.196 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 2451 ' ' VAL . . . . . . . . . . . . . 14.7 p -129.14 133.73 65.29 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 C-N-CA 124.834 1.253 . . . . 0.0 110.631 179.109 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 2452 ' ' VAL . . . . . . . . . . . . . 44.3 t -92.14 104.93 16.1 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 N-CA-C 107.017 -1.475 . . . . 0.0 107.017 169.117 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 2453 ' ' ASN . . . . . . . . . . . . . 19.5 t-20 -90.21 114.5 26.51 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.196 0.998 . . . . 0.0 112.161 -170.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 2454 ' ' THR . . . . . . . . . . . . . 43.7 p -95.88 -1.41 49.42 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 125.569 1.548 . . . . 0.0 113.902 -177.575 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 2455 ' ' SER . . . . . . . . . . . . . 29.8 m -56.76 -28.56 61.39 Favored 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 114.628 1.344 . . . . 0.0 114.628 -175.457 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 2456 ' ' ASN . . . . . . . . . . . . . 85.7 m-20 -79.47 -19.52 49.58 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 124.291 1.036 . . . . 0.0 113.483 175.673 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 2457 ' ' ALA . . . . . . . . . . . . . . . -112.2 -22.36 10.99 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 125.848 1.659 . . . . 0.0 113.902 -170.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 2458 ' ' GLY . . . . . . . . . . . . . . . 99.5 -99.87 2.15 Favored Glycine 0 CA--C 1.529 0.914 0 C-N-CA 125.322 1.439 . . . . 0.0 110.815 -173.32 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 2459 ' ' ALA . . . . . . . . . . . . . . . -153.63 155.4 35.98 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.254 1.422 . . . . 0.0 111.807 179.685 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 2460 ' ' GLY . . . . . . . . . . . . . . . 177.84 169.31 38.65 Favored Glycine 0 CA--C 1.529 0.918 0 C-N-CA 125.233 1.397 . . . . 0.0 112.959 -173.636 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 2461 ' ' ALA . . . . . . . . . . . . . . . -74.84 130.81 40.09 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 123.848 0.859 . . . . 0.0 111.874 -179.336 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 2462 ' ' LEU . . . . . . . . . . . . . 52.1 tp -108.19 138.6 44.19 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.374 1.47 . . . . 0.0 110.548 175.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 2463 ' ' SER . . . . . . . . . . . . . 30.7 t -103.56 -100.9 0.3 Allowed 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 124.806 1.242 . . . . 0.0 110.05 172.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 2464 ' ' VAL . . . . . . . . . . . . . 42.9 t 97.5 124.45 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.218 0 C-N-CA 130.837 3.655 . . . . 0.0 110.155 175.342 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 2465 ' ' THR . . . . . . . . . . . . . 99.8 m -125.01 135.6 52.92 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 125.271 1.428 . . . . 0.0 109.213 173.084 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 2466 ' ' ILE . . . . . . . . . . . . . 49.4 mt -115.93 117.64 56.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 123.998 0.919 . . . . 0.0 109.043 172.467 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 2467 ' ' ASP . . . . . . . . . . . . . 34.8 t70 -105.35 159.03 16.22 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 125.926 1.691 . . . . 0.0 110.255 169.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 2468 ' ' GLY . . . . . . . . . . . . . . . 156.44 -163.2 31.93 Favored Glycine 0 CA--C 1.535 1.332 0 O-C-N 121.253 -0.904 . . . . 0.0 114.367 178.718 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 2469 ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -72.47 -3.31 13.19 Favored 'Trans proline' 0 CA--C 1.542 0.923 0 C-N-CA 123.954 3.103 . . . . 0.0 114.622 -176.128 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 2470 ' ' SER . . . . . . . . . . . . . 85.7 p -153.59 154.56 34.46 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 119.751 1.16 . . . . 0.0 112.737 171.314 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 2471 ' ' LYS . . . . . . . . . . . . . 72.6 mmtt -74.52 86.5 2.08 Favored 'General case' 0 CA--C 1.544 0.736 0 O-C-N 120.789 -1.194 . . . . 0.0 110.026 168.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 2472 ' ' VAL . . . . . . . . . . . . . 18.4 m -55.7 146.1 5.29 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 C-N-CA 124.93 1.292 . . . . 0.0 113.19 -174.395 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 2473 ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -79.86 121.94 26.03 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 170.461 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 2474 ' ' MET . . . . . . . . . . . . . 26.1 ttt -132.08 142.43 49.52 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 124.556 1.143 . . . . 0.0 112.281 -164.328 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 2475 ' ' ASP . . . . . . . . . . . . . 20.1 m-20 -138.31 158.24 44.67 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 127.053 2.141 . . . . 0.0 110.713 174.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 2476 ' ' CYS . . . . . . . . . . . . . 43.5 t -149.32 148.57 29.69 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 125.207 1.403 . . . . 0.0 110.922 -179.3 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 2477 ' ' GLN . . . . . . . . . . . . . 26.2 tt0 -149.96 134.68 17.63 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.07 1.348 . . . . 0.0 110.347 -177.58 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 2478 ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -84.42 144.27 28.88 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.584 1.153 . . . . 0.0 111.784 172.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 2479 ' ' CYS . . . . . . . . . . . . . 25.5 p -161.0 175.23 3.23 Favored Pre-proline 0 CA--C 1.553 1.092 0 C-N-CA 125.785 1.634 . . . . 0.0 111.69 -173.157 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 2480 ' ' PRO . . . . . . . . . . . . . 77.6 Cg_exo -58.54 -24.03 67.72 Favored 'Trans proline' 0 CA--C 1.539 0.765 0 C-N-CA 123.328 2.685 . . . . 0.0 114.654 175.393 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 2481 ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -82.29 -4.56 57.42 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 124.678 1.191 . . . . 0.0 113.152 177.303 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 2482 ' ' GLY . . . . . . . . . . . . . . . 115.87 -124.62 6.33 Favored Glycine 0 N--CA 1.47 0.938 0 C-N-CA 125.848 1.689 . . . . 0.0 111.76 -175.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 2483 ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -116.77 113.22 22.25 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 124.408 1.083 . . . . 0.0 110.668 173.467 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 2484 ' ' ARG . . . . . . . . . . . . . 14.9 ttm180 -85.08 133.7 34.22 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 123.876 0.87 . . . . 0.0 109.926 173.102 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 2485 ' ' VAL . . . . . . . . . . . . . 90.8 t -121.62 136.25 59.13 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 C-N-CA 126.344 1.857 . . . . 0.0 108.847 179.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 2486 ' ' THR . . . . . . . . . . . . . 59.3 m -133.84 135.03 43.47 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.101 0.96 . . . . 0.0 108.913 175.018 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 2487 ' ' TYR . . . . . . . . . . . . . 28.2 p90 -141.99 151.4 42.47 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 112.976 0.732 . . . . 0.0 112.976 176.222 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 2488 ' ' THR . . . . . . . . . . . . . 91.6 m -109.75 107.54 59.17 Favored Pre-proline 0 N--CA 1.471 0.601 0 C-N-CA 124.508 1.123 . . . . 0.0 109.324 177.141 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 2489 ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -76.4 149.95 31.75 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 123.394 2.729 . . . . 0.0 110.131 169.655 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 2490 ' ' MET . . . . . . . . . . . . . 23.3 ptt? -128.74 11.02 6.11 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 114.397 1.258 . . . . 0.0 114.397 -177.58 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 2491 ' ' ALA . . . . . . . . . . . . . . . -141.59 147.64 46.74 Favored Pre-proline 0 CA--C 1.547 0.861 0 C-N-CA 125.269 1.428 . . . . 0.0 111.685 175.11 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 2492 ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -74.36 157.54 45.37 Favored 'Trans proline' 0 CA--C 1.537 0.628 0 C-N-CA 123.154 2.57 . . . . 0.0 111.062 172.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 2493 ' ' GLY . . . . . . . . . . . . . . . 130.34 -144.25 15.56 Favored Glycine 0 CA--C 1.528 0.858 0 C-N-CA 125.357 1.456 . . . . 0.0 111.796 -174.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 2494 ' ' SER . . . . . . . . . . . . . 10.5 t -134.91 133.81 40.01 Favored 'General case' 0 N--CA 1.468 0.464 0 O-C-N 121.824 -0.809 . . . . 0.0 111.63 177.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 2495 ' ' TYR . . . . . . . . . . . . . 87.8 m-85 -103.15 131.11 50.42 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.526 1.53 . . . . 0.0 110.352 176.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 2496 ' ' LEU . . . . . . . . . . . . . 21.9 tp -96.17 114.47 26.17 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.268 1.027 . . . . 0.0 109.457 178.381 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 2497 ' ' ILE . . . . . . . . . . . . . 36.4 mt -100.49 100.48 10.47 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 C-N-CA 125.459 1.504 . . . . 0.0 108.21 -178.543 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 2498 ' ' SER . . . . . . . . . . . . . 70.0 m -86.42 95.87 9.83 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 124.388 1.075 . . . . 0.0 109.241 174.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 2499 ' ' ILE . . . . . . . . . . . . . 49.9 mt -87.61 96.51 5.8 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 C-N-CA 124.51 1.124 . . . . 0.0 108.724 -178.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 2500 ' ' LYS . . . . . . . . . . . . . 85.6 mttt -104.18 135.74 45.09 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.713 1.205 . . . . 0.0 111.997 -179.207 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 2501 ' ' TYR . . . . . . . . . . . . . 56.5 t80 -151.07 148.76 28.71 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.269 1.428 . . . . 0.0 111.902 -169.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 2502 ' ' GLY . . . . . . . . . . . . . . . 67.21 26.53 73.42 Favored Glycine 0 CA--C 1.535 1.297 0 C-N-CA 123.897 0.76 . . . . 0.0 112.751 -178.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 2503 ' ' GLY . . . . . . . . . . . . . . . 118.16 -164.95 12.75 Favored Glycine 0 CA--C 1.542 1.725 0 C-N-CA 126.011 1.767 . . . . 0.0 112.112 -163.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 2504 ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -81.38 24.35 0.7 Allowed 'Trans proline' 0 CA--C 1.546 1.104 0 C-N-CA 124.933 3.756 . . . . 0.0 113.448 -174.626 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 2505 ' ' TYR . . . . . . . . . . . . . 67.9 m-85 -106.38 131.64 53.35 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.761 1.224 . . . . 0.0 112.764 -171.321 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 2506 ' ' HIS . . . . . . . . . . . . . 88.6 m-70 -59.63 139.27 57.34 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 125.017 1.327 . . . . 0.0 113.092 177.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 2507 ' ' ILE . . . . . . . . . . . . . 21.4 pt -72.6 171.88 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 170.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 2508 ' ' GLY . . . . . . . . . . . . . . . -58.61 119.56 18.12 Favored Glycine 0 CA--C 1.533 1.218 0 O-C-N 121.668 -0.645 . . . . 0.0 111.523 173.215 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 2509 ' ' GLY . . . . . . . . . . . . . . . 91.49 -9.05 78.15 Favored Glycine 0 CA--C 1.537 1.419 0 C-N-CA 125.62 1.581 . . . . 0.0 115.007 -177.012 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 2510 ' ' SER . . . . . . . . . . . . . 38.2 t -83.95 146.61 49.3 Favored Pre-proline 0 CA--C 1.55 0.968 0 CA-C-N 119.187 1.493 . . . . 0.0 112.044 179.311 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 2511 ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -77.41 147.67 85.47 Favored 'Cis proline' 0 C--N 1.354 0.84 0 CA-C-N 119.761 0.951 . . . . 0.0 112.901 -0.168 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 2512 ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -97.93 131.22 44.58 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 125.031 1.333 . . . . 0.0 110.346 178.367 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 2513 ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.03 112.4 24.69 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.078 0.951 . . . . 0.0 111.719 178.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 2514 ' ' ALA . . . . . . . . . . . . . . . -104.48 105.43 15.54 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 126.232 1.813 . . . . 0.0 110.765 -172.32 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 2515 ' ' LYS . . . . . . . . . . . . . 62.9 mtpt -84.49 125.98 32.87 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.737 1.215 . . . . 0.0 111.13 -175.724 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 2516 ' ' VAL . . . . . . . . . . . . . 70.4 t -123.46 137.53 56.4 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 C-N-CA 125.226 1.41 . . . . 0.0 110.003 -172.268 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 2517 ' ' THR . . . . . . . . . . . . . 66.9 p -127.16 173.31 9.82 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 125.419 1.488 . . . . 0.0 111.18 179.006 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 2518 ' ' GLY . . . . . . . . . . . . . . . 102.01 176.88 27.96 Favored Glycine 0 CA--C 1.539 1.566 0 C-N-CA 124.762 1.172 . . . . 0.0 113.359 -175.731 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 2519 ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -72.47 135.99 25.33 Favored 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 123.691 2.928 . . . . 0.0 112.089 -170.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 2520 ' ' ARG . . . . . . . . . . . . . 48.3 ttm-85 . . . . . 0 CA--C 1.539 0.556 0 C-N-CA 123.971 0.908 . . . . 0.0 110.487 174.37 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A 2427 ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.063 0 CA-C-O 121.77 0.65 . . . . 0.0 114.194 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A 2428 ' ' ASP . . . . . . . . . . . . . 12.6 t70 -160.42 138.56 7.34 Favored Pre-proline 0 CA--C 1.548 0.9 0 C-N-CA 125.702 1.601 . . . . 0.0 110.363 -172.402 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 2429 ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -64.94 -19.5 63.98 Favored 'Trans proline' 0 CA--C 1.54 0.784 0 C-N-CA 123.191 2.594 . . . . 0.0 114.307 -175.172 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 2430 ' ' GLY . . . . . . . . . . . . . . . -80.93 -24.87 57.18 Favored Glycine 0 CA--C 1.534 1.251 0 CA-C-N 119.256 0.934 . . . . 0.0 113.374 173.025 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 2431 ' ' LEU . . . . . . . . . . . . . 4.5 mm? -89.36 -30.4 18.42 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.615 1.166 . . . . 0.0 112.153 174.317 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 2432 ' ' VAL . . . . . . . . . . . . . 66.3 t -67.74 135.23 28.9 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 C-N-CA 123.94 0.896 . . . . 0.0 110.411 172.037 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 2433 ' ' SER . . . . . . . . . . . . . 71.3 m -123.36 -175.33 3.17 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 125.841 1.656 . . . . 0.0 110.896 176.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 2434 ' ' ALA . . . . . . . . . . . . . . . -151.14 142.95 23.81 Favored 'General case' 0 CA--C 1.537 0.478 0 O-C-N 120.605 -1.309 . . . . 0.0 111.749 173.224 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 2435 ' ' TYR . . . . . . . . . . . . . 66.4 m-85 -147.99 148.62 30.94 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 125.373 1.469 . . . . 0.0 111.981 -174.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 2436 ' ' GLY . . . . . . . . . . . . . . . 124.48 164.35 11.91 Favored Glycine 0 N--CA 1.474 1.204 0 C-N-CA 125.446 1.498 . . . . 0.0 114.422 174.718 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 2437 ' ' ALA . . . . . . . . . . . . . . . -60.48 -29.2 68.92 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.313 1.445 . . . . 0.0 114.443 -171.177 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 2438 ' ' GLY . . . . . . . . . . . . . . . -63.95 -20.14 64.21 Favored Glycine 0 CA--C 1.532 1.124 0 CA-C-O 118.937 -0.924 . . . . 0.0 113.959 178.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 2439 ' ' LEU . . . . . . . . . . . . . 79.5 mt -75.04 -24.02 58.23 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 118.916 1.358 . . . . 0.0 112.606 170.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 2440 ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -91.08 -30.29 16.83 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 125.131 1.372 . . . . 0.0 112.0 177.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 2441 ' ' GLY . . . . . . . . . . . . . . . 109.93 -152.58 17.22 Favored Glycine 0 CA--C 1.534 1.224 0 C-N-CA 126.122 1.82 . . . . 0.0 113.508 178.742 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 2442 ' ' GLY . . . . . . . . . . . . . . . 169.04 -159.37 32.4 Favored Glycine 0 CA--C 1.531 1.072 0 C-N-CA 124.316 0.96 . . . . 0.0 114.001 -174.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 2443 ' ' VAL . . . . . . . . . . . . . 20.7 t -95.77 141.57 15.09 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 C-N-CA 124.461 1.104 . . . . 0.0 110.231 179.185 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 2444 ' ' THR . . . . . . . . . . . . . 31.5 p -58.6 152.19 19.0 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 124.693 1.197 . . . . 0.0 112.88 174.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 2445 ' ' GLY . . . . . . . . . . . . . . . 71.73 2.73 52.29 Favored Glycine 0 CA--C 1.536 1.375 0 C-N-CA 124.032 0.825 . . . . 0.0 114.326 179.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 2446 ' ' ASN . . . . . . . . . . . . . 26.0 m-80 -130.72 146.71 63.12 Favored Pre-proline 0 CA--C 1.549 0.928 0 C-N-CA 126.606 1.962 . . . . 0.0 110.284 -178.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 2447 ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -76.55 149.08 30.17 Favored 'Trans proline' 0 C--N 1.349 0.583 0 C-N-CA 123.022 2.481 . . . . 0.0 112.689 -176.179 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 2448 ' ' ALA . . . . . . . . . . . . . . . -133.86 143.08 48.09 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 126.269 1.828 . . . . 0.0 109.525 166.234 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 2449 ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -134.33 149.88 50.9 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 113.78 1.03 . . . . 0.0 113.78 -165.786 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 2450 ' ' PHE . . . . . . . . . . . . . 33.4 p90 -156.11 167.15 31.32 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.814 1.646 . . . . 0.0 111.173 179.672 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 2451 ' ' VAL . . . . . . . . . . . . . 57.4 t -123.14 131.7 72.74 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 C-N-CA 124.74 1.216 . . . . 0.0 109.656 176.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 2452 ' ' VAL . . . . . . . . . . . . . 41.3 t -80.69 104.26 8.87 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 N-CA-C 107.086 -1.45 . . . . 0.0 107.086 163.608 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 2453 ' ' ASN . . . . . . . . . . . . . 13.9 t-20 -78.28 111.2 14.01 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 123.977 0.911 . . . . 0.0 111.86 -172.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 2454 ' ' THR . . . . . . . . . . . . . 37.3 p -106.09 -8.04 17.68 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 125.885 1.674 . . . . 0.0 113.811 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 2455 ' ' SER . . . . . . . . . . . . . 88.6 p -65.95 -24.35 66.79 Favored 'General case' 0 N--CA 1.478 0.938 0 CA-C-N 120.173 1.351 . . . . 0.0 113.8 -176.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 2456 ' ' ASN . . . . . . . . . . . . . 56.4 m-80 -77.72 -11.6 59.89 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 124.493 1.117 . . . . 0.0 113.57 171.243 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 2457 ' ' ALA . . . . . . . . . . . . . . . -113.5 -57.14 2.32 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 125.11 1.364 . . . . 0.0 113.169 -172.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 2458 ' ' GLY . . . . . . . . . . . . . . . 123.34 -159.87 17.93 Favored Glycine 0 CA--C 1.533 1.178 0 C-N-CA 125.522 1.534 . . . . 0.0 112.661 -169.279 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 2459 ' ' ALA . . . . . . . . . . . . . . . -84.13 150.34 25.59 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 124.809 1.244 . . . . 0.0 112.972 -177.625 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 2460 ' ' GLY . . . . . . . . . . . . . . . 164.91 166.92 24.67 Favored Glycine 0 CA--C 1.531 1.089 0 C-N-CA 124.462 1.03 . . . . 0.0 113.862 -178.138 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 2461 ' ' ALA . . . . . . . . . . . . . . . -82.77 135.7 34.9 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.249 1.02 . . . . 0.0 112.709 -175.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 2462 ' ' LEU . . . . . . . . . . . . . 40.9 tp -102.11 143.91 31.34 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.901 1.681 . . . . 0.0 110.585 174.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 2463 ' ' SER . . . . . . . . . . . . . 3.9 t -138.58 41.74 2.18 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 125.206 1.403 . . . . 0.0 111.152 -177.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 2464 ' ' VAL . . . . . . . . . . . . . 9.6 p -65.57 135.21 28.73 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 C-N-CA 124.987 1.315 . . . . 0.0 112.167 -176.723 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 2465 ' ' THR . . . . . . . . . . . . . 95.4 m -135.08 145.74 48.23 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 126.067 1.747 . . . . 0.0 110.102 -178.286 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 2466 ' ' ILE . . . . . . . . . . . . . 50.2 mt -122.58 133.39 68.91 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 C-N-CA 124.5 1.12 . . . . 0.0 110.027 176.053 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 2467 ' ' ASP . . . . . . . . . . . . . 34.7 t70 -139.97 151.69 45.72 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 126.675 1.99 . . . . 0.0 110.409 178.333 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 2468 ' ' GLY . . . . . . . . . . . . . . . 174.52 -144.48 7.48 Favored Glycine 0 CA--C 1.537 1.422 0 CA-C-O 118.495 -1.17 . . . . 0.0 114.567 -177.182 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 2469 ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo -67.99 -15.56 43.66 Favored 'Trans proline' 0 C--N 1.354 0.864 0 C-N-CA 123.83 3.02 . . . . 0.0 113.343 -179.577 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 2470 ' ' SER . . . . . . . . . . . . . 7.6 t -159.07 -161.1 0.91 Allowed 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 126.078 1.751 . . . . 0.0 109.491 170.115 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 2471 ' ' LYS . . . . . . . . . . . . . 98.5 mttt -79.68 -179.61 6.99 Favored 'General case' 0 CA--C 1.55 0.975 0 O-C-N 121.014 -1.054 . . . . 0.0 111.46 164.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 2472 ' ' VAL . . . . . . . . . . . . . 14.3 m -136.37 149.94 27.41 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 125.243 1.417 . . . . 0.0 109.979 170.269 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 2473 ' ' LYS . . . . . . . . . . . . . 25.9 tptp -78.34 107.26 10.83 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 167.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 2474 ' ' MET . . . . . . . . . . . . . 22.9 ttt -114.78 140.61 48.77 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 125.191 1.396 . . . . 0.0 112.285 -168.357 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 2475 ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -143.22 157.28 44.63 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 126.618 1.967 . . . . 0.0 110.323 173.359 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 2476 ' ' CYS . . . . . . . . . . . . . 30.9 p -162.15 164.29 28.0 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.043 0.937 . . . . 0.0 113.485 -176.006 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 2477 ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -164.77 173.18 12.08 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.841 1.657 . . . . 0.0 111.59 177.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 2478 ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -80.2 138.83 36.91 Favored 'General case' 0 CA--C 1.544 0.716 0 O-C-N 121.57 -0.706 . . . . 0.0 110.383 164.339 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 2479 ' ' CYS . . . . . . . . . . . . . 59.3 m -132.96 167.14 24.41 Favored Pre-proline 0 CA--C 1.554 1.106 0 C-N-CA 126.824 2.05 . . . . 0.0 110.367 169.52 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 2480 ' ' PRO . . . . . . . . . . . . . 70.2 Cg_exo -57.99 -31.9 93.98 Favored 'Trans proline' 0 C--N 1.353 0.796 0 C-N-CA 123.586 2.858 . . . . 0.0 114.586 177.643 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 2481 ' ' GLU . . . . . . . . . . . . . 20.8 tp10 -77.45 -13.0 60.02 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 125.079 1.352 . . . . 0.0 112.849 177.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 2482 ' ' GLY . . . . . . . . . . . . . . . 129.1 -169.0 20.59 Favored Glycine 0 CA--C 1.53 1.018 0 C-N-CA 126.587 2.041 . . . . 0.0 112.29 -172.618 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 2483 ' ' TYR . . . . . . . . . . . . . 66.8 m-85 -69.78 111.64 5.68 Favored 'General case' 0 CA--C 1.539 0.537 0 O-C-N 121.277 -1.131 . . . . 0.0 111.783 177.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 2484 ' ' ARG . . . . . . . . . . . . . 68.5 ttt180 -85.09 138.26 32.53 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 125.366 1.466 . . . . 0.0 110.692 179.319 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 2485 ' ' VAL . . . . . . . . . . . . . 96.4 t -128.59 136.96 58.63 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 C-N-CA 126.333 1.853 . . . . 0.0 108.93 179.261 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 2486 ' ' THR . . . . . . . . . . . . . 85.7 m -133.24 136.58 45.66 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 125.06 1.344 . . . . 0.0 108.303 173.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 2487 ' ' TYR . . . . . . . . . . . . . 31.0 p90 -145.72 148.97 33.58 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 113.489 0.922 . . . . 0.0 113.489 177.628 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 2488 ' ' THR . . . . . . . . . . . . . 23.9 m -109.24 114.31 57.89 Favored Pre-proline 0 N--CA 1.471 0.612 0 C-N-CA 125.308 1.443 . . . . 0.0 108.7 171.304 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 2489 ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -80.07 159.73 23.77 Favored 'Trans proline' 0 N--CA 1.457 -0.628 0 C-N-CA 123.153 2.569 . . . . 0.0 111.203 173.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 2490 ' ' MET . . . . . . . . . . . . . 26.1 ptm -128.79 2.14 5.42 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 114.935 1.458 . . . . 0.0 114.935 -171.406 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 2491 ' ' ALA . . . . . . . . . . . . . . . -145.79 143.46 19.75 Favored Pre-proline 0 CA--C 1.548 0.881 0 C-N-CA 124.74 1.216 . . . . 0.0 111.308 174.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 2492 ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -72.75 155.1 54.19 Favored 'Trans proline' 0 CA--C 1.537 0.641 0 C-N-CA 123.229 2.619 . . . . 0.0 111.106 174.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 2493 ' ' GLY . . . . . . . . . . . . . . . 131.26 -151.52 19.72 Favored Glycine 0 CA--C 1.528 0.875 0 C-N-CA 125.356 1.455 . . . . 0.0 111.992 -173.257 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 2494 ' ' SER . . . . . 0.49 ' HG ' ' HE2' ' A' 2513 ' ' LYS . 71.8 m -122.12 127.68 50.41 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 123.647 0.779 . . . . 0.0 112.074 177.874 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 2495 ' ' TYR . . . . . . . . . . . . . 86.2 m-85 -98.91 134.54 41.62 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.23 1.412 . . . . 0.0 110.676 171.688 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 2496 ' ' LEU . . . . . . . . . . . . . 10.3 mp -92.63 121.57 34.18 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.461 1.104 . . . . 0.0 108.819 168.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 2497 ' ' ILE . . . . . . . . . . . . . 40.5 mt -97.26 101.01 11.72 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.375 0 N-CA-C 107.286 -1.376 . . . . 0.0 107.286 173.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 2498 ' ' SER . . . . . . . . . . . . . 74.7 m -86.98 94.01 9.5 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 125.368 1.467 . . . . 0.0 109.512 179.159 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 2499 ' ' ILE . . . . . 0.495 ' H ' ' HG ' ' A' 2510 ' ' SER . 26.6 mt -90.46 101.32 12.22 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 C-N-CA 124.909 1.284 . . . . 0.0 108.768 -179.769 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 2500 ' ' LYS . . . . . . . . . . . . . 83.8 mttt -109.52 143.44 39.17 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 124.535 1.134 . . . . 0.0 111.622 178.538 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 2501 ' ' TYR . . . . . . . . . . . . . 53.8 t80 -151.17 141.4 22.28 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.918 0.887 . . . . 0.0 112.698 -171.022 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 2502 ' ' GLY . . . . . . . . . . . . . . . 68.28 15.15 67.47 Favored Glycine 0 CA--C 1.536 1.354 0 C-N-CA 124.262 0.934 . . . . 0.0 114.072 178.381 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 2503 ' ' GLY . . . . . . . . . . . . . . . 142.73 -167.78 26.14 Favored Glycine 0 CA--C 1.54 1.645 0 C-N-CA 125.934 1.73 . . . . 0.0 112.591 -168.419 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 2504 ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -82.37 18.71 1.38 Allowed 'Trans proline' 0 CA--C 1.545 1.026 0 C-N-CA 124.772 3.648 . . . . 0.0 113.833 -174.112 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 2505 ' ' TYR . . . . . . . . . . . . . 73.7 m-85 -110.32 139.36 45.59 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.661 1.185 . . . . 0.0 113.341 -172.494 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 2506 ' ' HIS . . . . . . . . . . . . . 91.1 m-70 -64.23 143.29 58.0 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 125.57 1.548 . . . . 0.0 113.516 179.399 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 2507 ' ' ILE . . . . . . . . . . . . . 1.8 pp -86.37 150.37 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.075 0 C-N-CA 123.882 0.873 . . . . 0.0 111.854 171.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 2508 ' ' GLY . . . . . . . . . . . . . . . 46.23 -114.12 1.3 Allowed Glycine 0 CA--C 1.536 1.38 0 C-N-CA 124.275 0.94 . . . . 0.0 114.531 165.642 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 2509 ' ' GLY . . . . . . . . . . . . . . . -99.67 12.74 61.2 Favored Glycine 0 CA--C 1.537 1.409 0 C-N-CA 126.193 1.854 . . . . 0.0 115.19 178.117 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 2510 ' ' SER . . . . . 0.495 ' HG ' ' H ' ' A' 2499 ' ' ILE . 42.6 t -65.84 146.27 99.0 Favored Pre-proline 0 CA--C 1.552 1.04 0 CA-C-N 119.17 1.485 . . . . 0.0 112.655 179.586 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 2511 ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -75.0 142.15 73.91 Favored 'Cis proline' 0 C--N 1.354 0.852 0 CA-C-N 119.821 0.972 . . . . 0.0 112.868 0.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 2512 ' ' PHE . . . . . . . . . . . . . 91.6 m-85 -93.33 127.98 39.16 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.547 1.139 . . . . 0.0 110.858 178.662 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 2513 ' ' LYS . . . . . 0.49 ' HE2' ' HG ' ' A' 2494 ' ' SER . 86.0 tttt -90.24 92.7 9.04 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 124.407 1.083 . . . . 0.0 111.893 -176.768 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 2514 ' ' ALA . . . . . . . . . . . . . . . -79.53 123.84 27.95 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.976 1.31 . . . . 0.0 110.682 174.747 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 2515 ' ' LYS . . . . . . . . . . . . . 26.6 mtmm -101.15 120.87 40.86 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.201 1.401 . . . . 0.0 110.278 -173.558 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 2516 ' ' VAL . . . . . . . . . . . . . 73.0 t -120.42 138.45 50.91 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 124.843 1.257 . . . . 0.0 111.133 -167.692 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 2517 ' ' THR . . . . . . . . . . . . . 68.1 p -128.9 178.53 6.31 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 125.986 1.714 . . . . 0.0 111.088 179.505 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 2518 ' ' GLY . . . . . . . . . . . . . . . 97.67 -176.31 30.96 Favored Glycine 0 CA--C 1.54 1.629 0 C-N-CA 124.545 1.069 . . . . 0.0 113.39 -176.68 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 2519 ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -71.6 148.25 53.04 Favored 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 123.72 2.947 . . . . 0.0 112.167 -174.408 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 2520 ' ' ARG . . . . . . . . . . . . . 35.8 ttp180 . . . . . 0 CA--C 1.539 0.544 0 C-N-CA 123.648 0.779 . . . . 0.0 110.217 173.882 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A 2427 ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.957 0 N-CA-C 111.579 -0.608 . . . . 0.0 111.579 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A 2428 ' ' ASP . . . . . . . . . . . . . 22.2 m-20 -97.33 128.59 34.37 Favored Pre-proline 0 CA--C 1.547 0.853 0 C-N-CA 123.909 0.884 . . . . 0.0 112.726 -175.516 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 2429 ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -66.67 -22.42 50.43 Favored 'Trans proline' 0 C--N 1.352 0.748 0 C-N-CA 122.993 2.462 . . . . 0.0 112.915 177.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 2430 ' ' GLY . . . . . . . . . . . . . . . -75.05 -23.16 75.24 Favored Glycine 0 CA--C 1.535 1.304 0 CA-C-N 119.062 0.847 . . . . 0.0 113.551 173.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 2431 ' ' LEU . . . . . . . . . . . . . 4.2 mm? -86.34 -29.82 22.69 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 124.483 1.113 . . . . 0.0 111.698 171.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 2432 ' ' VAL . . . . . . . . . . . . . 79.1 t -67.94 135.25 28.84 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 C-N-CA 123.51 0.724 . . . . 0.0 110.521 169.723 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 2433 ' ' SER . . . . . . . . . . . . . 57.9 m -140.44 144.66 36.23 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 125.463 1.505 . . . . 0.0 109.439 171.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 2434 ' ' ALA . . . . . . . . . . . . . . . -96.41 148.58 22.64 Favored 'General case' 0 CA--C 1.539 0.553 0 O-C-N 121.572 -0.705 . . . . 0.0 111.794 176.133 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 2435 ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -142.4 142.78 32.45 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.808 1.643 . . . . 0.0 111.468 -178.226 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 2436 ' ' GLY . . . . . . . . . . . . . . . 129.17 159.45 9.91 Favored Glycine 0 N--CA 1.473 1.11 0 C-N-CA 125.438 1.494 . . . . 0.0 113.534 -179.708 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 2437 ' ' ALA . . . . . . . . . . . . . . . -63.56 -26.94 68.92 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 114.259 1.207 . . . . 0.0 114.259 -171.22 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 2438 ' ' GLY . . . . . . . . . . . . . . . -68.19 -11.08 60.81 Favored Glycine 0 CA--C 1.53 0.969 0 C-N-CA 124.001 0.81 . . . . 0.0 114.702 -177.475 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 2439 ' ' LEU . . . . . . . . . . . . . 73.2 mt -78.46 -26.04 46.03 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.724 1.21 . . . . 0.0 112.405 171.607 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 2440 ' ' GLU . . . . . . . . . . . . . 37.5 mm-40 -89.07 -36.61 15.66 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 124.794 1.237 . . . . 0.0 111.853 -178.3 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 2441 ' ' GLY . . . . . . . . . . . . . . . 155.77 -148.39 18.46 Favored Glycine 0 CA--C 1.529 0.926 0 C-N-CA 124.389 0.995 . . . . 0.0 113.813 -176.135 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 2442 ' ' GLY . . . . . . . . . . . . . . . 157.49 -158.39 28.94 Favored Glycine 0 CA--C 1.53 1.012 0 C-N-CA 125.303 1.43 . . . . 0.0 112.924 -176.023 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 2443 ' ' VAL . . . . . . . . . . . . . 81.2 t -129.53 139.61 51.24 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.975 0 C-N-CA 125.321 1.449 . . . . 0.0 109.213 179.086 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 2444 ' ' THR . . . . . . . . . . . . . 33.5 p -60.45 138.06 58.06 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 124.016 0.926 . . . . 0.0 111.978 178.354 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 2445 ' ' GLY . . . . . . . . . . . . . . . 81.3 -10.65 48.23 Favored Glycine 0 CA--C 1.537 1.459 0 C-N-CA 124.75 1.167 . . . . 0.0 114.862 -175.371 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 2446 ' ' ASN . . . . . . . . . . . . . 88.4 m-20 -106.69 149.75 38.8 Favored Pre-proline 0 CA--C 1.548 0.888 0 C-N-CA 125.167 1.387 . . . . 0.0 111.192 174.611 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 2447 ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -73.07 135.83 23.69 Favored 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 122.849 2.366 . . . . 0.0 111.79 -179.485 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 2448 ' ' ALA . . . . . . . . . . . . . . . -109.83 142.17 41.47 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 127.236 2.214 . . . . 0.0 108.772 167.028 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 2449 ' ' GLU . . . . . . . . . . . . . 5.0 tm-20 -147.91 141.24 25.23 Favored 'General case' 0 N--CA 1.471 0.614 0 O-C-N 121.411 -0.806 . . . . 0.0 112.994 -162.598 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 2450 ' ' PHE . . . . . . . . . . . . . 52.9 p90 -156.29 157.44 35.76 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 125.83 1.652 . . . . 0.0 112.458 177.604 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 2451 ' ' VAL . . . . . . . . . . . . . 59.0 t -113.55 133.29 59.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 125.641 1.577 . . . . 0.0 109.443 171.78 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 2452 ' ' VAL . . . . . . . . . . . . . 39.3 t -87.14 105.1 14.78 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 C-N-CA 125.102 1.361 . . . . 0.0 107.819 168.225 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 2453 ' ' ASN . . . . . . . . . . . . . 32.7 t-20 -77.9 117.14 18.96 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 123.612 0.765 . . . . 0.0 110.926 -174.073 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 2454 ' ' THR . . . . . . . . . . . . . 39.5 p -105.1 -9.61 17.69 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 125.088 1.355 . . . . 0.0 113.634 -178.559 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 2455 ' ' SER . . . . . . . . . . . . . 41.2 m -57.94 -29.79 65.44 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.927 1.291 . . . . 0.0 114.234 -175.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 2456 ' ' ASN . . . . . . . . . . . . . 79.4 m-20 -83.79 -16.21 45.52 Favored 'General case' 0 CA--C 1.546 0.809 0 N-CA-C 113.767 1.025 . . . . 0.0 113.767 177.289 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 2457 ' ' ALA . . . . . . . . . . . . . . . -102.45 -41.94 6.14 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 114.458 1.281 . . . . 0.0 114.458 -166.574 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 2458 ' ' GLY . . . . . . . . . . . . . . . 121.64 -133.63 9.56 Favored Glycine 0 N--CA 1.471 1.03 0 C-N-CA 124.653 1.12 . . . . 0.0 112.06 -171.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 2459 ' ' ALA . . . . . . . . . . . . . . . -129.97 120.9 25.55 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.51 1.124 . . . . 0.0 111.944 -175.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 2460 ' ' GLY . . . . . . . . . . . . . . . -165.6 162.71 36.09 Favored Glycine 0 CA--C 1.529 0.963 0 C-N-CA 125.029 1.3 . . . . 0.0 113.029 -177.612 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 2461 ' ' ALA . . . . . . . . . . . . . . . -79.26 145.18 33.69 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.064 0.946 . . . . 0.0 112.484 -179.163 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 2462 ' ' LEU . . . . . . . . . . . . . 13.7 tp -95.26 147.2 23.74 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.178 1.391 . . . . 0.0 110.555 172.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 2463 ' ' SER . . . . . . . . . . . . . 9.1 t -137.12 34.58 2.57 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 125.301 1.44 . . . . 0.0 111.506 -178.302 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 2464 ' ' VAL . . . . . . . . . . . . . 10.5 p -59.65 135.17 24.52 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 C-N-CA 125.327 1.451 . . . . 0.0 112.58 -175.621 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 2465 ' ' THR . . . . . . . . . . . . . 96.4 m -134.91 142.9 46.67 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 125.759 1.623 . . . . 0.0 109.389 176.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 2466 ' ' ILE . . . . . . . . . . . . . 36.1 mt -120.27 122.2 67.68 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 C-N-CA 123.773 0.829 . . . . 0.0 109.953 174.05 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 2467 ' ' ASP . . . . . . . . . . . . . 33.0 t70 -104.68 166.8 10.14 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 126.392 1.877 . . . . 0.0 110.12 168.011 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 2468 ' ' GLY . . . . . . . . . . . . . . . 167.48 -160.57 34.24 Favored Glycine 0 CA--C 1.535 1.31 0 O-C-N 120.83 -1.169 . . . . 0.0 114.936 178.752 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 2469 ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -70.04 -16.44 36.39 Favored 'Trans proline' 0 CA--C 1.54 0.819 0 C-N-CA 123.915 3.077 . . . . 0.0 113.246 178.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 2470 ' ' SER . . . . . . . . . . . . . 38.0 m -157.95 -171.8 3.67 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 127.335 2.254 . . . . 0.0 109.819 177.506 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 2471 ' ' LYS . . . . . . . . . . . . . 99.0 mttt -70.74 175.95 4.58 Favored 'General case' 0 CA--C 1.551 0.985 0 O-C-N 120.956 -1.09 . . . . 0.0 112.343 167.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 2472 ' ' VAL . . . . . . . . . . . . . 33.9 m -132.11 148.87 32.09 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.925 0 C-N-CA 125.311 1.444 . . . . 0.0 110.466 169.624 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 2473 ' ' LYS . . . . . . . . . . . . . 62.0 mtpt -87.43 89.17 7.9 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 123.592 0.757 . . . . 0.0 109.52 169.6 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 2474 ' ' MET . . . . . . . . . . . . . 60.0 ttm -83.51 143.0 30.49 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 124.334 1.054 . . . . 0.0 112.071 -177.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 2475 ' ' ASP . . . . . . . . . . . . . 31.7 t70 -139.09 103.87 4.88 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 126.581 1.953 . . . . 0.0 109.221 167.026 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 2476 ' ' CYS . . . . . . . . . . . . . 28.7 p -102.3 155.19 18.39 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 124.954 1.302 . . . . 0.0 112.28 178.143 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 2477 ' ' GLN . . . . . . . . . . . . . 27.4 tt0 -161.59 146.56 13.36 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.26 1.024 . . . . 0.0 111.258 -172.156 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 2478 ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -77.89 122.67 25.79 Favored 'General case' 0 CA--C 1.541 0.615 0 O-C-N 121.478 -0.763 . . . . 0.0 110.609 173.682 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 2479 ' ' CYS . . . . . 0.536 ' HG ' ' HD2' ' A' 2484 ' ' ARG . 60.6 m -121.76 166.29 17.12 Favored Pre-proline 0 CA--C 1.553 1.082 0 C-N-CA 126.539 1.936 . . . . 0.0 111.041 179.869 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 2480 ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -65.32 -26.9 55.82 Favored 'Trans proline' 0 CA--C 1.54 0.797 0 C-N-CA 123.009 2.473 . . . . 0.0 114.567 -174.527 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 2481 ' ' GLU . . . . . . . . . . . . . 82.2 tt0 -82.24 -17.17 46.95 Favored 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 124.143 0.977 . . . . 0.0 112.997 174.46 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 2482 ' ' GLY . . . . . . . . . . . . . . . 140.11 -162.47 26.39 Favored Glycine 0 CA--C 1.528 0.875 0 C-N-CA 125.879 1.705 . . . . 0.0 112.608 -176.306 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 2483 ' ' TYR . . . . . . . . . . . . . 74.0 m-85 -70.36 119.07 13.99 Favored 'General case' 0 CA--C 1.539 0.541 0 O-C-N 121.479 -1.013 . . . . 0.0 111.75 -179.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 2484 ' ' ARG . . . . . 0.536 ' HD2' ' HG ' ' A' 2479 ' ' CYS . 21.5 ttt180 -95.34 141.83 28.45 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 125.038 1.335 . . . . 0.0 110.725 177.013 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 2485 ' ' VAL . . . . . . . . . . . . . 67.1 t -132.58 122.01 46.43 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 C-N-CA 124.98 1.312 . . . . 0.0 108.943 178.247 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 2486 ' ' THR . . . . . . . . . . . . . 89.9 m -110.07 144.35 38.78 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 124.856 1.262 . . . . 0.0 107.846 165.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 2487 ' ' TYR . . . . . . . . . . . . . 28.7 p90 -148.63 144.24 27.06 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 123.918 0.887 . . . . 0.0 112.185 174.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 2488 ' ' THR . . . . . . . . . . . . . 85.6 m -107.21 117.32 56.53 Favored Pre-proline 0 N--CA 1.476 0.86 0 CA-C-O 117.989 -1.005 . . . . 0.0 109.422 172.233 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 2489 ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -81.68 163.11 18.86 Favored 'Trans proline' 0 C--N 1.351 0.687 0 C-N-CA 124.319 3.346 . . . . 0.0 111.604 174.197 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 2490 ' ' MET . . . . . . . . . . . . . 28.4 ptm -133.85 -3.68 2.87 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 115.603 1.705 . . . . 0.0 115.603 -171.539 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 2491 ' ' ALA . . . . . . . . . . . . . . . -144.78 145.66 28.77 Favored Pre-proline 0 CA--C 1.548 0.871 0 C-N-CA 124.728 1.211 . . . . 0.0 110.937 172.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 2492 ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -71.29 151.98 60.8 Favored 'Trans proline' 0 CA--C 1.535 0.574 0 C-N-CA 123.504 2.803 . . . . 0.0 111.615 -178.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 2493 ' ' GLY . . . . . . . . . . . . . . . 129.88 -165.47 22.32 Favored Glycine 0 CA--C 1.53 1.003 0 C-N-CA 125.187 1.375 . . . . 0.0 113.578 -177.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 2494 ' ' SER . . . . . . . . . . . . . 16.7 p -89.96 115.02 26.94 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.835 1.254 . . . . 0.0 112.08 178.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 2495 ' ' TYR . . . . . . . . . . . . . 54.6 m-85 -87.74 122.78 31.82 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 123.536 0.735 . . . . 0.0 109.741 163.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 2496 ' ' LEU . . . . . . . . . . . . . 21.4 tp -94.34 104.61 16.59 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 124.597 1.159 . . . . 0.0 109.521 -178.467 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 2497 ' ' ILE . . . . . . . . . . . . . 30.2 mt -90.4 98.05 7.84 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 C-N-CA 125.826 1.65 . . . . 0.0 108.23 -177.627 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 2498 ' ' SER . . . . . . . . . . . . . 71.0 m -85.02 80.97 9.1 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 124.675 1.19 . . . . 0.0 109.624 175.783 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 2499 ' ' ILE . . . . . . . . . . . . . 17.9 mt -77.82 114.16 17.99 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 175.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 2500 ' ' LYS . . . . . . . . . . . . . 81.9 mttt -121.76 148.66 44.35 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.528 1.531 . . . . 0.0 111.037 -177.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 2501 ' ' TYR . . . . . . . . . . . . . 63.4 t80 -154.91 145.84 22.58 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.119 0.968 . . . . 0.0 112.499 -171.423 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 2502 ' ' GLY . . . . . . . . . . . . . . . 69.04 17.48 71.83 Favored Glycine 0 CA--C 1.536 1.394 0 C-N-CA 124.216 0.913 . . . . 0.0 113.704 178.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 2503 ' ' GLY . . . . . . . . . . . . . . . 135.6 -165.05 24.87 Favored Glycine 0 CA--C 1.54 1.643 0 C-N-CA 125.981 1.753 . . . . 0.0 112.528 -167.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 2504 ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -82.26 20.31 1.12 Allowed 'Trans proline' 0 CA--C 1.545 1.06 0 C-N-CA 124.855 3.703 . . . . 0.0 113.638 -174.545 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 2505 ' ' TYR . . . . . . . . . . . . . 80.5 m-85 -109.98 139.96 44.51 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.751 1.22 . . . . 0.0 113.355 -172.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 2506 ' ' HIS . . . . . . . . . . . . . 92.5 m-70 -62.57 144.31 56.27 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 125.571 1.548 . . . . 0.0 113.572 -179.61 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 2507 ' ' ILE . . . . . . . . . . . . . 28.0 pt -75.79 174.69 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 C-N-CA 123.633 0.773 . . . . 0.0 112.992 173.123 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 2508 ' ' GLY . . . . . . . . . . . . . . . -58.94 117.91 12.45 Favored Glycine 0 CA--C 1.532 1.152 0 N-CA-C 111.228 -0.749 . . . . 0.0 111.228 171.24 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 2509 ' ' GLY . . . . . . . . . . . . . . . 93.54 -9.77 73.59 Favored Glycine 0 CA--C 1.536 1.388 0 C-N-CA 125.677 1.608 . . . . 0.0 115.168 -178.142 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 2510 ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -78.23 156.09 79.17 Favored Pre-proline 0 N--CA 1.474 0.768 0 CA-C-N 119.647 1.723 . . . . 0.0 113.68 178.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 2511 ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -77.58 152.66 93.51 Favored 'Cis proline' 0 CA--C 1.539 0.768 0 CA-C-N 118.26 0.414 . . . . 0.0 111.435 -9.561 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 2512 ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -98.21 128.8 44.87 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.373 1.069 . . . . 0.0 110.633 179.693 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 2513 ' ' LYS . . . . . . . . . . . . . 24.9 pttm -88.22 7.58 31.29 Favored 'General case' 0 N--CA 1.479 0.995 0 N-CA-C 116.715 2.117 . . . . 0.0 116.715 -165.352 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 2514 ' ' ALA . . . . . . . . . . . . . . . -3.97 97.65 0.01 OUTLIER 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 129.467 3.107 . . . . 0.0 116.462 -175.616 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 2515 ' ' LYS . . . . . . . . . . . . . 62.8 mtpt -89.78 105.24 17.67 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.504 1.122 . . . . 0.0 110.683 -175.104 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 2516 ' ' VAL . . . . . . . . . . . . . 4.0 m -102.36 148.4 7.86 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 C-N-CA 124.315 1.046 . . . . 0.0 111.486 -174.161 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 2517 ' ' THR . . . . . . . . . . . . . 69.1 p -116.66 -169.37 1.62 Allowed 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 125.471 1.508 . . . . 0.0 110.922 179.349 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 2518 ' ' GLY . . . . . . . . . . . . . . . 96.29 -175.7 32.2 Favored Glycine 0 CA--C 1.539 1.575 0 C-N-CA 124.693 1.14 . . . . 0.0 113.331 -176.221 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 2519 ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -70.63 153.39 64.96 Favored 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 123.748 2.966 . . . . 0.0 112.537 -174.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 2520 ' ' ARG . . . . . . . . . . . . . 65.2 ttp85 . . . . . 0 CA--C 1.536 0.419 0 C-N-CA 124.686 1.194 . . . . 0.0 110.053 171.199 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A 2427 ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.111 0 CA-C-O 121.49 0.495 . . . . 0.0 113.787 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A 2428 ' ' ASP . . . . . . . . . . . . . 25.6 m-20 -117.68 137.1 23.94 Favored Pre-proline 0 CA--C 1.546 0.82 0 C-N-CA 125.07 1.348 . . . . 0.0 111.901 -179.595 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 2429 ' ' PRO . . . . . . . . . . . . . 81.1 Cg_exo -54.91 -26.79 50.49 Favored 'Trans proline' 0 C--N 1.353 0.792 0 C-N-CA 124.056 3.171 . . . . 0.0 115.089 174.707 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 2430 ' ' GLY . . . . . . . . . . . . . . . -78.93 -23.1 64.66 Favored Glycine 0 CA--C 1.534 1.225 0 C-N-CA 123.812 0.72 . . . . 0.0 113.786 176.174 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 2431 ' ' LEU . . . . . . . . . . . . . 4.4 mm? -91.04 -32.16 16.01 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.731 1.212 . . . . 0.0 111.89 174.458 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 2432 ' ' VAL . . . . . . . . . . . . . 94.1 t -64.84 134.32 29.5 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 CA-C-N 118.698 0.681 . . . . 0.0 109.76 170.033 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 2433 ' ' SER . . . . . . . . . . . . . 7.9 t -127.28 -167.91 1.81 Allowed 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.93 1.292 . . . . 0.0 111.163 177.545 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 2434 ' ' ALA . . . . . . . . . . . . . . . -153.25 139.37 18.32 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.538 1.135 . . . . 0.0 111.656 177.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 2435 ' ' TYR . . . . . . . . . . . . . 76.8 m-85 -146.54 141.9 27.48 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 125.265 1.426 . . . . 0.0 111.951 -176.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 2436 ' ' GLY . . . . . . . . . . . . . . . 126.0 163.05 11.46 Favored Glycine 0 CA--C 1.534 1.225 0 C-N-CA 125.704 1.621 . . . . 0.0 113.743 179.461 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 2437 ' ' ALA . . . . . . . . . . . . . . . -63.58 -28.39 69.9 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 114.706 1.373 . . . . 0.0 114.706 -168.782 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 2438 ' ' GLY . . . . . . . . . . . . . . . -64.42 -16.6 60.84 Favored Glycine 0 CA--C 1.532 1.095 0 C-N-CA 124.302 0.953 . . . . 0.0 114.502 -177.645 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 2439 ' ' LEU . . . . . . . . . . . . . 95.2 mt -68.73 -29.55 67.99 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 118.575 1.188 . . . . 0.0 112.548 170.159 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 2440 ' ' GLU . . . . . . . . . . . . . 41.7 mm-40 -90.24 -26.92 19.83 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.912 1.285 . . . . 0.0 112.33 178.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 2441 ' ' GLY . . . . . . . . . . . . . . . 102.86 -144.42 16.05 Favored Glycine 0 CA--C 1.531 1.087 0 C-N-CA 125.666 1.603 . . . . 0.0 112.881 -178.143 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 2442 ' ' GLY . . . . . . . . . . . . . . . 163.06 -160.26 32.79 Favored Glycine 0 CA--C 1.532 1.124 0 C-N-CA 123.836 0.731 . . . . 0.0 114.872 -176.349 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 2443 ' ' VAL . . . . . . . . . . . . . 83.2 t -83.14 141.49 14.82 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 C-N-CA 124.786 1.235 . . . . 0.0 110.96 -177.533 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 2444 ' ' THR . . . . . . . . . . . . . 18.9 p -56.1 131.41 47.52 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 124.996 1.318 . . . . 0.0 112.228 174.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 2445 ' ' GLY . . . . . . . . . . . . . . . 82.88 -10.93 56.05 Favored Glycine 0 CA--C 1.535 1.291 0 C-N-CA 124.993 1.282 . . . . 0.0 114.66 178.667 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 2446 ' ' ASN . . . . . . . . . . . . . 61.1 m-20 -91.99 147.93 35.85 Favored Pre-proline 0 CA--C 1.547 0.833 0 CA-C-N 118.63 1.215 . . . . 0.0 110.727 172.225 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 2447 ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -71.8 143.48 41.55 Favored 'Trans proline' 0 N--CA 1.457 -0.619 0 C-N-CA 122.817 2.345 . . . . 0.0 111.041 177.453 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 2448 ' ' ALA . . . . . . . . . . . . . . . -124.39 143.92 50.34 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 126.698 1.999 . . . . 0.0 109.126 172.495 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 2449 ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -154.41 152.43 30.17 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 113.392 0.886 . . . . 0.0 113.392 -173.462 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 2450 ' ' PHE . . . . . . . . . . . . . 14.0 p90 -161.46 167.14 26.11 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.902 1.681 . . . . 0.0 110.436 177.599 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 2451 ' ' VAL . . . . . . . . . . . . . 59.2 t -112.33 128.69 68.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 124.698 1.199 . . . . 0.0 110.209 177.537 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 2452 ' ' VAL . . . . . . . . . . . . . 48.8 t -77.53 106.11 7.35 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 162.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 2453 ' ' ASN . . . . . . . . . . . . . 16.3 t-20 -83.47 106.31 15.11 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 124.21 1.004 . . . . 0.0 111.732 -170.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 2454 ' ' THR . . . . . . . . . . . . . 40.6 p -97.7 -8.23 29.17 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 125.83 1.652 . . . . 0.0 113.514 177.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 2455 ' ' SER . . . . . . . . . . . . . 12.8 t -58.54 -31.69 68.18 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-N 119.364 0.983 . . . . 0.0 113.45 -176.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 2456 ' ' ASN . . . . . . . . . . . . . 57.8 m-80 -76.8 -14.86 59.87 Favored 'General case' 0 CA--C 1.549 0.907 0 N-CA-C 113.942 1.09 . . . . 0.0 113.942 174.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 2457 ' ' ALA . . . . . . . . . . . . . . . -109.0 -39.0 5.43 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 125.344 1.458 . . . . 0.0 113.98 -173.723 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 2458 ' ' GLY . . . . . . . . . . . . . . . 112.67 -148.3 18.42 Favored Glycine 0 CA--C 1.533 1.181 0 C-N-CA 125.379 1.466 . . . . 0.0 112.125 -171.432 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 2459 ' ' ALA . . . . . . . . . . . . . . . -92.36 154.7 18.39 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.21 1.004 . . . . 0.0 112.123 179.417 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 2460 ' ' GLY . . . . . . . . . . . . . . . 166.02 163.71 20.1 Favored Glycine 0 N--CA 1.47 0.924 0 C-N-CA 123.848 0.737 . . . . 0.0 114.3 177.488 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 2461 ' ' ALA . . . . . . . . . . . . . . . -80.04 137.3 36.77 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.349 1.06 . . . . 0.0 112.134 -178.559 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 2462 ' ' LEU . . . . . . . . . . . . . 25.8 tp -110.78 141.76 43.68 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.337 1.455 . . . . 0.0 110.591 176.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 2463 ' ' SER . . . . . . . . . . . . . 4.1 t -130.28 39.0 3.7 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 126.215 1.806 . . . . 0.0 110.653 -177.319 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 2464 ' ' VAL . . . . . . . . . . . . . 11.4 p -65.72 140.98 18.72 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 125.512 1.525 . . . . 0.0 112.058 -176.239 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 2465 ' ' THR . . . . . . . . . . . . . 8.3 t -154.45 167.19 30.88 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 125.137 1.375 . . . . 0.0 111.691 179.704 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 2466 ' ' ILE . . . . . . . . . . . . . 35.2 mt -135.02 131.01 52.56 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 C-N-CA 125.237 1.415 . . . . 0.0 109.936 -176.127 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 2467 ' ' ASP . . . . . . . . . . . . . 36.3 t70 -122.26 136.91 54.98 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 125.811 1.644 . . . . 0.0 110.735 174.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 2468 ' ' GLY . . . . . . . . . . . . . . . 172.94 -162.77 34.34 Favored Glycine 0 CA--C 1.537 1.444 0 CA-C-O 119.062 -0.855 . . . . 0.0 114.121 -177.624 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 2469 ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -72.81 1.2 6.68 Favored 'Trans proline' 0 CA--C 1.544 0.979 0 C-N-CA 123.999 3.133 . . . . 0.0 115.325 -172.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 2470 ' ' SER . . . . . . . . . . . . . 85.0 p -150.55 153.94 36.69 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 120.071 1.305 . . . . 0.0 112.989 167.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 2471 ' ' LYS . . . . . . . . . . . . . 99.1 mttt -75.44 74.45 2.5 Favored 'General case' 0 CA--C 1.545 0.77 0 O-C-N 120.906 -1.121 . . . . 0.0 111.073 175.624 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 2472 ' ' VAL . . . . . . . . . . . . . 18.6 m -54.76 143.14 7.57 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 C-N-CA 124.725 1.21 . . . . 0.0 113.403 -173.422 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 2473 ' ' LYS . . . . . . . . . . . . . 83.8 tttt -83.67 70.8 10.38 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 124.596 1.158 . . . . 0.0 111.129 178.471 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 2474 ' ' MET . . . . . . . . . . . . . 16.6 tmm? -79.78 129.61 34.63 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.185 0.994 . . . . 0.0 111.315 -179.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 2475 ' ' ASP . . . . . . . . . . . . . 35.6 t70 -123.38 126.23 46.43 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 126.209 1.804 . . . . 0.0 110.348 174.261 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 2476 ' ' CYS . . . . . . . . . . . . . 35.9 t -101.92 139.82 37.03 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.066 1.346 . . . . 0.0 111.535 179.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 2477 ' ' GLN . . . . . . . . . . . . . 83.5 mt-30 -141.42 145.25 35.06 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.424 1.49 . . . . 0.0 110.497 -174.092 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 2478 ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -88.11 136.81 32.8 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 123.716 0.806 . . . . 0.0 110.624 174.213 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 2479 ' ' CYS . . . . . . . . . . . . . 14.8 p -146.44 171.53 6.3 Favored Pre-proline 0 CA--C 1.554 1.11 0 C-N-CA 125.617 1.567 . . . . 0.0 111.717 177.69 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 2480 ' ' PRO . . . . . . . . . . . . . 70.5 Cg_exo -58.94 -28.31 87.2 Favored 'Trans proline' 0 CA--C 1.539 0.76 0 C-N-CA 123.468 2.779 . . . . 0.0 114.66 179.331 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 2481 ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -83.79 -14.19 52.01 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 124.62 1.168 . . . . 0.0 113.019 -179.656 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 2482 ' ' GLY . . . . . . . . . . . . . . . 136.09 -143.95 15.57 Favored Glycine 0 N--CA 1.47 0.937 0 C-N-CA 125.83 1.681 . . . . 0.0 112.677 -177.112 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 2483 ' ' TYR . . . . . . . . . . . . . 88.7 m-85 -92.8 108.82 20.28 Favored 'General case' 0 N--CA 1.469 0.506 0 O-C-N 121.678 -0.895 . . . . 0.0 110.911 173.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 2484 ' ' ARG . . . . . . . . . . . . . 12.7 ttp180 -74.44 140.94 45.0 Favored 'General case' 0 N--CA 1.468 0.451 0 O-C-N 121.705 -0.622 . . . . 0.0 109.859 169.217 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 2485 ' ' VAL . . . . . . . . . . . . . 22.5 m -126.18 141.69 45.01 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 C-N-CA 123.669 0.788 . . . . 0.0 110.368 165.583 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 2486 ' ' THR . . . . . . . . . . . . . 88.8 m -132.53 135.84 46.23 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 125.658 1.583 . . . . 0.0 108.443 177.582 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 2487 ' ' TYR . . . . . . . . . . . . . 23.1 p90 -149.84 159.92 43.98 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.792 1.237 . . . . 0.0 112.443 -179.747 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 2488 ' ' THR . . . . . . . . . . . . . 99.4 m -122.27 113.8 30.81 Favored Pre-proline 0 N--CA 1.476 0.871 0 C-N-CA 124.154 0.982 . . . . 0.0 109.59 174.23 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 2489 ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -83.74 134.89 6.56 Favored 'Trans proline' 0 N--CA 1.458 -0.598 0 C-N-CA 123.624 2.883 . . . . 0.0 109.957 169.653 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 2490 ' ' MET . . . . . . . . . . . . . 22.4 ptt? -101.71 -18.05 16.0 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 114.329 1.233 . . . . 0.0 114.329 179.348 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 2491 ' ' ALA . . . . . . . . . . . . . . . -112.98 146.34 34.93 Favored Pre-proline 0 CA--C 1.547 0.835 0 C-N-CA 124.68 1.192 . . . . 0.0 112.346 -175.067 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 2492 ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -72.07 156.67 55.55 Favored 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 122.99 2.46 . . . . 0.0 111.192 172.494 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 2493 ' ' GLY . . . . . . . . . . . . . . . 128.79 -147.83 17.77 Favored Glycine 0 CA--C 1.528 0.894 0 C-N-CA 125.465 1.507 . . . . 0.0 112.239 -175.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 2494 ' ' SER . . . . . . . . . . . . . 63.8 m -129.78 140.55 51.03 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 123.891 0.876 . . . . 0.0 111.973 177.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 2495 ' ' TYR . . . . . . . . . . . . . 62.3 m-85 -114.75 127.5 55.77 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 125.993 1.717 . . . . 0.0 109.797 177.245 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 2496 ' ' LEU . . . . . . . . . . . . . 9.9 mp -88.69 117.56 27.75 Favored 'General case' 0 N--CA 1.464 0.242 0 C-N-CA 123.879 0.871 . . . . 0.0 108.963 173.131 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 2497 ' ' ILE . . . . . . . . . . . . . 36.1 mt -93.45 103.95 15.22 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 C-N-CA 125.371 1.468 . . . . 0.0 107.462 176.101 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 2498 ' ' SER . . . . . . . . . . . . . 66.4 m -91.31 101.21 13.91 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 124.816 1.246 . . . . 0.0 109.524 -179.609 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 2499 ' ' ILE . . . . . 0.632 ' H ' ' HG ' ' A' 2510 ' ' SER . 24.0 mt -97.6 92.01 2.77 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 C-N-CA 125.332 1.453 . . . . 0.0 108.828 -178.05 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 2500 ' ' LYS . . . . . . . . . . . . . 84.2 mttt -102.51 139.68 37.79 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.32 1.048 . . . . 0.0 111.739 178.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 2501 ' ' TYR . . . . . . . . . . . . . 72.8 t80 -145.26 147.45 32.4 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.817 1.247 . . . . 0.0 112.429 -170.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 2502 ' ' GLY . . . . . . . . . . . . . . . 64.83 21.28 67.31 Favored Glycine 0 CA--C 1.535 1.299 0 C-N-CA 124.17 0.89 . . . . 0.0 113.505 177.725 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 2503 ' ' GLY . . . . . . . . . . . . . . . 126.69 -163.49 20.58 Favored Glycine 0 CA--C 1.541 1.686 0 C-N-CA 125.899 1.714 . . . . 0.0 112.173 -163.119 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 2504 ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -83.23 21.49 1.02 Allowed 'Trans proline' 0 CA--C 1.545 1.048 0 C-N-CA 124.776 3.65 . . . . 0.0 113.91 -172.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 2505 ' ' TYR . . . . . . . . . . . . . 80.7 m-85 -105.92 130.5 53.86 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.313 1.045 . . . . 0.0 113.129 -171.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 2506 ' ' HIS . . . . . . . . . . . . . 86.5 m-70 -62.39 140.03 58.55 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 125.369 1.468 . . . . 0.0 113.523 179.705 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 2507 ' ' ILE . . . . . . . . . . . . . 1.8 pp -87.82 150.73 3.68 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.163 0 C-N-CA 123.954 0.902 . . . . 0.0 111.812 172.33 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 2508 ' ' GLY . . . . . . . . . . . . . . . 48.88 -116.8 3.57 Favored Glycine 0 CA--C 1.536 1.377 0 C-N-CA 124.087 0.851 . . . . 0.0 114.074 167.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 2509 ' ' GLY . . . . . . . . . . . . . . . -98.59 13.16 62.84 Favored Glycine 0 CA--C 1.536 1.359 0 C-N-CA 126.156 1.836 . . . . 0.0 115.047 177.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 2510 ' ' SER . . . . . 0.632 ' HG ' ' H ' ' A' 2499 ' ' ILE . 44.2 t -65.36 145.39 99.08 Favored Pre-proline 0 CA--C 1.553 1.059 0 CA-C-N 119.207 1.503 . . . . 0.0 112.837 -179.004 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 2511 ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -74.7 141.0 70.45 Favored 'Cis proline' 0 C--N 1.355 0.888 0 CA-C-N 119.712 0.933 . . . . 0.0 112.636 0.663 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 2512 ' ' PHE . . . . . . . . . . . . . 87.8 m-85 -94.38 125.43 39.02 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.575 1.15 . . . . 0.0 110.518 178.246 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 2513 ' ' LYS . . . . . . . . . . . . . 25.7 pttm -85.5 105.02 15.8 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 123.545 0.738 . . . . 0.0 112.165 177.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 2514 ' ' ALA . . . . . . . . . . . . . . . -87.94 120.0 28.84 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.239 1.416 . . . . 0.0 109.902 173.433 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 2515 ' ' LYS . . . . . . . . . . . . . 54.0 mtmt -94.41 133.35 38.09 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.383 1.073 . . . . 0.0 110.84 -176.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 2516 ' ' VAL . . . . . . . . . . . . . 87.9 t -131.21 136.94 56.77 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 124.415 1.086 . . . . 0.0 110.743 -170.544 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 2517 ' ' THR . . . . . . . . . . . . . 34.2 p -138.41 156.76 47.28 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 125.265 1.426 . . . . 0.0 111.795 -175.705 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 2518 ' ' GLY . . . . . . . . . . . . . . . 114.73 -176.29 16.7 Favored Glycine 0 CA--C 1.541 1.698 0 C-N-CA 125.584 1.564 . . . . 0.0 113.04 -175.21 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 2519 ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -69.8 149.68 66.97 Favored 'Trans proline' 0 CA--C 1.535 0.562 0 C-N-CA 123.756 2.97 . . . . 0.0 112.246 -174.162 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 2520 ' ' ARG . . . . . . . . . . . . . 37.3 ttm105 . . . . . 0 CA--C 1.545 0.764 0 C-N-CA 123.908 0.883 . . . . 0.0 113.287 178.904 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A 2427 ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.002 0 CA-C-O 121.464 0.48 . . . . 0.0 114.018 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A 2428 ' ' ASP . . . . . . . . . . . . . 21.3 m-20 -132.89 138.71 32.51 Favored Pre-proline 0 CA--C 1.547 0.857 0 C-N-CA 125.381 1.472 . . . . 0.0 111.462 -179.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 2429 ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -56.79 -26.32 65.79 Favored 'Trans proline' 0 C--N 1.352 0.756 0 C-N-CA 123.854 3.036 . . . . 0.0 114.568 176.549 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 2430 ' ' GLY . . . . . . . . . . . . . . . -79.12 -23.5 63.38 Favored Glycine 0 CA--C 1.534 1.219 0 C-N-CA 123.737 0.684 . . . . 0.0 113.871 176.66 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 2431 ' ' LEU . . . . . . . . . . . . . 4.3 mm? -86.98 -39.64 15.5 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.519 1.128 . . . . 0.0 111.118 173.261 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 2432 ' ' VAL . . . . . . . . . . . . . 98.7 t -61.41 133.82 27.0 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 123.469 0.708 . . . . 0.0 109.992 172.53 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 2433 ' ' SER . . . . . . . . . . . . . 8.4 t -129.13 -170.09 2.21 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.892 1.277 . . . . 0.0 110.959 178.425 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 2434 ' ' ALA . . . . . . . . . . . . . . . -151.05 143.54 24.29 Favored 'General case' 0 CA--C 1.538 0.496 0 O-C-N 120.956 -1.09 . . . . 0.0 111.889 177.125 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 2435 ' ' TYR . . . . . . . . . . . . . 82.1 m-85 -145.89 143.64 29.7 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 125.242 1.417 . . . . 0.0 111.971 -176.142 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 2436 ' ' GLY . . . . . . . . . . . . . . . 125.71 162.7 11.38 Favored Glycine 0 N--CA 1.475 1.244 0 C-N-CA 125.607 1.575 . . . . 0.0 114.201 176.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 2437 ' ' ALA . . . . . . . . . . . . . . . -62.36 -27.16 68.87 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 125.244 1.418 . . . . 0.0 114.545 -170.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 2438 ' ' GLY . . . . . . . . . . . . . . . -61.87 -22.13 61.9 Favored Glycine 0 CA--C 1.531 1.06 0 C-N-CA 124.022 0.82 . . . . 0.0 113.903 179.326 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 2439 ' ' LEU . . . . . . . . . . . . . 85.5 mt -70.98 -22.8 62.14 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 118.547 1.173 . . . . 0.0 112.97 172.742 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 2440 ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -96.37 -26.44 15.35 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.11 1.364 . . . . 0.0 112.592 -179.796 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 2441 ' ' GLY . . . . . . . . . . . . . . . 101.8 -142.91 15.84 Favored Glycine 0 CA--C 1.532 1.127 0 C-N-CA 125.465 1.507 . . . . 0.0 112.652 -177.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 2442 ' ' GLY . . . . . . . . . . . . . . . 152.36 -152.58 24.26 Favored Glycine 0 CA--C 1.532 1.128 0 C-N-CA 124.205 0.907 . . . . 0.0 114.27 -177.14 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 2443 ' ' VAL . . . . . . . . . . . . . 38.4 t -88.32 141.27 14.53 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 C-N-CA 124.501 1.12 . . . . 0.0 110.333 -179.042 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 2444 ' ' THR . . . . . . . . . . . . . 33.1 p -59.07 152.69 19.49 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 124.361 1.065 . . . . 0.0 112.744 174.385 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 2445 ' ' GLY . . . . . . . . . . . . . . . 70.93 0.72 35.72 Favored Glycine 0 CA--C 1.534 1.224 0 C-N-CA 124.182 0.896 . . . . 0.0 115.133 177.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 2446 ' ' ASN . . . . . . . . . . . . . 14.6 m-80 -116.14 143.35 30.81 Favored Pre-proline 0 CA--C 1.546 0.803 0 C-N-CA 126.043 1.737 . . . . 0.0 110.066 177.095 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 2447 ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -72.99 141.92 33.85 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 122.805 2.337 . . . . 0.0 111.133 178.7 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 2448 ' ' ALA . . . . . . . . . . . . . . . -128.87 137.51 51.5 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.568 1.547 . . . . 0.0 109.403 169.66 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 2449 ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -131.35 151.81 51.18 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.21 1.004 . . . . 0.0 113.402 -166.6 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 2450 ' ' PHE . . . . . . . . . . . . . 27.2 p90 -158.48 163.65 36.93 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 125.915 1.686 . . . . 0.0 110.802 178.18 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 2451 ' ' VAL . . . . . . . . . . . . . 58.2 t -118.36 132.57 67.83 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 124.488 1.115 . . . . 0.0 109.717 175.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 2452 ' ' VAL . . . . . . . . . . . . . 40.3 t -79.19 106.69 10.64 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 162.716 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 2453 ' ' ASN . . . . . . . . . . . . . 15.0 t-20 -84.18 108.38 17.04 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 123.65 0.78 . . . . 0.0 111.7 -172.39 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 2454 ' ' THR . . . . . . . . . . . . . 29.9 p -97.67 -6.87 32.18 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 126.364 1.866 . . . . 0.0 113.644 -179.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 2455 ' ' SER . . . . . . . . . . . . . 14.9 m -58.11 -26.91 63.21 Favored 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 114.229 1.196 . . . . 0.0 114.229 -177.386 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 2456 ' ' ASN . . . . . . . . . . . . . 86.2 m-20 -75.27 -20.17 59.3 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.549 1.139 . . . . 0.0 113.355 175.524 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 2457 ' ' ALA . . . . . . . . . . . . . . . -116.62 -44.48 2.85 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.317 1.447 . . . . 0.0 113.451 -164.518 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 2458 ' ' GLY . . . . . . . . . . . . . . . 100.44 -148.11 18.24 Favored Glycine 0 CA--C 1.533 1.191 0 C-N-CA 124.98 1.276 . . . . 0.0 112.847 -175.135 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 2459 ' ' ALA . . . . . . . . . . . . . . . -73.66 139.26 45.29 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.352 1.061 . . . . 0.0 113.596 -172.553 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 2460 ' ' GLY . . . . . . . . . . . . . . . 168.67 154.79 9.14 Favored Glycine 0 CA--C 1.531 1.041 0 C-N-CA 125.327 1.441 . . . . 0.0 113.167 177.226 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 2461 ' ' ALA . . . . . . . . . . . . . . . -79.85 147.71 31.63 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 124.293 1.037 . . . . 0.0 112.567 -178.289 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 2462 ' ' LEU . . . . . . . . . . . . . 16.6 tp -108.55 143.39 37.64 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.148 1.379 . . . . 0.0 111.131 177.267 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 2463 ' ' SER . . . . . . . . . . . . . 49.4 m -135.0 38.97 2.98 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 125.699 1.6 . . . . 0.0 111.139 -176.514 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 2464 ' ' VAL . . . . . . . . . . . . . 8.5 p -66.03 138.12 23.63 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 C-N-CA 125.453 1.501 . . . . 0.0 112.43 -177.739 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 2465 ' ' THR . . . . . . . . . . . . . 93.1 m -137.87 141.69 40.7 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 125.608 1.563 . . . . 0.0 109.822 175.232 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 2466 ' ' ILE . . . . . . . . . . . . . 56.7 mt -105.61 119.89 55.54 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 123.661 0.784 . . . . 0.0 109.266 170.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 2467 ' ' ASP . . . . . . . . . . . . . 37.4 t70 -108.01 155.68 20.07 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 126.334 1.853 . . . . 0.0 110.603 173.5 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 2468 ' ' GLY . . . . . . . . . . . . . . . 163.56 -160.34 33.06 Favored Glycine 0 CA--C 1.535 1.327 0 CA-C-O 119.136 -0.814 . . . . 0.0 114.044 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 2469 ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -71.04 -14.62 32.16 Favored 'Trans proline' 0 CA--C 1.539 0.766 0 C-N-CA 123.788 2.992 . . . . 0.0 114.003 -177.342 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 2470 ' ' SER . . . . . . . . . . . . . 42.2 m -152.49 159.52 43.33 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 125.257 1.423 . . . . 0.0 111.959 178.573 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 2471 ' ' LYS . . . . . . . . . . . . . 68.3 mttm -76.42 98.07 4.46 Favored 'General case' 0 CA--C 1.544 0.722 0 O-C-N 120.966 -1.084 . . . . 0.0 110.482 172.574 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 2472 ' ' VAL . . . . . . . . . . . . . 16.2 m -60.77 148.38 8.98 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 C-N-CA 123.985 0.914 . . . . 0.0 111.743 179.252 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 2473 ' ' LYS . . . . . . . . . . . . . 88.6 tttt -77.1 109.85 11.28 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 171.015 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 2474 ' ' MET . . . . . . . . . . . . . 25.3 ttt -118.19 142.27 47.63 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.998 1.319 . . . . 0.0 112.434 -166.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 2475 ' ' ASP . . . . . . . . . . . . . 31.0 t70 -128.41 147.03 50.63 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 127.187 2.195 . . . . 0.0 110.16 169.428 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 2476 ' ' CYS . . . . . . . . . . . . . 37.8 t -138.12 140.58 39.99 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.668 1.187 . . . . 0.0 110.244 172.181 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 2477 ' ' GLN . . . . . . . . . . . . . 8.7 pt20 -156.89 163.13 39.51 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.182 1.393 . . . . 0.0 111.17 -172.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 2478 ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -95.13 138.5 32.76 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 123.775 0.83 . . . . 0.0 111.39 -179.365 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 2479 ' ' CYS . . . . . . . . . . . . . 14.0 p -139.18 170.9 9.01 Favored Pre-proline 0 CA--C 1.553 1.071 0 C-N-CA 125.43 1.492 . . . . 0.0 111.168 170.547 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 2480 ' ' PRO . . . . . . . . . . . . . 68.3 Cg_exo -58.43 -26.09 76.3 Favored 'Trans proline' 0 C--N 1.352 0.741 0 C-N-CA 123.508 2.805 . . . . 0.0 114.702 178.415 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 2481 ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -83.09 -11.04 58.37 Favored 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 125.01 1.324 . . . . 0.0 112.862 178.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 2482 ' ' GLY . . . . . . . . . . . . . . . 128.82 -155.49 20.65 Favored Glycine 0 N--CA 1.473 1.125 0 C-N-CA 125.893 1.711 . . . . 0.0 113.402 -178.276 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 2483 ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -76.06 109.29 9.59 Favored 'General case' 0 N--CA 1.47 0.575 0 O-C-N 121.621 -0.929 . . . . 0.0 110.767 175.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 2484 ' ' ARG . . . . . . . . . . . . . 31.5 ttm180 -85.27 131.66 34.38 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 124.892 1.277 . . . . 0.0 110.577 176.242 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 2485 ' ' VAL . . . . . . . . . . . . . 78.7 t -117.93 137.5 51.67 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 C-N-CA 126.062 1.745 . . . . 0.0 108.742 176.397 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 2486 ' ' THR . . . . . . . . . . . . . 85.0 m -131.9 139.0 48.62 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.771 1.229 . . . . 0.0 108.175 171.277 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 2487 ' ' TYR . . . . . . . . . . . . . 30.5 p90 -146.41 149.32 33.5 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 113.38 0.881 . . . . 0.0 113.38 175.61 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 2488 ' ' THR . . . . . . . . . . . . . 62.9 m -112.7 114.21 49.8 Favored Pre-proline 0 N--CA 1.472 0.639 0 C-N-CA 125.17 1.388 . . . . 0.0 108.61 172.411 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 2489 ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -81.06 134.99 9.57 Favored 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 122.851 2.367 . . . . 0.0 110.709 176.004 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 2490 ' ' MET . . . . . . . . . . . . . 17.7 ptm -91.25 -3.72 56.63 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 125.031 1.332 . . . . 0.0 114.192 -177.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 2491 ' ' ALA . . . . . . . . . . . . . . . -151.26 151.08 28.6 Favored Pre-proline 0 CA--C 1.546 0.826 0 C-N-CA 125.429 1.492 . . . . 0.0 112.001 -173.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 2492 ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -73.99 165.09 32.92 Favored 'Trans proline' 0 CA--C 1.538 0.685 0 C-N-CA 123.505 2.803 . . . . 0.0 111.727 173.447 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 2493 ' ' GLY . . . . . . . . . . . . . . . 127.09 -158.67 21.07 Favored Glycine 0 CA--C 1.53 0.994 0 C-N-CA 125.539 1.542 . . . . 0.0 112.973 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 2494 ' ' SER . . . . . . . . . . . . . 67.6 m -113.47 128.89 56.6 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.126 0.971 . . . . 0.0 111.262 179.257 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 2495 ' ' TYR . . . . . . . . . . . . . 88.9 m-85 -110.82 132.88 53.83 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.781 1.632 . . . . 0.0 110.531 177.748 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 2496 ' ' LEU . . . . . . . . . . . . . 9.5 mp -96.7 114.74 26.41 Favored 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 124.248 1.019 . . . . 0.0 108.908 173.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 2497 ' ' ILE . . . . . . . . . . . . . 30.6 mt -89.49 92.21 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 N-CA-C 107.306 -1.368 . . . . 0.0 107.306 174.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 2498 ' ' SER . . . . . . . . . . . . . 68.0 m -80.92 78.57 7.71 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 126.032 1.733 . . . . 0.0 110.305 -179.311 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 2499 ' ' ILE . . . . . . . . . . . . . 36.1 mt -75.42 107.15 5.83 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 C-N-CA 124.826 1.251 . . . . 0.0 109.204 176.1 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 2500 ' ' LYS . . . . . . . . . . . . . 42.8 mttp -113.02 148.6 34.79 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 124.775 1.23 . . . . 0.0 111.116 175.194 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 2501 ' ' TYR . . . . . . . . . . . . . 67.6 t80 -148.25 145.94 28.43 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.445 1.098 . . . . 0.0 112.281 -172.044 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 2502 ' ' GLY . . . . . . . . . . . . . . . 66.39 14.7 62.48 Favored Glycine 0 CA--C 1.535 1.33 0 C-N-CA 124.556 1.074 . . . . 0.0 114.373 175.162 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 2503 ' ' GLY . . . . . . . . . . . . . . . 138.02 -169.29 24.26 Favored Glycine 0 CA--C 1.54 1.633 0 C-N-CA 125.92 1.724 . . . . 0.0 112.537 -166.154 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 2504 ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -83.76 34.58 0.53 Allowed 'Trans proline' 0 CA--C 1.545 1.068 0 C-N-CA 124.859 3.706 . . . . 0.0 113.143 -171.588 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 2505 ' ' TYR . . . . . . . . . . . . . 92.8 m-85 -125.11 136.27 53.48 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 124.515 1.126 . . . . 0.0 113.053 -174.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 2506 ' ' HIS . . . . . . . . . . . . . 92.4 m-70 -63.48 146.09 54.32 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 125.405 1.482 . . . . 0.0 113.455 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 2507 ' ' ILE . . . . . . . . . . . . . 24.2 pt -75.43 173.28 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.192 0 C-N-CA 123.494 0.718 . . . . 0.0 112.684 171.485 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 2508 ' ' GLY . . . . . . . . . . . . . . . -59.29 120.73 24.02 Favored Glycine 0 CA--C 1.534 1.244 0 O-C-N 121.411 -0.806 . . . . 0.0 111.677 175.074 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 2509 ' ' GLY . . . . . . . . . . . . . . . 87.8 -5.77 84.44 Favored Glycine 0 CA--C 1.536 1.371 0 C-N-CA 125.393 1.473 . . . . 0.0 114.995 -177.25 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 2510 ' ' SER . . . . . . . . . . . . . 47.4 t -89.3 145.99 35.18 Favored Pre-proline 0 CA--C 1.551 0.992 0 CA-C-N 119.007 1.404 . . . . 0.0 112.088 -179.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 2511 ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -72.71 143.6 78.12 Favored 'Cis proline' 0 C--N 1.355 0.877 0 CA-C-N 120.042 1.051 . . . . 0.0 112.427 -0.319 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 2512 ' ' PHE . . . . . . . . . . . . . 83.0 m-85 -92.61 122.95 35.54 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.059 0.944 . . . . 0.0 110.718 178.202 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 2513 ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.34 105.08 13.12 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 124.023 0.929 . . . . 0.0 113.462 178.588 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 2514 ' ' ALA . . . . . . . . . . . . . . . -92.84 125.28 37.37 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.07 1.348 . . . . 0.0 110.208 173.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 2515 ' ' LYS . . . . . . . . . . . . . 54.6 mtmt -102.83 123.91 47.37 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.303 1.041 . . . . 0.0 110.637 -178.027 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 2516 ' ' VAL . . . . . . . . . . . . . 92.3 t -122.27 139.06 50.39 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 124.967 1.307 . . . . 0.0 110.523 -168.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 2517 ' ' THR . . . . . . . . . . . . . 38.5 p -132.64 164.66 26.21 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 125.391 1.476 . . . . 0.0 111.75 -177.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 2518 ' ' GLY . . . . . . . . . . . . . . . 108.96 -176.54 19.9 Favored Glycine 0 CA--C 1.54 1.601 0 C-N-CA 124.908 1.242 . . . . 0.0 113.313 -176.373 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 2519 ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -75.12 158.24 41.84 Favored 'Trans proline' 0 CA--C 1.535 0.541 0 C-N-CA 123.819 3.012 . . . . 0.0 112.127 -175.683 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 2520 ' ' ARG . . . . . . . . . . . . . 39.4 ttp180 . . . . . 0 CA--C 1.539 0.526 0 C-N-CA 123.053 0.541 . . . . 0.0 110.058 168.547 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A 2427 ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.107 0 N-CA-C 111.931 -0.467 . . . . 0.0 111.931 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A 2428 ' ' ASP . . . . . . . . . . . . . 13.8 t70 -149.71 136.16 10.63 Favored Pre-proline 0 CA--C 1.55 0.96 0 C-N-CA 123.939 0.896 . . . . 0.0 112.182 -173.658 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 2429 ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -65.79 -20.74 58.7 Favored 'Trans proline' 0 C--N 1.353 0.795 0 C-N-CA 123.58 2.854 . . . . 0.0 114.186 -176.089 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 2430 ' ' GLY . . . . . . . . . . . . . . . -81.69 -26.25 50.89 Favored Glycine 0 CA--C 1.533 1.163 0 CA-C-N 119.261 0.937 . . . . 0.0 113.106 173.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 2431 ' ' LEU . . . . . . . . . . . . . 4.4 mm? -81.7 -34.17 30.77 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.153 0.981 . . . . 0.0 111.383 171.123 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 2432 ' ' VAL . . . . . . . . . . . . . 57.7 t -64.21 138.28 23.34 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 123.516 0.726 . . . . 0.0 110.31 168.462 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 2433 ' ' SER . . . . . . . . . . . . . 8.9 t -131.18 -167.25 1.82 Allowed 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 125.128 1.371 . . . . 0.0 109.897 172.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 2434 ' ' ALA . . . . . . . . . . . . . . . -151.54 145.53 25.22 Favored 'General case' 0 CA--C 1.537 0.477 0 O-C-N 120.794 -1.191 . . . . 0.0 111.643 176.012 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 2435 ' ' TYR . . . . . . . . . . . . . 86.6 m-85 -143.2 149.67 38.3 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.334 1.454 . . . . 0.0 111.892 -177.307 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 2436 ' ' GLY . . . . . . . . . . . . . . . 120.42 160.59 11.2 Favored Glycine 0 N--CA 1.473 1.133 0 C-N-CA 125.534 1.54 . . . . 0.0 113.549 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 2437 ' ' ALA . . . . . . . . . . . . . . . -60.7 -31.74 71.01 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 114.535 1.309 . . . . 0.0 114.535 -168.665 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 2438 ' ' GLY . . . . . . . . . . . . . . . -67.97 -10.43 58.89 Favored Glycine 0 CA--C 1.532 1.132 0 C-N-CA 124.129 0.871 . . . . 0.0 114.891 -176.352 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 2439 ' ' LEU . . . . . . . . . . . . . 75.6 mt -77.75 -27.14 50.31 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 118.702 1.251 . . . . 0.0 112.162 169.208 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 2440 ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -93.19 -34.82 13.44 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 125.121 1.369 . . . . 0.0 111.595 176.493 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 2441 ' ' GLY . . . . . . . . . . . . . . . 138.68 -136.67 8.17 Favored Glycine 0 CA--C 1.531 1.061 0 C-N-CA 125.097 1.332 . . . . 0.0 114.469 176.171 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 2442 ' ' GLY . . . . . . . . . . . . . . . 162.89 -145.06 10.16 Favored Glycine 0 CA--C 1.534 1.246 0 C-N-CA 126.622 2.058 . . . . 0.0 111.148 -167.509 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 2443 ' ' VAL . . . . . . . . . . . . . 8.5 p -141.56 151.99 19.33 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 C-N-CA 124.739 1.216 . . . . 0.0 110.145 176.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 2444 ' ' THR . . . . . . . . . . . . . 22.7 p -53.49 130.27 35.15 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.855 0.862 . . . . 0.0 111.784 178.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 2445 ' ' GLY . . . . . . . . . . . . . . . 86.5 -8.37 75.14 Favored Glycine 0 CA--C 1.535 1.32 0 C-N-CA 125.205 1.384 . . . . 0.0 115.363 179.127 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 2446 ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -101.69 146.33 32.04 Favored Pre-proline 0 CA--C 1.551 0.986 0 CA-C-N 119.605 1.703 . . . . 0.0 112.235 177.53 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 2447 ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -75.52 124.53 8.36 Favored 'Trans proline' 0 N--CA 1.457 -0.641 0 C-N-CA 122.727 2.285 . . . . 0.0 110.507 175.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 2448 ' ' ALA . . . . . . . . . . . . . . . -107.13 149.03 28.1 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.77 1.628 . . . . 0.0 109.56 168.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 2449 ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -153.88 158.29 40.55 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 113.886 1.069 . . . . 0.0 113.886 -174.671 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 2450 ' ' PHE . . . . . . . . . . . . . 53.0 p90 -160.34 161.11 33.1 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 126.503 1.921 . . . . 0.0 110.838 -177.321 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 2451 ' ' VAL . . . . . . . . . . . . . 58.7 t -114.51 127.56 71.94 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 C-N-CA 124.866 1.266 . . . . 0.0 109.128 174.092 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 2452 ' ' VAL . . . . . . . . . . . . . 42.7 t -79.62 106.27 10.41 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 165.417 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 2453 ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -89.82 117.35 28.59 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 123.995 0.918 . . . . 0.0 111.976 -164.379 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 2454 ' ' THR . . . . . . . . . . . . . 52.5 p -102.19 -1.56 31.08 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 125.857 1.663 . . . . 0.0 113.672 -177.159 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 2455 ' ' SER . . . . . . . . . . . . . 16.9 t -60.94 -33.52 73.29 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-N 119.296 0.953 . . . . 0.0 113.356 -172.667 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 2456 ' ' ASN . . . . . . . . . . . . . 72.6 m-80 -81.96 -13.81 56.94 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 124.196 0.999 . . . . 0.0 113.674 175.684 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 2457 ' ' ALA . . . . . . . . . . . . . . . -102.75 -45.01 5.13 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.97 1.308 . . . . 0.0 113.547 -173.059 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 2458 ' ' GLY . . . . . . . . . . . . . . . 119.96 -113.42 2.45 Favored Glycine 0 CA--C 1.529 0.961 0 C-N-CA 124.93 1.252 . . . . 0.0 111.382 -170.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 2459 ' ' ALA . . . . . . . . . . . . . . . -147.97 155.45 41.56 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.432 1.093 . . . . 0.0 112.798 -176.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 2460 ' ' GLY . . . . . . . . . . . . . . . 164.52 173.29 33.01 Favored Glycine 0 CA--C 1.528 0.87 0 C-N-CA 124.269 0.938 . . . . 0.0 113.774 -176.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 2461 ' ' ALA . . . . . . . . . . . . . . . -73.29 146.2 45.51 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.193 0.997 . . . . 0.0 112.212 178.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 2462 ' ' LEU . . . . . . . . . . . . . 6.0 tt -128.36 147.66 50.64 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 125.742 1.617 . . . . 0.0 110.898 178.672 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 2463 ' ' SER . . . . . . . . . . . . . 14.0 t -132.04 161.21 33.75 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.676 1.191 . . . . 0.0 110.349 161.5 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 2464 ' ' VAL . . . . . . . . . . . . . 7.4 p -161.72 136.96 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.725 0 C-N-CA 124.644 1.178 . . . . 0.0 110.773 -175.056 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 2465 ' ' THR . . . . . . . . . . . . . 63.3 m -141.58 138.49 32.68 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 125.397 1.479 . . . . 0.0 109.711 -175.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 2466 ' ' ILE . . . . . . . . . . . . . 37.7 mt -117.41 119.41 61.72 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 124.399 1.08 . . . . 0.0 109.527 175.669 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 2467 ' ' ASP . . . . . . . . . . . . . 34.9 t70 -104.06 161.74 13.75 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 126.164 1.785 . . . . 0.0 110.019 167.527 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 2468 ' ' GLY . . . . . . . . . . . . . . . 172.18 -166.05 38.81 Favored Glycine 0 CA--C 1.536 1.386 0 O-C-N 120.875 -1.141 . . . . 0.0 115.878 179.313 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 2469 ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -70.11 -14.64 35.2 Favored 'Trans proline' 0 CA--C 1.541 0.836 0 C-N-CA 124.544 3.496 . . . . 0.0 113.93 -178.43 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 2470 ' ' SER . . . . . . . . . . . . . 16.8 m -155.79 -177.71 6.76 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 127.306 2.243 . . . . 0.0 109.434 172.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 2471 ' ' LYS . . . . . . . . . . . . . 24.8 pttm -66.31 175.42 2.19 Favored 'General case' 0 CA--C 1.549 0.917 0 O-C-N 121.069 -1.019 . . . . 0.0 112.839 169.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 2472 ' ' VAL . . . . . . . . . . . . . 27.0 m -132.76 148.39 31.6 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 125.331 1.452 . . . . 0.0 110.138 170.429 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 2473 ' ' LYS . . . . . . . . . . . . . 63.8 tttm -76.13 131.2 39.26 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 107.78 -1.192 . . . . 0.0 107.78 152.417 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 2474 ' ' MET . . . . . . . . . . . . . 27.1 ttt -139.23 139.81 37.56 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.024 0.93 . . . . 0.0 111.489 -172.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 2475 ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -141.7 157.44 45.06 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 126.907 2.083 . . . . 0.0 110.172 -178.103 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 2476 ' ' CYS . . . . . . . . . . . . . 49.7 t -152.43 150.03 29.22 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.191 0.996 . . . . 0.0 111.842 -175.433 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 2477 ' ' GLN . . . . . . . . . . . . . 51.7 tt0 -154.37 133.91 12.77 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 125.457 1.503 . . . . 0.0 110.077 -174.655 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 2478 ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -85.12 142.87 29.2 Favored 'General case' 0 CA--C 1.542 0.66 0 O-C-N 121.641 -0.662 . . . . 0.0 111.414 171.425 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 2479 ' ' CYS . . . . . . . . . . . . . 15.4 p -151.98 173.6 4.33 Favored Pre-proline 0 CA--C 1.553 1.096 0 C-N-CA 125.695 1.598 . . . . 0.0 111.47 -177.518 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 2480 ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -58.36 -27.44 81.39 Favored 'Trans proline' 0 C--N 1.353 0.794 0 C-N-CA 123.563 2.842 . . . . 0.0 114.853 179.288 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 2481 ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -80.37 -19.58 46.04 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 124.374 1.07 . . . . 0.0 112.755 178.234 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 2482 ' ' GLY . . . . . . . . . . . . . . . 134.94 -150.66 20.21 Favored Glycine 0 CA--C 1.529 0.955 0 C-N-CA 126.033 1.778 . . . . 0.0 112.864 -176.55 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 2483 ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -90.85 109.4 20.61 Favored 'General case' 0 CA--C 1.539 0.535 0 O-C-N 121.7 -0.883 . . . . 0.0 110.759 177.308 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 2484 ' ' ARG . . . . . . . . . . . . . 38.9 ttp85 -79.47 134.48 36.53 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 124.445 1.098 . . . . 0.0 110.09 172.355 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 2485 ' ' VAL . . . . . . . . . . . . . 93.4 t -125.51 135.84 62.7 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 126.05 1.74 . . . . 0.0 108.672 178.206 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 2486 ' ' THR . . . . . . . . . . . . . 86.2 m -129.6 140.69 51.12 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 125.653 1.581 . . . . 0.0 108.788 178.171 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 2487 ' ' TYR . . . . . . . . . . . . . 19.6 p90 -150.8 153.26 35.11 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 113.526 0.935 . . . . 0.0 113.526 175.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 2488 ' ' THR . . . . . . . . . . . . . 98.4 m -118.62 115.51 35.4 Favored Pre-proline 0 N--CA 1.474 0.749 0 C-N-CA 124.907 1.283 . . . . 0.0 109.181 175.315 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 2489 ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -82.44 165.15 16.47 Favored 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 124.464 3.443 . . . . 0.0 111.6 175.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 2490 ' ' MET . . . . . . . . . . . . . 24.5 ptm -143.57 5.16 1.39 Allowed 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 115.435 1.643 . . . . 0.0 115.435 -174.367 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 2491 ' ' ALA . . . . . . . . . . . . . . . -143.46 145.98 33.95 Favored Pre-proline 0 CA--C 1.546 0.825 0 C-N-CA 124.675 1.19 . . . . 0.0 110.896 170.184 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 2492 ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -71.65 149.2 54.63 Favored 'Trans proline' 0 CA--C 1.536 0.601 0 C-N-CA 123.063 2.508 . . . . 0.0 111.158 178.189 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 2493 ' ' GLY . . . . . . . . . . . . . . . 131.81 -159.89 23.37 Favored Glycine 0 CA--C 1.53 1.004 0 C-N-CA 125.36 1.457 . . . . 0.0 113.493 -177.354 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 2494 ' ' SER . . . . . . . . . . . . . 23.6 m -98.03 118.65 35.09 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 125.117 1.367 . . . . 0.0 111.523 -177.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 2495 ' ' TYR . . . . . . . . . . . . . 62.3 m-85 -92.64 120.23 32.85 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 123.614 0.766 . . . . 0.0 110.068 167.041 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 2496 ' ' LEU . . . . . . . . . . . . . 22.8 tp -92.94 111.33 22.91 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.626 1.17 . . . . 0.0 109.73 -177.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 2497 ' ' ILE . . . . . . . . . . . . . 32.2 mt -101.85 103.62 15.2 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 C-N-CA 125.922 1.689 . . . . 0.0 108.602 -175.552 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 2498 ' ' SER . . . . . . . . . . . . . 68.4 m -92.0 125.63 36.77 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.274 1.029 . . . . 0.0 109.958 175.503 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 2499 ' ' ILE . . . . . 0.559 ' H ' ' HG ' ' A' 2510 ' ' SER . 42.2 mt -128.26 123.99 61.31 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.725 0 C-N-CA 124.889 1.276 . . . . 0.0 108.645 -175.389 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 2500 ' ' LYS . . . . . . . . . . . . . 84.5 mttt -127.87 143.49 51.11 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.734 1.214 . . . . 0.0 111.774 -172.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 2501 ' ' TYR . . . . . . . . . . . . . 60.2 t80 -150.02 139.7 21.68 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 123.663 0.785 . . . . 0.0 112.681 -171.196 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 2502 ' ' GLY . . . . . . . . . . . . . . . 68.21 13.73 65.22 Favored Glycine 0 CA--C 1.537 1.419 0 C-N-CA 124.196 0.903 . . . . 0.0 114.162 179.279 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 2503 ' ' GLY . . . . . . . . . . . . . . . 146.46 -172.53 27.0 Favored Glycine 0 CA--C 1.539 1.583 0 C-N-CA 126.087 1.803 . . . . 0.0 112.822 -169.465 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 2504 ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -81.87 22.4 0.85 Allowed 'Trans proline' 0 CA--C 1.545 1.058 0 C-N-CA 124.99 3.794 . . . . 0.0 113.795 -174.52 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 2505 ' ' TYR . . . . . . . . . . . . . 72.8 m-85 -111.59 139.85 46.69 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.935 1.294 . . . . 0.0 112.803 -173.516 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 2506 ' ' HIS . . . . . . . . . . . . . 93.3 m-70 -62.19 144.15 55.84 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 124.447 1.099 . . . . 0.0 113.298 -179.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 2507 ' ' ILE . . . . . . . . . . . . . 26.7 pt -73.59 167.99 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 C-N-CA 123.149 0.58 . . . . 0.0 112.45 171.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 2508 ' ' GLY . . . . . . . . . . . . . . . -57.5 120.68 22.42 Favored Glycine 0 CA--C 1.534 1.223 0 C-N-CA 123.651 0.643 . . . . 0.0 111.982 176.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 2509 ' ' GLY . . . . . . . . . . . . . . . 88.58 -8.35 79.36 Favored Glycine 0 CA--C 1.535 1.331 0 C-N-CA 125.599 1.571 . . . . 0.0 115.145 -177.733 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 2510 ' ' SER . . . . . 0.559 ' HG ' ' H ' ' A' 2499 ' ' ILE . 8.4 t -89.33 146.3 35.78 Favored Pre-proline 0 CA--C 1.549 0.939 0 CA-C-N 119.231 1.516 . . . . 0.0 111.897 -179.595 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 2511 ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -75.74 149.78 93.15 Favored 'Cis proline' 0 C--N 1.353 0.786 0 CA-C-N 120.153 1.09 . . . . 0.0 113.424 1.168 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 2512 ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -100.8 131.84 46.49 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 125.386 1.475 . . . . 0.0 110.465 178.266 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 2513 ' ' LYS . . . . . . . . . . . . . 64.5 pttt -87.49 8.75 23.47 Favored 'General case' 0 N--CA 1.479 1.007 0 N-CA-C 116.292 1.96 . . . . 0.0 116.292 -169.084 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 2514 ' ' ALA . . . . . . . . . . . . . . . -7.09 99.45 0.01 OUTLIER 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 129.66 3.184 . . . . 0.0 116.047 -176.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 2515 ' ' LYS . . . . . . . . . . . . . 48.6 mtpt -94.86 135.18 36.68 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 124.031 0.932 . . . . 0.0 112.194 -171.27 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 2516 ' ' VAL . . . . . . . . . . . . . 6.0 m -131.82 153.8 39.23 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 C-N-CA 124.224 1.01 . . . . 0.0 111.82 -177.244 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 2517 ' ' THR . . . . . . . . . . . . . 64.0 p -120.64 -171.27 2.15 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.915 1.686 . . . . 0.0 110.106 177.026 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 2518 ' ' GLY . . . . . . . . . . . . . . . 99.1 177.58 31.82 Favored Glycine 0 CA--C 1.539 1.571 0 C-N-CA 124.972 1.272 . . . . 0.0 113.921 178.538 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 2519 ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -70.38 137.4 33.58 Favored 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 123.862 3.042 . . . . 0.0 112.195 -172.152 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 2520 ' ' ARG . . . . . . . . . . . . . 37.8 ttp180 . . . . . 0 CA--C 1.54 0.567 0 C-N-CA 124.127 0.971 . . . . 0.0 110.922 177.085 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A 2427 ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.206 0 CA-C-O 121.488 0.493 . . . . 0.0 113.987 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A 2428 ' ' ASP . . . . . . . . . . . . . 22.8 m-20 -106.0 134.56 19.69 Favored Pre-proline 0 CA--C 1.549 0.929 0 C-N-CA 124.778 1.231 . . . . 0.0 112.834 -176.16 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 2429 ' ' PRO . . . . . . . . . . . . . 77.0 Cg_exo -56.43 -28.9 75.37 Favored 'Trans proline' 0 C--N 1.353 0.794 0 C-N-CA 124.036 3.158 . . . . 0.0 114.45 174.041 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 2430 ' ' GLY . . . . . . . . . . . . . . . -77.15 -22.77 70.26 Favored Glycine 0 CA--C 1.533 1.183 0 C-N-CA 123.751 0.691 . . . . 0.0 113.747 177.074 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 2431 ' ' LEU . . . . . . . . . . . . . 4.2 mm? -86.53 -32.28 20.81 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.453 1.101 . . . . 0.0 111.405 172.642 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 2432 ' ' VAL . . . . . . . . . . . . . 74.6 t -65.07 137.68 24.55 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 CA-C-N 118.58 0.627 . . . . 0.0 110.453 169.243 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 2433 ' ' SER . . . . . . . . . . . . . 8.4 t -130.84 -169.81 2.23 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 125.054 1.342 . . . . 0.0 110.583 174.44 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 2434 ' ' ALA . . . . . . . . . . . . . . . -149.91 141.99 23.98 Favored 'General case' 0 CA--C 1.539 0.548 0 O-C-N 120.903 -1.123 . . . . 0.0 111.473 177.222 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 2435 ' ' TYR . . . . . . . . . . . . . 75.2 m-85 -145.85 151.49 37.98 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 125.511 1.524 . . . . 0.0 111.881 -176.212 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 2436 ' ' GLY . . . . . . . . . . . . . . . 117.23 162.14 12.47 Favored Glycine 0 N--CA 1.474 1.191 0 C-N-CA 125.384 1.469 . . . . 0.0 113.903 177.508 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 2437 ' ' ALA . . . . . . . . . . . . . . . -61.18 -28.7 69.32 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.045 1.338 . . . . 0.0 114.45 -169.687 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 2438 ' ' GLY . . . . . . . . . . . . . . . -65.63 -13.95 59.59 Favored Glycine 0 CA--C 1.533 1.17 0 C-N-CA 124.234 0.921 . . . . 0.0 114.688 -178.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 2439 ' ' LEU . . . . . . . . . . . . . 91.8 mt -75.9 -27.68 57.79 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 118.647 1.224 . . . . 0.0 112.526 169.353 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 2440 ' ' GLU . . . . . . . . . . . . . 43.4 mm-40 -88.02 -31.2 19.44 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.862 1.265 . . . . 0.0 111.519 174.442 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 2441 ' ' GLY . . . . . . . . . . . . . . . 113.83 -146.8 18.63 Favored Glycine 0 CA--C 1.53 1.012 0 C-N-CA 126.086 1.803 . . . . 0.0 113.381 177.013 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 2442 ' ' GLY . . . . . . . . . . . . . . . 170.87 -163.31 36.38 Favored Glycine 0 CA--C 1.53 1.001 0 C-N-CA 124.234 0.921 . . . . 0.0 114.001 -174.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 2443 ' ' VAL . . . . . . . . . . . . . 40.3 t -91.74 146.33 6.41 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 C-N-CA 124.51 1.124 . . . . 0.0 110.245 179.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 2444 ' ' THR . . . . . . . . . . . . . 20.2 p -54.61 142.89 26.42 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 124.898 1.279 . . . . 0.0 112.236 172.221 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 2445 ' ' GLY . . . . . . . . . . . . . . . 72.4 1.0 50.0 Favored Glycine 0 CA--C 1.536 1.361 0 C-N-CA 124.274 0.94 . . . . 0.0 114.685 179.318 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 2446 ' ' ASN . . . . . . . . . . . . . 16.3 m-80 -118.58 149.76 46.85 Favored Pre-proline 0 CA--C 1.549 0.93 0 C-N-CA 126.123 1.769 . . . . 0.0 110.623 179.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 2447 ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -74.48 133.1 16.97 Favored 'Trans proline' 0 C--N 1.35 0.648 0 C-N-CA 122.908 2.405 . . . . 0.0 111.99 -174.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 2448 ' ' ALA . . . . . . . . . . . . . . . -105.77 119.92 40.37 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 126.41 1.884 . . . . 0.0 108.645 168.372 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 2449 ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -124.6 135.02 52.77 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.568 1.147 . . . . 0.0 111.821 -169.44 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 2450 ' ' PHE . . . . . . . . . . . . . 15.2 p90 -152.99 170.21 20.98 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.6 1.56 . . . . 0.0 111.183 175.189 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 2451 ' ' VAL . . . . . . . . . . . . . 46.6 t -125.9 132.95 70.11 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 C-N-CA 124.911 1.285 . . . . 0.0 110.106 178.641 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 2452 ' ' VAL . . . . . . . . . . . . . 51.8 t -82.88 107.56 14.78 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 165.035 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 2453 ' ' ASN . . . . . . . . . . . . . 21.1 t-20 -83.3 113.07 20.45 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 123.551 0.74 . . . . 0.0 112.153 -171.741 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 2454 ' ' THR . . . . . . . . . . . . . 30.4 p -99.59 -6.55 27.16 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 126.001 1.72 . . . . 0.0 113.79 179.138 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 2455 ' ' SER . . . . . . . . . . . . . 16.4 m -55.78 -31.41 62.59 Favored 'General case' 0 N--CA 1.478 0.949 0 N-CA-C 114.538 1.31 . . . . 0.0 114.538 -174.26 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 2456 ' ' ASN . . . . . . . . . . . . . 66.3 m-80 -84.46 -15.83 44.7 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 124.49 1.116 . . . . 0.0 113.464 177.558 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 2457 ' ' ALA . . . . . . . . . . . . . . . -106.24 -25.73 11.85 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 125.72 1.608 . . . . 0.0 113.854 -176.386 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 2458 ' ' GLY . . . . . . . . . . . . . . . 104.24 -103.71 2.32 Favored Glycine 0 CA--C 1.529 0.966 0 C-N-CA 125.398 1.475 . . . . 0.0 111.067 -174.243 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 2459 ' ' ALA . . . . . . . . . . . . . . . -151.73 163.29 39.46 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 125.355 1.462 . . . . 0.0 111.768 -179.139 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 2460 ' ' GLY . . . . . . . . . . . . . . . 163.58 171.83 30.31 Favored Glycine 0 CA--C 1.53 1.007 0 C-N-CA 124.774 1.178 . . . . 0.0 113.293 -176.469 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 2461 ' ' ALA . . . . . . . . . . . . . . . -73.08 143.92 47.24 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.104 0.961 . . . . 0.0 112.216 179.473 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 2462 ' ' LEU . . . . . . . . . . . . . 15.7 tp -129.03 139.25 52.14 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.404 1.481 . . . . 0.0 110.662 -178.528 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 2463 ' ' SER . . . . . . . . . . . . . 66.5 m -139.6 52.65 1.72 Allowed 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 125.437 1.495 . . . . 0.0 111.616 -169.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 2464 ' ' VAL . . . . . . . . . . . . . 17.1 t -65.84 137.04 25.67 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.069 0 C-N-CA 124.044 0.938 . . . . 0.0 111.101 -178.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 2465 ' ' THR . . . . . . . . . . . . . 22.7 m -123.24 141.32 52.1 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 124.933 1.293 . . . . 0.0 109.236 170.528 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 2466 ' ' ILE . . . . . . . . . . . . . 52.1 mt -116.13 114.7 46.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 C-N-CA 123.679 0.792 . . . . 0.0 108.981 171.003 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 2467 ' ' ASP . . . . . . . . . . . . . 37.1 t70 -95.29 158.69 15.35 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 125.519 1.527 . . . . 0.0 110.297 168.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 2468 ' ' GLY . . . . . . . . . . . . . . . 174.61 -171.3 44.45 Favored Glycine 0 CA--C 1.536 1.36 0 O-C-N 121.271 -0.893 . . . . 0.0 114.789 179.71 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 2469 ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -68.15 -25.95 36.87 Favored 'Trans proline' 0 CA--C 1.538 0.716 0 C-N-CA 123.941 3.094 . . . . 0.0 112.802 178.56 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 2470 ' ' SER . . . . . . . . . . . . . 58.5 m -142.86 174.59 10.52 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 126.058 1.743 . . . . 0.0 110.685 174.177 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 2471 ' ' LYS . . . . . . . . . . . . . 57.1 mtmt -66.71 166.59 12.74 Favored 'General case' 0 CA--C 1.548 0.887 0 O-C-N 121.13 -0.981 . . . . 0.0 112.314 170.025 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 2472 ' ' VAL . . . . . . . . . . . . . 24.7 m -131.39 147.21 32.79 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 125.231 1.412 . . . . 0.0 111.464 -178.687 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 2473 ' ' LYS . . . . . . . . . . . . . 56.8 tttp -83.2 67.64 9.28 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 124.229 1.012 . . . . 0.0 110.931 174.715 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 2474 ' ' MET . . . . . . . . . . . . . 23.3 ttt -75.45 136.33 40.69 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 125.217 1.407 . . . . 0.0 111.979 -174.599 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 2475 ' ' ASP . . . . . . . . . . . . . 36.7 t70 -141.8 129.3 21.35 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 126.429 1.892 . . . . 0.0 110.33 176.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 2476 ' ' CYS . . . . . . . . . . . . . 74.5 m -113.91 148.62 36.47 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.931 1.293 . . . . 0.0 111.55 -176.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 2477 ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -150.3 148.1 28.44 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.269 1.027 . . . . 0.0 111.013 179.485 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 2478 ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -88.94 117.84 28.24 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 123.972 0.909 . . . . 0.0 109.845 173.508 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 2479 ' ' CYS . . . . . 0.66 ' HG ' ' HE ' ' A' 2484 ' ' ARG . 87.6 m -122.31 166.36 17.51 Favored Pre-proline 0 CA--C 1.552 1.037 0 C-N-CA 125.601 1.56 . . . . 0.0 111.284 179.82 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 2480 ' ' PRO . . . . . . . . . . . . . 58.0 Cg_exo -57.88 -30.3 89.14 Favored 'Trans proline' 0 C--N 1.353 0.8 0 C-N-CA 123.534 2.823 . . . . 0.0 114.216 175.394 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 2481 ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -78.44 -7.61 57.58 Favored 'General case' 0 CA--C 1.552 1.02 0 C-N-CA 125.357 1.463 . . . . 0.0 112.991 177.644 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 2482 ' ' GLY . . . . . . . . . . . . . . . 118.66 -163.23 13.16 Favored Glycine 0 CA--C 1.53 1.012 0 C-N-CA 126.313 1.911 . . . . 0.0 112.533 -173.106 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 2483 ' ' TYR . . . . . . . . . . . . . 83.4 m-85 -72.67 107.67 5.26 Favored 'General case' 0 CA--C 1.54 0.571 0 O-C-N 121.564 -0.962 . . . . 0.0 111.31 177.213 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 2484 ' ' ARG . . . . . 0.66 ' HE ' ' HG ' ' A' 2479 ' ' CYS . 51.5 ttp85 -79.19 136.89 37.22 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 124.753 1.221 . . . . 0.0 110.231 174.269 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 2485 ' ' VAL . . . . . . . . . . . . . 92.5 t -128.15 125.56 64.6 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 C-N-CA 125.931 1.692 . . . . 0.0 108.48 179.001 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 2486 ' ' THR . . . . . . . . . . . . . 57.9 m -123.99 139.59 53.8 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 124.619 1.168 . . . . 0.0 108.488 172.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 2487 ' ' TYR . . . . . . . . . . . . . 27.3 p90 -147.06 150.51 35.21 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 112.754 0.65 . . . . 0.0 112.754 176.58 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 2488 ' ' THR . . . . . . . . . . . . . 24.7 m -109.79 115.11 55.9 Favored Pre-proline 0 N--CA 1.474 0.736 0 CA-C-O 117.764 -1.112 . . . . 0.0 109.047 174.455 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 2489 ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -81.42 149.06 16.65 Favored 'Trans proline' 0 N--CA 1.459 -0.553 0 C-N-CA 123.515 2.81 . . . . 0.0 110.731 171.237 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 2490 ' ' MET . . . . . . . . . . . . . 27.6 ptm -118.6 6.4 11.66 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 114.411 1.263 . . . . 0.0 114.411 -174.255 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 2491 ' ' ALA . . . . . . . . . . . . . . . -152.57 147.69 19.73 Favored Pre-proline 0 CA--C 1.544 0.74 0 C-N-CA 125.548 1.539 . . . . 0.0 111.41 -179.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 2492 ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -72.86 156.91 52.35 Favored 'Trans proline' 0 CA--C 1.536 0.606 0 C-N-CA 123.379 2.72 . . . . 0.0 111.208 174.557 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 2493 ' ' GLY . . . . . . . . . . . . . . . 134.94 -148.93 19.75 Favored Glycine 0 CA--C 1.527 0.843 0 C-N-CA 125.428 1.489 . . . . 0.0 112.061 -174.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 2494 ' ' SER . . . . . . . . . . . . . 36.8 m -128.6 133.85 48.43 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.694 0.798 . . . . 0.0 111.423 176.57 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 2495 ' ' TYR . . . . . . . . . . . . . 52.3 m-85 -107.18 127.13 53.23 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 126.152 1.781 . . . . 0.0 109.709 179.276 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 2496 ' ' LEU . . . . . . . . . . . . . 26.3 tp -98.75 112.69 24.69 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.411 1.085 . . . . 0.0 109.495 -176.528 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 2497 ' ' ILE . . . . . . . . . . . . . 36.9 mt -96.43 103.29 14.51 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 C-N-CA 125.331 1.452 . . . . 0.0 108.383 -176.191 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 2498 ' ' SER . . . . . . . . . . . . . 74.4 m -96.7 91.16 5.57 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 125.617 1.567 . . . . 0.0 110.247 -177.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 2499 ' ' ILE . . . . . . . . . . . . . 59.6 mt -87.62 104.69 14.59 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 C-N-CA 126.363 1.865 . . . . 0.0 109.591 -172.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 2500 ' ' LYS . . . . . . . . . . . . . 30.6 mttp -110.52 138.06 47.41 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.207 1.003 . . . . 0.0 111.589 -176.715 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 2501 ' ' TYR . . . . . . . . . . . . . 76.7 t80 -139.24 148.08 42.59 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.671 1.189 . . . . 0.0 112.452 -174.355 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 2502 ' ' GLY . . . . . . . . . . . . . . . 65.04 20.88 67.36 Favored Glycine 0 CA--C 1.536 1.358 0 C-N-CA 124.143 0.878 . . . . 0.0 113.465 -179.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 2503 ' ' GLY . . . . . . . . . . . . . . . 126.57 -171.31 18.28 Favored Glycine 0 CA--C 1.541 1.66 0 C-N-CA 125.967 1.746 . . . . 0.0 112.238 -163.524 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 2504 ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -84.02 43.55 1.4 Allowed 'Trans proline' 0 CA--C 1.546 1.083 0 C-N-CA 124.898 3.732 . . . . 0.0 112.618 -172.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 2505 ' ' TYR . . . . . . . . . . . . . 78.9 m-85 -127.15 132.01 50.63 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 124.457 1.103 . . . . 0.0 112.81 -175.073 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 2506 ' ' HIS . . . . . . . . . . . . . 79.0 m-70 -60.14 141.71 55.45 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 125.629 1.572 . . . . 0.0 114.46 -173.587 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 2507 ' ' ILE . . . . . . . . . . . . . 1.8 pp -79.26 170.59 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.2 0 C-N-CA 124.028 0.931 . . . . 0.0 112.628 171.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 2508 ' ' GLY . . . . . . . . . . . . . . . -60.15 112.1 4.17 Favored Glycine 0 CA--C 1.533 1.216 0 C-N-CA 123.753 0.692 . . . . 0.0 112.628 -176.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 2509 ' ' GLY . . . . . . . . . . . . . . . 95.72 -7.36 67.96 Favored Glycine 0 CA--C 1.536 1.347 0 C-N-CA 125.699 1.618 . . . . 0.0 114.866 -177.476 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 2510 ' ' SER . . . . . . . . . . . . . 45.4 t -79.62 146.97 66.37 Favored Pre-proline 0 CA--C 1.55 0.952 0 CA-C-N 119.16 1.48 . . . . 0.0 111.82 176.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 2511 ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -80.15 157.35 87.41 Favored 'Cis proline' 0 C--N 1.353 0.803 0 CA-C-N 119.834 0.977 . . . . 0.0 113.409 0.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 2512 ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -109.96 125.66 53.1 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.18 1.392 . . . . 0.0 111.199 179.75 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 2513 ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.73 101.59 13.83 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 124.449 1.1 . . . . 0.0 112.283 175.167 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 2514 ' ' ALA . . . . . . . . . . . . . . . -88.35 122.87 32.35 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 125.211 1.404 . . . . 0.0 110.28 174.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 2515 ' ' LYS . . . . . . . . . . . . . 27.7 mtpp -97.08 134.95 39.76 Favored 'General case' 0 CA--C 1.542 0.653 0 O-C-N 121.231 -0.918 . . . . 0.0 111.285 -174.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 2516 ' ' VAL . . . . . . . . . . . . . 74.0 t -130.39 138.95 52.57 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.775 0 C-N-CA 124.911 1.285 . . . . 0.0 110.849 -169.07 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 2517 ' ' THR . . . . . . . . . . . . . 54.2 p -134.6 171.07 14.84 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 125.869 1.667 . . . . 0.0 110.892 179.605 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 2518 ' ' GLY . . . . . . . . . . . . . . . 106.37 178.65 23.26 Favored Glycine 0 CA--C 1.539 1.568 0 C-N-CA 124.828 1.204 . . . . 0.0 113.432 -176.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 2519 ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -70.98 136.11 29.04 Favored 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 123.715 2.943 . . . . 0.0 112.129 -171.053 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 2520 ' ' ARG . . . . . . . . . . . . . 50.9 ttp180 . . . . . 0 CA--C 1.539 0.546 0 C-N-CA 124.047 0.939 . . . . 0.0 110.778 176.053 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A 2427 ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.152 0 CA-C-O 121.196 0.331 . . . . 0.0 112.68 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A 2428 ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -144.76 128.22 8.64 Favored Pre-proline 0 CA--C 1.546 0.802 0 C-N-CA 125.65 1.58 . . . . 0.0 109.626 178.001 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 2429 ' ' PRO . . . . . . . . . . . . . 57.3 Cg_exo -56.46 -35.0 96.13 Favored 'Trans proline' 0 C--N 1.353 0.789 0 C-N-CA 123.183 2.588 . . . . 0.0 114.493 -175.378 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 2430 ' ' GLY . . . . . . . . . . . . . . . -73.04 -18.84 79.36 Favored Glycine 0 CA--C 1.534 1.257 0 CA-C-N 118.552 0.615 . . . . 0.0 114.186 179.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 2431 ' ' LEU . . . . . . . . . . . . . 4.1 mm? -87.02 -20.29 27.44 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.732 1.213 . . . . 0.0 111.904 173.075 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 2432 ' ' VAL . . . . . . . . . . . . . 60.8 t -80.97 138.31 19.87 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 C-N-CA 124.571 1.148 . . . . 0.0 109.178 172.143 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 2433 ' ' SER . . . . . . . . . . . . . 8.6 t -128.11 -169.86 2.14 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 125.083 1.353 . . . . 0.0 111.001 176.337 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 2434 ' ' ALA . . . . . . . . . . . . . . . -155.45 142.77 19.41 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.692 1.197 . . . . 0.0 111.656 177.303 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 2435 ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -145.24 145.12 31.16 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 125.245 1.418 . . . . 0.0 112.071 -176.433 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 2436 ' ' GLY . . . . . . . . . . . . . . . 129.08 158.48 9.6 Favored Glycine 0 N--CA 1.472 1.077 0 C-N-CA 125.622 1.582 . . . . 0.0 113.395 178.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 2437 ' ' ALA . . . . . . . . . . . . . . . -62.11 -27.79 69.18 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 114.206 1.187 . . . . 0.0 114.206 -170.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 2438 ' ' GLY . . . . . . . . . . . . . . . -65.57 -16.66 63.52 Favored Glycine 0 CA--C 1.531 1.035 0 CA-C-O 118.888 -0.951 . . . . 0.0 114.31 -178.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 2439 ' ' LEU . . . . . . . . . . . . . 87.7 mt -73.53 -28.69 62.02 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 118.673 1.237 . . . . 0.0 112.513 171.259 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 2440 ' ' GLU . . . . . . . . . . . . . 41.5 mm-40 -92.25 -33.47 14.64 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.942 1.297 . . . . 0.0 112.167 -177.037 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 2441 ' ' GLY . . . . . . . . . . . . . . . 161.15 -156.38 27.77 Favored Glycine 0 CA--C 1.528 0.894 0 N-CA-C 114.875 0.71 . . . . 0.0 114.875 -176.825 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 2442 ' ' GLY . . . . . . . . . . . . . . . 171.26 -167.14 40.26 Favored Glycine 0 CA--C 1.53 0.992 0 C-N-CA 125.648 1.594 . . . . 0.0 112.298 -178.657 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 2443 ' ' VAL . . . . . . . . . . . . . 98.2 t -125.27 144.83 33.93 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 C-N-CA 124.692 1.197 . . . . 0.0 109.36 175.638 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 2444 ' ' THR . . . . . . . . . . . . . 21.4 p -54.7 127.5 28.48 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 124.95 1.3 . . . . 0.0 111.812 176.42 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 2445 ' ' GLY . . . . . . . . . . . . . . . 79.26 -5.36 59.91 Favored Glycine 0 CA--C 1.536 1.383 0 C-N-CA 124.622 1.106 . . . . 0.0 114.846 -178.399 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 2446 ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -97.66 139.82 21.59 Favored Pre-proline 0 CA--C 1.551 1.019 0 C-N-CA 125.617 1.567 . . . . 0.0 110.953 176.519 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 2447 ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -75.56 122.15 6.78 Favored 'Trans proline' 0 N--CA 1.457 -0.64 0 C-N-CA 122.839 2.36 . . . . 0.0 110.632 176.163 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 2448 ' ' ALA . . . . . . . . . . . . . . . -105.16 156.57 17.97 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.97 1.708 . . . . 0.0 109.883 168.262 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 2449 ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -156.96 159.11 37.75 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 114.035 1.124 . . . . 0.0 114.035 -175.181 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 2450 ' ' PHE . . . . . . . . . . . . . 54.9 p90 -159.49 148.2 17.85 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 126.173 1.789 . . . . 0.0 110.571 178.314 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 2451 ' ' VAL . . . . . . . . . . . . . 11.2 t -102.35 124.22 56.15 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 C-N-CA 124.439 1.095 . . . . 0.0 108.886 174.594 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 2452 ' ' VAL . . . . . . . . . . . . . 43.5 t -75.13 108.81 7.28 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 N-CA-C 106.838 -1.542 . . . . 0.0 106.838 167.303 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 2453 ' ' ASN . . . . . . . . . . . . . 62.7 t-20 -87.55 113.89 23.66 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.136 0.974 . . . . 0.0 110.802 -171.055 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 2454 ' ' THR . . . . . . . . . . . . . 73.1 p -104.92 2.09 29.49 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 126.079 1.752 . . . . 0.0 112.958 -175.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 2455 ' ' SER . . . . . . . . . . . . . 46.9 m -58.42 -30.36 66.82 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 114.518 1.303 . . . . 0.0 114.518 -169.341 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 2456 ' ' ASN . . . . . . . . . . . . . 29.3 m120 -92.89 -11.21 34.05 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 124.663 1.185 . . . . 0.0 113.683 177.251 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 2457 ' ' ALA . . . . . . . . . . . . . . . -101.74 -32.81 10.11 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 125.309 1.444 . . . . 0.0 113.502 -178.427 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 2458 ' ' GLY . . . . . . . . . . . . . . . 85.81 -159.24 32.84 Favored Glycine 0 CA--C 1.533 1.214 0 C-N-CA 124.976 1.274 . . . . 0.0 112.846 -174.77 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 2459 ' ' ALA . . . . . . . . . . . . . . . -60.84 155.48 19.46 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 124.991 1.317 . . . . 0.0 114.016 -177.423 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 2460 ' ' GLY . . . . . . . . . . . . . . . 159.09 -174.62 36.06 Favored Glycine 0 CA--C 1.534 1.228 0 C-N-CA 125.922 1.725 . . . . 0.0 112.904 -176.556 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 2461 ' ' ALA . . . . . . . . . . . . . . . -123.61 143.24 50.35 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.904 1.282 . . . . 0.0 112.198 -177.089 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 2462 ' ' LEU . . . . . . . . . . . . . 24.8 tp -92.69 145.23 24.57 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.588 1.555 . . . . 0.0 111.254 179.093 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 2463 ' ' SER . . . . . . . . . . . . . 4.3 t -138.13 40.07 2.3 Favored 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 125.667 1.587 . . . . 0.0 111.004 -179.794 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 2464 ' ' VAL . . . . . . . . . . . . . 12.6 p -65.2 147.63 12.49 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 C-N-CA 126.008 1.723 . . . . 0.0 112.638 -175.498 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 2465 ' ' THR . . . . . . . . . . . . . 10.8 t -151.9 160.92 43.37 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 125.13 1.372 . . . . 0.0 111.412 172.388 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 2466 ' ' ILE . . . . . . . . . . . . . 55.5 mt -135.11 124.63 42.97 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 124.913 1.285 . . . . 0.0 110.16 -173.853 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 2467 ' ' ASP . . . . . . . . . . . . . 29.9 m-20 -106.36 173.35 6.35 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 126.44 1.896 . . . . 0.0 110.79 169.808 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 2468 ' ' GLY . . . . . . . . . . . . . . . 153.49 -155.02 25.89 Favored Glycine 0 CA--C 1.535 1.331 0 CA-C-O 118.916 -0.935 . . . . 0.0 113.872 179.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 2469 ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -70.21 -10.52 28.39 Favored 'Trans proline' 0 CA--C 1.542 0.883 0 C-N-CA 123.705 2.936 . . . . 0.0 113.756 178.294 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 2470 ' ' SER . . . . . 0.442 ' HG ' ' HG3' ' A' 2490 ' ' MET . 34.0 p -166.77 169.09 13.67 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 125.488 1.515 . . . . 0.0 111.934 -176.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 2471 ' ' LYS . . . . . . . . . . . . . 64.5 mttp -79.73 106.54 11.82 Favored 'General case' 0 CA--C 1.542 0.669 0 O-C-N 121.017 -1.052 . . . . 0.0 110.599 172.547 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 2472 ' ' VAL . . . . . . . . . . . . . 32.9 m -60.84 151.03 6.62 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.15 0 C-N-CA 123.821 0.848 . . . . 0.0 111.838 175.755 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 2473 ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.46 132.92 35.78 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 162.394 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 2474 ' ' MET . . . . . . . . . . . . . 16.3 tmm? -152.1 143.35 23.28 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-N 119.755 1.161 . . . . 0.0 112.975 -170.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 2475 ' ' ASP . . . . . . . . . . . . . 36.7 t70 -139.5 146.0 39.45 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 126.947 2.099 . . . . 0.0 110.295 174.214 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 2476 ' ' CYS . . . . . . . . . . . . . 30.0 t -124.35 144.99 49.71 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.515 1.126 . . . . 0.0 111.546 -179.361 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 2477 ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -143.36 169.57 17.42 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.128 1.371 . . . . 0.0 111.87 -179.763 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 2478 ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -77.78 147.21 35.4 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 123.807 0.843 . . . . 0.0 110.711 166.512 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 2479 ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -146.25 168.81 10.77 Favored Pre-proline 0 CA--C 1.552 1.054 0 C-N-CA 127.009 2.123 . . . . 0.0 111.072 178.377 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 2480 ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo -64.56 -29.35 61.33 Favored 'Trans proline' 0 CA--C 1.539 0.765 0 C-N-CA 122.75 2.3 . . . . 0.0 114.47 -173.315 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 2481 ' ' GLU . . . . . . . . . . . . . 5.6 mp0 -88.24 -10.19 50.51 Favored 'General case' 0 CA--C 1.547 0.847 0 N-CA-C 113.765 1.024 . . . . 0.0 113.765 174.216 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 2482 ' ' GLY . . . . . . . . . . . . . . . 151.45 -111.11 0.49 Allowed Glycine 0 N--CA 1.471 1.014 0 CA-C-N 119.794 1.179 . . . . 0.0 113.494 -176.188 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 2483 ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -123.14 123.85 41.73 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.437 1.095 . . . . 0.0 111.714 179.159 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 2484 ' ' ARG . . . . . 0.682 HH21 ' HG1' ' A' 2486 ' ' THR . 25.5 ttp180 -91.3 129.52 37.28 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 123.369 0.667 . . . . 0.0 111.108 175.097 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 2485 ' ' VAL . . . . . . . . . . . . . 98.7 t -99.2 132.03 45.35 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.475 0 C-N-CA 125.162 1.385 . . . . 0.0 107.99 168.101 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 2486 ' ' THR . . . . . 0.682 ' HG1' HH21 ' A' 2484 ' ' ARG . 20.5 m -124.5 126.3 45.64 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 125.415 1.486 . . . . 0.0 107.619 176.132 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 2487 ' ' TYR . . . . . . . . . . . . . 15.8 p90 -143.19 150.13 38.96 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 113.584 0.957 . . . . 0.0 113.584 -176.842 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 2488 ' ' THR . . . . . . . . . . . . . 91.2 m -119.59 115.03 34.05 Favored Pre-proline 0 N--CA 1.468 0.471 0 C-N-CA 125.342 1.457 . . . . 0.0 108.618 176.37 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 2489 ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -79.08 153.3 24.88 Favored 'Trans proline' 0 N--CA 1.456 -0.68 0 C-N-CA 123.339 2.693 . . . . 0.0 110.774 175.084 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 2490 ' ' MET . . . . . 0.442 ' HG3' ' HG ' ' A' 2470 ' ' SER . 24.8 ptm -118.09 -4.87 10.98 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 114.584 1.327 . . . . 0.0 114.584 -174.044 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 2491 ' ' ALA . . . . . . . . . . . . . . . -145.38 152.25 49.54 Favored Pre-proline 0 CA--C 1.548 0.899 0 C-N-CA 125.296 1.439 . . . . 0.0 111.601 177.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 2492 ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -72.83 154.85 53.83 Favored 'Trans proline' 0 CA--C 1.537 0.635 0 C-N-CA 123.001 2.467 . . . . 0.0 111.076 173.186 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 2493 ' ' GLY . . . . . . . . . . . . . . . 130.81 -168.37 21.88 Favored Glycine 0 CA--C 1.529 0.964 0 C-N-CA 125.473 1.511 . . . . 0.0 113.508 -178.163 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 2494 ' ' SER . . . . . . . . . . . . . 70.5 m -99.62 116.53 31.96 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 123.923 0.889 . . . . 0.0 111.333 178.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 2495 ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -87.93 150.77 23.27 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.582 1.153 . . . . 0.0 110.53 166.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 2496 ' ' LEU . . . . . . . . . . . . . 32.0 tp -121.99 114.73 21.37 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.803 1.241 . . . . 0.0 109.359 179.583 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 2497 ' ' ILE . . . . . . . . . . . . . 63.4 mt -99.38 108.18 22.01 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 C-N-CA 125.318 1.447 . . . . 0.0 108.415 -172.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 2498 ' ' SER . . . . . . . . . . . . . 73.2 m -95.47 101.44 13.16 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 124.507 1.123 . . . . 0.0 109.732 179.358 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 2499 ' ' ILE . . . . . 0.426 ' H ' ' HG ' ' A' 2510 ' ' SER . 42.8 mt -96.38 105.98 17.79 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 C-N-CA 124.762 1.225 . . . . 0.0 108.729 -178.023 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 2500 ' ' LYS . . . . . . . . . . . . . 85.1 mttt -113.2 142.51 45.71 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.406 1.082 . . . . 0.0 110.912 177.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 2501 ' ' TYR . . . . . . . . . . . . . 43.8 t80 -151.2 139.95 20.79 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.881 0.873 . . . . 0.0 112.258 -174.423 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 2502 ' ' GLY . . . . . . . . . . . . . . . 69.68 12.85 67.91 Favored Glycine 0 CA--C 1.536 1.402 0 C-N-CA 124.308 0.956 . . . . 0.0 114.267 177.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 2503 ' ' GLY . . . . . . . . . . . . . . . 150.81 -169.96 30.61 Favored Glycine 0 CA--C 1.539 1.54 0 C-N-CA 125.844 1.687 . . . . 0.0 113.025 -170.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 2504 ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -82.16 14.29 2.28 Favored 'Trans proline' 0 CA--C 1.544 1.011 0 C-N-CA 124.838 3.692 . . . . 0.0 113.918 -174.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 2505 ' ' TYR . . . . . . . . . . . . . 68.7 m-85 -108.44 141.64 40.0 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.77 1.228 . . . . 0.0 113.491 -171.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 2506 ' ' HIS . . . . . . . . . . . . . 84.3 m-70 -63.24 141.4 58.78 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 125.114 1.365 . . . . 0.0 112.988 176.246 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 2507 ' ' ILE . . . . . . . . . . . . . 1.6 pp -77.88 172.04 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 C-N-CA 123.612 0.765 . . . . 0.0 112.666 174.823 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 2508 ' ' GLY . . . . . . . . . . . . . . . -59.95 111.29 3.44 Favored Glycine 0 CA--C 1.534 1.264 0 O-C-N 121.531 -0.731 . . . . 0.0 112.582 -176.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 2509 ' ' GLY . . . . . . . . . . . . . . . 96.6 -7.3 65.66 Favored Glycine 0 CA--C 1.536 1.348 0 C-N-CA 125.822 1.677 . . . . 0.0 114.939 -177.19 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 2510 ' ' SER . . . . . 0.426 ' HG ' ' H ' ' A' 2499 ' ' ILE . 47.8 t -82.36 147.55 56.9 Favored Pre-proline 0 CA--C 1.551 0.981 0 CA-C-N 119.098 1.449 . . . . 0.0 112.106 178.123 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 2511 ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -78.41 154.42 92.64 Favored 'Cis proline' 0 C--N 1.353 0.808 0 CA-C-N 119.788 0.96 . . . . 0.0 113.091 -1.108 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 2512 ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -105.71 127.95 53.38 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.32 1.448 . . . . 0.0 110.998 -179.628 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 2513 ' ' LYS . . . . . . . . . . . . . 61.1 pttt -87.06 115.61 24.57 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 123.719 0.808 . . . . 0.0 111.906 175.836 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 2514 ' ' ALA . . . . . . . . . . . . . . . -105.94 114.9 29.32 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.645 1.578 . . . . 0.0 110.522 -179.051 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 2515 ' ' LYS . . . . . . . . . . . . . 54.2 mtpt -94.75 112.94 24.65 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.107 0.963 . . . . 0.0 110.755 -173.282 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 2516 ' ' VAL . . . . . . . . . . . . . 75.6 t -110.67 144.21 19.11 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 125.417 1.487 . . . . 0.0 110.542 -173.22 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 2517 ' ' THR . . . . . . . . . . . . . 66.4 p -133.45 172.53 12.6 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 125.3 1.44 . . . . 0.0 111.232 176.127 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 2518 ' ' GLY . . . . . . . . . . . . . . . 107.35 177.28 22.63 Favored Glycine 0 CA--C 1.541 1.676 0 C-N-CA 125.215 1.388 . . . . 0.0 113.954 -179.733 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 2519 ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -73.74 136.63 23.51 Favored 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 123.972 3.115 . . . . 0.0 112.172 -172.283 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 2520 ' ' ARG . . . . . . . . . . . . . 34.9 ttm180 . . . . . 0 CA--C 1.542 0.664 0 C-N-CA 123.976 0.91 . . . . 0.0 111.286 177.322 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A 2427 ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.821 0 N-CA-C 112.128 -0.389 . . . . 0.0 112.128 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A 2428 ' ' ASP . . . . . . . . . . . . . 12.9 t70 -100.67 129.9 26.62 Favored Pre-proline 0 CA--C 1.552 1.025 0 C-N-CA 124.242 1.017 . . . . 0.0 112.347 -175.572 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 2429 ' ' PRO . . . . . . . . . . . . . 53.8 Cg_exo -58.24 -27.1 79.43 Favored 'Trans proline' 0 C--N 1.354 0.829 0 C-N-CA 123.719 2.946 . . . . 0.0 114.99 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 2430 ' ' GLY . . . . . . . . . . . . . . . -80.05 -23.33 61.66 Favored Glycine 0 CA--C 1.532 1.143 0 CA-C-N 119.154 0.888 . . . . 0.0 113.322 177.674 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 2431 ' ' LEU . . . . . . . . . . . . . 4.3 mm? -82.82 -31.56 28.06 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 124.212 1.005 . . . . 0.0 111.415 170.567 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 2432 ' ' VAL . . . . . . . . . . . . . 81.3 t -69.08 136.57 26.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 123.571 0.748 . . . . 0.0 110.573 169.403 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 2433 ' ' SER . . . . . . . . . . . . . 58.6 m -139.92 144.92 37.36 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 125.174 1.39 . . . . 0.0 109.788 171.817 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 2434 ' ' ALA . . . . . . . . . . . . . . . -94.29 148.48 22.17 Favored 'General case' 0 CA--C 1.541 0.609 0 O-C-N 121.771 -0.581 . . . . 0.0 111.781 175.109 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 2435 ' ' TYR . . . . . . . . . . . . . 93.3 m-85 -142.97 147.73 35.66 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 126.136 1.775 . . . . 0.0 111.453 -178.402 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 2436 ' ' GLY . . . . . . . . . . . . . . . 120.31 161.14 11.4 Favored Glycine 0 N--CA 1.473 1.145 0 C-N-CA 125.151 1.358 . . . . 0.0 113.876 178.374 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 2437 ' ' ALA . . . . . . . . . . . . . . . -62.8 -28.88 70.3 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 114.409 1.263 . . . . 0.0 114.409 -169.682 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 2438 ' ' GLY . . . . . . . . . . . . . . . -66.99 -12.3 59.87 Favored Glycine 0 CA--C 1.532 1.108 0 CA-C-O 119.077 -0.846 . . . . 0.0 114.773 -177.425 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 2439 ' ' LEU . . . . . . . . . . . . . 79.5 mt -76.41 -27.78 56.41 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.54 1.136 . . . . 0.0 112.5 170.265 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 2440 ' ' GLU . . . . . . . . . . . . . 41.5 mm-40 -88.61 -32.51 18.05 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.893 1.277 . . . . 0.0 111.529 176.507 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 2441 ' ' GLY . . . . . . . . . . . . . . . 115.9 -130.55 9.12 Favored Glycine 0 CA--C 1.531 1.05 0 C-N-CA 125.706 1.622 . . . . 0.0 112.503 -179.754 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 2442 ' ' GLY . . . . . . . . . . . . . . . 135.11 -150.0 20.07 Favored Glycine 0 CA--C 1.535 1.311 0 C-N-CA 125.155 1.36 . . . . 0.0 113.701 -174.365 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 2443 ' ' VAL . . . . . . . . . . . . . 90.2 t -89.55 136.26 24.06 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 C-N-CA 124.804 1.242 . . . . 0.0 111.025 -174.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 2444 ' ' THR . . . . . . . . . . . . . 46.3 p -72.24 146.65 47.12 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 124.47 1.108 . . . . 0.0 112.049 176.818 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 2445 ' ' GLY . . . . . . . . . . . . . . . 78.28 -10.73 26.96 Favored Glycine 0 CA--C 1.538 1.5 0 C-N-CA 124.243 0.925 . . . . 0.0 114.193 -172.753 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 2446 ' ' ASN . . . . . . . . . . . . . 77.0 m-20 -102.12 152.54 38.25 Favored Pre-proline 0 CA--C 1.55 0.944 0 C-N-CA 125.469 1.507 . . . . 0.0 111.034 172.474 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 2447 ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -72.07 140.34 34.35 Favored 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 123.075 2.516 . . . . 0.0 111.55 178.25 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 2448 ' ' ALA . . . . . . . . . . . . . . . -121.3 131.14 54.03 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 127.115 2.166 . . . . 0.0 109.089 173.725 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 2449 ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -128.55 141.4 51.38 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.294 1.038 . . . . 0.0 111.806 -166.854 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 2450 ' ' PHE . . . . . . . . . . . . . 37.8 p90 -155.2 161.34 41.22 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.211 1.405 . . . . 0.0 111.998 173.164 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 2451 ' ' VAL . . . . . . . . . . . . . 8.1 p -118.44 139.05 47.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 125.616 1.566 . . . . 0.0 110.417 176.666 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 2452 ' ' VAL . . . . . . . . . . . . . 61.4 t -95.81 101.41 12.37 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 N-CA-C 107.194 -1.41 . . . . 0.0 107.194 168.555 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 2453 ' ' ASN . . . . . . . . . . . . . 22.6 t-20 -83.49 120.29 25.73 Favored 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 -169.601 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 2454 ' ' THR . . . . . . . . . . . . . 35.4 p -99.52 -5.98 28.3 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 125.878 1.671 . . . . 0.0 113.993 -177.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 2455 ' ' SER . . . . . . . . . . . . . 19.9 m -57.39 -32.99 67.38 Favored 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 114.556 1.317 . . . . 0.0 114.556 -172.772 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 2456 ' ' ASN . . . . . . . . . . . . . 28.0 m120 -83.4 -15.9 48.0 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 124.149 0.98 . . . . 0.0 113.601 176.228 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 2457 ' ' ALA . . . . . . . . . . . . . . . -102.49 -42.22 6.03 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.032 1.333 . . . . 0.0 113.505 -173.217 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 2458 ' ' GLY . . . . . . . . . . . . . . . 120.55 -111.4 1.94 Allowed Glycine 0 CA--C 1.53 0.995 0 C-N-CA 125.323 1.439 . . . . 0.0 111.631 -172.246 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 2459 ' ' ALA . . . . . . . . . . . . . . . -148.04 149.92 32.99 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.721 1.208 . . . . 0.0 112.835 -175.808 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 2460 ' ' GLY . . . . . . . . . . . . . . . 171.11 171.09 36.0 Favored Glycine 0 CA--C 1.529 0.906 0 C-N-CA 124.748 1.166 . . . . 0.0 113.152 -176.492 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 2461 ' ' ALA . . . . . . . . . . . . . . . -81.82 142.42 32.58 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.014 0.925 . . . . 0.0 112.454 -179.433 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 2462 ' ' LEU . . . . . . . . . . . . . 16.9 tp -102.02 145.2 29.63 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.154 1.382 . . . . 0.0 110.38 172.559 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 2463 ' ' SER . . . . . . . . . . . . . 5.4 t -138.3 45.09 2.1 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 124.972 1.309 . . . . 0.0 110.625 179.745 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 2464 ' ' VAL . . . . . . . . . . . . . 9.1 p -65.94 134.86 29.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 124.975 1.31 . . . . 0.0 111.855 -177.105 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 2465 ' ' THR . . . . . . . . . . . . . 85.5 m -130.9 144.73 51.68 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 125.992 1.717 . . . . 0.0 109.144 177.617 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 2466 ' ' ILE . . . . . . . . . . . . . 47.7 mt -123.86 120.93 61.01 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 123.617 0.767 . . . . 0.0 109.808 175.764 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 2467 ' ' ASP . . . . . . . . . . . . . 31.2 m-20 -103.06 167.57 9.74 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 125.951 1.7 . . . . 0.0 110.742 169.785 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 2468 ' ' GLY . . . . . . . . . . . . . . . 167.27 -167.06 39.65 Favored Glycine 0 CA--C 1.537 1.41 0 O-C-N 121.387 -0.821 . . . . 0.0 114.534 179.776 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 2469 ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -70.68 -15.74 33.66 Favored 'Trans proline' 0 CA--C 1.54 0.822 0 C-N-CA 124.219 3.279 . . . . 0.0 113.284 178.248 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 2470 ' ' SER . . . . . . . . . . . . . 49.9 m -153.01 179.2 8.9 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 127.081 2.152 . . . . 0.0 110.051 173.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 2471 ' ' LYS . . . . . . . . . . . . . 65.1 pttt -69.4 171.2 9.04 Favored 'General case' 0 CA--C 1.549 0.937 0 O-C-N 121.083 -1.011 . . . . 0.0 112.926 171.269 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 2472 ' ' VAL . . . . . . . . . . . . . 26.7 m -130.9 147.38 33.09 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 125.173 1.389 . . . . 0.0 111.032 175.206 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 2473 ' ' LYS . . . . . . . . . . . . . 51.8 mtmt -88.57 58.73 4.81 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 124.382 1.073 . . . . 0.0 111.688 177.033 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 2474 ' ' MET . . . . . . . . . . . . . 16.0 tmm? -77.53 134.84 38.2 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.31 1.044 . . . . 0.0 112.635 -174.578 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 2475 ' ' ASP . . . . . . . . . . . . . 35.5 t70 -130.56 144.63 51.54 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 126.927 2.091 . . . . 0.0 110.451 172.286 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 2476 ' ' CYS . . . . . . . . . . . . . 48.9 t -127.53 147.63 50.33 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 125.543 1.537 . . . . 0.0 112.583 -173.102 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 2477 ' ' GLN . . . . . . . . . . . . . 23.1 tt0 -151.79 136.96 17.44 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.477 1.111 . . . . 0.0 110.964 170.747 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 2478 ' ' GLU . . . . . . . . . . . . . 4.1 pm0 -75.67 132.41 40.54 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.671 1.188 . . . . 0.0 111.886 172.63 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 2479 ' ' CYS . . . . . . . . . . . . . 80.0 m -133.98 169.37 14.08 Favored Pre-proline 0 CA--C 1.554 1.105 0 C-N-CA 126.157 1.783 . . . . 0.0 110.849 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 2480 ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -57.07 -27.27 73.14 Favored 'Trans proline' 0 CA--C 1.54 0.819 0 C-N-CA 123.569 2.846 . . . . 0.0 113.912 170.073 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 2481 ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -76.46 -3.66 38.37 Favored 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 125.684 1.594 . . . . 0.0 113.093 175.057 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 2482 ' ' GLY . . . . . . . . . . . . . . . 104.39 -170.01 17.97 Favored Glycine 0 CA--C 1.529 0.96 0 C-N-CA 125.949 1.737 . . . . 0.0 112.381 -169.178 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 2483 ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -71.56 116.37 11.83 Favored 'General case' 0 N--CA 1.469 0.488 0 O-C-N 121.493 -1.004 . . . . 0.0 111.116 175.336 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 2484 ' ' ARG . . . . . . . . . . . . . 15.2 ttp-105 -98.8 143.36 29.22 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 123.793 0.837 . . . . 0.0 110.512 174.574 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 2485 ' ' VAL . . . . . . . . . . . . . 35.1 m -132.96 150.03 32.44 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 C-N-CA 124.095 0.958 . . . . 0.0 111.563 174.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 2486 ' ' THR . . . . . . . . . . . . . 73.0 m -133.75 135.66 44.08 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 125.332 1.453 . . . . 0.0 108.217 171.8 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 2487 ' ' TYR . . . . . . . . . . . . . 26.4 p90 -141.12 150.98 43.53 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 124.424 1.09 . . . . 0.0 112.5 179.354 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 2488 ' ' THR . . . . . . . . . . . . . 92.2 m -115.49 116.25 41.56 Favored Pre-proline 0 N--CA 1.473 0.676 0 CA-C-O 117.844 -1.074 . . . . 0.0 109.097 173.1 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 2489 ' ' PRO . . . . . . . . . . . . . 77.8 Cg_endo -82.6 135.01 7.78 Favored 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 123.755 2.97 . . . . 0.0 110.382 172.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 2490 ' ' MET . . . . . . . . . . . . . 24.1 ptm -98.12 3.43 49.16 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 114.918 1.451 . . . . 0.0 114.918 -172.421 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 2491 ' ' ALA . . . . . . . . . . . . . . . -153.48 148.64 20.03 Favored Pre-proline 0 CA--C 1.543 0.687 0 C-N-CA 125.146 1.378 . . . . 0.0 111.654 -177.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 2492 ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -73.93 153.48 47.48 Favored 'Trans proline' 0 C--N 1.35 0.631 0 C-N-CA 123.522 2.815 . . . . 0.0 111.569 178.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 2493 ' ' GLY . . . . . . . . . . . . . . . 136.85 -150.8 20.71 Favored Glycine 0 CA--C 1.53 1.026 0 C-N-CA 125.297 1.427 . . . . 0.0 113.166 -178.19 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 2494 ' ' SER . . . . . . . . . . . . . 45.3 m -118.31 124.01 46.76 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.625 1.17 . . . . 0.0 110.982 -178.271 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 2495 ' ' TYR . . . . . . . . . . . . . 40.7 m-85 -103.11 125.82 50.0 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 124.803 1.241 . . . . 0.0 110.164 177.477 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 2496 ' ' LEU . . . . . . . . . . . . . 20.1 tp -95.0 106.8 18.81 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.056 0.943 . . . . 0.0 109.467 -178.412 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 2497 ' ' ILE . . . . . . . . . . . . . 51.9 mt -90.89 103.07 14.06 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 C-N-CA 125.837 1.655 . . . . 0.0 107.849 -178.688 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 2498 ' ' SER . . . . . . . . . . . . . 25.5 t -94.61 91.83 6.75 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 126.042 1.737 . . . . 0.0 109.388 -178.402 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 2499 ' ' ILE . . . . . . . . . . . . . 30.1 mt -91.57 90.37 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 C-N-CA 124.521 1.128 . . . . 0.0 109.52 -174.069 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 2500 ' ' LYS . . . . . . . . . . . . . 56.4 mttp -89.99 142.84 27.31 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 123.79 0.836 . . . . 0.0 111.412 174.695 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 2501 ' ' TYR . . . . . . . . . . . . . 85.7 t80 -148.59 147.96 29.59 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 124.756 1.222 . . . . 0.0 112.226 -175.573 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 2502 ' ' GLY . . . . . . . . . . . . . . . 65.29 16.07 62.03 Favored Glycine 0 CA--C 1.535 1.319 0 C-N-CA 124.567 1.08 . . . . 0.0 114.152 175.38 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 2503 ' ' GLY . . . . . . . . . . . . . . . 134.45 -170.84 22.5 Favored Glycine 0 CA--C 1.542 1.749 0 C-N-CA 126.191 1.853 . . . . 0.0 111.904 -161.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 2504 ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -84.11 33.88 0.51 Allowed 'Trans proline' 0 CA--C 1.547 1.127 0 C-N-CA 124.681 3.587 . . . . 0.0 113.202 -172.806 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 2505 ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -124.51 138.51 54.33 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.483 1.113 . . . . 0.0 113.446 -172.77 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 2506 ' ' HIS . . . . . . . . . . . . . 82.6 m-70 -60.28 143.71 52.14 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 125.694 1.598 . . . . 0.0 113.799 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 2507 ' ' ILE . . . . . . . . . . . . . 31.3 pt -75.1 172.31 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 C-N-CA 123.545 0.738 . . . . 0.0 112.73 168.057 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 2508 ' ' GLY . . . . . . . . . . . . . . . -58.63 121.95 28.26 Favored Glycine 0 CA--C 1.533 1.203 0 C-N-CA 123.661 0.648 . . . . 0.0 111.723 172.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 2509 ' ' GLY . . . . . . . . . . . . . . . 88.82 -9.89 74.61 Favored Glycine 0 CA--C 1.536 1.348 0 C-N-CA 125.653 1.597 . . . . 0.0 115.07 -178.003 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 2510 ' ' SER . . . . . . . . . . . . . 40.3 t -83.59 146.31 49.75 Favored Pre-proline 0 CA--C 1.55 0.978 0 CA-C-N 119.193 1.496 . . . . 0.0 111.893 179.158 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 2511 ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -78.81 154.15 91.17 Favored 'Cis proline' 0 C--N 1.353 0.791 0 CA-C-N 119.751 0.947 . . . . 0.0 113.071 0.072 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 2512 ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -103.63 132.24 50.07 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.043 1.337 . . . . 0.0 110.334 177.174 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 2513 ' ' LYS . . . . . . . . . . . . . 64.6 pttt -93.81 15.88 15.48 Favored 'General case' 0 N--CA 1.479 0.982 0 N-CA-C 116.123 1.897 . . . . 0.0 116.123 -165.565 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 2514 ' ' ALA . . . . . . . . . . . . . . . -12.78 104.23 0.02 OUTLIER 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 129.239 3.016 . . . . 0.0 116.205 -174.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 2515 ' ' LYS . . . . . . . . . . . . . 50.2 mtmt -93.27 130.18 39.09 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 124.406 1.083 . . . . 0.0 111.015 -176.114 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 2516 ' ' VAL . . . . . . . . . . . . . 25.7 m -134.12 148.37 30.09 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 C-N-CA 124.026 0.93 . . . . 0.0 112.253 -172.042 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 2517 ' ' THR . . . . . . . . . . . . . 45.1 p -139.45 165.84 26.16 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 125.568 1.547 . . . . 0.0 111.08 -175.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 2518 ' ' GLY . . . . . . . . . . . . . . . 119.18 -157.67 15.25 Favored Glycine 0 CA--C 1.539 1.535 0 C-N-CA 124.971 1.272 . . . . 0.0 112.331 -173.62 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 2519 ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -71.7 160.73 47.32 Favored 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 123.486 2.791 . . . . 0.0 112.684 -175.146 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 2520 ' ' ARG . . . . . . . . . . . . . 55.1 ttt85 . . . . . 0 CA--C 1.537 0.469 0 C-N-CA 124.707 1.203 . . . . 0.0 108.941 167.644 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A 2427 ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.081 0 CA-C-O 121.417 0.454 . . . . 0.0 113.148 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A 2428 ' ' ASP . . . . . . . . . . . . . 13.3 t70 -93.01 135.97 25.23 Favored Pre-proline 0 CA--C 1.551 0.984 0 C-N-CA 124.754 1.222 . . . . 0.0 111.625 -178.195 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 2429 ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -67.93 -14.62 41.78 Favored 'Trans proline' 0 CA--C 1.539 0.77 0 C-N-CA 123.575 2.85 . . . . 0.0 114.294 -175.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 2430 ' ' GLY . . . . . . . . . . . . . . . -87.54 -27.03 28.38 Favored Glycine 0 CA--C 1.534 1.222 0 C-N-CA 124.392 0.996 . . . . 0.0 113.187 171.475 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 2431 ' ' LEU . . . . . . . . . . . . . 4.3 mm? -78.29 -36.45 46.62 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 118.247 1.023 . . . . 0.0 111.037 170.436 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 2432 ' ' VAL . . . . . . . . . . . . . 72.8 t -64.63 136.86 25.92 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 C-N-CA 123.356 0.662 . . . . 0.0 109.724 166.515 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 2433 ' ' SER . . . . . . . . . . . . . 8.7 t -134.1 -166.68 1.83 Allowed 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.995 1.318 . . . . 0.0 110.1 176.256 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 2434 ' ' ALA . . . . . . . . . . . . . . . -152.12 143.35 23.26 Favored 'General case' 0 CA--C 1.537 0.478 0 O-C-N 121.002 -1.061 . . . . 0.0 111.308 174.188 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 2435 ' ' TYR . . . . . . . . . . . . . 81.4 m-85 -142.38 156.29 45.21 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 125.269 1.428 . . . . 0.0 112.076 -176.712 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 2436 ' ' GLY . . . . . . . . . . . . . . . 116.55 157.27 10.93 Favored Glycine 0 N--CA 1.472 1.06 0 C-N-CA 125.705 1.621 . . . . 0.0 113.266 -179.532 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 2437 ' ' ALA . . . . . . . . . . . . . . . -60.82 -28.46 68.81 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.863 1.265 . . . . 0.0 114.222 -170.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 2438 ' ' GLY . . . . . . . . . . . . . . . -67.68 -9.98 57.04 Favored Glycine 0 CA--C 1.531 1.045 0 CA-C-O 118.894 -0.948 . . . . 0.0 114.957 -178.008 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 2439 ' ' LEU . . . . . . . . . . . . . 79.4 mt -83.33 -24.86 31.92 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 124.747 1.219 . . . . 0.0 112.709 170.048 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 2440 ' ' GLU . . . . . . . . . . . . . 39.5 mm-40 -91.15 -39.23 12.26 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.885 1.274 . . . . 0.0 111.382 -179.34 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 2441 ' ' GLY . . . . . . . . . . . . . . . 164.13 -158.73 31.41 Favored Glycine 0 CA--C 1.528 0.876 0 N-CA-C 115.617 1.007 . . . . 0.0 115.617 -177.834 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 2442 ' ' GLY . . . . . . . . . . . . . . . 175.74 -165.77 36.69 Favored Glycine 0 CA--C 1.531 1.047 0 C-N-CA 125.638 1.589 . . . . 0.0 112.871 179.3 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 2443 ' ' VAL . . . . . . . . . . . . . 86.6 t -129.18 146.4 34.29 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 125.414 1.486 . . . . 0.0 108.672 174.423 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 2444 ' ' THR . . . . . . . . . . . . . 41.6 p -58.34 133.81 56.04 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-O 121.427 0.632 . . . . 0.0 111.661 178.231 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 2445 ' ' GLY . . . . . . . . . . . . . . . 79.14 -6.9 55.33 Favored Glycine 0 CA--C 1.537 1.464 0 C-N-CA 124.734 1.159 . . . . 0.0 115.052 -175.633 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 2446 ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -100.97 142.26 24.27 Favored Pre-proline 0 CA--C 1.553 1.059 0 C-N-CA 125.751 1.62 . . . . 0.0 111.179 177.573 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 2447 ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -74.29 129.52 13.1 Favored 'Trans proline' 0 C--N 1.351 0.68 0 C-N-CA 122.98 2.453 . . . . 0.0 111.34 179.768 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 2448 ' ' ALA . . . . . . . . . . . . . . . -105.57 120.33 41.38 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 126.365 1.866 . . . . 0.0 109.207 172.548 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 2449 ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -119.16 138.49 52.89 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.775 1.23 . . . . 0.0 111.542 -170.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 2450 ' ' PHE . . . . . . . . . . . . . 37.5 p90 -153.34 165.28 36.26 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.311 1.444 . . . . 0.0 111.85 173.272 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 2451 ' ' VAL . . . . . . . . . . . . . 43.0 t -126.85 131.75 70.74 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 C-N-CA 124.897 1.279 . . . . 0.0 109.701 176.172 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 2452 ' ' VAL . . . . . . . . . . . . . 40.0 t -78.6 105.43 7.78 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 N-CA-C 107.318 -1.364 . . . . 0.0 107.318 165.577 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 2453 ' ' ASN . . . . . . . . . . . . . 14.7 t-20 -83.19 115.1 21.78 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 123.804 0.842 . . . . 0.0 112.292 -169.161 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 2454 ' ' THR . . . . . . . . . . . . . 43.9 p -103.96 -9.1 19.14 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 125.687 1.595 . . . . 0.0 113.812 -177.648 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 2455 ' ' SER . . . . . . . . . . . . . 16.3 m -57.29 -29.21 63.69 Favored 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 114.637 1.347 . . . . 0.0 114.637 -172.622 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 2456 ' ' ASN . . . . . . . . . . . . . 68.9 m-80 -85.49 -13.25 49.7 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 124.671 1.188 . . . . 0.0 113.579 177.332 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 2457 ' ' ALA . . . . . . . . . . . . . . . -112.09 -25.6 9.26 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 125.576 1.55 . . . . 0.0 114.162 -174.312 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 2458 ' ' GLY . . . . . . . . . . . . . . . 103.75 -111.89 4.02 Favored Glycine 0 CA--C 1.53 0.987 0 C-N-CA 125.095 1.331 . . . . 0.0 111.844 -177.603 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 2459 ' ' ALA . . . . . . . . . . . . . . . -137.87 160.52 39.07 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.291 1.436 . . . . 0.0 112.201 -176.817 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 2460 ' ' GLY . . . . . . . . . . . . . . . 158.19 174.24 27.64 Favored Glycine 0 CA--C 1.529 0.946 0 C-N-CA 124.427 1.013 . . . . 0.0 113.973 -172.696 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 2461 ' ' ALA . . . . . . . . . . . . . . . -83.03 148.71 27.39 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.48 1.112 . . . . 0.0 112.706 -178.16 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 2462 ' ' LEU . . . . . . . . . . . . . 59.7 tp -129.22 138.85 51.93 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 125.545 1.538 . . . . 0.0 110.588 177.16 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 2463 ' ' SER . . . . . . . . . . . . . 18.2 t -118.26 151.25 38.01 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.478 1.111 . . . . 0.0 109.604 156.559 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 2464 ' ' VAL . . . . . . . . . . . . . 7.5 p -161.77 133.16 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 124.184 0.993 . . . . 0.0 110.819 -178.054 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 2465 ' ' THR . . . . . . . . . . . . . 62.7 m -140.85 142.83 34.51 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 125.578 1.551 . . . . 0.0 109.516 -175.377 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 2466 ' ' ILE . . . . . . . . . . . . . 41.9 mt -114.96 115.94 51.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 124.433 1.093 . . . . 0.0 109.442 177.132 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 2467 ' ' ASP . . . . . . . . . . . . . 35.1 t70 -96.63 161.41 13.9 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 125.929 1.692 . . . . 0.0 110.34 168.657 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 2468 ' ' GLY . . . . . . . . . . . . . . . 166.2 -164.21 37.39 Favored Glycine 0 CA--C 1.536 1.361 0 O-C-N 121.18 -0.95 . . . . 0.0 114.973 178.521 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 2469 ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -70.07 -14.08 34.68 Favored 'Trans proline' 0 CA--C 1.541 0.852 0 C-N-CA 124.202 3.268 . . . . 0.0 114.004 -178.836 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 2470 ' ' SER . . . . . . . . . . . . . 29.1 m -156.87 174.91 14.8 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 126.769 2.027 . . . . 0.0 110.363 175.637 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 2471 ' ' LYS . . . . . . . . . . . . . 58.4 mtmt -68.14 165.82 17.41 Favored 'General case' 0 CA--C 1.549 0.912 0 O-C-N 121.117 -0.989 . . . . 0.0 111.734 166.443 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 2472 ' ' VAL . . . . . . . . . . . . . 19.1 m -135.43 152.26 31.51 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 C-N-CA 124.777 1.231 . . . . 0.0 111.421 -179.442 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 2473 ' ' LYS . . . . . . . . . . . . . 29.2 mtpp -81.18 64.29 5.86 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 124.488 1.115 . . . . 0.0 111.806 179.463 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 2474 ' ' MET . . . . . . . . . . . . . 19.0 ttt -69.43 133.53 47.87 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 125.27 1.428 . . . . 0.0 112.161 -174.518 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 2475 ' ' ASP . . . . . . . . . . . . . 35.1 t70 -139.13 122.94 17.63 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 126.361 1.865 . . . . 0.0 110.109 176.266 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 2476 ' ' CYS . . . . . . . . . . . . . 73.6 m -104.38 140.79 37.41 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.733 1.213 . . . . 0.0 111.182 -179.021 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 2477 ' ' GLN . . . . . . . . . . . . . 81.0 mt-30 -140.83 148.01 39.91 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.127 1.371 . . . . 0.0 110.283 -176.223 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 2478 ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -95.03 118.58 32.08 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 123.686 0.795 . . . . 0.0 109.839 174.74 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 2479 ' ' CYS . . . . . . . . . . . . . 88.8 m -123.21 163.24 35.06 Favored Pre-proline 0 CA--C 1.551 0.992 0 C-N-CA 125.386 1.474 . . . . 0.0 111.587 -179.3 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 2480 ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -57.8 -31.29 91.94 Favored 'Trans proline' 0 C--N 1.353 0.803 0 C-N-CA 123.624 2.883 . . . . 0.0 114.071 174.579 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 2481 ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -77.19 -11.23 59.79 Favored 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 125.329 1.452 . . . . 0.0 112.98 178.216 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 2482 ' ' GLY . . . . . . . . . . . . . . . 125.57 -162.4 19.82 Favored Glycine 0 CA--C 1.53 0.983 0 C-N-CA 126.3 1.905 . . . . 0.0 112.993 -175.688 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 2483 ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -73.27 108.52 6.2 Favored 'General case' 0 CA--C 1.54 0.576 0 O-C-N 121.574 -0.957 . . . . 0.0 111.133 178.345 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 2484 ' ' ARG . . . . . . . . . . . . . 44.5 ttm180 -81.05 140.72 34.96 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 124.756 1.222 . . . . 0.0 110.448 174.561 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 2485 ' ' VAL . . . . . . . . . . . . . 90.4 t -130.72 129.05 63.82 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 C-N-CA 125.608 1.563 . . . . 0.0 108.592 174.499 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 2486 ' ' THR . . . . . . . . . . . . . 48.7 m -122.02 140.24 52.72 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 124.41 1.084 . . . . 0.0 108.351 170.18 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 2487 ' ' TYR . . . . . . . . . . . . . 34.7 p90 -146.22 149.14 33.35 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 123.852 0.861 . . . . 0.0 112.089 176.751 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 2488 ' ' THR . . . . . . . . . . . . . 87.7 m -111.87 115.53 50.78 Favored Pre-proline 0 N--CA 1.473 0.701 0 CA-C-O 117.875 -1.06 . . . . 0.0 108.9 174.161 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 2489 ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -79.61 161.88 24.76 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 123.965 3.11 . . . . 0.0 111.107 174.08 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 2490 ' ' MET . . . . . . . . . . . . . 25.6 ptm -138.32 3.43 2.36 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 114.977 1.473 . . . . 0.0 114.977 -173.071 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 2491 ' ' ALA . . . . . . . . . . . . . . . -143.47 146.23 34.9 Favored Pre-proline 0 CA--C 1.546 0.817 0 C-N-CA 125.179 1.391 . . . . 0.0 110.741 173.058 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 2492 ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -71.92 151.03 56.1 Favored 'Trans proline' 0 CA--C 1.536 0.594 0 C-N-CA 122.852 2.368 . . . . 0.0 111.04 175.51 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 2493 ' ' GLY . . . . . . . . . . . . . . . 135.5 -162.15 24.83 Favored Glycine 0 CA--C 1.529 0.944 0 C-N-CA 125.167 1.365 . . . . 0.0 113.366 -177.159 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 2494 ' ' SER . . . . . . . . . . . . . 42.2 m -101.34 123.46 45.47 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.151 0.98 . . . . 0.0 111.186 178.69 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 2495 ' ' TYR . . . . . . . . . . . . . 79.2 m-85 -96.82 134.34 40.25 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.508 1.123 . . . . 0.0 110.084 168.299 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 2496 ' ' LEU . . . . . . . . . . . . . 23.8 tp -110.4 115.12 29.1 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.724 1.21 . . . . 0.0 109.86 -176.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 2497 ' ' ILE . . . . . . . . . . . . . 45.0 mt -101.72 102.84 14.08 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 C-N-CA 125.683 1.593 . . . . 0.0 108.474 -173.68 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 2498 ' ' SER . . . . . . . . . . . . . 72.3 m -90.71 90.34 7.91 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 124.457 1.103 . . . . 0.0 110.67 -177.814 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 2499 ' ' ILE . . . . . . . . . . . . . 28.3 mt -91.14 118.09 35.71 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 125.035 1.334 . . . . 0.0 109.756 -178.286 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 2500 ' ' LYS . . . . . . . . . . . . . 82.0 mttt -131.71 106.93 8.45 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 124.865 1.266 . . . . 0.0 112.375 -171.733 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 2501 ' ' TYR . . . . . . . . . . . . . 39.3 t80 -109.49 142.89 39.87 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.721 1.208 . . . . 0.0 112.713 -175.183 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 2502 ' ' GLY . . . . . . . . . . . . . . . 70.87 9.55 66.28 Favored Glycine 0 CA--C 1.535 1.307 0 C-N-CA 124.682 1.134 . . . . 0.0 114.756 175.021 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 2503 ' ' GLY . . . . . . . . . . . . . . . 153.28 -171.73 32.19 Favored Glycine 0 CA--C 1.538 1.502 0 C-N-CA 125.802 1.668 . . . . 0.0 113.129 -172.144 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 2504 ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -82.09 19.04 1.3 Allowed 'Trans proline' 0 CA--C 1.546 1.106 0 C-N-CA 124.877 3.718 . . . . 0.0 113.749 -174.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 2505 ' ' TYR . . . . . . . . . . . . . 80.3 m-85 -113.94 143.7 44.28 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.213 1.405 . . . . 0.0 112.751 -175.26 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 2506 ' ' HIS . . . . . . . . . . . . . 97.5 m-70 -63.99 145.14 56.4 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 124.382 1.073 . . . . 0.0 113.632 -178.45 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 2507 ' ' ILE . . . . . . . . . . . . . 29.4 pt -75.06 173.68 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.213 0 C-N-CA 123.56 0.744 . . . . 0.0 112.869 171.373 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 2508 ' ' GLY . . . . . . . . . . . . . . . -58.7 120.5 22.65 Favored Glycine 0 CA--C 1.533 1.206 0 O-C-N 121.486 -0.759 . . . . 0.0 111.704 174.379 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 2509 ' ' GLY . . . . . . . . . . . . . . . 87.0 -8.2 77.36 Favored Glycine 0 CA--C 1.537 1.414 0 C-N-CA 125.52 1.533 . . . . 0.0 115.023 -177.07 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 2510 ' ' SER . . . . . . . . . . . . . 45.8 t -87.64 147.19 40.95 Favored Pre-proline 0 CA--C 1.549 0.937 0 CA-C-N 118.927 1.364 . . . . 0.0 111.826 179.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 2511 ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -76.34 151.9 95.47 Favored 'Cis proline' 0 C--N 1.352 0.722 0 CA-C-N 119.711 0.933 . . . . 0.0 112.748 -1.437 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 2512 ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -99.53 132.13 45.07 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 124.705 1.202 . . . . 0.0 111.151 179.851 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 2513 ' ' LYS . . . . . . . . . . . . . 64.9 pttt -96.26 22.85 7.22 Favored 'General case' 0 CA--C 1.552 1.02 0 N-CA-C 115.991 1.849 . . . . 0.0 115.991 -164.38 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 2514 ' ' ALA . . . . . . . . . . . . . . . -28.64 114.74 0.09 Allowed 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 128.118 2.567 . . . . 0.0 115.612 -173.807 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 2515 ' ' LYS . . . . . . . . . . . . . 89.0 mttt -98.17 135.13 40.26 Favored 'General case' 0 N--CA 1.474 0.77 0 O-C-N 121.312 -0.868 . . . . 0.0 112.74 -174.519 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 2516 ' ' VAL . . . . . . . . . . . . . 75.4 t -122.51 139.28 49.88 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 C-N-CA 125.284 1.434 . . . . 0.0 110.609 -170.604 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 2517 ' ' THR . . . . . . . . . . . . . 66.1 p -120.99 178.86 4.56 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 125.783 1.633 . . . . 0.0 111.107 176.331 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 2518 ' ' GLY . . . . . . . . . . . . . . . 100.51 179.55 29.59 Favored Glycine 0 CA--C 1.539 1.585 0 C-N-CA 124.828 1.204 . . . . 0.0 113.263 -175.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 2519 ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -72.53 152.05 53.74 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 123.788 2.992 . . . . 0.0 111.86 -175.449 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 2520 ' ' ARG . . . . . . . . . . . . . 45.8 ttp180 . . . . . 0 CA--C 1.538 0.501 0 C-N-CA 123.384 0.673 . . . . 0.0 110.14 172.476 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A 2427 ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.781 0 N-CA-C 110.132 -1.187 . . . . 0.0 110.132 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A 2428 ' ' ASP . . . . . . . . . . . . . 41.8 m-20 -87.24 142.49 33.54 Favored Pre-proline 0 CA--C 1.548 0.872 0 C-N-CA 123.638 0.775 . . . . 0.0 112.283 -170.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 2429 ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -64.66 -27.12 60.83 Favored 'Trans proline' 0 C--N 1.351 0.69 0 C-N-CA 123.207 2.605 . . . . 0.0 113.216 -176.153 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 2430 ' ' GLY . . . . . . . . . . . . . . . -73.87 -22.24 78.33 Favored Glycine 0 CA--C 1.535 1.295 0 CA-C-N 118.905 0.775 . . . . 0.0 113.652 175.347 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 2431 ' ' LEU . . . . . . . . . . . . . 4.4 mm? -88.67 -28.75 20.39 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 124.622 1.169 . . . . 0.0 111.869 173.108 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 2432 ' ' VAL . . . . . . . . . . . . . 71.1 t -68.79 136.63 25.98 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 123.756 0.823 . . . . 0.0 110.292 169.681 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 2433 ' ' SER . . . . . . . . . . . . . 74.6 m -123.61 -177.86 3.85 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 125.419 1.488 . . . . 0.0 110.261 172.862 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 2434 ' ' ALA . . . . . . . . . . . . . . . -143.77 146.17 32.92 Favored 'General case' 0 CA--C 1.538 0.501 0 O-C-N 120.701 -1.25 . . . . 0.0 111.499 170.541 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 2435 ' ' TYR . . . . . . . . . . . . . 76.2 m-85 -145.06 152.22 39.77 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.441 1.497 . . . . 0.0 111.992 -174.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 2436 ' ' GLY . . . . . . . . . . . . . . . 121.74 158.66 10.41 Favored Glycine 0 N--CA 1.473 1.114 0 C-N-CA 125.492 1.52 . . . . 0.0 113.404 179.184 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 2437 ' ' ALA . . . . . . . . . . . . . . . -61.32 -27.06 68.22 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.79 1.236 . . . . 0.0 114.245 -171.398 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 2438 ' ' GLY . . . . . . . . . . . . . . . -66.79 -14.17 62.55 Favored Glycine 0 CA--C 1.53 0.982 0 CA-C-O 119.067 -0.851 . . . . 0.0 114.492 -179.183 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 2439 ' ' LEU . . . . . . . . . . . . . 67.6 mt -78.82 -23.19 45.24 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 118.442 1.121 . . . . 0.0 112.449 170.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 2440 ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -92.41 -29.28 16.37 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.168 1.387 . . . . 0.0 111.83 176.117 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 2441 ' ' GLY . . . . . . . . . . . . . . . 108.31 -134.66 12.35 Favored Glycine 0 CA--C 1.532 1.114 0 C-N-CA 125.829 1.68 . . . . 0.0 112.525 178.433 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 2442 ' ' GLY . . . . . . . . . . . . . . . 136.78 -153.9 21.92 Favored Glycine 0 CA--C 1.534 1.265 0 C-N-CA 124.884 1.231 . . . . 0.0 114.494 -176.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 2443 ' ' VAL . . . . . . . . . . . . . 87.5 t -79.84 134.65 27.12 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 C-N-CA 124.622 1.169 . . . . 0.0 111.029 -174.83 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 2444 ' ' THR . . . . . . . . . . . . . 39.1 p -68.92 144.06 54.29 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.251 1.021 . . . . 0.0 112.021 176.276 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 2445 ' ' GLY . . . . . . . . . . . . . . . 83.38 -22.28 7.57 Favored Glycine 0 CA--C 1.536 1.359 0 C-N-CA 125.416 1.484 . . . . 0.0 113.903 -174.541 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 2446 ' ' ASN . . . . . . . . . . . . . 80.4 m-20 -87.19 152.96 53.69 Favored Pre-proline 0 CA--C 1.547 0.864 0 C-N-CA 124.749 1.22 . . . . 0.0 110.816 170.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 2447 ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -72.04 144.06 41.78 Favored 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 122.942 2.428 . . . . 0.0 111.658 179.387 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 2448 ' ' ALA . . . . . . . . . . . . . . . -119.04 137.98 53.17 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 127.309 2.244 . . . . 0.0 108.847 172.634 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 2449 ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -146.21 138.16 25.01 Favored 'General case' 0 N--CA 1.471 0.589 0 O-C-N 121.517 -0.74 . . . . 0.0 112.585 -163.041 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 2450 ' ' PHE . . . . . . . . . . . . . 50.6 p90 -154.22 159.73 41.49 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 125.52 1.528 . . . . 0.0 112.383 -179.109 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 2451 ' ' VAL . . . . . . . . . . . . . 88.3 t -112.65 132.73 60.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 125.552 1.541 . . . . 0.0 109.349 173.049 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 2452 ' ' VAL . . . . . . . . . . . . . 33.3 t -84.86 103.68 12.27 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 164.638 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 2453 ' ' ASN . . . . . . . . . . . . . 15.5 t-20 -87.06 116.89 25.42 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.2 1.0 . . . . 0.0 112.314 -168.568 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 2454 ' ' THR . . . . . . . . . . . . . 43.3 p -103.2 -4.44 24.37 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 126.214 1.806 . . . . 0.0 114.241 -173.09 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 2455 ' ' SER . . . . . . . . . . . . . 19.6 m -56.0 -34.55 65.9 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 114.961 1.467 . . . . 0.0 114.961 -170.296 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 2456 ' ' ASN . . . . . . . . . . . . . 29.8 m120 -86.94 -10.93 52.08 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 124.329 1.051 . . . . 0.0 113.495 178.061 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 2457 ' ' ALA . . . . . . . . . . . . . . . -103.32 -53.96 2.7 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.206 1.402 . . . . 0.0 112.85 -174.763 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 2458 ' ' GLY . . . . . . . . . . . . . . . 125.63 -121.04 4.05 Favored Glycine 0 CA--C 1.531 1.064 0 C-N-CA 124.967 1.27 . . . . 0.0 112.658 -172.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 2459 ' ' ALA . . . . . . . . . . . . . . . -126.65 166.25 17.69 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 125.679 1.592 . . . . 0.0 112.781 -173.326 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 2460 ' ' GLY . . . . . . . . . . . . . . . 146.77 173.06 17.67 Favored Glycine 0 CA--C 1.531 1.047 0 C-N-CA 124.394 0.997 . . . . 0.0 114.054 -177.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 2461 ' ' ALA . . . . . . . . . . . . . . . -82.37 150.92 26.89 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.512 1.125 . . . . 0.0 112.811 -178.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 2462 ' ' LEU . . . . . . . . . . . . . 23.4 tp -109.42 148.27 31.41 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 126.272 1.829 . . . . 0.0 110.678 177.301 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 2463 ' ' SER . . . . . . . . . . . . . 8.4 t -150.03 68.7 1.0 Allowed 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 124.128 0.971 . . . . 0.0 111.449 177.5 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 2464 ' ' VAL . . . . . . . . . . . . . 42.2 t -74.3 139.62 18.96 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.24 0 O-C-N 120.692 -1.255 . . . . 0.0 110.764 178.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 2465 ' ' THR . . . . . . . . . . . . . 16.4 m -125.41 141.34 52.11 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 125.043 1.337 . . . . 0.0 108.929 169.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 2466 ' ' ILE . . . . . . . . . . . . . 26.5 mt -122.14 126.36 74.25 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 123.425 0.69 . . . . 0.0 109.921 171.677 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 2467 ' ' ASP . . . . . . . . . . . . . 35.8 t70 -110.95 148.53 32.29 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 126.044 1.738 . . . . 0.0 110.192 170.176 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 2468 ' ' GLY . . . . . . . . . . . . . . . 170.51 -164.81 38.07 Favored Glycine 0 CA--C 1.536 1.395 0 N-CA-C 114.996 0.758 . . . . 0.0 114.996 -178.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 2469 ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -68.34 -25.02 36.53 Favored 'Trans proline' 0 CA--C 1.54 0.79 0 C-N-CA 124.002 3.135 . . . . 0.0 114.752 -171.712 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 2470 ' ' SER . . . . . . . . . . . . . 17.3 m -159.53 142.54 14.15 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 125.82 1.648 . . . . 0.0 110.566 174.693 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 2471 ' ' LYS . . . . . . . . . . . . . 55.3 mtmt -61.57 122.06 14.31 Favored 'General case' 0 N--CA 1.476 0.862 0 O-C-N 121.074 -1.016 . . . . 0.0 112.9 -172.818 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 2472 ' ' VAL . . . . . . . . . . . . . 21.0 m -77.21 151.6 5.66 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 C-N-CA 124.441 1.096 . . . . 0.0 112.512 -175.598 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 2473 ' ' LYS . . . . . . . . . . . . . 38.3 mtmm -78.63 145.62 34.57 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 123.234 0.614 . . . . 0.0 109.867 160.315 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 2474 ' ' MET . . . . . . . . . . . . . 56.5 ttm -147.94 144.29 27.92 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 124.273 1.029 . . . . 0.0 112.518 -174.804 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 2475 ' ' ASP . . . . . . . . . . . . . 21.5 m-20 -125.81 149.93 48.22 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 126.843 2.057 . . . . 0.0 109.996 162.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 2476 ' ' CYS . . . . . . . . . . . . . 44.7 t -142.98 142.17 31.56 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.89 1.276 . . . . 0.0 110.757 179.075 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 2477 ' ' GLN . . . . . . . . . . . . . 6.0 tp-100 -155.9 146.82 22.21 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.309 1.044 . . . . 0.0 111.017 -175.704 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 2478 ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -78.53 128.63 33.82 Favored 'General case' 0 CA--C 1.541 0.628 0 O-C-N 121.62 -0.675 . . . . 0.0 111.455 174.637 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 2479 ' ' CYS . . . . . . . . . . . . . 95.3 m -124.5 167.09 16.68 Favored Pre-proline 0 CA--C 1.552 1.046 0 C-N-CA 126.152 1.781 . . . . 0.0 110.644 177.148 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 2480 ' ' PRO . . . . . . . . . . . . . 64.3 Cg_exo -57.46 -29.92 86.33 Favored 'Trans proline' 0 C--N 1.353 0.793 0 C-N-CA 123.53 2.82 . . . . 0.0 114.374 175.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 2481 ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -80.53 -6.93 58.94 Favored 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 125.356 1.462 . . . . 0.0 113.099 177.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 2482 ' ' GLY . . . . . . . . . . . . . . . 119.39 -169.39 13.68 Favored Glycine 0 CA--C 1.532 1.095 0 C-N-CA 126.326 1.917 . . . . 0.0 112.408 -172.016 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 2483 ' ' TYR . . . . . . . . . . . . . 63.0 m-85 -69.4 118.69 12.6 Favored 'General case' 0 N--CA 1.47 0.565 0 O-C-N 121.206 -1.173 . . . . 0.0 111.69 177.279 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 2484 ' ' ARG . . . . . . . . . . . . . 58.8 ttt180 -96.19 132.07 42.0 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 125.414 1.486 . . . . 0.0 110.273 178.536 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 2485 ' ' VAL . . . . . . . . . . . . . 67.0 t -123.11 131.98 72.24 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 C-N-CA 125.825 1.65 . . . . 0.0 109.065 -177.372 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 2486 ' ' THR . . . . . . . . . . . . . 50.3 m -124.54 132.96 53.44 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 124.845 1.258 . . . . 0.0 108.126 172.217 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 2487 ' ' TYR . . . . . . . . . . . . . 22.0 p90 -140.45 157.85 44.89 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.194 0.998 . . . . 0.0 112.392 179.162 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 2488 ' ' THR . . . . . . . . . . . . . 91.8 m -113.87 105.2 54.75 Favored Pre-proline 0 N--CA 1.476 0.852 0 CA-C-O 118.107 -0.949 . . . . 0.0 109.818 179.121 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 2489 ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -69.44 128.87 16.96 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 123.022 2.481 . . . . 0.0 109.437 170.344 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 2490 ' ' MET . . . . . . . . . . . . . 27.9 ptm -114.35 -1.47 13.52 Favored 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 114.777 1.399 . . . . 0.0 114.777 -171.33 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 2491 ' ' ALA . . . . . . . . . . . . . . . -147.4 144.82 20.05 Favored Pre-proline 0 CA--C 1.546 0.806 0 C-N-CA 124.902 1.281 . . . . 0.0 110.982 -179.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 2492 ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -72.6 151.43 52.56 Favored 'Trans proline' 0 C--N 1.351 0.688 0 C-N-CA 123.414 2.743 . . . . 0.0 111.392 -176.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 2493 ' ' GLY . . . . . . . . . . . . . . . 133.0 -142.49 14.01 Favored Glycine 0 CA--C 1.529 0.909 0 C-N-CA 124.875 1.226 . . . . 0.0 112.507 -175.386 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 2494 ' ' SER . . . . . . . . . . . . . 39.6 m -123.96 128.5 49.5 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.349 1.059 . . . . 0.0 111.292 -179.576 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 2495 ' ' TYR . . . . . . . . . . . . . 41.7 m-85 -101.04 119.16 38.33 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.775 1.23 . . . . 0.0 110.578 171.602 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 2496 ' ' LEU . . . . . . . . . . . . . 25.3 tp -91.97 110.2 21.55 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.543 1.137 . . . . 0.0 109.512 179.084 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 2497 ' ' ILE . . . . . . . . . . . . . 21.9 mt -97.75 98.99 7.99 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 C-N-CA 125.863 1.665 . . . . 0.0 108.768 -176.299 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 2498 ' ' SER . . . . . . . . . . . . . 69.4 m -86.56 81.92 8.1 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 125.482 1.513 . . . . 0.0 110.133 177.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 2499 ' ' ILE . . . . . . . . . . . . . 51.9 mt -76.62 117.71 21.85 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 C-N-CA 124.99 1.316 . . . . 0.0 109.407 177.41 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 2500 ' ' LYS . . . . . . . . . . . . . 2.2 mtmp? -129.01 143.19 50.79 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 125.122 1.369 . . . . 0.0 110.712 -178.627 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 2501 ' ' TYR . . . . . . . . . . . . . 49.5 t80 -152.37 144.46 23.83 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 124.496 1.118 . . . . 0.0 112.321 -171.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 2502 ' ' GLY . . . . . . . . . . . . . . . 67.65 16.24 67.52 Favored Glycine 0 CA--C 1.536 1.384 0 C-N-CA 124.177 0.894 . . . . 0.0 113.728 178.061 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 2503 ' ' GLY . . . . . . . . . . . . . . . 147.04 -174.76 26.73 Favored Glycine 0 CA--C 1.54 1.624 0 C-N-CA 126.216 1.865 . . . . 0.0 112.436 -167.508 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 2504 ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -84.7 12.56 3.02 Favored 'Trans proline' 0 CA--C 1.544 1.006 0 C-N-CA 124.551 3.501 . . . . 0.0 113.904 -173.159 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 2505 ' ' TYR . . . . . . . . . . . . . 58.9 m-85 -110.47 147.58 33.8 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 124.474 1.11 . . . . 0.0 113.849 -171.486 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 2506 ' ' HIS . . . . . . . . . . . . . 92.8 m-70 -63.47 141.14 58.88 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 125.095 1.358 . . . . 0.0 113.497 -175.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 2507 ' ' ILE . . . . . . . . . . . . . 1.7 pp -79.45 175.53 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 N-CA-C 113.281 0.845 . . . . 0.0 113.281 176.449 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 2508 ' ' GLY . . . . . . . . . . . . . . . -60.75 111.14 3.48 Favored Glycine 0 CA--C 1.532 1.155 0 O-C-N 121.237 -0.915 . . . . 0.0 112.652 -178.575 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 2509 ' ' GLY . . . . . . . . . . . . . . . 95.38 -8.72 69.38 Favored Glycine 0 CA--C 1.536 1.353 0 C-N-CA 125.984 1.754 . . . . 0.0 114.7 -176.349 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 2510 ' ' SER . . . . . . . . . . . . . 47.9 t -83.2 147.52 53.87 Favored Pre-proline 0 CA--C 1.549 0.936 0 CA-C-N 118.802 1.301 . . . . 0.0 111.997 179.538 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 2511 ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -78.18 154.76 93.65 Favored 'Cis proline' 0 C--N 1.353 0.781 0 CA-C-N 119.809 0.967 . . . . 0.0 112.98 -1.383 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 2512 ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -104.86 131.67 52.06 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 125.141 1.376 . . . . 0.0 110.728 178.32 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 2513 ' ' LYS . . . . . . . . . . . . . 19.5 ptpt -89.13 8.04 32.02 Favored 'General case' 0 N--CA 1.479 0.983 0 N-CA-C 116.617 2.08 . . . . 0.0 116.617 -166.707 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 2514 ' ' ALA . . . . . . . . . . . . . . . -2.52 96.99 0.01 OUTLIER 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 129.436 3.095 . . . . 0.0 116.316 -177.722 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 2515 ' ' LYS . . . . . . . . . . . . . 44.9 mtpt -90.03 133.18 34.98 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.157 0.983 . . . . 0.0 111.354 -173.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 2516 ' ' VAL . . . . . . . . . . . . . 31.7 m -133.0 149.22 31.53 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 C-N-CA 124.326 1.05 . . . . 0.0 112.426 -168.764 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 2517 ' ' THR . . . . . . . . . . . . . 35.8 p -140.3 164.18 30.79 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 125.611 1.565 . . . . 0.0 111.365 -174.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 2518 ' ' GLY . . . . . . . . . . . . . . . 116.42 -162.19 12.74 Favored Glycine 0 CA--C 1.539 1.538 0 C-N-CA 125.046 1.308 . . . . 0.0 112.441 -174.308 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 2519 ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -72.56 167.23 27.64 Favored 'Trans proline' 0 CA--C 1.536 0.576 0 C-N-CA 123.562 2.842 . . . . 0.0 112.09 -177.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 2520 ' ' ARG . . . . . . . . . . . . . 49.1 ttp180 . . . . . 0 CA--C 1.537 0.457 0 C-N-CA 124.148 0.979 . . . . 0.0 109.189 167.476 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A 2427 ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.961 0 CA-C-O 121.455 0.475 . . . . 0.0 113.832 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A 2428 ' ' ASP . . . . . . . . . . . . . 12.5 t70 -82.89 136.06 44.77 Favored Pre-proline 0 CA--C 1.548 0.896 0 C-N-CA 125.285 1.434 . . . . 0.0 111.211 177.4 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 2429 ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -63.06 -22.08 73.28 Favored 'Trans proline' 0 C--N 1.353 0.771 0 C-N-CA 123.642 2.895 . . . . 0.0 114.244 -174.661 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 2430 ' ' GLY . . . . . . . . . . . . . . . -80.79 -20.2 66.23 Favored Glycine 0 CA--C 1.534 1.232 0 C-N-CA 124.054 0.835 . . . . 0.0 113.691 174.738 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 2431 ' ' LEU . . . . . . . . . . . . . 4.3 mm? -84.49 -28.42 26.77 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.462 1.105 . . . . 0.0 111.999 173.433 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 2432 ' ' VAL . . . . . . . . . . . . . 2.3 t -67.74 143.12 15.65 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 CA-C-N 118.7 0.682 . . . . 0.0 109.491 169.561 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 2433 ' ' SER . . . . . . . . . . . . . 8.1 t -135.86 -172.77 3.19 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.311 1.044 . . . . 0.0 110.569 171.436 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 2434 ' ' ALA . . . . . . . . . . . . . . . -148.93 142.33 25.23 Favored 'General case' 0 CA--C 1.537 0.455 0 O-C-N 120.921 -1.112 . . . . 0.0 111.638 177.232 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 2435 ' ' TYR . . . . . . . . . . . . . 74.7 m-85 -143.67 146.81 33.5 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.229 1.411 . . . . 0.0 112.027 -174.326 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 2436 ' ' GLY . . . . . . . . . . . . . . . 128.35 159.98 10.2 Favored Glycine 0 N--CA 1.473 1.108 0 C-N-CA 125.767 1.651 . . . . 0.0 113.571 179.34 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 2437 ' ' ALA . . . . . . . . . . . . . . . -61.17 -29.6 69.9 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.938 1.295 . . . . 0.0 114.193 -171.27 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 2438 ' ' GLY . . . . . . . . . . . . . . . -65.89 -16.15 63.5 Favored Glycine 0 CA--C 1.53 1.005 0 C-N-CA 124.361 0.981 . . . . 0.0 114.375 -178.082 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 2439 ' ' LEU . . . . . . . . . . . . . 79.0 mt -80.03 -26.87 39.58 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 118.77 1.285 . . . . 0.0 112.594 172.556 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 2440 ' ' GLU . . . . . . . . . . . . . 35.0 mm-40 -87.36 -38.04 16.55 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.72 1.208 . . . . 0.0 111.582 -178.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 2441 ' ' GLY . . . . . . . . . . . . . . . 162.29 -150.43 19.65 Favored Glycine 0 CA--C 1.527 0.8 0 C-N-CA 124.046 0.831 . . . . 0.0 114.173 -175.61 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 2442 ' ' GLY . . . . . . . . . . . . . . . 167.58 -170.29 41.62 Favored Glycine 0 CA--C 1.53 0.999 0 C-N-CA 124.951 1.262 . . . . 0.0 113.616 -179.735 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 2443 ' ' VAL . . . . . . . . . . . . . 97.9 t -120.93 137.02 56.01 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 C-N-CA 125.435 1.494 . . . . 0.0 109.115 176.611 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 2444 ' ' THR . . . . . . . . . . . . . 27.9 p -56.23 128.22 34.6 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.598 1.159 . . . . 0.0 111.837 177.68 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 2445 ' ' GLY . . . . . . . . . . . . . . . 86.26 -10.89 64.73 Favored Glycine 0 CA--C 1.533 1.165 0 C-N-CA 125.28 1.419 . . . . 0.0 114.891 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 2446 ' ' ASN . . . . . . . . . . . . . 86.6 m-20 -104.72 141.72 23.14 Favored Pre-proline 0 CA--C 1.546 0.796 0 C-N-CA 124.693 1.197 . . . . 0.0 110.684 175.338 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 2447 ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -71.63 142.15 39.44 Favored 'Trans proline' 0 N--CA 1.457 -0.641 0 C-N-CA 122.64 2.226 . . . . 0.0 111.118 177.046 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 2448 ' ' ALA . . . . . . . . . . . . . . . -125.51 156.25 39.28 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 126.082 1.753 . . . . 0.0 109.341 167.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 2449 ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -152.52 160.17 43.25 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 114.019 1.118 . . . . 0.0 114.019 -166.986 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 2450 ' ' PHE . . . . . . . . . . . . . 52.0 p90 -161.75 159.02 26.68 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 126.193 1.797 . . . . 0.0 111.24 -177.425 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 2451 ' ' VAL . . . . . . . . . . . . . 48.2 t -115.98 130.22 71.06 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 C-N-CA 124.847 1.259 . . . . 0.0 109.219 173.151 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 2452 ' ' VAL . . . . . . . . . . . . . 21.4 t -78.95 102.76 5.27 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 N-CA-C 106.795 -1.558 . . . . 0.0 106.795 164.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 2453 ' ' ASN . . . . . . . . . . . . . 10.7 t-20 -81.69 114.3 20.27 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.051 0.94 . . . . 0.0 111.856 -169.48 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 2454 ' ' THR . . . . . . . . . . . . . 58.3 p -99.92 -7.25 25.45 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 125.65 1.58 . . . . 0.0 113.856 -176.318 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 2455 ' ' SER . . . . . . . . . . . . . 16.7 m -55.41 -32.92 63.08 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 114.534 1.309 . . . . 0.0 114.534 -174.274 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 2456 ' ' ASN . . . . . . . . . . . . . 92.1 m-20 -85.26 -14.08 47.8 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 124.324 1.049 . . . . 0.0 113.465 177.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 2457 ' ' ALA . . . . . . . . . . . . . . . -105.61 -48.88 3.55 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 125.097 1.359 . . . . 0.0 113.158 -171.491 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 2458 ' ' GLY . . . . . . . . . . . . . . . 117.92 -138.4 13.92 Favored Glycine 0 CA--C 1.532 1.102 0 C-N-CA 125.066 1.317 . . . . 0.0 112.526 -173.464 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 2459 ' ' ALA . . . . . . . . . . . . . . . -97.3 175.86 6.11 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 125.553 1.541 . . . . 0.0 112.575 -179.746 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 2460 ' ' GLY . . . . . . . . . . . . . . . 134.07 162.76 10.08 Favored Glycine 0 CA--C 1.53 0.978 0 C-N-CA 125.21 1.386 . . . . 0.0 113.677 -179.379 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 2461 ' ' ALA . . . . . . . . . . . . . . . -80.49 146.78 31.19 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.273 1.029 . . . . 0.0 112.566 -178.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 2462 ' ' LEU . . . . . . . . . . . . . 14.6 tp -104.14 145.88 29.56 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.765 1.626 . . . . 0.0 110.391 172.363 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 2463 ' ' SER . . . . . . . . . . . . . 22.6 t -124.87 147.6 48.71 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 123.949 0.9 . . . . 0.0 109.335 153.052 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 2464 ' ' VAL . . . . . . . . . . . . . 12.1 p -160.16 139.6 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 O-C-N 121.256 -0.902 . . . . 0.0 111.039 -172.816 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 2465 ' ' THR . . . . . . . . . . . . . 9.5 t -161.5 161.77 30.13 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 125.112 1.365 . . . . 0.0 111.256 -177.727 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 2466 ' ' ILE . . . . . . . . . . . . . 39.7 mt -134.67 121.91 36.94 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 C-N-CA 125.089 1.356 . . . . 0.0 109.934 -173.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 2467 ' ' ASP . . . . . . . . . . . . . 36.7 t70 -98.18 156.74 16.54 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.691 1.596 . . . . 0.0 110.234 167.716 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 2468 ' ' GLY . . . . . . . . . . . . . . . 171.93 -165.83 38.65 Favored Glycine 0 CA--C 1.535 1.309 0 O-C-N 120.951 -1.093 . . . . 0.0 115.175 -179.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 2469 ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -69.81 -12.67 33.27 Favored 'Trans proline' 0 CA--C 1.541 0.871 0 C-N-CA 124.116 3.211 . . . . 0.0 113.841 -179.808 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 2470 ' ' SER . . . . . . . . . . . . . 33.3 m -156.16 170.89 21.16 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 126.887 2.075 . . . . 0.0 110.174 173.406 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 2471 ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -67.73 162.0 24.77 Favored 'General case' 0 CA--C 1.548 0.889 0 O-C-N 121.116 -0.99 . . . . 0.0 111.752 167.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 2472 ' ' VAL . . . . . . . . . . . . . 35.8 m -137.79 145.06 29.61 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 C-N-CA 124.785 1.234 . . . . 0.0 111.639 -179.207 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 2473 ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -87.52 90.72 8.48 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.411 1.084 . . . . 0.0 110.867 -179.795 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 2474 ' ' MET . . . . . . . . . . . . . 96.7 mtp -80.93 133.82 35.61 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 124.279 1.032 . . . . 0.0 111.591 178.75 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 2475 ' ' ASP . . . . . . . . . . . . . 21.1 t70 -116.3 118.65 33.35 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 125.865 1.666 . . . . 0.0 109.044 162.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 2476 ' ' CYS . . . . . . . . . . . . . 72.4 m -102.81 137.85 40.48 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.397 1.079 . . . . 0.0 110.106 175.053 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 2477 ' ' GLN . . . . . . . . . . . . . 5.4 pt20 -154.12 155.35 35.22 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.499 1.119 . . . . 0.0 110.731 -175.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 2478 ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -97.68 138.07 35.63 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.84 0.856 . . . . 0.0 110.844 -179.425 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 2479 ' ' CYS . . . . . . . . . . . . . 17.0 p -137.02 171.59 8.34 Favored Pre-proline 0 CA--C 1.554 1.107 0 C-N-CA 125.602 1.561 . . . . 0.0 111.479 175.529 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 2480 ' ' PRO . . . . . . . . . . . . . 73.4 Cg_exo -58.6 -27.1 81.6 Favored 'Trans proline' 0 CA--C 1.54 0.791 0 C-N-CA 123.42 2.746 . . . . 0.0 114.572 178.588 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 2481 ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -84.7 -14.29 48.86 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 124.748 1.219 . . . . 0.0 113.135 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 2482 ' ' GLY . . . . . . . . . . . . . . . 139.82 -143.8 14.25 Favored Glycine 0 N--CA 1.471 0.987 0 C-N-CA 125.228 1.394 . . . . 0.0 113.425 178.511 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 2483 ' ' TYR . . . . . . . . . . . . . 66.5 m-85 -91.08 115.83 28.32 Favored 'General case' 0 N--CA 1.467 0.425 0 O-C-N 121.934 -0.745 . . . . 0.0 111.185 175.33 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 2484 ' ' ARG . . . . . . . . . . . . . 43.4 ttt180 -92.01 139.63 30.45 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 125.563 1.545 . . . . 0.0 110.87 178.111 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 2485 ' ' VAL . . . . . . . . . . . . . 65.4 t -126.83 129.59 71.42 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 125.542 1.537 . . . . 0.0 108.855 175.272 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 2486 ' ' THR . . . . . . . . . . . . . 93.8 m -117.6 139.2 51.3 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 125.37 1.468 . . . . 0.0 108.004 169.315 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 2487 ' ' TYR . . . . . . . . . . . . . 19.4 p90 -149.0 150.3 32.6 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 123.692 0.797 . . . . 0.0 112.851 176.656 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 2488 ' ' THR . . . . . . . . . . . . . 99.6 m -110.99 113.71 54.63 Favored Pre-proline 0 N--CA 1.474 0.738 0 C-N-CA 124.37 1.068 . . . . 0.0 109.609 176.712 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 2489 ' ' PRO . . . . . . . . . . . . . 79.3 Cg_endo -77.25 164.31 29.27 Favored 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 123.748 2.965 . . . . 0.0 110.947 169.269 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 2490 ' ' MET . . . . . . . . . . . . . 28.1 ptm -143.85 -3.17 0.89 Allowed 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 115.561 1.689 . . . . 0.0 115.561 -172.3 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 2491 ' ' ALA . . . . . . . . . . . . . . . -140.01 148.02 53.16 Favored Pre-proline 0 CA--C 1.546 0.821 0 C-N-CA 125.167 1.387 . . . . 0.0 110.737 174.139 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 2492 ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -71.34 146.83 51.63 Favored 'Trans proline' 0 CA--C 1.537 0.666 0 C-N-CA 122.856 2.37 . . . . 0.0 110.933 177.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 2493 ' ' GLY . . . . . . . . . . . . . . . 136.39 -167.62 24.4 Favored Glycine 0 CA--C 1.531 1.075 0 C-N-CA 125.214 1.388 . . . . 0.0 113.603 -176.602 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 2494 ' ' SER . . . . . . . . . . . . . 49.4 m -95.22 123.18 38.59 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 124.417 1.087 . . . . 0.0 111.299 179.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 2495 ' ' TYR . . . . . . . . . . . . . 73.1 m-85 -97.97 116.95 31.22 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.346 1.058 . . . . 0.0 110.129 170.003 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 2496 ' ' LEU . . . . . . . . . . . . . 23.2 tp -93.16 105.64 17.71 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.943 1.297 . . . . 0.0 109.904 -176.586 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 2497 ' ' ILE . . . . . . . . . . . . . 44.4 mt -93.32 112.37 26.32 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 C-N-CA 126.443 1.897 . . . . 0.0 108.636 -176.545 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 2498 ' ' SER . . . . . . . . . . . . . 75.4 m -96.61 123.87 40.42 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 123.512 0.725 . . . . 0.0 110.002 174.521 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 2499 ' ' ILE . . . . . 0.681 ' H ' ' HG ' ' A' 2510 ' ' SER . 23.9 mt -124.95 116.23 46.58 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 C-N-CA 125.269 1.427 . . . . 0.0 109.297 -175.785 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 2500 ' ' LYS . . . . . . . . . . . . . 96.0 mttt -127.28 140.77 51.99 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.783 1.233 . . . . 0.0 111.817 -172.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 2501 ' ' TYR . . . . . . . . . . . . . 44.4 t80 -146.85 144.47 29.33 Favored 'General case' 0 N--CA 1.474 0.769 0 O-C-N 121.303 -0.873 . . . . 0.0 113.329 -172.331 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 2502 ' ' GLY . . . . . . . . . . . . . . . 69.57 19.46 74.73 Favored Glycine 0 CA--C 1.536 1.345 0 C-N-CA 124.101 0.858 . . . . 0.0 113.207 -179.152 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 2503 ' ' GLY . . . . . . . . . . . . . . . 132.17 -176.04 19.52 Favored Glycine 0 CA--C 1.54 1.637 0 C-N-CA 126.325 1.917 . . . . 0.0 112.293 -166.304 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 2504 ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -82.21 43.97 1.61 Allowed 'Trans proline' 0 CA--C 1.545 1.047 0 C-N-CA 124.959 3.773 . . . . 0.0 112.662 -173.722 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 2505 ' ' TYR . . . . . . . . . . . . . 76.0 m-85 -125.43 131.19 52.95 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.817 1.247 . . . . 0.0 112.475 -174.134 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 2506 ' ' HIS . . . . . . . . . . . . . 88.0 m-70 -59.33 138.07 57.76 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 124.921 1.288 . . . . 0.0 113.536 -177.26 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 2507 ' ' ILE . . . . . . . . . . . . . 2.3 pp -88.97 147.6 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 C-N-CA 123.854 0.862 . . . . 0.0 112.535 175.154 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 2508 ' ' GLY . . . . . . . . . . . . . . . 48.26 -115.32 2.35 Favored Glycine 0 CA--C 1.535 1.323 0 C-N-CA 124.239 0.923 . . . . 0.0 114.031 167.093 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 2509 ' ' GLY . . . . . . . . . . . . . . . -97.05 11.11 65.91 Favored Glycine 0 CA--C 1.537 1.417 0 C-N-CA 126.061 1.791 . . . . 0.0 115.212 177.693 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 2510 ' ' SER . . . . . 0.681 ' HG ' ' H ' ' A' 2499 ' ' ILE . 46.5 t -63.17 144.82 97.28 Favored Pre-proline 0 CA--C 1.55 0.974 0 CA-C-N 119.342 1.571 . . . . 0.0 112.458 178.917 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 2511 ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -79.64 152.34 86.25 Favored 'Cis proline' 0 C--N 1.353 0.779 0 CA-C-N 119.343 0.801 . . . . 0.0 113.349 -0.364 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 2512 ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -103.81 130.46 51.36 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 125.62 1.568 . . . . 0.0 110.782 -179.363 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 2513 ' ' LYS . . . . . . . . . . . . . 7.4 ptpp? -90.57 9.77 28.17 Favored 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 116.833 2.16 . . . . 0.0 116.833 -165.112 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 2514 ' ' ALA . . . . . . . . . . . . . . . -4.0 101.3 0.01 OUTLIER 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 129.404 3.082 . . . . 0.0 116.532 -176.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 2515 ' ' LYS . . . . . . . . . . . . . 35.2 mtmm -88.23 119.41 28.6 Favored 'General case' 0 CA--C 1.544 0.715 0 O-C-N 121.293 -0.88 . . . . 0.0 111.778 -173.419 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 2516 ' ' VAL . . . . . . . . . . . . . 54.1 t -111.27 144.08 19.87 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 125.83 1.652 . . . . 0.0 110.605 -173.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 2517 ' ' THR . . . . . . . . . . . . . 53.0 p -131.52 173.44 11.11 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 125.693 1.597 . . . . 0.0 110.949 174.299 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 2518 ' ' GLY . . . . . . . . . . . . . . . 112.88 179.43 19.47 Favored Glycine 0 CA--C 1.54 1.607 0 C-N-CA 125.1 1.333 . . . . 0.0 113.651 -177.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 2519 ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -69.68 129.31 17.46 Favored 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 123.896 3.064 . . . . 0.0 111.819 -172.67 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 2520 ' ' ARG . . . . . . . . . . . . . 35.2 ttt-85 . . . . . 0 CA--C 1.538 0.485 0 C-N-CA 123.716 0.806 . . . . 0.0 110.449 177.541 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A 2427 ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.14 0 CA-C-O 121.506 0.503 . . . . 0.0 113.69 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A 2428 ' ' ASP . . . . . . . . . . . . . 22.7 m-20 -94.33 129.69 36.22 Favored Pre-proline 0 CA--C 1.549 0.914 0 C-N-CA 124.496 1.119 . . . . 0.0 112.43 -178.414 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 2429 ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -56.46 -30.3 81.47 Favored 'Trans proline' 0 C--N 1.353 0.775 0 C-N-CA 123.659 2.906 . . . . 0.0 113.916 174.458 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 2430 ' ' GLY . . . . . . . . . . . . . . . -75.41 -21.23 77.88 Favored Glycine 0 CA--C 1.534 1.258 0 CA-C-O 119.379 -0.678 . . . . 0.0 113.92 177.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 2431 ' ' LEU . . . . . . . . . . . . . 4.3 mm? -88.86 -32.01 18.0 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.463 1.105 . . . . 0.0 111.698 173.143 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 2432 ' ' VAL . . . . . . . . . . . . . 95.4 t -68.15 136.22 26.92 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 C-N-CA 123.39 0.676 . . . . 0.0 110.439 170.549 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 2433 ' ' SER . . . . . . . . . . . . . 57.0 m -140.73 144.79 35.76 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 125.27 1.428 . . . . 0.0 109.998 175.544 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 2434 ' ' ALA . . . . . . . . . . . . . . . -100.61 148.19 25.11 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 123.351 0.66 . . . . 0.0 112.134 177.096 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 2435 ' ' TYR . . . . . . . . . . . . . 82.2 m-85 -143.93 146.26 32.84 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 125.852 1.661 . . . . 0.0 111.591 -176.282 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 2436 ' ' GLY . . . . . . . . . . . . . . . 124.89 163.52 11.67 Favored Glycine 0 N--CA 1.475 1.284 0 C-N-CA 125.09 1.328 . . . . 0.0 114.577 175.175 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 2437 ' ' ALA . . . . . . . . . . . . . . . -62.31 -30.62 71.28 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.184 1.394 . . . . 0.0 114.433 -170.064 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 2438 ' ' GLY . . . . . . . . . . . . . . . -66.05 -13.37 59.6 Favored Glycine 0 CA--C 1.532 1.152 0 C-N-CA 124.306 0.955 . . . . 0.0 114.282 -179.501 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 2439 ' ' LEU . . . . . . . . . . . . . 81.6 mt -79.84 -23.91 41.68 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 118.637 1.219 . . . . 0.0 112.801 171.049 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 2440 ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -92.78 -34.96 13.68 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 124.792 1.237 . . . . 0.0 111.985 -175.882 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 2441 ' ' GLY . . . . . . . . . . . . . . . 159.68 -153.22 24.23 Favored Glycine 0 C--N 1.339 0.748 0 C-N-CA 123.806 0.717 . . . . 0.0 114.31 -176.71 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 2442 ' ' GLY . . . . . . . . . . . . . . . 169.85 -168.76 41.63 Favored Glycine 0 CA--C 1.528 0.883 0 C-N-CA 124.802 1.191 . . . . 0.0 113.387 -178.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 2443 ' ' VAL . . . . . . . . . . . . . 38.9 t -128.31 139.11 52.79 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 C-N-CA 124.915 1.286 . . . . 0.0 108.867 174.657 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 2444 ' ' THR . . . . . . . . . . . . . 40.1 p -58.28 141.44 50.92 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.864 0.866 . . . . 0.0 112.706 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 2445 ' ' GLY . . . . . . . . . . . . . . . 78.2 -9.74 31.67 Favored Glycine 0 CA--C 1.535 1.316 0 C-N-CA 124.811 1.196 . . . . 0.0 114.859 -178.505 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 2446 ' ' ASN . . . . . . . . . . . . . 86.1 m-20 -111.59 144.87 31.46 Favored Pre-proline 0 CA--C 1.547 0.862 0 C-N-CA 125.318 1.447 . . . . 0.0 111.289 176.503 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 2447 ' ' PRO . . . . . . . . . . . . . 82.2 Cg_endo -74.71 149.46 38.21 Favored 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 122.893 2.395 . . . . 0.0 111.882 178.681 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 2448 ' ' ALA . . . . . . . . . . . . . . . -136.83 148.59 47.22 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 126.069 1.748 . . . . 0.0 109.654 168.354 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 2449 ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -141.1 157.42 45.32 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 114.164 1.172 . . . . 0.0 114.164 -166.443 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 2450 ' ' PHE . . . . . . . . . . . . . 50.7 p90 -156.59 162.64 39.88 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 126.421 1.888 . . . . 0.0 110.911 178.76 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 2451 ' ' VAL . . . . . . . . . . . . . 8.2 p -122.91 133.9 67.66 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 C-N-CA 124.698 1.199 . . . . 0.0 110.305 175.747 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 2452 ' ' VAL . . . . . . . . . . . . . 45.4 t -90.09 102.45 13.26 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 N-CA-C 106.943 -1.503 . . . . 0.0 106.943 169.64 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 2453 ' ' ASN . . . . . . . . . . . . . 19.6 t-20 -86.35 117.96 25.49 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 112.411 0.523 . . . . 0.0 112.411 -169.528 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 2454 ' ' THR . . . . . . . . . . . . . 53.0 p -97.83 -5.54 34.49 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 125.292 1.437 . . . . 0.0 113.851 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 2455 ' ' SER . . . . . . . . . . . . . 20.5 m -56.51 -28.29 59.49 Favored 'General case' 0 N--CA 1.479 1.006 0 CA-C-N 120.148 1.34 . . . . 0.0 114.54 -175.358 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 2456 ' ' ASN . . . . . . . . . . . . . 64.7 m-80 -83.33 -14.82 52.09 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 124.653 1.181 . . . . 0.0 113.593 176.532 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 2457 ' ' ALA . . . . . . . . . . . . . . . -115.58 -19.69 10.48 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 125.964 1.706 . . . . 0.0 114.271 -173.867 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 2458 ' ' GLY . . . . . . . . . . . . . . . 103.85 -103.13 2.26 Favored Glycine 0 CA--C 1.529 0.929 0 C-N-CA 125.585 1.564 . . . . 0.0 110.923 -172.699 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 2459 ' ' ALA . . . . . . . . . . . . . . . -158.61 163.39 37.01 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 125.898 1.679 . . . . 0.0 111.337 179.755 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 2460 ' ' GLY . . . . . . . . . . . . . . . 167.45 174.97 37.0 Favored Glycine 0 CA--C 1.528 0.9 0 N-CA-C 114.878 0.711 . . . . 0.0 114.878 -175.752 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 2461 ' ' ALA . . . . . . . . . . . . . . . -77.98 128.17 33.47 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.387 1.075 . . . . 0.0 112.434 -176.627 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 2462 ' ' LEU . . . . . . . . . . . . . 25.3 tp -106.64 144.28 33.53 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 125.58 1.552 . . . . 0.0 110.83 177.437 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 2463 ' ' SER . . . . . . . . . . . . . 3.8 t -136.2 40.89 2.65 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 125.843 1.657 . . . . 0.0 110.923 -176.248 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 2464 ' ' VAL . . . . . . . . . . . . . 7.5 p -64.27 133.41 29.86 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 C-N-CA 125.013 1.325 . . . . 0.0 112.107 -176.01 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 2465 ' ' THR . . . . . . . . . . . . . 97.8 m -134.18 142.84 47.57 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 126.027 1.731 . . . . 0.0 109.994 -177.196 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 2466 ' ' ILE . . . . . . . . . . . . . 50.6 mt -118.54 121.67 67.6 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 C-N-CA 124.201 1.0 . . . . 0.0 109.949 175.354 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 2467 ' ' ASP . . . . . . . . . . . . . 36.4 t70 -105.51 159.75 15.7 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 126.269 1.828 . . . . 0.0 110.592 169.314 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 2468 ' ' GLY . . . . . . . . . . . . . . . 172.97 -168.17 41.14 Favored Glycine 0 CA--C 1.535 1.313 0 O-C-N 121.305 -0.872 . . . . 0.0 114.472 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 2469 ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -66.13 -27.17 49.43 Favored 'Trans proline' 0 CA--C 1.54 0.78 0 C-N-CA 123.865 3.043 . . . . 0.0 112.833 177.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 2470 ' ' SER . . . . . . . . . . . . . 70.4 m -143.64 166.1 25.8 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 126.042 1.737 . . . . 0.0 110.184 172.196 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 2471 ' ' LYS . . . . . . . . . . . . . 68.2 mttm -71.65 131.98 43.95 Favored 'General case' 0 CA--C 1.545 0.753 0 O-C-N 120.706 -1.246 . . . . 0.0 110.989 171.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 2472 ' ' VAL . . . . . . . . . . . . . 20.5 m -87.47 155.52 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 C-N-CA 123.92 0.888 . . . . 0.0 111.52 177.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 2473 ' ' LYS . . . . . . . . . . . . . 97.5 mttt -80.84 72.35 7.82 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 124.399 1.08 . . . . 0.0 110.843 175.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 2474 ' ' MET . . . . . . . . . . . . . 22.4 ttt -78.97 139.91 38.13 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 125.745 1.618 . . . . 0.0 112.74 -171.588 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 2475 ' ' ASP . . . . . . . . . . . . . 17.6 m-20 -138.99 132.4 30.16 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 126.155 1.782 . . . . 0.0 109.844 167.116 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 2476 ' ' CYS . . . . . . . . . . . . . 48.0 t -118.19 140.67 49.44 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.076 1.35 . . . . 0.0 110.728 176.524 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 2477 ' ' GLN . . . . . . . . . . . . . 42.2 mt-30 -136.4 142.82 43.73 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 125.497 1.519 . . . . 0.0 110.444 -177.071 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 2478 ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -86.37 139.23 31.15 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.08 0.952 . . . . 0.0 110.161 171.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 2479 ' ' CYS . . . . . . . . . . . . . 29.3 p -150.52 169.76 8.75 Favored Pre-proline 0 CA--C 1.552 1.043 0 C-N-CA 125.01 1.324 . . . . 0.0 112.325 -176.866 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 2480 ' ' PRO . . . . . . . . . . . . . 56.3 Cg_exo -58.59 -25.46 74.78 Favored 'Trans proline' 0 CA--C 1.539 0.754 0 C-N-CA 123.356 2.704 . . . . 0.0 114.08 174.436 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 2481 ' ' GLU . . . . . . . . . . . . . 21.6 tt0 -85.23 -2.32 57.91 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 125.242 1.417 . . . . 0.0 113.13 178.37 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 2482 ' ' GLY . . . . . . . . . . . . . . . 121.88 -118.89 3.85 Favored Glycine 0 N--CA 1.47 0.938 0 C-N-CA 125.826 1.679 . . . . 0.0 112.202 -179.394 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 2483 ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -123.88 116.76 23.46 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.083 0.953 . . . . 0.0 110.881 174.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 2484 ' ' ARG . . . . . . . . . . . . . 41.4 ttm-85 -94.25 132.53 38.73 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 124.6 1.16 . . . . 0.0 110.169 179.227 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 2485 ' ' VAL . . . . . . . . . . . . . 86.1 t -119.98 135.36 60.52 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 C-N-CA 125.676 1.59 . . . . 0.0 108.998 -179.603 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 2486 ' ' THR . . . . . . . . . . . . . 88.4 m -129.07 142.84 50.77 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 125.244 1.417 . . . . 0.0 108.449 172.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 2487 ' ' TYR . . . . . . . . . . . . . 37.2 p90 -149.36 148.27 29.29 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 113.085 0.772 . . . . 0.0 113.085 174.041 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 2488 ' ' THR . . . . . . . . . . . . . 59.2 m -108.47 118.51 51.93 Favored Pre-proline 0 N--CA 1.473 0.725 0 C-N-CA 124.628 1.171 . . . . 0.0 108.759 168.358 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 2489 ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -82.76 157.34 15.98 Favored 'Trans proline' 0 N--CA 1.457 -0.654 0 C-N-CA 123.719 2.946 . . . . 0.0 111.189 174.108 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 2490 ' ' MET . . . . . . . . . . . . . 28.8 ptm -124.32 5.44 8.42 Favored 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 114.308 1.225 . . . . 0.0 114.308 -174.842 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 2491 ' ' ALA . . . . . . . . . . . . . . . -151.56 148.89 22.91 Favored Pre-proline 0 CA--C 1.546 0.807 0 C-N-CA 125.826 1.651 . . . . 0.0 111.117 178.25 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 2492 ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -74.66 155.33 44.61 Favored 'Trans proline' 0 CA--C 1.536 0.599 0 C-N-CA 123.094 2.529 . . . . 0.0 111.229 173.561 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 2493 ' ' GLY . . . . . . . . . . . . . . . 131.5 -174.37 20.09 Favored Glycine 0 CA--C 1.529 0.935 0 C-N-CA 125.337 1.446 . . . . 0.0 113.662 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 2494 ' ' SER . . . . . . . . . . . . . 11.1 p -86.28 129.81 34.72 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.361 1.064 . . . . 0.0 111.85 174.338 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 2495 ' ' TYR . . . . . . . . . . . . . 60.0 m-85 -107.2 125.48 51.17 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 125.578 1.551 . . . . 0.0 109.279 172.305 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 2496 ' ' LEU . . . . . . . . . . . . . 19.1 tp -94.48 107.0 18.99 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 123.857 0.863 . . . . 0.0 109.546 -178.255 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 2497 ' ' ILE . . . . . . . . . . . . . 48.7 mt -92.66 101.73 12.89 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 C-N-CA 125.631 1.572 . . . . 0.0 107.624 -179.763 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 2498 ' ' SER . . . . . . . . . . . . . 75.8 m -90.36 99.33 12.37 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 124.606 1.162 . . . . 0.0 109.519 176.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 2499 ' ' ILE . . . . . . . . . . . . . 23.0 mt -93.47 89.79 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 C-N-CA 124.511 1.125 . . . . 0.0 108.451 -178.133 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 2500 ' ' LYS . . . . . . . . . . . . . 85.1 mttt -99.53 142.52 30.91 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 124.334 1.054 . . . . 0.0 111.722 -178.715 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 2501 ' ' TYR . . . . . . . . . . . . . 72.9 t80 -146.5 138.08 24.58 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 124.738 1.215 . . . . 0.0 111.4 -168.176 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 2502 ' ' GLY . . . . . . . . . . . . . . . 69.03 12.08 64.63 Favored Glycine 0 CA--C 1.534 1.241 0 C-N-CA 124.356 0.979 . . . . 0.0 114.971 -179.45 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 2503 ' ' GLY . . . . . . . . . . . . . . . 138.41 -153.24 22.36 Favored Glycine 0 CA--C 1.539 1.552 0 C-N-CA 125.507 1.527 . . . . 0.0 112.388 -169.421 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 2504 ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -81.75 6.86 5.38 Favored 'Trans proline' 0 CA--C 1.543 0.938 0 C-N-CA 124.354 3.369 . . . . 0.0 114.123 -172.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 2505 ' ' TYR . . . . . . . . . . . . . 64.5 m-85 -99.26 136.14 39.64 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.272 1.029 . . . . 0.0 113.18 -172.479 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 2506 ' ' HIS . . . . . . . . . . . . . 93.4 m-70 -64.75 148.2 51.62 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 125.036 1.334 . . . . 0.0 113.305 176.778 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 2507 ' ' ILE . . . . . . . . . . . . . 30.4 pt -73.59 173.27 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 C-N-CA 123.387 0.675 . . . . 0.0 112.523 167.599 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 2508 ' ' GLY . . . . . . . . . . . . . . . -58.97 122.19 29.34 Favored Glycine 0 CA--C 1.534 1.253 0 O-C-N 121.659 -0.651 . . . . 0.0 111.791 172.808 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 2509 ' ' GLY . . . . . . . . . . . . . . . 88.75 -9.99 74.07 Favored Glycine 0 CA--C 1.536 1.362 0 C-N-CA 125.654 1.597 . . . . 0.0 115.226 -178.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 2510 ' ' SER . . . . . . . . . . . . . 41.6 t -84.95 147.77 49.06 Favored Pre-proline 0 CA--C 1.549 0.914 0 CA-C-N 119.053 1.426 . . . . 0.0 112.023 179.325 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 2511 ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -79.34 158.7 90.17 Favored 'Cis proline' 0 C--N 1.353 0.801 0 CA-C-N 119.867 0.988 . . . . 0.0 113.456 0.245 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 2512 ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -107.66 137.97 44.72 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 125.471 1.508 . . . . 0.0 110.747 177.847 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 2513 ' ' LYS . . . . . . . . . . . . . 19.1 ptpt -99.5 15.42 26.56 Favored 'General case' 0 N--CA 1.48 1.068 0 N-CA-C 116.289 1.959 . . . . 0.0 116.289 -163.48 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 2514 ' ' ALA . . . . . . . . . . . . . . . -14.89 108.57 0.02 OUTLIER 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 129.388 3.075 . . . . 0.0 116.722 -173.409 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 2515 ' ' LYS . . . . . . . . . . . . . 67.5 mttm -92.24 107.85 19.51 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 124.66 1.184 . . . . 0.0 111.72 -175.26 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 2516 ' ' VAL . . . . . . . . . . . . . 71.3 t -95.74 142.07 14.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 C-N-CA 125.726 1.61 . . . . 0.0 110.493 -177.828 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 2517 ' ' THR . . . . . . . . . . . . . 77.8 p -121.42 179.31 4.47 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 125.28 1.432 . . . . 0.0 111.456 174.321 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 2518 ' ' GLY . . . . . . . . . . . . . . . 99.91 178.78 30.59 Favored Glycine 0 CA--C 1.54 1.635 0 C-N-CA 124.676 1.131 . . . . 0.0 113.635 -178.231 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 2519 ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -72.98 148.4 45.18 Favored 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 123.857 3.038 . . . . 0.0 112.218 -174.46 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 2520 ' ' ARG . . . . . . . . . . . . . 49.4 ttm-85 . . . . . 0 CA--C 1.539 0.538 0 C-N-CA 123.63 0.772 . . . . 0.0 110.281 173.189 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A 2427 ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.145 0 CA-C-O 121.533 0.518 . . . . 0.0 113.879 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A 2428 ' ' ASP . . . . . . . . . . . . . 24.5 m-20 -91.0 133.12 32.6 Favored Pre-proline 0 CA--C 1.549 0.905 0 C-N-CA 124.233 1.013 . . . . 0.0 112.857 -175.205 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 2429 ' ' PRO . . . . . . . . . . . . . 72.5 Cg_exo -55.2 -27.88 58.73 Favored 'Trans proline' 0 C--N 1.352 0.711 0 C-N-CA 124.097 3.198 . . . . 0.0 114.308 171.611 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 2430 ' ' GLY . . . . . . . . . . . . . . . -77.04 -23.13 69.7 Favored Glycine 0 CA--C 1.534 1.254 0 C-N-CA 123.851 0.739 . . . . 0.0 113.819 176.525 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 2431 ' ' LEU . . . . . . . . . . . . . 4.4 mm? -87.42 -31.63 19.96 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.393 1.077 . . . . 0.0 111.612 171.768 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 2432 ' ' VAL . . . . . . . . . . . . . 87.5 t -64.67 130.23 29.55 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 CA-C-N 118.68 0.673 . . . . 0.0 109.901 168.824 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 2433 ' ' SER . . . . . . . . . . . . . 68.0 m -125.59 172.35 9.81 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 125.436 1.494 . . . . 0.0 110.338 174.787 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 2434 ' ' ALA . . . . . . . . . . . . . . . -131.52 143.24 50.24 Favored 'General case' 0 CA--C 1.539 0.53 0 O-C-N 121.205 -0.934 . . . . 0.0 111.29 174.638 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 2435 ' ' TYR . . . . . . . . . . . . . 75.8 m-85 -144.37 147.39 33.37 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 125.234 1.413 . . . . 0.0 112.001 -175.421 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 2436 ' ' GLY . . . . . . . . . . . . . . . 122.33 163.22 11.81 Favored Glycine 0 N--CA 1.473 1.154 0 C-N-CA 125.087 1.327 . . . . 0.0 114.198 175.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 2437 ' ' ALA . . . . . . . . . . . . . . . -61.9 -28.64 69.66 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.123 1.369 . . . . 0.0 114.398 -170.445 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 2438 ' ' GLY . . . . . . . . . . . . . . . -64.35 -18.18 62.77 Favored Glycine 0 CA--C 1.533 1.164 0 CA-C-O 118.984 -0.898 . . . . 0.0 114.12 -179.581 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 2439 ' ' LEU . . . . . . . . . . . . . 80.0 mt -76.44 -24.29 53.93 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 118.663 1.232 . . . . 0.0 112.754 171.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 2440 ' ' GLU . . . . . . . . . . . . . 37.9 mm-40 -89.05 -27.71 20.64 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.983 1.313 . . . . 0.0 111.792 177.205 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 2441 ' ' GLY . . . . . . . . . . . . . . . 111.93 -138.56 15.05 Favored Glycine 0 CA--C 1.53 1.009 0 C-N-CA 125.943 1.735 . . . . 0.0 112.301 -178.452 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 2442 ' ' GLY . . . . . . . . . . . . . . . 154.32 -148.29 18.62 Favored Glycine 0 N--CA 1.474 1.18 0 C-N-CA 124.019 0.819 . . . . 0.0 113.971 -177.418 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 2443 ' ' VAL . . . . . . . . . . . . . 60.1 t -105.79 139.23 27.64 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 C-N-CA 125.334 1.454 . . . . 0.0 110.032 -178.322 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 2444 ' ' THR . . . . . . . . . . . . . 39.3 p -59.39 144.87 45.55 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.505 1.122 . . . . 0.0 112.675 175.556 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 2445 ' ' GLY . . . . . . . . . . . . . . . 80.0 -18.3 8.03 Favored Glycine 0 CA--C 1.535 1.339 0 C-N-CA 125.033 1.301 . . . . 0.0 114.47 -179.804 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 2446 ' ' ASN . . . . . . . . . . . . . 87.4 m-20 -99.64 144.55 28.54 Favored Pre-proline 0 CA--C 1.545 0.763 0 C-N-CA 125.081 1.353 . . . . 0.0 110.98 176.321 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 2447 ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -73.85 151.26 45.45 Favored 'Trans proline' 0 N--CA 1.457 -0.637 0 C-N-CA 122.816 2.344 . . . . 0.0 111.479 178.281 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 2448 ' ' ALA . . . . . . . . . . . . . . . -135.74 158.7 43.75 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 126.534 1.934 . . . . 0.0 109.492 169.437 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 2449 ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -149.37 155.65 40.82 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 113.913 1.079 . . . . 0.0 113.913 -171.457 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 2450 ' ' PHE . . . . . . . . . . . . . 47.9 p90 -155.03 153.61 31.23 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 126.042 1.737 . . . . 0.0 110.434 178.579 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 2451 ' ' VAL . . . . . . . . . . . . . 12.0 p -107.43 132.4 55.05 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 C-N-CA 124.603 1.161 . . . . 0.0 110.087 175.089 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 2452 ' ' VAL . . . . . . . . . . . . . 34.8 t -86.6 101.57 10.97 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 N-CA-C 106.594 -1.632 . . . . 0.0 106.594 165.684 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 2453 ' ' ASN . . . . . . . . . . . . . 13.2 t-20 -79.57 111.93 16.33 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.23 1.012 . . . . 0.0 111.821 -171.218 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 2454 ' ' THR . . . . . . . . . . . . . 27.9 p -101.16 -13.47 18.13 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 125.335 1.454 . . . . 0.0 113.865 -179.734 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 2455 ' ' SER . . . . . . . . . . . . . 98.1 p -64.39 -24.65 67.71 Favored 'General case' 0 N--CA 1.478 0.957 0 CA-C-N 120.234 1.379 . . . . 0.0 114.213 -174.577 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 2456 ' ' ASN . . . . . . . . . . . . . 49.8 m-80 -77.35 -18.31 57.52 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 124.283 1.033 . . . . 0.0 113.568 171.731 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 2457 ' ' ALA . . . . . . . . . . . . . . . -106.04 -31.3 8.8 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 125.4 1.48 . . . . 0.0 113.827 -176.131 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 2458 ' ' GLY . . . . . . . . . . . . . . . 113.99 -113.85 3.17 Favored Glycine 0 CA--C 1.53 1.008 0 C-N-CA 125.516 1.531 . . . . 0.0 111.491 -174.171 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 2459 ' ' ALA . . . . . . . . . . . . . . . -144.31 158.85 43.52 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 125.17 1.388 . . . . 0.0 111.943 -179.559 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 2460 ' ' GLY . . . . . . . . . . . . . . . 160.28 171.78 26.64 Favored Glycine 0 CA--C 1.531 1.092 0 C-N-CA 125.112 1.339 . . . . 0.0 113.161 -174.098 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 2461 ' ' ALA . . . . . . . . . . . . . . . -75.62 138.2 41.24 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 123.959 0.904 . . . . 0.0 112.241 -178.76 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 2462 ' ' LEU . . . . . . . . . . . . . 50.0 tp -119.84 143.09 48.08 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.462 1.505 . . . . 0.0 110.658 176.734 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 2463 ' ' SER . . . . . . . . . . . . . 12.5 t -128.37 162.71 26.47 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.114 1.365 . . . . 0.0 110.355 160.637 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 2464 ' ' VAL . . . . . . . . . . . . . 7.2 p -162.18 133.06 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 C-N-CA 124.852 1.261 . . . . 0.0 110.353 -178.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 2465 ' ' THR . . . . . . . . . . . . . 79.8 m -133.95 138.73 45.66 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 125.236 1.414 . . . . 0.0 109.184 -178.374 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 2466 ' ' ILE . . . . . . . . . . . . . 33.7 mt -119.08 114.94 46.31 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 C-N-CA 124.036 0.934 . . . . 0.0 109.388 177.065 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 2467 ' ' ASP . . . . . . . . . . . . . 33.4 t70 -99.11 165.47 11.71 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 126.01 1.724 . . . . 0.0 110.151 168.501 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 2468 ' ' GLY . . . . . . . . . . . . . . . 168.93 -161.9 35.62 Favored Glycine 0 CA--C 1.536 1.391 0 O-C-N 121.009 -1.057 . . . . 0.0 115.283 178.009 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 2469 ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -67.94 -16.23 45.01 Favored 'Trans proline' 0 CA--C 1.54 0.8 0 C-N-CA 124.297 3.331 . . . . 0.0 113.404 178.808 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 2470 ' ' SER . . . . . . . . . . . . . 32.9 m -151.98 175.09 12.87 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 127.14 2.176 . . . . 0.0 109.31 169.743 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 2471 ' ' LYS . . . . . . . . . . . . . 98.7 mttt -67.74 164.41 19.5 Favored 'General case' 0 CA--C 1.548 0.886 0 O-C-N 121.002 -1.061 . . . . 0.0 111.69 166.484 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 2472 ' ' VAL . . . . . . . . . . . . . 27.2 m -123.08 153.68 28.33 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 C-N-CA 125.168 1.387 . . . . 0.0 111.011 177.057 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 2473 ' ' LYS . . . . . . . . . . . . . 88.3 tttt -91.62 129.17 37.64 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 123.229 0.611 . . . . 0.0 109.387 163.243 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 2474 ' ' MET . . . . . . . . . . . . . 99.0 mtp -121.01 149.55 42.5 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 124.989 1.315 . . . . 0.0 111.895 -177.467 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 2475 ' ' ASP . . . . . . . . . . . . . 38.6 t0 -138.69 83.18 1.95 Allowed 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 126.953 2.101 . . . . 0.0 109.135 174.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 2476 ' ' CYS . . . . . . . . . . . . . 24.1 t -77.15 133.5 38.95 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 123.853 0.861 . . . . 0.0 111.126 177.783 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 2477 ' ' GLN . . . . . . . . . . . . . 34.9 mt-30 -138.81 179.93 6.2 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 127.734 2.414 . . . . 0.0 109.357 -169.328 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 2478 ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -143.57 149.18 37.03 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.364 1.066 . . . . 0.0 112.019 179.909 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 2479 ' ' CYS . . . . . . . . . . . . . 20.8 p -156.84 174.14 4.31 Favored Pre-proline 0 CA--C 1.553 1.086 0 C-N-CA 126.108 1.763 . . . . 0.0 110.99 -176.752 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 2480 ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -58.44 -24.72 70.34 Favored 'Trans proline' 0 CA--C 1.539 0.748 0 C-N-CA 123.349 2.7 . . . . 0.0 114.711 177.776 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 2481 ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -79.76 -17.27 53.87 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 124.285 1.034 . . . . 0.0 112.987 178.172 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 2482 ' ' GLY . . . . . . . . . . . . . . . 136.26 -154.5 22.01 Favored Glycine 0 CA--C 1.531 1.056 0 C-N-CA 125.818 1.675 . . . . 0.0 113.372 -178.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 2483 ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -85.55 115.23 23.13 Favored 'General case' 0 N--CA 1.468 0.449 0 O-C-N 121.78 -0.835 . . . . 0.0 110.774 175.541 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 2484 ' ' ARG . . . . . . . . . . . . . 35.9 ttt-85 -95.95 121.73 38.0 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 124.401 1.08 . . . . 0.0 110.241 -178.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 2485 ' ' VAL . . . . . . . . . . . . . 66.1 t -103.02 125.67 57.39 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 C-N-CA 124.933 1.293 . . . . 0.0 108.392 177.187 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 2486 ' ' THR . . . . . . . . . . . . . 91.8 m -111.69 139.49 47.11 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 167.434 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 2487 ' ' TYR . . . . . . . . . . . . . 14.1 p90 -151.01 154.85 37.84 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 113.361 0.875 . . . . 0.0 113.361 177.022 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 2488 ' ' THR . . . . . . . . . . . . . 98.9 m -118.33 115.49 35.96 Favored Pre-proline 0 N--CA 1.475 0.78 0 C-N-CA 124.717 1.207 . . . . 0.0 109.725 176.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 2489 ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -81.3 163.14 19.77 Favored 'Trans proline' 0 C--N 1.351 0.667 0 C-N-CA 123.987 3.125 . . . . 0.0 111.165 169.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 2490 ' ' MET . . . . . . . . . . . . . 25.8 ptm -143.05 4.29 1.43 Allowed 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 115.482 1.66 . . . . 0.0 115.482 -170.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 2491 ' ' ALA . . . . . 0.407 ' H ' ' HH ' ' A' 2495 ' ' TYR . . . -146.11 148.37 34.99 Favored Pre-proline 0 CA--C 1.546 0.819 0 C-N-CA 125.112 1.365 . . . . 0.0 110.901 174.769 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 2492 ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -72.2 145.37 43.73 Favored 'Trans proline' 0 CA--C 1.536 0.61 0 C-N-CA 122.813 2.342 . . . . 0.0 110.997 177.025 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 2493 ' ' GLY . . . . . . . . . . . . . . . 136.77 -167.03 24.72 Favored Glycine 0 CA--C 1.53 0.971 0 C-N-CA 125.34 1.448 . . . . 0.0 113.44 -177.141 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 2494 ' ' SER . . . . . . . . . . . . . 50.2 m -98.77 120.14 38.7 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.271 1.028 . . . . 0.0 111.298 -179.128 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 2495 ' ' TYR . . . . . 0.407 ' HH ' ' H ' ' A' 2491 ' ' ALA . 73.0 m-85 -93.01 124.96 37.35 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.215 1.006 . . . . 0.0 110.395 170.855 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 2496 ' ' LEU . . . . . . . . . . . . . 22.8 tp -96.65 111.35 23.53 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.423 1.089 . . . . 0.0 109.788 -178.888 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 2497 ' ' ILE . . . . . . . . . . . . . 49.9 mt -98.73 102.1 12.98 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 C-N-CA 126.057 1.743 . . . . 0.0 108.429 -176.663 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 2498 ' ' SER . . . . . . . . . . . . . 73.2 m -92.76 98.34 11.34 Favored 'General case' 0 N--CA 1.468 0.425 0 C-N-CA 124.608 1.163 . . . . 0.0 110.25 178.492 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 2499 ' ' ILE . . . . . . . . . . . . . 28.0 mt -96.05 120.53 45.54 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 C-N-CA 125.834 1.654 . . . . 0.0 109.349 179.65 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 2500 ' ' LYS . . . . . . . . . . . . . 90.5 mttt -134.08 127.78 32.86 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.264 1.026 . . . . 0.0 112.788 -171.137 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 2501 ' ' TYR . . . . . . . . . . . . . 57.5 t80 -128.09 151.56 49.04 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 124.828 1.251 . . . . 0.0 112.621 -171.674 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 2502 ' ' GLY . . . . . . . . . . . . . . . 64.91 20.02 66.17 Favored Glycine 0 CA--C 1.536 1.378 0 C-N-CA 124.241 0.924 . . . . 0.0 113.733 178.297 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 2503 ' ' GLY . . . . . . . . . . . . . . . 126.32 -166.46 19.09 Favored Glycine 0 CA--C 1.542 1.721 0 C-N-CA 125.878 1.704 . . . . 0.0 112.42 -164.785 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 2504 ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -82.11 31.77 0.52 Allowed 'Trans proline' 0 CA--C 1.546 1.113 0 C-N-CA 124.985 3.79 . . . . 0.0 113.522 -173.043 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 2505 ' ' TYR . . . . . . . . . . . . . 75.5 m-85 -113.87 131.47 56.26 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.66 1.184 . . . . 0.0 112.773 -172.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 2506 ' ' HIS . . . . . . . . . . . . . 89.5 m-70 -60.54 140.05 57.5 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 124.681 1.192 . . . . 0.0 113.687 -177.072 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 2507 ' ' ILE . . . . . . . . . . . . . 2.2 pp -84.45 160.58 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.199 0 C-N-CA 123.962 0.905 . . . . 0.0 112.442 173.691 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 2508 ' ' GLY . . . . . . . . . . . . . . . 38.67 -110.63 0.14 Allowed Glycine 0 CA--C 1.537 1.435 0 C-N-CA 125.291 1.424 . . . . 0.0 115.607 161.641 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 2509 ' ' GLY . . . . . . . . . . . . . . . -104.75 15.82 48.26 Favored Glycine 0 CA--C 1.538 1.51 0 C-N-CA 126.37 1.938 . . . . 0.0 114.637 175.74 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 2510 ' ' SER . . . . . . . . . . . . . 33.3 t -67.85 146.38 98.32 Favored Pre-proline 0 CA--C 1.551 0.987 0 C-N-CA 125.38 1.472 . . . . 0.0 112.181 179.449 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 2511 ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -79.6 156.19 89.34 Favored 'Cis proline' 0 C--N 1.351 0.687 0 CA-C-N 119.728 0.939 . . . . 0.0 112.915 -0.544 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 2512 ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -106.17 136.14 46.39 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 125.178 1.391 . . . . 0.0 111.07 179.822 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 2513 ' ' LYS . . . . . . . . . . . . . 19.5 ptpt -94.17 11.72 29.11 Favored 'General case' 0 CA--C 1.552 1.024 0 N-CA-C 116.51 2.041 . . . . 0.0 116.51 -164.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 2514 ' ' ALA . . . . . . . . . . . . . . . -4.78 99.35 0.01 OUTLIER 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 129.561 3.145 . . . . 0.0 116.474 -179.211 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 2515 ' ' LYS . . . . . . . . . . . . . 52.9 mtpt -89.02 120.0 30.05 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.258 1.023 . . . . 0.0 111.529 -173.332 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 2516 ' ' VAL . . . . . . . . . . . . . 55.0 t -113.14 142.58 25.1 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 125.788 1.635 . . . . 0.0 110.435 -172.484 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 2517 ' ' THR . . . . . . . . . . . . . 40.9 p -127.88 171.88 11.38 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 125.664 1.586 . . . . 0.0 111.458 178.151 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 2518 ' ' GLY . . . . . . . . . . . . . . . 107.31 -173.74 19.08 Favored Glycine 0 CA--C 1.538 1.53 0 C-N-CA 124.919 1.247 . . . . 0.0 113.264 -176.792 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 2519 ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -71.05 156.2 60.32 Favored 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 123.705 2.937 . . . . 0.0 112.209 -176.092 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 2520 ' ' ARG . . . . . . . . . . . . . 39.9 ttm105 . . . . . 0 CA--C 1.537 0.479 0 C-N-CA 123.915 0.886 . . . . 0.0 110.0 171.852 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A 2427 ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.951 0 CA-C-O 121.109 0.283 . . . . 0.0 113.099 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A 2428 ' ' ASP . . . . . . . . . . . . . 29.4 m-20 -91.66 136.5 26.47 Favored Pre-proline 0 CA--C 1.547 0.853 0 C-N-CA 124.517 1.127 . . . . 0.0 112.0 -179.087 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 2429 ' ' PRO . . . . . . . . . . . . . 79.6 Cg_exo -54.75 -27.58 53.0 Favored 'Trans proline' 0 C--N 1.353 0.772 0 C-N-CA 123.994 3.129 . . . . 0.0 114.862 175.577 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 2430 ' ' GLY . . . . . . . . . . . . . . . -80.02 -24.54 59.54 Favored Glycine 0 CA--C 1.535 1.285 0 C-N-CA 123.762 0.696 . . . . 0.0 113.969 176.615 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 2431 ' ' LEU . . . . . . . . . . . . . 4.2 mm? -86.22 -32.77 21.0 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.575 1.15 . . . . 0.0 111.315 172.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 2432 ' ' VAL . . . . . . . . . . . . . 82.5 t -65.08 136.75 26.18 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 C-N-CA 123.723 0.809 . . . . 0.0 109.723 167.758 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 2433 ' ' SER . . . . . . . . . . . . . 8.4 t -131.88 -168.85 2.1 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.827 1.251 . . . . 0.0 110.823 177.311 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 2434 ' ' ALA . . . . . . . . . . . . . . . -149.91 142.64 24.63 Favored 'General case' 0 CA--C 1.539 0.531 0 O-C-N 121.062 -1.024 . . . . 0.0 111.988 176.395 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 2435 ' ' TYR . . . . . . . . . . . . . 77.4 m-85 -145.79 148.85 33.38 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 125.386 1.474 . . . . 0.0 112.001 -176.416 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 2436 ' ' GLY . . . . . . . . . . . . . . . 123.99 160.42 10.79 Favored Glycine 0 N--CA 1.474 1.2 0 C-N-CA 125.245 1.402 . . . . 0.0 113.974 176.708 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 2437 ' ' ALA . . . . . . . . . . . . . . . -60.93 -30.19 70.06 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.007 1.323 . . . . 0.0 114.167 -171.057 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 2438 ' ' GLY . . . . . . . . . . . . . . . -67.19 -9.81 55.21 Favored Glycine 0 CA--C 1.533 1.169 0 C-N-CA 124.57 1.081 . . . . 0.0 114.514 -179.632 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 2439 ' ' LEU . . . . . . . . . . . . . 88.3 mt -79.41 -26.12 41.95 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 118.973 1.386 . . . . 0.0 112.553 168.397 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 2440 ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -95.94 -36.37 11.09 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.081 1.352 . . . . 0.0 112.236 -173.851 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 2441 ' ' GLY . . . . . . . . . . . . . . . 160.32 -148.96 17.97 Favored Glycine 0 CA--C 1.532 1.134 0 C-N-CA 124.79 1.186 . . . . 0.0 113.146 -176.053 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 2442 ' ' GLY . . . . . . . . . . . . . . . 150.68 178.63 25.72 Favored Glycine 0 CA--C 1.534 1.249 0 C-N-CA 125.412 1.482 . . . . 0.0 112.796 -175.85 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 2443 ' ' VAL . . . . . . . . . . . . . 83.9 t -101.81 134.77 41.33 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 C-N-CA 124.722 1.209 . . . . 0.0 110.097 -179.583 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 2444 ' ' THR . . . . . . . . . . . . . 25.5 p -63.19 140.07 58.84 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.212 1.005 . . . . 0.0 112.325 176.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 2445 ' ' GLY . . . . . . . . . . . . . . . 79.58 -11.51 32.19 Favored Glycine 0 CA--C 1.536 1.385 0 C-N-CA 124.705 1.145 . . . . 0.0 114.328 -174.887 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 2446 ' ' ASN . . . . . . . . . . . . . 82.1 m-20 -106.36 152.14 40.48 Favored Pre-proline 0 CA--C 1.548 0.884 0 C-N-CA 125.453 1.501 . . . . 0.0 110.901 173.19 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 2447 ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -73.05 134.28 21.11 Favored 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 122.789 2.326 . . . . 0.0 111.335 175.875 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 2448 ' ' ALA . . . . . . . . . . . . . . . -111.48 156.69 21.3 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 126.232 1.813 . . . . 0.0 109.225 162.049 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 2449 ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -153.37 153.93 33.52 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 113.901 1.074 . . . . 0.0 113.901 -173.389 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 2450 ' ' PHE . . . . . . . . . . . . . 40.2 p90 -158.0 161.02 38.08 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.863 1.665 . . . . 0.0 110.696 177.336 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 2451 ' ' VAL . . . . . . . . . . . . . 14.7 p -113.04 135.07 53.68 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 C-N-CA 124.697 1.199 . . . . 0.0 110.968 175.121 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 2452 ' ' VAL . . . . . . . . . . . . . 25.1 t -84.89 101.76 9.86 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 N-CA-C 106.337 -1.727 . . . . 0.0 106.337 163.315 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 2453 ' ' ASN . . . . . . . . . . . . . 15.8 t-20 -88.66 123.5 33.17 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 123.72 0.808 . . . . 0.0 112.335 -167.006 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 2454 ' ' THR . . . . . . . . . . . . . 69.0 p -109.89 2.03 19.56 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 125.878 1.671 . . . . 0.0 113.745 -174.178 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 2455 ' ' SER . . . . . . . . . . . . . 42.0 m -56.57 -30.93 63.71 Favored 'General case' 0 N--CA 1.479 0.976 0 N-CA-C 114.537 1.31 . . . . 0.0 114.537 -172.887 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 2456 ' ' ASN . . . . . . . . . . . . . 28.0 m120 -88.96 -8.44 54.12 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 124.896 1.278 . . . . 0.0 113.55 177.297 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 2457 ' ' ALA . . . . . . . . . . . . . . . -113.18 -47.64 3.01 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 125.387 1.475 . . . . 0.0 113.755 -170.166 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 2458 ' ' GLY . . . . . . . . . . . . . . . 105.48 -151.29 17.12 Favored Glycine 0 CA--C 1.534 1.277 0 C-N-CA 125.333 1.444 . . . . 0.0 113.144 -174.219 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 2459 ' ' ALA . . . . . . . . . . . . . . . -77.44 156.64 30.97 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.811 1.245 . . . . 0.0 114.023 -174.43 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 2460 ' ' GLY . . . . . . . . . . . . . . . 158.22 172.09 24.93 Favored Glycine 0 CA--C 1.531 1.073 0 C-N-CA 125.246 1.403 . . . . 0.0 113.655 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 2461 ' ' ALA . . . . . . . . . . . . . . . -100.39 148.9 24.2 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.9 1.28 . . . . 0.0 112.84 -176.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 2462 ' ' LEU . . . . . . . . . . . . . 16.3 tp -101.97 149.41 24.26 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 125.526 1.531 . . . . 0.0 111.357 176.888 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 2463 ' ' SER . . . . . . . . . . . . . 3.7 t -140.89 40.29 1.82 Allowed 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 125.223 1.409 . . . . 0.0 111.427 179.136 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 2464 ' ' VAL . . . . . . . . . . . . . 14.2 p -65.36 139.23 21.7 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 C-N-CA 125.124 1.37 . . . . 0.0 112.574 -174.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 2465 ' ' THR . . . . . . . . . . . . . 93.5 m -135.04 143.38 46.71 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 125.791 1.636 . . . . 0.0 109.706 175.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 2466 ' ' ILE . . . . . . . . . . . . . 35.2 mt -121.12 123.97 71.13 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 C-N-CA 124.079 0.951 . . . . 0.0 110.122 175.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 2467 ' ' ASP . . . . . . . . . . . . . 34.4 t70 -104.17 162.91 12.78 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 126.809 2.044 . . . . 0.0 110.077 169.048 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 2468 ' ' GLY . . . . . . . . . . . . . . . 168.95 -161.55 35.25 Favored Glycine 0 CA--C 1.536 1.376 0 O-C-N 120.841 -1.162 . . . . 0.0 115.414 178.265 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 2469 ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -71.48 -17.72 30.05 Favored 'Trans proline' 0 CA--C 1.539 0.747 0 C-N-CA 124.006 3.138 . . . . 0.0 113.341 -178.827 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 2470 ' ' SER . . . . . . . . . . . . . 43.3 m -156.79 -168.36 2.65 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 127.213 2.205 . . . . 0.0 109.762 178.775 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 2471 ' ' LYS . . . . . . . . . . . . . 49.0 mmtm -74.12 174.78 8.21 Favored 'General case' 0 CA--C 1.55 0.968 0 O-C-N 120.661 -1.275 . . . . 0.0 112.523 170.32 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 2472 ' ' VAL . . . . . . . . . . . . . 35.4 m -131.06 148.36 33.01 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 C-N-CA 125.448 1.499 . . . . 0.0 109.971 165.848 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 2473 ' ' LYS . . . . . . . . . . . . . 88.5 tttt -94.44 102.89 14.87 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 166.146 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 2474 ' ' MET . . . . . . . . . . . . . 55.4 ttp -117.27 144.56 44.71 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.994 1.317 . . . . 0.0 112.732 -173.193 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 2475 ' ' ASP . . . . . . . . . . . . . 31.7 t70 -127.98 132.97 49.15 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 126.991 2.116 . . . . 0.0 110.057 170.479 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 2476 ' ' CYS . . . . . . . . . . . . . 45.3 t -109.73 138.55 45.93 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 125.138 1.375 . . . . 0.0 111.334 178.291 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 2477 ' ' GLN . . . . . . . . . . . . . 81.6 mt-30 -133.68 128.65 35.46 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.035 1.334 . . . . 0.0 110.392 -175.079 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 2478 ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -81.57 137.01 35.58 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.34 1.056 . . . . 0.0 109.9 173.159 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 2479 ' ' CYS . . . . . . . . . . . . . 29.6 p -156.01 167.24 14.69 Favored Pre-proline 0 CA--C 1.552 1.034 0 C-N-CA 125.024 1.33 . . . . 0.0 111.607 -172.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 2480 ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -65.28 -16.81 56.3 Favored 'Trans proline' 0 CA--C 1.543 0.941 0 C-N-CA 122.701 2.267 . . . . 0.0 113.266 174.807 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 2481 ' ' GLU . . . . . . . . . . . . . 19.6 tt0 -80.21 -10.72 59.77 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 124.969 1.308 . . . . 0.0 112.535 173.374 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 2482 ' ' GLY . . . . . . . . . . . . . . . 122.57 -126.35 6.34 Favored Glycine 0 N--CA 1.473 1.115 0 C-N-CA 125.999 1.761 . . . . 0.0 112.102 -177.048 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 2483 ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -115.85 108.84 16.82 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 123.789 0.836 . . . . 0.0 110.572 171.422 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 2484 ' ' ARG . . . . . . . . . . . . . 42.2 ttm-85 -92.59 132.49 36.82 Favored 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 124.007 0.923 . . . . 0.0 109.63 175.8 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 2485 ' ' VAL . . . . . . . . . . . . . 32.6 m -117.65 144.37 25.75 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 C-N-CA 123.845 0.858 . . . . 0.0 110.327 174.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 2486 ' ' THR . . . . . . . . . . . . . 88.6 m -124.32 132.75 53.57 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 125.447 1.499 . . . . 0.0 107.49 171.089 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 2487 ' ' TYR . . . . . . . . . . . . . 19.4 p90 -142.46 146.83 35.2 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 113.34 0.867 . . . . 0.0 113.34 178.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 2488 ' ' THR . . . . . . . . . . . . . 65.1 m -106.17 116.11 59.98 Favored Pre-proline 0 N--CA 1.471 0.608 0 C-N-CA 124.501 1.12 . . . . 0.0 109.216 172.49 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 2489 ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -79.98 153.8 22.39 Favored 'Trans proline' 0 C--N 1.351 0.681 0 C-N-CA 123.717 2.945 . . . . 0.0 110.665 170.475 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 2490 ' ' MET . . . . . . . . . . . . . 28.5 ptm -117.08 -5.3 11.41 Favored 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 115.055 1.502 . . . . 0.0 115.055 -174.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 2491 ' ' ALA . . . . . . . . . . . . . . . -146.5 144.73 21.43 Favored Pre-proline 0 CA--C 1.548 0.898 0 C-N-CA 124.731 1.212 . . . . 0.0 111.447 177.801 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 2492 ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -70.26 156.05 62.91 Favored 'Trans proline' 0 C--N 1.35 0.64 0 C-N-CA 123.571 2.847 . . . . 0.0 111.357 177.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 2493 ' ' GLY . . . . . . . . . . . . . . . 126.52 -154.62 19.18 Favored Glycine 0 CA--C 1.528 0.898 0 C-N-CA 124.886 1.231 . . . . 0.0 113.241 -178.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 2494 ' ' SER . . . . . . . . . . . . . 74.0 m -104.5 112.94 26.2 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 123.709 0.804 . . . . 0.0 112.206 -176.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 2495 ' ' TYR . . . . . . . . . . . . . 69.0 m-85 -88.64 129.6 35.47 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 123.524 0.73 . . . . 0.0 109.89 162.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 2496 ' ' LEU . . . . . . . . . . . . . 29.0 tp -101.55 117.69 35.43 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.697 1.199 . . . . 0.0 109.521 179.052 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 2497 ' ' ILE . . . . . . . . . . . . . 61.9 mt -103.46 99.98 9.5 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 C-N-CA 125.574 1.55 . . . . 0.0 108.407 -170.087 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 2498 ' ' SER . . . . . . . . . . . . . 74.6 m -83.32 86.28 7.08 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 125.071 1.348 . . . . 0.0 109.864 176.495 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 2499 ' ' ILE . . . . . . . . . . . . . 37.0 mt -79.19 110.86 15.36 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 C-N-CA 124.124 0.97 . . . . 0.0 109.162 175.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 2500 ' ' LYS . . . . . . . . . . . . . 83.7 mttt -121.75 145.46 48.02 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.859 1.264 . . . . 0.0 111.51 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 2501 ' ' TYR . . . . . . . . . . . . . 47.5 t80 -149.31 146.54 27.59 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.563 1.145 . . . . 0.0 112.16 -171.447 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 2502 ' ' GLY . . . . . . . . . . . . . . . 67.19 19.36 70.18 Favored Glycine 0 CA--C 1.536 1.394 0 C-N-CA 124.25 0.928 . . . . 0.0 113.735 177.552 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 2503 ' ' GLY . . . . . . . . . . . . . . . 131.7 -167.32 22.73 Favored Glycine 0 CA--C 1.541 1.699 0 C-N-CA 125.93 1.729 . . . . 0.0 112.364 -166.13 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 2504 ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -81.83 26.77 0.61 Allowed 'Trans proline' 0 CA--C 1.547 1.154 0 C-N-CA 124.921 3.747 . . . . 0.0 113.588 -174.291 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 2505 ' ' TYR . . . . . . . . . . . . . 60.2 m-85 -112.23 134.36 53.82 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 124.638 1.175 . . . . 0.0 113.02 -171.72 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 2506 ' ' HIS . . . . . . . . . . . . . 95.2 m-70 -63.4 142.53 58.36 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 124.842 1.257 . . . . 0.0 113.462 -179.326 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 2507 ' ' ILE . . . . . . . . . . . . . 1.8 pp -83.37 173.43 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.319 0 C-N-CA 123.628 0.771 . . . . 0.0 113.015 174.428 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 2508 ' ' GLY . . . . . . . . . . . . . . . -59.69 113.73 5.57 Favored Glycine 0 CA--C 1.534 1.248 0 O-C-N 121.469 -0.769 . . . . 0.0 112.783 -177.027 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 2509 ' ' GLY . . . . . . . . . . . . . . . 92.66 -5.32 76.79 Favored Glycine 0 CA--C 1.536 1.354 0 C-N-CA 125.615 1.579 . . . . 0.0 114.861 -177.238 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 2510 ' ' SER . . . . . . . . . . . . . 35.0 t -82.22 146.56 54.96 Favored Pre-proline 0 CA--C 1.55 0.969 0 CA-C-N 118.898 1.349 . . . . 0.0 112.271 179.381 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 2511 ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -77.49 156.54 96.09 Favored 'Cis proline' 0 C--N 1.354 0.845 0 CA-C-N 120.02 1.043 . . . . 0.0 113.305 -0.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 2512 ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -107.47 134.47 50.45 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 125.32 1.448 . . . . 0.0 111.263 178.682 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 2513 ' ' LYS . . . . . . . . . . . . . 40.4 ttmt -99.47 100.48 11.52 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 123.856 0.862 . . . . 0.0 111.966 -178.15 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 2514 ' ' ALA . . . . . . . . . . . . . . . -82.06 109.35 16.31 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.025 1.33 . . . . 0.0 110.787 177.069 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 2515 ' ' LYS . . . . . . . . . . . . . 30.6 mtmm -91.65 81.2 5.3 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.805 1.642 . . . . 0.0 109.324 -175.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 2516 ' ' VAL . . . . . . . . . . . . . 21.0 m -83.49 153.7 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 C-N-CA 124.338 1.055 . . . . 0.0 111.41 -173.226 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 2517 ' ' THR . . . . . . . . . . . . . 77.0 p -132.31 179.46 6.1 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 125.853 1.661 . . . . 0.0 111.118 -175.437 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 2518 ' ' GLY . . . . . . . . . . . . . . . 104.49 -176.15 23.08 Favored Glycine 0 CA--C 1.539 1.576 0 C-N-CA 124.891 1.234 . . . . 0.0 113.309 -176.492 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 2519 ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -74.28 148.59 39.04 Favored 'Trans proline' 0 CA--C 1.537 0.644 0 C-N-CA 123.72 2.946 . . . . 0.0 112.085 -173.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 2520 ' ' ARG . . . . . . . . . . . . . 38.3 ttp-105 . . . . . 0 CA--C 1.54 0.596 0 C-N-CA 124.17 0.988 . . . . 0.0 111.883 -179.582 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A 2427 ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.971 0 CA-C-O 121.198 0.332 . . . . 0.0 113.408 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A 2428 ' ' ASP . . . . . . . . . . . . . 15.3 t70 -100.08 138.87 20.38 Favored Pre-proline 0 CA--C 1.55 0.953 0 C-N-CA 125.314 1.446 . . . . 0.0 111.471 179.448 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 2429 ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -55.49 -26.83 56.11 Favored 'Trans proline' 0 C--N 1.353 0.785 0 C-N-CA 123.782 2.988 . . . . 0.0 115.448 179.85 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 2430 ' ' GLY . . . . . . . . . . . . . . . -81.99 -24.36 55.33 Favored Glycine 0 CA--C 1.533 1.157 0 CA-C-N 119.155 0.889 . . . . 0.0 113.548 176.738 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 2431 ' ' LEU . . . . . . . . . . . . . 4.4 mm? -85.56 -33.75 21.64 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.481 1.112 . . . . 0.0 111.535 172.825 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 2432 ' ' VAL . . . . . . . . . . . . . 87.0 t -66.76 137.2 25.31 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 123.483 0.713 . . . . 0.0 109.539 168.477 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 2433 ' ' SER . . . . . . . . . . . . . 8.3 t -133.39 -170.58 2.51 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 124.85 1.26 . . . . 0.0 110.801 177.773 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 2434 ' ' ALA . . . . . . . . . . . . . . . -152.79 144.39 23.45 Favored 'General case' 0 CA--C 1.537 0.477 0 O-C-N 120.963 -1.086 . . . . 0.0 111.996 176.089 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 2435 ' ' TYR . . . . . . . . . . . . . 74.7 m-85 -147.33 150.2 34.29 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 125.566 1.547 . . . . 0.0 111.825 -174.455 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 2436 ' ' GLY . . . . . . . . . . . . . . . 121.79 162.91 11.77 Favored Glycine 0 N--CA 1.473 1.118 0 C-N-CA 125.288 1.423 . . . . 0.0 113.999 177.135 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 2437 ' ' ALA . . . . . . . . . . . . . . . -60.95 -28.77 69.21 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 125.099 1.36 . . . . 0.0 114.407 -169.677 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 2438 ' ' GLY . . . . . . . . . . . . . . . -66.72 -15.53 64.48 Favored Glycine 0 CA--C 1.532 1.103 0 CA-C-O 118.867 -0.963 . . . . 0.0 114.417 -178.802 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 2439 ' ' LEU . . . . . . . . . . . . . 84.4 mt -76.37 -24.96 54.16 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 118.866 1.333 . . . . 0.0 112.44 169.716 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 2440 ' ' GLU . . . . . . . . . . . . . 43.0 mm-40 -90.89 -31.79 16.27 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.15 1.38 . . . . 0.0 111.896 176.189 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 2441 ' ' GLY . . . . . . . . . . . . . . . 109.22 -133.41 11.63 Favored Glycine 0 CA--C 1.531 1.042 0 C-N-CA 125.921 1.724 . . . . 0.0 112.763 178.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 2442 ' ' GLY . . . . . . . . . . . . . . . 135.41 -154.59 21.76 Favored Glycine 0 CA--C 1.533 1.195 0 C-N-CA 124.826 1.203 . . . . 0.0 114.433 -176.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 2443 ' ' VAL . . . . . . . . . . . . . 93.0 t -74.37 136.14 25.88 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 C-N-CA 124.284 1.034 . . . . 0.0 111.488 -172.516 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 2444 ' ' THR . . . . . . . . . . . . . 25.1 p -63.37 133.13 53.54 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.445 1.098 . . . . 0.0 111.471 174.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 2445 ' ' GLY . . . . . . . . . . . . . . . 85.03 -8.41 70.44 Favored Glycine 0 CA--C 1.536 1.361 0 C-N-CA 124.667 1.127 . . . . 0.0 114.76 -176.511 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 2446 ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -86.01 152.86 56.78 Favored Pre-proline 0 CA--C 1.551 1.018 0 CA-C-N 118.976 1.388 . . . . 0.0 111.796 174.811 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 2447 ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -75.5 97.5 1.1 Allowed 'Trans proline' 0 CA--C 1.538 0.693 0 C-N-CA 123.156 2.571 . . . . 0.0 110.024 173.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 2448 ' ' ALA . . . . . . . . . . . . . . . -78.47 143.23 36.85 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.034 0.934 . . . . 0.0 109.481 168.759 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 2449 ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -155.1 148.32 24.89 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 114.33 1.233 . . . . 0.0 114.33 -173.386 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 2450 ' ' PHE . . . . . . . . . . . . . 49.5 p90 -153.93 162.47 41.19 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 126.439 1.895 . . . . 0.0 110.496 -178.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 2451 ' ' VAL . . . . . . . . . . . . . 71.5 t -112.68 130.96 65.52 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 C-N-CA 124.821 1.248 . . . . 0.0 109.498 174.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 2452 ' ' VAL . . . . . . . . . . . . . 45.5 t -79.52 109.33 14.02 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 161.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 2453 ' ' ASN . . . . . . . . . . . . . 12.4 t-20 -88.68 114.5 25.37 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.188 0.995 . . . . 0.0 111.909 -172.372 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 2454 ' ' THR . . . . . . . . . . . . . 70.0 p -107.43 -5.59 17.59 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 125.521 1.528 . . . . 0.0 113.65 -177.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 2455 ' ' SER . . . . . . . . . . . . . 13.9 m -57.77 -29.7 65.03 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 124.797 1.239 . . . . 0.0 114.242 -175.033 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 2456 ' ' ASN . . . . . . . . . . . . . 69.0 m-80 -83.16 -10.24 58.75 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 124.688 1.195 . . . . 0.0 113.453 177.097 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 2457 ' ' ALA . . . . . . . . . . . . . . . -115.17 -50.53 2.75 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 125.187 1.395 . . . . 0.0 113.482 -169.459 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 2458 ' ' GLY . . . . . . . . . . . . . . . 121.81 -145.2 16.73 Favored Glycine 0 CA--C 1.533 1.208 0 C-N-CA 125.054 1.312 . . . . 0.0 113.108 -174.083 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 2459 ' ' ALA . . . . . . . . . . . . . . . -96.41 160.22 14.53 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 125.195 1.398 . . . . 0.0 113.113 -175.534 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 2460 ' ' GLY . . . . . . . . . . . . . . . 153.76 164.01 12.33 Favored Glycine 0 CA--C 1.53 1.017 0 C-N-CA 124.261 0.934 . . . . 0.0 114.025 -178.561 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 2461 ' ' ALA . . . . . . . . . . . . . . . -79.7 144.76 33.39 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.37 1.068 . . . . 0.0 112.51 -179.411 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 2462 ' ' LEU . . . . . . . . . . . . . 69.5 tp -115.14 141.38 48.09 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 126.006 1.722 . . . . 0.0 110.526 178.283 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 2463 ' ' SER . . . . . . . . . . . . . 16.4 t -142.11 106.1 4.74 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.532 1.133 . . . . 0.0 109.639 170.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 2464 ' ' VAL . . . . . . . . . . . . . 60.5 t -102.39 128.2 55.3 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 C-N-CA 124.083 0.953 . . . . 0.0 109.487 178.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 2465 ' ' THR . . . . . . . . . . . . . 98.2 m -116.15 134.22 55.17 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 125.326 1.45 . . . . 0.0 108.636 174.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 2466 ' ' ILE . . . . . . . . . . . . . 41.1 mt -122.88 120.3 60.27 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 C-N-CA 123.542 0.737 . . . . 0.0 109.586 177.433 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 2467 ' ' ASP . . . . . . . . . . . . . 32.0 m-20 -107.0 167.69 9.72 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 126.204 1.802 . . . . 0.0 110.168 169.511 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 2468 ' ' GLY . . . . . . . . . . . . . . . 162.78 -153.1 23.56 Favored Glycine 0 CA--C 1.536 1.366 0 CA-C-O 118.854 -0.97 . . . . 0.0 114.481 179.694 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 2469 ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -70.18 -17.54 35.62 Favored 'Trans proline' 0 CA--C 1.54 0.79 0 C-N-CA 123.774 2.983 . . . . 0.0 113.189 180.0 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 2470 ' ' SER . . . . . . . . . . . . . 38.7 m -157.57 -165.17 1.71 Allowed 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 127.546 2.338 . . . . 0.0 109.382 176.383 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 2471 ' ' LYS . . . . . . . . . . . . . 59.3 mtmt -79.13 -175.3 4.53 Favored 'General case' 0 CA--C 1.552 1.042 0 O-C-N 120.802 -1.187 . . . . 0.0 111.79 167.614 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 2472 ' ' VAL . . . . . . . . . . . . . 33.4 m -139.78 151.78 22.32 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 C-N-CA 125.26 1.424 . . . . 0.0 111.09 171.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 2473 ' ' LYS . . . . . . . . . . . . . 60.6 mtpt -87.99 86.51 7.14 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 123.836 0.854 . . . . 0.0 110.126 171.706 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 2474 ' ' MET . . . . . . . . . . . . . 58.3 ttm -79.28 143.29 35.38 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 124.277 1.031 . . . . 0.0 112.38 -176.706 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 2475 ' ' ASP . . . . . . . . . . . . . 23.1 t70 -135.56 100.25 4.44 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 126.448 1.899 . . . . 0.0 109.581 165.067 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 2476 ' ' CYS . . . . . . . . . . . . . 44.3 t -95.47 132.3 40.69 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.642 1.177 . . . . 0.0 110.639 175.778 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 2477 ' ' GLN . . . . . . . . . . . . . 86.7 mt-30 -144.99 154.96 43.1 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 125.286 1.434 . . . . 0.0 110.711 -176.511 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 2478 ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -75.95 152.02 37.14 Favored 'General case' 0 CA--C 1.543 0.696 0 O-C-N 121.389 -0.819 . . . . 0.0 112.068 172.464 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 2479 ' ' CYS . . . . . . . . . . . . . 17.3 p -151.39 166.21 15.65 Favored Pre-proline 0 CA--C 1.554 1.106 0 C-N-CA 125.782 1.633 . . . . 0.0 110.774 -179.59 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 2480 ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -66.93 -18.84 52.55 Favored 'Trans proline' 0 CA--C 1.54 0.794 0 C-N-CA 122.327 2.018 . . . . 0.0 113.643 -178.005 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 2481 ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -92.9 -4.0 53.59 Favored 'General case' 0 CA--C 1.553 1.062 0 C-N-CA 125.164 1.386 . . . . 0.0 112.992 175.831 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 2482 ' ' GLY . . . . . . . . . . . . . . . 139.11 -110.85 0.74 Allowed Glycine 0 N--CA 1.471 0.974 0 C-N-CA 125.482 1.515 . . . . 0.0 112.985 179.828 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 2483 ' ' TYR . . . . . . . . . . . . . 95.3 m-85 -130.03 120.08 24.15 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 124.401 1.08 . . . . 0.0 111.317 175.397 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 2484 ' ' ARG . . . . . . . . . . . . . 19.0 ttp-105 -81.05 133.76 35.54 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 123.785 0.834 . . . . 0.0 110.161 171.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 2485 ' ' VAL . . . . . . . . . . . . . 89.9 t -115.06 118.07 57.63 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 C-N-CA 125.234 1.414 . . . . 0.0 107.996 168.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 2486 ' ' THR . . . . . . . . . . . . . 98.9 m -100.16 146.42 26.85 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 124.872 1.269 . . . . 0.0 108.166 165.405 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 2487 ' ' TYR . . . . . . . . . . . . . 29.2 p90 -153.13 152.0 30.8 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.246 1.018 . . . . 0.0 112.618 171.8 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 2488 ' ' THR . . . . . . . . . . . . . 59.6 m -107.09 113.69 62.14 Favored Pre-proline 0 N--CA 1.473 0.719 0 CA-C-O 117.799 -1.096 . . . . 0.0 109.438 173.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 2489 ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -76.01 114.21 3.87 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 123.504 2.803 . . . . 0.0 109.424 172.383 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 2490 ' ' MET . . . . . . . . . . . . . 27.8 ptm -86.42 -7.91 58.06 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 114.661 1.356 . . . . 0.0 114.661 -173.675 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 2491 ' ' ALA . . . . . . . . . . . . . . . -147.04 149.43 35.48 Favored Pre-proline 0 CA--C 1.547 0.855 0 C-N-CA 124.792 1.237 . . . . 0.0 112.146 -179.249 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 2492 ' ' PRO . . . . . . . . . . . . . 78.0 Cg_endo -73.17 155.05 52.21 Favored 'Trans proline' 0 C--N 1.35 0.646 0 C-N-CA 123.627 2.884 . . . . 0.0 111.489 178.243 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 2493 ' ' GLY . . . . . . . . . . . . . . . 131.89 -139.69 11.16 Favored Glycine 0 CA--C 1.529 0.944 0 C-N-CA 125.342 1.449 . . . . 0.0 112.093 -173.635 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 2494 ' ' SER . . . . . . . . . . . . . 65.9 m -133.77 124.99 27.56 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 123.937 0.895 . . . . 0.0 111.465 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 2495 ' ' TYR . . . . . . . . . . . . . 65.6 m-85 -95.53 131.88 41.24 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.845 1.258 . . . . 0.0 111.06 172.759 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 2496 ' ' LEU . . . . . . . . . . . . . 27.8 tp -100.13 114.98 28.76 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 125.297 1.439 . . . . 0.0 109.364 177.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 2497 ' ' ILE . . . . . . . . . . . . . 48.2 mt -102.57 102.33 13.42 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 C-N-CA 125.863 1.665 . . . . 0.0 108.667 -173.472 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 2498 ' ' SER . . . . . . . . . . . . . 67.2 m -92.14 109.0 20.35 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 124.888 1.275 . . . . 0.0 109.988 177.413 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 2499 ' ' ILE . . . . . 0.605 ' H ' ' HG ' ' A' 2510 ' ' SER . 69.1 mt -104.36 104.96 17.64 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 C-N-CA 124.684 1.194 . . . . 0.0 107.926 -176.692 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 2500 ' ' LYS . . . . . . . . . . . . . 84.0 mttt -110.96 137.36 48.68 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.35 1.06 . . . . 0.0 111.244 -179.725 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 2501 ' ' TYR . . . . . . . . . . . . . 51.7 t80 -143.63 137.69 28.48 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 123.915 0.886 . . . . 0.0 111.93 -170.45 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 2502 ' ' GLY . . . . . . . . . . . . . . . 66.54 11.04 55.95 Favored Glycine 0 CA--C 1.537 1.452 0 C-N-CA 124.449 1.023 . . . . 0.0 114.808 177.247 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 2503 ' ' GLY . . . . . . . . . . . . . . . 153.93 -167.53 32.21 Favored Glycine 0 CA--C 1.54 1.625 0 C-N-CA 125.507 1.527 . . . . 0.0 113.31 -170.189 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 2504 ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -82.87 7.88 4.93 Favored 'Trans proline' 0 CA--C 1.543 0.931 0 C-N-CA 124.731 3.621 . . . . 0.0 114.143 -173.43 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 2505 ' ' TYR . . . . . . . . . . . . . 64.4 m-85 -103.24 142.29 34.44 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.648 1.179 . . . . 0.0 113.234 -173.497 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 2506 ' ' HIS . . . . . . . . . . . . . 91.0 m-70 -65.27 147.28 53.72 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 124.278 1.031 . . . . 0.0 112.585 174.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 2507 ' ' ILE . . . . . . . . . . . . . 26.9 pt -74.29 169.2 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 O-C-N 121.574 -0.704 . . . . 0.0 112.47 170.524 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 2508 ' ' GLY . . . . . . . . . . . . . . . -57.89 123.88 34.37 Favored Glycine 0 CA--C 1.533 1.18 0 C-N-CA 123.838 0.732 . . . . 0.0 112.179 178.138 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 2509 ' ' GLY . . . . . . . . . . . . . . . 86.92 -10.22 69.02 Favored Glycine 0 CA--C 1.535 1.3 0 C-N-CA 125.535 1.54 . . . . 0.0 114.946 -177.364 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 2510 ' ' SER . . . . . 0.605 ' HG ' ' H ' ' A' 2499 ' ' ILE . 7.2 t -91.65 147.67 35.64 Favored Pre-proline 0 CA--C 1.552 1.045 0 CA-C-N 119.006 1.403 . . . . 0.0 111.538 -179.464 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 2511 ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -73.65 148.0 90.97 Favored 'Cis proline' 0 C--N 1.353 0.814 0 CA-C-N 120.474 1.205 . . . . 0.0 113.546 3.207 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 2512 ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -102.41 131.78 48.85 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 125.262 1.425 . . . . 0.0 110.703 177.764 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 2513 ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.67 106.87 19.03 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 123.934 0.894 . . . . 0.0 111.79 176.149 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 2514 ' ' ALA . . . . . . . . . . . . . . . -92.64 118.55 31.15 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.829 1.652 . . . . 0.0 110.401 177.478 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 2515 ' ' LYS . . . . . . . . . . . . . 48.1 mtpt -94.9 131.51 40.72 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.257 1.023 . . . . 0.0 110.742 -176.733 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 2516 ' ' VAL . . . . . . . . . . . . . 26.9 m -135.43 144.66 33.4 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 C-N-CA 123.832 0.853 . . . . 0.0 112.275 -170.025 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 2517 ' ' THR . . . . . . . . . . . . . 41.3 p -144.76 162.57 36.41 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 125.327 1.451 . . . . 0.0 111.46 -173.177 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 2518 ' ' GLY . . . . . . . . . . . . . . . 117.94 -176.93 16.36 Favored Glycine 0 CA--C 1.539 1.552 0 C-N-CA 125.252 1.406 . . . . 0.0 113.046 -175.039 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 2519 ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -75.41 133.12 15.62 Favored 'Trans proline' 0 C--N 1.349 0.553 0 C-N-CA 123.503 2.802 . . . . 0.0 111.324 -173.72 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 2520 ' ' ARG . . . . . . . . . . . . . 37.7 ttm105 . . . . . 0 CA--C 1.54 0.561 0 C-N-CA 123.938 0.895 . . . . 0.0 111.699 -179.984 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A 2427 ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.967 0 N-CA-C 112.032 -0.427 . . . . 0.0 112.032 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A 2428 ' ' ASP . . . . . . . . . . . . . 28.5 m-20 -121.46 142.86 36.4 Favored Pre-proline 0 CA--C 1.544 0.714 0 C-N-CA 124.983 1.313 . . . . 0.0 112.098 -177.65 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 2429 ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -64.49 -24.98 63.15 Favored 'Trans proline' 0 CA--C 1.539 0.734 0 C-N-CA 123.196 2.597 . . . . 0.0 112.966 179.12 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 2430 ' ' GLY . . . . . . . . . . . . . . . -73.88 -22.72 77.77 Favored Glycine 0 CA--C 1.535 1.341 0 CA-C-N 118.844 0.747 . . . . 0.0 113.738 174.59 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 2431 ' ' LEU . . . . . . . . . . . . . 4.3 mm? -88.47 -40.96 13.07 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 124.634 1.174 . . . . 0.0 111.201 173.157 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 2432 ' ' VAL . . . . . . . . . . . . . 59.4 t -59.19 137.97 20.91 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 123.936 0.894 . . . . 0.0 111.069 175.038 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 2433 ' ' SER . . . . . . . . . . . . . 8.2 t -127.02 -174.69 3.22 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 125.136 1.374 . . . . 0.0 110.45 171.855 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 2434 ' ' ALA . . . . . . . . . . . . . . . -145.95 146.95 31.23 Favored 'General case' 0 CA--C 1.538 0.487 0 O-C-N 120.91 -1.119 . . . . 0.0 112.123 177.875 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 2435 ' ' TYR . . . . . . . . . . . . . 68.2 m-85 -145.35 150.05 35.89 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 125.411 1.484 . . . . 0.0 111.92 -173.746 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 2436 ' ' GLY . . . . . . . . . . . . . . . 120.63 159.79 10.91 Favored Glycine 0 N--CA 1.474 1.203 0 C-N-CA 125.462 1.506 . . . . 0.0 114.051 177.098 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 2437 ' ' ALA . . . . . . . . . . . . . . . -61.83 -26.98 68.45 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 125.118 1.367 . . . . 0.0 114.446 -171.362 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 2438 ' ' GLY . . . . . . . . . . . . . . . -65.49 -14.48 60.11 Favored Glycine 0 CA--C 1.533 1.183 0 C-N-CA 124.183 0.897 . . . . 0.0 114.217 178.494 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 2439 ' ' LEU . . . . . . . . . . . . . 86.3 mt -78.22 -22.01 49.14 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 118.894 1.347 . . . . 0.0 112.779 169.807 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 2440 ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -98.29 -28.25 13.76 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 125.338 1.455 . . . . 0.0 112.407 -179.268 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 2441 ' ' GLY . . . . . . . . . . . . . . . 105.86 -155.04 16.92 Favored Glycine 0 CA--C 1.533 1.189 0 C-N-CA 125.747 1.641 . . . . 0.0 113.341 179.059 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 2442 ' ' GLY . . . . . . . . . . . . . . . 163.72 -157.06 29.17 Favored Glycine 0 CA--C 1.532 1.102 0 C-N-CA 124.342 0.972 . . . . 0.0 114.071 -175.458 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 2443 ' ' VAL . . . . . . . . . . . . . 61.0 t -87.64 141.33 14.47 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 C-N-CA 124.597 1.159 . . . . 0.0 110.873 -178.192 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 2444 ' ' THR . . . . . . . . . . . . . 26.1 p -62.66 144.3 56.43 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 124.933 1.293 . . . . 0.0 112.666 174.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 2445 ' ' GLY . . . . . . . . . . . . . . . 76.33 -9.91 18.59 Favored Glycine 0 CA--C 1.537 1.466 0 C-N-CA 124.605 1.098 . . . . 0.0 114.254 -176.088 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 2446 ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -101.0 142.11 23.97 Favored Pre-proline 0 CA--C 1.553 1.059 0 C-N-CA 126.744 2.018 . . . . 0.0 110.312 175.184 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 2447 ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -76.72 149.32 29.77 Favored 'Trans proline' 0 CA--C 1.536 0.598 0 C-N-CA 123.196 2.597 . . . . 0.0 111.858 178.757 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 2448 ' ' ALA . . . . . . . . . . . . . . . -138.89 141.51 38.56 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 125.648 1.579 . . . . 0.0 109.972 170.834 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 2449 ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -130.21 152.22 49.88 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.23 1.012 . . . . 0.0 113.396 -167.711 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 2450 ' ' PHE . . . . . . . . . . . . . 40.2 p90 -154.3 161.58 41.7 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.972 1.309 . . . . 0.0 111.746 175.445 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 2451 ' ' VAL . . . . . . . . . . . . . 12.3 p -118.26 135.37 58.89 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 C-N-CA 125.273 1.429 . . . . 0.0 110.454 175.35 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 2452 ' ' VAL . . . . . . . . . . . . . 40.9 t -89.19 104.0 14.54 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 N-CA-C 106.751 -1.574 . . . . 0.0 106.751 166.16 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 2453 ' ' ASN . . . . . . . . . . . . . 15.1 t-20 -89.17 117.1 27.9 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 123.955 0.902 . . . . 0.0 112.791 -165.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 2454 ' ' THR . . . . . . . . . . . . . 48.5 p -97.63 -2.67 41.01 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 125.809 1.643 . . . . 0.0 114.432 -175.592 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 2455 ' ' SER . . . . . . . . . . . . . 24.4 m -58.0 -27.43 63.5 Favored 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 114.326 1.232 . . . . 0.0 114.326 -176.672 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 2456 ' ' ASN . . . . . . . . . . . . . 81.8 m-20 -76.42 -20.78 56.75 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 124.44 1.096 . . . . 0.0 113.289 175.744 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 2457 ' ' ALA . . . . . . . . . . . . . . . -117.34 -56.49 2.23 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.649 1.18 . . . . 0.0 113.646 -157.151 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 2458 ' ' GLY . . . . . . . . . . . . . . . 113.68 -155.96 15.95 Favored Glycine 0 CA--C 1.534 1.252 0 C-N-CA 124.852 1.215 . . . . 0.0 112.375 -166.893 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 2459 ' ' ALA . . . . . . . . . . . . . . . -85.53 145.52 27.35 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 124.206 1.002 . . . . 0.0 113.681 -173.19 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 2460 ' ' GLY . . . . . . . . . . . . . . . 174.61 160.67 23.1 Favored Glycine 0 CA--C 1.532 1.127 0 C-N-CA 125.357 1.455 . . . . 0.0 113.145 -179.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 2461 ' ' ALA . . . . . . . . . . . . . . . -82.2 150.59 27.3 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 124.278 1.031 . . . . 0.0 112.847 -178.388 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 2462 ' ' LEU . . . . . . . . . . . . . 16.9 tp -107.68 147.36 30.83 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.56 1.544 . . . . 0.0 110.976 176.004 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 2463 ' ' SER . . . . . . . . . . . . . 9.5 t -141.06 37.37 1.75 Allowed 'General case' 0 CA--C 1.551 1.005 0 C-N-CA 125.294 1.438 . . . . 0.0 111.563 -179.469 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 2464 ' ' VAL . . . . . . . . . . . . . 12.6 p -61.01 135.73 25.45 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 C-N-CA 125.164 1.386 . . . . 0.0 112.512 -174.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 2465 ' ' THR . . . . . . . . . . . . . 95.9 m -136.57 145.24 44.74 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 126.003 1.721 . . . . 0.0 109.727 -179.758 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 2466 ' ' ILE . . . . . . . . . . . . . 30.1 mt -124.89 130.51 73.27 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 124.072 0.949 . . . . 0.0 110.094 176.519 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 2467 ' ' ASP . . . . . . . . . . . . . 33.7 t70 -122.51 128.12 50.4 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 125.949 1.7 . . . . 0.0 109.976 173.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 2468 ' ' GLY . . . . . . . . . . . . . . . -155.49 -166.2 15.32 Favored Glycine 0 CA--C 1.537 1.43 0 N-CA-C 115.685 1.034 . . . . 0.0 115.685 -171.174 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 2469 ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -67.72 -16.16 45.83 Favored 'Trans proline' 0 CA--C 1.539 0.765 0 C-N-CA 124.464 3.442 . . . . 0.0 113.267 178.474 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 2470 ' ' SER . . . . . . . . . . . . . 8.1 t -156.63 -168.07 2.58 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 126.491 1.916 . . . . 0.0 109.307 166.346 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 2471 ' ' LYS . . . . . . . . . . . . . 67.7 mttm -74.28 173.66 9.89 Favored 'General case' 0 CA--C 1.55 0.97 0 O-C-N 120.881 -1.137 . . . . 0.0 112.31 169.587 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 2472 ' ' VAL . . . . . . . . . . . . . 33.5 m -127.05 149.18 31.96 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 C-N-CA 125.624 1.57 . . . . 0.0 110.696 174.503 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 2473 ' ' LYS . . . . . . . . . . . . . 59.6 tttp -92.71 97.21 10.64 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 165.685 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 2474 ' ' MET . . . . . . . . . . . . . 48.4 ttp -111.58 142.26 44.12 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 124.874 1.27 . . . . 0.0 112.369 -175.445 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 2475 ' ' ASP . . . . . . . . . . . . . 36.9 t70 -126.05 141.15 52.08 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 126.791 2.037 . . . . 0.0 110.23 170.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 2476 ' ' CYS . . . . . . . . . . . . . 63.6 m -123.06 150.82 42.63 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 125.203 1.401 . . . . 0.0 111.989 -173.218 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 2477 ' ' GLN . . . . . . . . . . . . . 3.8 tt0 -151.24 147.14 26.63 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.447 1.099 . . . . 0.0 111.121 179.486 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 2478 ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -90.13 150.06 22.19 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 123.716 0.806 . . . . 0.0 111.083 163.752 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 2479 ' ' CYS . . . . . . . . . . . . . 19.9 p -160.68 172.22 6.14 Favored Pre-proline 0 CA--C 1.554 1.099 0 C-N-CA 125.626 1.571 . . . . 0.0 111.572 -178.384 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 2480 ' ' PRO . . . . . . . . . . . . . 63.6 Cg_exo -58.67 -25.06 73.73 Favored 'Trans proline' 0 CA--C 1.539 0.743 0 C-N-CA 123.454 2.77 . . . . 0.0 114.481 175.362 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 2481 ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -81.72 -8.65 59.72 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 124.814 1.246 . . . . 0.0 113.076 178.162 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 2482 ' ' GLY . . . . . . . . . . . . . . . 120.47 -143.25 16.41 Favored Glycine 0 N--CA 1.471 1.015 0 C-N-CA 126.11 1.814 . . . . 0.0 112.238 -175.263 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 2483 ' ' TYR . . . . . . . . . . . . . 80.1 m-85 -96.23 113.66 25.28 Favored 'General case' 0 N--CA 1.469 0.517 0 O-C-N 121.7 -0.883 . . . . 0.0 110.811 173.381 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 2484 ' ' ARG . . . . . . . . . . . . . 55.6 ttp85 -96.76 142.02 29.28 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 124.62 1.168 . . . . 0.0 110.278 176.85 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 2485 ' ' VAL . . . . . . . . . . . . . 11.3 m -133.97 152.78 35.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 123.806 0.843 . . . . 0.0 111.083 173.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 2486 ' ' THR . . . . . . . . . . . . . 40.5 m -131.99 133.86 44.93 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 125.656 1.583 . . . . 0.0 107.66 172.682 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 2487 ' ' TYR . . . . . . . . . . . . . 15.3 p90 -140.5 148.98 41.92 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 113.839 1.051 . . . . 0.0 113.839 176.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 2488 ' ' THR . . . . . . . . . . . . . 69.2 m -108.7 115.71 57.11 Favored Pre-proline 0 N--CA 1.469 0.514 0 C-N-CA 124.941 1.297 . . . . 0.0 109.108 172.611 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 2489 ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -80.49 161.26 22.37 Favored 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 123.794 2.996 . . . . 0.0 110.864 169.571 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 2490 ' ' MET . . . . . . . . . . . . . 25.7 ptm -133.4 2.8 3.56 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 114.94 1.459 . . . . 0.0 114.94 -173.703 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 2491 ' ' ALA . . . . . . . . . . . . . . . -143.42 145.55 32.35 Favored Pre-proline 0 CA--C 1.547 0.828 0 C-N-CA 124.644 1.178 . . . . 0.0 111.68 177.764 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 2492 ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -73.23 148.66 44.36 Favored 'Trans proline' 0 CA--C 1.536 0.615 0 C-N-CA 123.126 2.55 . . . . 0.0 111.08 175.851 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 2493 ' ' GLY . . . . . . . . . . . . . . . 135.05 -161.75 24.64 Favored Glycine 0 CA--C 1.53 0.988 0 C-N-CA 125.307 1.432 . . . . 0.0 112.975 -175.54 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 2494 ' ' SER . . . . . . . . . . . . . 49.3 m -105.8 118.04 35.57 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.835 0.854 . . . . 0.0 111.522 179.193 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 2495 ' ' TYR . . . . . . . . . . . . . 78.1 m-85 -88.53 114.44 25.15 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.704 1.202 . . . . 0.0 109.386 167.033 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 2496 ' ' LEU . . . . . . . . . . . . . 27.2 tp -91.0 114.36 26.86 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 125.158 1.383 . . . . 0.0 109.072 179.073 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 2497 ' ' ILE . . . . . . . . . . . . . 44.0 mt -99.88 102.17 13.07 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 C-N-CA 125.534 1.534 . . . . 0.0 108.503 -173.417 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 2498 ' ' SER . . . . . . . . . . . . . 66.5 m -84.87 93.95 8.64 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 124.954 1.302 . . . . 0.0 109.391 174.841 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 2499 ' ' ILE . . . . . . . . . . . . . 48.6 mt -87.38 95.85 5.31 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 C-N-CA 124.402 1.081 . . . . 0.0 108.526 178.884 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 2500 ' ' LYS . . . . . . . . . . . . . 91.2 mttt -98.84 138.89 35.32 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.099 0.959 . . . . 0.0 111.385 177.212 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 2501 ' ' TYR . . . . . . . . . . . . . 64.6 t80 -149.58 148.46 29.37 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.046 1.338 . . . . 0.0 112.228 -172.765 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 2502 ' ' GLY . . . . . . . . . . . . . . . 69.01 26.3 74.8 Favored Glycine 0 CA--C 1.534 1.22 0 C-N-CA 124.065 0.84 . . . . 0.0 112.639 -178.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 2503 ' ' GLY . . . . . . . . . . . . . . . 116.19 -164.45 12.28 Favored Glycine 0 CA--C 1.54 1.645 0 C-N-CA 125.877 1.703 . . . . 0.0 112.04 -164.022 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 2504 ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -81.49 33.87 0.54 Allowed 'Trans proline' 0 CA--C 1.548 1.179 0 C-N-CA 124.936 3.757 . . . . 0.0 113.165 -173.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 2505 ' ' TYR . . . . . . . . . . . . . 74.9 m-85 -114.8 127.21 55.59 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.815 1.246 . . . . 0.0 112.576 -172.053 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 2506 ' ' HIS . . . . . . . . . . . . . 86.4 m-70 -57.61 138.74 54.97 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 124.802 1.241 . . . . 0.0 113.037 178.326 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 2507 ' ' ILE . . . . . . . . . . . . . 27.1 pt -69.08 166.96 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 O-C-N 121.827 -0.545 . . . . 0.0 112.26 169.689 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 2508 ' ' GLY . . . . . . . . . . . . . . . -59.84 -21.94 56.39 Favored Glycine 0 CA--C 1.539 1.538 0 N-CA-C 116.483 1.353 . . . . 0.0 116.483 -166.688 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 2509 ' ' GLY . . . . . . . . . . . . . . . -106.36 -0.42 37.75 Favored Glycine 0 CA--C 1.536 1.399 0 C-N-CA 125.136 1.351 . . . . 0.0 114.969 174.302 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 2510 ' ' SER . . . . . . . . . . . . . 46.8 t -88.77 148.69 42.16 Favored Pre-proline 0 CA--C 1.549 0.916 0 CA-C-N 118.678 1.239 . . . . 0.0 112.824 -172.488 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 2511 ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -78.39 152.34 90.64 Favored 'Cis proline' 0 C--N 1.353 0.794 0 CA-C-N 119.31 0.789 . . . . 0.0 113.288 -1.669 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 2512 ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -102.29 128.91 48.64 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 125.291 1.437 . . . . 0.0 110.739 179.26 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 2513 ' ' LYS . . . . . . . . . . . . . 57.0 pttt -92.04 100.36 13.02 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 124.097 0.959 . . . . 0.0 112.214 178.644 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 2514 ' ' ALA . . . . . . . . . . . . . . . -88.3 114.59 25.08 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.714 1.206 . . . . 0.0 110.109 175.209 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 2515 ' ' LYS . . . . . . . . . . . . . 66.3 mttm -95.92 119.07 33.76 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 123.867 0.867 . . . . 0.0 111.093 -175.188 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 2516 ' ' VAL . . . . . . . . . . . . . 49.4 t -113.4 140.15 35.09 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 C-N-CA 125.731 1.612 . . . . 0.0 110.408 -169.798 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 2517 ' ' THR . . . . . . . . . . . . . 64.2 p -129.85 173.6 10.51 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 125.82 1.648 . . . . 0.0 111.403 -177.027 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 2518 ' ' GLY . . . . . . . . . . . . . . . 100.5 -171.14 22.81 Favored Glycine 0 CA--C 1.539 1.55 0 C-N-CA 124.705 1.145 . . . . 0.0 113.03 -174.695 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 2519 ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -72.19 157.36 54.04 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 123.719 2.946 . . . . 0.0 112.106 -176.005 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 2520 ' ' ARG . . . . . . . . . . . . . 50.9 ttt85 . . . . . 0 CA--C 1.538 0.51 0 C-N-CA 123.635 0.774 . . . . 0.0 109.665 170.499 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.537 0 N-CA-C 111.383 -0.687 . . . . 0.0 111.383 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -76.71 -28.15 55.73 Favored 'General case' 0 CA--C 1.545 0.773 0 N-CA-C 113.904 1.076 . . . . 0.0 113.904 -177.66 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 99.4 mmm -83.56 138.18 33.51 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 124.634 1.174 . . . . 0.0 112.04 -179.099 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 2427 ' ' GLY . . . . . . . . . . . . . . . -78.92 167.09 52.45 Favored Glycine 0 CA--C 1.532 1.134 0 C-N-CA 124.592 1.092 . . . . 0.0 113.003 171.638 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 2428 ' ' ASP . . . . . . . . . . . . . 13.4 t70 -150.4 135.48 9.91 Favored Pre-proline 0 CA--C 1.55 0.958 0 C-N-CA 124.471 1.108 . . . . 0.0 111.658 -174.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 2429 ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -67.16 -21.18 48.91 Favored 'Trans proline' 0 C--N 1.352 0.717 0 C-N-CA 123.44 2.76 . . . . 0.0 113.946 -175.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 2430 ' ' GLY . . . . . . . . . . . . . . . -80.48 -25.6 56.44 Favored Glycine 0 CA--C 1.532 1.115 0 CA-C-N 119.29 0.95 . . . . 0.0 113.021 174.319 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 2431 ' ' LEU . . . . . . . . . . . . . 4.4 mm? -80.61 -37.55 30.94 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 124.138 0.975 . . . . 0.0 111.058 171.218 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 2432 ' ' VAL . . . . . . . . . . . . . 74.7 t -63.5 137.62 24.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 CA-C-O 121.598 0.713 . . . . 0.0 110.607 170.333 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 2433 ' ' SER . . . . . . . . . . . . . 8.1 t -133.5 -171.4 2.7 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 125.224 1.41 . . . . 0.0 110.103 173.007 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 2434 ' ' ALA . . . . . . . . . . . . . . . -144.59 145.65 31.91 Favored 'General case' 0 CA--C 1.538 0.487 0 O-C-N 121.029 -1.044 . . . . 0.0 111.502 176.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 2435 ' ' TYR . . . . . . . . . . . . . 80.5 m-85 -145.72 154.42 42.05 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 125.454 1.501 . . . . 0.0 111.844 -174.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 2436 ' ' GLY . . . . . . . . . . . . . . . 113.64 162.28 14.7 Favored Glycine 0 N--CA 1.473 1.149 0 C-N-CA 125.167 1.365 . . . . 0.0 113.954 176.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 2437 ' ' ALA . . . . . . . . . . . . . . . -60.62 -27.3 67.66 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.322 1.449 . . . . 0.0 114.462 -170.19 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 2438 ' ' GLY . . . . . . . . . . . . . . . -64.83 -18.59 64.4 Favored Glycine 0 CA--C 1.531 1.033 0 CA-C-O 119.025 -0.875 . . . . 0.0 114.33 -179.081 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 2439 ' ' LEU . . . . . . . . . . . . . 87.2 mt -74.33 -24.43 59.19 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 118.576 1.188 . . . . 0.0 112.698 170.703 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 2440 ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -90.07 -28.0 19.31 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.844 1.258 . . . . 0.0 111.691 174.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 2441 ' ' GLY . . . . . . . . . . . . . . . 110.93 -137.1 14.08 Favored Glycine 0 CA--C 1.529 0.931 0 C-N-CA 125.83 1.681 . . . . 0.0 113.428 175.079 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 2442 ' ' GLY . . . . . . . . . . . . . . . 165.34 -136.31 4.13 Favored Glycine 0 N--CA 1.471 1.025 0 C-N-CA 124.032 0.825 . . . . 0.0 113.7 -172.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 2443 ' ' VAL . . . . . . . . . . . . . 73.8 t -130.2 149.3 33.45 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 125.921 1.688 . . . . 0.0 109.302 -178.104 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 2444 ' ' THR . . . . . . . . . . . . . 38.1 p -58.31 136.26 57.33 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.608 0.763 . . . . 0.0 112.005 176.566 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 2445 ' ' GLY . . . . . . . . . . . . . . . 77.67 -10.89 22.0 Favored Glycine 0 CA--C 1.538 1.484 0 C-N-CA 124.905 1.241 . . . . 0.0 114.805 -175.655 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 2446 ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -95.07 141.68 23.57 Favored Pre-proline 0 CA--C 1.553 1.079 0 C-N-CA 125.63 1.572 . . . . 0.0 110.981 177.588 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 2447 ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -74.18 134.74 19.73 Favored 'Trans proline' 0 C--N 1.35 0.649 0 C-N-CA 123.113 2.542 . . . . 0.0 111.437 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 2448 ' ' ALA . . . . . . . . . . . . . . . -116.65 119.98 37.21 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 126.688 1.995 . . . . 0.0 108.919 175.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 2449 ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -122.62 131.7 53.94 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 124.094 0.958 . . . . 0.0 111.94 -168.336 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 2450 ' ' PHE . . . . . . . . . . . . . 15.3 p90 -147.56 166.67 26.62 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 125.283 1.433 . . . . 0.0 111.107 174.307 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 2451 ' ' VAL . . . . . . . . . . . . . 15.0 p -122.42 135.47 62.42 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 C-N-CA 125.045 1.338 . . . . 0.0 110.987 176.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 2452 ' ' VAL . . . . . . . . . . . . . 56.9 t -85.08 107.09 15.64 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 N-CA-C 106.825 -1.546 . . . . 0.0 106.825 163.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 2453 ' ' ASN . . . . . . . . . . . . . 17.4 t-20 -92.7 119.77 32.43 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 123.389 0.676 . . . . 0.0 112.49 -168.088 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 2454 ' ' THR . . . . . . . . . . . . . 76.8 p -102.8 -1.17 30.29 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 125.739 1.615 . . . . 0.0 113.906 -178.126 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 2455 ' ' SER . . . . . . . . . . . . . 29.5 m -56.93 -29.63 63.29 Favored 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 114.478 1.288 . . . . 0.0 114.478 -174.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 2456 ' ' ASN . . . . . . . . . . . . . 86.8 m-20 -82.96 -18.42 40.02 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 124.321 1.048 . . . . 0.0 113.396 175.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 2457 ' ' ALA . . . . . . . . . . . . . . . -104.03 -36.03 7.88 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 125.533 1.533 . . . . 0.0 113.626 -172.48 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 2458 ' ' GLY . . . . . . . . . . . . . . . 105.99 -107.17 2.72 Favored Glycine 0 CA--C 1.529 0.958 0 C-N-CA 124.9 1.238 . . . . 0.0 111.167 -172.616 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 2459 ' ' ALA . . . . . . . . . . . . . . . -143.31 156.22 44.66 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.706 1.202 . . . . 0.0 112.905 -176.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 2460 ' ' GLY . . . . . . . . . . . . . . . 164.26 166.81 23.78 Favored Glycine 0 CA--C 1.532 1.136 0 C-N-CA 125.825 1.678 . . . . 0.0 112.772 -174.634 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 2461 ' ' ALA . . . . . . . . . . . . . . . -74.98 144.18 43.27 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 123.921 0.889 . . . . 0.0 112.363 -179.422 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 2462 ' ' LEU . . . . . . . . . . . . . 48.2 tp -124.83 141.73 51.92 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.291 1.436 . . . . 0.0 111.328 179.417 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 2463 ' ' SER . . . . . . . . . . . . . 15.8 t -123.71 160.42 27.27 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 125.005 1.322 . . . . 0.0 110.291 158.11 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 2464 ' ' VAL . . . . . . . . . . . . . 5.8 p -161.68 133.82 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 124.892 1.277 . . . . 0.0 110.634 -176.334 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 2465 ' ' THR . . . . . . . . . . . . . 94.2 m -137.84 138.5 39.2 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 126.048 1.739 . . . . 0.0 109.369 -177.407 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 2466 ' ' ILE . . . . . . . . . . . . . 45.3 mt -119.67 125.3 74.21 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 C-N-CA 124.39 1.076 . . . . 0.0 108.821 176.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 2467 ' ' ASP . . . . . . . . . . . . . 35.7 t70 -137.05 130.5 31.44 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 125.135 1.374 . . . . 0.0 111.296 -174.397 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 2468 ' ' GLY . . . . . . . . . . . . . . . -167.17 -142.43 3.45 Favored Glycine 0 CA--C 1.538 1.506 0 CA-C-O 118.524 -1.153 . . . . 0.0 113.883 -175.111 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 2469 ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo -68.61 -14.36 39.33 Favored 'Trans proline' 0 CA--C 1.539 0.759 0 C-N-CA 123.977 3.118 . . . . 0.0 113.58 -178.465 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 2470 ' ' SER . . . . . . . . . . . . . 7.5 t -157.73 -170.4 3.18 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 125.776 1.63 . . . . 0.0 110.356 170.625 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 2471 ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -77.48 171.39 14.96 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 124.245 1.018 . . . . 0.0 111.824 168.079 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 2472 ' ' VAL . . . . . . . . . . . . . 28.7 m -135.07 151.75 31.4 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 125.376 1.471 . . . . 0.0 110.389 175.097 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 2473 ' ' LYS . . . . . . . . . . . . . 99.7 mttt -93.59 118.51 31.46 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.811 0.845 . . . . 0.0 109.451 170.088 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 2474 ' ' MET . . . . . . . . . . . . . 77.2 mtp -111.13 137.34 48.93 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 125.282 1.433 . . . . 0.0 112.54 -175.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 2475 ' ' ASP . . . . . . . . . . . . . 25.8 t70 -113.59 94.89 5.06 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 126.364 1.866 . . . . 0.0 109.042 162.371 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 2476 ' ' CYS . . . . . . . . . . . . . 47.5 t -91.35 129.43 37.34 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.382 1.073 . . . . 0.0 110.123 173.374 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 2477 ' ' GLN . . . . . . . . . . . . . 70.1 mm-40 -142.33 140.17 32.04 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 124.571 1.148 . . . . 0.0 110.821 -175.527 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 2478 ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -82.22 148.1 28.61 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 123.63 0.772 . . . . 0.0 111.854 173.06 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 2479 ' ' CYS . . . . . . . . . . . . . 31.9 p -161.36 171.7 6.59 Favored Pre-proline 0 CA--C 1.553 1.086 0 C-N-CA 125.639 1.576 . . . . 0.0 111.863 -175.005 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 2480 ' ' PRO . . . . . . . . . . . . . 66.0 Cg_exo -58.42 -24.73 70.24 Favored 'Trans proline' 0 CA--C 1.539 0.772 0 C-N-CA 123.348 2.699 . . . . 0.0 114.341 174.137 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 2481 ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -81.69 -6.51 59.09 Favored 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 124.981 1.312 . . . . 0.0 113.047 177.374 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 2482 ' ' GLY . . . . . . . . . . . . . . . 120.43 -118.04 3.73 Favored Glycine 0 N--CA 1.469 0.883 0 C-N-CA 126.08 1.8 . . . . 0.0 111.987 -176.709 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 2483 ' ' TYR . . . . . . . . . . . . . 93.4 m-85 -124.14 111.78 16.32 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.211 1.004 . . . . 0.0 110.651 173.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 2484 ' ' ARG . . . . . . . . . . . . . 13.7 ttp-105 -78.07 139.52 39.08 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 123.871 0.869 . . . . 0.0 109.807 173.571 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 2485 ' ' VAL . . . . . . . . . . . . . 90.7 t -126.96 116.09 43.5 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 C-N-CA 125.202 1.401 . . . . 0.0 108.257 170.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 2486 ' ' THR . . . . . . . . . . . . . 87.2 m -103.44 133.61 48.2 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 107.478 -1.304 . . . . 0.0 107.478 164.403 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 2487 ' ' TYR . . . . . . . . . . . . . 27.5 p90 -139.14 155.13 48.09 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 113.166 0.802 . . . . 0.0 113.166 176.4 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 2488 ' ' THR . . . . . . . . . . . . . 93.0 m -120.1 116.97 32.33 Favored Pre-proline 0 N--CA 1.474 0.737 0 C-N-CA 124.205 1.002 . . . . 0.0 109.774 176.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 2489 ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -82.5 158.4 16.83 Favored 'Trans proline' 0 C--N 1.351 0.681 0 C-N-CA 123.97 3.113 . . . . 0.0 111.551 173.402 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 2490 ' ' MET . . . . . . . . . . . . . 25.3 ptm -132.78 7.71 4.09 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 114.612 1.338 . . . . 0.0 114.612 -176.218 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 2491 ' ' ALA . . . . . . . . . . . . . . . -144.83 143.83 22.3 Favored Pre-proline 0 CA--C 1.547 0.838 0 C-N-CA 125.357 1.463 . . . . 0.0 111.224 172.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 2492 ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -76.16 156.86 38.0 Favored 'Trans proline' 0 CA--C 1.536 0.616 0 C-N-CA 123.704 2.936 . . . . 0.0 111.138 175.47 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 2493 ' ' GLY . . . . . . . . . . . . . . . 130.47 -140.37 11.71 Favored Glycine 0 CA--C 1.528 0.89 0 C-N-CA 125.643 1.592 . . . . 0.0 111.181 -171.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 2494 ' ' SER . . . . . . . . . . . . . 54.4 p -140.93 138.59 33.95 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 113.333 0.864 . . . . 0.0 113.333 178.628 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 2495 ' ' TYR . . . . . . . . . . . . . 56.6 m-85 -111.13 131.48 55.06 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 126.215 1.806 . . . . 0.0 110.412 -178.666 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 2496 ' ' LEU . . . . . . . . . . . . . 86.2 mt -86.62 123.2 31.54 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 124.459 1.103 . . . . 0.0 109.33 169.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 2497 ' ' ILE . . . . . . . . . . . . . 49.7 mt -100.93 94.45 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 C-N-CA 125.641 1.576 . . . . 0.0 107.939 179.391 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 2498 ' ' SER . . . . . . . . . . . . . 67.1 m -88.71 119.3 29.06 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 125.594 1.557 . . . . 0.0 110.245 -178.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 2499 ' ' ILE . . . . . 0.686 ' H ' ' HG ' ' A' 2510 ' ' SER . 33.7 mt -127.09 121.4 57.76 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 C-N-CA 125.223 1.409 . . . . 0.0 108.088 -170.883 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 2500 ' ' LYS . . . . . . . . . . . . . 93.0 mttt -131.8 119.22 20.96 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 123.857 0.863 . . . . 0.0 112.063 -168.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 2501 ' ' TYR . . . . . . . . . . . . . 66.6 t80 -125.87 137.74 53.76 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.796 1.239 . . . . 0.0 112.507 -169.459 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 2502 ' ' GLY . . . . . . . . . . . . . . . 70.06 10.26 64.9 Favored Glycine 0 CA--C 1.537 1.444 0 C-N-CA 124.445 1.022 . . . . 0.0 114.318 -178.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 2503 ' ' GLY . . . . . . . . . . . . . . . 149.94 -176.3 28.66 Favored Glycine 0 CA--C 1.54 1.615 0 C-N-CA 126.094 1.806 . . . . 0.0 112.849 -171.454 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 2504 ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -81.45 34.57 0.55 Allowed 'Trans proline' 0 CA--C 1.546 1.111 0 C-N-CA 125.193 3.929 . . . . 0.0 113.346 -173.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 2505 ' ' TYR . . . . . . . . . . . . . 82.6 m-85 -122.53 135.63 54.69 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 125.026 1.33 . . . . 0.0 112.296 -174.355 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 2506 ' ' HIS . . . . . . . . . . . . . 94.8 m-70 -60.51 140.75 57.17 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 124.254 1.022 . . . . 0.0 113.676 -176.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 2507 ' ' ILE . . . . . . . . . . . . . 1.9 pp -75.98 167.85 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 C-N-CA 123.562 0.745 . . . . 0.0 112.505 172.277 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 2508 ' ' GLY . . . . . . . . . . . . . . . -58.33 112.4 3.93 Favored Glycine 0 CA--C 1.533 1.166 0 C-N-CA 124.003 0.811 . . . . 0.0 112.877 -174.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 2509 ' ' GLY . . . . . . . . . . . . . . . 95.47 -8.94 69.24 Favored Glycine 0 CA--C 1.536 1.37 0 C-N-CA 125.983 1.754 . . . . 0.0 115.004 -178.105 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 2510 ' ' SER . . . . . 0.686 ' HG ' ' H ' ' A' 2499 ' ' ILE . 13.3 t -84.78 145.82 44.94 Favored Pre-proline 0 CA--C 1.552 1.047 0 CA-C-N 119.195 1.498 . . . . 0.0 112.0 179.731 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 2511 ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -75.39 144.25 79.9 Favored 'Cis proline' 0 C--N 1.354 0.83 0 CA-C-N 120.217 1.113 . . . . 0.0 113.026 -0.57 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 2512 ' ' PHE . . . . . . . . . . . . . 94.9 m-85 -96.94 134.1 40.73 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.511 1.124 . . . . 0.0 110.519 175.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 2513 ' ' LYS . . . . . . . . . . . . . 59.6 pttt -89.54 105.56 17.88 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 123.686 0.794 . . . . 0.0 112.358 176.27 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 2514 ' ' ALA . . . . . . . . . . . . . . . -91.88 126.86 37.13 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 125.261 1.424 . . . . 0.0 110.374 174.522 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 2515 ' ' LYS . . . . . . . . . . . . . 30.6 mtpp -101.38 134.44 44.46 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 124.712 1.205 . . . . 0.0 111.123 -175.295 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 2516 ' ' VAL . . . . . . . . . . . . . 84.7 t -132.58 137.01 55.09 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 C-N-CA 124.493 1.117 . . . . 0.0 110.715 -169.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 2517 ' ' THR . . . . . . . . . . . . . 73.4 p -123.65 -177.27 3.68 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 125.741 1.616 . . . . 0.0 110.965 176.219 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 2518 ' ' GLY . . . . . . . . . . . . . . . 98.62 -176.52 29.98 Favored Glycine 0 CA--C 1.54 1.621 0 C-N-CA 124.749 1.166 . . . . 0.0 113.465 -176.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 2519 ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -71.1 151.08 61.11 Favored 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 123.814 3.009 . . . . 0.0 111.885 -176.263 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 2520 ' ' ARG . . . . . . . . . . . . . 21.5 ttt85 -91.15 129.0 37.19 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 123.872 0.869 . . . . 0.0 110.896 176.144 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 2521 ' ' LEU . . . . . . . . . . . . . 3.9 mm? -92.45 -12.15 32.86 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.374 1.07 . . . . 0.0 113.79 -174.635 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 2522 ' ' VAL . . . . . . . . . . . . . 9.2 p . . . . . 0 N--CA 1.483 1.202 0 C-N-CA 125.028 1.331 . . . . 0.0 113.425 -171.942 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.509 0 N-CA-C 111.447 -0.661 . . . . 0.0 111.447 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -72.86 165.83 24.15 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 124.452 1.101 . . . . 0.0 112.861 177.398 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 97.9 mmm -75.94 -18.17 59.45 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.389 1.076 . . . . 0.0 113.769 179.487 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 2427 ' ' GLY . . . . . . . . . . . . . . . -76.28 128.81 9.61 Favored Glycine 0 CA--C 1.527 0.795 0 C-N-CA 124.437 1.018 . . . . 0.0 112.594 -175.258 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 2428 ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -148.9 143.37 17.02 Favored Pre-proline 0 CA--C 1.545 0.765 0 C-N-CA 125.078 1.351 . . . . 0.0 111.643 178.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 2429 ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -65.32 -24.4 57.83 Favored 'Trans proline' 0 C--N 1.351 0.707 0 C-N-CA 123.215 2.61 . . . . 0.0 112.773 177.715 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 2430 ' ' GLY . . . . . . . . . . . . . . . -75.59 -23.28 73.38 Favored Glycine 0 CA--C 1.535 1.317 0 CA-C-N 119.065 0.848 . . . . 0.0 113.805 174.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 2431 ' ' LEU . . . . . . . . . . . . . 4.4 mm? -86.95 -33.16 19.76 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.492 1.117 . . . . 0.0 111.616 173.682 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 2432 ' ' VAL . . . . . . . . . . . . . 53.4 t -70.16 138.31 22.26 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 C-N-CA 124.166 0.987 . . . . 0.0 111.092 172.005 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 2433 ' ' SER . . . . . . . . . . . . . 58.5 m -139.13 146.96 41.28 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 125.705 1.602 . . . . 0.0 109.628 173.549 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 2434 ' ' ALA . . . . . . . . . . . . . . . -98.98 149.36 23.06 Favored 'General case' 0 CA--C 1.54 0.568 0 O-C-N 121.528 -0.733 . . . . 0.0 112.13 176.219 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 2435 ' ' TYR . . . . . . . . . . . . . 89.7 m-85 -142.67 145.18 33.17 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.831 1.652 . . . . 0.0 111.563 -178.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 2436 ' ' GLY . . . . . . . . . . . . . . . 126.93 160.4 10.52 Favored Glycine 0 N--CA 1.474 1.193 0 C-N-CA 125.325 1.44 . . . . 0.0 113.948 178.379 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 2437 ' ' ALA . . . . . . . . . . . . . . . -63.18 -28.83 70.32 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 114.283 1.216 . . . . 0.0 114.283 -171.186 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 2438 ' ' GLY . . . . . . . . . . . . . . . -66.95 -11.08 57.62 Favored Glycine 0 CA--C 1.531 1.093 0 C-N-CA 124.437 1.018 . . . . 0.0 114.501 -178.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 2439 ' ' LEU . . . . . . . . . . . . . 75.6 mt -78.68 -25.22 44.8 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 118.537 1.168 . . . . 0.0 112.594 170.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 2440 ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -94.46 -31.98 13.72 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.897 1.279 . . . . 0.0 112.361 -175.165 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 2441 ' ' GLY . . . . . . . . . . . . . . . 159.22 -155.08 26.15 Favored Glycine 0 CA--C 1.527 0.807 0 C-N-CA 124.45 1.024 . . . . 0.0 113.575 -176.225 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 2442 ' ' GLY . . . . . . . . . . . . . . . 168.01 -171.9 42.54 Favored Glycine 0 CA--C 1.529 0.93 0 C-N-CA 124.636 1.112 . . . . 0.0 113.498 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 2443 ' ' VAL . . . . . . . . . . . . . 95.4 t -117.6 137.55 51.17 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 125.379 1.471 . . . . 0.0 108.996 176.452 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 2444 ' ' THR . . . . . . . . . . . . . 21.5 p -57.99 136.62 57.13 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.18 0.992 . . . . 0.0 112.232 177.308 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 2445 ' ' GLY . . . . . . . . . . . . . . . 79.61 -12.53 27.53 Favored Glycine 0 CA--C 1.534 1.274 0 C-N-CA 124.624 1.107 . . . . 0.0 114.713 -178.644 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 2446 ' ' ASN . . . . . . . . . . . . . 80.5 m-20 -99.43 150.15 36.5 Favored Pre-proline 0 CA--C 1.547 0.843 0 C-N-CA 124.898 1.279 . . . . 0.0 110.825 173.266 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 2447 ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -70.75 142.51 43.76 Favored 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 122.756 2.304 . . . . 0.0 111.01 175.163 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 2448 ' ' ALA . . . . . . . . . . . . . . . -128.35 135.31 49.4 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 126.726 2.011 . . . . 0.0 108.618 171.209 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 2449 ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -142.11 154.04 44.59 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 114.324 1.231 . . . . 0.0 114.324 -163.12 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 2450 ' ' PHE . . . . . . . . . . . . . 54.3 p90 -158.56 155.28 28.04 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 126.118 1.767 . . . . 0.0 111.405 -179.225 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 2451 ' ' VAL . . . . . . . . . . . . . 59.6 t -111.39 129.29 67.0 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 C-N-CA 125.11 1.364 . . . . 0.0 108.914 173.361 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 2452 ' ' VAL . . . . . . . . . . . . . 39.0 t -84.19 101.4 8.71 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 N-CA-C 107.208 -1.405 . . . . 0.0 107.208 166.016 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 2453 ' ' ASN . . . . . . . . . . . . . 19.3 t-20 -83.11 124.74 30.77 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 123.478 0.711 . . . . 0.0 112.472 -169.356 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 2454 ' ' THR . . . . . . . . . . . . . 40.4 p -103.96 -1.25 27.86 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 125.696 1.598 . . . . 0.0 113.881 -179.001 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 2455 ' ' SER . . . . . . . . . . . . . 44.5 m -57.8 -29.13 64.64 Favored 'General case' 0 N--CA 1.48 1.047 0 CA-C-N 120.32 1.418 . . . . 0.0 114.441 -175.445 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 2456 ' ' ASN . . . . . . . . . . . . . 67.3 m-80 -86.86 -11.99 49.18 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 124.688 1.195 . . . . 0.0 113.557 176.152 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 2457 ' ' ALA . . . . . . . . . . . . . . . -112.54 -22.33 10.85 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 126.172 1.789 . . . . 0.0 113.851 -174.073 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 2458 ' ' GLY . . . . . . . . . . . . . . . 91.36 -85.89 1.28 Allowed Glycine 0 CA--C 1.529 0.943 0 C-N-CA 124.986 1.279 . . . . 0.0 111.338 -176.496 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 2459 ' ' ALA . . . . . . . . . . . . . . . -157.84 157.14 32.7 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 124.987 1.315 . . . . 0.0 112.617 -176.466 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 2460 ' ' GLY . . . . . . . . . . . . . . . 165.09 167.34 25.52 Favored Glycine 0 CA--C 1.532 1.126 0 C-N-CA 125.545 1.545 . . . . 0.0 113.008 -176.145 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 2461 ' ' ALA . . . . . . . . . . . . . . . -77.96 145.64 35.94 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.265 1.026 . . . . 0.0 112.572 -178.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 2462 ' ' LEU . . . . . . . . . . . . . 29.9 tp -121.21 141.6 50.7 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 125.336 1.455 . . . . 0.0 110.999 178.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 2463 ' ' SER . . . . . . . . . . . . . 29.7 t -102.24 -109.75 0.23 Allowed 'General case' 0 CA--C 1.552 1.02 0 C-N-CA 125.24 1.416 . . . . 0.0 110.014 171.119 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 2464 ' ' VAL . . . . . . . . . . . . . 48.3 t 105.31 123.57 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.247 0 C-N-CA 131.659 3.984 . . . . 0.0 109.702 172.647 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 2465 ' ' THR . . . . . . . . . . . . . 89.9 m -131.95 139.29 48.64 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 125.408 1.483 . . . . 0.0 109.076 174.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 2466 ' ' ILE . . . . . . . . . . . . . 35.8 mt -119.15 117.39 54.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 123.634 0.773 . . . . 0.0 109.649 175.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 2467 ' ' ASP . . . . . . . . . . . . . 34.8 t70 -95.17 162.34 13.74 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 125.776 1.631 . . . . 0.0 110.286 168.638 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 2468 ' ' GLY . . . . . . . . . . . . . . . 168.73 -166.78 39.9 Favored Glycine 0 CA--C 1.536 1.358 0 O-C-N 121.125 -0.985 . . . . 0.0 114.717 178.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 2469 ' ' PRO . . . . . . . . . . . . . 76.1 Cg_endo -70.94 -15.86 32.66 Favored 'Trans proline' 0 CA--C 1.541 0.853 0 C-N-CA 123.969 3.113 . . . . 0.0 113.088 177.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 2470 ' ' SER . . . . . . . . . . . . . 37.2 m -153.67 174.52 14.38 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 126.868 2.067 . . . . 0.0 110.343 175.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 2471 ' ' LYS . . . . . . . . . . . . . 67.9 mttm -68.32 167.54 14.3 Favored 'General case' 0 CA--C 1.549 0.918 0 O-C-N 121.252 -0.905 . . . . 0.0 112.181 168.611 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 2472 ' ' VAL . . . . . . . . . . . . . 14.3 m -133.35 144.9 34.84 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 125.468 1.507 . . . . 0.0 111.34 -179.583 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 2473 ' ' LYS . . . . . . . . . . . . . 14.5 mmmm -89.31 71.27 8.18 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.337 1.055 . . . . 0.0 111.588 -179.263 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 2474 ' ' MET . . . . . . . . . . . . . 92.0 mtp -69.77 140.74 53.43 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 124.494 1.118 . . . . 0.0 112.969 -178.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 2475 ' ' ASP . . . . . . . . . . . . . 30.5 t70 -133.4 125.15 28.46 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 126.97 2.108 . . . . 0.0 108.755 163.117 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 2476 ' ' CYS . . . . . . . . . . . . . 42.6 t -122.18 132.75 54.61 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.797 1.239 . . . . 0.0 110.956 -177.706 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 2477 ' ' GLN . . . . . . . . . . . . . 15.9 mm100 -142.02 151.86 42.85 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 125.454 1.502 . . . . 0.0 110.721 -178.622 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 2478 ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -79.88 151.75 30.01 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 123.412 0.685 . . . . 0.0 111.67 169.343 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 2479 ' ' CYS . . . . . . . . . . . . . 19.5 p -156.82 172.15 6.5 Favored Pre-proline 0 CA--C 1.553 1.096 0 C-N-CA 126.083 1.753 . . . . 0.0 111.505 -176.576 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 2480 ' ' PRO . . . . . . . . . . . . . 58.0 Cg_exo -59.02 -26.2 80.71 Favored 'Trans proline' 0 CA--C 1.539 0.75 0 C-N-CA 123.342 2.694 . . . . 0.0 114.584 176.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 2481 ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -88.37 -6.1 57.9 Favored 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 125.382 1.473 . . . . 0.0 113.154 -179.086 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 2482 ' ' GLY . . . . . . . . . . . . . . . 128.24 -132.21 7.26 Favored Glycine 0 N--CA 1.472 1.055 0 C-N-CA 125.335 1.445 . . . . 0.0 112.164 -176.324 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 2483 ' ' TYR . . . . . . . . . . . . . 95.1 m-85 -108.78 117.62 34.67 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 123.809 0.844 . . . . 0.0 110.854 173.551 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 2484 ' ' ARG . . . . . . . . . . . . . 57.5 ttt180 -92.43 130.55 38.07 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 124.117 0.967 . . . . 0.0 110.676 177.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 2485 ' ' VAL . . . . . . . . . . . . . 89.9 t -114.09 132.76 62.18 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 C-N-CA 125.863 1.665 . . . . 0.0 108.47 172.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 2486 ' ' THR . . . . . . . . . . . . . 95.4 m -125.6 137.22 53.89 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 125.11 1.364 . . . . 0.0 107.821 169.06 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 2487 ' ' TYR . . . . . . . . . . . . . 21.6 p90 -144.09 152.75 41.37 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 123.72 0.808 . . . . 0.0 112.604 177.415 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 2488 ' ' THR . . . . . . . . . . . . . 84.4 m -113.25 119.71 41.61 Favored Pre-proline 0 N--CA 1.474 0.753 0 CA-C-O 117.892 -1.051 . . . . 0.0 109.466 173.287 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 2489 ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -83.67 154.75 13.66 Favored 'Trans proline' 0 CA--C 1.537 0.634 0 C-N-CA 124.064 3.176 . . . . 0.0 111.209 171.298 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 2490 ' ' MET . . . . . . . . . . . . . 28.0 ptm -119.69 -2.37 10.44 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 114.892 1.441 . . . . 0.0 114.892 -174.211 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 2491 ' ' ALA . . . . . . . . . . . . . . . -147.25 148.23 31.14 Favored Pre-proline 0 CA--C 1.545 0.786 0 C-N-CA 125.687 1.595 . . . . 0.0 110.896 177.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 2492 ' ' PRO . . . . . . . . . . . . . 74.9 Cg_endo -72.18 153.91 56.9 Favored 'Trans proline' 0 CA--C 1.536 0.584 0 C-N-CA 123.043 2.495 . . . . 0.0 111.161 174.546 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 2493 ' ' GLY . . . . . . . . . . . . . . . 135.39 -170.12 23.12 Favored Glycine 0 CA--C 1.529 0.949 0 C-N-CA 125.363 1.459 . . . . 0.0 113.313 -177.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 2494 ' ' SER . . . . . 0.471 ' HG ' ' HE2' ' A' 2513 ' ' LYS . 70.3 m -95.54 121.07 36.85 Favored 'General case' 0 N--CA 1.471 0.61 0 O-C-N 121.839 -0.8 . . . . 0.0 111.818 179.303 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 2495 ' ' TYR . . . . . . . . . . . . . 63.5 m-85 -99.07 126.01 44.71 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 125.156 1.382 . . . . 0.0 109.706 171.43 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 2496 ' ' LEU . . . . . . . . . . . . . 26.1 tp -101.2 110.68 22.73 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.359 1.064 . . . . 0.0 109.44 -176.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 2497 ' ' ILE . . . . . . . . . . . . . 39.8 mt -96.56 96.48 5.54 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 C-N-CA 125.688 1.595 . . . . 0.0 108.618 -172.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 2498 ' ' SER . . . . . . . . . . . . . 68.9 m -80.86 83.54 6.58 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 125.409 1.484 . . . . 0.0 110.165 176.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 2499 ' ' ILE . . . . . . . . . . . . . 50.5 mt -79.91 114.53 20.9 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 C-N-CA 124.31 1.044 . . . . 0.0 109.227 177.025 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 2500 ' ' LYS . . . . . . . . . . . . . 83.7 mttt -127.52 133.33 49.83 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 125.03 1.332 . . . . 0.0 111.769 -175.165 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 2501 ' ' TYR . . . . . . . . . . . . . 64.4 t80 -141.83 143.09 33.22 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 125.465 1.506 . . . . 0.0 111.805 -170.332 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 2502 ' ' GLY . . . . . . . . . . . . . . . 69.26 11.86 65.01 Favored Glycine 0 CA--C 1.536 1.388 0 C-N-CA 124.443 1.02 . . . . 0.0 114.474 177.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 2503 ' ' GLY . . . . . . . . . . . . . . . 145.9 -165.6 28.05 Favored Glycine 0 CA--C 1.54 1.614 0 C-N-CA 125.731 1.634 . . . . 0.0 112.999 -170.487 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 2504 ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -82.28 13.72 2.46 Favored 'Trans proline' 0 CA--C 1.544 0.999 0 C-N-CA 124.762 3.641 . . . . 0.0 113.962 -174.318 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 2505 ' ' TYR . . . . . . . . . . . . . 84.0 m-85 -106.22 142.32 36.1 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.78 1.232 . . . . 0.0 113.452 -173.325 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 2506 ' ' HIS . . . . . . . . . . . . . 97.7 m-70 -65.03 143.89 57.64 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 124.762 1.225 . . . . 0.0 113.046 178.282 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 2507 ' ' ILE . . . . . . . . . . . . . 20.4 pt -73.65 175.6 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 N-CA-C 113.437 0.902 . . . . 0.0 113.437 173.583 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 2508 ' ' GLY . . . . . . . . . . . . . . . -58.95 119.53 18.34 Favored Glycine 0 CA--C 1.534 1.232 0 O-C-N 121.487 -0.758 . . . . 0.0 111.512 172.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 2509 ' ' GLY . . . . . . . . . . . . . . . 87.19 -6.76 82.76 Favored Glycine 0 CA--C 1.536 1.359 0 C-N-CA 125.616 1.579 . . . . 0.0 115.034 -176.733 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 2510 ' ' SER . . . . . . . . . . . . . 43.8 t -89.09 147.67 39.13 Favored Pre-proline 0 CA--C 1.549 0.938 0 CA-C-N 118.914 1.357 . . . . 0.0 112.043 -179.005 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 2511 ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -74.46 146.22 86.16 Favored 'Cis proline' 0 C--N 1.353 0.808 0 CA-C-N 119.671 0.918 . . . . 0.0 112.608 -1.036 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 2512 ' ' PHE . . . . . . . . . . . . . 94.7 m-85 -96.3 126.41 41.49 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.612 1.165 . . . . 0.0 110.797 179.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 2513 ' ' LYS . . . . . 0.471 ' HE2' ' HG ' ' A' 2494 ' ' SER . 85.0 tttt -94.5 100.16 12.2 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.025 0.93 . . . . 0.0 111.407 -179.03 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 2514 ' ' ALA . . . . . . . . . . . . . . . -89.02 115.46 26.6 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.355 1.462 . . . . 0.0 110.913 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 2515 ' ' LYS . . . . . . . . . . . . . 48.4 mtpt -94.04 98.64 11.14 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 124.099 0.959 . . . . 0.0 110.529 -174.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 2516 ' ' VAL . . . . . . . . . . . . . 63.7 t -90.96 140.74 15.49 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 125.673 1.589 . . . . 0.0 110.496 -173.39 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 2517 ' ' THR . . . . . . . . . . . . . 72.0 p -124.4 -177.33 3.76 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 125.582 1.553 . . . . 0.0 111.121 177.093 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 2518 ' ' GLY . . . . . . . . . . . . . . . 98.34 178.34 32.81 Favored Glycine 0 CA--C 1.539 1.558 0 C-N-CA 124.752 1.167 . . . . 0.0 113.561 -177.183 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 2519 ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -73.43 141.82 32.24 Favored 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 123.776 2.984 . . . . 0.0 111.932 -173.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 2520 ' ' ARG . . . . . . . . . . . . . 37.6 ttm180 -68.13 126.46 29.58 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 122.959 0.503 . . . . 0.0 110.004 172.733 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 2521 ' ' LEU . . . . . . . . . . . . . 52.5 mt -83.27 -28.57 29.05 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 123.613 0.765 . . . . 0.0 112.762 -175.624 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 2522 ' ' VAL . . . . . . . . . . . . . 9.1 p . . . . . 0 C--O 1.253 1.249 0 C-N-CA 126.013 1.725 . . . . 0.0 112.625 176.105 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.552 0 N-CA-C 112.092 -0.403 . . . . 0.0 112.092 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -73.89 164.2 26.94 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 124.456 1.102 . . . . 0.0 113.002 178.271 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 98.6 mmm -87.49 -9.27 55.0 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.966 1.306 . . . . 0.0 113.629 175.516 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 2427 ' ' GLY . . . . . . . . . . . . . . . 81.01 161.56 26.62 Favored Glycine 0 CA--C 1.531 1.055 0 C-N-CA 125.332 1.444 . . . . 0.0 113.166 -177.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 2428 ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -143.52 135.64 13.2 Favored Pre-proline 0 CA--C 1.544 0.738 0 C-N-CA 124.785 1.234 . . . . 0.0 111.204 178.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 2429 ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -67.94 -22.59 41.95 Favored 'Trans proline' 0 CA--C 1.537 0.648 0 C-N-CA 122.964 2.443 . . . . 0.0 113.003 -178.347 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 2430 ' ' GLY . . . . . . . . . . . . . . . -76.72 -23.12 70.64 Favored Glycine 0 CA--C 1.535 1.292 0 CA-C-N 118.864 0.756 . . . . 0.0 113.557 173.399 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 2431 ' ' LEU . . . . . . . . . . . . . 4.3 mm? -87.72 -35.46 17.93 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.514 1.126 . . . . 0.0 111.353 173.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 2432 ' ' VAL . . . . . . . . . . . . . 74.2 t -64.91 139.6 21.13 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 123.389 0.676 . . . . 0.0 110.473 169.639 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 2433 ' ' SER . . . . . . . . . . . . . 8.5 t -131.37 -176.21 3.95 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.942 1.297 . . . . 0.0 110.507 173.162 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 2434 ' ' ALA . . . . . . . . . . . . . . . -141.96 143.19 33.1 Favored 'General case' 0 CA--C 1.538 0.5 0 O-C-N 121.042 -1.036 . . . . 0.0 111.712 177.107 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 2435 ' ' TYR . . . . . . . . . . . . . 79.1 m-85 -143.65 157.5 44.36 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.536 1.534 . . . . 0.0 111.899 -175.111 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 2436 ' ' GLY . . . . . . . . . . . . . . . 108.05 159.75 20.37 Favored Glycine 0 N--CA 1.474 1.17 0 C-N-CA 125.244 1.402 . . . . 0.0 113.694 177.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 2437 ' ' ALA . . . . . . . . . . . . . . . -62.88 -27.42 69.34 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.075 1.35 . . . . 0.0 114.582 -169.294 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 2438 ' ' GLY . . . . . . . . . . . . . . . -66.27 -14.12 61.29 Favored Glycine 0 CA--C 1.532 1.114 0 C-N-CA 123.974 0.797 . . . . 0.0 114.683 -176.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 2439 ' ' LEU . . . . . . . . . . . . . 88.1 mt -72.07 -22.74 61.32 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 118.466 1.133 . . . . 0.0 112.761 170.233 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 2440 ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -94.48 -16.59 23.21 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 125.076 1.35 . . . . 0.0 112.82 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 2441 ' ' GLY . . . . . . . . . . . . . . . 102.92 -138.82 14.15 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 125.559 1.552 . . . . 0.0 112.39 -177.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 2442 ' ' GLY . . . . . . . . . . . . . . . 150.81 -140.72 8.1 Favored Glycine 0 CA--C 1.532 1.125 0 C-N-CA 124.007 0.813 . . . . 0.0 114.088 -177.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 2443 ' ' VAL . . . . . . . . . . . . . 99.2 t -113.08 139.15 39.77 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 C-N-CA 125.601 1.561 . . . . 0.0 110.115 -175.156 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 2444 ' ' THR . . . . . . . . . . . . . 30.1 p -61.72 142.9 56.95 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 124.302 1.041 . . . . 0.0 112.412 176.41 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 2445 ' ' GLY . . . . . . . . . . . . . . . 79.01 -10.61 32.65 Favored Glycine 0 CA--C 1.537 1.412 0 C-N-CA 124.462 1.03 . . . . 0.0 114.558 -177.118 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 2446 ' ' ASN . . . . . . . . . . . . . 79.7 m-20 -101.59 148.39 35.17 Favored Pre-proline 0 CA--C 1.548 0.87 0 C-N-CA 124.94 1.296 . . . . 0.0 111.117 174.159 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 2447 ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -73.75 129.88 14.02 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 123.176 2.584 . . . . 0.0 111.276 178.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 2448 ' ' ALA . . . . . . . . . . . . . . . -101.87 116.34 32.5 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 126.222 1.809 . . . . 0.0 109.031 170.485 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 2449 ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -111.96 132.79 54.55 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.389 1.076 . . . . 0.0 111.66 -172.319 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 2450 ' ' PHE . . . . . . . . . . . . . 37.8 p90 -147.59 168.56 21.68 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.48 1.512 . . . . 0.0 110.882 171.277 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 2451 ' ' VAL . . . . . . . . . . . . . 14.7 p -126.94 136.93 59.4 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 C-N-CA 124.609 1.164 . . . . 0.0 110.508 174.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 2452 ' ' VAL . . . . . . . . . . . . . 22.0 t -89.5 103.8 14.43 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 N-CA-C 106.797 -1.557 . . . . 0.0 106.797 164.669 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 2453 ' ' ASN . . . . . . . . . . . . . 18.6 t-20 -91.29 120.18 31.96 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 123.874 0.87 . . . . 0.0 112.271 -167.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 2454 ' ' THR . . . . . . . . . . . . . 75.1 p -104.24 2.62 31.84 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 125.958 1.703 . . . . 0.0 113.887 -175.397 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 2455 ' ' SER . . . . . . . . . . . . . 45.2 m -56.89 -27.5 60.72 Favored 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 114.782 1.401 . . . . 0.0 114.782 -173.482 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 2456 ' ' ASN . . . . . . . . . . . . . 70.1 m-80 -91.6 -12.22 34.93 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 124.537 1.135 . . . . 0.0 113.644 176.339 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 2457 ' ' ALA . . . . . . . . . . . . . . . -106.6 -33.43 7.66 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 125.575 1.55 . . . . 0.0 113.759 -174.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 2458 ' ' GLY . . . . . . . . . . . . . . . 87.28 -152.84 24.76 Favored Glycine 0 CA--C 1.533 1.171 0 C-N-CA 124.779 1.181 . . . . 0.0 112.202 -172.099 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 2459 ' ' ALA . . . . . . . . . . . . . . . -69.22 151.94 45.69 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 123.924 0.89 . . . . 0.0 112.6 178.127 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 2460 ' ' GLY . . . . . . . . . . . . . . . 159.86 157.62 8.72 Favored Glycine 0 CA--C 1.532 1.103 0 C-N-CA 125.302 1.43 . . . . 0.0 113.193 179.4 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 2461 ' ' ALA . . . . . . . . . . . . . . . -85.1 139.88 31.39 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.262 1.025 . . . . 0.0 113.346 -172.659 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 2462 ' ' LEU . . . . . . . . . . . . . 31.6 tp -106.4 146.55 30.34 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.778 1.631 . . . . 0.0 111.023 175.765 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 2463 ' ' SER . . . . . . . . . . . . . 4.0 t -137.62 42.13 2.34 Favored 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 125.885 1.674 . . . . 0.0 110.91 -178.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 2464 ' ' VAL . . . . . . . . . . . . . 11.0 p -63.98 135.34 27.94 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.975 0 C-N-CA 124.982 1.313 . . . . 0.0 112.017 -175.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 2465 ' ' THR . . . . . . . . . . . . . 96.3 m -136.41 145.17 44.98 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 125.925 1.69 . . . . 0.0 109.591 -179.16 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 2466 ' ' ILE . . . . . . . . . . . . . 40.6 mt -121.96 123.42 69.06 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 C-N-CA 123.748 0.819 . . . . 0.0 109.98 173.717 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 2467 ' ' ASP . . . . . . . . . . . . . 36.7 t70 -99.39 155.62 17.44 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 125.836 1.655 . . . . 0.0 110.179 166.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 2468 ' ' GLY . . . . . . . . . . . . . . . 177.17 -169.43 41.7 Favored Glycine 0 CA--C 1.537 1.44 0 O-C-N 121.043 -1.036 . . . . 0.0 115.562 -179.28 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 2469 ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -69.73 -17.49 37.69 Favored 'Trans proline' 0 CA--C 1.54 0.79 0 C-N-CA 124.322 3.348 . . . . 0.0 113.411 179.463 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 2470 ' ' SER . . . . . . . . . . . . . 35.0 m -153.92 176.09 12.58 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 127.165 2.186 . . . . 0.0 109.617 174.228 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 2471 ' ' LYS . . . . . . . . . . . . . 4.0 mppt? -66.84 162.96 20.47 Favored 'General case' 0 CA--C 1.551 0.989 0 O-C-N 121.03 -1.044 . . . . 0.0 111.455 168.432 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 2472 ' ' VAL . . . . . . . . . . . . . 33.0 m -118.84 145.87 24.26 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 C-N-CA 124.928 1.291 . . . . 0.0 110.954 175.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 2473 ' ' LYS . . . . . . . . . . . . . 99.0 mttt -86.04 90.9 8.24 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 123.678 0.791 . . . . 0.0 109.357 171.158 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 2474 ' ' MET . . . . . . . . . . . . . 60.5 ttm -89.9 143.38 26.84 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.546 1.139 . . . . 0.0 112.532 -175.068 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 2475 ' ' ASP . . . . . . . . . . . . . 35.8 t0 -133.94 82.04 1.95 Allowed 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 127.96 2.504 . . . . 0.0 108.559 171.637 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 2476 ' ' CYS . . . . . . . . . . . . . 52.6 t -88.01 134.43 33.74 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.841 1.256 . . . . 0.0 110.666 175.609 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 2477 ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -139.51 140.78 37.29 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.519 1.127 . . . . 0.0 111.394 -175.745 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 2478 ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -82.24 139.61 34.14 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.654 1.181 . . . . 0.0 110.304 172.54 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 2479 ' ' CYS . . . . . . . . . . . . . 30.7 p -158.95 169.23 10.91 Favored Pre-proline 0 CA--C 1.553 1.064 0 C-N-CA 125.293 1.437 . . . . 0.0 111.604 -171.558 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 2480 ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -65.91 -15.66 49.74 Favored 'Trans proline' 0 CA--C 1.543 0.943 0 C-N-CA 122.569 2.179 . . . . 0.0 113.427 173.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 2481 ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -77.51 -11.21 59.83 Favored 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 124.69 1.196 . . . . 0.0 112.953 172.133 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 2482 ' ' GLY . . . . . . . . . . . . . . . 117.36 -122.91 5.6 Favored Glycine 0 C--N 1.342 0.911 0 C-N-CA 126.439 1.971 . . . . 0.0 111.48 -172.167 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 2483 ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -117.18 110.4 18.11 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 123.91 0.884 . . . . 0.0 110.209 171.221 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 2484 ' ' ARG . . . . . . . . . . . . . 51.7 ttm-85 -86.37 128.56 34.95 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.741 0.816 . . . . 0.0 109.258 177.289 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 2485 ' ' VAL . . . . . . . . . . . . . 58.4 t -118.98 114.28 44.22 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 C-N-CA 125.331 1.452 . . . . 0.0 108.436 -177.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 2486 ' ' THR . . . . . . . . . . . . . 62.8 m -104.58 140.46 37.96 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 165.654 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 2487 ' ' TYR . . . . . . . . . . . . . 23.3 p90 -146.65 144.63 29.63 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 112.538 0.57 . . . . 0.0 112.538 171.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 2488 ' ' THR . . . . . . . . . . . . . 90.5 m -107.11 114.94 60.79 Favored Pre-proline 0 N--CA 1.473 0.685 0 CA-C-O 118.228 -0.892 . . . . 0.0 109.403 173.554 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 2489 ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -81.38 158.31 19.7 Favored 'Trans proline' 0 C--N 1.351 0.69 0 C-N-CA 124.075 3.184 . . . . 0.0 111.218 173.123 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 2490 ' ' MET . . . . . . . . . . . . . 28.9 ptm -128.77 3.31 5.44 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 115.153 1.538 . . . . 0.0 115.153 -171.198 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 2491 ' ' ALA . . . . . . . . . . . . . . . -152.04 150.33 25.51 Favored Pre-proline 0 CA--C 1.548 0.876 0 C-N-CA 125.505 1.522 . . . . 0.0 110.925 175.558 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 2492 ' ' PRO . . . . . . . . . . . . . 99.0 Cg_endo -74.45 151.21 42.16 Favored 'Trans proline' 0 CA--C 1.539 0.738 0 C-N-CA 123.24 2.627 . . . . 0.0 111.375 178.448 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 2493 ' ' GLY . . . . . . . . . . . . . . . 138.39 -173.66 22.39 Favored Glycine 0 CA--C 1.532 1.116 0 C-N-CA 125.55 1.548 . . . . 0.0 113.382 -177.068 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 2494 ' ' SER . . . . . . . . . . . . . 18.1 p -88.69 120.44 30.09 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.304 1.042 . . . . 0.0 111.55 175.085 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 2495 ' ' TYR . . . . . . . . . . . . . 68.8 m-85 -94.51 116.13 28.42 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 124.027 0.931 . . . . 0.0 109.652 168.539 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 2496 ' ' LEU . . . . . . . . . . . . . 22.8 tp -89.94 105.42 17.79 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 124.041 0.936 . . . . 0.0 109.561 -179.081 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 2497 ' ' ILE . . . . . . . . . . . . . 28.1 mt -88.33 103.1 13.39 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 C-N-CA 125.747 1.619 . . . . 0.0 108.335 -179.201 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 2498 ' ' SER . . . . . . . . . . . . . 73.7 m -90.14 95.98 10.46 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 124.819 1.248 . . . . 0.0 109.638 175.442 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 2499 ' ' ILE . . . . . . . . . . . . . 40.1 mt -91.29 92.52 3.94 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 C-N-CA 124.602 1.161 . . . . 0.0 108.566 -178.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 2500 ' ' LYS . . . . . . . . . . . . . 84.1 mttt -103.37 137.02 42.06 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 124.286 1.035 . . . . 0.0 111.721 -179.463 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 2501 ' ' TYR . . . . . . . . . . . . . 60.3 t80 -146.32 144.11 29.58 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.63 1.172 . . . . 0.0 112.357 -171.047 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 2502 ' ' GLY . . . . . . . . . . . . . . . 67.75 18.29 70.15 Favored Glycine 0 CA--C 1.535 1.314 0 C-N-CA 124.252 0.93 . . . . 0.0 113.673 179.209 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 2503 ' ' GLY . . . . . . . . . . . . . . . 134.44 -167.58 23.8 Favored Glycine 0 CA--C 1.54 1.636 0 C-N-CA 126.119 1.819 . . . . 0.0 112.43 -166.366 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 2504 ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -82.19 24.34 0.72 Allowed 'Trans proline' 0 CA--C 1.545 1.072 0 C-N-CA 124.903 3.735 . . . . 0.0 113.653 -173.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 2505 ' ' TYR . . . . . . . . . . . . . 73.9 m-85 -114.15 135.46 54.01 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.684 1.194 . . . . 0.0 113.022 -172.062 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 2506 ' ' HIS . . . . . . . . . . . . . 92.7 m-70 -63.33 142.85 58.23 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 125.359 1.464 . . . . 0.0 113.566 -179.246 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 2507 ' ' ILE . . . . . . . . . . . . . 1.7 pp -76.01 171.93 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 C-N-CA 123.716 0.806 . . . . 0.0 112.898 172.614 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 2508 ' ' GLY . . . . . . . . . . . . . . . -59.8 111.13 3.27 Favored Glycine 0 CA--C 1.534 1.235 0 C-N-CA 123.733 0.682 . . . . 0.0 112.609 -177.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 2509 ' ' GLY . . . . . . . . . . . . . . . 96.26 -8.22 66.97 Favored Glycine 0 CA--C 1.536 1.346 0 C-N-CA 125.835 1.683 . . . . 0.0 114.904 -177.262 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 2510 ' ' SER . . . . . . . . . . . . . 44.3 t -81.98 147.88 59.13 Favored Pre-proline 0 CA--C 1.55 0.962 0 CA-C-N 119.114 1.457 . . . . 0.0 111.841 177.577 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 2511 ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -79.29 155.71 90.42 Favored 'Cis proline' 0 C--N 1.354 0.817 0 CA-C-N 119.794 0.962 . . . . 0.0 113.333 -0.182 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 2512 ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -106.25 130.74 54.05 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.348 1.459 . . . . 0.0 110.466 177.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 2513 ' ' LYS . . . . . . . . . . . . . 19.7 ptpt -86.41 4.89 37.56 Favored 'General case' 0 N--CA 1.479 0.997 0 N-CA-C 116.488 2.032 . . . . 0.0 116.488 -167.664 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 2514 ' ' ALA . . . . . . . . . . . . . . . 3.17 93.19 0.01 OUTLIER 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 129.777 3.231 . . . . 0.0 116.188 -178.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 2515 ' ' LYS . . . . . . . . . . . . . 9.3 mtpm? -84.59 116.51 23.2 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 124.101 0.961 . . . . 0.0 111.364 -174.004 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 2516 ' ' VAL . . . . . . . . . . . . . 52.9 t -108.62 143.48 18.85 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 C-N-CA 125.958 1.703 . . . . 0.0 110.261 -174.5 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 2517 ' ' THR . . . . . . . . . . . . . 77.1 p -132.47 177.94 7.21 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 125.489 1.516 . . . . 0.0 111.438 178.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 2518 ' ' GLY . . . . . . . . . . . . . . . 104.5 -165.73 14.91 Favored Glycine 0 CA--C 1.54 1.643 0 C-N-CA 124.903 1.24 . . . . 0.0 113.424 -177.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 2519 ' ' PRO . . . . . . . . . . . . . 77.3 Cg_endo -70.94 176.53 7.54 Favored 'Trans proline' 0 CA--C 1.538 0.684 0 C-N-CA 124.17 3.247 . . . . 0.0 112.36 -178.302 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 2520 ' ' ARG . . . . . . . . . . . . . 50.9 ptt85 -125.99 140.51 52.56 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.774 1.23 . . . . 0.0 111.683 177.769 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 2521 ' ' LEU . . . . . . . . . . . . . 4.2 mm? -85.16 -14.97 45.3 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.683 1.193 . . . . 0.0 112.72 179.551 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 2522 ' ' VAL . . . . . . . . . . . . . 13.0 m . . . . . 0 C--O 1.251 1.149 0 C-N-CA 127.119 2.168 . . . . 0.0 112.62 -178.365 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.497 0 N-CA-C 111.379 -0.689 . . . . 0.0 111.379 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -73.69 160.76 31.09 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 124.373 1.069 . . . . 0.0 113.015 178.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 44.2 mtp -131.15 -179.92 5.63 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 125.985 1.714 . . . . 0.0 110.978 175.327 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 2427 ' ' GLY . . . . . . . . . . . . . . . -66.02 154.2 51.4 Favored Glycine 0 CA--C 1.532 1.156 0 C-N-CA 124.51 1.053 . . . . 0.0 113.652 -178.719 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 2428 ' ' ASP . . . . . . . . . . . . . 13.8 t70 -106.86 136.52 19.43 Favored Pre-proline 0 CA--C 1.55 0.973 0 C-N-CA 124.958 1.303 . . . . 0.0 112.366 -172.181 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 2429 ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -64.58 -23.99 63.48 Favored 'Trans proline' 0 C--N 1.351 0.693 0 C-N-CA 123.222 2.615 . . . . 0.0 113.855 -178.275 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 2430 ' ' GLY . . . . . . . . . . . . . . . -75.43 -22.44 75.62 Favored Glycine 0 CA--C 1.533 1.209 0 CA-C-N 119.349 0.977 . . . . 0.0 113.345 175.267 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 2431 ' ' LEU . . . . . . . . . . . . . 4.3 mm? -83.96 -37.85 21.74 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.419 1.088 . . . . 0.0 111.197 170.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 2432 ' ' VAL . . . . . . . . . . . . . 69.5 t -61.85 136.8 24.82 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 123.775 0.83 . . . . 0.0 111.166 173.541 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 2433 ' ' SER . . . . . . . . . . . . . 68.5 m -128.72 163.11 25.85 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 125.867 1.667 . . . . 0.0 110.084 172.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 2434 ' ' ALA . . . . . . . . . . . . . . . -124.48 150.38 45.8 Favored 'General case' 0 CA--C 1.538 0.505 0 O-C-N 121.335 -0.853 . . . . 0.0 112.053 174.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 2435 ' ' TYR . . . . . . . . . . . . . 76.4 m-85 -143.24 161.61 37.83 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 126.063 1.745 . . . . 0.0 111.797 -175.183 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 2436 ' ' GLY . . . . . . . . . . . . . . . 106.43 159.75 22.11 Favored Glycine 0 N--CA 1.473 1.116 0 C-N-CA 125.131 1.348 . . . . 0.0 113.851 176.695 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 2437 ' ' ALA . . . . . . . . . . . . . . . -61.82 -28.55 69.55 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.005 1.322 . . . . 0.0 114.428 -169.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 2438 ' ' GLY . . . . . . . . . . . . . . . -66.48 -14.32 62.09 Favored Glycine 0 CA--C 1.532 1.154 0 C-N-CA 124.148 0.88 . . . . 0.0 114.581 -177.501 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 2439 ' ' LEU . . . . . . . . . . . . . 81.5 mt -74.4 -26.99 60.43 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 118.601 1.201 . . . . 0.0 112.338 169.31 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 2440 ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -93.67 -21.26 19.47 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 125.511 1.524 . . . . 0.0 112.255 177.39 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 2441 ' ' GLY . . . . . . . . . . . . . . . 110.65 -136.34 13.52 Favored Glycine 0 N--CA 1.47 0.945 0 C-N-CA 126.004 1.764 . . . . 0.0 113.181 177.234 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 2442 ' ' GLY . . . . . . . . . . . . . . . 156.52 -138.3 5.88 Favored Glycine 0 CA--C 1.53 1.022 0 C-N-CA 123.859 0.742 . . . . 0.0 114.227 -174.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 2443 ' ' VAL . . . . . . . . . . . . . 61.9 t -119.25 141.14 40.61 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 C-N-CA 125.369 1.468 . . . . 0.0 110.474 -173.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 2444 ' ' THR . . . . . . . . . . . . . 19.8 p -54.7 133.84 47.15 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 125.316 1.446 . . . . 0.0 112.29 174.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 2445 ' ' GLY . . . . . . . . . . . . . . . 81.68 -10.02 53.15 Favored Glycine 0 CA--C 1.535 1.314 0 C-N-CA 125.035 1.302 . . . . 0.0 114.844 178.67 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 2446 ' ' ASN . . . . . . . . . . . . . 91.0 m-20 -101.61 150.91 37.7 Favored Pre-proline 0 CA--C 1.548 0.876 0 C-N-CA 125.061 1.344 . . . . 0.0 111.257 175.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 2447 ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -72.68 130.9 16.46 Favored 'Trans proline' 0 C--N 1.35 0.656 0 C-N-CA 122.977 2.451 . . . . 0.0 111.538 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 2448 ' ' ALA . . . . . . . . . . . . . . . -99.82 118.2 35.77 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 126.417 1.887 . . . . 0.0 109.11 170.005 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 2449 ' ' GLU . . . . . . . . . . . . . 45.0 tt0 -115.88 131.8 56.83 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 124.994 1.317 . . . . 0.0 111.356 -169.459 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 2450 ' ' PHE . . . . . . . . . . . . . 40.4 p90 -148.02 165.7 29.96 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.096 1.358 . . . . 0.0 111.742 174.196 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 2451 ' ' VAL . . . . . . . . . . . . . 14.7 p -129.14 133.73 65.29 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 C-N-CA 124.834 1.253 . . . . 0.0 110.631 179.109 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 2452 ' ' VAL . . . . . . . . . . . . . 44.3 t -92.14 104.93 16.1 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 N-CA-C 107.017 -1.475 . . . . 0.0 107.017 169.117 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 2453 ' ' ASN . . . . . . . . . . . . . 19.5 t-20 -90.21 114.5 26.51 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.196 0.998 . . . . 0.0 112.161 -170.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 2454 ' ' THR . . . . . . . . . . . . . 43.7 p -95.88 -1.41 49.42 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 125.569 1.548 . . . . 0.0 113.902 -177.575 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 2455 ' ' SER . . . . . . . . . . . . . 29.8 m -56.76 -28.56 61.39 Favored 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 114.628 1.344 . . . . 0.0 114.628 -175.457 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 2456 ' ' ASN . . . . . . . . . . . . . 85.7 m-20 -79.47 -19.52 49.58 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 124.291 1.036 . . . . 0.0 113.483 175.673 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 2457 ' ' ALA . . . . . . . . . . . . . . . -112.2 -22.36 10.99 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 125.848 1.659 . . . . 0.0 113.902 -170.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 2458 ' ' GLY . . . . . . . . . . . . . . . 99.5 -99.87 2.15 Favored Glycine 0 CA--C 1.529 0.914 0 C-N-CA 125.322 1.439 . . . . 0.0 110.815 -173.32 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 2459 ' ' ALA . . . . . . . . . . . . . . . -153.63 155.4 35.98 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.254 1.422 . . . . 0.0 111.807 179.685 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 2460 ' ' GLY . . . . . . . . . . . . . . . 177.84 169.31 38.65 Favored Glycine 0 CA--C 1.529 0.918 0 C-N-CA 125.233 1.397 . . . . 0.0 112.959 -173.636 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 2461 ' ' ALA . . . . . . . . . . . . . . . -74.84 130.81 40.09 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 123.848 0.859 . . . . 0.0 111.874 -179.336 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 2462 ' ' LEU . . . . . . . . . . . . . 52.1 tp -108.19 138.6 44.19 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.374 1.47 . . . . 0.0 110.548 175.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 2463 ' ' SER . . . . . . . . . . . . . 30.7 t -103.56 -100.9 0.3 Allowed 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 124.806 1.242 . . . . 0.0 110.05 172.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 2464 ' ' VAL . . . . . . . . . . . . . 42.9 t 97.5 124.45 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.218 0 C-N-CA 130.837 3.655 . . . . 0.0 110.155 175.342 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 2465 ' ' THR . . . . . . . . . . . . . 99.8 m -125.01 135.6 52.92 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 125.271 1.428 . . . . 0.0 109.213 173.084 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 2466 ' ' ILE . . . . . . . . . . . . . 49.4 mt -115.93 117.64 56.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 123.998 0.919 . . . . 0.0 109.043 172.467 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 2467 ' ' ASP . . . . . . . . . . . . . 34.8 t70 -105.35 159.03 16.22 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 125.926 1.691 . . . . 0.0 110.255 169.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 2468 ' ' GLY . . . . . . . . . . . . . . . 156.44 -163.2 31.93 Favored Glycine 0 CA--C 1.535 1.332 0 O-C-N 121.253 -0.904 . . . . 0.0 114.367 178.718 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 2469 ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -72.47 -3.31 13.19 Favored 'Trans proline' 0 CA--C 1.542 0.923 0 C-N-CA 123.954 3.103 . . . . 0.0 114.622 -176.128 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 2470 ' ' SER . . . . . . . . . . . . . 85.7 p -153.59 154.56 34.46 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 119.751 1.16 . . . . 0.0 112.737 171.314 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 2471 ' ' LYS . . . . . . . . . . . . . 72.6 mmtt -74.52 86.5 2.08 Favored 'General case' 0 CA--C 1.544 0.736 0 O-C-N 120.789 -1.194 . . . . 0.0 110.026 168.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 2472 ' ' VAL . . . . . . . . . . . . . 18.4 m -55.7 146.1 5.29 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 C-N-CA 124.93 1.292 . . . . 0.0 113.19 -174.395 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 2473 ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -79.86 121.94 26.03 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 170.461 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 2474 ' ' MET . . . . . . . . . . . . . 26.1 ttt -132.08 142.43 49.52 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 124.556 1.143 . . . . 0.0 112.281 -164.328 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 2475 ' ' ASP . . . . . . . . . . . . . 20.1 m-20 -138.31 158.24 44.67 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 127.053 2.141 . . . . 0.0 110.713 174.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 2476 ' ' CYS . . . . . . . . . . . . . 43.5 t -149.32 148.57 29.69 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 125.207 1.403 . . . . 0.0 110.922 -179.3 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 2477 ' ' GLN . . . . . . . . . . . . . 26.2 tt0 -149.96 134.68 17.63 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.07 1.348 . . . . 0.0 110.347 -177.58 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 2478 ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -84.42 144.27 28.88 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.584 1.153 . . . . 0.0 111.784 172.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 2479 ' ' CYS . . . . . . . . . . . . . 25.5 p -161.0 175.23 3.23 Favored Pre-proline 0 CA--C 1.553 1.092 0 C-N-CA 125.785 1.634 . . . . 0.0 111.69 -173.157 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 2480 ' ' PRO . . . . . . . . . . . . . 77.6 Cg_exo -58.54 -24.03 67.72 Favored 'Trans proline' 0 CA--C 1.539 0.765 0 C-N-CA 123.328 2.685 . . . . 0.0 114.654 175.393 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 2481 ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -82.29 -4.56 57.42 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 124.678 1.191 . . . . 0.0 113.152 177.303 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 2482 ' ' GLY . . . . . . . . . . . . . . . 115.87 -124.62 6.33 Favored Glycine 0 N--CA 1.47 0.938 0 C-N-CA 125.848 1.689 . . . . 0.0 111.76 -175.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 2483 ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -116.77 113.22 22.25 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 124.408 1.083 . . . . 0.0 110.668 173.467 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 2484 ' ' ARG . . . . . . . . . . . . . 14.9 ttm180 -85.08 133.7 34.22 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 123.876 0.87 . . . . 0.0 109.926 173.102 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 2485 ' ' VAL . . . . . . . . . . . . . 90.8 t -121.62 136.25 59.13 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 C-N-CA 126.344 1.857 . . . . 0.0 108.847 179.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 2486 ' ' THR . . . . . . . . . . . . . 59.3 m -133.84 135.03 43.47 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.101 0.96 . . . . 0.0 108.913 175.018 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 2487 ' ' TYR . . . . . . . . . . . . . 28.2 p90 -141.99 151.4 42.47 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 112.976 0.732 . . . . 0.0 112.976 176.222 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 2488 ' ' THR . . . . . . . . . . . . . 91.6 m -109.75 107.54 59.17 Favored Pre-proline 0 N--CA 1.471 0.601 0 C-N-CA 124.508 1.123 . . . . 0.0 109.324 177.141 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 2489 ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -76.4 149.95 31.75 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 123.394 2.729 . . . . 0.0 110.131 169.655 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 2490 ' ' MET . . . . . . . . . . . . . 23.3 ptt? -128.74 11.02 6.11 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 114.397 1.258 . . . . 0.0 114.397 -177.58 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 2491 ' ' ALA . . . . . . . . . . . . . . . -141.59 147.64 46.74 Favored Pre-proline 0 CA--C 1.547 0.861 0 C-N-CA 125.269 1.428 . . . . 0.0 111.685 175.11 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 2492 ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -74.36 157.54 45.37 Favored 'Trans proline' 0 CA--C 1.537 0.628 0 C-N-CA 123.154 2.57 . . . . 0.0 111.062 172.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 2493 ' ' GLY . . . . . . . . . . . . . . . 130.34 -144.25 15.56 Favored Glycine 0 CA--C 1.528 0.858 0 C-N-CA 125.357 1.456 . . . . 0.0 111.796 -174.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 2494 ' ' SER . . . . . . . . . . . . . 10.5 t -134.91 133.81 40.01 Favored 'General case' 0 N--CA 1.468 0.464 0 O-C-N 121.824 -0.809 . . . . 0.0 111.63 177.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 2495 ' ' TYR . . . . . . . . . . . . . 87.8 m-85 -103.15 131.11 50.42 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.526 1.53 . . . . 0.0 110.352 176.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 2496 ' ' LEU . . . . . . . . . . . . . 21.9 tp -96.17 114.47 26.17 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.268 1.027 . . . . 0.0 109.457 178.381 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 2497 ' ' ILE . . . . . . . . . . . . . 36.4 mt -100.49 100.48 10.47 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 C-N-CA 125.459 1.504 . . . . 0.0 108.21 -178.543 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 2498 ' ' SER . . . . . . . . . . . . . 70.0 m -86.42 95.87 9.83 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 124.388 1.075 . . . . 0.0 109.241 174.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 2499 ' ' ILE . . . . . . . . . . . . . 49.9 mt -87.61 96.51 5.8 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 C-N-CA 124.51 1.124 . . . . 0.0 108.724 -178.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 2500 ' ' LYS . . . . . . . . . . . . . 85.6 mttt -104.18 135.74 45.09 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.713 1.205 . . . . 0.0 111.997 -179.207 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 2501 ' ' TYR . . . . . . . . . . . . . 56.5 t80 -151.07 148.76 28.71 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.269 1.428 . . . . 0.0 111.902 -169.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 2502 ' ' GLY . . . . . . . . . . . . . . . 67.21 26.53 73.42 Favored Glycine 0 CA--C 1.535 1.297 0 C-N-CA 123.897 0.76 . . . . 0.0 112.751 -178.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 2503 ' ' GLY . . . . . . . . . . . . . . . 118.16 -164.95 12.75 Favored Glycine 0 CA--C 1.542 1.725 0 C-N-CA 126.011 1.767 . . . . 0.0 112.112 -163.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 2504 ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -81.38 24.35 0.7 Allowed 'Trans proline' 0 CA--C 1.546 1.104 0 C-N-CA 124.933 3.756 . . . . 0.0 113.448 -174.626 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 2505 ' ' TYR . . . . . . . . . . . . . 67.9 m-85 -106.38 131.64 53.35 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.761 1.224 . . . . 0.0 112.764 -171.321 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 2506 ' ' HIS . . . . . . . . . . . . . 88.6 m-70 -59.63 139.27 57.34 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 125.017 1.327 . . . . 0.0 113.092 177.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 2507 ' ' ILE . . . . . . . . . . . . . 21.4 pt -72.6 171.88 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 170.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 2508 ' ' GLY . . . . . . . . . . . . . . . -58.61 119.56 18.12 Favored Glycine 0 CA--C 1.533 1.218 0 O-C-N 121.668 -0.645 . . . . 0.0 111.523 173.215 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 2509 ' ' GLY . . . . . . . . . . . . . . . 91.49 -9.05 78.15 Favored Glycine 0 CA--C 1.537 1.419 0 C-N-CA 125.62 1.581 . . . . 0.0 115.007 -177.012 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 2510 ' ' SER . . . . . . . . . . . . . 38.2 t -83.95 146.61 49.3 Favored Pre-proline 0 CA--C 1.55 0.968 0 CA-C-N 119.187 1.493 . . . . 0.0 112.044 179.311 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 2511 ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -77.41 147.67 85.47 Favored 'Cis proline' 0 C--N 1.354 0.84 0 CA-C-N 119.761 0.951 . . . . 0.0 112.901 -0.168 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 2512 ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -97.93 131.22 44.58 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 125.031 1.333 . . . . 0.0 110.346 178.367 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 2513 ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.03 112.4 24.69 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.078 0.951 . . . . 0.0 111.719 178.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 2514 ' ' ALA . . . . . . . . . . . . . . . -104.48 105.43 15.54 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 126.232 1.813 . . . . 0.0 110.765 -172.32 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 2515 ' ' LYS . . . . . . . . . . . . . 62.9 mtpt -84.49 125.98 32.87 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.737 1.215 . . . . 0.0 111.13 -175.724 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 2516 ' ' VAL . . . . . . . . . . . . . 70.4 t -123.46 137.53 56.4 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 C-N-CA 125.226 1.41 . . . . 0.0 110.003 -172.268 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 2517 ' ' THR . . . . . . . . . . . . . 66.9 p -127.16 173.31 9.82 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 125.419 1.488 . . . . 0.0 111.18 179.006 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 2518 ' ' GLY . . . . . . . . . . . . . . . 102.01 176.88 27.96 Favored Glycine 0 CA--C 1.539 1.566 0 C-N-CA 124.762 1.172 . . . . 0.0 113.359 -175.731 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 2519 ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -72.47 135.99 25.33 Favored 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 123.691 2.928 . . . . 0.0 112.089 -170.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 2520 ' ' ARG . . . . . . . . . . . . . 48.3 ttm-85 -67.09 131.5 45.96 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 123.971 0.908 . . . . 0.0 110.487 174.37 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 2521 ' ' LEU . . . . . . . . . . . . . 4.2 mm? -74.94 -29.4 60.93 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.676 0.79 . . . . 0.0 112.162 178.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 2522 ' ' VAL . . . . . . . . . . . . . 36.5 t . . . . . 0 C--O 1.253 1.26 0 C-N-CA 126.216 1.806 . . . . 0.0 111.329 176.733 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.551 0 N-CA-C 111.592 -0.603 . . . . 0.0 111.592 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -70.79 156.16 39.88 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 124.325 1.05 . . . . 0.0 112.631 178.019 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 37.7 mmt -83.95 139.51 32.53 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.283 1.033 . . . . 0.0 111.595 176.566 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 2427 ' ' GLY . . . . . . . . . . . . . . . -85.14 -176.59 50.74 Favored Glycine 0 CA--C 1.531 1.063 0 C-N-CA 125.439 1.495 . . . . 0.0 114.194 179.691 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 2428 ' ' ASP . . . . . . . . . . . . . 12.6 t70 -160.42 138.56 7.34 Favored Pre-proline 0 CA--C 1.548 0.9 0 C-N-CA 125.702 1.601 . . . . 0.0 110.363 -172.402 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 2429 ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -64.94 -19.5 63.98 Favored 'Trans proline' 0 CA--C 1.54 0.784 0 C-N-CA 123.191 2.594 . . . . 0.0 114.307 -175.172 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 2430 ' ' GLY . . . . . . . . . . . . . . . -80.93 -24.87 57.18 Favored Glycine 0 CA--C 1.534 1.251 0 CA-C-N 119.256 0.934 . . . . 0.0 113.374 173.025 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 2431 ' ' LEU . . . . . . . . . . . . . 4.5 mm? -89.36 -30.4 18.42 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.615 1.166 . . . . 0.0 112.153 174.317 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 2432 ' ' VAL . . . . . . . . . . . . . 66.3 t -67.74 135.23 28.9 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 C-N-CA 123.94 0.896 . . . . 0.0 110.411 172.037 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 2433 ' ' SER . . . . . . . . . . . . . 71.3 m -123.36 -175.33 3.17 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 125.841 1.656 . . . . 0.0 110.896 176.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 2434 ' ' ALA . . . . . . . . . . . . . . . -151.14 142.95 23.81 Favored 'General case' 0 CA--C 1.537 0.478 0 O-C-N 120.605 -1.309 . . . . 0.0 111.749 173.224 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 2435 ' ' TYR . . . . . . . . . . . . . 66.4 m-85 -147.99 148.62 30.94 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 125.373 1.469 . . . . 0.0 111.981 -174.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 2436 ' ' GLY . . . . . . . . . . . . . . . 124.48 164.35 11.91 Favored Glycine 0 N--CA 1.474 1.204 0 C-N-CA 125.446 1.498 . . . . 0.0 114.422 174.718 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 2437 ' ' ALA . . . . . . . . . . . . . . . -60.48 -29.2 68.92 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.313 1.445 . . . . 0.0 114.443 -171.177 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 2438 ' ' GLY . . . . . . . . . . . . . . . -63.95 -20.14 64.21 Favored Glycine 0 CA--C 1.532 1.124 0 CA-C-O 118.937 -0.924 . . . . 0.0 113.959 178.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 2439 ' ' LEU . . . . . . . . . . . . . 79.5 mt -75.04 -24.02 58.23 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 118.916 1.358 . . . . 0.0 112.606 170.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 2440 ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -91.08 -30.29 16.83 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 125.131 1.372 . . . . 0.0 112.0 177.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 2441 ' ' GLY . . . . . . . . . . . . . . . 109.93 -152.58 17.22 Favored Glycine 0 CA--C 1.534 1.224 0 C-N-CA 126.122 1.82 . . . . 0.0 113.508 178.742 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 2442 ' ' GLY . . . . . . . . . . . . . . . 169.04 -159.37 32.4 Favored Glycine 0 CA--C 1.531 1.072 0 C-N-CA 124.316 0.96 . . . . 0.0 114.001 -174.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 2443 ' ' VAL . . . . . . . . . . . . . 20.7 t -95.77 141.57 15.09 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 C-N-CA 124.461 1.104 . . . . 0.0 110.231 179.185 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 2444 ' ' THR . . . . . . . . . . . . . 31.5 p -58.6 152.19 19.0 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 124.693 1.197 . . . . 0.0 112.88 174.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 2445 ' ' GLY . . . . . . . . . . . . . . . 71.73 2.73 52.29 Favored Glycine 0 CA--C 1.536 1.375 0 C-N-CA 124.032 0.825 . . . . 0.0 114.326 179.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 2446 ' ' ASN . . . . . . . . . . . . . 26.0 m-80 -130.72 146.71 63.12 Favored Pre-proline 0 CA--C 1.549 0.928 0 C-N-CA 126.606 1.962 . . . . 0.0 110.284 -178.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 2447 ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -76.55 149.08 30.17 Favored 'Trans proline' 0 C--N 1.349 0.583 0 C-N-CA 123.022 2.481 . . . . 0.0 112.689 -176.179 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 2448 ' ' ALA . . . . . . . . . . . . . . . -133.86 143.08 48.09 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 126.269 1.828 . . . . 0.0 109.525 166.234 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 2449 ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -134.33 149.88 50.9 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 113.78 1.03 . . . . 0.0 113.78 -165.786 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 2450 ' ' PHE . . . . . . . . . . . . . 33.4 p90 -156.11 167.15 31.32 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.814 1.646 . . . . 0.0 111.173 179.672 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 2451 ' ' VAL . . . . . . . . . . . . . 57.4 t -123.14 131.7 72.74 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 C-N-CA 124.74 1.216 . . . . 0.0 109.656 176.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 2452 ' ' VAL . . . . . . . . . . . . . 41.3 t -80.69 104.26 8.87 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 N-CA-C 107.086 -1.45 . . . . 0.0 107.086 163.608 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 2453 ' ' ASN . . . . . . . . . . . . . 13.9 t-20 -78.28 111.2 14.01 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 123.977 0.911 . . . . 0.0 111.86 -172.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 2454 ' ' THR . . . . . . . . . . . . . 37.3 p -106.09 -8.04 17.68 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 125.885 1.674 . . . . 0.0 113.811 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 2455 ' ' SER . . . . . . . . . . . . . 88.6 p -65.95 -24.35 66.79 Favored 'General case' 0 N--CA 1.478 0.938 0 CA-C-N 120.173 1.351 . . . . 0.0 113.8 -176.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 2456 ' ' ASN . . . . . . . . . . . . . 56.4 m-80 -77.72 -11.6 59.89 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 124.493 1.117 . . . . 0.0 113.57 171.243 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 2457 ' ' ALA . . . . . . . . . . . . . . . -113.5 -57.14 2.32 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 125.11 1.364 . . . . 0.0 113.169 -172.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 2458 ' ' GLY . . . . . . . . . . . . . . . 123.34 -159.87 17.93 Favored Glycine 0 CA--C 1.533 1.178 0 C-N-CA 125.522 1.534 . . . . 0.0 112.661 -169.279 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 2459 ' ' ALA . . . . . . . . . . . . . . . -84.13 150.34 25.59 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 124.809 1.244 . . . . 0.0 112.972 -177.625 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 2460 ' ' GLY . . . . . . . . . . . . . . . 164.91 166.92 24.67 Favored Glycine 0 CA--C 1.531 1.089 0 C-N-CA 124.462 1.03 . . . . 0.0 113.862 -178.138 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 2461 ' ' ALA . . . . . . . . . . . . . . . -82.77 135.7 34.9 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.249 1.02 . . . . 0.0 112.709 -175.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 2462 ' ' LEU . . . . . . . . . . . . . 40.9 tp -102.11 143.91 31.34 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.901 1.681 . . . . 0.0 110.585 174.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 2463 ' ' SER . . . . . . . . . . . . . 3.9 t -138.58 41.74 2.18 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 125.206 1.403 . . . . 0.0 111.152 -177.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 2464 ' ' VAL . . . . . . . . . . . . . 9.6 p -65.57 135.21 28.73 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 C-N-CA 124.987 1.315 . . . . 0.0 112.167 -176.723 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 2465 ' ' THR . . . . . . . . . . . . . 95.4 m -135.08 145.74 48.23 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 126.067 1.747 . . . . 0.0 110.102 -178.286 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 2466 ' ' ILE . . . . . . . . . . . . . 50.2 mt -122.58 133.39 68.91 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 C-N-CA 124.5 1.12 . . . . 0.0 110.027 176.053 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 2467 ' ' ASP . . . . . . . . . . . . . 34.7 t70 -139.97 151.69 45.72 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 126.675 1.99 . . . . 0.0 110.409 178.333 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 2468 ' ' GLY . . . . . . . . . . . . . . . 174.52 -144.48 7.48 Favored Glycine 0 CA--C 1.537 1.422 0 CA-C-O 118.495 -1.17 . . . . 0.0 114.567 -177.182 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 2469 ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo -67.99 -15.56 43.66 Favored 'Trans proline' 0 C--N 1.354 0.864 0 C-N-CA 123.83 3.02 . . . . 0.0 113.343 -179.577 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 2470 ' ' SER . . . . . . . . . . . . . 7.6 t -159.07 -161.1 0.91 Allowed 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 126.078 1.751 . . . . 0.0 109.491 170.115 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 2471 ' ' LYS . . . . . . . . . . . . . 98.5 mttt -79.68 -179.61 6.99 Favored 'General case' 0 CA--C 1.55 0.975 0 O-C-N 121.014 -1.054 . . . . 0.0 111.46 164.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 2472 ' ' VAL . . . . . . . . . . . . . 14.3 m -136.37 149.94 27.41 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 125.243 1.417 . . . . 0.0 109.979 170.269 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 2473 ' ' LYS . . . . . . . . . . . . . 25.9 tptp -78.34 107.26 10.83 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 167.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 2474 ' ' MET . . . . . . . . . . . . . 22.9 ttt -114.78 140.61 48.77 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 125.191 1.396 . . . . 0.0 112.285 -168.357 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 2475 ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -143.22 157.28 44.63 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 126.618 1.967 . . . . 0.0 110.323 173.359 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 2476 ' ' CYS . . . . . . . . . . . . . 30.9 p -162.15 164.29 28.0 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.043 0.937 . . . . 0.0 113.485 -176.006 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 2477 ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -164.77 173.18 12.08 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.841 1.657 . . . . 0.0 111.59 177.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 2478 ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -80.2 138.83 36.91 Favored 'General case' 0 CA--C 1.544 0.716 0 O-C-N 121.57 -0.706 . . . . 0.0 110.383 164.339 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 2479 ' ' CYS . . . . . . . . . . . . . 59.3 m -132.96 167.14 24.41 Favored Pre-proline 0 CA--C 1.554 1.106 0 C-N-CA 126.824 2.05 . . . . 0.0 110.367 169.52 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 2480 ' ' PRO . . . . . . . . . . . . . 70.2 Cg_exo -57.99 -31.9 93.98 Favored 'Trans proline' 0 C--N 1.353 0.796 0 C-N-CA 123.586 2.858 . . . . 0.0 114.586 177.643 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 2481 ' ' GLU . . . . . . . . . . . . . 20.8 tp10 -77.45 -13.0 60.02 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 125.079 1.352 . . . . 0.0 112.849 177.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 2482 ' ' GLY . . . . . . . . . . . . . . . 129.1 -169.0 20.59 Favored Glycine 0 CA--C 1.53 1.018 0 C-N-CA 126.587 2.041 . . . . 0.0 112.29 -172.618 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 2483 ' ' TYR . . . . . . . . . . . . . 66.8 m-85 -69.78 111.64 5.68 Favored 'General case' 0 CA--C 1.539 0.537 0 O-C-N 121.277 -1.131 . . . . 0.0 111.783 177.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 2484 ' ' ARG . . . . . . . . . . . . . 68.5 ttt180 -85.09 138.26 32.53 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 125.366 1.466 . . . . 0.0 110.692 179.319 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 2485 ' ' VAL . . . . . . . . . . . . . 96.4 t -128.59 136.96 58.63 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 C-N-CA 126.333 1.853 . . . . 0.0 108.93 179.261 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 2486 ' ' THR . . . . . . . . . . . . . 85.7 m -133.24 136.58 45.66 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 125.06 1.344 . . . . 0.0 108.303 173.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 2487 ' ' TYR . . . . . . . . . . . . . 31.0 p90 -145.72 148.97 33.58 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 113.489 0.922 . . . . 0.0 113.489 177.628 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 2488 ' ' THR . . . . . . . . . . . . . 23.9 m -109.24 114.31 57.89 Favored Pre-proline 0 N--CA 1.471 0.612 0 C-N-CA 125.308 1.443 . . . . 0.0 108.7 171.304 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 2489 ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -80.07 159.73 23.77 Favored 'Trans proline' 0 N--CA 1.457 -0.628 0 C-N-CA 123.153 2.569 . . . . 0.0 111.203 173.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 2490 ' ' MET . . . . . . . . . . . . . 26.1 ptm -128.79 2.14 5.42 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 114.935 1.458 . . . . 0.0 114.935 -171.406 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 2491 ' ' ALA . . . . . . . . . . . . . . . -145.79 143.46 19.75 Favored Pre-proline 0 CA--C 1.548 0.881 0 C-N-CA 124.74 1.216 . . . . 0.0 111.308 174.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 2492 ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -72.75 155.1 54.19 Favored 'Trans proline' 0 CA--C 1.537 0.641 0 C-N-CA 123.229 2.619 . . . . 0.0 111.106 174.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 2493 ' ' GLY . . . . . . . . . . . . . . . 131.26 -151.52 19.72 Favored Glycine 0 CA--C 1.528 0.875 0 C-N-CA 125.356 1.455 . . . . 0.0 111.992 -173.257 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 2494 ' ' SER . . . . . 0.49 ' HG ' ' HE2' ' A' 2513 ' ' LYS . 71.8 m -122.12 127.68 50.41 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 123.647 0.779 . . . . 0.0 112.074 177.874 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 2495 ' ' TYR . . . . . . . . . . . . . 86.2 m-85 -98.91 134.54 41.62 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.23 1.412 . . . . 0.0 110.676 171.688 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 2496 ' ' LEU . . . . . . . . . . . . . 10.3 mp -92.63 121.57 34.18 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.461 1.104 . . . . 0.0 108.819 168.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 2497 ' ' ILE . . . . . . . . . . . . . 40.5 mt -97.26 101.01 11.72 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.375 0 N-CA-C 107.286 -1.376 . . . . 0.0 107.286 173.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 2498 ' ' SER . . . . . . . . . . . . . 74.7 m -86.98 94.01 9.5 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 125.368 1.467 . . . . 0.0 109.512 179.159 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 2499 ' ' ILE . . . . . 0.495 ' H ' ' HG ' ' A' 2510 ' ' SER . 26.6 mt -90.46 101.32 12.22 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 C-N-CA 124.909 1.284 . . . . 0.0 108.768 -179.769 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 2500 ' ' LYS . . . . . . . . . . . . . 83.8 mttt -109.52 143.44 39.17 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 124.535 1.134 . . . . 0.0 111.622 178.538 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 2501 ' ' TYR . . . . . . . . . . . . . 53.8 t80 -151.17 141.4 22.28 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.918 0.887 . . . . 0.0 112.698 -171.022 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 2502 ' ' GLY . . . . . . . . . . . . . . . 68.28 15.15 67.47 Favored Glycine 0 CA--C 1.536 1.354 0 C-N-CA 124.262 0.934 . . . . 0.0 114.072 178.381 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 2503 ' ' GLY . . . . . . . . . . . . . . . 142.73 -167.78 26.14 Favored Glycine 0 CA--C 1.54 1.645 0 C-N-CA 125.934 1.73 . . . . 0.0 112.591 -168.419 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 2504 ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -82.37 18.71 1.38 Allowed 'Trans proline' 0 CA--C 1.545 1.026 0 C-N-CA 124.772 3.648 . . . . 0.0 113.833 -174.112 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 2505 ' ' TYR . . . . . . . . . . . . . 73.7 m-85 -110.32 139.36 45.59 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.661 1.185 . . . . 0.0 113.341 -172.494 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 2506 ' ' HIS . . . . . . . . . . . . . 91.1 m-70 -64.23 143.29 58.0 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 125.57 1.548 . . . . 0.0 113.516 179.399 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 2507 ' ' ILE . . . . . . . . . . . . . 1.8 pp -86.37 150.37 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.075 0 C-N-CA 123.882 0.873 . . . . 0.0 111.854 171.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 2508 ' ' GLY . . . . . . . . . . . . . . . 46.23 -114.12 1.3 Allowed Glycine 0 CA--C 1.536 1.38 0 C-N-CA 124.275 0.94 . . . . 0.0 114.531 165.642 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 2509 ' ' GLY . . . . . . . . . . . . . . . -99.67 12.74 61.2 Favored Glycine 0 CA--C 1.537 1.409 0 C-N-CA 126.193 1.854 . . . . 0.0 115.19 178.117 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 2510 ' ' SER . . . . . 0.495 ' HG ' ' H ' ' A' 2499 ' ' ILE . 42.6 t -65.84 146.27 99.0 Favored Pre-proline 0 CA--C 1.552 1.04 0 CA-C-N 119.17 1.485 . . . . 0.0 112.655 179.586 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 2511 ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -75.0 142.15 73.91 Favored 'Cis proline' 0 C--N 1.354 0.852 0 CA-C-N 119.821 0.972 . . . . 0.0 112.868 0.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 2512 ' ' PHE . . . . . . . . . . . . . 91.6 m-85 -93.33 127.98 39.16 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.547 1.139 . . . . 0.0 110.858 178.662 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 2513 ' ' LYS . . . . . 0.49 ' HE2' ' HG ' ' A' 2494 ' ' SER . 86.0 tttt -90.24 92.7 9.04 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 124.407 1.083 . . . . 0.0 111.893 -176.768 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 2514 ' ' ALA . . . . . . . . . . . . . . . -79.53 123.84 27.95 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.976 1.31 . . . . 0.0 110.682 174.747 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 2515 ' ' LYS . . . . . . . . . . . . . 26.6 mtmm -101.15 120.87 40.86 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.201 1.401 . . . . 0.0 110.278 -173.558 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 2516 ' ' VAL . . . . . . . . . . . . . 73.0 t -120.42 138.45 50.91 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 124.843 1.257 . . . . 0.0 111.133 -167.692 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 2517 ' ' THR . . . . . . . . . . . . . 68.1 p -128.9 178.53 6.31 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 125.986 1.714 . . . . 0.0 111.088 179.505 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 2518 ' ' GLY . . . . . . . . . . . . . . . 97.67 -176.31 30.96 Favored Glycine 0 CA--C 1.54 1.629 0 C-N-CA 124.545 1.069 . . . . 0.0 113.39 -176.68 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 2519 ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -71.6 148.25 53.04 Favored 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 123.72 2.947 . . . . 0.0 112.167 -174.408 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 2520 ' ' ARG . . . . . . . . . . . . . 35.8 ttp180 -82.13 128.31 34.01 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 123.648 0.779 . . . . 0.0 110.217 173.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 2521 ' ' LEU . . . . . . . . . . . . . 3.8 mm? -84.76 -23.13 29.35 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.208 1.003 . . . . 0.0 112.25 177.508 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 2522 ' ' VAL . . . . . . . . . . . . . 35.2 t . . . . . 0 C--O 1.253 1.282 0 C-N-CA 126.398 1.879 . . . . 0.0 111.808 179.045 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.578 0 N-CA-C 111.359 -0.697 . . . . 0.0 111.359 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -68.88 160.52 30.53 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 124.269 1.028 . . . . 0.0 112.671 176.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 90.0 mtp -138.32 165.83 25.75 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 125.368 1.467 . . . . 0.0 111.997 -179.012 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 2427 ' ' GLY . . . . . . . . . . . . . . . -148.11 145.85 14.82 Favored Glycine 0 CA--C 1.529 0.957 0 C-N-CA 125.666 1.603 . . . . 0.0 111.579 171.618 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 2428 ' ' ASP . . . . . . . . . . . . . 22.2 m-20 -97.33 128.59 34.37 Favored Pre-proline 0 CA--C 1.547 0.853 0 C-N-CA 123.909 0.884 . . . . 0.0 112.726 -175.516 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 2429 ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -66.67 -22.42 50.43 Favored 'Trans proline' 0 C--N 1.352 0.748 0 C-N-CA 122.993 2.462 . . . . 0.0 112.915 177.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 2430 ' ' GLY . . . . . . . . . . . . . . . -75.05 -23.16 75.24 Favored Glycine 0 CA--C 1.535 1.304 0 CA-C-N 119.062 0.847 . . . . 0.0 113.551 173.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 2431 ' ' LEU . . . . . . . . . . . . . 4.2 mm? -86.34 -29.82 22.69 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 124.483 1.113 . . . . 0.0 111.698 171.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 2432 ' ' VAL . . . . . . . . . . . . . 79.1 t -67.94 135.25 28.84 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 C-N-CA 123.51 0.724 . . . . 0.0 110.521 169.723 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 2433 ' ' SER . . . . . . . . . . . . . 57.9 m -140.44 144.66 36.23 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 125.463 1.505 . . . . 0.0 109.439 171.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 2434 ' ' ALA . . . . . . . . . . . . . . . -96.41 148.58 22.64 Favored 'General case' 0 CA--C 1.539 0.553 0 O-C-N 121.572 -0.705 . . . . 0.0 111.794 176.133 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 2435 ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -142.4 142.78 32.45 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.808 1.643 . . . . 0.0 111.468 -178.226 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 2436 ' ' GLY . . . . . . . . . . . . . . . 129.17 159.45 9.91 Favored Glycine 0 N--CA 1.473 1.11 0 C-N-CA 125.438 1.494 . . . . 0.0 113.534 -179.708 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 2437 ' ' ALA . . . . . . . . . . . . . . . -63.56 -26.94 68.92 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 114.259 1.207 . . . . 0.0 114.259 -171.22 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 2438 ' ' GLY . . . . . . . . . . . . . . . -68.19 -11.08 60.81 Favored Glycine 0 CA--C 1.53 0.969 0 C-N-CA 124.001 0.81 . . . . 0.0 114.702 -177.475 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 2439 ' ' LEU . . . . . . . . . . . . . 73.2 mt -78.46 -26.04 46.03 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.724 1.21 . . . . 0.0 112.405 171.607 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 2440 ' ' GLU . . . . . . . . . . . . . 37.5 mm-40 -89.07 -36.61 15.66 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 124.794 1.237 . . . . 0.0 111.853 -178.3 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 2441 ' ' GLY . . . . . . . . . . . . . . . 155.77 -148.39 18.46 Favored Glycine 0 CA--C 1.529 0.926 0 C-N-CA 124.389 0.995 . . . . 0.0 113.813 -176.135 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 2442 ' ' GLY . . . . . . . . . . . . . . . 157.49 -158.39 28.94 Favored Glycine 0 CA--C 1.53 1.012 0 C-N-CA 125.303 1.43 . . . . 0.0 112.924 -176.023 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 2443 ' ' VAL . . . . . . . . . . . . . 81.2 t -129.53 139.61 51.24 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.975 0 C-N-CA 125.321 1.449 . . . . 0.0 109.213 179.086 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 2444 ' ' THR . . . . . . . . . . . . . 33.5 p -60.45 138.06 58.06 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 124.016 0.926 . . . . 0.0 111.978 178.354 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 2445 ' ' GLY . . . . . . . . . . . . . . . 81.3 -10.65 48.23 Favored Glycine 0 CA--C 1.537 1.459 0 C-N-CA 124.75 1.167 . . . . 0.0 114.862 -175.371 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 2446 ' ' ASN . . . . . . . . . . . . . 88.4 m-20 -106.69 149.75 38.8 Favored Pre-proline 0 CA--C 1.548 0.888 0 C-N-CA 125.167 1.387 . . . . 0.0 111.192 174.611 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 2447 ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -73.07 135.83 23.69 Favored 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 122.849 2.366 . . . . 0.0 111.79 -179.485 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 2448 ' ' ALA . . . . . . . . . . . . . . . -109.83 142.17 41.47 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 127.236 2.214 . . . . 0.0 108.772 167.028 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 2449 ' ' GLU . . . . . . . . . . . . . 5.0 tm-20 -147.91 141.24 25.23 Favored 'General case' 0 N--CA 1.471 0.614 0 O-C-N 121.411 -0.806 . . . . 0.0 112.994 -162.598 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 2450 ' ' PHE . . . . . . . . . . . . . 52.9 p90 -156.29 157.44 35.76 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 125.83 1.652 . . . . 0.0 112.458 177.604 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 2451 ' ' VAL . . . . . . . . . . . . . 59.0 t -113.55 133.29 59.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 125.641 1.577 . . . . 0.0 109.443 171.78 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 2452 ' ' VAL . . . . . . . . . . . . . 39.3 t -87.14 105.1 14.78 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 C-N-CA 125.102 1.361 . . . . 0.0 107.819 168.225 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 2453 ' ' ASN . . . . . . . . . . . . . 32.7 t-20 -77.9 117.14 18.96 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 123.612 0.765 . . . . 0.0 110.926 -174.073 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 2454 ' ' THR . . . . . . . . . . . . . 39.5 p -105.1 -9.61 17.69 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 125.088 1.355 . . . . 0.0 113.634 -178.559 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 2455 ' ' SER . . . . . . . . . . . . . 41.2 m -57.94 -29.79 65.44 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.927 1.291 . . . . 0.0 114.234 -175.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 2456 ' ' ASN . . . . . . . . . . . . . 79.4 m-20 -83.79 -16.21 45.52 Favored 'General case' 0 CA--C 1.546 0.809 0 N-CA-C 113.767 1.025 . . . . 0.0 113.767 177.289 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 2457 ' ' ALA . . . . . . . . . . . . . . . -102.45 -41.94 6.14 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 114.458 1.281 . . . . 0.0 114.458 -166.574 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 2458 ' ' GLY . . . . . . . . . . . . . . . 121.64 -133.63 9.56 Favored Glycine 0 N--CA 1.471 1.03 0 C-N-CA 124.653 1.12 . . . . 0.0 112.06 -171.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 2459 ' ' ALA . . . . . . . . . . . . . . . -129.97 120.9 25.55 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.51 1.124 . . . . 0.0 111.944 -175.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 2460 ' ' GLY . . . . . . . . . . . . . . . -165.6 162.71 36.09 Favored Glycine 0 CA--C 1.529 0.963 0 C-N-CA 125.029 1.3 . . . . 0.0 113.029 -177.612 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 2461 ' ' ALA . . . . . . . . . . . . . . . -79.26 145.18 33.69 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.064 0.946 . . . . 0.0 112.484 -179.163 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 2462 ' ' LEU . . . . . . . . . . . . . 13.7 tp -95.26 147.2 23.74 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.178 1.391 . . . . 0.0 110.555 172.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 2463 ' ' SER . . . . . . . . . . . . . 9.1 t -137.12 34.58 2.57 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 125.301 1.44 . . . . 0.0 111.506 -178.302 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 2464 ' ' VAL . . . . . . . . . . . . . 10.5 p -59.65 135.17 24.52 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 C-N-CA 125.327 1.451 . . . . 0.0 112.58 -175.621 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 2465 ' ' THR . . . . . . . . . . . . . 96.4 m -134.91 142.9 46.67 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 125.759 1.623 . . . . 0.0 109.389 176.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 2466 ' ' ILE . . . . . . . . . . . . . 36.1 mt -120.27 122.2 67.68 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 C-N-CA 123.773 0.829 . . . . 0.0 109.953 174.05 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 2467 ' ' ASP . . . . . . . . . . . . . 33.0 t70 -104.68 166.8 10.14 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 126.392 1.877 . . . . 0.0 110.12 168.011 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 2468 ' ' GLY . . . . . . . . . . . . . . . 167.48 -160.57 34.24 Favored Glycine 0 CA--C 1.535 1.31 0 O-C-N 120.83 -1.169 . . . . 0.0 114.936 178.752 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 2469 ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -70.04 -16.44 36.39 Favored 'Trans proline' 0 CA--C 1.54 0.819 0 C-N-CA 123.915 3.077 . . . . 0.0 113.246 178.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 2470 ' ' SER . . . . . . . . . . . . . 38.0 m -157.95 -171.8 3.67 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 127.335 2.254 . . . . 0.0 109.819 177.506 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 2471 ' ' LYS . . . . . . . . . . . . . 99.0 mttt -70.74 175.95 4.58 Favored 'General case' 0 CA--C 1.551 0.985 0 O-C-N 120.956 -1.09 . . . . 0.0 112.343 167.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 2472 ' ' VAL . . . . . . . . . . . . . 33.9 m -132.11 148.87 32.09 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.925 0 C-N-CA 125.311 1.444 . . . . 0.0 110.466 169.624 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 2473 ' ' LYS . . . . . . . . . . . . . 62.0 mtpt -87.43 89.17 7.9 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 123.592 0.757 . . . . 0.0 109.52 169.6 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 2474 ' ' MET . . . . . . . . . . . . . 60.0 ttm -83.51 143.0 30.49 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 124.334 1.054 . . . . 0.0 112.071 -177.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 2475 ' ' ASP . . . . . . . . . . . . . 31.7 t70 -139.09 103.87 4.88 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 126.581 1.953 . . . . 0.0 109.221 167.026 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 2476 ' ' CYS . . . . . . . . . . . . . 28.7 p -102.3 155.19 18.39 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 124.954 1.302 . . . . 0.0 112.28 178.143 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 2477 ' ' GLN . . . . . . . . . . . . . 27.4 tt0 -161.59 146.56 13.36 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.26 1.024 . . . . 0.0 111.258 -172.156 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 2478 ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -77.89 122.67 25.79 Favored 'General case' 0 CA--C 1.541 0.615 0 O-C-N 121.478 -0.763 . . . . 0.0 110.609 173.682 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 2479 ' ' CYS . . . . . 0.536 ' HG ' ' HD2' ' A' 2484 ' ' ARG . 60.6 m -121.76 166.29 17.12 Favored Pre-proline 0 CA--C 1.553 1.082 0 C-N-CA 126.539 1.936 . . . . 0.0 111.041 179.869 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 2480 ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -65.32 -26.9 55.82 Favored 'Trans proline' 0 CA--C 1.54 0.797 0 C-N-CA 123.009 2.473 . . . . 0.0 114.567 -174.527 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 2481 ' ' GLU . . . . . . . . . . . . . 82.2 tt0 -82.24 -17.17 46.95 Favored 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 124.143 0.977 . . . . 0.0 112.997 174.46 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 2482 ' ' GLY . . . . . . . . . . . . . . . 140.11 -162.47 26.39 Favored Glycine 0 CA--C 1.528 0.875 0 C-N-CA 125.879 1.705 . . . . 0.0 112.608 -176.306 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 2483 ' ' TYR . . . . . . . . . . . . . 74.0 m-85 -70.36 119.07 13.99 Favored 'General case' 0 CA--C 1.539 0.541 0 O-C-N 121.479 -1.013 . . . . 0.0 111.75 -179.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 2484 ' ' ARG . . . . . 0.536 ' HD2' ' HG ' ' A' 2479 ' ' CYS . 21.5 ttt180 -95.34 141.83 28.45 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 125.038 1.335 . . . . 0.0 110.725 177.013 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 2485 ' ' VAL . . . . . . . . . . . . . 67.1 t -132.58 122.01 46.43 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 C-N-CA 124.98 1.312 . . . . 0.0 108.943 178.247 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 2486 ' ' THR . . . . . . . . . . . . . 89.9 m -110.07 144.35 38.78 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 124.856 1.262 . . . . 0.0 107.846 165.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 2487 ' ' TYR . . . . . . . . . . . . . 28.7 p90 -148.63 144.24 27.06 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 123.918 0.887 . . . . 0.0 112.185 174.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 2488 ' ' THR . . . . . . . . . . . . . 85.6 m -107.21 117.32 56.53 Favored Pre-proline 0 N--CA 1.476 0.86 0 CA-C-O 117.989 -1.005 . . . . 0.0 109.422 172.233 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 2489 ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -81.68 163.11 18.86 Favored 'Trans proline' 0 C--N 1.351 0.687 0 C-N-CA 124.319 3.346 . . . . 0.0 111.604 174.197 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 2490 ' ' MET . . . . . . . . . . . . . 28.4 ptm -133.85 -3.68 2.87 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 115.603 1.705 . . . . 0.0 115.603 -171.539 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 2491 ' ' ALA . . . . . . . . . . . . . . . -144.78 145.66 28.77 Favored Pre-proline 0 CA--C 1.548 0.871 0 C-N-CA 124.728 1.211 . . . . 0.0 110.937 172.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 2492 ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -71.29 151.98 60.8 Favored 'Trans proline' 0 CA--C 1.535 0.574 0 C-N-CA 123.504 2.803 . . . . 0.0 111.615 -178.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 2493 ' ' GLY . . . . . . . . . . . . . . . 129.88 -165.47 22.32 Favored Glycine 0 CA--C 1.53 1.003 0 C-N-CA 125.187 1.375 . . . . 0.0 113.578 -177.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 2494 ' ' SER . . . . . . . . . . . . . 16.7 p -89.96 115.02 26.94 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.835 1.254 . . . . 0.0 112.08 178.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 2495 ' ' TYR . . . . . . . . . . . . . 54.6 m-85 -87.74 122.78 31.82 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 123.536 0.735 . . . . 0.0 109.741 163.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 2496 ' ' LEU . . . . . . . . . . . . . 21.4 tp -94.34 104.61 16.59 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 124.597 1.159 . . . . 0.0 109.521 -178.467 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 2497 ' ' ILE . . . . . . . . . . . . . 30.2 mt -90.4 98.05 7.84 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 C-N-CA 125.826 1.65 . . . . 0.0 108.23 -177.627 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 2498 ' ' SER . . . . . . . . . . . . . 71.0 m -85.02 80.97 9.1 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 124.675 1.19 . . . . 0.0 109.624 175.783 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 2499 ' ' ILE . . . . . . . . . . . . . 17.9 mt -77.82 114.16 17.99 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 175.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 2500 ' ' LYS . . . . . . . . . . . . . 81.9 mttt -121.76 148.66 44.35 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.528 1.531 . . . . 0.0 111.037 -177.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 2501 ' ' TYR . . . . . . . . . . . . . 63.4 t80 -154.91 145.84 22.58 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.119 0.968 . . . . 0.0 112.499 -171.423 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 2502 ' ' GLY . . . . . . . . . . . . . . . 69.04 17.48 71.83 Favored Glycine 0 CA--C 1.536 1.394 0 C-N-CA 124.216 0.913 . . . . 0.0 113.704 178.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 2503 ' ' GLY . . . . . . . . . . . . . . . 135.6 -165.05 24.87 Favored Glycine 0 CA--C 1.54 1.643 0 C-N-CA 125.981 1.753 . . . . 0.0 112.528 -167.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 2504 ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -82.26 20.31 1.12 Allowed 'Trans proline' 0 CA--C 1.545 1.06 0 C-N-CA 124.855 3.703 . . . . 0.0 113.638 -174.545 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 2505 ' ' TYR . . . . . . . . . . . . . 80.5 m-85 -109.98 139.96 44.51 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.751 1.22 . . . . 0.0 113.355 -172.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 2506 ' ' HIS . . . . . . . . . . . . . 92.5 m-70 -62.57 144.31 56.27 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 125.571 1.548 . . . . 0.0 113.572 -179.61 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 2507 ' ' ILE . . . . . . . . . . . . . 28.0 pt -75.79 174.69 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 C-N-CA 123.633 0.773 . . . . 0.0 112.992 173.123 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 2508 ' ' GLY . . . . . . . . . . . . . . . -58.94 117.91 12.45 Favored Glycine 0 CA--C 1.532 1.152 0 N-CA-C 111.228 -0.749 . . . . 0.0 111.228 171.24 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 2509 ' ' GLY . . . . . . . . . . . . . . . 93.54 -9.77 73.59 Favored Glycine 0 CA--C 1.536 1.388 0 C-N-CA 125.677 1.608 . . . . 0.0 115.168 -178.142 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 2510 ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -78.23 156.09 79.17 Favored Pre-proline 0 N--CA 1.474 0.768 0 CA-C-N 119.647 1.723 . . . . 0.0 113.68 178.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 2511 ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -77.58 152.66 93.51 Favored 'Cis proline' 0 CA--C 1.539 0.768 0 CA-C-N 118.26 0.414 . . . . 0.0 111.435 -9.561 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 2512 ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -98.21 128.8 44.87 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.373 1.069 . . . . 0.0 110.633 179.693 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 2513 ' ' LYS . . . . . . . . . . . . . 24.9 pttm -88.22 7.58 31.29 Favored 'General case' 0 N--CA 1.479 0.995 0 N-CA-C 116.715 2.117 . . . . 0.0 116.715 -165.352 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 2514 ' ' ALA . . . . . . . . . . . . . . . -3.97 97.65 0.01 OUTLIER 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 129.467 3.107 . . . . 0.0 116.462 -175.616 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 2515 ' ' LYS . . . . . . . . . . . . . 62.8 mtpt -89.78 105.24 17.67 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.504 1.122 . . . . 0.0 110.683 -175.104 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 2516 ' ' VAL . . . . . . . . . . . . . 4.0 m -102.36 148.4 7.86 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 C-N-CA 124.315 1.046 . . . . 0.0 111.486 -174.161 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 2517 ' ' THR . . . . . . . . . . . . . 69.1 p -116.66 -169.37 1.62 Allowed 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 125.471 1.508 . . . . 0.0 110.922 179.349 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 2518 ' ' GLY . . . . . . . . . . . . . . . 96.29 -175.7 32.2 Favored Glycine 0 CA--C 1.539 1.575 0 C-N-CA 124.693 1.14 . . . . 0.0 113.331 -176.221 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 2519 ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -70.63 153.39 64.96 Favored 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 123.748 2.966 . . . . 0.0 112.537 -174.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 2520 ' ' ARG . . . . . . . . . . . . . 65.2 ttp85 -94.81 122.93 37.94 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.686 1.194 . . . . 0.0 110.053 171.199 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 2521 ' ' LEU . . . . . . . . . . . . . 4.1 mm? -95.28 -13.35 24.92 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 124.266 1.026 . . . . 0.0 113.7 -175.204 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 2522 ' ' VAL . . . . . . . . . . . . . 14.8 m . . . . . 0 N--CA 1.484 1.264 0 C-N-CA 125.858 1.663 . . . . 0.0 113.66 -174.194 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.545 0 N-CA-C 111.758 -0.537 . . . . 0.0 111.758 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -72.17 -34.47 68.49 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.021 0.929 . . . . 0.0 113.257 -179.588 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 51.1 tpp -73.53 131.47 41.79 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 124.903 1.281 . . . . 0.0 110.99 175.309 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 2427 ' ' GLY . . . . . . . . . . . . . . . -77.76 171.74 55.15 Favored Glycine 0 CA--C 1.532 1.111 0 C-N-CA 124.904 1.24 . . . . 0.0 113.787 179.034 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 2428 ' ' ASP . . . . . . . . . . . . . 25.6 m-20 -117.68 137.1 23.94 Favored Pre-proline 0 CA--C 1.546 0.82 0 C-N-CA 125.07 1.348 . . . . 0.0 111.901 -179.595 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 2429 ' ' PRO . . . . . . . . . . . . . 81.1 Cg_exo -54.91 -26.79 50.49 Favored 'Trans proline' 0 C--N 1.353 0.792 0 C-N-CA 124.056 3.171 . . . . 0.0 115.089 174.707 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 2430 ' ' GLY . . . . . . . . . . . . . . . -78.93 -23.1 64.66 Favored Glycine 0 CA--C 1.534 1.225 0 C-N-CA 123.812 0.72 . . . . 0.0 113.786 176.174 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 2431 ' ' LEU . . . . . . . . . . . . . 4.4 mm? -91.04 -32.16 16.01 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.731 1.212 . . . . 0.0 111.89 174.458 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 2432 ' ' VAL . . . . . . . . . . . . . 94.1 t -64.84 134.32 29.5 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 CA-C-N 118.698 0.681 . . . . 0.0 109.76 170.033 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 2433 ' ' SER . . . . . . . . . . . . . 7.9 t -127.28 -167.91 1.81 Allowed 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.93 1.292 . . . . 0.0 111.163 177.545 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 2434 ' ' ALA . . . . . . . . . . . . . . . -153.25 139.37 18.32 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.538 1.135 . . . . 0.0 111.656 177.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 2435 ' ' TYR . . . . . . . . . . . . . 76.8 m-85 -146.54 141.9 27.48 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 125.265 1.426 . . . . 0.0 111.951 -176.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 2436 ' ' GLY . . . . . . . . . . . . . . . 126.0 163.05 11.46 Favored Glycine 0 CA--C 1.534 1.225 0 C-N-CA 125.704 1.621 . . . . 0.0 113.743 179.461 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 2437 ' ' ALA . . . . . . . . . . . . . . . -63.58 -28.39 69.9 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 114.706 1.373 . . . . 0.0 114.706 -168.782 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 2438 ' ' GLY . . . . . . . . . . . . . . . -64.42 -16.6 60.84 Favored Glycine 0 CA--C 1.532 1.095 0 C-N-CA 124.302 0.953 . . . . 0.0 114.502 -177.645 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 2439 ' ' LEU . . . . . . . . . . . . . 95.2 mt -68.73 -29.55 67.99 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 118.575 1.188 . . . . 0.0 112.548 170.159 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 2440 ' ' GLU . . . . . . . . . . . . . 41.7 mm-40 -90.24 -26.92 19.83 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.912 1.285 . . . . 0.0 112.33 178.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 2441 ' ' GLY . . . . . . . . . . . . . . . 102.86 -144.42 16.05 Favored Glycine 0 CA--C 1.531 1.087 0 C-N-CA 125.666 1.603 . . . . 0.0 112.881 -178.143 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 2442 ' ' GLY . . . . . . . . . . . . . . . 163.06 -160.26 32.79 Favored Glycine 0 CA--C 1.532 1.124 0 C-N-CA 123.836 0.731 . . . . 0.0 114.872 -176.349 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 2443 ' ' VAL . . . . . . . . . . . . . 83.2 t -83.14 141.49 14.82 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 C-N-CA 124.786 1.235 . . . . 0.0 110.96 -177.533 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 2444 ' ' THR . . . . . . . . . . . . . 18.9 p -56.1 131.41 47.52 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 124.996 1.318 . . . . 0.0 112.228 174.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 2445 ' ' GLY . . . . . . . . . . . . . . . 82.88 -10.93 56.05 Favored Glycine 0 CA--C 1.535 1.291 0 C-N-CA 124.993 1.282 . . . . 0.0 114.66 178.667 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 2446 ' ' ASN . . . . . . . . . . . . . 61.1 m-20 -91.99 147.93 35.85 Favored Pre-proline 0 CA--C 1.547 0.833 0 CA-C-N 118.63 1.215 . . . . 0.0 110.727 172.225 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 2447 ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -71.8 143.48 41.55 Favored 'Trans proline' 0 N--CA 1.457 -0.619 0 C-N-CA 122.817 2.345 . . . . 0.0 111.041 177.453 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 2448 ' ' ALA . . . . . . . . . . . . . . . -124.39 143.92 50.34 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 126.698 1.999 . . . . 0.0 109.126 172.495 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 2449 ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -154.41 152.43 30.17 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 113.392 0.886 . . . . 0.0 113.392 -173.462 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 2450 ' ' PHE . . . . . . . . . . . . . 14.0 p90 -161.46 167.14 26.11 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.902 1.681 . . . . 0.0 110.436 177.599 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 2451 ' ' VAL . . . . . . . . . . . . . 59.2 t -112.33 128.69 68.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 124.698 1.199 . . . . 0.0 110.209 177.537 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 2452 ' ' VAL . . . . . . . . . . . . . 48.8 t -77.53 106.11 7.35 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 162.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 2453 ' ' ASN . . . . . . . . . . . . . 16.3 t-20 -83.47 106.31 15.11 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 124.21 1.004 . . . . 0.0 111.732 -170.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 2454 ' ' THR . . . . . . . . . . . . . 40.6 p -97.7 -8.23 29.17 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 125.83 1.652 . . . . 0.0 113.514 177.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 2455 ' ' SER . . . . . . . . . . . . . 12.8 t -58.54 -31.69 68.18 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-N 119.364 0.983 . . . . 0.0 113.45 -176.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 2456 ' ' ASN . . . . . . . . . . . . . 57.8 m-80 -76.8 -14.86 59.87 Favored 'General case' 0 CA--C 1.549 0.907 0 N-CA-C 113.942 1.09 . . . . 0.0 113.942 174.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 2457 ' ' ALA . . . . . . . . . . . . . . . -109.0 -39.0 5.43 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 125.344 1.458 . . . . 0.0 113.98 -173.723 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 2458 ' ' GLY . . . . . . . . . . . . . . . 112.67 -148.3 18.42 Favored Glycine 0 CA--C 1.533 1.181 0 C-N-CA 125.379 1.466 . . . . 0.0 112.125 -171.432 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 2459 ' ' ALA . . . . . . . . . . . . . . . -92.36 154.7 18.39 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.21 1.004 . . . . 0.0 112.123 179.417 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 2460 ' ' GLY . . . . . . . . . . . . . . . 166.02 163.71 20.1 Favored Glycine 0 N--CA 1.47 0.924 0 C-N-CA 123.848 0.737 . . . . 0.0 114.3 177.488 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 2461 ' ' ALA . . . . . . . . . . . . . . . -80.04 137.3 36.77 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.349 1.06 . . . . 0.0 112.134 -178.559 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 2462 ' ' LEU . . . . . . . . . . . . . 25.8 tp -110.78 141.76 43.68 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.337 1.455 . . . . 0.0 110.591 176.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 2463 ' ' SER . . . . . . . . . . . . . 4.1 t -130.28 39.0 3.7 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 126.215 1.806 . . . . 0.0 110.653 -177.319 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 2464 ' ' VAL . . . . . . . . . . . . . 11.4 p -65.72 140.98 18.72 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 125.512 1.525 . . . . 0.0 112.058 -176.239 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 2465 ' ' THR . . . . . . . . . . . . . 8.3 t -154.45 167.19 30.88 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 125.137 1.375 . . . . 0.0 111.691 179.704 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 2466 ' ' ILE . . . . . . . . . . . . . 35.2 mt -135.02 131.01 52.56 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 C-N-CA 125.237 1.415 . . . . 0.0 109.936 -176.127 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 2467 ' ' ASP . . . . . . . . . . . . . 36.3 t70 -122.26 136.91 54.98 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 125.811 1.644 . . . . 0.0 110.735 174.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 2468 ' ' GLY . . . . . . . . . . . . . . . 172.94 -162.77 34.34 Favored Glycine 0 CA--C 1.537 1.444 0 CA-C-O 119.062 -0.855 . . . . 0.0 114.121 -177.624 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 2469 ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -72.81 1.2 6.68 Favored 'Trans proline' 0 CA--C 1.544 0.979 0 C-N-CA 123.999 3.133 . . . . 0.0 115.325 -172.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 2470 ' ' SER . . . . . . . . . . . . . 85.0 p -150.55 153.94 36.69 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 120.071 1.305 . . . . 0.0 112.989 167.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 2471 ' ' LYS . . . . . . . . . . . . . 99.1 mttt -75.44 74.45 2.5 Favored 'General case' 0 CA--C 1.545 0.77 0 O-C-N 120.906 -1.121 . . . . 0.0 111.073 175.624 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 2472 ' ' VAL . . . . . . . . . . . . . 18.6 m -54.76 143.14 7.57 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 C-N-CA 124.725 1.21 . . . . 0.0 113.403 -173.422 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 2473 ' ' LYS . . . . . . . . . . . . . 83.8 tttt -83.67 70.8 10.38 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 124.596 1.158 . . . . 0.0 111.129 178.471 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 2474 ' ' MET . . . . . . . . . . . . . 16.6 tmm? -79.78 129.61 34.63 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.185 0.994 . . . . 0.0 111.315 -179.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 2475 ' ' ASP . . . . . . . . . . . . . 35.6 t70 -123.38 126.23 46.43 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 126.209 1.804 . . . . 0.0 110.348 174.261 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 2476 ' ' CYS . . . . . . . . . . . . . 35.9 t -101.92 139.82 37.03 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.066 1.346 . . . . 0.0 111.535 179.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 2477 ' ' GLN . . . . . . . . . . . . . 83.5 mt-30 -141.42 145.25 35.06 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.424 1.49 . . . . 0.0 110.497 -174.092 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 2478 ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -88.11 136.81 32.8 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 123.716 0.806 . . . . 0.0 110.624 174.213 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 2479 ' ' CYS . . . . . . . . . . . . . 14.8 p -146.44 171.53 6.3 Favored Pre-proline 0 CA--C 1.554 1.11 0 C-N-CA 125.617 1.567 . . . . 0.0 111.717 177.69 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 2480 ' ' PRO . . . . . . . . . . . . . 70.5 Cg_exo -58.94 -28.31 87.2 Favored 'Trans proline' 0 CA--C 1.539 0.76 0 C-N-CA 123.468 2.779 . . . . 0.0 114.66 179.331 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 2481 ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -83.79 -14.19 52.01 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 124.62 1.168 . . . . 0.0 113.019 -179.656 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 2482 ' ' GLY . . . . . . . . . . . . . . . 136.09 -143.95 15.57 Favored Glycine 0 N--CA 1.47 0.937 0 C-N-CA 125.83 1.681 . . . . 0.0 112.677 -177.112 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 2483 ' ' TYR . . . . . . . . . . . . . 88.7 m-85 -92.8 108.82 20.28 Favored 'General case' 0 N--CA 1.469 0.506 0 O-C-N 121.678 -0.895 . . . . 0.0 110.911 173.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 2484 ' ' ARG . . . . . . . . . . . . . 12.7 ttp180 -74.44 140.94 45.0 Favored 'General case' 0 N--CA 1.468 0.451 0 O-C-N 121.705 -0.622 . . . . 0.0 109.859 169.217 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 2485 ' ' VAL . . . . . . . . . . . . . 22.5 m -126.18 141.69 45.01 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 C-N-CA 123.669 0.788 . . . . 0.0 110.368 165.583 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 2486 ' ' THR . . . . . . . . . . . . . 88.8 m -132.53 135.84 46.23 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 125.658 1.583 . . . . 0.0 108.443 177.582 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 2487 ' ' TYR . . . . . . . . . . . . . 23.1 p90 -149.84 159.92 43.98 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.792 1.237 . . . . 0.0 112.443 -179.747 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 2488 ' ' THR . . . . . . . . . . . . . 99.4 m -122.27 113.8 30.81 Favored Pre-proline 0 N--CA 1.476 0.871 0 C-N-CA 124.154 0.982 . . . . 0.0 109.59 174.23 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 2489 ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -83.74 134.89 6.56 Favored 'Trans proline' 0 N--CA 1.458 -0.598 0 C-N-CA 123.624 2.883 . . . . 0.0 109.957 169.653 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 2490 ' ' MET . . . . . . . . . . . . . 22.4 ptt? -101.71 -18.05 16.0 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 114.329 1.233 . . . . 0.0 114.329 179.348 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 2491 ' ' ALA . . . . . . . . . . . . . . . -112.98 146.34 34.93 Favored Pre-proline 0 CA--C 1.547 0.835 0 C-N-CA 124.68 1.192 . . . . 0.0 112.346 -175.067 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 2492 ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -72.07 156.67 55.55 Favored 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 122.99 2.46 . . . . 0.0 111.192 172.494 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 2493 ' ' GLY . . . . . . . . . . . . . . . 128.79 -147.83 17.77 Favored Glycine 0 CA--C 1.528 0.894 0 C-N-CA 125.465 1.507 . . . . 0.0 112.239 -175.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 2494 ' ' SER . . . . . . . . . . . . . 63.8 m -129.78 140.55 51.03 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 123.891 0.876 . . . . 0.0 111.973 177.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 2495 ' ' TYR . . . . . . . . . . . . . 62.3 m-85 -114.75 127.5 55.77 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 125.993 1.717 . . . . 0.0 109.797 177.245 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 2496 ' ' LEU . . . . . . . . . . . . . 9.9 mp -88.69 117.56 27.75 Favored 'General case' 0 N--CA 1.464 0.242 0 C-N-CA 123.879 0.871 . . . . 0.0 108.963 173.131 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 2497 ' ' ILE . . . . . . . . . . . . . 36.1 mt -93.45 103.95 15.22 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 C-N-CA 125.371 1.468 . . . . 0.0 107.462 176.101 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 2498 ' ' SER . . . . . . . . . . . . . 66.4 m -91.31 101.21 13.91 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 124.816 1.246 . . . . 0.0 109.524 -179.609 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 2499 ' ' ILE . . . . . 0.632 ' H ' ' HG ' ' A' 2510 ' ' SER . 24.0 mt -97.6 92.01 2.77 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 C-N-CA 125.332 1.453 . . . . 0.0 108.828 -178.05 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 2500 ' ' LYS . . . . . . . . . . . . . 84.2 mttt -102.51 139.68 37.79 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.32 1.048 . . . . 0.0 111.739 178.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 2501 ' ' TYR . . . . . . . . . . . . . 72.8 t80 -145.26 147.45 32.4 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.817 1.247 . . . . 0.0 112.429 -170.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 2502 ' ' GLY . . . . . . . . . . . . . . . 64.83 21.28 67.31 Favored Glycine 0 CA--C 1.535 1.299 0 C-N-CA 124.17 0.89 . . . . 0.0 113.505 177.725 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 2503 ' ' GLY . . . . . . . . . . . . . . . 126.69 -163.49 20.58 Favored Glycine 0 CA--C 1.541 1.686 0 C-N-CA 125.899 1.714 . . . . 0.0 112.173 -163.119 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 2504 ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -83.23 21.49 1.02 Allowed 'Trans proline' 0 CA--C 1.545 1.048 0 C-N-CA 124.776 3.65 . . . . 0.0 113.91 -172.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 2505 ' ' TYR . . . . . . . . . . . . . 80.7 m-85 -105.92 130.5 53.86 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.313 1.045 . . . . 0.0 113.129 -171.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 2506 ' ' HIS . . . . . . . . . . . . . 86.5 m-70 -62.39 140.03 58.55 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 125.369 1.468 . . . . 0.0 113.523 179.705 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 2507 ' ' ILE . . . . . . . . . . . . . 1.8 pp -87.82 150.73 3.68 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.163 0 C-N-CA 123.954 0.902 . . . . 0.0 111.812 172.33 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 2508 ' ' GLY . . . . . . . . . . . . . . . 48.88 -116.8 3.57 Favored Glycine 0 CA--C 1.536 1.377 0 C-N-CA 124.087 0.851 . . . . 0.0 114.074 167.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 2509 ' ' GLY . . . . . . . . . . . . . . . -98.59 13.16 62.84 Favored Glycine 0 CA--C 1.536 1.359 0 C-N-CA 126.156 1.836 . . . . 0.0 115.047 177.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 2510 ' ' SER . . . . . 0.632 ' HG ' ' H ' ' A' 2499 ' ' ILE . 44.2 t -65.36 145.39 99.08 Favored Pre-proline 0 CA--C 1.553 1.059 0 CA-C-N 119.207 1.503 . . . . 0.0 112.837 -179.004 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 2511 ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -74.7 141.0 70.45 Favored 'Cis proline' 0 C--N 1.355 0.888 0 CA-C-N 119.712 0.933 . . . . 0.0 112.636 0.663 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 2512 ' ' PHE . . . . . . . . . . . . . 87.8 m-85 -94.38 125.43 39.02 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.575 1.15 . . . . 0.0 110.518 178.246 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 2513 ' ' LYS . . . . . . . . . . . . . 25.7 pttm -85.5 105.02 15.8 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 123.545 0.738 . . . . 0.0 112.165 177.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 2514 ' ' ALA . . . . . . . . . . . . . . . -87.94 120.0 28.84 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.239 1.416 . . . . 0.0 109.902 173.433 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 2515 ' ' LYS . . . . . . . . . . . . . 54.0 mtmt -94.41 133.35 38.09 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.383 1.073 . . . . 0.0 110.84 -176.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 2516 ' ' VAL . . . . . . . . . . . . . 87.9 t -131.21 136.94 56.77 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 124.415 1.086 . . . . 0.0 110.743 -170.544 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 2517 ' ' THR . . . . . . . . . . . . . 34.2 p -138.41 156.76 47.28 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 125.265 1.426 . . . . 0.0 111.795 -175.705 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 2518 ' ' GLY . . . . . . . . . . . . . . . 114.73 -176.29 16.7 Favored Glycine 0 CA--C 1.541 1.698 0 C-N-CA 125.584 1.564 . . . . 0.0 113.04 -175.21 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 2519 ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -69.8 149.68 66.97 Favored 'Trans proline' 0 CA--C 1.535 0.562 0 C-N-CA 123.756 2.97 . . . . 0.0 112.246 -174.162 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 2520 ' ' ARG . . . . . . . . . . . . . 37.3 ttm105 -79.11 -23.03 44.36 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 123.908 0.883 . . . . 0.0 113.287 178.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 2521 ' ' LEU . . . . . . . . . . . . . 3.6 mm? 70.24 -55.28 0.61 Allowed 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 129.374 3.069 . . . . 0.0 112.221 -175.617 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 2522 ' ' VAL . . . . . . . . . . . . . 26.9 m . . . . . 0 C--O 1.252 1.233 0 C-N-CA 125.64 1.576 . . . . 0.0 113.465 176.439 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.554 0 N-CA-C 111.431 -0.668 . . . . 0.0 111.431 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -151.74 155.59 38.57 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 125.656 1.582 . . . . 0.0 111.38 -179.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -88.77 -31.82 18.2 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.763 1.225 . . . . 0.0 111.778 179.647 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 2427 ' ' GLY . . . . . . . . . . . . . . . -82.08 174.43 53.68 Favored Glycine 0 CA--C 1.53 1.002 0 C-N-CA 125.024 1.297 . . . . 0.0 114.018 177.744 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 2428 ' ' ASP . . . . . . . . . . . . . 21.3 m-20 -132.89 138.71 32.51 Favored Pre-proline 0 CA--C 1.547 0.857 0 C-N-CA 125.381 1.472 . . . . 0.0 111.462 -179.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 2429 ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -56.79 -26.32 65.79 Favored 'Trans proline' 0 C--N 1.352 0.756 0 C-N-CA 123.854 3.036 . . . . 0.0 114.568 176.549 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 2430 ' ' GLY . . . . . . . . . . . . . . . -79.12 -23.5 63.38 Favored Glycine 0 CA--C 1.534 1.219 0 C-N-CA 123.737 0.684 . . . . 0.0 113.871 176.66 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 2431 ' ' LEU . . . . . . . . . . . . . 4.3 mm? -86.98 -39.64 15.5 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.519 1.128 . . . . 0.0 111.118 173.261 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 2432 ' ' VAL . . . . . . . . . . . . . 98.7 t -61.41 133.82 27.0 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 123.469 0.708 . . . . 0.0 109.992 172.53 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 2433 ' ' SER . . . . . . . . . . . . . 8.4 t -129.13 -170.09 2.21 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.892 1.277 . . . . 0.0 110.959 178.425 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 2434 ' ' ALA . . . . . . . . . . . . . . . -151.05 143.54 24.29 Favored 'General case' 0 CA--C 1.538 0.496 0 O-C-N 120.956 -1.09 . . . . 0.0 111.889 177.125 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 2435 ' ' TYR . . . . . . . . . . . . . 82.1 m-85 -145.89 143.64 29.7 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 125.242 1.417 . . . . 0.0 111.971 -176.142 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 2436 ' ' GLY . . . . . . . . . . . . . . . 125.71 162.7 11.38 Favored Glycine 0 N--CA 1.475 1.244 0 C-N-CA 125.607 1.575 . . . . 0.0 114.201 176.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 2437 ' ' ALA . . . . . . . . . . . . . . . -62.36 -27.16 68.87 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 125.244 1.418 . . . . 0.0 114.545 -170.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 2438 ' ' GLY . . . . . . . . . . . . . . . -61.87 -22.13 61.9 Favored Glycine 0 CA--C 1.531 1.06 0 C-N-CA 124.022 0.82 . . . . 0.0 113.903 179.326 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 2439 ' ' LEU . . . . . . . . . . . . . 85.5 mt -70.98 -22.8 62.14 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 118.547 1.173 . . . . 0.0 112.97 172.742 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 2440 ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -96.37 -26.44 15.35 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.11 1.364 . . . . 0.0 112.592 -179.796 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 2441 ' ' GLY . . . . . . . . . . . . . . . 101.8 -142.91 15.84 Favored Glycine 0 CA--C 1.532 1.127 0 C-N-CA 125.465 1.507 . . . . 0.0 112.652 -177.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 2442 ' ' GLY . . . . . . . . . . . . . . . 152.36 -152.58 24.26 Favored Glycine 0 CA--C 1.532 1.128 0 C-N-CA 124.205 0.907 . . . . 0.0 114.27 -177.14 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 2443 ' ' VAL . . . . . . . . . . . . . 38.4 t -88.32 141.27 14.53 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 C-N-CA 124.501 1.12 . . . . 0.0 110.333 -179.042 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 2444 ' ' THR . . . . . . . . . . . . . 33.1 p -59.07 152.69 19.49 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 124.361 1.065 . . . . 0.0 112.744 174.385 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 2445 ' ' GLY . . . . . . . . . . . . . . . 70.93 0.72 35.72 Favored Glycine 0 CA--C 1.534 1.224 0 C-N-CA 124.182 0.896 . . . . 0.0 115.133 177.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 2446 ' ' ASN . . . . . . . . . . . . . 14.6 m-80 -116.14 143.35 30.81 Favored Pre-proline 0 CA--C 1.546 0.803 0 C-N-CA 126.043 1.737 . . . . 0.0 110.066 177.095 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 2447 ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -72.99 141.92 33.85 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 122.805 2.337 . . . . 0.0 111.133 178.7 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 2448 ' ' ALA . . . . . . . . . . . . . . . -128.87 137.51 51.5 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.568 1.547 . . . . 0.0 109.403 169.66 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 2449 ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -131.35 151.81 51.18 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.21 1.004 . . . . 0.0 113.402 -166.6 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 2450 ' ' PHE . . . . . . . . . . . . . 27.2 p90 -158.48 163.65 36.93 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 125.915 1.686 . . . . 0.0 110.802 178.18 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 2451 ' ' VAL . . . . . . . . . . . . . 58.2 t -118.36 132.57 67.83 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 124.488 1.115 . . . . 0.0 109.717 175.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 2452 ' ' VAL . . . . . . . . . . . . . 40.3 t -79.19 106.69 10.64 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 162.716 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 2453 ' ' ASN . . . . . . . . . . . . . 15.0 t-20 -84.18 108.38 17.04 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 123.65 0.78 . . . . 0.0 111.7 -172.39 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 2454 ' ' THR . . . . . . . . . . . . . 29.9 p -97.67 -6.87 32.18 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 126.364 1.866 . . . . 0.0 113.644 -179.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 2455 ' ' SER . . . . . . . . . . . . . 14.9 m -58.11 -26.91 63.21 Favored 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 114.229 1.196 . . . . 0.0 114.229 -177.386 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 2456 ' ' ASN . . . . . . . . . . . . . 86.2 m-20 -75.27 -20.17 59.3 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.549 1.139 . . . . 0.0 113.355 175.524 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 2457 ' ' ALA . . . . . . . . . . . . . . . -116.62 -44.48 2.85 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.317 1.447 . . . . 0.0 113.451 -164.518 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 2458 ' ' GLY . . . . . . . . . . . . . . . 100.44 -148.11 18.24 Favored Glycine 0 CA--C 1.533 1.191 0 C-N-CA 124.98 1.276 . . . . 0.0 112.847 -175.135 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 2459 ' ' ALA . . . . . . . . . . . . . . . -73.66 139.26 45.29 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.352 1.061 . . . . 0.0 113.596 -172.553 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 2460 ' ' GLY . . . . . . . . . . . . . . . 168.67 154.79 9.14 Favored Glycine 0 CA--C 1.531 1.041 0 C-N-CA 125.327 1.441 . . . . 0.0 113.167 177.226 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 2461 ' ' ALA . . . . . . . . . . . . . . . -79.85 147.71 31.63 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 124.293 1.037 . . . . 0.0 112.567 -178.289 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 2462 ' ' LEU . . . . . . . . . . . . . 16.6 tp -108.55 143.39 37.64 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.148 1.379 . . . . 0.0 111.131 177.267 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 2463 ' ' SER . . . . . . . . . . . . . 49.4 m -135.0 38.97 2.98 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 125.699 1.6 . . . . 0.0 111.139 -176.514 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 2464 ' ' VAL . . . . . . . . . . . . . 8.5 p -66.03 138.12 23.63 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 C-N-CA 125.453 1.501 . . . . 0.0 112.43 -177.739 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 2465 ' ' THR . . . . . . . . . . . . . 93.1 m -137.87 141.69 40.7 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 125.608 1.563 . . . . 0.0 109.822 175.232 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 2466 ' ' ILE . . . . . . . . . . . . . 56.7 mt -105.61 119.89 55.54 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 123.661 0.784 . . . . 0.0 109.266 170.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 2467 ' ' ASP . . . . . . . . . . . . . 37.4 t70 -108.01 155.68 20.07 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 126.334 1.853 . . . . 0.0 110.603 173.5 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 2468 ' ' GLY . . . . . . . . . . . . . . . 163.56 -160.34 33.06 Favored Glycine 0 CA--C 1.535 1.327 0 CA-C-O 119.136 -0.814 . . . . 0.0 114.044 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 2469 ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -71.04 -14.62 32.16 Favored 'Trans proline' 0 CA--C 1.539 0.766 0 C-N-CA 123.788 2.992 . . . . 0.0 114.003 -177.342 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 2470 ' ' SER . . . . . . . . . . . . . 42.2 m -152.49 159.52 43.33 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 125.257 1.423 . . . . 0.0 111.959 178.573 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 2471 ' ' LYS . . . . . . . . . . . . . 68.3 mttm -76.42 98.07 4.46 Favored 'General case' 0 CA--C 1.544 0.722 0 O-C-N 120.966 -1.084 . . . . 0.0 110.482 172.574 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 2472 ' ' VAL . . . . . . . . . . . . . 16.2 m -60.77 148.38 8.98 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 C-N-CA 123.985 0.914 . . . . 0.0 111.743 179.252 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 2473 ' ' LYS . . . . . . . . . . . . . 88.6 tttt -77.1 109.85 11.28 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 171.015 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 2474 ' ' MET . . . . . . . . . . . . . 25.3 ttt -118.19 142.27 47.63 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.998 1.319 . . . . 0.0 112.434 -166.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 2475 ' ' ASP . . . . . . . . . . . . . 31.0 t70 -128.41 147.03 50.63 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 127.187 2.195 . . . . 0.0 110.16 169.428 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 2476 ' ' CYS . . . . . . . . . . . . . 37.8 t -138.12 140.58 39.99 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.668 1.187 . . . . 0.0 110.244 172.181 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 2477 ' ' GLN . . . . . . . . . . . . . 8.7 pt20 -156.89 163.13 39.51 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.182 1.393 . . . . 0.0 111.17 -172.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 2478 ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -95.13 138.5 32.76 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 123.775 0.83 . . . . 0.0 111.39 -179.365 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 2479 ' ' CYS . . . . . . . . . . . . . 14.0 p -139.18 170.9 9.01 Favored Pre-proline 0 CA--C 1.553 1.071 0 C-N-CA 125.43 1.492 . . . . 0.0 111.168 170.547 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 2480 ' ' PRO . . . . . . . . . . . . . 68.3 Cg_exo -58.43 -26.09 76.3 Favored 'Trans proline' 0 C--N 1.352 0.741 0 C-N-CA 123.508 2.805 . . . . 0.0 114.702 178.415 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 2481 ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -83.09 -11.04 58.37 Favored 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 125.01 1.324 . . . . 0.0 112.862 178.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 2482 ' ' GLY . . . . . . . . . . . . . . . 128.82 -155.49 20.65 Favored Glycine 0 N--CA 1.473 1.125 0 C-N-CA 125.893 1.711 . . . . 0.0 113.402 -178.276 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 2483 ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -76.06 109.29 9.59 Favored 'General case' 0 N--CA 1.47 0.575 0 O-C-N 121.621 -0.929 . . . . 0.0 110.767 175.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 2484 ' ' ARG . . . . . . . . . . . . . 31.5 ttm180 -85.27 131.66 34.38 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 124.892 1.277 . . . . 0.0 110.577 176.242 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 2485 ' ' VAL . . . . . . . . . . . . . 78.7 t -117.93 137.5 51.67 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 C-N-CA 126.062 1.745 . . . . 0.0 108.742 176.397 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 2486 ' ' THR . . . . . . . . . . . . . 85.0 m -131.9 139.0 48.62 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.771 1.229 . . . . 0.0 108.175 171.277 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 2487 ' ' TYR . . . . . . . . . . . . . 30.5 p90 -146.41 149.32 33.5 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 113.38 0.881 . . . . 0.0 113.38 175.61 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 2488 ' ' THR . . . . . . . . . . . . . 62.9 m -112.7 114.21 49.8 Favored Pre-proline 0 N--CA 1.472 0.639 0 C-N-CA 125.17 1.388 . . . . 0.0 108.61 172.411 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 2489 ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -81.06 134.99 9.57 Favored 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 122.851 2.367 . . . . 0.0 110.709 176.004 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 2490 ' ' MET . . . . . . . . . . . . . 17.7 ptm -91.25 -3.72 56.63 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 125.031 1.332 . . . . 0.0 114.192 -177.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 2491 ' ' ALA . . . . . . . . . . . . . . . -151.26 151.08 28.6 Favored Pre-proline 0 CA--C 1.546 0.826 0 C-N-CA 125.429 1.492 . . . . 0.0 112.001 -173.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 2492 ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -73.99 165.09 32.92 Favored 'Trans proline' 0 CA--C 1.538 0.685 0 C-N-CA 123.505 2.803 . . . . 0.0 111.727 173.447 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 2493 ' ' GLY . . . . . . . . . . . . . . . 127.09 -158.67 21.07 Favored Glycine 0 CA--C 1.53 0.994 0 C-N-CA 125.539 1.542 . . . . 0.0 112.973 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 2494 ' ' SER . . . . . . . . . . . . . 67.6 m -113.47 128.89 56.6 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.126 0.971 . . . . 0.0 111.262 179.257 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 2495 ' ' TYR . . . . . . . . . . . . . 88.9 m-85 -110.82 132.88 53.83 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.781 1.632 . . . . 0.0 110.531 177.748 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 2496 ' ' LEU . . . . . . . . . . . . . 9.5 mp -96.7 114.74 26.41 Favored 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 124.248 1.019 . . . . 0.0 108.908 173.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 2497 ' ' ILE . . . . . . . . . . . . . 30.6 mt -89.49 92.21 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 N-CA-C 107.306 -1.368 . . . . 0.0 107.306 174.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 2498 ' ' SER . . . . . . . . . . . . . 68.0 m -80.92 78.57 7.71 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 126.032 1.733 . . . . 0.0 110.305 -179.311 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 2499 ' ' ILE . . . . . . . . . . . . . 36.1 mt -75.42 107.15 5.83 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 C-N-CA 124.826 1.251 . . . . 0.0 109.204 176.1 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 2500 ' ' LYS . . . . . . . . . . . . . 42.8 mttp -113.02 148.6 34.79 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 124.775 1.23 . . . . 0.0 111.116 175.194 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 2501 ' ' TYR . . . . . . . . . . . . . 67.6 t80 -148.25 145.94 28.43 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.445 1.098 . . . . 0.0 112.281 -172.044 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 2502 ' ' GLY . . . . . . . . . . . . . . . 66.39 14.7 62.48 Favored Glycine 0 CA--C 1.535 1.33 0 C-N-CA 124.556 1.074 . . . . 0.0 114.373 175.162 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 2503 ' ' GLY . . . . . . . . . . . . . . . 138.02 -169.29 24.26 Favored Glycine 0 CA--C 1.54 1.633 0 C-N-CA 125.92 1.724 . . . . 0.0 112.537 -166.154 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 2504 ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -83.76 34.58 0.53 Allowed 'Trans proline' 0 CA--C 1.545 1.068 0 C-N-CA 124.859 3.706 . . . . 0.0 113.143 -171.588 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 2505 ' ' TYR . . . . . . . . . . . . . 92.8 m-85 -125.11 136.27 53.48 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 124.515 1.126 . . . . 0.0 113.053 -174.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 2506 ' ' HIS . . . . . . . . . . . . . 92.4 m-70 -63.48 146.09 54.32 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 125.405 1.482 . . . . 0.0 113.455 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 2507 ' ' ILE . . . . . . . . . . . . . 24.2 pt -75.43 173.28 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.192 0 C-N-CA 123.494 0.718 . . . . 0.0 112.684 171.485 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 2508 ' ' GLY . . . . . . . . . . . . . . . -59.29 120.73 24.02 Favored Glycine 0 CA--C 1.534 1.244 0 O-C-N 121.411 -0.806 . . . . 0.0 111.677 175.074 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 2509 ' ' GLY . . . . . . . . . . . . . . . 87.8 -5.77 84.44 Favored Glycine 0 CA--C 1.536 1.371 0 C-N-CA 125.393 1.473 . . . . 0.0 114.995 -177.25 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 2510 ' ' SER . . . . . . . . . . . . . 47.4 t -89.3 145.99 35.18 Favored Pre-proline 0 CA--C 1.551 0.992 0 CA-C-N 119.007 1.404 . . . . 0.0 112.088 -179.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 2511 ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -72.71 143.6 78.12 Favored 'Cis proline' 0 C--N 1.355 0.877 0 CA-C-N 120.042 1.051 . . . . 0.0 112.427 -0.319 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 2512 ' ' PHE . . . . . . . . . . . . . 83.0 m-85 -92.61 122.95 35.54 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.059 0.944 . . . . 0.0 110.718 178.202 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 2513 ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.34 105.08 13.12 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 124.023 0.929 . . . . 0.0 113.462 178.588 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 2514 ' ' ALA . . . . . . . . . . . . . . . -92.84 125.28 37.37 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.07 1.348 . . . . 0.0 110.208 173.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 2515 ' ' LYS . . . . . . . . . . . . . 54.6 mtmt -102.83 123.91 47.37 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.303 1.041 . . . . 0.0 110.637 -178.027 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 2516 ' ' VAL . . . . . . . . . . . . . 92.3 t -122.27 139.06 50.39 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 124.967 1.307 . . . . 0.0 110.523 -168.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 2517 ' ' THR . . . . . . . . . . . . . 38.5 p -132.64 164.66 26.21 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 125.391 1.476 . . . . 0.0 111.75 -177.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 2518 ' ' GLY . . . . . . . . . . . . . . . 108.96 -176.54 19.9 Favored Glycine 0 CA--C 1.54 1.601 0 C-N-CA 124.908 1.242 . . . . 0.0 113.313 -176.373 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 2519 ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -75.12 158.24 41.84 Favored 'Trans proline' 0 CA--C 1.535 0.541 0 C-N-CA 123.819 3.012 . . . . 0.0 112.127 -175.683 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 2520 ' ' ARG . . . . . . . . . . . . . 39.4 ttp180 -78.02 132.29 37.73 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 123.053 0.541 . . . . 0.0 110.058 168.547 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 2521 ' ' LEU . . . . . . . . . . . . . 10.3 mp -78.77 -33.76 46.19 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 113.382 0.882 . . . . 0.0 113.382 -174.45 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 2522 ' ' VAL . . . . . . . . . . . . . 59.2 t . . . . . 0 C--O 1.252 1.234 0 C-N-CA 125.386 1.474 . . . . 0.0 111.527 -175.287 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.517 0 N-CA-C 111.759 -0.536 . . . . 0.0 111.759 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -157.3 165.71 35.1 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 125.383 1.473 . . . . 0.0 112.186 -178.419 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 49.1 mtm -86.05 11.96 10.55 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 126.007 1.723 . . . . 0.0 113.362 178.756 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 2427 ' ' GLY . . . . . . . . . . . . . . . -165.2 178.94 40.0 Favored Glycine 0 CA--C 1.532 1.107 0 C-N-CA 127.177 2.322 . . . . 0.0 111.931 175.625 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 2428 ' ' ASP . . . . . . . . . . . . . 13.8 t70 -149.71 136.16 10.63 Favored Pre-proline 0 CA--C 1.55 0.96 0 C-N-CA 123.939 0.896 . . . . 0.0 112.182 -173.658 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 2429 ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -65.79 -20.74 58.7 Favored 'Trans proline' 0 C--N 1.353 0.795 0 C-N-CA 123.58 2.854 . . . . 0.0 114.186 -176.089 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 2430 ' ' GLY . . . . . . . . . . . . . . . -81.69 -26.25 50.89 Favored Glycine 0 CA--C 1.533 1.163 0 CA-C-N 119.261 0.937 . . . . 0.0 113.106 173.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 2431 ' ' LEU . . . . . . . . . . . . . 4.4 mm? -81.7 -34.17 30.77 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.153 0.981 . . . . 0.0 111.383 171.123 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 2432 ' ' VAL . . . . . . . . . . . . . 57.7 t -64.21 138.28 23.34 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 123.516 0.726 . . . . 0.0 110.31 168.462 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 2433 ' ' SER . . . . . . . . . . . . . 8.9 t -131.18 -167.25 1.82 Allowed 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 125.128 1.371 . . . . 0.0 109.897 172.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 2434 ' ' ALA . . . . . . . . . . . . . . . -151.54 145.53 25.22 Favored 'General case' 0 CA--C 1.537 0.477 0 O-C-N 120.794 -1.191 . . . . 0.0 111.643 176.012 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 2435 ' ' TYR . . . . . . . . . . . . . 86.6 m-85 -143.2 149.67 38.3 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.334 1.454 . . . . 0.0 111.892 -177.307 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 2436 ' ' GLY . . . . . . . . . . . . . . . 120.42 160.59 11.2 Favored Glycine 0 N--CA 1.473 1.133 0 C-N-CA 125.534 1.54 . . . . 0.0 113.549 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 2437 ' ' ALA . . . . . . . . . . . . . . . -60.7 -31.74 71.01 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 114.535 1.309 . . . . 0.0 114.535 -168.665 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 2438 ' ' GLY . . . . . . . . . . . . . . . -67.97 -10.43 58.89 Favored Glycine 0 CA--C 1.532 1.132 0 C-N-CA 124.129 0.871 . . . . 0.0 114.891 -176.352 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 2439 ' ' LEU . . . . . . . . . . . . . 75.6 mt -77.75 -27.14 50.31 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 118.702 1.251 . . . . 0.0 112.162 169.208 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 2440 ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -93.19 -34.82 13.44 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 125.121 1.369 . . . . 0.0 111.595 176.493 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 2441 ' ' GLY . . . . . . . . . . . . . . . 138.68 -136.67 8.17 Favored Glycine 0 CA--C 1.531 1.061 0 C-N-CA 125.097 1.332 . . . . 0.0 114.469 176.171 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 2442 ' ' GLY . . . . . . . . . . . . . . . 162.89 -145.06 10.16 Favored Glycine 0 CA--C 1.534 1.246 0 C-N-CA 126.622 2.058 . . . . 0.0 111.148 -167.509 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 2443 ' ' VAL . . . . . . . . . . . . . 8.5 p -141.56 151.99 19.33 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 C-N-CA 124.739 1.216 . . . . 0.0 110.145 176.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 2444 ' ' THR . . . . . . . . . . . . . 22.7 p -53.49 130.27 35.15 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.855 0.862 . . . . 0.0 111.784 178.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 2445 ' ' GLY . . . . . . . . . . . . . . . 86.5 -8.37 75.14 Favored Glycine 0 CA--C 1.535 1.32 0 C-N-CA 125.205 1.384 . . . . 0.0 115.363 179.127 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 2446 ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -101.69 146.33 32.04 Favored Pre-proline 0 CA--C 1.551 0.986 0 CA-C-N 119.605 1.703 . . . . 0.0 112.235 177.53 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 2447 ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -75.52 124.53 8.36 Favored 'Trans proline' 0 N--CA 1.457 -0.641 0 C-N-CA 122.727 2.285 . . . . 0.0 110.507 175.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 2448 ' ' ALA . . . . . . . . . . . . . . . -107.13 149.03 28.1 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.77 1.628 . . . . 0.0 109.56 168.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 2449 ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -153.88 158.29 40.55 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 113.886 1.069 . . . . 0.0 113.886 -174.671 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 2450 ' ' PHE . . . . . . . . . . . . . 53.0 p90 -160.34 161.11 33.1 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 126.503 1.921 . . . . 0.0 110.838 -177.321 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 2451 ' ' VAL . . . . . . . . . . . . . 58.7 t -114.51 127.56 71.94 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 C-N-CA 124.866 1.266 . . . . 0.0 109.128 174.092 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 2452 ' ' VAL . . . . . . . . . . . . . 42.7 t -79.62 106.27 10.41 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 165.417 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 2453 ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -89.82 117.35 28.59 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 123.995 0.918 . . . . 0.0 111.976 -164.379 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 2454 ' ' THR . . . . . . . . . . . . . 52.5 p -102.19 -1.56 31.08 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 125.857 1.663 . . . . 0.0 113.672 -177.159 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 2455 ' ' SER . . . . . . . . . . . . . 16.9 t -60.94 -33.52 73.29 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-N 119.296 0.953 . . . . 0.0 113.356 -172.667 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 2456 ' ' ASN . . . . . . . . . . . . . 72.6 m-80 -81.96 -13.81 56.94 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 124.196 0.999 . . . . 0.0 113.674 175.684 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 2457 ' ' ALA . . . . . . . . . . . . . . . -102.75 -45.01 5.13 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.97 1.308 . . . . 0.0 113.547 -173.059 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 2458 ' ' GLY . . . . . . . . . . . . . . . 119.96 -113.42 2.45 Favored Glycine 0 CA--C 1.529 0.961 0 C-N-CA 124.93 1.252 . . . . 0.0 111.382 -170.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 2459 ' ' ALA . . . . . . . . . . . . . . . -147.97 155.45 41.56 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.432 1.093 . . . . 0.0 112.798 -176.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 2460 ' ' GLY . . . . . . . . . . . . . . . 164.52 173.29 33.01 Favored Glycine 0 CA--C 1.528 0.87 0 C-N-CA 124.269 0.938 . . . . 0.0 113.774 -176.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 2461 ' ' ALA . . . . . . . . . . . . . . . -73.29 146.2 45.51 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.193 0.997 . . . . 0.0 112.212 178.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 2462 ' ' LEU . . . . . . . . . . . . . 6.0 tt -128.36 147.66 50.64 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 125.742 1.617 . . . . 0.0 110.898 178.672 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 2463 ' ' SER . . . . . . . . . . . . . 14.0 t -132.04 161.21 33.75 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.676 1.191 . . . . 0.0 110.349 161.5 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 2464 ' ' VAL . . . . . . . . . . . . . 7.4 p -161.72 136.96 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.725 0 C-N-CA 124.644 1.178 . . . . 0.0 110.773 -175.056 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 2465 ' ' THR . . . . . . . . . . . . . 63.3 m -141.58 138.49 32.68 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 125.397 1.479 . . . . 0.0 109.711 -175.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 2466 ' ' ILE . . . . . . . . . . . . . 37.7 mt -117.41 119.41 61.72 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 124.399 1.08 . . . . 0.0 109.527 175.669 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 2467 ' ' ASP . . . . . . . . . . . . . 34.9 t70 -104.06 161.74 13.75 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 126.164 1.785 . . . . 0.0 110.019 167.527 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 2468 ' ' GLY . . . . . . . . . . . . . . . 172.18 -166.05 38.81 Favored Glycine 0 CA--C 1.536 1.386 0 O-C-N 120.875 -1.141 . . . . 0.0 115.878 179.313 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 2469 ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -70.11 -14.64 35.2 Favored 'Trans proline' 0 CA--C 1.541 0.836 0 C-N-CA 124.544 3.496 . . . . 0.0 113.93 -178.43 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 2470 ' ' SER . . . . . . . . . . . . . 16.8 m -155.79 -177.71 6.76 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 127.306 2.243 . . . . 0.0 109.434 172.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 2471 ' ' LYS . . . . . . . . . . . . . 24.8 pttm -66.31 175.42 2.19 Favored 'General case' 0 CA--C 1.549 0.917 0 O-C-N 121.069 -1.019 . . . . 0.0 112.839 169.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 2472 ' ' VAL . . . . . . . . . . . . . 27.0 m -132.76 148.39 31.6 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 125.331 1.452 . . . . 0.0 110.138 170.429 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 2473 ' ' LYS . . . . . . . . . . . . . 63.8 tttm -76.13 131.2 39.26 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 107.78 -1.192 . . . . 0.0 107.78 152.417 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 2474 ' ' MET . . . . . . . . . . . . . 27.1 ttt -139.23 139.81 37.56 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.024 0.93 . . . . 0.0 111.489 -172.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 2475 ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -141.7 157.44 45.06 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 126.907 2.083 . . . . 0.0 110.172 -178.103 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 2476 ' ' CYS . . . . . . . . . . . . . 49.7 t -152.43 150.03 29.22 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.191 0.996 . . . . 0.0 111.842 -175.433 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 2477 ' ' GLN . . . . . . . . . . . . . 51.7 tt0 -154.37 133.91 12.77 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 125.457 1.503 . . . . 0.0 110.077 -174.655 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 2478 ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -85.12 142.87 29.2 Favored 'General case' 0 CA--C 1.542 0.66 0 O-C-N 121.641 -0.662 . . . . 0.0 111.414 171.425 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 2479 ' ' CYS . . . . . . . . . . . . . 15.4 p -151.98 173.6 4.33 Favored Pre-proline 0 CA--C 1.553 1.096 0 C-N-CA 125.695 1.598 . . . . 0.0 111.47 -177.518 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 2480 ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -58.36 -27.44 81.39 Favored 'Trans proline' 0 C--N 1.353 0.794 0 C-N-CA 123.563 2.842 . . . . 0.0 114.853 179.288 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 2481 ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -80.37 -19.58 46.04 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 124.374 1.07 . . . . 0.0 112.755 178.234 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 2482 ' ' GLY . . . . . . . . . . . . . . . 134.94 -150.66 20.21 Favored Glycine 0 CA--C 1.529 0.955 0 C-N-CA 126.033 1.778 . . . . 0.0 112.864 -176.55 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 2483 ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -90.85 109.4 20.61 Favored 'General case' 0 CA--C 1.539 0.535 0 O-C-N 121.7 -0.883 . . . . 0.0 110.759 177.308 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 2484 ' ' ARG . . . . . . . . . . . . . 38.9 ttp85 -79.47 134.48 36.53 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 124.445 1.098 . . . . 0.0 110.09 172.355 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 2485 ' ' VAL . . . . . . . . . . . . . 93.4 t -125.51 135.84 62.7 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 126.05 1.74 . . . . 0.0 108.672 178.206 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 2486 ' ' THR . . . . . . . . . . . . . 86.2 m -129.6 140.69 51.12 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 125.653 1.581 . . . . 0.0 108.788 178.171 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 2487 ' ' TYR . . . . . . . . . . . . . 19.6 p90 -150.8 153.26 35.11 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 113.526 0.935 . . . . 0.0 113.526 175.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 2488 ' ' THR . . . . . . . . . . . . . 98.4 m -118.62 115.51 35.4 Favored Pre-proline 0 N--CA 1.474 0.749 0 C-N-CA 124.907 1.283 . . . . 0.0 109.181 175.315 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 2489 ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -82.44 165.15 16.47 Favored 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 124.464 3.443 . . . . 0.0 111.6 175.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 2490 ' ' MET . . . . . . . . . . . . . 24.5 ptm -143.57 5.16 1.39 Allowed 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 115.435 1.643 . . . . 0.0 115.435 -174.367 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 2491 ' ' ALA . . . . . . . . . . . . . . . -143.46 145.98 33.95 Favored Pre-proline 0 CA--C 1.546 0.825 0 C-N-CA 124.675 1.19 . . . . 0.0 110.896 170.184 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 2492 ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -71.65 149.2 54.63 Favored 'Trans proline' 0 CA--C 1.536 0.601 0 C-N-CA 123.063 2.508 . . . . 0.0 111.158 178.189 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 2493 ' ' GLY . . . . . . . . . . . . . . . 131.81 -159.89 23.37 Favored Glycine 0 CA--C 1.53 1.004 0 C-N-CA 125.36 1.457 . . . . 0.0 113.493 -177.354 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 2494 ' ' SER . . . . . . . . . . . . . 23.6 m -98.03 118.65 35.09 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 125.117 1.367 . . . . 0.0 111.523 -177.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 2495 ' ' TYR . . . . . . . . . . . . . 62.3 m-85 -92.64 120.23 32.85 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 123.614 0.766 . . . . 0.0 110.068 167.041 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 2496 ' ' LEU . . . . . . . . . . . . . 22.8 tp -92.94 111.33 22.91 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.626 1.17 . . . . 0.0 109.73 -177.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 2497 ' ' ILE . . . . . . . . . . . . . 32.2 mt -101.85 103.62 15.2 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 C-N-CA 125.922 1.689 . . . . 0.0 108.602 -175.552 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 2498 ' ' SER . . . . . . . . . . . . . 68.4 m -92.0 125.63 36.77 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.274 1.029 . . . . 0.0 109.958 175.503 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 2499 ' ' ILE . . . . . 0.559 ' H ' ' HG ' ' A' 2510 ' ' SER . 42.2 mt -128.26 123.99 61.31 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.725 0 C-N-CA 124.889 1.276 . . . . 0.0 108.645 -175.389 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 2500 ' ' LYS . . . . . . . . . . . . . 84.5 mttt -127.87 143.49 51.11 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.734 1.214 . . . . 0.0 111.774 -172.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 2501 ' ' TYR . . . . . . . . . . . . . 60.2 t80 -150.02 139.7 21.68 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 123.663 0.785 . . . . 0.0 112.681 -171.196 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 2502 ' ' GLY . . . . . . . . . . . . . . . 68.21 13.73 65.22 Favored Glycine 0 CA--C 1.537 1.419 0 C-N-CA 124.196 0.903 . . . . 0.0 114.162 179.279 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 2503 ' ' GLY . . . . . . . . . . . . . . . 146.46 -172.53 27.0 Favored Glycine 0 CA--C 1.539 1.583 0 C-N-CA 126.087 1.803 . . . . 0.0 112.822 -169.465 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 2504 ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -81.87 22.4 0.85 Allowed 'Trans proline' 0 CA--C 1.545 1.058 0 C-N-CA 124.99 3.794 . . . . 0.0 113.795 -174.52 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 2505 ' ' TYR . . . . . . . . . . . . . 72.8 m-85 -111.59 139.85 46.69 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.935 1.294 . . . . 0.0 112.803 -173.516 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 2506 ' ' HIS . . . . . . . . . . . . . 93.3 m-70 -62.19 144.15 55.84 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 124.447 1.099 . . . . 0.0 113.298 -179.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 2507 ' ' ILE . . . . . . . . . . . . . 26.7 pt -73.59 167.99 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 C-N-CA 123.149 0.58 . . . . 0.0 112.45 171.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 2508 ' ' GLY . . . . . . . . . . . . . . . -57.5 120.68 22.42 Favored Glycine 0 CA--C 1.534 1.223 0 C-N-CA 123.651 0.643 . . . . 0.0 111.982 176.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 2509 ' ' GLY . . . . . . . . . . . . . . . 88.58 -8.35 79.36 Favored Glycine 0 CA--C 1.535 1.331 0 C-N-CA 125.599 1.571 . . . . 0.0 115.145 -177.733 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 2510 ' ' SER . . . . . 0.559 ' HG ' ' H ' ' A' 2499 ' ' ILE . 8.4 t -89.33 146.3 35.78 Favored Pre-proline 0 CA--C 1.549 0.939 0 CA-C-N 119.231 1.516 . . . . 0.0 111.897 -179.595 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 2511 ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -75.74 149.78 93.15 Favored 'Cis proline' 0 C--N 1.353 0.786 0 CA-C-N 120.153 1.09 . . . . 0.0 113.424 1.168 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 2512 ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -100.8 131.84 46.49 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 125.386 1.475 . . . . 0.0 110.465 178.266 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 2513 ' ' LYS . . . . . . . . . . . . . 64.5 pttt -87.49 8.75 23.47 Favored 'General case' 0 N--CA 1.479 1.007 0 N-CA-C 116.292 1.96 . . . . 0.0 116.292 -169.084 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 2514 ' ' ALA . . . . . . . . . . . . . . . -7.09 99.45 0.01 OUTLIER 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 129.66 3.184 . . . . 0.0 116.047 -176.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 2515 ' ' LYS . . . . . . . . . . . . . 48.6 mtpt -94.86 135.18 36.68 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 124.031 0.932 . . . . 0.0 112.194 -171.27 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 2516 ' ' VAL . . . . . . . . . . . . . 6.0 m -131.82 153.8 39.23 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 C-N-CA 124.224 1.01 . . . . 0.0 111.82 -177.244 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 2517 ' ' THR . . . . . . . . . . . . . 64.0 p -120.64 -171.27 2.15 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.915 1.686 . . . . 0.0 110.106 177.026 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 2518 ' ' GLY . . . . . . . . . . . . . . . 99.1 177.58 31.82 Favored Glycine 0 CA--C 1.539 1.571 0 C-N-CA 124.972 1.272 . . . . 0.0 113.921 178.538 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 2519 ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -70.38 137.4 33.58 Favored 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 123.862 3.042 . . . . 0.0 112.195 -172.152 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 2520 ' ' ARG . . . . . . . . . . . . . 37.8 ttp180 -74.89 131.01 40.4 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.127 0.971 . . . . 0.0 110.922 177.085 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 2521 ' ' LEU . . . . . . . . . . . . . 4.3 mm? -83.36 -34.33 25.64 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.858 0.863 . . . . 0.0 112.764 179.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 2522 ' ' VAL . . . . . . . . . . . . . 35.0 m . . . . . 0 N--CA 1.484 1.24 0 C-N-CA 124.58 1.152 . . . . 0.0 113.996 -177.155 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.565 0 N-CA-C 111.727 -0.549 . . . . 0.0 111.727 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -70.13 149.68 47.32 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.271 1.029 . . . . 0.0 112.452 177.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 2.2 mpt? -74.92 146.77 41.53 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.337 1.055 . . . . 0.0 112.555 -176.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 2427 ' ' GLY . . . . . . . . . . . . . . . -79.0 -178.23 50.62 Favored Glycine 0 CA--C 1.533 1.206 0 C-N-CA 125.14 1.352 . . . . 0.0 113.987 176.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 2428 ' ' ASP . . . . . . . . . . . . . 22.8 m-20 -106.0 134.56 19.69 Favored Pre-proline 0 CA--C 1.549 0.929 0 C-N-CA 124.778 1.231 . . . . 0.0 112.834 -176.16 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 2429 ' ' PRO . . . . . . . . . . . . . 77.0 Cg_exo -56.43 -28.9 75.37 Favored 'Trans proline' 0 C--N 1.353 0.794 0 C-N-CA 124.036 3.158 . . . . 0.0 114.45 174.041 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 2430 ' ' GLY . . . . . . . . . . . . . . . -77.15 -22.77 70.26 Favored Glycine 0 CA--C 1.533 1.183 0 C-N-CA 123.751 0.691 . . . . 0.0 113.747 177.074 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 2431 ' ' LEU . . . . . . . . . . . . . 4.2 mm? -86.53 -32.28 20.81 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.453 1.101 . . . . 0.0 111.405 172.642 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 2432 ' ' VAL . . . . . . . . . . . . . 74.6 t -65.07 137.68 24.55 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 CA-C-N 118.58 0.627 . . . . 0.0 110.453 169.243 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 2433 ' ' SER . . . . . . . . . . . . . 8.4 t -130.84 -169.81 2.23 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 125.054 1.342 . . . . 0.0 110.583 174.44 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 2434 ' ' ALA . . . . . . . . . . . . . . . -149.91 141.99 23.98 Favored 'General case' 0 CA--C 1.539 0.548 0 O-C-N 120.903 -1.123 . . . . 0.0 111.473 177.222 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 2435 ' ' TYR . . . . . . . . . . . . . 75.2 m-85 -145.85 151.49 37.98 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 125.511 1.524 . . . . 0.0 111.881 -176.212 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 2436 ' ' GLY . . . . . . . . . . . . . . . 117.23 162.14 12.47 Favored Glycine 0 N--CA 1.474 1.191 0 C-N-CA 125.384 1.469 . . . . 0.0 113.903 177.508 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 2437 ' ' ALA . . . . . . . . . . . . . . . -61.18 -28.7 69.32 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.045 1.338 . . . . 0.0 114.45 -169.687 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 2438 ' ' GLY . . . . . . . . . . . . . . . -65.63 -13.95 59.59 Favored Glycine 0 CA--C 1.533 1.17 0 C-N-CA 124.234 0.921 . . . . 0.0 114.688 -178.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 2439 ' ' LEU . . . . . . . . . . . . . 91.8 mt -75.9 -27.68 57.79 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 118.647 1.224 . . . . 0.0 112.526 169.353 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 2440 ' ' GLU . . . . . . . . . . . . . 43.4 mm-40 -88.02 -31.2 19.44 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.862 1.265 . . . . 0.0 111.519 174.442 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 2441 ' ' GLY . . . . . . . . . . . . . . . 113.83 -146.8 18.63 Favored Glycine 0 CA--C 1.53 1.012 0 C-N-CA 126.086 1.803 . . . . 0.0 113.381 177.013 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 2442 ' ' GLY . . . . . . . . . . . . . . . 170.87 -163.31 36.38 Favored Glycine 0 CA--C 1.53 1.001 0 C-N-CA 124.234 0.921 . . . . 0.0 114.001 -174.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 2443 ' ' VAL . . . . . . . . . . . . . 40.3 t -91.74 146.33 6.41 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 C-N-CA 124.51 1.124 . . . . 0.0 110.245 179.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 2444 ' ' THR . . . . . . . . . . . . . 20.2 p -54.61 142.89 26.42 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 124.898 1.279 . . . . 0.0 112.236 172.221 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 2445 ' ' GLY . . . . . . . . . . . . . . . 72.4 1.0 50.0 Favored Glycine 0 CA--C 1.536 1.361 0 C-N-CA 124.274 0.94 . . . . 0.0 114.685 179.318 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 2446 ' ' ASN . . . . . . . . . . . . . 16.3 m-80 -118.58 149.76 46.85 Favored Pre-proline 0 CA--C 1.549 0.93 0 C-N-CA 126.123 1.769 . . . . 0.0 110.623 179.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 2447 ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -74.48 133.1 16.97 Favored 'Trans proline' 0 C--N 1.35 0.648 0 C-N-CA 122.908 2.405 . . . . 0.0 111.99 -174.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 2448 ' ' ALA . . . . . . . . . . . . . . . -105.77 119.92 40.37 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 126.41 1.884 . . . . 0.0 108.645 168.372 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 2449 ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -124.6 135.02 52.77 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.568 1.147 . . . . 0.0 111.821 -169.44 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 2450 ' ' PHE . . . . . . . . . . . . . 15.2 p90 -152.99 170.21 20.98 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.6 1.56 . . . . 0.0 111.183 175.189 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 2451 ' ' VAL . . . . . . . . . . . . . 46.6 t -125.9 132.95 70.11 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 C-N-CA 124.911 1.285 . . . . 0.0 110.106 178.641 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 2452 ' ' VAL . . . . . . . . . . . . . 51.8 t -82.88 107.56 14.78 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 165.035 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 2453 ' ' ASN . . . . . . . . . . . . . 21.1 t-20 -83.3 113.07 20.45 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 123.551 0.74 . . . . 0.0 112.153 -171.741 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 2454 ' ' THR . . . . . . . . . . . . . 30.4 p -99.59 -6.55 27.16 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 126.001 1.72 . . . . 0.0 113.79 179.138 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 2455 ' ' SER . . . . . . . . . . . . . 16.4 m -55.78 -31.41 62.59 Favored 'General case' 0 N--CA 1.478 0.949 0 N-CA-C 114.538 1.31 . . . . 0.0 114.538 -174.26 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 2456 ' ' ASN . . . . . . . . . . . . . 66.3 m-80 -84.46 -15.83 44.7 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 124.49 1.116 . . . . 0.0 113.464 177.558 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 2457 ' ' ALA . . . . . . . . . . . . . . . -106.24 -25.73 11.85 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 125.72 1.608 . . . . 0.0 113.854 -176.386 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 2458 ' ' GLY . . . . . . . . . . . . . . . 104.24 -103.71 2.32 Favored Glycine 0 CA--C 1.529 0.966 0 C-N-CA 125.398 1.475 . . . . 0.0 111.067 -174.243 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 2459 ' ' ALA . . . . . . . . . . . . . . . -151.73 163.29 39.46 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 125.355 1.462 . . . . 0.0 111.768 -179.139 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 2460 ' ' GLY . . . . . . . . . . . . . . . 163.58 171.83 30.31 Favored Glycine 0 CA--C 1.53 1.007 0 C-N-CA 124.774 1.178 . . . . 0.0 113.293 -176.469 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 2461 ' ' ALA . . . . . . . . . . . . . . . -73.08 143.92 47.24 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.104 0.961 . . . . 0.0 112.216 179.473 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 2462 ' ' LEU . . . . . . . . . . . . . 15.7 tp -129.03 139.25 52.14 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.404 1.481 . . . . 0.0 110.662 -178.528 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 2463 ' ' SER . . . . . . . . . . . . . 66.5 m -139.6 52.65 1.72 Allowed 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 125.437 1.495 . . . . 0.0 111.616 -169.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 2464 ' ' VAL . . . . . . . . . . . . . 17.1 t -65.84 137.04 25.67 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.069 0 C-N-CA 124.044 0.938 . . . . 0.0 111.101 -178.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 2465 ' ' THR . . . . . . . . . . . . . 22.7 m -123.24 141.32 52.1 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 124.933 1.293 . . . . 0.0 109.236 170.528 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 2466 ' ' ILE . . . . . . . . . . . . . 52.1 mt -116.13 114.7 46.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 C-N-CA 123.679 0.792 . . . . 0.0 108.981 171.003 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 2467 ' ' ASP . . . . . . . . . . . . . 37.1 t70 -95.29 158.69 15.35 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 125.519 1.527 . . . . 0.0 110.297 168.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 2468 ' ' GLY . . . . . . . . . . . . . . . 174.61 -171.3 44.45 Favored Glycine 0 CA--C 1.536 1.36 0 O-C-N 121.271 -0.893 . . . . 0.0 114.789 179.71 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 2469 ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -68.15 -25.95 36.87 Favored 'Trans proline' 0 CA--C 1.538 0.716 0 C-N-CA 123.941 3.094 . . . . 0.0 112.802 178.56 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 2470 ' ' SER . . . . . . . . . . . . . 58.5 m -142.86 174.59 10.52 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 126.058 1.743 . . . . 0.0 110.685 174.177 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 2471 ' ' LYS . . . . . . . . . . . . . 57.1 mtmt -66.71 166.59 12.74 Favored 'General case' 0 CA--C 1.548 0.887 0 O-C-N 121.13 -0.981 . . . . 0.0 112.314 170.025 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 2472 ' ' VAL . . . . . . . . . . . . . 24.7 m -131.39 147.21 32.79 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 125.231 1.412 . . . . 0.0 111.464 -178.687 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 2473 ' ' LYS . . . . . . . . . . . . . 56.8 tttp -83.2 67.64 9.28 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 124.229 1.012 . . . . 0.0 110.931 174.715 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 2474 ' ' MET . . . . . . . . . . . . . 23.3 ttt -75.45 136.33 40.69 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 125.217 1.407 . . . . 0.0 111.979 -174.599 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 2475 ' ' ASP . . . . . . . . . . . . . 36.7 t70 -141.8 129.3 21.35 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 126.429 1.892 . . . . 0.0 110.33 176.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 2476 ' ' CYS . . . . . . . . . . . . . 74.5 m -113.91 148.62 36.47 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.931 1.293 . . . . 0.0 111.55 -176.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 2477 ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -150.3 148.1 28.44 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.269 1.027 . . . . 0.0 111.013 179.485 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 2478 ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -88.94 117.84 28.24 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 123.972 0.909 . . . . 0.0 109.845 173.508 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 2479 ' ' CYS . . . . . 0.66 ' HG ' ' HE ' ' A' 2484 ' ' ARG . 87.6 m -122.31 166.36 17.51 Favored Pre-proline 0 CA--C 1.552 1.037 0 C-N-CA 125.601 1.56 . . . . 0.0 111.284 179.82 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 2480 ' ' PRO . . . . . . . . . . . . . 58.0 Cg_exo -57.88 -30.3 89.14 Favored 'Trans proline' 0 C--N 1.353 0.8 0 C-N-CA 123.534 2.823 . . . . 0.0 114.216 175.394 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 2481 ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -78.44 -7.61 57.58 Favored 'General case' 0 CA--C 1.552 1.02 0 C-N-CA 125.357 1.463 . . . . 0.0 112.991 177.644 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 2482 ' ' GLY . . . . . . . . . . . . . . . 118.66 -163.23 13.16 Favored Glycine 0 CA--C 1.53 1.012 0 C-N-CA 126.313 1.911 . . . . 0.0 112.533 -173.106 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 2483 ' ' TYR . . . . . . . . . . . . . 83.4 m-85 -72.67 107.67 5.26 Favored 'General case' 0 CA--C 1.54 0.571 0 O-C-N 121.564 -0.962 . . . . 0.0 111.31 177.213 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 2484 ' ' ARG . . . . . 0.66 ' HE ' ' HG ' ' A' 2479 ' ' CYS . 51.5 ttp85 -79.19 136.89 37.22 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 124.753 1.221 . . . . 0.0 110.231 174.269 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 2485 ' ' VAL . . . . . . . . . . . . . 92.5 t -128.15 125.56 64.6 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 C-N-CA 125.931 1.692 . . . . 0.0 108.48 179.001 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 2486 ' ' THR . . . . . . . . . . . . . 57.9 m -123.99 139.59 53.8 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 124.619 1.168 . . . . 0.0 108.488 172.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 2487 ' ' TYR . . . . . . . . . . . . . 27.3 p90 -147.06 150.51 35.21 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 112.754 0.65 . . . . 0.0 112.754 176.58 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 2488 ' ' THR . . . . . . . . . . . . . 24.7 m -109.79 115.11 55.9 Favored Pre-proline 0 N--CA 1.474 0.736 0 CA-C-O 117.764 -1.112 . . . . 0.0 109.047 174.455 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 2489 ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -81.42 149.06 16.65 Favored 'Trans proline' 0 N--CA 1.459 -0.553 0 C-N-CA 123.515 2.81 . . . . 0.0 110.731 171.237 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 2490 ' ' MET . . . . . . . . . . . . . 27.6 ptm -118.6 6.4 11.66 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 114.411 1.263 . . . . 0.0 114.411 -174.255 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 2491 ' ' ALA . . . . . . . . . . . . . . . -152.57 147.69 19.73 Favored Pre-proline 0 CA--C 1.544 0.74 0 C-N-CA 125.548 1.539 . . . . 0.0 111.41 -179.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 2492 ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -72.86 156.91 52.35 Favored 'Trans proline' 0 CA--C 1.536 0.606 0 C-N-CA 123.379 2.72 . . . . 0.0 111.208 174.557 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 2493 ' ' GLY . . . . . . . . . . . . . . . 134.94 -148.93 19.75 Favored Glycine 0 CA--C 1.527 0.843 0 C-N-CA 125.428 1.489 . . . . 0.0 112.061 -174.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 2494 ' ' SER . . . . . . . . . . . . . 36.8 m -128.6 133.85 48.43 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.694 0.798 . . . . 0.0 111.423 176.57 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 2495 ' ' TYR . . . . . . . . . . . . . 52.3 m-85 -107.18 127.13 53.23 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 126.152 1.781 . . . . 0.0 109.709 179.276 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 2496 ' ' LEU . . . . . . . . . . . . . 26.3 tp -98.75 112.69 24.69 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.411 1.085 . . . . 0.0 109.495 -176.528 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 2497 ' ' ILE . . . . . . . . . . . . . 36.9 mt -96.43 103.29 14.51 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 C-N-CA 125.331 1.452 . . . . 0.0 108.383 -176.191 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 2498 ' ' SER . . . . . . . . . . . . . 74.4 m -96.7 91.16 5.57 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 125.617 1.567 . . . . 0.0 110.247 -177.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 2499 ' ' ILE . . . . . . . . . . . . . 59.6 mt -87.62 104.69 14.59 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 C-N-CA 126.363 1.865 . . . . 0.0 109.591 -172.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 2500 ' ' LYS . . . . . . . . . . . . . 30.6 mttp -110.52 138.06 47.41 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.207 1.003 . . . . 0.0 111.589 -176.715 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 2501 ' ' TYR . . . . . . . . . . . . . 76.7 t80 -139.24 148.08 42.59 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.671 1.189 . . . . 0.0 112.452 -174.355 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 2502 ' ' GLY . . . . . . . . . . . . . . . 65.04 20.88 67.36 Favored Glycine 0 CA--C 1.536 1.358 0 C-N-CA 124.143 0.878 . . . . 0.0 113.465 -179.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 2503 ' ' GLY . . . . . . . . . . . . . . . 126.57 -171.31 18.28 Favored Glycine 0 CA--C 1.541 1.66 0 C-N-CA 125.967 1.746 . . . . 0.0 112.238 -163.524 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 2504 ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -84.02 43.55 1.4 Allowed 'Trans proline' 0 CA--C 1.546 1.083 0 C-N-CA 124.898 3.732 . . . . 0.0 112.618 -172.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 2505 ' ' TYR . . . . . . . . . . . . . 78.9 m-85 -127.15 132.01 50.63 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 124.457 1.103 . . . . 0.0 112.81 -175.073 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 2506 ' ' HIS . . . . . . . . . . . . . 79.0 m-70 -60.14 141.71 55.45 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 125.629 1.572 . . . . 0.0 114.46 -173.587 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 2507 ' ' ILE . . . . . . . . . . . . . 1.8 pp -79.26 170.59 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.2 0 C-N-CA 124.028 0.931 . . . . 0.0 112.628 171.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 2508 ' ' GLY . . . . . . . . . . . . . . . -60.15 112.1 4.17 Favored Glycine 0 CA--C 1.533 1.216 0 C-N-CA 123.753 0.692 . . . . 0.0 112.628 -176.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 2509 ' ' GLY . . . . . . . . . . . . . . . 95.72 -7.36 67.96 Favored Glycine 0 CA--C 1.536 1.347 0 C-N-CA 125.699 1.618 . . . . 0.0 114.866 -177.476 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 2510 ' ' SER . . . . . . . . . . . . . 45.4 t -79.62 146.97 66.37 Favored Pre-proline 0 CA--C 1.55 0.952 0 CA-C-N 119.16 1.48 . . . . 0.0 111.82 176.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 2511 ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -80.15 157.35 87.41 Favored 'Cis proline' 0 C--N 1.353 0.803 0 CA-C-N 119.834 0.977 . . . . 0.0 113.409 0.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 2512 ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -109.96 125.66 53.1 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.18 1.392 . . . . 0.0 111.199 179.75 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 2513 ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.73 101.59 13.83 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 124.449 1.1 . . . . 0.0 112.283 175.167 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 2514 ' ' ALA . . . . . . . . . . . . . . . -88.35 122.87 32.35 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 125.211 1.404 . . . . 0.0 110.28 174.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 2515 ' ' LYS . . . . . . . . . . . . . 27.7 mtpp -97.08 134.95 39.76 Favored 'General case' 0 CA--C 1.542 0.653 0 O-C-N 121.231 -0.918 . . . . 0.0 111.285 -174.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 2516 ' ' VAL . . . . . . . . . . . . . 74.0 t -130.39 138.95 52.57 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.775 0 C-N-CA 124.911 1.285 . . . . 0.0 110.849 -169.07 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 2517 ' ' THR . . . . . . . . . . . . . 54.2 p -134.6 171.07 14.84 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 125.869 1.667 . . . . 0.0 110.892 179.605 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 2518 ' ' GLY . . . . . . . . . . . . . . . 106.37 178.65 23.26 Favored Glycine 0 CA--C 1.539 1.568 0 C-N-CA 124.828 1.204 . . . . 0.0 113.432 -176.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 2519 ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -70.98 136.11 29.04 Favored 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 123.715 2.943 . . . . 0.0 112.129 -171.053 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 2520 ' ' ARG . . . . . . . . . . . . . 50.9 ttp180 -70.9 132.88 45.9 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.047 0.939 . . . . 0.0 110.778 176.053 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 2521 ' ' LEU . . . . . . . . . . . . . 4.2 mm? -78.03 -25.5 47.92 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.856 0.862 . . . . 0.0 112.466 178.282 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 2522 ' ' VAL . . . . . . . . . . . . . 38.9 t . . . . . 0 C--O 1.252 1.206 0 C-N-CA 125.985 1.714 . . . . 0.0 111.512 177.84 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.543 0 N-CA-C 111.41 -0.676 . . . . 0.0 111.41 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -72.34 154.98 40.64 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 124.203 1.001 . . . . 0.0 112.822 178.605 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 16.3 tpt -78.42 -41.99 31.4 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.328 1.051 . . . . 0.0 112.37 177.789 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 2427 ' ' GLY . . . . . . . . . . . . . . . 81.56 147.48 5.88 Favored Glycine 0 CA--C 1.532 1.152 0 C-N-CA 125.123 1.344 . . . . 0.0 112.68 -173.536 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 2428 ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -144.76 128.22 8.64 Favored Pre-proline 0 CA--C 1.546 0.802 0 C-N-CA 125.65 1.58 . . . . 0.0 109.626 178.001 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 2429 ' ' PRO . . . . . . . . . . . . . 57.3 Cg_exo -56.46 -35.0 96.13 Favored 'Trans proline' 0 C--N 1.353 0.789 0 C-N-CA 123.183 2.588 . . . . 0.0 114.493 -175.378 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 2430 ' ' GLY . . . . . . . . . . . . . . . -73.04 -18.84 79.36 Favored Glycine 0 CA--C 1.534 1.257 0 CA-C-N 118.552 0.615 . . . . 0.0 114.186 179.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 2431 ' ' LEU . . . . . . . . . . . . . 4.1 mm? -87.02 -20.29 27.44 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.732 1.213 . . . . 0.0 111.904 173.075 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 2432 ' ' VAL . . . . . . . . . . . . . 60.8 t -80.97 138.31 19.87 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 C-N-CA 124.571 1.148 . . . . 0.0 109.178 172.143 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 2433 ' ' SER . . . . . . . . . . . . . 8.6 t -128.11 -169.86 2.14 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 125.083 1.353 . . . . 0.0 111.001 176.337 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 2434 ' ' ALA . . . . . . . . . . . . . . . -155.45 142.77 19.41 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.692 1.197 . . . . 0.0 111.656 177.303 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 2435 ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -145.24 145.12 31.16 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 125.245 1.418 . . . . 0.0 112.071 -176.433 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 2436 ' ' GLY . . . . . . . . . . . . . . . 129.08 158.48 9.6 Favored Glycine 0 N--CA 1.472 1.077 0 C-N-CA 125.622 1.582 . . . . 0.0 113.395 178.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 2437 ' ' ALA . . . . . . . . . . . . . . . -62.11 -27.79 69.18 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 114.206 1.187 . . . . 0.0 114.206 -170.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 2438 ' ' GLY . . . . . . . . . . . . . . . -65.57 -16.66 63.52 Favored Glycine 0 CA--C 1.531 1.035 0 CA-C-O 118.888 -0.951 . . . . 0.0 114.31 -178.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 2439 ' ' LEU . . . . . . . . . . . . . 87.7 mt -73.53 -28.69 62.02 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 118.673 1.237 . . . . 0.0 112.513 171.259 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 2440 ' ' GLU . . . . . . . . . . . . . 41.5 mm-40 -92.25 -33.47 14.64 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.942 1.297 . . . . 0.0 112.167 -177.037 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 2441 ' ' GLY . . . . . . . . . . . . . . . 161.15 -156.38 27.77 Favored Glycine 0 CA--C 1.528 0.894 0 N-CA-C 114.875 0.71 . . . . 0.0 114.875 -176.825 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 2442 ' ' GLY . . . . . . . . . . . . . . . 171.26 -167.14 40.26 Favored Glycine 0 CA--C 1.53 0.992 0 C-N-CA 125.648 1.594 . . . . 0.0 112.298 -178.657 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 2443 ' ' VAL . . . . . . . . . . . . . 98.2 t -125.27 144.83 33.93 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 C-N-CA 124.692 1.197 . . . . 0.0 109.36 175.638 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 2444 ' ' THR . . . . . . . . . . . . . 21.4 p -54.7 127.5 28.48 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 124.95 1.3 . . . . 0.0 111.812 176.42 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 2445 ' ' GLY . . . . . . . . . . . . . . . 79.26 -5.36 59.91 Favored Glycine 0 CA--C 1.536 1.383 0 C-N-CA 124.622 1.106 . . . . 0.0 114.846 -178.399 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 2446 ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -97.66 139.82 21.59 Favored Pre-proline 0 CA--C 1.551 1.019 0 C-N-CA 125.617 1.567 . . . . 0.0 110.953 176.519 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 2447 ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -75.56 122.15 6.78 Favored 'Trans proline' 0 N--CA 1.457 -0.64 0 C-N-CA 122.839 2.36 . . . . 0.0 110.632 176.163 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 2448 ' ' ALA . . . . . . . . . . . . . . . -105.16 156.57 17.97 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.97 1.708 . . . . 0.0 109.883 168.262 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 2449 ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -156.96 159.11 37.75 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 114.035 1.124 . . . . 0.0 114.035 -175.181 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 2450 ' ' PHE . . . . . . . . . . . . . 54.9 p90 -159.49 148.2 17.85 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 126.173 1.789 . . . . 0.0 110.571 178.314 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 2451 ' ' VAL . . . . . . . . . . . . . 11.2 t -102.35 124.22 56.15 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 C-N-CA 124.439 1.095 . . . . 0.0 108.886 174.594 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 2452 ' ' VAL . . . . . . . . . . . . . 43.5 t -75.13 108.81 7.28 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 N-CA-C 106.838 -1.542 . . . . 0.0 106.838 167.303 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 2453 ' ' ASN . . . . . . . . . . . . . 62.7 t-20 -87.55 113.89 23.66 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.136 0.974 . . . . 0.0 110.802 -171.055 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 2454 ' ' THR . . . . . . . . . . . . . 73.1 p -104.92 2.09 29.49 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 126.079 1.752 . . . . 0.0 112.958 -175.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 2455 ' ' SER . . . . . . . . . . . . . 46.9 m -58.42 -30.36 66.82 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 114.518 1.303 . . . . 0.0 114.518 -169.341 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 2456 ' ' ASN . . . . . . . . . . . . . 29.3 m120 -92.89 -11.21 34.05 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 124.663 1.185 . . . . 0.0 113.683 177.251 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 2457 ' ' ALA . . . . . . . . . . . . . . . -101.74 -32.81 10.11 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 125.309 1.444 . . . . 0.0 113.502 -178.427 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 2458 ' ' GLY . . . . . . . . . . . . . . . 85.81 -159.24 32.84 Favored Glycine 0 CA--C 1.533 1.214 0 C-N-CA 124.976 1.274 . . . . 0.0 112.846 -174.77 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 2459 ' ' ALA . . . . . . . . . . . . . . . -60.84 155.48 19.46 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 124.991 1.317 . . . . 0.0 114.016 -177.423 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 2460 ' ' GLY . . . . . . . . . . . . . . . 159.09 -174.62 36.06 Favored Glycine 0 CA--C 1.534 1.228 0 C-N-CA 125.922 1.725 . . . . 0.0 112.904 -176.556 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 2461 ' ' ALA . . . . . . . . . . . . . . . -123.61 143.24 50.35 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.904 1.282 . . . . 0.0 112.198 -177.089 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 2462 ' ' LEU . . . . . . . . . . . . . 24.8 tp -92.69 145.23 24.57 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.588 1.555 . . . . 0.0 111.254 179.093 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 2463 ' ' SER . . . . . . . . . . . . . 4.3 t -138.13 40.07 2.3 Favored 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 125.667 1.587 . . . . 0.0 111.004 -179.794 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 2464 ' ' VAL . . . . . . . . . . . . . 12.6 p -65.2 147.63 12.49 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 C-N-CA 126.008 1.723 . . . . 0.0 112.638 -175.498 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 2465 ' ' THR . . . . . . . . . . . . . 10.8 t -151.9 160.92 43.37 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 125.13 1.372 . . . . 0.0 111.412 172.388 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 2466 ' ' ILE . . . . . . . . . . . . . 55.5 mt -135.11 124.63 42.97 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 124.913 1.285 . . . . 0.0 110.16 -173.853 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 2467 ' ' ASP . . . . . . . . . . . . . 29.9 m-20 -106.36 173.35 6.35 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 126.44 1.896 . . . . 0.0 110.79 169.808 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 2468 ' ' GLY . . . . . . . . . . . . . . . 153.49 -155.02 25.89 Favored Glycine 0 CA--C 1.535 1.331 0 CA-C-O 118.916 -0.935 . . . . 0.0 113.872 179.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 2469 ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -70.21 -10.52 28.39 Favored 'Trans proline' 0 CA--C 1.542 0.883 0 C-N-CA 123.705 2.936 . . . . 0.0 113.756 178.294 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 2470 ' ' SER . . . . . 0.442 ' HG ' ' HG3' ' A' 2490 ' ' MET . 34.0 p -166.77 169.09 13.67 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 125.488 1.515 . . . . 0.0 111.934 -176.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 2471 ' ' LYS . . . . . . . . . . . . . 64.5 mttp -79.73 106.54 11.82 Favored 'General case' 0 CA--C 1.542 0.669 0 O-C-N 121.017 -1.052 . . . . 0.0 110.599 172.547 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 2472 ' ' VAL . . . . . . . . . . . . . 32.9 m -60.84 151.03 6.62 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.15 0 C-N-CA 123.821 0.848 . . . . 0.0 111.838 175.755 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 2473 ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.46 132.92 35.78 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 162.394 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 2474 ' ' MET . . . . . . . . . . . . . 16.3 tmm? -152.1 143.35 23.28 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-N 119.755 1.161 . . . . 0.0 112.975 -170.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 2475 ' ' ASP . . . . . . . . . . . . . 36.7 t70 -139.5 146.0 39.45 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 126.947 2.099 . . . . 0.0 110.295 174.214 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 2476 ' ' CYS . . . . . . . . . . . . . 30.0 t -124.35 144.99 49.71 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.515 1.126 . . . . 0.0 111.546 -179.361 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 2477 ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -143.36 169.57 17.42 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.128 1.371 . . . . 0.0 111.87 -179.763 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 2478 ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -77.78 147.21 35.4 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 123.807 0.843 . . . . 0.0 110.711 166.512 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 2479 ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -146.25 168.81 10.77 Favored Pre-proline 0 CA--C 1.552 1.054 0 C-N-CA 127.009 2.123 . . . . 0.0 111.072 178.377 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 2480 ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo -64.56 -29.35 61.33 Favored 'Trans proline' 0 CA--C 1.539 0.765 0 C-N-CA 122.75 2.3 . . . . 0.0 114.47 -173.315 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 2481 ' ' GLU . . . . . . . . . . . . . 5.6 mp0 -88.24 -10.19 50.51 Favored 'General case' 0 CA--C 1.547 0.847 0 N-CA-C 113.765 1.024 . . . . 0.0 113.765 174.216 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 2482 ' ' GLY . . . . . . . . . . . . . . . 151.45 -111.11 0.49 Allowed Glycine 0 N--CA 1.471 1.014 0 CA-C-N 119.794 1.179 . . . . 0.0 113.494 -176.188 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 2483 ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -123.14 123.85 41.73 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.437 1.095 . . . . 0.0 111.714 179.159 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 2484 ' ' ARG . . . . . 0.682 HH21 ' HG1' ' A' 2486 ' ' THR . 25.5 ttp180 -91.3 129.52 37.28 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 123.369 0.667 . . . . 0.0 111.108 175.097 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 2485 ' ' VAL . . . . . . . . . . . . . 98.7 t -99.2 132.03 45.35 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.475 0 C-N-CA 125.162 1.385 . . . . 0.0 107.99 168.101 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 2486 ' ' THR . . . . . 0.682 ' HG1' HH21 ' A' 2484 ' ' ARG . 20.5 m -124.5 126.3 45.64 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 125.415 1.486 . . . . 0.0 107.619 176.132 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 2487 ' ' TYR . . . . . . . . . . . . . 15.8 p90 -143.19 150.13 38.96 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 113.584 0.957 . . . . 0.0 113.584 -176.842 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 2488 ' ' THR . . . . . . . . . . . . . 91.2 m -119.59 115.03 34.05 Favored Pre-proline 0 N--CA 1.468 0.471 0 C-N-CA 125.342 1.457 . . . . 0.0 108.618 176.37 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 2489 ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -79.08 153.3 24.88 Favored 'Trans proline' 0 N--CA 1.456 -0.68 0 C-N-CA 123.339 2.693 . . . . 0.0 110.774 175.084 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 2490 ' ' MET . . . . . 0.442 ' HG3' ' HG ' ' A' 2470 ' ' SER . 24.8 ptm -118.09 -4.87 10.98 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 114.584 1.327 . . . . 0.0 114.584 -174.044 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 2491 ' ' ALA . . . . . . . . . . . . . . . -145.38 152.25 49.54 Favored Pre-proline 0 CA--C 1.548 0.899 0 C-N-CA 125.296 1.439 . . . . 0.0 111.601 177.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 2492 ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -72.83 154.85 53.83 Favored 'Trans proline' 0 CA--C 1.537 0.635 0 C-N-CA 123.001 2.467 . . . . 0.0 111.076 173.186 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 2493 ' ' GLY . . . . . . . . . . . . . . . 130.81 -168.37 21.88 Favored Glycine 0 CA--C 1.529 0.964 0 C-N-CA 125.473 1.511 . . . . 0.0 113.508 -178.163 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 2494 ' ' SER . . . . . . . . . . . . . 70.5 m -99.62 116.53 31.96 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 123.923 0.889 . . . . 0.0 111.333 178.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 2495 ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -87.93 150.77 23.27 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.582 1.153 . . . . 0.0 110.53 166.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 2496 ' ' LEU . . . . . . . . . . . . . 32.0 tp -121.99 114.73 21.37 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.803 1.241 . . . . 0.0 109.359 179.583 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 2497 ' ' ILE . . . . . . . . . . . . . 63.4 mt -99.38 108.18 22.01 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 C-N-CA 125.318 1.447 . . . . 0.0 108.415 -172.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 2498 ' ' SER . . . . . . . . . . . . . 73.2 m -95.47 101.44 13.16 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 124.507 1.123 . . . . 0.0 109.732 179.358 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 2499 ' ' ILE . . . . . 0.426 ' H ' ' HG ' ' A' 2510 ' ' SER . 42.8 mt -96.38 105.98 17.79 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 C-N-CA 124.762 1.225 . . . . 0.0 108.729 -178.023 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 2500 ' ' LYS . . . . . . . . . . . . . 85.1 mttt -113.2 142.51 45.71 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.406 1.082 . . . . 0.0 110.912 177.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 2501 ' ' TYR . . . . . . . . . . . . . 43.8 t80 -151.2 139.95 20.79 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.881 0.873 . . . . 0.0 112.258 -174.423 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 2502 ' ' GLY . . . . . . . . . . . . . . . 69.68 12.85 67.91 Favored Glycine 0 CA--C 1.536 1.402 0 C-N-CA 124.308 0.956 . . . . 0.0 114.267 177.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 2503 ' ' GLY . . . . . . . . . . . . . . . 150.81 -169.96 30.61 Favored Glycine 0 CA--C 1.539 1.54 0 C-N-CA 125.844 1.687 . . . . 0.0 113.025 -170.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 2504 ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -82.16 14.29 2.28 Favored 'Trans proline' 0 CA--C 1.544 1.011 0 C-N-CA 124.838 3.692 . . . . 0.0 113.918 -174.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 2505 ' ' TYR . . . . . . . . . . . . . 68.7 m-85 -108.44 141.64 40.0 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.77 1.228 . . . . 0.0 113.491 -171.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 2506 ' ' HIS . . . . . . . . . . . . . 84.3 m-70 -63.24 141.4 58.78 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 125.114 1.365 . . . . 0.0 112.988 176.246 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 2507 ' ' ILE . . . . . . . . . . . . . 1.6 pp -77.88 172.04 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 C-N-CA 123.612 0.765 . . . . 0.0 112.666 174.823 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 2508 ' ' GLY . . . . . . . . . . . . . . . -59.95 111.29 3.44 Favored Glycine 0 CA--C 1.534 1.264 0 O-C-N 121.531 -0.731 . . . . 0.0 112.582 -176.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 2509 ' ' GLY . . . . . . . . . . . . . . . 96.6 -7.3 65.66 Favored Glycine 0 CA--C 1.536 1.348 0 C-N-CA 125.822 1.677 . . . . 0.0 114.939 -177.19 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 2510 ' ' SER . . . . . 0.426 ' HG ' ' H ' ' A' 2499 ' ' ILE . 47.8 t -82.36 147.55 56.9 Favored Pre-proline 0 CA--C 1.551 0.981 0 CA-C-N 119.098 1.449 . . . . 0.0 112.106 178.123 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 2511 ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -78.41 154.42 92.64 Favored 'Cis proline' 0 C--N 1.353 0.808 0 CA-C-N 119.788 0.96 . . . . 0.0 113.091 -1.108 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 2512 ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -105.71 127.95 53.38 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.32 1.448 . . . . 0.0 110.998 -179.628 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 2513 ' ' LYS . . . . . . . . . . . . . 61.1 pttt -87.06 115.61 24.57 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 123.719 0.808 . . . . 0.0 111.906 175.836 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 2514 ' ' ALA . . . . . . . . . . . . . . . -105.94 114.9 29.32 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.645 1.578 . . . . 0.0 110.522 -179.051 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 2515 ' ' LYS . . . . . . . . . . . . . 54.2 mtpt -94.75 112.94 24.65 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.107 0.963 . . . . 0.0 110.755 -173.282 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 2516 ' ' VAL . . . . . . . . . . . . . 75.6 t -110.67 144.21 19.11 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 125.417 1.487 . . . . 0.0 110.542 -173.22 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 2517 ' ' THR . . . . . . . . . . . . . 66.4 p -133.45 172.53 12.6 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 125.3 1.44 . . . . 0.0 111.232 176.127 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 2518 ' ' GLY . . . . . . . . . . . . . . . 107.35 177.28 22.63 Favored Glycine 0 CA--C 1.541 1.676 0 C-N-CA 125.215 1.388 . . . . 0.0 113.954 -179.733 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 2519 ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -73.74 136.63 23.51 Favored 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 123.972 3.115 . . . . 0.0 112.172 -172.283 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 2520 ' ' ARG . . . . . . . . . . . . . 34.9 ttm180 -62.64 135.4 57.36 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 123.976 0.91 . . . . 0.0 111.286 177.322 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 2521 ' ' LEU . . . . . . . . . . . . . 10.3 mp -75.53 -27.87 58.86 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.212 1.005 . . . . 0.0 113.056 -177.289 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 2522 ' ' VAL . . . . . . . . . . . . . 18.4 m . . . . . 0 C--O 1.253 1.269 0 C-N-CA 126.164 1.786 . . . . 0.0 113.498 179.845 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.575 0 N-CA-C 111.22 -0.752 . . . . 0.0 111.22 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -75.41 -15.36 60.46 Favored 'General case' 0 CA--C 1.546 0.81 0 N-CA-C 114.797 1.406 . . . . 0.0 114.797 -174.467 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 97.2 mmm -74.2 -11.78 60.39 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 114.372 1.249 . . . . 0.0 114.372 -177.069 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 2427 ' ' GLY . . . . . . . . . . . . . . . -159.92 126.68 1.67 Allowed Glycine 0 N--CA 1.468 0.821 0 C-N-CA 124.962 1.268 . . . . 0.0 112.128 176.269 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 2428 ' ' ASP . . . . . . . . . . . . . 12.9 t70 -100.67 129.9 26.62 Favored Pre-proline 0 CA--C 1.552 1.025 0 C-N-CA 124.242 1.017 . . . . 0.0 112.347 -175.572 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 2429 ' ' PRO . . . . . . . . . . . . . 53.8 Cg_exo -58.24 -27.1 79.43 Favored 'Trans proline' 0 C--N 1.354 0.829 0 C-N-CA 123.719 2.946 . . . . 0.0 114.99 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 2430 ' ' GLY . . . . . . . . . . . . . . . -80.05 -23.33 61.66 Favored Glycine 0 CA--C 1.532 1.143 0 CA-C-N 119.154 0.888 . . . . 0.0 113.322 177.674 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 2431 ' ' LEU . . . . . . . . . . . . . 4.3 mm? -82.82 -31.56 28.06 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 124.212 1.005 . . . . 0.0 111.415 170.567 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 2432 ' ' VAL . . . . . . . . . . . . . 81.3 t -69.08 136.57 26.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 123.571 0.748 . . . . 0.0 110.573 169.403 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 2433 ' ' SER . . . . . . . . . . . . . 58.6 m -139.92 144.92 37.36 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 125.174 1.39 . . . . 0.0 109.788 171.817 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 2434 ' ' ALA . . . . . . . . . . . . . . . -94.29 148.48 22.17 Favored 'General case' 0 CA--C 1.541 0.609 0 O-C-N 121.771 -0.581 . . . . 0.0 111.781 175.109 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 2435 ' ' TYR . . . . . . . . . . . . . 93.3 m-85 -142.97 147.73 35.66 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 126.136 1.775 . . . . 0.0 111.453 -178.402 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 2436 ' ' GLY . . . . . . . . . . . . . . . 120.31 161.14 11.4 Favored Glycine 0 N--CA 1.473 1.145 0 C-N-CA 125.151 1.358 . . . . 0.0 113.876 178.374 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 2437 ' ' ALA . . . . . . . . . . . . . . . -62.8 -28.88 70.3 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 114.409 1.263 . . . . 0.0 114.409 -169.682 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 2438 ' ' GLY . . . . . . . . . . . . . . . -66.99 -12.3 59.87 Favored Glycine 0 CA--C 1.532 1.108 0 CA-C-O 119.077 -0.846 . . . . 0.0 114.773 -177.425 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 2439 ' ' LEU . . . . . . . . . . . . . 79.5 mt -76.41 -27.78 56.41 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.54 1.136 . . . . 0.0 112.5 170.265 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 2440 ' ' GLU . . . . . . . . . . . . . 41.5 mm-40 -88.61 -32.51 18.05 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.893 1.277 . . . . 0.0 111.529 176.507 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 2441 ' ' GLY . . . . . . . . . . . . . . . 115.9 -130.55 9.12 Favored Glycine 0 CA--C 1.531 1.05 0 C-N-CA 125.706 1.622 . . . . 0.0 112.503 -179.754 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 2442 ' ' GLY . . . . . . . . . . . . . . . 135.11 -150.0 20.07 Favored Glycine 0 CA--C 1.535 1.311 0 C-N-CA 125.155 1.36 . . . . 0.0 113.701 -174.365 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 2443 ' ' VAL . . . . . . . . . . . . . 90.2 t -89.55 136.26 24.06 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 C-N-CA 124.804 1.242 . . . . 0.0 111.025 -174.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 2444 ' ' THR . . . . . . . . . . . . . 46.3 p -72.24 146.65 47.12 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 124.47 1.108 . . . . 0.0 112.049 176.818 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 2445 ' ' GLY . . . . . . . . . . . . . . . 78.28 -10.73 26.96 Favored Glycine 0 CA--C 1.538 1.5 0 C-N-CA 124.243 0.925 . . . . 0.0 114.193 -172.753 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 2446 ' ' ASN . . . . . . . . . . . . . 77.0 m-20 -102.12 152.54 38.25 Favored Pre-proline 0 CA--C 1.55 0.944 0 C-N-CA 125.469 1.507 . . . . 0.0 111.034 172.474 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 2447 ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -72.07 140.34 34.35 Favored 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 123.075 2.516 . . . . 0.0 111.55 178.25 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 2448 ' ' ALA . . . . . . . . . . . . . . . -121.3 131.14 54.03 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 127.115 2.166 . . . . 0.0 109.089 173.725 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 2449 ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -128.55 141.4 51.38 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.294 1.038 . . . . 0.0 111.806 -166.854 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 2450 ' ' PHE . . . . . . . . . . . . . 37.8 p90 -155.2 161.34 41.22 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.211 1.405 . . . . 0.0 111.998 173.164 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 2451 ' ' VAL . . . . . . . . . . . . . 8.1 p -118.44 139.05 47.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 125.616 1.566 . . . . 0.0 110.417 176.666 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 2452 ' ' VAL . . . . . . . . . . . . . 61.4 t -95.81 101.41 12.37 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 N-CA-C 107.194 -1.41 . . . . 0.0 107.194 168.555 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 2453 ' ' ASN . . . . . . . . . . . . . 22.6 t-20 -83.49 120.29 25.73 Favored 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 -169.601 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 2454 ' ' THR . . . . . . . . . . . . . 35.4 p -99.52 -5.98 28.3 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 125.878 1.671 . . . . 0.0 113.993 -177.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 2455 ' ' SER . . . . . . . . . . . . . 19.9 m -57.39 -32.99 67.38 Favored 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 114.556 1.317 . . . . 0.0 114.556 -172.772 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 2456 ' ' ASN . . . . . . . . . . . . . 28.0 m120 -83.4 -15.9 48.0 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 124.149 0.98 . . . . 0.0 113.601 176.228 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 2457 ' ' ALA . . . . . . . . . . . . . . . -102.49 -42.22 6.03 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.032 1.333 . . . . 0.0 113.505 -173.217 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 2458 ' ' GLY . . . . . . . . . . . . . . . 120.55 -111.4 1.94 Allowed Glycine 0 CA--C 1.53 0.995 0 C-N-CA 125.323 1.439 . . . . 0.0 111.631 -172.246 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 2459 ' ' ALA . . . . . . . . . . . . . . . -148.04 149.92 32.99 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.721 1.208 . . . . 0.0 112.835 -175.808 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 2460 ' ' GLY . . . . . . . . . . . . . . . 171.11 171.09 36.0 Favored Glycine 0 CA--C 1.529 0.906 0 C-N-CA 124.748 1.166 . . . . 0.0 113.152 -176.492 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 2461 ' ' ALA . . . . . . . . . . . . . . . -81.82 142.42 32.58 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.014 0.925 . . . . 0.0 112.454 -179.433 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 2462 ' ' LEU . . . . . . . . . . . . . 16.9 tp -102.02 145.2 29.63 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.154 1.382 . . . . 0.0 110.38 172.559 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 2463 ' ' SER . . . . . . . . . . . . . 5.4 t -138.3 45.09 2.1 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 124.972 1.309 . . . . 0.0 110.625 179.745 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 2464 ' ' VAL . . . . . . . . . . . . . 9.1 p -65.94 134.86 29.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 124.975 1.31 . . . . 0.0 111.855 -177.105 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 2465 ' ' THR . . . . . . . . . . . . . 85.5 m -130.9 144.73 51.68 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 125.992 1.717 . . . . 0.0 109.144 177.617 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 2466 ' ' ILE . . . . . . . . . . . . . 47.7 mt -123.86 120.93 61.01 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 123.617 0.767 . . . . 0.0 109.808 175.764 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 2467 ' ' ASP . . . . . . . . . . . . . 31.2 m-20 -103.06 167.57 9.74 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 125.951 1.7 . . . . 0.0 110.742 169.785 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 2468 ' ' GLY . . . . . . . . . . . . . . . 167.27 -167.06 39.65 Favored Glycine 0 CA--C 1.537 1.41 0 O-C-N 121.387 -0.821 . . . . 0.0 114.534 179.776 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 2469 ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -70.68 -15.74 33.66 Favored 'Trans proline' 0 CA--C 1.54 0.822 0 C-N-CA 124.219 3.279 . . . . 0.0 113.284 178.248 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 2470 ' ' SER . . . . . . . . . . . . . 49.9 m -153.01 179.2 8.9 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 127.081 2.152 . . . . 0.0 110.051 173.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 2471 ' ' LYS . . . . . . . . . . . . . 65.1 pttt -69.4 171.2 9.04 Favored 'General case' 0 CA--C 1.549 0.937 0 O-C-N 121.083 -1.011 . . . . 0.0 112.926 171.269 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 2472 ' ' VAL . . . . . . . . . . . . . 26.7 m -130.9 147.38 33.09 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 125.173 1.389 . . . . 0.0 111.032 175.206 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 2473 ' ' LYS . . . . . . . . . . . . . 51.8 mtmt -88.57 58.73 4.81 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 124.382 1.073 . . . . 0.0 111.688 177.033 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 2474 ' ' MET . . . . . . . . . . . . . 16.0 tmm? -77.53 134.84 38.2 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.31 1.044 . . . . 0.0 112.635 -174.578 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 2475 ' ' ASP . . . . . . . . . . . . . 35.5 t70 -130.56 144.63 51.54 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 126.927 2.091 . . . . 0.0 110.451 172.286 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 2476 ' ' CYS . . . . . . . . . . . . . 48.9 t -127.53 147.63 50.33 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 125.543 1.537 . . . . 0.0 112.583 -173.102 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 2477 ' ' GLN . . . . . . . . . . . . . 23.1 tt0 -151.79 136.96 17.44 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.477 1.111 . . . . 0.0 110.964 170.747 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 2478 ' ' GLU . . . . . . . . . . . . . 4.1 pm0 -75.67 132.41 40.54 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.671 1.188 . . . . 0.0 111.886 172.63 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 2479 ' ' CYS . . . . . . . . . . . . . 80.0 m -133.98 169.37 14.08 Favored Pre-proline 0 CA--C 1.554 1.105 0 C-N-CA 126.157 1.783 . . . . 0.0 110.849 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 2480 ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -57.07 -27.27 73.14 Favored 'Trans proline' 0 CA--C 1.54 0.819 0 C-N-CA 123.569 2.846 . . . . 0.0 113.912 170.073 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 2481 ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -76.46 -3.66 38.37 Favored 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 125.684 1.594 . . . . 0.0 113.093 175.057 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 2482 ' ' GLY . . . . . . . . . . . . . . . 104.39 -170.01 17.97 Favored Glycine 0 CA--C 1.529 0.96 0 C-N-CA 125.949 1.737 . . . . 0.0 112.381 -169.178 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 2483 ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -71.56 116.37 11.83 Favored 'General case' 0 N--CA 1.469 0.488 0 O-C-N 121.493 -1.004 . . . . 0.0 111.116 175.336 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 2484 ' ' ARG . . . . . . . . . . . . . 15.2 ttp-105 -98.8 143.36 29.22 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 123.793 0.837 . . . . 0.0 110.512 174.574 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 2485 ' ' VAL . . . . . . . . . . . . . 35.1 m -132.96 150.03 32.44 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 C-N-CA 124.095 0.958 . . . . 0.0 111.563 174.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 2486 ' ' THR . . . . . . . . . . . . . 73.0 m -133.75 135.66 44.08 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 125.332 1.453 . . . . 0.0 108.217 171.8 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 2487 ' ' TYR . . . . . . . . . . . . . 26.4 p90 -141.12 150.98 43.53 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 124.424 1.09 . . . . 0.0 112.5 179.354 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 2488 ' ' THR . . . . . . . . . . . . . 92.2 m -115.49 116.25 41.56 Favored Pre-proline 0 N--CA 1.473 0.676 0 CA-C-O 117.844 -1.074 . . . . 0.0 109.097 173.1 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 2489 ' ' PRO . . . . . . . . . . . . . 77.8 Cg_endo -82.6 135.01 7.78 Favored 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 123.755 2.97 . . . . 0.0 110.382 172.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 2490 ' ' MET . . . . . . . . . . . . . 24.1 ptm -98.12 3.43 49.16 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 114.918 1.451 . . . . 0.0 114.918 -172.421 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 2491 ' ' ALA . . . . . . . . . . . . . . . -153.48 148.64 20.03 Favored Pre-proline 0 CA--C 1.543 0.687 0 C-N-CA 125.146 1.378 . . . . 0.0 111.654 -177.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 2492 ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -73.93 153.48 47.48 Favored 'Trans proline' 0 C--N 1.35 0.631 0 C-N-CA 123.522 2.815 . . . . 0.0 111.569 178.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 2493 ' ' GLY . . . . . . . . . . . . . . . 136.85 -150.8 20.71 Favored Glycine 0 CA--C 1.53 1.026 0 C-N-CA 125.297 1.427 . . . . 0.0 113.166 -178.19 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 2494 ' ' SER . . . . . . . . . . . . . 45.3 m -118.31 124.01 46.76 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.625 1.17 . . . . 0.0 110.982 -178.271 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 2495 ' ' TYR . . . . . . . . . . . . . 40.7 m-85 -103.11 125.82 50.0 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 124.803 1.241 . . . . 0.0 110.164 177.477 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 2496 ' ' LEU . . . . . . . . . . . . . 20.1 tp -95.0 106.8 18.81 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.056 0.943 . . . . 0.0 109.467 -178.412 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 2497 ' ' ILE . . . . . . . . . . . . . 51.9 mt -90.89 103.07 14.06 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 C-N-CA 125.837 1.655 . . . . 0.0 107.849 -178.688 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 2498 ' ' SER . . . . . . . . . . . . . 25.5 t -94.61 91.83 6.75 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 126.042 1.737 . . . . 0.0 109.388 -178.402 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 2499 ' ' ILE . . . . . . . . . . . . . 30.1 mt -91.57 90.37 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 C-N-CA 124.521 1.128 . . . . 0.0 109.52 -174.069 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 2500 ' ' LYS . . . . . . . . . . . . . 56.4 mttp -89.99 142.84 27.31 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 123.79 0.836 . . . . 0.0 111.412 174.695 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 2501 ' ' TYR . . . . . . . . . . . . . 85.7 t80 -148.59 147.96 29.59 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 124.756 1.222 . . . . 0.0 112.226 -175.573 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 2502 ' ' GLY . . . . . . . . . . . . . . . 65.29 16.07 62.03 Favored Glycine 0 CA--C 1.535 1.319 0 C-N-CA 124.567 1.08 . . . . 0.0 114.152 175.38 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 2503 ' ' GLY . . . . . . . . . . . . . . . 134.45 -170.84 22.5 Favored Glycine 0 CA--C 1.542 1.749 0 C-N-CA 126.191 1.853 . . . . 0.0 111.904 -161.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 2504 ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -84.11 33.88 0.51 Allowed 'Trans proline' 0 CA--C 1.547 1.127 0 C-N-CA 124.681 3.587 . . . . 0.0 113.202 -172.806 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 2505 ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -124.51 138.51 54.33 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.483 1.113 . . . . 0.0 113.446 -172.77 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 2506 ' ' HIS . . . . . . . . . . . . . 82.6 m-70 -60.28 143.71 52.14 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 125.694 1.598 . . . . 0.0 113.799 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 2507 ' ' ILE . . . . . . . . . . . . . 31.3 pt -75.1 172.31 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 C-N-CA 123.545 0.738 . . . . 0.0 112.73 168.057 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 2508 ' ' GLY . . . . . . . . . . . . . . . -58.63 121.95 28.26 Favored Glycine 0 CA--C 1.533 1.203 0 C-N-CA 123.661 0.648 . . . . 0.0 111.723 172.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 2509 ' ' GLY . . . . . . . . . . . . . . . 88.82 -9.89 74.61 Favored Glycine 0 CA--C 1.536 1.348 0 C-N-CA 125.653 1.597 . . . . 0.0 115.07 -178.003 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 2510 ' ' SER . . . . . . . . . . . . . 40.3 t -83.59 146.31 49.75 Favored Pre-proline 0 CA--C 1.55 0.978 0 CA-C-N 119.193 1.496 . . . . 0.0 111.893 179.158 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 2511 ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -78.81 154.15 91.17 Favored 'Cis proline' 0 C--N 1.353 0.791 0 CA-C-N 119.751 0.947 . . . . 0.0 113.071 0.072 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 2512 ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -103.63 132.24 50.07 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.043 1.337 . . . . 0.0 110.334 177.174 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 2513 ' ' LYS . . . . . . . . . . . . . 64.6 pttt -93.81 15.88 15.48 Favored 'General case' 0 N--CA 1.479 0.982 0 N-CA-C 116.123 1.897 . . . . 0.0 116.123 -165.565 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 2514 ' ' ALA . . . . . . . . . . . . . . . -12.78 104.23 0.02 OUTLIER 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 129.239 3.016 . . . . 0.0 116.205 -174.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 2515 ' ' LYS . . . . . . . . . . . . . 50.2 mtmt -93.27 130.18 39.09 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 124.406 1.083 . . . . 0.0 111.015 -176.114 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 2516 ' ' VAL . . . . . . . . . . . . . 25.7 m -134.12 148.37 30.09 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 C-N-CA 124.026 0.93 . . . . 0.0 112.253 -172.042 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 2517 ' ' THR . . . . . . . . . . . . . 45.1 p -139.45 165.84 26.16 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 125.568 1.547 . . . . 0.0 111.08 -175.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 2518 ' ' GLY . . . . . . . . . . . . . . . 119.18 -157.67 15.25 Favored Glycine 0 CA--C 1.539 1.535 0 C-N-CA 124.971 1.272 . . . . 0.0 112.331 -173.62 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 2519 ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -71.7 160.73 47.32 Favored 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 123.486 2.791 . . . . 0.0 112.684 -175.146 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 2520 ' ' ARG . . . . . . . . . . . . . 55.1 ttt85 -101.33 117.96 36.01 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.707 1.203 . . . . 0.0 108.941 167.644 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 2521 ' ' LEU . . . . . . . . . . . . . 2.8 mm? -93.17 -7.03 46.46 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 125.264 1.426 . . . . 0.0 112.774 -176.054 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 2522 ' ' VAL . . . . . . . . . . . . . 25.5 t . . . . . 0 C--O 1.254 1.326 0 C-N-CA 126.895 2.078 . . . . 0.0 112.071 176.421 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.513 0 N-CA-C 111.488 -0.645 . . . . 0.0 111.488 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -74.78 168.87 19.02 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 124.593 1.157 . . . . 0.0 113.201 178.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 46.4 tpp -150.29 130.69 13.79 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 125.819 1.648 . . . . 0.0 110.079 177.25 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 2427 ' ' GLY . . . . . . . . . . . . . . . -76.55 150.97 39.03 Favored Glycine 0 CA--C 1.531 1.081 0 C-N-CA 124.383 0.992 . . . . 0.0 113.148 -178.738 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 2428 ' ' ASP . . . . . . . . . . . . . 13.3 t70 -93.01 135.97 25.23 Favored Pre-proline 0 CA--C 1.551 0.984 0 C-N-CA 124.754 1.222 . . . . 0.0 111.625 -178.195 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 2429 ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -67.93 -14.62 41.78 Favored 'Trans proline' 0 CA--C 1.539 0.77 0 C-N-CA 123.575 2.85 . . . . 0.0 114.294 -175.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 2430 ' ' GLY . . . . . . . . . . . . . . . -87.54 -27.03 28.38 Favored Glycine 0 CA--C 1.534 1.222 0 C-N-CA 124.392 0.996 . . . . 0.0 113.187 171.475 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 2431 ' ' LEU . . . . . . . . . . . . . 4.3 mm? -78.29 -36.45 46.62 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 118.247 1.023 . . . . 0.0 111.037 170.436 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 2432 ' ' VAL . . . . . . . . . . . . . 72.8 t -64.63 136.86 25.92 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 C-N-CA 123.356 0.662 . . . . 0.0 109.724 166.515 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 2433 ' ' SER . . . . . . . . . . . . . 8.7 t -134.1 -166.68 1.83 Allowed 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.995 1.318 . . . . 0.0 110.1 176.256 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 2434 ' ' ALA . . . . . . . . . . . . . . . -152.12 143.35 23.26 Favored 'General case' 0 CA--C 1.537 0.478 0 O-C-N 121.002 -1.061 . . . . 0.0 111.308 174.188 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 2435 ' ' TYR . . . . . . . . . . . . . 81.4 m-85 -142.38 156.29 45.21 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 125.269 1.428 . . . . 0.0 112.076 -176.712 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 2436 ' ' GLY . . . . . . . . . . . . . . . 116.55 157.27 10.93 Favored Glycine 0 N--CA 1.472 1.06 0 C-N-CA 125.705 1.621 . . . . 0.0 113.266 -179.532 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 2437 ' ' ALA . . . . . . . . . . . . . . . -60.82 -28.46 68.81 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.863 1.265 . . . . 0.0 114.222 -170.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 2438 ' ' GLY . . . . . . . . . . . . . . . -67.68 -9.98 57.04 Favored Glycine 0 CA--C 1.531 1.045 0 CA-C-O 118.894 -0.948 . . . . 0.0 114.957 -178.008 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 2439 ' ' LEU . . . . . . . . . . . . . 79.4 mt -83.33 -24.86 31.92 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 124.747 1.219 . . . . 0.0 112.709 170.048 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 2440 ' ' GLU . . . . . . . . . . . . . 39.5 mm-40 -91.15 -39.23 12.26 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.885 1.274 . . . . 0.0 111.382 -179.34 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 2441 ' ' GLY . . . . . . . . . . . . . . . 164.13 -158.73 31.41 Favored Glycine 0 CA--C 1.528 0.876 0 N-CA-C 115.617 1.007 . . . . 0.0 115.617 -177.834 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 2442 ' ' GLY . . . . . . . . . . . . . . . 175.74 -165.77 36.69 Favored Glycine 0 CA--C 1.531 1.047 0 C-N-CA 125.638 1.589 . . . . 0.0 112.871 179.3 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 2443 ' ' VAL . . . . . . . . . . . . . 86.6 t -129.18 146.4 34.29 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 125.414 1.486 . . . . 0.0 108.672 174.423 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 2444 ' ' THR . . . . . . . . . . . . . 41.6 p -58.34 133.81 56.04 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-O 121.427 0.632 . . . . 0.0 111.661 178.231 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 2445 ' ' GLY . . . . . . . . . . . . . . . 79.14 -6.9 55.33 Favored Glycine 0 CA--C 1.537 1.464 0 C-N-CA 124.734 1.159 . . . . 0.0 115.052 -175.633 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 2446 ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -100.97 142.26 24.27 Favored Pre-proline 0 CA--C 1.553 1.059 0 C-N-CA 125.751 1.62 . . . . 0.0 111.179 177.573 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 2447 ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -74.29 129.52 13.1 Favored 'Trans proline' 0 C--N 1.351 0.68 0 C-N-CA 122.98 2.453 . . . . 0.0 111.34 179.768 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 2448 ' ' ALA . . . . . . . . . . . . . . . -105.57 120.33 41.38 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 126.365 1.866 . . . . 0.0 109.207 172.548 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 2449 ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -119.16 138.49 52.89 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.775 1.23 . . . . 0.0 111.542 -170.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 2450 ' ' PHE . . . . . . . . . . . . . 37.5 p90 -153.34 165.28 36.26 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.311 1.444 . . . . 0.0 111.85 173.272 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 2451 ' ' VAL . . . . . . . . . . . . . 43.0 t -126.85 131.75 70.74 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 C-N-CA 124.897 1.279 . . . . 0.0 109.701 176.172 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 2452 ' ' VAL . . . . . . . . . . . . . 40.0 t -78.6 105.43 7.78 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 N-CA-C 107.318 -1.364 . . . . 0.0 107.318 165.577 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 2453 ' ' ASN . . . . . . . . . . . . . 14.7 t-20 -83.19 115.1 21.78 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 123.804 0.842 . . . . 0.0 112.292 -169.161 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 2454 ' ' THR . . . . . . . . . . . . . 43.9 p -103.96 -9.1 19.14 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 125.687 1.595 . . . . 0.0 113.812 -177.648 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 2455 ' ' SER . . . . . . . . . . . . . 16.3 m -57.29 -29.21 63.69 Favored 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 114.637 1.347 . . . . 0.0 114.637 -172.622 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 2456 ' ' ASN . . . . . . . . . . . . . 68.9 m-80 -85.49 -13.25 49.7 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 124.671 1.188 . . . . 0.0 113.579 177.332 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 2457 ' ' ALA . . . . . . . . . . . . . . . -112.09 -25.6 9.26 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 125.576 1.55 . . . . 0.0 114.162 -174.312 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 2458 ' ' GLY . . . . . . . . . . . . . . . 103.75 -111.89 4.02 Favored Glycine 0 CA--C 1.53 0.987 0 C-N-CA 125.095 1.331 . . . . 0.0 111.844 -177.603 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 2459 ' ' ALA . . . . . . . . . . . . . . . -137.87 160.52 39.07 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.291 1.436 . . . . 0.0 112.201 -176.817 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 2460 ' ' GLY . . . . . . . . . . . . . . . 158.19 174.24 27.64 Favored Glycine 0 CA--C 1.529 0.946 0 C-N-CA 124.427 1.013 . . . . 0.0 113.973 -172.696 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 2461 ' ' ALA . . . . . . . . . . . . . . . -83.03 148.71 27.39 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.48 1.112 . . . . 0.0 112.706 -178.16 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 2462 ' ' LEU . . . . . . . . . . . . . 59.7 tp -129.22 138.85 51.93 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 125.545 1.538 . . . . 0.0 110.588 177.16 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 2463 ' ' SER . . . . . . . . . . . . . 18.2 t -118.26 151.25 38.01 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.478 1.111 . . . . 0.0 109.604 156.559 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 2464 ' ' VAL . . . . . . . . . . . . . 7.5 p -161.77 133.16 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 124.184 0.993 . . . . 0.0 110.819 -178.054 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 2465 ' ' THR . . . . . . . . . . . . . 62.7 m -140.85 142.83 34.51 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 125.578 1.551 . . . . 0.0 109.516 -175.377 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 2466 ' ' ILE . . . . . . . . . . . . . 41.9 mt -114.96 115.94 51.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 124.433 1.093 . . . . 0.0 109.442 177.132 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 2467 ' ' ASP . . . . . . . . . . . . . 35.1 t70 -96.63 161.41 13.9 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 125.929 1.692 . . . . 0.0 110.34 168.657 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 2468 ' ' GLY . . . . . . . . . . . . . . . 166.2 -164.21 37.39 Favored Glycine 0 CA--C 1.536 1.361 0 O-C-N 121.18 -0.95 . . . . 0.0 114.973 178.521 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 2469 ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -70.07 -14.08 34.68 Favored 'Trans proline' 0 CA--C 1.541 0.852 0 C-N-CA 124.202 3.268 . . . . 0.0 114.004 -178.836 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 2470 ' ' SER . . . . . . . . . . . . . 29.1 m -156.87 174.91 14.8 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 126.769 2.027 . . . . 0.0 110.363 175.637 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 2471 ' ' LYS . . . . . . . . . . . . . 58.4 mtmt -68.14 165.82 17.41 Favored 'General case' 0 CA--C 1.549 0.912 0 O-C-N 121.117 -0.989 . . . . 0.0 111.734 166.443 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 2472 ' ' VAL . . . . . . . . . . . . . 19.1 m -135.43 152.26 31.51 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 C-N-CA 124.777 1.231 . . . . 0.0 111.421 -179.442 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 2473 ' ' LYS . . . . . . . . . . . . . 29.2 mtpp -81.18 64.29 5.86 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 124.488 1.115 . . . . 0.0 111.806 179.463 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 2474 ' ' MET . . . . . . . . . . . . . 19.0 ttt -69.43 133.53 47.87 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 125.27 1.428 . . . . 0.0 112.161 -174.518 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 2475 ' ' ASP . . . . . . . . . . . . . 35.1 t70 -139.13 122.94 17.63 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 126.361 1.865 . . . . 0.0 110.109 176.266 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 2476 ' ' CYS . . . . . . . . . . . . . 73.6 m -104.38 140.79 37.41 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.733 1.213 . . . . 0.0 111.182 -179.021 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 2477 ' ' GLN . . . . . . . . . . . . . 81.0 mt-30 -140.83 148.01 39.91 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.127 1.371 . . . . 0.0 110.283 -176.223 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 2478 ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -95.03 118.58 32.08 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 123.686 0.795 . . . . 0.0 109.839 174.74 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 2479 ' ' CYS . . . . . . . . . . . . . 88.8 m -123.21 163.24 35.06 Favored Pre-proline 0 CA--C 1.551 0.992 0 C-N-CA 125.386 1.474 . . . . 0.0 111.587 -179.3 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 2480 ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -57.8 -31.29 91.94 Favored 'Trans proline' 0 C--N 1.353 0.803 0 C-N-CA 123.624 2.883 . . . . 0.0 114.071 174.579 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 2481 ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -77.19 -11.23 59.79 Favored 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 125.329 1.452 . . . . 0.0 112.98 178.216 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 2482 ' ' GLY . . . . . . . . . . . . . . . 125.57 -162.4 19.82 Favored Glycine 0 CA--C 1.53 0.983 0 C-N-CA 126.3 1.905 . . . . 0.0 112.993 -175.688 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 2483 ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -73.27 108.52 6.2 Favored 'General case' 0 CA--C 1.54 0.576 0 O-C-N 121.574 -0.957 . . . . 0.0 111.133 178.345 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 2484 ' ' ARG . . . . . . . . . . . . . 44.5 ttm180 -81.05 140.72 34.96 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 124.756 1.222 . . . . 0.0 110.448 174.561 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 2485 ' ' VAL . . . . . . . . . . . . . 90.4 t -130.72 129.05 63.82 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 C-N-CA 125.608 1.563 . . . . 0.0 108.592 174.499 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 2486 ' ' THR . . . . . . . . . . . . . 48.7 m -122.02 140.24 52.72 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 124.41 1.084 . . . . 0.0 108.351 170.18 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 2487 ' ' TYR . . . . . . . . . . . . . 34.7 p90 -146.22 149.14 33.35 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 123.852 0.861 . . . . 0.0 112.089 176.751 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 2488 ' ' THR . . . . . . . . . . . . . 87.7 m -111.87 115.53 50.78 Favored Pre-proline 0 N--CA 1.473 0.701 0 CA-C-O 117.875 -1.06 . . . . 0.0 108.9 174.161 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 2489 ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -79.61 161.88 24.76 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 123.965 3.11 . . . . 0.0 111.107 174.08 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 2490 ' ' MET . . . . . . . . . . . . . 25.6 ptm -138.32 3.43 2.36 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 114.977 1.473 . . . . 0.0 114.977 -173.071 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 2491 ' ' ALA . . . . . . . . . . . . . . . -143.47 146.23 34.9 Favored Pre-proline 0 CA--C 1.546 0.817 0 C-N-CA 125.179 1.391 . . . . 0.0 110.741 173.058 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 2492 ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -71.92 151.03 56.1 Favored 'Trans proline' 0 CA--C 1.536 0.594 0 C-N-CA 122.852 2.368 . . . . 0.0 111.04 175.51 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 2493 ' ' GLY . . . . . . . . . . . . . . . 135.5 -162.15 24.83 Favored Glycine 0 CA--C 1.529 0.944 0 C-N-CA 125.167 1.365 . . . . 0.0 113.366 -177.159 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 2494 ' ' SER . . . . . . . . . . . . . 42.2 m -101.34 123.46 45.47 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.151 0.98 . . . . 0.0 111.186 178.69 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 2495 ' ' TYR . . . . . . . . . . . . . 79.2 m-85 -96.82 134.34 40.25 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.508 1.123 . . . . 0.0 110.084 168.299 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 2496 ' ' LEU . . . . . . . . . . . . . 23.8 tp -110.4 115.12 29.1 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.724 1.21 . . . . 0.0 109.86 -176.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 2497 ' ' ILE . . . . . . . . . . . . . 45.0 mt -101.72 102.84 14.08 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 C-N-CA 125.683 1.593 . . . . 0.0 108.474 -173.68 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 2498 ' ' SER . . . . . . . . . . . . . 72.3 m -90.71 90.34 7.91 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 124.457 1.103 . . . . 0.0 110.67 -177.814 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 2499 ' ' ILE . . . . . . . . . . . . . 28.3 mt -91.14 118.09 35.71 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 125.035 1.334 . . . . 0.0 109.756 -178.286 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 2500 ' ' LYS . . . . . . . . . . . . . 82.0 mttt -131.71 106.93 8.45 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 124.865 1.266 . . . . 0.0 112.375 -171.733 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 2501 ' ' TYR . . . . . . . . . . . . . 39.3 t80 -109.49 142.89 39.87 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.721 1.208 . . . . 0.0 112.713 -175.183 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 2502 ' ' GLY . . . . . . . . . . . . . . . 70.87 9.55 66.28 Favored Glycine 0 CA--C 1.535 1.307 0 C-N-CA 124.682 1.134 . . . . 0.0 114.756 175.021 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 2503 ' ' GLY . . . . . . . . . . . . . . . 153.28 -171.73 32.19 Favored Glycine 0 CA--C 1.538 1.502 0 C-N-CA 125.802 1.668 . . . . 0.0 113.129 -172.144 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 2504 ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -82.09 19.04 1.3 Allowed 'Trans proline' 0 CA--C 1.546 1.106 0 C-N-CA 124.877 3.718 . . . . 0.0 113.749 -174.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 2505 ' ' TYR . . . . . . . . . . . . . 80.3 m-85 -113.94 143.7 44.28 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.213 1.405 . . . . 0.0 112.751 -175.26 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 2506 ' ' HIS . . . . . . . . . . . . . 97.5 m-70 -63.99 145.14 56.4 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 124.382 1.073 . . . . 0.0 113.632 -178.45 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 2507 ' ' ILE . . . . . . . . . . . . . 29.4 pt -75.06 173.68 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.213 0 C-N-CA 123.56 0.744 . . . . 0.0 112.869 171.373 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 2508 ' ' GLY . . . . . . . . . . . . . . . -58.7 120.5 22.65 Favored Glycine 0 CA--C 1.533 1.206 0 O-C-N 121.486 -0.759 . . . . 0.0 111.704 174.379 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 2509 ' ' GLY . . . . . . . . . . . . . . . 87.0 -8.2 77.36 Favored Glycine 0 CA--C 1.537 1.414 0 C-N-CA 125.52 1.533 . . . . 0.0 115.023 -177.07 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 2510 ' ' SER . . . . . . . . . . . . . 45.8 t -87.64 147.19 40.95 Favored Pre-proline 0 CA--C 1.549 0.937 0 CA-C-N 118.927 1.364 . . . . 0.0 111.826 179.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 2511 ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -76.34 151.9 95.47 Favored 'Cis proline' 0 C--N 1.352 0.722 0 CA-C-N 119.711 0.933 . . . . 0.0 112.748 -1.437 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 2512 ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -99.53 132.13 45.07 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 124.705 1.202 . . . . 0.0 111.151 179.851 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 2513 ' ' LYS . . . . . . . . . . . . . 64.9 pttt -96.26 22.85 7.22 Favored 'General case' 0 CA--C 1.552 1.02 0 N-CA-C 115.991 1.849 . . . . 0.0 115.991 -164.38 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 2514 ' ' ALA . . . . . . . . . . . . . . . -28.64 114.74 0.09 Allowed 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 128.118 2.567 . . . . 0.0 115.612 -173.807 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 2515 ' ' LYS . . . . . . . . . . . . . 89.0 mttt -98.17 135.13 40.26 Favored 'General case' 0 N--CA 1.474 0.77 0 O-C-N 121.312 -0.868 . . . . 0.0 112.74 -174.519 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 2516 ' ' VAL . . . . . . . . . . . . . 75.4 t -122.51 139.28 49.88 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 C-N-CA 125.284 1.434 . . . . 0.0 110.609 -170.604 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 2517 ' ' THR . . . . . . . . . . . . . 66.1 p -120.99 178.86 4.56 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 125.783 1.633 . . . . 0.0 111.107 176.331 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 2518 ' ' GLY . . . . . . . . . . . . . . . 100.51 179.55 29.59 Favored Glycine 0 CA--C 1.539 1.585 0 C-N-CA 124.828 1.204 . . . . 0.0 113.263 -175.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 2519 ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -72.53 152.05 53.74 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 123.788 2.992 . . . . 0.0 111.86 -175.449 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 2520 ' ' ARG . . . . . . . . . . . . . 45.8 ttp180 -79.15 127.95 32.68 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 123.384 0.673 . . . . 0.0 110.14 172.476 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 2521 ' ' LEU . . . . . . . . . . . . . 4.0 mm? -82.85 -23.26 33.78 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.854 0.862 . . . . 0.0 112.368 178.377 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 2522 ' ' VAL . . . . . . . . . . . . . 43.2 t . . . . . 0 C--O 1.252 1.207 0 C-N-CA 125.884 1.674 . . . . 0.0 111.391 176.493 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.596 0 N-CA-C 111.629 -0.588 . . . . 0.0 111.629 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -78.61 178.68 7.63 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 124.067 0.947 . . . . 0.0 112.45 176.38 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 37.3 mmt -66.46 -16.87 64.44 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.802 0.841 . . . . 0.0 112.702 168.089 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 2427 ' ' GLY . . . . . . . . . . . . . . . -172.2 118.28 0.71 Allowed Glycine 0 CA--C 1.527 0.781 0 C-N-CA 127.116 2.293 . . . . 0.0 110.132 172.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 2428 ' ' ASP . . . . . . . . . . . . . 41.8 m-20 -87.24 142.49 33.54 Favored Pre-proline 0 CA--C 1.548 0.872 0 C-N-CA 123.638 0.775 . . . . 0.0 112.283 -170.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 2429 ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -64.66 -27.12 60.83 Favored 'Trans proline' 0 C--N 1.351 0.69 0 C-N-CA 123.207 2.605 . . . . 0.0 113.216 -176.153 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 2430 ' ' GLY . . . . . . . . . . . . . . . -73.87 -22.24 78.33 Favored Glycine 0 CA--C 1.535 1.295 0 CA-C-N 118.905 0.775 . . . . 0.0 113.652 175.347 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 2431 ' ' LEU . . . . . . . . . . . . . 4.4 mm? -88.67 -28.75 20.39 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 124.622 1.169 . . . . 0.0 111.869 173.108 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 2432 ' ' VAL . . . . . . . . . . . . . 71.1 t -68.79 136.63 25.98 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 123.756 0.823 . . . . 0.0 110.292 169.681 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 2433 ' ' SER . . . . . . . . . . . . . 74.6 m -123.61 -177.86 3.85 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 125.419 1.488 . . . . 0.0 110.261 172.862 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 2434 ' ' ALA . . . . . . . . . . . . . . . -143.77 146.17 32.92 Favored 'General case' 0 CA--C 1.538 0.501 0 O-C-N 120.701 -1.25 . . . . 0.0 111.499 170.541 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 2435 ' ' TYR . . . . . . . . . . . . . 76.2 m-85 -145.06 152.22 39.77 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.441 1.497 . . . . 0.0 111.992 -174.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 2436 ' ' GLY . . . . . . . . . . . . . . . 121.74 158.66 10.41 Favored Glycine 0 N--CA 1.473 1.114 0 C-N-CA 125.492 1.52 . . . . 0.0 113.404 179.184 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 2437 ' ' ALA . . . . . . . . . . . . . . . -61.32 -27.06 68.22 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.79 1.236 . . . . 0.0 114.245 -171.398 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 2438 ' ' GLY . . . . . . . . . . . . . . . -66.79 -14.17 62.55 Favored Glycine 0 CA--C 1.53 0.982 0 CA-C-O 119.067 -0.851 . . . . 0.0 114.492 -179.183 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 2439 ' ' LEU . . . . . . . . . . . . . 67.6 mt -78.82 -23.19 45.24 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 118.442 1.121 . . . . 0.0 112.449 170.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 2440 ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -92.41 -29.28 16.37 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.168 1.387 . . . . 0.0 111.83 176.117 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 2441 ' ' GLY . . . . . . . . . . . . . . . 108.31 -134.66 12.35 Favored Glycine 0 CA--C 1.532 1.114 0 C-N-CA 125.829 1.68 . . . . 0.0 112.525 178.433 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 2442 ' ' GLY . . . . . . . . . . . . . . . 136.78 -153.9 21.92 Favored Glycine 0 CA--C 1.534 1.265 0 C-N-CA 124.884 1.231 . . . . 0.0 114.494 -176.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 2443 ' ' VAL . . . . . . . . . . . . . 87.5 t -79.84 134.65 27.12 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 C-N-CA 124.622 1.169 . . . . 0.0 111.029 -174.83 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 2444 ' ' THR . . . . . . . . . . . . . 39.1 p -68.92 144.06 54.29 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.251 1.021 . . . . 0.0 112.021 176.276 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 2445 ' ' GLY . . . . . . . . . . . . . . . 83.38 -22.28 7.57 Favored Glycine 0 CA--C 1.536 1.359 0 C-N-CA 125.416 1.484 . . . . 0.0 113.903 -174.541 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 2446 ' ' ASN . . . . . . . . . . . . . 80.4 m-20 -87.19 152.96 53.69 Favored Pre-proline 0 CA--C 1.547 0.864 0 C-N-CA 124.749 1.22 . . . . 0.0 110.816 170.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 2447 ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -72.04 144.06 41.78 Favored 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 122.942 2.428 . . . . 0.0 111.658 179.387 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 2448 ' ' ALA . . . . . . . . . . . . . . . -119.04 137.98 53.17 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 127.309 2.244 . . . . 0.0 108.847 172.634 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 2449 ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -146.21 138.16 25.01 Favored 'General case' 0 N--CA 1.471 0.589 0 O-C-N 121.517 -0.74 . . . . 0.0 112.585 -163.041 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 2450 ' ' PHE . . . . . . . . . . . . . 50.6 p90 -154.22 159.73 41.49 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 125.52 1.528 . . . . 0.0 112.383 -179.109 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 2451 ' ' VAL . . . . . . . . . . . . . 88.3 t -112.65 132.73 60.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 125.552 1.541 . . . . 0.0 109.349 173.049 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 2452 ' ' VAL . . . . . . . . . . . . . 33.3 t -84.86 103.68 12.27 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 164.638 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 2453 ' ' ASN . . . . . . . . . . . . . 15.5 t-20 -87.06 116.89 25.42 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.2 1.0 . . . . 0.0 112.314 -168.568 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 2454 ' ' THR . . . . . . . . . . . . . 43.3 p -103.2 -4.44 24.37 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 126.214 1.806 . . . . 0.0 114.241 -173.09 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 2455 ' ' SER . . . . . . . . . . . . . 19.6 m -56.0 -34.55 65.9 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 114.961 1.467 . . . . 0.0 114.961 -170.296 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 2456 ' ' ASN . . . . . . . . . . . . . 29.8 m120 -86.94 -10.93 52.08 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 124.329 1.051 . . . . 0.0 113.495 178.061 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 2457 ' ' ALA . . . . . . . . . . . . . . . -103.32 -53.96 2.7 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.206 1.402 . . . . 0.0 112.85 -174.763 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 2458 ' ' GLY . . . . . . . . . . . . . . . 125.63 -121.04 4.05 Favored Glycine 0 CA--C 1.531 1.064 0 C-N-CA 124.967 1.27 . . . . 0.0 112.658 -172.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 2459 ' ' ALA . . . . . . . . . . . . . . . -126.65 166.25 17.69 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 125.679 1.592 . . . . 0.0 112.781 -173.326 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 2460 ' ' GLY . . . . . . . . . . . . . . . 146.77 173.06 17.67 Favored Glycine 0 CA--C 1.531 1.047 0 C-N-CA 124.394 0.997 . . . . 0.0 114.054 -177.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 2461 ' ' ALA . . . . . . . . . . . . . . . -82.37 150.92 26.89 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.512 1.125 . . . . 0.0 112.811 -178.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 2462 ' ' LEU . . . . . . . . . . . . . 23.4 tp -109.42 148.27 31.41 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 126.272 1.829 . . . . 0.0 110.678 177.301 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 2463 ' ' SER . . . . . . . . . . . . . 8.4 t -150.03 68.7 1.0 Allowed 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 124.128 0.971 . . . . 0.0 111.449 177.5 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 2464 ' ' VAL . . . . . . . . . . . . . 42.2 t -74.3 139.62 18.96 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.24 0 O-C-N 120.692 -1.255 . . . . 0.0 110.764 178.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 2465 ' ' THR . . . . . . . . . . . . . 16.4 m -125.41 141.34 52.11 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 125.043 1.337 . . . . 0.0 108.929 169.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 2466 ' ' ILE . . . . . . . . . . . . . 26.5 mt -122.14 126.36 74.25 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 123.425 0.69 . . . . 0.0 109.921 171.677 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 2467 ' ' ASP . . . . . . . . . . . . . 35.8 t70 -110.95 148.53 32.29 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 126.044 1.738 . . . . 0.0 110.192 170.176 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 2468 ' ' GLY . . . . . . . . . . . . . . . 170.51 -164.81 38.07 Favored Glycine 0 CA--C 1.536 1.395 0 N-CA-C 114.996 0.758 . . . . 0.0 114.996 -178.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 2469 ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -68.34 -25.02 36.53 Favored 'Trans proline' 0 CA--C 1.54 0.79 0 C-N-CA 124.002 3.135 . . . . 0.0 114.752 -171.712 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 2470 ' ' SER . . . . . . . . . . . . . 17.3 m -159.53 142.54 14.15 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 125.82 1.648 . . . . 0.0 110.566 174.693 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 2471 ' ' LYS . . . . . . . . . . . . . 55.3 mtmt -61.57 122.06 14.31 Favored 'General case' 0 N--CA 1.476 0.862 0 O-C-N 121.074 -1.016 . . . . 0.0 112.9 -172.818 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 2472 ' ' VAL . . . . . . . . . . . . . 21.0 m -77.21 151.6 5.66 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 C-N-CA 124.441 1.096 . . . . 0.0 112.512 -175.598 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 2473 ' ' LYS . . . . . . . . . . . . . 38.3 mtmm -78.63 145.62 34.57 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 123.234 0.614 . . . . 0.0 109.867 160.315 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 2474 ' ' MET . . . . . . . . . . . . . 56.5 ttm -147.94 144.29 27.92 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 124.273 1.029 . . . . 0.0 112.518 -174.804 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 2475 ' ' ASP . . . . . . . . . . . . . 21.5 m-20 -125.81 149.93 48.22 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 126.843 2.057 . . . . 0.0 109.996 162.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 2476 ' ' CYS . . . . . . . . . . . . . 44.7 t -142.98 142.17 31.56 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.89 1.276 . . . . 0.0 110.757 179.075 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 2477 ' ' GLN . . . . . . . . . . . . . 6.0 tp-100 -155.9 146.82 22.21 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.309 1.044 . . . . 0.0 111.017 -175.704 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 2478 ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -78.53 128.63 33.82 Favored 'General case' 0 CA--C 1.541 0.628 0 O-C-N 121.62 -0.675 . . . . 0.0 111.455 174.637 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 2479 ' ' CYS . . . . . . . . . . . . . 95.3 m -124.5 167.09 16.68 Favored Pre-proline 0 CA--C 1.552 1.046 0 C-N-CA 126.152 1.781 . . . . 0.0 110.644 177.148 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 2480 ' ' PRO . . . . . . . . . . . . . 64.3 Cg_exo -57.46 -29.92 86.33 Favored 'Trans proline' 0 C--N 1.353 0.793 0 C-N-CA 123.53 2.82 . . . . 0.0 114.374 175.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 2481 ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -80.53 -6.93 58.94 Favored 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 125.356 1.462 . . . . 0.0 113.099 177.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 2482 ' ' GLY . . . . . . . . . . . . . . . 119.39 -169.39 13.68 Favored Glycine 0 CA--C 1.532 1.095 0 C-N-CA 126.326 1.917 . . . . 0.0 112.408 -172.016 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 2483 ' ' TYR . . . . . . . . . . . . . 63.0 m-85 -69.4 118.69 12.6 Favored 'General case' 0 N--CA 1.47 0.565 0 O-C-N 121.206 -1.173 . . . . 0.0 111.69 177.279 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 2484 ' ' ARG . . . . . . . . . . . . . 58.8 ttt180 -96.19 132.07 42.0 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 125.414 1.486 . . . . 0.0 110.273 178.536 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 2485 ' ' VAL . . . . . . . . . . . . . 67.0 t -123.11 131.98 72.24 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 C-N-CA 125.825 1.65 . . . . 0.0 109.065 -177.372 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 2486 ' ' THR . . . . . . . . . . . . . 50.3 m -124.54 132.96 53.44 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 124.845 1.258 . . . . 0.0 108.126 172.217 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 2487 ' ' TYR . . . . . . . . . . . . . 22.0 p90 -140.45 157.85 44.89 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.194 0.998 . . . . 0.0 112.392 179.162 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 2488 ' ' THR . . . . . . . . . . . . . 91.8 m -113.87 105.2 54.75 Favored Pre-proline 0 N--CA 1.476 0.852 0 CA-C-O 118.107 -0.949 . . . . 0.0 109.818 179.121 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 2489 ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -69.44 128.87 16.96 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 123.022 2.481 . . . . 0.0 109.437 170.344 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 2490 ' ' MET . . . . . . . . . . . . . 27.9 ptm -114.35 -1.47 13.52 Favored 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 114.777 1.399 . . . . 0.0 114.777 -171.33 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 2491 ' ' ALA . . . . . . . . . . . . . . . -147.4 144.82 20.05 Favored Pre-proline 0 CA--C 1.546 0.806 0 C-N-CA 124.902 1.281 . . . . 0.0 110.982 -179.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 2492 ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -72.6 151.43 52.56 Favored 'Trans proline' 0 C--N 1.351 0.688 0 C-N-CA 123.414 2.743 . . . . 0.0 111.392 -176.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 2493 ' ' GLY . . . . . . . . . . . . . . . 133.0 -142.49 14.01 Favored Glycine 0 CA--C 1.529 0.909 0 C-N-CA 124.875 1.226 . . . . 0.0 112.507 -175.386 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 2494 ' ' SER . . . . . . . . . . . . . 39.6 m -123.96 128.5 49.5 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.349 1.059 . . . . 0.0 111.292 -179.576 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 2495 ' ' TYR . . . . . . . . . . . . . 41.7 m-85 -101.04 119.16 38.33 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.775 1.23 . . . . 0.0 110.578 171.602 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 2496 ' ' LEU . . . . . . . . . . . . . 25.3 tp -91.97 110.2 21.55 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.543 1.137 . . . . 0.0 109.512 179.084 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 2497 ' ' ILE . . . . . . . . . . . . . 21.9 mt -97.75 98.99 7.99 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 C-N-CA 125.863 1.665 . . . . 0.0 108.768 -176.299 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 2498 ' ' SER . . . . . . . . . . . . . 69.4 m -86.56 81.92 8.1 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 125.482 1.513 . . . . 0.0 110.133 177.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 2499 ' ' ILE . . . . . . . . . . . . . 51.9 mt -76.62 117.71 21.85 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 C-N-CA 124.99 1.316 . . . . 0.0 109.407 177.41 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 2500 ' ' LYS . . . . . . . . . . . . . 2.2 mtmp? -129.01 143.19 50.79 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 125.122 1.369 . . . . 0.0 110.712 -178.627 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 2501 ' ' TYR . . . . . . . . . . . . . 49.5 t80 -152.37 144.46 23.83 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 124.496 1.118 . . . . 0.0 112.321 -171.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 2502 ' ' GLY . . . . . . . . . . . . . . . 67.65 16.24 67.52 Favored Glycine 0 CA--C 1.536 1.384 0 C-N-CA 124.177 0.894 . . . . 0.0 113.728 178.061 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 2503 ' ' GLY . . . . . . . . . . . . . . . 147.04 -174.76 26.73 Favored Glycine 0 CA--C 1.54 1.624 0 C-N-CA 126.216 1.865 . . . . 0.0 112.436 -167.508 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 2504 ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -84.7 12.56 3.02 Favored 'Trans proline' 0 CA--C 1.544 1.006 0 C-N-CA 124.551 3.501 . . . . 0.0 113.904 -173.159 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 2505 ' ' TYR . . . . . . . . . . . . . 58.9 m-85 -110.47 147.58 33.8 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 124.474 1.11 . . . . 0.0 113.849 -171.486 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 2506 ' ' HIS . . . . . . . . . . . . . 92.8 m-70 -63.47 141.14 58.88 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 125.095 1.358 . . . . 0.0 113.497 -175.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 2507 ' ' ILE . . . . . . . . . . . . . 1.7 pp -79.45 175.53 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 N-CA-C 113.281 0.845 . . . . 0.0 113.281 176.449 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 2508 ' ' GLY . . . . . . . . . . . . . . . -60.75 111.14 3.48 Favored Glycine 0 CA--C 1.532 1.155 0 O-C-N 121.237 -0.915 . . . . 0.0 112.652 -178.575 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 2509 ' ' GLY . . . . . . . . . . . . . . . 95.38 -8.72 69.38 Favored Glycine 0 CA--C 1.536 1.353 0 C-N-CA 125.984 1.754 . . . . 0.0 114.7 -176.349 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 2510 ' ' SER . . . . . . . . . . . . . 47.9 t -83.2 147.52 53.87 Favored Pre-proline 0 CA--C 1.549 0.936 0 CA-C-N 118.802 1.301 . . . . 0.0 111.997 179.538 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 2511 ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -78.18 154.76 93.65 Favored 'Cis proline' 0 C--N 1.353 0.781 0 CA-C-N 119.809 0.967 . . . . 0.0 112.98 -1.383 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 2512 ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -104.86 131.67 52.06 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 125.141 1.376 . . . . 0.0 110.728 178.32 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 2513 ' ' LYS . . . . . . . . . . . . . 19.5 ptpt -89.13 8.04 32.02 Favored 'General case' 0 N--CA 1.479 0.983 0 N-CA-C 116.617 2.08 . . . . 0.0 116.617 -166.707 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 2514 ' ' ALA . . . . . . . . . . . . . . . -2.52 96.99 0.01 OUTLIER 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 129.436 3.095 . . . . 0.0 116.316 -177.722 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 2515 ' ' LYS . . . . . . . . . . . . . 44.9 mtpt -90.03 133.18 34.98 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.157 0.983 . . . . 0.0 111.354 -173.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 2516 ' ' VAL . . . . . . . . . . . . . 31.7 m -133.0 149.22 31.53 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 C-N-CA 124.326 1.05 . . . . 0.0 112.426 -168.764 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 2517 ' ' THR . . . . . . . . . . . . . 35.8 p -140.3 164.18 30.79 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 125.611 1.565 . . . . 0.0 111.365 -174.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 2518 ' ' GLY . . . . . . . . . . . . . . . 116.42 -162.19 12.74 Favored Glycine 0 CA--C 1.539 1.538 0 C-N-CA 125.046 1.308 . . . . 0.0 112.441 -174.308 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 2519 ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -72.56 167.23 27.64 Favored 'Trans proline' 0 CA--C 1.536 0.576 0 C-N-CA 123.562 2.842 . . . . 0.0 112.09 -177.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 2520 ' ' ARG . . . . . . . . . . . . . 49.1 ttp180 -98.2 121.3 39.96 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.148 0.979 . . . . 0.0 109.189 167.476 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 2521 ' ' LEU . . . . . . . . . . . . . 2.8 mm? -91.28 44.96 1.21 Allowed 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 124.944 1.298 . . . . 0.0 111.794 -173.766 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 2522 ' ' VAL . . . . . . . . . . . . . 7.2 p . . . . . 0 C--O 1.252 1.22 0 C-N-CA 127.683 2.393 . . . . 0.0 111.374 -179.864 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.547 0 N-CA-C 112.065 -0.414 . . . . 0.0 112.065 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -154.41 155.55 35.2 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 125.637 1.575 . . . . 0.0 111.511 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 97.6 mmm -67.05 133.8 50.61 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 124.396 1.078 . . . . 0.0 112.562 -176.776 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 2427 ' ' GLY . . . . . . . . . . . . . . . -92.4 147.23 18.57 Favored Glycine 0 CA--C 1.529 0.961 0 C-N-CA 125.344 1.449 . . . . 0.0 113.832 -179.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 2428 ' ' ASP . . . . . . . . . . . . . 12.5 t70 -82.89 136.06 44.77 Favored Pre-proline 0 CA--C 1.548 0.896 0 C-N-CA 125.285 1.434 . . . . 0.0 111.211 177.4 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 2429 ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -63.06 -22.08 73.28 Favored 'Trans proline' 0 C--N 1.353 0.771 0 C-N-CA 123.642 2.895 . . . . 0.0 114.244 -174.661 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 2430 ' ' GLY . . . . . . . . . . . . . . . -80.79 -20.2 66.23 Favored Glycine 0 CA--C 1.534 1.232 0 C-N-CA 124.054 0.835 . . . . 0.0 113.691 174.738 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 2431 ' ' LEU . . . . . . . . . . . . . 4.3 mm? -84.49 -28.42 26.77 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.462 1.105 . . . . 0.0 111.999 173.433 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 2432 ' ' VAL . . . . . . . . . . . . . 2.3 t -67.74 143.12 15.65 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 CA-C-N 118.7 0.682 . . . . 0.0 109.491 169.561 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 2433 ' ' SER . . . . . . . . . . . . . 8.1 t -135.86 -172.77 3.19 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.311 1.044 . . . . 0.0 110.569 171.436 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 2434 ' ' ALA . . . . . . . . . . . . . . . -148.93 142.33 25.23 Favored 'General case' 0 CA--C 1.537 0.455 0 O-C-N 120.921 -1.112 . . . . 0.0 111.638 177.232 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 2435 ' ' TYR . . . . . . . . . . . . . 74.7 m-85 -143.67 146.81 33.5 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.229 1.411 . . . . 0.0 112.027 -174.326 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 2436 ' ' GLY . . . . . . . . . . . . . . . 128.35 159.98 10.2 Favored Glycine 0 N--CA 1.473 1.108 0 C-N-CA 125.767 1.651 . . . . 0.0 113.571 179.34 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 2437 ' ' ALA . . . . . . . . . . . . . . . -61.17 -29.6 69.9 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.938 1.295 . . . . 0.0 114.193 -171.27 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 2438 ' ' GLY . . . . . . . . . . . . . . . -65.89 -16.15 63.5 Favored Glycine 0 CA--C 1.53 1.005 0 C-N-CA 124.361 0.981 . . . . 0.0 114.375 -178.082 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 2439 ' ' LEU . . . . . . . . . . . . . 79.0 mt -80.03 -26.87 39.58 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 118.77 1.285 . . . . 0.0 112.594 172.556 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 2440 ' ' GLU . . . . . . . . . . . . . 35.0 mm-40 -87.36 -38.04 16.55 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.72 1.208 . . . . 0.0 111.582 -178.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 2441 ' ' GLY . . . . . . . . . . . . . . . 162.29 -150.43 19.65 Favored Glycine 0 CA--C 1.527 0.8 0 C-N-CA 124.046 0.831 . . . . 0.0 114.173 -175.61 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 2442 ' ' GLY . . . . . . . . . . . . . . . 167.58 -170.29 41.62 Favored Glycine 0 CA--C 1.53 0.999 0 C-N-CA 124.951 1.262 . . . . 0.0 113.616 -179.735 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 2443 ' ' VAL . . . . . . . . . . . . . 97.9 t -120.93 137.02 56.01 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 C-N-CA 125.435 1.494 . . . . 0.0 109.115 176.611 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 2444 ' ' THR . . . . . . . . . . . . . 27.9 p -56.23 128.22 34.6 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.598 1.159 . . . . 0.0 111.837 177.68 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 2445 ' ' GLY . . . . . . . . . . . . . . . 86.26 -10.89 64.73 Favored Glycine 0 CA--C 1.533 1.165 0 C-N-CA 125.28 1.419 . . . . 0.0 114.891 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 2446 ' ' ASN . . . . . . . . . . . . . 86.6 m-20 -104.72 141.72 23.14 Favored Pre-proline 0 CA--C 1.546 0.796 0 C-N-CA 124.693 1.197 . . . . 0.0 110.684 175.338 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 2447 ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -71.63 142.15 39.44 Favored 'Trans proline' 0 N--CA 1.457 -0.641 0 C-N-CA 122.64 2.226 . . . . 0.0 111.118 177.046 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 2448 ' ' ALA . . . . . . . . . . . . . . . -125.51 156.25 39.28 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 126.082 1.753 . . . . 0.0 109.341 167.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 2449 ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -152.52 160.17 43.25 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 114.019 1.118 . . . . 0.0 114.019 -166.986 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 2450 ' ' PHE . . . . . . . . . . . . . 52.0 p90 -161.75 159.02 26.68 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 126.193 1.797 . . . . 0.0 111.24 -177.425 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 2451 ' ' VAL . . . . . . . . . . . . . 48.2 t -115.98 130.22 71.06 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 C-N-CA 124.847 1.259 . . . . 0.0 109.219 173.151 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 2452 ' ' VAL . . . . . . . . . . . . . 21.4 t -78.95 102.76 5.27 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 N-CA-C 106.795 -1.558 . . . . 0.0 106.795 164.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 2453 ' ' ASN . . . . . . . . . . . . . 10.7 t-20 -81.69 114.3 20.27 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.051 0.94 . . . . 0.0 111.856 -169.48 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 2454 ' ' THR . . . . . . . . . . . . . 58.3 p -99.92 -7.25 25.45 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 125.65 1.58 . . . . 0.0 113.856 -176.318 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 2455 ' ' SER . . . . . . . . . . . . . 16.7 m -55.41 -32.92 63.08 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 114.534 1.309 . . . . 0.0 114.534 -174.274 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 2456 ' ' ASN . . . . . . . . . . . . . 92.1 m-20 -85.26 -14.08 47.8 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 124.324 1.049 . . . . 0.0 113.465 177.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 2457 ' ' ALA . . . . . . . . . . . . . . . -105.61 -48.88 3.55 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 125.097 1.359 . . . . 0.0 113.158 -171.491 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 2458 ' ' GLY . . . . . . . . . . . . . . . 117.92 -138.4 13.92 Favored Glycine 0 CA--C 1.532 1.102 0 C-N-CA 125.066 1.317 . . . . 0.0 112.526 -173.464 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 2459 ' ' ALA . . . . . . . . . . . . . . . -97.3 175.86 6.11 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 125.553 1.541 . . . . 0.0 112.575 -179.746 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 2460 ' ' GLY . . . . . . . . . . . . . . . 134.07 162.76 10.08 Favored Glycine 0 CA--C 1.53 0.978 0 C-N-CA 125.21 1.386 . . . . 0.0 113.677 -179.379 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 2461 ' ' ALA . . . . . . . . . . . . . . . -80.49 146.78 31.19 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.273 1.029 . . . . 0.0 112.566 -178.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 2462 ' ' LEU . . . . . . . . . . . . . 14.6 tp -104.14 145.88 29.56 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.765 1.626 . . . . 0.0 110.391 172.363 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 2463 ' ' SER . . . . . . . . . . . . . 22.6 t -124.87 147.6 48.71 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 123.949 0.9 . . . . 0.0 109.335 153.052 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 2464 ' ' VAL . . . . . . . . . . . . . 12.1 p -160.16 139.6 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 O-C-N 121.256 -0.902 . . . . 0.0 111.039 -172.816 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 2465 ' ' THR . . . . . . . . . . . . . 9.5 t -161.5 161.77 30.13 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 125.112 1.365 . . . . 0.0 111.256 -177.727 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 2466 ' ' ILE . . . . . . . . . . . . . 39.7 mt -134.67 121.91 36.94 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 C-N-CA 125.089 1.356 . . . . 0.0 109.934 -173.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 2467 ' ' ASP . . . . . . . . . . . . . 36.7 t70 -98.18 156.74 16.54 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.691 1.596 . . . . 0.0 110.234 167.716 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 2468 ' ' GLY . . . . . . . . . . . . . . . 171.93 -165.83 38.65 Favored Glycine 0 CA--C 1.535 1.309 0 O-C-N 120.951 -1.093 . . . . 0.0 115.175 -179.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 2469 ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -69.81 -12.67 33.27 Favored 'Trans proline' 0 CA--C 1.541 0.871 0 C-N-CA 124.116 3.211 . . . . 0.0 113.841 -179.808 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 2470 ' ' SER . . . . . . . . . . . . . 33.3 m -156.16 170.89 21.16 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 126.887 2.075 . . . . 0.0 110.174 173.406 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 2471 ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -67.73 162.0 24.77 Favored 'General case' 0 CA--C 1.548 0.889 0 O-C-N 121.116 -0.99 . . . . 0.0 111.752 167.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 2472 ' ' VAL . . . . . . . . . . . . . 35.8 m -137.79 145.06 29.61 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 C-N-CA 124.785 1.234 . . . . 0.0 111.639 -179.207 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 2473 ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -87.52 90.72 8.48 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.411 1.084 . . . . 0.0 110.867 -179.795 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 2474 ' ' MET . . . . . . . . . . . . . 96.7 mtp -80.93 133.82 35.61 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 124.279 1.032 . . . . 0.0 111.591 178.75 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 2475 ' ' ASP . . . . . . . . . . . . . 21.1 t70 -116.3 118.65 33.35 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 125.865 1.666 . . . . 0.0 109.044 162.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 2476 ' ' CYS . . . . . . . . . . . . . 72.4 m -102.81 137.85 40.48 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.397 1.079 . . . . 0.0 110.106 175.053 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 2477 ' ' GLN . . . . . . . . . . . . . 5.4 pt20 -154.12 155.35 35.22 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.499 1.119 . . . . 0.0 110.731 -175.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 2478 ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -97.68 138.07 35.63 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.84 0.856 . . . . 0.0 110.844 -179.425 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 2479 ' ' CYS . . . . . . . . . . . . . 17.0 p -137.02 171.59 8.34 Favored Pre-proline 0 CA--C 1.554 1.107 0 C-N-CA 125.602 1.561 . . . . 0.0 111.479 175.529 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 2480 ' ' PRO . . . . . . . . . . . . . 73.4 Cg_exo -58.6 -27.1 81.6 Favored 'Trans proline' 0 CA--C 1.54 0.791 0 C-N-CA 123.42 2.746 . . . . 0.0 114.572 178.588 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 2481 ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -84.7 -14.29 48.86 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 124.748 1.219 . . . . 0.0 113.135 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 2482 ' ' GLY . . . . . . . . . . . . . . . 139.82 -143.8 14.25 Favored Glycine 0 N--CA 1.471 0.987 0 C-N-CA 125.228 1.394 . . . . 0.0 113.425 178.511 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 2483 ' ' TYR . . . . . . . . . . . . . 66.5 m-85 -91.08 115.83 28.32 Favored 'General case' 0 N--CA 1.467 0.425 0 O-C-N 121.934 -0.745 . . . . 0.0 111.185 175.33 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 2484 ' ' ARG . . . . . . . . . . . . . 43.4 ttt180 -92.01 139.63 30.45 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 125.563 1.545 . . . . 0.0 110.87 178.111 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 2485 ' ' VAL . . . . . . . . . . . . . 65.4 t -126.83 129.59 71.42 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 125.542 1.537 . . . . 0.0 108.855 175.272 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 2486 ' ' THR . . . . . . . . . . . . . 93.8 m -117.6 139.2 51.3 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 125.37 1.468 . . . . 0.0 108.004 169.315 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 2487 ' ' TYR . . . . . . . . . . . . . 19.4 p90 -149.0 150.3 32.6 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 123.692 0.797 . . . . 0.0 112.851 176.656 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 2488 ' ' THR . . . . . . . . . . . . . 99.6 m -110.99 113.71 54.63 Favored Pre-proline 0 N--CA 1.474 0.738 0 C-N-CA 124.37 1.068 . . . . 0.0 109.609 176.712 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 2489 ' ' PRO . . . . . . . . . . . . . 79.3 Cg_endo -77.25 164.31 29.27 Favored 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 123.748 2.965 . . . . 0.0 110.947 169.269 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 2490 ' ' MET . . . . . . . . . . . . . 28.1 ptm -143.85 -3.17 0.89 Allowed 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 115.561 1.689 . . . . 0.0 115.561 -172.3 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 2491 ' ' ALA . . . . . . . . . . . . . . . -140.01 148.02 53.16 Favored Pre-proline 0 CA--C 1.546 0.821 0 C-N-CA 125.167 1.387 . . . . 0.0 110.737 174.139 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 2492 ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -71.34 146.83 51.63 Favored 'Trans proline' 0 CA--C 1.537 0.666 0 C-N-CA 122.856 2.37 . . . . 0.0 110.933 177.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 2493 ' ' GLY . . . . . . . . . . . . . . . 136.39 -167.62 24.4 Favored Glycine 0 CA--C 1.531 1.075 0 C-N-CA 125.214 1.388 . . . . 0.0 113.603 -176.602 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 2494 ' ' SER . . . . . . . . . . . . . 49.4 m -95.22 123.18 38.59 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 124.417 1.087 . . . . 0.0 111.299 179.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 2495 ' ' TYR . . . . . . . . . . . . . 73.1 m-85 -97.97 116.95 31.22 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.346 1.058 . . . . 0.0 110.129 170.003 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 2496 ' ' LEU . . . . . . . . . . . . . 23.2 tp -93.16 105.64 17.71 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.943 1.297 . . . . 0.0 109.904 -176.586 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 2497 ' ' ILE . . . . . . . . . . . . . 44.4 mt -93.32 112.37 26.32 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 C-N-CA 126.443 1.897 . . . . 0.0 108.636 -176.545 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 2498 ' ' SER . . . . . . . . . . . . . 75.4 m -96.61 123.87 40.42 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 123.512 0.725 . . . . 0.0 110.002 174.521 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 2499 ' ' ILE . . . . . 0.681 ' H ' ' HG ' ' A' 2510 ' ' SER . 23.9 mt -124.95 116.23 46.58 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 C-N-CA 125.269 1.427 . . . . 0.0 109.297 -175.785 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 2500 ' ' LYS . . . . . . . . . . . . . 96.0 mttt -127.28 140.77 51.99 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.783 1.233 . . . . 0.0 111.817 -172.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 2501 ' ' TYR . . . . . . . . . . . . . 44.4 t80 -146.85 144.47 29.33 Favored 'General case' 0 N--CA 1.474 0.769 0 O-C-N 121.303 -0.873 . . . . 0.0 113.329 -172.331 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 2502 ' ' GLY . . . . . . . . . . . . . . . 69.57 19.46 74.73 Favored Glycine 0 CA--C 1.536 1.345 0 C-N-CA 124.101 0.858 . . . . 0.0 113.207 -179.152 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 2503 ' ' GLY . . . . . . . . . . . . . . . 132.17 -176.04 19.52 Favored Glycine 0 CA--C 1.54 1.637 0 C-N-CA 126.325 1.917 . . . . 0.0 112.293 -166.304 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 2504 ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -82.21 43.97 1.61 Allowed 'Trans proline' 0 CA--C 1.545 1.047 0 C-N-CA 124.959 3.773 . . . . 0.0 112.662 -173.722 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 2505 ' ' TYR . . . . . . . . . . . . . 76.0 m-85 -125.43 131.19 52.95 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.817 1.247 . . . . 0.0 112.475 -174.134 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 2506 ' ' HIS . . . . . . . . . . . . . 88.0 m-70 -59.33 138.07 57.76 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 124.921 1.288 . . . . 0.0 113.536 -177.26 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 2507 ' ' ILE . . . . . . . . . . . . . 2.3 pp -88.97 147.6 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 C-N-CA 123.854 0.862 . . . . 0.0 112.535 175.154 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 2508 ' ' GLY . . . . . . . . . . . . . . . 48.26 -115.32 2.35 Favored Glycine 0 CA--C 1.535 1.323 0 C-N-CA 124.239 0.923 . . . . 0.0 114.031 167.093 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 2509 ' ' GLY . . . . . . . . . . . . . . . -97.05 11.11 65.91 Favored Glycine 0 CA--C 1.537 1.417 0 C-N-CA 126.061 1.791 . . . . 0.0 115.212 177.693 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 2510 ' ' SER . . . . . 0.681 ' HG ' ' H ' ' A' 2499 ' ' ILE . 46.5 t -63.17 144.82 97.28 Favored Pre-proline 0 CA--C 1.55 0.974 0 CA-C-N 119.342 1.571 . . . . 0.0 112.458 178.917 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 2511 ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -79.64 152.34 86.25 Favored 'Cis proline' 0 C--N 1.353 0.779 0 CA-C-N 119.343 0.801 . . . . 0.0 113.349 -0.364 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 2512 ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -103.81 130.46 51.36 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 125.62 1.568 . . . . 0.0 110.782 -179.363 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 2513 ' ' LYS . . . . . . . . . . . . . 7.4 ptpp? -90.57 9.77 28.17 Favored 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 116.833 2.16 . . . . 0.0 116.833 -165.112 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 2514 ' ' ALA . . . . . . . . . . . . . . . -4.0 101.3 0.01 OUTLIER 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 129.404 3.082 . . . . 0.0 116.532 -176.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 2515 ' ' LYS . . . . . . . . . . . . . 35.2 mtmm -88.23 119.41 28.6 Favored 'General case' 0 CA--C 1.544 0.715 0 O-C-N 121.293 -0.88 . . . . 0.0 111.778 -173.419 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 2516 ' ' VAL . . . . . . . . . . . . . 54.1 t -111.27 144.08 19.87 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 125.83 1.652 . . . . 0.0 110.605 -173.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 2517 ' ' THR . . . . . . . . . . . . . 53.0 p -131.52 173.44 11.11 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 125.693 1.597 . . . . 0.0 110.949 174.299 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 2518 ' ' GLY . . . . . . . . . . . . . . . 112.88 179.43 19.47 Favored Glycine 0 CA--C 1.54 1.607 0 C-N-CA 125.1 1.333 . . . . 0.0 113.651 -177.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 2519 ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -69.68 129.31 17.46 Favored 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 123.896 3.064 . . . . 0.0 111.819 -172.67 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 2520 ' ' ARG . . . . . . . . . . . . . 35.2 ttt-85 -66.56 124.6 23.25 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 123.716 0.806 . . . . 0.0 110.449 177.541 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 2521 ' ' LEU . . . . . . . . . . . . . 62.9 mt -91.36 25.11 2.69 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 124.969 1.307 . . . . 0.0 112.913 -173.779 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 2522 ' ' VAL . . . . . . . . . . . . . 6.3 p . . . . . 0 C--O 1.253 1.245 0 C-N-CA 127.142 2.177 . . . . 0.0 111.555 -171.111 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.565 0 N-CA-C 111.435 -0.666 . . . . 0.0 111.435 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -81.29 -9.39 59.77 Favored 'General case' 0 CA--C 1.548 0.891 0 N-CA-C 114.669 1.359 . . . . 0.0 114.669 -176.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 10.3 tpt -146.96 131.55 17.78 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 125.777 1.631 . . . . 0.0 110.489 -177.113 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 2427 ' ' GLY . . . . . . . . . . . . . . . -81.04 169.21 51.63 Favored Glycine 0 CA--C 1.532 1.14 0 C-N-CA 124.979 1.276 . . . . 0.0 113.69 178.023 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 2428 ' ' ASP . . . . . . . . . . . . . 22.7 m-20 -94.33 129.69 36.22 Favored Pre-proline 0 CA--C 1.549 0.914 0 C-N-CA 124.496 1.119 . . . . 0.0 112.43 -178.414 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 2429 ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -56.46 -30.3 81.47 Favored 'Trans proline' 0 C--N 1.353 0.775 0 C-N-CA 123.659 2.906 . . . . 0.0 113.916 174.458 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 2430 ' ' GLY . . . . . . . . . . . . . . . -75.41 -21.23 77.88 Favored Glycine 0 CA--C 1.534 1.258 0 CA-C-O 119.379 -0.678 . . . . 0.0 113.92 177.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 2431 ' ' LEU . . . . . . . . . . . . . 4.3 mm? -88.86 -32.01 18.0 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.463 1.105 . . . . 0.0 111.698 173.143 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 2432 ' ' VAL . . . . . . . . . . . . . 95.4 t -68.15 136.22 26.92 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 C-N-CA 123.39 0.676 . . . . 0.0 110.439 170.549 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 2433 ' ' SER . . . . . . . . . . . . . 57.0 m -140.73 144.79 35.76 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 125.27 1.428 . . . . 0.0 109.998 175.544 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 2434 ' ' ALA . . . . . . . . . . . . . . . -100.61 148.19 25.11 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 123.351 0.66 . . . . 0.0 112.134 177.096 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 2435 ' ' TYR . . . . . . . . . . . . . 82.2 m-85 -143.93 146.26 32.84 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 125.852 1.661 . . . . 0.0 111.591 -176.282 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 2436 ' ' GLY . . . . . . . . . . . . . . . 124.89 163.52 11.67 Favored Glycine 0 N--CA 1.475 1.284 0 C-N-CA 125.09 1.328 . . . . 0.0 114.577 175.175 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 2437 ' ' ALA . . . . . . . . . . . . . . . -62.31 -30.62 71.28 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.184 1.394 . . . . 0.0 114.433 -170.064 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 2438 ' ' GLY . . . . . . . . . . . . . . . -66.05 -13.37 59.6 Favored Glycine 0 CA--C 1.532 1.152 0 C-N-CA 124.306 0.955 . . . . 0.0 114.282 -179.501 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 2439 ' ' LEU . . . . . . . . . . . . . 81.6 mt -79.84 -23.91 41.68 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 118.637 1.219 . . . . 0.0 112.801 171.049 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 2440 ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -92.78 -34.96 13.68 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 124.792 1.237 . . . . 0.0 111.985 -175.882 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 2441 ' ' GLY . . . . . . . . . . . . . . . 159.68 -153.22 24.23 Favored Glycine 0 C--N 1.339 0.748 0 C-N-CA 123.806 0.717 . . . . 0.0 114.31 -176.71 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 2442 ' ' GLY . . . . . . . . . . . . . . . 169.85 -168.76 41.63 Favored Glycine 0 CA--C 1.528 0.883 0 C-N-CA 124.802 1.191 . . . . 0.0 113.387 -178.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 2443 ' ' VAL . . . . . . . . . . . . . 38.9 t -128.31 139.11 52.79 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 C-N-CA 124.915 1.286 . . . . 0.0 108.867 174.657 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 2444 ' ' THR . . . . . . . . . . . . . 40.1 p -58.28 141.44 50.92 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.864 0.866 . . . . 0.0 112.706 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 2445 ' ' GLY . . . . . . . . . . . . . . . 78.2 -9.74 31.67 Favored Glycine 0 CA--C 1.535 1.316 0 C-N-CA 124.811 1.196 . . . . 0.0 114.859 -178.505 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 2446 ' ' ASN . . . . . . . . . . . . . 86.1 m-20 -111.59 144.87 31.46 Favored Pre-proline 0 CA--C 1.547 0.862 0 C-N-CA 125.318 1.447 . . . . 0.0 111.289 176.503 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 2447 ' ' PRO . . . . . . . . . . . . . 82.2 Cg_endo -74.71 149.46 38.21 Favored 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 122.893 2.395 . . . . 0.0 111.882 178.681 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 2448 ' ' ALA . . . . . . . . . . . . . . . -136.83 148.59 47.22 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 126.069 1.748 . . . . 0.0 109.654 168.354 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 2449 ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -141.1 157.42 45.32 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 114.164 1.172 . . . . 0.0 114.164 -166.443 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 2450 ' ' PHE . . . . . . . . . . . . . 50.7 p90 -156.59 162.64 39.88 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 126.421 1.888 . . . . 0.0 110.911 178.76 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 2451 ' ' VAL . . . . . . . . . . . . . 8.2 p -122.91 133.9 67.66 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 C-N-CA 124.698 1.199 . . . . 0.0 110.305 175.747 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 2452 ' ' VAL . . . . . . . . . . . . . 45.4 t -90.09 102.45 13.26 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 N-CA-C 106.943 -1.503 . . . . 0.0 106.943 169.64 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 2453 ' ' ASN . . . . . . . . . . . . . 19.6 t-20 -86.35 117.96 25.49 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 112.411 0.523 . . . . 0.0 112.411 -169.528 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 2454 ' ' THR . . . . . . . . . . . . . 53.0 p -97.83 -5.54 34.49 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 125.292 1.437 . . . . 0.0 113.851 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 2455 ' ' SER . . . . . . . . . . . . . 20.5 m -56.51 -28.29 59.49 Favored 'General case' 0 N--CA 1.479 1.006 0 CA-C-N 120.148 1.34 . . . . 0.0 114.54 -175.358 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 2456 ' ' ASN . . . . . . . . . . . . . 64.7 m-80 -83.33 -14.82 52.09 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 124.653 1.181 . . . . 0.0 113.593 176.532 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 2457 ' ' ALA . . . . . . . . . . . . . . . -115.58 -19.69 10.48 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 125.964 1.706 . . . . 0.0 114.271 -173.867 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 2458 ' ' GLY . . . . . . . . . . . . . . . 103.85 -103.13 2.26 Favored Glycine 0 CA--C 1.529 0.929 0 C-N-CA 125.585 1.564 . . . . 0.0 110.923 -172.699 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 2459 ' ' ALA . . . . . . . . . . . . . . . -158.61 163.39 37.01 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 125.898 1.679 . . . . 0.0 111.337 179.755 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 2460 ' ' GLY . . . . . . . . . . . . . . . 167.45 174.97 37.0 Favored Glycine 0 CA--C 1.528 0.9 0 N-CA-C 114.878 0.711 . . . . 0.0 114.878 -175.752 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 2461 ' ' ALA . . . . . . . . . . . . . . . -77.98 128.17 33.47 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.387 1.075 . . . . 0.0 112.434 -176.627 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 2462 ' ' LEU . . . . . . . . . . . . . 25.3 tp -106.64 144.28 33.53 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 125.58 1.552 . . . . 0.0 110.83 177.437 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 2463 ' ' SER . . . . . . . . . . . . . 3.8 t -136.2 40.89 2.65 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 125.843 1.657 . . . . 0.0 110.923 -176.248 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 2464 ' ' VAL . . . . . . . . . . . . . 7.5 p -64.27 133.41 29.86 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 C-N-CA 125.013 1.325 . . . . 0.0 112.107 -176.01 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 2465 ' ' THR . . . . . . . . . . . . . 97.8 m -134.18 142.84 47.57 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 126.027 1.731 . . . . 0.0 109.994 -177.196 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 2466 ' ' ILE . . . . . . . . . . . . . 50.6 mt -118.54 121.67 67.6 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 C-N-CA 124.201 1.0 . . . . 0.0 109.949 175.354 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 2467 ' ' ASP . . . . . . . . . . . . . 36.4 t70 -105.51 159.75 15.7 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 126.269 1.828 . . . . 0.0 110.592 169.314 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 2468 ' ' GLY . . . . . . . . . . . . . . . 172.97 -168.17 41.14 Favored Glycine 0 CA--C 1.535 1.313 0 O-C-N 121.305 -0.872 . . . . 0.0 114.472 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 2469 ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -66.13 -27.17 49.43 Favored 'Trans proline' 0 CA--C 1.54 0.78 0 C-N-CA 123.865 3.043 . . . . 0.0 112.833 177.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 2470 ' ' SER . . . . . . . . . . . . . 70.4 m -143.64 166.1 25.8 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 126.042 1.737 . . . . 0.0 110.184 172.196 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 2471 ' ' LYS . . . . . . . . . . . . . 68.2 mttm -71.65 131.98 43.95 Favored 'General case' 0 CA--C 1.545 0.753 0 O-C-N 120.706 -1.246 . . . . 0.0 110.989 171.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 2472 ' ' VAL . . . . . . . . . . . . . 20.5 m -87.47 155.52 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 C-N-CA 123.92 0.888 . . . . 0.0 111.52 177.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 2473 ' ' LYS . . . . . . . . . . . . . 97.5 mttt -80.84 72.35 7.82 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 124.399 1.08 . . . . 0.0 110.843 175.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 2474 ' ' MET . . . . . . . . . . . . . 22.4 ttt -78.97 139.91 38.13 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 125.745 1.618 . . . . 0.0 112.74 -171.588 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 2475 ' ' ASP . . . . . . . . . . . . . 17.6 m-20 -138.99 132.4 30.16 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 126.155 1.782 . . . . 0.0 109.844 167.116 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 2476 ' ' CYS . . . . . . . . . . . . . 48.0 t -118.19 140.67 49.44 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.076 1.35 . . . . 0.0 110.728 176.524 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 2477 ' ' GLN . . . . . . . . . . . . . 42.2 mt-30 -136.4 142.82 43.73 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 125.497 1.519 . . . . 0.0 110.444 -177.071 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 2478 ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -86.37 139.23 31.15 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.08 0.952 . . . . 0.0 110.161 171.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 2479 ' ' CYS . . . . . . . . . . . . . 29.3 p -150.52 169.76 8.75 Favored Pre-proline 0 CA--C 1.552 1.043 0 C-N-CA 125.01 1.324 . . . . 0.0 112.325 -176.866 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 2480 ' ' PRO . . . . . . . . . . . . . 56.3 Cg_exo -58.59 -25.46 74.78 Favored 'Trans proline' 0 CA--C 1.539 0.754 0 C-N-CA 123.356 2.704 . . . . 0.0 114.08 174.436 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 2481 ' ' GLU . . . . . . . . . . . . . 21.6 tt0 -85.23 -2.32 57.91 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 125.242 1.417 . . . . 0.0 113.13 178.37 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 2482 ' ' GLY . . . . . . . . . . . . . . . 121.88 -118.89 3.85 Favored Glycine 0 N--CA 1.47 0.938 0 C-N-CA 125.826 1.679 . . . . 0.0 112.202 -179.394 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 2483 ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -123.88 116.76 23.46 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.083 0.953 . . . . 0.0 110.881 174.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 2484 ' ' ARG . . . . . . . . . . . . . 41.4 ttm-85 -94.25 132.53 38.73 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 124.6 1.16 . . . . 0.0 110.169 179.227 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 2485 ' ' VAL . . . . . . . . . . . . . 86.1 t -119.98 135.36 60.52 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 C-N-CA 125.676 1.59 . . . . 0.0 108.998 -179.603 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 2486 ' ' THR . . . . . . . . . . . . . 88.4 m -129.07 142.84 50.77 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 125.244 1.417 . . . . 0.0 108.449 172.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 2487 ' ' TYR . . . . . . . . . . . . . 37.2 p90 -149.36 148.27 29.29 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 113.085 0.772 . . . . 0.0 113.085 174.041 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 2488 ' ' THR . . . . . . . . . . . . . 59.2 m -108.47 118.51 51.93 Favored Pre-proline 0 N--CA 1.473 0.725 0 C-N-CA 124.628 1.171 . . . . 0.0 108.759 168.358 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 2489 ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -82.76 157.34 15.98 Favored 'Trans proline' 0 N--CA 1.457 -0.654 0 C-N-CA 123.719 2.946 . . . . 0.0 111.189 174.108 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 2490 ' ' MET . . . . . . . . . . . . . 28.8 ptm -124.32 5.44 8.42 Favored 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 114.308 1.225 . . . . 0.0 114.308 -174.842 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 2491 ' ' ALA . . . . . . . . . . . . . . . -151.56 148.89 22.91 Favored Pre-proline 0 CA--C 1.546 0.807 0 C-N-CA 125.826 1.651 . . . . 0.0 111.117 178.25 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 2492 ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -74.66 155.33 44.61 Favored 'Trans proline' 0 CA--C 1.536 0.599 0 C-N-CA 123.094 2.529 . . . . 0.0 111.229 173.561 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 2493 ' ' GLY . . . . . . . . . . . . . . . 131.5 -174.37 20.09 Favored Glycine 0 CA--C 1.529 0.935 0 C-N-CA 125.337 1.446 . . . . 0.0 113.662 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 2494 ' ' SER . . . . . . . . . . . . . 11.1 p -86.28 129.81 34.72 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.361 1.064 . . . . 0.0 111.85 174.338 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 2495 ' ' TYR . . . . . . . . . . . . . 60.0 m-85 -107.2 125.48 51.17 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 125.578 1.551 . . . . 0.0 109.279 172.305 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 2496 ' ' LEU . . . . . . . . . . . . . 19.1 tp -94.48 107.0 18.99 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 123.857 0.863 . . . . 0.0 109.546 -178.255 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 2497 ' ' ILE . . . . . . . . . . . . . 48.7 mt -92.66 101.73 12.89 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 C-N-CA 125.631 1.572 . . . . 0.0 107.624 -179.763 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 2498 ' ' SER . . . . . . . . . . . . . 75.8 m -90.36 99.33 12.37 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 124.606 1.162 . . . . 0.0 109.519 176.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 2499 ' ' ILE . . . . . . . . . . . . . 23.0 mt -93.47 89.79 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 C-N-CA 124.511 1.125 . . . . 0.0 108.451 -178.133 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 2500 ' ' LYS . . . . . . . . . . . . . 85.1 mttt -99.53 142.52 30.91 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 124.334 1.054 . . . . 0.0 111.722 -178.715 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 2501 ' ' TYR . . . . . . . . . . . . . 72.9 t80 -146.5 138.08 24.58 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 124.738 1.215 . . . . 0.0 111.4 -168.176 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 2502 ' ' GLY . . . . . . . . . . . . . . . 69.03 12.08 64.63 Favored Glycine 0 CA--C 1.534 1.241 0 C-N-CA 124.356 0.979 . . . . 0.0 114.971 -179.45 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 2503 ' ' GLY . . . . . . . . . . . . . . . 138.41 -153.24 22.36 Favored Glycine 0 CA--C 1.539 1.552 0 C-N-CA 125.507 1.527 . . . . 0.0 112.388 -169.421 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 2504 ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -81.75 6.86 5.38 Favored 'Trans proline' 0 CA--C 1.543 0.938 0 C-N-CA 124.354 3.369 . . . . 0.0 114.123 -172.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 2505 ' ' TYR . . . . . . . . . . . . . 64.5 m-85 -99.26 136.14 39.64 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.272 1.029 . . . . 0.0 113.18 -172.479 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 2506 ' ' HIS . . . . . . . . . . . . . 93.4 m-70 -64.75 148.2 51.62 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 125.036 1.334 . . . . 0.0 113.305 176.778 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 2507 ' ' ILE . . . . . . . . . . . . . 30.4 pt -73.59 173.27 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 C-N-CA 123.387 0.675 . . . . 0.0 112.523 167.599 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 2508 ' ' GLY . . . . . . . . . . . . . . . -58.97 122.19 29.34 Favored Glycine 0 CA--C 1.534 1.253 0 O-C-N 121.659 -0.651 . . . . 0.0 111.791 172.808 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 2509 ' ' GLY . . . . . . . . . . . . . . . 88.75 -9.99 74.07 Favored Glycine 0 CA--C 1.536 1.362 0 C-N-CA 125.654 1.597 . . . . 0.0 115.226 -178.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 2510 ' ' SER . . . . . . . . . . . . . 41.6 t -84.95 147.77 49.06 Favored Pre-proline 0 CA--C 1.549 0.914 0 CA-C-N 119.053 1.426 . . . . 0.0 112.023 179.325 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 2511 ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -79.34 158.7 90.17 Favored 'Cis proline' 0 C--N 1.353 0.801 0 CA-C-N 119.867 0.988 . . . . 0.0 113.456 0.245 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 2512 ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -107.66 137.97 44.72 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 125.471 1.508 . . . . 0.0 110.747 177.847 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 2513 ' ' LYS . . . . . . . . . . . . . 19.1 ptpt -99.5 15.42 26.56 Favored 'General case' 0 N--CA 1.48 1.068 0 N-CA-C 116.289 1.959 . . . . 0.0 116.289 -163.48 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 2514 ' ' ALA . . . . . . . . . . . . . . . -14.89 108.57 0.02 OUTLIER 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 129.388 3.075 . . . . 0.0 116.722 -173.409 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 2515 ' ' LYS . . . . . . . . . . . . . 67.5 mttm -92.24 107.85 19.51 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 124.66 1.184 . . . . 0.0 111.72 -175.26 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 2516 ' ' VAL . . . . . . . . . . . . . 71.3 t -95.74 142.07 14.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 C-N-CA 125.726 1.61 . . . . 0.0 110.493 -177.828 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 2517 ' ' THR . . . . . . . . . . . . . 77.8 p -121.42 179.31 4.47 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 125.28 1.432 . . . . 0.0 111.456 174.321 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 2518 ' ' GLY . . . . . . . . . . . . . . . 99.91 178.78 30.59 Favored Glycine 0 CA--C 1.54 1.635 0 C-N-CA 124.676 1.131 . . . . 0.0 113.635 -178.231 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 2519 ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -72.98 148.4 45.18 Favored 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 123.857 3.038 . . . . 0.0 112.218 -174.46 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 2520 ' ' ARG . . . . . . . . . . . . . 49.4 ttm-85 -77.83 131.91 37.78 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 123.63 0.772 . . . . 0.0 110.281 173.189 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 2521 ' ' LEU . . . . . . . . . . . . . 4.2 mm? -79.85 -16.73 54.83 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.077 0.951 . . . . 0.0 113.279 -176.604 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 2522 ' ' VAL . . . . . . . . . . . . . 14.4 m . . . . . 0 C--O 1.252 1.223 0 C-N-CA 126.675 1.99 . . . . 0.0 113.374 179.838 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.563 0 N-CA-C 111.576 -0.61 . . . . 0.0 111.576 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -158.75 161.87 37.05 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 125.345 1.458 . . . . 0.0 112.313 -178.048 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 2.0 mpt? -74.74 166.38 23.68 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.36 1.464 . . . . 0.0 112.136 176.201 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 2427 ' ' GLY . . . . . . . . . . . . . . . -67.48 160.52 49.35 Favored Glycine 0 CA--C 1.532 1.145 0 C-N-CA 124.844 1.211 . . . . 0.0 113.879 -179.417 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 2428 ' ' ASP . . . . . . . . . . . . . 24.5 m-20 -91.0 133.12 32.6 Favored Pre-proline 0 CA--C 1.549 0.905 0 C-N-CA 124.233 1.013 . . . . 0.0 112.857 -175.205 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 2429 ' ' PRO . . . . . . . . . . . . . 72.5 Cg_exo -55.2 -27.88 58.73 Favored 'Trans proline' 0 C--N 1.352 0.711 0 C-N-CA 124.097 3.198 . . . . 0.0 114.308 171.611 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 2430 ' ' GLY . . . . . . . . . . . . . . . -77.04 -23.13 69.7 Favored Glycine 0 CA--C 1.534 1.254 0 C-N-CA 123.851 0.739 . . . . 0.0 113.819 176.525 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 2431 ' ' LEU . . . . . . . . . . . . . 4.4 mm? -87.42 -31.63 19.96 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.393 1.077 . . . . 0.0 111.612 171.768 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 2432 ' ' VAL . . . . . . . . . . . . . 87.5 t -64.67 130.23 29.55 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 CA-C-N 118.68 0.673 . . . . 0.0 109.901 168.824 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 2433 ' ' SER . . . . . . . . . . . . . 68.0 m -125.59 172.35 9.81 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 125.436 1.494 . . . . 0.0 110.338 174.787 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 2434 ' ' ALA . . . . . . . . . . . . . . . -131.52 143.24 50.24 Favored 'General case' 0 CA--C 1.539 0.53 0 O-C-N 121.205 -0.934 . . . . 0.0 111.29 174.638 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 2435 ' ' TYR . . . . . . . . . . . . . 75.8 m-85 -144.37 147.39 33.37 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 125.234 1.413 . . . . 0.0 112.001 -175.421 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 2436 ' ' GLY . . . . . . . . . . . . . . . 122.33 163.22 11.81 Favored Glycine 0 N--CA 1.473 1.154 0 C-N-CA 125.087 1.327 . . . . 0.0 114.198 175.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 2437 ' ' ALA . . . . . . . . . . . . . . . -61.9 -28.64 69.66 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.123 1.369 . . . . 0.0 114.398 -170.445 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 2438 ' ' GLY . . . . . . . . . . . . . . . -64.35 -18.18 62.77 Favored Glycine 0 CA--C 1.533 1.164 0 CA-C-O 118.984 -0.898 . . . . 0.0 114.12 -179.581 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 2439 ' ' LEU . . . . . . . . . . . . . 80.0 mt -76.44 -24.29 53.93 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 118.663 1.232 . . . . 0.0 112.754 171.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 2440 ' ' GLU . . . . . . . . . . . . . 37.9 mm-40 -89.05 -27.71 20.64 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.983 1.313 . . . . 0.0 111.792 177.205 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 2441 ' ' GLY . . . . . . . . . . . . . . . 111.93 -138.56 15.05 Favored Glycine 0 CA--C 1.53 1.009 0 C-N-CA 125.943 1.735 . . . . 0.0 112.301 -178.452 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 2442 ' ' GLY . . . . . . . . . . . . . . . 154.32 -148.29 18.62 Favored Glycine 0 N--CA 1.474 1.18 0 C-N-CA 124.019 0.819 . . . . 0.0 113.971 -177.418 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 2443 ' ' VAL . . . . . . . . . . . . . 60.1 t -105.79 139.23 27.64 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 C-N-CA 125.334 1.454 . . . . 0.0 110.032 -178.322 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 2444 ' ' THR . . . . . . . . . . . . . 39.3 p -59.39 144.87 45.55 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.505 1.122 . . . . 0.0 112.675 175.556 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 2445 ' ' GLY . . . . . . . . . . . . . . . 80.0 -18.3 8.03 Favored Glycine 0 CA--C 1.535 1.339 0 C-N-CA 125.033 1.301 . . . . 0.0 114.47 -179.804 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 2446 ' ' ASN . . . . . . . . . . . . . 87.4 m-20 -99.64 144.55 28.54 Favored Pre-proline 0 CA--C 1.545 0.763 0 C-N-CA 125.081 1.353 . . . . 0.0 110.98 176.321 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 2447 ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -73.85 151.26 45.45 Favored 'Trans proline' 0 N--CA 1.457 -0.637 0 C-N-CA 122.816 2.344 . . . . 0.0 111.479 178.281 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 2448 ' ' ALA . . . . . . . . . . . . . . . -135.74 158.7 43.75 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 126.534 1.934 . . . . 0.0 109.492 169.437 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 2449 ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -149.37 155.65 40.82 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 113.913 1.079 . . . . 0.0 113.913 -171.457 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 2450 ' ' PHE . . . . . . . . . . . . . 47.9 p90 -155.03 153.61 31.23 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 126.042 1.737 . . . . 0.0 110.434 178.579 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 2451 ' ' VAL . . . . . . . . . . . . . 12.0 p -107.43 132.4 55.05 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 C-N-CA 124.603 1.161 . . . . 0.0 110.087 175.089 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 2452 ' ' VAL . . . . . . . . . . . . . 34.8 t -86.6 101.57 10.97 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 N-CA-C 106.594 -1.632 . . . . 0.0 106.594 165.684 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 2453 ' ' ASN . . . . . . . . . . . . . 13.2 t-20 -79.57 111.93 16.33 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.23 1.012 . . . . 0.0 111.821 -171.218 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 2454 ' ' THR . . . . . . . . . . . . . 27.9 p -101.16 -13.47 18.13 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 125.335 1.454 . . . . 0.0 113.865 -179.734 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 2455 ' ' SER . . . . . . . . . . . . . 98.1 p -64.39 -24.65 67.71 Favored 'General case' 0 N--CA 1.478 0.957 0 CA-C-N 120.234 1.379 . . . . 0.0 114.213 -174.577 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 2456 ' ' ASN . . . . . . . . . . . . . 49.8 m-80 -77.35 -18.31 57.52 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 124.283 1.033 . . . . 0.0 113.568 171.731 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 2457 ' ' ALA . . . . . . . . . . . . . . . -106.04 -31.3 8.8 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 125.4 1.48 . . . . 0.0 113.827 -176.131 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 2458 ' ' GLY . . . . . . . . . . . . . . . 113.99 -113.85 3.17 Favored Glycine 0 CA--C 1.53 1.008 0 C-N-CA 125.516 1.531 . . . . 0.0 111.491 -174.171 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 2459 ' ' ALA . . . . . . . . . . . . . . . -144.31 158.85 43.52 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 125.17 1.388 . . . . 0.0 111.943 -179.559 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 2460 ' ' GLY . . . . . . . . . . . . . . . 160.28 171.78 26.64 Favored Glycine 0 CA--C 1.531 1.092 0 C-N-CA 125.112 1.339 . . . . 0.0 113.161 -174.098 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 2461 ' ' ALA . . . . . . . . . . . . . . . -75.62 138.2 41.24 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 123.959 0.904 . . . . 0.0 112.241 -178.76 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 2462 ' ' LEU . . . . . . . . . . . . . 50.0 tp -119.84 143.09 48.08 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.462 1.505 . . . . 0.0 110.658 176.734 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 2463 ' ' SER . . . . . . . . . . . . . 12.5 t -128.37 162.71 26.47 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.114 1.365 . . . . 0.0 110.355 160.637 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 2464 ' ' VAL . . . . . . . . . . . . . 7.2 p -162.18 133.06 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 C-N-CA 124.852 1.261 . . . . 0.0 110.353 -178.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 2465 ' ' THR . . . . . . . . . . . . . 79.8 m -133.95 138.73 45.66 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 125.236 1.414 . . . . 0.0 109.184 -178.374 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 2466 ' ' ILE . . . . . . . . . . . . . 33.7 mt -119.08 114.94 46.31 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 C-N-CA 124.036 0.934 . . . . 0.0 109.388 177.065 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 2467 ' ' ASP . . . . . . . . . . . . . 33.4 t70 -99.11 165.47 11.71 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 126.01 1.724 . . . . 0.0 110.151 168.501 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 2468 ' ' GLY . . . . . . . . . . . . . . . 168.93 -161.9 35.62 Favored Glycine 0 CA--C 1.536 1.391 0 O-C-N 121.009 -1.057 . . . . 0.0 115.283 178.009 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 2469 ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -67.94 -16.23 45.01 Favored 'Trans proline' 0 CA--C 1.54 0.8 0 C-N-CA 124.297 3.331 . . . . 0.0 113.404 178.808 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 2470 ' ' SER . . . . . . . . . . . . . 32.9 m -151.98 175.09 12.87 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 127.14 2.176 . . . . 0.0 109.31 169.743 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 2471 ' ' LYS . . . . . . . . . . . . . 98.7 mttt -67.74 164.41 19.5 Favored 'General case' 0 CA--C 1.548 0.886 0 O-C-N 121.002 -1.061 . . . . 0.0 111.69 166.484 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 2472 ' ' VAL . . . . . . . . . . . . . 27.2 m -123.08 153.68 28.33 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 C-N-CA 125.168 1.387 . . . . 0.0 111.011 177.057 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 2473 ' ' LYS . . . . . . . . . . . . . 88.3 tttt -91.62 129.17 37.64 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 123.229 0.611 . . . . 0.0 109.387 163.243 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 2474 ' ' MET . . . . . . . . . . . . . 99.0 mtp -121.01 149.55 42.5 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 124.989 1.315 . . . . 0.0 111.895 -177.467 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 2475 ' ' ASP . . . . . . . . . . . . . 38.6 t0 -138.69 83.18 1.95 Allowed 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 126.953 2.101 . . . . 0.0 109.135 174.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 2476 ' ' CYS . . . . . . . . . . . . . 24.1 t -77.15 133.5 38.95 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 123.853 0.861 . . . . 0.0 111.126 177.783 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 2477 ' ' GLN . . . . . . . . . . . . . 34.9 mt-30 -138.81 179.93 6.2 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 127.734 2.414 . . . . 0.0 109.357 -169.328 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 2478 ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -143.57 149.18 37.03 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.364 1.066 . . . . 0.0 112.019 179.909 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 2479 ' ' CYS . . . . . . . . . . . . . 20.8 p -156.84 174.14 4.31 Favored Pre-proline 0 CA--C 1.553 1.086 0 C-N-CA 126.108 1.763 . . . . 0.0 110.99 -176.752 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 2480 ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -58.44 -24.72 70.34 Favored 'Trans proline' 0 CA--C 1.539 0.748 0 C-N-CA 123.349 2.7 . . . . 0.0 114.711 177.776 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 2481 ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -79.76 -17.27 53.87 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 124.285 1.034 . . . . 0.0 112.987 178.172 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 2482 ' ' GLY . . . . . . . . . . . . . . . 136.26 -154.5 22.01 Favored Glycine 0 CA--C 1.531 1.056 0 C-N-CA 125.818 1.675 . . . . 0.0 113.372 -178.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 2483 ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -85.55 115.23 23.13 Favored 'General case' 0 N--CA 1.468 0.449 0 O-C-N 121.78 -0.835 . . . . 0.0 110.774 175.541 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 2484 ' ' ARG . . . . . . . . . . . . . 35.9 ttt-85 -95.95 121.73 38.0 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 124.401 1.08 . . . . 0.0 110.241 -178.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 2485 ' ' VAL . . . . . . . . . . . . . 66.1 t -103.02 125.67 57.39 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 C-N-CA 124.933 1.293 . . . . 0.0 108.392 177.187 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 2486 ' ' THR . . . . . . . . . . . . . 91.8 m -111.69 139.49 47.11 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 167.434 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 2487 ' ' TYR . . . . . . . . . . . . . 14.1 p90 -151.01 154.85 37.84 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 113.361 0.875 . . . . 0.0 113.361 177.022 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 2488 ' ' THR . . . . . . . . . . . . . 98.9 m -118.33 115.49 35.96 Favored Pre-proline 0 N--CA 1.475 0.78 0 C-N-CA 124.717 1.207 . . . . 0.0 109.725 176.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 2489 ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -81.3 163.14 19.77 Favored 'Trans proline' 0 C--N 1.351 0.667 0 C-N-CA 123.987 3.125 . . . . 0.0 111.165 169.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 2490 ' ' MET . . . . . . . . . . . . . 25.8 ptm -143.05 4.29 1.43 Allowed 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 115.482 1.66 . . . . 0.0 115.482 -170.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 2491 ' ' ALA . . . . . 0.407 ' H ' ' HH ' ' A' 2495 ' ' TYR . . . -146.11 148.37 34.99 Favored Pre-proline 0 CA--C 1.546 0.819 0 C-N-CA 125.112 1.365 . . . . 0.0 110.901 174.769 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 2492 ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -72.2 145.37 43.73 Favored 'Trans proline' 0 CA--C 1.536 0.61 0 C-N-CA 122.813 2.342 . . . . 0.0 110.997 177.025 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 2493 ' ' GLY . . . . . . . . . . . . . . . 136.77 -167.03 24.72 Favored Glycine 0 CA--C 1.53 0.971 0 C-N-CA 125.34 1.448 . . . . 0.0 113.44 -177.141 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 2494 ' ' SER . . . . . . . . . . . . . 50.2 m -98.77 120.14 38.7 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.271 1.028 . . . . 0.0 111.298 -179.128 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 2495 ' ' TYR . . . . . 0.407 ' HH ' ' H ' ' A' 2491 ' ' ALA . 73.0 m-85 -93.01 124.96 37.35 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.215 1.006 . . . . 0.0 110.395 170.855 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 2496 ' ' LEU . . . . . . . . . . . . . 22.8 tp -96.65 111.35 23.53 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.423 1.089 . . . . 0.0 109.788 -178.888 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 2497 ' ' ILE . . . . . . . . . . . . . 49.9 mt -98.73 102.1 12.98 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 C-N-CA 126.057 1.743 . . . . 0.0 108.429 -176.663 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 2498 ' ' SER . . . . . . . . . . . . . 73.2 m -92.76 98.34 11.34 Favored 'General case' 0 N--CA 1.468 0.425 0 C-N-CA 124.608 1.163 . . . . 0.0 110.25 178.492 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 2499 ' ' ILE . . . . . . . . . . . . . 28.0 mt -96.05 120.53 45.54 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 C-N-CA 125.834 1.654 . . . . 0.0 109.349 179.65 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 2500 ' ' LYS . . . . . . . . . . . . . 90.5 mttt -134.08 127.78 32.86 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.264 1.026 . . . . 0.0 112.788 -171.137 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 2501 ' ' TYR . . . . . . . . . . . . . 57.5 t80 -128.09 151.56 49.04 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 124.828 1.251 . . . . 0.0 112.621 -171.674 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 2502 ' ' GLY . . . . . . . . . . . . . . . 64.91 20.02 66.17 Favored Glycine 0 CA--C 1.536 1.378 0 C-N-CA 124.241 0.924 . . . . 0.0 113.733 178.297 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 2503 ' ' GLY . . . . . . . . . . . . . . . 126.32 -166.46 19.09 Favored Glycine 0 CA--C 1.542 1.721 0 C-N-CA 125.878 1.704 . . . . 0.0 112.42 -164.785 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 2504 ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -82.11 31.77 0.52 Allowed 'Trans proline' 0 CA--C 1.546 1.113 0 C-N-CA 124.985 3.79 . . . . 0.0 113.522 -173.043 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 2505 ' ' TYR . . . . . . . . . . . . . 75.5 m-85 -113.87 131.47 56.26 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.66 1.184 . . . . 0.0 112.773 -172.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 2506 ' ' HIS . . . . . . . . . . . . . 89.5 m-70 -60.54 140.05 57.5 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 124.681 1.192 . . . . 0.0 113.687 -177.072 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 2507 ' ' ILE . . . . . . . . . . . . . 2.2 pp -84.45 160.58 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.199 0 C-N-CA 123.962 0.905 . . . . 0.0 112.442 173.691 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 2508 ' ' GLY . . . . . . . . . . . . . . . 38.67 -110.63 0.14 Allowed Glycine 0 CA--C 1.537 1.435 0 C-N-CA 125.291 1.424 . . . . 0.0 115.607 161.641 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 2509 ' ' GLY . . . . . . . . . . . . . . . -104.75 15.82 48.26 Favored Glycine 0 CA--C 1.538 1.51 0 C-N-CA 126.37 1.938 . . . . 0.0 114.637 175.74 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 2510 ' ' SER . . . . . . . . . . . . . 33.3 t -67.85 146.38 98.32 Favored Pre-proline 0 CA--C 1.551 0.987 0 C-N-CA 125.38 1.472 . . . . 0.0 112.181 179.449 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 2511 ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -79.6 156.19 89.34 Favored 'Cis proline' 0 C--N 1.351 0.687 0 CA-C-N 119.728 0.939 . . . . 0.0 112.915 -0.544 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 2512 ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -106.17 136.14 46.39 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 125.178 1.391 . . . . 0.0 111.07 179.822 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 2513 ' ' LYS . . . . . . . . . . . . . 19.5 ptpt -94.17 11.72 29.11 Favored 'General case' 0 CA--C 1.552 1.024 0 N-CA-C 116.51 2.041 . . . . 0.0 116.51 -164.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 2514 ' ' ALA . . . . . . . . . . . . . . . -4.78 99.35 0.01 OUTLIER 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 129.561 3.145 . . . . 0.0 116.474 -179.211 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 2515 ' ' LYS . . . . . . . . . . . . . 52.9 mtpt -89.02 120.0 30.05 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.258 1.023 . . . . 0.0 111.529 -173.332 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 2516 ' ' VAL . . . . . . . . . . . . . 55.0 t -113.14 142.58 25.1 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 125.788 1.635 . . . . 0.0 110.435 -172.484 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 2517 ' ' THR . . . . . . . . . . . . . 40.9 p -127.88 171.88 11.38 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 125.664 1.586 . . . . 0.0 111.458 178.151 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 2518 ' ' GLY . . . . . . . . . . . . . . . 107.31 -173.74 19.08 Favored Glycine 0 CA--C 1.538 1.53 0 C-N-CA 124.919 1.247 . . . . 0.0 113.264 -176.792 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 2519 ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -71.05 156.2 60.32 Favored 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 123.705 2.937 . . . . 0.0 112.209 -176.092 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 2520 ' ' ARG . . . . . . . . . . . . . 39.9 ttm105 -88.13 122.86 32.19 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 123.915 0.886 . . . . 0.0 110.0 171.852 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 2521 ' ' LEU . . . . . . . . . . . . . 4.1 mm? -85.8 -27.39 25.19 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.105 0.962 . . . . 0.0 112.823 -175.665 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 2522 ' ' VAL . . . . . . . . . . . . . 9.9 p . . . . . 0 C--O 1.254 1.292 0 C-N-CA 124.97 1.308 . . . . 0.0 112.625 176.297 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.569 0 N-CA-C 112.009 -0.437 . . . . 0.0 112.009 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -158.82 163.75 36.4 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 125.707 1.603 . . . . 0.0 112.141 -178.489 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 93.3 mmm 79.83 138.41 0.07 Allowed 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 129.042 2.937 . . . . 0.0 113.215 175.394 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 2427 ' ' GLY . . . . . . . . . . . . . . . -86.41 147.18 21.31 Favored Glycine 0 CA--C 1.529 0.951 0 C-N-CA 125.508 1.527 . . . . 0.0 113.099 178.202 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 2428 ' ' ASP . . . . . . . . . . . . . 29.4 m-20 -91.66 136.5 26.47 Favored Pre-proline 0 CA--C 1.547 0.853 0 C-N-CA 124.517 1.127 . . . . 0.0 112.0 -179.087 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 2429 ' ' PRO . . . . . . . . . . . . . 79.6 Cg_exo -54.75 -27.58 53.0 Favored 'Trans proline' 0 C--N 1.353 0.772 0 C-N-CA 123.994 3.129 . . . . 0.0 114.862 175.577 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 2430 ' ' GLY . . . . . . . . . . . . . . . -80.02 -24.54 59.54 Favored Glycine 0 CA--C 1.535 1.285 0 C-N-CA 123.762 0.696 . . . . 0.0 113.969 176.615 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 2431 ' ' LEU . . . . . . . . . . . . . 4.2 mm? -86.22 -32.77 21.0 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.575 1.15 . . . . 0.0 111.315 172.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 2432 ' ' VAL . . . . . . . . . . . . . 82.5 t -65.08 136.75 26.18 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 C-N-CA 123.723 0.809 . . . . 0.0 109.723 167.758 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 2433 ' ' SER . . . . . . . . . . . . . 8.4 t -131.88 -168.85 2.1 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.827 1.251 . . . . 0.0 110.823 177.311 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 2434 ' ' ALA . . . . . . . . . . . . . . . -149.91 142.64 24.63 Favored 'General case' 0 CA--C 1.539 0.531 0 O-C-N 121.062 -1.024 . . . . 0.0 111.988 176.395 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 2435 ' ' TYR . . . . . . . . . . . . . 77.4 m-85 -145.79 148.85 33.38 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 125.386 1.474 . . . . 0.0 112.001 -176.416 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 2436 ' ' GLY . . . . . . . . . . . . . . . 123.99 160.42 10.79 Favored Glycine 0 N--CA 1.474 1.2 0 C-N-CA 125.245 1.402 . . . . 0.0 113.974 176.708 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 2437 ' ' ALA . . . . . . . . . . . . . . . -60.93 -30.19 70.06 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.007 1.323 . . . . 0.0 114.167 -171.057 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 2438 ' ' GLY . . . . . . . . . . . . . . . -67.19 -9.81 55.21 Favored Glycine 0 CA--C 1.533 1.169 0 C-N-CA 124.57 1.081 . . . . 0.0 114.514 -179.632 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 2439 ' ' LEU . . . . . . . . . . . . . 88.3 mt -79.41 -26.12 41.95 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 118.973 1.386 . . . . 0.0 112.553 168.397 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 2440 ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -95.94 -36.37 11.09 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.081 1.352 . . . . 0.0 112.236 -173.851 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 2441 ' ' GLY . . . . . . . . . . . . . . . 160.32 -148.96 17.97 Favored Glycine 0 CA--C 1.532 1.134 0 C-N-CA 124.79 1.186 . . . . 0.0 113.146 -176.053 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 2442 ' ' GLY . . . . . . . . . . . . . . . 150.68 178.63 25.72 Favored Glycine 0 CA--C 1.534 1.249 0 C-N-CA 125.412 1.482 . . . . 0.0 112.796 -175.85 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 2443 ' ' VAL . . . . . . . . . . . . . 83.9 t -101.81 134.77 41.33 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 C-N-CA 124.722 1.209 . . . . 0.0 110.097 -179.583 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 2444 ' ' THR . . . . . . . . . . . . . 25.5 p -63.19 140.07 58.84 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.212 1.005 . . . . 0.0 112.325 176.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 2445 ' ' GLY . . . . . . . . . . . . . . . 79.58 -11.51 32.19 Favored Glycine 0 CA--C 1.536 1.385 0 C-N-CA 124.705 1.145 . . . . 0.0 114.328 -174.887 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 2446 ' ' ASN . . . . . . . . . . . . . 82.1 m-20 -106.36 152.14 40.48 Favored Pre-proline 0 CA--C 1.548 0.884 0 C-N-CA 125.453 1.501 . . . . 0.0 110.901 173.19 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 2447 ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -73.05 134.28 21.11 Favored 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 122.789 2.326 . . . . 0.0 111.335 175.875 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 2448 ' ' ALA . . . . . . . . . . . . . . . -111.48 156.69 21.3 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 126.232 1.813 . . . . 0.0 109.225 162.049 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 2449 ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -153.37 153.93 33.52 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 113.901 1.074 . . . . 0.0 113.901 -173.389 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 2450 ' ' PHE . . . . . . . . . . . . . 40.2 p90 -158.0 161.02 38.08 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.863 1.665 . . . . 0.0 110.696 177.336 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 2451 ' ' VAL . . . . . . . . . . . . . 14.7 p -113.04 135.07 53.68 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 C-N-CA 124.697 1.199 . . . . 0.0 110.968 175.121 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 2452 ' ' VAL . . . . . . . . . . . . . 25.1 t -84.89 101.76 9.86 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 N-CA-C 106.337 -1.727 . . . . 0.0 106.337 163.315 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 2453 ' ' ASN . . . . . . . . . . . . . 15.8 t-20 -88.66 123.5 33.17 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 123.72 0.808 . . . . 0.0 112.335 -167.006 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 2454 ' ' THR . . . . . . . . . . . . . 69.0 p -109.89 2.03 19.56 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 125.878 1.671 . . . . 0.0 113.745 -174.178 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 2455 ' ' SER . . . . . . . . . . . . . 42.0 m -56.57 -30.93 63.71 Favored 'General case' 0 N--CA 1.479 0.976 0 N-CA-C 114.537 1.31 . . . . 0.0 114.537 -172.887 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 2456 ' ' ASN . . . . . . . . . . . . . 28.0 m120 -88.96 -8.44 54.12 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 124.896 1.278 . . . . 0.0 113.55 177.297 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 2457 ' ' ALA . . . . . . . . . . . . . . . -113.18 -47.64 3.01 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 125.387 1.475 . . . . 0.0 113.755 -170.166 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 2458 ' ' GLY . . . . . . . . . . . . . . . 105.48 -151.29 17.12 Favored Glycine 0 CA--C 1.534 1.277 0 C-N-CA 125.333 1.444 . . . . 0.0 113.144 -174.219 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 2459 ' ' ALA . . . . . . . . . . . . . . . -77.44 156.64 30.97 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.811 1.245 . . . . 0.0 114.023 -174.43 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 2460 ' ' GLY . . . . . . . . . . . . . . . 158.22 172.09 24.93 Favored Glycine 0 CA--C 1.531 1.073 0 C-N-CA 125.246 1.403 . . . . 0.0 113.655 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 2461 ' ' ALA . . . . . . . . . . . . . . . -100.39 148.9 24.2 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.9 1.28 . . . . 0.0 112.84 -176.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 2462 ' ' LEU . . . . . . . . . . . . . 16.3 tp -101.97 149.41 24.26 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 125.526 1.531 . . . . 0.0 111.357 176.888 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 2463 ' ' SER . . . . . . . . . . . . . 3.7 t -140.89 40.29 1.82 Allowed 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 125.223 1.409 . . . . 0.0 111.427 179.136 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 2464 ' ' VAL . . . . . . . . . . . . . 14.2 p -65.36 139.23 21.7 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 C-N-CA 125.124 1.37 . . . . 0.0 112.574 -174.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 2465 ' ' THR . . . . . . . . . . . . . 93.5 m -135.04 143.38 46.71 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 125.791 1.636 . . . . 0.0 109.706 175.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 2466 ' ' ILE . . . . . . . . . . . . . 35.2 mt -121.12 123.97 71.13 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 C-N-CA 124.079 0.951 . . . . 0.0 110.122 175.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 2467 ' ' ASP . . . . . . . . . . . . . 34.4 t70 -104.17 162.91 12.78 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 126.809 2.044 . . . . 0.0 110.077 169.048 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 2468 ' ' GLY . . . . . . . . . . . . . . . 168.95 -161.55 35.25 Favored Glycine 0 CA--C 1.536 1.376 0 O-C-N 120.841 -1.162 . . . . 0.0 115.414 178.265 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 2469 ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -71.48 -17.72 30.05 Favored 'Trans proline' 0 CA--C 1.539 0.747 0 C-N-CA 124.006 3.138 . . . . 0.0 113.341 -178.827 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 2470 ' ' SER . . . . . . . . . . . . . 43.3 m -156.79 -168.36 2.65 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 127.213 2.205 . . . . 0.0 109.762 178.775 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 2471 ' ' LYS . . . . . . . . . . . . . 49.0 mmtm -74.12 174.78 8.21 Favored 'General case' 0 CA--C 1.55 0.968 0 O-C-N 120.661 -1.275 . . . . 0.0 112.523 170.32 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 2472 ' ' VAL . . . . . . . . . . . . . 35.4 m -131.06 148.36 33.01 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 C-N-CA 125.448 1.499 . . . . 0.0 109.971 165.848 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 2473 ' ' LYS . . . . . . . . . . . . . 88.5 tttt -94.44 102.89 14.87 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 166.146 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 2474 ' ' MET . . . . . . . . . . . . . 55.4 ttp -117.27 144.56 44.71 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.994 1.317 . . . . 0.0 112.732 -173.193 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 2475 ' ' ASP . . . . . . . . . . . . . 31.7 t70 -127.98 132.97 49.15 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 126.991 2.116 . . . . 0.0 110.057 170.479 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 2476 ' ' CYS . . . . . . . . . . . . . 45.3 t -109.73 138.55 45.93 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 125.138 1.375 . . . . 0.0 111.334 178.291 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 2477 ' ' GLN . . . . . . . . . . . . . 81.6 mt-30 -133.68 128.65 35.46 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.035 1.334 . . . . 0.0 110.392 -175.079 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 2478 ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -81.57 137.01 35.58 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.34 1.056 . . . . 0.0 109.9 173.159 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 2479 ' ' CYS . . . . . . . . . . . . . 29.6 p -156.01 167.24 14.69 Favored Pre-proline 0 CA--C 1.552 1.034 0 C-N-CA 125.024 1.33 . . . . 0.0 111.607 -172.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 2480 ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -65.28 -16.81 56.3 Favored 'Trans proline' 0 CA--C 1.543 0.941 0 C-N-CA 122.701 2.267 . . . . 0.0 113.266 174.807 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 2481 ' ' GLU . . . . . . . . . . . . . 19.6 tt0 -80.21 -10.72 59.77 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 124.969 1.308 . . . . 0.0 112.535 173.374 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 2482 ' ' GLY . . . . . . . . . . . . . . . 122.57 -126.35 6.34 Favored Glycine 0 N--CA 1.473 1.115 0 C-N-CA 125.999 1.761 . . . . 0.0 112.102 -177.048 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 2483 ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -115.85 108.84 16.82 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 123.789 0.836 . . . . 0.0 110.572 171.422 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 2484 ' ' ARG . . . . . . . . . . . . . 42.2 ttm-85 -92.59 132.49 36.82 Favored 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 124.007 0.923 . . . . 0.0 109.63 175.8 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 2485 ' ' VAL . . . . . . . . . . . . . 32.6 m -117.65 144.37 25.75 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 C-N-CA 123.845 0.858 . . . . 0.0 110.327 174.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 2486 ' ' THR . . . . . . . . . . . . . 88.6 m -124.32 132.75 53.57 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 125.447 1.499 . . . . 0.0 107.49 171.089 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 2487 ' ' TYR . . . . . . . . . . . . . 19.4 p90 -142.46 146.83 35.2 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 113.34 0.867 . . . . 0.0 113.34 178.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 2488 ' ' THR . . . . . . . . . . . . . 65.1 m -106.17 116.11 59.98 Favored Pre-proline 0 N--CA 1.471 0.608 0 C-N-CA 124.501 1.12 . . . . 0.0 109.216 172.49 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 2489 ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -79.98 153.8 22.39 Favored 'Trans proline' 0 C--N 1.351 0.681 0 C-N-CA 123.717 2.945 . . . . 0.0 110.665 170.475 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 2490 ' ' MET . . . . . . . . . . . . . 28.5 ptm -117.08 -5.3 11.41 Favored 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 115.055 1.502 . . . . 0.0 115.055 -174.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 2491 ' ' ALA . . . . . . . . . . . . . . . -146.5 144.73 21.43 Favored Pre-proline 0 CA--C 1.548 0.898 0 C-N-CA 124.731 1.212 . . . . 0.0 111.447 177.801 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 2492 ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -70.26 156.05 62.91 Favored 'Trans proline' 0 C--N 1.35 0.64 0 C-N-CA 123.571 2.847 . . . . 0.0 111.357 177.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 2493 ' ' GLY . . . . . . . . . . . . . . . 126.52 -154.62 19.18 Favored Glycine 0 CA--C 1.528 0.898 0 C-N-CA 124.886 1.231 . . . . 0.0 113.241 -178.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 2494 ' ' SER . . . . . . . . . . . . . 74.0 m -104.5 112.94 26.2 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 123.709 0.804 . . . . 0.0 112.206 -176.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 2495 ' ' TYR . . . . . . . . . . . . . 69.0 m-85 -88.64 129.6 35.47 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 123.524 0.73 . . . . 0.0 109.89 162.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 2496 ' ' LEU . . . . . . . . . . . . . 29.0 tp -101.55 117.69 35.43 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.697 1.199 . . . . 0.0 109.521 179.052 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 2497 ' ' ILE . . . . . . . . . . . . . 61.9 mt -103.46 99.98 9.5 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 C-N-CA 125.574 1.55 . . . . 0.0 108.407 -170.087 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 2498 ' ' SER . . . . . . . . . . . . . 74.6 m -83.32 86.28 7.08 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 125.071 1.348 . . . . 0.0 109.864 176.495 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 2499 ' ' ILE . . . . . . . . . . . . . 37.0 mt -79.19 110.86 15.36 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 C-N-CA 124.124 0.97 . . . . 0.0 109.162 175.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 2500 ' ' LYS . . . . . . . . . . . . . 83.7 mttt -121.75 145.46 48.02 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.859 1.264 . . . . 0.0 111.51 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 2501 ' ' TYR . . . . . . . . . . . . . 47.5 t80 -149.31 146.54 27.59 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.563 1.145 . . . . 0.0 112.16 -171.447 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 2502 ' ' GLY . . . . . . . . . . . . . . . 67.19 19.36 70.18 Favored Glycine 0 CA--C 1.536 1.394 0 C-N-CA 124.25 0.928 . . . . 0.0 113.735 177.552 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 2503 ' ' GLY . . . . . . . . . . . . . . . 131.7 -167.32 22.73 Favored Glycine 0 CA--C 1.541 1.699 0 C-N-CA 125.93 1.729 . . . . 0.0 112.364 -166.13 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 2504 ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -81.83 26.77 0.61 Allowed 'Trans proline' 0 CA--C 1.547 1.154 0 C-N-CA 124.921 3.747 . . . . 0.0 113.588 -174.291 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 2505 ' ' TYR . . . . . . . . . . . . . 60.2 m-85 -112.23 134.36 53.82 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 124.638 1.175 . . . . 0.0 113.02 -171.72 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 2506 ' ' HIS . . . . . . . . . . . . . 95.2 m-70 -63.4 142.53 58.36 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 124.842 1.257 . . . . 0.0 113.462 -179.326 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 2507 ' ' ILE . . . . . . . . . . . . . 1.8 pp -83.37 173.43 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.319 0 C-N-CA 123.628 0.771 . . . . 0.0 113.015 174.428 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 2508 ' ' GLY . . . . . . . . . . . . . . . -59.69 113.73 5.57 Favored Glycine 0 CA--C 1.534 1.248 0 O-C-N 121.469 -0.769 . . . . 0.0 112.783 -177.027 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 2509 ' ' GLY . . . . . . . . . . . . . . . 92.66 -5.32 76.79 Favored Glycine 0 CA--C 1.536 1.354 0 C-N-CA 125.615 1.579 . . . . 0.0 114.861 -177.238 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 2510 ' ' SER . . . . . . . . . . . . . 35.0 t -82.22 146.56 54.96 Favored Pre-proline 0 CA--C 1.55 0.969 0 CA-C-N 118.898 1.349 . . . . 0.0 112.271 179.381 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 2511 ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -77.49 156.54 96.09 Favored 'Cis proline' 0 C--N 1.354 0.845 0 CA-C-N 120.02 1.043 . . . . 0.0 113.305 -0.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 2512 ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -107.47 134.47 50.45 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 125.32 1.448 . . . . 0.0 111.263 178.682 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 2513 ' ' LYS . . . . . . . . . . . . . 40.4 ttmt -99.47 100.48 11.52 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 123.856 0.862 . . . . 0.0 111.966 -178.15 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 2514 ' ' ALA . . . . . . . . . . . . . . . -82.06 109.35 16.31 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.025 1.33 . . . . 0.0 110.787 177.069 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 2515 ' ' LYS . . . . . . . . . . . . . 30.6 mtmm -91.65 81.2 5.3 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.805 1.642 . . . . 0.0 109.324 -175.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 2516 ' ' VAL . . . . . . . . . . . . . 21.0 m -83.49 153.7 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 C-N-CA 124.338 1.055 . . . . 0.0 111.41 -173.226 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 2517 ' ' THR . . . . . . . . . . . . . 77.0 p -132.31 179.46 6.1 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 125.853 1.661 . . . . 0.0 111.118 -175.437 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 2518 ' ' GLY . . . . . . . . . . . . . . . 104.49 -176.15 23.08 Favored Glycine 0 CA--C 1.539 1.576 0 C-N-CA 124.891 1.234 . . . . 0.0 113.309 -176.492 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 2519 ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -74.28 148.59 39.04 Favored 'Trans proline' 0 CA--C 1.537 0.644 0 C-N-CA 123.72 2.946 . . . . 0.0 112.085 -173.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 2520 ' ' ARG . . . . . . . . . . . . . 38.3 ttp-105 -89.31 -60.68 1.88 Allowed 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 124.17 0.988 . . . . 0.0 111.883 -179.582 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 2521 ' ' LEU . . . . . . . . . . . . . 40.7 mt 68.7 6.94 5.8 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 127.543 2.337 . . . . 0.0 114.852 175.136 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 2522 ' ' VAL . . . . . . . . . . . . . 31.0 m . . . . . 0 N--CA 1.485 1.321 0 C-N-CA 126.34 1.856 . . . . 0.0 113.057 178.493 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.451 0 N-CA-C 111.237 -0.745 . . . . 0.0 111.237 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -81.24 -176.79 6.16 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 124.831 1.252 . . . . 0.0 112.671 177.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 38.0 mmt -72.11 135.23 46.17 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 123.833 0.853 . . . . 0.0 111.306 172.757 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 2427 ' ' GLY . . . . . . . . . . . . . . . -83.27 144.4 22.5 Favored Glycine 0 CA--C 1.53 0.971 0 C-N-CA 125.047 1.308 . . . . 0.0 113.408 -177.012 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 2428 ' ' ASP . . . . . . . . . . . . . 15.3 t70 -100.08 138.87 20.38 Favored Pre-proline 0 CA--C 1.55 0.953 0 C-N-CA 125.314 1.446 . . . . 0.0 111.471 179.448 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 2429 ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -55.49 -26.83 56.11 Favored 'Trans proline' 0 C--N 1.353 0.785 0 C-N-CA 123.782 2.988 . . . . 0.0 115.448 179.85 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 2430 ' ' GLY . . . . . . . . . . . . . . . -81.99 -24.36 55.33 Favored Glycine 0 CA--C 1.533 1.157 0 CA-C-N 119.155 0.889 . . . . 0.0 113.548 176.738 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 2431 ' ' LEU . . . . . . . . . . . . . 4.4 mm? -85.56 -33.75 21.64 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.481 1.112 . . . . 0.0 111.535 172.825 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 2432 ' ' VAL . . . . . . . . . . . . . 87.0 t -66.76 137.2 25.31 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 123.483 0.713 . . . . 0.0 109.539 168.477 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 2433 ' ' SER . . . . . . . . . . . . . 8.3 t -133.39 -170.58 2.51 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 124.85 1.26 . . . . 0.0 110.801 177.773 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 2434 ' ' ALA . . . . . . . . . . . . . . . -152.79 144.39 23.45 Favored 'General case' 0 CA--C 1.537 0.477 0 O-C-N 120.963 -1.086 . . . . 0.0 111.996 176.089 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 2435 ' ' TYR . . . . . . . . . . . . . 74.7 m-85 -147.33 150.2 34.29 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 125.566 1.547 . . . . 0.0 111.825 -174.455 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 2436 ' ' GLY . . . . . . . . . . . . . . . 121.79 162.91 11.77 Favored Glycine 0 N--CA 1.473 1.118 0 C-N-CA 125.288 1.423 . . . . 0.0 113.999 177.135 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 2437 ' ' ALA . . . . . . . . . . . . . . . -60.95 -28.77 69.21 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 125.099 1.36 . . . . 0.0 114.407 -169.677 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 2438 ' ' GLY . . . . . . . . . . . . . . . -66.72 -15.53 64.48 Favored Glycine 0 CA--C 1.532 1.103 0 CA-C-O 118.867 -0.963 . . . . 0.0 114.417 -178.802 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 2439 ' ' LEU . . . . . . . . . . . . . 84.4 mt -76.37 -24.96 54.16 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 118.866 1.333 . . . . 0.0 112.44 169.716 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 2440 ' ' GLU . . . . . . . . . . . . . 43.0 mm-40 -90.89 -31.79 16.27 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.15 1.38 . . . . 0.0 111.896 176.189 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 2441 ' ' GLY . . . . . . . . . . . . . . . 109.22 -133.41 11.63 Favored Glycine 0 CA--C 1.531 1.042 0 C-N-CA 125.921 1.724 . . . . 0.0 112.763 178.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 2442 ' ' GLY . . . . . . . . . . . . . . . 135.41 -154.59 21.76 Favored Glycine 0 CA--C 1.533 1.195 0 C-N-CA 124.826 1.203 . . . . 0.0 114.433 -176.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 2443 ' ' VAL . . . . . . . . . . . . . 93.0 t -74.37 136.14 25.88 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 C-N-CA 124.284 1.034 . . . . 0.0 111.488 -172.516 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 2444 ' ' THR . . . . . . . . . . . . . 25.1 p -63.37 133.13 53.54 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.445 1.098 . . . . 0.0 111.471 174.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 2445 ' ' GLY . . . . . . . . . . . . . . . 85.03 -8.41 70.44 Favored Glycine 0 CA--C 1.536 1.361 0 C-N-CA 124.667 1.127 . . . . 0.0 114.76 -176.511 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 2446 ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -86.01 152.86 56.78 Favored Pre-proline 0 CA--C 1.551 1.018 0 CA-C-N 118.976 1.388 . . . . 0.0 111.796 174.811 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 2447 ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -75.5 97.5 1.1 Allowed 'Trans proline' 0 CA--C 1.538 0.693 0 C-N-CA 123.156 2.571 . . . . 0.0 110.024 173.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 2448 ' ' ALA . . . . . . . . . . . . . . . -78.47 143.23 36.85 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.034 0.934 . . . . 0.0 109.481 168.759 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 2449 ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -155.1 148.32 24.89 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 114.33 1.233 . . . . 0.0 114.33 -173.386 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 2450 ' ' PHE . . . . . . . . . . . . . 49.5 p90 -153.93 162.47 41.19 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 126.439 1.895 . . . . 0.0 110.496 -178.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 2451 ' ' VAL . . . . . . . . . . . . . 71.5 t -112.68 130.96 65.52 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 C-N-CA 124.821 1.248 . . . . 0.0 109.498 174.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 2452 ' ' VAL . . . . . . . . . . . . . 45.5 t -79.52 109.33 14.02 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 161.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 2453 ' ' ASN . . . . . . . . . . . . . 12.4 t-20 -88.68 114.5 25.37 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.188 0.995 . . . . 0.0 111.909 -172.372 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 2454 ' ' THR . . . . . . . . . . . . . 70.0 p -107.43 -5.59 17.59 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 125.521 1.528 . . . . 0.0 113.65 -177.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 2455 ' ' SER . . . . . . . . . . . . . 13.9 m -57.77 -29.7 65.03 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 124.797 1.239 . . . . 0.0 114.242 -175.033 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 2456 ' ' ASN . . . . . . . . . . . . . 69.0 m-80 -83.16 -10.24 58.75 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 124.688 1.195 . . . . 0.0 113.453 177.097 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 2457 ' ' ALA . . . . . . . . . . . . . . . -115.17 -50.53 2.75 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 125.187 1.395 . . . . 0.0 113.482 -169.459 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 2458 ' ' GLY . . . . . . . . . . . . . . . 121.81 -145.2 16.73 Favored Glycine 0 CA--C 1.533 1.208 0 C-N-CA 125.054 1.312 . . . . 0.0 113.108 -174.083 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 2459 ' ' ALA . . . . . . . . . . . . . . . -96.41 160.22 14.53 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 125.195 1.398 . . . . 0.0 113.113 -175.534 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 2460 ' ' GLY . . . . . . . . . . . . . . . 153.76 164.01 12.33 Favored Glycine 0 CA--C 1.53 1.017 0 C-N-CA 124.261 0.934 . . . . 0.0 114.025 -178.561 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 2461 ' ' ALA . . . . . . . . . . . . . . . -79.7 144.76 33.39 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.37 1.068 . . . . 0.0 112.51 -179.411 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 2462 ' ' LEU . . . . . . . . . . . . . 69.5 tp -115.14 141.38 48.09 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 126.006 1.722 . . . . 0.0 110.526 178.283 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 2463 ' ' SER . . . . . . . . . . . . . 16.4 t -142.11 106.1 4.74 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.532 1.133 . . . . 0.0 109.639 170.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 2464 ' ' VAL . . . . . . . . . . . . . 60.5 t -102.39 128.2 55.3 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 C-N-CA 124.083 0.953 . . . . 0.0 109.487 178.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 2465 ' ' THR . . . . . . . . . . . . . 98.2 m -116.15 134.22 55.17 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 125.326 1.45 . . . . 0.0 108.636 174.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 2466 ' ' ILE . . . . . . . . . . . . . 41.1 mt -122.88 120.3 60.27 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 C-N-CA 123.542 0.737 . . . . 0.0 109.586 177.433 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 2467 ' ' ASP . . . . . . . . . . . . . 32.0 m-20 -107.0 167.69 9.72 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 126.204 1.802 . . . . 0.0 110.168 169.511 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 2468 ' ' GLY . . . . . . . . . . . . . . . 162.78 -153.1 23.56 Favored Glycine 0 CA--C 1.536 1.366 0 CA-C-O 118.854 -0.97 . . . . 0.0 114.481 179.694 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 2469 ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -70.18 -17.54 35.62 Favored 'Trans proline' 0 CA--C 1.54 0.79 0 C-N-CA 123.774 2.983 . . . . 0.0 113.189 180.0 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 2470 ' ' SER . . . . . . . . . . . . . 38.7 m -157.57 -165.17 1.71 Allowed 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 127.546 2.338 . . . . 0.0 109.382 176.383 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 2471 ' ' LYS . . . . . . . . . . . . . 59.3 mtmt -79.13 -175.3 4.53 Favored 'General case' 0 CA--C 1.552 1.042 0 O-C-N 120.802 -1.187 . . . . 0.0 111.79 167.614 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 2472 ' ' VAL . . . . . . . . . . . . . 33.4 m -139.78 151.78 22.32 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 C-N-CA 125.26 1.424 . . . . 0.0 111.09 171.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 2473 ' ' LYS . . . . . . . . . . . . . 60.6 mtpt -87.99 86.51 7.14 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 123.836 0.854 . . . . 0.0 110.126 171.706 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 2474 ' ' MET . . . . . . . . . . . . . 58.3 ttm -79.28 143.29 35.38 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 124.277 1.031 . . . . 0.0 112.38 -176.706 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 2475 ' ' ASP . . . . . . . . . . . . . 23.1 t70 -135.56 100.25 4.44 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 126.448 1.899 . . . . 0.0 109.581 165.067 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 2476 ' ' CYS . . . . . . . . . . . . . 44.3 t -95.47 132.3 40.69 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.642 1.177 . . . . 0.0 110.639 175.778 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 2477 ' ' GLN . . . . . . . . . . . . . 86.7 mt-30 -144.99 154.96 43.1 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 125.286 1.434 . . . . 0.0 110.711 -176.511 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 2478 ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -75.95 152.02 37.14 Favored 'General case' 0 CA--C 1.543 0.696 0 O-C-N 121.389 -0.819 . . . . 0.0 112.068 172.464 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 2479 ' ' CYS . . . . . . . . . . . . . 17.3 p -151.39 166.21 15.65 Favored Pre-proline 0 CA--C 1.554 1.106 0 C-N-CA 125.782 1.633 . . . . 0.0 110.774 -179.59 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 2480 ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -66.93 -18.84 52.55 Favored 'Trans proline' 0 CA--C 1.54 0.794 0 C-N-CA 122.327 2.018 . . . . 0.0 113.643 -178.005 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 2481 ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -92.9 -4.0 53.59 Favored 'General case' 0 CA--C 1.553 1.062 0 C-N-CA 125.164 1.386 . . . . 0.0 112.992 175.831 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 2482 ' ' GLY . . . . . . . . . . . . . . . 139.11 -110.85 0.74 Allowed Glycine 0 N--CA 1.471 0.974 0 C-N-CA 125.482 1.515 . . . . 0.0 112.985 179.828 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 2483 ' ' TYR . . . . . . . . . . . . . 95.3 m-85 -130.03 120.08 24.15 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 124.401 1.08 . . . . 0.0 111.317 175.397 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 2484 ' ' ARG . . . . . . . . . . . . . 19.0 ttp-105 -81.05 133.76 35.54 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 123.785 0.834 . . . . 0.0 110.161 171.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 2485 ' ' VAL . . . . . . . . . . . . . 89.9 t -115.06 118.07 57.63 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 C-N-CA 125.234 1.414 . . . . 0.0 107.996 168.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 2486 ' ' THR . . . . . . . . . . . . . 98.9 m -100.16 146.42 26.85 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 124.872 1.269 . . . . 0.0 108.166 165.405 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 2487 ' ' TYR . . . . . . . . . . . . . 29.2 p90 -153.13 152.0 30.8 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.246 1.018 . . . . 0.0 112.618 171.8 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 2488 ' ' THR . . . . . . . . . . . . . 59.6 m -107.09 113.69 62.14 Favored Pre-proline 0 N--CA 1.473 0.719 0 CA-C-O 117.799 -1.096 . . . . 0.0 109.438 173.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 2489 ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -76.01 114.21 3.87 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 123.504 2.803 . . . . 0.0 109.424 172.383 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 2490 ' ' MET . . . . . . . . . . . . . 27.8 ptm -86.42 -7.91 58.06 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 114.661 1.356 . . . . 0.0 114.661 -173.675 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 2491 ' ' ALA . . . . . . . . . . . . . . . -147.04 149.43 35.48 Favored Pre-proline 0 CA--C 1.547 0.855 0 C-N-CA 124.792 1.237 . . . . 0.0 112.146 -179.249 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 2492 ' ' PRO . . . . . . . . . . . . . 78.0 Cg_endo -73.17 155.05 52.21 Favored 'Trans proline' 0 C--N 1.35 0.646 0 C-N-CA 123.627 2.884 . . . . 0.0 111.489 178.243 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 2493 ' ' GLY . . . . . . . . . . . . . . . 131.89 -139.69 11.16 Favored Glycine 0 CA--C 1.529 0.944 0 C-N-CA 125.342 1.449 . . . . 0.0 112.093 -173.635 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 2494 ' ' SER . . . . . . . . . . . . . 65.9 m -133.77 124.99 27.56 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 123.937 0.895 . . . . 0.0 111.465 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 2495 ' ' TYR . . . . . . . . . . . . . 65.6 m-85 -95.53 131.88 41.24 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.845 1.258 . . . . 0.0 111.06 172.759 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 2496 ' ' LEU . . . . . . . . . . . . . 27.8 tp -100.13 114.98 28.76 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 125.297 1.439 . . . . 0.0 109.364 177.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 2497 ' ' ILE . . . . . . . . . . . . . 48.2 mt -102.57 102.33 13.42 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 C-N-CA 125.863 1.665 . . . . 0.0 108.667 -173.472 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 2498 ' ' SER . . . . . . . . . . . . . 67.2 m -92.14 109.0 20.35 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 124.888 1.275 . . . . 0.0 109.988 177.413 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 2499 ' ' ILE . . . . . 0.605 ' H ' ' HG ' ' A' 2510 ' ' SER . 69.1 mt -104.36 104.96 17.64 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 C-N-CA 124.684 1.194 . . . . 0.0 107.926 -176.692 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 2500 ' ' LYS . . . . . . . . . . . . . 84.0 mttt -110.96 137.36 48.68 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.35 1.06 . . . . 0.0 111.244 -179.725 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 2501 ' ' TYR . . . . . . . . . . . . . 51.7 t80 -143.63 137.69 28.48 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 123.915 0.886 . . . . 0.0 111.93 -170.45 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 2502 ' ' GLY . . . . . . . . . . . . . . . 66.54 11.04 55.95 Favored Glycine 0 CA--C 1.537 1.452 0 C-N-CA 124.449 1.023 . . . . 0.0 114.808 177.247 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 2503 ' ' GLY . . . . . . . . . . . . . . . 153.93 -167.53 32.21 Favored Glycine 0 CA--C 1.54 1.625 0 C-N-CA 125.507 1.527 . . . . 0.0 113.31 -170.189 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 2504 ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -82.87 7.88 4.93 Favored 'Trans proline' 0 CA--C 1.543 0.931 0 C-N-CA 124.731 3.621 . . . . 0.0 114.143 -173.43 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 2505 ' ' TYR . . . . . . . . . . . . . 64.4 m-85 -103.24 142.29 34.44 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.648 1.179 . . . . 0.0 113.234 -173.497 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 2506 ' ' HIS . . . . . . . . . . . . . 91.0 m-70 -65.27 147.28 53.72 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 124.278 1.031 . . . . 0.0 112.585 174.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 2507 ' ' ILE . . . . . . . . . . . . . 26.9 pt -74.29 169.2 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 O-C-N 121.574 -0.704 . . . . 0.0 112.47 170.524 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 2508 ' ' GLY . . . . . . . . . . . . . . . -57.89 123.88 34.37 Favored Glycine 0 CA--C 1.533 1.18 0 C-N-CA 123.838 0.732 . . . . 0.0 112.179 178.138 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 2509 ' ' GLY . . . . . . . . . . . . . . . 86.92 -10.22 69.02 Favored Glycine 0 CA--C 1.535 1.3 0 C-N-CA 125.535 1.54 . . . . 0.0 114.946 -177.364 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 2510 ' ' SER . . . . . 0.605 ' HG ' ' H ' ' A' 2499 ' ' ILE . 7.2 t -91.65 147.67 35.64 Favored Pre-proline 0 CA--C 1.552 1.045 0 CA-C-N 119.006 1.403 . . . . 0.0 111.538 -179.464 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 2511 ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -73.65 148.0 90.97 Favored 'Cis proline' 0 C--N 1.353 0.814 0 CA-C-N 120.474 1.205 . . . . 0.0 113.546 3.207 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 2512 ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -102.41 131.78 48.85 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 125.262 1.425 . . . . 0.0 110.703 177.764 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 2513 ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.67 106.87 19.03 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 123.934 0.894 . . . . 0.0 111.79 176.149 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 2514 ' ' ALA . . . . . . . . . . . . . . . -92.64 118.55 31.15 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.829 1.652 . . . . 0.0 110.401 177.478 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 2515 ' ' LYS . . . . . . . . . . . . . 48.1 mtpt -94.9 131.51 40.72 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.257 1.023 . . . . 0.0 110.742 -176.733 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 2516 ' ' VAL . . . . . . . . . . . . . 26.9 m -135.43 144.66 33.4 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 C-N-CA 123.832 0.853 . . . . 0.0 112.275 -170.025 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 2517 ' ' THR . . . . . . . . . . . . . 41.3 p -144.76 162.57 36.41 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 125.327 1.451 . . . . 0.0 111.46 -173.177 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 2518 ' ' GLY . . . . . . . . . . . . . . . 117.94 -176.93 16.36 Favored Glycine 0 CA--C 1.539 1.552 0 C-N-CA 125.252 1.406 . . . . 0.0 113.046 -175.039 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 2519 ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -75.41 133.12 15.62 Favored 'Trans proline' 0 C--N 1.349 0.553 0 C-N-CA 123.503 2.802 . . . . 0.0 111.324 -173.72 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 2520 ' ' ARG . . . . . . . . . . . . . 37.7 ttm105 -68.15 -54.11 20.33 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 123.938 0.895 . . . . 0.0 111.699 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 2521 ' ' LEU . . . . . . . . . . . . . 73.1 mt 69.96 -40.57 0.47 Allowed 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 128.966 2.906 . . . . 0.0 114.275 178.809 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 2522 ' ' VAL . . . . . . . . . . . . . 28.4 m . . . . . 0 C--O 1.254 1.311 0 C-N-CA 125.82 1.648 . . . . 0.0 113.772 177.014 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.552 0 N-CA-C 111.476 -0.65 . . . . 0.0 111.476 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -71.99 137.46 47.28 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 124.128 0.971 . . . . 0.0 112.167 179.468 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 25.6 mmt -93.79 138.92 31.45 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.668 1.187 . . . . 0.0 111.507 -179.187 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 2427 ' ' GLY . . . . . . . . . . . . . . . -86.8 153.14 25.53 Favored Glycine 0 CA--C 1.529 0.967 0 C-N-CA 124.967 1.27 . . . . 0.0 112.032 169.658 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 2428 ' ' ASP . . . . . . . . . . . . . 28.5 m-20 -121.46 142.86 36.4 Favored Pre-proline 0 CA--C 1.544 0.714 0 C-N-CA 124.983 1.313 . . . . 0.0 112.098 -177.65 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 2429 ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -64.49 -24.98 63.15 Favored 'Trans proline' 0 CA--C 1.539 0.734 0 C-N-CA 123.196 2.597 . . . . 0.0 112.966 179.12 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 2430 ' ' GLY . . . . . . . . . . . . . . . -73.88 -22.72 77.77 Favored Glycine 0 CA--C 1.535 1.341 0 CA-C-N 118.844 0.747 . . . . 0.0 113.738 174.59 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 2431 ' ' LEU . . . . . . . . . . . . . 4.3 mm? -88.47 -40.96 13.07 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 124.634 1.174 . . . . 0.0 111.201 173.157 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 2432 ' ' VAL . . . . . . . . . . . . . 59.4 t -59.19 137.97 20.91 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 123.936 0.894 . . . . 0.0 111.069 175.038 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 2433 ' ' SER . . . . . . . . . . . . . 8.2 t -127.02 -174.69 3.22 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 125.136 1.374 . . . . 0.0 110.45 171.855 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 2434 ' ' ALA . . . . . . . . . . . . . . . -145.95 146.95 31.23 Favored 'General case' 0 CA--C 1.538 0.487 0 O-C-N 120.91 -1.119 . . . . 0.0 112.123 177.875 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 2435 ' ' TYR . . . . . . . . . . . . . 68.2 m-85 -145.35 150.05 35.89 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 125.411 1.484 . . . . 0.0 111.92 -173.746 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 2436 ' ' GLY . . . . . . . . . . . . . . . 120.63 159.79 10.91 Favored Glycine 0 N--CA 1.474 1.203 0 C-N-CA 125.462 1.506 . . . . 0.0 114.051 177.098 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 2437 ' ' ALA . . . . . . . . . . . . . . . -61.83 -26.98 68.45 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 125.118 1.367 . . . . 0.0 114.446 -171.362 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 2438 ' ' GLY . . . . . . . . . . . . . . . -65.49 -14.48 60.11 Favored Glycine 0 CA--C 1.533 1.183 0 C-N-CA 124.183 0.897 . . . . 0.0 114.217 178.494 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 2439 ' ' LEU . . . . . . . . . . . . . 86.3 mt -78.22 -22.01 49.14 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 118.894 1.347 . . . . 0.0 112.779 169.807 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 2440 ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -98.29 -28.25 13.76 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 125.338 1.455 . . . . 0.0 112.407 -179.268 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 2441 ' ' GLY . . . . . . . . . . . . . . . 105.86 -155.04 16.92 Favored Glycine 0 CA--C 1.533 1.189 0 C-N-CA 125.747 1.641 . . . . 0.0 113.341 179.059 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 2442 ' ' GLY . . . . . . . . . . . . . . . 163.72 -157.06 29.17 Favored Glycine 0 CA--C 1.532 1.102 0 C-N-CA 124.342 0.972 . . . . 0.0 114.071 -175.458 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 2443 ' ' VAL . . . . . . . . . . . . . 61.0 t -87.64 141.33 14.47 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 C-N-CA 124.597 1.159 . . . . 0.0 110.873 -178.192 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 2444 ' ' THR . . . . . . . . . . . . . 26.1 p -62.66 144.3 56.43 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 124.933 1.293 . . . . 0.0 112.666 174.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 2445 ' ' GLY . . . . . . . . . . . . . . . 76.33 -9.91 18.59 Favored Glycine 0 CA--C 1.537 1.466 0 C-N-CA 124.605 1.098 . . . . 0.0 114.254 -176.088 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 2446 ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -101.0 142.11 23.97 Favored Pre-proline 0 CA--C 1.553 1.059 0 C-N-CA 126.744 2.018 . . . . 0.0 110.312 175.184 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 2447 ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -76.72 149.32 29.77 Favored 'Trans proline' 0 CA--C 1.536 0.598 0 C-N-CA 123.196 2.597 . . . . 0.0 111.858 178.757 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 2448 ' ' ALA . . . . . . . . . . . . . . . -138.89 141.51 38.56 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 125.648 1.579 . . . . 0.0 109.972 170.834 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 2449 ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -130.21 152.22 49.88 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.23 1.012 . . . . 0.0 113.396 -167.711 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 2450 ' ' PHE . . . . . . . . . . . . . 40.2 p90 -154.3 161.58 41.7 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.972 1.309 . . . . 0.0 111.746 175.445 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 2451 ' ' VAL . . . . . . . . . . . . . 12.3 p -118.26 135.37 58.89 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 C-N-CA 125.273 1.429 . . . . 0.0 110.454 175.35 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 2452 ' ' VAL . . . . . . . . . . . . . 40.9 t -89.19 104.0 14.54 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 N-CA-C 106.751 -1.574 . . . . 0.0 106.751 166.16 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 2453 ' ' ASN . . . . . . . . . . . . . 15.1 t-20 -89.17 117.1 27.9 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 123.955 0.902 . . . . 0.0 112.791 -165.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 2454 ' ' THR . . . . . . . . . . . . . 48.5 p -97.63 -2.67 41.01 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 125.809 1.643 . . . . 0.0 114.432 -175.592 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 2455 ' ' SER . . . . . . . . . . . . . 24.4 m -58.0 -27.43 63.5 Favored 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 114.326 1.232 . . . . 0.0 114.326 -176.672 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 2456 ' ' ASN . . . . . . . . . . . . . 81.8 m-20 -76.42 -20.78 56.75 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 124.44 1.096 . . . . 0.0 113.289 175.744 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 2457 ' ' ALA . . . . . . . . . . . . . . . -117.34 -56.49 2.23 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.649 1.18 . . . . 0.0 113.646 -157.151 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 2458 ' ' GLY . . . . . . . . . . . . . . . 113.68 -155.96 15.95 Favored Glycine 0 CA--C 1.534 1.252 0 C-N-CA 124.852 1.215 . . . . 0.0 112.375 -166.893 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 2459 ' ' ALA . . . . . . . . . . . . . . . -85.53 145.52 27.35 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 124.206 1.002 . . . . 0.0 113.681 -173.19 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 2460 ' ' GLY . . . . . . . . . . . . . . . 174.61 160.67 23.1 Favored Glycine 0 CA--C 1.532 1.127 0 C-N-CA 125.357 1.455 . . . . 0.0 113.145 -179.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 2461 ' ' ALA . . . . . . . . . . . . . . . -82.2 150.59 27.3 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 124.278 1.031 . . . . 0.0 112.847 -178.388 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 2462 ' ' LEU . . . . . . . . . . . . . 16.9 tp -107.68 147.36 30.83 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.56 1.544 . . . . 0.0 110.976 176.004 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 2463 ' ' SER . . . . . . . . . . . . . 9.5 t -141.06 37.37 1.75 Allowed 'General case' 0 CA--C 1.551 1.005 0 C-N-CA 125.294 1.438 . . . . 0.0 111.563 -179.469 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 2464 ' ' VAL . . . . . . . . . . . . . 12.6 p -61.01 135.73 25.45 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 C-N-CA 125.164 1.386 . . . . 0.0 112.512 -174.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 2465 ' ' THR . . . . . . . . . . . . . 95.9 m -136.57 145.24 44.74 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 126.003 1.721 . . . . 0.0 109.727 -179.758 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 2466 ' ' ILE . . . . . . . . . . . . . 30.1 mt -124.89 130.51 73.27 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 124.072 0.949 . . . . 0.0 110.094 176.519 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 2467 ' ' ASP . . . . . . . . . . . . . 33.7 t70 -122.51 128.12 50.4 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 125.949 1.7 . . . . 0.0 109.976 173.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 2468 ' ' GLY . . . . . . . . . . . . . . . -155.49 -166.2 15.32 Favored Glycine 0 CA--C 1.537 1.43 0 N-CA-C 115.685 1.034 . . . . 0.0 115.685 -171.174 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 2469 ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -67.72 -16.16 45.83 Favored 'Trans proline' 0 CA--C 1.539 0.765 0 C-N-CA 124.464 3.442 . . . . 0.0 113.267 178.474 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 2470 ' ' SER . . . . . . . . . . . . . 8.1 t -156.63 -168.07 2.58 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 126.491 1.916 . . . . 0.0 109.307 166.346 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 2471 ' ' LYS . . . . . . . . . . . . . 67.7 mttm -74.28 173.66 9.89 Favored 'General case' 0 CA--C 1.55 0.97 0 O-C-N 120.881 -1.137 . . . . 0.0 112.31 169.587 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 2472 ' ' VAL . . . . . . . . . . . . . 33.5 m -127.05 149.18 31.96 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 C-N-CA 125.624 1.57 . . . . 0.0 110.696 174.503 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 2473 ' ' LYS . . . . . . . . . . . . . 59.6 tttp -92.71 97.21 10.64 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 165.685 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 2474 ' ' MET . . . . . . . . . . . . . 48.4 ttp -111.58 142.26 44.12 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 124.874 1.27 . . . . 0.0 112.369 -175.445 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 2475 ' ' ASP . . . . . . . . . . . . . 36.9 t70 -126.05 141.15 52.08 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 126.791 2.037 . . . . 0.0 110.23 170.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 2476 ' ' CYS . . . . . . . . . . . . . 63.6 m -123.06 150.82 42.63 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 125.203 1.401 . . . . 0.0 111.989 -173.218 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 2477 ' ' GLN . . . . . . . . . . . . . 3.8 tt0 -151.24 147.14 26.63 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.447 1.099 . . . . 0.0 111.121 179.486 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 2478 ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -90.13 150.06 22.19 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 123.716 0.806 . . . . 0.0 111.083 163.752 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 2479 ' ' CYS . . . . . . . . . . . . . 19.9 p -160.68 172.22 6.14 Favored Pre-proline 0 CA--C 1.554 1.099 0 C-N-CA 125.626 1.571 . . . . 0.0 111.572 -178.384 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 2480 ' ' PRO . . . . . . . . . . . . . 63.6 Cg_exo -58.67 -25.06 73.73 Favored 'Trans proline' 0 CA--C 1.539 0.743 0 C-N-CA 123.454 2.77 . . . . 0.0 114.481 175.362 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 2481 ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -81.72 -8.65 59.72 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 124.814 1.246 . . . . 0.0 113.076 178.162 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 2482 ' ' GLY . . . . . . . . . . . . . . . 120.47 -143.25 16.41 Favored Glycine 0 N--CA 1.471 1.015 0 C-N-CA 126.11 1.814 . . . . 0.0 112.238 -175.263 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 2483 ' ' TYR . . . . . . . . . . . . . 80.1 m-85 -96.23 113.66 25.28 Favored 'General case' 0 N--CA 1.469 0.517 0 O-C-N 121.7 -0.883 . . . . 0.0 110.811 173.381 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 2484 ' ' ARG . . . . . . . . . . . . . 55.6 ttp85 -96.76 142.02 29.28 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 124.62 1.168 . . . . 0.0 110.278 176.85 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 2485 ' ' VAL . . . . . . . . . . . . . 11.3 m -133.97 152.78 35.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 123.806 0.843 . . . . 0.0 111.083 173.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 2486 ' ' THR . . . . . . . . . . . . . 40.5 m -131.99 133.86 44.93 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 125.656 1.583 . . . . 0.0 107.66 172.682 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 2487 ' ' TYR . . . . . . . . . . . . . 15.3 p90 -140.5 148.98 41.92 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 113.839 1.051 . . . . 0.0 113.839 176.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 2488 ' ' THR . . . . . . . . . . . . . 69.2 m -108.7 115.71 57.11 Favored Pre-proline 0 N--CA 1.469 0.514 0 C-N-CA 124.941 1.297 . . . . 0.0 109.108 172.611 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 2489 ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -80.49 161.26 22.37 Favored 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 123.794 2.996 . . . . 0.0 110.864 169.571 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 2490 ' ' MET . . . . . . . . . . . . . 25.7 ptm -133.4 2.8 3.56 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 114.94 1.459 . . . . 0.0 114.94 -173.703 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 2491 ' ' ALA . . . . . . . . . . . . . . . -143.42 145.55 32.35 Favored Pre-proline 0 CA--C 1.547 0.828 0 C-N-CA 124.644 1.178 . . . . 0.0 111.68 177.764 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 2492 ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -73.23 148.66 44.36 Favored 'Trans proline' 0 CA--C 1.536 0.615 0 C-N-CA 123.126 2.55 . . . . 0.0 111.08 175.851 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 2493 ' ' GLY . . . . . . . . . . . . . . . 135.05 -161.75 24.64 Favored Glycine 0 CA--C 1.53 0.988 0 C-N-CA 125.307 1.432 . . . . 0.0 112.975 -175.54 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 2494 ' ' SER . . . . . . . . . . . . . 49.3 m -105.8 118.04 35.57 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.835 0.854 . . . . 0.0 111.522 179.193 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 2495 ' ' TYR . . . . . . . . . . . . . 78.1 m-85 -88.53 114.44 25.15 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.704 1.202 . . . . 0.0 109.386 167.033 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 2496 ' ' LEU . . . . . . . . . . . . . 27.2 tp -91.0 114.36 26.86 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 125.158 1.383 . . . . 0.0 109.072 179.073 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 2497 ' ' ILE . . . . . . . . . . . . . 44.0 mt -99.88 102.17 13.07 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 C-N-CA 125.534 1.534 . . . . 0.0 108.503 -173.417 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 2498 ' ' SER . . . . . . . . . . . . . 66.5 m -84.87 93.95 8.64 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 124.954 1.302 . . . . 0.0 109.391 174.841 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 2499 ' ' ILE . . . . . . . . . . . . . 48.6 mt -87.38 95.85 5.31 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 C-N-CA 124.402 1.081 . . . . 0.0 108.526 178.884 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 2500 ' ' LYS . . . . . . . . . . . . . 91.2 mttt -98.84 138.89 35.32 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.099 0.959 . . . . 0.0 111.385 177.212 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 2501 ' ' TYR . . . . . . . . . . . . . 64.6 t80 -149.58 148.46 29.37 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.046 1.338 . . . . 0.0 112.228 -172.765 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 2502 ' ' GLY . . . . . . . . . . . . . . . 69.01 26.3 74.8 Favored Glycine 0 CA--C 1.534 1.22 0 C-N-CA 124.065 0.84 . . . . 0.0 112.639 -178.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 2503 ' ' GLY . . . . . . . . . . . . . . . 116.19 -164.45 12.28 Favored Glycine 0 CA--C 1.54 1.645 0 C-N-CA 125.877 1.703 . . . . 0.0 112.04 -164.022 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 2504 ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -81.49 33.87 0.54 Allowed 'Trans proline' 0 CA--C 1.548 1.179 0 C-N-CA 124.936 3.757 . . . . 0.0 113.165 -173.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 2505 ' ' TYR . . . . . . . . . . . . . 74.9 m-85 -114.8 127.21 55.59 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.815 1.246 . . . . 0.0 112.576 -172.053 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 2506 ' ' HIS . . . . . . . . . . . . . 86.4 m-70 -57.61 138.74 54.97 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 124.802 1.241 . . . . 0.0 113.037 178.326 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 2507 ' ' ILE . . . . . . . . . . . . . 27.1 pt -69.08 166.96 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 O-C-N 121.827 -0.545 . . . . 0.0 112.26 169.689 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 2508 ' ' GLY . . . . . . . . . . . . . . . -59.84 -21.94 56.39 Favored Glycine 0 CA--C 1.539 1.538 0 N-CA-C 116.483 1.353 . . . . 0.0 116.483 -166.688 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 2509 ' ' GLY . . . . . . . . . . . . . . . -106.36 -0.42 37.75 Favored Glycine 0 CA--C 1.536 1.399 0 C-N-CA 125.136 1.351 . . . . 0.0 114.969 174.302 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 2510 ' ' SER . . . . . . . . . . . . . 46.8 t -88.77 148.69 42.16 Favored Pre-proline 0 CA--C 1.549 0.916 0 CA-C-N 118.678 1.239 . . . . 0.0 112.824 -172.488 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 2511 ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -78.39 152.34 90.64 Favored 'Cis proline' 0 C--N 1.353 0.794 0 CA-C-N 119.31 0.789 . . . . 0.0 113.288 -1.669 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 2512 ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -102.29 128.91 48.64 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 125.291 1.437 . . . . 0.0 110.739 179.26 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 2513 ' ' LYS . . . . . . . . . . . . . 57.0 pttt -92.04 100.36 13.02 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 124.097 0.959 . . . . 0.0 112.214 178.644 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 2514 ' ' ALA . . . . . . . . . . . . . . . -88.3 114.59 25.08 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.714 1.206 . . . . 0.0 110.109 175.209 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 2515 ' ' LYS . . . . . . . . . . . . . 66.3 mttm -95.92 119.07 33.76 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 123.867 0.867 . . . . 0.0 111.093 -175.188 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 2516 ' ' VAL . . . . . . . . . . . . . 49.4 t -113.4 140.15 35.09 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 C-N-CA 125.731 1.612 . . . . 0.0 110.408 -169.798 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 2517 ' ' THR . . . . . . . . . . . . . 64.2 p -129.85 173.6 10.51 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 125.82 1.648 . . . . 0.0 111.403 -177.027 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 2518 ' ' GLY . . . . . . . . . . . . . . . 100.5 -171.14 22.81 Favored Glycine 0 CA--C 1.539 1.55 0 C-N-CA 124.705 1.145 . . . . 0.0 113.03 -174.695 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 2519 ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -72.19 157.36 54.04 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 123.719 2.946 . . . . 0.0 112.106 -176.005 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 2520 ' ' ARG . . . . . . . . . . . . . 50.9 ttt85 -87.12 120.12 28.06 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 123.635 0.774 . . . . 0.0 109.665 170.499 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 2521 ' ' LEU . . . . . . . . . . . . . 9.3 mp -85.11 -16.9 39.02 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.571 1.148 . . . . 0.0 112.433 -177.552 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 2522 ' ' VAL . . . . . . . . . . . . . 24.9 t . . . . . 0 C--O 1.253 1.249 0 C-N-CA 126.694 1.997 . . . . 0.0 112.025 179.135 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A 2427 ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.134 0 CA-C-O 121.049 0.249 . . . . 0.0 113.003 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A 2428 ' ' ASP . . . . . . . . . . . . . 13.4 t70 -150.4 135.48 9.91 Favored Pre-proline 0 CA--C 1.55 0.958 0 C-N-CA 124.471 1.108 . . . . 0.0 111.658 -174.936 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 2429 ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -67.16 -21.18 48.91 Favored 'Trans proline' 0 C--N 1.352 0.717 0 C-N-CA 123.44 2.76 . . . . 0.0 113.946 -175.782 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 2430 ' ' GLY . . . . . . . . . . . . . . . -80.48 -25.6 56.44 Favored Glycine 0 CA--C 1.532 1.115 0 CA-C-N 119.29 0.95 . . . . 0.0 113.021 174.319 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 2431 ' ' LEU . . . . . . . . . . . . . 4.4 mm? -80.61 -37.55 30.94 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 124.138 0.975 . . . . 0.0 111.058 171.218 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 2432 ' ' VAL . . . . . . . . . . . . . 74.7 t -63.5 137.62 24.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 CA-C-O 121.598 0.713 . . . . 0.0 110.607 170.333 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 2433 ' ' SER . . . . . . . . . . . . . 8.1 t -133.5 -171.4 2.7 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 125.224 1.41 . . . . 0.0 110.103 173.007 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 2434 ' ' ALA . . . . . . . . . . . . . . . -144.59 145.65 31.91 Favored 'General case' 0 CA--C 1.538 0.487 0 O-C-N 121.029 -1.044 . . . . 0.0 111.502 176.927 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 2435 ' ' TYR . . . . . . . . . . . . . 80.5 m-85 -145.72 154.42 42.05 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 125.454 1.501 . . . . 0.0 111.844 -174.58 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 2436 ' ' GLY . . . . . . . . . . . . . . . 113.64 162.28 14.7 Favored Glycine 0 N--CA 1.473 1.149 0 C-N-CA 125.167 1.365 . . . . 0.0 113.954 176.852 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 2437 ' ' ALA . . . . . . . . . . . . . . . -60.62 -27.3 67.66 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.322 1.449 . . . . 0.0 114.462 -170.19 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 2438 ' ' GLY . . . . . . . . . . . . . . . -64.83 -18.59 64.4 Favored Glycine 0 CA--C 1.531 1.033 0 CA-C-O 119.025 -0.875 . . . . 0.0 114.33 -179.081 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 2439 ' ' LEU . . . . . . . . . . . . . 87.2 mt -74.33 -24.43 59.19 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 118.576 1.188 . . . . 0.0 112.698 170.703 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 2440 ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -90.07 -28.0 19.31 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.844 1.258 . . . . 0.0 111.691 174.953 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 2441 ' ' GLY . . . . . . . . . . . . . . . 110.93 -137.1 14.08 Favored Glycine 0 CA--C 1.529 0.931 0 C-N-CA 125.83 1.681 . . . . 0.0 113.428 175.079 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 2442 ' ' GLY . . . . . . . . . . . . . . . 165.34 -136.31 4.13 Favored Glycine 0 N--CA 1.471 1.025 0 C-N-CA 124.032 0.825 . . . . 0.0 113.7 -172.947 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 2443 ' ' VAL . . . . . . . . . . . . . 73.8 t -130.2 149.3 33.45 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 125.921 1.688 . . . . 0.0 109.302 -178.104 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 2444 ' ' THR . . . . . . . . . . . . . 38.1 p -58.31 136.26 57.33 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.608 0.763 . . . . 0.0 112.005 176.566 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 2445 ' ' GLY . . . . . . . . . . . . . . . 77.67 -10.89 22.0 Favored Glycine 0 CA--C 1.538 1.484 0 C-N-CA 124.905 1.241 . . . . 0.0 114.805 -175.655 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 2446 ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -95.07 141.68 23.57 Favored Pre-proline 0 CA--C 1.553 1.079 0 C-N-CA 125.63 1.572 . . . . 0.0 110.981 177.588 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 2447 ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -74.18 134.74 19.73 Favored 'Trans proline' 0 C--N 1.35 0.649 0 C-N-CA 123.113 2.542 . . . . 0.0 111.437 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 2448 ' ' ALA . . . . . . . . . . . . . . . -116.65 119.98 37.21 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 126.688 1.995 . . . . 0.0 108.919 175.916 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 2449 ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -122.62 131.7 53.94 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 124.094 0.958 . . . . 0.0 111.94 -168.336 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 2450 ' ' PHE . . . . . . . . . . . . . 15.3 p90 -147.56 166.67 26.62 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 125.283 1.433 . . . . 0.0 111.107 174.307 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 2451 ' ' VAL . . . . . . . . . . . . . 15.0 p -122.42 135.47 62.42 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 C-N-CA 125.045 1.338 . . . . 0.0 110.987 176.796 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 2452 ' ' VAL . . . . . . . . . . . . . 56.9 t -85.08 107.09 15.64 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 N-CA-C 106.825 -1.546 . . . . 0.0 106.825 163.968 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 2453 ' ' ASN . . . . . . . . . . . . . 17.4 t-20 -92.7 119.77 32.43 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 123.389 0.676 . . . . 0.0 112.49 -168.088 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 2454 ' ' THR . . . . . . . . . . . . . 76.8 p -102.8 -1.17 30.29 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 125.739 1.615 . . . . 0.0 113.906 -178.126 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 2455 ' ' SER . . . . . . . . . . . . . 29.5 m -56.93 -29.63 63.29 Favored 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 114.478 1.288 . . . . 0.0 114.478 -174.96 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 2456 ' ' ASN . . . . . . . . . . . . . 86.8 m-20 -82.96 -18.42 40.02 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 124.321 1.048 . . . . 0.0 113.396 175.897 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 2457 ' ' ALA . . . . . . . . . . . . . . . -104.03 -36.03 7.88 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 125.533 1.533 . . . . 0.0 113.626 -172.48 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 2458 ' ' GLY . . . . . . . . . . . . . . . 105.99 -107.17 2.72 Favored Glycine 0 CA--C 1.529 0.958 0 C-N-CA 124.9 1.238 . . . . 0.0 111.167 -172.616 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 2459 ' ' ALA . . . . . . . . . . . . . . . -143.31 156.22 44.66 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.706 1.202 . . . . 0.0 112.905 -176.952 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 2460 ' ' GLY . . . . . . . . . . . . . . . 164.26 166.81 23.78 Favored Glycine 0 CA--C 1.532 1.136 0 C-N-CA 125.825 1.678 . . . . 0.0 112.772 -174.634 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 2461 ' ' ALA . . . . . . . . . . . . . . . -74.98 144.18 43.27 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 123.921 0.889 . . . . 0.0 112.363 -179.422 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 2462 ' ' LEU . . . . . . . . . . . . . 48.2 tp -124.83 141.73 51.92 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.291 1.436 . . . . 0.0 111.328 179.417 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 2463 ' ' SER . . . . . . . . . . . . . 15.8 t -123.71 160.42 27.27 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 125.005 1.322 . . . . 0.0 110.291 158.11 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 2464 ' ' VAL . . . . . . . . . . . . . 5.8 p -161.68 133.82 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 124.892 1.277 . . . . 0.0 110.634 -176.334 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 2465 ' ' THR . . . . . . . . . . . . . 94.2 m -137.84 138.5 39.2 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 126.048 1.739 . . . . 0.0 109.369 -177.407 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 2466 ' ' ILE . . . . . . . . . . . . . 45.3 mt -119.67 125.3 74.21 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 C-N-CA 124.39 1.076 . . . . 0.0 108.821 176.689 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 2467 ' ' ASP . . . . . . . . . . . . . 35.7 t70 -137.05 130.5 31.44 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 125.135 1.374 . . . . 0.0 111.296 -174.397 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 2468 ' ' GLY . . . . . . . . . . . . . . . -167.17 -142.43 3.45 Favored Glycine 0 CA--C 1.538 1.506 0 CA-C-O 118.524 -1.153 . . . . 0.0 113.883 -175.111 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 2469 ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo -68.61 -14.36 39.33 Favored 'Trans proline' 0 CA--C 1.539 0.759 0 C-N-CA 123.977 3.118 . . . . 0.0 113.58 -178.465 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 2470 ' ' SER . . . . . . . . . . . . . 7.5 t -157.73 -170.4 3.18 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 125.776 1.63 . . . . 0.0 110.356 170.625 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 2471 ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -77.48 171.39 14.96 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 124.245 1.018 . . . . 0.0 111.824 168.079 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 2472 ' ' VAL . . . . . . . . . . . . . 28.7 m -135.07 151.75 31.4 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 125.376 1.471 . . . . 0.0 110.389 175.097 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 2473 ' ' LYS . . . . . . . . . . . . . 99.7 mttt -93.59 118.51 31.46 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.811 0.845 . . . . 0.0 109.451 170.088 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 2474 ' ' MET . . . . . . . . . . . . . 77.2 mtp -111.13 137.34 48.93 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 125.282 1.433 . . . . 0.0 112.54 -175.758 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 2475 ' ' ASP . . . . . . . . . . . . . 25.8 t70 -113.59 94.89 5.06 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 126.364 1.866 . . . . 0.0 109.042 162.371 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 2476 ' ' CYS . . . . . . . . . . . . . 47.5 t -91.35 129.43 37.34 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.382 1.073 . . . . 0.0 110.123 173.374 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 2477 ' ' GLN . . . . . . . . . . . . . 70.1 mm-40 -142.33 140.17 32.04 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 124.571 1.148 . . . . 0.0 110.821 -175.527 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 2478 ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -82.22 148.1 28.61 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 123.63 0.772 . . . . 0.0 111.854 173.06 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 2479 ' ' CYS . . . . . . . . . . . . . 31.9 p -161.36 171.7 6.59 Favored Pre-proline 0 CA--C 1.553 1.086 0 C-N-CA 125.639 1.576 . . . . 0.0 111.863 -175.005 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 2480 ' ' PRO . . . . . . . . . . . . . 66.0 Cg_exo -58.42 -24.73 70.24 Favored 'Trans proline' 0 CA--C 1.539 0.772 0 C-N-CA 123.348 2.699 . . . . 0.0 114.341 174.137 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 2481 ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -81.69 -6.51 59.09 Favored 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 124.981 1.312 . . . . 0.0 113.047 177.374 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 2482 ' ' GLY . . . . . . . . . . . . . . . 120.43 -118.04 3.73 Favored Glycine 0 N--CA 1.469 0.883 0 C-N-CA 126.08 1.8 . . . . 0.0 111.987 -176.709 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 2483 ' ' TYR . . . . . . . . . . . . . 93.4 m-85 -124.14 111.78 16.32 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.211 1.004 . . . . 0.0 110.651 173.787 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 2484 ' ' ARG . . . . . . . . . . . . . 13.7 ttp-105 -78.07 139.52 39.08 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 123.871 0.869 . . . . 0.0 109.807 173.571 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 2485 ' ' VAL . . . . . . . . . . . . . 90.7 t -126.96 116.09 43.5 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 C-N-CA 125.202 1.401 . . . . 0.0 108.257 170.719 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 2486 ' ' THR . . . . . . . . . . . . . 87.2 m -103.44 133.61 48.2 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 107.478 -1.304 . . . . 0.0 107.478 164.403 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 2487 ' ' TYR . . . . . . . . . . . . . 27.5 p90 -139.14 155.13 48.09 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 113.166 0.802 . . . . 0.0 113.166 176.4 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 2488 ' ' THR . . . . . . . . . . . . . 93.0 m -120.1 116.97 32.33 Favored Pre-proline 0 N--CA 1.474 0.737 0 C-N-CA 124.205 1.002 . . . . 0.0 109.774 176.925 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 2489 ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -82.5 158.4 16.83 Favored 'Trans proline' 0 C--N 1.351 0.681 0 C-N-CA 123.97 3.113 . . . . 0.0 111.551 173.402 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 2490 ' ' MET . . . . . . . . . . . . . 25.3 ptm -132.78 7.71 4.09 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 114.612 1.338 . . . . 0.0 114.612 -176.218 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 2491 ' ' ALA . . . . . . . . . . . . . . . -144.83 143.83 22.3 Favored Pre-proline 0 CA--C 1.547 0.838 0 C-N-CA 125.357 1.463 . . . . 0.0 111.224 172.975 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 2492 ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -76.16 156.86 38.0 Favored 'Trans proline' 0 CA--C 1.536 0.616 0 C-N-CA 123.704 2.936 . . . . 0.0 111.138 175.47 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 2493 ' ' GLY . . . . . . . . . . . . . . . 130.47 -140.37 11.71 Favored Glycine 0 CA--C 1.528 0.89 0 C-N-CA 125.643 1.592 . . . . 0.0 111.181 -171.92 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 2494 ' ' SER . . . . . . . . . . . . . 54.4 p -140.93 138.59 33.95 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 113.333 0.864 . . . . 0.0 113.333 178.628 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 2495 ' ' TYR . . . . . . . . . . . . . 56.6 m-85 -111.13 131.48 55.06 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 126.215 1.806 . . . . 0.0 110.412 -178.666 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 2496 ' ' LEU . . . . . . . . . . . . . 86.2 mt -86.62 123.2 31.54 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 124.459 1.103 . . . . 0.0 109.33 169.766 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 2497 ' ' ILE . . . . . . . . . . . . . 49.7 mt -100.93 94.45 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 C-N-CA 125.641 1.576 . . . . 0.0 107.939 179.391 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 2498 ' ' SER . . . . . . . . . . . . . 67.1 m -88.71 119.3 29.06 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 125.594 1.557 . . . . 0.0 110.245 -178.97 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 2499 ' ' ILE . . . . . . . . . . . . . 33.7 mt -127.09 121.4 57.76 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 C-N-CA 125.223 1.409 . . . . 0.0 108.088 -170.883 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 2500 ' ' LYS . . . . . . . . . . . . . 93.0 mttt -131.8 119.22 20.96 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 123.857 0.863 . . . . 0.0 112.063 -168.772 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 2501 ' ' TYR . . . . . . . . . . . . . 66.6 t80 -125.87 137.74 53.76 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.796 1.239 . . . . 0.0 112.507 -169.459 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 2502 ' ' GLY . . . . . . . . . . . . . . . 70.06 10.26 64.9 Favored Glycine 0 CA--C 1.537 1.444 0 C-N-CA 124.445 1.022 . . . . 0.0 114.318 -178.805 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 2503 ' ' GLY . . . . . . . . . . . . . . . 149.94 -176.3 28.66 Favored Glycine 0 CA--C 1.54 1.615 0 C-N-CA 126.094 1.806 . . . . 0.0 112.849 -171.454 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 2504 ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -81.45 34.57 0.55 Allowed 'Trans proline' 0 CA--C 1.546 1.111 0 C-N-CA 125.193 3.929 . . . . 0.0 113.346 -173.953 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 2505 ' ' TYR . . . . . . . . . . . . . 82.6 m-85 -122.53 135.63 54.69 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 125.026 1.33 . . . . 0.0 112.296 -174.355 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 2506 ' ' HIS . . . . . . . . . . . . . 94.8 m-70 -60.51 140.75 57.17 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 124.254 1.022 . . . . 0.0 113.676 -176.802 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 2507 ' ' ILE . . . . . . . . . . . . . 1.9 pp -75.98 167.85 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 C-N-CA 123.562 0.745 . . . . 0.0 112.505 172.277 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 2508 ' ' GLY . . . . . . . . . . . . . . . -58.33 112.4 3.93 Favored Glycine 0 CA--C 1.533 1.166 0 C-N-CA 124.003 0.811 . . . . 0.0 112.877 -174.873 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 2509 ' ' GLY . . . . . . . . . . . . . . . 95.47 -8.94 69.24 Favored Glycine 0 CA--C 1.536 1.37 0 C-N-CA 125.983 1.754 . . . . 0.0 115.004 -178.105 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 2510 ' ' SER . . . . . . . . . . . . . 13.3 t -84.78 145.82 44.94 Favored Pre-proline 0 CA--C 1.552 1.047 0 CA-C-N 119.195 1.498 . . . . 0.0 112.0 179.731 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 2511 ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -75.39 144.25 79.9 Favored 'Cis proline' 0 C--N 1.354 0.83 0 CA-C-N 120.217 1.113 . . . . 0.0 113.026 -0.57 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 2512 ' ' PHE . . . . . . . . . . . . . 94.9 m-85 -96.94 134.1 40.73 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.511 1.124 . . . . 0.0 110.519 175.899 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 2513 ' ' LYS . . . . . . . . . . . . . 59.6 pttt -89.54 105.56 17.88 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 123.686 0.794 . . . . 0.0 112.358 176.27 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 2514 ' ' ALA . . . . . . . . . . . . . . . -91.88 126.86 37.13 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 125.261 1.424 . . . . 0.0 110.374 174.522 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 2515 ' ' LYS . . . . . . . . . . . . . 30.6 mtpp -101.38 134.44 44.46 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 124.712 1.205 . . . . 0.0 111.123 -175.295 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 2516 ' ' VAL . . . . . . . . . . . . . 84.7 t -132.58 137.01 55.09 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 C-N-CA 124.493 1.117 . . . . 0.0 110.715 -169.854 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 2517 ' ' THR . . . . . . . . . . . . . 73.4 p -123.65 -177.27 3.68 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 125.741 1.616 . . . . 0.0 110.965 176.219 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 2518 ' ' GLY . . . . . . . . . . . . . . . 98.62 -176.52 29.98 Favored Glycine 0 CA--C 1.54 1.621 0 C-N-CA 124.749 1.166 . . . . 0.0 113.465 -176.866 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 2519 ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -71.1 151.08 61.11 Favored 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 123.814 3.009 . . . . 0.0 111.885 -176.263 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 2520 ' ' ARG . . . . . . . . . . . . . 21.5 ttt85 . . . . . 0 CA--C 1.539 0.542 0 C-N-CA 123.872 0.869 . . . . 0.0 110.896 176.144 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A 2427 ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.795 0 N-CA-C 112.594 -0.202 . . . . 0.0 112.594 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A 2428 ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -148.9 143.37 17.02 Favored Pre-proline 0 CA--C 1.545 0.765 0 C-N-CA 125.078 1.351 . . . . 0.0 111.643 178.7 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 2429 ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -65.32 -24.4 57.83 Favored 'Trans proline' 0 C--N 1.351 0.707 0 C-N-CA 123.215 2.61 . . . . 0.0 112.773 177.715 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 2430 ' ' GLY . . . . . . . . . . . . . . . -75.59 -23.28 73.38 Favored Glycine 0 CA--C 1.535 1.317 0 CA-C-N 119.065 0.848 . . . . 0.0 113.805 174.923 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 2431 ' ' LEU . . . . . . . . . . . . . 4.4 mm? -86.95 -33.16 19.76 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.492 1.117 . . . . 0.0 111.616 173.682 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 2432 ' ' VAL . . . . . . . . . . . . . 53.4 t -70.16 138.31 22.26 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 C-N-CA 124.166 0.987 . . . . 0.0 111.092 172.005 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 2433 ' ' SER . . . . . . . . . . . . . 58.5 m -139.13 146.96 41.28 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 125.705 1.602 . . . . 0.0 109.628 173.549 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 2434 ' ' ALA . . . . . . . . . . . . . . . -98.98 149.36 23.06 Favored 'General case' 0 CA--C 1.54 0.568 0 O-C-N 121.528 -0.733 . . . . 0.0 112.13 176.219 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 2435 ' ' TYR . . . . . . . . . . . . . 89.7 m-85 -142.67 145.18 33.17 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.831 1.652 . . . . 0.0 111.563 -178.87 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 2436 ' ' GLY . . . . . . . . . . . . . . . 126.93 160.4 10.52 Favored Glycine 0 N--CA 1.474 1.193 0 C-N-CA 125.325 1.44 . . . . 0.0 113.948 178.379 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 2437 ' ' ALA . . . . . . . . . . . . . . . -63.18 -28.83 70.32 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 114.283 1.216 . . . . 0.0 114.283 -171.186 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 2438 ' ' GLY . . . . . . . . . . . . . . . -66.95 -11.08 57.62 Favored Glycine 0 CA--C 1.531 1.093 0 C-N-CA 124.437 1.018 . . . . 0.0 114.501 -178.895 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 2439 ' ' LEU . . . . . . . . . . . . . 75.6 mt -78.68 -25.22 44.8 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 118.537 1.168 . . . . 0.0 112.594 170.832 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 2440 ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -94.46 -31.98 13.72 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.897 1.279 . . . . 0.0 112.361 -175.165 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 2441 ' ' GLY . . . . . . . . . . . . . . . 159.22 -155.08 26.15 Favored Glycine 0 CA--C 1.527 0.807 0 C-N-CA 124.45 1.024 . . . . 0.0 113.575 -176.225 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 2442 ' ' GLY . . . . . . . . . . . . . . . 168.01 -171.9 42.54 Favored Glycine 0 CA--C 1.529 0.93 0 C-N-CA 124.636 1.112 . . . . 0.0 113.498 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 2443 ' ' VAL . . . . . . . . . . . . . 95.4 t -117.6 137.55 51.17 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 125.379 1.471 . . . . 0.0 108.996 176.452 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 2444 ' ' THR . . . . . . . . . . . . . 21.5 p -57.99 136.62 57.13 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.18 0.992 . . . . 0.0 112.232 177.308 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 2445 ' ' GLY . . . . . . . . . . . . . . . 79.61 -12.53 27.53 Favored Glycine 0 CA--C 1.534 1.274 0 C-N-CA 124.624 1.107 . . . . 0.0 114.713 -178.644 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 2446 ' ' ASN . . . . . . . . . . . . . 80.5 m-20 -99.43 150.15 36.5 Favored Pre-proline 0 CA--C 1.547 0.843 0 C-N-CA 124.898 1.279 . . . . 0.0 110.825 173.266 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 2447 ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -70.75 142.51 43.76 Favored 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 122.756 2.304 . . . . 0.0 111.01 175.163 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 2448 ' ' ALA . . . . . . . . . . . . . . . -128.35 135.31 49.4 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 126.726 2.011 . . . . 0.0 108.618 171.209 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 2449 ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -142.11 154.04 44.59 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 114.324 1.231 . . . . 0.0 114.324 -163.12 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 2450 ' ' PHE . . . . . . . . . . . . . 54.3 p90 -158.56 155.28 28.04 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 126.118 1.767 . . . . 0.0 111.405 -179.225 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 2451 ' ' VAL . . . . . . . . . . . . . 59.6 t -111.39 129.29 67.0 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 C-N-CA 125.11 1.364 . . . . 0.0 108.914 173.361 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 2452 ' ' VAL . . . . . . . . . . . . . 39.0 t -84.19 101.4 8.71 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 N-CA-C 107.208 -1.405 . . . . 0.0 107.208 166.016 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 2453 ' ' ASN . . . . . . . . . . . . . 19.3 t-20 -83.11 124.74 30.77 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 123.478 0.711 . . . . 0.0 112.472 -169.356 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 2454 ' ' THR . . . . . . . . . . . . . 40.4 p -103.96 -1.25 27.86 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 125.696 1.598 . . . . 0.0 113.881 -179.001 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 2455 ' ' SER . . . . . . . . . . . . . 44.5 m -57.8 -29.13 64.64 Favored 'General case' 0 N--CA 1.48 1.047 0 CA-C-N 120.32 1.418 . . . . 0.0 114.441 -175.445 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 2456 ' ' ASN . . . . . . . . . . . . . 67.3 m-80 -86.86 -11.99 49.18 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 124.688 1.195 . . . . 0.0 113.557 176.152 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 2457 ' ' ALA . . . . . . . . . . . . . . . -112.54 -22.33 10.85 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 126.172 1.789 . . . . 0.0 113.851 -174.073 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 2458 ' ' GLY . . . . . . . . . . . . . . . 91.36 -85.89 1.28 Allowed Glycine 0 CA--C 1.529 0.943 0 C-N-CA 124.986 1.279 . . . . 0.0 111.338 -176.496 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 2459 ' ' ALA . . . . . . . . . . . . . . . -157.84 157.14 32.7 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 124.987 1.315 . . . . 0.0 112.617 -176.466 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 2460 ' ' GLY . . . . . . . . . . . . . . . 165.09 167.34 25.52 Favored Glycine 0 CA--C 1.532 1.126 0 C-N-CA 125.545 1.545 . . . . 0.0 113.008 -176.145 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 2461 ' ' ALA . . . . . . . . . . . . . . . -77.96 145.64 35.94 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.265 1.026 . . . . 0.0 112.572 -178.737 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 2462 ' ' LEU . . . . . . . . . . . . . 29.9 tp -121.21 141.6 50.7 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 125.336 1.455 . . . . 0.0 110.999 178.824 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 2463 ' ' SER . . . . . . . . . . . . . 29.7 t -102.24 -109.75 0.23 Allowed 'General case' 0 CA--C 1.552 1.02 0 C-N-CA 125.24 1.416 . . . . 0.0 110.014 171.119 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 2464 ' ' VAL . . . . . . . . . . . . . 48.3 t 105.31 123.57 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.247 0 C-N-CA 131.659 3.984 . . . . 0.0 109.702 172.647 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 2465 ' ' THR . . . . . . . . . . . . . 89.9 m -131.95 139.29 48.64 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 125.408 1.483 . . . . 0.0 109.076 174.948 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 2466 ' ' ILE . . . . . . . . . . . . . 35.8 mt -119.15 117.39 54.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 123.634 0.773 . . . . 0.0 109.649 175.806 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 2467 ' ' ASP . . . . . . . . . . . . . 34.8 t70 -95.17 162.34 13.74 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 125.776 1.631 . . . . 0.0 110.286 168.638 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 2468 ' ' GLY . . . . . . . . . . . . . . . 168.73 -166.78 39.9 Favored Glycine 0 CA--C 1.536 1.358 0 O-C-N 121.125 -0.985 . . . . 0.0 114.717 178.794 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 2469 ' ' PRO . . . . . . . . . . . . . 76.1 Cg_endo -70.94 -15.86 32.66 Favored 'Trans proline' 0 CA--C 1.541 0.853 0 C-N-CA 123.969 3.113 . . . . 0.0 113.088 177.924 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 2470 ' ' SER . . . . . . . . . . . . . 37.2 m -153.67 174.52 14.38 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 126.868 2.067 . . . . 0.0 110.343 175.905 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 2471 ' ' LYS . . . . . . . . . . . . . 67.9 mttm -68.32 167.54 14.3 Favored 'General case' 0 CA--C 1.549 0.918 0 O-C-N 121.252 -0.905 . . . . 0.0 112.181 168.611 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 2472 ' ' VAL . . . . . . . . . . . . . 14.3 m -133.35 144.9 34.84 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 125.468 1.507 . . . . 0.0 111.34 -179.583 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 2473 ' ' LYS . . . . . . . . . . . . . 14.5 mmmm -89.31 71.27 8.18 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.337 1.055 . . . . 0.0 111.588 -179.263 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 2474 ' ' MET . . . . . . . . . . . . . 92.0 mtp -69.77 140.74 53.43 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 124.494 1.118 . . . . 0.0 112.969 -178.815 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 2475 ' ' ASP . . . . . . . . . . . . . 30.5 t70 -133.4 125.15 28.46 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 126.97 2.108 . . . . 0.0 108.755 163.117 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 2476 ' ' CYS . . . . . . . . . . . . . 42.6 t -122.18 132.75 54.61 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.797 1.239 . . . . 0.0 110.956 -177.706 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 2477 ' ' GLN . . . . . . . . . . . . . 15.9 mm100 -142.02 151.86 42.85 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 125.454 1.502 . . . . 0.0 110.721 -178.622 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 2478 ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -79.88 151.75 30.01 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 123.412 0.685 . . . . 0.0 111.67 169.343 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 2479 ' ' CYS . . . . . . . . . . . . . 19.5 p -156.82 172.15 6.5 Favored Pre-proline 0 CA--C 1.553 1.096 0 C-N-CA 126.083 1.753 . . . . 0.0 111.505 -176.576 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 2480 ' ' PRO . . . . . . . . . . . . . 58.0 Cg_exo -59.02 -26.2 80.71 Favored 'Trans proline' 0 CA--C 1.539 0.75 0 C-N-CA 123.342 2.694 . . . . 0.0 114.584 176.962 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 2481 ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -88.37 -6.1 57.9 Favored 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 125.382 1.473 . . . . 0.0 113.154 -179.086 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 2482 ' ' GLY . . . . . . . . . . . . . . . 128.24 -132.21 7.26 Favored Glycine 0 N--CA 1.472 1.055 0 C-N-CA 125.335 1.445 . . . . 0.0 112.164 -176.324 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 2483 ' ' TYR . . . . . . . . . . . . . 95.1 m-85 -108.78 117.62 34.67 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 123.809 0.844 . . . . 0.0 110.854 173.551 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 2484 ' ' ARG . . . . . . . . . . . . . 57.5 ttt180 -92.43 130.55 38.07 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 124.117 0.967 . . . . 0.0 110.676 177.939 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 2485 ' ' VAL . . . . . . . . . . . . . 89.9 t -114.09 132.76 62.18 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 C-N-CA 125.863 1.665 . . . . 0.0 108.47 172.823 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 2486 ' ' THR . . . . . . . . . . . . . 95.4 m -125.6 137.22 53.89 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 125.11 1.364 . . . . 0.0 107.821 169.06 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 2487 ' ' TYR . . . . . . . . . . . . . 21.6 p90 -144.09 152.75 41.37 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 123.72 0.808 . . . . 0.0 112.604 177.415 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 2488 ' ' THR . . . . . . . . . . . . . 84.4 m -113.25 119.71 41.61 Favored Pre-proline 0 N--CA 1.474 0.753 0 CA-C-O 117.892 -1.051 . . . . 0.0 109.466 173.287 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 2489 ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -83.67 154.75 13.66 Favored 'Trans proline' 0 CA--C 1.537 0.634 0 C-N-CA 124.064 3.176 . . . . 0.0 111.209 171.298 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 2490 ' ' MET . . . . . . . . . . . . . 28.0 ptm -119.69 -2.37 10.44 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 114.892 1.441 . . . . 0.0 114.892 -174.211 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 2491 ' ' ALA . . . . . . . . . . . . . . . -147.25 148.23 31.14 Favored Pre-proline 0 CA--C 1.545 0.786 0 C-N-CA 125.687 1.595 . . . . 0.0 110.896 177.985 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 2492 ' ' PRO . . . . . . . . . . . . . 74.9 Cg_endo -72.18 153.91 56.9 Favored 'Trans proline' 0 CA--C 1.536 0.584 0 C-N-CA 123.043 2.495 . . . . 0.0 111.161 174.546 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 2493 ' ' GLY . . . . . . . . . . . . . . . 135.39 -170.12 23.12 Favored Glycine 0 CA--C 1.529 0.949 0 C-N-CA 125.363 1.459 . . . . 0.0 113.313 -177.871 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 2494 ' ' SER . . . . . . . . . . . . . 70.3 m -95.54 121.07 36.85 Favored 'General case' 0 N--CA 1.471 0.61 0 O-C-N 121.839 -0.8 . . . . 0.0 111.818 179.303 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 2495 ' ' TYR . . . . . . . . . . . . . 63.5 m-85 -99.07 126.01 44.71 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 125.156 1.382 . . . . 0.0 109.706 171.43 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 2496 ' ' LEU . . . . . . . . . . . . . 26.1 tp -101.2 110.68 22.73 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.359 1.064 . . . . 0.0 109.44 -176.908 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 2497 ' ' ILE . . . . . . . . . . . . . 39.8 mt -96.56 96.48 5.54 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 C-N-CA 125.688 1.595 . . . . 0.0 108.618 -172.693 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 2498 ' ' SER . . . . . . . . . . . . . 68.9 m -80.86 83.54 6.58 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 125.409 1.484 . . . . 0.0 110.165 176.795 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 2499 ' ' ILE . . . . . . . . . . . . . 50.5 mt -79.91 114.53 20.9 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 C-N-CA 124.31 1.044 . . . . 0.0 109.227 177.025 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 2500 ' ' LYS . . . . . . . . . . . . . 83.7 mttt -127.52 133.33 49.83 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 125.03 1.332 . . . . 0.0 111.769 -175.165 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 2501 ' ' TYR . . . . . . . . . . . . . 64.4 t80 -141.83 143.09 33.22 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 125.465 1.506 . . . . 0.0 111.805 -170.332 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 2502 ' ' GLY . . . . . . . . . . . . . . . 69.26 11.86 65.01 Favored Glycine 0 CA--C 1.536 1.388 0 C-N-CA 124.443 1.02 . . . . 0.0 114.474 177.729 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 2503 ' ' GLY . . . . . . . . . . . . . . . 145.9 -165.6 28.05 Favored Glycine 0 CA--C 1.54 1.614 0 C-N-CA 125.731 1.634 . . . . 0.0 112.999 -170.487 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 2504 ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -82.28 13.72 2.46 Favored 'Trans proline' 0 CA--C 1.544 0.999 0 C-N-CA 124.762 3.641 . . . . 0.0 113.962 -174.318 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 2505 ' ' TYR . . . . . . . . . . . . . 84.0 m-85 -106.22 142.32 36.1 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.78 1.232 . . . . 0.0 113.452 -173.325 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 2506 ' ' HIS . . . . . . . . . . . . . 97.7 m-70 -65.03 143.89 57.64 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 124.762 1.225 . . . . 0.0 113.046 178.282 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 2507 ' ' ILE . . . . . . . . . . . . . 20.4 pt -73.65 175.6 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 N-CA-C 113.437 0.902 . . . . 0.0 113.437 173.583 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 2508 ' ' GLY . . . . . . . . . . . . . . . -58.95 119.53 18.34 Favored Glycine 0 CA--C 1.534 1.232 0 O-C-N 121.487 -0.758 . . . . 0.0 111.512 172.858 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 2509 ' ' GLY . . . . . . . . . . . . . . . 87.19 -6.76 82.76 Favored Glycine 0 CA--C 1.536 1.359 0 C-N-CA 125.616 1.579 . . . . 0.0 115.034 -176.733 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 2510 ' ' SER . . . . . . . . . . . . . 43.8 t -89.09 147.67 39.13 Favored Pre-proline 0 CA--C 1.549 0.938 0 CA-C-N 118.914 1.357 . . . . 0.0 112.043 -179.005 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 2511 ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -74.46 146.22 86.16 Favored 'Cis proline' 0 C--N 1.353 0.808 0 CA-C-N 119.671 0.918 . . . . 0.0 112.608 -1.036 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 2512 ' ' PHE . . . . . . . . . . . . . 94.7 m-85 -96.3 126.41 41.49 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.612 1.165 . . . . 0.0 110.797 179.627 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 2513 ' ' LYS . . . . . . . . . . . . . 85.0 tttt -94.5 100.16 12.2 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.025 0.93 . . . . 0.0 111.407 -179.03 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 2514 ' ' ALA . . . . . . . . . . . . . . . -89.02 115.46 26.6 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.355 1.462 . . . . 0.0 110.913 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 2515 ' ' LYS . . . . . . . . . . . . . 48.4 mtpt -94.04 98.64 11.14 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 124.099 0.959 . . . . 0.0 110.529 -174.915 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 2516 ' ' VAL . . . . . . . . . . . . . 63.7 t -90.96 140.74 15.49 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 125.673 1.589 . . . . 0.0 110.496 -173.39 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 2517 ' ' THR . . . . . . . . . . . . . 72.0 p -124.4 -177.33 3.76 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 125.582 1.553 . . . . 0.0 111.121 177.093 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 2518 ' ' GLY . . . . . . . . . . . . . . . 98.34 178.34 32.81 Favored Glycine 0 CA--C 1.539 1.558 0 C-N-CA 124.752 1.167 . . . . 0.0 113.561 -177.183 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 2519 ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -73.43 141.82 32.24 Favored 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 123.776 2.984 . . . . 0.0 111.932 -173.924 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 2520 ' ' ARG . . . . . . . . . . . . . 37.6 ttm180 . . . . . 0 CA--C 1.539 0.525 0 C-N-CA 122.959 0.503 . . . . 0.0 110.004 172.733 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A 2427 ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.055 0 CA-C-O 121.335 0.408 . . . . 0.0 113.166 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A 2428 ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -143.52 135.64 13.2 Favored Pre-proline 0 CA--C 1.544 0.738 0 C-N-CA 124.785 1.234 . . . . 0.0 111.204 178.877 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 2429 ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -67.94 -22.59 41.95 Favored 'Trans proline' 0 CA--C 1.537 0.648 0 C-N-CA 122.964 2.443 . . . . 0.0 113.003 -178.347 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 2430 ' ' GLY . . . . . . . . . . . . . . . -76.72 -23.12 70.64 Favored Glycine 0 CA--C 1.535 1.292 0 CA-C-N 118.864 0.756 . . . . 0.0 113.557 173.399 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 2431 ' ' LEU . . . . . . . . . . . . . 4.3 mm? -87.72 -35.46 17.93 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.514 1.126 . . . . 0.0 111.353 173.95 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 2432 ' ' VAL . . . . . . . . . . . . . 74.2 t -64.91 139.6 21.13 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 123.389 0.676 . . . . 0.0 110.473 169.639 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 2433 ' ' SER . . . . . . . . . . . . . 8.5 t -131.37 -176.21 3.95 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.942 1.297 . . . . 0.0 110.507 173.162 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 2434 ' ' ALA . . . . . . . . . . . . . . . -141.96 143.19 33.1 Favored 'General case' 0 CA--C 1.538 0.5 0 O-C-N 121.042 -1.036 . . . . 0.0 111.712 177.107 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 2435 ' ' TYR . . . . . . . . . . . . . 79.1 m-85 -143.65 157.5 44.36 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.536 1.534 . . . . 0.0 111.899 -175.111 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 2436 ' ' GLY . . . . . . . . . . . . . . . 108.05 159.75 20.37 Favored Glycine 0 N--CA 1.474 1.17 0 C-N-CA 125.244 1.402 . . . . 0.0 113.694 177.899 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 2437 ' ' ALA . . . . . . . . . . . . . . . -62.88 -27.42 69.34 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.075 1.35 . . . . 0.0 114.582 -169.294 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 2438 ' ' GLY . . . . . . . . . . . . . . . -66.27 -14.12 61.29 Favored Glycine 0 CA--C 1.532 1.114 0 C-N-CA 123.974 0.797 . . . . 0.0 114.683 -176.695 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 2439 ' ' LEU . . . . . . . . . . . . . 88.1 mt -72.07 -22.74 61.32 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 118.466 1.133 . . . . 0.0 112.761 170.233 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 2440 ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -94.48 -16.59 23.21 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 125.076 1.35 . . . . 0.0 112.82 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 2441 ' ' GLY . . . . . . . . . . . . . . . 102.92 -138.82 14.15 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 125.559 1.552 . . . . 0.0 112.39 -177.903 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 2442 ' ' GLY . . . . . . . . . . . . . . . 150.81 -140.72 8.1 Favored Glycine 0 CA--C 1.532 1.125 0 C-N-CA 124.007 0.813 . . . . 0.0 114.088 -177.695 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 2443 ' ' VAL . . . . . . . . . . . . . 99.2 t -113.08 139.15 39.77 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 C-N-CA 125.601 1.561 . . . . 0.0 110.115 -175.156 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 2444 ' ' THR . . . . . . . . . . . . . 30.1 p -61.72 142.9 56.95 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 124.302 1.041 . . . . 0.0 112.412 176.41 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 2445 ' ' GLY . . . . . . . . . . . . . . . 79.01 -10.61 32.65 Favored Glycine 0 CA--C 1.537 1.412 0 C-N-CA 124.462 1.03 . . . . 0.0 114.558 -177.118 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 2446 ' ' ASN . . . . . . . . . . . . . 79.7 m-20 -101.59 148.39 35.17 Favored Pre-proline 0 CA--C 1.548 0.87 0 C-N-CA 124.94 1.296 . . . . 0.0 111.117 174.159 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 2447 ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -73.75 129.88 14.02 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 123.176 2.584 . . . . 0.0 111.276 178.876 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 2448 ' ' ALA . . . . . . . . . . . . . . . -101.87 116.34 32.5 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 126.222 1.809 . . . . 0.0 109.031 170.485 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 2449 ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -111.96 132.79 54.55 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.389 1.076 . . . . 0.0 111.66 -172.319 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 2450 ' ' PHE . . . . . . . . . . . . . 37.8 p90 -147.59 168.56 21.68 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.48 1.512 . . . . 0.0 110.882 171.277 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 2451 ' ' VAL . . . . . . . . . . . . . 14.7 p -126.94 136.93 59.4 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 C-N-CA 124.609 1.164 . . . . 0.0 110.508 174.977 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 2452 ' ' VAL . . . . . . . . . . . . . 22.0 t -89.5 103.8 14.43 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 N-CA-C 106.797 -1.557 . . . . 0.0 106.797 164.669 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 2453 ' ' ASN . . . . . . . . . . . . . 18.6 t-20 -91.29 120.18 31.96 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 123.874 0.87 . . . . 0.0 112.271 -167.867 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 2454 ' ' THR . . . . . . . . . . . . . 75.1 p -104.24 2.62 31.84 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 125.958 1.703 . . . . 0.0 113.887 -175.397 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 2455 ' ' SER . . . . . . . . . . . . . 45.2 m -56.89 -27.5 60.72 Favored 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 114.782 1.401 . . . . 0.0 114.782 -173.482 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 2456 ' ' ASN . . . . . . . . . . . . . 70.1 m-80 -91.6 -12.22 34.93 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 124.537 1.135 . . . . 0.0 113.644 176.339 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 2457 ' ' ALA . . . . . . . . . . . . . . . -106.6 -33.43 7.66 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 125.575 1.55 . . . . 0.0 113.759 -174.801 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 2458 ' ' GLY . . . . . . . . . . . . . . . 87.28 -152.84 24.76 Favored Glycine 0 CA--C 1.533 1.171 0 C-N-CA 124.779 1.181 . . . . 0.0 112.202 -172.099 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 2459 ' ' ALA . . . . . . . . . . . . . . . -69.22 151.94 45.69 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 123.924 0.89 . . . . 0.0 112.6 178.127 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 2460 ' ' GLY . . . . . . . . . . . . . . . 159.86 157.62 8.72 Favored Glycine 0 CA--C 1.532 1.103 0 C-N-CA 125.302 1.43 . . . . 0.0 113.193 179.4 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 2461 ' ' ALA . . . . . . . . . . . . . . . -85.1 139.88 31.39 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.262 1.025 . . . . 0.0 113.346 -172.659 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 2462 ' ' LEU . . . . . . . . . . . . . 31.6 tp -106.4 146.55 30.34 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.778 1.631 . . . . 0.0 111.023 175.765 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 2463 ' ' SER . . . . . . . . . . . . . 4.0 t -137.62 42.13 2.34 Favored 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 125.885 1.674 . . . . 0.0 110.91 -178.828 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 2464 ' ' VAL . . . . . . . . . . . . . 11.0 p -63.98 135.34 27.94 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.975 0 C-N-CA 124.982 1.313 . . . . 0.0 112.017 -175.973 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 2465 ' ' THR . . . . . . . . . . . . . 96.3 m -136.41 145.17 44.98 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 125.925 1.69 . . . . 0.0 109.591 -179.16 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 2466 ' ' ILE . . . . . . . . . . . . . 40.6 mt -121.96 123.42 69.06 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 C-N-CA 123.748 0.819 . . . . 0.0 109.98 173.717 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 2467 ' ' ASP . . . . . . . . . . . . . 36.7 t70 -99.39 155.62 17.44 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 125.836 1.655 . . . . 0.0 110.179 166.885 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 2468 ' ' GLY . . . . . . . . . . . . . . . 177.17 -169.43 41.7 Favored Glycine 0 CA--C 1.537 1.44 0 O-C-N 121.043 -1.036 . . . . 0.0 115.562 -179.28 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 2469 ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -69.73 -17.49 37.69 Favored 'Trans proline' 0 CA--C 1.54 0.79 0 C-N-CA 124.322 3.348 . . . . 0.0 113.411 179.463 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 2470 ' ' SER . . . . . . . . . . . . . 35.0 m -153.92 176.09 12.58 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 127.165 2.186 . . . . 0.0 109.617 174.228 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 2471 ' ' LYS . . . . . . . . . . . . . 4.0 mppt? -66.84 162.96 20.47 Favored 'General case' 0 CA--C 1.551 0.989 0 O-C-N 121.03 -1.044 . . . . 0.0 111.455 168.432 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 2472 ' ' VAL . . . . . . . . . . . . . 33.0 m -118.84 145.87 24.26 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 C-N-CA 124.928 1.291 . . . . 0.0 110.954 175.83 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 2473 ' ' LYS . . . . . . . . . . . . . 99.0 mttt -86.04 90.9 8.24 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 123.678 0.791 . . . . 0.0 109.357 171.158 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 2474 ' ' MET . . . . . . . . . . . . . 60.5 ttm -89.9 143.38 26.84 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.546 1.139 . . . . 0.0 112.532 -175.068 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 2475 ' ' ASP . . . . . . . . . . . . . 35.8 t0 -133.94 82.04 1.95 Allowed 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 127.96 2.504 . . . . 0.0 108.559 171.637 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 2476 ' ' CYS . . . . . . . . . . . . . 52.6 t -88.01 134.43 33.74 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.841 1.256 . . . . 0.0 110.666 175.609 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 2477 ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -139.51 140.78 37.29 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.519 1.127 . . . . 0.0 111.394 -175.745 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 2478 ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -82.24 139.61 34.14 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.654 1.181 . . . . 0.0 110.304 172.54 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 2479 ' ' CYS . . . . . . . . . . . . . 30.7 p -158.95 169.23 10.91 Favored Pre-proline 0 CA--C 1.553 1.064 0 C-N-CA 125.293 1.437 . . . . 0.0 111.604 -171.558 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 2480 ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -65.91 -15.66 49.74 Favored 'Trans proline' 0 CA--C 1.543 0.943 0 C-N-CA 122.569 2.179 . . . . 0.0 113.427 173.776 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 2481 ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -77.51 -11.21 59.83 Favored 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 124.69 1.196 . . . . 0.0 112.953 172.133 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 2482 ' ' GLY . . . . . . . . . . . . . . . 117.36 -122.91 5.6 Favored Glycine 0 C--N 1.342 0.911 0 C-N-CA 126.439 1.971 . . . . 0.0 111.48 -172.167 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 2483 ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -117.18 110.4 18.11 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 123.91 0.884 . . . . 0.0 110.209 171.221 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 2484 ' ' ARG . . . . . . . . . . . . . 51.7 ttm-85 -86.37 128.56 34.95 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.741 0.816 . . . . 0.0 109.258 177.289 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 2485 ' ' VAL . . . . . . . . . . . . . 58.4 t -118.98 114.28 44.22 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 C-N-CA 125.331 1.452 . . . . 0.0 108.436 -177.781 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 2486 ' ' THR . . . . . . . . . . . . . 62.8 m -104.58 140.46 37.96 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 165.654 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 2487 ' ' TYR . . . . . . . . . . . . . 23.3 p90 -146.65 144.63 29.63 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 112.538 0.57 . . . . 0.0 112.538 171.842 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 2488 ' ' THR . . . . . . . . . . . . . 90.5 m -107.11 114.94 60.79 Favored Pre-proline 0 N--CA 1.473 0.685 0 CA-C-O 118.228 -0.892 . . . . 0.0 109.403 173.554 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 2489 ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -81.38 158.31 19.7 Favored 'Trans proline' 0 C--N 1.351 0.69 0 C-N-CA 124.075 3.184 . . . . 0.0 111.218 173.123 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 2490 ' ' MET . . . . . . . . . . . . . 28.9 ptm -128.77 3.31 5.44 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 115.153 1.538 . . . . 0.0 115.153 -171.198 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 2491 ' ' ALA . . . . . . . . . . . . . . . -152.04 150.33 25.51 Favored Pre-proline 0 CA--C 1.548 0.876 0 C-N-CA 125.505 1.522 . . . . 0.0 110.925 175.558 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 2492 ' ' PRO . . . . . . . . . . . . . 99.0 Cg_endo -74.45 151.21 42.16 Favored 'Trans proline' 0 CA--C 1.539 0.738 0 C-N-CA 123.24 2.627 . . . . 0.0 111.375 178.448 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 2493 ' ' GLY . . . . . . . . . . . . . . . 138.39 -173.66 22.39 Favored Glycine 0 CA--C 1.532 1.116 0 C-N-CA 125.55 1.548 . . . . 0.0 113.382 -177.068 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 2494 ' ' SER . . . . . . . . . . . . . 18.1 p -88.69 120.44 30.09 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.304 1.042 . . . . 0.0 111.55 175.085 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 2495 ' ' TYR . . . . . . . . . . . . . 68.8 m-85 -94.51 116.13 28.42 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 124.027 0.931 . . . . 0.0 109.652 168.539 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 2496 ' ' LEU . . . . . . . . . . . . . 22.8 tp -89.94 105.42 17.79 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 124.041 0.936 . . . . 0.0 109.561 -179.081 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 2497 ' ' ILE . . . . . . . . . . . . . 28.1 mt -88.33 103.1 13.39 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 C-N-CA 125.747 1.619 . . . . 0.0 108.335 -179.201 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 2498 ' ' SER . . . . . . . . . . . . . 73.7 m -90.14 95.98 10.46 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 124.819 1.248 . . . . 0.0 109.638 175.442 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 2499 ' ' ILE . . . . . . . . . . . . . 40.1 mt -91.29 92.52 3.94 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 C-N-CA 124.602 1.161 . . . . 0.0 108.566 -178.997 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 2500 ' ' LYS . . . . . . . . . . . . . 84.1 mttt -103.37 137.02 42.06 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 124.286 1.035 . . . . 0.0 111.721 -179.463 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 2501 ' ' TYR . . . . . . . . . . . . . 60.3 t80 -146.32 144.11 29.58 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.63 1.172 . . . . 0.0 112.357 -171.047 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 2502 ' ' GLY . . . . . . . . . . . . . . . 67.75 18.29 70.15 Favored Glycine 0 CA--C 1.535 1.314 0 C-N-CA 124.252 0.93 . . . . 0.0 113.673 179.209 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 2503 ' ' GLY . . . . . . . . . . . . . . . 134.44 -167.58 23.8 Favored Glycine 0 CA--C 1.54 1.636 0 C-N-CA 126.119 1.819 . . . . 0.0 112.43 -166.366 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 2504 ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -82.19 24.34 0.72 Allowed 'Trans proline' 0 CA--C 1.545 1.072 0 C-N-CA 124.903 3.735 . . . . 0.0 113.653 -173.779 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 2505 ' ' TYR . . . . . . . . . . . . . 73.9 m-85 -114.15 135.46 54.01 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.684 1.194 . . . . 0.0 113.022 -172.062 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 2506 ' ' HIS . . . . . . . . . . . . . 92.7 m-70 -63.33 142.85 58.23 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 125.359 1.464 . . . . 0.0 113.566 -179.246 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 2507 ' ' ILE . . . . . . . . . . . . . 1.7 pp -76.01 171.93 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 C-N-CA 123.716 0.806 . . . . 0.0 112.898 172.614 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 2508 ' ' GLY . . . . . . . . . . . . . . . -59.8 111.13 3.27 Favored Glycine 0 CA--C 1.534 1.235 0 C-N-CA 123.733 0.682 . . . . 0.0 112.609 -177.861 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 2509 ' ' GLY . . . . . . . . . . . . . . . 96.26 -8.22 66.97 Favored Glycine 0 CA--C 1.536 1.346 0 C-N-CA 125.835 1.683 . . . . 0.0 114.904 -177.262 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 2510 ' ' SER . . . . . . . . . . . . . 44.3 t -81.98 147.88 59.13 Favored Pre-proline 0 CA--C 1.55 0.962 0 CA-C-N 119.114 1.457 . . . . 0.0 111.841 177.577 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 2511 ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -79.29 155.71 90.42 Favored 'Cis proline' 0 C--N 1.354 0.817 0 CA-C-N 119.794 0.962 . . . . 0.0 113.333 -0.182 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 2512 ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -106.25 130.74 54.05 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.348 1.459 . . . . 0.0 110.466 177.791 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 2513 ' ' LYS . . . . . . . . . . . . . 19.7 ptpt -86.41 4.89 37.56 Favored 'General case' 0 N--CA 1.479 0.997 0 N-CA-C 116.488 2.032 . . . . 0.0 116.488 -167.664 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 2514 ' ' ALA . . . . . . . . . . . . . . . 3.17 93.19 0.01 OUTLIER 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 129.777 3.231 . . . . 0.0 116.188 -178.913 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 2515 ' ' LYS . . . . . . . . . . . . . 9.3 mtpm? -84.59 116.51 23.2 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 124.101 0.961 . . . . 0.0 111.364 -174.004 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 2516 ' ' VAL . . . . . . . . . . . . . 52.9 t -108.62 143.48 18.85 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 C-N-CA 125.958 1.703 . . . . 0.0 110.261 -174.5 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 2517 ' ' THR . . . . . . . . . . . . . 77.1 p -132.47 177.94 7.21 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 125.489 1.516 . . . . 0.0 111.438 178.999 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 2518 ' ' GLY . . . . . . . . . . . . . . . 104.5 -165.73 14.91 Favored Glycine 0 CA--C 1.54 1.643 0 C-N-CA 124.903 1.24 . . . . 0.0 113.424 -177.992 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 2519 ' ' PRO . . . . . . . . . . . . . 77.3 Cg_endo -70.94 176.53 7.54 Favored 'Trans proline' 0 CA--C 1.538 0.684 0 C-N-CA 124.17 3.247 . . . . 0.0 112.36 -178.302 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 2520 ' ' ARG . . . . . . . . . . . . . 50.9 ptt85 . . . . . 0 N--CA 1.47 0.556 0 C-N-CA 124.774 1.23 . . . . 0.0 111.683 177.769 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A 2427 ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.156 0 CA-C-O 121.312 0.396 . . . . 0.0 113.652 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A 2428 ' ' ASP . . . . . . . . . . . . . 13.8 t70 -106.86 136.52 19.43 Favored Pre-proline 0 CA--C 1.55 0.973 0 C-N-CA 124.958 1.303 . . . . 0.0 112.366 -172.181 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 2429 ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -64.58 -23.99 63.48 Favored 'Trans proline' 0 C--N 1.351 0.693 0 C-N-CA 123.222 2.615 . . . . 0.0 113.855 -178.275 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 2430 ' ' GLY . . . . . . . . . . . . . . . -75.43 -22.44 75.62 Favored Glycine 0 CA--C 1.533 1.209 0 CA-C-N 119.349 0.977 . . . . 0.0 113.345 175.267 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 2431 ' ' LEU . . . . . . . . . . . . . 4.3 mm? -83.96 -37.85 21.74 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.419 1.088 . . . . 0.0 111.197 170.963 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 2432 ' ' VAL . . . . . . . . . . . . . 69.5 t -61.85 136.8 24.82 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 123.775 0.83 . . . . 0.0 111.166 173.541 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 2433 ' ' SER . . . . . . . . . . . . . 68.5 m -128.72 163.11 25.85 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 125.867 1.667 . . . . 0.0 110.084 172.832 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 2434 ' ' ALA . . . . . . . . . . . . . . . -124.48 150.38 45.8 Favored 'General case' 0 CA--C 1.538 0.505 0 O-C-N 121.335 -0.853 . . . . 0.0 112.053 174.827 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 2435 ' ' TYR . . . . . . . . . . . . . 76.4 m-85 -143.24 161.61 37.83 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 126.063 1.745 . . . . 0.0 111.797 -175.183 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 2436 ' ' GLY . . . . . . . . . . . . . . . 106.43 159.75 22.11 Favored Glycine 0 N--CA 1.473 1.116 0 C-N-CA 125.131 1.348 . . . . 0.0 113.851 176.695 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 2437 ' ' ALA . . . . . . . . . . . . . . . -61.82 -28.55 69.55 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.005 1.322 . . . . 0.0 114.428 -169.931 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 2438 ' ' GLY . . . . . . . . . . . . . . . -66.48 -14.32 62.09 Favored Glycine 0 CA--C 1.532 1.154 0 C-N-CA 124.148 0.88 . . . . 0.0 114.581 -177.501 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 2439 ' ' LEU . . . . . . . . . . . . . 81.5 mt -74.4 -26.99 60.43 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 118.601 1.201 . . . . 0.0 112.338 169.31 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 2440 ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -93.67 -21.26 19.47 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 125.511 1.524 . . . . 0.0 112.255 177.39 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 2441 ' ' GLY . . . . . . . . . . . . . . . 110.65 -136.34 13.52 Favored Glycine 0 N--CA 1.47 0.945 0 C-N-CA 126.004 1.764 . . . . 0.0 113.181 177.234 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 2442 ' ' GLY . . . . . . . . . . . . . . . 156.52 -138.3 5.88 Favored Glycine 0 CA--C 1.53 1.022 0 C-N-CA 123.859 0.742 . . . . 0.0 114.227 -174.964 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 2443 ' ' VAL . . . . . . . . . . . . . 61.9 t -119.25 141.14 40.61 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 C-N-CA 125.369 1.468 . . . . 0.0 110.474 -173.828 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 2444 ' ' THR . . . . . . . . . . . . . 19.8 p -54.7 133.84 47.15 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 125.316 1.446 . . . . 0.0 112.29 174.8 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 2445 ' ' GLY . . . . . . . . . . . . . . . 81.68 -10.02 53.15 Favored Glycine 0 CA--C 1.535 1.314 0 C-N-CA 125.035 1.302 . . . . 0.0 114.844 178.67 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 2446 ' ' ASN . . . . . . . . . . . . . 91.0 m-20 -101.61 150.91 37.7 Favored Pre-proline 0 CA--C 1.548 0.876 0 C-N-CA 125.061 1.344 . . . . 0.0 111.257 175.914 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 2447 ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -72.68 130.9 16.46 Favored 'Trans proline' 0 C--N 1.35 0.656 0 C-N-CA 122.977 2.451 . . . . 0.0 111.538 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 2448 ' ' ALA . . . . . . . . . . . . . . . -99.82 118.2 35.77 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 126.417 1.887 . . . . 0.0 109.11 170.005 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 2449 ' ' GLU . . . . . . . . . . . . . 45.0 tt0 -115.88 131.8 56.83 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 124.994 1.317 . . . . 0.0 111.356 -169.459 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 2450 ' ' PHE . . . . . . . . . . . . . 40.4 p90 -148.02 165.7 29.96 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.096 1.358 . . . . 0.0 111.742 174.196 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 2451 ' ' VAL . . . . . . . . . . . . . 14.7 p -129.14 133.73 65.29 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 C-N-CA 124.834 1.253 . . . . 0.0 110.631 179.109 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 2452 ' ' VAL . . . . . . . . . . . . . 44.3 t -92.14 104.93 16.1 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 N-CA-C 107.017 -1.475 . . . . 0.0 107.017 169.117 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 2453 ' ' ASN . . . . . . . . . . . . . 19.5 t-20 -90.21 114.5 26.51 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.196 0.998 . . . . 0.0 112.161 -170.833 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 2454 ' ' THR . . . . . . . . . . . . . 43.7 p -95.88 -1.41 49.42 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 125.569 1.548 . . . . 0.0 113.902 -177.575 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 2455 ' ' SER . . . . . . . . . . . . . 29.8 m -56.76 -28.56 61.39 Favored 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 114.628 1.344 . . . . 0.0 114.628 -175.457 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 2456 ' ' ASN . . . . . . . . . . . . . 85.7 m-20 -79.47 -19.52 49.58 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 124.291 1.036 . . . . 0.0 113.483 175.673 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 2457 ' ' ALA . . . . . . . . . . . . . . . -112.2 -22.36 10.99 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 125.848 1.659 . . . . 0.0 113.902 -170.982 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 2458 ' ' GLY . . . . . . . . . . . . . . . 99.5 -99.87 2.15 Favored Glycine 0 CA--C 1.529 0.914 0 C-N-CA 125.322 1.439 . . . . 0.0 110.815 -173.32 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 2459 ' ' ALA . . . . . . . . . . . . . . . -153.63 155.4 35.98 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.254 1.422 . . . . 0.0 111.807 179.685 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 2460 ' ' GLY . . . . . . . . . . . . . . . 177.84 169.31 38.65 Favored Glycine 0 CA--C 1.529 0.918 0 C-N-CA 125.233 1.397 . . . . 0.0 112.959 -173.636 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 2461 ' ' ALA . . . . . . . . . . . . . . . -74.84 130.81 40.09 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 123.848 0.859 . . . . 0.0 111.874 -179.336 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 2462 ' ' LEU . . . . . . . . . . . . . 52.1 tp -108.19 138.6 44.19 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.374 1.47 . . . . 0.0 110.548 175.937 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 2463 ' ' SER . . . . . . . . . . . . . 30.7 t -103.56 -100.9 0.3 Allowed 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 124.806 1.242 . . . . 0.0 110.05 172.854 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 2464 ' ' VAL . . . . . . . . . . . . . 42.9 t 97.5 124.45 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.218 0 C-N-CA 130.837 3.655 . . . . 0.0 110.155 175.342 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 2465 ' ' THR . . . . . . . . . . . . . 99.8 m -125.01 135.6 52.92 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 125.271 1.428 . . . . 0.0 109.213 173.084 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 2466 ' ' ILE . . . . . . . . . . . . . 49.4 mt -115.93 117.64 56.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 123.998 0.919 . . . . 0.0 109.043 172.467 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 2467 ' ' ASP . . . . . . . . . . . . . 34.8 t70 -105.35 159.03 16.22 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 125.926 1.691 . . . . 0.0 110.255 169.721 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 2468 ' ' GLY . . . . . . . . . . . . . . . 156.44 -163.2 31.93 Favored Glycine 0 CA--C 1.535 1.332 0 O-C-N 121.253 -0.904 . . . . 0.0 114.367 178.718 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 2469 ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -72.47 -3.31 13.19 Favored 'Trans proline' 0 CA--C 1.542 0.923 0 C-N-CA 123.954 3.103 . . . . 0.0 114.622 -176.128 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 2470 ' ' SER . . . . . . . . . . . . . 85.7 p -153.59 154.56 34.46 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 119.751 1.16 . . . . 0.0 112.737 171.314 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 2471 ' ' LYS . . . . . . . . . . . . . 72.6 mmtt -74.52 86.5 2.08 Favored 'General case' 0 CA--C 1.544 0.736 0 O-C-N 120.789 -1.194 . . . . 0.0 110.026 168.765 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 2472 ' ' VAL . . . . . . . . . . . . . 18.4 m -55.7 146.1 5.29 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 C-N-CA 124.93 1.292 . . . . 0.0 113.19 -174.395 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 2473 ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -79.86 121.94 26.03 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 170.461 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 2474 ' ' MET . . . . . . . . . . . . . 26.1 ttt -132.08 142.43 49.52 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 124.556 1.143 . . . . 0.0 112.281 -164.328 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 2475 ' ' ASP . . . . . . . . . . . . . 20.1 m-20 -138.31 158.24 44.67 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 127.053 2.141 . . . . 0.0 110.713 174.99 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 2476 ' ' CYS . . . . . . . . . . . . . 43.5 t -149.32 148.57 29.69 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 125.207 1.403 . . . . 0.0 110.922 -179.3 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 2477 ' ' GLN . . . . . . . . . . . . . 26.2 tt0 -149.96 134.68 17.63 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.07 1.348 . . . . 0.0 110.347 -177.58 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 2478 ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -84.42 144.27 28.88 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.584 1.153 . . . . 0.0 111.784 172.984 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 2479 ' ' CYS . . . . . . . . . . . . . 25.5 p -161.0 175.23 3.23 Favored Pre-proline 0 CA--C 1.553 1.092 0 C-N-CA 125.785 1.634 . . . . 0.0 111.69 -173.157 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 2480 ' ' PRO . . . . . . . . . . . . . 77.6 Cg_exo -58.54 -24.03 67.72 Favored 'Trans proline' 0 CA--C 1.539 0.765 0 C-N-CA 123.328 2.685 . . . . 0.0 114.654 175.393 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 2481 ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -82.29 -4.56 57.42 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 124.678 1.191 . . . . 0.0 113.152 177.303 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 2482 ' ' GLY . . . . . . . . . . . . . . . 115.87 -124.62 6.33 Favored Glycine 0 N--CA 1.47 0.938 0 C-N-CA 125.848 1.689 . . . . 0.0 111.76 -175.868 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 2483 ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -116.77 113.22 22.25 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 124.408 1.083 . . . . 0.0 110.668 173.467 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 2484 ' ' ARG . . . . . . . . . . . . . 14.9 ttm180 -85.08 133.7 34.22 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 123.876 0.87 . . . . 0.0 109.926 173.102 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 2485 ' ' VAL . . . . . . . . . . . . . 90.8 t -121.62 136.25 59.13 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 C-N-CA 126.344 1.857 . . . . 0.0 108.847 179.751 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 2486 ' ' THR . . . . . . . . . . . . . 59.3 m -133.84 135.03 43.47 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.101 0.96 . . . . 0.0 108.913 175.018 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 2487 ' ' TYR . . . . . . . . . . . . . 28.2 p90 -141.99 151.4 42.47 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 112.976 0.732 . . . . 0.0 112.976 176.222 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 2488 ' ' THR . . . . . . . . . . . . . 91.6 m -109.75 107.54 59.17 Favored Pre-proline 0 N--CA 1.471 0.601 0 C-N-CA 124.508 1.123 . . . . 0.0 109.324 177.141 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 2489 ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -76.4 149.95 31.75 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 123.394 2.729 . . . . 0.0 110.131 169.655 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 2490 ' ' MET . . . . . . . . . . . . . 23.3 ptt? -128.74 11.02 6.11 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 114.397 1.258 . . . . 0.0 114.397 -177.58 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 2491 ' ' ALA . . . . . . . . . . . . . . . -141.59 147.64 46.74 Favored Pre-proline 0 CA--C 1.547 0.861 0 C-N-CA 125.269 1.428 . . . . 0.0 111.685 175.11 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 2492 ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -74.36 157.54 45.37 Favored 'Trans proline' 0 CA--C 1.537 0.628 0 C-N-CA 123.154 2.57 . . . . 0.0 111.062 172.7 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 2493 ' ' GLY . . . . . . . . . . . . . . . 130.34 -144.25 15.56 Favored Glycine 0 CA--C 1.528 0.858 0 C-N-CA 125.357 1.456 . . . . 0.0 111.796 -174.759 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 2494 ' ' SER . . . . . . . . . . . . . 10.5 t -134.91 133.81 40.01 Favored 'General case' 0 N--CA 1.468 0.464 0 O-C-N 121.824 -0.809 . . . . 0.0 111.63 177.602 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 2495 ' ' TYR . . . . . . . . . . . . . 87.8 m-85 -103.15 131.11 50.42 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.526 1.53 . . . . 0.0 110.352 176.818 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 2496 ' ' LEU . . . . . . . . . . . . . 21.9 tp -96.17 114.47 26.17 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.268 1.027 . . . . 0.0 109.457 178.381 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 2497 ' ' ILE . . . . . . . . . . . . . 36.4 mt -100.49 100.48 10.47 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 C-N-CA 125.459 1.504 . . . . 0.0 108.21 -178.543 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 2498 ' ' SER . . . . . . . . . . . . . 70.0 m -86.42 95.87 9.83 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 124.388 1.075 . . . . 0.0 109.241 174.95 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 2499 ' ' ILE . . . . . . . . . . . . . 49.9 mt -87.61 96.51 5.8 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 C-N-CA 124.51 1.124 . . . . 0.0 108.724 -178.8 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 2500 ' ' LYS . . . . . . . . . . . . . 85.6 mttt -104.18 135.74 45.09 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.713 1.205 . . . . 0.0 111.997 -179.207 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 2501 ' ' TYR . . . . . . . . . . . . . 56.5 t80 -151.07 148.76 28.71 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.269 1.428 . . . . 0.0 111.902 -169.932 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 2502 ' ' GLY . . . . . . . . . . . . . . . 67.21 26.53 73.42 Favored Glycine 0 CA--C 1.535 1.297 0 C-N-CA 123.897 0.76 . . . . 0.0 112.751 -178.945 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 2503 ' ' GLY . . . . . . . . . . . . . . . 118.16 -164.95 12.75 Favored Glycine 0 CA--C 1.542 1.725 0 C-N-CA 126.011 1.767 . . . . 0.0 112.112 -163.927 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 2504 ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -81.38 24.35 0.7 Allowed 'Trans proline' 0 CA--C 1.546 1.104 0 C-N-CA 124.933 3.756 . . . . 0.0 113.448 -174.626 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 2505 ' ' TYR . . . . . . . . . . . . . 67.9 m-85 -106.38 131.64 53.35 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.761 1.224 . . . . 0.0 112.764 -171.321 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 2506 ' ' HIS . . . . . . . . . . . . . 88.6 m-70 -59.63 139.27 57.34 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 125.017 1.327 . . . . 0.0 113.092 177.89 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 2507 ' ' ILE . . . . . . . . . . . . . 21.4 pt -72.6 171.88 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 170.991 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 2508 ' ' GLY . . . . . . . . . . . . . . . -58.61 119.56 18.12 Favored Glycine 0 CA--C 1.533 1.218 0 O-C-N 121.668 -0.645 . . . . 0.0 111.523 173.215 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 2509 ' ' GLY . . . . . . . . . . . . . . . 91.49 -9.05 78.15 Favored Glycine 0 CA--C 1.537 1.419 0 C-N-CA 125.62 1.581 . . . . 0.0 115.007 -177.012 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 2510 ' ' SER . . . . . . . . . . . . . 38.2 t -83.95 146.61 49.3 Favored Pre-proline 0 CA--C 1.55 0.968 0 CA-C-N 119.187 1.493 . . . . 0.0 112.044 179.311 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 2511 ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -77.41 147.67 85.47 Favored 'Cis proline' 0 C--N 1.354 0.84 0 CA-C-N 119.761 0.951 . . . . 0.0 112.901 -0.168 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 2512 ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -97.93 131.22 44.58 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 125.031 1.333 . . . . 0.0 110.346 178.367 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 2513 ' ' LYS . . . . . 0.435 ' H ' ' HD2' ' A' 2513 ' ' LYS . 0.0 OUTLIER -100.03 112.4 24.69 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.078 0.951 . . . . 0.0 111.719 178.95 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A 2514 ' ' ALA . . . . . . . . . . . . . . . -104.48 105.43 15.54 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 126.232 1.813 . . . . 0.0 110.765 -172.32 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 2515 ' ' LYS . . . . . . . . . . . . . 62.9 mtpt -84.49 125.98 32.87 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.737 1.215 . . . . 0.0 111.13 -175.724 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 2516 ' ' VAL . . . . . . . . . . . . . 70.4 t -123.46 137.53 56.4 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 C-N-CA 125.226 1.41 . . . . 0.0 110.003 -172.268 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 2517 ' ' THR . . . . . . . . . . . . . 66.9 p -127.16 173.31 9.82 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 125.419 1.488 . . . . 0.0 111.18 179.006 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 2518 ' ' GLY . . . . . . . . . . . . . . . 102.01 176.88 27.96 Favored Glycine 0 CA--C 1.539 1.566 0 C-N-CA 124.762 1.172 . . . . 0.0 113.359 -175.731 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 2519 ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -72.47 135.99 25.33 Favored 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 123.691 2.928 . . . . 0.0 112.089 -170.839 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 2520 ' ' ARG . . . . . . . . . . . . . 48.3 ttm-85 . . . . . 0 CA--C 1.539 0.556 0 C-N-CA 123.971 0.908 . . . . 0.0 110.487 174.37 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A 2427 ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.063 0 CA-C-O 121.77 0.65 . . . . 0.0 114.194 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A 2428 ' ' ASP . . . . . . . . . . . . . 12.6 t70 -160.42 138.56 7.34 Favored Pre-proline 0 CA--C 1.548 0.9 0 C-N-CA 125.702 1.601 . . . . 0.0 110.363 -172.402 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 2429 ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -64.94 -19.5 63.98 Favored 'Trans proline' 0 CA--C 1.54 0.784 0 C-N-CA 123.191 2.594 . . . . 0.0 114.307 -175.172 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 2430 ' ' GLY . . . . . . . . . . . . . . . -80.93 -24.87 57.18 Favored Glycine 0 CA--C 1.534 1.251 0 CA-C-N 119.256 0.934 . . . . 0.0 113.374 173.025 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 2431 ' ' LEU . . . . . . . . . . . . . 4.5 mm? -89.36 -30.4 18.42 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.615 1.166 . . . . 0.0 112.153 174.317 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 2432 ' ' VAL . . . . . . . . . . . . . 66.3 t -67.74 135.23 28.9 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 C-N-CA 123.94 0.896 . . . . 0.0 110.411 172.037 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 2433 ' ' SER . . . . . . . . . . . . . 71.3 m -123.36 -175.33 3.17 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 125.841 1.656 . . . . 0.0 110.896 176.717 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 2434 ' ' ALA . . . . . . . . . . . . . . . -151.14 142.95 23.81 Favored 'General case' 0 CA--C 1.537 0.478 0 O-C-N 120.605 -1.309 . . . . 0.0 111.749 173.224 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 2435 ' ' TYR . . . . . . . . . . . . . 66.4 m-85 -147.99 148.62 30.94 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 125.373 1.469 . . . . 0.0 111.981 -174.916 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 2436 ' ' GLY . . . . . . . . . . . . . . . 124.48 164.35 11.91 Favored Glycine 0 N--CA 1.474 1.204 0 C-N-CA 125.446 1.498 . . . . 0.0 114.422 174.718 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 2437 ' ' ALA . . . . . . . . . . . . . . . -60.48 -29.2 68.92 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.313 1.445 . . . . 0.0 114.443 -171.177 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 2438 ' ' GLY . . . . . . . . . . . . . . . -63.95 -20.14 64.21 Favored Glycine 0 CA--C 1.532 1.124 0 CA-C-O 118.937 -0.924 . . . . 0.0 113.959 178.976 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 2439 ' ' LEU . . . . . . . . . . . . . 79.5 mt -75.04 -24.02 58.23 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 118.916 1.358 . . . . 0.0 112.606 170.905 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 2440 ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -91.08 -30.29 16.83 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 125.131 1.372 . . . . 0.0 112.0 177.808 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 2441 ' ' GLY . . . . . . . . . . . . . . . 109.93 -152.58 17.22 Favored Glycine 0 CA--C 1.534 1.224 0 C-N-CA 126.122 1.82 . . . . 0.0 113.508 178.742 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 2442 ' ' GLY . . . . . . . . . . . . . . . 169.04 -159.37 32.4 Favored Glycine 0 CA--C 1.531 1.072 0 C-N-CA 124.316 0.96 . . . . 0.0 114.001 -174.949 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 2443 ' ' VAL . . . . . . . . . . . . . 20.7 t -95.77 141.57 15.09 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 C-N-CA 124.461 1.104 . . . . 0.0 110.231 179.185 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 2444 ' ' THR . . . . . . . . . . . . . 31.5 p -58.6 152.19 19.0 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 124.693 1.197 . . . . 0.0 112.88 174.757 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 2445 ' ' GLY . . . . . . . . . . . . . . . 71.73 2.73 52.29 Favored Glycine 0 CA--C 1.536 1.375 0 C-N-CA 124.032 0.825 . . . . 0.0 114.326 179.857 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 2446 ' ' ASN . . . . . . . . . . . . . 26.0 m-80 -130.72 146.71 63.12 Favored Pre-proline 0 CA--C 1.549 0.928 0 C-N-CA 126.606 1.962 . . . . 0.0 110.284 -178.952 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 2447 ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -76.55 149.08 30.17 Favored 'Trans proline' 0 C--N 1.349 0.583 0 C-N-CA 123.022 2.481 . . . . 0.0 112.689 -176.179 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 2448 ' ' ALA . . . . . . . . . . . . . . . -133.86 143.08 48.09 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 126.269 1.828 . . . . 0.0 109.525 166.234 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 2449 ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -134.33 149.88 50.9 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 113.78 1.03 . . . . 0.0 113.78 -165.786 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 2450 ' ' PHE . . . . . . . . . . . . . 33.4 p90 -156.11 167.15 31.32 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.814 1.646 . . . . 0.0 111.173 179.672 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 2451 ' ' VAL . . . . . . . . . . . . . 57.4 t -123.14 131.7 72.74 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 C-N-CA 124.74 1.216 . . . . 0.0 109.656 176.964 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 2452 ' ' VAL . . . . . . . . . . . . . 41.3 t -80.69 104.26 8.87 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 N-CA-C 107.086 -1.45 . . . . 0.0 107.086 163.608 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 2453 ' ' ASN . . . . . . . . . . . . . 13.9 t-20 -78.28 111.2 14.01 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 123.977 0.911 . . . . 0.0 111.86 -172.702 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 2454 ' ' THR . . . . . . . . . . . . . 37.3 p -106.09 -8.04 17.68 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 125.885 1.674 . . . . 0.0 113.811 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 2455 ' ' SER . . . . . . . . . . . . . 88.6 p -65.95 -24.35 66.79 Favored 'General case' 0 N--CA 1.478 0.938 0 CA-C-N 120.173 1.351 . . . . 0.0 113.8 -176.653 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 2456 ' ' ASN . . . . . . . . . . . . . 56.4 m-80 -77.72 -11.6 59.89 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 124.493 1.117 . . . . 0.0 113.57 171.243 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 2457 ' ' ALA . . . . . . . . . . . . . . . -113.5 -57.14 2.32 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 125.11 1.364 . . . . 0.0 113.169 -172.714 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 2458 ' ' GLY . . . . . . . . . . . . . . . 123.34 -159.87 17.93 Favored Glycine 0 CA--C 1.533 1.178 0 C-N-CA 125.522 1.534 . . . . 0.0 112.661 -169.279 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 2459 ' ' ALA . . . . . . . . . . . . . . . -84.13 150.34 25.59 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 124.809 1.244 . . . . 0.0 112.972 -177.625 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 2460 ' ' GLY . . . . . . . . . . . . . . . 164.91 166.92 24.67 Favored Glycine 0 CA--C 1.531 1.089 0 C-N-CA 124.462 1.03 . . . . 0.0 113.862 -178.138 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 2461 ' ' ALA . . . . . . . . . . . . . . . -82.77 135.7 34.9 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.249 1.02 . . . . 0.0 112.709 -175.895 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 2462 ' ' LEU . . . . . . . . . . . . . 40.9 tp -102.11 143.91 31.34 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.901 1.681 . . . . 0.0 110.585 174.902 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 2463 ' ' SER . . . . . . . . . . . . . 3.9 t -138.58 41.74 2.18 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 125.206 1.403 . . . . 0.0 111.152 -177.956 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 2464 ' ' VAL . . . . . . . . . . . . . 9.6 p -65.57 135.21 28.73 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 C-N-CA 124.987 1.315 . . . . 0.0 112.167 -176.723 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 2465 ' ' THR . . . . . . . . . . . . . 95.4 m -135.08 145.74 48.23 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 126.067 1.747 . . . . 0.0 110.102 -178.286 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 2466 ' ' ILE . . . . . . . . . . . . . 50.2 mt -122.58 133.39 68.91 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 C-N-CA 124.5 1.12 . . . . 0.0 110.027 176.053 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 2467 ' ' ASP . . . . . . . . . . . . . 34.7 t70 -139.97 151.69 45.72 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 126.675 1.99 . . . . 0.0 110.409 178.333 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 2468 ' ' GLY . . . . . . . . . . . . . . . 174.52 -144.48 7.48 Favored Glycine 0 CA--C 1.537 1.422 0 CA-C-O 118.495 -1.17 . . . . 0.0 114.567 -177.182 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 2469 ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo -67.99 -15.56 43.66 Favored 'Trans proline' 0 C--N 1.354 0.864 0 C-N-CA 123.83 3.02 . . . . 0.0 113.343 -179.577 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 2470 ' ' SER . . . . . . . . . . . . . 7.6 t -159.07 -161.1 0.91 Allowed 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 126.078 1.751 . . . . 0.0 109.491 170.115 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 2471 ' ' LYS . . . . . . . . . . . . . 98.5 mttt -79.68 -179.61 6.99 Favored 'General case' 0 CA--C 1.55 0.975 0 O-C-N 121.014 -1.054 . . . . 0.0 111.46 164.86 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 2472 ' ' VAL . . . . . . . . . . . . . 14.3 m -136.37 149.94 27.41 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 125.243 1.417 . . . . 0.0 109.979 170.269 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 2473 ' ' LYS . . . . . . . . . . . . . 25.9 tptp -78.34 107.26 10.83 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 167.77 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 2474 ' ' MET . . . . . . . . . . . . . 22.9 ttt -114.78 140.61 48.77 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 125.191 1.396 . . . . 0.0 112.285 -168.357 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 2475 ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -143.22 157.28 44.63 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 126.618 1.967 . . . . 0.0 110.323 173.359 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 2476 ' ' CYS . . . . . . . . . . . . . 30.9 p -162.15 164.29 28.0 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.043 0.937 . . . . 0.0 113.485 -176.006 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 2477 ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -164.77 173.18 12.08 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.841 1.657 . . . . 0.0 111.59 177.982 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 2478 ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -80.2 138.83 36.91 Favored 'General case' 0 CA--C 1.544 0.716 0 O-C-N 121.57 -0.706 . . . . 0.0 110.383 164.339 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 2479 ' ' CYS . . . . . . . . . . . . . 59.3 m -132.96 167.14 24.41 Favored Pre-proline 0 CA--C 1.554 1.106 0 C-N-CA 126.824 2.05 . . . . 0.0 110.367 169.52 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 2480 ' ' PRO . . . . . . . . . . . . . 70.2 Cg_exo -57.99 -31.9 93.98 Favored 'Trans proline' 0 C--N 1.353 0.796 0 C-N-CA 123.586 2.858 . . . . 0.0 114.586 177.643 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 2481 ' ' GLU . . . . . . . . . . . . . 20.8 tp10 -77.45 -13.0 60.02 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 125.079 1.352 . . . . 0.0 112.849 177.927 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 2482 ' ' GLY . . . . . . . . . . . . . . . 129.1 -169.0 20.59 Favored Glycine 0 CA--C 1.53 1.018 0 C-N-CA 126.587 2.041 . . . . 0.0 112.29 -172.618 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 2483 ' ' TYR . . . . . . . . . . . . . 66.8 m-85 -69.78 111.64 5.68 Favored 'General case' 0 CA--C 1.539 0.537 0 O-C-N 121.277 -1.131 . . . . 0.0 111.783 177.808 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 2484 ' ' ARG . . . . . . . . . . . . . 68.5 ttt180 -85.09 138.26 32.53 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 125.366 1.466 . . . . 0.0 110.692 179.319 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 2485 ' ' VAL . . . . . . . . . . . . . 96.4 t -128.59 136.96 58.63 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 C-N-CA 126.333 1.853 . . . . 0.0 108.93 179.261 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 2486 ' ' THR . . . . . . . . . . . . . 85.7 m -133.24 136.58 45.66 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 125.06 1.344 . . . . 0.0 108.303 173.877 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 2487 ' ' TYR . . . . . . . . . . . . . 31.0 p90 -145.72 148.97 33.58 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 113.489 0.922 . . . . 0.0 113.489 177.628 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 2488 ' ' THR . . . . . . . . . . . . . 23.9 m -109.24 114.31 57.89 Favored Pre-proline 0 N--CA 1.471 0.612 0 C-N-CA 125.308 1.443 . . . . 0.0 108.7 171.304 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 2489 ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -80.07 159.73 23.77 Favored 'Trans proline' 0 N--CA 1.457 -0.628 0 C-N-CA 123.153 2.569 . . . . 0.0 111.203 173.959 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 2490 ' ' MET . . . . . . . . . . . . . 26.1 ptm -128.79 2.14 5.42 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 114.935 1.458 . . . . 0.0 114.935 -171.406 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 2491 ' ' ALA . . . . . . . . . . . . . . . -145.79 143.46 19.75 Favored Pre-proline 0 CA--C 1.548 0.881 0 C-N-CA 124.74 1.216 . . . . 0.0 111.308 174.934 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 2492 ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -72.75 155.1 54.19 Favored 'Trans proline' 0 CA--C 1.537 0.641 0 C-N-CA 123.229 2.619 . . . . 0.0 111.106 174.97 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 2493 ' ' GLY . . . . . . . . . . . . . . . 131.26 -151.52 19.72 Favored Glycine 0 CA--C 1.528 0.875 0 C-N-CA 125.356 1.455 . . . . 0.0 111.992 -173.257 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 2494 ' ' SER . . . . . . . . . . . . . 71.8 m -122.12 127.68 50.41 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 123.647 0.779 . . . . 0.0 112.074 177.874 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 2495 ' ' TYR . . . . . . . . . . . . . 86.2 m-85 -98.91 134.54 41.62 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.23 1.412 . . . . 0.0 110.676 171.688 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 2496 ' ' LEU . . . . . . . . . . . . . 10.3 mp -92.63 121.57 34.18 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.461 1.104 . . . . 0.0 108.819 168.832 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 2497 ' ' ILE . . . . . . . . . . . . . 40.5 mt -97.26 101.01 11.72 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.375 0 N-CA-C 107.286 -1.376 . . . . 0.0 107.286 173.829 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 2498 ' ' SER . . . . . . . . . . . . . 74.7 m -86.98 94.01 9.5 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 125.368 1.467 . . . . 0.0 109.512 179.159 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 2499 ' ' ILE . . . . . . . . . . . . . 26.6 mt -90.46 101.32 12.22 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 C-N-CA 124.909 1.284 . . . . 0.0 108.768 -179.769 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 2500 ' ' LYS . . . . . . . . . . . . . 83.8 mttt -109.52 143.44 39.17 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 124.535 1.134 . . . . 0.0 111.622 178.538 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 2501 ' ' TYR . . . . . . . . . . . . . 53.8 t80 -151.17 141.4 22.28 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.918 0.887 . . . . 0.0 112.698 -171.022 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 2502 ' ' GLY . . . . . . . . . . . . . . . 68.28 15.15 67.47 Favored Glycine 0 CA--C 1.536 1.354 0 C-N-CA 124.262 0.934 . . . . 0.0 114.072 178.381 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 2503 ' ' GLY . . . . . . . . . . . . . . . 142.73 -167.78 26.14 Favored Glycine 0 CA--C 1.54 1.645 0 C-N-CA 125.934 1.73 . . . . 0.0 112.591 -168.419 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 2504 ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -82.37 18.71 1.38 Allowed 'Trans proline' 0 CA--C 1.545 1.026 0 C-N-CA 124.772 3.648 . . . . 0.0 113.833 -174.112 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 2505 ' ' TYR . . . . . . . . . . . . . 73.7 m-85 -110.32 139.36 45.59 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.661 1.185 . . . . 0.0 113.341 -172.494 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 2506 ' ' HIS . . . . . . . . . . . . . 91.1 m-70 -64.23 143.29 58.0 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 125.57 1.548 . . . . 0.0 113.516 179.399 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 2507 ' ' ILE . . . . . . . . . . . . . 1.8 pp -86.37 150.37 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.075 0 C-N-CA 123.882 0.873 . . . . 0.0 111.854 171.99 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 2508 ' ' GLY . . . . . . . . . . . . . . . 46.23 -114.12 1.3 Allowed Glycine 0 CA--C 1.536 1.38 0 C-N-CA 124.275 0.94 . . . . 0.0 114.531 165.642 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 2509 ' ' GLY . . . . . . . . . . . . . . . -99.67 12.74 61.2 Favored Glycine 0 CA--C 1.537 1.409 0 C-N-CA 126.193 1.854 . . . . 0.0 115.19 178.117 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 2510 ' ' SER . . . . . . . . . . . . . 42.6 t -65.84 146.27 99.0 Favored Pre-proline 0 CA--C 1.552 1.04 0 CA-C-N 119.17 1.485 . . . . 0.0 112.655 179.586 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 2511 ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -75.0 142.15 73.91 Favored 'Cis proline' 0 C--N 1.354 0.852 0 CA-C-N 119.821 0.972 . . . . 0.0 112.868 0.727 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 2512 ' ' PHE . . . . . . . . . . . . . 91.6 m-85 -93.33 127.98 39.16 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.547 1.139 . . . . 0.0 110.858 178.662 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 2513 ' ' LYS . . . . . . . . . . . . . 86.0 tttt -90.24 92.7 9.04 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 124.407 1.083 . . . . 0.0 111.893 -176.768 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 2514 ' ' ALA . . . . . . . . . . . . . . . -79.53 123.84 27.95 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.976 1.31 . . . . 0.0 110.682 174.747 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 2515 ' ' LYS . . . . . . . . . . . . . 26.6 mtmm -101.15 120.87 40.86 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.201 1.401 . . . . 0.0 110.278 -173.558 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 2516 ' ' VAL . . . . . . . . . . . . . 73.0 t -120.42 138.45 50.91 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 124.843 1.257 . . . . 0.0 111.133 -167.692 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 2517 ' ' THR . . . . . . . . . . . . . 68.1 p -128.9 178.53 6.31 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 125.986 1.714 . . . . 0.0 111.088 179.505 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 2518 ' ' GLY . . . . . . . . . . . . . . . 97.67 -176.31 30.96 Favored Glycine 0 CA--C 1.54 1.629 0 C-N-CA 124.545 1.069 . . . . 0.0 113.39 -176.68 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 2519 ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -71.6 148.25 53.04 Favored 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 123.72 2.947 . . . . 0.0 112.167 -174.408 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 2520 ' ' ARG . . . . . . . . . . . . . 35.8 ttp180 . . . . . 0 CA--C 1.539 0.544 0 C-N-CA 123.648 0.779 . . . . 0.0 110.217 173.882 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A 2427 ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.957 0 N-CA-C 111.579 -0.608 . . . . 0.0 111.579 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A 2428 ' ' ASP . . . . . . . . . . . . . 22.2 m-20 -97.33 128.59 34.37 Favored Pre-proline 0 CA--C 1.547 0.853 0 C-N-CA 123.909 0.884 . . . . 0.0 112.726 -175.516 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 2429 ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -66.67 -22.42 50.43 Favored 'Trans proline' 0 C--N 1.352 0.748 0 C-N-CA 122.993 2.462 . . . . 0.0 112.915 177.966 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 2430 ' ' GLY . . . . . . . . . . . . . . . -75.05 -23.16 75.24 Favored Glycine 0 CA--C 1.535 1.304 0 CA-C-N 119.062 0.847 . . . . 0.0 113.551 173.979 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 2431 ' ' LEU . . . . . . . . . . . . . 4.2 mm? -86.34 -29.82 22.69 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 124.483 1.113 . . . . 0.0 111.698 171.908 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 2432 ' ' VAL . . . . . . . . . . . . . 79.1 t -67.94 135.25 28.84 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 C-N-CA 123.51 0.724 . . . . 0.0 110.521 169.723 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 2433 ' ' SER . . . . . . . . . . . . . 57.9 m -140.44 144.66 36.23 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 125.463 1.505 . . . . 0.0 109.439 171.908 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 2434 ' ' ALA . . . . . . . . . . . . . . . -96.41 148.58 22.64 Favored 'General case' 0 CA--C 1.539 0.553 0 O-C-N 121.572 -0.705 . . . . 0.0 111.794 176.133 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 2435 ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -142.4 142.78 32.45 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.808 1.643 . . . . 0.0 111.468 -178.226 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 2436 ' ' GLY . . . . . . . . . . . . . . . 129.17 159.45 9.91 Favored Glycine 0 N--CA 1.473 1.11 0 C-N-CA 125.438 1.494 . . . . 0.0 113.534 -179.708 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 2437 ' ' ALA . . . . . . . . . . . . . . . -63.56 -26.94 68.92 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 114.259 1.207 . . . . 0.0 114.259 -171.22 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 2438 ' ' GLY . . . . . . . . . . . . . . . -68.19 -11.08 60.81 Favored Glycine 0 CA--C 1.53 0.969 0 C-N-CA 124.001 0.81 . . . . 0.0 114.702 -177.475 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 2439 ' ' LEU . . . . . . . . . . . . . 73.2 mt -78.46 -26.04 46.03 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.724 1.21 . . . . 0.0 112.405 171.607 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 2440 ' ' GLU . . . . . . . . . . . . . 37.5 mm-40 -89.07 -36.61 15.66 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 124.794 1.237 . . . . 0.0 111.853 -178.3 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 2441 ' ' GLY . . . . . . . . . . . . . . . 155.77 -148.39 18.46 Favored Glycine 0 CA--C 1.529 0.926 0 C-N-CA 124.389 0.995 . . . . 0.0 113.813 -176.135 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 2442 ' ' GLY . . . . . . . . . . . . . . . 157.49 -158.39 28.94 Favored Glycine 0 CA--C 1.53 1.012 0 C-N-CA 125.303 1.43 . . . . 0.0 112.924 -176.023 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 2443 ' ' VAL . . . . . . . . . . . . . 81.2 t -129.53 139.61 51.24 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.975 0 C-N-CA 125.321 1.449 . . . . 0.0 109.213 179.086 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 2444 ' ' THR . . . . . . . . . . . . . 33.5 p -60.45 138.06 58.06 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 124.016 0.926 . . . . 0.0 111.978 178.354 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 2445 ' ' GLY . . . . . . . . . . . . . . . 81.3 -10.65 48.23 Favored Glycine 0 CA--C 1.537 1.459 0 C-N-CA 124.75 1.167 . . . . 0.0 114.862 -175.371 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 2446 ' ' ASN . . . . . . . . . . . . . 88.4 m-20 -106.69 149.75 38.8 Favored Pre-proline 0 CA--C 1.548 0.888 0 C-N-CA 125.167 1.387 . . . . 0.0 111.192 174.611 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 2447 ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -73.07 135.83 23.69 Favored 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 122.849 2.366 . . . . 0.0 111.79 -179.485 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 2448 ' ' ALA . . . . . . . . . . . . . . . -109.83 142.17 41.47 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 127.236 2.214 . . . . 0.0 108.772 167.028 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 2449 ' ' GLU . . . . . . . . . . . . . 5.0 tm-20 -147.91 141.24 25.23 Favored 'General case' 0 N--CA 1.471 0.614 0 O-C-N 121.411 -0.806 . . . . 0.0 112.994 -162.598 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 2450 ' ' PHE . . . . . . . . . . . . . 52.9 p90 -156.29 157.44 35.76 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 125.83 1.652 . . . . 0.0 112.458 177.604 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 2451 ' ' VAL . . . . . . . . . . . . . 59.0 t -113.55 133.29 59.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 125.641 1.577 . . . . 0.0 109.443 171.78 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 2452 ' ' VAL . . . . . . . . . . . . . 39.3 t -87.14 105.1 14.78 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 C-N-CA 125.102 1.361 . . . . 0.0 107.819 168.225 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 2453 ' ' ASN . . . . . . . . . . . . . 32.7 t-20 -77.9 117.14 18.96 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 123.612 0.765 . . . . 0.0 110.926 -174.073 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 2454 ' ' THR . . . . . . . . . . . . . 39.5 p -105.1 -9.61 17.69 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 125.088 1.355 . . . . 0.0 113.634 -178.559 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 2455 ' ' SER . . . . . . . . . . . . . 41.2 m -57.94 -29.79 65.44 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.927 1.291 . . . . 0.0 114.234 -175.997 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 2456 ' ' ASN . . . . . . . . . . . . . 79.4 m-20 -83.79 -16.21 45.52 Favored 'General case' 0 CA--C 1.546 0.809 0 N-CA-C 113.767 1.025 . . . . 0.0 113.767 177.289 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 2457 ' ' ALA . . . . . . . . . . . . . . . -102.45 -41.94 6.14 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 114.458 1.281 . . . . 0.0 114.458 -166.574 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 2458 ' ' GLY . . . . . . . . . . . . . . . 121.64 -133.63 9.56 Favored Glycine 0 N--CA 1.471 1.03 0 C-N-CA 124.653 1.12 . . . . 0.0 112.06 -171.896 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 2459 ' ' ALA . . . . . . . . . . . . . . . -129.97 120.9 25.55 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.51 1.124 . . . . 0.0 111.944 -175.862 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 2460 ' ' GLY . . . . . . . . . . . . . . . -165.6 162.71 36.09 Favored Glycine 0 CA--C 1.529 0.963 0 C-N-CA 125.029 1.3 . . . . 0.0 113.029 -177.612 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 2461 ' ' ALA . . . . . . . . . . . . . . . -79.26 145.18 33.69 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.064 0.946 . . . . 0.0 112.484 -179.163 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 2462 ' ' LEU . . . . . . . . . . . . . 13.7 tp -95.26 147.2 23.74 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.178 1.391 . . . . 0.0 110.555 172.812 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 2463 ' ' SER . . . . . . . . . . . . . 9.1 t -137.12 34.58 2.57 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 125.301 1.44 . . . . 0.0 111.506 -178.302 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 2464 ' ' VAL . . . . . . . . . . . . . 10.5 p -59.65 135.17 24.52 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 C-N-CA 125.327 1.451 . . . . 0.0 112.58 -175.621 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 2465 ' ' THR . . . . . . . . . . . . . 96.4 m -134.91 142.9 46.67 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 125.759 1.623 . . . . 0.0 109.389 176.758 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 2466 ' ' ILE . . . . . . . . . . . . . 36.1 mt -120.27 122.2 67.68 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 C-N-CA 123.773 0.829 . . . . 0.0 109.953 174.05 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 2467 ' ' ASP . . . . . . . . . . . . . 33.0 t70 -104.68 166.8 10.14 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 126.392 1.877 . . . . 0.0 110.12 168.011 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 2468 ' ' GLY . . . . . . . . . . . . . . . 167.48 -160.57 34.24 Favored Glycine 0 CA--C 1.535 1.31 0 O-C-N 120.83 -1.169 . . . . 0.0 114.936 178.752 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 2469 ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -70.04 -16.44 36.39 Favored 'Trans proline' 0 CA--C 1.54 0.819 0 C-N-CA 123.915 3.077 . . . . 0.0 113.246 178.826 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 2470 ' ' SER . . . . . . . . . . . . . 38.0 m -157.95 -171.8 3.67 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 127.335 2.254 . . . . 0.0 109.819 177.506 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 2471 ' ' LYS . . . . . . . . . . . . . 99.0 mttt -70.74 175.95 4.58 Favored 'General case' 0 CA--C 1.551 0.985 0 O-C-N 120.956 -1.09 . . . . 0.0 112.343 167.915 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 2472 ' ' VAL . . . . . . . . . . . . . 33.9 m -132.11 148.87 32.09 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.925 0 C-N-CA 125.311 1.444 . . . . 0.0 110.466 169.624 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 2473 ' ' LYS . . . . . . . . . . . . . 62.0 mtpt -87.43 89.17 7.9 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 123.592 0.757 . . . . 0.0 109.52 169.6 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 2474 ' ' MET . . . . . . . . . . . . . 60.0 ttm -83.51 143.0 30.49 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 124.334 1.054 . . . . 0.0 112.071 -177.978 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 2475 ' ' ASP . . . . . . . . . . . . . 31.7 t70 -139.09 103.87 4.88 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 126.581 1.953 . . . . 0.0 109.221 167.026 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 2476 ' ' CYS . . . . . . . . . . . . . 28.7 p -102.3 155.19 18.39 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 124.954 1.302 . . . . 0.0 112.28 178.143 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 2477 ' ' GLN . . . . . . . . . . . . . 27.4 tt0 -161.59 146.56 13.36 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.26 1.024 . . . . 0.0 111.258 -172.156 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 2478 ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -77.89 122.67 25.79 Favored 'General case' 0 CA--C 1.541 0.615 0 O-C-N 121.478 -0.763 . . . . 0.0 110.609 173.682 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 2479 ' ' CYS . . . . . . . . . . . . . 60.6 m -121.76 166.29 17.12 Favored Pre-proline 0 CA--C 1.553 1.082 0 C-N-CA 126.539 1.936 . . . . 0.0 111.041 179.869 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 2480 ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -65.32 -26.9 55.82 Favored 'Trans proline' 0 CA--C 1.54 0.797 0 C-N-CA 123.009 2.473 . . . . 0.0 114.567 -174.527 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 2481 ' ' GLU . . . . . . . . . . . . . 82.2 tt0 -82.24 -17.17 46.95 Favored 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 124.143 0.977 . . . . 0.0 112.997 174.46 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 2482 ' ' GLY . . . . . . . . . . . . . . . 140.11 -162.47 26.39 Favored Glycine 0 CA--C 1.528 0.875 0 C-N-CA 125.879 1.705 . . . . 0.0 112.608 -176.306 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 2483 ' ' TYR . . . . . . . . . . . . . 74.0 m-85 -70.36 119.07 13.99 Favored 'General case' 0 CA--C 1.539 0.541 0 O-C-N 121.479 -1.013 . . . . 0.0 111.75 -179.848 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 2484 ' ' ARG . . . . . . . . . . . . . 21.5 ttt180 -95.34 141.83 28.45 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 125.038 1.335 . . . . 0.0 110.725 177.013 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 2485 ' ' VAL . . . . . . . . . . . . . 67.1 t -132.58 122.01 46.43 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 C-N-CA 124.98 1.312 . . . . 0.0 108.943 178.247 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 2486 ' ' THR . . . . . . . . . . . . . 89.9 m -110.07 144.35 38.78 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 124.856 1.262 . . . . 0.0 107.846 165.988 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 2487 ' ' TYR . . . . . . . . . . . . . 28.7 p90 -148.63 144.24 27.06 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 123.918 0.887 . . . . 0.0 112.185 174.953 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 2488 ' ' THR . . . . . . . . . . . . . 85.6 m -107.21 117.32 56.53 Favored Pre-proline 0 N--CA 1.476 0.86 0 CA-C-O 117.989 -1.005 . . . . 0.0 109.422 172.233 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 2489 ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -81.68 163.11 18.86 Favored 'Trans proline' 0 C--N 1.351 0.687 0 C-N-CA 124.319 3.346 . . . . 0.0 111.604 174.197 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 2490 ' ' MET . . . . . . . . . . . . . 28.4 ptm -133.85 -3.68 2.87 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 115.603 1.705 . . . . 0.0 115.603 -171.539 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 2491 ' ' ALA . . . . . . . . . . . . . . . -144.78 145.66 28.77 Favored Pre-proline 0 CA--C 1.548 0.871 0 C-N-CA 124.728 1.211 . . . . 0.0 110.937 172.813 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 2492 ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -71.29 151.98 60.8 Favored 'Trans proline' 0 CA--C 1.535 0.574 0 C-N-CA 123.504 2.803 . . . . 0.0 111.615 -178.715 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 2493 ' ' GLY . . . . . . . . . . . . . . . 129.88 -165.47 22.32 Favored Glycine 0 CA--C 1.53 1.003 0 C-N-CA 125.187 1.375 . . . . 0.0 113.578 -177.903 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 2494 ' ' SER . . . . . . . . . . . . . 16.7 p -89.96 115.02 26.94 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.835 1.254 . . . . 0.0 112.08 178.823 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 2495 ' ' TYR . . . . . . . . . . . . . 54.6 m-85 -87.74 122.78 31.82 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 123.536 0.735 . . . . 0.0 109.741 163.819 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 2496 ' ' LEU . . . . . . . . . . . . . 21.4 tp -94.34 104.61 16.59 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 124.597 1.159 . . . . 0.0 109.521 -178.467 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 2497 ' ' ILE . . . . . . . . . . . . . 30.2 mt -90.4 98.05 7.84 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 C-N-CA 125.826 1.65 . . . . 0.0 108.23 -177.627 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 2498 ' ' SER . . . . . . . . . . . . . 71.0 m -85.02 80.97 9.1 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 124.675 1.19 . . . . 0.0 109.624 175.783 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 2499 ' ' ILE . . . . . . . . . . . . . 17.9 mt -77.82 114.16 17.99 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 175.845 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 2500 ' ' LYS . . . . . . . . . . . . . 81.9 mttt -121.76 148.66 44.35 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.528 1.531 . . . . 0.0 111.037 -177.781 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 2501 ' ' TYR . . . . . . . . . . . . . 63.4 t80 -154.91 145.84 22.58 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.119 0.968 . . . . 0.0 112.499 -171.423 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 2502 ' ' GLY . . . . . . . . . . . . . . . 69.04 17.48 71.83 Favored Glycine 0 CA--C 1.536 1.394 0 C-N-CA 124.216 0.913 . . . . 0.0 113.704 178.823 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 2503 ' ' GLY . . . . . . . . . . . . . . . 135.6 -165.05 24.87 Favored Glycine 0 CA--C 1.54 1.643 0 C-N-CA 125.981 1.753 . . . . 0.0 112.528 -167.988 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 2504 ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -82.26 20.31 1.12 Allowed 'Trans proline' 0 CA--C 1.545 1.06 0 C-N-CA 124.855 3.703 . . . . 0.0 113.638 -174.545 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 2505 ' ' TYR . . . . . . . . . . . . . 80.5 m-85 -109.98 139.96 44.51 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.751 1.22 . . . . 0.0 113.355 -172.644 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 2506 ' ' HIS . . . . . . . . . . . . . 92.5 m-70 -62.57 144.31 56.27 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 125.571 1.548 . . . . 0.0 113.572 -179.61 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 2507 ' ' ILE . . . . . . . . . . . . . 28.0 pt -75.79 174.69 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 C-N-CA 123.633 0.773 . . . . 0.0 112.992 173.123 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 2508 ' ' GLY . . . . . . . . . . . . . . . -58.94 117.91 12.45 Favored Glycine 0 CA--C 1.532 1.152 0 N-CA-C 111.228 -0.749 . . . . 0.0 111.228 171.24 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 2509 ' ' GLY . . . . . . . . . . . . . . . 93.54 -9.77 73.59 Favored Glycine 0 CA--C 1.536 1.388 0 C-N-CA 125.677 1.608 . . . . 0.0 115.168 -178.142 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 2510 ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -78.23 156.09 79.17 Favored Pre-proline 0 N--CA 1.474 0.768 0 CA-C-N 119.647 1.723 . . . . 0.0 113.68 178.938 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 2511 ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -77.58 152.66 93.51 Favored 'Cis proline' 0 CA--C 1.539 0.768 0 CA-C-N 118.26 0.414 . . . . 0.0 111.435 -9.561 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 2512 ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -98.21 128.8 44.87 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.373 1.069 . . . . 0.0 110.633 179.693 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 2513 ' ' LYS . . . . . . . . . . . . . 24.9 pttm -88.22 7.58 31.29 Favored 'General case' 0 N--CA 1.479 0.995 0 N-CA-C 116.715 2.117 . . . . 0.0 116.715 -165.352 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 2514 ' ' ALA . . . . . . . . . . . . . . . -3.97 97.65 0.01 OUTLIER 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 129.467 3.107 . . . . 0.0 116.462 -175.616 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 2515 ' ' LYS . . . . . . . . . . . . . 62.8 mtpt -89.78 105.24 17.67 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.504 1.122 . . . . 0.0 110.683 -175.104 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 2516 ' ' VAL . . . . . . . . . . . . . 4.0 m -102.36 148.4 7.86 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 C-N-CA 124.315 1.046 . . . . 0.0 111.486 -174.161 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 2517 ' ' THR . . . . . . . . . . . . . 69.1 p -116.66 -169.37 1.62 Allowed 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 125.471 1.508 . . . . 0.0 110.922 179.349 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 2518 ' ' GLY . . . . . . . . . . . . . . . 96.29 -175.7 32.2 Favored Glycine 0 CA--C 1.539 1.575 0 C-N-CA 124.693 1.14 . . . . 0.0 113.331 -176.221 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 2519 ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -70.63 153.39 64.96 Favored 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 123.748 2.966 . . . . 0.0 112.537 -174.998 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 2520 ' ' ARG . . . . . . . . . . . . . 65.2 ttp85 . . . . . 0 CA--C 1.536 0.419 0 C-N-CA 124.686 1.194 . . . . 0.0 110.053 171.199 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A 2427 ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.111 0 CA-C-O 121.49 0.495 . . . . 0.0 113.787 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A 2428 ' ' ASP . . . . . . . . . . . . . 25.6 m-20 -117.68 137.1 23.94 Favored Pre-proline 0 CA--C 1.546 0.82 0 C-N-CA 125.07 1.348 . . . . 0.0 111.901 -179.595 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 2429 ' ' PRO . . . . . . . . . . . . . 81.1 Cg_exo -54.91 -26.79 50.49 Favored 'Trans proline' 0 C--N 1.353 0.792 0 C-N-CA 124.056 3.171 . . . . 0.0 115.089 174.707 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 2430 ' ' GLY . . . . . . . . . . . . . . . -78.93 -23.1 64.66 Favored Glycine 0 CA--C 1.534 1.225 0 C-N-CA 123.812 0.72 . . . . 0.0 113.786 176.174 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 2431 ' ' LEU . . . . . . . . . . . . . 4.4 mm? -91.04 -32.16 16.01 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.731 1.212 . . . . 0.0 111.89 174.458 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 2432 ' ' VAL . . . . . . . . . . . . . 94.1 t -64.84 134.32 29.5 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 CA-C-N 118.698 0.681 . . . . 0.0 109.76 170.033 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 2433 ' ' SER . . . . . . . . . . . . . 7.9 t -127.28 -167.91 1.81 Allowed 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.93 1.292 . . . . 0.0 111.163 177.545 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 2434 ' ' ALA . . . . . . . . . . . . . . . -153.25 139.37 18.32 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.538 1.135 . . . . 0.0 111.656 177.865 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 2435 ' ' TYR . . . . . . . . . . . . . 76.8 m-85 -146.54 141.9 27.48 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 125.265 1.426 . . . . 0.0 111.951 -176.875 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 2436 ' ' GLY . . . . . . . . . . . . . . . 126.0 163.05 11.46 Favored Glycine 0 CA--C 1.534 1.225 0 C-N-CA 125.704 1.621 . . . . 0.0 113.743 179.461 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 2437 ' ' ALA . . . . . . . . . . . . . . . -63.58 -28.39 69.9 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 114.706 1.373 . . . . 0.0 114.706 -168.782 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 2438 ' ' GLY . . . . . . . . . . . . . . . -64.42 -16.6 60.84 Favored Glycine 0 CA--C 1.532 1.095 0 C-N-CA 124.302 0.953 . . . . 0.0 114.502 -177.645 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 2439 ' ' LEU . . . . . . . . . . . . . 95.2 mt -68.73 -29.55 67.99 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 118.575 1.188 . . . . 0.0 112.548 170.159 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 2440 ' ' GLU . . . . . . . . . . . . . 41.7 mm-40 -90.24 -26.92 19.83 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.912 1.285 . . . . 0.0 112.33 178.765 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 2441 ' ' GLY . . . . . . . . . . . . . . . 102.86 -144.42 16.05 Favored Glycine 0 CA--C 1.531 1.087 0 C-N-CA 125.666 1.603 . . . . 0.0 112.881 -178.143 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 2442 ' ' GLY . . . . . . . . . . . . . . . 163.06 -160.26 32.79 Favored Glycine 0 CA--C 1.532 1.124 0 C-N-CA 123.836 0.731 . . . . 0.0 114.872 -176.349 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 2443 ' ' VAL . . . . . . . . . . . . . 83.2 t -83.14 141.49 14.82 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 C-N-CA 124.786 1.235 . . . . 0.0 110.96 -177.533 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 2444 ' ' THR . . . . . . . . . . . . . 18.9 p -56.1 131.41 47.52 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 124.996 1.318 . . . . 0.0 112.228 174.674 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 2445 ' ' GLY . . . . . . . . . . . . . . . 82.88 -10.93 56.05 Favored Glycine 0 CA--C 1.535 1.291 0 C-N-CA 124.993 1.282 . . . . 0.0 114.66 178.667 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 2446 ' ' ASN . . . . . . . . . . . . . 61.1 m-20 -91.99 147.93 35.85 Favored Pre-proline 0 CA--C 1.547 0.833 0 CA-C-N 118.63 1.215 . . . . 0.0 110.727 172.225 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 2447 ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -71.8 143.48 41.55 Favored 'Trans proline' 0 N--CA 1.457 -0.619 0 C-N-CA 122.817 2.345 . . . . 0.0 111.041 177.453 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 2448 ' ' ALA . . . . . . . . . . . . . . . -124.39 143.92 50.34 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 126.698 1.999 . . . . 0.0 109.126 172.495 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 2449 ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -154.41 152.43 30.17 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 113.392 0.886 . . . . 0.0 113.392 -173.462 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 2450 ' ' PHE . . . . . . . . . . . . . 14.0 p90 -161.46 167.14 26.11 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.902 1.681 . . . . 0.0 110.436 177.599 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 2451 ' ' VAL . . . . . . . . . . . . . 59.2 t -112.33 128.69 68.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 124.698 1.199 . . . . 0.0 110.209 177.537 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 2452 ' ' VAL . . . . . . . . . . . . . 48.8 t -77.53 106.11 7.35 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 162.86 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 2453 ' ' ASN . . . . . . . . . . . . . 16.3 t-20 -83.47 106.31 15.11 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 124.21 1.004 . . . . 0.0 111.732 -170.888 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 2454 ' ' THR . . . . . . . . . . . . . 40.6 p -97.7 -8.23 29.17 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 125.83 1.652 . . . . 0.0 113.514 177.954 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 2455 ' ' SER . . . . . . . . . . . . . 12.8 t -58.54 -31.69 68.18 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-N 119.364 0.983 . . . . 0.0 113.45 -176.629 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 2456 ' ' ASN . . . . . . . . . . . . . 57.8 m-80 -76.8 -14.86 59.87 Favored 'General case' 0 CA--C 1.549 0.907 0 N-CA-C 113.942 1.09 . . . . 0.0 113.942 174.861 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 2457 ' ' ALA . . . . . . . . . . . . . . . -109.0 -39.0 5.43 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 125.344 1.458 . . . . 0.0 113.98 -173.723 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 2458 ' ' GLY . . . . . . . . . . . . . . . 112.67 -148.3 18.42 Favored Glycine 0 CA--C 1.533 1.181 0 C-N-CA 125.379 1.466 . . . . 0.0 112.125 -171.432 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 2459 ' ' ALA . . . . . . . . . . . . . . . -92.36 154.7 18.39 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.21 1.004 . . . . 0.0 112.123 179.417 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 2460 ' ' GLY . . . . . . . . . . . . . . . 166.02 163.71 20.1 Favored Glycine 0 N--CA 1.47 0.924 0 C-N-CA 123.848 0.737 . . . . 0.0 114.3 177.488 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 2461 ' ' ALA . . . . . . . . . . . . . . . -80.04 137.3 36.77 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.349 1.06 . . . . 0.0 112.134 -178.559 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 2462 ' ' LEU . . . . . . . . . . . . . 25.8 tp -110.78 141.76 43.68 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.337 1.455 . . . . 0.0 110.591 176.889 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 2463 ' ' SER . . . . . . . . . . . . . 4.1 t -130.28 39.0 3.7 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 126.215 1.806 . . . . 0.0 110.653 -177.319 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 2464 ' ' VAL . . . . . . . . . . . . . 11.4 p -65.72 140.98 18.72 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 125.512 1.525 . . . . 0.0 112.058 -176.239 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 2465 ' ' THR . . . . . . . . . . . . . 8.3 t -154.45 167.19 30.88 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 125.137 1.375 . . . . 0.0 111.691 179.704 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 2466 ' ' ILE . . . . . . . . . . . . . 35.2 mt -135.02 131.01 52.56 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 C-N-CA 125.237 1.415 . . . . 0.0 109.936 -176.127 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 2467 ' ' ASP . . . . . . . . . . . . . 36.3 t70 -122.26 136.91 54.98 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 125.811 1.644 . . . . 0.0 110.735 174.963 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 2468 ' ' GLY . . . . . . . . . . . . . . . 172.94 -162.77 34.34 Favored Glycine 0 CA--C 1.537 1.444 0 CA-C-O 119.062 -0.855 . . . . 0.0 114.121 -177.624 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 2469 ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -72.81 1.2 6.68 Favored 'Trans proline' 0 CA--C 1.544 0.979 0 C-N-CA 123.999 3.133 . . . . 0.0 115.325 -172.788 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 2470 ' ' SER . . . . . . . . . . . . . 85.0 p -150.55 153.94 36.69 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 120.071 1.305 . . . . 0.0 112.989 167.791 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 2471 ' ' LYS . . . . . . . . . . . . . 99.1 mttt -75.44 74.45 2.5 Favored 'General case' 0 CA--C 1.545 0.77 0 O-C-N 120.906 -1.121 . . . . 0.0 111.073 175.624 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 2472 ' ' VAL . . . . . . . . . . . . . 18.6 m -54.76 143.14 7.57 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 C-N-CA 124.725 1.21 . . . . 0.0 113.403 -173.422 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 2473 ' ' LYS . . . . . . . . . . . . . 83.8 tttt -83.67 70.8 10.38 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 124.596 1.158 . . . . 0.0 111.129 178.471 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 2474 ' ' MET . . . . . . . . . . . . . 16.6 tmm? -79.78 129.61 34.63 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.185 0.994 . . . . 0.0 111.315 -179.764 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 2475 ' ' ASP . . . . . . . . . . . . . 35.6 t70 -123.38 126.23 46.43 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 126.209 1.804 . . . . 0.0 110.348 174.261 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 2476 ' ' CYS . . . . . . . . . . . . . 35.9 t -101.92 139.82 37.03 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.066 1.346 . . . . 0.0 111.535 179.777 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 2477 ' ' GLN . . . . . . . . . . . . . 83.5 mt-30 -141.42 145.25 35.06 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.424 1.49 . . . . 0.0 110.497 -174.092 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 2478 ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -88.11 136.81 32.8 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 123.716 0.806 . . . . 0.0 110.624 174.213 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 2479 ' ' CYS . . . . . . . . . . . . . 14.8 p -146.44 171.53 6.3 Favored Pre-proline 0 CA--C 1.554 1.11 0 C-N-CA 125.617 1.567 . . . . 0.0 111.717 177.69 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 2480 ' ' PRO . . . . . . . . . . . . . 70.5 Cg_exo -58.94 -28.31 87.2 Favored 'Trans proline' 0 CA--C 1.539 0.76 0 C-N-CA 123.468 2.779 . . . . 0.0 114.66 179.331 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 2481 ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -83.79 -14.19 52.01 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 124.62 1.168 . . . . 0.0 113.019 -179.656 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 2482 ' ' GLY . . . . . . . . . . . . . . . 136.09 -143.95 15.57 Favored Glycine 0 N--CA 1.47 0.937 0 C-N-CA 125.83 1.681 . . . . 0.0 112.677 -177.112 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 2483 ' ' TYR . . . . . . . . . . . . . 88.7 m-85 -92.8 108.82 20.28 Favored 'General case' 0 N--CA 1.469 0.506 0 O-C-N 121.678 -0.895 . . . . 0.0 110.911 173.92 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 2484 ' ' ARG . . . . . . . . . . . . . 12.7 ttp180 -74.44 140.94 45.0 Favored 'General case' 0 N--CA 1.468 0.451 0 O-C-N 121.705 -0.622 . . . . 0.0 109.859 169.217 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 2485 ' ' VAL . . . . . . . . . . . . . 22.5 m -126.18 141.69 45.01 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 C-N-CA 123.669 0.788 . . . . 0.0 110.368 165.583 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 2486 ' ' THR . . . . . . . . . . . . . 88.8 m -132.53 135.84 46.23 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 125.658 1.583 . . . . 0.0 108.443 177.582 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 2487 ' ' TYR . . . . . . . . . . . . . 23.1 p90 -149.84 159.92 43.98 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.792 1.237 . . . . 0.0 112.443 -179.747 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 2488 ' ' THR . . . . . . . . . . . . . 99.4 m -122.27 113.8 30.81 Favored Pre-proline 0 N--CA 1.476 0.871 0 C-N-CA 124.154 0.982 . . . . 0.0 109.59 174.23 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 2489 ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -83.74 134.89 6.56 Favored 'Trans proline' 0 N--CA 1.458 -0.598 0 C-N-CA 123.624 2.883 . . . . 0.0 109.957 169.653 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 2490 ' ' MET . . . . . . . . . . . . . 22.4 ptt? -101.71 -18.05 16.0 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 114.329 1.233 . . . . 0.0 114.329 179.348 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 2491 ' ' ALA . . . . . . . . . . . . . . . -112.98 146.34 34.93 Favored Pre-proline 0 CA--C 1.547 0.835 0 C-N-CA 124.68 1.192 . . . . 0.0 112.346 -175.067 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 2492 ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -72.07 156.67 55.55 Favored 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 122.99 2.46 . . . . 0.0 111.192 172.494 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 2493 ' ' GLY . . . . . . . . . . . . . . . 128.79 -147.83 17.77 Favored Glycine 0 CA--C 1.528 0.894 0 C-N-CA 125.465 1.507 . . . . 0.0 112.239 -175.794 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 2494 ' ' SER . . . . . . . . . . . . . 63.8 m -129.78 140.55 51.03 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 123.891 0.876 . . . . 0.0 111.973 177.686 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 2495 ' ' TYR . . . . . . . . . . . . . 62.3 m-85 -114.75 127.5 55.77 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 125.993 1.717 . . . . 0.0 109.797 177.245 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 2496 ' ' LEU . . . . . . . . . . . . . 9.9 mp -88.69 117.56 27.75 Favored 'General case' 0 N--CA 1.464 0.242 0 C-N-CA 123.879 0.871 . . . . 0.0 108.963 173.131 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 2497 ' ' ILE . . . . . . . . . . . . . 36.1 mt -93.45 103.95 15.22 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 C-N-CA 125.371 1.468 . . . . 0.0 107.462 176.101 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 2498 ' ' SER . . . . . . . . . . . . . 66.4 m -91.31 101.21 13.91 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 124.816 1.246 . . . . 0.0 109.524 -179.609 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 2499 ' ' ILE . . . . . . . . . . . . . 24.0 mt -97.6 92.01 2.77 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 C-N-CA 125.332 1.453 . . . . 0.0 108.828 -178.05 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 2500 ' ' LYS . . . . . . . . . . . . . 84.2 mttt -102.51 139.68 37.79 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.32 1.048 . . . . 0.0 111.739 178.93 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 2501 ' ' TYR . . . . . . . . . . . . . 72.8 t80 -145.26 147.45 32.4 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.817 1.247 . . . . 0.0 112.429 -170.823 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 2502 ' ' GLY . . . . . . . . . . . . . . . 64.83 21.28 67.31 Favored Glycine 0 CA--C 1.535 1.299 0 C-N-CA 124.17 0.89 . . . . 0.0 113.505 177.725 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 2503 ' ' GLY . . . . . . . . . . . . . . . 126.69 -163.49 20.58 Favored Glycine 0 CA--C 1.541 1.686 0 C-N-CA 125.899 1.714 . . . . 0.0 112.173 -163.119 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 2504 ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -83.23 21.49 1.02 Allowed 'Trans proline' 0 CA--C 1.545 1.048 0 C-N-CA 124.776 3.65 . . . . 0.0 113.91 -172.766 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 2505 ' ' TYR . . . . . . . . . . . . . 80.7 m-85 -105.92 130.5 53.86 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.313 1.045 . . . . 0.0 113.129 -171.759 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 2506 ' ' HIS . . . . . . . . . . . . . 86.5 m-70 -62.39 140.03 58.55 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 125.369 1.468 . . . . 0.0 113.523 179.705 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 2507 ' ' ILE . . . . . . . . . . . . . 1.8 pp -87.82 150.73 3.68 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.163 0 C-N-CA 123.954 0.902 . . . . 0.0 111.812 172.33 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 2508 ' ' GLY . . . . . . . . . . . . . . . 48.88 -116.8 3.57 Favored Glycine 0 CA--C 1.536 1.377 0 C-N-CA 124.087 0.851 . . . . 0.0 114.074 167.765 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 2509 ' ' GLY . . . . . . . . . . . . . . . -98.59 13.16 62.84 Favored Glycine 0 CA--C 1.536 1.359 0 C-N-CA 126.156 1.836 . . . . 0.0 115.047 177.811 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 2510 ' ' SER . . . . . . . . . . . . . 44.2 t -65.36 145.39 99.08 Favored Pre-proline 0 CA--C 1.553 1.059 0 CA-C-N 119.207 1.503 . . . . 0.0 112.837 -179.004 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 2511 ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -74.7 141.0 70.45 Favored 'Cis proline' 0 C--N 1.355 0.888 0 CA-C-N 119.712 0.933 . . . . 0.0 112.636 0.663 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 2512 ' ' PHE . . . . . . . . . . . . . 87.8 m-85 -94.38 125.43 39.02 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.575 1.15 . . . . 0.0 110.518 178.246 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 2513 ' ' LYS . . . . . . . . . . . . . 25.7 pttm -85.5 105.02 15.8 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 123.545 0.738 . . . . 0.0 112.165 177.798 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 2514 ' ' ALA . . . . . . . . . . . . . . . -87.94 120.0 28.84 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.239 1.416 . . . . 0.0 109.902 173.433 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 2515 ' ' LYS . . . . . . . . . . . . . 54.0 mtmt -94.41 133.35 38.09 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.383 1.073 . . . . 0.0 110.84 -176.953 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 2516 ' ' VAL . . . . . . . . . . . . . 87.9 t -131.21 136.94 56.77 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 124.415 1.086 . . . . 0.0 110.743 -170.544 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 2517 ' ' THR . . . . . . . . . . . . . 34.2 p -138.41 156.76 47.28 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 125.265 1.426 . . . . 0.0 111.795 -175.705 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 2518 ' ' GLY . . . . . . . . . . . . . . . 114.73 -176.29 16.7 Favored Glycine 0 CA--C 1.541 1.698 0 C-N-CA 125.584 1.564 . . . . 0.0 113.04 -175.21 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 2519 ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -69.8 149.68 66.97 Favored 'Trans proline' 0 CA--C 1.535 0.562 0 C-N-CA 123.756 2.97 . . . . 0.0 112.246 -174.162 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 2520 ' ' ARG . . . . . . . . . . . . . 37.3 ttm105 . . . . . 0 CA--C 1.545 0.764 0 C-N-CA 123.908 0.883 . . . . 0.0 113.287 178.904 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A 2427 ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.002 0 CA-C-O 121.464 0.48 . . . . 0.0 114.018 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A 2428 ' ' ASP . . . . . . . . . . . . . 21.3 m-20 -132.89 138.71 32.51 Favored Pre-proline 0 CA--C 1.547 0.857 0 C-N-CA 125.381 1.472 . . . . 0.0 111.462 -179.58 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 2429 ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -56.79 -26.32 65.79 Favored 'Trans proline' 0 C--N 1.352 0.756 0 C-N-CA 123.854 3.036 . . . . 0.0 114.568 176.549 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 2430 ' ' GLY . . . . . . . . . . . . . . . -79.12 -23.5 63.38 Favored Glycine 0 CA--C 1.534 1.219 0 C-N-CA 123.737 0.684 . . . . 0.0 113.871 176.66 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 2431 ' ' LEU . . . . . . . . . . . . . 4.3 mm? -86.98 -39.64 15.5 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.519 1.128 . . . . 0.0 111.118 173.261 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 2432 ' ' VAL . . . . . . . . . . . . . 98.7 t -61.41 133.82 27.0 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 123.469 0.708 . . . . 0.0 109.992 172.53 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 2433 ' ' SER . . . . . . . . . . . . . 8.4 t -129.13 -170.09 2.21 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.892 1.277 . . . . 0.0 110.959 178.425 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 2434 ' ' ALA . . . . . . . . . . . . . . . -151.05 143.54 24.29 Favored 'General case' 0 CA--C 1.538 0.496 0 O-C-N 120.956 -1.09 . . . . 0.0 111.889 177.125 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 2435 ' ' TYR . . . . . . . . . . . . . 82.1 m-85 -145.89 143.64 29.7 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 125.242 1.417 . . . . 0.0 111.971 -176.142 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 2436 ' ' GLY . . . . . . . . . . . . . . . 125.71 162.7 11.38 Favored Glycine 0 N--CA 1.475 1.244 0 C-N-CA 125.607 1.575 . . . . 0.0 114.201 176.806 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 2437 ' ' ALA . . . . . . . . . . . . . . . -62.36 -27.16 68.87 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 125.244 1.418 . . . . 0.0 114.545 -170.887 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 2438 ' ' GLY . . . . . . . . . . . . . . . -61.87 -22.13 61.9 Favored Glycine 0 CA--C 1.531 1.06 0 C-N-CA 124.022 0.82 . . . . 0.0 113.903 179.326 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 2439 ' ' LEU . . . . . . . . . . . . . 85.5 mt -70.98 -22.8 62.14 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 118.547 1.173 . . . . 0.0 112.97 172.742 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 2440 ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -96.37 -26.44 15.35 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.11 1.364 . . . . 0.0 112.592 -179.796 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 2441 ' ' GLY . . . . . . . . . . . . . . . 101.8 -142.91 15.84 Favored Glycine 0 CA--C 1.532 1.127 0 C-N-CA 125.465 1.507 . . . . 0.0 112.652 -177.947 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 2442 ' ' GLY . . . . . . . . . . . . . . . 152.36 -152.58 24.26 Favored Glycine 0 CA--C 1.532 1.128 0 C-N-CA 124.205 0.907 . . . . 0.0 114.27 -177.14 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 2443 ' ' VAL . . . . . . . . . . . . . 38.4 t -88.32 141.27 14.53 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 C-N-CA 124.501 1.12 . . . . 0.0 110.333 -179.042 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 2444 ' ' THR . . . . . . . . . . . . . 33.1 p -59.07 152.69 19.49 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 124.361 1.065 . . . . 0.0 112.744 174.385 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 2445 ' ' GLY . . . . . . . . . . . . . . . 70.93 0.72 35.72 Favored Glycine 0 CA--C 1.534 1.224 0 C-N-CA 124.182 0.896 . . . . 0.0 115.133 177.887 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 2446 ' ' ASN . . . . . . . . . . . . . 14.6 m-80 -116.14 143.35 30.81 Favored Pre-proline 0 CA--C 1.546 0.803 0 C-N-CA 126.043 1.737 . . . . 0.0 110.066 177.095 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 2447 ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -72.99 141.92 33.85 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 122.805 2.337 . . . . 0.0 111.133 178.7 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 2448 ' ' ALA . . . . . . . . . . . . . . . -128.87 137.51 51.5 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.568 1.547 . . . . 0.0 109.403 169.66 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 2449 ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -131.35 151.81 51.18 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.21 1.004 . . . . 0.0 113.402 -166.6 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 2450 ' ' PHE . . . . . . . . . . . . . 27.2 p90 -158.48 163.65 36.93 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 125.915 1.686 . . . . 0.0 110.802 178.18 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 2451 ' ' VAL . . . . . . . . . . . . . 58.2 t -118.36 132.57 67.83 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 124.488 1.115 . . . . 0.0 109.717 175.992 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 2452 ' ' VAL . . . . . . . . . . . . . 40.3 t -79.19 106.69 10.64 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 162.716 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 2453 ' ' ASN . . . . . . . . . . . . . 15.0 t-20 -84.18 108.38 17.04 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 123.65 0.78 . . . . 0.0 111.7 -172.39 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 2454 ' ' THR . . . . . . . . . . . . . 29.9 p -97.67 -6.87 32.18 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 126.364 1.866 . . . . 0.0 113.644 -179.779 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 2455 ' ' SER . . . . . . . . . . . . . 14.9 m -58.11 -26.91 63.21 Favored 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 114.229 1.196 . . . . 0.0 114.229 -177.386 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 2456 ' ' ASN . . . . . . . . . . . . . 86.2 m-20 -75.27 -20.17 59.3 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.549 1.139 . . . . 0.0 113.355 175.524 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 2457 ' ' ALA . . . . . . . . . . . . . . . -116.62 -44.48 2.85 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.317 1.447 . . . . 0.0 113.451 -164.518 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 2458 ' ' GLY . . . . . . . . . . . . . . . 100.44 -148.11 18.24 Favored Glycine 0 CA--C 1.533 1.191 0 C-N-CA 124.98 1.276 . . . . 0.0 112.847 -175.135 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 2459 ' ' ALA . . . . . . . . . . . . . . . -73.66 139.26 45.29 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.352 1.061 . . . . 0.0 113.596 -172.553 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 2460 ' ' GLY . . . . . . . . . . . . . . . 168.67 154.79 9.14 Favored Glycine 0 CA--C 1.531 1.041 0 C-N-CA 125.327 1.441 . . . . 0.0 113.167 177.226 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 2461 ' ' ALA . . . . . . . . . . . . . . . -79.85 147.71 31.63 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 124.293 1.037 . . . . 0.0 112.567 -178.289 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 2462 ' ' LEU . . . . . . . . . . . . . 16.6 tp -108.55 143.39 37.64 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.148 1.379 . . . . 0.0 111.131 177.267 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 2463 ' ' SER . . . . . . . . . . . . . 49.4 m -135.0 38.97 2.98 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 125.699 1.6 . . . . 0.0 111.139 -176.514 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 2464 ' ' VAL . . . . . . . . . . . . . 8.5 p -66.03 138.12 23.63 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 C-N-CA 125.453 1.501 . . . . 0.0 112.43 -177.739 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 2465 ' ' THR . . . . . . . . . . . . . 93.1 m -137.87 141.69 40.7 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 125.608 1.563 . . . . 0.0 109.822 175.232 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 2466 ' ' ILE . . . . . . . . . . . . . 56.7 mt -105.61 119.89 55.54 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 123.661 0.784 . . . . 0.0 109.266 170.885 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 2467 ' ' ASP . . . . . . . . . . . . . 37.4 t70 -108.01 155.68 20.07 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 126.334 1.853 . . . . 0.0 110.603 173.5 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 2468 ' ' GLY . . . . . . . . . . . . . . . 163.56 -160.34 33.06 Favored Glycine 0 CA--C 1.535 1.327 0 CA-C-O 119.136 -0.814 . . . . 0.0 114.044 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 2469 ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -71.04 -14.62 32.16 Favored 'Trans proline' 0 CA--C 1.539 0.766 0 C-N-CA 123.788 2.992 . . . . 0.0 114.003 -177.342 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 2470 ' ' SER . . . . . . . . . . . . . 42.2 m -152.49 159.52 43.33 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 125.257 1.423 . . . . 0.0 111.959 178.573 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 2471 ' ' LYS . . . . . . . . . . . . . 68.3 mttm -76.42 98.07 4.46 Favored 'General case' 0 CA--C 1.544 0.722 0 O-C-N 120.966 -1.084 . . . . 0.0 110.482 172.574 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 2472 ' ' VAL . . . . . . . . . . . . . 16.2 m -60.77 148.38 8.98 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 C-N-CA 123.985 0.914 . . . . 0.0 111.743 179.252 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 2473 ' ' LYS . . . . . . . . . . . . . 88.6 tttt -77.1 109.85 11.28 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 171.015 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 2474 ' ' MET . . . . . . . . . . . . . 25.3 ttt -118.19 142.27 47.63 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.998 1.319 . . . . 0.0 112.434 -166.831 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 2475 ' ' ASP . . . . . . . . . . . . . 31.0 t70 -128.41 147.03 50.63 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 127.187 2.195 . . . . 0.0 110.16 169.428 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 2476 ' ' CYS . . . . . . . . . . . . . 37.8 t -138.12 140.58 39.99 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.668 1.187 . . . . 0.0 110.244 172.181 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 2477 ' ' GLN . . . . . . . . . . . . . 8.7 pt20 -156.89 163.13 39.51 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.182 1.393 . . . . 0.0 111.17 -172.893 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 2478 ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -95.13 138.5 32.76 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 123.775 0.83 . . . . 0.0 111.39 -179.365 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 2479 ' ' CYS . . . . . . . . . . . . . 14.0 p -139.18 170.9 9.01 Favored Pre-proline 0 CA--C 1.553 1.071 0 C-N-CA 125.43 1.492 . . . . 0.0 111.168 170.547 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 2480 ' ' PRO . . . . . . . . . . . . . 68.3 Cg_exo -58.43 -26.09 76.3 Favored 'Trans proline' 0 C--N 1.352 0.741 0 C-N-CA 123.508 2.805 . . . . 0.0 114.702 178.415 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 2481 ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -83.09 -11.04 58.37 Favored 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 125.01 1.324 . . . . 0.0 112.862 178.89 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 2482 ' ' GLY . . . . . . . . . . . . . . . 128.82 -155.49 20.65 Favored Glycine 0 N--CA 1.473 1.125 0 C-N-CA 125.893 1.711 . . . . 0.0 113.402 -178.276 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 2483 ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -76.06 109.29 9.59 Favored 'General case' 0 N--CA 1.47 0.575 0 O-C-N 121.621 -0.929 . . . . 0.0 110.767 175.893 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 2484 ' ' ARG . . . . . . . . . . . . . 31.5 ttm180 -85.27 131.66 34.38 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 124.892 1.277 . . . . 0.0 110.577 176.242 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 2485 ' ' VAL . . . . . . . . . . . . . 78.7 t -117.93 137.5 51.67 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 C-N-CA 126.062 1.745 . . . . 0.0 108.742 176.397 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 2486 ' ' THR . . . . . . . . . . . . . 85.0 m -131.9 139.0 48.62 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.771 1.229 . . . . 0.0 108.175 171.277 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 2487 ' ' TYR . . . . . . . . . . . . . 30.5 p90 -146.41 149.32 33.5 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 113.38 0.881 . . . . 0.0 113.38 175.61 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 2488 ' ' THR . . . . . . . . . . . . . 62.9 m -112.7 114.21 49.8 Favored Pre-proline 0 N--CA 1.472 0.639 0 C-N-CA 125.17 1.388 . . . . 0.0 108.61 172.411 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 2489 ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -81.06 134.99 9.57 Favored 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 122.851 2.367 . . . . 0.0 110.709 176.004 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 2490 ' ' MET . . . . . . . . . . . . . 17.7 ptm -91.25 -3.72 56.63 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 125.031 1.332 . . . . 0.0 114.192 -177.893 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 2491 ' ' ALA . . . . . . . . . . . . . . . -151.26 151.08 28.6 Favored Pre-proline 0 CA--C 1.546 0.826 0 C-N-CA 125.429 1.492 . . . . 0.0 112.001 -173.83 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 2492 ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -73.99 165.09 32.92 Favored 'Trans proline' 0 CA--C 1.538 0.685 0 C-N-CA 123.505 2.803 . . . . 0.0 111.727 173.447 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 2493 ' ' GLY . . . . . . . . . . . . . . . 127.09 -158.67 21.07 Favored Glycine 0 CA--C 1.53 0.994 0 C-N-CA 125.539 1.542 . . . . 0.0 112.973 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 2494 ' ' SER . . . . . . . . . . . . . 67.6 m -113.47 128.89 56.6 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.126 0.971 . . . . 0.0 111.262 179.257 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 2495 ' ' TYR . . . . . . . . . . . . . 88.9 m-85 -110.82 132.88 53.83 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.781 1.632 . . . . 0.0 110.531 177.748 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 2496 ' ' LEU . . . . . . . . . . . . . 9.5 mp -96.7 114.74 26.41 Favored 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 124.248 1.019 . . . . 0.0 108.908 173.921 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 2497 ' ' ILE . . . . . . . . . . . . . 30.6 mt -89.49 92.21 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 N-CA-C 107.306 -1.368 . . . . 0.0 107.306 174.763 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 2498 ' ' SER . . . . . . . . . . . . . 68.0 m -80.92 78.57 7.71 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 126.032 1.733 . . . . 0.0 110.305 -179.311 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 2499 ' ' ILE . . . . . . . . . . . . . 36.1 mt -75.42 107.15 5.83 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 C-N-CA 124.826 1.251 . . . . 0.0 109.204 176.1 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 2500 ' ' LYS . . . . . . . . . . . . . 42.8 mttp -113.02 148.6 34.79 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 124.775 1.23 . . . . 0.0 111.116 175.194 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 2501 ' ' TYR . . . . . . . . . . . . . 67.6 t80 -148.25 145.94 28.43 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.445 1.098 . . . . 0.0 112.281 -172.044 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 2502 ' ' GLY . . . . . . . . . . . . . . . 66.39 14.7 62.48 Favored Glycine 0 CA--C 1.535 1.33 0 C-N-CA 124.556 1.074 . . . . 0.0 114.373 175.162 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 2503 ' ' GLY . . . . . . . . . . . . . . . 138.02 -169.29 24.26 Favored Glycine 0 CA--C 1.54 1.633 0 C-N-CA 125.92 1.724 . . . . 0.0 112.537 -166.154 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 2504 ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -83.76 34.58 0.53 Allowed 'Trans proline' 0 CA--C 1.545 1.068 0 C-N-CA 124.859 3.706 . . . . 0.0 113.143 -171.588 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 2505 ' ' TYR . . . . . . . . . . . . . 92.8 m-85 -125.11 136.27 53.48 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 124.515 1.126 . . . . 0.0 113.053 -174.786 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 2506 ' ' HIS . . . . . . . . . . . . . 92.4 m-70 -63.48 146.09 54.32 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 125.405 1.482 . . . . 0.0 113.455 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 2507 ' ' ILE . . . . . . . . . . . . . 24.2 pt -75.43 173.28 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.192 0 C-N-CA 123.494 0.718 . . . . 0.0 112.684 171.485 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 2508 ' ' GLY . . . . . . . . . . . . . . . -59.29 120.73 24.02 Favored Glycine 0 CA--C 1.534 1.244 0 O-C-N 121.411 -0.806 . . . . 0.0 111.677 175.074 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 2509 ' ' GLY . . . . . . . . . . . . . . . 87.8 -5.77 84.44 Favored Glycine 0 CA--C 1.536 1.371 0 C-N-CA 125.393 1.473 . . . . 0.0 114.995 -177.25 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 2510 ' ' SER . . . . . . . . . . . . . 47.4 t -89.3 145.99 35.18 Favored Pre-proline 0 CA--C 1.551 0.992 0 CA-C-N 119.007 1.404 . . . . 0.0 112.088 -179.875 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 2511 ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -72.71 143.6 78.12 Favored 'Cis proline' 0 C--N 1.355 0.877 0 CA-C-N 120.042 1.051 . . . . 0.0 112.427 -0.319 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 2512 ' ' PHE . . . . . . . . . . . . . 83.0 m-85 -92.61 122.95 35.54 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.059 0.944 . . . . 0.0 110.718 178.202 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 2513 ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.34 105.08 13.12 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 124.023 0.929 . . . . 0.0 113.462 178.588 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 2514 ' ' ALA . . . . . . . . . . . . . . . -92.84 125.28 37.37 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.07 1.348 . . . . 0.0 110.208 173.993 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 2515 ' ' LYS . . . . . . . . . . . . . 54.6 mtmt -102.83 123.91 47.37 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.303 1.041 . . . . 0.0 110.637 -178.027 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 2516 ' ' VAL . . . . . . . . . . . . . 92.3 t -122.27 139.06 50.39 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 124.967 1.307 . . . . 0.0 110.523 -168.968 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 2517 ' ' THR . . . . . . . . . . . . . 38.5 p -132.64 164.66 26.21 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 125.391 1.476 . . . . 0.0 111.75 -177.794 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 2518 ' ' GLY . . . . . . . . . . . . . . . 108.96 -176.54 19.9 Favored Glycine 0 CA--C 1.54 1.601 0 C-N-CA 124.908 1.242 . . . . 0.0 113.313 -176.373 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 2519 ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -75.12 158.24 41.84 Favored 'Trans proline' 0 CA--C 1.535 0.541 0 C-N-CA 123.819 3.012 . . . . 0.0 112.127 -175.683 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 2520 ' ' ARG . . . . . . . . . . . . . 39.4 ttp180 . . . . . 0 CA--C 1.539 0.526 0 C-N-CA 123.053 0.541 . . . . 0.0 110.058 168.547 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A 2427 ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.107 0 N-CA-C 111.931 -0.467 . . . . 0.0 111.931 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A 2428 ' ' ASP . . . . . . . . . . . . . 13.8 t70 -149.71 136.16 10.63 Favored Pre-proline 0 CA--C 1.55 0.96 0 C-N-CA 123.939 0.896 . . . . 0.0 112.182 -173.658 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 2429 ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -65.79 -20.74 58.7 Favored 'Trans proline' 0 C--N 1.353 0.795 0 C-N-CA 123.58 2.854 . . . . 0.0 114.186 -176.089 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 2430 ' ' GLY . . . . . . . . . . . . . . . -81.69 -26.25 50.89 Favored Glycine 0 CA--C 1.533 1.163 0 CA-C-N 119.261 0.937 . . . . 0.0 113.106 173.997 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 2431 ' ' LEU . . . . . . . . . . . . . 4.4 mm? -81.7 -34.17 30.77 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.153 0.981 . . . . 0.0 111.383 171.123 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 2432 ' ' VAL . . . . . . . . . . . . . 57.7 t -64.21 138.28 23.34 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 123.516 0.726 . . . . 0.0 110.31 168.462 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 2433 ' ' SER . . . . . . . . . . . . . 8.9 t -131.18 -167.25 1.82 Allowed 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 125.128 1.371 . . . . 0.0 109.897 172.873 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 2434 ' ' ALA . . . . . . . . . . . . . . . -151.54 145.53 25.22 Favored 'General case' 0 CA--C 1.537 0.477 0 O-C-N 120.794 -1.191 . . . . 0.0 111.643 176.012 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 2435 ' ' TYR . . . . . . . . . . . . . 86.6 m-85 -143.2 149.67 38.3 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.334 1.454 . . . . 0.0 111.892 -177.307 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 2436 ' ' GLY . . . . . . . . . . . . . . . 120.42 160.59 11.2 Favored Glycine 0 N--CA 1.473 1.133 0 C-N-CA 125.534 1.54 . . . . 0.0 113.549 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 2437 ' ' ALA . . . . . . . . . . . . . . . -60.7 -31.74 71.01 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 114.535 1.309 . . . . 0.0 114.535 -168.665 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 2438 ' ' GLY . . . . . . . . . . . . . . . -67.97 -10.43 58.89 Favored Glycine 0 CA--C 1.532 1.132 0 C-N-CA 124.129 0.871 . . . . 0.0 114.891 -176.352 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 2439 ' ' LEU . . . . . . . . . . . . . 75.6 mt -77.75 -27.14 50.31 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 118.702 1.251 . . . . 0.0 112.162 169.208 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 2440 ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -93.19 -34.82 13.44 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 125.121 1.369 . . . . 0.0 111.595 176.493 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 2441 ' ' GLY . . . . . . . . . . . . . . . 138.68 -136.67 8.17 Favored Glycine 0 CA--C 1.531 1.061 0 C-N-CA 125.097 1.332 . . . . 0.0 114.469 176.171 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 2442 ' ' GLY . . . . . . . . . . . . . . . 162.89 -145.06 10.16 Favored Glycine 0 CA--C 1.534 1.246 0 C-N-CA 126.622 2.058 . . . . 0.0 111.148 -167.509 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 2443 ' ' VAL . . . . . . . . . . . . . 8.5 p -141.56 151.99 19.33 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 C-N-CA 124.739 1.216 . . . . 0.0 110.145 176.0 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 2444 ' ' THR . . . . . . . . . . . . . 22.7 p -53.49 130.27 35.15 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.855 0.862 . . . . 0.0 111.784 178.688 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 2445 ' ' GLY . . . . . . . . . . . . . . . 86.5 -8.37 75.14 Favored Glycine 0 CA--C 1.535 1.32 0 C-N-CA 125.205 1.384 . . . . 0.0 115.363 179.127 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 2446 ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -101.69 146.33 32.04 Favored Pre-proline 0 CA--C 1.551 0.986 0 CA-C-N 119.605 1.703 . . . . 0.0 112.235 177.53 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 2447 ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -75.52 124.53 8.36 Favored 'Trans proline' 0 N--CA 1.457 -0.641 0 C-N-CA 122.727 2.285 . . . . 0.0 110.507 175.781 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 2448 ' ' ALA . . . . . . . . . . . . . . . -107.13 149.03 28.1 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.77 1.628 . . . . 0.0 109.56 168.972 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 2449 ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -153.88 158.29 40.55 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 113.886 1.069 . . . . 0.0 113.886 -174.671 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 2450 ' ' PHE . . . . . . . . . . . . . 53.0 p90 -160.34 161.11 33.1 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 126.503 1.921 . . . . 0.0 110.838 -177.321 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 2451 ' ' VAL . . . . . . . . . . . . . 58.7 t -114.51 127.56 71.94 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 C-N-CA 124.866 1.266 . . . . 0.0 109.128 174.092 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 2452 ' ' VAL . . . . . . . . . . . . . 42.7 t -79.62 106.27 10.41 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 165.417 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 2453 ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -89.82 117.35 28.59 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 123.995 0.918 . . . . 0.0 111.976 -164.379 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 2454 ' ' THR . . . . . . . . . . . . . 52.5 p -102.19 -1.56 31.08 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 125.857 1.663 . . . . 0.0 113.672 -177.159 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 2455 ' ' SER . . . . . . . . . . . . . 16.9 t -60.94 -33.52 73.29 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-N 119.296 0.953 . . . . 0.0 113.356 -172.667 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 2456 ' ' ASN . . . . . . . . . . . . . 72.6 m-80 -81.96 -13.81 56.94 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 124.196 0.999 . . . . 0.0 113.674 175.684 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 2457 ' ' ALA . . . . . . . . . . . . . . . -102.75 -45.01 5.13 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.97 1.308 . . . . 0.0 113.547 -173.059 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 2458 ' ' GLY . . . . . . . . . . . . . . . 119.96 -113.42 2.45 Favored Glycine 0 CA--C 1.529 0.961 0 C-N-CA 124.93 1.252 . . . . 0.0 111.382 -170.984 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 2459 ' ' ALA . . . . . . . . . . . . . . . -147.97 155.45 41.56 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.432 1.093 . . . . 0.0 112.798 -176.876 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 2460 ' ' GLY . . . . . . . . . . . . . . . 164.52 173.29 33.01 Favored Glycine 0 CA--C 1.528 0.87 0 C-N-CA 124.269 0.938 . . . . 0.0 113.774 -176.859 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 2461 ' ' ALA . . . . . . . . . . . . . . . -73.29 146.2 45.51 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.193 0.997 . . . . 0.0 112.212 178.859 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 2462 ' ' LEU . . . . . . . . . . . . . 6.0 tt -128.36 147.66 50.64 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 125.742 1.617 . . . . 0.0 110.898 178.672 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 2463 ' ' SER . . . . . . . . . . . . . 14.0 t -132.04 161.21 33.75 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.676 1.191 . . . . 0.0 110.349 161.5 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 2464 ' ' VAL . . . . . . . . . . . . . 7.4 p -161.72 136.96 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.725 0 C-N-CA 124.644 1.178 . . . . 0.0 110.773 -175.056 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 2465 ' ' THR . . . . . . . . . . . . . 63.3 m -141.58 138.49 32.68 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 125.397 1.479 . . . . 0.0 109.711 -175.821 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 2466 ' ' ILE . . . . . . . . . . . . . 37.7 mt -117.41 119.41 61.72 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 124.399 1.08 . . . . 0.0 109.527 175.669 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 2467 ' ' ASP . . . . . . . . . . . . . 34.9 t70 -104.06 161.74 13.75 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 126.164 1.785 . . . . 0.0 110.019 167.527 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 2468 ' ' GLY . . . . . . . . . . . . . . . 172.18 -166.05 38.81 Favored Glycine 0 CA--C 1.536 1.386 0 O-C-N 120.875 -1.141 . . . . 0.0 115.878 179.313 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 2469 ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -70.11 -14.64 35.2 Favored 'Trans proline' 0 CA--C 1.541 0.836 0 C-N-CA 124.544 3.496 . . . . 0.0 113.93 -178.43 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 2470 ' ' SER . . . . . . . . . . . . . 16.8 m -155.79 -177.71 6.76 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 127.306 2.243 . . . . 0.0 109.434 172.746 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 2471 ' ' LYS . . . . . . . . . . . . . 24.8 pttm -66.31 175.42 2.19 Favored 'General case' 0 CA--C 1.549 0.917 0 O-C-N 121.069 -1.019 . . . . 0.0 112.839 169.712 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 2472 ' ' VAL . . . . . . . . . . . . . 27.0 m -132.76 148.39 31.6 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 125.331 1.452 . . . . 0.0 110.138 170.429 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 2473 ' ' LYS . . . . . . . . . . . . . 63.8 tttm -76.13 131.2 39.26 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 107.78 -1.192 . . . . 0.0 107.78 152.417 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 2474 ' ' MET . . . . . . . . . . . . . 27.1 ttt -139.23 139.81 37.56 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.024 0.93 . . . . 0.0 111.489 -172.973 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 2475 ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -141.7 157.44 45.06 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 126.907 2.083 . . . . 0.0 110.172 -178.103 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 2476 ' ' CYS . . . . . . . . . . . . . 49.7 t -152.43 150.03 29.22 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.191 0.996 . . . . 0.0 111.842 -175.433 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 2477 ' ' GLN . . . . . . . . . . . . . 51.7 tt0 -154.37 133.91 12.77 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 125.457 1.503 . . . . 0.0 110.077 -174.655 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 2478 ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -85.12 142.87 29.2 Favored 'General case' 0 CA--C 1.542 0.66 0 O-C-N 121.641 -0.662 . . . . 0.0 111.414 171.425 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 2479 ' ' CYS . . . . . . . . . . . . . 15.4 p -151.98 173.6 4.33 Favored Pre-proline 0 CA--C 1.553 1.096 0 C-N-CA 125.695 1.598 . . . . 0.0 111.47 -177.518 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 2480 ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -58.36 -27.44 81.39 Favored 'Trans proline' 0 C--N 1.353 0.794 0 C-N-CA 123.563 2.842 . . . . 0.0 114.853 179.288 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 2481 ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -80.37 -19.58 46.04 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 124.374 1.07 . . . . 0.0 112.755 178.234 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 2482 ' ' GLY . . . . . . . . . . . . . . . 134.94 -150.66 20.21 Favored Glycine 0 CA--C 1.529 0.955 0 C-N-CA 126.033 1.778 . . . . 0.0 112.864 -176.55 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 2483 ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -90.85 109.4 20.61 Favored 'General case' 0 CA--C 1.539 0.535 0 O-C-N 121.7 -0.883 . . . . 0.0 110.759 177.308 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 2484 ' ' ARG . . . . . . . . . . . . . 38.9 ttp85 -79.47 134.48 36.53 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 124.445 1.098 . . . . 0.0 110.09 172.355 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 2485 ' ' VAL . . . . . . . . . . . . . 93.4 t -125.51 135.84 62.7 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 126.05 1.74 . . . . 0.0 108.672 178.206 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 2486 ' ' THR . . . . . . . . . . . . . 86.2 m -129.6 140.69 51.12 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 125.653 1.581 . . . . 0.0 108.788 178.171 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 2487 ' ' TYR . . . . . . . . . . . . . 19.6 p90 -150.8 153.26 35.11 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 113.526 0.935 . . . . 0.0 113.526 175.901 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 2488 ' ' THR . . . . . . . . . . . . . 98.4 m -118.62 115.51 35.4 Favored Pre-proline 0 N--CA 1.474 0.749 0 C-N-CA 124.907 1.283 . . . . 0.0 109.181 175.315 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 2489 ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -82.44 165.15 16.47 Favored 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 124.464 3.443 . . . . 0.0 111.6 175.888 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 2490 ' ' MET . . . . . . . . . . . . . 24.5 ptm -143.57 5.16 1.39 Allowed 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 115.435 1.643 . . . . 0.0 115.435 -174.367 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 2491 ' ' ALA . . . . . . . . . . . . . . . -143.46 145.98 33.95 Favored Pre-proline 0 CA--C 1.546 0.825 0 C-N-CA 124.675 1.19 . . . . 0.0 110.896 170.184 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 2492 ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -71.65 149.2 54.63 Favored 'Trans proline' 0 CA--C 1.536 0.601 0 C-N-CA 123.063 2.508 . . . . 0.0 111.158 178.189 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 2493 ' ' GLY . . . . . . . . . . . . . . . 131.81 -159.89 23.37 Favored Glycine 0 CA--C 1.53 1.004 0 C-N-CA 125.36 1.457 . . . . 0.0 113.493 -177.354 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 2494 ' ' SER . . . . . . . . . . . . . 23.6 m -98.03 118.65 35.09 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 125.117 1.367 . . . . 0.0 111.523 -177.953 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 2495 ' ' TYR . . . . . . . . . . . . . 62.3 m-85 -92.64 120.23 32.85 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 123.614 0.766 . . . . 0.0 110.068 167.041 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 2496 ' ' LEU . . . . . . . . . . . . . 22.8 tp -92.94 111.33 22.91 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.626 1.17 . . . . 0.0 109.73 -177.989 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 2497 ' ' ILE . . . . . . . . . . . . . 32.2 mt -101.85 103.62 15.2 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 C-N-CA 125.922 1.689 . . . . 0.0 108.602 -175.552 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 2498 ' ' SER . . . . . . . . . . . . . 68.4 m -92.0 125.63 36.77 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.274 1.029 . . . . 0.0 109.958 175.503 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 2499 ' ' ILE . . . . . . . . . . . . . 42.2 mt -128.26 123.99 61.31 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.725 0 C-N-CA 124.889 1.276 . . . . 0.0 108.645 -175.389 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 2500 ' ' LYS . . . . . . . . . . . . . 84.5 mttt -127.87 143.49 51.11 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.734 1.214 . . . . 0.0 111.774 -172.973 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 2501 ' ' TYR . . . . . . . . . . . . . 60.2 t80 -150.02 139.7 21.68 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 123.663 0.785 . . . . 0.0 112.681 -171.196 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 2502 ' ' GLY . . . . . . . . . . . . . . . 68.21 13.73 65.22 Favored Glycine 0 CA--C 1.537 1.419 0 C-N-CA 124.196 0.903 . . . . 0.0 114.162 179.279 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 2503 ' ' GLY . . . . . . . . . . . . . . . 146.46 -172.53 27.0 Favored Glycine 0 CA--C 1.539 1.583 0 C-N-CA 126.087 1.803 . . . . 0.0 112.822 -169.465 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 2504 ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -81.87 22.4 0.85 Allowed 'Trans proline' 0 CA--C 1.545 1.058 0 C-N-CA 124.99 3.794 . . . . 0.0 113.795 -174.52 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 2505 ' ' TYR . . . . . . . . . . . . . 72.8 m-85 -111.59 139.85 46.69 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.935 1.294 . . . . 0.0 112.803 -173.516 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 2506 ' ' HIS . . . . . . . . . . . . . 93.3 m-70 -62.19 144.15 55.84 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 124.447 1.099 . . . . 0.0 113.298 -179.787 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 2507 ' ' ILE . . . . . . . . . . . . . 26.7 pt -73.59 167.99 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 C-N-CA 123.149 0.58 . . . . 0.0 112.45 171.777 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 2508 ' ' GLY . . . . . . . . . . . . . . . -57.5 120.68 22.42 Favored Glycine 0 CA--C 1.534 1.223 0 C-N-CA 123.651 0.643 . . . . 0.0 111.982 176.994 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 2509 ' ' GLY . . . . . . . . . . . . . . . 88.58 -8.35 79.36 Favored Glycine 0 CA--C 1.535 1.331 0 C-N-CA 125.599 1.571 . . . . 0.0 115.145 -177.733 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 2510 ' ' SER . . . . . . . . . . . . . 8.4 t -89.33 146.3 35.78 Favored Pre-proline 0 CA--C 1.549 0.939 0 CA-C-N 119.231 1.516 . . . . 0.0 111.897 -179.595 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 2511 ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -75.74 149.78 93.15 Favored 'Cis proline' 0 C--N 1.353 0.786 0 CA-C-N 120.153 1.09 . . . . 0.0 113.424 1.168 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 2512 ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -100.8 131.84 46.49 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 125.386 1.475 . . . . 0.0 110.465 178.266 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 2513 ' ' LYS . . . . . . . . . . . . . 64.5 pttt -87.49 8.75 23.47 Favored 'General case' 0 N--CA 1.479 1.007 0 N-CA-C 116.292 1.96 . . . . 0.0 116.292 -169.084 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 2514 ' ' ALA . . . . . . . . . . . . . . . -7.09 99.45 0.01 OUTLIER 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 129.66 3.184 . . . . 0.0 116.047 -176.783 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 2515 ' ' LYS . . . . . . . . . . . . . 48.6 mtpt -94.86 135.18 36.68 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 124.031 0.932 . . . . 0.0 112.194 -171.27 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 2516 ' ' VAL . . . . . . . . . . . . . 6.0 m -131.82 153.8 39.23 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 C-N-CA 124.224 1.01 . . . . 0.0 111.82 -177.244 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 2517 ' ' THR . . . . . . . . . . . . . 64.0 p -120.64 -171.27 2.15 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.915 1.686 . . . . 0.0 110.106 177.026 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 2518 ' ' GLY . . . . . . . . . . . . . . . 99.1 177.58 31.82 Favored Glycine 0 CA--C 1.539 1.571 0 C-N-CA 124.972 1.272 . . . . 0.0 113.921 178.538 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 2519 ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -70.38 137.4 33.58 Favored 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 123.862 3.042 . . . . 0.0 112.195 -172.152 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 2520 ' ' ARG . . . . . . . . . . . . . 37.8 ttp180 . . . . . 0 CA--C 1.54 0.567 0 C-N-CA 124.127 0.971 . . . . 0.0 110.922 177.085 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A 2427 ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.206 0 CA-C-O 121.488 0.493 . . . . 0.0 113.987 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A 2428 ' ' ASP . . . . . . . . . . . . . 22.8 m-20 -106.0 134.56 19.69 Favored Pre-proline 0 CA--C 1.549 0.929 0 C-N-CA 124.778 1.231 . . . . 0.0 112.834 -176.16 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 2429 ' ' PRO . . . . . . . . . . . . . 77.0 Cg_exo -56.43 -28.9 75.37 Favored 'Trans proline' 0 C--N 1.353 0.794 0 C-N-CA 124.036 3.158 . . . . 0.0 114.45 174.041 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 2430 ' ' GLY . . . . . . . . . . . . . . . -77.15 -22.77 70.26 Favored Glycine 0 CA--C 1.533 1.183 0 C-N-CA 123.751 0.691 . . . . 0.0 113.747 177.074 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 2431 ' ' LEU . . . . . . . . . . . . . 4.2 mm? -86.53 -32.28 20.81 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.453 1.101 . . . . 0.0 111.405 172.642 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 2432 ' ' VAL . . . . . . . . . . . . . 74.6 t -65.07 137.68 24.55 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 CA-C-N 118.58 0.627 . . . . 0.0 110.453 169.243 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 2433 ' ' SER . . . . . . . . . . . . . 8.4 t -130.84 -169.81 2.23 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 125.054 1.342 . . . . 0.0 110.583 174.44 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 2434 ' ' ALA . . . . . . . . . . . . . . . -149.91 141.99 23.98 Favored 'General case' 0 CA--C 1.539 0.548 0 O-C-N 120.903 -1.123 . . . . 0.0 111.473 177.222 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 2435 ' ' TYR . . . . . . . . . . . . . 75.2 m-85 -145.85 151.49 37.98 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 125.511 1.524 . . . . 0.0 111.881 -176.212 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 2436 ' ' GLY . . . . . . . . . . . . . . . 117.23 162.14 12.47 Favored Glycine 0 N--CA 1.474 1.191 0 C-N-CA 125.384 1.469 . . . . 0.0 113.903 177.508 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 2437 ' ' ALA . . . . . . . . . . . . . . . -61.18 -28.7 69.32 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.045 1.338 . . . . 0.0 114.45 -169.687 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 2438 ' ' GLY . . . . . . . . . . . . . . . -65.63 -13.95 59.59 Favored Glycine 0 CA--C 1.533 1.17 0 C-N-CA 124.234 0.921 . . . . 0.0 114.688 -178.779 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 2439 ' ' LEU . . . . . . . . . . . . . 91.8 mt -75.9 -27.68 57.79 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 118.647 1.224 . . . . 0.0 112.526 169.353 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 2440 ' ' GLU . . . . . . . . . . . . . 43.4 mm-40 -88.02 -31.2 19.44 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.862 1.265 . . . . 0.0 111.519 174.442 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 2441 ' ' GLY . . . . . . . . . . . . . . . 113.83 -146.8 18.63 Favored Glycine 0 CA--C 1.53 1.012 0 C-N-CA 126.086 1.803 . . . . 0.0 113.381 177.013 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 2442 ' ' GLY . . . . . . . . . . . . . . . 170.87 -163.31 36.38 Favored Glycine 0 CA--C 1.53 1.001 0 C-N-CA 124.234 0.921 . . . . 0.0 114.001 -174.979 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 2443 ' ' VAL . . . . . . . . . . . . . 40.3 t -91.74 146.33 6.41 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 C-N-CA 124.51 1.124 . . . . 0.0 110.245 179.896 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 2444 ' ' THR . . . . . . . . . . . . . 20.2 p -54.61 142.89 26.42 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 124.898 1.279 . . . . 0.0 112.236 172.221 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 2445 ' ' GLY . . . . . . . . . . . . . . . 72.4 1.0 50.0 Favored Glycine 0 CA--C 1.536 1.361 0 C-N-CA 124.274 0.94 . . . . 0.0 114.685 179.318 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 2446 ' ' ASN . . . . . . . . . . . . . 16.3 m-80 -118.58 149.76 46.85 Favored Pre-proline 0 CA--C 1.549 0.93 0 C-N-CA 126.123 1.769 . . . . 0.0 110.623 179.814 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 2447 ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -74.48 133.1 16.97 Favored 'Trans proline' 0 C--N 1.35 0.648 0 C-N-CA 122.908 2.405 . . . . 0.0 111.99 -174.886 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 2448 ' ' ALA . . . . . . . . . . . . . . . -105.77 119.92 40.37 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 126.41 1.884 . . . . 0.0 108.645 168.372 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 2449 ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -124.6 135.02 52.77 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.568 1.147 . . . . 0.0 111.821 -169.44 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 2450 ' ' PHE . . . . . . . . . . . . . 15.2 p90 -152.99 170.21 20.98 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.6 1.56 . . . . 0.0 111.183 175.189 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 2451 ' ' VAL . . . . . . . . . . . . . 46.6 t -125.9 132.95 70.11 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 C-N-CA 124.911 1.285 . . . . 0.0 110.106 178.641 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 2452 ' ' VAL . . . . . . . . . . . . . 51.8 t -82.88 107.56 14.78 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 165.035 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 2453 ' ' ASN . . . . . . . . . . . . . 21.1 t-20 -83.3 113.07 20.45 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 123.551 0.74 . . . . 0.0 112.153 -171.741 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 2454 ' ' THR . . . . . . . . . . . . . 30.4 p -99.59 -6.55 27.16 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 126.001 1.72 . . . . 0.0 113.79 179.138 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 2455 ' ' SER . . . . . . . . . . . . . 16.4 m -55.78 -31.41 62.59 Favored 'General case' 0 N--CA 1.478 0.949 0 N-CA-C 114.538 1.31 . . . . 0.0 114.538 -174.26 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 2456 ' ' ASN . . . . . . . . . . . . . 66.3 m-80 -84.46 -15.83 44.7 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 124.49 1.116 . . . . 0.0 113.464 177.558 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 2457 ' ' ALA . . . . . . . . . . . . . . . -106.24 -25.73 11.85 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 125.72 1.608 . . . . 0.0 113.854 -176.386 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 2458 ' ' GLY . . . . . . . . . . . . . . . 104.24 -103.71 2.32 Favored Glycine 0 CA--C 1.529 0.966 0 C-N-CA 125.398 1.475 . . . . 0.0 111.067 -174.243 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 2459 ' ' ALA . . . . . . . . . . . . . . . -151.73 163.29 39.46 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 125.355 1.462 . . . . 0.0 111.768 -179.139 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 2460 ' ' GLY . . . . . . . . . . . . . . . 163.58 171.83 30.31 Favored Glycine 0 CA--C 1.53 1.007 0 C-N-CA 124.774 1.178 . . . . 0.0 113.293 -176.469 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 2461 ' ' ALA . . . . . . . . . . . . . . . -73.08 143.92 47.24 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.104 0.961 . . . . 0.0 112.216 179.473 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 2462 ' ' LEU . . . . . . . . . . . . . 15.7 tp -129.03 139.25 52.14 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.404 1.481 . . . . 0.0 110.662 -178.528 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 2463 ' ' SER . . . . . . . . . . . . . 66.5 m -139.6 52.65 1.72 Allowed 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 125.437 1.495 . . . . 0.0 111.616 -169.906 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 2464 ' ' VAL . . . . . . . . . . . . . 17.1 t -65.84 137.04 25.67 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.069 0 C-N-CA 124.044 0.938 . . . . 0.0 111.101 -178.86 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 2465 ' ' THR . . . . . . . . . . . . . 22.7 m -123.24 141.32 52.1 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 124.933 1.293 . . . . 0.0 109.236 170.528 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 2466 ' ' ILE . . . . . . . . . . . . . 52.1 mt -116.13 114.7 46.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 C-N-CA 123.679 0.792 . . . . 0.0 108.981 171.003 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 2467 ' ' ASP . . . . . . . . . . . . . 37.1 t70 -95.29 158.69 15.35 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 125.519 1.527 . . . . 0.0 110.297 168.802 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 2468 ' ' GLY . . . . . . . . . . . . . . . 174.61 -171.3 44.45 Favored Glycine 0 CA--C 1.536 1.36 0 O-C-N 121.271 -0.893 . . . . 0.0 114.789 179.71 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 2469 ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -68.15 -25.95 36.87 Favored 'Trans proline' 0 CA--C 1.538 0.716 0 C-N-CA 123.941 3.094 . . . . 0.0 112.802 178.56 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 2470 ' ' SER . . . . . . . . . . . . . 58.5 m -142.86 174.59 10.52 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 126.058 1.743 . . . . 0.0 110.685 174.177 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 2471 ' ' LYS . . . . . . . . . . . . . 57.1 mtmt -66.71 166.59 12.74 Favored 'General case' 0 CA--C 1.548 0.887 0 O-C-N 121.13 -0.981 . . . . 0.0 112.314 170.025 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 2472 ' ' VAL . . . . . . . . . . . . . 24.7 m -131.39 147.21 32.79 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 125.231 1.412 . . . . 0.0 111.464 -178.687 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 2473 ' ' LYS . . . . . . . . . . . . . 56.8 tttp -83.2 67.64 9.28 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 124.229 1.012 . . . . 0.0 110.931 174.715 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 2474 ' ' MET . . . . . . . . . . . . . 23.3 ttt -75.45 136.33 40.69 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 125.217 1.407 . . . . 0.0 111.979 -174.599 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 2475 ' ' ASP . . . . . . . . . . . . . 36.7 t70 -141.8 129.3 21.35 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 126.429 1.892 . . . . 0.0 110.33 176.948 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 2476 ' ' CYS . . . . . . . . . . . . . 74.5 m -113.91 148.62 36.47 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.931 1.293 . . . . 0.0 111.55 -176.89 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 2477 ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -150.3 148.1 28.44 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.269 1.027 . . . . 0.0 111.013 179.485 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 2478 ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -88.94 117.84 28.24 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 123.972 0.909 . . . . 0.0 109.845 173.508 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 2479 ' ' CYS . . . . . . . . . . . . . 87.6 m -122.31 166.36 17.51 Favored Pre-proline 0 CA--C 1.552 1.037 0 C-N-CA 125.601 1.56 . . . . 0.0 111.284 179.82 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 2480 ' ' PRO . . . . . . . . . . . . . 58.0 Cg_exo -57.88 -30.3 89.14 Favored 'Trans proline' 0 C--N 1.353 0.8 0 C-N-CA 123.534 2.823 . . . . 0.0 114.216 175.394 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 2481 ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -78.44 -7.61 57.58 Favored 'General case' 0 CA--C 1.552 1.02 0 C-N-CA 125.357 1.463 . . . . 0.0 112.991 177.644 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 2482 ' ' GLY . . . . . . . . . . . . . . . 118.66 -163.23 13.16 Favored Glycine 0 CA--C 1.53 1.012 0 C-N-CA 126.313 1.911 . . . . 0.0 112.533 -173.106 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 2483 ' ' TYR . . . . . . . . . . . . . 83.4 m-85 -72.67 107.67 5.26 Favored 'General case' 0 CA--C 1.54 0.571 0 O-C-N 121.564 -0.962 . . . . 0.0 111.31 177.213 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 2484 ' ' ARG . . . . . . . . . . . . . 51.5 ttp85 -79.19 136.89 37.22 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 124.753 1.221 . . . . 0.0 110.231 174.269 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 2485 ' ' VAL . . . . . . . . . . . . . 92.5 t -128.15 125.56 64.6 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 C-N-CA 125.931 1.692 . . . . 0.0 108.48 179.001 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 2486 ' ' THR . . . . . . . . . . . . . 57.9 m -123.99 139.59 53.8 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 124.619 1.168 . . . . 0.0 108.488 172.968 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 2487 ' ' TYR . . . . . . . . . . . . . 27.3 p90 -147.06 150.51 35.21 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 112.754 0.65 . . . . 0.0 112.754 176.58 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 2488 ' ' THR . . . . . . . . . . . . . 24.7 m -109.79 115.11 55.9 Favored Pre-proline 0 N--CA 1.474 0.736 0 CA-C-O 117.764 -1.112 . . . . 0.0 109.047 174.455 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 2489 ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -81.42 149.06 16.65 Favored 'Trans proline' 0 N--CA 1.459 -0.553 0 C-N-CA 123.515 2.81 . . . . 0.0 110.731 171.237 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 2490 ' ' MET . . . . . . . . . . . . . 27.6 ptm -118.6 6.4 11.66 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 114.411 1.263 . . . . 0.0 114.411 -174.255 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 2491 ' ' ALA . . . . . . . . . . . . . . . -152.57 147.69 19.73 Favored Pre-proline 0 CA--C 1.544 0.74 0 C-N-CA 125.548 1.539 . . . . 0.0 111.41 -179.785 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 2492 ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -72.86 156.91 52.35 Favored 'Trans proline' 0 CA--C 1.536 0.606 0 C-N-CA 123.379 2.72 . . . . 0.0 111.208 174.557 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 2493 ' ' GLY . . . . . . . . . . . . . . . 134.94 -148.93 19.75 Favored Glycine 0 CA--C 1.527 0.843 0 C-N-CA 125.428 1.489 . . . . 0.0 112.061 -174.748 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 2494 ' ' SER . . . . . . . . . . . . . 36.8 m -128.6 133.85 48.43 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.694 0.798 . . . . 0.0 111.423 176.57 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 2495 ' ' TYR . . . . . . . . . . . . . 52.3 m-85 -107.18 127.13 53.23 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 126.152 1.781 . . . . 0.0 109.709 179.276 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 2496 ' ' LEU . . . . . . . . . . . . . 26.3 tp -98.75 112.69 24.69 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.411 1.085 . . . . 0.0 109.495 -176.528 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 2497 ' ' ILE . . . . . . . . . . . . . 36.9 mt -96.43 103.29 14.51 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 C-N-CA 125.331 1.452 . . . . 0.0 108.383 -176.191 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 2498 ' ' SER . . . . . . . . . . . . . 74.4 m -96.7 91.16 5.57 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 125.617 1.567 . . . . 0.0 110.247 -177.805 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 2499 ' ' ILE . . . . . . . . . . . . . 59.6 mt -87.62 104.69 14.59 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 C-N-CA 126.363 1.865 . . . . 0.0 109.591 -172.949 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 2500 ' ' LYS . . . . . . . . . . . . . 30.6 mttp -110.52 138.06 47.41 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.207 1.003 . . . . 0.0 111.589 -176.715 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 2501 ' ' TYR . . . . . . . . . . . . . 76.7 t80 -139.24 148.08 42.59 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.671 1.189 . . . . 0.0 112.452 -174.355 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 2502 ' ' GLY . . . . . . . . . . . . . . . 65.04 20.88 67.36 Favored Glycine 0 CA--C 1.536 1.358 0 C-N-CA 124.143 0.878 . . . . 0.0 113.465 -179.818 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 2503 ' ' GLY . . . . . . . . . . . . . . . 126.57 -171.31 18.28 Favored Glycine 0 CA--C 1.541 1.66 0 C-N-CA 125.967 1.746 . . . . 0.0 112.238 -163.524 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 2504 ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -84.02 43.55 1.4 Allowed 'Trans proline' 0 CA--C 1.546 1.083 0 C-N-CA 124.898 3.732 . . . . 0.0 112.618 -172.881 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 2505 ' ' TYR . . . . . . . . . . . . . 78.9 m-85 -127.15 132.01 50.63 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 124.457 1.103 . . . . 0.0 112.81 -175.073 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 2506 ' ' HIS . . . . . . . . . . . . . 79.0 m-70 -60.14 141.71 55.45 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 125.629 1.572 . . . . 0.0 114.46 -173.587 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 2507 ' ' ILE . . . . . . . . . . . . . 1.8 pp -79.26 170.59 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.2 0 C-N-CA 124.028 0.931 . . . . 0.0 112.628 171.725 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 2508 ' ' GLY . . . . . . . . . . . . . . . -60.15 112.1 4.17 Favored Glycine 0 CA--C 1.533 1.216 0 C-N-CA 123.753 0.692 . . . . 0.0 112.628 -176.846 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 2509 ' ' GLY . . . . . . . . . . . . . . . 95.72 -7.36 67.96 Favored Glycine 0 CA--C 1.536 1.347 0 C-N-CA 125.699 1.618 . . . . 0.0 114.866 -177.476 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 2510 ' ' SER . . . . . . . . . . . . . 45.4 t -79.62 146.97 66.37 Favored Pre-proline 0 CA--C 1.55 0.952 0 CA-C-N 119.16 1.48 . . . . 0.0 111.82 176.974 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 2511 ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -80.15 157.35 87.41 Favored 'Cis proline' 0 C--N 1.353 0.803 0 CA-C-N 119.834 0.977 . . . . 0.0 113.409 0.668 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 2512 ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -109.96 125.66 53.1 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.18 1.392 . . . . 0.0 111.199 179.75 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 2513 ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.73 101.59 13.83 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 124.449 1.1 . . . . 0.0 112.283 175.167 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 2514 ' ' ALA . . . . . . . . . . . . . . . -88.35 122.87 32.35 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 125.211 1.404 . . . . 0.0 110.28 174.984 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 2515 ' ' LYS . . . . . . . . . . . . . 27.7 mtpp -97.08 134.95 39.76 Favored 'General case' 0 CA--C 1.542 0.653 0 O-C-N 121.231 -0.918 . . . . 0.0 111.285 -174.857 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 2516 ' ' VAL . . . . . . . . . . . . . 74.0 t -130.39 138.95 52.57 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.775 0 C-N-CA 124.911 1.285 . . . . 0.0 110.849 -169.07 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 2517 ' ' THR . . . . . . . . . . . . . 54.2 p -134.6 171.07 14.84 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 125.869 1.667 . . . . 0.0 110.892 179.605 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 2518 ' ' GLY . . . . . . . . . . . . . . . 106.37 178.65 23.26 Favored Glycine 0 CA--C 1.539 1.568 0 C-N-CA 124.828 1.204 . . . . 0.0 113.432 -176.686 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 2519 ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -70.98 136.11 29.04 Favored 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 123.715 2.943 . . . . 0.0 112.129 -171.053 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 2520 ' ' ARG . . . . . . . . . . . . . 50.9 ttp180 . . . . . 0 CA--C 1.539 0.546 0 C-N-CA 124.047 0.939 . . . . 0.0 110.778 176.053 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A 2427 ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.152 0 CA-C-O 121.196 0.331 . . . . 0.0 112.68 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A 2428 ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -144.76 128.22 8.64 Favored Pre-proline 0 CA--C 1.546 0.802 0 C-N-CA 125.65 1.58 . . . . 0.0 109.626 178.001 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 2429 ' ' PRO . . . . . . . . . . . . . 57.3 Cg_exo -56.46 -35.0 96.13 Favored 'Trans proline' 0 C--N 1.353 0.789 0 C-N-CA 123.183 2.588 . . . . 0.0 114.493 -175.378 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 2430 ' ' GLY . . . . . . . . . . . . . . . -73.04 -18.84 79.36 Favored Glycine 0 CA--C 1.534 1.257 0 CA-C-N 118.552 0.615 . . . . 0.0 114.186 179.866 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 2431 ' ' LEU . . . . . . . . . . . . . 4.1 mm? -87.02 -20.29 27.44 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.732 1.213 . . . . 0.0 111.904 173.075 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 2432 ' ' VAL . . . . . . . . . . . . . 60.8 t -80.97 138.31 19.87 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 C-N-CA 124.571 1.148 . . . . 0.0 109.178 172.143 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 2433 ' ' SER . . . . . . . . . . . . . 8.6 t -128.11 -169.86 2.14 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 125.083 1.353 . . . . 0.0 111.001 176.337 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 2434 ' ' ALA . . . . . . . . . . . . . . . -155.45 142.77 19.41 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.692 1.197 . . . . 0.0 111.656 177.303 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 2435 ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -145.24 145.12 31.16 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 125.245 1.418 . . . . 0.0 112.071 -176.433 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 2436 ' ' GLY . . . . . . . . . . . . . . . 129.08 158.48 9.6 Favored Glycine 0 N--CA 1.472 1.077 0 C-N-CA 125.622 1.582 . . . . 0.0 113.395 178.996 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 2437 ' ' ALA . . . . . . . . . . . . . . . -62.11 -27.79 69.18 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 114.206 1.187 . . . . 0.0 114.206 -170.933 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 2438 ' ' GLY . . . . . . . . . . . . . . . -65.57 -16.66 63.52 Favored Glycine 0 CA--C 1.531 1.035 0 CA-C-O 118.888 -0.951 . . . . 0.0 114.31 -178.867 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 2439 ' ' LEU . . . . . . . . . . . . . 87.7 mt -73.53 -28.69 62.02 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 118.673 1.237 . . . . 0.0 112.513 171.259 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 2440 ' ' GLU . . . . . . . . . . . . . 41.5 mm-40 -92.25 -33.47 14.64 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.942 1.297 . . . . 0.0 112.167 -177.037 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 2441 ' ' GLY . . . . . . . . . . . . . . . 161.15 -156.38 27.77 Favored Glycine 0 CA--C 1.528 0.894 0 N-CA-C 114.875 0.71 . . . . 0.0 114.875 -176.825 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 2442 ' ' GLY . . . . . . . . . . . . . . . 171.26 -167.14 40.26 Favored Glycine 0 CA--C 1.53 0.992 0 C-N-CA 125.648 1.594 . . . . 0.0 112.298 -178.657 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 2443 ' ' VAL . . . . . . . . . . . . . 98.2 t -125.27 144.83 33.93 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 C-N-CA 124.692 1.197 . . . . 0.0 109.36 175.638 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 2444 ' ' THR . . . . . . . . . . . . . 21.4 p -54.7 127.5 28.48 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 124.95 1.3 . . . . 0.0 111.812 176.42 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 2445 ' ' GLY . . . . . . . . . . . . . . . 79.26 -5.36 59.91 Favored Glycine 0 CA--C 1.536 1.383 0 C-N-CA 124.622 1.106 . . . . 0.0 114.846 -178.399 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 2446 ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -97.66 139.82 21.59 Favored Pre-proline 0 CA--C 1.551 1.019 0 C-N-CA 125.617 1.567 . . . . 0.0 110.953 176.519 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 2447 ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -75.56 122.15 6.78 Favored 'Trans proline' 0 N--CA 1.457 -0.64 0 C-N-CA 122.839 2.36 . . . . 0.0 110.632 176.163 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 2448 ' ' ALA . . . . . . . . . . . . . . . -105.16 156.57 17.97 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.97 1.708 . . . . 0.0 109.883 168.262 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 2449 ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -156.96 159.11 37.75 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 114.035 1.124 . . . . 0.0 114.035 -175.181 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 2450 ' ' PHE . . . . . . . . . . . . . 54.9 p90 -159.49 148.2 17.85 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 126.173 1.789 . . . . 0.0 110.571 178.314 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 2451 ' ' VAL . . . . . . . . . . . . . 11.2 t -102.35 124.22 56.15 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 C-N-CA 124.439 1.095 . . . . 0.0 108.886 174.594 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 2452 ' ' VAL . . . . . . . . . . . . . 43.5 t -75.13 108.81 7.28 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 N-CA-C 106.838 -1.542 . . . . 0.0 106.838 167.303 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 2453 ' ' ASN . . . . . . . . . . . . . 62.7 t-20 -87.55 113.89 23.66 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.136 0.974 . . . . 0.0 110.802 -171.055 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 2454 ' ' THR . . . . . . . . . . . . . 73.1 p -104.92 2.09 29.49 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 126.079 1.752 . . . . 0.0 112.958 -175.978 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 2455 ' ' SER . . . . . . . . . . . . . 46.9 m -58.42 -30.36 66.82 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 114.518 1.303 . . . . 0.0 114.518 -169.341 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 2456 ' ' ASN . . . . . . . . . . . . . 29.3 m120 -92.89 -11.21 34.05 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 124.663 1.185 . . . . 0.0 113.683 177.251 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 2457 ' ' ALA . . . . . . . . . . . . . . . -101.74 -32.81 10.11 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 125.309 1.444 . . . . 0.0 113.502 -178.427 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 2458 ' ' GLY . . . . . . . . . . . . . . . 85.81 -159.24 32.84 Favored Glycine 0 CA--C 1.533 1.214 0 C-N-CA 124.976 1.274 . . . . 0.0 112.846 -174.77 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 2459 ' ' ALA . . . . . . . . . . . . . . . -60.84 155.48 19.46 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 124.991 1.317 . . . . 0.0 114.016 -177.423 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 2460 ' ' GLY . . . . . . . . . . . . . . . 159.09 -174.62 36.06 Favored Glycine 0 CA--C 1.534 1.228 0 C-N-CA 125.922 1.725 . . . . 0.0 112.904 -176.556 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 2461 ' ' ALA . . . . . . . . . . . . . . . -123.61 143.24 50.35 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.904 1.282 . . . . 0.0 112.198 -177.089 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 2462 ' ' LEU . . . . . . . . . . . . . 24.8 tp -92.69 145.23 24.57 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.588 1.555 . . . . 0.0 111.254 179.093 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 2463 ' ' SER . . . . . . . . . . . . . 4.3 t -138.13 40.07 2.3 Favored 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 125.667 1.587 . . . . 0.0 111.004 -179.794 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 2464 ' ' VAL . . . . . . . . . . . . . 12.6 p -65.2 147.63 12.49 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 C-N-CA 126.008 1.723 . . . . 0.0 112.638 -175.498 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 2465 ' ' THR . . . . . . . . . . . . . 10.8 t -151.9 160.92 43.37 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 125.13 1.372 . . . . 0.0 111.412 172.388 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 2466 ' ' ILE . . . . . . . . . . . . . 55.5 mt -135.11 124.63 42.97 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 124.913 1.285 . . . . 0.0 110.16 -173.853 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 2467 ' ' ASP . . . . . . . . . . . . . 29.9 m-20 -106.36 173.35 6.35 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 126.44 1.896 . . . . 0.0 110.79 169.808 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 2468 ' ' GLY . . . . . . . . . . . . . . . 153.49 -155.02 25.89 Favored Glycine 0 CA--C 1.535 1.331 0 CA-C-O 118.916 -0.935 . . . . 0.0 113.872 179.851 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 2469 ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -70.21 -10.52 28.39 Favored 'Trans proline' 0 CA--C 1.542 0.883 0 C-N-CA 123.705 2.936 . . . . 0.0 113.756 178.294 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 2470 ' ' SER . . . . . . . . . . . . . 34.0 p -166.77 169.09 13.67 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 125.488 1.515 . . . . 0.0 111.934 -176.992 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 2471 ' ' LYS . . . . . . . . . . . . . 64.5 mttp -79.73 106.54 11.82 Favored 'General case' 0 CA--C 1.542 0.669 0 O-C-N 121.017 -1.052 . . . . 0.0 110.599 172.547 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 2472 ' ' VAL . . . . . . . . . . . . . 32.9 m -60.84 151.03 6.62 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.15 0 C-N-CA 123.821 0.848 . . . . 0.0 111.838 175.755 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 2473 ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.46 132.92 35.78 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 162.394 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 2474 ' ' MET . . . . . . . . . . . . . 16.3 tmm? -152.1 143.35 23.28 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-N 119.755 1.161 . . . . 0.0 112.975 -170.815 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 2475 ' ' ASP . . . . . . . . . . . . . 36.7 t70 -139.5 146.0 39.45 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 126.947 2.099 . . . . 0.0 110.295 174.214 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 2476 ' ' CYS . . . . . . . . . . . . . 30.0 t -124.35 144.99 49.71 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.515 1.126 . . . . 0.0 111.546 -179.361 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 2477 ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -143.36 169.57 17.42 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.128 1.371 . . . . 0.0 111.87 -179.763 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 2478 ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -77.78 147.21 35.4 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 123.807 0.843 . . . . 0.0 110.711 166.512 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 2479 ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -146.25 168.81 10.77 Favored Pre-proline 0 CA--C 1.552 1.054 0 C-N-CA 127.009 2.123 . . . . 0.0 111.072 178.377 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 2480 ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo -64.56 -29.35 61.33 Favored 'Trans proline' 0 CA--C 1.539 0.765 0 C-N-CA 122.75 2.3 . . . . 0.0 114.47 -173.315 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 2481 ' ' GLU . . . . . . . . . . . . . 5.6 mp0 -88.24 -10.19 50.51 Favored 'General case' 0 CA--C 1.547 0.847 0 N-CA-C 113.765 1.024 . . . . 0.0 113.765 174.216 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 2482 ' ' GLY . . . . . . . . . . . . . . . 151.45 -111.11 0.49 Allowed Glycine 0 N--CA 1.471 1.014 0 CA-C-N 119.794 1.179 . . . . 0.0 113.494 -176.188 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 2483 ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -123.14 123.85 41.73 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.437 1.095 . . . . 0.0 111.714 179.159 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 2484 ' ' ARG . . . . . . . . . . . . . 25.5 ttp180 -91.3 129.52 37.28 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 123.369 0.667 . . . . 0.0 111.108 175.097 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 2485 ' ' VAL . . . . . . . . . . . . . 98.7 t -99.2 132.03 45.35 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.475 0 C-N-CA 125.162 1.385 . . . . 0.0 107.99 168.101 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 2486 ' ' THR . . . . . . . . . . . . . 20.5 m -124.5 126.3 45.64 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 125.415 1.486 . . . . 0.0 107.619 176.132 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 2487 ' ' TYR . . . . . . . . . . . . . 15.8 p90 -143.19 150.13 38.96 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 113.584 0.957 . . . . 0.0 113.584 -176.842 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 2488 ' ' THR . . . . . . . . . . . . . 91.2 m -119.59 115.03 34.05 Favored Pre-proline 0 N--CA 1.468 0.471 0 C-N-CA 125.342 1.457 . . . . 0.0 108.618 176.37 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 2489 ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -79.08 153.3 24.88 Favored 'Trans proline' 0 N--CA 1.456 -0.68 0 C-N-CA 123.339 2.693 . . . . 0.0 110.774 175.084 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 2490 ' ' MET . . . . . . . . . . . . . 24.8 ptm -118.09 -4.87 10.98 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 114.584 1.327 . . . . 0.0 114.584 -174.044 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 2491 ' ' ALA . . . . . . . . . . . . . . . -145.38 152.25 49.54 Favored Pre-proline 0 CA--C 1.548 0.899 0 C-N-CA 125.296 1.439 . . . . 0.0 111.601 177.859 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 2492 ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -72.83 154.85 53.83 Favored 'Trans proline' 0 CA--C 1.537 0.635 0 C-N-CA 123.001 2.467 . . . . 0.0 111.076 173.186 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 2493 ' ' GLY . . . . . . . . . . . . . . . 130.81 -168.37 21.88 Favored Glycine 0 CA--C 1.529 0.964 0 C-N-CA 125.473 1.511 . . . . 0.0 113.508 -178.163 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 2494 ' ' SER . . . . . . . . . . . . . 70.5 m -99.62 116.53 31.96 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 123.923 0.889 . . . . 0.0 111.333 178.97 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 2495 ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -87.93 150.77 23.27 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.582 1.153 . . . . 0.0 110.53 166.893 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 2496 ' ' LEU . . . . . . . . . . . . . 32.0 tp -121.99 114.73 21.37 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.803 1.241 . . . . 0.0 109.359 179.583 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 2497 ' ' ILE . . . . . . . . . . . . . 63.4 mt -99.38 108.18 22.01 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 C-N-CA 125.318 1.447 . . . . 0.0 108.415 -172.881 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 2498 ' ' SER . . . . . . . . . . . . . 73.2 m -95.47 101.44 13.16 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 124.507 1.123 . . . . 0.0 109.732 179.358 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 2499 ' ' ILE . . . . . . . . . . . . . 42.8 mt -96.38 105.98 17.79 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 C-N-CA 124.762 1.225 . . . . 0.0 108.729 -178.023 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 2500 ' ' LYS . . . . . . . . . . . . . 85.1 mttt -113.2 142.51 45.71 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.406 1.082 . . . . 0.0 110.912 177.908 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 2501 ' ' TYR . . . . . . . . . . . . . 43.8 t80 -151.2 139.95 20.79 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.881 0.873 . . . . 0.0 112.258 -174.423 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 2502 ' ' GLY . . . . . . . . . . . . . . . 69.68 12.85 67.91 Favored Glycine 0 CA--C 1.536 1.402 0 C-N-CA 124.308 0.956 . . . . 0.0 114.267 177.862 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 2503 ' ' GLY . . . . . . . . . . . . . . . 150.81 -169.96 30.61 Favored Glycine 0 CA--C 1.539 1.54 0 C-N-CA 125.844 1.687 . . . . 0.0 113.025 -170.902 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 2504 ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -82.16 14.29 2.28 Favored 'Trans proline' 0 CA--C 1.544 1.011 0 C-N-CA 124.838 3.692 . . . . 0.0 113.918 -174.837 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 2505 ' ' TYR . . . . . . . . . . . . . 68.7 m-85 -108.44 141.64 40.0 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.77 1.228 . . . . 0.0 113.491 -171.916 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 2506 ' ' HIS . . . . . . . . . . . . . 84.3 m-70 -63.24 141.4 58.78 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 125.114 1.365 . . . . 0.0 112.988 176.246 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 2507 ' ' ILE . . . . . . . . . . . . . 1.6 pp -77.88 172.04 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 C-N-CA 123.612 0.765 . . . . 0.0 112.666 174.823 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 2508 ' ' GLY . . . . . . . . . . . . . . . -59.95 111.29 3.44 Favored Glycine 0 CA--C 1.534 1.264 0 O-C-N 121.531 -0.731 . . . . 0.0 112.582 -176.954 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 2509 ' ' GLY . . . . . . . . . . . . . . . 96.6 -7.3 65.66 Favored Glycine 0 CA--C 1.536 1.348 0 C-N-CA 125.822 1.677 . . . . 0.0 114.939 -177.19 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 2510 ' ' SER . . . . . . . . . . . . . 47.8 t -82.36 147.55 56.9 Favored Pre-proline 0 CA--C 1.551 0.981 0 CA-C-N 119.098 1.449 . . . . 0.0 112.106 178.123 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 2511 ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -78.41 154.42 92.64 Favored 'Cis proline' 0 C--N 1.353 0.808 0 CA-C-N 119.788 0.96 . . . . 0.0 113.091 -1.108 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 2512 ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -105.71 127.95 53.38 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.32 1.448 . . . . 0.0 110.998 -179.628 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 2513 ' ' LYS . . . . . . . . . . . . . 61.1 pttt -87.06 115.61 24.57 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 123.719 0.808 . . . . 0.0 111.906 175.836 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 2514 ' ' ALA . . . . . . . . . . . . . . . -105.94 114.9 29.32 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.645 1.578 . . . . 0.0 110.522 -179.051 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 2515 ' ' LYS . . . . . . . . . . . . . 54.2 mtpt -94.75 112.94 24.65 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.107 0.963 . . . . 0.0 110.755 -173.282 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 2516 ' ' VAL . . . . . . . . . . . . . 75.6 t -110.67 144.21 19.11 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 125.417 1.487 . . . . 0.0 110.542 -173.22 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 2517 ' ' THR . . . . . . . . . . . . . 66.4 p -133.45 172.53 12.6 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 125.3 1.44 . . . . 0.0 111.232 176.127 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 2518 ' ' GLY . . . . . . . . . . . . . . . 107.35 177.28 22.63 Favored Glycine 0 CA--C 1.541 1.676 0 C-N-CA 125.215 1.388 . . . . 0.0 113.954 -179.733 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 2519 ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -73.74 136.63 23.51 Favored 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 123.972 3.115 . . . . 0.0 112.172 -172.283 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 2520 ' ' ARG . . . . . . . . . . . . . 34.9 ttm180 . . . . . 0 CA--C 1.542 0.664 0 C-N-CA 123.976 0.91 . . . . 0.0 111.286 177.322 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A 2427 ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.821 0 N-CA-C 112.128 -0.389 . . . . 0.0 112.128 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A 2428 ' ' ASP . . . . . . . . . . . . . 12.9 t70 -100.67 129.9 26.62 Favored Pre-proline 0 CA--C 1.552 1.025 0 C-N-CA 124.242 1.017 . . . . 0.0 112.347 -175.572 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 2429 ' ' PRO . . . . . . . . . . . . . 53.8 Cg_exo -58.24 -27.1 79.43 Favored 'Trans proline' 0 C--N 1.354 0.829 0 C-N-CA 123.719 2.946 . . . . 0.0 114.99 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 2430 ' ' GLY . . . . . . . . . . . . . . . -80.05 -23.33 61.66 Favored Glycine 0 CA--C 1.532 1.143 0 CA-C-N 119.154 0.888 . . . . 0.0 113.322 177.674 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 2431 ' ' LEU . . . . . . . . . . . . . 4.3 mm? -82.82 -31.56 28.06 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 124.212 1.005 . . . . 0.0 111.415 170.567 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 2432 ' ' VAL . . . . . . . . . . . . . 81.3 t -69.08 136.57 26.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 123.571 0.748 . . . . 0.0 110.573 169.403 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 2433 ' ' SER . . . . . . . . . . . . . 58.6 m -139.92 144.92 37.36 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 125.174 1.39 . . . . 0.0 109.788 171.817 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 2434 ' ' ALA . . . . . . . . . . . . . . . -94.29 148.48 22.17 Favored 'General case' 0 CA--C 1.541 0.609 0 O-C-N 121.771 -0.581 . . . . 0.0 111.781 175.109 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 2435 ' ' TYR . . . . . . . . . . . . . 93.3 m-85 -142.97 147.73 35.66 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 126.136 1.775 . . . . 0.0 111.453 -178.402 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 2436 ' ' GLY . . . . . . . . . . . . . . . 120.31 161.14 11.4 Favored Glycine 0 N--CA 1.473 1.145 0 C-N-CA 125.151 1.358 . . . . 0.0 113.876 178.374 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 2437 ' ' ALA . . . . . . . . . . . . . . . -62.8 -28.88 70.3 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 114.409 1.263 . . . . 0.0 114.409 -169.682 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 2438 ' ' GLY . . . . . . . . . . . . . . . -66.99 -12.3 59.87 Favored Glycine 0 CA--C 1.532 1.108 0 CA-C-O 119.077 -0.846 . . . . 0.0 114.773 -177.425 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 2439 ' ' LEU . . . . . . . . . . . . . 79.5 mt -76.41 -27.78 56.41 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.54 1.136 . . . . 0.0 112.5 170.265 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 2440 ' ' GLU . . . . . . . . . . . . . 41.5 mm-40 -88.61 -32.51 18.05 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.893 1.277 . . . . 0.0 111.529 176.507 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 2441 ' ' GLY . . . . . . . . . . . . . . . 115.9 -130.55 9.12 Favored Glycine 0 CA--C 1.531 1.05 0 C-N-CA 125.706 1.622 . . . . 0.0 112.503 -179.754 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 2442 ' ' GLY . . . . . . . . . . . . . . . 135.11 -150.0 20.07 Favored Glycine 0 CA--C 1.535 1.311 0 C-N-CA 125.155 1.36 . . . . 0.0 113.701 -174.365 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 2443 ' ' VAL . . . . . . . . . . . . . 90.2 t -89.55 136.26 24.06 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 C-N-CA 124.804 1.242 . . . . 0.0 111.025 -174.887 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 2444 ' ' THR . . . . . . . . . . . . . 46.3 p -72.24 146.65 47.12 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 124.47 1.108 . . . . 0.0 112.049 176.818 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 2445 ' ' GLY . . . . . . . . . . . . . . . 78.28 -10.73 26.96 Favored Glycine 0 CA--C 1.538 1.5 0 C-N-CA 124.243 0.925 . . . . 0.0 114.193 -172.753 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 2446 ' ' ASN . . . . . . . . . . . . . 77.0 m-20 -102.12 152.54 38.25 Favored Pre-proline 0 CA--C 1.55 0.944 0 C-N-CA 125.469 1.507 . . . . 0.0 111.034 172.474 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 2447 ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -72.07 140.34 34.35 Favored 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 123.075 2.516 . . . . 0.0 111.55 178.25 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 2448 ' ' ALA . . . . . . . . . . . . . . . -121.3 131.14 54.03 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 127.115 2.166 . . . . 0.0 109.089 173.725 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 2449 ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -128.55 141.4 51.38 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.294 1.038 . . . . 0.0 111.806 -166.854 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 2450 ' ' PHE . . . . . . . . . . . . . 37.8 p90 -155.2 161.34 41.22 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.211 1.405 . . . . 0.0 111.998 173.164 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 2451 ' ' VAL . . . . . . . . . . . . . 8.1 p -118.44 139.05 47.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 125.616 1.566 . . . . 0.0 110.417 176.666 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 2452 ' ' VAL . . . . . . . . . . . . . 61.4 t -95.81 101.41 12.37 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 N-CA-C 107.194 -1.41 . . . . 0.0 107.194 168.555 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 2453 ' ' ASN . . . . . . . . . . . . . 22.6 t-20 -83.49 120.29 25.73 Favored 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 -169.601 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 2454 ' ' THR . . . . . . . . . . . . . 35.4 p -99.52 -5.98 28.3 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 125.878 1.671 . . . . 0.0 113.993 -177.92 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 2455 ' ' SER . . . . . . . . . . . . . 19.9 m -57.39 -32.99 67.38 Favored 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 114.556 1.317 . . . . 0.0 114.556 -172.772 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 2456 ' ' ASN . . . . . . . . . . . . . 28.0 m120 -83.4 -15.9 48.0 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 124.149 0.98 . . . . 0.0 113.601 176.228 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 2457 ' ' ALA . . . . . . . . . . . . . . . -102.49 -42.22 6.03 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.032 1.333 . . . . 0.0 113.505 -173.217 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 2458 ' ' GLY . . . . . . . . . . . . . . . 120.55 -111.4 1.94 Allowed Glycine 0 CA--C 1.53 0.995 0 C-N-CA 125.323 1.439 . . . . 0.0 111.631 -172.246 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 2459 ' ' ALA . . . . . . . . . . . . . . . -148.04 149.92 32.99 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.721 1.208 . . . . 0.0 112.835 -175.808 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 2460 ' ' GLY . . . . . . . . . . . . . . . 171.11 171.09 36.0 Favored Glycine 0 CA--C 1.529 0.906 0 C-N-CA 124.748 1.166 . . . . 0.0 113.152 -176.492 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 2461 ' ' ALA . . . . . . . . . . . . . . . -81.82 142.42 32.58 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.014 0.925 . . . . 0.0 112.454 -179.433 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 2462 ' ' LEU . . . . . . . . . . . . . 16.9 tp -102.02 145.2 29.63 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.154 1.382 . . . . 0.0 110.38 172.559 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 2463 ' ' SER . . . . . . . . . . . . . 5.4 t -138.3 45.09 2.1 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 124.972 1.309 . . . . 0.0 110.625 179.745 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 2464 ' ' VAL . . . . . . . . . . . . . 9.1 p -65.94 134.86 29.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 124.975 1.31 . . . . 0.0 111.855 -177.105 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 2465 ' ' THR . . . . . . . . . . . . . 85.5 m -130.9 144.73 51.68 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 125.992 1.717 . . . . 0.0 109.144 177.617 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 2466 ' ' ILE . . . . . . . . . . . . . 47.7 mt -123.86 120.93 61.01 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 123.617 0.767 . . . . 0.0 109.808 175.764 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 2467 ' ' ASP . . . . . . . . . . . . . 31.2 m-20 -103.06 167.57 9.74 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 125.951 1.7 . . . . 0.0 110.742 169.785 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 2468 ' ' GLY . . . . . . . . . . . . . . . 167.27 -167.06 39.65 Favored Glycine 0 CA--C 1.537 1.41 0 O-C-N 121.387 -0.821 . . . . 0.0 114.534 179.776 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 2469 ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -70.68 -15.74 33.66 Favored 'Trans proline' 0 CA--C 1.54 0.822 0 C-N-CA 124.219 3.279 . . . . 0.0 113.284 178.248 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 2470 ' ' SER . . . . . . . . . . . . . 49.9 m -153.01 179.2 8.9 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 127.081 2.152 . . . . 0.0 110.051 173.997 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 2471 ' ' LYS . . . . . . . . . . . . . 65.1 pttt -69.4 171.2 9.04 Favored 'General case' 0 CA--C 1.549 0.937 0 O-C-N 121.083 -1.011 . . . . 0.0 112.926 171.269 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 2472 ' ' VAL . . . . . . . . . . . . . 26.7 m -130.9 147.38 33.09 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 125.173 1.389 . . . . 0.0 111.032 175.206 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 2473 ' ' LYS . . . . . . . . . . . . . 51.8 mtmt -88.57 58.73 4.81 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 124.382 1.073 . . . . 0.0 111.688 177.033 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 2474 ' ' MET . . . . . . . . . . . . . 16.0 tmm? -77.53 134.84 38.2 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.31 1.044 . . . . 0.0 112.635 -174.578 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 2475 ' ' ASP . . . . . . . . . . . . . 35.5 t70 -130.56 144.63 51.54 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 126.927 2.091 . . . . 0.0 110.451 172.286 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 2476 ' ' CYS . . . . . . . . . . . . . 48.9 t -127.53 147.63 50.33 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 125.543 1.537 . . . . 0.0 112.583 -173.102 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 2477 ' ' GLN . . . . . . . . . . . . . 23.1 tt0 -151.79 136.96 17.44 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.477 1.111 . . . . 0.0 110.964 170.747 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 2478 ' ' GLU . . . . . . . . . . . . . 4.1 pm0 -75.67 132.41 40.54 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.671 1.188 . . . . 0.0 111.886 172.63 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 2479 ' ' CYS . . . . . . . . . . . . . 80.0 m -133.98 169.37 14.08 Favored Pre-proline 0 CA--C 1.554 1.105 0 C-N-CA 126.157 1.783 . . . . 0.0 110.849 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 2480 ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -57.07 -27.27 73.14 Favored 'Trans proline' 0 CA--C 1.54 0.819 0 C-N-CA 123.569 2.846 . . . . 0.0 113.912 170.073 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 2481 ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -76.46 -3.66 38.37 Favored 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 125.684 1.594 . . . . 0.0 113.093 175.057 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 2482 ' ' GLY . . . . . . . . . . . . . . . 104.39 -170.01 17.97 Favored Glycine 0 CA--C 1.529 0.96 0 C-N-CA 125.949 1.737 . . . . 0.0 112.381 -169.178 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 2483 ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -71.56 116.37 11.83 Favored 'General case' 0 N--CA 1.469 0.488 0 O-C-N 121.493 -1.004 . . . . 0.0 111.116 175.336 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 2484 ' ' ARG . . . . . . . . . . . . . 15.2 ttp-105 -98.8 143.36 29.22 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 123.793 0.837 . . . . 0.0 110.512 174.574 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 2485 ' ' VAL . . . . . . . . . . . . . 35.1 m -132.96 150.03 32.44 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 C-N-CA 124.095 0.958 . . . . 0.0 111.563 174.873 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 2486 ' ' THR . . . . . . . . . . . . . 73.0 m -133.75 135.66 44.08 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 125.332 1.453 . . . . 0.0 108.217 171.8 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 2487 ' ' TYR . . . . . . . . . . . . . 26.4 p90 -141.12 150.98 43.53 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 124.424 1.09 . . . . 0.0 112.5 179.354 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 2488 ' ' THR . . . . . . . . . . . . . 92.2 m -115.49 116.25 41.56 Favored Pre-proline 0 N--CA 1.473 0.676 0 CA-C-O 117.844 -1.074 . . . . 0.0 109.097 173.1 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 2489 ' ' PRO . . . . . . . . . . . . . 77.8 Cg_endo -82.6 135.01 7.78 Favored 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 123.755 2.97 . . . . 0.0 110.382 172.974 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 2490 ' ' MET . . . . . . . . . . . . . 24.1 ptm -98.12 3.43 49.16 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 114.918 1.451 . . . . 0.0 114.918 -172.421 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 2491 ' ' ALA . . . . . . . . . . . . . . . -153.48 148.64 20.03 Favored Pre-proline 0 CA--C 1.543 0.687 0 C-N-CA 125.146 1.378 . . . . 0.0 111.654 -177.852 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 2492 ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -73.93 153.48 47.48 Favored 'Trans proline' 0 C--N 1.35 0.631 0 C-N-CA 123.522 2.815 . . . . 0.0 111.569 178.903 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 2493 ' ' GLY . . . . . . . . . . . . . . . 136.85 -150.8 20.71 Favored Glycine 0 CA--C 1.53 1.026 0 C-N-CA 125.297 1.427 . . . . 0.0 113.166 -178.19 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 2494 ' ' SER . . . . . . . . . . . . . 45.3 m -118.31 124.01 46.76 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.625 1.17 . . . . 0.0 110.982 -178.271 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 2495 ' ' TYR . . . . . . . . . . . . . 40.7 m-85 -103.11 125.82 50.0 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 124.803 1.241 . . . . 0.0 110.164 177.477 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 2496 ' ' LEU . . . . . . . . . . . . . 20.1 tp -95.0 106.8 18.81 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.056 0.943 . . . . 0.0 109.467 -178.412 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 2497 ' ' ILE . . . . . . . . . . . . . 51.9 mt -90.89 103.07 14.06 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 C-N-CA 125.837 1.655 . . . . 0.0 107.849 -178.688 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 2498 ' ' SER . . . . . . . . . . . . . 25.5 t -94.61 91.83 6.75 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 126.042 1.737 . . . . 0.0 109.388 -178.402 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 2499 ' ' ILE . . . . . . . . . . . . . 30.1 mt -91.57 90.37 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 C-N-CA 124.521 1.128 . . . . 0.0 109.52 -174.069 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 2500 ' ' LYS . . . . . . . . . . . . . 56.4 mttp -89.99 142.84 27.31 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 123.79 0.836 . . . . 0.0 111.412 174.695 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 2501 ' ' TYR . . . . . . . . . . . . . 85.7 t80 -148.59 147.96 29.59 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 124.756 1.222 . . . . 0.0 112.226 -175.573 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 2502 ' ' GLY . . . . . . . . . . . . . . . 65.29 16.07 62.03 Favored Glycine 0 CA--C 1.535 1.319 0 C-N-CA 124.567 1.08 . . . . 0.0 114.152 175.38 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 2503 ' ' GLY . . . . . . . . . . . . . . . 134.45 -170.84 22.5 Favored Glycine 0 CA--C 1.542 1.749 0 C-N-CA 126.191 1.853 . . . . 0.0 111.904 -161.998 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 2504 ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -84.11 33.88 0.51 Allowed 'Trans proline' 0 CA--C 1.547 1.127 0 C-N-CA 124.681 3.587 . . . . 0.0 113.202 -172.806 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 2505 ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -124.51 138.51 54.33 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.483 1.113 . . . . 0.0 113.446 -172.77 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 2506 ' ' HIS . . . . . . . . . . . . . 82.6 m-70 -60.28 143.71 52.14 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 125.694 1.598 . . . . 0.0 113.799 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 2507 ' ' ILE . . . . . . . . . . . . . 31.3 pt -75.1 172.31 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 C-N-CA 123.545 0.738 . . . . 0.0 112.73 168.057 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 2508 ' ' GLY . . . . . . . . . . . . . . . -58.63 121.95 28.26 Favored Glycine 0 CA--C 1.533 1.203 0 C-N-CA 123.661 0.648 . . . . 0.0 111.723 172.978 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 2509 ' ' GLY . . . . . . . . . . . . . . . 88.82 -9.89 74.61 Favored Glycine 0 CA--C 1.536 1.348 0 C-N-CA 125.653 1.597 . . . . 0.0 115.07 -178.003 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 2510 ' ' SER . . . . . . . . . . . . . 40.3 t -83.59 146.31 49.75 Favored Pre-proline 0 CA--C 1.55 0.978 0 CA-C-N 119.193 1.496 . . . . 0.0 111.893 179.158 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 2511 ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -78.81 154.15 91.17 Favored 'Cis proline' 0 C--N 1.353 0.791 0 CA-C-N 119.751 0.947 . . . . 0.0 113.071 0.072 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 2512 ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -103.63 132.24 50.07 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.043 1.337 . . . . 0.0 110.334 177.174 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 2513 ' ' LYS . . . . . . . . . . . . . 64.6 pttt -93.81 15.88 15.48 Favored 'General case' 0 N--CA 1.479 0.982 0 N-CA-C 116.123 1.897 . . . . 0.0 116.123 -165.565 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 2514 ' ' ALA . . . . . . . . . . . . . . . -12.78 104.23 0.02 OUTLIER 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 129.239 3.016 . . . . 0.0 116.205 -174.851 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 2515 ' ' LYS . . . . . . . . . . . . . 50.2 mtmt -93.27 130.18 39.09 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 124.406 1.083 . . . . 0.0 111.015 -176.114 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 2516 ' ' VAL . . . . . . . . . . . . . 25.7 m -134.12 148.37 30.09 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 C-N-CA 124.026 0.93 . . . . 0.0 112.253 -172.042 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 2517 ' ' THR . . . . . . . . . . . . . 45.1 p -139.45 165.84 26.16 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 125.568 1.547 . . . . 0.0 111.08 -175.902 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 2518 ' ' GLY . . . . . . . . . . . . . . . 119.18 -157.67 15.25 Favored Glycine 0 CA--C 1.539 1.535 0 C-N-CA 124.971 1.272 . . . . 0.0 112.331 -173.62 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 2519 ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -71.7 160.73 47.32 Favored 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 123.486 2.791 . . . . 0.0 112.684 -175.146 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 2520 ' ' ARG . . . . . . . . . . . . . 55.1 ttt85 . . . . . 0 CA--C 1.537 0.469 0 C-N-CA 124.707 1.203 . . . . 0.0 108.941 167.644 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A 2427 ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.081 0 CA-C-O 121.417 0.454 . . . . 0.0 113.148 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A 2428 ' ' ASP . . . . . . . . . . . . . 13.3 t70 -93.01 135.97 25.23 Favored Pre-proline 0 CA--C 1.551 0.984 0 C-N-CA 124.754 1.222 . . . . 0.0 111.625 -178.195 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 2429 ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -67.93 -14.62 41.78 Favored 'Trans proline' 0 CA--C 1.539 0.77 0 C-N-CA 123.575 2.85 . . . . 0.0 114.294 -175.871 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 2430 ' ' GLY . . . . . . . . . . . . . . . -87.54 -27.03 28.38 Favored Glycine 0 CA--C 1.534 1.222 0 C-N-CA 124.392 0.996 . . . . 0.0 113.187 171.475 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 2431 ' ' LEU . . . . . . . . . . . . . 4.3 mm? -78.29 -36.45 46.62 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 118.247 1.023 . . . . 0.0 111.037 170.436 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 2432 ' ' VAL . . . . . . . . . . . . . 72.8 t -64.63 136.86 25.92 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 C-N-CA 123.356 0.662 . . . . 0.0 109.724 166.515 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 2433 ' ' SER . . . . . . . . . . . . . 8.7 t -134.1 -166.68 1.83 Allowed 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.995 1.318 . . . . 0.0 110.1 176.256 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 2434 ' ' ALA . . . . . . . . . . . . . . . -152.12 143.35 23.26 Favored 'General case' 0 CA--C 1.537 0.478 0 O-C-N 121.002 -1.061 . . . . 0.0 111.308 174.188 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 2435 ' ' TYR . . . . . . . . . . . . . 81.4 m-85 -142.38 156.29 45.21 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 125.269 1.428 . . . . 0.0 112.076 -176.712 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 2436 ' ' GLY . . . . . . . . . . . . . . . 116.55 157.27 10.93 Favored Glycine 0 N--CA 1.472 1.06 0 C-N-CA 125.705 1.621 . . . . 0.0 113.266 -179.532 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 2437 ' ' ALA . . . . . . . . . . . . . . . -60.82 -28.46 68.81 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.863 1.265 . . . . 0.0 114.222 -170.971 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 2438 ' ' GLY . . . . . . . . . . . . . . . -67.68 -9.98 57.04 Favored Glycine 0 CA--C 1.531 1.045 0 CA-C-O 118.894 -0.948 . . . . 0.0 114.957 -178.008 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 2439 ' ' LEU . . . . . . . . . . . . . 79.4 mt -83.33 -24.86 31.92 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 124.747 1.219 . . . . 0.0 112.709 170.048 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 2440 ' ' GLU . . . . . . . . . . . . . 39.5 mm-40 -91.15 -39.23 12.26 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.885 1.274 . . . . 0.0 111.382 -179.34 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 2441 ' ' GLY . . . . . . . . . . . . . . . 164.13 -158.73 31.41 Favored Glycine 0 CA--C 1.528 0.876 0 N-CA-C 115.617 1.007 . . . . 0.0 115.617 -177.834 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 2442 ' ' GLY . . . . . . . . . . . . . . . 175.74 -165.77 36.69 Favored Glycine 0 CA--C 1.531 1.047 0 C-N-CA 125.638 1.589 . . . . 0.0 112.871 179.3 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 2443 ' ' VAL . . . . . . . . . . . . . 86.6 t -129.18 146.4 34.29 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 125.414 1.486 . . . . 0.0 108.672 174.423 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 2444 ' ' THR . . . . . . . . . . . . . 41.6 p -58.34 133.81 56.04 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-O 121.427 0.632 . . . . 0.0 111.661 178.231 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 2445 ' ' GLY . . . . . . . . . . . . . . . 79.14 -6.9 55.33 Favored Glycine 0 CA--C 1.537 1.464 0 C-N-CA 124.734 1.159 . . . . 0.0 115.052 -175.633 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 2446 ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -100.97 142.26 24.27 Favored Pre-proline 0 CA--C 1.553 1.059 0 C-N-CA 125.751 1.62 . . . . 0.0 111.179 177.573 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 2447 ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -74.29 129.52 13.1 Favored 'Trans proline' 0 C--N 1.351 0.68 0 C-N-CA 122.98 2.453 . . . . 0.0 111.34 179.768 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 2448 ' ' ALA . . . . . . . . . . . . . . . -105.57 120.33 41.38 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 126.365 1.866 . . . . 0.0 109.207 172.548 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 2449 ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -119.16 138.49 52.89 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.775 1.23 . . . . 0.0 111.542 -170.925 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 2450 ' ' PHE . . . . . . . . . . . . . 37.5 p90 -153.34 165.28 36.26 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.311 1.444 . . . . 0.0 111.85 173.272 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 2451 ' ' VAL . . . . . . . . . . . . . 43.0 t -126.85 131.75 70.74 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 C-N-CA 124.897 1.279 . . . . 0.0 109.701 176.172 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 2452 ' ' VAL . . . . . . . . . . . . . 40.0 t -78.6 105.43 7.78 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 N-CA-C 107.318 -1.364 . . . . 0.0 107.318 165.577 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 2453 ' ' ASN . . . . . . . . . . . . . 14.7 t-20 -83.19 115.1 21.78 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 123.804 0.842 . . . . 0.0 112.292 -169.161 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 2454 ' ' THR . . . . . . . . . . . . . 43.9 p -103.96 -9.1 19.14 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 125.687 1.595 . . . . 0.0 113.812 -177.648 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 2455 ' ' SER . . . . . . . . . . . . . 16.3 m -57.29 -29.21 63.69 Favored 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 114.637 1.347 . . . . 0.0 114.637 -172.622 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 2456 ' ' ASN . . . . . . . . . . . . . 68.9 m-80 -85.49 -13.25 49.7 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 124.671 1.188 . . . . 0.0 113.579 177.332 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 2457 ' ' ALA . . . . . . . . . . . . . . . -112.09 -25.6 9.26 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 125.576 1.55 . . . . 0.0 114.162 -174.312 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 2458 ' ' GLY . . . . . . . . . . . . . . . 103.75 -111.89 4.02 Favored Glycine 0 CA--C 1.53 0.987 0 C-N-CA 125.095 1.331 . . . . 0.0 111.844 -177.603 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 2459 ' ' ALA . . . . . . . . . . . . . . . -137.87 160.52 39.07 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.291 1.436 . . . . 0.0 112.201 -176.817 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 2460 ' ' GLY . . . . . . . . . . . . . . . 158.19 174.24 27.64 Favored Glycine 0 CA--C 1.529 0.946 0 C-N-CA 124.427 1.013 . . . . 0.0 113.973 -172.696 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 2461 ' ' ALA . . . . . . . . . . . . . . . -83.03 148.71 27.39 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.48 1.112 . . . . 0.0 112.706 -178.16 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 2462 ' ' LEU . . . . . . . . . . . . . 59.7 tp -129.22 138.85 51.93 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 125.545 1.538 . . . . 0.0 110.588 177.16 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 2463 ' ' SER . . . . . . . . . . . . . 18.2 t -118.26 151.25 38.01 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.478 1.111 . . . . 0.0 109.604 156.559 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 2464 ' ' VAL . . . . . . . . . . . . . 7.5 p -161.77 133.16 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 124.184 0.993 . . . . 0.0 110.819 -178.054 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 2465 ' ' THR . . . . . . . . . . . . . 62.7 m -140.85 142.83 34.51 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 125.578 1.551 . . . . 0.0 109.516 -175.377 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 2466 ' ' ILE . . . . . . . . . . . . . 41.9 mt -114.96 115.94 51.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 124.433 1.093 . . . . 0.0 109.442 177.132 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 2467 ' ' ASP . . . . . . . . . . . . . 35.1 t70 -96.63 161.41 13.9 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 125.929 1.692 . . . . 0.0 110.34 168.657 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 2468 ' ' GLY . . . . . . . . . . . . . . . 166.2 -164.21 37.39 Favored Glycine 0 CA--C 1.536 1.361 0 O-C-N 121.18 -0.95 . . . . 0.0 114.973 178.521 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 2469 ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -70.07 -14.08 34.68 Favored 'Trans proline' 0 CA--C 1.541 0.852 0 C-N-CA 124.202 3.268 . . . . 0.0 114.004 -178.836 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 2470 ' ' SER . . . . . . . . . . . . . 29.1 m -156.87 174.91 14.8 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 126.769 2.027 . . . . 0.0 110.363 175.637 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 2471 ' ' LYS . . . . . . . . . . . . . 58.4 mtmt -68.14 165.82 17.41 Favored 'General case' 0 CA--C 1.549 0.912 0 O-C-N 121.117 -0.989 . . . . 0.0 111.734 166.443 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 2472 ' ' VAL . . . . . . . . . . . . . 19.1 m -135.43 152.26 31.51 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 C-N-CA 124.777 1.231 . . . . 0.0 111.421 -179.442 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 2473 ' ' LYS . . . . . . . . . . . . . 29.2 mtpp -81.18 64.29 5.86 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 124.488 1.115 . . . . 0.0 111.806 179.463 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 2474 ' ' MET . . . . . . . . . . . . . 19.0 ttt -69.43 133.53 47.87 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 125.27 1.428 . . . . 0.0 112.161 -174.518 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 2475 ' ' ASP . . . . . . . . . . . . . 35.1 t70 -139.13 122.94 17.63 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 126.361 1.865 . . . . 0.0 110.109 176.266 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 2476 ' ' CYS . . . . . . . . . . . . . 73.6 m -104.38 140.79 37.41 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.733 1.213 . . . . 0.0 111.182 -179.021 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 2477 ' ' GLN . . . . . . . . . . . . . 81.0 mt-30 -140.83 148.01 39.91 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.127 1.371 . . . . 0.0 110.283 -176.223 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 2478 ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -95.03 118.58 32.08 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 123.686 0.795 . . . . 0.0 109.839 174.74 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 2479 ' ' CYS . . . . . . . . . . . . . 88.8 m -123.21 163.24 35.06 Favored Pre-proline 0 CA--C 1.551 0.992 0 C-N-CA 125.386 1.474 . . . . 0.0 111.587 -179.3 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 2480 ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -57.8 -31.29 91.94 Favored 'Trans proline' 0 C--N 1.353 0.803 0 C-N-CA 123.624 2.883 . . . . 0.0 114.071 174.579 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 2481 ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -77.19 -11.23 59.79 Favored 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 125.329 1.452 . . . . 0.0 112.98 178.216 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 2482 ' ' GLY . . . . . . . . . . . . . . . 125.57 -162.4 19.82 Favored Glycine 0 CA--C 1.53 0.983 0 C-N-CA 126.3 1.905 . . . . 0.0 112.993 -175.688 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 2483 ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -73.27 108.52 6.2 Favored 'General case' 0 CA--C 1.54 0.576 0 O-C-N 121.574 -0.957 . . . . 0.0 111.133 178.345 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 2484 ' ' ARG . . . . . . . . . . . . . 44.5 ttm180 -81.05 140.72 34.96 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 124.756 1.222 . . . . 0.0 110.448 174.561 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 2485 ' ' VAL . . . . . . . . . . . . . 90.4 t -130.72 129.05 63.82 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 C-N-CA 125.608 1.563 . . . . 0.0 108.592 174.499 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 2486 ' ' THR . . . . . . . . . . . . . 48.7 m -122.02 140.24 52.72 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 124.41 1.084 . . . . 0.0 108.351 170.18 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 2487 ' ' TYR . . . . . . . . . . . . . 34.7 p90 -146.22 149.14 33.35 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 123.852 0.861 . . . . 0.0 112.089 176.751 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 2488 ' ' THR . . . . . . . . . . . . . 87.7 m -111.87 115.53 50.78 Favored Pre-proline 0 N--CA 1.473 0.701 0 CA-C-O 117.875 -1.06 . . . . 0.0 108.9 174.161 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 2489 ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -79.61 161.88 24.76 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 123.965 3.11 . . . . 0.0 111.107 174.08 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 2490 ' ' MET . . . . . . . . . . . . . 25.6 ptm -138.32 3.43 2.36 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 114.977 1.473 . . . . 0.0 114.977 -173.071 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 2491 ' ' ALA . . . . . . . . . . . . . . . -143.47 146.23 34.9 Favored Pre-proline 0 CA--C 1.546 0.817 0 C-N-CA 125.179 1.391 . . . . 0.0 110.741 173.058 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 2492 ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -71.92 151.03 56.1 Favored 'Trans proline' 0 CA--C 1.536 0.594 0 C-N-CA 122.852 2.368 . . . . 0.0 111.04 175.51 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 2493 ' ' GLY . . . . . . . . . . . . . . . 135.5 -162.15 24.83 Favored Glycine 0 CA--C 1.529 0.944 0 C-N-CA 125.167 1.365 . . . . 0.0 113.366 -177.159 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 2494 ' ' SER . . . . . . . . . . . . . 42.2 m -101.34 123.46 45.47 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.151 0.98 . . . . 0.0 111.186 178.69 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 2495 ' ' TYR . . . . . . . . . . . . . 79.2 m-85 -96.82 134.34 40.25 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.508 1.123 . . . . 0.0 110.084 168.299 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 2496 ' ' LEU . . . . . . . . . . . . . 23.8 tp -110.4 115.12 29.1 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.724 1.21 . . . . 0.0 109.86 -176.869 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 2497 ' ' ILE . . . . . . . . . . . . . 45.0 mt -101.72 102.84 14.08 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 C-N-CA 125.683 1.593 . . . . 0.0 108.474 -173.68 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 2498 ' ' SER . . . . . . . . . . . . . 72.3 m -90.71 90.34 7.91 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 124.457 1.103 . . . . 0.0 110.67 -177.814 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 2499 ' ' ILE . . . . . . . . . . . . . 28.3 mt -91.14 118.09 35.71 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 125.035 1.334 . . . . 0.0 109.756 -178.286 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 2500 ' ' LYS . . . . . . . . . . . . . 82.0 mttt -131.71 106.93 8.45 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 124.865 1.266 . . . . 0.0 112.375 -171.733 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 2501 ' ' TYR . . . . . . . . . . . . . 39.3 t80 -109.49 142.89 39.87 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.721 1.208 . . . . 0.0 112.713 -175.183 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 2502 ' ' GLY . . . . . . . . . . . . . . . 70.87 9.55 66.28 Favored Glycine 0 CA--C 1.535 1.307 0 C-N-CA 124.682 1.134 . . . . 0.0 114.756 175.021 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 2503 ' ' GLY . . . . . . . . . . . . . . . 153.28 -171.73 32.19 Favored Glycine 0 CA--C 1.538 1.502 0 C-N-CA 125.802 1.668 . . . . 0.0 113.129 -172.144 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 2504 ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -82.09 19.04 1.3 Allowed 'Trans proline' 0 CA--C 1.546 1.106 0 C-N-CA 124.877 3.718 . . . . 0.0 113.749 -174.977 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 2505 ' ' TYR . . . . . . . . . . . . . 80.3 m-85 -113.94 143.7 44.28 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.213 1.405 . . . . 0.0 112.751 -175.26 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 2506 ' ' HIS . . . . . . . . . . . . . 97.5 m-70 -63.99 145.14 56.4 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 124.382 1.073 . . . . 0.0 113.632 -178.45 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 2507 ' ' ILE . . . . . . . . . . . . . 29.4 pt -75.06 173.68 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.213 0 C-N-CA 123.56 0.744 . . . . 0.0 112.869 171.373 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 2508 ' ' GLY . . . . . . . . . . . . . . . -58.7 120.5 22.65 Favored Glycine 0 CA--C 1.533 1.206 0 O-C-N 121.486 -0.759 . . . . 0.0 111.704 174.379 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 2509 ' ' GLY . . . . . . . . . . . . . . . 87.0 -8.2 77.36 Favored Glycine 0 CA--C 1.537 1.414 0 C-N-CA 125.52 1.533 . . . . 0.0 115.023 -177.07 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 2510 ' ' SER . . . . . . . . . . . . . 45.8 t -87.64 147.19 40.95 Favored Pre-proline 0 CA--C 1.549 0.937 0 CA-C-N 118.927 1.364 . . . . 0.0 111.826 179.845 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 2511 ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -76.34 151.9 95.47 Favored 'Cis proline' 0 C--N 1.352 0.722 0 CA-C-N 119.711 0.933 . . . . 0.0 112.748 -1.437 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 2512 ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -99.53 132.13 45.07 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 124.705 1.202 . . . . 0.0 111.151 179.851 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 2513 ' ' LYS . . . . . . . . . . . . . 64.9 pttt -96.26 22.85 7.22 Favored 'General case' 0 CA--C 1.552 1.02 0 N-CA-C 115.991 1.849 . . . . 0.0 115.991 -164.38 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 2514 ' ' ALA . . . . . . . . . . . . . . . -28.64 114.74 0.09 Allowed 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 128.118 2.567 . . . . 0.0 115.612 -173.807 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 2515 ' ' LYS . . . . . . . . . . . . . 89.0 mttt -98.17 135.13 40.26 Favored 'General case' 0 N--CA 1.474 0.77 0 O-C-N 121.312 -0.868 . . . . 0.0 112.74 -174.519 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 2516 ' ' VAL . . . . . . . . . . . . . 75.4 t -122.51 139.28 49.88 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 C-N-CA 125.284 1.434 . . . . 0.0 110.609 -170.604 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 2517 ' ' THR . . . . . . . . . . . . . 66.1 p -120.99 178.86 4.56 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 125.783 1.633 . . . . 0.0 111.107 176.331 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 2518 ' ' GLY . . . . . . . . . . . . . . . 100.51 179.55 29.59 Favored Glycine 0 CA--C 1.539 1.585 0 C-N-CA 124.828 1.204 . . . . 0.0 113.263 -175.912 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 2519 ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -72.53 152.05 53.74 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 123.788 2.992 . . . . 0.0 111.86 -175.449 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 2520 ' ' ARG . . . . . . . . . . . . . 45.8 ttp180 . . . . . 0 CA--C 1.538 0.501 0 C-N-CA 123.384 0.673 . . . . 0.0 110.14 172.476 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A 2427 ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.781 0 N-CA-C 110.132 -1.187 . . . . 0.0 110.132 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A 2428 ' ' ASP . . . . . . . . . . . . . 41.8 m-20 -87.24 142.49 33.54 Favored Pre-proline 0 CA--C 1.548 0.872 0 C-N-CA 123.638 0.775 . . . . 0.0 112.283 -170.995 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 2429 ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -64.66 -27.12 60.83 Favored 'Trans proline' 0 C--N 1.351 0.69 0 C-N-CA 123.207 2.605 . . . . 0.0 113.216 -176.153 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 2430 ' ' GLY . . . . . . . . . . . . . . . -73.87 -22.24 78.33 Favored Glycine 0 CA--C 1.535 1.295 0 CA-C-N 118.905 0.775 . . . . 0.0 113.652 175.347 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 2431 ' ' LEU . . . . . . . . . . . . . 4.4 mm? -88.67 -28.75 20.39 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 124.622 1.169 . . . . 0.0 111.869 173.108 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 2432 ' ' VAL . . . . . . . . . . . . . 71.1 t -68.79 136.63 25.98 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 123.756 0.823 . . . . 0.0 110.292 169.681 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 2433 ' ' SER . . . . . . . . . . . . . 74.6 m -123.61 -177.86 3.85 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 125.419 1.488 . . . . 0.0 110.261 172.862 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 2434 ' ' ALA . . . . . . . . . . . . . . . -143.77 146.17 32.92 Favored 'General case' 0 CA--C 1.538 0.501 0 O-C-N 120.701 -1.25 . . . . 0.0 111.499 170.541 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 2435 ' ' TYR . . . . . . . . . . . . . 76.2 m-85 -145.06 152.22 39.77 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.441 1.497 . . . . 0.0 111.992 -174.994 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 2436 ' ' GLY . . . . . . . . . . . . . . . 121.74 158.66 10.41 Favored Glycine 0 N--CA 1.473 1.114 0 C-N-CA 125.492 1.52 . . . . 0.0 113.404 179.184 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 2437 ' ' ALA . . . . . . . . . . . . . . . -61.32 -27.06 68.22 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.79 1.236 . . . . 0.0 114.245 -171.398 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 2438 ' ' GLY . . . . . . . . . . . . . . . -66.79 -14.17 62.55 Favored Glycine 0 CA--C 1.53 0.982 0 CA-C-O 119.067 -0.851 . . . . 0.0 114.492 -179.183 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 2439 ' ' LEU . . . . . . . . . . . . . 67.6 mt -78.82 -23.19 45.24 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 118.442 1.121 . . . . 0.0 112.449 170.943 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 2440 ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -92.41 -29.28 16.37 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.168 1.387 . . . . 0.0 111.83 176.117 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 2441 ' ' GLY . . . . . . . . . . . . . . . 108.31 -134.66 12.35 Favored Glycine 0 CA--C 1.532 1.114 0 C-N-CA 125.829 1.68 . . . . 0.0 112.525 178.433 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 2442 ' ' GLY . . . . . . . . . . . . . . . 136.78 -153.9 21.92 Favored Glycine 0 CA--C 1.534 1.265 0 C-N-CA 124.884 1.231 . . . . 0.0 114.494 -176.951 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 2443 ' ' VAL . . . . . . . . . . . . . 87.5 t -79.84 134.65 27.12 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 C-N-CA 124.622 1.169 . . . . 0.0 111.029 -174.83 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 2444 ' ' THR . . . . . . . . . . . . . 39.1 p -68.92 144.06 54.29 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.251 1.021 . . . . 0.0 112.021 176.276 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 2445 ' ' GLY . . . . . . . . . . . . . . . 83.38 -22.28 7.57 Favored Glycine 0 CA--C 1.536 1.359 0 C-N-CA 125.416 1.484 . . . . 0.0 113.903 -174.541 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 2446 ' ' ASN . . . . . . . . . . . . . 80.4 m-20 -87.19 152.96 53.69 Favored Pre-proline 0 CA--C 1.547 0.864 0 C-N-CA 124.749 1.22 . . . . 0.0 110.816 170.851 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 2447 ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -72.04 144.06 41.78 Favored 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 122.942 2.428 . . . . 0.0 111.658 179.387 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 2448 ' ' ALA . . . . . . . . . . . . . . . -119.04 137.98 53.17 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 127.309 2.244 . . . . 0.0 108.847 172.634 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 2449 ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -146.21 138.16 25.01 Favored 'General case' 0 N--CA 1.471 0.589 0 O-C-N 121.517 -0.74 . . . . 0.0 112.585 -163.041 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 2450 ' ' PHE . . . . . . . . . . . . . 50.6 p90 -154.22 159.73 41.49 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 125.52 1.528 . . . . 0.0 112.383 -179.109 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 2451 ' ' VAL . . . . . . . . . . . . . 88.3 t -112.65 132.73 60.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 125.552 1.541 . . . . 0.0 109.349 173.049 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 2452 ' ' VAL . . . . . . . . . . . . . 33.3 t -84.86 103.68 12.27 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 164.638 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 2453 ' ' ASN . . . . . . . . . . . . . 15.5 t-20 -87.06 116.89 25.42 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.2 1.0 . . . . 0.0 112.314 -168.568 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 2454 ' ' THR . . . . . . . . . . . . . 43.3 p -103.2 -4.44 24.37 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 126.214 1.806 . . . . 0.0 114.241 -173.09 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 2455 ' ' SER . . . . . . . . . . . . . 19.6 m -56.0 -34.55 65.9 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 114.961 1.467 . . . . 0.0 114.961 -170.296 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 2456 ' ' ASN . . . . . . . . . . . . . 29.8 m120 -86.94 -10.93 52.08 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 124.329 1.051 . . . . 0.0 113.495 178.061 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 2457 ' ' ALA . . . . . . . . . . . . . . . -103.32 -53.96 2.7 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.206 1.402 . . . . 0.0 112.85 -174.763 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 2458 ' ' GLY . . . . . . . . . . . . . . . 125.63 -121.04 4.05 Favored Glycine 0 CA--C 1.531 1.064 0 C-N-CA 124.967 1.27 . . . . 0.0 112.658 -172.887 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 2459 ' ' ALA . . . . . . . . . . . . . . . -126.65 166.25 17.69 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 125.679 1.592 . . . . 0.0 112.781 -173.326 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 2460 ' ' GLY . . . . . . . . . . . . . . . 146.77 173.06 17.67 Favored Glycine 0 CA--C 1.531 1.047 0 C-N-CA 124.394 0.997 . . . . 0.0 114.054 -177.92 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 2461 ' ' ALA . . . . . . . . . . . . . . . -82.37 150.92 26.89 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.512 1.125 . . . . 0.0 112.811 -178.908 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 2462 ' ' LEU . . . . . . . . . . . . . 23.4 tp -109.42 148.27 31.41 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 126.272 1.829 . . . . 0.0 110.678 177.301 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 2463 ' ' SER . . . . . . . . . . . . . 8.4 t -150.03 68.7 1.0 Allowed 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 124.128 0.971 . . . . 0.0 111.449 177.5 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 2464 ' ' VAL . . . . . . . . . . . . . 42.2 t -74.3 139.62 18.96 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.24 0 O-C-N 120.692 -1.255 . . . . 0.0 110.764 178.925 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 2465 ' ' THR . . . . . . . . . . . . . 16.4 m -125.41 141.34 52.11 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 125.043 1.337 . . . . 0.0 108.929 169.888 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 2466 ' ' ILE . . . . . . . . . . . . . 26.5 mt -122.14 126.36 74.25 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 123.425 0.69 . . . . 0.0 109.921 171.677 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 2467 ' ' ASP . . . . . . . . . . . . . 35.8 t70 -110.95 148.53 32.29 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 126.044 1.738 . . . . 0.0 110.192 170.176 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 2468 ' ' GLY . . . . . . . . . . . . . . . 170.51 -164.81 38.07 Favored Glycine 0 CA--C 1.536 1.395 0 N-CA-C 114.996 0.758 . . . . 0.0 114.996 -178.99 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 2469 ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -68.34 -25.02 36.53 Favored 'Trans proline' 0 CA--C 1.54 0.79 0 C-N-CA 124.002 3.135 . . . . 0.0 114.752 -171.712 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 2470 ' ' SER . . . . . . . . . . . . . 17.3 m -159.53 142.54 14.15 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 125.82 1.648 . . . . 0.0 110.566 174.693 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 2471 ' ' LYS . . . . . . . . . . . . . 55.3 mtmt -61.57 122.06 14.31 Favored 'General case' 0 N--CA 1.476 0.862 0 O-C-N 121.074 -1.016 . . . . 0.0 112.9 -172.818 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 2472 ' ' VAL . . . . . . . . . . . . . 21.0 m -77.21 151.6 5.66 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 C-N-CA 124.441 1.096 . . . . 0.0 112.512 -175.598 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 2473 ' ' LYS . . . . . . . . . . . . . 38.3 mtmm -78.63 145.62 34.57 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 123.234 0.614 . . . . 0.0 109.867 160.315 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 2474 ' ' MET . . . . . . . . . . . . . 56.5 ttm -147.94 144.29 27.92 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 124.273 1.029 . . . . 0.0 112.518 -174.804 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 2475 ' ' ASP . . . . . . . . . . . . . 21.5 m-20 -125.81 149.93 48.22 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 126.843 2.057 . . . . 0.0 109.996 162.857 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 2476 ' ' CYS . . . . . . . . . . . . . 44.7 t -142.98 142.17 31.56 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.89 1.276 . . . . 0.0 110.757 179.075 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 2477 ' ' GLN . . . . . . . . . . . . . 6.0 tp-100 -155.9 146.82 22.21 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.309 1.044 . . . . 0.0 111.017 -175.704 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 2478 ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -78.53 128.63 33.82 Favored 'General case' 0 CA--C 1.541 0.628 0 O-C-N 121.62 -0.675 . . . . 0.0 111.455 174.637 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 2479 ' ' CYS . . . . . . . . . . . . . 95.3 m -124.5 167.09 16.68 Favored Pre-proline 0 CA--C 1.552 1.046 0 C-N-CA 126.152 1.781 . . . . 0.0 110.644 177.148 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 2480 ' ' PRO . . . . . . . . . . . . . 64.3 Cg_exo -57.46 -29.92 86.33 Favored 'Trans proline' 0 C--N 1.353 0.793 0 C-N-CA 123.53 2.82 . . . . 0.0 114.374 175.905 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 2481 ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -80.53 -6.93 58.94 Favored 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 125.356 1.462 . . . . 0.0 113.099 177.971 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 2482 ' ' GLY . . . . . . . . . . . . . . . 119.39 -169.39 13.68 Favored Glycine 0 CA--C 1.532 1.095 0 C-N-CA 126.326 1.917 . . . . 0.0 112.408 -172.016 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 2483 ' ' TYR . . . . . . . . . . . . . 63.0 m-85 -69.4 118.69 12.6 Favored 'General case' 0 N--CA 1.47 0.565 0 O-C-N 121.206 -1.173 . . . . 0.0 111.69 177.279 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 2484 ' ' ARG . . . . . . . . . . . . . 58.8 ttt180 -96.19 132.07 42.0 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 125.414 1.486 . . . . 0.0 110.273 178.536 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 2485 ' ' VAL . . . . . . . . . . . . . 67.0 t -123.11 131.98 72.24 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 C-N-CA 125.825 1.65 . . . . 0.0 109.065 -177.372 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 2486 ' ' THR . . . . . . . . . . . . . 50.3 m -124.54 132.96 53.44 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 124.845 1.258 . . . . 0.0 108.126 172.217 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 2487 ' ' TYR . . . . . . . . . . . . . 22.0 p90 -140.45 157.85 44.89 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.194 0.998 . . . . 0.0 112.392 179.162 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 2488 ' ' THR . . . . . . . . . . . . . 91.8 m -113.87 105.2 54.75 Favored Pre-proline 0 N--CA 1.476 0.852 0 CA-C-O 118.107 -0.949 . . . . 0.0 109.818 179.121 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 2489 ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -69.44 128.87 16.96 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 123.022 2.481 . . . . 0.0 109.437 170.344 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 2490 ' ' MET . . . . . . . . . . . . . 27.9 ptm -114.35 -1.47 13.52 Favored 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 114.777 1.399 . . . . 0.0 114.777 -171.33 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 2491 ' ' ALA . . . . . . . . . . . . . . . -147.4 144.82 20.05 Favored Pre-proline 0 CA--C 1.546 0.806 0 C-N-CA 124.902 1.281 . . . . 0.0 110.982 -179.852 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 2492 ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -72.6 151.43 52.56 Favored 'Trans proline' 0 C--N 1.351 0.688 0 C-N-CA 123.414 2.743 . . . . 0.0 111.392 -176.998 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 2493 ' ' GLY . . . . . . . . . . . . . . . 133.0 -142.49 14.01 Favored Glycine 0 CA--C 1.529 0.909 0 C-N-CA 124.875 1.226 . . . . 0.0 112.507 -175.386 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 2494 ' ' SER . . . . . . . . . . . . . 39.6 m -123.96 128.5 49.5 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.349 1.059 . . . . 0.0 111.292 -179.576 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 2495 ' ' TYR . . . . . . . . . . . . . 41.7 m-85 -101.04 119.16 38.33 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.775 1.23 . . . . 0.0 110.578 171.602 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 2496 ' ' LEU . . . . . . . . . . . . . 25.3 tp -91.97 110.2 21.55 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.543 1.137 . . . . 0.0 109.512 179.084 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 2497 ' ' ILE . . . . . . . . . . . . . 21.9 mt -97.75 98.99 7.99 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 C-N-CA 125.863 1.665 . . . . 0.0 108.768 -176.299 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 2498 ' ' SER . . . . . . . . . . . . . 69.4 m -86.56 81.92 8.1 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 125.482 1.513 . . . . 0.0 110.133 177.831 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 2499 ' ' ILE . . . . . . . . . . . . . 51.9 mt -76.62 117.71 21.85 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 C-N-CA 124.99 1.316 . . . . 0.0 109.407 177.41 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 2500 ' ' LYS . . . . . . . . . . . . . 2.2 mtmp? -129.01 143.19 50.79 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 125.122 1.369 . . . . 0.0 110.712 -178.627 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 2501 ' ' TYR . . . . . . . . . . . . . 49.5 t80 -152.37 144.46 23.83 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 124.496 1.118 . . . . 0.0 112.321 -171.873 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 2502 ' ' GLY . . . . . . . . . . . . . . . 67.65 16.24 67.52 Favored Glycine 0 CA--C 1.536 1.384 0 C-N-CA 124.177 0.894 . . . . 0.0 113.728 178.061 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 2503 ' ' GLY . . . . . . . . . . . . . . . 147.04 -174.76 26.73 Favored Glycine 0 CA--C 1.54 1.624 0 C-N-CA 126.216 1.865 . . . . 0.0 112.436 -167.508 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 2504 ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -84.7 12.56 3.02 Favored 'Trans proline' 0 CA--C 1.544 1.006 0 C-N-CA 124.551 3.501 . . . . 0.0 113.904 -173.159 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 2505 ' ' TYR . . . . . . . . . . . . . 58.9 m-85 -110.47 147.58 33.8 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 124.474 1.11 . . . . 0.0 113.849 -171.486 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 2506 ' ' HIS . . . . . . . . . . . . . 92.8 m-70 -63.47 141.14 58.88 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 125.095 1.358 . . . . 0.0 113.497 -175.982 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 2507 ' ' ILE . . . . . . . . . . . . . 1.7 pp -79.45 175.53 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 N-CA-C 113.281 0.845 . . . . 0.0 113.281 176.449 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 2508 ' ' GLY . . . . . . . . . . . . . . . -60.75 111.14 3.48 Favored Glycine 0 CA--C 1.532 1.155 0 O-C-N 121.237 -0.915 . . . . 0.0 112.652 -178.575 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 2509 ' ' GLY . . . . . . . . . . . . . . . 95.38 -8.72 69.38 Favored Glycine 0 CA--C 1.536 1.353 0 C-N-CA 125.984 1.754 . . . . 0.0 114.7 -176.349 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 2510 ' ' SER . . . . . . . . . . . . . 47.9 t -83.2 147.52 53.87 Favored Pre-proline 0 CA--C 1.549 0.936 0 CA-C-N 118.802 1.301 . . . . 0.0 111.997 179.538 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 2511 ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -78.18 154.76 93.65 Favored 'Cis proline' 0 C--N 1.353 0.781 0 CA-C-N 119.809 0.967 . . . . 0.0 112.98 -1.383 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 2512 ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -104.86 131.67 52.06 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 125.141 1.376 . . . . 0.0 110.728 178.32 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 2513 ' ' LYS . . . . . . . . . . . . . 19.5 ptpt -89.13 8.04 32.02 Favored 'General case' 0 N--CA 1.479 0.983 0 N-CA-C 116.617 2.08 . . . . 0.0 116.617 -166.707 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 2514 ' ' ALA . . . . . . . . . . . . . . . -2.52 96.99 0.01 OUTLIER 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 129.436 3.095 . . . . 0.0 116.316 -177.722 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 2515 ' ' LYS . . . . . . . . . . . . . 44.9 mtpt -90.03 133.18 34.98 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.157 0.983 . . . . 0.0 111.354 -173.99 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 2516 ' ' VAL . . . . . . . . . . . . . 31.7 m -133.0 149.22 31.53 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 C-N-CA 124.326 1.05 . . . . 0.0 112.426 -168.764 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 2517 ' ' THR . . . . . . . . . . . . . 35.8 p -140.3 164.18 30.79 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 125.611 1.565 . . . . 0.0 111.365 -174.986 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 2518 ' ' GLY . . . . . . . . . . . . . . . 116.42 -162.19 12.74 Favored Glycine 0 CA--C 1.539 1.538 0 C-N-CA 125.046 1.308 . . . . 0.0 112.441 -174.308 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 2519 ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -72.56 167.23 27.64 Favored 'Trans proline' 0 CA--C 1.536 0.576 0 C-N-CA 123.562 2.842 . . . . 0.0 112.09 -177.896 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 2520 ' ' ARG . . . . . . . . . . . . . 49.1 ttp180 . . . . . 0 CA--C 1.537 0.457 0 C-N-CA 124.148 0.979 . . . . 0.0 109.189 167.476 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A 2427 ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.961 0 CA-C-O 121.455 0.475 . . . . 0.0 113.832 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A 2428 ' ' ASP . . . . . . . . . . . . . 12.5 t70 -82.89 136.06 44.77 Favored Pre-proline 0 CA--C 1.548 0.896 0 C-N-CA 125.285 1.434 . . . . 0.0 111.211 177.4 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 2429 ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -63.06 -22.08 73.28 Favored 'Trans proline' 0 C--N 1.353 0.771 0 C-N-CA 123.642 2.895 . . . . 0.0 114.244 -174.661 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 2430 ' ' GLY . . . . . . . . . . . . . . . -80.79 -20.2 66.23 Favored Glycine 0 CA--C 1.534 1.232 0 C-N-CA 124.054 0.835 . . . . 0.0 113.691 174.738 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 2431 ' ' LEU . . . . . . . . . . . . . 4.3 mm? -84.49 -28.42 26.77 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.462 1.105 . . . . 0.0 111.999 173.433 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 2432 ' ' VAL . . . . . . . . . . . . . 2.3 t -67.74 143.12 15.65 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 CA-C-N 118.7 0.682 . . . . 0.0 109.491 169.561 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 2433 ' ' SER . . . . . . . . . . . . . 8.1 t -135.86 -172.77 3.19 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.311 1.044 . . . . 0.0 110.569 171.436 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 2434 ' ' ALA . . . . . . . . . . . . . . . -148.93 142.33 25.23 Favored 'General case' 0 CA--C 1.537 0.455 0 O-C-N 120.921 -1.112 . . . . 0.0 111.638 177.232 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 2435 ' ' TYR . . . . . . . . . . . . . 74.7 m-85 -143.67 146.81 33.5 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.229 1.411 . . . . 0.0 112.027 -174.326 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 2436 ' ' GLY . . . . . . . . . . . . . . . 128.35 159.98 10.2 Favored Glycine 0 N--CA 1.473 1.108 0 C-N-CA 125.767 1.651 . . . . 0.0 113.571 179.34 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 2437 ' ' ALA . . . . . . . . . . . . . . . -61.17 -29.6 69.9 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.938 1.295 . . . . 0.0 114.193 -171.27 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 2438 ' ' GLY . . . . . . . . . . . . . . . -65.89 -16.15 63.5 Favored Glycine 0 CA--C 1.53 1.005 0 C-N-CA 124.361 0.981 . . . . 0.0 114.375 -178.082 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 2439 ' ' LEU . . . . . . . . . . . . . 79.0 mt -80.03 -26.87 39.58 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 118.77 1.285 . . . . 0.0 112.594 172.556 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 2440 ' ' GLU . . . . . . . . . . . . . 35.0 mm-40 -87.36 -38.04 16.55 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.72 1.208 . . . . 0.0 111.582 -178.957 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 2441 ' ' GLY . . . . . . . . . . . . . . . 162.29 -150.43 19.65 Favored Glycine 0 CA--C 1.527 0.8 0 C-N-CA 124.046 0.831 . . . . 0.0 114.173 -175.61 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 2442 ' ' GLY . . . . . . . . . . . . . . . 167.58 -170.29 41.62 Favored Glycine 0 CA--C 1.53 0.999 0 C-N-CA 124.951 1.262 . . . . 0.0 113.616 -179.735 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 2443 ' ' VAL . . . . . . . . . . . . . 97.9 t -120.93 137.02 56.01 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 C-N-CA 125.435 1.494 . . . . 0.0 109.115 176.611 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 2444 ' ' THR . . . . . . . . . . . . . 27.9 p -56.23 128.22 34.6 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.598 1.159 . . . . 0.0 111.837 177.68 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 2445 ' ' GLY . . . . . . . . . . . . . . . 86.26 -10.89 64.73 Favored Glycine 0 CA--C 1.533 1.165 0 C-N-CA 125.28 1.419 . . . . 0.0 114.891 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 2446 ' ' ASN . . . . . . . . . . . . . 86.6 m-20 -104.72 141.72 23.14 Favored Pre-proline 0 CA--C 1.546 0.796 0 C-N-CA 124.693 1.197 . . . . 0.0 110.684 175.338 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 2447 ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -71.63 142.15 39.44 Favored 'Trans proline' 0 N--CA 1.457 -0.641 0 C-N-CA 122.64 2.226 . . . . 0.0 111.118 177.046 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 2448 ' ' ALA . . . . . . . . . . . . . . . -125.51 156.25 39.28 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 126.082 1.753 . . . . 0.0 109.341 167.983 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 2449 ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -152.52 160.17 43.25 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 114.019 1.118 . . . . 0.0 114.019 -166.986 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 2450 ' ' PHE . . . . . . . . . . . . . 52.0 p90 -161.75 159.02 26.68 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 126.193 1.797 . . . . 0.0 111.24 -177.425 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 2451 ' ' VAL . . . . . . . . . . . . . 48.2 t -115.98 130.22 71.06 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 C-N-CA 124.847 1.259 . . . . 0.0 109.219 173.151 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 2452 ' ' VAL . . . . . . . . . . . . . 21.4 t -78.95 102.76 5.27 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 N-CA-C 106.795 -1.558 . . . . 0.0 106.795 164.884 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 2453 ' ' ASN . . . . . . . . . . . . . 10.7 t-20 -81.69 114.3 20.27 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.051 0.94 . . . . 0.0 111.856 -169.48 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 2454 ' ' THR . . . . . . . . . . . . . 58.3 p -99.92 -7.25 25.45 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 125.65 1.58 . . . . 0.0 113.856 -176.318 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 2455 ' ' SER . . . . . . . . . . . . . 16.7 m -55.41 -32.92 63.08 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 114.534 1.309 . . . . 0.0 114.534 -174.274 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 2456 ' ' ASN . . . . . . . . . . . . . 92.1 m-20 -85.26 -14.08 47.8 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 124.324 1.049 . . . . 0.0 113.465 177.95 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 2457 ' ' ALA . . . . . . . . . . . . . . . -105.61 -48.88 3.55 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 125.097 1.359 . . . . 0.0 113.158 -171.491 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 2458 ' ' GLY . . . . . . . . . . . . . . . 117.92 -138.4 13.92 Favored Glycine 0 CA--C 1.532 1.102 0 C-N-CA 125.066 1.317 . . . . 0.0 112.526 -173.464 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 2459 ' ' ALA . . . . . . . . . . . . . . . -97.3 175.86 6.11 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 125.553 1.541 . . . . 0.0 112.575 -179.746 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 2460 ' ' GLY . . . . . . . . . . . . . . . 134.07 162.76 10.08 Favored Glycine 0 CA--C 1.53 0.978 0 C-N-CA 125.21 1.386 . . . . 0.0 113.677 -179.379 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 2461 ' ' ALA . . . . . . . . . . . . . . . -80.49 146.78 31.19 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.273 1.029 . . . . 0.0 112.566 -178.935 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 2462 ' ' LEU . . . . . . . . . . . . . 14.6 tp -104.14 145.88 29.56 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.765 1.626 . . . . 0.0 110.391 172.363 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 2463 ' ' SER . . . . . . . . . . . . . 22.6 t -124.87 147.6 48.71 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 123.949 0.9 . . . . 0.0 109.335 153.052 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 2464 ' ' VAL . . . . . . . . . . . . . 12.1 p -160.16 139.6 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 O-C-N 121.256 -0.902 . . . . 0.0 111.039 -172.816 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 2465 ' ' THR . . . . . . . . . . . . . 9.5 t -161.5 161.77 30.13 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 125.112 1.365 . . . . 0.0 111.256 -177.727 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 2466 ' ' ILE . . . . . . . . . . . . . 39.7 mt -134.67 121.91 36.94 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 C-N-CA 125.089 1.356 . . . . 0.0 109.934 -173.864 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 2467 ' ' ASP . . . . . . . . . . . . . 36.7 t70 -98.18 156.74 16.54 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.691 1.596 . . . . 0.0 110.234 167.716 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 2468 ' ' GLY . . . . . . . . . . . . . . . 171.93 -165.83 38.65 Favored Glycine 0 CA--C 1.535 1.309 0 O-C-N 120.951 -1.093 . . . . 0.0 115.175 -179.888 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 2469 ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -69.81 -12.67 33.27 Favored 'Trans proline' 0 CA--C 1.541 0.871 0 C-N-CA 124.116 3.211 . . . . 0.0 113.841 -179.808 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 2470 ' ' SER . . . . . . . . . . . . . 33.3 m -156.16 170.89 21.16 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 126.887 2.075 . . . . 0.0 110.174 173.406 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 2471 ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -67.73 162.0 24.77 Favored 'General case' 0 CA--C 1.548 0.889 0 O-C-N 121.116 -0.99 . . . . 0.0 111.752 167.869 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 2472 ' ' VAL . . . . . . . . . . . . . 35.8 m -137.79 145.06 29.61 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 C-N-CA 124.785 1.234 . . . . 0.0 111.639 -179.207 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 2473 ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -87.52 90.72 8.48 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.411 1.084 . . . . 0.0 110.867 -179.795 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 2474 ' ' MET . . . . . . . . . . . . . 96.7 mtp -80.93 133.82 35.61 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 124.279 1.032 . . . . 0.0 111.591 178.75 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 2475 ' ' ASP . . . . . . . . . . . . . 21.1 t70 -116.3 118.65 33.35 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 125.865 1.666 . . . . 0.0 109.044 162.892 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 2476 ' ' CYS . . . . . . . . . . . . . 72.4 m -102.81 137.85 40.48 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.397 1.079 . . . . 0.0 110.106 175.053 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 2477 ' ' GLN . . . . . . . . . . . . . 5.4 pt20 -154.12 155.35 35.22 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.499 1.119 . . . . 0.0 110.731 -175.96 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 2478 ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -97.68 138.07 35.63 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.84 0.856 . . . . 0.0 110.844 -179.425 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 2479 ' ' CYS . . . . . . . . . . . . . 17.0 p -137.02 171.59 8.34 Favored Pre-proline 0 CA--C 1.554 1.107 0 C-N-CA 125.602 1.561 . . . . 0.0 111.479 175.529 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 2480 ' ' PRO . . . . . . . . . . . . . 73.4 Cg_exo -58.6 -27.1 81.6 Favored 'Trans proline' 0 CA--C 1.54 0.791 0 C-N-CA 123.42 2.746 . . . . 0.0 114.572 178.588 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 2481 ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -84.7 -14.29 48.86 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 124.748 1.219 . . . . 0.0 113.135 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 2482 ' ' GLY . . . . . . . . . . . . . . . 139.82 -143.8 14.25 Favored Glycine 0 N--CA 1.471 0.987 0 C-N-CA 125.228 1.394 . . . . 0.0 113.425 178.511 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 2483 ' ' TYR . . . . . . . . . . . . . 66.5 m-85 -91.08 115.83 28.32 Favored 'General case' 0 N--CA 1.467 0.425 0 O-C-N 121.934 -0.745 . . . . 0.0 111.185 175.33 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 2484 ' ' ARG . . . . . . . . . . . . . 43.4 ttt180 -92.01 139.63 30.45 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 125.563 1.545 . . . . 0.0 110.87 178.111 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 2485 ' ' VAL . . . . . . . . . . . . . 65.4 t -126.83 129.59 71.42 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 125.542 1.537 . . . . 0.0 108.855 175.272 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 2486 ' ' THR . . . . . . . . . . . . . 93.8 m -117.6 139.2 51.3 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 125.37 1.468 . . . . 0.0 108.004 169.315 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 2487 ' ' TYR . . . . . . . . . . . . . 19.4 p90 -149.0 150.3 32.6 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 123.692 0.797 . . . . 0.0 112.851 176.656 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 2488 ' ' THR . . . . . . . . . . . . . 99.6 m -110.99 113.71 54.63 Favored Pre-proline 0 N--CA 1.474 0.738 0 C-N-CA 124.37 1.068 . . . . 0.0 109.609 176.712 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 2489 ' ' PRO . . . . . . . . . . . . . 79.3 Cg_endo -77.25 164.31 29.27 Favored 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 123.748 2.965 . . . . 0.0 110.947 169.269 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 2490 ' ' MET . . . . . . . . . . . . . 28.1 ptm -143.85 -3.17 0.89 Allowed 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 115.561 1.689 . . . . 0.0 115.561 -172.3 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 2491 ' ' ALA . . . . . . . . . . . . . . . -140.01 148.02 53.16 Favored Pre-proline 0 CA--C 1.546 0.821 0 C-N-CA 125.167 1.387 . . . . 0.0 110.737 174.139 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 2492 ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -71.34 146.83 51.63 Favored 'Trans proline' 0 CA--C 1.537 0.666 0 C-N-CA 122.856 2.37 . . . . 0.0 110.933 177.896 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 2493 ' ' GLY . . . . . . . . . . . . . . . 136.39 -167.62 24.4 Favored Glycine 0 CA--C 1.531 1.075 0 C-N-CA 125.214 1.388 . . . . 0.0 113.603 -176.602 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 2494 ' ' SER . . . . . . . . . . . . . 49.4 m -95.22 123.18 38.59 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 124.417 1.087 . . . . 0.0 111.299 179.863 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 2495 ' ' TYR . . . . . . . . . . . . . 73.1 m-85 -97.97 116.95 31.22 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.346 1.058 . . . . 0.0 110.129 170.003 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 2496 ' ' LEU . . . . . . . . . . . . . 23.2 tp -93.16 105.64 17.71 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.943 1.297 . . . . 0.0 109.904 -176.586 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 2497 ' ' ILE . . . . . . . . . . . . . 44.4 mt -93.32 112.37 26.32 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 C-N-CA 126.443 1.897 . . . . 0.0 108.636 -176.545 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 2498 ' ' SER . . . . . . . . . . . . . 75.4 m -96.61 123.87 40.42 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 123.512 0.725 . . . . 0.0 110.002 174.521 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 2499 ' ' ILE . . . . . . . . . . . . . 23.9 mt -124.95 116.23 46.58 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 C-N-CA 125.269 1.427 . . . . 0.0 109.297 -175.785 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 2500 ' ' LYS . . . . . . . . . . . . . 96.0 mttt -127.28 140.77 51.99 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.783 1.233 . . . . 0.0 111.817 -172.821 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 2501 ' ' TYR . . . . . . . . . . . . . 44.4 t80 -146.85 144.47 29.33 Favored 'General case' 0 N--CA 1.474 0.769 0 O-C-N 121.303 -0.873 . . . . 0.0 113.329 -172.331 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 2502 ' ' GLY . . . . . . . . . . . . . . . 69.57 19.46 74.73 Favored Glycine 0 CA--C 1.536 1.345 0 C-N-CA 124.101 0.858 . . . . 0.0 113.207 -179.152 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 2503 ' ' GLY . . . . . . . . . . . . . . . 132.17 -176.04 19.52 Favored Glycine 0 CA--C 1.54 1.637 0 C-N-CA 126.325 1.917 . . . . 0.0 112.293 -166.304 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 2504 ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -82.21 43.97 1.61 Allowed 'Trans proline' 0 CA--C 1.545 1.047 0 C-N-CA 124.959 3.773 . . . . 0.0 112.662 -173.722 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 2505 ' ' TYR . . . . . . . . . . . . . 76.0 m-85 -125.43 131.19 52.95 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.817 1.247 . . . . 0.0 112.475 -174.134 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 2506 ' ' HIS . . . . . . . . . . . . . 88.0 m-70 -59.33 138.07 57.76 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 124.921 1.288 . . . . 0.0 113.536 -177.26 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 2507 ' ' ILE . . . . . . . . . . . . . 2.3 pp -88.97 147.6 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 C-N-CA 123.854 0.862 . . . . 0.0 112.535 175.154 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 2508 ' ' GLY . . . . . . . . . . . . . . . 48.26 -115.32 2.35 Favored Glycine 0 CA--C 1.535 1.323 0 C-N-CA 124.239 0.923 . . . . 0.0 114.031 167.093 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 2509 ' ' GLY . . . . . . . . . . . . . . . -97.05 11.11 65.91 Favored Glycine 0 CA--C 1.537 1.417 0 C-N-CA 126.061 1.791 . . . . 0.0 115.212 177.693 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 2510 ' ' SER . . . . . . . . . . . . . 46.5 t -63.17 144.82 97.28 Favored Pre-proline 0 CA--C 1.55 0.974 0 CA-C-N 119.342 1.571 . . . . 0.0 112.458 178.917 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 2511 ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -79.64 152.34 86.25 Favored 'Cis proline' 0 C--N 1.353 0.779 0 CA-C-N 119.343 0.801 . . . . 0.0 113.349 -0.364 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 2512 ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -103.81 130.46 51.36 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 125.62 1.568 . . . . 0.0 110.782 -179.363 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 2513 ' ' LYS . . . . . . . . . . . . . 7.4 ptpp? -90.57 9.77 28.17 Favored 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 116.833 2.16 . . . . 0.0 116.833 -165.112 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 2514 ' ' ALA . . . . . . . . . . . . . . . -4.0 101.3 0.01 OUTLIER 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 129.404 3.082 . . . . 0.0 116.532 -176.847 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 2515 ' ' LYS . . . . . . . . . . . . . 35.2 mtmm -88.23 119.41 28.6 Favored 'General case' 0 CA--C 1.544 0.715 0 O-C-N 121.293 -0.88 . . . . 0.0 111.778 -173.419 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 2516 ' ' VAL . . . . . . . . . . . . . 54.1 t -111.27 144.08 19.87 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 125.83 1.652 . . . . 0.0 110.605 -173.971 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 2517 ' ' THR . . . . . . . . . . . . . 53.0 p -131.52 173.44 11.11 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 125.693 1.597 . . . . 0.0 110.949 174.299 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 2518 ' ' GLY . . . . . . . . . . . . . . . 112.88 179.43 19.47 Favored Glycine 0 CA--C 1.54 1.607 0 C-N-CA 125.1 1.333 . . . . 0.0 113.651 -177.863 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 2519 ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -69.68 129.31 17.46 Favored 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 123.896 3.064 . . . . 0.0 111.819 -172.67 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 2520 ' ' ARG . . . . . . . . . . . . . 35.2 ttt-85 . . . . . 0 CA--C 1.538 0.485 0 C-N-CA 123.716 0.806 . . . . 0.0 110.449 177.541 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A 2427 ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.14 0 CA-C-O 121.506 0.503 . . . . 0.0 113.69 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A 2428 ' ' ASP . . . . . . . . . . . . . 22.7 m-20 -94.33 129.69 36.22 Favored Pre-proline 0 CA--C 1.549 0.914 0 C-N-CA 124.496 1.119 . . . . 0.0 112.43 -178.414 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 2429 ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -56.46 -30.3 81.47 Favored 'Trans proline' 0 C--N 1.353 0.775 0 C-N-CA 123.659 2.906 . . . . 0.0 113.916 174.458 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 2430 ' ' GLY . . . . . . . . . . . . . . . -75.41 -21.23 77.88 Favored Glycine 0 CA--C 1.534 1.258 0 CA-C-O 119.379 -0.678 . . . . 0.0 113.92 177.979 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 2431 ' ' LEU . . . . . . . . . . . . . 4.3 mm? -88.86 -32.01 18.0 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.463 1.105 . . . . 0.0 111.698 173.143 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 2432 ' ' VAL . . . . . . . . . . . . . 95.4 t -68.15 136.22 26.92 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 C-N-CA 123.39 0.676 . . . . 0.0 110.439 170.549 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 2433 ' ' SER . . . . . . . . . . . . . 57.0 m -140.73 144.79 35.76 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 125.27 1.428 . . . . 0.0 109.998 175.544 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 2434 ' ' ALA . . . . . . . . . . . . . . . -100.61 148.19 25.11 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 123.351 0.66 . . . . 0.0 112.134 177.096 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 2435 ' ' TYR . . . . . . . . . . . . . 82.2 m-85 -143.93 146.26 32.84 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 125.852 1.661 . . . . 0.0 111.591 -176.282 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 2436 ' ' GLY . . . . . . . . . . . . . . . 124.89 163.52 11.67 Favored Glycine 0 N--CA 1.475 1.284 0 C-N-CA 125.09 1.328 . . . . 0.0 114.577 175.175 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 2437 ' ' ALA . . . . . . . . . . . . . . . -62.31 -30.62 71.28 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.184 1.394 . . . . 0.0 114.433 -170.064 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 2438 ' ' GLY . . . . . . . . . . . . . . . -66.05 -13.37 59.6 Favored Glycine 0 CA--C 1.532 1.152 0 C-N-CA 124.306 0.955 . . . . 0.0 114.282 -179.501 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 2439 ' ' LEU . . . . . . . . . . . . . 81.6 mt -79.84 -23.91 41.68 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 118.637 1.219 . . . . 0.0 112.801 171.049 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 2440 ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -92.78 -34.96 13.68 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 124.792 1.237 . . . . 0.0 111.985 -175.882 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 2441 ' ' GLY . . . . . . . . . . . . . . . 159.68 -153.22 24.23 Favored Glycine 0 C--N 1.339 0.748 0 C-N-CA 123.806 0.717 . . . . 0.0 114.31 -176.71 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 2442 ' ' GLY . . . . . . . . . . . . . . . 169.85 -168.76 41.63 Favored Glycine 0 CA--C 1.528 0.883 0 C-N-CA 124.802 1.191 . . . . 0.0 113.387 -178.926 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 2443 ' ' VAL . . . . . . . . . . . . . 38.9 t -128.31 139.11 52.79 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 C-N-CA 124.915 1.286 . . . . 0.0 108.867 174.657 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 2444 ' ' THR . . . . . . . . . . . . . 40.1 p -58.28 141.44 50.92 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.864 0.866 . . . . 0.0 112.706 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 2445 ' ' GLY . . . . . . . . . . . . . . . 78.2 -9.74 31.67 Favored Glycine 0 CA--C 1.535 1.316 0 C-N-CA 124.811 1.196 . . . . 0.0 114.859 -178.505 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 2446 ' ' ASN . . . . . . . . . . . . . 86.1 m-20 -111.59 144.87 31.46 Favored Pre-proline 0 CA--C 1.547 0.862 0 C-N-CA 125.318 1.447 . . . . 0.0 111.289 176.503 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 2447 ' ' PRO . . . . . . . . . . . . . 82.2 Cg_endo -74.71 149.46 38.21 Favored 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 122.893 2.395 . . . . 0.0 111.882 178.681 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 2448 ' ' ALA . . . . . . . . . . . . . . . -136.83 148.59 47.22 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 126.069 1.748 . . . . 0.0 109.654 168.354 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 2449 ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -141.1 157.42 45.32 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 114.164 1.172 . . . . 0.0 114.164 -166.443 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 2450 ' ' PHE . . . . . . . . . . . . . 50.7 p90 -156.59 162.64 39.88 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 126.421 1.888 . . . . 0.0 110.911 178.76 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 2451 ' ' VAL . . . . . . . . . . . . . 8.2 p -122.91 133.9 67.66 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 C-N-CA 124.698 1.199 . . . . 0.0 110.305 175.747 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 2452 ' ' VAL . . . . . . . . . . . . . 45.4 t -90.09 102.45 13.26 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 N-CA-C 106.943 -1.503 . . . . 0.0 106.943 169.64 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 2453 ' ' ASN . . . . . . . . . . . . . 19.6 t-20 -86.35 117.96 25.49 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 112.411 0.523 . . . . 0.0 112.411 -169.528 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 2454 ' ' THR . . . . . . . . . . . . . 53.0 p -97.83 -5.54 34.49 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 125.292 1.437 . . . . 0.0 113.851 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 2455 ' ' SER . . . . . . . . . . . . . 20.5 m -56.51 -28.29 59.49 Favored 'General case' 0 N--CA 1.479 1.006 0 CA-C-N 120.148 1.34 . . . . 0.0 114.54 -175.358 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 2456 ' ' ASN . . . . . . . . . . . . . 64.7 m-80 -83.33 -14.82 52.09 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 124.653 1.181 . . . . 0.0 113.593 176.532 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 2457 ' ' ALA . . . . . . . . . . . . . . . -115.58 -19.69 10.48 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 125.964 1.706 . . . . 0.0 114.271 -173.867 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 2458 ' ' GLY . . . . . . . . . . . . . . . 103.85 -103.13 2.26 Favored Glycine 0 CA--C 1.529 0.929 0 C-N-CA 125.585 1.564 . . . . 0.0 110.923 -172.699 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 2459 ' ' ALA . . . . . . . . . . . . . . . -158.61 163.39 37.01 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 125.898 1.679 . . . . 0.0 111.337 179.755 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 2460 ' ' GLY . . . . . . . . . . . . . . . 167.45 174.97 37.0 Favored Glycine 0 CA--C 1.528 0.9 0 N-CA-C 114.878 0.711 . . . . 0.0 114.878 -175.752 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 2461 ' ' ALA . . . . . . . . . . . . . . . -77.98 128.17 33.47 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.387 1.075 . . . . 0.0 112.434 -176.627 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 2462 ' ' LEU . . . . . . . . . . . . . 25.3 tp -106.64 144.28 33.53 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 125.58 1.552 . . . . 0.0 110.83 177.437 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 2463 ' ' SER . . . . . . . . . . . . . 3.8 t -136.2 40.89 2.65 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 125.843 1.657 . . . . 0.0 110.923 -176.248 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 2464 ' ' VAL . . . . . . . . . . . . . 7.5 p -64.27 133.41 29.86 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 C-N-CA 125.013 1.325 . . . . 0.0 112.107 -176.01 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 2465 ' ' THR . . . . . . . . . . . . . 97.8 m -134.18 142.84 47.57 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 126.027 1.731 . . . . 0.0 109.994 -177.196 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 2466 ' ' ILE . . . . . . . . . . . . . 50.6 mt -118.54 121.67 67.6 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 C-N-CA 124.201 1.0 . . . . 0.0 109.949 175.354 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 2467 ' ' ASP . . . . . . . . . . . . . 36.4 t70 -105.51 159.75 15.7 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 126.269 1.828 . . . . 0.0 110.592 169.314 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 2468 ' ' GLY . . . . . . . . . . . . . . . 172.97 -168.17 41.14 Favored Glycine 0 CA--C 1.535 1.313 0 O-C-N 121.305 -0.872 . . . . 0.0 114.472 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 2469 ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -66.13 -27.17 49.43 Favored 'Trans proline' 0 CA--C 1.54 0.78 0 C-N-CA 123.865 3.043 . . . . 0.0 112.833 177.95 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 2470 ' ' SER . . . . . . . . . . . . . 70.4 m -143.64 166.1 25.8 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 126.042 1.737 . . . . 0.0 110.184 172.196 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 2471 ' ' LYS . . . . . . . . . . . . . 68.2 mttm -71.65 131.98 43.95 Favored 'General case' 0 CA--C 1.545 0.753 0 O-C-N 120.706 -1.246 . . . . 0.0 110.989 171.9 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 2472 ' ' VAL . . . . . . . . . . . . . 20.5 m -87.47 155.52 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 C-N-CA 123.92 0.888 . . . . 0.0 111.52 177.911 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 2473 ' ' LYS . . . . . . . . . . . . . 97.5 mttt -80.84 72.35 7.82 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 124.399 1.08 . . . . 0.0 110.843 175.987 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 2474 ' ' MET . . . . . . . . . . . . . 22.4 ttt -78.97 139.91 38.13 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 125.745 1.618 . . . . 0.0 112.74 -171.588 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 2475 ' ' ASP . . . . . . . . . . . . . 17.6 m-20 -138.99 132.4 30.16 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 126.155 1.782 . . . . 0.0 109.844 167.116 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 2476 ' ' CYS . . . . . . . . . . . . . 48.0 t -118.19 140.67 49.44 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.076 1.35 . . . . 0.0 110.728 176.524 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 2477 ' ' GLN . . . . . . . . . . . . . 42.2 mt-30 -136.4 142.82 43.73 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 125.497 1.519 . . . . 0.0 110.444 -177.071 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 2478 ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -86.37 139.23 31.15 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.08 0.952 . . . . 0.0 110.161 171.899 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 2479 ' ' CYS . . . . . . . . . . . . . 29.3 p -150.52 169.76 8.75 Favored Pre-proline 0 CA--C 1.552 1.043 0 C-N-CA 125.01 1.324 . . . . 0.0 112.325 -176.866 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 2480 ' ' PRO . . . . . . . . . . . . . 56.3 Cg_exo -58.59 -25.46 74.78 Favored 'Trans proline' 0 CA--C 1.539 0.754 0 C-N-CA 123.356 2.704 . . . . 0.0 114.08 174.436 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 2481 ' ' GLU . . . . . . . . . . . . . 21.6 tt0 -85.23 -2.32 57.91 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 125.242 1.417 . . . . 0.0 113.13 178.37 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 2482 ' ' GLY . . . . . . . . . . . . . . . 121.88 -118.89 3.85 Favored Glycine 0 N--CA 1.47 0.938 0 C-N-CA 125.826 1.679 . . . . 0.0 112.202 -179.394 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 2483 ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -123.88 116.76 23.46 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.083 0.953 . . . . 0.0 110.881 174.922 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 2484 ' ' ARG . . . . . . . . . . . . . 41.4 ttm-85 -94.25 132.53 38.73 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 124.6 1.16 . . . . 0.0 110.169 179.227 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 2485 ' ' VAL . . . . . . . . . . . . . 86.1 t -119.98 135.36 60.52 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 C-N-CA 125.676 1.59 . . . . 0.0 108.998 -179.603 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 2486 ' ' THR . . . . . . . . . . . . . 88.4 m -129.07 142.84 50.77 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 125.244 1.417 . . . . 0.0 108.449 172.901 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 2487 ' ' TYR . . . . . . . . . . . . . 37.2 p90 -149.36 148.27 29.29 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 113.085 0.772 . . . . 0.0 113.085 174.041 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 2488 ' ' THR . . . . . . . . . . . . . 59.2 m -108.47 118.51 51.93 Favored Pre-proline 0 N--CA 1.473 0.725 0 C-N-CA 124.628 1.171 . . . . 0.0 108.759 168.358 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 2489 ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -82.76 157.34 15.98 Favored 'Trans proline' 0 N--CA 1.457 -0.654 0 C-N-CA 123.719 2.946 . . . . 0.0 111.189 174.108 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 2490 ' ' MET . . . . . . . . . . . . . 28.8 ptm -124.32 5.44 8.42 Favored 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 114.308 1.225 . . . . 0.0 114.308 -174.842 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 2491 ' ' ALA . . . . . . . . . . . . . . . -151.56 148.89 22.91 Favored Pre-proline 0 CA--C 1.546 0.807 0 C-N-CA 125.826 1.651 . . . . 0.0 111.117 178.25 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 2492 ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -74.66 155.33 44.61 Favored 'Trans proline' 0 CA--C 1.536 0.599 0 C-N-CA 123.094 2.529 . . . . 0.0 111.229 173.561 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 2493 ' ' GLY . . . . . . . . . . . . . . . 131.5 -174.37 20.09 Favored Glycine 0 CA--C 1.529 0.935 0 C-N-CA 125.337 1.446 . . . . 0.0 113.662 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 2494 ' ' SER . . . . . . . . . . . . . 11.1 p -86.28 129.81 34.72 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.361 1.064 . . . . 0.0 111.85 174.338 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 2495 ' ' TYR . . . . . . . . . . . . . 60.0 m-85 -107.2 125.48 51.17 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 125.578 1.551 . . . . 0.0 109.279 172.305 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 2496 ' ' LEU . . . . . . . . . . . . . 19.1 tp -94.48 107.0 18.99 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 123.857 0.863 . . . . 0.0 109.546 -178.255 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 2497 ' ' ILE . . . . . . . . . . . . . 48.7 mt -92.66 101.73 12.89 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 C-N-CA 125.631 1.572 . . . . 0.0 107.624 -179.763 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 2498 ' ' SER . . . . . . . . . . . . . 75.8 m -90.36 99.33 12.37 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 124.606 1.162 . . . . 0.0 109.519 176.917 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 2499 ' ' ILE . . . . . . . . . . . . . 23.0 mt -93.47 89.79 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 C-N-CA 124.511 1.125 . . . . 0.0 108.451 -178.133 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 2500 ' ' LYS . . . . . . . . . . . . . 85.1 mttt -99.53 142.52 30.91 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 124.334 1.054 . . . . 0.0 111.722 -178.715 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 2501 ' ' TYR . . . . . . . . . . . . . 72.9 t80 -146.5 138.08 24.58 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 124.738 1.215 . . . . 0.0 111.4 -168.176 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 2502 ' ' GLY . . . . . . . . . . . . . . . 69.03 12.08 64.63 Favored Glycine 0 CA--C 1.534 1.241 0 C-N-CA 124.356 0.979 . . . . 0.0 114.971 -179.45 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 2503 ' ' GLY . . . . . . . . . . . . . . . 138.41 -153.24 22.36 Favored Glycine 0 CA--C 1.539 1.552 0 C-N-CA 125.507 1.527 . . . . 0.0 112.388 -169.421 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 2504 ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -81.75 6.86 5.38 Favored 'Trans proline' 0 CA--C 1.543 0.938 0 C-N-CA 124.354 3.369 . . . . 0.0 114.123 -172.961 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 2505 ' ' TYR . . . . . . . . . . . . . 64.5 m-85 -99.26 136.14 39.64 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.272 1.029 . . . . 0.0 113.18 -172.479 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 2506 ' ' HIS . . . . . . . . . . . . . 93.4 m-70 -64.75 148.2 51.62 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 125.036 1.334 . . . . 0.0 113.305 176.778 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 2507 ' ' ILE . . . . . . . . . . . . . 30.4 pt -73.59 173.27 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 C-N-CA 123.387 0.675 . . . . 0.0 112.523 167.599 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 2508 ' ' GLY . . . . . . . . . . . . . . . -58.97 122.19 29.34 Favored Glycine 0 CA--C 1.534 1.253 0 O-C-N 121.659 -0.651 . . . . 0.0 111.791 172.808 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 2509 ' ' GLY . . . . . . . . . . . . . . . 88.75 -9.99 74.07 Favored Glycine 0 CA--C 1.536 1.362 0 C-N-CA 125.654 1.597 . . . . 0.0 115.226 -178.932 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 2510 ' ' SER . . . . . . . . . . . . . 41.6 t -84.95 147.77 49.06 Favored Pre-proline 0 CA--C 1.549 0.914 0 CA-C-N 119.053 1.426 . . . . 0.0 112.023 179.325 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 2511 ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -79.34 158.7 90.17 Favored 'Cis proline' 0 C--N 1.353 0.801 0 CA-C-N 119.867 0.988 . . . . 0.0 113.456 0.245 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 2512 ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -107.66 137.97 44.72 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 125.471 1.508 . . . . 0.0 110.747 177.847 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 2513 ' ' LYS . . . . . . . . . . . . . 19.1 ptpt -99.5 15.42 26.56 Favored 'General case' 0 N--CA 1.48 1.068 0 N-CA-C 116.289 1.959 . . . . 0.0 116.289 -163.48 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 2514 ' ' ALA . . . . . . . . . . . . . . . -14.89 108.57 0.02 OUTLIER 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 129.388 3.075 . . . . 0.0 116.722 -173.409 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 2515 ' ' LYS . . . . . . . . . . . . . 67.5 mttm -92.24 107.85 19.51 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 124.66 1.184 . . . . 0.0 111.72 -175.26 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 2516 ' ' VAL . . . . . . . . . . . . . 71.3 t -95.74 142.07 14.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 C-N-CA 125.726 1.61 . . . . 0.0 110.493 -177.828 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 2517 ' ' THR . . . . . . . . . . . . . 77.8 p -121.42 179.31 4.47 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 125.28 1.432 . . . . 0.0 111.456 174.321 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 2518 ' ' GLY . . . . . . . . . . . . . . . 99.91 178.78 30.59 Favored Glycine 0 CA--C 1.54 1.635 0 C-N-CA 124.676 1.131 . . . . 0.0 113.635 -178.231 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 2519 ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -72.98 148.4 45.18 Favored 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 123.857 3.038 . . . . 0.0 112.218 -174.46 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 2520 ' ' ARG . . . . . . . . . . . . . 49.4 ttm-85 . . . . . 0 CA--C 1.539 0.538 0 C-N-CA 123.63 0.772 . . . . 0.0 110.281 173.189 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A 2427 ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.145 0 CA-C-O 121.533 0.518 . . . . 0.0 113.879 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A 2428 ' ' ASP . . . . . . . . . . . . . 24.5 m-20 -91.0 133.12 32.6 Favored Pre-proline 0 CA--C 1.549 0.905 0 C-N-CA 124.233 1.013 . . . . 0.0 112.857 -175.205 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 2429 ' ' PRO . . . . . . . . . . . . . 72.5 Cg_exo -55.2 -27.88 58.73 Favored 'Trans proline' 0 C--N 1.352 0.711 0 C-N-CA 124.097 3.198 . . . . 0.0 114.308 171.611 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 2430 ' ' GLY . . . . . . . . . . . . . . . -77.04 -23.13 69.7 Favored Glycine 0 CA--C 1.534 1.254 0 C-N-CA 123.851 0.739 . . . . 0.0 113.819 176.525 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 2431 ' ' LEU . . . . . . . . . . . . . 4.4 mm? -87.42 -31.63 19.96 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.393 1.077 . . . . 0.0 111.612 171.768 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 2432 ' ' VAL . . . . . . . . . . . . . 87.5 t -64.67 130.23 29.55 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 CA-C-N 118.68 0.673 . . . . 0.0 109.901 168.824 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 2433 ' ' SER . . . . . . . . . . . . . 68.0 m -125.59 172.35 9.81 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 125.436 1.494 . . . . 0.0 110.338 174.787 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 2434 ' ' ALA . . . . . . . . . . . . . . . -131.52 143.24 50.24 Favored 'General case' 0 CA--C 1.539 0.53 0 O-C-N 121.205 -0.934 . . . . 0.0 111.29 174.638 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 2435 ' ' TYR . . . . . . . . . . . . . 75.8 m-85 -144.37 147.39 33.37 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 125.234 1.413 . . . . 0.0 112.001 -175.421 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 2436 ' ' GLY . . . . . . . . . . . . . . . 122.33 163.22 11.81 Favored Glycine 0 N--CA 1.473 1.154 0 C-N-CA 125.087 1.327 . . . . 0.0 114.198 175.902 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 2437 ' ' ALA . . . . . . . . . . . . . . . -61.9 -28.64 69.66 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.123 1.369 . . . . 0.0 114.398 -170.445 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 2438 ' ' GLY . . . . . . . . . . . . . . . -64.35 -18.18 62.77 Favored Glycine 0 CA--C 1.533 1.164 0 CA-C-O 118.984 -0.898 . . . . 0.0 114.12 -179.581 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 2439 ' ' LEU . . . . . . . . . . . . . 80.0 mt -76.44 -24.29 53.93 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 118.663 1.232 . . . . 0.0 112.754 171.928 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 2440 ' ' GLU . . . . . . . . . . . . . 37.9 mm-40 -89.05 -27.71 20.64 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.983 1.313 . . . . 0.0 111.792 177.205 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 2441 ' ' GLY . . . . . . . . . . . . . . . 111.93 -138.56 15.05 Favored Glycine 0 CA--C 1.53 1.009 0 C-N-CA 125.943 1.735 . . . . 0.0 112.301 -178.452 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 2442 ' ' GLY . . . . . . . . . . . . . . . 154.32 -148.29 18.62 Favored Glycine 0 N--CA 1.474 1.18 0 C-N-CA 124.019 0.819 . . . . 0.0 113.971 -177.418 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 2443 ' ' VAL . . . . . . . . . . . . . 60.1 t -105.79 139.23 27.64 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 C-N-CA 125.334 1.454 . . . . 0.0 110.032 -178.322 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 2444 ' ' THR . . . . . . . . . . . . . 39.3 p -59.39 144.87 45.55 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.505 1.122 . . . . 0.0 112.675 175.556 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 2445 ' ' GLY . . . . . . . . . . . . . . . 80.0 -18.3 8.03 Favored Glycine 0 CA--C 1.535 1.339 0 C-N-CA 125.033 1.301 . . . . 0.0 114.47 -179.804 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 2446 ' ' ASN . . . . . . . . . . . . . 87.4 m-20 -99.64 144.55 28.54 Favored Pre-proline 0 CA--C 1.545 0.763 0 C-N-CA 125.081 1.353 . . . . 0.0 110.98 176.321 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 2447 ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -73.85 151.26 45.45 Favored 'Trans proline' 0 N--CA 1.457 -0.637 0 C-N-CA 122.816 2.344 . . . . 0.0 111.479 178.281 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 2448 ' ' ALA . . . . . . . . . . . . . . . -135.74 158.7 43.75 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 126.534 1.934 . . . . 0.0 109.492 169.437 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 2449 ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -149.37 155.65 40.82 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 113.913 1.079 . . . . 0.0 113.913 -171.457 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 2450 ' ' PHE . . . . . . . . . . . . . 47.9 p90 -155.03 153.61 31.23 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 126.042 1.737 . . . . 0.0 110.434 178.579 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 2451 ' ' VAL . . . . . . . . . . . . . 12.0 p -107.43 132.4 55.05 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 C-N-CA 124.603 1.161 . . . . 0.0 110.087 175.089 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 2452 ' ' VAL . . . . . . . . . . . . . 34.8 t -86.6 101.57 10.97 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 N-CA-C 106.594 -1.632 . . . . 0.0 106.594 165.684 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 2453 ' ' ASN . . . . . . . . . . . . . 13.2 t-20 -79.57 111.93 16.33 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.23 1.012 . . . . 0.0 111.821 -171.218 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 2454 ' ' THR . . . . . . . . . . . . . 27.9 p -101.16 -13.47 18.13 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 125.335 1.454 . . . . 0.0 113.865 -179.734 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 2455 ' ' SER . . . . . . . . . . . . . 98.1 p -64.39 -24.65 67.71 Favored 'General case' 0 N--CA 1.478 0.957 0 CA-C-N 120.234 1.379 . . . . 0.0 114.213 -174.577 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 2456 ' ' ASN . . . . . . . . . . . . . 49.8 m-80 -77.35 -18.31 57.52 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 124.283 1.033 . . . . 0.0 113.568 171.731 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 2457 ' ' ALA . . . . . . . . . . . . . . . -106.04 -31.3 8.8 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 125.4 1.48 . . . . 0.0 113.827 -176.131 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 2458 ' ' GLY . . . . . . . . . . . . . . . 113.99 -113.85 3.17 Favored Glycine 0 CA--C 1.53 1.008 0 C-N-CA 125.516 1.531 . . . . 0.0 111.491 -174.171 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 2459 ' ' ALA . . . . . . . . . . . . . . . -144.31 158.85 43.52 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 125.17 1.388 . . . . 0.0 111.943 -179.559 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 2460 ' ' GLY . . . . . . . . . . . . . . . 160.28 171.78 26.64 Favored Glycine 0 CA--C 1.531 1.092 0 C-N-CA 125.112 1.339 . . . . 0.0 113.161 -174.098 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 2461 ' ' ALA . . . . . . . . . . . . . . . -75.62 138.2 41.24 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 123.959 0.904 . . . . 0.0 112.241 -178.76 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 2462 ' ' LEU . . . . . . . . . . . . . 50.0 tp -119.84 143.09 48.08 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.462 1.505 . . . . 0.0 110.658 176.734 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 2463 ' ' SER . . . . . . . . . . . . . 12.5 t -128.37 162.71 26.47 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.114 1.365 . . . . 0.0 110.355 160.637 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 2464 ' ' VAL . . . . . . . . . . . . . 7.2 p -162.18 133.06 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 C-N-CA 124.852 1.261 . . . . 0.0 110.353 -178.94 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 2465 ' ' THR . . . . . . . . . . . . . 79.8 m -133.95 138.73 45.66 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 125.236 1.414 . . . . 0.0 109.184 -178.374 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 2466 ' ' ILE . . . . . . . . . . . . . 33.7 mt -119.08 114.94 46.31 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 C-N-CA 124.036 0.934 . . . . 0.0 109.388 177.065 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 2467 ' ' ASP . . . . . . . . . . . . . 33.4 t70 -99.11 165.47 11.71 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 126.01 1.724 . . . . 0.0 110.151 168.501 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 2468 ' ' GLY . . . . . . . . . . . . . . . 168.93 -161.9 35.62 Favored Glycine 0 CA--C 1.536 1.391 0 O-C-N 121.009 -1.057 . . . . 0.0 115.283 178.009 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 2469 ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -67.94 -16.23 45.01 Favored 'Trans proline' 0 CA--C 1.54 0.8 0 C-N-CA 124.297 3.331 . . . . 0.0 113.404 178.808 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 2470 ' ' SER . . . . . . . . . . . . . 32.9 m -151.98 175.09 12.87 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 127.14 2.176 . . . . 0.0 109.31 169.743 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 2471 ' ' LYS . . . . . . . . . . . . . 98.7 mttt -67.74 164.41 19.5 Favored 'General case' 0 CA--C 1.548 0.886 0 O-C-N 121.002 -1.061 . . . . 0.0 111.69 166.484 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 2472 ' ' VAL . . . . . . . . . . . . . 27.2 m -123.08 153.68 28.33 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 C-N-CA 125.168 1.387 . . . . 0.0 111.011 177.057 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 2473 ' ' LYS . . . . . . . . . . . . . 88.3 tttt -91.62 129.17 37.64 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 123.229 0.611 . . . . 0.0 109.387 163.243 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 2474 ' ' MET . . . . . . . . . . . . . 99.0 mtp -121.01 149.55 42.5 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 124.989 1.315 . . . . 0.0 111.895 -177.467 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 2475 ' ' ASP . . . . . . . . . . . . . 38.6 t0 -138.69 83.18 1.95 Allowed 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 126.953 2.101 . . . . 0.0 109.135 174.961 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 2476 ' ' CYS . . . . . . . . . . . . . 24.1 t -77.15 133.5 38.95 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 123.853 0.861 . . . . 0.0 111.126 177.783 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 2477 ' ' GLN . . . . . . . . . . . . . 34.9 mt-30 -138.81 179.93 6.2 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 127.734 2.414 . . . . 0.0 109.357 -169.328 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 2478 ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -143.57 149.18 37.03 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.364 1.066 . . . . 0.0 112.019 179.909 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 2479 ' ' CYS . . . . . . . . . . . . . 20.8 p -156.84 174.14 4.31 Favored Pre-proline 0 CA--C 1.553 1.086 0 C-N-CA 126.108 1.763 . . . . 0.0 110.99 -176.752 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 2480 ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -58.44 -24.72 70.34 Favored 'Trans proline' 0 CA--C 1.539 0.748 0 C-N-CA 123.349 2.7 . . . . 0.0 114.711 177.776 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 2481 ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -79.76 -17.27 53.87 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 124.285 1.034 . . . . 0.0 112.987 178.172 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 2482 ' ' GLY . . . . . . . . . . . . . . . 136.26 -154.5 22.01 Favored Glycine 0 CA--C 1.531 1.056 0 C-N-CA 125.818 1.675 . . . . 0.0 113.372 -178.853 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 2483 ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -85.55 115.23 23.13 Favored 'General case' 0 N--CA 1.468 0.449 0 O-C-N 121.78 -0.835 . . . . 0.0 110.774 175.541 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 2484 ' ' ARG . . . . . . . . . . . . . 35.9 ttt-85 -95.95 121.73 38.0 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 124.401 1.08 . . . . 0.0 110.241 -178.0 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 2485 ' ' VAL . . . . . . . . . . . . . 66.1 t -103.02 125.67 57.39 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 C-N-CA 124.933 1.293 . . . . 0.0 108.392 177.187 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 2486 ' ' THR . . . . . . . . . . . . . 91.8 m -111.69 139.49 47.11 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 167.434 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 2487 ' ' TYR . . . . . . . . . . . . . 14.1 p90 -151.01 154.85 37.84 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 113.361 0.875 . . . . 0.0 113.361 177.022 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 2488 ' ' THR . . . . . . . . . . . . . 98.9 m -118.33 115.49 35.96 Favored Pre-proline 0 N--CA 1.475 0.78 0 C-N-CA 124.717 1.207 . . . . 0.0 109.725 176.996 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 2489 ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -81.3 163.14 19.77 Favored 'Trans proline' 0 C--N 1.351 0.667 0 C-N-CA 123.987 3.125 . . . . 0.0 111.165 169.89 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 2490 ' ' MET . . . . . . . . . . . . . 25.8 ptm -143.05 4.29 1.43 Allowed 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 115.482 1.66 . . . . 0.0 115.482 -170.895 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 2491 ' ' ALA . . . . . . . . . . . . . . . -146.11 148.37 34.99 Favored Pre-proline 0 CA--C 1.546 0.819 0 C-N-CA 125.112 1.365 . . . . 0.0 110.901 174.769 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 2492 ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -72.2 145.37 43.73 Favored 'Trans proline' 0 CA--C 1.536 0.61 0 C-N-CA 122.813 2.342 . . . . 0.0 110.997 177.025 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 2493 ' ' GLY . . . . . . . . . . . . . . . 136.77 -167.03 24.72 Favored Glycine 0 CA--C 1.53 0.971 0 C-N-CA 125.34 1.448 . . . . 0.0 113.44 -177.141 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 2494 ' ' SER . . . . . . . . . . . . . 50.2 m -98.77 120.14 38.7 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.271 1.028 . . . . 0.0 111.298 -179.128 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 2495 ' ' TYR . . . . . . . . . . . . . 73.0 m-85 -93.01 124.96 37.35 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.215 1.006 . . . . 0.0 110.395 170.855 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 2496 ' ' LEU . . . . . . . . . . . . . 22.8 tp -96.65 111.35 23.53 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.423 1.089 . . . . 0.0 109.788 -178.888 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 2497 ' ' ILE . . . . . . . . . . . . . 49.9 mt -98.73 102.1 12.98 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 C-N-CA 126.057 1.743 . . . . 0.0 108.429 -176.663 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 2498 ' ' SER . . . . . . . . . . . . . 73.2 m -92.76 98.34 11.34 Favored 'General case' 0 N--CA 1.468 0.425 0 C-N-CA 124.608 1.163 . . . . 0.0 110.25 178.492 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 2499 ' ' ILE . . . . . . . . . . . . . 28.0 mt -96.05 120.53 45.54 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 C-N-CA 125.834 1.654 . . . . 0.0 109.349 179.65 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 2500 ' ' LYS . . . . . . . . . . . . . 90.5 mttt -134.08 127.78 32.86 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.264 1.026 . . . . 0.0 112.788 -171.137 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 2501 ' ' TYR . . . . . . . . . . . . . 57.5 t80 -128.09 151.56 49.04 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 124.828 1.251 . . . . 0.0 112.621 -171.674 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 2502 ' ' GLY . . . . . . . . . . . . . . . 64.91 20.02 66.17 Favored Glycine 0 CA--C 1.536 1.378 0 C-N-CA 124.241 0.924 . . . . 0.0 113.733 178.297 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 2503 ' ' GLY . . . . . . . . . . . . . . . 126.32 -166.46 19.09 Favored Glycine 0 CA--C 1.542 1.721 0 C-N-CA 125.878 1.704 . . . . 0.0 112.42 -164.785 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 2504 ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -82.11 31.77 0.52 Allowed 'Trans proline' 0 CA--C 1.546 1.113 0 C-N-CA 124.985 3.79 . . . . 0.0 113.522 -173.043 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 2505 ' ' TYR . . . . . . . . . . . . . 75.5 m-85 -113.87 131.47 56.26 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.66 1.184 . . . . 0.0 112.773 -172.933 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 2506 ' ' HIS . . . . . . . . . . . . . 89.5 m-70 -60.54 140.05 57.5 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 124.681 1.192 . . . . 0.0 113.687 -177.072 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 2507 ' ' ILE . . . . . . . . . . . . . 2.2 pp -84.45 160.58 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.199 0 C-N-CA 123.962 0.905 . . . . 0.0 112.442 173.691 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 2508 ' ' GLY . . . . . . . . . . . . . . . 38.67 -110.63 0.14 Allowed Glycine 0 CA--C 1.537 1.435 0 C-N-CA 125.291 1.424 . . . . 0.0 115.607 161.641 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 2509 ' ' GLY . . . . . . . . . . . . . . . -104.75 15.82 48.26 Favored Glycine 0 CA--C 1.538 1.51 0 C-N-CA 126.37 1.938 . . . . 0.0 114.637 175.74 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 2510 ' ' SER . . . . . . . . . . . . . 33.3 t -67.85 146.38 98.32 Favored Pre-proline 0 CA--C 1.551 0.987 0 C-N-CA 125.38 1.472 . . . . 0.0 112.181 179.449 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 2511 ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -79.6 156.19 89.34 Favored 'Cis proline' 0 C--N 1.351 0.687 0 CA-C-N 119.728 0.939 . . . . 0.0 112.915 -0.544 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 2512 ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -106.17 136.14 46.39 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 125.178 1.391 . . . . 0.0 111.07 179.822 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 2513 ' ' LYS . . . . . . . . . . . . . 19.5 ptpt -94.17 11.72 29.11 Favored 'General case' 0 CA--C 1.552 1.024 0 N-CA-C 116.51 2.041 . . . . 0.0 116.51 -164.994 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 2514 ' ' ALA . . . . . . . . . . . . . . . -4.78 99.35 0.01 OUTLIER 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 129.561 3.145 . . . . 0.0 116.474 -179.211 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 2515 ' ' LYS . . . . . . . . . . . . . 52.9 mtpt -89.02 120.0 30.05 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.258 1.023 . . . . 0.0 111.529 -173.332 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 2516 ' ' VAL . . . . . . . . . . . . . 55.0 t -113.14 142.58 25.1 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 125.788 1.635 . . . . 0.0 110.435 -172.484 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 2517 ' ' THR . . . . . . . . . . . . . 40.9 p -127.88 171.88 11.38 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 125.664 1.586 . . . . 0.0 111.458 178.151 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 2518 ' ' GLY . . . . . . . . . . . . . . . 107.31 -173.74 19.08 Favored Glycine 0 CA--C 1.538 1.53 0 C-N-CA 124.919 1.247 . . . . 0.0 113.264 -176.792 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 2519 ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -71.05 156.2 60.32 Favored 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 123.705 2.937 . . . . 0.0 112.209 -176.092 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 2520 ' ' ARG . . . . . . . . . . . . . 39.9 ttm105 . . . . . 0 CA--C 1.537 0.479 0 C-N-CA 123.915 0.886 . . . . 0.0 110.0 171.852 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A 2427 ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.951 0 CA-C-O 121.109 0.283 . . . . 0.0 113.099 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A 2428 ' ' ASP . . . . . . . . . . . . . 29.4 m-20 -91.66 136.5 26.47 Favored Pre-proline 0 CA--C 1.547 0.853 0 C-N-CA 124.517 1.127 . . . . 0.0 112.0 -179.087 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 2429 ' ' PRO . . . . . . . . . . . . . 79.6 Cg_exo -54.75 -27.58 53.0 Favored 'Trans proline' 0 C--N 1.353 0.772 0 C-N-CA 123.994 3.129 . . . . 0.0 114.862 175.577 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 2430 ' ' GLY . . . . . . . . . . . . . . . -80.02 -24.54 59.54 Favored Glycine 0 CA--C 1.535 1.285 0 C-N-CA 123.762 0.696 . . . . 0.0 113.969 176.615 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 2431 ' ' LEU . . . . . . . . . . . . . 4.2 mm? -86.22 -32.77 21.0 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.575 1.15 . . . . 0.0 111.315 172.896 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 2432 ' ' VAL . . . . . . . . . . . . . 82.5 t -65.08 136.75 26.18 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 C-N-CA 123.723 0.809 . . . . 0.0 109.723 167.758 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 2433 ' ' SER . . . . . . . . . . . . . 8.4 t -131.88 -168.85 2.1 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.827 1.251 . . . . 0.0 110.823 177.311 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 2434 ' ' ALA . . . . . . . . . . . . . . . -149.91 142.64 24.63 Favored 'General case' 0 CA--C 1.539 0.531 0 O-C-N 121.062 -1.024 . . . . 0.0 111.988 176.395 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 2435 ' ' TYR . . . . . . . . . . . . . 77.4 m-85 -145.79 148.85 33.38 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 125.386 1.474 . . . . 0.0 112.001 -176.416 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 2436 ' ' GLY . . . . . . . . . . . . . . . 123.99 160.42 10.79 Favored Glycine 0 N--CA 1.474 1.2 0 C-N-CA 125.245 1.402 . . . . 0.0 113.974 176.708 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 2437 ' ' ALA . . . . . . . . . . . . . . . -60.93 -30.19 70.06 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.007 1.323 . . . . 0.0 114.167 -171.057 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 2438 ' ' GLY . . . . . . . . . . . . . . . -67.19 -9.81 55.21 Favored Glycine 0 CA--C 1.533 1.169 0 C-N-CA 124.57 1.081 . . . . 0.0 114.514 -179.632 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 2439 ' ' LEU . . . . . . . . . . . . . 88.3 mt -79.41 -26.12 41.95 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 118.973 1.386 . . . . 0.0 112.553 168.397 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 2440 ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -95.94 -36.37 11.09 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.081 1.352 . . . . 0.0 112.236 -173.851 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 2441 ' ' GLY . . . . . . . . . . . . . . . 160.32 -148.96 17.97 Favored Glycine 0 CA--C 1.532 1.134 0 C-N-CA 124.79 1.186 . . . . 0.0 113.146 -176.053 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 2442 ' ' GLY . . . . . . . . . . . . . . . 150.68 178.63 25.72 Favored Glycine 0 CA--C 1.534 1.249 0 C-N-CA 125.412 1.482 . . . . 0.0 112.796 -175.85 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 2443 ' ' VAL . . . . . . . . . . . . . 83.9 t -101.81 134.77 41.33 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 C-N-CA 124.722 1.209 . . . . 0.0 110.097 -179.583 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 2444 ' ' THR . . . . . . . . . . . . . 25.5 p -63.19 140.07 58.84 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.212 1.005 . . . . 0.0 112.325 176.935 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 2445 ' ' GLY . . . . . . . . . . . . . . . 79.58 -11.51 32.19 Favored Glycine 0 CA--C 1.536 1.385 0 C-N-CA 124.705 1.145 . . . . 0.0 114.328 -174.887 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 2446 ' ' ASN . . . . . . . . . . . . . 82.1 m-20 -106.36 152.14 40.48 Favored Pre-proline 0 CA--C 1.548 0.884 0 C-N-CA 125.453 1.501 . . . . 0.0 110.901 173.19 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 2447 ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -73.05 134.28 21.11 Favored 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 122.789 2.326 . . . . 0.0 111.335 175.875 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 2448 ' ' ALA . . . . . . . . . . . . . . . -111.48 156.69 21.3 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 126.232 1.813 . . . . 0.0 109.225 162.049 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 2449 ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -153.37 153.93 33.52 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 113.901 1.074 . . . . 0.0 113.901 -173.389 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 2450 ' ' PHE . . . . . . . . . . . . . 40.2 p90 -158.0 161.02 38.08 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.863 1.665 . . . . 0.0 110.696 177.336 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 2451 ' ' VAL . . . . . . . . . . . . . 14.7 p -113.04 135.07 53.68 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 C-N-CA 124.697 1.199 . . . . 0.0 110.968 175.121 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 2452 ' ' VAL . . . . . . . . . . . . . 25.1 t -84.89 101.76 9.86 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 N-CA-C 106.337 -1.727 . . . . 0.0 106.337 163.315 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 2453 ' ' ASN . . . . . . . . . . . . . 15.8 t-20 -88.66 123.5 33.17 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 123.72 0.808 . . . . 0.0 112.335 -167.006 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 2454 ' ' THR . . . . . . . . . . . . . 69.0 p -109.89 2.03 19.56 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 125.878 1.671 . . . . 0.0 113.745 -174.178 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 2455 ' ' SER . . . . . . . . . . . . . 42.0 m -56.57 -30.93 63.71 Favored 'General case' 0 N--CA 1.479 0.976 0 N-CA-C 114.537 1.31 . . . . 0.0 114.537 -172.887 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 2456 ' ' ASN . . . . . . . . . . . . . 28.0 m120 -88.96 -8.44 54.12 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 124.896 1.278 . . . . 0.0 113.55 177.297 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 2457 ' ' ALA . . . . . . . . . . . . . . . -113.18 -47.64 3.01 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 125.387 1.475 . . . . 0.0 113.755 -170.166 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 2458 ' ' GLY . . . . . . . . . . . . . . . 105.48 -151.29 17.12 Favored Glycine 0 CA--C 1.534 1.277 0 C-N-CA 125.333 1.444 . . . . 0.0 113.144 -174.219 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 2459 ' ' ALA . . . . . . . . . . . . . . . -77.44 156.64 30.97 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.811 1.245 . . . . 0.0 114.023 -174.43 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 2460 ' ' GLY . . . . . . . . . . . . . . . 158.22 172.09 24.93 Favored Glycine 0 CA--C 1.531 1.073 0 C-N-CA 125.246 1.403 . . . . 0.0 113.655 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 2461 ' ' ALA . . . . . . . . . . . . . . . -100.39 148.9 24.2 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.9 1.28 . . . . 0.0 112.84 -176.965 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 2462 ' ' LEU . . . . . . . . . . . . . 16.3 tp -101.97 149.41 24.26 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 125.526 1.531 . . . . 0.0 111.357 176.888 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 2463 ' ' SER . . . . . . . . . . . . . 3.7 t -140.89 40.29 1.82 Allowed 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 125.223 1.409 . . . . 0.0 111.427 179.136 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 2464 ' ' VAL . . . . . . . . . . . . . 14.2 p -65.36 139.23 21.7 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 C-N-CA 125.124 1.37 . . . . 0.0 112.574 -174.928 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 2465 ' ' THR . . . . . . . . . . . . . 93.5 m -135.04 143.38 46.71 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 125.791 1.636 . . . . 0.0 109.706 175.869 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 2466 ' ' ILE . . . . . . . . . . . . . 35.2 mt -121.12 123.97 71.13 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 C-N-CA 124.079 0.951 . . . . 0.0 110.122 175.989 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 2467 ' ' ASP . . . . . . . . . . . . . 34.4 t70 -104.17 162.91 12.78 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 126.809 2.044 . . . . 0.0 110.077 169.048 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 2468 ' ' GLY . . . . . . . . . . . . . . . 168.95 -161.55 35.25 Favored Glycine 0 CA--C 1.536 1.376 0 O-C-N 120.841 -1.162 . . . . 0.0 115.414 178.265 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 2469 ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -71.48 -17.72 30.05 Favored 'Trans proline' 0 CA--C 1.539 0.747 0 C-N-CA 124.006 3.138 . . . . 0.0 113.341 -178.827 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 2470 ' ' SER . . . . . . . . . . . . . 43.3 m -156.79 -168.36 2.65 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 127.213 2.205 . . . . 0.0 109.762 178.775 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 2471 ' ' LYS . . . . . . . . . . . . . 49.0 mmtm -74.12 174.78 8.21 Favored 'General case' 0 CA--C 1.55 0.968 0 O-C-N 120.661 -1.275 . . . . 0.0 112.523 170.32 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 2472 ' ' VAL . . . . . . . . . . . . . 35.4 m -131.06 148.36 33.01 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 C-N-CA 125.448 1.499 . . . . 0.0 109.971 165.848 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 2473 ' ' LYS . . . . . . . . . . . . . 88.5 tttt -94.44 102.89 14.87 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 166.146 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 2474 ' ' MET . . . . . . . . . . . . . 55.4 ttp -117.27 144.56 44.71 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.994 1.317 . . . . 0.0 112.732 -173.193 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 2475 ' ' ASP . . . . . . . . . . . . . 31.7 t70 -127.98 132.97 49.15 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 126.991 2.116 . . . . 0.0 110.057 170.479 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 2476 ' ' CYS . . . . . . . . . . . . . 45.3 t -109.73 138.55 45.93 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 125.138 1.375 . . . . 0.0 111.334 178.291 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 2477 ' ' GLN . . . . . . . . . . . . . 81.6 mt-30 -133.68 128.65 35.46 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.035 1.334 . . . . 0.0 110.392 -175.079 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 2478 ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -81.57 137.01 35.58 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.34 1.056 . . . . 0.0 109.9 173.159 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 2479 ' ' CYS . . . . . . . . . . . . . 29.6 p -156.01 167.24 14.69 Favored Pre-proline 0 CA--C 1.552 1.034 0 C-N-CA 125.024 1.33 . . . . 0.0 111.607 -172.922 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 2480 ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -65.28 -16.81 56.3 Favored 'Trans proline' 0 CA--C 1.543 0.941 0 C-N-CA 122.701 2.267 . . . . 0.0 113.266 174.807 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 2481 ' ' GLU . . . . . . . . . . . . . 19.6 tt0 -80.21 -10.72 59.77 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 124.969 1.308 . . . . 0.0 112.535 173.374 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 2482 ' ' GLY . . . . . . . . . . . . . . . 122.57 -126.35 6.34 Favored Glycine 0 N--CA 1.473 1.115 0 C-N-CA 125.999 1.761 . . . . 0.0 112.102 -177.048 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 2483 ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -115.85 108.84 16.82 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 123.789 0.836 . . . . 0.0 110.572 171.422 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 2484 ' ' ARG . . . . . . . . . . . . . 42.2 ttm-85 -92.59 132.49 36.82 Favored 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 124.007 0.923 . . . . 0.0 109.63 175.8 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 2485 ' ' VAL . . . . . . . . . . . . . 32.6 m -117.65 144.37 25.75 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 C-N-CA 123.845 0.858 . . . . 0.0 110.327 174.97 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 2486 ' ' THR . . . . . . . . . . . . . 88.6 m -124.32 132.75 53.57 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 125.447 1.499 . . . . 0.0 107.49 171.089 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 2487 ' ' TYR . . . . . . . . . . . . . 19.4 p90 -142.46 146.83 35.2 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 113.34 0.867 . . . . 0.0 113.34 178.973 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 2488 ' ' THR . . . . . . . . . . . . . 65.1 m -106.17 116.11 59.98 Favored Pre-proline 0 N--CA 1.471 0.608 0 C-N-CA 124.501 1.12 . . . . 0.0 109.216 172.49 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 2489 ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -79.98 153.8 22.39 Favored 'Trans proline' 0 C--N 1.351 0.681 0 C-N-CA 123.717 2.945 . . . . 0.0 110.665 170.475 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 2490 ' ' MET . . . . . . . . . . . . . 28.5 ptm -117.08 -5.3 11.41 Favored 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 115.055 1.502 . . . . 0.0 115.055 -174.861 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 2491 ' ' ALA . . . . . . . . . . . . . . . -146.5 144.73 21.43 Favored Pre-proline 0 CA--C 1.548 0.898 0 C-N-CA 124.731 1.212 . . . . 0.0 111.447 177.801 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 2492 ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -70.26 156.05 62.91 Favored 'Trans proline' 0 C--N 1.35 0.64 0 C-N-CA 123.571 2.847 . . . . 0.0 111.357 177.88 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 2493 ' ' GLY . . . . . . . . . . . . . . . 126.52 -154.62 19.18 Favored Glycine 0 CA--C 1.528 0.898 0 C-N-CA 124.886 1.231 . . . . 0.0 113.241 -178.929 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 2494 ' ' SER . . . . . . . . . . . . . 74.0 m -104.5 112.94 26.2 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 123.709 0.804 . . . . 0.0 112.206 -176.893 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 2495 ' ' TYR . . . . . . . . . . . . . 69.0 m-85 -88.64 129.6 35.47 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 123.524 0.73 . . . . 0.0 109.89 162.877 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 2496 ' ' LEU . . . . . . . . . . . . . 29.0 tp -101.55 117.69 35.43 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.697 1.199 . . . . 0.0 109.521 179.052 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 2497 ' ' ILE . . . . . . . . . . . . . 61.9 mt -103.46 99.98 9.5 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 C-N-CA 125.574 1.55 . . . . 0.0 108.407 -170.087 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 2498 ' ' SER . . . . . . . . . . . . . 74.6 m -83.32 86.28 7.08 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 125.071 1.348 . . . . 0.0 109.864 176.495 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 2499 ' ' ILE . . . . . . . . . . . . . 37.0 mt -79.19 110.86 15.36 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 C-N-CA 124.124 0.97 . . . . 0.0 109.162 175.876 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 2500 ' ' LYS . . . . . . . . . . . . . 83.7 mttt -121.75 145.46 48.02 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.859 1.264 . . . . 0.0 111.51 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 2501 ' ' TYR . . . . . . . . . . . . . 47.5 t80 -149.31 146.54 27.59 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.563 1.145 . . . . 0.0 112.16 -171.447 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 2502 ' ' GLY . . . . . . . . . . . . . . . 67.19 19.36 70.18 Favored Glycine 0 CA--C 1.536 1.394 0 C-N-CA 124.25 0.928 . . . . 0.0 113.735 177.552 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 2503 ' ' GLY . . . . . . . . . . . . . . . 131.7 -167.32 22.73 Favored Glycine 0 CA--C 1.541 1.699 0 C-N-CA 125.93 1.729 . . . . 0.0 112.364 -166.13 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 2504 ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -81.83 26.77 0.61 Allowed 'Trans proline' 0 CA--C 1.547 1.154 0 C-N-CA 124.921 3.747 . . . . 0.0 113.588 -174.291 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 2505 ' ' TYR . . . . . . . . . . . . . 60.2 m-85 -112.23 134.36 53.82 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 124.638 1.175 . . . . 0.0 113.02 -171.72 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 2506 ' ' HIS . . . . . . . . . . . . . 95.2 m-70 -63.4 142.53 58.36 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 124.842 1.257 . . . . 0.0 113.462 -179.326 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 2507 ' ' ILE . . . . . . . . . . . . . 1.8 pp -83.37 173.43 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.319 0 C-N-CA 123.628 0.771 . . . . 0.0 113.015 174.428 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 2508 ' ' GLY . . . . . . . . . . . . . . . -59.69 113.73 5.57 Favored Glycine 0 CA--C 1.534 1.248 0 O-C-N 121.469 -0.769 . . . . 0.0 112.783 -177.027 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 2509 ' ' GLY . . . . . . . . . . . . . . . 92.66 -5.32 76.79 Favored Glycine 0 CA--C 1.536 1.354 0 C-N-CA 125.615 1.579 . . . . 0.0 114.861 -177.238 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 2510 ' ' SER . . . . . . . . . . . . . 35.0 t -82.22 146.56 54.96 Favored Pre-proline 0 CA--C 1.55 0.969 0 CA-C-N 118.898 1.349 . . . . 0.0 112.271 179.381 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 2511 ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -77.49 156.54 96.09 Favored 'Cis proline' 0 C--N 1.354 0.845 0 CA-C-N 120.02 1.043 . . . . 0.0 113.305 -0.886 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 2512 ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -107.47 134.47 50.45 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 125.32 1.448 . . . . 0.0 111.263 178.682 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 2513 ' ' LYS . . . . . . . . . . . . . 40.4 ttmt -99.47 100.48 11.52 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 123.856 0.862 . . . . 0.0 111.966 -178.15 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 2514 ' ' ALA . . . . . . . . . . . . . . . -82.06 109.35 16.31 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.025 1.33 . . . . 0.0 110.787 177.069 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 2515 ' ' LYS . . . . . . . . . . . . . 30.6 mtmm -91.65 81.2 5.3 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.805 1.642 . . . . 0.0 109.324 -175.954 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 2516 ' ' VAL . . . . . . . . . . . . . 21.0 m -83.49 153.7 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 C-N-CA 124.338 1.055 . . . . 0.0 111.41 -173.226 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 2517 ' ' THR . . . . . . . . . . . . . 77.0 p -132.31 179.46 6.1 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 125.853 1.661 . . . . 0.0 111.118 -175.437 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 2518 ' ' GLY . . . . . . . . . . . . . . . 104.49 -176.15 23.08 Favored Glycine 0 CA--C 1.539 1.576 0 C-N-CA 124.891 1.234 . . . . 0.0 113.309 -176.492 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 2519 ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -74.28 148.59 39.04 Favored 'Trans proline' 0 CA--C 1.537 0.644 0 C-N-CA 123.72 2.946 . . . . 0.0 112.085 -173.92 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 2520 ' ' ARG . . . . . . . . . . . . . 38.3 ttp-105 . . . . . 0 CA--C 1.54 0.596 0 C-N-CA 124.17 0.988 . . . . 0.0 111.883 -179.582 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A 2427 ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.971 0 CA-C-O 121.198 0.332 . . . . 0.0 113.408 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A 2428 ' ' ASP . . . . . . . . . . . . . 15.3 t70 -100.08 138.87 20.38 Favored Pre-proline 0 CA--C 1.55 0.953 0 C-N-CA 125.314 1.446 . . . . 0.0 111.471 179.448 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 2429 ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -55.49 -26.83 56.11 Favored 'Trans proline' 0 C--N 1.353 0.785 0 C-N-CA 123.782 2.988 . . . . 0.0 115.448 179.85 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 2430 ' ' GLY . . . . . . . . . . . . . . . -81.99 -24.36 55.33 Favored Glycine 0 CA--C 1.533 1.157 0 CA-C-N 119.155 0.889 . . . . 0.0 113.548 176.738 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 2431 ' ' LEU . . . . . . . . . . . . . 4.4 mm? -85.56 -33.75 21.64 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.481 1.112 . . . . 0.0 111.535 172.825 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 2432 ' ' VAL . . . . . . . . . . . . . 87.0 t -66.76 137.2 25.31 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 123.483 0.713 . . . . 0.0 109.539 168.477 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 2433 ' ' SER . . . . . . . . . . . . . 8.3 t -133.39 -170.58 2.51 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 124.85 1.26 . . . . 0.0 110.801 177.773 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 2434 ' ' ALA . . . . . . . . . . . . . . . -152.79 144.39 23.45 Favored 'General case' 0 CA--C 1.537 0.477 0 O-C-N 120.963 -1.086 . . . . 0.0 111.996 176.089 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 2435 ' ' TYR . . . . . . . . . . . . . 74.7 m-85 -147.33 150.2 34.29 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 125.566 1.547 . . . . 0.0 111.825 -174.455 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 2436 ' ' GLY . . . . . . . . . . . . . . . 121.79 162.91 11.77 Favored Glycine 0 N--CA 1.473 1.118 0 C-N-CA 125.288 1.423 . . . . 0.0 113.999 177.135 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 2437 ' ' ALA . . . . . . . . . . . . . . . -60.95 -28.77 69.21 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 125.099 1.36 . . . . 0.0 114.407 -169.677 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 2438 ' ' GLY . . . . . . . . . . . . . . . -66.72 -15.53 64.48 Favored Glycine 0 CA--C 1.532 1.103 0 CA-C-O 118.867 -0.963 . . . . 0.0 114.417 -178.802 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 2439 ' ' LEU . . . . . . . . . . . . . 84.4 mt -76.37 -24.96 54.16 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 118.866 1.333 . . . . 0.0 112.44 169.716 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 2440 ' ' GLU . . . . . . . . . . . . . 43.0 mm-40 -90.89 -31.79 16.27 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.15 1.38 . . . . 0.0 111.896 176.189 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 2441 ' ' GLY . . . . . . . . . . . . . . . 109.22 -133.41 11.63 Favored Glycine 0 CA--C 1.531 1.042 0 C-N-CA 125.921 1.724 . . . . 0.0 112.763 178.928 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 2442 ' ' GLY . . . . . . . . . . . . . . . 135.41 -154.59 21.76 Favored Glycine 0 CA--C 1.533 1.195 0 C-N-CA 124.826 1.203 . . . . 0.0 114.433 -176.998 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 2443 ' ' VAL . . . . . . . . . . . . . 93.0 t -74.37 136.14 25.88 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 C-N-CA 124.284 1.034 . . . . 0.0 111.488 -172.516 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 2444 ' ' THR . . . . . . . . . . . . . 25.1 p -63.37 133.13 53.54 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.445 1.098 . . . . 0.0 111.471 174.908 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 2445 ' ' GLY . . . . . . . . . . . . . . . 85.03 -8.41 70.44 Favored Glycine 0 CA--C 1.536 1.361 0 C-N-CA 124.667 1.127 . . . . 0.0 114.76 -176.511 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 2446 ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -86.01 152.86 56.78 Favored Pre-proline 0 CA--C 1.551 1.018 0 CA-C-N 118.976 1.388 . . . . 0.0 111.796 174.811 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 2447 ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -75.5 97.5 1.1 Allowed 'Trans proline' 0 CA--C 1.538 0.693 0 C-N-CA 123.156 2.571 . . . . 0.0 110.024 173.979 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 2448 ' ' ALA . . . . . . . . . . . . . . . -78.47 143.23 36.85 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.034 0.934 . . . . 0.0 109.481 168.759 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 2449 ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -155.1 148.32 24.89 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 114.33 1.233 . . . . 0.0 114.33 -173.386 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 2450 ' ' PHE . . . . . . . . . . . . . 49.5 p90 -153.93 162.47 41.19 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 126.439 1.895 . . . . 0.0 110.496 -178.91 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 2451 ' ' VAL . . . . . . . . . . . . . 71.5 t -112.68 130.96 65.52 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 C-N-CA 124.821 1.248 . . . . 0.0 109.498 174.953 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 2452 ' ' VAL . . . . . . . . . . . . . 45.5 t -79.52 109.33 14.02 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 161.92 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 2453 ' ' ASN . . . . . . . . . . . . . 12.4 t-20 -88.68 114.5 25.37 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.188 0.995 . . . . 0.0 111.909 -172.372 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 2454 ' ' THR . . . . . . . . . . . . . 70.0 p -107.43 -5.59 17.59 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 125.521 1.528 . . . . 0.0 113.65 -177.91 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 2455 ' ' SER . . . . . . . . . . . . . 13.9 m -57.77 -29.7 65.03 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 124.797 1.239 . . . . 0.0 114.242 -175.033 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 2456 ' ' ASN . . . . . . . . . . . . . 69.0 m-80 -83.16 -10.24 58.75 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 124.688 1.195 . . . . 0.0 113.453 177.097 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 2457 ' ' ALA . . . . . . . . . . . . . . . -115.17 -50.53 2.75 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 125.187 1.395 . . . . 0.0 113.482 -169.459 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 2458 ' ' GLY . . . . . . . . . . . . . . . 121.81 -145.2 16.73 Favored Glycine 0 CA--C 1.533 1.208 0 C-N-CA 125.054 1.312 . . . . 0.0 113.108 -174.083 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 2459 ' ' ALA . . . . . . . . . . . . . . . -96.41 160.22 14.53 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 125.195 1.398 . . . . 0.0 113.113 -175.534 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 2460 ' ' GLY . . . . . . . . . . . . . . . 153.76 164.01 12.33 Favored Glycine 0 CA--C 1.53 1.017 0 C-N-CA 124.261 0.934 . . . . 0.0 114.025 -178.561 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 2461 ' ' ALA . . . . . . . . . . . . . . . -79.7 144.76 33.39 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.37 1.068 . . . . 0.0 112.51 -179.411 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 2462 ' ' LEU . . . . . . . . . . . . . 69.5 tp -115.14 141.38 48.09 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 126.006 1.722 . . . . 0.0 110.526 178.283 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 2463 ' ' SER . . . . . . . . . . . . . 16.4 t -142.11 106.1 4.74 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.532 1.133 . . . . 0.0 109.639 170.959 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 2464 ' ' VAL . . . . . . . . . . . . . 60.5 t -102.39 128.2 55.3 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 C-N-CA 124.083 0.953 . . . . 0.0 109.487 178.881 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 2465 ' ' THR . . . . . . . . . . . . . 98.2 m -116.15 134.22 55.17 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 125.326 1.45 . . . . 0.0 108.636 174.98 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 2466 ' ' ILE . . . . . . . . . . . . . 41.1 mt -122.88 120.3 60.27 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 C-N-CA 123.542 0.737 . . . . 0.0 109.586 177.433 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 2467 ' ' ASP . . . . . . . . . . . . . 32.0 m-20 -107.0 167.69 9.72 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 126.204 1.802 . . . . 0.0 110.168 169.511 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 2468 ' ' GLY . . . . . . . . . . . . . . . 162.78 -153.1 23.56 Favored Glycine 0 CA--C 1.536 1.366 0 CA-C-O 118.854 -0.97 . . . . 0.0 114.481 179.694 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 2469 ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -70.18 -17.54 35.62 Favored 'Trans proline' 0 CA--C 1.54 0.79 0 C-N-CA 123.774 2.983 . . . . 0.0 113.189 180.0 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 2470 ' ' SER . . . . . . . . . . . . . 38.7 m -157.57 -165.17 1.71 Allowed 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 127.546 2.338 . . . . 0.0 109.382 176.383 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 2471 ' ' LYS . . . . . . . . . . . . . 59.3 mtmt -79.13 -175.3 4.53 Favored 'General case' 0 CA--C 1.552 1.042 0 O-C-N 120.802 -1.187 . . . . 0.0 111.79 167.614 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 2472 ' ' VAL . . . . . . . . . . . . . 33.4 m -139.78 151.78 22.32 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 C-N-CA 125.26 1.424 . . . . 0.0 111.09 171.909 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 2473 ' ' LYS . . . . . . . . . . . . . 60.6 mtpt -87.99 86.51 7.14 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 123.836 0.854 . . . . 0.0 110.126 171.706 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 2474 ' ' MET . . . . . . . . . . . . . 58.3 ttm -79.28 143.29 35.38 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 124.277 1.031 . . . . 0.0 112.38 -176.706 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 2475 ' ' ASP . . . . . . . . . . . . . 23.1 t70 -135.56 100.25 4.44 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 126.448 1.899 . . . . 0.0 109.581 165.067 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 2476 ' ' CYS . . . . . . . . . . . . . 44.3 t -95.47 132.3 40.69 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.642 1.177 . . . . 0.0 110.639 175.778 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 2477 ' ' GLN . . . . . . . . . . . . . 86.7 mt-30 -144.99 154.96 43.1 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 125.286 1.434 . . . . 0.0 110.711 -176.511 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 2478 ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -75.95 152.02 37.14 Favored 'General case' 0 CA--C 1.543 0.696 0 O-C-N 121.389 -0.819 . . . . 0.0 112.068 172.464 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 2479 ' ' CYS . . . . . . . . . . . . . 17.3 p -151.39 166.21 15.65 Favored Pre-proline 0 CA--C 1.554 1.106 0 C-N-CA 125.782 1.633 . . . . 0.0 110.774 -179.59 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 2480 ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -66.93 -18.84 52.55 Favored 'Trans proline' 0 CA--C 1.54 0.794 0 C-N-CA 122.327 2.018 . . . . 0.0 113.643 -178.005 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 2481 ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -92.9 -4.0 53.59 Favored 'General case' 0 CA--C 1.553 1.062 0 C-N-CA 125.164 1.386 . . . . 0.0 112.992 175.831 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 2482 ' ' GLY . . . . . . . . . . . . . . . 139.11 -110.85 0.74 Allowed Glycine 0 N--CA 1.471 0.974 0 C-N-CA 125.482 1.515 . . . . 0.0 112.985 179.828 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 2483 ' ' TYR . . . . . . . . . . . . . 95.3 m-85 -130.03 120.08 24.15 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 124.401 1.08 . . . . 0.0 111.317 175.397 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 2484 ' ' ARG . . . . . . . . . . . . . 19.0 ttp-105 -81.05 133.76 35.54 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 123.785 0.834 . . . . 0.0 110.161 171.982 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 2485 ' ' VAL . . . . . . . . . . . . . 89.9 t -115.06 118.07 57.63 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 C-N-CA 125.234 1.414 . . . . 0.0 107.996 168.858 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 2486 ' ' THR . . . . . . . . . . . . . 98.9 m -100.16 146.42 26.85 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 124.872 1.269 . . . . 0.0 108.166 165.405 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 2487 ' ' TYR . . . . . . . . . . . . . 29.2 p90 -153.13 152.0 30.8 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.246 1.018 . . . . 0.0 112.618 171.8 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 2488 ' ' THR . . . . . . . . . . . . . 59.6 m -107.09 113.69 62.14 Favored Pre-proline 0 N--CA 1.473 0.719 0 CA-C-O 117.799 -1.096 . . . . 0.0 109.438 173.918 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 2489 ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -76.01 114.21 3.87 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 123.504 2.803 . . . . 0.0 109.424 172.383 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 2490 ' ' MET . . . . . . . . . . . . . 27.8 ptm -86.42 -7.91 58.06 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 114.661 1.356 . . . . 0.0 114.661 -173.675 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 2491 ' ' ALA . . . . . . . . . . . . . . . -147.04 149.43 35.48 Favored Pre-proline 0 CA--C 1.547 0.855 0 C-N-CA 124.792 1.237 . . . . 0.0 112.146 -179.249 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 2492 ' ' PRO . . . . . . . . . . . . . 78.0 Cg_endo -73.17 155.05 52.21 Favored 'Trans proline' 0 C--N 1.35 0.646 0 C-N-CA 123.627 2.884 . . . . 0.0 111.489 178.243 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 2493 ' ' GLY . . . . . . . . . . . . . . . 131.89 -139.69 11.16 Favored Glycine 0 CA--C 1.529 0.944 0 C-N-CA 125.342 1.449 . . . . 0.0 112.093 -173.635 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 2494 ' ' SER . . . . . . . . . . . . . 65.9 m -133.77 124.99 27.56 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 123.937 0.895 . . . . 0.0 111.465 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 2495 ' ' TYR . . . . . . . . . . . . . 65.6 m-85 -95.53 131.88 41.24 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.845 1.258 . . . . 0.0 111.06 172.759 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 2496 ' ' LEU . . . . . . . . . . . . . 27.8 tp -100.13 114.98 28.76 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 125.297 1.439 . . . . 0.0 109.364 177.881 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 2497 ' ' ILE . . . . . . . . . . . . . 48.2 mt -102.57 102.33 13.42 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 C-N-CA 125.863 1.665 . . . . 0.0 108.667 -173.472 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 2498 ' ' SER . . . . . . . . . . . . . 67.2 m -92.14 109.0 20.35 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 124.888 1.275 . . . . 0.0 109.988 177.413 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 2499 ' ' ILE . . . . . . . . . . . . . 69.1 mt -104.36 104.96 17.64 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 C-N-CA 124.684 1.194 . . . . 0.0 107.926 -176.692 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 2500 ' ' LYS . . . . . . . . . . . . . 84.0 mttt -110.96 137.36 48.68 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.35 1.06 . . . . 0.0 111.244 -179.725 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 2501 ' ' TYR . . . . . . . . . . . . . 51.7 t80 -143.63 137.69 28.48 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 123.915 0.886 . . . . 0.0 111.93 -170.45 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 2502 ' ' GLY . . . . . . . . . . . . . . . 66.54 11.04 55.95 Favored Glycine 0 CA--C 1.537 1.452 0 C-N-CA 124.449 1.023 . . . . 0.0 114.808 177.247 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 2503 ' ' GLY . . . . . . . . . . . . . . . 153.93 -167.53 32.21 Favored Glycine 0 CA--C 1.54 1.625 0 C-N-CA 125.507 1.527 . . . . 0.0 113.31 -170.189 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 2504 ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -82.87 7.88 4.93 Favored 'Trans proline' 0 CA--C 1.543 0.931 0 C-N-CA 124.731 3.621 . . . . 0.0 114.143 -173.43 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 2505 ' ' TYR . . . . . . . . . . . . . 64.4 m-85 -103.24 142.29 34.44 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.648 1.179 . . . . 0.0 113.234 -173.497 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 2506 ' ' HIS . . . . . . . . . . . . . 91.0 m-70 -65.27 147.28 53.72 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 124.278 1.031 . . . . 0.0 112.585 174.891 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 2507 ' ' ILE . . . . . . . . . . . . . 26.9 pt -74.29 169.2 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 O-C-N 121.574 -0.704 . . . . 0.0 112.47 170.524 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 2508 ' ' GLY . . . . . . . . . . . . . . . -57.89 123.88 34.37 Favored Glycine 0 CA--C 1.533 1.18 0 C-N-CA 123.838 0.732 . . . . 0.0 112.179 178.138 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 2509 ' ' GLY . . . . . . . . . . . . . . . 86.92 -10.22 69.02 Favored Glycine 0 CA--C 1.535 1.3 0 C-N-CA 125.535 1.54 . . . . 0.0 114.946 -177.364 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 2510 ' ' SER . . . . . . . . . . . . . 7.2 t -91.65 147.67 35.64 Favored Pre-proline 0 CA--C 1.552 1.045 0 CA-C-N 119.006 1.403 . . . . 0.0 111.538 -179.464 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 2511 ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -73.65 148.0 90.97 Favored 'Cis proline' 0 C--N 1.353 0.814 0 CA-C-N 120.474 1.205 . . . . 0.0 113.546 3.207 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 2512 ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -102.41 131.78 48.85 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 125.262 1.425 . . . . 0.0 110.703 177.764 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 2513 ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.67 106.87 19.03 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 123.934 0.894 . . . . 0.0 111.79 176.149 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 2514 ' ' ALA . . . . . . . . . . . . . . . -92.64 118.55 31.15 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.829 1.652 . . . . 0.0 110.401 177.478 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 2515 ' ' LYS . . . . . . . . . . . . . 48.1 mtpt -94.9 131.51 40.72 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.257 1.023 . . . . 0.0 110.742 -176.733 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 2516 ' ' VAL . . . . . . . . . . . . . 26.9 m -135.43 144.66 33.4 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 C-N-CA 123.832 0.853 . . . . 0.0 112.275 -170.025 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 2517 ' ' THR . . . . . . . . . . . . . 41.3 p -144.76 162.57 36.41 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 125.327 1.451 . . . . 0.0 111.46 -173.177 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 2518 ' ' GLY . . . . . . . . . . . . . . . 117.94 -176.93 16.36 Favored Glycine 0 CA--C 1.539 1.552 0 C-N-CA 125.252 1.406 . . . . 0.0 113.046 -175.039 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 2519 ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -75.41 133.12 15.62 Favored 'Trans proline' 0 C--N 1.349 0.553 0 C-N-CA 123.503 2.802 . . . . 0.0 111.324 -173.72 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 2520 ' ' ARG . . . . . . . . . . . . . 37.7 ttm105 . . . . . 0 CA--C 1.54 0.561 0 C-N-CA 123.938 0.895 . . . . 0.0 111.699 -179.984 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A 2427 ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.967 0 N-CA-C 112.032 -0.427 . . . . 0.0 112.032 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A 2428 ' ' ASP . . . . . . . . . . . . . 28.5 m-20 -121.46 142.86 36.4 Favored Pre-proline 0 CA--C 1.544 0.714 0 C-N-CA 124.983 1.313 . . . . 0.0 112.098 -177.65 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 2429 ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -64.49 -24.98 63.15 Favored 'Trans proline' 0 CA--C 1.539 0.734 0 C-N-CA 123.196 2.597 . . . . 0.0 112.966 179.12 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 2430 ' ' GLY . . . . . . . . . . . . . . . -73.88 -22.72 77.77 Favored Glycine 0 CA--C 1.535 1.341 0 CA-C-N 118.844 0.747 . . . . 0.0 113.738 174.59 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 2431 ' ' LEU . . . . . . . . . . . . . 4.3 mm? -88.47 -40.96 13.07 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 124.634 1.174 . . . . 0.0 111.201 173.157 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 2432 ' ' VAL . . . . . . . . . . . . . 59.4 t -59.19 137.97 20.91 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 123.936 0.894 . . . . 0.0 111.069 175.038 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 2433 ' ' SER . . . . . . . . . . . . . 8.2 t -127.02 -174.69 3.22 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 125.136 1.374 . . . . 0.0 110.45 171.855 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 2434 ' ' ALA . . . . . . . . . . . . . . . -145.95 146.95 31.23 Favored 'General case' 0 CA--C 1.538 0.487 0 O-C-N 120.91 -1.119 . . . . 0.0 112.123 177.875 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 2435 ' ' TYR . . . . . . . . . . . . . 68.2 m-85 -145.35 150.05 35.89 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 125.411 1.484 . . . . 0.0 111.92 -173.746 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 2436 ' ' GLY . . . . . . . . . . . . . . . 120.63 159.79 10.91 Favored Glycine 0 N--CA 1.474 1.203 0 C-N-CA 125.462 1.506 . . . . 0.0 114.051 177.098 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 2437 ' ' ALA . . . . . . . . . . . . . . . -61.83 -26.98 68.45 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 125.118 1.367 . . . . 0.0 114.446 -171.362 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 2438 ' ' GLY . . . . . . . . . . . . . . . -65.49 -14.48 60.11 Favored Glycine 0 CA--C 1.533 1.183 0 C-N-CA 124.183 0.897 . . . . 0.0 114.217 178.494 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 2439 ' ' LEU . . . . . . . . . . . . . 86.3 mt -78.22 -22.01 49.14 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 118.894 1.347 . . . . 0.0 112.779 169.807 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 2440 ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -98.29 -28.25 13.76 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 125.338 1.455 . . . . 0.0 112.407 -179.268 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 2441 ' ' GLY . . . . . . . . . . . . . . . 105.86 -155.04 16.92 Favored Glycine 0 CA--C 1.533 1.189 0 C-N-CA 125.747 1.641 . . . . 0.0 113.341 179.059 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 2442 ' ' GLY . . . . . . . . . . . . . . . 163.72 -157.06 29.17 Favored Glycine 0 CA--C 1.532 1.102 0 C-N-CA 124.342 0.972 . . . . 0.0 114.071 -175.458 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 2443 ' ' VAL . . . . . . . . . . . . . 61.0 t -87.64 141.33 14.47 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 C-N-CA 124.597 1.159 . . . . 0.0 110.873 -178.192 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 2444 ' ' THR . . . . . . . . . . . . . 26.1 p -62.66 144.3 56.43 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 124.933 1.293 . . . . 0.0 112.666 174.949 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 2445 ' ' GLY . . . . . . . . . . . . . . . 76.33 -9.91 18.59 Favored Glycine 0 CA--C 1.537 1.466 0 C-N-CA 124.605 1.098 . . . . 0.0 114.254 -176.088 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 2446 ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -101.0 142.11 23.97 Favored Pre-proline 0 CA--C 1.553 1.059 0 C-N-CA 126.744 2.018 . . . . 0.0 110.312 175.184 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 2447 ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -76.72 149.32 29.77 Favored 'Trans proline' 0 CA--C 1.536 0.598 0 C-N-CA 123.196 2.597 . . . . 0.0 111.858 178.757 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 2448 ' ' ALA . . . . . . . . . . . . . . . -138.89 141.51 38.56 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 125.648 1.579 . . . . 0.0 109.972 170.834 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 2449 ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -130.21 152.22 49.88 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.23 1.012 . . . . 0.0 113.396 -167.711 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 2450 ' ' PHE . . . . . . . . . . . . . 40.2 p90 -154.3 161.58 41.7 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.972 1.309 . . . . 0.0 111.746 175.445 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 2451 ' ' VAL . . . . . . . . . . . . . 12.3 p -118.26 135.37 58.89 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 C-N-CA 125.273 1.429 . . . . 0.0 110.454 175.35 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 2452 ' ' VAL . . . . . . . . . . . . . 40.9 t -89.19 104.0 14.54 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 N-CA-C 106.751 -1.574 . . . . 0.0 106.751 166.16 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 2453 ' ' ASN . . . . . . . . . . . . . 15.1 t-20 -89.17 117.1 27.9 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 123.955 0.902 . . . . 0.0 112.791 -165.904 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 2454 ' ' THR . . . . . . . . . . . . . 48.5 p -97.63 -2.67 41.01 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 125.809 1.643 . . . . 0.0 114.432 -175.592 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 2455 ' ' SER . . . . . . . . . . . . . 24.4 m -58.0 -27.43 63.5 Favored 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 114.326 1.232 . . . . 0.0 114.326 -176.672 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 2456 ' ' ASN . . . . . . . . . . . . . 81.8 m-20 -76.42 -20.78 56.75 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 124.44 1.096 . . . . 0.0 113.289 175.744 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 2457 ' ' ALA . . . . . . . . . . . . . . . -117.34 -56.49 2.23 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.649 1.18 . . . . 0.0 113.646 -157.151 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 2458 ' ' GLY . . . . . . . . . . . . . . . 113.68 -155.96 15.95 Favored Glycine 0 CA--C 1.534 1.252 0 C-N-CA 124.852 1.215 . . . . 0.0 112.375 -166.893 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 2459 ' ' ALA . . . . . . . . . . . . . . . -85.53 145.52 27.35 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 124.206 1.002 . . . . 0.0 113.681 -173.19 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 2460 ' ' GLY . . . . . . . . . . . . . . . 174.61 160.67 23.1 Favored Glycine 0 CA--C 1.532 1.127 0 C-N-CA 125.357 1.455 . . . . 0.0 113.145 -179.885 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 2461 ' ' ALA . . . . . . . . . . . . . . . -82.2 150.59 27.3 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 124.278 1.031 . . . . 0.0 112.847 -178.388 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 2462 ' ' LEU . . . . . . . . . . . . . 16.9 tp -107.68 147.36 30.83 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.56 1.544 . . . . 0.0 110.976 176.004 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 2463 ' ' SER . . . . . . . . . . . . . 9.5 t -141.06 37.37 1.75 Allowed 'General case' 0 CA--C 1.551 1.005 0 C-N-CA 125.294 1.438 . . . . 0.0 111.563 -179.469 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 2464 ' ' VAL . . . . . . . . . . . . . 12.6 p -61.01 135.73 25.45 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 C-N-CA 125.164 1.386 . . . . 0.0 112.512 -174.888 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 2465 ' ' THR . . . . . . . . . . . . . 95.9 m -136.57 145.24 44.74 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 126.003 1.721 . . . . 0.0 109.727 -179.758 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 2466 ' ' ILE . . . . . . . . . . . . . 30.1 mt -124.89 130.51 73.27 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 124.072 0.949 . . . . 0.0 110.094 176.519 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 2467 ' ' ASP . . . . . . . . . . . . . 33.7 t70 -122.51 128.12 50.4 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 125.949 1.7 . . . . 0.0 109.976 173.919 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 2468 ' ' GLY . . . . . . . . . . . . . . . -155.49 -166.2 15.32 Favored Glycine 0 CA--C 1.537 1.43 0 N-CA-C 115.685 1.034 . . . . 0.0 115.685 -171.174 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 2469 ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -67.72 -16.16 45.83 Favored 'Trans proline' 0 CA--C 1.539 0.765 0 C-N-CA 124.464 3.442 . . . . 0.0 113.267 178.474 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 2470 ' ' SER . . . . . . . . . . . . . 8.1 t -156.63 -168.07 2.58 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 126.491 1.916 . . . . 0.0 109.307 166.346 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 2471 ' ' LYS . . . . . . . . . . . . . 67.7 mttm -74.28 173.66 9.89 Favored 'General case' 0 CA--C 1.55 0.97 0 O-C-N 120.881 -1.137 . . . . 0.0 112.31 169.587 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 2472 ' ' VAL . . . . . . . . . . . . . 33.5 m -127.05 149.18 31.96 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 C-N-CA 125.624 1.57 . . . . 0.0 110.696 174.503 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 2473 ' ' LYS . . . . . . . . . . . . . 59.6 tttp -92.71 97.21 10.64 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 165.685 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 2474 ' ' MET . . . . . . . . . . . . . 48.4 ttp -111.58 142.26 44.12 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 124.874 1.27 . . . . 0.0 112.369 -175.445 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 2475 ' ' ASP . . . . . . . . . . . . . 36.9 t70 -126.05 141.15 52.08 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 126.791 2.037 . . . . 0.0 110.23 170.938 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 2476 ' ' CYS . . . . . . . . . . . . . 63.6 m -123.06 150.82 42.63 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 125.203 1.401 . . . . 0.0 111.989 -173.218 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 2477 ' ' GLN . . . . . . . . . . . . . 3.8 tt0 -151.24 147.14 26.63 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.447 1.099 . . . . 0.0 111.121 179.486 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 2478 ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -90.13 150.06 22.19 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 123.716 0.806 . . . . 0.0 111.083 163.752 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 2479 ' ' CYS . . . . . . . . . . . . . 19.9 p -160.68 172.22 6.14 Favored Pre-proline 0 CA--C 1.554 1.099 0 C-N-CA 125.626 1.571 . . . . 0.0 111.572 -178.384 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 2480 ' ' PRO . . . . . . . . . . . . . 63.6 Cg_exo -58.67 -25.06 73.73 Favored 'Trans proline' 0 CA--C 1.539 0.743 0 C-N-CA 123.454 2.77 . . . . 0.0 114.481 175.362 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 2481 ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -81.72 -8.65 59.72 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 124.814 1.246 . . . . 0.0 113.076 178.162 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 2482 ' ' GLY . . . . . . . . . . . . . . . 120.47 -143.25 16.41 Favored Glycine 0 N--CA 1.471 1.015 0 C-N-CA 126.11 1.814 . . . . 0.0 112.238 -175.263 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 2483 ' ' TYR . . . . . . . . . . . . . 80.1 m-85 -96.23 113.66 25.28 Favored 'General case' 0 N--CA 1.469 0.517 0 O-C-N 121.7 -0.883 . . . . 0.0 110.811 173.381 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 2484 ' ' ARG . . . . . . . . . . . . . 55.6 ttp85 -96.76 142.02 29.28 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 124.62 1.168 . . . . 0.0 110.278 176.85 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 2485 ' ' VAL . . . . . . . . . . . . . 11.3 m -133.97 152.78 35.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 123.806 0.843 . . . . 0.0 111.083 173.962 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 2486 ' ' THR . . . . . . . . . . . . . 40.5 m -131.99 133.86 44.93 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 125.656 1.583 . . . . 0.0 107.66 172.682 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 2487 ' ' TYR . . . . . . . . . . . . . 15.3 p90 -140.5 148.98 41.92 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 113.839 1.051 . . . . 0.0 113.839 176.876 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 2488 ' ' THR . . . . . . . . . . . . . 69.2 m -108.7 115.71 57.11 Favored Pre-proline 0 N--CA 1.469 0.514 0 C-N-CA 124.941 1.297 . . . . 0.0 109.108 172.611 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 2489 ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -80.49 161.26 22.37 Favored 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 123.794 2.996 . . . . 0.0 110.864 169.571 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 2490 ' ' MET . . . . . . . . . . . . . 25.7 ptm -133.4 2.8 3.56 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 114.94 1.459 . . . . 0.0 114.94 -173.703 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 2491 ' ' ALA . . . . . . . . . . . . . . . -143.42 145.55 32.35 Favored Pre-proline 0 CA--C 1.547 0.828 0 C-N-CA 124.644 1.178 . . . . 0.0 111.68 177.764 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 2492 ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -73.23 148.66 44.36 Favored 'Trans proline' 0 CA--C 1.536 0.615 0 C-N-CA 123.126 2.55 . . . . 0.0 111.08 175.851 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 2493 ' ' GLY . . . . . . . . . . . . . . . 135.05 -161.75 24.64 Favored Glycine 0 CA--C 1.53 0.988 0 C-N-CA 125.307 1.432 . . . . 0.0 112.975 -175.54 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 2494 ' ' SER . . . . . . . . . . . . . 49.3 m -105.8 118.04 35.57 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.835 0.854 . . . . 0.0 111.522 179.193 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 2495 ' ' TYR . . . . . . . . . . . . . 78.1 m-85 -88.53 114.44 25.15 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.704 1.202 . . . . 0.0 109.386 167.033 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 2496 ' ' LEU . . . . . . . . . . . . . 27.2 tp -91.0 114.36 26.86 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 125.158 1.383 . . . . 0.0 109.072 179.073 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 2497 ' ' ILE . . . . . . . . . . . . . 44.0 mt -99.88 102.17 13.07 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 C-N-CA 125.534 1.534 . . . . 0.0 108.503 -173.417 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 2498 ' ' SER . . . . . . . . . . . . . 66.5 m -84.87 93.95 8.64 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 124.954 1.302 . . . . 0.0 109.391 174.841 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 2499 ' ' ILE . . . . . . . . . . . . . 48.6 mt -87.38 95.85 5.31 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 C-N-CA 124.402 1.081 . . . . 0.0 108.526 178.884 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 2500 ' ' LYS . . . . . . . . . . . . . 91.2 mttt -98.84 138.89 35.32 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.099 0.959 . . . . 0.0 111.385 177.212 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 2501 ' ' TYR . . . . . . . . . . . . . 64.6 t80 -149.58 148.46 29.37 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.046 1.338 . . . . 0.0 112.228 -172.765 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 2502 ' ' GLY . . . . . . . . . . . . . . . 69.01 26.3 74.8 Favored Glycine 0 CA--C 1.534 1.22 0 C-N-CA 124.065 0.84 . . . . 0.0 112.639 -178.992 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 2503 ' ' GLY . . . . . . . . . . . . . . . 116.19 -164.45 12.28 Favored Glycine 0 CA--C 1.54 1.645 0 C-N-CA 125.877 1.703 . . . . 0.0 112.04 -164.022 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 2504 ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -81.49 33.87 0.54 Allowed 'Trans proline' 0 CA--C 1.548 1.179 0 C-N-CA 124.936 3.757 . . . . 0.0 113.165 -173.991 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 2505 ' ' TYR . . . . . . . . . . . . . 74.9 m-85 -114.8 127.21 55.59 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.815 1.246 . . . . 0.0 112.576 -172.053 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 2506 ' ' HIS . . . . . . . . . . . . . 86.4 m-70 -57.61 138.74 54.97 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 124.802 1.241 . . . . 0.0 113.037 178.326 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 2507 ' ' ILE . . . . . . . . . . . . . 27.1 pt -69.08 166.96 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 O-C-N 121.827 -0.545 . . . . 0.0 112.26 169.689 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 2508 ' ' GLY . . . . . . . . . . . . . . . -59.84 -21.94 56.39 Favored Glycine 0 CA--C 1.539 1.538 0 N-CA-C 116.483 1.353 . . . . 0.0 116.483 -166.688 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 2509 ' ' GLY . . . . . . . . . . . . . . . -106.36 -0.42 37.75 Favored Glycine 0 CA--C 1.536 1.399 0 C-N-CA 125.136 1.351 . . . . 0.0 114.969 174.302 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 2510 ' ' SER . . . . . . . . . . . . . 46.8 t -88.77 148.69 42.16 Favored Pre-proline 0 CA--C 1.549 0.916 0 CA-C-N 118.678 1.239 . . . . 0.0 112.824 -172.488 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 2511 ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -78.39 152.34 90.64 Favored 'Cis proline' 0 C--N 1.353 0.794 0 CA-C-N 119.31 0.789 . . . . 0.0 113.288 -1.669 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 2512 ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -102.29 128.91 48.64 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 125.291 1.437 . . . . 0.0 110.739 179.26 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 2513 ' ' LYS . . . . . . . . . . . . . 57.0 pttt -92.04 100.36 13.02 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 124.097 0.959 . . . . 0.0 112.214 178.644 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 2514 ' ' ALA . . . . . . . . . . . . . . . -88.3 114.59 25.08 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.714 1.206 . . . . 0.0 110.109 175.209 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 2515 ' ' LYS . . . . . . . . . . . . . 66.3 mttm -95.92 119.07 33.76 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 123.867 0.867 . . . . 0.0 111.093 -175.188 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 2516 ' ' VAL . . . . . . . . . . . . . 49.4 t -113.4 140.15 35.09 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 C-N-CA 125.731 1.612 . . . . 0.0 110.408 -169.798 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 2517 ' ' THR . . . . . . . . . . . . . 64.2 p -129.85 173.6 10.51 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 125.82 1.648 . . . . 0.0 111.403 -177.027 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 2518 ' ' GLY . . . . . . . . . . . . . . . 100.5 -171.14 22.81 Favored Glycine 0 CA--C 1.539 1.55 0 C-N-CA 124.705 1.145 . . . . 0.0 113.03 -174.695 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 2519 ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -72.19 157.36 54.04 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 123.719 2.946 . . . . 0.0 112.106 -176.005 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 2520 ' ' ARG . . . . . . . . . . . . . 50.9 ttt85 . . . . . 0 CA--C 1.538 0.51 0 C-N-CA 123.635 0.774 . . . . 0.0 109.665 170.499 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.537 0 N-CA-C 111.383 -0.687 . . . . 0.0 111.383 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -76.71 -28.15 55.73 Favored 'General case' 0 CA--C 1.545 0.773 0 N-CA-C 113.904 1.076 . . . . 0.0 113.904 -177.66 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 99.4 mmm -83.56 138.18 33.51 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 124.634 1.174 . . . . 0.0 112.04 -179.099 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 2427 ' ' GLY . . . . . . . . . . . . . . . -78.92 167.09 52.45 Favored Glycine 0 CA--C 1.532 1.134 0 C-N-CA 124.592 1.092 . . . . 0.0 113.003 171.638 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 2428 ' ' ASP . . . . . . . . . . . . . 13.4 t70 -150.4 135.48 9.91 Favored Pre-proline 0 CA--C 1.55 0.958 0 C-N-CA 124.471 1.108 . . . . 0.0 111.658 -174.936 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 2429 ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -67.16 -21.18 48.91 Favored 'Trans proline' 0 C--N 1.352 0.717 0 C-N-CA 123.44 2.76 . . . . 0.0 113.946 -175.782 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 2430 ' ' GLY . . . . . . . . . . . . . . . -80.48 -25.6 56.44 Favored Glycine 0 CA--C 1.532 1.115 0 CA-C-N 119.29 0.95 . . . . 0.0 113.021 174.319 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 2431 ' ' LEU . . . . . . . . . . . . . 4.4 mm? -80.61 -37.55 30.94 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 124.138 0.975 . . . . 0.0 111.058 171.218 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 2432 ' ' VAL . . . . . . . . . . . . . 74.7 t -63.5 137.62 24.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 CA-C-O 121.598 0.713 . . . . 0.0 110.607 170.333 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 2433 ' ' SER . . . . . . . . . . . . . 8.1 t -133.5 -171.4 2.7 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 125.224 1.41 . . . . 0.0 110.103 173.007 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 2434 ' ' ALA . . . . . . . . . . . . . . . -144.59 145.65 31.91 Favored 'General case' 0 CA--C 1.538 0.487 0 O-C-N 121.029 -1.044 . . . . 0.0 111.502 176.927 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 2435 ' ' TYR . . . . . . . . . . . . . 80.5 m-85 -145.72 154.42 42.05 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 125.454 1.501 . . . . 0.0 111.844 -174.58 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 2436 ' ' GLY . . . . . . . . . . . . . . . 113.64 162.28 14.7 Favored Glycine 0 N--CA 1.473 1.149 0 C-N-CA 125.167 1.365 . . . . 0.0 113.954 176.852 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 2437 ' ' ALA . . . . . . . . . . . . . . . -60.62 -27.3 67.66 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.322 1.449 . . . . 0.0 114.462 -170.19 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 2438 ' ' GLY . . . . . . . . . . . . . . . -64.83 -18.59 64.4 Favored Glycine 0 CA--C 1.531 1.033 0 CA-C-O 119.025 -0.875 . . . . 0.0 114.33 -179.081 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 2439 ' ' LEU . . . . . . . . . . . . . 87.2 mt -74.33 -24.43 59.19 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 118.576 1.188 . . . . 0.0 112.698 170.703 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 2440 ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -90.07 -28.0 19.31 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.844 1.258 . . . . 0.0 111.691 174.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 2441 ' ' GLY . . . . . . . . . . . . . . . 110.93 -137.1 14.08 Favored Glycine 0 CA--C 1.529 0.931 0 C-N-CA 125.83 1.681 . . . . 0.0 113.428 175.079 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 2442 ' ' GLY . . . . . . . . . . . . . . . 165.34 -136.31 4.13 Favored Glycine 0 N--CA 1.471 1.025 0 C-N-CA 124.032 0.825 . . . . 0.0 113.7 -172.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 2443 ' ' VAL . . . . . . . . . . . . . 73.8 t -130.2 149.3 33.45 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 125.921 1.688 . . . . 0.0 109.302 -178.104 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 2444 ' ' THR . . . . . . . . . . . . . 38.1 p -58.31 136.26 57.33 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.608 0.763 . . . . 0.0 112.005 176.566 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 2445 ' ' GLY . . . . . . . . . . . . . . . 77.67 -10.89 22.0 Favored Glycine 0 CA--C 1.538 1.484 0 C-N-CA 124.905 1.241 . . . . 0.0 114.805 -175.655 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 2446 ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -95.07 141.68 23.57 Favored Pre-proline 0 CA--C 1.553 1.079 0 C-N-CA 125.63 1.572 . . . . 0.0 110.981 177.588 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 2447 ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -74.18 134.74 19.73 Favored 'Trans proline' 0 C--N 1.35 0.649 0 C-N-CA 123.113 2.542 . . . . 0.0 111.437 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 2448 ' ' ALA . . . . . . . . . . . . . . . -116.65 119.98 37.21 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 126.688 1.995 . . . . 0.0 108.919 175.916 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 2449 ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -122.62 131.7 53.94 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 124.094 0.958 . . . . 0.0 111.94 -168.336 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 2450 ' ' PHE . . . . . . . . . . . . . 15.3 p90 -147.56 166.67 26.62 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 125.283 1.433 . . . . 0.0 111.107 174.307 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 2451 ' ' VAL . . . . . . . . . . . . . 15.0 p -122.42 135.47 62.42 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 C-N-CA 125.045 1.338 . . . . 0.0 110.987 176.796 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 2452 ' ' VAL . . . . . . . . . . . . . 56.9 t -85.08 107.09 15.64 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 N-CA-C 106.825 -1.546 . . . . 0.0 106.825 163.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 2453 ' ' ASN . . . . . . . . . . . . . 17.4 t-20 -92.7 119.77 32.43 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 123.389 0.676 . . . . 0.0 112.49 -168.088 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 2454 ' ' THR . . . . . . . . . . . . . 76.8 p -102.8 -1.17 30.29 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 125.739 1.615 . . . . 0.0 113.906 -178.126 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 2455 ' ' SER . . . . . . . . . . . . . 29.5 m -56.93 -29.63 63.29 Favored 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 114.478 1.288 . . . . 0.0 114.478 -174.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 2456 ' ' ASN . . . . . . . . . . . . . 86.8 m-20 -82.96 -18.42 40.02 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 124.321 1.048 . . . . 0.0 113.396 175.897 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 2457 ' ' ALA . . . . . . . . . . . . . . . -104.03 -36.03 7.88 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 125.533 1.533 . . . . 0.0 113.626 -172.48 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 2458 ' ' GLY . . . . . . . . . . . . . . . 105.99 -107.17 2.72 Favored Glycine 0 CA--C 1.529 0.958 0 C-N-CA 124.9 1.238 . . . . 0.0 111.167 -172.616 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 2459 ' ' ALA . . . . . . . . . . . . . . . -143.31 156.22 44.66 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.706 1.202 . . . . 0.0 112.905 -176.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 2460 ' ' GLY . . . . . . . . . . . . . . . 164.26 166.81 23.78 Favored Glycine 0 CA--C 1.532 1.136 0 C-N-CA 125.825 1.678 . . . . 0.0 112.772 -174.634 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 2461 ' ' ALA . . . . . . . . . . . . . . . -74.98 144.18 43.27 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 123.921 0.889 . . . . 0.0 112.363 -179.422 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 2462 ' ' LEU . . . . . . . . . . . . . 48.2 tp -124.83 141.73 51.92 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.291 1.436 . . . . 0.0 111.328 179.417 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 2463 ' ' SER . . . . . . . . . . . . . 15.8 t -123.71 160.42 27.27 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 125.005 1.322 . . . . 0.0 110.291 158.11 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 2464 ' ' VAL . . . . . . . . . . . . . 5.8 p -161.68 133.82 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 124.892 1.277 . . . . 0.0 110.634 -176.334 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 2465 ' ' THR . . . . . . . . . . . . . 94.2 m -137.84 138.5 39.2 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 126.048 1.739 . . . . 0.0 109.369 -177.407 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 2466 ' ' ILE . . . . . . . . . . . . . 45.3 mt -119.67 125.3 74.21 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 C-N-CA 124.39 1.076 . . . . 0.0 108.821 176.689 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 2467 ' ' ASP . . . . . . . . . . . . . 35.7 t70 -137.05 130.5 31.44 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 125.135 1.374 . . . . 0.0 111.296 -174.397 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 2468 ' ' GLY . . . . . . . . . . . . . . . -167.17 -142.43 3.45 Favored Glycine 0 CA--C 1.538 1.506 0 CA-C-O 118.524 -1.153 . . . . 0.0 113.883 -175.111 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 2469 ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo -68.61 -14.36 39.33 Favored 'Trans proline' 0 CA--C 1.539 0.759 0 C-N-CA 123.977 3.118 . . . . 0.0 113.58 -178.465 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 2470 ' ' SER . . . . . . . . . . . . . 7.5 t -157.73 -170.4 3.18 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 125.776 1.63 . . . . 0.0 110.356 170.625 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 2471 ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -77.48 171.39 14.96 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 124.245 1.018 . . . . 0.0 111.824 168.079 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 2472 ' ' VAL . . . . . . . . . . . . . 28.7 m -135.07 151.75 31.4 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 125.376 1.471 . . . . 0.0 110.389 175.097 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 2473 ' ' LYS . . . . . . . . . . . . . 99.7 mttt -93.59 118.51 31.46 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.811 0.845 . . . . 0.0 109.451 170.088 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 2474 ' ' MET . . . . . . . . . . . . . 77.2 mtp -111.13 137.34 48.93 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 125.282 1.433 . . . . 0.0 112.54 -175.758 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 2475 ' ' ASP . . . . . . . . . . . . . 25.8 t70 -113.59 94.89 5.06 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 126.364 1.866 . . . . 0.0 109.042 162.371 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 2476 ' ' CYS . . . . . . . . . . . . . 47.5 t -91.35 129.43 37.34 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.382 1.073 . . . . 0.0 110.123 173.374 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 2477 ' ' GLN . . . . . . . . . . . . . 70.1 mm-40 -142.33 140.17 32.04 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 124.571 1.148 . . . . 0.0 110.821 -175.527 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 2478 ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -82.22 148.1 28.61 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 123.63 0.772 . . . . 0.0 111.854 173.06 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 2479 ' ' CYS . . . . . . . . . . . . . 31.9 p -161.36 171.7 6.59 Favored Pre-proline 0 CA--C 1.553 1.086 0 C-N-CA 125.639 1.576 . . . . 0.0 111.863 -175.005 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 2480 ' ' PRO . . . . . . . . . . . . . 66.0 Cg_exo -58.42 -24.73 70.24 Favored 'Trans proline' 0 CA--C 1.539 0.772 0 C-N-CA 123.348 2.699 . . . . 0.0 114.341 174.137 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 2481 ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -81.69 -6.51 59.09 Favored 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 124.981 1.312 . . . . 0.0 113.047 177.374 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 2482 ' ' GLY . . . . . . . . . . . . . . . 120.43 -118.04 3.73 Favored Glycine 0 N--CA 1.469 0.883 0 C-N-CA 126.08 1.8 . . . . 0.0 111.987 -176.709 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 2483 ' ' TYR . . . . . . . . . . . . . 93.4 m-85 -124.14 111.78 16.32 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.211 1.004 . . . . 0.0 110.651 173.787 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 2484 ' ' ARG . . . . . . . . . . . . . 13.7 ttp-105 -78.07 139.52 39.08 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 123.871 0.869 . . . . 0.0 109.807 173.571 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 2485 ' ' VAL . . . . . . . . . . . . . 90.7 t -126.96 116.09 43.5 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 C-N-CA 125.202 1.401 . . . . 0.0 108.257 170.719 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 2486 ' ' THR . . . . . . . . . . . . . 87.2 m -103.44 133.61 48.2 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 107.478 -1.304 . . . . 0.0 107.478 164.403 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 2487 ' ' TYR . . . . . . . . . . . . . 27.5 p90 -139.14 155.13 48.09 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 113.166 0.802 . . . . 0.0 113.166 176.4 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 2488 ' ' THR . . . . . . . . . . . . . 93.0 m -120.1 116.97 32.33 Favored Pre-proline 0 N--CA 1.474 0.737 0 C-N-CA 124.205 1.002 . . . . 0.0 109.774 176.925 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 2489 ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -82.5 158.4 16.83 Favored 'Trans proline' 0 C--N 1.351 0.681 0 C-N-CA 123.97 3.113 . . . . 0.0 111.551 173.402 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 2490 ' ' MET . . . . . . . . . . . . . 25.3 ptm -132.78 7.71 4.09 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 114.612 1.338 . . . . 0.0 114.612 -176.218 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 2491 ' ' ALA . . . . . . . . . . . . . . . -144.83 143.83 22.3 Favored Pre-proline 0 CA--C 1.547 0.838 0 C-N-CA 125.357 1.463 . . . . 0.0 111.224 172.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 2492 ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -76.16 156.86 38.0 Favored 'Trans proline' 0 CA--C 1.536 0.616 0 C-N-CA 123.704 2.936 . . . . 0.0 111.138 175.47 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 2493 ' ' GLY . . . . . . . . . . . . . . . 130.47 -140.37 11.71 Favored Glycine 0 CA--C 1.528 0.89 0 C-N-CA 125.643 1.592 . . . . 0.0 111.181 -171.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 2494 ' ' SER . . . . . . . . . . . . . 54.4 p -140.93 138.59 33.95 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 113.333 0.864 . . . . 0.0 113.333 178.628 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 2495 ' ' TYR . . . . . . . . . . . . . 56.6 m-85 -111.13 131.48 55.06 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 126.215 1.806 . . . . 0.0 110.412 -178.666 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 2496 ' ' LEU . . . . . . . . . . . . . 86.2 mt -86.62 123.2 31.54 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 124.459 1.103 . . . . 0.0 109.33 169.766 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 2497 ' ' ILE . . . . . . . . . . . . . 49.7 mt -100.93 94.45 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 C-N-CA 125.641 1.576 . . . . 0.0 107.939 179.391 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 2498 ' ' SER . . . . . . . . . . . . . 67.1 m -88.71 119.3 29.06 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 125.594 1.557 . . . . 0.0 110.245 -178.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 2499 ' ' ILE . . . . . . . . . . . . . 33.7 mt -127.09 121.4 57.76 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 C-N-CA 125.223 1.409 . . . . 0.0 108.088 -170.883 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 2500 ' ' LYS . . . . . . . . . . . . . 93.0 mttt -131.8 119.22 20.96 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 123.857 0.863 . . . . 0.0 112.063 -168.772 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 2501 ' ' TYR . . . . . . . . . . . . . 66.6 t80 -125.87 137.74 53.76 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.796 1.239 . . . . 0.0 112.507 -169.459 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 2502 ' ' GLY . . . . . . . . . . . . . . . 70.06 10.26 64.9 Favored Glycine 0 CA--C 1.537 1.444 0 C-N-CA 124.445 1.022 . . . . 0.0 114.318 -178.805 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 2503 ' ' GLY . . . . . . . . . . . . . . . 149.94 -176.3 28.66 Favored Glycine 0 CA--C 1.54 1.615 0 C-N-CA 126.094 1.806 . . . . 0.0 112.849 -171.454 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 2504 ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -81.45 34.57 0.55 Allowed 'Trans proline' 0 CA--C 1.546 1.111 0 C-N-CA 125.193 3.929 . . . . 0.0 113.346 -173.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 2505 ' ' TYR . . . . . . . . . . . . . 82.6 m-85 -122.53 135.63 54.69 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 125.026 1.33 . . . . 0.0 112.296 -174.355 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 2506 ' ' HIS . . . . . . . . . . . . . 94.8 m-70 -60.51 140.75 57.17 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 124.254 1.022 . . . . 0.0 113.676 -176.802 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 2507 ' ' ILE . . . . . . . . . . . . . 1.9 pp -75.98 167.85 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 C-N-CA 123.562 0.745 . . . . 0.0 112.505 172.277 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 2508 ' ' GLY . . . . . . . . . . . . . . . -58.33 112.4 3.93 Favored Glycine 0 CA--C 1.533 1.166 0 C-N-CA 124.003 0.811 . . . . 0.0 112.877 -174.873 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 2509 ' ' GLY . . . . . . . . . . . . . . . 95.47 -8.94 69.24 Favored Glycine 0 CA--C 1.536 1.37 0 C-N-CA 125.983 1.754 . . . . 0.0 115.004 -178.105 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 2510 ' ' SER . . . . . . . . . . . . . 13.3 t -84.78 145.82 44.94 Favored Pre-proline 0 CA--C 1.552 1.047 0 CA-C-N 119.195 1.498 . . . . 0.0 112.0 179.731 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 2511 ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -75.39 144.25 79.9 Favored 'Cis proline' 0 C--N 1.354 0.83 0 CA-C-N 120.217 1.113 . . . . 0.0 113.026 -0.57 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 2512 ' ' PHE . . . . . . . . . . . . . 94.9 m-85 -96.94 134.1 40.73 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.511 1.124 . . . . 0.0 110.519 175.899 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 2513 ' ' LYS . . . . . . . . . . . . . 59.6 pttt -89.54 105.56 17.88 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 123.686 0.794 . . . . 0.0 112.358 176.27 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 2514 ' ' ALA . . . . . . . . . . . . . . . -91.88 126.86 37.13 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 125.261 1.424 . . . . 0.0 110.374 174.522 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 2515 ' ' LYS . . . . . . . . . . . . . 30.6 mtpp -101.38 134.44 44.46 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 124.712 1.205 . . . . 0.0 111.123 -175.295 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 2516 ' ' VAL . . . . . . . . . . . . . 84.7 t -132.58 137.01 55.09 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 C-N-CA 124.493 1.117 . . . . 0.0 110.715 -169.854 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 2517 ' ' THR . . . . . . . . . . . . . 73.4 p -123.65 -177.27 3.68 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 125.741 1.616 . . . . 0.0 110.965 176.219 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 2518 ' ' GLY . . . . . . . . . . . . . . . 98.62 -176.52 29.98 Favored Glycine 0 CA--C 1.54 1.621 0 C-N-CA 124.749 1.166 . . . . 0.0 113.465 -176.866 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 2519 ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -71.1 151.08 61.11 Favored 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 123.814 3.009 . . . . 0.0 111.885 -176.263 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 2520 ' ' ARG . . . . . . . . . . . . . 21.5 ttt85 -91.15 129.0 37.19 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 123.872 0.869 . . . . 0.0 110.896 176.144 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 2521 ' ' LEU . . . . . . . . . . . . . 3.9 mm? -92.45 -12.15 32.86 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.374 1.07 . . . . 0.0 113.79 -174.635 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 2522 ' ' VAL . . . . . . . . . . . . . 9.2 p . . . . . 0 N--CA 1.483 1.202 0 C-N-CA 125.028 1.331 . . . . 0.0 113.425 -171.942 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.509 0 N-CA-C 111.447 -0.661 . . . . 0.0 111.447 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -72.86 165.83 24.15 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 124.452 1.101 . . . . 0.0 112.861 177.398 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 97.9 mmm -75.94 -18.17 59.45 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.389 1.076 . . . . 0.0 113.769 179.487 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 2427 ' ' GLY . . . . . . . . . . . . . . . -76.28 128.81 9.61 Favored Glycine 0 CA--C 1.527 0.795 0 C-N-CA 124.437 1.018 . . . . 0.0 112.594 -175.258 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 2428 ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -148.9 143.37 17.02 Favored Pre-proline 0 CA--C 1.545 0.765 0 C-N-CA 125.078 1.351 . . . . 0.0 111.643 178.7 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 2429 ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -65.32 -24.4 57.83 Favored 'Trans proline' 0 C--N 1.351 0.707 0 C-N-CA 123.215 2.61 . . . . 0.0 112.773 177.715 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 2430 ' ' GLY . . . . . . . . . . . . . . . -75.59 -23.28 73.38 Favored Glycine 0 CA--C 1.535 1.317 0 CA-C-N 119.065 0.848 . . . . 0.0 113.805 174.923 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 2431 ' ' LEU . . . . . . . . . . . . . 4.4 mm? -86.95 -33.16 19.76 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.492 1.117 . . . . 0.0 111.616 173.682 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 2432 ' ' VAL . . . . . . . . . . . . . 53.4 t -70.16 138.31 22.26 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 C-N-CA 124.166 0.987 . . . . 0.0 111.092 172.005 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 2433 ' ' SER . . . . . . . . . . . . . 58.5 m -139.13 146.96 41.28 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 125.705 1.602 . . . . 0.0 109.628 173.549 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 2434 ' ' ALA . . . . . . . . . . . . . . . -98.98 149.36 23.06 Favored 'General case' 0 CA--C 1.54 0.568 0 O-C-N 121.528 -0.733 . . . . 0.0 112.13 176.219 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 2435 ' ' TYR . . . . . . . . . . . . . 89.7 m-85 -142.67 145.18 33.17 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.831 1.652 . . . . 0.0 111.563 -178.87 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 2436 ' ' GLY . . . . . . . . . . . . . . . 126.93 160.4 10.52 Favored Glycine 0 N--CA 1.474 1.193 0 C-N-CA 125.325 1.44 . . . . 0.0 113.948 178.379 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 2437 ' ' ALA . . . . . . . . . . . . . . . -63.18 -28.83 70.32 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 114.283 1.216 . . . . 0.0 114.283 -171.186 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 2438 ' ' GLY . . . . . . . . . . . . . . . -66.95 -11.08 57.62 Favored Glycine 0 CA--C 1.531 1.093 0 C-N-CA 124.437 1.018 . . . . 0.0 114.501 -178.895 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 2439 ' ' LEU . . . . . . . . . . . . . 75.6 mt -78.68 -25.22 44.8 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 118.537 1.168 . . . . 0.0 112.594 170.832 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 2440 ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -94.46 -31.98 13.72 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.897 1.279 . . . . 0.0 112.361 -175.165 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 2441 ' ' GLY . . . . . . . . . . . . . . . 159.22 -155.08 26.15 Favored Glycine 0 CA--C 1.527 0.807 0 C-N-CA 124.45 1.024 . . . . 0.0 113.575 -176.225 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 2442 ' ' GLY . . . . . . . . . . . . . . . 168.01 -171.9 42.54 Favored Glycine 0 CA--C 1.529 0.93 0 C-N-CA 124.636 1.112 . . . . 0.0 113.498 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 2443 ' ' VAL . . . . . . . . . . . . . 95.4 t -117.6 137.55 51.17 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 125.379 1.471 . . . . 0.0 108.996 176.452 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 2444 ' ' THR . . . . . . . . . . . . . 21.5 p -57.99 136.62 57.13 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.18 0.992 . . . . 0.0 112.232 177.308 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 2445 ' ' GLY . . . . . . . . . . . . . . . 79.61 -12.53 27.53 Favored Glycine 0 CA--C 1.534 1.274 0 C-N-CA 124.624 1.107 . . . . 0.0 114.713 -178.644 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 2446 ' ' ASN . . . . . . . . . . . . . 80.5 m-20 -99.43 150.15 36.5 Favored Pre-proline 0 CA--C 1.547 0.843 0 C-N-CA 124.898 1.279 . . . . 0.0 110.825 173.266 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 2447 ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -70.75 142.51 43.76 Favored 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 122.756 2.304 . . . . 0.0 111.01 175.163 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 2448 ' ' ALA . . . . . . . . . . . . . . . -128.35 135.31 49.4 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 126.726 2.011 . . . . 0.0 108.618 171.209 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 2449 ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -142.11 154.04 44.59 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 114.324 1.231 . . . . 0.0 114.324 -163.12 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 2450 ' ' PHE . . . . . . . . . . . . . 54.3 p90 -158.56 155.28 28.04 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 126.118 1.767 . . . . 0.0 111.405 -179.225 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 2451 ' ' VAL . . . . . . . . . . . . . 59.6 t -111.39 129.29 67.0 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 C-N-CA 125.11 1.364 . . . . 0.0 108.914 173.361 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 2452 ' ' VAL . . . . . . . . . . . . . 39.0 t -84.19 101.4 8.71 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 N-CA-C 107.208 -1.405 . . . . 0.0 107.208 166.016 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 2453 ' ' ASN . . . . . . . . . . . . . 19.3 t-20 -83.11 124.74 30.77 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 123.478 0.711 . . . . 0.0 112.472 -169.356 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 2454 ' ' THR . . . . . . . . . . . . . 40.4 p -103.96 -1.25 27.86 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 125.696 1.598 . . . . 0.0 113.881 -179.001 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 2455 ' ' SER . . . . . . . . . . . . . 44.5 m -57.8 -29.13 64.64 Favored 'General case' 0 N--CA 1.48 1.047 0 CA-C-N 120.32 1.418 . . . . 0.0 114.441 -175.445 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 2456 ' ' ASN . . . . . . . . . . . . . 67.3 m-80 -86.86 -11.99 49.18 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 124.688 1.195 . . . . 0.0 113.557 176.152 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 2457 ' ' ALA . . . . . . . . . . . . . . . -112.54 -22.33 10.85 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 126.172 1.789 . . . . 0.0 113.851 -174.073 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 2458 ' ' GLY . . . . . . . . . . . . . . . 91.36 -85.89 1.28 Allowed Glycine 0 CA--C 1.529 0.943 0 C-N-CA 124.986 1.279 . . . . 0.0 111.338 -176.496 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 2459 ' ' ALA . . . . . . . . . . . . . . . -157.84 157.14 32.7 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 124.987 1.315 . . . . 0.0 112.617 -176.466 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 2460 ' ' GLY . . . . . . . . . . . . . . . 165.09 167.34 25.52 Favored Glycine 0 CA--C 1.532 1.126 0 C-N-CA 125.545 1.545 . . . . 0.0 113.008 -176.145 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 2461 ' ' ALA . . . . . . . . . . . . . . . -77.96 145.64 35.94 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.265 1.026 . . . . 0.0 112.572 -178.737 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 2462 ' ' LEU . . . . . . . . . . . . . 29.9 tp -121.21 141.6 50.7 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 125.336 1.455 . . . . 0.0 110.999 178.824 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 2463 ' ' SER . . . . . . . . . . . . . 29.7 t -102.24 -109.75 0.23 Allowed 'General case' 0 CA--C 1.552 1.02 0 C-N-CA 125.24 1.416 . . . . 0.0 110.014 171.119 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 2464 ' ' VAL . . . . . . . . . . . . . 48.3 t 105.31 123.57 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.247 0 C-N-CA 131.659 3.984 . . . . 0.0 109.702 172.647 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 2465 ' ' THR . . . . . . . . . . . . . 89.9 m -131.95 139.29 48.64 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 125.408 1.483 . . . . 0.0 109.076 174.948 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 2466 ' ' ILE . . . . . . . . . . . . . 35.8 mt -119.15 117.39 54.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 123.634 0.773 . . . . 0.0 109.649 175.806 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 2467 ' ' ASP . . . . . . . . . . . . . 34.8 t70 -95.17 162.34 13.74 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 125.776 1.631 . . . . 0.0 110.286 168.638 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 2468 ' ' GLY . . . . . . . . . . . . . . . 168.73 -166.78 39.9 Favored Glycine 0 CA--C 1.536 1.358 0 O-C-N 121.125 -0.985 . . . . 0.0 114.717 178.794 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 2469 ' ' PRO . . . . . . . . . . . . . 76.1 Cg_endo -70.94 -15.86 32.66 Favored 'Trans proline' 0 CA--C 1.541 0.853 0 C-N-CA 123.969 3.113 . . . . 0.0 113.088 177.924 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 2470 ' ' SER . . . . . . . . . . . . . 37.2 m -153.67 174.52 14.38 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 126.868 2.067 . . . . 0.0 110.343 175.905 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 2471 ' ' LYS . . . . . . . . . . . . . 67.9 mttm -68.32 167.54 14.3 Favored 'General case' 0 CA--C 1.549 0.918 0 O-C-N 121.252 -0.905 . . . . 0.0 112.181 168.611 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 2472 ' ' VAL . . . . . . . . . . . . . 14.3 m -133.35 144.9 34.84 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 125.468 1.507 . . . . 0.0 111.34 -179.583 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 2473 ' ' LYS . . . . . . . . . . . . . 14.5 mmmm -89.31 71.27 8.18 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.337 1.055 . . . . 0.0 111.588 -179.263 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 2474 ' ' MET . . . . . . . . . . . . . 92.0 mtp -69.77 140.74 53.43 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 124.494 1.118 . . . . 0.0 112.969 -178.815 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 2475 ' ' ASP . . . . . . . . . . . . . 30.5 t70 -133.4 125.15 28.46 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 126.97 2.108 . . . . 0.0 108.755 163.117 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 2476 ' ' CYS . . . . . . . . . . . . . 42.6 t -122.18 132.75 54.61 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.797 1.239 . . . . 0.0 110.956 -177.706 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 2477 ' ' GLN . . . . . . . . . . . . . 15.9 mm100 -142.02 151.86 42.85 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 125.454 1.502 . . . . 0.0 110.721 -178.622 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 2478 ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -79.88 151.75 30.01 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 123.412 0.685 . . . . 0.0 111.67 169.343 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 2479 ' ' CYS . . . . . . . . . . . . . 19.5 p -156.82 172.15 6.5 Favored Pre-proline 0 CA--C 1.553 1.096 0 C-N-CA 126.083 1.753 . . . . 0.0 111.505 -176.576 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 2480 ' ' PRO . . . . . . . . . . . . . 58.0 Cg_exo -59.02 -26.2 80.71 Favored 'Trans proline' 0 CA--C 1.539 0.75 0 C-N-CA 123.342 2.694 . . . . 0.0 114.584 176.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 2481 ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -88.37 -6.1 57.9 Favored 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 125.382 1.473 . . . . 0.0 113.154 -179.086 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 2482 ' ' GLY . . . . . . . . . . . . . . . 128.24 -132.21 7.26 Favored Glycine 0 N--CA 1.472 1.055 0 C-N-CA 125.335 1.445 . . . . 0.0 112.164 -176.324 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 2483 ' ' TYR . . . . . . . . . . . . . 95.1 m-85 -108.78 117.62 34.67 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 123.809 0.844 . . . . 0.0 110.854 173.551 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 2484 ' ' ARG . . . . . . . . . . . . . 57.5 ttt180 -92.43 130.55 38.07 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 124.117 0.967 . . . . 0.0 110.676 177.939 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 2485 ' ' VAL . . . . . . . . . . . . . 89.9 t -114.09 132.76 62.18 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 C-N-CA 125.863 1.665 . . . . 0.0 108.47 172.823 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 2486 ' ' THR . . . . . . . . . . . . . 95.4 m -125.6 137.22 53.89 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 125.11 1.364 . . . . 0.0 107.821 169.06 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 2487 ' ' TYR . . . . . . . . . . . . . 21.6 p90 -144.09 152.75 41.37 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 123.72 0.808 . . . . 0.0 112.604 177.415 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 2488 ' ' THR . . . . . . . . . . . . . 84.4 m -113.25 119.71 41.61 Favored Pre-proline 0 N--CA 1.474 0.753 0 CA-C-O 117.892 -1.051 . . . . 0.0 109.466 173.287 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 2489 ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -83.67 154.75 13.66 Favored 'Trans proline' 0 CA--C 1.537 0.634 0 C-N-CA 124.064 3.176 . . . . 0.0 111.209 171.298 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 2490 ' ' MET . . . . . . . . . . . . . 28.0 ptm -119.69 -2.37 10.44 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 114.892 1.441 . . . . 0.0 114.892 -174.211 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 2491 ' ' ALA . . . . . . . . . . . . . . . -147.25 148.23 31.14 Favored Pre-proline 0 CA--C 1.545 0.786 0 C-N-CA 125.687 1.595 . . . . 0.0 110.896 177.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 2492 ' ' PRO . . . . . . . . . . . . . 74.9 Cg_endo -72.18 153.91 56.9 Favored 'Trans proline' 0 CA--C 1.536 0.584 0 C-N-CA 123.043 2.495 . . . . 0.0 111.161 174.546 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 2493 ' ' GLY . . . . . . . . . . . . . . . 135.39 -170.12 23.12 Favored Glycine 0 CA--C 1.529 0.949 0 C-N-CA 125.363 1.459 . . . . 0.0 113.313 -177.871 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 2494 ' ' SER . . . . . . . . . . . . . 70.3 m -95.54 121.07 36.85 Favored 'General case' 0 N--CA 1.471 0.61 0 O-C-N 121.839 -0.8 . . . . 0.0 111.818 179.303 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 2495 ' ' TYR . . . . . . . . . . . . . 63.5 m-85 -99.07 126.01 44.71 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 125.156 1.382 . . . . 0.0 109.706 171.43 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 2496 ' ' LEU . . . . . . . . . . . . . 26.1 tp -101.2 110.68 22.73 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.359 1.064 . . . . 0.0 109.44 -176.908 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 2497 ' ' ILE . . . . . . . . . . . . . 39.8 mt -96.56 96.48 5.54 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 C-N-CA 125.688 1.595 . . . . 0.0 108.618 -172.693 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 2498 ' ' SER . . . . . . . . . . . . . 68.9 m -80.86 83.54 6.58 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 125.409 1.484 . . . . 0.0 110.165 176.795 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 2499 ' ' ILE . . . . . . . . . . . . . 50.5 mt -79.91 114.53 20.9 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 C-N-CA 124.31 1.044 . . . . 0.0 109.227 177.025 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 2500 ' ' LYS . . . . . . . . . . . . . 83.7 mttt -127.52 133.33 49.83 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 125.03 1.332 . . . . 0.0 111.769 -175.165 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 2501 ' ' TYR . . . . . . . . . . . . . 64.4 t80 -141.83 143.09 33.22 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 125.465 1.506 . . . . 0.0 111.805 -170.332 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 2502 ' ' GLY . . . . . . . . . . . . . . . 69.26 11.86 65.01 Favored Glycine 0 CA--C 1.536 1.388 0 C-N-CA 124.443 1.02 . . . . 0.0 114.474 177.729 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 2503 ' ' GLY . . . . . . . . . . . . . . . 145.9 -165.6 28.05 Favored Glycine 0 CA--C 1.54 1.614 0 C-N-CA 125.731 1.634 . . . . 0.0 112.999 -170.487 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 2504 ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -82.28 13.72 2.46 Favored 'Trans proline' 0 CA--C 1.544 0.999 0 C-N-CA 124.762 3.641 . . . . 0.0 113.962 -174.318 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 2505 ' ' TYR . . . . . . . . . . . . . 84.0 m-85 -106.22 142.32 36.1 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.78 1.232 . . . . 0.0 113.452 -173.325 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 2506 ' ' HIS . . . . . . . . . . . . . 97.7 m-70 -65.03 143.89 57.64 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 124.762 1.225 . . . . 0.0 113.046 178.282 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 2507 ' ' ILE . . . . . . . . . . . . . 20.4 pt -73.65 175.6 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 N-CA-C 113.437 0.902 . . . . 0.0 113.437 173.583 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 2508 ' ' GLY . . . . . . . . . . . . . . . -58.95 119.53 18.34 Favored Glycine 0 CA--C 1.534 1.232 0 O-C-N 121.487 -0.758 . . . . 0.0 111.512 172.858 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 2509 ' ' GLY . . . . . . . . . . . . . . . 87.19 -6.76 82.76 Favored Glycine 0 CA--C 1.536 1.359 0 C-N-CA 125.616 1.579 . . . . 0.0 115.034 -176.733 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 2510 ' ' SER . . . . . . . . . . . . . 43.8 t -89.09 147.67 39.13 Favored Pre-proline 0 CA--C 1.549 0.938 0 CA-C-N 118.914 1.357 . . . . 0.0 112.043 -179.005 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 2511 ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -74.46 146.22 86.16 Favored 'Cis proline' 0 C--N 1.353 0.808 0 CA-C-N 119.671 0.918 . . . . 0.0 112.608 -1.036 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 2512 ' ' PHE . . . . . . . . . . . . . 94.7 m-85 -96.3 126.41 41.49 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.612 1.165 . . . . 0.0 110.797 179.627 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 2513 ' ' LYS . . . . . . . . . . . . . 85.0 tttt -94.5 100.16 12.2 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.025 0.93 . . . . 0.0 111.407 -179.03 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 2514 ' ' ALA . . . . . . . . . . . . . . . -89.02 115.46 26.6 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.355 1.462 . . . . 0.0 110.913 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 2515 ' ' LYS . . . . . . . . . . . . . 48.4 mtpt -94.04 98.64 11.14 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 124.099 0.959 . . . . 0.0 110.529 -174.915 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 2516 ' ' VAL . . . . . . . . . . . . . 63.7 t -90.96 140.74 15.49 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 125.673 1.589 . . . . 0.0 110.496 -173.39 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 2517 ' ' THR . . . . . . . . . . . . . 72.0 p -124.4 -177.33 3.76 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 125.582 1.553 . . . . 0.0 111.121 177.093 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 2518 ' ' GLY . . . . . . . . . . . . . . . 98.34 178.34 32.81 Favored Glycine 0 CA--C 1.539 1.558 0 C-N-CA 124.752 1.167 . . . . 0.0 113.561 -177.183 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 2519 ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -73.43 141.82 32.24 Favored 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 123.776 2.984 . . . . 0.0 111.932 -173.924 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 2520 ' ' ARG . . . . . . . . . . . . . 37.6 ttm180 -68.13 126.46 29.58 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 122.959 0.503 . . . . 0.0 110.004 172.733 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 2521 ' ' LEU . . . . . . . . . . . . . 52.5 mt -83.27 -28.57 29.05 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 123.613 0.765 . . . . 0.0 112.762 -175.624 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 2522 ' ' VAL . . . . . . . . . . . . . 9.1 p . . . . . 0 C--O 1.253 1.249 0 C-N-CA 126.013 1.725 . . . . 0.0 112.625 176.105 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.552 0 N-CA-C 112.092 -0.403 . . . . 0.0 112.092 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -73.89 164.2 26.94 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 124.456 1.102 . . . . 0.0 113.002 178.271 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 98.6 mmm -87.49 -9.27 55.0 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.966 1.306 . . . . 0.0 113.629 175.516 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 2427 ' ' GLY . . . . . . . . . . . . . . . 81.01 161.56 26.62 Favored Glycine 0 CA--C 1.531 1.055 0 C-N-CA 125.332 1.444 . . . . 0.0 113.166 -177.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 2428 ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -143.52 135.64 13.2 Favored Pre-proline 0 CA--C 1.544 0.738 0 C-N-CA 124.785 1.234 . . . . 0.0 111.204 178.877 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 2429 ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -67.94 -22.59 41.95 Favored 'Trans proline' 0 CA--C 1.537 0.648 0 C-N-CA 122.964 2.443 . . . . 0.0 113.003 -178.347 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 2430 ' ' GLY . . . . . . . . . . . . . . . -76.72 -23.12 70.64 Favored Glycine 0 CA--C 1.535 1.292 0 CA-C-N 118.864 0.756 . . . . 0.0 113.557 173.399 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 2431 ' ' LEU . . . . . . . . . . . . . 4.3 mm? -87.72 -35.46 17.93 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.514 1.126 . . . . 0.0 111.353 173.95 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 2432 ' ' VAL . . . . . . . . . . . . . 74.2 t -64.91 139.6 21.13 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 123.389 0.676 . . . . 0.0 110.473 169.639 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 2433 ' ' SER . . . . . . . . . . . . . 8.5 t -131.37 -176.21 3.95 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.942 1.297 . . . . 0.0 110.507 173.162 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 2434 ' ' ALA . . . . . . . . . . . . . . . -141.96 143.19 33.1 Favored 'General case' 0 CA--C 1.538 0.5 0 O-C-N 121.042 -1.036 . . . . 0.0 111.712 177.107 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 2435 ' ' TYR . . . . . . . . . . . . . 79.1 m-85 -143.65 157.5 44.36 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.536 1.534 . . . . 0.0 111.899 -175.111 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 2436 ' ' GLY . . . . . . . . . . . . . . . 108.05 159.75 20.37 Favored Glycine 0 N--CA 1.474 1.17 0 C-N-CA 125.244 1.402 . . . . 0.0 113.694 177.899 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 2437 ' ' ALA . . . . . . . . . . . . . . . -62.88 -27.42 69.34 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.075 1.35 . . . . 0.0 114.582 -169.294 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 2438 ' ' GLY . . . . . . . . . . . . . . . -66.27 -14.12 61.29 Favored Glycine 0 CA--C 1.532 1.114 0 C-N-CA 123.974 0.797 . . . . 0.0 114.683 -176.695 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 2439 ' ' LEU . . . . . . . . . . . . . 88.1 mt -72.07 -22.74 61.32 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 118.466 1.133 . . . . 0.0 112.761 170.233 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 2440 ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -94.48 -16.59 23.21 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 125.076 1.35 . . . . 0.0 112.82 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 2441 ' ' GLY . . . . . . . . . . . . . . . 102.92 -138.82 14.15 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 125.559 1.552 . . . . 0.0 112.39 -177.903 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 2442 ' ' GLY . . . . . . . . . . . . . . . 150.81 -140.72 8.1 Favored Glycine 0 CA--C 1.532 1.125 0 C-N-CA 124.007 0.813 . . . . 0.0 114.088 -177.695 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 2443 ' ' VAL . . . . . . . . . . . . . 99.2 t -113.08 139.15 39.77 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 C-N-CA 125.601 1.561 . . . . 0.0 110.115 -175.156 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 2444 ' ' THR . . . . . . . . . . . . . 30.1 p -61.72 142.9 56.95 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 124.302 1.041 . . . . 0.0 112.412 176.41 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 2445 ' ' GLY . . . . . . . . . . . . . . . 79.01 -10.61 32.65 Favored Glycine 0 CA--C 1.537 1.412 0 C-N-CA 124.462 1.03 . . . . 0.0 114.558 -177.118 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 2446 ' ' ASN . . . . . . . . . . . . . 79.7 m-20 -101.59 148.39 35.17 Favored Pre-proline 0 CA--C 1.548 0.87 0 C-N-CA 124.94 1.296 . . . . 0.0 111.117 174.159 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 2447 ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -73.75 129.88 14.02 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 123.176 2.584 . . . . 0.0 111.276 178.876 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 2448 ' ' ALA . . . . . . . . . . . . . . . -101.87 116.34 32.5 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 126.222 1.809 . . . . 0.0 109.031 170.485 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 2449 ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -111.96 132.79 54.55 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.389 1.076 . . . . 0.0 111.66 -172.319 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 2450 ' ' PHE . . . . . . . . . . . . . 37.8 p90 -147.59 168.56 21.68 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.48 1.512 . . . . 0.0 110.882 171.277 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 2451 ' ' VAL . . . . . . . . . . . . . 14.7 p -126.94 136.93 59.4 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 C-N-CA 124.609 1.164 . . . . 0.0 110.508 174.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 2452 ' ' VAL . . . . . . . . . . . . . 22.0 t -89.5 103.8 14.43 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 N-CA-C 106.797 -1.557 . . . . 0.0 106.797 164.669 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 2453 ' ' ASN . . . . . . . . . . . . . 18.6 t-20 -91.29 120.18 31.96 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 123.874 0.87 . . . . 0.0 112.271 -167.867 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 2454 ' ' THR . . . . . . . . . . . . . 75.1 p -104.24 2.62 31.84 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 125.958 1.703 . . . . 0.0 113.887 -175.397 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 2455 ' ' SER . . . . . . . . . . . . . 45.2 m -56.89 -27.5 60.72 Favored 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 114.782 1.401 . . . . 0.0 114.782 -173.482 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 2456 ' ' ASN . . . . . . . . . . . . . 70.1 m-80 -91.6 -12.22 34.93 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 124.537 1.135 . . . . 0.0 113.644 176.339 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 2457 ' ' ALA . . . . . . . . . . . . . . . -106.6 -33.43 7.66 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 125.575 1.55 . . . . 0.0 113.759 -174.801 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 2458 ' ' GLY . . . . . . . . . . . . . . . 87.28 -152.84 24.76 Favored Glycine 0 CA--C 1.533 1.171 0 C-N-CA 124.779 1.181 . . . . 0.0 112.202 -172.099 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 2459 ' ' ALA . . . . . . . . . . . . . . . -69.22 151.94 45.69 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 123.924 0.89 . . . . 0.0 112.6 178.127 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 2460 ' ' GLY . . . . . . . . . . . . . . . 159.86 157.62 8.72 Favored Glycine 0 CA--C 1.532 1.103 0 C-N-CA 125.302 1.43 . . . . 0.0 113.193 179.4 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 2461 ' ' ALA . . . . . . . . . . . . . . . -85.1 139.88 31.39 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.262 1.025 . . . . 0.0 113.346 -172.659 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 2462 ' ' LEU . . . . . . . . . . . . . 31.6 tp -106.4 146.55 30.34 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.778 1.631 . . . . 0.0 111.023 175.765 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 2463 ' ' SER . . . . . . . . . . . . . 4.0 t -137.62 42.13 2.34 Favored 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 125.885 1.674 . . . . 0.0 110.91 -178.828 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 2464 ' ' VAL . . . . . . . . . . . . . 11.0 p -63.98 135.34 27.94 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.975 0 C-N-CA 124.982 1.313 . . . . 0.0 112.017 -175.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 2465 ' ' THR . . . . . . . . . . . . . 96.3 m -136.41 145.17 44.98 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 125.925 1.69 . . . . 0.0 109.591 -179.16 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 2466 ' ' ILE . . . . . . . . . . . . . 40.6 mt -121.96 123.42 69.06 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 C-N-CA 123.748 0.819 . . . . 0.0 109.98 173.717 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 2467 ' ' ASP . . . . . . . . . . . . . 36.7 t70 -99.39 155.62 17.44 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 125.836 1.655 . . . . 0.0 110.179 166.885 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 2468 ' ' GLY . . . . . . . . . . . . . . . 177.17 -169.43 41.7 Favored Glycine 0 CA--C 1.537 1.44 0 O-C-N 121.043 -1.036 . . . . 0.0 115.562 -179.28 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 2469 ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -69.73 -17.49 37.69 Favored 'Trans proline' 0 CA--C 1.54 0.79 0 C-N-CA 124.322 3.348 . . . . 0.0 113.411 179.463 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 2470 ' ' SER . . . . . . . . . . . . . 35.0 m -153.92 176.09 12.58 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 127.165 2.186 . . . . 0.0 109.617 174.228 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 2471 ' ' LYS . . . . . . . . . . . . . 4.0 mppt? -66.84 162.96 20.47 Favored 'General case' 0 CA--C 1.551 0.989 0 O-C-N 121.03 -1.044 . . . . 0.0 111.455 168.432 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 2472 ' ' VAL . . . . . . . . . . . . . 33.0 m -118.84 145.87 24.26 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 C-N-CA 124.928 1.291 . . . . 0.0 110.954 175.83 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 2473 ' ' LYS . . . . . . . . . . . . . 99.0 mttt -86.04 90.9 8.24 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 123.678 0.791 . . . . 0.0 109.357 171.158 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 2474 ' ' MET . . . . . . . . . . . . . 60.5 ttm -89.9 143.38 26.84 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.546 1.139 . . . . 0.0 112.532 -175.068 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 2475 ' ' ASP . . . . . . . . . . . . . 35.8 t0 -133.94 82.04 1.95 Allowed 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 127.96 2.504 . . . . 0.0 108.559 171.637 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 2476 ' ' CYS . . . . . . . . . . . . . 52.6 t -88.01 134.43 33.74 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.841 1.256 . . . . 0.0 110.666 175.609 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 2477 ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -139.51 140.78 37.29 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.519 1.127 . . . . 0.0 111.394 -175.745 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 2478 ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -82.24 139.61 34.14 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.654 1.181 . . . . 0.0 110.304 172.54 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 2479 ' ' CYS . . . . . . . . . . . . . 30.7 p -158.95 169.23 10.91 Favored Pre-proline 0 CA--C 1.553 1.064 0 C-N-CA 125.293 1.437 . . . . 0.0 111.604 -171.558 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 2480 ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -65.91 -15.66 49.74 Favored 'Trans proline' 0 CA--C 1.543 0.943 0 C-N-CA 122.569 2.179 . . . . 0.0 113.427 173.776 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 2481 ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -77.51 -11.21 59.83 Favored 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 124.69 1.196 . . . . 0.0 112.953 172.133 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 2482 ' ' GLY . . . . . . . . . . . . . . . 117.36 -122.91 5.6 Favored Glycine 0 C--N 1.342 0.911 0 C-N-CA 126.439 1.971 . . . . 0.0 111.48 -172.167 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 2483 ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -117.18 110.4 18.11 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 123.91 0.884 . . . . 0.0 110.209 171.221 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 2484 ' ' ARG . . . . . . . . . . . . . 51.7 ttm-85 -86.37 128.56 34.95 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.741 0.816 . . . . 0.0 109.258 177.289 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 2485 ' ' VAL . . . . . . . . . . . . . 58.4 t -118.98 114.28 44.22 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 C-N-CA 125.331 1.452 . . . . 0.0 108.436 -177.781 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 2486 ' ' THR . . . . . . . . . . . . . 62.8 m -104.58 140.46 37.96 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 165.654 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 2487 ' ' TYR . . . . . . . . . . . . . 23.3 p90 -146.65 144.63 29.63 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 112.538 0.57 . . . . 0.0 112.538 171.842 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 2488 ' ' THR . . . . . . . . . . . . . 90.5 m -107.11 114.94 60.79 Favored Pre-proline 0 N--CA 1.473 0.685 0 CA-C-O 118.228 -0.892 . . . . 0.0 109.403 173.554 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 2489 ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -81.38 158.31 19.7 Favored 'Trans proline' 0 C--N 1.351 0.69 0 C-N-CA 124.075 3.184 . . . . 0.0 111.218 173.123 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 2490 ' ' MET . . . . . . . . . . . . . 28.9 ptm -128.77 3.31 5.44 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 115.153 1.538 . . . . 0.0 115.153 -171.198 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 2491 ' ' ALA . . . . . . . . . . . . . . . -152.04 150.33 25.51 Favored Pre-proline 0 CA--C 1.548 0.876 0 C-N-CA 125.505 1.522 . . . . 0.0 110.925 175.558 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 2492 ' ' PRO . . . . . . . . . . . . . 99.0 Cg_endo -74.45 151.21 42.16 Favored 'Trans proline' 0 CA--C 1.539 0.738 0 C-N-CA 123.24 2.627 . . . . 0.0 111.375 178.448 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 2493 ' ' GLY . . . . . . . . . . . . . . . 138.39 -173.66 22.39 Favored Glycine 0 CA--C 1.532 1.116 0 C-N-CA 125.55 1.548 . . . . 0.0 113.382 -177.068 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 2494 ' ' SER . . . . . . . . . . . . . 18.1 p -88.69 120.44 30.09 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.304 1.042 . . . . 0.0 111.55 175.085 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 2495 ' ' TYR . . . . . . . . . . . . . 68.8 m-85 -94.51 116.13 28.42 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 124.027 0.931 . . . . 0.0 109.652 168.539 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 2496 ' ' LEU . . . . . . . . . . . . . 22.8 tp -89.94 105.42 17.79 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 124.041 0.936 . . . . 0.0 109.561 -179.081 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 2497 ' ' ILE . . . . . . . . . . . . . 28.1 mt -88.33 103.1 13.39 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 C-N-CA 125.747 1.619 . . . . 0.0 108.335 -179.201 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 2498 ' ' SER . . . . . . . . . . . . . 73.7 m -90.14 95.98 10.46 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 124.819 1.248 . . . . 0.0 109.638 175.442 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 2499 ' ' ILE . . . . . . . . . . . . . 40.1 mt -91.29 92.52 3.94 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 C-N-CA 124.602 1.161 . . . . 0.0 108.566 -178.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 2500 ' ' LYS . . . . . . . . . . . . . 84.1 mttt -103.37 137.02 42.06 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 124.286 1.035 . . . . 0.0 111.721 -179.463 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 2501 ' ' TYR . . . . . . . . . . . . . 60.3 t80 -146.32 144.11 29.58 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.63 1.172 . . . . 0.0 112.357 -171.047 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 2502 ' ' GLY . . . . . . . . . . . . . . . 67.75 18.29 70.15 Favored Glycine 0 CA--C 1.535 1.314 0 C-N-CA 124.252 0.93 . . . . 0.0 113.673 179.209 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 2503 ' ' GLY . . . . . . . . . . . . . . . 134.44 -167.58 23.8 Favored Glycine 0 CA--C 1.54 1.636 0 C-N-CA 126.119 1.819 . . . . 0.0 112.43 -166.366 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 2504 ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -82.19 24.34 0.72 Allowed 'Trans proline' 0 CA--C 1.545 1.072 0 C-N-CA 124.903 3.735 . . . . 0.0 113.653 -173.779 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 2505 ' ' TYR . . . . . . . . . . . . . 73.9 m-85 -114.15 135.46 54.01 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.684 1.194 . . . . 0.0 113.022 -172.062 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 2506 ' ' HIS . . . . . . . . . . . . . 92.7 m-70 -63.33 142.85 58.23 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 125.359 1.464 . . . . 0.0 113.566 -179.246 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 2507 ' ' ILE . . . . . . . . . . . . . 1.7 pp -76.01 171.93 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 C-N-CA 123.716 0.806 . . . . 0.0 112.898 172.614 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 2508 ' ' GLY . . . . . . . . . . . . . . . -59.8 111.13 3.27 Favored Glycine 0 CA--C 1.534 1.235 0 C-N-CA 123.733 0.682 . . . . 0.0 112.609 -177.861 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 2509 ' ' GLY . . . . . . . . . . . . . . . 96.26 -8.22 66.97 Favored Glycine 0 CA--C 1.536 1.346 0 C-N-CA 125.835 1.683 . . . . 0.0 114.904 -177.262 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 2510 ' ' SER . . . . . . . . . . . . . 44.3 t -81.98 147.88 59.13 Favored Pre-proline 0 CA--C 1.55 0.962 0 CA-C-N 119.114 1.457 . . . . 0.0 111.841 177.577 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 2511 ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -79.29 155.71 90.42 Favored 'Cis proline' 0 C--N 1.354 0.817 0 CA-C-N 119.794 0.962 . . . . 0.0 113.333 -0.182 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 2512 ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -106.25 130.74 54.05 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.348 1.459 . . . . 0.0 110.466 177.791 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 2513 ' ' LYS . . . . . . . . . . . . . 19.7 ptpt -86.41 4.89 37.56 Favored 'General case' 0 N--CA 1.479 0.997 0 N-CA-C 116.488 2.032 . . . . 0.0 116.488 -167.664 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 2514 ' ' ALA . . . . . . . . . . . . . . . 3.17 93.19 0.01 OUTLIER 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 129.777 3.231 . . . . 0.0 116.188 -178.913 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 2515 ' ' LYS . . . . . . . . . . . . . 9.3 mtpm? -84.59 116.51 23.2 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 124.101 0.961 . . . . 0.0 111.364 -174.004 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 2516 ' ' VAL . . . . . . . . . . . . . 52.9 t -108.62 143.48 18.85 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 C-N-CA 125.958 1.703 . . . . 0.0 110.261 -174.5 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 2517 ' ' THR . . . . . . . . . . . . . 77.1 p -132.47 177.94 7.21 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 125.489 1.516 . . . . 0.0 111.438 178.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 2518 ' ' GLY . . . . . . . . . . . . . . . 104.5 -165.73 14.91 Favored Glycine 0 CA--C 1.54 1.643 0 C-N-CA 124.903 1.24 . . . . 0.0 113.424 -177.992 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 2519 ' ' PRO . . . . . . . . . . . . . 77.3 Cg_endo -70.94 176.53 7.54 Favored 'Trans proline' 0 CA--C 1.538 0.684 0 C-N-CA 124.17 3.247 . . . . 0.0 112.36 -178.302 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 2520 ' ' ARG . . . . . . . . . . . . . 50.9 ptt85 -125.99 140.51 52.56 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.774 1.23 . . . . 0.0 111.683 177.769 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 2521 ' ' LEU . . . . . . . . . . . . . 4.2 mm? -85.16 -14.97 45.3 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.683 1.193 . . . . 0.0 112.72 179.551 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 2522 ' ' VAL . . . . . . . . . . . . . 13.0 m . . . . . 0 C--O 1.251 1.149 0 C-N-CA 127.119 2.168 . . . . 0.0 112.62 -178.365 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.497 0 N-CA-C 111.379 -0.689 . . . . 0.0 111.379 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -73.69 160.76 31.09 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 124.373 1.069 . . . . 0.0 113.015 178.757 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 44.2 mtp -131.15 -179.92 5.63 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 125.985 1.714 . . . . 0.0 110.978 175.327 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 2427 ' ' GLY . . . . . . . . . . . . . . . -66.02 154.2 51.4 Favored Glycine 0 CA--C 1.532 1.156 0 C-N-CA 124.51 1.053 . . . . 0.0 113.652 -178.719 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 2428 ' ' ASP . . . . . . . . . . . . . 13.8 t70 -106.86 136.52 19.43 Favored Pre-proline 0 CA--C 1.55 0.973 0 C-N-CA 124.958 1.303 . . . . 0.0 112.366 -172.181 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 2429 ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -64.58 -23.99 63.48 Favored 'Trans proline' 0 C--N 1.351 0.693 0 C-N-CA 123.222 2.615 . . . . 0.0 113.855 -178.275 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 2430 ' ' GLY . . . . . . . . . . . . . . . -75.43 -22.44 75.62 Favored Glycine 0 CA--C 1.533 1.209 0 CA-C-N 119.349 0.977 . . . . 0.0 113.345 175.267 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 2431 ' ' LEU . . . . . . . . . . . . . 4.3 mm? -83.96 -37.85 21.74 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.419 1.088 . . . . 0.0 111.197 170.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 2432 ' ' VAL . . . . . . . . . . . . . 69.5 t -61.85 136.8 24.82 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 123.775 0.83 . . . . 0.0 111.166 173.541 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 2433 ' ' SER . . . . . . . . . . . . . 68.5 m -128.72 163.11 25.85 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 125.867 1.667 . . . . 0.0 110.084 172.832 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 2434 ' ' ALA . . . . . . . . . . . . . . . -124.48 150.38 45.8 Favored 'General case' 0 CA--C 1.538 0.505 0 O-C-N 121.335 -0.853 . . . . 0.0 112.053 174.827 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 2435 ' ' TYR . . . . . . . . . . . . . 76.4 m-85 -143.24 161.61 37.83 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 126.063 1.745 . . . . 0.0 111.797 -175.183 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 2436 ' ' GLY . . . . . . . . . . . . . . . 106.43 159.75 22.11 Favored Glycine 0 N--CA 1.473 1.116 0 C-N-CA 125.131 1.348 . . . . 0.0 113.851 176.695 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 2437 ' ' ALA . . . . . . . . . . . . . . . -61.82 -28.55 69.55 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.005 1.322 . . . . 0.0 114.428 -169.931 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 2438 ' ' GLY . . . . . . . . . . . . . . . -66.48 -14.32 62.09 Favored Glycine 0 CA--C 1.532 1.154 0 C-N-CA 124.148 0.88 . . . . 0.0 114.581 -177.501 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 2439 ' ' LEU . . . . . . . . . . . . . 81.5 mt -74.4 -26.99 60.43 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 118.601 1.201 . . . . 0.0 112.338 169.31 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 2440 ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -93.67 -21.26 19.47 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 125.511 1.524 . . . . 0.0 112.255 177.39 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 2441 ' ' GLY . . . . . . . . . . . . . . . 110.65 -136.34 13.52 Favored Glycine 0 N--CA 1.47 0.945 0 C-N-CA 126.004 1.764 . . . . 0.0 113.181 177.234 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 2442 ' ' GLY . . . . . . . . . . . . . . . 156.52 -138.3 5.88 Favored Glycine 0 CA--C 1.53 1.022 0 C-N-CA 123.859 0.742 . . . . 0.0 114.227 -174.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 2443 ' ' VAL . . . . . . . . . . . . . 61.9 t -119.25 141.14 40.61 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 C-N-CA 125.369 1.468 . . . . 0.0 110.474 -173.828 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 2444 ' ' THR . . . . . . . . . . . . . 19.8 p -54.7 133.84 47.15 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 125.316 1.446 . . . . 0.0 112.29 174.8 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 2445 ' ' GLY . . . . . . . . . . . . . . . 81.68 -10.02 53.15 Favored Glycine 0 CA--C 1.535 1.314 0 C-N-CA 125.035 1.302 . . . . 0.0 114.844 178.67 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 2446 ' ' ASN . . . . . . . . . . . . . 91.0 m-20 -101.61 150.91 37.7 Favored Pre-proline 0 CA--C 1.548 0.876 0 C-N-CA 125.061 1.344 . . . . 0.0 111.257 175.914 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 2447 ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -72.68 130.9 16.46 Favored 'Trans proline' 0 C--N 1.35 0.656 0 C-N-CA 122.977 2.451 . . . . 0.0 111.538 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 2448 ' ' ALA . . . . . . . . . . . . . . . -99.82 118.2 35.77 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 126.417 1.887 . . . . 0.0 109.11 170.005 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 2449 ' ' GLU . . . . . . . . . . . . . 45.0 tt0 -115.88 131.8 56.83 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 124.994 1.317 . . . . 0.0 111.356 -169.459 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 2450 ' ' PHE . . . . . . . . . . . . . 40.4 p90 -148.02 165.7 29.96 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.096 1.358 . . . . 0.0 111.742 174.196 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 2451 ' ' VAL . . . . . . . . . . . . . 14.7 p -129.14 133.73 65.29 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 C-N-CA 124.834 1.253 . . . . 0.0 110.631 179.109 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 2452 ' ' VAL . . . . . . . . . . . . . 44.3 t -92.14 104.93 16.1 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 N-CA-C 107.017 -1.475 . . . . 0.0 107.017 169.117 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 2453 ' ' ASN . . . . . . . . . . . . . 19.5 t-20 -90.21 114.5 26.51 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.196 0.998 . . . . 0.0 112.161 -170.833 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 2454 ' ' THR . . . . . . . . . . . . . 43.7 p -95.88 -1.41 49.42 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 125.569 1.548 . . . . 0.0 113.902 -177.575 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 2455 ' ' SER . . . . . . . . . . . . . 29.8 m -56.76 -28.56 61.39 Favored 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 114.628 1.344 . . . . 0.0 114.628 -175.457 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 2456 ' ' ASN . . . . . . . . . . . . . 85.7 m-20 -79.47 -19.52 49.58 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 124.291 1.036 . . . . 0.0 113.483 175.673 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 2457 ' ' ALA . . . . . . . . . . . . . . . -112.2 -22.36 10.99 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 125.848 1.659 . . . . 0.0 113.902 -170.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 2458 ' ' GLY . . . . . . . . . . . . . . . 99.5 -99.87 2.15 Favored Glycine 0 CA--C 1.529 0.914 0 C-N-CA 125.322 1.439 . . . . 0.0 110.815 -173.32 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 2459 ' ' ALA . . . . . . . . . . . . . . . -153.63 155.4 35.98 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.254 1.422 . . . . 0.0 111.807 179.685 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 2460 ' ' GLY . . . . . . . . . . . . . . . 177.84 169.31 38.65 Favored Glycine 0 CA--C 1.529 0.918 0 C-N-CA 125.233 1.397 . . . . 0.0 112.959 -173.636 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 2461 ' ' ALA . . . . . . . . . . . . . . . -74.84 130.81 40.09 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 123.848 0.859 . . . . 0.0 111.874 -179.336 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 2462 ' ' LEU . . . . . . . . . . . . . 52.1 tp -108.19 138.6 44.19 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.374 1.47 . . . . 0.0 110.548 175.937 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 2463 ' ' SER . . . . . . . . . . . . . 30.7 t -103.56 -100.9 0.3 Allowed 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 124.806 1.242 . . . . 0.0 110.05 172.854 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 2464 ' ' VAL . . . . . . . . . . . . . 42.9 t 97.5 124.45 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.218 0 C-N-CA 130.837 3.655 . . . . 0.0 110.155 175.342 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 2465 ' ' THR . . . . . . . . . . . . . 99.8 m -125.01 135.6 52.92 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 125.271 1.428 . . . . 0.0 109.213 173.084 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 2466 ' ' ILE . . . . . . . . . . . . . 49.4 mt -115.93 117.64 56.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 123.998 0.919 . . . . 0.0 109.043 172.467 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 2467 ' ' ASP . . . . . . . . . . . . . 34.8 t70 -105.35 159.03 16.22 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 125.926 1.691 . . . . 0.0 110.255 169.721 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 2468 ' ' GLY . . . . . . . . . . . . . . . 156.44 -163.2 31.93 Favored Glycine 0 CA--C 1.535 1.332 0 O-C-N 121.253 -0.904 . . . . 0.0 114.367 178.718 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 2469 ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -72.47 -3.31 13.19 Favored 'Trans proline' 0 CA--C 1.542 0.923 0 C-N-CA 123.954 3.103 . . . . 0.0 114.622 -176.128 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 2470 ' ' SER . . . . . . . . . . . . . 85.7 p -153.59 154.56 34.46 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 119.751 1.16 . . . . 0.0 112.737 171.314 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 2471 ' ' LYS . . . . . . . . . . . . . 72.6 mmtt -74.52 86.5 2.08 Favored 'General case' 0 CA--C 1.544 0.736 0 O-C-N 120.789 -1.194 . . . . 0.0 110.026 168.765 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 2472 ' ' VAL . . . . . . . . . . . . . 18.4 m -55.7 146.1 5.29 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 C-N-CA 124.93 1.292 . . . . 0.0 113.19 -174.395 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 2473 ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -79.86 121.94 26.03 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 170.461 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 2474 ' ' MET . . . . . . . . . . . . . 26.1 ttt -132.08 142.43 49.52 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 124.556 1.143 . . . . 0.0 112.281 -164.328 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 2475 ' ' ASP . . . . . . . . . . . . . 20.1 m-20 -138.31 158.24 44.67 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 127.053 2.141 . . . . 0.0 110.713 174.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 2476 ' ' CYS . . . . . . . . . . . . . 43.5 t -149.32 148.57 29.69 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 125.207 1.403 . . . . 0.0 110.922 -179.3 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 2477 ' ' GLN . . . . . . . . . . . . . 26.2 tt0 -149.96 134.68 17.63 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.07 1.348 . . . . 0.0 110.347 -177.58 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 2478 ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -84.42 144.27 28.88 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.584 1.153 . . . . 0.0 111.784 172.984 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 2479 ' ' CYS . . . . . . . . . . . . . 25.5 p -161.0 175.23 3.23 Favored Pre-proline 0 CA--C 1.553 1.092 0 C-N-CA 125.785 1.634 . . . . 0.0 111.69 -173.157 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 2480 ' ' PRO . . . . . . . . . . . . . 77.6 Cg_exo -58.54 -24.03 67.72 Favored 'Trans proline' 0 CA--C 1.539 0.765 0 C-N-CA 123.328 2.685 . . . . 0.0 114.654 175.393 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 2481 ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -82.29 -4.56 57.42 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 124.678 1.191 . . . . 0.0 113.152 177.303 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 2482 ' ' GLY . . . . . . . . . . . . . . . 115.87 -124.62 6.33 Favored Glycine 0 N--CA 1.47 0.938 0 C-N-CA 125.848 1.689 . . . . 0.0 111.76 -175.868 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 2483 ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -116.77 113.22 22.25 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 124.408 1.083 . . . . 0.0 110.668 173.467 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 2484 ' ' ARG . . . . . . . . . . . . . 14.9 ttm180 -85.08 133.7 34.22 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 123.876 0.87 . . . . 0.0 109.926 173.102 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 2485 ' ' VAL . . . . . . . . . . . . . 90.8 t -121.62 136.25 59.13 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 C-N-CA 126.344 1.857 . . . . 0.0 108.847 179.751 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 2486 ' ' THR . . . . . . . . . . . . . 59.3 m -133.84 135.03 43.47 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.101 0.96 . . . . 0.0 108.913 175.018 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 2487 ' ' TYR . . . . . . . . . . . . . 28.2 p90 -141.99 151.4 42.47 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 112.976 0.732 . . . . 0.0 112.976 176.222 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 2488 ' ' THR . . . . . . . . . . . . . 91.6 m -109.75 107.54 59.17 Favored Pre-proline 0 N--CA 1.471 0.601 0 C-N-CA 124.508 1.123 . . . . 0.0 109.324 177.141 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 2489 ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -76.4 149.95 31.75 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 123.394 2.729 . . . . 0.0 110.131 169.655 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 2490 ' ' MET . . . . . . . . . . . . . 23.3 ptt? -128.74 11.02 6.11 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 114.397 1.258 . . . . 0.0 114.397 -177.58 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 2491 ' ' ALA . . . . . . . . . . . . . . . -141.59 147.64 46.74 Favored Pre-proline 0 CA--C 1.547 0.861 0 C-N-CA 125.269 1.428 . . . . 0.0 111.685 175.11 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 2492 ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -74.36 157.54 45.37 Favored 'Trans proline' 0 CA--C 1.537 0.628 0 C-N-CA 123.154 2.57 . . . . 0.0 111.062 172.7 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 2493 ' ' GLY . . . . . . . . . . . . . . . 130.34 -144.25 15.56 Favored Glycine 0 CA--C 1.528 0.858 0 C-N-CA 125.357 1.456 . . . . 0.0 111.796 -174.759 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 2494 ' ' SER . . . . . . . . . . . . . 10.5 t -134.91 133.81 40.01 Favored 'General case' 0 N--CA 1.468 0.464 0 O-C-N 121.824 -0.809 . . . . 0.0 111.63 177.602 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 2495 ' ' TYR . . . . . . . . . . . . . 87.8 m-85 -103.15 131.11 50.42 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.526 1.53 . . . . 0.0 110.352 176.818 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 2496 ' ' LEU . . . . . . . . . . . . . 21.9 tp -96.17 114.47 26.17 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.268 1.027 . . . . 0.0 109.457 178.381 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 2497 ' ' ILE . . . . . . . . . . . . . 36.4 mt -100.49 100.48 10.47 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 C-N-CA 125.459 1.504 . . . . 0.0 108.21 -178.543 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 2498 ' ' SER . . . . . . . . . . . . . 70.0 m -86.42 95.87 9.83 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 124.388 1.075 . . . . 0.0 109.241 174.95 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 2499 ' ' ILE . . . . . . . . . . . . . 49.9 mt -87.61 96.51 5.8 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 C-N-CA 124.51 1.124 . . . . 0.0 108.724 -178.8 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 2500 ' ' LYS . . . . . . . . . . . . . 85.6 mttt -104.18 135.74 45.09 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.713 1.205 . . . . 0.0 111.997 -179.207 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 2501 ' ' TYR . . . . . . . . . . . . . 56.5 t80 -151.07 148.76 28.71 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.269 1.428 . . . . 0.0 111.902 -169.932 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 2502 ' ' GLY . . . . . . . . . . . . . . . 67.21 26.53 73.42 Favored Glycine 0 CA--C 1.535 1.297 0 C-N-CA 123.897 0.76 . . . . 0.0 112.751 -178.945 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 2503 ' ' GLY . . . . . . . . . . . . . . . 118.16 -164.95 12.75 Favored Glycine 0 CA--C 1.542 1.725 0 C-N-CA 126.011 1.767 . . . . 0.0 112.112 -163.927 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 2504 ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -81.38 24.35 0.7 Allowed 'Trans proline' 0 CA--C 1.546 1.104 0 C-N-CA 124.933 3.756 . . . . 0.0 113.448 -174.626 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 2505 ' ' TYR . . . . . . . . . . . . . 67.9 m-85 -106.38 131.64 53.35 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.761 1.224 . . . . 0.0 112.764 -171.321 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 2506 ' ' HIS . . . . . . . . . . . . . 88.6 m-70 -59.63 139.27 57.34 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 125.017 1.327 . . . . 0.0 113.092 177.89 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 2507 ' ' ILE . . . . . . . . . . . . . 21.4 pt -72.6 171.88 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 170.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 2508 ' ' GLY . . . . . . . . . . . . . . . -58.61 119.56 18.12 Favored Glycine 0 CA--C 1.533 1.218 0 O-C-N 121.668 -0.645 . . . . 0.0 111.523 173.215 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 2509 ' ' GLY . . . . . . . . . . . . . . . 91.49 -9.05 78.15 Favored Glycine 0 CA--C 1.537 1.419 0 C-N-CA 125.62 1.581 . . . . 0.0 115.007 -177.012 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 2510 ' ' SER . . . . . . . . . . . . . 38.2 t -83.95 146.61 49.3 Favored Pre-proline 0 CA--C 1.55 0.968 0 CA-C-N 119.187 1.493 . . . . 0.0 112.044 179.311 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 2511 ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -77.41 147.67 85.47 Favored 'Cis proline' 0 C--N 1.354 0.84 0 CA-C-N 119.761 0.951 . . . . 0.0 112.901 -0.168 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 2512 ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -97.93 131.22 44.58 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 125.031 1.333 . . . . 0.0 110.346 178.367 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 2513 ' ' LYS . . . . . 0.435 ' H ' ' HD2' ' A' 2513 ' ' LYS . 0.0 OUTLIER -100.03 112.4 24.69 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.078 0.951 . . . . 0.0 111.719 178.95 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A 2514 ' ' ALA . . . . . . . . . . . . . . . -104.48 105.43 15.54 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 126.232 1.813 . . . . 0.0 110.765 -172.32 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 2515 ' ' LYS . . . . . . . . . . . . . 62.9 mtpt -84.49 125.98 32.87 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.737 1.215 . . . . 0.0 111.13 -175.724 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 2516 ' ' VAL . . . . . . . . . . . . . 70.4 t -123.46 137.53 56.4 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 C-N-CA 125.226 1.41 . . . . 0.0 110.003 -172.268 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 2517 ' ' THR . . . . . . . . . . . . . 66.9 p -127.16 173.31 9.82 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 125.419 1.488 . . . . 0.0 111.18 179.006 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 2518 ' ' GLY . . . . . . . . . . . . . . . 102.01 176.88 27.96 Favored Glycine 0 CA--C 1.539 1.566 0 C-N-CA 124.762 1.172 . . . . 0.0 113.359 -175.731 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 2519 ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -72.47 135.99 25.33 Favored 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 123.691 2.928 . . . . 0.0 112.089 -170.839 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 2520 ' ' ARG . . . . . . . . . . . . . 48.3 ttm-85 -67.09 131.5 45.96 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 123.971 0.908 . . . . 0.0 110.487 174.37 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 2521 ' ' LEU . . . . . . . . . . . . . 4.2 mm? -74.94 -29.4 60.93 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.676 0.79 . . . . 0.0 112.162 178.767 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 2522 ' ' VAL . . . . . . . . . . . . . 36.5 t . . . . . 0 C--O 1.253 1.26 0 C-N-CA 126.216 1.806 . . . . 0.0 111.329 176.733 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.551 0 N-CA-C 111.592 -0.603 . . . . 0.0 111.592 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -70.79 156.16 39.88 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 124.325 1.05 . . . . 0.0 112.631 178.019 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 37.7 mmt -83.95 139.51 32.53 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.283 1.033 . . . . 0.0 111.595 176.566 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 2427 ' ' GLY . . . . . . . . . . . . . . . -85.14 -176.59 50.74 Favored Glycine 0 CA--C 1.531 1.063 0 C-N-CA 125.439 1.495 . . . . 0.0 114.194 179.691 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 2428 ' ' ASP . . . . . . . . . . . . . 12.6 t70 -160.42 138.56 7.34 Favored Pre-proline 0 CA--C 1.548 0.9 0 C-N-CA 125.702 1.601 . . . . 0.0 110.363 -172.402 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 2429 ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -64.94 -19.5 63.98 Favored 'Trans proline' 0 CA--C 1.54 0.784 0 C-N-CA 123.191 2.594 . . . . 0.0 114.307 -175.172 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 2430 ' ' GLY . . . . . . . . . . . . . . . -80.93 -24.87 57.18 Favored Glycine 0 CA--C 1.534 1.251 0 CA-C-N 119.256 0.934 . . . . 0.0 113.374 173.025 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 2431 ' ' LEU . . . . . . . . . . . . . 4.5 mm? -89.36 -30.4 18.42 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.615 1.166 . . . . 0.0 112.153 174.317 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 2432 ' ' VAL . . . . . . . . . . . . . 66.3 t -67.74 135.23 28.9 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 C-N-CA 123.94 0.896 . . . . 0.0 110.411 172.037 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 2433 ' ' SER . . . . . . . . . . . . . 71.3 m -123.36 -175.33 3.17 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 125.841 1.656 . . . . 0.0 110.896 176.717 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 2434 ' ' ALA . . . . . . . . . . . . . . . -151.14 142.95 23.81 Favored 'General case' 0 CA--C 1.537 0.478 0 O-C-N 120.605 -1.309 . . . . 0.0 111.749 173.224 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 2435 ' ' TYR . . . . . . . . . . . . . 66.4 m-85 -147.99 148.62 30.94 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 125.373 1.469 . . . . 0.0 111.981 -174.916 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 2436 ' ' GLY . . . . . . . . . . . . . . . 124.48 164.35 11.91 Favored Glycine 0 N--CA 1.474 1.204 0 C-N-CA 125.446 1.498 . . . . 0.0 114.422 174.718 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 2437 ' ' ALA . . . . . . . . . . . . . . . -60.48 -29.2 68.92 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.313 1.445 . . . . 0.0 114.443 -171.177 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 2438 ' ' GLY . . . . . . . . . . . . . . . -63.95 -20.14 64.21 Favored Glycine 0 CA--C 1.532 1.124 0 CA-C-O 118.937 -0.924 . . . . 0.0 113.959 178.976 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 2439 ' ' LEU . . . . . . . . . . . . . 79.5 mt -75.04 -24.02 58.23 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 118.916 1.358 . . . . 0.0 112.606 170.905 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 2440 ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -91.08 -30.29 16.83 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 125.131 1.372 . . . . 0.0 112.0 177.808 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 2441 ' ' GLY . . . . . . . . . . . . . . . 109.93 -152.58 17.22 Favored Glycine 0 CA--C 1.534 1.224 0 C-N-CA 126.122 1.82 . . . . 0.0 113.508 178.742 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 2442 ' ' GLY . . . . . . . . . . . . . . . 169.04 -159.37 32.4 Favored Glycine 0 CA--C 1.531 1.072 0 C-N-CA 124.316 0.96 . . . . 0.0 114.001 -174.949 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 2443 ' ' VAL . . . . . . . . . . . . . 20.7 t -95.77 141.57 15.09 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 C-N-CA 124.461 1.104 . . . . 0.0 110.231 179.185 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 2444 ' ' THR . . . . . . . . . . . . . 31.5 p -58.6 152.19 19.0 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 124.693 1.197 . . . . 0.0 112.88 174.757 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 2445 ' ' GLY . . . . . . . . . . . . . . . 71.73 2.73 52.29 Favored Glycine 0 CA--C 1.536 1.375 0 C-N-CA 124.032 0.825 . . . . 0.0 114.326 179.857 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 2446 ' ' ASN . . . . . . . . . . . . . 26.0 m-80 -130.72 146.71 63.12 Favored Pre-proline 0 CA--C 1.549 0.928 0 C-N-CA 126.606 1.962 . . . . 0.0 110.284 -178.952 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 2447 ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -76.55 149.08 30.17 Favored 'Trans proline' 0 C--N 1.349 0.583 0 C-N-CA 123.022 2.481 . . . . 0.0 112.689 -176.179 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 2448 ' ' ALA . . . . . . . . . . . . . . . -133.86 143.08 48.09 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 126.269 1.828 . . . . 0.0 109.525 166.234 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 2449 ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -134.33 149.88 50.9 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 113.78 1.03 . . . . 0.0 113.78 -165.786 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 2450 ' ' PHE . . . . . . . . . . . . . 33.4 p90 -156.11 167.15 31.32 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.814 1.646 . . . . 0.0 111.173 179.672 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 2451 ' ' VAL . . . . . . . . . . . . . 57.4 t -123.14 131.7 72.74 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 C-N-CA 124.74 1.216 . . . . 0.0 109.656 176.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 2452 ' ' VAL . . . . . . . . . . . . . 41.3 t -80.69 104.26 8.87 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 N-CA-C 107.086 -1.45 . . . . 0.0 107.086 163.608 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 2453 ' ' ASN . . . . . . . . . . . . . 13.9 t-20 -78.28 111.2 14.01 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 123.977 0.911 . . . . 0.0 111.86 -172.702 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 2454 ' ' THR . . . . . . . . . . . . . 37.3 p -106.09 -8.04 17.68 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 125.885 1.674 . . . . 0.0 113.811 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 2455 ' ' SER . . . . . . . . . . . . . 88.6 p -65.95 -24.35 66.79 Favored 'General case' 0 N--CA 1.478 0.938 0 CA-C-N 120.173 1.351 . . . . 0.0 113.8 -176.653 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 2456 ' ' ASN . . . . . . . . . . . . . 56.4 m-80 -77.72 -11.6 59.89 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 124.493 1.117 . . . . 0.0 113.57 171.243 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 2457 ' ' ALA . . . . . . . . . . . . . . . -113.5 -57.14 2.32 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 125.11 1.364 . . . . 0.0 113.169 -172.714 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 2458 ' ' GLY . . . . . . . . . . . . . . . 123.34 -159.87 17.93 Favored Glycine 0 CA--C 1.533 1.178 0 C-N-CA 125.522 1.534 . . . . 0.0 112.661 -169.279 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 2459 ' ' ALA . . . . . . . . . . . . . . . -84.13 150.34 25.59 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 124.809 1.244 . . . . 0.0 112.972 -177.625 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 2460 ' ' GLY . . . . . . . . . . . . . . . 164.91 166.92 24.67 Favored Glycine 0 CA--C 1.531 1.089 0 C-N-CA 124.462 1.03 . . . . 0.0 113.862 -178.138 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 2461 ' ' ALA . . . . . . . . . . . . . . . -82.77 135.7 34.9 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.249 1.02 . . . . 0.0 112.709 -175.895 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 2462 ' ' LEU . . . . . . . . . . . . . 40.9 tp -102.11 143.91 31.34 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.901 1.681 . . . . 0.0 110.585 174.902 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 2463 ' ' SER . . . . . . . . . . . . . 3.9 t -138.58 41.74 2.18 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 125.206 1.403 . . . . 0.0 111.152 -177.956 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 2464 ' ' VAL . . . . . . . . . . . . . 9.6 p -65.57 135.21 28.73 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 C-N-CA 124.987 1.315 . . . . 0.0 112.167 -176.723 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 2465 ' ' THR . . . . . . . . . . . . . 95.4 m -135.08 145.74 48.23 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 126.067 1.747 . . . . 0.0 110.102 -178.286 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 2466 ' ' ILE . . . . . . . . . . . . . 50.2 mt -122.58 133.39 68.91 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 C-N-CA 124.5 1.12 . . . . 0.0 110.027 176.053 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 2467 ' ' ASP . . . . . . . . . . . . . 34.7 t70 -139.97 151.69 45.72 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 126.675 1.99 . . . . 0.0 110.409 178.333 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 2468 ' ' GLY . . . . . . . . . . . . . . . 174.52 -144.48 7.48 Favored Glycine 0 CA--C 1.537 1.422 0 CA-C-O 118.495 -1.17 . . . . 0.0 114.567 -177.182 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 2469 ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo -67.99 -15.56 43.66 Favored 'Trans proline' 0 C--N 1.354 0.864 0 C-N-CA 123.83 3.02 . . . . 0.0 113.343 -179.577 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 2470 ' ' SER . . . . . . . . . . . . . 7.6 t -159.07 -161.1 0.91 Allowed 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 126.078 1.751 . . . . 0.0 109.491 170.115 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 2471 ' ' LYS . . . . . . . . . . . . . 98.5 mttt -79.68 -179.61 6.99 Favored 'General case' 0 CA--C 1.55 0.975 0 O-C-N 121.014 -1.054 . . . . 0.0 111.46 164.86 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 2472 ' ' VAL . . . . . . . . . . . . . 14.3 m -136.37 149.94 27.41 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 125.243 1.417 . . . . 0.0 109.979 170.269 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 2473 ' ' LYS . . . . . . . . . . . . . 25.9 tptp -78.34 107.26 10.83 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 167.77 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 2474 ' ' MET . . . . . . . . . . . . . 22.9 ttt -114.78 140.61 48.77 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 125.191 1.396 . . . . 0.0 112.285 -168.357 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 2475 ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -143.22 157.28 44.63 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 126.618 1.967 . . . . 0.0 110.323 173.359 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 2476 ' ' CYS . . . . . . . . . . . . . 30.9 p -162.15 164.29 28.0 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.043 0.937 . . . . 0.0 113.485 -176.006 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 2477 ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -164.77 173.18 12.08 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.841 1.657 . . . . 0.0 111.59 177.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 2478 ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -80.2 138.83 36.91 Favored 'General case' 0 CA--C 1.544 0.716 0 O-C-N 121.57 -0.706 . . . . 0.0 110.383 164.339 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 2479 ' ' CYS . . . . . . . . . . . . . 59.3 m -132.96 167.14 24.41 Favored Pre-proline 0 CA--C 1.554 1.106 0 C-N-CA 126.824 2.05 . . . . 0.0 110.367 169.52 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 2480 ' ' PRO . . . . . . . . . . . . . 70.2 Cg_exo -57.99 -31.9 93.98 Favored 'Trans proline' 0 C--N 1.353 0.796 0 C-N-CA 123.586 2.858 . . . . 0.0 114.586 177.643 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 2481 ' ' GLU . . . . . . . . . . . . . 20.8 tp10 -77.45 -13.0 60.02 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 125.079 1.352 . . . . 0.0 112.849 177.927 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 2482 ' ' GLY . . . . . . . . . . . . . . . 129.1 -169.0 20.59 Favored Glycine 0 CA--C 1.53 1.018 0 C-N-CA 126.587 2.041 . . . . 0.0 112.29 -172.618 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 2483 ' ' TYR . . . . . . . . . . . . . 66.8 m-85 -69.78 111.64 5.68 Favored 'General case' 0 CA--C 1.539 0.537 0 O-C-N 121.277 -1.131 . . . . 0.0 111.783 177.808 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 2484 ' ' ARG . . . . . . . . . . . . . 68.5 ttt180 -85.09 138.26 32.53 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 125.366 1.466 . . . . 0.0 110.692 179.319 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 2485 ' ' VAL . . . . . . . . . . . . . 96.4 t -128.59 136.96 58.63 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 C-N-CA 126.333 1.853 . . . . 0.0 108.93 179.261 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 2486 ' ' THR . . . . . . . . . . . . . 85.7 m -133.24 136.58 45.66 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 125.06 1.344 . . . . 0.0 108.303 173.877 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 2487 ' ' TYR . . . . . . . . . . . . . 31.0 p90 -145.72 148.97 33.58 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 113.489 0.922 . . . . 0.0 113.489 177.628 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 2488 ' ' THR . . . . . . . . . . . . . 23.9 m -109.24 114.31 57.89 Favored Pre-proline 0 N--CA 1.471 0.612 0 C-N-CA 125.308 1.443 . . . . 0.0 108.7 171.304 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 2489 ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -80.07 159.73 23.77 Favored 'Trans proline' 0 N--CA 1.457 -0.628 0 C-N-CA 123.153 2.569 . . . . 0.0 111.203 173.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 2490 ' ' MET . . . . . . . . . . . . . 26.1 ptm -128.79 2.14 5.42 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 114.935 1.458 . . . . 0.0 114.935 -171.406 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 2491 ' ' ALA . . . . . . . . . . . . . . . -145.79 143.46 19.75 Favored Pre-proline 0 CA--C 1.548 0.881 0 C-N-CA 124.74 1.216 . . . . 0.0 111.308 174.934 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 2492 ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -72.75 155.1 54.19 Favored 'Trans proline' 0 CA--C 1.537 0.641 0 C-N-CA 123.229 2.619 . . . . 0.0 111.106 174.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 2493 ' ' GLY . . . . . . . . . . . . . . . 131.26 -151.52 19.72 Favored Glycine 0 CA--C 1.528 0.875 0 C-N-CA 125.356 1.455 . . . . 0.0 111.992 -173.257 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 2494 ' ' SER . . . . . . . . . . . . . 71.8 m -122.12 127.68 50.41 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 123.647 0.779 . . . . 0.0 112.074 177.874 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 2495 ' ' TYR . . . . . . . . . . . . . 86.2 m-85 -98.91 134.54 41.62 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.23 1.412 . . . . 0.0 110.676 171.688 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 2496 ' ' LEU . . . . . . . . . . . . . 10.3 mp -92.63 121.57 34.18 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.461 1.104 . . . . 0.0 108.819 168.832 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 2497 ' ' ILE . . . . . . . . . . . . . 40.5 mt -97.26 101.01 11.72 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.375 0 N-CA-C 107.286 -1.376 . . . . 0.0 107.286 173.829 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 2498 ' ' SER . . . . . . . . . . . . . 74.7 m -86.98 94.01 9.5 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 125.368 1.467 . . . . 0.0 109.512 179.159 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 2499 ' ' ILE . . . . . . . . . . . . . 26.6 mt -90.46 101.32 12.22 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 C-N-CA 124.909 1.284 . . . . 0.0 108.768 -179.769 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 2500 ' ' LYS . . . . . . . . . . . . . 83.8 mttt -109.52 143.44 39.17 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 124.535 1.134 . . . . 0.0 111.622 178.538 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 2501 ' ' TYR . . . . . . . . . . . . . 53.8 t80 -151.17 141.4 22.28 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.918 0.887 . . . . 0.0 112.698 -171.022 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 2502 ' ' GLY . . . . . . . . . . . . . . . 68.28 15.15 67.47 Favored Glycine 0 CA--C 1.536 1.354 0 C-N-CA 124.262 0.934 . . . . 0.0 114.072 178.381 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 2503 ' ' GLY . . . . . . . . . . . . . . . 142.73 -167.78 26.14 Favored Glycine 0 CA--C 1.54 1.645 0 C-N-CA 125.934 1.73 . . . . 0.0 112.591 -168.419 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 2504 ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -82.37 18.71 1.38 Allowed 'Trans proline' 0 CA--C 1.545 1.026 0 C-N-CA 124.772 3.648 . . . . 0.0 113.833 -174.112 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 2505 ' ' TYR . . . . . . . . . . . . . 73.7 m-85 -110.32 139.36 45.59 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.661 1.185 . . . . 0.0 113.341 -172.494 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 2506 ' ' HIS . . . . . . . . . . . . . 91.1 m-70 -64.23 143.29 58.0 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 125.57 1.548 . . . . 0.0 113.516 179.399 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 2507 ' ' ILE . . . . . . . . . . . . . 1.8 pp -86.37 150.37 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.075 0 C-N-CA 123.882 0.873 . . . . 0.0 111.854 171.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 2508 ' ' GLY . . . . . . . . . . . . . . . 46.23 -114.12 1.3 Allowed Glycine 0 CA--C 1.536 1.38 0 C-N-CA 124.275 0.94 . . . . 0.0 114.531 165.642 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 2509 ' ' GLY . . . . . . . . . . . . . . . -99.67 12.74 61.2 Favored Glycine 0 CA--C 1.537 1.409 0 C-N-CA 126.193 1.854 . . . . 0.0 115.19 178.117 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 2510 ' ' SER . . . . . . . . . . . . . 42.6 t -65.84 146.27 99.0 Favored Pre-proline 0 CA--C 1.552 1.04 0 CA-C-N 119.17 1.485 . . . . 0.0 112.655 179.586 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 2511 ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -75.0 142.15 73.91 Favored 'Cis proline' 0 C--N 1.354 0.852 0 CA-C-N 119.821 0.972 . . . . 0.0 112.868 0.727 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 2512 ' ' PHE . . . . . . . . . . . . . 91.6 m-85 -93.33 127.98 39.16 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.547 1.139 . . . . 0.0 110.858 178.662 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 2513 ' ' LYS . . . . . . . . . . . . . 86.0 tttt -90.24 92.7 9.04 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 124.407 1.083 . . . . 0.0 111.893 -176.768 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 2514 ' ' ALA . . . . . . . . . . . . . . . -79.53 123.84 27.95 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.976 1.31 . . . . 0.0 110.682 174.747 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 2515 ' ' LYS . . . . . . . . . . . . . 26.6 mtmm -101.15 120.87 40.86 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.201 1.401 . . . . 0.0 110.278 -173.558 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 2516 ' ' VAL . . . . . . . . . . . . . 73.0 t -120.42 138.45 50.91 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 124.843 1.257 . . . . 0.0 111.133 -167.692 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 2517 ' ' THR . . . . . . . . . . . . . 68.1 p -128.9 178.53 6.31 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 125.986 1.714 . . . . 0.0 111.088 179.505 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 2518 ' ' GLY . . . . . . . . . . . . . . . 97.67 -176.31 30.96 Favored Glycine 0 CA--C 1.54 1.629 0 C-N-CA 124.545 1.069 . . . . 0.0 113.39 -176.68 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 2519 ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -71.6 148.25 53.04 Favored 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 123.72 2.947 . . . . 0.0 112.167 -174.408 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 2520 ' ' ARG . . . . . . . . . . . . . 35.8 ttp180 -82.13 128.31 34.01 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 123.648 0.779 . . . . 0.0 110.217 173.882 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 2521 ' ' LEU . . . . . . . . . . . . . 3.8 mm? -84.76 -23.13 29.35 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.208 1.003 . . . . 0.0 112.25 177.508 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 2522 ' ' VAL . . . . . . . . . . . . . 35.2 t . . . . . 0 C--O 1.253 1.282 0 C-N-CA 126.398 1.879 . . . . 0.0 111.808 179.045 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.578 0 N-CA-C 111.359 -0.697 . . . . 0.0 111.359 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -68.88 160.52 30.53 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 124.269 1.028 . . . . 0.0 112.671 176.768 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 90.0 mtp -138.32 165.83 25.75 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 125.368 1.467 . . . . 0.0 111.997 -179.012 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 2427 ' ' GLY . . . . . . . . . . . . . . . -148.11 145.85 14.82 Favored Glycine 0 CA--C 1.529 0.957 0 C-N-CA 125.666 1.603 . . . . 0.0 111.579 171.618 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 2428 ' ' ASP . . . . . . . . . . . . . 22.2 m-20 -97.33 128.59 34.37 Favored Pre-proline 0 CA--C 1.547 0.853 0 C-N-CA 123.909 0.884 . . . . 0.0 112.726 -175.516 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 2429 ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -66.67 -22.42 50.43 Favored 'Trans proline' 0 C--N 1.352 0.748 0 C-N-CA 122.993 2.462 . . . . 0.0 112.915 177.966 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 2430 ' ' GLY . . . . . . . . . . . . . . . -75.05 -23.16 75.24 Favored Glycine 0 CA--C 1.535 1.304 0 CA-C-N 119.062 0.847 . . . . 0.0 113.551 173.979 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 2431 ' ' LEU . . . . . . . . . . . . . 4.2 mm? -86.34 -29.82 22.69 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 124.483 1.113 . . . . 0.0 111.698 171.908 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 2432 ' ' VAL . . . . . . . . . . . . . 79.1 t -67.94 135.25 28.84 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 C-N-CA 123.51 0.724 . . . . 0.0 110.521 169.723 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 2433 ' ' SER . . . . . . . . . . . . . 57.9 m -140.44 144.66 36.23 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 125.463 1.505 . . . . 0.0 109.439 171.908 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 2434 ' ' ALA . . . . . . . . . . . . . . . -96.41 148.58 22.64 Favored 'General case' 0 CA--C 1.539 0.553 0 O-C-N 121.572 -0.705 . . . . 0.0 111.794 176.133 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 2435 ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -142.4 142.78 32.45 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.808 1.643 . . . . 0.0 111.468 -178.226 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 2436 ' ' GLY . . . . . . . . . . . . . . . 129.17 159.45 9.91 Favored Glycine 0 N--CA 1.473 1.11 0 C-N-CA 125.438 1.494 . . . . 0.0 113.534 -179.708 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 2437 ' ' ALA . . . . . . . . . . . . . . . -63.56 -26.94 68.92 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 114.259 1.207 . . . . 0.0 114.259 -171.22 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 2438 ' ' GLY . . . . . . . . . . . . . . . -68.19 -11.08 60.81 Favored Glycine 0 CA--C 1.53 0.969 0 C-N-CA 124.001 0.81 . . . . 0.0 114.702 -177.475 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 2439 ' ' LEU . . . . . . . . . . . . . 73.2 mt -78.46 -26.04 46.03 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.724 1.21 . . . . 0.0 112.405 171.607 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 2440 ' ' GLU . . . . . . . . . . . . . 37.5 mm-40 -89.07 -36.61 15.66 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 124.794 1.237 . . . . 0.0 111.853 -178.3 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 2441 ' ' GLY . . . . . . . . . . . . . . . 155.77 -148.39 18.46 Favored Glycine 0 CA--C 1.529 0.926 0 C-N-CA 124.389 0.995 . . . . 0.0 113.813 -176.135 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 2442 ' ' GLY . . . . . . . . . . . . . . . 157.49 -158.39 28.94 Favored Glycine 0 CA--C 1.53 1.012 0 C-N-CA 125.303 1.43 . . . . 0.0 112.924 -176.023 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 2443 ' ' VAL . . . . . . . . . . . . . 81.2 t -129.53 139.61 51.24 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.975 0 C-N-CA 125.321 1.449 . . . . 0.0 109.213 179.086 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 2444 ' ' THR . . . . . . . . . . . . . 33.5 p -60.45 138.06 58.06 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 124.016 0.926 . . . . 0.0 111.978 178.354 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 2445 ' ' GLY . . . . . . . . . . . . . . . 81.3 -10.65 48.23 Favored Glycine 0 CA--C 1.537 1.459 0 C-N-CA 124.75 1.167 . . . . 0.0 114.862 -175.371 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 2446 ' ' ASN . . . . . . . . . . . . . 88.4 m-20 -106.69 149.75 38.8 Favored Pre-proline 0 CA--C 1.548 0.888 0 C-N-CA 125.167 1.387 . . . . 0.0 111.192 174.611 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 2447 ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -73.07 135.83 23.69 Favored 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 122.849 2.366 . . . . 0.0 111.79 -179.485 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 2448 ' ' ALA . . . . . . . . . . . . . . . -109.83 142.17 41.47 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 127.236 2.214 . . . . 0.0 108.772 167.028 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 2449 ' ' GLU . . . . . . . . . . . . . 5.0 tm-20 -147.91 141.24 25.23 Favored 'General case' 0 N--CA 1.471 0.614 0 O-C-N 121.411 -0.806 . . . . 0.0 112.994 -162.598 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 2450 ' ' PHE . . . . . . . . . . . . . 52.9 p90 -156.29 157.44 35.76 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 125.83 1.652 . . . . 0.0 112.458 177.604 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 2451 ' ' VAL . . . . . . . . . . . . . 59.0 t -113.55 133.29 59.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 125.641 1.577 . . . . 0.0 109.443 171.78 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 2452 ' ' VAL . . . . . . . . . . . . . 39.3 t -87.14 105.1 14.78 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 C-N-CA 125.102 1.361 . . . . 0.0 107.819 168.225 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 2453 ' ' ASN . . . . . . . . . . . . . 32.7 t-20 -77.9 117.14 18.96 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 123.612 0.765 . . . . 0.0 110.926 -174.073 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 2454 ' ' THR . . . . . . . . . . . . . 39.5 p -105.1 -9.61 17.69 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 125.088 1.355 . . . . 0.0 113.634 -178.559 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 2455 ' ' SER . . . . . . . . . . . . . 41.2 m -57.94 -29.79 65.44 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.927 1.291 . . . . 0.0 114.234 -175.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 2456 ' ' ASN . . . . . . . . . . . . . 79.4 m-20 -83.79 -16.21 45.52 Favored 'General case' 0 CA--C 1.546 0.809 0 N-CA-C 113.767 1.025 . . . . 0.0 113.767 177.289 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 2457 ' ' ALA . . . . . . . . . . . . . . . -102.45 -41.94 6.14 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 114.458 1.281 . . . . 0.0 114.458 -166.574 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 2458 ' ' GLY . . . . . . . . . . . . . . . 121.64 -133.63 9.56 Favored Glycine 0 N--CA 1.471 1.03 0 C-N-CA 124.653 1.12 . . . . 0.0 112.06 -171.896 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 2459 ' ' ALA . . . . . . . . . . . . . . . -129.97 120.9 25.55 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.51 1.124 . . . . 0.0 111.944 -175.862 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 2460 ' ' GLY . . . . . . . . . . . . . . . -165.6 162.71 36.09 Favored Glycine 0 CA--C 1.529 0.963 0 C-N-CA 125.029 1.3 . . . . 0.0 113.029 -177.612 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 2461 ' ' ALA . . . . . . . . . . . . . . . -79.26 145.18 33.69 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.064 0.946 . . . . 0.0 112.484 -179.163 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 2462 ' ' LEU . . . . . . . . . . . . . 13.7 tp -95.26 147.2 23.74 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.178 1.391 . . . . 0.0 110.555 172.812 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 2463 ' ' SER . . . . . . . . . . . . . 9.1 t -137.12 34.58 2.57 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 125.301 1.44 . . . . 0.0 111.506 -178.302 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 2464 ' ' VAL . . . . . . . . . . . . . 10.5 p -59.65 135.17 24.52 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 C-N-CA 125.327 1.451 . . . . 0.0 112.58 -175.621 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 2465 ' ' THR . . . . . . . . . . . . . 96.4 m -134.91 142.9 46.67 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 125.759 1.623 . . . . 0.0 109.389 176.758 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 2466 ' ' ILE . . . . . . . . . . . . . 36.1 mt -120.27 122.2 67.68 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 C-N-CA 123.773 0.829 . . . . 0.0 109.953 174.05 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 2467 ' ' ASP . . . . . . . . . . . . . 33.0 t70 -104.68 166.8 10.14 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 126.392 1.877 . . . . 0.0 110.12 168.011 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 2468 ' ' GLY . . . . . . . . . . . . . . . 167.48 -160.57 34.24 Favored Glycine 0 CA--C 1.535 1.31 0 O-C-N 120.83 -1.169 . . . . 0.0 114.936 178.752 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 2469 ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -70.04 -16.44 36.39 Favored 'Trans proline' 0 CA--C 1.54 0.819 0 C-N-CA 123.915 3.077 . . . . 0.0 113.246 178.826 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 2470 ' ' SER . . . . . . . . . . . . . 38.0 m -157.95 -171.8 3.67 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 127.335 2.254 . . . . 0.0 109.819 177.506 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 2471 ' ' LYS . . . . . . . . . . . . . 99.0 mttt -70.74 175.95 4.58 Favored 'General case' 0 CA--C 1.551 0.985 0 O-C-N 120.956 -1.09 . . . . 0.0 112.343 167.915 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 2472 ' ' VAL . . . . . . . . . . . . . 33.9 m -132.11 148.87 32.09 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.925 0 C-N-CA 125.311 1.444 . . . . 0.0 110.466 169.624 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 2473 ' ' LYS . . . . . . . . . . . . . 62.0 mtpt -87.43 89.17 7.9 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 123.592 0.757 . . . . 0.0 109.52 169.6 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 2474 ' ' MET . . . . . . . . . . . . . 60.0 ttm -83.51 143.0 30.49 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 124.334 1.054 . . . . 0.0 112.071 -177.978 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 2475 ' ' ASP . . . . . . . . . . . . . 31.7 t70 -139.09 103.87 4.88 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 126.581 1.953 . . . . 0.0 109.221 167.026 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 2476 ' ' CYS . . . . . . . . . . . . . 28.7 p -102.3 155.19 18.39 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 124.954 1.302 . . . . 0.0 112.28 178.143 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 2477 ' ' GLN . . . . . . . . . . . . . 27.4 tt0 -161.59 146.56 13.36 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.26 1.024 . . . . 0.0 111.258 -172.156 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 2478 ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -77.89 122.67 25.79 Favored 'General case' 0 CA--C 1.541 0.615 0 O-C-N 121.478 -0.763 . . . . 0.0 110.609 173.682 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 2479 ' ' CYS . . . . . . . . . . . . . 60.6 m -121.76 166.29 17.12 Favored Pre-proline 0 CA--C 1.553 1.082 0 C-N-CA 126.539 1.936 . . . . 0.0 111.041 179.869 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 2480 ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -65.32 -26.9 55.82 Favored 'Trans proline' 0 CA--C 1.54 0.797 0 C-N-CA 123.009 2.473 . . . . 0.0 114.567 -174.527 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 2481 ' ' GLU . . . . . . . . . . . . . 82.2 tt0 -82.24 -17.17 46.95 Favored 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 124.143 0.977 . . . . 0.0 112.997 174.46 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 2482 ' ' GLY . . . . . . . . . . . . . . . 140.11 -162.47 26.39 Favored Glycine 0 CA--C 1.528 0.875 0 C-N-CA 125.879 1.705 . . . . 0.0 112.608 -176.306 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 2483 ' ' TYR . . . . . . . . . . . . . 74.0 m-85 -70.36 119.07 13.99 Favored 'General case' 0 CA--C 1.539 0.541 0 O-C-N 121.479 -1.013 . . . . 0.0 111.75 -179.848 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 2484 ' ' ARG . . . . . . . . . . . . . 21.5 ttt180 -95.34 141.83 28.45 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 125.038 1.335 . . . . 0.0 110.725 177.013 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 2485 ' ' VAL . . . . . . . . . . . . . 67.1 t -132.58 122.01 46.43 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 C-N-CA 124.98 1.312 . . . . 0.0 108.943 178.247 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 2486 ' ' THR . . . . . . . . . . . . . 89.9 m -110.07 144.35 38.78 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 124.856 1.262 . . . . 0.0 107.846 165.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 2487 ' ' TYR . . . . . . . . . . . . . 28.7 p90 -148.63 144.24 27.06 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 123.918 0.887 . . . . 0.0 112.185 174.953 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 2488 ' ' THR . . . . . . . . . . . . . 85.6 m -107.21 117.32 56.53 Favored Pre-proline 0 N--CA 1.476 0.86 0 CA-C-O 117.989 -1.005 . . . . 0.0 109.422 172.233 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 2489 ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -81.68 163.11 18.86 Favored 'Trans proline' 0 C--N 1.351 0.687 0 C-N-CA 124.319 3.346 . . . . 0.0 111.604 174.197 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 2490 ' ' MET . . . . . . . . . . . . . 28.4 ptm -133.85 -3.68 2.87 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 115.603 1.705 . . . . 0.0 115.603 -171.539 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 2491 ' ' ALA . . . . . . . . . . . . . . . -144.78 145.66 28.77 Favored Pre-proline 0 CA--C 1.548 0.871 0 C-N-CA 124.728 1.211 . . . . 0.0 110.937 172.813 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 2492 ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -71.29 151.98 60.8 Favored 'Trans proline' 0 CA--C 1.535 0.574 0 C-N-CA 123.504 2.803 . . . . 0.0 111.615 -178.715 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 2493 ' ' GLY . . . . . . . . . . . . . . . 129.88 -165.47 22.32 Favored Glycine 0 CA--C 1.53 1.003 0 C-N-CA 125.187 1.375 . . . . 0.0 113.578 -177.903 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 2494 ' ' SER . . . . . . . . . . . . . 16.7 p -89.96 115.02 26.94 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.835 1.254 . . . . 0.0 112.08 178.823 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 2495 ' ' TYR . . . . . . . . . . . . . 54.6 m-85 -87.74 122.78 31.82 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 123.536 0.735 . . . . 0.0 109.741 163.819 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 2496 ' ' LEU . . . . . . . . . . . . . 21.4 tp -94.34 104.61 16.59 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 124.597 1.159 . . . . 0.0 109.521 -178.467 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 2497 ' ' ILE . . . . . . . . . . . . . 30.2 mt -90.4 98.05 7.84 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 C-N-CA 125.826 1.65 . . . . 0.0 108.23 -177.627 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 2498 ' ' SER . . . . . . . . . . . . . 71.0 m -85.02 80.97 9.1 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 124.675 1.19 . . . . 0.0 109.624 175.783 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 2499 ' ' ILE . . . . . . . . . . . . . 17.9 mt -77.82 114.16 17.99 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 175.845 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 2500 ' ' LYS . . . . . . . . . . . . . 81.9 mttt -121.76 148.66 44.35 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.528 1.531 . . . . 0.0 111.037 -177.781 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 2501 ' ' TYR . . . . . . . . . . . . . 63.4 t80 -154.91 145.84 22.58 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.119 0.968 . . . . 0.0 112.499 -171.423 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 2502 ' ' GLY . . . . . . . . . . . . . . . 69.04 17.48 71.83 Favored Glycine 0 CA--C 1.536 1.394 0 C-N-CA 124.216 0.913 . . . . 0.0 113.704 178.823 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 2503 ' ' GLY . . . . . . . . . . . . . . . 135.6 -165.05 24.87 Favored Glycine 0 CA--C 1.54 1.643 0 C-N-CA 125.981 1.753 . . . . 0.0 112.528 -167.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 2504 ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -82.26 20.31 1.12 Allowed 'Trans proline' 0 CA--C 1.545 1.06 0 C-N-CA 124.855 3.703 . . . . 0.0 113.638 -174.545 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 2505 ' ' TYR . . . . . . . . . . . . . 80.5 m-85 -109.98 139.96 44.51 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.751 1.22 . . . . 0.0 113.355 -172.644 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 2506 ' ' HIS . . . . . . . . . . . . . 92.5 m-70 -62.57 144.31 56.27 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 125.571 1.548 . . . . 0.0 113.572 -179.61 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 2507 ' ' ILE . . . . . . . . . . . . . 28.0 pt -75.79 174.69 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 C-N-CA 123.633 0.773 . . . . 0.0 112.992 173.123 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 2508 ' ' GLY . . . . . . . . . . . . . . . -58.94 117.91 12.45 Favored Glycine 0 CA--C 1.532 1.152 0 N-CA-C 111.228 -0.749 . . . . 0.0 111.228 171.24 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 2509 ' ' GLY . . . . . . . . . . . . . . . 93.54 -9.77 73.59 Favored Glycine 0 CA--C 1.536 1.388 0 C-N-CA 125.677 1.608 . . . . 0.0 115.168 -178.142 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 2510 ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -78.23 156.09 79.17 Favored Pre-proline 0 N--CA 1.474 0.768 0 CA-C-N 119.647 1.723 . . . . 0.0 113.68 178.938 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 2511 ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -77.58 152.66 93.51 Favored 'Cis proline' 0 CA--C 1.539 0.768 0 CA-C-N 118.26 0.414 . . . . 0.0 111.435 -9.561 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 2512 ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -98.21 128.8 44.87 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.373 1.069 . . . . 0.0 110.633 179.693 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 2513 ' ' LYS . . . . . . . . . . . . . 24.9 pttm -88.22 7.58 31.29 Favored 'General case' 0 N--CA 1.479 0.995 0 N-CA-C 116.715 2.117 . . . . 0.0 116.715 -165.352 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 2514 ' ' ALA . . . . . . . . . . . . . . . -3.97 97.65 0.01 OUTLIER 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 129.467 3.107 . . . . 0.0 116.462 -175.616 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 2515 ' ' LYS . . . . . . . . . . . . . 62.8 mtpt -89.78 105.24 17.67 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.504 1.122 . . . . 0.0 110.683 -175.104 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 2516 ' ' VAL . . . . . . . . . . . . . 4.0 m -102.36 148.4 7.86 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 C-N-CA 124.315 1.046 . . . . 0.0 111.486 -174.161 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 2517 ' ' THR . . . . . . . . . . . . . 69.1 p -116.66 -169.37 1.62 Allowed 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 125.471 1.508 . . . . 0.0 110.922 179.349 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 2518 ' ' GLY . . . . . . . . . . . . . . . 96.29 -175.7 32.2 Favored Glycine 0 CA--C 1.539 1.575 0 C-N-CA 124.693 1.14 . . . . 0.0 113.331 -176.221 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 2519 ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -70.63 153.39 64.96 Favored 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 123.748 2.966 . . . . 0.0 112.537 -174.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 2520 ' ' ARG . . . . . . . . . . . . . 65.2 ttp85 -94.81 122.93 37.94 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.686 1.194 . . . . 0.0 110.053 171.199 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 2521 ' ' LEU . . . . . . . . . . . . . 4.1 mm? -95.28 -13.35 24.92 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 124.266 1.026 . . . . 0.0 113.7 -175.204 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 2522 ' ' VAL . . . . . . . . . . . . . 14.8 m . . . . . 0 N--CA 1.484 1.264 0 C-N-CA 125.858 1.663 . . . . 0.0 113.66 -174.194 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.545 0 N-CA-C 111.758 -0.537 . . . . 0.0 111.758 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -72.17 -34.47 68.49 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.021 0.929 . . . . 0.0 113.257 -179.588 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 51.1 tpp -73.53 131.47 41.79 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 124.903 1.281 . . . . 0.0 110.99 175.309 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 2427 ' ' GLY . . . . . . . . . . . . . . . -77.76 171.74 55.15 Favored Glycine 0 CA--C 1.532 1.111 0 C-N-CA 124.904 1.24 . . . . 0.0 113.787 179.034 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 2428 ' ' ASP . . . . . . . . . . . . . 25.6 m-20 -117.68 137.1 23.94 Favored Pre-proline 0 CA--C 1.546 0.82 0 C-N-CA 125.07 1.348 . . . . 0.0 111.901 -179.595 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 2429 ' ' PRO . . . . . . . . . . . . . 81.1 Cg_exo -54.91 -26.79 50.49 Favored 'Trans proline' 0 C--N 1.353 0.792 0 C-N-CA 124.056 3.171 . . . . 0.0 115.089 174.707 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 2430 ' ' GLY . . . . . . . . . . . . . . . -78.93 -23.1 64.66 Favored Glycine 0 CA--C 1.534 1.225 0 C-N-CA 123.812 0.72 . . . . 0.0 113.786 176.174 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 2431 ' ' LEU . . . . . . . . . . . . . 4.4 mm? -91.04 -32.16 16.01 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.731 1.212 . . . . 0.0 111.89 174.458 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 2432 ' ' VAL . . . . . . . . . . . . . 94.1 t -64.84 134.32 29.5 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 CA-C-N 118.698 0.681 . . . . 0.0 109.76 170.033 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 2433 ' ' SER . . . . . . . . . . . . . 7.9 t -127.28 -167.91 1.81 Allowed 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.93 1.292 . . . . 0.0 111.163 177.545 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 2434 ' ' ALA . . . . . . . . . . . . . . . -153.25 139.37 18.32 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.538 1.135 . . . . 0.0 111.656 177.865 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 2435 ' ' TYR . . . . . . . . . . . . . 76.8 m-85 -146.54 141.9 27.48 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 125.265 1.426 . . . . 0.0 111.951 -176.875 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 2436 ' ' GLY . . . . . . . . . . . . . . . 126.0 163.05 11.46 Favored Glycine 0 CA--C 1.534 1.225 0 C-N-CA 125.704 1.621 . . . . 0.0 113.743 179.461 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 2437 ' ' ALA . . . . . . . . . . . . . . . -63.58 -28.39 69.9 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 114.706 1.373 . . . . 0.0 114.706 -168.782 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 2438 ' ' GLY . . . . . . . . . . . . . . . -64.42 -16.6 60.84 Favored Glycine 0 CA--C 1.532 1.095 0 C-N-CA 124.302 0.953 . . . . 0.0 114.502 -177.645 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 2439 ' ' LEU . . . . . . . . . . . . . 95.2 mt -68.73 -29.55 67.99 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 118.575 1.188 . . . . 0.0 112.548 170.159 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 2440 ' ' GLU . . . . . . . . . . . . . 41.7 mm-40 -90.24 -26.92 19.83 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.912 1.285 . . . . 0.0 112.33 178.765 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 2441 ' ' GLY . . . . . . . . . . . . . . . 102.86 -144.42 16.05 Favored Glycine 0 CA--C 1.531 1.087 0 C-N-CA 125.666 1.603 . . . . 0.0 112.881 -178.143 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 2442 ' ' GLY . . . . . . . . . . . . . . . 163.06 -160.26 32.79 Favored Glycine 0 CA--C 1.532 1.124 0 C-N-CA 123.836 0.731 . . . . 0.0 114.872 -176.349 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 2443 ' ' VAL . . . . . . . . . . . . . 83.2 t -83.14 141.49 14.82 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 C-N-CA 124.786 1.235 . . . . 0.0 110.96 -177.533 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 2444 ' ' THR . . . . . . . . . . . . . 18.9 p -56.1 131.41 47.52 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 124.996 1.318 . . . . 0.0 112.228 174.674 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 2445 ' ' GLY . . . . . . . . . . . . . . . 82.88 -10.93 56.05 Favored Glycine 0 CA--C 1.535 1.291 0 C-N-CA 124.993 1.282 . . . . 0.0 114.66 178.667 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 2446 ' ' ASN . . . . . . . . . . . . . 61.1 m-20 -91.99 147.93 35.85 Favored Pre-proline 0 CA--C 1.547 0.833 0 CA-C-N 118.63 1.215 . . . . 0.0 110.727 172.225 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 2447 ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -71.8 143.48 41.55 Favored 'Trans proline' 0 N--CA 1.457 -0.619 0 C-N-CA 122.817 2.345 . . . . 0.0 111.041 177.453 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 2448 ' ' ALA . . . . . . . . . . . . . . . -124.39 143.92 50.34 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 126.698 1.999 . . . . 0.0 109.126 172.495 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 2449 ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -154.41 152.43 30.17 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 113.392 0.886 . . . . 0.0 113.392 -173.462 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 2450 ' ' PHE . . . . . . . . . . . . . 14.0 p90 -161.46 167.14 26.11 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.902 1.681 . . . . 0.0 110.436 177.599 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 2451 ' ' VAL . . . . . . . . . . . . . 59.2 t -112.33 128.69 68.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 124.698 1.199 . . . . 0.0 110.209 177.537 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 2452 ' ' VAL . . . . . . . . . . . . . 48.8 t -77.53 106.11 7.35 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 162.86 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 2453 ' ' ASN . . . . . . . . . . . . . 16.3 t-20 -83.47 106.31 15.11 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 124.21 1.004 . . . . 0.0 111.732 -170.888 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 2454 ' ' THR . . . . . . . . . . . . . 40.6 p -97.7 -8.23 29.17 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 125.83 1.652 . . . . 0.0 113.514 177.954 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 2455 ' ' SER . . . . . . . . . . . . . 12.8 t -58.54 -31.69 68.18 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-N 119.364 0.983 . . . . 0.0 113.45 -176.629 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 2456 ' ' ASN . . . . . . . . . . . . . 57.8 m-80 -76.8 -14.86 59.87 Favored 'General case' 0 CA--C 1.549 0.907 0 N-CA-C 113.942 1.09 . . . . 0.0 113.942 174.861 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 2457 ' ' ALA . . . . . . . . . . . . . . . -109.0 -39.0 5.43 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 125.344 1.458 . . . . 0.0 113.98 -173.723 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 2458 ' ' GLY . . . . . . . . . . . . . . . 112.67 -148.3 18.42 Favored Glycine 0 CA--C 1.533 1.181 0 C-N-CA 125.379 1.466 . . . . 0.0 112.125 -171.432 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 2459 ' ' ALA . . . . . . . . . . . . . . . -92.36 154.7 18.39 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.21 1.004 . . . . 0.0 112.123 179.417 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 2460 ' ' GLY . . . . . . . . . . . . . . . 166.02 163.71 20.1 Favored Glycine 0 N--CA 1.47 0.924 0 C-N-CA 123.848 0.737 . . . . 0.0 114.3 177.488 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 2461 ' ' ALA . . . . . . . . . . . . . . . -80.04 137.3 36.77 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.349 1.06 . . . . 0.0 112.134 -178.559 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 2462 ' ' LEU . . . . . . . . . . . . . 25.8 tp -110.78 141.76 43.68 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.337 1.455 . . . . 0.0 110.591 176.889 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 2463 ' ' SER . . . . . . . . . . . . . 4.1 t -130.28 39.0 3.7 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 126.215 1.806 . . . . 0.0 110.653 -177.319 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 2464 ' ' VAL . . . . . . . . . . . . . 11.4 p -65.72 140.98 18.72 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 125.512 1.525 . . . . 0.0 112.058 -176.239 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 2465 ' ' THR . . . . . . . . . . . . . 8.3 t -154.45 167.19 30.88 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 125.137 1.375 . . . . 0.0 111.691 179.704 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 2466 ' ' ILE . . . . . . . . . . . . . 35.2 mt -135.02 131.01 52.56 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 C-N-CA 125.237 1.415 . . . . 0.0 109.936 -176.127 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 2467 ' ' ASP . . . . . . . . . . . . . 36.3 t70 -122.26 136.91 54.98 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 125.811 1.644 . . . . 0.0 110.735 174.963 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 2468 ' ' GLY . . . . . . . . . . . . . . . 172.94 -162.77 34.34 Favored Glycine 0 CA--C 1.537 1.444 0 CA-C-O 119.062 -0.855 . . . . 0.0 114.121 -177.624 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 2469 ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -72.81 1.2 6.68 Favored 'Trans proline' 0 CA--C 1.544 0.979 0 C-N-CA 123.999 3.133 . . . . 0.0 115.325 -172.788 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 2470 ' ' SER . . . . . . . . . . . . . 85.0 p -150.55 153.94 36.69 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 120.071 1.305 . . . . 0.0 112.989 167.791 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 2471 ' ' LYS . . . . . . . . . . . . . 99.1 mttt -75.44 74.45 2.5 Favored 'General case' 0 CA--C 1.545 0.77 0 O-C-N 120.906 -1.121 . . . . 0.0 111.073 175.624 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 2472 ' ' VAL . . . . . . . . . . . . . 18.6 m -54.76 143.14 7.57 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 C-N-CA 124.725 1.21 . . . . 0.0 113.403 -173.422 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 2473 ' ' LYS . . . . . . . . . . . . . 83.8 tttt -83.67 70.8 10.38 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 124.596 1.158 . . . . 0.0 111.129 178.471 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 2474 ' ' MET . . . . . . . . . . . . . 16.6 tmm? -79.78 129.61 34.63 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.185 0.994 . . . . 0.0 111.315 -179.764 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 2475 ' ' ASP . . . . . . . . . . . . . 35.6 t70 -123.38 126.23 46.43 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 126.209 1.804 . . . . 0.0 110.348 174.261 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 2476 ' ' CYS . . . . . . . . . . . . . 35.9 t -101.92 139.82 37.03 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.066 1.346 . . . . 0.0 111.535 179.777 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 2477 ' ' GLN . . . . . . . . . . . . . 83.5 mt-30 -141.42 145.25 35.06 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.424 1.49 . . . . 0.0 110.497 -174.092 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 2478 ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -88.11 136.81 32.8 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 123.716 0.806 . . . . 0.0 110.624 174.213 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 2479 ' ' CYS . . . . . . . . . . . . . 14.8 p -146.44 171.53 6.3 Favored Pre-proline 0 CA--C 1.554 1.11 0 C-N-CA 125.617 1.567 . . . . 0.0 111.717 177.69 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 2480 ' ' PRO . . . . . . . . . . . . . 70.5 Cg_exo -58.94 -28.31 87.2 Favored 'Trans proline' 0 CA--C 1.539 0.76 0 C-N-CA 123.468 2.779 . . . . 0.0 114.66 179.331 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 2481 ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -83.79 -14.19 52.01 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 124.62 1.168 . . . . 0.0 113.019 -179.656 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 2482 ' ' GLY . . . . . . . . . . . . . . . 136.09 -143.95 15.57 Favored Glycine 0 N--CA 1.47 0.937 0 C-N-CA 125.83 1.681 . . . . 0.0 112.677 -177.112 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 2483 ' ' TYR . . . . . . . . . . . . . 88.7 m-85 -92.8 108.82 20.28 Favored 'General case' 0 N--CA 1.469 0.506 0 O-C-N 121.678 -0.895 . . . . 0.0 110.911 173.92 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 2484 ' ' ARG . . . . . . . . . . . . . 12.7 ttp180 -74.44 140.94 45.0 Favored 'General case' 0 N--CA 1.468 0.451 0 O-C-N 121.705 -0.622 . . . . 0.0 109.859 169.217 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 2485 ' ' VAL . . . . . . . . . . . . . 22.5 m -126.18 141.69 45.01 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 C-N-CA 123.669 0.788 . . . . 0.0 110.368 165.583 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 2486 ' ' THR . . . . . . . . . . . . . 88.8 m -132.53 135.84 46.23 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 125.658 1.583 . . . . 0.0 108.443 177.582 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 2487 ' ' TYR . . . . . . . . . . . . . 23.1 p90 -149.84 159.92 43.98 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.792 1.237 . . . . 0.0 112.443 -179.747 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 2488 ' ' THR . . . . . . . . . . . . . 99.4 m -122.27 113.8 30.81 Favored Pre-proline 0 N--CA 1.476 0.871 0 C-N-CA 124.154 0.982 . . . . 0.0 109.59 174.23 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 2489 ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -83.74 134.89 6.56 Favored 'Trans proline' 0 N--CA 1.458 -0.598 0 C-N-CA 123.624 2.883 . . . . 0.0 109.957 169.653 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 2490 ' ' MET . . . . . . . . . . . . . 22.4 ptt? -101.71 -18.05 16.0 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 114.329 1.233 . . . . 0.0 114.329 179.348 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 2491 ' ' ALA . . . . . . . . . . . . . . . -112.98 146.34 34.93 Favored Pre-proline 0 CA--C 1.547 0.835 0 C-N-CA 124.68 1.192 . . . . 0.0 112.346 -175.067 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 2492 ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -72.07 156.67 55.55 Favored 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 122.99 2.46 . . . . 0.0 111.192 172.494 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 2493 ' ' GLY . . . . . . . . . . . . . . . 128.79 -147.83 17.77 Favored Glycine 0 CA--C 1.528 0.894 0 C-N-CA 125.465 1.507 . . . . 0.0 112.239 -175.794 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 2494 ' ' SER . . . . . . . . . . . . . 63.8 m -129.78 140.55 51.03 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 123.891 0.876 . . . . 0.0 111.973 177.686 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 2495 ' ' TYR . . . . . . . . . . . . . 62.3 m-85 -114.75 127.5 55.77 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 125.993 1.717 . . . . 0.0 109.797 177.245 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 2496 ' ' LEU . . . . . . . . . . . . . 9.9 mp -88.69 117.56 27.75 Favored 'General case' 0 N--CA 1.464 0.242 0 C-N-CA 123.879 0.871 . . . . 0.0 108.963 173.131 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 2497 ' ' ILE . . . . . . . . . . . . . 36.1 mt -93.45 103.95 15.22 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 C-N-CA 125.371 1.468 . . . . 0.0 107.462 176.101 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 2498 ' ' SER . . . . . . . . . . . . . 66.4 m -91.31 101.21 13.91 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 124.816 1.246 . . . . 0.0 109.524 -179.609 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 2499 ' ' ILE . . . . . . . . . . . . . 24.0 mt -97.6 92.01 2.77 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 C-N-CA 125.332 1.453 . . . . 0.0 108.828 -178.05 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 2500 ' ' LYS . . . . . . . . . . . . . 84.2 mttt -102.51 139.68 37.79 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.32 1.048 . . . . 0.0 111.739 178.93 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 2501 ' ' TYR . . . . . . . . . . . . . 72.8 t80 -145.26 147.45 32.4 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.817 1.247 . . . . 0.0 112.429 -170.823 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 2502 ' ' GLY . . . . . . . . . . . . . . . 64.83 21.28 67.31 Favored Glycine 0 CA--C 1.535 1.299 0 C-N-CA 124.17 0.89 . . . . 0.0 113.505 177.725 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 2503 ' ' GLY . . . . . . . . . . . . . . . 126.69 -163.49 20.58 Favored Glycine 0 CA--C 1.541 1.686 0 C-N-CA 125.899 1.714 . . . . 0.0 112.173 -163.119 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 2504 ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -83.23 21.49 1.02 Allowed 'Trans proline' 0 CA--C 1.545 1.048 0 C-N-CA 124.776 3.65 . . . . 0.0 113.91 -172.766 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 2505 ' ' TYR . . . . . . . . . . . . . 80.7 m-85 -105.92 130.5 53.86 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.313 1.045 . . . . 0.0 113.129 -171.759 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 2506 ' ' HIS . . . . . . . . . . . . . 86.5 m-70 -62.39 140.03 58.55 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 125.369 1.468 . . . . 0.0 113.523 179.705 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 2507 ' ' ILE . . . . . . . . . . . . . 1.8 pp -87.82 150.73 3.68 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.163 0 C-N-CA 123.954 0.902 . . . . 0.0 111.812 172.33 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 2508 ' ' GLY . . . . . . . . . . . . . . . 48.88 -116.8 3.57 Favored Glycine 0 CA--C 1.536 1.377 0 C-N-CA 124.087 0.851 . . . . 0.0 114.074 167.765 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 2509 ' ' GLY . . . . . . . . . . . . . . . -98.59 13.16 62.84 Favored Glycine 0 CA--C 1.536 1.359 0 C-N-CA 126.156 1.836 . . . . 0.0 115.047 177.811 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 2510 ' ' SER . . . . . . . . . . . . . 44.2 t -65.36 145.39 99.08 Favored Pre-proline 0 CA--C 1.553 1.059 0 CA-C-N 119.207 1.503 . . . . 0.0 112.837 -179.004 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 2511 ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -74.7 141.0 70.45 Favored 'Cis proline' 0 C--N 1.355 0.888 0 CA-C-N 119.712 0.933 . . . . 0.0 112.636 0.663 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 2512 ' ' PHE . . . . . . . . . . . . . 87.8 m-85 -94.38 125.43 39.02 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.575 1.15 . . . . 0.0 110.518 178.246 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 2513 ' ' LYS . . . . . . . . . . . . . 25.7 pttm -85.5 105.02 15.8 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 123.545 0.738 . . . . 0.0 112.165 177.798 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 2514 ' ' ALA . . . . . . . . . . . . . . . -87.94 120.0 28.84 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.239 1.416 . . . . 0.0 109.902 173.433 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 2515 ' ' LYS . . . . . . . . . . . . . 54.0 mtmt -94.41 133.35 38.09 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.383 1.073 . . . . 0.0 110.84 -176.953 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 2516 ' ' VAL . . . . . . . . . . . . . 87.9 t -131.21 136.94 56.77 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 124.415 1.086 . . . . 0.0 110.743 -170.544 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 2517 ' ' THR . . . . . . . . . . . . . 34.2 p -138.41 156.76 47.28 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 125.265 1.426 . . . . 0.0 111.795 -175.705 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 2518 ' ' GLY . . . . . . . . . . . . . . . 114.73 -176.29 16.7 Favored Glycine 0 CA--C 1.541 1.698 0 C-N-CA 125.584 1.564 . . . . 0.0 113.04 -175.21 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 2519 ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -69.8 149.68 66.97 Favored 'Trans proline' 0 CA--C 1.535 0.562 0 C-N-CA 123.756 2.97 . . . . 0.0 112.246 -174.162 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 2520 ' ' ARG . . . . . . . . . . . . . 37.3 ttm105 -79.11 -23.03 44.36 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 123.908 0.883 . . . . 0.0 113.287 178.904 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 2521 ' ' LEU . . . . . . . . . . . . . 3.6 mm? 70.24 -55.28 0.61 Allowed 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 129.374 3.069 . . . . 0.0 112.221 -175.617 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 2522 ' ' VAL . . . . . . . . . . . . . 26.9 m . . . . . 0 C--O 1.252 1.233 0 C-N-CA 125.64 1.576 . . . . 0.0 113.465 176.439 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.554 0 N-CA-C 111.431 -0.668 . . . . 0.0 111.431 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -151.74 155.59 38.57 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 125.656 1.582 . . . . 0.0 111.38 -179.875 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -88.77 -31.82 18.2 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.763 1.225 . . . . 0.0 111.778 179.647 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 2427 ' ' GLY . . . . . . . . . . . . . . . -82.08 174.43 53.68 Favored Glycine 0 CA--C 1.53 1.002 0 C-N-CA 125.024 1.297 . . . . 0.0 114.018 177.744 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 2428 ' ' ASP . . . . . . . . . . . . . 21.3 m-20 -132.89 138.71 32.51 Favored Pre-proline 0 CA--C 1.547 0.857 0 C-N-CA 125.381 1.472 . . . . 0.0 111.462 -179.58 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 2429 ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -56.79 -26.32 65.79 Favored 'Trans proline' 0 C--N 1.352 0.756 0 C-N-CA 123.854 3.036 . . . . 0.0 114.568 176.549 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 2430 ' ' GLY . . . . . . . . . . . . . . . -79.12 -23.5 63.38 Favored Glycine 0 CA--C 1.534 1.219 0 C-N-CA 123.737 0.684 . . . . 0.0 113.871 176.66 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 2431 ' ' LEU . . . . . . . . . . . . . 4.3 mm? -86.98 -39.64 15.5 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.519 1.128 . . . . 0.0 111.118 173.261 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 2432 ' ' VAL . . . . . . . . . . . . . 98.7 t -61.41 133.82 27.0 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 123.469 0.708 . . . . 0.0 109.992 172.53 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 2433 ' ' SER . . . . . . . . . . . . . 8.4 t -129.13 -170.09 2.21 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.892 1.277 . . . . 0.0 110.959 178.425 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 2434 ' ' ALA . . . . . . . . . . . . . . . -151.05 143.54 24.29 Favored 'General case' 0 CA--C 1.538 0.496 0 O-C-N 120.956 -1.09 . . . . 0.0 111.889 177.125 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 2435 ' ' TYR . . . . . . . . . . . . . 82.1 m-85 -145.89 143.64 29.7 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 125.242 1.417 . . . . 0.0 111.971 -176.142 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 2436 ' ' GLY . . . . . . . . . . . . . . . 125.71 162.7 11.38 Favored Glycine 0 N--CA 1.475 1.244 0 C-N-CA 125.607 1.575 . . . . 0.0 114.201 176.806 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 2437 ' ' ALA . . . . . . . . . . . . . . . -62.36 -27.16 68.87 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 125.244 1.418 . . . . 0.0 114.545 -170.887 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 2438 ' ' GLY . . . . . . . . . . . . . . . -61.87 -22.13 61.9 Favored Glycine 0 CA--C 1.531 1.06 0 C-N-CA 124.022 0.82 . . . . 0.0 113.903 179.326 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 2439 ' ' LEU . . . . . . . . . . . . . 85.5 mt -70.98 -22.8 62.14 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 118.547 1.173 . . . . 0.0 112.97 172.742 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 2440 ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -96.37 -26.44 15.35 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.11 1.364 . . . . 0.0 112.592 -179.796 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 2441 ' ' GLY . . . . . . . . . . . . . . . 101.8 -142.91 15.84 Favored Glycine 0 CA--C 1.532 1.127 0 C-N-CA 125.465 1.507 . . . . 0.0 112.652 -177.947 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 2442 ' ' GLY . . . . . . . . . . . . . . . 152.36 -152.58 24.26 Favored Glycine 0 CA--C 1.532 1.128 0 C-N-CA 124.205 0.907 . . . . 0.0 114.27 -177.14 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 2443 ' ' VAL . . . . . . . . . . . . . 38.4 t -88.32 141.27 14.53 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 C-N-CA 124.501 1.12 . . . . 0.0 110.333 -179.042 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 2444 ' ' THR . . . . . . . . . . . . . 33.1 p -59.07 152.69 19.49 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 124.361 1.065 . . . . 0.0 112.744 174.385 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 2445 ' ' GLY . . . . . . . . . . . . . . . 70.93 0.72 35.72 Favored Glycine 0 CA--C 1.534 1.224 0 C-N-CA 124.182 0.896 . . . . 0.0 115.133 177.887 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 2446 ' ' ASN . . . . . . . . . . . . . 14.6 m-80 -116.14 143.35 30.81 Favored Pre-proline 0 CA--C 1.546 0.803 0 C-N-CA 126.043 1.737 . . . . 0.0 110.066 177.095 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 2447 ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -72.99 141.92 33.85 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 122.805 2.337 . . . . 0.0 111.133 178.7 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 2448 ' ' ALA . . . . . . . . . . . . . . . -128.87 137.51 51.5 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.568 1.547 . . . . 0.0 109.403 169.66 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 2449 ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -131.35 151.81 51.18 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.21 1.004 . . . . 0.0 113.402 -166.6 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 2450 ' ' PHE . . . . . . . . . . . . . 27.2 p90 -158.48 163.65 36.93 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 125.915 1.686 . . . . 0.0 110.802 178.18 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 2451 ' ' VAL . . . . . . . . . . . . . 58.2 t -118.36 132.57 67.83 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 124.488 1.115 . . . . 0.0 109.717 175.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 2452 ' ' VAL . . . . . . . . . . . . . 40.3 t -79.19 106.69 10.64 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 162.716 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 2453 ' ' ASN . . . . . . . . . . . . . 15.0 t-20 -84.18 108.38 17.04 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 123.65 0.78 . . . . 0.0 111.7 -172.39 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 2454 ' ' THR . . . . . . . . . . . . . 29.9 p -97.67 -6.87 32.18 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 126.364 1.866 . . . . 0.0 113.644 -179.779 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 2455 ' ' SER . . . . . . . . . . . . . 14.9 m -58.11 -26.91 63.21 Favored 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 114.229 1.196 . . . . 0.0 114.229 -177.386 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 2456 ' ' ASN . . . . . . . . . . . . . 86.2 m-20 -75.27 -20.17 59.3 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.549 1.139 . . . . 0.0 113.355 175.524 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 2457 ' ' ALA . . . . . . . . . . . . . . . -116.62 -44.48 2.85 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.317 1.447 . . . . 0.0 113.451 -164.518 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 2458 ' ' GLY . . . . . . . . . . . . . . . 100.44 -148.11 18.24 Favored Glycine 0 CA--C 1.533 1.191 0 C-N-CA 124.98 1.276 . . . . 0.0 112.847 -175.135 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 2459 ' ' ALA . . . . . . . . . . . . . . . -73.66 139.26 45.29 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.352 1.061 . . . . 0.0 113.596 -172.553 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 2460 ' ' GLY . . . . . . . . . . . . . . . 168.67 154.79 9.14 Favored Glycine 0 CA--C 1.531 1.041 0 C-N-CA 125.327 1.441 . . . . 0.0 113.167 177.226 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 2461 ' ' ALA . . . . . . . . . . . . . . . -79.85 147.71 31.63 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 124.293 1.037 . . . . 0.0 112.567 -178.289 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 2462 ' ' LEU . . . . . . . . . . . . . 16.6 tp -108.55 143.39 37.64 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.148 1.379 . . . . 0.0 111.131 177.267 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 2463 ' ' SER . . . . . . . . . . . . . 49.4 m -135.0 38.97 2.98 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 125.699 1.6 . . . . 0.0 111.139 -176.514 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 2464 ' ' VAL . . . . . . . . . . . . . 8.5 p -66.03 138.12 23.63 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 C-N-CA 125.453 1.501 . . . . 0.0 112.43 -177.739 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 2465 ' ' THR . . . . . . . . . . . . . 93.1 m -137.87 141.69 40.7 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 125.608 1.563 . . . . 0.0 109.822 175.232 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 2466 ' ' ILE . . . . . . . . . . . . . 56.7 mt -105.61 119.89 55.54 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 123.661 0.784 . . . . 0.0 109.266 170.885 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 2467 ' ' ASP . . . . . . . . . . . . . 37.4 t70 -108.01 155.68 20.07 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 126.334 1.853 . . . . 0.0 110.603 173.5 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 2468 ' ' GLY . . . . . . . . . . . . . . . 163.56 -160.34 33.06 Favored Glycine 0 CA--C 1.535 1.327 0 CA-C-O 119.136 -0.814 . . . . 0.0 114.044 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 2469 ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -71.04 -14.62 32.16 Favored 'Trans proline' 0 CA--C 1.539 0.766 0 C-N-CA 123.788 2.992 . . . . 0.0 114.003 -177.342 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 2470 ' ' SER . . . . . . . . . . . . . 42.2 m -152.49 159.52 43.33 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 125.257 1.423 . . . . 0.0 111.959 178.573 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 2471 ' ' LYS . . . . . . . . . . . . . 68.3 mttm -76.42 98.07 4.46 Favored 'General case' 0 CA--C 1.544 0.722 0 O-C-N 120.966 -1.084 . . . . 0.0 110.482 172.574 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 2472 ' ' VAL . . . . . . . . . . . . . 16.2 m -60.77 148.38 8.98 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 C-N-CA 123.985 0.914 . . . . 0.0 111.743 179.252 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 2473 ' ' LYS . . . . . . . . . . . . . 88.6 tttt -77.1 109.85 11.28 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 171.015 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 2474 ' ' MET . . . . . . . . . . . . . 25.3 ttt -118.19 142.27 47.63 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.998 1.319 . . . . 0.0 112.434 -166.831 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 2475 ' ' ASP . . . . . . . . . . . . . 31.0 t70 -128.41 147.03 50.63 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 127.187 2.195 . . . . 0.0 110.16 169.428 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 2476 ' ' CYS . . . . . . . . . . . . . 37.8 t -138.12 140.58 39.99 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.668 1.187 . . . . 0.0 110.244 172.181 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 2477 ' ' GLN . . . . . . . . . . . . . 8.7 pt20 -156.89 163.13 39.51 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.182 1.393 . . . . 0.0 111.17 -172.893 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 2478 ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -95.13 138.5 32.76 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 123.775 0.83 . . . . 0.0 111.39 -179.365 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 2479 ' ' CYS . . . . . . . . . . . . . 14.0 p -139.18 170.9 9.01 Favored Pre-proline 0 CA--C 1.553 1.071 0 C-N-CA 125.43 1.492 . . . . 0.0 111.168 170.547 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 2480 ' ' PRO . . . . . . . . . . . . . 68.3 Cg_exo -58.43 -26.09 76.3 Favored 'Trans proline' 0 C--N 1.352 0.741 0 C-N-CA 123.508 2.805 . . . . 0.0 114.702 178.415 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 2481 ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -83.09 -11.04 58.37 Favored 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 125.01 1.324 . . . . 0.0 112.862 178.89 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 2482 ' ' GLY . . . . . . . . . . . . . . . 128.82 -155.49 20.65 Favored Glycine 0 N--CA 1.473 1.125 0 C-N-CA 125.893 1.711 . . . . 0.0 113.402 -178.276 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 2483 ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -76.06 109.29 9.59 Favored 'General case' 0 N--CA 1.47 0.575 0 O-C-N 121.621 -0.929 . . . . 0.0 110.767 175.893 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 2484 ' ' ARG . . . . . . . . . . . . . 31.5 ttm180 -85.27 131.66 34.38 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 124.892 1.277 . . . . 0.0 110.577 176.242 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 2485 ' ' VAL . . . . . . . . . . . . . 78.7 t -117.93 137.5 51.67 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 C-N-CA 126.062 1.745 . . . . 0.0 108.742 176.397 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 2486 ' ' THR . . . . . . . . . . . . . 85.0 m -131.9 139.0 48.62 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.771 1.229 . . . . 0.0 108.175 171.277 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 2487 ' ' TYR . . . . . . . . . . . . . 30.5 p90 -146.41 149.32 33.5 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 113.38 0.881 . . . . 0.0 113.38 175.61 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 2488 ' ' THR . . . . . . . . . . . . . 62.9 m -112.7 114.21 49.8 Favored Pre-proline 0 N--CA 1.472 0.639 0 C-N-CA 125.17 1.388 . . . . 0.0 108.61 172.411 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 2489 ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -81.06 134.99 9.57 Favored 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 122.851 2.367 . . . . 0.0 110.709 176.004 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 2490 ' ' MET . . . . . . . . . . . . . 17.7 ptm -91.25 -3.72 56.63 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 125.031 1.332 . . . . 0.0 114.192 -177.893 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 2491 ' ' ALA . . . . . . . . . . . . . . . -151.26 151.08 28.6 Favored Pre-proline 0 CA--C 1.546 0.826 0 C-N-CA 125.429 1.492 . . . . 0.0 112.001 -173.83 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 2492 ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -73.99 165.09 32.92 Favored 'Trans proline' 0 CA--C 1.538 0.685 0 C-N-CA 123.505 2.803 . . . . 0.0 111.727 173.447 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 2493 ' ' GLY . . . . . . . . . . . . . . . 127.09 -158.67 21.07 Favored Glycine 0 CA--C 1.53 0.994 0 C-N-CA 125.539 1.542 . . . . 0.0 112.973 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 2494 ' ' SER . . . . . . . . . . . . . 67.6 m -113.47 128.89 56.6 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.126 0.971 . . . . 0.0 111.262 179.257 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 2495 ' ' TYR . . . . . . . . . . . . . 88.9 m-85 -110.82 132.88 53.83 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.781 1.632 . . . . 0.0 110.531 177.748 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 2496 ' ' LEU . . . . . . . . . . . . . 9.5 mp -96.7 114.74 26.41 Favored 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 124.248 1.019 . . . . 0.0 108.908 173.921 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 2497 ' ' ILE . . . . . . . . . . . . . 30.6 mt -89.49 92.21 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 N-CA-C 107.306 -1.368 . . . . 0.0 107.306 174.763 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 2498 ' ' SER . . . . . . . . . . . . . 68.0 m -80.92 78.57 7.71 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 126.032 1.733 . . . . 0.0 110.305 -179.311 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 2499 ' ' ILE . . . . . . . . . . . . . 36.1 mt -75.42 107.15 5.83 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 C-N-CA 124.826 1.251 . . . . 0.0 109.204 176.1 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 2500 ' ' LYS . . . . . . . . . . . . . 42.8 mttp -113.02 148.6 34.79 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 124.775 1.23 . . . . 0.0 111.116 175.194 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 2501 ' ' TYR . . . . . . . . . . . . . 67.6 t80 -148.25 145.94 28.43 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.445 1.098 . . . . 0.0 112.281 -172.044 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 2502 ' ' GLY . . . . . . . . . . . . . . . 66.39 14.7 62.48 Favored Glycine 0 CA--C 1.535 1.33 0 C-N-CA 124.556 1.074 . . . . 0.0 114.373 175.162 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 2503 ' ' GLY . . . . . . . . . . . . . . . 138.02 -169.29 24.26 Favored Glycine 0 CA--C 1.54 1.633 0 C-N-CA 125.92 1.724 . . . . 0.0 112.537 -166.154 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 2504 ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -83.76 34.58 0.53 Allowed 'Trans proline' 0 CA--C 1.545 1.068 0 C-N-CA 124.859 3.706 . . . . 0.0 113.143 -171.588 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 2505 ' ' TYR . . . . . . . . . . . . . 92.8 m-85 -125.11 136.27 53.48 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 124.515 1.126 . . . . 0.0 113.053 -174.786 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 2506 ' ' HIS . . . . . . . . . . . . . 92.4 m-70 -63.48 146.09 54.32 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 125.405 1.482 . . . . 0.0 113.455 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 2507 ' ' ILE . . . . . . . . . . . . . 24.2 pt -75.43 173.28 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.192 0 C-N-CA 123.494 0.718 . . . . 0.0 112.684 171.485 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 2508 ' ' GLY . . . . . . . . . . . . . . . -59.29 120.73 24.02 Favored Glycine 0 CA--C 1.534 1.244 0 O-C-N 121.411 -0.806 . . . . 0.0 111.677 175.074 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 2509 ' ' GLY . . . . . . . . . . . . . . . 87.8 -5.77 84.44 Favored Glycine 0 CA--C 1.536 1.371 0 C-N-CA 125.393 1.473 . . . . 0.0 114.995 -177.25 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 2510 ' ' SER . . . . . . . . . . . . . 47.4 t -89.3 145.99 35.18 Favored Pre-proline 0 CA--C 1.551 0.992 0 CA-C-N 119.007 1.404 . . . . 0.0 112.088 -179.875 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 2511 ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -72.71 143.6 78.12 Favored 'Cis proline' 0 C--N 1.355 0.877 0 CA-C-N 120.042 1.051 . . . . 0.0 112.427 -0.319 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 2512 ' ' PHE . . . . . . . . . . . . . 83.0 m-85 -92.61 122.95 35.54 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.059 0.944 . . . . 0.0 110.718 178.202 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 2513 ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.34 105.08 13.12 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 124.023 0.929 . . . . 0.0 113.462 178.588 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 2514 ' ' ALA . . . . . . . . . . . . . . . -92.84 125.28 37.37 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.07 1.348 . . . . 0.0 110.208 173.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 2515 ' ' LYS . . . . . . . . . . . . . 54.6 mtmt -102.83 123.91 47.37 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.303 1.041 . . . . 0.0 110.637 -178.027 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 2516 ' ' VAL . . . . . . . . . . . . . 92.3 t -122.27 139.06 50.39 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 124.967 1.307 . . . . 0.0 110.523 -168.968 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 2517 ' ' THR . . . . . . . . . . . . . 38.5 p -132.64 164.66 26.21 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 125.391 1.476 . . . . 0.0 111.75 -177.794 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 2518 ' ' GLY . . . . . . . . . . . . . . . 108.96 -176.54 19.9 Favored Glycine 0 CA--C 1.54 1.601 0 C-N-CA 124.908 1.242 . . . . 0.0 113.313 -176.373 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 2519 ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -75.12 158.24 41.84 Favored 'Trans proline' 0 CA--C 1.535 0.541 0 C-N-CA 123.819 3.012 . . . . 0.0 112.127 -175.683 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 2520 ' ' ARG . . . . . . . . . . . . . 39.4 ttp180 -78.02 132.29 37.73 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 123.053 0.541 . . . . 0.0 110.058 168.547 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 2521 ' ' LEU . . . . . . . . . . . . . 10.3 mp -78.77 -33.76 46.19 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 113.382 0.882 . . . . 0.0 113.382 -174.45 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 2522 ' ' VAL . . . . . . . . . . . . . 59.2 t . . . . . 0 C--O 1.252 1.234 0 C-N-CA 125.386 1.474 . . . . 0.0 111.527 -175.287 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.517 0 N-CA-C 111.759 -0.536 . . . . 0.0 111.759 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -157.3 165.71 35.1 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 125.383 1.473 . . . . 0.0 112.186 -178.419 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 49.1 mtm -86.05 11.96 10.55 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 126.007 1.723 . . . . 0.0 113.362 178.756 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 2427 ' ' GLY . . . . . . . . . . . . . . . -165.2 178.94 40.0 Favored Glycine 0 CA--C 1.532 1.107 0 C-N-CA 127.177 2.322 . . . . 0.0 111.931 175.625 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 2428 ' ' ASP . . . . . . . . . . . . . 13.8 t70 -149.71 136.16 10.63 Favored Pre-proline 0 CA--C 1.55 0.96 0 C-N-CA 123.939 0.896 . . . . 0.0 112.182 -173.658 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 2429 ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -65.79 -20.74 58.7 Favored 'Trans proline' 0 C--N 1.353 0.795 0 C-N-CA 123.58 2.854 . . . . 0.0 114.186 -176.089 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 2430 ' ' GLY . . . . . . . . . . . . . . . -81.69 -26.25 50.89 Favored Glycine 0 CA--C 1.533 1.163 0 CA-C-N 119.261 0.937 . . . . 0.0 113.106 173.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 2431 ' ' LEU . . . . . . . . . . . . . 4.4 mm? -81.7 -34.17 30.77 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.153 0.981 . . . . 0.0 111.383 171.123 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 2432 ' ' VAL . . . . . . . . . . . . . 57.7 t -64.21 138.28 23.34 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 123.516 0.726 . . . . 0.0 110.31 168.462 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 2433 ' ' SER . . . . . . . . . . . . . 8.9 t -131.18 -167.25 1.82 Allowed 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 125.128 1.371 . . . . 0.0 109.897 172.873 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 2434 ' ' ALA . . . . . . . . . . . . . . . -151.54 145.53 25.22 Favored 'General case' 0 CA--C 1.537 0.477 0 O-C-N 120.794 -1.191 . . . . 0.0 111.643 176.012 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 2435 ' ' TYR . . . . . . . . . . . . . 86.6 m-85 -143.2 149.67 38.3 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.334 1.454 . . . . 0.0 111.892 -177.307 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 2436 ' ' GLY . . . . . . . . . . . . . . . 120.42 160.59 11.2 Favored Glycine 0 N--CA 1.473 1.133 0 C-N-CA 125.534 1.54 . . . . 0.0 113.549 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 2437 ' ' ALA . . . . . . . . . . . . . . . -60.7 -31.74 71.01 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 114.535 1.309 . . . . 0.0 114.535 -168.665 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 2438 ' ' GLY . . . . . . . . . . . . . . . -67.97 -10.43 58.89 Favored Glycine 0 CA--C 1.532 1.132 0 C-N-CA 124.129 0.871 . . . . 0.0 114.891 -176.352 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 2439 ' ' LEU . . . . . . . . . . . . . 75.6 mt -77.75 -27.14 50.31 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 118.702 1.251 . . . . 0.0 112.162 169.208 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 2440 ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -93.19 -34.82 13.44 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 125.121 1.369 . . . . 0.0 111.595 176.493 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 2441 ' ' GLY . . . . . . . . . . . . . . . 138.68 -136.67 8.17 Favored Glycine 0 CA--C 1.531 1.061 0 C-N-CA 125.097 1.332 . . . . 0.0 114.469 176.171 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 2442 ' ' GLY . . . . . . . . . . . . . . . 162.89 -145.06 10.16 Favored Glycine 0 CA--C 1.534 1.246 0 C-N-CA 126.622 2.058 . . . . 0.0 111.148 -167.509 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 2443 ' ' VAL . . . . . . . . . . . . . 8.5 p -141.56 151.99 19.33 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 C-N-CA 124.739 1.216 . . . . 0.0 110.145 176.0 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 2444 ' ' THR . . . . . . . . . . . . . 22.7 p -53.49 130.27 35.15 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.855 0.862 . . . . 0.0 111.784 178.688 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 2445 ' ' GLY . . . . . . . . . . . . . . . 86.5 -8.37 75.14 Favored Glycine 0 CA--C 1.535 1.32 0 C-N-CA 125.205 1.384 . . . . 0.0 115.363 179.127 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 2446 ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -101.69 146.33 32.04 Favored Pre-proline 0 CA--C 1.551 0.986 0 CA-C-N 119.605 1.703 . . . . 0.0 112.235 177.53 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 2447 ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -75.52 124.53 8.36 Favored 'Trans proline' 0 N--CA 1.457 -0.641 0 C-N-CA 122.727 2.285 . . . . 0.0 110.507 175.781 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 2448 ' ' ALA . . . . . . . . . . . . . . . -107.13 149.03 28.1 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.77 1.628 . . . . 0.0 109.56 168.972 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 2449 ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -153.88 158.29 40.55 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 113.886 1.069 . . . . 0.0 113.886 -174.671 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 2450 ' ' PHE . . . . . . . . . . . . . 53.0 p90 -160.34 161.11 33.1 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 126.503 1.921 . . . . 0.0 110.838 -177.321 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 2451 ' ' VAL . . . . . . . . . . . . . 58.7 t -114.51 127.56 71.94 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 C-N-CA 124.866 1.266 . . . . 0.0 109.128 174.092 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 2452 ' ' VAL . . . . . . . . . . . . . 42.7 t -79.62 106.27 10.41 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 165.417 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 2453 ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -89.82 117.35 28.59 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 123.995 0.918 . . . . 0.0 111.976 -164.379 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 2454 ' ' THR . . . . . . . . . . . . . 52.5 p -102.19 -1.56 31.08 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 125.857 1.663 . . . . 0.0 113.672 -177.159 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 2455 ' ' SER . . . . . . . . . . . . . 16.9 t -60.94 -33.52 73.29 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-N 119.296 0.953 . . . . 0.0 113.356 -172.667 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 2456 ' ' ASN . . . . . . . . . . . . . 72.6 m-80 -81.96 -13.81 56.94 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 124.196 0.999 . . . . 0.0 113.674 175.684 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 2457 ' ' ALA . . . . . . . . . . . . . . . -102.75 -45.01 5.13 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.97 1.308 . . . . 0.0 113.547 -173.059 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 2458 ' ' GLY . . . . . . . . . . . . . . . 119.96 -113.42 2.45 Favored Glycine 0 CA--C 1.529 0.961 0 C-N-CA 124.93 1.252 . . . . 0.0 111.382 -170.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 2459 ' ' ALA . . . . . . . . . . . . . . . -147.97 155.45 41.56 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.432 1.093 . . . . 0.0 112.798 -176.876 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 2460 ' ' GLY . . . . . . . . . . . . . . . 164.52 173.29 33.01 Favored Glycine 0 CA--C 1.528 0.87 0 C-N-CA 124.269 0.938 . . . . 0.0 113.774 -176.859 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 2461 ' ' ALA . . . . . . . . . . . . . . . -73.29 146.2 45.51 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.193 0.997 . . . . 0.0 112.212 178.859 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 2462 ' ' LEU . . . . . . . . . . . . . 6.0 tt -128.36 147.66 50.64 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 125.742 1.617 . . . . 0.0 110.898 178.672 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 2463 ' ' SER . . . . . . . . . . . . . 14.0 t -132.04 161.21 33.75 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.676 1.191 . . . . 0.0 110.349 161.5 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 2464 ' ' VAL . . . . . . . . . . . . . 7.4 p -161.72 136.96 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.725 0 C-N-CA 124.644 1.178 . . . . 0.0 110.773 -175.056 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 2465 ' ' THR . . . . . . . . . . . . . 63.3 m -141.58 138.49 32.68 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 125.397 1.479 . . . . 0.0 109.711 -175.821 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 2466 ' ' ILE . . . . . . . . . . . . . 37.7 mt -117.41 119.41 61.72 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 124.399 1.08 . . . . 0.0 109.527 175.669 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 2467 ' ' ASP . . . . . . . . . . . . . 34.9 t70 -104.06 161.74 13.75 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 126.164 1.785 . . . . 0.0 110.019 167.527 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 2468 ' ' GLY . . . . . . . . . . . . . . . 172.18 -166.05 38.81 Favored Glycine 0 CA--C 1.536 1.386 0 O-C-N 120.875 -1.141 . . . . 0.0 115.878 179.313 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 2469 ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -70.11 -14.64 35.2 Favored 'Trans proline' 0 CA--C 1.541 0.836 0 C-N-CA 124.544 3.496 . . . . 0.0 113.93 -178.43 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 2470 ' ' SER . . . . . . . . . . . . . 16.8 m -155.79 -177.71 6.76 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 127.306 2.243 . . . . 0.0 109.434 172.746 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 2471 ' ' LYS . . . . . . . . . . . . . 24.8 pttm -66.31 175.42 2.19 Favored 'General case' 0 CA--C 1.549 0.917 0 O-C-N 121.069 -1.019 . . . . 0.0 112.839 169.712 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 2472 ' ' VAL . . . . . . . . . . . . . 27.0 m -132.76 148.39 31.6 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 125.331 1.452 . . . . 0.0 110.138 170.429 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 2473 ' ' LYS . . . . . . . . . . . . . 63.8 tttm -76.13 131.2 39.26 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 107.78 -1.192 . . . . 0.0 107.78 152.417 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 2474 ' ' MET . . . . . . . . . . . . . 27.1 ttt -139.23 139.81 37.56 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.024 0.93 . . . . 0.0 111.489 -172.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 2475 ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -141.7 157.44 45.06 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 126.907 2.083 . . . . 0.0 110.172 -178.103 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 2476 ' ' CYS . . . . . . . . . . . . . 49.7 t -152.43 150.03 29.22 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.191 0.996 . . . . 0.0 111.842 -175.433 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 2477 ' ' GLN . . . . . . . . . . . . . 51.7 tt0 -154.37 133.91 12.77 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 125.457 1.503 . . . . 0.0 110.077 -174.655 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 2478 ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -85.12 142.87 29.2 Favored 'General case' 0 CA--C 1.542 0.66 0 O-C-N 121.641 -0.662 . . . . 0.0 111.414 171.425 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 2479 ' ' CYS . . . . . . . . . . . . . 15.4 p -151.98 173.6 4.33 Favored Pre-proline 0 CA--C 1.553 1.096 0 C-N-CA 125.695 1.598 . . . . 0.0 111.47 -177.518 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 2480 ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -58.36 -27.44 81.39 Favored 'Trans proline' 0 C--N 1.353 0.794 0 C-N-CA 123.563 2.842 . . . . 0.0 114.853 179.288 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 2481 ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -80.37 -19.58 46.04 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 124.374 1.07 . . . . 0.0 112.755 178.234 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 2482 ' ' GLY . . . . . . . . . . . . . . . 134.94 -150.66 20.21 Favored Glycine 0 CA--C 1.529 0.955 0 C-N-CA 126.033 1.778 . . . . 0.0 112.864 -176.55 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 2483 ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -90.85 109.4 20.61 Favored 'General case' 0 CA--C 1.539 0.535 0 O-C-N 121.7 -0.883 . . . . 0.0 110.759 177.308 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 2484 ' ' ARG . . . . . . . . . . . . . 38.9 ttp85 -79.47 134.48 36.53 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 124.445 1.098 . . . . 0.0 110.09 172.355 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 2485 ' ' VAL . . . . . . . . . . . . . 93.4 t -125.51 135.84 62.7 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 126.05 1.74 . . . . 0.0 108.672 178.206 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 2486 ' ' THR . . . . . . . . . . . . . 86.2 m -129.6 140.69 51.12 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 125.653 1.581 . . . . 0.0 108.788 178.171 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 2487 ' ' TYR . . . . . . . . . . . . . 19.6 p90 -150.8 153.26 35.11 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 113.526 0.935 . . . . 0.0 113.526 175.901 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 2488 ' ' THR . . . . . . . . . . . . . 98.4 m -118.62 115.51 35.4 Favored Pre-proline 0 N--CA 1.474 0.749 0 C-N-CA 124.907 1.283 . . . . 0.0 109.181 175.315 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 2489 ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -82.44 165.15 16.47 Favored 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 124.464 3.443 . . . . 0.0 111.6 175.888 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 2490 ' ' MET . . . . . . . . . . . . . 24.5 ptm -143.57 5.16 1.39 Allowed 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 115.435 1.643 . . . . 0.0 115.435 -174.367 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 2491 ' ' ALA . . . . . . . . . . . . . . . -143.46 145.98 33.95 Favored Pre-proline 0 CA--C 1.546 0.825 0 C-N-CA 124.675 1.19 . . . . 0.0 110.896 170.184 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 2492 ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -71.65 149.2 54.63 Favored 'Trans proline' 0 CA--C 1.536 0.601 0 C-N-CA 123.063 2.508 . . . . 0.0 111.158 178.189 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 2493 ' ' GLY . . . . . . . . . . . . . . . 131.81 -159.89 23.37 Favored Glycine 0 CA--C 1.53 1.004 0 C-N-CA 125.36 1.457 . . . . 0.0 113.493 -177.354 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 2494 ' ' SER . . . . . . . . . . . . . 23.6 m -98.03 118.65 35.09 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 125.117 1.367 . . . . 0.0 111.523 -177.953 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 2495 ' ' TYR . . . . . . . . . . . . . 62.3 m-85 -92.64 120.23 32.85 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 123.614 0.766 . . . . 0.0 110.068 167.041 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 2496 ' ' LEU . . . . . . . . . . . . . 22.8 tp -92.94 111.33 22.91 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.626 1.17 . . . . 0.0 109.73 -177.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 2497 ' ' ILE . . . . . . . . . . . . . 32.2 mt -101.85 103.62 15.2 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 C-N-CA 125.922 1.689 . . . . 0.0 108.602 -175.552 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 2498 ' ' SER . . . . . . . . . . . . . 68.4 m -92.0 125.63 36.77 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.274 1.029 . . . . 0.0 109.958 175.503 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 2499 ' ' ILE . . . . . . . . . . . . . 42.2 mt -128.26 123.99 61.31 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.725 0 C-N-CA 124.889 1.276 . . . . 0.0 108.645 -175.389 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 2500 ' ' LYS . . . . . . . . . . . . . 84.5 mttt -127.87 143.49 51.11 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.734 1.214 . . . . 0.0 111.774 -172.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 2501 ' ' TYR . . . . . . . . . . . . . 60.2 t80 -150.02 139.7 21.68 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 123.663 0.785 . . . . 0.0 112.681 -171.196 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 2502 ' ' GLY . . . . . . . . . . . . . . . 68.21 13.73 65.22 Favored Glycine 0 CA--C 1.537 1.419 0 C-N-CA 124.196 0.903 . . . . 0.0 114.162 179.279 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 2503 ' ' GLY . . . . . . . . . . . . . . . 146.46 -172.53 27.0 Favored Glycine 0 CA--C 1.539 1.583 0 C-N-CA 126.087 1.803 . . . . 0.0 112.822 -169.465 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 2504 ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -81.87 22.4 0.85 Allowed 'Trans proline' 0 CA--C 1.545 1.058 0 C-N-CA 124.99 3.794 . . . . 0.0 113.795 -174.52 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 2505 ' ' TYR . . . . . . . . . . . . . 72.8 m-85 -111.59 139.85 46.69 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.935 1.294 . . . . 0.0 112.803 -173.516 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 2506 ' ' HIS . . . . . . . . . . . . . 93.3 m-70 -62.19 144.15 55.84 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 124.447 1.099 . . . . 0.0 113.298 -179.787 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 2507 ' ' ILE . . . . . . . . . . . . . 26.7 pt -73.59 167.99 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 C-N-CA 123.149 0.58 . . . . 0.0 112.45 171.777 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 2508 ' ' GLY . . . . . . . . . . . . . . . -57.5 120.68 22.42 Favored Glycine 0 CA--C 1.534 1.223 0 C-N-CA 123.651 0.643 . . . . 0.0 111.982 176.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 2509 ' ' GLY . . . . . . . . . . . . . . . 88.58 -8.35 79.36 Favored Glycine 0 CA--C 1.535 1.331 0 C-N-CA 125.599 1.571 . . . . 0.0 115.145 -177.733 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 2510 ' ' SER . . . . . . . . . . . . . 8.4 t -89.33 146.3 35.78 Favored Pre-proline 0 CA--C 1.549 0.939 0 CA-C-N 119.231 1.516 . . . . 0.0 111.897 -179.595 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 2511 ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -75.74 149.78 93.15 Favored 'Cis proline' 0 C--N 1.353 0.786 0 CA-C-N 120.153 1.09 . . . . 0.0 113.424 1.168 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 2512 ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -100.8 131.84 46.49 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 125.386 1.475 . . . . 0.0 110.465 178.266 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 2513 ' ' LYS . . . . . . . . . . . . . 64.5 pttt -87.49 8.75 23.47 Favored 'General case' 0 N--CA 1.479 1.007 0 N-CA-C 116.292 1.96 . . . . 0.0 116.292 -169.084 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 2514 ' ' ALA . . . . . . . . . . . . . . . -7.09 99.45 0.01 OUTLIER 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 129.66 3.184 . . . . 0.0 116.047 -176.783 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 2515 ' ' LYS . . . . . . . . . . . . . 48.6 mtpt -94.86 135.18 36.68 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 124.031 0.932 . . . . 0.0 112.194 -171.27 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 2516 ' ' VAL . . . . . . . . . . . . . 6.0 m -131.82 153.8 39.23 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 C-N-CA 124.224 1.01 . . . . 0.0 111.82 -177.244 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 2517 ' ' THR . . . . . . . . . . . . . 64.0 p -120.64 -171.27 2.15 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.915 1.686 . . . . 0.0 110.106 177.026 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 2518 ' ' GLY . . . . . . . . . . . . . . . 99.1 177.58 31.82 Favored Glycine 0 CA--C 1.539 1.571 0 C-N-CA 124.972 1.272 . . . . 0.0 113.921 178.538 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 2519 ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -70.38 137.4 33.58 Favored 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 123.862 3.042 . . . . 0.0 112.195 -172.152 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 2520 ' ' ARG . . . . . . . . . . . . . 37.8 ttp180 -74.89 131.01 40.4 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.127 0.971 . . . . 0.0 110.922 177.085 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 2521 ' ' LEU . . . . . . . . . . . . . 4.3 mm? -83.36 -34.33 25.64 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.858 0.863 . . . . 0.0 112.764 179.849 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 2522 ' ' VAL . . . . . . . . . . . . . 35.0 m . . . . . 0 N--CA 1.484 1.24 0 C-N-CA 124.58 1.152 . . . . 0.0 113.996 -177.155 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.565 0 N-CA-C 111.727 -0.549 . . . . 0.0 111.727 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -70.13 149.68 47.32 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.271 1.029 . . . . 0.0 112.452 177.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 2.2 mpt? -74.92 146.77 41.53 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.337 1.055 . . . . 0.0 112.555 -176.864 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 2427 ' ' GLY . . . . . . . . . . . . . . . -79.0 -178.23 50.62 Favored Glycine 0 CA--C 1.533 1.206 0 C-N-CA 125.14 1.352 . . . . 0.0 113.987 176.841 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 2428 ' ' ASP . . . . . . . . . . . . . 22.8 m-20 -106.0 134.56 19.69 Favored Pre-proline 0 CA--C 1.549 0.929 0 C-N-CA 124.778 1.231 . . . . 0.0 112.834 -176.16 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 2429 ' ' PRO . . . . . . . . . . . . . 77.0 Cg_exo -56.43 -28.9 75.37 Favored 'Trans proline' 0 C--N 1.353 0.794 0 C-N-CA 124.036 3.158 . . . . 0.0 114.45 174.041 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 2430 ' ' GLY . . . . . . . . . . . . . . . -77.15 -22.77 70.26 Favored Glycine 0 CA--C 1.533 1.183 0 C-N-CA 123.751 0.691 . . . . 0.0 113.747 177.074 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 2431 ' ' LEU . . . . . . . . . . . . . 4.2 mm? -86.53 -32.28 20.81 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.453 1.101 . . . . 0.0 111.405 172.642 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 2432 ' ' VAL . . . . . . . . . . . . . 74.6 t -65.07 137.68 24.55 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 CA-C-N 118.58 0.627 . . . . 0.0 110.453 169.243 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 2433 ' ' SER . . . . . . . . . . . . . 8.4 t -130.84 -169.81 2.23 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 125.054 1.342 . . . . 0.0 110.583 174.44 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 2434 ' ' ALA . . . . . . . . . . . . . . . -149.91 141.99 23.98 Favored 'General case' 0 CA--C 1.539 0.548 0 O-C-N 120.903 -1.123 . . . . 0.0 111.473 177.222 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 2435 ' ' TYR . . . . . . . . . . . . . 75.2 m-85 -145.85 151.49 37.98 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 125.511 1.524 . . . . 0.0 111.881 -176.212 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 2436 ' ' GLY . . . . . . . . . . . . . . . 117.23 162.14 12.47 Favored Glycine 0 N--CA 1.474 1.191 0 C-N-CA 125.384 1.469 . . . . 0.0 113.903 177.508 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 2437 ' ' ALA . . . . . . . . . . . . . . . -61.18 -28.7 69.32 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.045 1.338 . . . . 0.0 114.45 -169.687 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 2438 ' ' GLY . . . . . . . . . . . . . . . -65.63 -13.95 59.59 Favored Glycine 0 CA--C 1.533 1.17 0 C-N-CA 124.234 0.921 . . . . 0.0 114.688 -178.779 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 2439 ' ' LEU . . . . . . . . . . . . . 91.8 mt -75.9 -27.68 57.79 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 118.647 1.224 . . . . 0.0 112.526 169.353 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 2440 ' ' GLU . . . . . . . . . . . . . 43.4 mm-40 -88.02 -31.2 19.44 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.862 1.265 . . . . 0.0 111.519 174.442 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 2441 ' ' GLY . . . . . . . . . . . . . . . 113.83 -146.8 18.63 Favored Glycine 0 CA--C 1.53 1.012 0 C-N-CA 126.086 1.803 . . . . 0.0 113.381 177.013 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 2442 ' ' GLY . . . . . . . . . . . . . . . 170.87 -163.31 36.38 Favored Glycine 0 CA--C 1.53 1.001 0 C-N-CA 124.234 0.921 . . . . 0.0 114.001 -174.979 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 2443 ' ' VAL . . . . . . . . . . . . . 40.3 t -91.74 146.33 6.41 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 C-N-CA 124.51 1.124 . . . . 0.0 110.245 179.896 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 2444 ' ' THR . . . . . . . . . . . . . 20.2 p -54.61 142.89 26.42 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 124.898 1.279 . . . . 0.0 112.236 172.221 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 2445 ' ' GLY . . . . . . . . . . . . . . . 72.4 1.0 50.0 Favored Glycine 0 CA--C 1.536 1.361 0 C-N-CA 124.274 0.94 . . . . 0.0 114.685 179.318 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 2446 ' ' ASN . . . . . . . . . . . . . 16.3 m-80 -118.58 149.76 46.85 Favored Pre-proline 0 CA--C 1.549 0.93 0 C-N-CA 126.123 1.769 . . . . 0.0 110.623 179.814 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 2447 ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -74.48 133.1 16.97 Favored 'Trans proline' 0 C--N 1.35 0.648 0 C-N-CA 122.908 2.405 . . . . 0.0 111.99 -174.886 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 2448 ' ' ALA . . . . . . . . . . . . . . . -105.77 119.92 40.37 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 126.41 1.884 . . . . 0.0 108.645 168.372 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 2449 ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -124.6 135.02 52.77 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.568 1.147 . . . . 0.0 111.821 -169.44 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 2450 ' ' PHE . . . . . . . . . . . . . 15.2 p90 -152.99 170.21 20.98 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.6 1.56 . . . . 0.0 111.183 175.189 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 2451 ' ' VAL . . . . . . . . . . . . . 46.6 t -125.9 132.95 70.11 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 C-N-CA 124.911 1.285 . . . . 0.0 110.106 178.641 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 2452 ' ' VAL . . . . . . . . . . . . . 51.8 t -82.88 107.56 14.78 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 165.035 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 2453 ' ' ASN . . . . . . . . . . . . . 21.1 t-20 -83.3 113.07 20.45 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 123.551 0.74 . . . . 0.0 112.153 -171.741 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 2454 ' ' THR . . . . . . . . . . . . . 30.4 p -99.59 -6.55 27.16 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 126.001 1.72 . . . . 0.0 113.79 179.138 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 2455 ' ' SER . . . . . . . . . . . . . 16.4 m -55.78 -31.41 62.59 Favored 'General case' 0 N--CA 1.478 0.949 0 N-CA-C 114.538 1.31 . . . . 0.0 114.538 -174.26 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 2456 ' ' ASN . . . . . . . . . . . . . 66.3 m-80 -84.46 -15.83 44.7 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 124.49 1.116 . . . . 0.0 113.464 177.558 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 2457 ' ' ALA . . . . . . . . . . . . . . . -106.24 -25.73 11.85 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 125.72 1.608 . . . . 0.0 113.854 -176.386 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 2458 ' ' GLY . . . . . . . . . . . . . . . 104.24 -103.71 2.32 Favored Glycine 0 CA--C 1.529 0.966 0 C-N-CA 125.398 1.475 . . . . 0.0 111.067 -174.243 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 2459 ' ' ALA . . . . . . . . . . . . . . . -151.73 163.29 39.46 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 125.355 1.462 . . . . 0.0 111.768 -179.139 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 2460 ' ' GLY . . . . . . . . . . . . . . . 163.58 171.83 30.31 Favored Glycine 0 CA--C 1.53 1.007 0 C-N-CA 124.774 1.178 . . . . 0.0 113.293 -176.469 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 2461 ' ' ALA . . . . . . . . . . . . . . . -73.08 143.92 47.24 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.104 0.961 . . . . 0.0 112.216 179.473 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 2462 ' ' LEU . . . . . . . . . . . . . 15.7 tp -129.03 139.25 52.14 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.404 1.481 . . . . 0.0 110.662 -178.528 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 2463 ' ' SER . . . . . . . . . . . . . 66.5 m -139.6 52.65 1.72 Allowed 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 125.437 1.495 . . . . 0.0 111.616 -169.906 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 2464 ' ' VAL . . . . . . . . . . . . . 17.1 t -65.84 137.04 25.67 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.069 0 C-N-CA 124.044 0.938 . . . . 0.0 111.101 -178.86 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 2465 ' ' THR . . . . . . . . . . . . . 22.7 m -123.24 141.32 52.1 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 124.933 1.293 . . . . 0.0 109.236 170.528 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 2466 ' ' ILE . . . . . . . . . . . . . 52.1 mt -116.13 114.7 46.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 C-N-CA 123.679 0.792 . . . . 0.0 108.981 171.003 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 2467 ' ' ASP . . . . . . . . . . . . . 37.1 t70 -95.29 158.69 15.35 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 125.519 1.527 . . . . 0.0 110.297 168.802 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 2468 ' ' GLY . . . . . . . . . . . . . . . 174.61 -171.3 44.45 Favored Glycine 0 CA--C 1.536 1.36 0 O-C-N 121.271 -0.893 . . . . 0.0 114.789 179.71 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 2469 ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -68.15 -25.95 36.87 Favored 'Trans proline' 0 CA--C 1.538 0.716 0 C-N-CA 123.941 3.094 . . . . 0.0 112.802 178.56 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 2470 ' ' SER . . . . . . . . . . . . . 58.5 m -142.86 174.59 10.52 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 126.058 1.743 . . . . 0.0 110.685 174.177 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 2471 ' ' LYS . . . . . . . . . . . . . 57.1 mtmt -66.71 166.59 12.74 Favored 'General case' 0 CA--C 1.548 0.887 0 O-C-N 121.13 -0.981 . . . . 0.0 112.314 170.025 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 2472 ' ' VAL . . . . . . . . . . . . . 24.7 m -131.39 147.21 32.79 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 125.231 1.412 . . . . 0.0 111.464 -178.687 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 2473 ' ' LYS . . . . . . . . . . . . . 56.8 tttp -83.2 67.64 9.28 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 124.229 1.012 . . . . 0.0 110.931 174.715 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 2474 ' ' MET . . . . . . . . . . . . . 23.3 ttt -75.45 136.33 40.69 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 125.217 1.407 . . . . 0.0 111.979 -174.599 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 2475 ' ' ASP . . . . . . . . . . . . . 36.7 t70 -141.8 129.3 21.35 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 126.429 1.892 . . . . 0.0 110.33 176.948 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 2476 ' ' CYS . . . . . . . . . . . . . 74.5 m -113.91 148.62 36.47 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.931 1.293 . . . . 0.0 111.55 -176.89 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 2477 ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -150.3 148.1 28.44 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.269 1.027 . . . . 0.0 111.013 179.485 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 2478 ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -88.94 117.84 28.24 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 123.972 0.909 . . . . 0.0 109.845 173.508 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 2479 ' ' CYS . . . . . . . . . . . . . 87.6 m -122.31 166.36 17.51 Favored Pre-proline 0 CA--C 1.552 1.037 0 C-N-CA 125.601 1.56 . . . . 0.0 111.284 179.82 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 2480 ' ' PRO . . . . . . . . . . . . . 58.0 Cg_exo -57.88 -30.3 89.14 Favored 'Trans proline' 0 C--N 1.353 0.8 0 C-N-CA 123.534 2.823 . . . . 0.0 114.216 175.394 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 2481 ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -78.44 -7.61 57.58 Favored 'General case' 0 CA--C 1.552 1.02 0 C-N-CA 125.357 1.463 . . . . 0.0 112.991 177.644 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 2482 ' ' GLY . . . . . . . . . . . . . . . 118.66 -163.23 13.16 Favored Glycine 0 CA--C 1.53 1.012 0 C-N-CA 126.313 1.911 . . . . 0.0 112.533 -173.106 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 2483 ' ' TYR . . . . . . . . . . . . . 83.4 m-85 -72.67 107.67 5.26 Favored 'General case' 0 CA--C 1.54 0.571 0 O-C-N 121.564 -0.962 . . . . 0.0 111.31 177.213 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 2484 ' ' ARG . . . . . . . . . . . . . 51.5 ttp85 -79.19 136.89 37.22 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 124.753 1.221 . . . . 0.0 110.231 174.269 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 2485 ' ' VAL . . . . . . . . . . . . . 92.5 t -128.15 125.56 64.6 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 C-N-CA 125.931 1.692 . . . . 0.0 108.48 179.001 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 2486 ' ' THR . . . . . . . . . . . . . 57.9 m -123.99 139.59 53.8 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 124.619 1.168 . . . . 0.0 108.488 172.968 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 2487 ' ' TYR . . . . . . . . . . . . . 27.3 p90 -147.06 150.51 35.21 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 112.754 0.65 . . . . 0.0 112.754 176.58 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 2488 ' ' THR . . . . . . . . . . . . . 24.7 m -109.79 115.11 55.9 Favored Pre-proline 0 N--CA 1.474 0.736 0 CA-C-O 117.764 -1.112 . . . . 0.0 109.047 174.455 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 2489 ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -81.42 149.06 16.65 Favored 'Trans proline' 0 N--CA 1.459 -0.553 0 C-N-CA 123.515 2.81 . . . . 0.0 110.731 171.237 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 2490 ' ' MET . . . . . . . . . . . . . 27.6 ptm -118.6 6.4 11.66 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 114.411 1.263 . . . . 0.0 114.411 -174.255 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 2491 ' ' ALA . . . . . . . . . . . . . . . -152.57 147.69 19.73 Favored Pre-proline 0 CA--C 1.544 0.74 0 C-N-CA 125.548 1.539 . . . . 0.0 111.41 -179.785 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 2492 ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -72.86 156.91 52.35 Favored 'Trans proline' 0 CA--C 1.536 0.606 0 C-N-CA 123.379 2.72 . . . . 0.0 111.208 174.557 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 2493 ' ' GLY . . . . . . . . . . . . . . . 134.94 -148.93 19.75 Favored Glycine 0 CA--C 1.527 0.843 0 C-N-CA 125.428 1.489 . . . . 0.0 112.061 -174.748 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 2494 ' ' SER . . . . . . . . . . . . . 36.8 m -128.6 133.85 48.43 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.694 0.798 . . . . 0.0 111.423 176.57 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 2495 ' ' TYR . . . . . . . . . . . . . 52.3 m-85 -107.18 127.13 53.23 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 126.152 1.781 . . . . 0.0 109.709 179.276 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 2496 ' ' LEU . . . . . . . . . . . . . 26.3 tp -98.75 112.69 24.69 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.411 1.085 . . . . 0.0 109.495 -176.528 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 2497 ' ' ILE . . . . . . . . . . . . . 36.9 mt -96.43 103.29 14.51 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 C-N-CA 125.331 1.452 . . . . 0.0 108.383 -176.191 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 2498 ' ' SER . . . . . . . . . . . . . 74.4 m -96.7 91.16 5.57 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 125.617 1.567 . . . . 0.0 110.247 -177.805 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 2499 ' ' ILE . . . . . . . . . . . . . 59.6 mt -87.62 104.69 14.59 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 C-N-CA 126.363 1.865 . . . . 0.0 109.591 -172.949 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 2500 ' ' LYS . . . . . . . . . . . . . 30.6 mttp -110.52 138.06 47.41 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.207 1.003 . . . . 0.0 111.589 -176.715 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 2501 ' ' TYR . . . . . . . . . . . . . 76.7 t80 -139.24 148.08 42.59 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.671 1.189 . . . . 0.0 112.452 -174.355 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 2502 ' ' GLY . . . . . . . . . . . . . . . 65.04 20.88 67.36 Favored Glycine 0 CA--C 1.536 1.358 0 C-N-CA 124.143 0.878 . . . . 0.0 113.465 -179.818 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 2503 ' ' GLY . . . . . . . . . . . . . . . 126.57 -171.31 18.28 Favored Glycine 0 CA--C 1.541 1.66 0 C-N-CA 125.967 1.746 . . . . 0.0 112.238 -163.524 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 2504 ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -84.02 43.55 1.4 Allowed 'Trans proline' 0 CA--C 1.546 1.083 0 C-N-CA 124.898 3.732 . . . . 0.0 112.618 -172.881 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 2505 ' ' TYR . . . . . . . . . . . . . 78.9 m-85 -127.15 132.01 50.63 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 124.457 1.103 . . . . 0.0 112.81 -175.073 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 2506 ' ' HIS . . . . . . . . . . . . . 79.0 m-70 -60.14 141.71 55.45 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 125.629 1.572 . . . . 0.0 114.46 -173.587 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 2507 ' ' ILE . . . . . . . . . . . . . 1.8 pp -79.26 170.59 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.2 0 C-N-CA 124.028 0.931 . . . . 0.0 112.628 171.725 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 2508 ' ' GLY . . . . . . . . . . . . . . . -60.15 112.1 4.17 Favored Glycine 0 CA--C 1.533 1.216 0 C-N-CA 123.753 0.692 . . . . 0.0 112.628 -176.846 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 2509 ' ' GLY . . . . . . . . . . . . . . . 95.72 -7.36 67.96 Favored Glycine 0 CA--C 1.536 1.347 0 C-N-CA 125.699 1.618 . . . . 0.0 114.866 -177.476 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 2510 ' ' SER . . . . . . . . . . . . . 45.4 t -79.62 146.97 66.37 Favored Pre-proline 0 CA--C 1.55 0.952 0 CA-C-N 119.16 1.48 . . . . 0.0 111.82 176.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 2511 ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -80.15 157.35 87.41 Favored 'Cis proline' 0 C--N 1.353 0.803 0 CA-C-N 119.834 0.977 . . . . 0.0 113.409 0.668 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 2512 ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -109.96 125.66 53.1 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.18 1.392 . . . . 0.0 111.199 179.75 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 2513 ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.73 101.59 13.83 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 124.449 1.1 . . . . 0.0 112.283 175.167 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 2514 ' ' ALA . . . . . . . . . . . . . . . -88.35 122.87 32.35 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 125.211 1.404 . . . . 0.0 110.28 174.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 2515 ' ' LYS . . . . . . . . . . . . . 27.7 mtpp -97.08 134.95 39.76 Favored 'General case' 0 CA--C 1.542 0.653 0 O-C-N 121.231 -0.918 . . . . 0.0 111.285 -174.857 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 2516 ' ' VAL . . . . . . . . . . . . . 74.0 t -130.39 138.95 52.57 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.775 0 C-N-CA 124.911 1.285 . . . . 0.0 110.849 -169.07 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 2517 ' ' THR . . . . . . . . . . . . . 54.2 p -134.6 171.07 14.84 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 125.869 1.667 . . . . 0.0 110.892 179.605 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 2518 ' ' GLY . . . . . . . . . . . . . . . 106.37 178.65 23.26 Favored Glycine 0 CA--C 1.539 1.568 0 C-N-CA 124.828 1.204 . . . . 0.0 113.432 -176.686 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 2519 ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -70.98 136.11 29.04 Favored 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 123.715 2.943 . . . . 0.0 112.129 -171.053 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 2520 ' ' ARG . . . . . . . . . . . . . 50.9 ttp180 -70.9 132.88 45.9 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.047 0.939 . . . . 0.0 110.778 176.053 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 2521 ' ' LEU . . . . . . . . . . . . . 4.2 mm? -78.03 -25.5 47.92 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.856 0.862 . . . . 0.0 112.466 178.282 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 2522 ' ' VAL . . . . . . . . . . . . . 38.9 t . . . . . 0 C--O 1.252 1.206 0 C-N-CA 125.985 1.714 . . . . 0.0 111.512 177.84 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.543 0 N-CA-C 111.41 -0.676 . . . . 0.0 111.41 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -72.34 154.98 40.64 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 124.203 1.001 . . . . 0.0 112.822 178.605 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 16.3 tpt -78.42 -41.99 31.4 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.328 1.051 . . . . 0.0 112.37 177.789 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 2427 ' ' GLY . . . . . . . . . . . . . . . 81.56 147.48 5.88 Favored Glycine 0 CA--C 1.532 1.152 0 C-N-CA 125.123 1.344 . . . . 0.0 112.68 -173.536 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 2428 ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -144.76 128.22 8.64 Favored Pre-proline 0 CA--C 1.546 0.802 0 C-N-CA 125.65 1.58 . . . . 0.0 109.626 178.001 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 2429 ' ' PRO . . . . . . . . . . . . . 57.3 Cg_exo -56.46 -35.0 96.13 Favored 'Trans proline' 0 C--N 1.353 0.789 0 C-N-CA 123.183 2.588 . . . . 0.0 114.493 -175.378 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 2430 ' ' GLY . . . . . . . . . . . . . . . -73.04 -18.84 79.36 Favored Glycine 0 CA--C 1.534 1.257 0 CA-C-N 118.552 0.615 . . . . 0.0 114.186 179.866 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 2431 ' ' LEU . . . . . . . . . . . . . 4.1 mm? -87.02 -20.29 27.44 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.732 1.213 . . . . 0.0 111.904 173.075 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 2432 ' ' VAL . . . . . . . . . . . . . 60.8 t -80.97 138.31 19.87 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 C-N-CA 124.571 1.148 . . . . 0.0 109.178 172.143 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 2433 ' ' SER . . . . . . . . . . . . . 8.6 t -128.11 -169.86 2.14 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 125.083 1.353 . . . . 0.0 111.001 176.337 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 2434 ' ' ALA . . . . . . . . . . . . . . . -155.45 142.77 19.41 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.692 1.197 . . . . 0.0 111.656 177.303 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 2435 ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -145.24 145.12 31.16 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 125.245 1.418 . . . . 0.0 112.071 -176.433 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 2436 ' ' GLY . . . . . . . . . . . . . . . 129.08 158.48 9.6 Favored Glycine 0 N--CA 1.472 1.077 0 C-N-CA 125.622 1.582 . . . . 0.0 113.395 178.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 2437 ' ' ALA . . . . . . . . . . . . . . . -62.11 -27.79 69.18 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 114.206 1.187 . . . . 0.0 114.206 -170.933 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 2438 ' ' GLY . . . . . . . . . . . . . . . -65.57 -16.66 63.52 Favored Glycine 0 CA--C 1.531 1.035 0 CA-C-O 118.888 -0.951 . . . . 0.0 114.31 -178.867 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 2439 ' ' LEU . . . . . . . . . . . . . 87.7 mt -73.53 -28.69 62.02 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 118.673 1.237 . . . . 0.0 112.513 171.259 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 2440 ' ' GLU . . . . . . . . . . . . . 41.5 mm-40 -92.25 -33.47 14.64 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.942 1.297 . . . . 0.0 112.167 -177.037 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 2441 ' ' GLY . . . . . . . . . . . . . . . 161.15 -156.38 27.77 Favored Glycine 0 CA--C 1.528 0.894 0 N-CA-C 114.875 0.71 . . . . 0.0 114.875 -176.825 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 2442 ' ' GLY . . . . . . . . . . . . . . . 171.26 -167.14 40.26 Favored Glycine 0 CA--C 1.53 0.992 0 C-N-CA 125.648 1.594 . . . . 0.0 112.298 -178.657 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 2443 ' ' VAL . . . . . . . . . . . . . 98.2 t -125.27 144.83 33.93 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 C-N-CA 124.692 1.197 . . . . 0.0 109.36 175.638 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 2444 ' ' THR . . . . . . . . . . . . . 21.4 p -54.7 127.5 28.48 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 124.95 1.3 . . . . 0.0 111.812 176.42 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 2445 ' ' GLY . . . . . . . . . . . . . . . 79.26 -5.36 59.91 Favored Glycine 0 CA--C 1.536 1.383 0 C-N-CA 124.622 1.106 . . . . 0.0 114.846 -178.399 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 2446 ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -97.66 139.82 21.59 Favored Pre-proline 0 CA--C 1.551 1.019 0 C-N-CA 125.617 1.567 . . . . 0.0 110.953 176.519 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 2447 ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -75.56 122.15 6.78 Favored 'Trans proline' 0 N--CA 1.457 -0.64 0 C-N-CA 122.839 2.36 . . . . 0.0 110.632 176.163 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 2448 ' ' ALA . . . . . . . . . . . . . . . -105.16 156.57 17.97 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.97 1.708 . . . . 0.0 109.883 168.262 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 2449 ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -156.96 159.11 37.75 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 114.035 1.124 . . . . 0.0 114.035 -175.181 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 2450 ' ' PHE . . . . . . . . . . . . . 54.9 p90 -159.49 148.2 17.85 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 126.173 1.789 . . . . 0.0 110.571 178.314 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 2451 ' ' VAL . . . . . . . . . . . . . 11.2 t -102.35 124.22 56.15 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 C-N-CA 124.439 1.095 . . . . 0.0 108.886 174.594 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 2452 ' ' VAL . . . . . . . . . . . . . 43.5 t -75.13 108.81 7.28 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 N-CA-C 106.838 -1.542 . . . . 0.0 106.838 167.303 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 2453 ' ' ASN . . . . . . . . . . . . . 62.7 t-20 -87.55 113.89 23.66 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.136 0.974 . . . . 0.0 110.802 -171.055 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 2454 ' ' THR . . . . . . . . . . . . . 73.1 p -104.92 2.09 29.49 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 126.079 1.752 . . . . 0.0 112.958 -175.978 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 2455 ' ' SER . . . . . . . . . . . . . 46.9 m -58.42 -30.36 66.82 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 114.518 1.303 . . . . 0.0 114.518 -169.341 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 2456 ' ' ASN . . . . . . . . . . . . . 29.3 m120 -92.89 -11.21 34.05 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 124.663 1.185 . . . . 0.0 113.683 177.251 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 2457 ' ' ALA . . . . . . . . . . . . . . . -101.74 -32.81 10.11 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 125.309 1.444 . . . . 0.0 113.502 -178.427 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 2458 ' ' GLY . . . . . . . . . . . . . . . 85.81 -159.24 32.84 Favored Glycine 0 CA--C 1.533 1.214 0 C-N-CA 124.976 1.274 . . . . 0.0 112.846 -174.77 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 2459 ' ' ALA . . . . . . . . . . . . . . . -60.84 155.48 19.46 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 124.991 1.317 . . . . 0.0 114.016 -177.423 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 2460 ' ' GLY . . . . . . . . . . . . . . . 159.09 -174.62 36.06 Favored Glycine 0 CA--C 1.534 1.228 0 C-N-CA 125.922 1.725 . . . . 0.0 112.904 -176.556 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 2461 ' ' ALA . . . . . . . . . . . . . . . -123.61 143.24 50.35 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.904 1.282 . . . . 0.0 112.198 -177.089 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 2462 ' ' LEU . . . . . . . . . . . . . 24.8 tp -92.69 145.23 24.57 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.588 1.555 . . . . 0.0 111.254 179.093 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 2463 ' ' SER . . . . . . . . . . . . . 4.3 t -138.13 40.07 2.3 Favored 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 125.667 1.587 . . . . 0.0 111.004 -179.794 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 2464 ' ' VAL . . . . . . . . . . . . . 12.6 p -65.2 147.63 12.49 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 C-N-CA 126.008 1.723 . . . . 0.0 112.638 -175.498 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 2465 ' ' THR . . . . . . . . . . . . . 10.8 t -151.9 160.92 43.37 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 125.13 1.372 . . . . 0.0 111.412 172.388 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 2466 ' ' ILE . . . . . . . . . . . . . 55.5 mt -135.11 124.63 42.97 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 124.913 1.285 . . . . 0.0 110.16 -173.853 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 2467 ' ' ASP . . . . . . . . . . . . . 29.9 m-20 -106.36 173.35 6.35 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 126.44 1.896 . . . . 0.0 110.79 169.808 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 2468 ' ' GLY . . . . . . . . . . . . . . . 153.49 -155.02 25.89 Favored Glycine 0 CA--C 1.535 1.331 0 CA-C-O 118.916 -0.935 . . . . 0.0 113.872 179.851 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 2469 ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -70.21 -10.52 28.39 Favored 'Trans proline' 0 CA--C 1.542 0.883 0 C-N-CA 123.705 2.936 . . . . 0.0 113.756 178.294 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 2470 ' ' SER . . . . . . . . . . . . . 34.0 p -166.77 169.09 13.67 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 125.488 1.515 . . . . 0.0 111.934 -176.992 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 2471 ' ' LYS . . . . . . . . . . . . . 64.5 mttp -79.73 106.54 11.82 Favored 'General case' 0 CA--C 1.542 0.669 0 O-C-N 121.017 -1.052 . . . . 0.0 110.599 172.547 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 2472 ' ' VAL . . . . . . . . . . . . . 32.9 m -60.84 151.03 6.62 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.15 0 C-N-CA 123.821 0.848 . . . . 0.0 111.838 175.755 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 2473 ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.46 132.92 35.78 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 162.394 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 2474 ' ' MET . . . . . . . . . . . . . 16.3 tmm? -152.1 143.35 23.28 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-N 119.755 1.161 . . . . 0.0 112.975 -170.815 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 2475 ' ' ASP . . . . . . . . . . . . . 36.7 t70 -139.5 146.0 39.45 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 126.947 2.099 . . . . 0.0 110.295 174.214 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 2476 ' ' CYS . . . . . . . . . . . . . 30.0 t -124.35 144.99 49.71 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.515 1.126 . . . . 0.0 111.546 -179.361 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 2477 ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -143.36 169.57 17.42 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.128 1.371 . . . . 0.0 111.87 -179.763 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 2478 ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -77.78 147.21 35.4 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 123.807 0.843 . . . . 0.0 110.711 166.512 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 2479 ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -146.25 168.81 10.77 Favored Pre-proline 0 CA--C 1.552 1.054 0 C-N-CA 127.009 2.123 . . . . 0.0 111.072 178.377 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 2480 ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo -64.56 -29.35 61.33 Favored 'Trans proline' 0 CA--C 1.539 0.765 0 C-N-CA 122.75 2.3 . . . . 0.0 114.47 -173.315 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 2481 ' ' GLU . . . . . . . . . . . . . 5.6 mp0 -88.24 -10.19 50.51 Favored 'General case' 0 CA--C 1.547 0.847 0 N-CA-C 113.765 1.024 . . . . 0.0 113.765 174.216 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 2482 ' ' GLY . . . . . . . . . . . . . . . 151.45 -111.11 0.49 Allowed Glycine 0 N--CA 1.471 1.014 0 CA-C-N 119.794 1.179 . . . . 0.0 113.494 -176.188 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 2483 ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -123.14 123.85 41.73 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.437 1.095 . . . . 0.0 111.714 179.159 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 2484 ' ' ARG . . . . . . . . . . . . . 25.5 ttp180 -91.3 129.52 37.28 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 123.369 0.667 . . . . 0.0 111.108 175.097 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 2485 ' ' VAL . . . . . . . . . . . . . 98.7 t -99.2 132.03 45.35 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.475 0 C-N-CA 125.162 1.385 . . . . 0.0 107.99 168.101 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 2486 ' ' THR . . . . . . . . . . . . . 20.5 m -124.5 126.3 45.64 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 125.415 1.486 . . . . 0.0 107.619 176.132 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 2487 ' ' TYR . . . . . . . . . . . . . 15.8 p90 -143.19 150.13 38.96 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 113.584 0.957 . . . . 0.0 113.584 -176.842 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 2488 ' ' THR . . . . . . . . . . . . . 91.2 m -119.59 115.03 34.05 Favored Pre-proline 0 N--CA 1.468 0.471 0 C-N-CA 125.342 1.457 . . . . 0.0 108.618 176.37 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 2489 ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -79.08 153.3 24.88 Favored 'Trans proline' 0 N--CA 1.456 -0.68 0 C-N-CA 123.339 2.693 . . . . 0.0 110.774 175.084 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 2490 ' ' MET . . . . . . . . . . . . . 24.8 ptm -118.09 -4.87 10.98 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 114.584 1.327 . . . . 0.0 114.584 -174.044 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 2491 ' ' ALA . . . . . . . . . . . . . . . -145.38 152.25 49.54 Favored Pre-proline 0 CA--C 1.548 0.899 0 C-N-CA 125.296 1.439 . . . . 0.0 111.601 177.859 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 2492 ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -72.83 154.85 53.83 Favored 'Trans proline' 0 CA--C 1.537 0.635 0 C-N-CA 123.001 2.467 . . . . 0.0 111.076 173.186 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 2493 ' ' GLY . . . . . . . . . . . . . . . 130.81 -168.37 21.88 Favored Glycine 0 CA--C 1.529 0.964 0 C-N-CA 125.473 1.511 . . . . 0.0 113.508 -178.163 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 2494 ' ' SER . . . . . . . . . . . . . 70.5 m -99.62 116.53 31.96 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 123.923 0.889 . . . . 0.0 111.333 178.97 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 2495 ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -87.93 150.77 23.27 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.582 1.153 . . . . 0.0 110.53 166.893 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 2496 ' ' LEU . . . . . . . . . . . . . 32.0 tp -121.99 114.73 21.37 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.803 1.241 . . . . 0.0 109.359 179.583 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 2497 ' ' ILE . . . . . . . . . . . . . 63.4 mt -99.38 108.18 22.01 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 C-N-CA 125.318 1.447 . . . . 0.0 108.415 -172.881 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 2498 ' ' SER . . . . . . . . . . . . . 73.2 m -95.47 101.44 13.16 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 124.507 1.123 . . . . 0.0 109.732 179.358 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 2499 ' ' ILE . . . . . . . . . . . . . 42.8 mt -96.38 105.98 17.79 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 C-N-CA 124.762 1.225 . . . . 0.0 108.729 -178.023 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 2500 ' ' LYS . . . . . . . . . . . . . 85.1 mttt -113.2 142.51 45.71 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.406 1.082 . . . . 0.0 110.912 177.908 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 2501 ' ' TYR . . . . . . . . . . . . . 43.8 t80 -151.2 139.95 20.79 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.881 0.873 . . . . 0.0 112.258 -174.423 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 2502 ' ' GLY . . . . . . . . . . . . . . . 69.68 12.85 67.91 Favored Glycine 0 CA--C 1.536 1.402 0 C-N-CA 124.308 0.956 . . . . 0.0 114.267 177.862 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 2503 ' ' GLY . . . . . . . . . . . . . . . 150.81 -169.96 30.61 Favored Glycine 0 CA--C 1.539 1.54 0 C-N-CA 125.844 1.687 . . . . 0.0 113.025 -170.902 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 2504 ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -82.16 14.29 2.28 Favored 'Trans proline' 0 CA--C 1.544 1.011 0 C-N-CA 124.838 3.692 . . . . 0.0 113.918 -174.837 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 2505 ' ' TYR . . . . . . . . . . . . . 68.7 m-85 -108.44 141.64 40.0 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.77 1.228 . . . . 0.0 113.491 -171.916 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 2506 ' ' HIS . . . . . . . . . . . . . 84.3 m-70 -63.24 141.4 58.78 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 125.114 1.365 . . . . 0.0 112.988 176.246 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 2507 ' ' ILE . . . . . . . . . . . . . 1.6 pp -77.88 172.04 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 C-N-CA 123.612 0.765 . . . . 0.0 112.666 174.823 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 2508 ' ' GLY . . . . . . . . . . . . . . . -59.95 111.29 3.44 Favored Glycine 0 CA--C 1.534 1.264 0 O-C-N 121.531 -0.731 . . . . 0.0 112.582 -176.954 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 2509 ' ' GLY . . . . . . . . . . . . . . . 96.6 -7.3 65.66 Favored Glycine 0 CA--C 1.536 1.348 0 C-N-CA 125.822 1.677 . . . . 0.0 114.939 -177.19 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 2510 ' ' SER . . . . . . . . . . . . . 47.8 t -82.36 147.55 56.9 Favored Pre-proline 0 CA--C 1.551 0.981 0 CA-C-N 119.098 1.449 . . . . 0.0 112.106 178.123 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 2511 ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -78.41 154.42 92.64 Favored 'Cis proline' 0 C--N 1.353 0.808 0 CA-C-N 119.788 0.96 . . . . 0.0 113.091 -1.108 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 2512 ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -105.71 127.95 53.38 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.32 1.448 . . . . 0.0 110.998 -179.628 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 2513 ' ' LYS . . . . . . . . . . . . . 61.1 pttt -87.06 115.61 24.57 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 123.719 0.808 . . . . 0.0 111.906 175.836 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 2514 ' ' ALA . . . . . . . . . . . . . . . -105.94 114.9 29.32 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.645 1.578 . . . . 0.0 110.522 -179.051 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 2515 ' ' LYS . . . . . . . . . . . . . 54.2 mtpt -94.75 112.94 24.65 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.107 0.963 . . . . 0.0 110.755 -173.282 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 2516 ' ' VAL . . . . . . . . . . . . . 75.6 t -110.67 144.21 19.11 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 125.417 1.487 . . . . 0.0 110.542 -173.22 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 2517 ' ' THR . . . . . . . . . . . . . 66.4 p -133.45 172.53 12.6 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 125.3 1.44 . . . . 0.0 111.232 176.127 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 2518 ' ' GLY . . . . . . . . . . . . . . . 107.35 177.28 22.63 Favored Glycine 0 CA--C 1.541 1.676 0 C-N-CA 125.215 1.388 . . . . 0.0 113.954 -179.733 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 2519 ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -73.74 136.63 23.51 Favored 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 123.972 3.115 . . . . 0.0 112.172 -172.283 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 2520 ' ' ARG . . . . . . . . . . . . . 34.9 ttm180 -62.64 135.4 57.36 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 123.976 0.91 . . . . 0.0 111.286 177.322 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 2521 ' ' LEU . . . . . . . . . . . . . 10.3 mp -75.53 -27.87 58.86 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.212 1.005 . . . . 0.0 113.056 -177.289 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 2522 ' ' VAL . . . . . . . . . . . . . 18.4 m . . . . . 0 C--O 1.253 1.269 0 C-N-CA 126.164 1.786 . . . . 0.0 113.498 179.845 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.575 0 N-CA-C 111.22 -0.752 . . . . 0.0 111.22 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -75.41 -15.36 60.46 Favored 'General case' 0 CA--C 1.546 0.81 0 N-CA-C 114.797 1.406 . . . . 0.0 114.797 -174.467 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 97.2 mmm -74.2 -11.78 60.39 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 114.372 1.249 . . . . 0.0 114.372 -177.069 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 2427 ' ' GLY . . . . . . . . . . . . . . . -159.92 126.68 1.67 Allowed Glycine 0 N--CA 1.468 0.821 0 C-N-CA 124.962 1.268 . . . . 0.0 112.128 176.269 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 2428 ' ' ASP . . . . . . . . . . . . . 12.9 t70 -100.67 129.9 26.62 Favored Pre-proline 0 CA--C 1.552 1.025 0 C-N-CA 124.242 1.017 . . . . 0.0 112.347 -175.572 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 2429 ' ' PRO . . . . . . . . . . . . . 53.8 Cg_exo -58.24 -27.1 79.43 Favored 'Trans proline' 0 C--N 1.354 0.829 0 C-N-CA 123.719 2.946 . . . . 0.0 114.99 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 2430 ' ' GLY . . . . . . . . . . . . . . . -80.05 -23.33 61.66 Favored Glycine 0 CA--C 1.532 1.143 0 CA-C-N 119.154 0.888 . . . . 0.0 113.322 177.674 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 2431 ' ' LEU . . . . . . . . . . . . . 4.3 mm? -82.82 -31.56 28.06 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 124.212 1.005 . . . . 0.0 111.415 170.567 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 2432 ' ' VAL . . . . . . . . . . . . . 81.3 t -69.08 136.57 26.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 123.571 0.748 . . . . 0.0 110.573 169.403 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 2433 ' ' SER . . . . . . . . . . . . . 58.6 m -139.92 144.92 37.36 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 125.174 1.39 . . . . 0.0 109.788 171.817 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 2434 ' ' ALA . . . . . . . . . . . . . . . -94.29 148.48 22.17 Favored 'General case' 0 CA--C 1.541 0.609 0 O-C-N 121.771 -0.581 . . . . 0.0 111.781 175.109 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 2435 ' ' TYR . . . . . . . . . . . . . 93.3 m-85 -142.97 147.73 35.66 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 126.136 1.775 . . . . 0.0 111.453 -178.402 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 2436 ' ' GLY . . . . . . . . . . . . . . . 120.31 161.14 11.4 Favored Glycine 0 N--CA 1.473 1.145 0 C-N-CA 125.151 1.358 . . . . 0.0 113.876 178.374 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 2437 ' ' ALA . . . . . . . . . . . . . . . -62.8 -28.88 70.3 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 114.409 1.263 . . . . 0.0 114.409 -169.682 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 2438 ' ' GLY . . . . . . . . . . . . . . . -66.99 -12.3 59.87 Favored Glycine 0 CA--C 1.532 1.108 0 CA-C-O 119.077 -0.846 . . . . 0.0 114.773 -177.425 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 2439 ' ' LEU . . . . . . . . . . . . . 79.5 mt -76.41 -27.78 56.41 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.54 1.136 . . . . 0.0 112.5 170.265 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 2440 ' ' GLU . . . . . . . . . . . . . 41.5 mm-40 -88.61 -32.51 18.05 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.893 1.277 . . . . 0.0 111.529 176.507 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 2441 ' ' GLY . . . . . . . . . . . . . . . 115.9 -130.55 9.12 Favored Glycine 0 CA--C 1.531 1.05 0 C-N-CA 125.706 1.622 . . . . 0.0 112.503 -179.754 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 2442 ' ' GLY . . . . . . . . . . . . . . . 135.11 -150.0 20.07 Favored Glycine 0 CA--C 1.535 1.311 0 C-N-CA 125.155 1.36 . . . . 0.0 113.701 -174.365 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 2443 ' ' VAL . . . . . . . . . . . . . 90.2 t -89.55 136.26 24.06 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 C-N-CA 124.804 1.242 . . . . 0.0 111.025 -174.887 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 2444 ' ' THR . . . . . . . . . . . . . 46.3 p -72.24 146.65 47.12 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 124.47 1.108 . . . . 0.0 112.049 176.818 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 2445 ' ' GLY . . . . . . . . . . . . . . . 78.28 -10.73 26.96 Favored Glycine 0 CA--C 1.538 1.5 0 C-N-CA 124.243 0.925 . . . . 0.0 114.193 -172.753 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 2446 ' ' ASN . . . . . . . . . . . . . 77.0 m-20 -102.12 152.54 38.25 Favored Pre-proline 0 CA--C 1.55 0.944 0 C-N-CA 125.469 1.507 . . . . 0.0 111.034 172.474 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 2447 ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -72.07 140.34 34.35 Favored 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 123.075 2.516 . . . . 0.0 111.55 178.25 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 2448 ' ' ALA . . . . . . . . . . . . . . . -121.3 131.14 54.03 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 127.115 2.166 . . . . 0.0 109.089 173.725 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 2449 ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -128.55 141.4 51.38 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.294 1.038 . . . . 0.0 111.806 -166.854 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 2450 ' ' PHE . . . . . . . . . . . . . 37.8 p90 -155.2 161.34 41.22 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.211 1.405 . . . . 0.0 111.998 173.164 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 2451 ' ' VAL . . . . . . . . . . . . . 8.1 p -118.44 139.05 47.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 125.616 1.566 . . . . 0.0 110.417 176.666 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 2452 ' ' VAL . . . . . . . . . . . . . 61.4 t -95.81 101.41 12.37 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 N-CA-C 107.194 -1.41 . . . . 0.0 107.194 168.555 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 2453 ' ' ASN . . . . . . . . . . . . . 22.6 t-20 -83.49 120.29 25.73 Favored 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 -169.601 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 2454 ' ' THR . . . . . . . . . . . . . 35.4 p -99.52 -5.98 28.3 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 125.878 1.671 . . . . 0.0 113.993 -177.92 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 2455 ' ' SER . . . . . . . . . . . . . 19.9 m -57.39 -32.99 67.38 Favored 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 114.556 1.317 . . . . 0.0 114.556 -172.772 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 2456 ' ' ASN . . . . . . . . . . . . . 28.0 m120 -83.4 -15.9 48.0 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 124.149 0.98 . . . . 0.0 113.601 176.228 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 2457 ' ' ALA . . . . . . . . . . . . . . . -102.49 -42.22 6.03 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.032 1.333 . . . . 0.0 113.505 -173.217 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 2458 ' ' GLY . . . . . . . . . . . . . . . 120.55 -111.4 1.94 Allowed Glycine 0 CA--C 1.53 0.995 0 C-N-CA 125.323 1.439 . . . . 0.0 111.631 -172.246 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 2459 ' ' ALA . . . . . . . . . . . . . . . -148.04 149.92 32.99 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.721 1.208 . . . . 0.0 112.835 -175.808 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 2460 ' ' GLY . . . . . . . . . . . . . . . 171.11 171.09 36.0 Favored Glycine 0 CA--C 1.529 0.906 0 C-N-CA 124.748 1.166 . . . . 0.0 113.152 -176.492 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 2461 ' ' ALA . . . . . . . . . . . . . . . -81.82 142.42 32.58 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.014 0.925 . . . . 0.0 112.454 -179.433 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 2462 ' ' LEU . . . . . . . . . . . . . 16.9 tp -102.02 145.2 29.63 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.154 1.382 . . . . 0.0 110.38 172.559 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 2463 ' ' SER . . . . . . . . . . . . . 5.4 t -138.3 45.09 2.1 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 124.972 1.309 . . . . 0.0 110.625 179.745 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 2464 ' ' VAL . . . . . . . . . . . . . 9.1 p -65.94 134.86 29.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 124.975 1.31 . . . . 0.0 111.855 -177.105 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 2465 ' ' THR . . . . . . . . . . . . . 85.5 m -130.9 144.73 51.68 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 125.992 1.717 . . . . 0.0 109.144 177.617 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 2466 ' ' ILE . . . . . . . . . . . . . 47.7 mt -123.86 120.93 61.01 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 123.617 0.767 . . . . 0.0 109.808 175.764 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 2467 ' ' ASP . . . . . . . . . . . . . 31.2 m-20 -103.06 167.57 9.74 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 125.951 1.7 . . . . 0.0 110.742 169.785 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 2468 ' ' GLY . . . . . . . . . . . . . . . 167.27 -167.06 39.65 Favored Glycine 0 CA--C 1.537 1.41 0 O-C-N 121.387 -0.821 . . . . 0.0 114.534 179.776 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 2469 ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -70.68 -15.74 33.66 Favored 'Trans proline' 0 CA--C 1.54 0.822 0 C-N-CA 124.219 3.279 . . . . 0.0 113.284 178.248 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 2470 ' ' SER . . . . . . . . . . . . . 49.9 m -153.01 179.2 8.9 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 127.081 2.152 . . . . 0.0 110.051 173.997 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 2471 ' ' LYS . . . . . . . . . . . . . 65.1 pttt -69.4 171.2 9.04 Favored 'General case' 0 CA--C 1.549 0.937 0 O-C-N 121.083 -1.011 . . . . 0.0 112.926 171.269 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 2472 ' ' VAL . . . . . . . . . . . . . 26.7 m -130.9 147.38 33.09 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 125.173 1.389 . . . . 0.0 111.032 175.206 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 2473 ' ' LYS . . . . . . . . . . . . . 51.8 mtmt -88.57 58.73 4.81 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 124.382 1.073 . . . . 0.0 111.688 177.033 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 2474 ' ' MET . . . . . . . . . . . . . 16.0 tmm? -77.53 134.84 38.2 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.31 1.044 . . . . 0.0 112.635 -174.578 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 2475 ' ' ASP . . . . . . . . . . . . . 35.5 t70 -130.56 144.63 51.54 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 126.927 2.091 . . . . 0.0 110.451 172.286 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 2476 ' ' CYS . . . . . . . . . . . . . 48.9 t -127.53 147.63 50.33 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 125.543 1.537 . . . . 0.0 112.583 -173.102 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 2477 ' ' GLN . . . . . . . . . . . . . 23.1 tt0 -151.79 136.96 17.44 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.477 1.111 . . . . 0.0 110.964 170.747 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 2478 ' ' GLU . . . . . . . . . . . . . 4.1 pm0 -75.67 132.41 40.54 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.671 1.188 . . . . 0.0 111.886 172.63 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 2479 ' ' CYS . . . . . . . . . . . . . 80.0 m -133.98 169.37 14.08 Favored Pre-proline 0 CA--C 1.554 1.105 0 C-N-CA 126.157 1.783 . . . . 0.0 110.849 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 2480 ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -57.07 -27.27 73.14 Favored 'Trans proline' 0 CA--C 1.54 0.819 0 C-N-CA 123.569 2.846 . . . . 0.0 113.912 170.073 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 2481 ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -76.46 -3.66 38.37 Favored 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 125.684 1.594 . . . . 0.0 113.093 175.057 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 2482 ' ' GLY . . . . . . . . . . . . . . . 104.39 -170.01 17.97 Favored Glycine 0 CA--C 1.529 0.96 0 C-N-CA 125.949 1.737 . . . . 0.0 112.381 -169.178 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 2483 ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -71.56 116.37 11.83 Favored 'General case' 0 N--CA 1.469 0.488 0 O-C-N 121.493 -1.004 . . . . 0.0 111.116 175.336 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 2484 ' ' ARG . . . . . . . . . . . . . 15.2 ttp-105 -98.8 143.36 29.22 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 123.793 0.837 . . . . 0.0 110.512 174.574 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 2485 ' ' VAL . . . . . . . . . . . . . 35.1 m -132.96 150.03 32.44 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 C-N-CA 124.095 0.958 . . . . 0.0 111.563 174.873 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 2486 ' ' THR . . . . . . . . . . . . . 73.0 m -133.75 135.66 44.08 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 125.332 1.453 . . . . 0.0 108.217 171.8 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 2487 ' ' TYR . . . . . . . . . . . . . 26.4 p90 -141.12 150.98 43.53 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 124.424 1.09 . . . . 0.0 112.5 179.354 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 2488 ' ' THR . . . . . . . . . . . . . 92.2 m -115.49 116.25 41.56 Favored Pre-proline 0 N--CA 1.473 0.676 0 CA-C-O 117.844 -1.074 . . . . 0.0 109.097 173.1 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 2489 ' ' PRO . . . . . . . . . . . . . 77.8 Cg_endo -82.6 135.01 7.78 Favored 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 123.755 2.97 . . . . 0.0 110.382 172.974 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 2490 ' ' MET . . . . . . . . . . . . . 24.1 ptm -98.12 3.43 49.16 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 114.918 1.451 . . . . 0.0 114.918 -172.421 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 2491 ' ' ALA . . . . . . . . . . . . . . . -153.48 148.64 20.03 Favored Pre-proline 0 CA--C 1.543 0.687 0 C-N-CA 125.146 1.378 . . . . 0.0 111.654 -177.852 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 2492 ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -73.93 153.48 47.48 Favored 'Trans proline' 0 C--N 1.35 0.631 0 C-N-CA 123.522 2.815 . . . . 0.0 111.569 178.903 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 2493 ' ' GLY . . . . . . . . . . . . . . . 136.85 -150.8 20.71 Favored Glycine 0 CA--C 1.53 1.026 0 C-N-CA 125.297 1.427 . . . . 0.0 113.166 -178.19 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 2494 ' ' SER . . . . . . . . . . . . . 45.3 m -118.31 124.01 46.76 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.625 1.17 . . . . 0.0 110.982 -178.271 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 2495 ' ' TYR . . . . . . . . . . . . . 40.7 m-85 -103.11 125.82 50.0 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 124.803 1.241 . . . . 0.0 110.164 177.477 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 2496 ' ' LEU . . . . . . . . . . . . . 20.1 tp -95.0 106.8 18.81 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.056 0.943 . . . . 0.0 109.467 -178.412 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 2497 ' ' ILE . . . . . . . . . . . . . 51.9 mt -90.89 103.07 14.06 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 C-N-CA 125.837 1.655 . . . . 0.0 107.849 -178.688 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 2498 ' ' SER . . . . . . . . . . . . . 25.5 t -94.61 91.83 6.75 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 126.042 1.737 . . . . 0.0 109.388 -178.402 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 2499 ' ' ILE . . . . . . . . . . . . . 30.1 mt -91.57 90.37 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 C-N-CA 124.521 1.128 . . . . 0.0 109.52 -174.069 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 2500 ' ' LYS . . . . . . . . . . . . . 56.4 mttp -89.99 142.84 27.31 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 123.79 0.836 . . . . 0.0 111.412 174.695 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 2501 ' ' TYR . . . . . . . . . . . . . 85.7 t80 -148.59 147.96 29.59 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 124.756 1.222 . . . . 0.0 112.226 -175.573 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 2502 ' ' GLY . . . . . . . . . . . . . . . 65.29 16.07 62.03 Favored Glycine 0 CA--C 1.535 1.319 0 C-N-CA 124.567 1.08 . . . . 0.0 114.152 175.38 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 2503 ' ' GLY . . . . . . . . . . . . . . . 134.45 -170.84 22.5 Favored Glycine 0 CA--C 1.542 1.749 0 C-N-CA 126.191 1.853 . . . . 0.0 111.904 -161.998 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 2504 ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -84.11 33.88 0.51 Allowed 'Trans proline' 0 CA--C 1.547 1.127 0 C-N-CA 124.681 3.587 . . . . 0.0 113.202 -172.806 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 2505 ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -124.51 138.51 54.33 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.483 1.113 . . . . 0.0 113.446 -172.77 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 2506 ' ' HIS . . . . . . . . . . . . . 82.6 m-70 -60.28 143.71 52.14 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 125.694 1.598 . . . . 0.0 113.799 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 2507 ' ' ILE . . . . . . . . . . . . . 31.3 pt -75.1 172.31 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 C-N-CA 123.545 0.738 . . . . 0.0 112.73 168.057 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 2508 ' ' GLY . . . . . . . . . . . . . . . -58.63 121.95 28.26 Favored Glycine 0 CA--C 1.533 1.203 0 C-N-CA 123.661 0.648 . . . . 0.0 111.723 172.978 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 2509 ' ' GLY . . . . . . . . . . . . . . . 88.82 -9.89 74.61 Favored Glycine 0 CA--C 1.536 1.348 0 C-N-CA 125.653 1.597 . . . . 0.0 115.07 -178.003 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 2510 ' ' SER . . . . . . . . . . . . . 40.3 t -83.59 146.31 49.75 Favored Pre-proline 0 CA--C 1.55 0.978 0 CA-C-N 119.193 1.496 . . . . 0.0 111.893 179.158 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 2511 ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -78.81 154.15 91.17 Favored 'Cis proline' 0 C--N 1.353 0.791 0 CA-C-N 119.751 0.947 . . . . 0.0 113.071 0.072 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 2512 ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -103.63 132.24 50.07 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.043 1.337 . . . . 0.0 110.334 177.174 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 2513 ' ' LYS . . . . . . . . . . . . . 64.6 pttt -93.81 15.88 15.48 Favored 'General case' 0 N--CA 1.479 0.982 0 N-CA-C 116.123 1.897 . . . . 0.0 116.123 -165.565 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 2514 ' ' ALA . . . . . . . . . . . . . . . -12.78 104.23 0.02 OUTLIER 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 129.239 3.016 . . . . 0.0 116.205 -174.851 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 2515 ' ' LYS . . . . . . . . . . . . . 50.2 mtmt -93.27 130.18 39.09 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 124.406 1.083 . . . . 0.0 111.015 -176.114 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 2516 ' ' VAL . . . . . . . . . . . . . 25.7 m -134.12 148.37 30.09 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 C-N-CA 124.026 0.93 . . . . 0.0 112.253 -172.042 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 2517 ' ' THR . . . . . . . . . . . . . 45.1 p -139.45 165.84 26.16 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 125.568 1.547 . . . . 0.0 111.08 -175.902 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 2518 ' ' GLY . . . . . . . . . . . . . . . 119.18 -157.67 15.25 Favored Glycine 0 CA--C 1.539 1.535 0 C-N-CA 124.971 1.272 . . . . 0.0 112.331 -173.62 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 2519 ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -71.7 160.73 47.32 Favored 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 123.486 2.791 . . . . 0.0 112.684 -175.146 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 2520 ' ' ARG . . . . . . . . . . . . . 55.1 ttt85 -101.33 117.96 36.01 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.707 1.203 . . . . 0.0 108.941 167.644 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 2521 ' ' LEU . . . . . . . . . . . . . 2.8 mm? -93.17 -7.03 46.46 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 125.264 1.426 . . . . 0.0 112.774 -176.054 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 2522 ' ' VAL . . . . . . . . . . . . . 25.5 t . . . . . 0 C--O 1.254 1.326 0 C-N-CA 126.895 2.078 . . . . 0.0 112.071 176.421 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.513 0 N-CA-C 111.488 -0.645 . . . . 0.0 111.488 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -74.78 168.87 19.02 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 124.593 1.157 . . . . 0.0 113.201 178.867 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 46.4 tpp -150.29 130.69 13.79 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 125.819 1.648 . . . . 0.0 110.079 177.25 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 2427 ' ' GLY . . . . . . . . . . . . . . . -76.55 150.97 39.03 Favored Glycine 0 CA--C 1.531 1.081 0 C-N-CA 124.383 0.992 . . . . 0.0 113.148 -178.738 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 2428 ' ' ASP . . . . . . . . . . . . . 13.3 t70 -93.01 135.97 25.23 Favored Pre-proline 0 CA--C 1.551 0.984 0 C-N-CA 124.754 1.222 . . . . 0.0 111.625 -178.195 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 2429 ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -67.93 -14.62 41.78 Favored 'Trans proline' 0 CA--C 1.539 0.77 0 C-N-CA 123.575 2.85 . . . . 0.0 114.294 -175.871 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 2430 ' ' GLY . . . . . . . . . . . . . . . -87.54 -27.03 28.38 Favored Glycine 0 CA--C 1.534 1.222 0 C-N-CA 124.392 0.996 . . . . 0.0 113.187 171.475 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 2431 ' ' LEU . . . . . . . . . . . . . 4.3 mm? -78.29 -36.45 46.62 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 118.247 1.023 . . . . 0.0 111.037 170.436 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 2432 ' ' VAL . . . . . . . . . . . . . 72.8 t -64.63 136.86 25.92 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 C-N-CA 123.356 0.662 . . . . 0.0 109.724 166.515 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 2433 ' ' SER . . . . . . . . . . . . . 8.7 t -134.1 -166.68 1.83 Allowed 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.995 1.318 . . . . 0.0 110.1 176.256 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 2434 ' ' ALA . . . . . . . . . . . . . . . -152.12 143.35 23.26 Favored 'General case' 0 CA--C 1.537 0.478 0 O-C-N 121.002 -1.061 . . . . 0.0 111.308 174.188 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 2435 ' ' TYR . . . . . . . . . . . . . 81.4 m-85 -142.38 156.29 45.21 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 125.269 1.428 . . . . 0.0 112.076 -176.712 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 2436 ' ' GLY . . . . . . . . . . . . . . . 116.55 157.27 10.93 Favored Glycine 0 N--CA 1.472 1.06 0 C-N-CA 125.705 1.621 . . . . 0.0 113.266 -179.532 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 2437 ' ' ALA . . . . . . . . . . . . . . . -60.82 -28.46 68.81 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.863 1.265 . . . . 0.0 114.222 -170.971 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 2438 ' ' GLY . . . . . . . . . . . . . . . -67.68 -9.98 57.04 Favored Glycine 0 CA--C 1.531 1.045 0 CA-C-O 118.894 -0.948 . . . . 0.0 114.957 -178.008 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 2439 ' ' LEU . . . . . . . . . . . . . 79.4 mt -83.33 -24.86 31.92 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 124.747 1.219 . . . . 0.0 112.709 170.048 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 2440 ' ' GLU . . . . . . . . . . . . . 39.5 mm-40 -91.15 -39.23 12.26 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.885 1.274 . . . . 0.0 111.382 -179.34 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 2441 ' ' GLY . . . . . . . . . . . . . . . 164.13 -158.73 31.41 Favored Glycine 0 CA--C 1.528 0.876 0 N-CA-C 115.617 1.007 . . . . 0.0 115.617 -177.834 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 2442 ' ' GLY . . . . . . . . . . . . . . . 175.74 -165.77 36.69 Favored Glycine 0 CA--C 1.531 1.047 0 C-N-CA 125.638 1.589 . . . . 0.0 112.871 179.3 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 2443 ' ' VAL . . . . . . . . . . . . . 86.6 t -129.18 146.4 34.29 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 125.414 1.486 . . . . 0.0 108.672 174.423 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 2444 ' ' THR . . . . . . . . . . . . . 41.6 p -58.34 133.81 56.04 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-O 121.427 0.632 . . . . 0.0 111.661 178.231 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 2445 ' ' GLY . . . . . . . . . . . . . . . 79.14 -6.9 55.33 Favored Glycine 0 CA--C 1.537 1.464 0 C-N-CA 124.734 1.159 . . . . 0.0 115.052 -175.633 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 2446 ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -100.97 142.26 24.27 Favored Pre-proline 0 CA--C 1.553 1.059 0 C-N-CA 125.751 1.62 . . . . 0.0 111.179 177.573 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 2447 ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -74.29 129.52 13.1 Favored 'Trans proline' 0 C--N 1.351 0.68 0 C-N-CA 122.98 2.453 . . . . 0.0 111.34 179.768 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 2448 ' ' ALA . . . . . . . . . . . . . . . -105.57 120.33 41.38 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 126.365 1.866 . . . . 0.0 109.207 172.548 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 2449 ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -119.16 138.49 52.89 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.775 1.23 . . . . 0.0 111.542 -170.925 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 2450 ' ' PHE . . . . . . . . . . . . . 37.5 p90 -153.34 165.28 36.26 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.311 1.444 . . . . 0.0 111.85 173.272 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 2451 ' ' VAL . . . . . . . . . . . . . 43.0 t -126.85 131.75 70.74 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 C-N-CA 124.897 1.279 . . . . 0.0 109.701 176.172 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 2452 ' ' VAL . . . . . . . . . . . . . 40.0 t -78.6 105.43 7.78 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 N-CA-C 107.318 -1.364 . . . . 0.0 107.318 165.577 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 2453 ' ' ASN . . . . . . . . . . . . . 14.7 t-20 -83.19 115.1 21.78 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 123.804 0.842 . . . . 0.0 112.292 -169.161 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 2454 ' ' THR . . . . . . . . . . . . . 43.9 p -103.96 -9.1 19.14 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 125.687 1.595 . . . . 0.0 113.812 -177.648 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 2455 ' ' SER . . . . . . . . . . . . . 16.3 m -57.29 -29.21 63.69 Favored 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 114.637 1.347 . . . . 0.0 114.637 -172.622 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 2456 ' ' ASN . . . . . . . . . . . . . 68.9 m-80 -85.49 -13.25 49.7 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 124.671 1.188 . . . . 0.0 113.579 177.332 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 2457 ' ' ALA . . . . . . . . . . . . . . . -112.09 -25.6 9.26 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 125.576 1.55 . . . . 0.0 114.162 -174.312 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 2458 ' ' GLY . . . . . . . . . . . . . . . 103.75 -111.89 4.02 Favored Glycine 0 CA--C 1.53 0.987 0 C-N-CA 125.095 1.331 . . . . 0.0 111.844 -177.603 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 2459 ' ' ALA . . . . . . . . . . . . . . . -137.87 160.52 39.07 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.291 1.436 . . . . 0.0 112.201 -176.817 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 2460 ' ' GLY . . . . . . . . . . . . . . . 158.19 174.24 27.64 Favored Glycine 0 CA--C 1.529 0.946 0 C-N-CA 124.427 1.013 . . . . 0.0 113.973 -172.696 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 2461 ' ' ALA . . . . . . . . . . . . . . . -83.03 148.71 27.39 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.48 1.112 . . . . 0.0 112.706 -178.16 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 2462 ' ' LEU . . . . . . . . . . . . . 59.7 tp -129.22 138.85 51.93 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 125.545 1.538 . . . . 0.0 110.588 177.16 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 2463 ' ' SER . . . . . . . . . . . . . 18.2 t -118.26 151.25 38.01 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.478 1.111 . . . . 0.0 109.604 156.559 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 2464 ' ' VAL . . . . . . . . . . . . . 7.5 p -161.77 133.16 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 124.184 0.993 . . . . 0.0 110.819 -178.054 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 2465 ' ' THR . . . . . . . . . . . . . 62.7 m -140.85 142.83 34.51 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 125.578 1.551 . . . . 0.0 109.516 -175.377 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 2466 ' ' ILE . . . . . . . . . . . . . 41.9 mt -114.96 115.94 51.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 124.433 1.093 . . . . 0.0 109.442 177.132 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 2467 ' ' ASP . . . . . . . . . . . . . 35.1 t70 -96.63 161.41 13.9 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 125.929 1.692 . . . . 0.0 110.34 168.657 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 2468 ' ' GLY . . . . . . . . . . . . . . . 166.2 -164.21 37.39 Favored Glycine 0 CA--C 1.536 1.361 0 O-C-N 121.18 -0.95 . . . . 0.0 114.973 178.521 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 2469 ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -70.07 -14.08 34.68 Favored 'Trans proline' 0 CA--C 1.541 0.852 0 C-N-CA 124.202 3.268 . . . . 0.0 114.004 -178.836 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 2470 ' ' SER . . . . . . . . . . . . . 29.1 m -156.87 174.91 14.8 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 126.769 2.027 . . . . 0.0 110.363 175.637 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 2471 ' ' LYS . . . . . . . . . . . . . 58.4 mtmt -68.14 165.82 17.41 Favored 'General case' 0 CA--C 1.549 0.912 0 O-C-N 121.117 -0.989 . . . . 0.0 111.734 166.443 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 2472 ' ' VAL . . . . . . . . . . . . . 19.1 m -135.43 152.26 31.51 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 C-N-CA 124.777 1.231 . . . . 0.0 111.421 -179.442 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 2473 ' ' LYS . . . . . . . . . . . . . 29.2 mtpp -81.18 64.29 5.86 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 124.488 1.115 . . . . 0.0 111.806 179.463 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 2474 ' ' MET . . . . . . . . . . . . . 19.0 ttt -69.43 133.53 47.87 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 125.27 1.428 . . . . 0.0 112.161 -174.518 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 2475 ' ' ASP . . . . . . . . . . . . . 35.1 t70 -139.13 122.94 17.63 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 126.361 1.865 . . . . 0.0 110.109 176.266 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 2476 ' ' CYS . . . . . . . . . . . . . 73.6 m -104.38 140.79 37.41 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.733 1.213 . . . . 0.0 111.182 -179.021 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 2477 ' ' GLN . . . . . . . . . . . . . 81.0 mt-30 -140.83 148.01 39.91 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.127 1.371 . . . . 0.0 110.283 -176.223 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 2478 ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -95.03 118.58 32.08 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 123.686 0.795 . . . . 0.0 109.839 174.74 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 2479 ' ' CYS . . . . . . . . . . . . . 88.8 m -123.21 163.24 35.06 Favored Pre-proline 0 CA--C 1.551 0.992 0 C-N-CA 125.386 1.474 . . . . 0.0 111.587 -179.3 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 2480 ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -57.8 -31.29 91.94 Favored 'Trans proline' 0 C--N 1.353 0.803 0 C-N-CA 123.624 2.883 . . . . 0.0 114.071 174.579 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 2481 ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -77.19 -11.23 59.79 Favored 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 125.329 1.452 . . . . 0.0 112.98 178.216 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 2482 ' ' GLY . . . . . . . . . . . . . . . 125.57 -162.4 19.82 Favored Glycine 0 CA--C 1.53 0.983 0 C-N-CA 126.3 1.905 . . . . 0.0 112.993 -175.688 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 2483 ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -73.27 108.52 6.2 Favored 'General case' 0 CA--C 1.54 0.576 0 O-C-N 121.574 -0.957 . . . . 0.0 111.133 178.345 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 2484 ' ' ARG . . . . . . . . . . . . . 44.5 ttm180 -81.05 140.72 34.96 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 124.756 1.222 . . . . 0.0 110.448 174.561 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 2485 ' ' VAL . . . . . . . . . . . . . 90.4 t -130.72 129.05 63.82 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 C-N-CA 125.608 1.563 . . . . 0.0 108.592 174.499 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 2486 ' ' THR . . . . . . . . . . . . . 48.7 m -122.02 140.24 52.72 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 124.41 1.084 . . . . 0.0 108.351 170.18 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 2487 ' ' TYR . . . . . . . . . . . . . 34.7 p90 -146.22 149.14 33.35 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 123.852 0.861 . . . . 0.0 112.089 176.751 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 2488 ' ' THR . . . . . . . . . . . . . 87.7 m -111.87 115.53 50.78 Favored Pre-proline 0 N--CA 1.473 0.701 0 CA-C-O 117.875 -1.06 . . . . 0.0 108.9 174.161 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 2489 ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -79.61 161.88 24.76 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 123.965 3.11 . . . . 0.0 111.107 174.08 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 2490 ' ' MET . . . . . . . . . . . . . 25.6 ptm -138.32 3.43 2.36 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 114.977 1.473 . . . . 0.0 114.977 -173.071 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 2491 ' ' ALA . . . . . . . . . . . . . . . -143.47 146.23 34.9 Favored Pre-proline 0 CA--C 1.546 0.817 0 C-N-CA 125.179 1.391 . . . . 0.0 110.741 173.058 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 2492 ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -71.92 151.03 56.1 Favored 'Trans proline' 0 CA--C 1.536 0.594 0 C-N-CA 122.852 2.368 . . . . 0.0 111.04 175.51 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 2493 ' ' GLY . . . . . . . . . . . . . . . 135.5 -162.15 24.83 Favored Glycine 0 CA--C 1.529 0.944 0 C-N-CA 125.167 1.365 . . . . 0.0 113.366 -177.159 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 2494 ' ' SER . . . . . . . . . . . . . 42.2 m -101.34 123.46 45.47 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.151 0.98 . . . . 0.0 111.186 178.69 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 2495 ' ' TYR . . . . . . . . . . . . . 79.2 m-85 -96.82 134.34 40.25 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.508 1.123 . . . . 0.0 110.084 168.299 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 2496 ' ' LEU . . . . . . . . . . . . . 23.8 tp -110.4 115.12 29.1 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.724 1.21 . . . . 0.0 109.86 -176.869 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 2497 ' ' ILE . . . . . . . . . . . . . 45.0 mt -101.72 102.84 14.08 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 C-N-CA 125.683 1.593 . . . . 0.0 108.474 -173.68 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 2498 ' ' SER . . . . . . . . . . . . . 72.3 m -90.71 90.34 7.91 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 124.457 1.103 . . . . 0.0 110.67 -177.814 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 2499 ' ' ILE . . . . . . . . . . . . . 28.3 mt -91.14 118.09 35.71 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 125.035 1.334 . . . . 0.0 109.756 -178.286 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 2500 ' ' LYS . . . . . . . . . . . . . 82.0 mttt -131.71 106.93 8.45 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 124.865 1.266 . . . . 0.0 112.375 -171.733 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 2501 ' ' TYR . . . . . . . . . . . . . 39.3 t80 -109.49 142.89 39.87 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.721 1.208 . . . . 0.0 112.713 -175.183 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 2502 ' ' GLY . . . . . . . . . . . . . . . 70.87 9.55 66.28 Favored Glycine 0 CA--C 1.535 1.307 0 C-N-CA 124.682 1.134 . . . . 0.0 114.756 175.021 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 2503 ' ' GLY . . . . . . . . . . . . . . . 153.28 -171.73 32.19 Favored Glycine 0 CA--C 1.538 1.502 0 C-N-CA 125.802 1.668 . . . . 0.0 113.129 -172.144 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 2504 ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -82.09 19.04 1.3 Allowed 'Trans proline' 0 CA--C 1.546 1.106 0 C-N-CA 124.877 3.718 . . . . 0.0 113.749 -174.977 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 2505 ' ' TYR . . . . . . . . . . . . . 80.3 m-85 -113.94 143.7 44.28 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.213 1.405 . . . . 0.0 112.751 -175.26 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 2506 ' ' HIS . . . . . . . . . . . . . 97.5 m-70 -63.99 145.14 56.4 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 124.382 1.073 . . . . 0.0 113.632 -178.45 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 2507 ' ' ILE . . . . . . . . . . . . . 29.4 pt -75.06 173.68 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.213 0 C-N-CA 123.56 0.744 . . . . 0.0 112.869 171.373 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 2508 ' ' GLY . . . . . . . . . . . . . . . -58.7 120.5 22.65 Favored Glycine 0 CA--C 1.533 1.206 0 O-C-N 121.486 -0.759 . . . . 0.0 111.704 174.379 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 2509 ' ' GLY . . . . . . . . . . . . . . . 87.0 -8.2 77.36 Favored Glycine 0 CA--C 1.537 1.414 0 C-N-CA 125.52 1.533 . . . . 0.0 115.023 -177.07 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 2510 ' ' SER . . . . . . . . . . . . . 45.8 t -87.64 147.19 40.95 Favored Pre-proline 0 CA--C 1.549 0.937 0 CA-C-N 118.927 1.364 . . . . 0.0 111.826 179.845 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 2511 ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -76.34 151.9 95.47 Favored 'Cis proline' 0 C--N 1.352 0.722 0 CA-C-N 119.711 0.933 . . . . 0.0 112.748 -1.437 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 2512 ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -99.53 132.13 45.07 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 124.705 1.202 . . . . 0.0 111.151 179.851 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 2513 ' ' LYS . . . . . . . . . . . . . 64.9 pttt -96.26 22.85 7.22 Favored 'General case' 0 CA--C 1.552 1.02 0 N-CA-C 115.991 1.849 . . . . 0.0 115.991 -164.38 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 2514 ' ' ALA . . . . . . . . . . . . . . . -28.64 114.74 0.09 Allowed 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 128.118 2.567 . . . . 0.0 115.612 -173.807 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 2515 ' ' LYS . . . . . . . . . . . . . 89.0 mttt -98.17 135.13 40.26 Favored 'General case' 0 N--CA 1.474 0.77 0 O-C-N 121.312 -0.868 . . . . 0.0 112.74 -174.519 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 2516 ' ' VAL . . . . . . . . . . . . . 75.4 t -122.51 139.28 49.88 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 C-N-CA 125.284 1.434 . . . . 0.0 110.609 -170.604 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 2517 ' ' THR . . . . . . . . . . . . . 66.1 p -120.99 178.86 4.56 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 125.783 1.633 . . . . 0.0 111.107 176.331 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 2518 ' ' GLY . . . . . . . . . . . . . . . 100.51 179.55 29.59 Favored Glycine 0 CA--C 1.539 1.585 0 C-N-CA 124.828 1.204 . . . . 0.0 113.263 -175.912 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 2519 ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -72.53 152.05 53.74 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 123.788 2.992 . . . . 0.0 111.86 -175.449 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 2520 ' ' ARG . . . . . . . . . . . . . 45.8 ttp180 -79.15 127.95 32.68 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 123.384 0.673 . . . . 0.0 110.14 172.476 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 2521 ' ' LEU . . . . . . . . . . . . . 4.0 mm? -82.85 -23.26 33.78 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.854 0.862 . . . . 0.0 112.368 178.377 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 2522 ' ' VAL . . . . . . . . . . . . . 43.2 t . . . . . 0 C--O 1.252 1.207 0 C-N-CA 125.884 1.674 . . . . 0.0 111.391 176.493 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.596 0 N-CA-C 111.629 -0.588 . . . . 0.0 111.629 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -78.61 178.68 7.63 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 124.067 0.947 . . . . 0.0 112.45 176.38 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 37.3 mmt -66.46 -16.87 64.44 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.802 0.841 . . . . 0.0 112.702 168.089 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 2427 ' ' GLY . . . . . . . . . . . . . . . -172.2 118.28 0.71 Allowed Glycine 0 CA--C 1.527 0.781 0 C-N-CA 127.116 2.293 . . . . 0.0 110.132 172.874 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 2428 ' ' ASP . . . . . . . . . . . . . 41.8 m-20 -87.24 142.49 33.54 Favored Pre-proline 0 CA--C 1.548 0.872 0 C-N-CA 123.638 0.775 . . . . 0.0 112.283 -170.995 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 2429 ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -64.66 -27.12 60.83 Favored 'Trans proline' 0 C--N 1.351 0.69 0 C-N-CA 123.207 2.605 . . . . 0.0 113.216 -176.153 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 2430 ' ' GLY . . . . . . . . . . . . . . . -73.87 -22.24 78.33 Favored Glycine 0 CA--C 1.535 1.295 0 CA-C-N 118.905 0.775 . . . . 0.0 113.652 175.347 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 2431 ' ' LEU . . . . . . . . . . . . . 4.4 mm? -88.67 -28.75 20.39 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 124.622 1.169 . . . . 0.0 111.869 173.108 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 2432 ' ' VAL . . . . . . . . . . . . . 71.1 t -68.79 136.63 25.98 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 123.756 0.823 . . . . 0.0 110.292 169.681 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 2433 ' ' SER . . . . . . . . . . . . . 74.6 m -123.61 -177.86 3.85 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 125.419 1.488 . . . . 0.0 110.261 172.862 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 2434 ' ' ALA . . . . . . . . . . . . . . . -143.77 146.17 32.92 Favored 'General case' 0 CA--C 1.538 0.501 0 O-C-N 120.701 -1.25 . . . . 0.0 111.499 170.541 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 2435 ' ' TYR . . . . . . . . . . . . . 76.2 m-85 -145.06 152.22 39.77 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.441 1.497 . . . . 0.0 111.992 -174.994 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 2436 ' ' GLY . . . . . . . . . . . . . . . 121.74 158.66 10.41 Favored Glycine 0 N--CA 1.473 1.114 0 C-N-CA 125.492 1.52 . . . . 0.0 113.404 179.184 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 2437 ' ' ALA . . . . . . . . . . . . . . . -61.32 -27.06 68.22 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.79 1.236 . . . . 0.0 114.245 -171.398 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 2438 ' ' GLY . . . . . . . . . . . . . . . -66.79 -14.17 62.55 Favored Glycine 0 CA--C 1.53 0.982 0 CA-C-O 119.067 -0.851 . . . . 0.0 114.492 -179.183 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 2439 ' ' LEU . . . . . . . . . . . . . 67.6 mt -78.82 -23.19 45.24 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 118.442 1.121 . . . . 0.0 112.449 170.943 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 2440 ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -92.41 -29.28 16.37 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.168 1.387 . . . . 0.0 111.83 176.117 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 2441 ' ' GLY . . . . . . . . . . . . . . . 108.31 -134.66 12.35 Favored Glycine 0 CA--C 1.532 1.114 0 C-N-CA 125.829 1.68 . . . . 0.0 112.525 178.433 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 2442 ' ' GLY . . . . . . . . . . . . . . . 136.78 -153.9 21.92 Favored Glycine 0 CA--C 1.534 1.265 0 C-N-CA 124.884 1.231 . . . . 0.0 114.494 -176.951 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 2443 ' ' VAL . . . . . . . . . . . . . 87.5 t -79.84 134.65 27.12 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 C-N-CA 124.622 1.169 . . . . 0.0 111.029 -174.83 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 2444 ' ' THR . . . . . . . . . . . . . 39.1 p -68.92 144.06 54.29 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.251 1.021 . . . . 0.0 112.021 176.276 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 2445 ' ' GLY . . . . . . . . . . . . . . . 83.38 -22.28 7.57 Favored Glycine 0 CA--C 1.536 1.359 0 C-N-CA 125.416 1.484 . . . . 0.0 113.903 -174.541 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 2446 ' ' ASN . . . . . . . . . . . . . 80.4 m-20 -87.19 152.96 53.69 Favored Pre-proline 0 CA--C 1.547 0.864 0 C-N-CA 124.749 1.22 . . . . 0.0 110.816 170.851 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 2447 ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -72.04 144.06 41.78 Favored 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 122.942 2.428 . . . . 0.0 111.658 179.387 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 2448 ' ' ALA . . . . . . . . . . . . . . . -119.04 137.98 53.17 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 127.309 2.244 . . . . 0.0 108.847 172.634 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 2449 ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -146.21 138.16 25.01 Favored 'General case' 0 N--CA 1.471 0.589 0 O-C-N 121.517 -0.74 . . . . 0.0 112.585 -163.041 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 2450 ' ' PHE . . . . . . . . . . . . . 50.6 p90 -154.22 159.73 41.49 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 125.52 1.528 . . . . 0.0 112.383 -179.109 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 2451 ' ' VAL . . . . . . . . . . . . . 88.3 t -112.65 132.73 60.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 125.552 1.541 . . . . 0.0 109.349 173.049 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 2452 ' ' VAL . . . . . . . . . . . . . 33.3 t -84.86 103.68 12.27 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 164.638 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 2453 ' ' ASN . . . . . . . . . . . . . 15.5 t-20 -87.06 116.89 25.42 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.2 1.0 . . . . 0.0 112.314 -168.568 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 2454 ' ' THR . . . . . . . . . . . . . 43.3 p -103.2 -4.44 24.37 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 126.214 1.806 . . . . 0.0 114.241 -173.09 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 2455 ' ' SER . . . . . . . . . . . . . 19.6 m -56.0 -34.55 65.9 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 114.961 1.467 . . . . 0.0 114.961 -170.296 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 2456 ' ' ASN . . . . . . . . . . . . . 29.8 m120 -86.94 -10.93 52.08 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 124.329 1.051 . . . . 0.0 113.495 178.061 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 2457 ' ' ALA . . . . . . . . . . . . . . . -103.32 -53.96 2.7 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.206 1.402 . . . . 0.0 112.85 -174.763 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 2458 ' ' GLY . . . . . . . . . . . . . . . 125.63 -121.04 4.05 Favored Glycine 0 CA--C 1.531 1.064 0 C-N-CA 124.967 1.27 . . . . 0.0 112.658 -172.887 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 2459 ' ' ALA . . . . . . . . . . . . . . . -126.65 166.25 17.69 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 125.679 1.592 . . . . 0.0 112.781 -173.326 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 2460 ' ' GLY . . . . . . . . . . . . . . . 146.77 173.06 17.67 Favored Glycine 0 CA--C 1.531 1.047 0 C-N-CA 124.394 0.997 . . . . 0.0 114.054 -177.92 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 2461 ' ' ALA . . . . . . . . . . . . . . . -82.37 150.92 26.89 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.512 1.125 . . . . 0.0 112.811 -178.908 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 2462 ' ' LEU . . . . . . . . . . . . . 23.4 tp -109.42 148.27 31.41 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 126.272 1.829 . . . . 0.0 110.678 177.301 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 2463 ' ' SER . . . . . . . . . . . . . 8.4 t -150.03 68.7 1.0 Allowed 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 124.128 0.971 . . . . 0.0 111.449 177.5 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 2464 ' ' VAL . . . . . . . . . . . . . 42.2 t -74.3 139.62 18.96 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.24 0 O-C-N 120.692 -1.255 . . . . 0.0 110.764 178.925 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 2465 ' ' THR . . . . . . . . . . . . . 16.4 m -125.41 141.34 52.11 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 125.043 1.337 . . . . 0.0 108.929 169.888 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 2466 ' ' ILE . . . . . . . . . . . . . 26.5 mt -122.14 126.36 74.25 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 123.425 0.69 . . . . 0.0 109.921 171.677 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 2467 ' ' ASP . . . . . . . . . . . . . 35.8 t70 -110.95 148.53 32.29 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 126.044 1.738 . . . . 0.0 110.192 170.176 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 2468 ' ' GLY . . . . . . . . . . . . . . . 170.51 -164.81 38.07 Favored Glycine 0 CA--C 1.536 1.395 0 N-CA-C 114.996 0.758 . . . . 0.0 114.996 -178.99 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 2469 ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -68.34 -25.02 36.53 Favored 'Trans proline' 0 CA--C 1.54 0.79 0 C-N-CA 124.002 3.135 . . . . 0.0 114.752 -171.712 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 2470 ' ' SER . . . . . . . . . . . . . 17.3 m -159.53 142.54 14.15 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 125.82 1.648 . . . . 0.0 110.566 174.693 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 2471 ' ' LYS . . . . . . . . . . . . . 55.3 mtmt -61.57 122.06 14.31 Favored 'General case' 0 N--CA 1.476 0.862 0 O-C-N 121.074 -1.016 . . . . 0.0 112.9 -172.818 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 2472 ' ' VAL . . . . . . . . . . . . . 21.0 m -77.21 151.6 5.66 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 C-N-CA 124.441 1.096 . . . . 0.0 112.512 -175.598 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 2473 ' ' LYS . . . . . . . . . . . . . 38.3 mtmm -78.63 145.62 34.57 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 123.234 0.614 . . . . 0.0 109.867 160.315 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 2474 ' ' MET . . . . . . . . . . . . . 56.5 ttm -147.94 144.29 27.92 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 124.273 1.029 . . . . 0.0 112.518 -174.804 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 2475 ' ' ASP . . . . . . . . . . . . . 21.5 m-20 -125.81 149.93 48.22 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 126.843 2.057 . . . . 0.0 109.996 162.857 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 2476 ' ' CYS . . . . . . . . . . . . . 44.7 t -142.98 142.17 31.56 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.89 1.276 . . . . 0.0 110.757 179.075 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 2477 ' ' GLN . . . . . . . . . . . . . 6.0 tp-100 -155.9 146.82 22.21 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.309 1.044 . . . . 0.0 111.017 -175.704 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 2478 ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -78.53 128.63 33.82 Favored 'General case' 0 CA--C 1.541 0.628 0 O-C-N 121.62 -0.675 . . . . 0.0 111.455 174.637 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 2479 ' ' CYS . . . . . . . . . . . . . 95.3 m -124.5 167.09 16.68 Favored Pre-proline 0 CA--C 1.552 1.046 0 C-N-CA 126.152 1.781 . . . . 0.0 110.644 177.148 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 2480 ' ' PRO . . . . . . . . . . . . . 64.3 Cg_exo -57.46 -29.92 86.33 Favored 'Trans proline' 0 C--N 1.353 0.793 0 C-N-CA 123.53 2.82 . . . . 0.0 114.374 175.905 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 2481 ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -80.53 -6.93 58.94 Favored 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 125.356 1.462 . . . . 0.0 113.099 177.971 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 2482 ' ' GLY . . . . . . . . . . . . . . . 119.39 -169.39 13.68 Favored Glycine 0 CA--C 1.532 1.095 0 C-N-CA 126.326 1.917 . . . . 0.0 112.408 -172.016 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 2483 ' ' TYR . . . . . . . . . . . . . 63.0 m-85 -69.4 118.69 12.6 Favored 'General case' 0 N--CA 1.47 0.565 0 O-C-N 121.206 -1.173 . . . . 0.0 111.69 177.279 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 2484 ' ' ARG . . . . . . . . . . . . . 58.8 ttt180 -96.19 132.07 42.0 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 125.414 1.486 . . . . 0.0 110.273 178.536 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 2485 ' ' VAL . . . . . . . . . . . . . 67.0 t -123.11 131.98 72.24 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 C-N-CA 125.825 1.65 . . . . 0.0 109.065 -177.372 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 2486 ' ' THR . . . . . . . . . . . . . 50.3 m -124.54 132.96 53.44 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 124.845 1.258 . . . . 0.0 108.126 172.217 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 2487 ' ' TYR . . . . . . . . . . . . . 22.0 p90 -140.45 157.85 44.89 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.194 0.998 . . . . 0.0 112.392 179.162 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 2488 ' ' THR . . . . . . . . . . . . . 91.8 m -113.87 105.2 54.75 Favored Pre-proline 0 N--CA 1.476 0.852 0 CA-C-O 118.107 -0.949 . . . . 0.0 109.818 179.121 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 2489 ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -69.44 128.87 16.96 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 123.022 2.481 . . . . 0.0 109.437 170.344 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 2490 ' ' MET . . . . . . . . . . . . . 27.9 ptm -114.35 -1.47 13.52 Favored 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 114.777 1.399 . . . . 0.0 114.777 -171.33 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 2491 ' ' ALA . . . . . . . . . . . . . . . -147.4 144.82 20.05 Favored Pre-proline 0 CA--C 1.546 0.806 0 C-N-CA 124.902 1.281 . . . . 0.0 110.982 -179.852 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 2492 ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -72.6 151.43 52.56 Favored 'Trans proline' 0 C--N 1.351 0.688 0 C-N-CA 123.414 2.743 . . . . 0.0 111.392 -176.998 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 2493 ' ' GLY . . . . . . . . . . . . . . . 133.0 -142.49 14.01 Favored Glycine 0 CA--C 1.529 0.909 0 C-N-CA 124.875 1.226 . . . . 0.0 112.507 -175.386 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 2494 ' ' SER . . . . . . . . . . . . . 39.6 m -123.96 128.5 49.5 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.349 1.059 . . . . 0.0 111.292 -179.576 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 2495 ' ' TYR . . . . . . . . . . . . . 41.7 m-85 -101.04 119.16 38.33 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.775 1.23 . . . . 0.0 110.578 171.602 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 2496 ' ' LEU . . . . . . . . . . . . . 25.3 tp -91.97 110.2 21.55 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.543 1.137 . . . . 0.0 109.512 179.084 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 2497 ' ' ILE . . . . . . . . . . . . . 21.9 mt -97.75 98.99 7.99 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 C-N-CA 125.863 1.665 . . . . 0.0 108.768 -176.299 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 2498 ' ' SER . . . . . . . . . . . . . 69.4 m -86.56 81.92 8.1 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 125.482 1.513 . . . . 0.0 110.133 177.831 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 2499 ' ' ILE . . . . . . . . . . . . . 51.9 mt -76.62 117.71 21.85 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 C-N-CA 124.99 1.316 . . . . 0.0 109.407 177.41 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 2500 ' ' LYS . . . . . . . . . . . . . 2.2 mtmp? -129.01 143.19 50.79 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 125.122 1.369 . . . . 0.0 110.712 -178.627 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 2501 ' ' TYR . . . . . . . . . . . . . 49.5 t80 -152.37 144.46 23.83 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 124.496 1.118 . . . . 0.0 112.321 -171.873 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 2502 ' ' GLY . . . . . . . . . . . . . . . 67.65 16.24 67.52 Favored Glycine 0 CA--C 1.536 1.384 0 C-N-CA 124.177 0.894 . . . . 0.0 113.728 178.061 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 2503 ' ' GLY . . . . . . . . . . . . . . . 147.04 -174.76 26.73 Favored Glycine 0 CA--C 1.54 1.624 0 C-N-CA 126.216 1.865 . . . . 0.0 112.436 -167.508 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 2504 ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -84.7 12.56 3.02 Favored 'Trans proline' 0 CA--C 1.544 1.006 0 C-N-CA 124.551 3.501 . . . . 0.0 113.904 -173.159 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 2505 ' ' TYR . . . . . . . . . . . . . 58.9 m-85 -110.47 147.58 33.8 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 124.474 1.11 . . . . 0.0 113.849 -171.486 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 2506 ' ' HIS . . . . . . . . . . . . . 92.8 m-70 -63.47 141.14 58.88 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 125.095 1.358 . . . . 0.0 113.497 -175.982 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 2507 ' ' ILE . . . . . . . . . . . . . 1.7 pp -79.45 175.53 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 N-CA-C 113.281 0.845 . . . . 0.0 113.281 176.449 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 2508 ' ' GLY . . . . . . . . . . . . . . . -60.75 111.14 3.48 Favored Glycine 0 CA--C 1.532 1.155 0 O-C-N 121.237 -0.915 . . . . 0.0 112.652 -178.575 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 2509 ' ' GLY . . . . . . . . . . . . . . . 95.38 -8.72 69.38 Favored Glycine 0 CA--C 1.536 1.353 0 C-N-CA 125.984 1.754 . . . . 0.0 114.7 -176.349 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 2510 ' ' SER . . . . . . . . . . . . . 47.9 t -83.2 147.52 53.87 Favored Pre-proline 0 CA--C 1.549 0.936 0 CA-C-N 118.802 1.301 . . . . 0.0 111.997 179.538 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 2511 ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -78.18 154.76 93.65 Favored 'Cis proline' 0 C--N 1.353 0.781 0 CA-C-N 119.809 0.967 . . . . 0.0 112.98 -1.383 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 2512 ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -104.86 131.67 52.06 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 125.141 1.376 . . . . 0.0 110.728 178.32 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 2513 ' ' LYS . . . . . . . . . . . . . 19.5 ptpt -89.13 8.04 32.02 Favored 'General case' 0 N--CA 1.479 0.983 0 N-CA-C 116.617 2.08 . . . . 0.0 116.617 -166.707 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 2514 ' ' ALA . . . . . . . . . . . . . . . -2.52 96.99 0.01 OUTLIER 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 129.436 3.095 . . . . 0.0 116.316 -177.722 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 2515 ' ' LYS . . . . . . . . . . . . . 44.9 mtpt -90.03 133.18 34.98 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.157 0.983 . . . . 0.0 111.354 -173.99 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 2516 ' ' VAL . . . . . . . . . . . . . 31.7 m -133.0 149.22 31.53 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 C-N-CA 124.326 1.05 . . . . 0.0 112.426 -168.764 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 2517 ' ' THR . . . . . . . . . . . . . 35.8 p -140.3 164.18 30.79 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 125.611 1.565 . . . . 0.0 111.365 -174.986 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 2518 ' ' GLY . . . . . . . . . . . . . . . 116.42 -162.19 12.74 Favored Glycine 0 CA--C 1.539 1.538 0 C-N-CA 125.046 1.308 . . . . 0.0 112.441 -174.308 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 2519 ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -72.56 167.23 27.64 Favored 'Trans proline' 0 CA--C 1.536 0.576 0 C-N-CA 123.562 2.842 . . . . 0.0 112.09 -177.896 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 2520 ' ' ARG . . . . . . . . . . . . . 49.1 ttp180 -98.2 121.3 39.96 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.148 0.979 . . . . 0.0 109.189 167.476 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 2521 ' ' LEU . . . . . . . . . . . . . 2.8 mm? -91.28 44.96 1.21 Allowed 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 124.944 1.298 . . . . 0.0 111.794 -173.766 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 2522 ' ' VAL . . . . . . . . . . . . . 7.2 p . . . . . 0 C--O 1.252 1.22 0 C-N-CA 127.683 2.393 . . . . 0.0 111.374 -179.864 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.547 0 N-CA-C 112.065 -0.414 . . . . 0.0 112.065 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -154.41 155.55 35.2 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 125.637 1.575 . . . . 0.0 111.511 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 97.6 mmm -67.05 133.8 50.61 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 124.396 1.078 . . . . 0.0 112.562 -176.776 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 2427 ' ' GLY . . . . . . . . . . . . . . . -92.4 147.23 18.57 Favored Glycine 0 CA--C 1.529 0.961 0 C-N-CA 125.344 1.449 . . . . 0.0 113.832 -179.902 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 2428 ' ' ASP . . . . . . . . . . . . . 12.5 t70 -82.89 136.06 44.77 Favored Pre-proline 0 CA--C 1.548 0.896 0 C-N-CA 125.285 1.434 . . . . 0.0 111.211 177.4 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 2429 ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -63.06 -22.08 73.28 Favored 'Trans proline' 0 C--N 1.353 0.771 0 C-N-CA 123.642 2.895 . . . . 0.0 114.244 -174.661 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 2430 ' ' GLY . . . . . . . . . . . . . . . -80.79 -20.2 66.23 Favored Glycine 0 CA--C 1.534 1.232 0 C-N-CA 124.054 0.835 . . . . 0.0 113.691 174.738 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 2431 ' ' LEU . . . . . . . . . . . . . 4.3 mm? -84.49 -28.42 26.77 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.462 1.105 . . . . 0.0 111.999 173.433 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 2432 ' ' VAL . . . . . . . . . . . . . 2.3 t -67.74 143.12 15.65 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 CA-C-N 118.7 0.682 . . . . 0.0 109.491 169.561 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 2433 ' ' SER . . . . . . . . . . . . . 8.1 t -135.86 -172.77 3.19 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.311 1.044 . . . . 0.0 110.569 171.436 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 2434 ' ' ALA . . . . . . . . . . . . . . . -148.93 142.33 25.23 Favored 'General case' 0 CA--C 1.537 0.455 0 O-C-N 120.921 -1.112 . . . . 0.0 111.638 177.232 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 2435 ' ' TYR . . . . . . . . . . . . . 74.7 m-85 -143.67 146.81 33.5 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.229 1.411 . . . . 0.0 112.027 -174.326 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 2436 ' ' GLY . . . . . . . . . . . . . . . 128.35 159.98 10.2 Favored Glycine 0 N--CA 1.473 1.108 0 C-N-CA 125.767 1.651 . . . . 0.0 113.571 179.34 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 2437 ' ' ALA . . . . . . . . . . . . . . . -61.17 -29.6 69.9 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.938 1.295 . . . . 0.0 114.193 -171.27 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 2438 ' ' GLY . . . . . . . . . . . . . . . -65.89 -16.15 63.5 Favored Glycine 0 CA--C 1.53 1.005 0 C-N-CA 124.361 0.981 . . . . 0.0 114.375 -178.082 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 2439 ' ' LEU . . . . . . . . . . . . . 79.0 mt -80.03 -26.87 39.58 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 118.77 1.285 . . . . 0.0 112.594 172.556 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 2440 ' ' GLU . . . . . . . . . . . . . 35.0 mm-40 -87.36 -38.04 16.55 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.72 1.208 . . . . 0.0 111.582 -178.957 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 2441 ' ' GLY . . . . . . . . . . . . . . . 162.29 -150.43 19.65 Favored Glycine 0 CA--C 1.527 0.8 0 C-N-CA 124.046 0.831 . . . . 0.0 114.173 -175.61 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 2442 ' ' GLY . . . . . . . . . . . . . . . 167.58 -170.29 41.62 Favored Glycine 0 CA--C 1.53 0.999 0 C-N-CA 124.951 1.262 . . . . 0.0 113.616 -179.735 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 2443 ' ' VAL . . . . . . . . . . . . . 97.9 t -120.93 137.02 56.01 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 C-N-CA 125.435 1.494 . . . . 0.0 109.115 176.611 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 2444 ' ' THR . . . . . . . . . . . . . 27.9 p -56.23 128.22 34.6 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.598 1.159 . . . . 0.0 111.837 177.68 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 2445 ' ' GLY . . . . . . . . . . . . . . . 86.26 -10.89 64.73 Favored Glycine 0 CA--C 1.533 1.165 0 C-N-CA 125.28 1.419 . . . . 0.0 114.891 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 2446 ' ' ASN . . . . . . . . . . . . . 86.6 m-20 -104.72 141.72 23.14 Favored Pre-proline 0 CA--C 1.546 0.796 0 C-N-CA 124.693 1.197 . . . . 0.0 110.684 175.338 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 2447 ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -71.63 142.15 39.44 Favored 'Trans proline' 0 N--CA 1.457 -0.641 0 C-N-CA 122.64 2.226 . . . . 0.0 111.118 177.046 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 2448 ' ' ALA . . . . . . . . . . . . . . . -125.51 156.25 39.28 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 126.082 1.753 . . . . 0.0 109.341 167.983 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 2449 ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -152.52 160.17 43.25 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 114.019 1.118 . . . . 0.0 114.019 -166.986 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 2450 ' ' PHE . . . . . . . . . . . . . 52.0 p90 -161.75 159.02 26.68 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 126.193 1.797 . . . . 0.0 111.24 -177.425 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 2451 ' ' VAL . . . . . . . . . . . . . 48.2 t -115.98 130.22 71.06 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 C-N-CA 124.847 1.259 . . . . 0.0 109.219 173.151 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 2452 ' ' VAL . . . . . . . . . . . . . 21.4 t -78.95 102.76 5.27 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 N-CA-C 106.795 -1.558 . . . . 0.0 106.795 164.884 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 2453 ' ' ASN . . . . . . . . . . . . . 10.7 t-20 -81.69 114.3 20.27 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.051 0.94 . . . . 0.0 111.856 -169.48 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 2454 ' ' THR . . . . . . . . . . . . . 58.3 p -99.92 -7.25 25.45 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 125.65 1.58 . . . . 0.0 113.856 -176.318 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 2455 ' ' SER . . . . . . . . . . . . . 16.7 m -55.41 -32.92 63.08 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 114.534 1.309 . . . . 0.0 114.534 -174.274 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 2456 ' ' ASN . . . . . . . . . . . . . 92.1 m-20 -85.26 -14.08 47.8 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 124.324 1.049 . . . . 0.0 113.465 177.95 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 2457 ' ' ALA . . . . . . . . . . . . . . . -105.61 -48.88 3.55 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 125.097 1.359 . . . . 0.0 113.158 -171.491 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 2458 ' ' GLY . . . . . . . . . . . . . . . 117.92 -138.4 13.92 Favored Glycine 0 CA--C 1.532 1.102 0 C-N-CA 125.066 1.317 . . . . 0.0 112.526 -173.464 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 2459 ' ' ALA . . . . . . . . . . . . . . . -97.3 175.86 6.11 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 125.553 1.541 . . . . 0.0 112.575 -179.746 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 2460 ' ' GLY . . . . . . . . . . . . . . . 134.07 162.76 10.08 Favored Glycine 0 CA--C 1.53 0.978 0 C-N-CA 125.21 1.386 . . . . 0.0 113.677 -179.379 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 2461 ' ' ALA . . . . . . . . . . . . . . . -80.49 146.78 31.19 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.273 1.029 . . . . 0.0 112.566 -178.935 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 2462 ' ' LEU . . . . . . . . . . . . . 14.6 tp -104.14 145.88 29.56 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.765 1.626 . . . . 0.0 110.391 172.363 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 2463 ' ' SER . . . . . . . . . . . . . 22.6 t -124.87 147.6 48.71 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 123.949 0.9 . . . . 0.0 109.335 153.052 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 2464 ' ' VAL . . . . . . . . . . . . . 12.1 p -160.16 139.6 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 O-C-N 121.256 -0.902 . . . . 0.0 111.039 -172.816 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 2465 ' ' THR . . . . . . . . . . . . . 9.5 t -161.5 161.77 30.13 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 125.112 1.365 . . . . 0.0 111.256 -177.727 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 2466 ' ' ILE . . . . . . . . . . . . . 39.7 mt -134.67 121.91 36.94 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 C-N-CA 125.089 1.356 . . . . 0.0 109.934 -173.864 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 2467 ' ' ASP . . . . . . . . . . . . . 36.7 t70 -98.18 156.74 16.54 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.691 1.596 . . . . 0.0 110.234 167.716 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 2468 ' ' GLY . . . . . . . . . . . . . . . 171.93 -165.83 38.65 Favored Glycine 0 CA--C 1.535 1.309 0 O-C-N 120.951 -1.093 . . . . 0.0 115.175 -179.888 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 2469 ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -69.81 -12.67 33.27 Favored 'Trans proline' 0 CA--C 1.541 0.871 0 C-N-CA 124.116 3.211 . . . . 0.0 113.841 -179.808 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 2470 ' ' SER . . . . . . . . . . . . . 33.3 m -156.16 170.89 21.16 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 126.887 2.075 . . . . 0.0 110.174 173.406 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 2471 ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -67.73 162.0 24.77 Favored 'General case' 0 CA--C 1.548 0.889 0 O-C-N 121.116 -0.99 . . . . 0.0 111.752 167.869 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 2472 ' ' VAL . . . . . . . . . . . . . 35.8 m -137.79 145.06 29.61 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 C-N-CA 124.785 1.234 . . . . 0.0 111.639 -179.207 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 2473 ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -87.52 90.72 8.48 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.411 1.084 . . . . 0.0 110.867 -179.795 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 2474 ' ' MET . . . . . . . . . . . . . 96.7 mtp -80.93 133.82 35.61 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 124.279 1.032 . . . . 0.0 111.591 178.75 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 2475 ' ' ASP . . . . . . . . . . . . . 21.1 t70 -116.3 118.65 33.35 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 125.865 1.666 . . . . 0.0 109.044 162.892 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 2476 ' ' CYS . . . . . . . . . . . . . 72.4 m -102.81 137.85 40.48 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.397 1.079 . . . . 0.0 110.106 175.053 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 2477 ' ' GLN . . . . . . . . . . . . . 5.4 pt20 -154.12 155.35 35.22 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.499 1.119 . . . . 0.0 110.731 -175.96 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 2478 ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -97.68 138.07 35.63 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.84 0.856 . . . . 0.0 110.844 -179.425 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 2479 ' ' CYS . . . . . . . . . . . . . 17.0 p -137.02 171.59 8.34 Favored Pre-proline 0 CA--C 1.554 1.107 0 C-N-CA 125.602 1.561 . . . . 0.0 111.479 175.529 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 2480 ' ' PRO . . . . . . . . . . . . . 73.4 Cg_exo -58.6 -27.1 81.6 Favored 'Trans proline' 0 CA--C 1.54 0.791 0 C-N-CA 123.42 2.746 . . . . 0.0 114.572 178.588 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 2481 ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -84.7 -14.29 48.86 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 124.748 1.219 . . . . 0.0 113.135 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 2482 ' ' GLY . . . . . . . . . . . . . . . 139.82 -143.8 14.25 Favored Glycine 0 N--CA 1.471 0.987 0 C-N-CA 125.228 1.394 . . . . 0.0 113.425 178.511 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 2483 ' ' TYR . . . . . . . . . . . . . 66.5 m-85 -91.08 115.83 28.32 Favored 'General case' 0 N--CA 1.467 0.425 0 O-C-N 121.934 -0.745 . . . . 0.0 111.185 175.33 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 2484 ' ' ARG . . . . . . . . . . . . . 43.4 ttt180 -92.01 139.63 30.45 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 125.563 1.545 . . . . 0.0 110.87 178.111 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 2485 ' ' VAL . . . . . . . . . . . . . 65.4 t -126.83 129.59 71.42 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 125.542 1.537 . . . . 0.0 108.855 175.272 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 2486 ' ' THR . . . . . . . . . . . . . 93.8 m -117.6 139.2 51.3 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 125.37 1.468 . . . . 0.0 108.004 169.315 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 2487 ' ' TYR . . . . . . . . . . . . . 19.4 p90 -149.0 150.3 32.6 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 123.692 0.797 . . . . 0.0 112.851 176.656 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 2488 ' ' THR . . . . . . . . . . . . . 99.6 m -110.99 113.71 54.63 Favored Pre-proline 0 N--CA 1.474 0.738 0 C-N-CA 124.37 1.068 . . . . 0.0 109.609 176.712 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 2489 ' ' PRO . . . . . . . . . . . . . 79.3 Cg_endo -77.25 164.31 29.27 Favored 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 123.748 2.965 . . . . 0.0 110.947 169.269 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 2490 ' ' MET . . . . . . . . . . . . . 28.1 ptm -143.85 -3.17 0.89 Allowed 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 115.561 1.689 . . . . 0.0 115.561 -172.3 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 2491 ' ' ALA . . . . . . . . . . . . . . . -140.01 148.02 53.16 Favored Pre-proline 0 CA--C 1.546 0.821 0 C-N-CA 125.167 1.387 . . . . 0.0 110.737 174.139 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 2492 ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -71.34 146.83 51.63 Favored 'Trans proline' 0 CA--C 1.537 0.666 0 C-N-CA 122.856 2.37 . . . . 0.0 110.933 177.896 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 2493 ' ' GLY . . . . . . . . . . . . . . . 136.39 -167.62 24.4 Favored Glycine 0 CA--C 1.531 1.075 0 C-N-CA 125.214 1.388 . . . . 0.0 113.603 -176.602 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 2494 ' ' SER . . . . . . . . . . . . . 49.4 m -95.22 123.18 38.59 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 124.417 1.087 . . . . 0.0 111.299 179.863 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 2495 ' ' TYR . . . . . . . . . . . . . 73.1 m-85 -97.97 116.95 31.22 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.346 1.058 . . . . 0.0 110.129 170.003 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 2496 ' ' LEU . . . . . . . . . . . . . 23.2 tp -93.16 105.64 17.71 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.943 1.297 . . . . 0.0 109.904 -176.586 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 2497 ' ' ILE . . . . . . . . . . . . . 44.4 mt -93.32 112.37 26.32 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 C-N-CA 126.443 1.897 . . . . 0.0 108.636 -176.545 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 2498 ' ' SER . . . . . . . . . . . . . 75.4 m -96.61 123.87 40.42 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 123.512 0.725 . . . . 0.0 110.002 174.521 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 2499 ' ' ILE . . . . . . . . . . . . . 23.9 mt -124.95 116.23 46.58 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 C-N-CA 125.269 1.427 . . . . 0.0 109.297 -175.785 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 2500 ' ' LYS . . . . . . . . . . . . . 96.0 mttt -127.28 140.77 51.99 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.783 1.233 . . . . 0.0 111.817 -172.821 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 2501 ' ' TYR . . . . . . . . . . . . . 44.4 t80 -146.85 144.47 29.33 Favored 'General case' 0 N--CA 1.474 0.769 0 O-C-N 121.303 -0.873 . . . . 0.0 113.329 -172.331 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 2502 ' ' GLY . . . . . . . . . . . . . . . 69.57 19.46 74.73 Favored Glycine 0 CA--C 1.536 1.345 0 C-N-CA 124.101 0.858 . . . . 0.0 113.207 -179.152 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 2503 ' ' GLY . . . . . . . . . . . . . . . 132.17 -176.04 19.52 Favored Glycine 0 CA--C 1.54 1.637 0 C-N-CA 126.325 1.917 . . . . 0.0 112.293 -166.304 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 2504 ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -82.21 43.97 1.61 Allowed 'Trans proline' 0 CA--C 1.545 1.047 0 C-N-CA 124.959 3.773 . . . . 0.0 112.662 -173.722 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 2505 ' ' TYR . . . . . . . . . . . . . 76.0 m-85 -125.43 131.19 52.95 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.817 1.247 . . . . 0.0 112.475 -174.134 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 2506 ' ' HIS . . . . . . . . . . . . . 88.0 m-70 -59.33 138.07 57.76 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 124.921 1.288 . . . . 0.0 113.536 -177.26 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 2507 ' ' ILE . . . . . . . . . . . . . 2.3 pp -88.97 147.6 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 C-N-CA 123.854 0.862 . . . . 0.0 112.535 175.154 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 2508 ' ' GLY . . . . . . . . . . . . . . . 48.26 -115.32 2.35 Favored Glycine 0 CA--C 1.535 1.323 0 C-N-CA 124.239 0.923 . . . . 0.0 114.031 167.093 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 2509 ' ' GLY . . . . . . . . . . . . . . . -97.05 11.11 65.91 Favored Glycine 0 CA--C 1.537 1.417 0 C-N-CA 126.061 1.791 . . . . 0.0 115.212 177.693 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 2510 ' ' SER . . . . . . . . . . . . . 46.5 t -63.17 144.82 97.28 Favored Pre-proline 0 CA--C 1.55 0.974 0 CA-C-N 119.342 1.571 . . . . 0.0 112.458 178.917 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 2511 ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -79.64 152.34 86.25 Favored 'Cis proline' 0 C--N 1.353 0.779 0 CA-C-N 119.343 0.801 . . . . 0.0 113.349 -0.364 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 2512 ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -103.81 130.46 51.36 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 125.62 1.568 . . . . 0.0 110.782 -179.363 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 2513 ' ' LYS . . . . . . . . . . . . . 7.4 ptpp? -90.57 9.77 28.17 Favored 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 116.833 2.16 . . . . 0.0 116.833 -165.112 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 2514 ' ' ALA . . . . . . . . . . . . . . . -4.0 101.3 0.01 OUTLIER 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 129.404 3.082 . . . . 0.0 116.532 -176.847 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 2515 ' ' LYS . . . . . . . . . . . . . 35.2 mtmm -88.23 119.41 28.6 Favored 'General case' 0 CA--C 1.544 0.715 0 O-C-N 121.293 -0.88 . . . . 0.0 111.778 -173.419 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 2516 ' ' VAL . . . . . . . . . . . . . 54.1 t -111.27 144.08 19.87 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 125.83 1.652 . . . . 0.0 110.605 -173.971 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 2517 ' ' THR . . . . . . . . . . . . . 53.0 p -131.52 173.44 11.11 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 125.693 1.597 . . . . 0.0 110.949 174.299 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 2518 ' ' GLY . . . . . . . . . . . . . . . 112.88 179.43 19.47 Favored Glycine 0 CA--C 1.54 1.607 0 C-N-CA 125.1 1.333 . . . . 0.0 113.651 -177.863 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 2519 ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -69.68 129.31 17.46 Favored 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 123.896 3.064 . . . . 0.0 111.819 -172.67 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 2520 ' ' ARG . . . . . . . . . . . . . 35.2 ttt-85 -66.56 124.6 23.25 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 123.716 0.806 . . . . 0.0 110.449 177.541 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 2521 ' ' LEU . . . . . . . . . . . . . 62.9 mt -91.36 25.11 2.69 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 124.969 1.307 . . . . 0.0 112.913 -173.779 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 2522 ' ' VAL . . . . . . . . . . . . . 6.3 p . . . . . 0 C--O 1.253 1.245 0 C-N-CA 127.142 2.177 . . . . 0.0 111.555 -171.111 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.565 0 N-CA-C 111.435 -0.666 . . . . 0.0 111.435 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -81.29 -9.39 59.77 Favored 'General case' 0 CA--C 1.548 0.891 0 N-CA-C 114.669 1.359 . . . . 0.0 114.669 -176.9 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 10.3 tpt -146.96 131.55 17.78 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 125.777 1.631 . . . . 0.0 110.489 -177.113 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 2427 ' ' GLY . . . . . . . . . . . . . . . -81.04 169.21 51.63 Favored Glycine 0 CA--C 1.532 1.14 0 C-N-CA 124.979 1.276 . . . . 0.0 113.69 178.023 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 2428 ' ' ASP . . . . . . . . . . . . . 22.7 m-20 -94.33 129.69 36.22 Favored Pre-proline 0 CA--C 1.549 0.914 0 C-N-CA 124.496 1.119 . . . . 0.0 112.43 -178.414 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 2429 ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -56.46 -30.3 81.47 Favored 'Trans proline' 0 C--N 1.353 0.775 0 C-N-CA 123.659 2.906 . . . . 0.0 113.916 174.458 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 2430 ' ' GLY . . . . . . . . . . . . . . . -75.41 -21.23 77.88 Favored Glycine 0 CA--C 1.534 1.258 0 CA-C-O 119.379 -0.678 . . . . 0.0 113.92 177.979 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 2431 ' ' LEU . . . . . . . . . . . . . 4.3 mm? -88.86 -32.01 18.0 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.463 1.105 . . . . 0.0 111.698 173.143 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 2432 ' ' VAL . . . . . . . . . . . . . 95.4 t -68.15 136.22 26.92 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 C-N-CA 123.39 0.676 . . . . 0.0 110.439 170.549 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 2433 ' ' SER . . . . . . . . . . . . . 57.0 m -140.73 144.79 35.76 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 125.27 1.428 . . . . 0.0 109.998 175.544 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 2434 ' ' ALA . . . . . . . . . . . . . . . -100.61 148.19 25.11 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 123.351 0.66 . . . . 0.0 112.134 177.096 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 2435 ' ' TYR . . . . . . . . . . . . . 82.2 m-85 -143.93 146.26 32.84 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 125.852 1.661 . . . . 0.0 111.591 -176.282 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 2436 ' ' GLY . . . . . . . . . . . . . . . 124.89 163.52 11.67 Favored Glycine 0 N--CA 1.475 1.284 0 C-N-CA 125.09 1.328 . . . . 0.0 114.577 175.175 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 2437 ' ' ALA . . . . . . . . . . . . . . . -62.31 -30.62 71.28 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.184 1.394 . . . . 0.0 114.433 -170.064 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 2438 ' ' GLY . . . . . . . . . . . . . . . -66.05 -13.37 59.6 Favored Glycine 0 CA--C 1.532 1.152 0 C-N-CA 124.306 0.955 . . . . 0.0 114.282 -179.501 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 2439 ' ' LEU . . . . . . . . . . . . . 81.6 mt -79.84 -23.91 41.68 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 118.637 1.219 . . . . 0.0 112.801 171.049 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 2440 ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -92.78 -34.96 13.68 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 124.792 1.237 . . . . 0.0 111.985 -175.882 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 2441 ' ' GLY . . . . . . . . . . . . . . . 159.68 -153.22 24.23 Favored Glycine 0 C--N 1.339 0.748 0 C-N-CA 123.806 0.717 . . . . 0.0 114.31 -176.71 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 2442 ' ' GLY . . . . . . . . . . . . . . . 169.85 -168.76 41.63 Favored Glycine 0 CA--C 1.528 0.883 0 C-N-CA 124.802 1.191 . . . . 0.0 113.387 -178.926 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 2443 ' ' VAL . . . . . . . . . . . . . 38.9 t -128.31 139.11 52.79 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 C-N-CA 124.915 1.286 . . . . 0.0 108.867 174.657 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 2444 ' ' THR . . . . . . . . . . . . . 40.1 p -58.28 141.44 50.92 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.864 0.866 . . . . 0.0 112.706 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 2445 ' ' GLY . . . . . . . . . . . . . . . 78.2 -9.74 31.67 Favored Glycine 0 CA--C 1.535 1.316 0 C-N-CA 124.811 1.196 . . . . 0.0 114.859 -178.505 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 2446 ' ' ASN . . . . . . . . . . . . . 86.1 m-20 -111.59 144.87 31.46 Favored Pre-proline 0 CA--C 1.547 0.862 0 C-N-CA 125.318 1.447 . . . . 0.0 111.289 176.503 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 2447 ' ' PRO . . . . . . . . . . . . . 82.2 Cg_endo -74.71 149.46 38.21 Favored 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 122.893 2.395 . . . . 0.0 111.882 178.681 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 2448 ' ' ALA . . . . . . . . . . . . . . . -136.83 148.59 47.22 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 126.069 1.748 . . . . 0.0 109.654 168.354 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 2449 ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -141.1 157.42 45.32 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 114.164 1.172 . . . . 0.0 114.164 -166.443 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 2450 ' ' PHE . . . . . . . . . . . . . 50.7 p90 -156.59 162.64 39.88 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 126.421 1.888 . . . . 0.0 110.911 178.76 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 2451 ' ' VAL . . . . . . . . . . . . . 8.2 p -122.91 133.9 67.66 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 C-N-CA 124.698 1.199 . . . . 0.0 110.305 175.747 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 2452 ' ' VAL . . . . . . . . . . . . . 45.4 t -90.09 102.45 13.26 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 N-CA-C 106.943 -1.503 . . . . 0.0 106.943 169.64 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 2453 ' ' ASN . . . . . . . . . . . . . 19.6 t-20 -86.35 117.96 25.49 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 112.411 0.523 . . . . 0.0 112.411 -169.528 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 2454 ' ' THR . . . . . . . . . . . . . 53.0 p -97.83 -5.54 34.49 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 125.292 1.437 . . . . 0.0 113.851 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 2455 ' ' SER . . . . . . . . . . . . . 20.5 m -56.51 -28.29 59.49 Favored 'General case' 0 N--CA 1.479 1.006 0 CA-C-N 120.148 1.34 . . . . 0.0 114.54 -175.358 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 2456 ' ' ASN . . . . . . . . . . . . . 64.7 m-80 -83.33 -14.82 52.09 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 124.653 1.181 . . . . 0.0 113.593 176.532 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 2457 ' ' ALA . . . . . . . . . . . . . . . -115.58 -19.69 10.48 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 125.964 1.706 . . . . 0.0 114.271 -173.867 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 2458 ' ' GLY . . . . . . . . . . . . . . . 103.85 -103.13 2.26 Favored Glycine 0 CA--C 1.529 0.929 0 C-N-CA 125.585 1.564 . . . . 0.0 110.923 -172.699 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 2459 ' ' ALA . . . . . . . . . . . . . . . -158.61 163.39 37.01 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 125.898 1.679 . . . . 0.0 111.337 179.755 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 2460 ' ' GLY . . . . . . . . . . . . . . . 167.45 174.97 37.0 Favored Glycine 0 CA--C 1.528 0.9 0 N-CA-C 114.878 0.711 . . . . 0.0 114.878 -175.752 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 2461 ' ' ALA . . . . . . . . . . . . . . . -77.98 128.17 33.47 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.387 1.075 . . . . 0.0 112.434 -176.627 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 2462 ' ' LEU . . . . . . . . . . . . . 25.3 tp -106.64 144.28 33.53 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 125.58 1.552 . . . . 0.0 110.83 177.437 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 2463 ' ' SER . . . . . . . . . . . . . 3.8 t -136.2 40.89 2.65 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 125.843 1.657 . . . . 0.0 110.923 -176.248 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 2464 ' ' VAL . . . . . . . . . . . . . 7.5 p -64.27 133.41 29.86 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 C-N-CA 125.013 1.325 . . . . 0.0 112.107 -176.01 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 2465 ' ' THR . . . . . . . . . . . . . 97.8 m -134.18 142.84 47.57 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 126.027 1.731 . . . . 0.0 109.994 -177.196 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 2466 ' ' ILE . . . . . . . . . . . . . 50.6 mt -118.54 121.67 67.6 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 C-N-CA 124.201 1.0 . . . . 0.0 109.949 175.354 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 2467 ' ' ASP . . . . . . . . . . . . . 36.4 t70 -105.51 159.75 15.7 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 126.269 1.828 . . . . 0.0 110.592 169.314 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 2468 ' ' GLY . . . . . . . . . . . . . . . 172.97 -168.17 41.14 Favored Glycine 0 CA--C 1.535 1.313 0 O-C-N 121.305 -0.872 . . . . 0.0 114.472 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 2469 ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -66.13 -27.17 49.43 Favored 'Trans proline' 0 CA--C 1.54 0.78 0 C-N-CA 123.865 3.043 . . . . 0.0 112.833 177.95 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 2470 ' ' SER . . . . . . . . . . . . . 70.4 m -143.64 166.1 25.8 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 126.042 1.737 . . . . 0.0 110.184 172.196 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 2471 ' ' LYS . . . . . . . . . . . . . 68.2 mttm -71.65 131.98 43.95 Favored 'General case' 0 CA--C 1.545 0.753 0 O-C-N 120.706 -1.246 . . . . 0.0 110.989 171.9 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 2472 ' ' VAL . . . . . . . . . . . . . 20.5 m -87.47 155.52 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 C-N-CA 123.92 0.888 . . . . 0.0 111.52 177.911 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 2473 ' ' LYS . . . . . . . . . . . . . 97.5 mttt -80.84 72.35 7.82 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 124.399 1.08 . . . . 0.0 110.843 175.987 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 2474 ' ' MET . . . . . . . . . . . . . 22.4 ttt -78.97 139.91 38.13 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 125.745 1.618 . . . . 0.0 112.74 -171.588 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 2475 ' ' ASP . . . . . . . . . . . . . 17.6 m-20 -138.99 132.4 30.16 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 126.155 1.782 . . . . 0.0 109.844 167.116 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 2476 ' ' CYS . . . . . . . . . . . . . 48.0 t -118.19 140.67 49.44 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.076 1.35 . . . . 0.0 110.728 176.524 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 2477 ' ' GLN . . . . . . . . . . . . . 42.2 mt-30 -136.4 142.82 43.73 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 125.497 1.519 . . . . 0.0 110.444 -177.071 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 2478 ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -86.37 139.23 31.15 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.08 0.952 . . . . 0.0 110.161 171.899 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 2479 ' ' CYS . . . . . . . . . . . . . 29.3 p -150.52 169.76 8.75 Favored Pre-proline 0 CA--C 1.552 1.043 0 C-N-CA 125.01 1.324 . . . . 0.0 112.325 -176.866 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 2480 ' ' PRO . . . . . . . . . . . . . 56.3 Cg_exo -58.59 -25.46 74.78 Favored 'Trans proline' 0 CA--C 1.539 0.754 0 C-N-CA 123.356 2.704 . . . . 0.0 114.08 174.436 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 2481 ' ' GLU . . . . . . . . . . . . . 21.6 tt0 -85.23 -2.32 57.91 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 125.242 1.417 . . . . 0.0 113.13 178.37 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 2482 ' ' GLY . . . . . . . . . . . . . . . 121.88 -118.89 3.85 Favored Glycine 0 N--CA 1.47 0.938 0 C-N-CA 125.826 1.679 . . . . 0.0 112.202 -179.394 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 2483 ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -123.88 116.76 23.46 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.083 0.953 . . . . 0.0 110.881 174.922 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 2484 ' ' ARG . . . . . . . . . . . . . 41.4 ttm-85 -94.25 132.53 38.73 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 124.6 1.16 . . . . 0.0 110.169 179.227 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 2485 ' ' VAL . . . . . . . . . . . . . 86.1 t -119.98 135.36 60.52 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 C-N-CA 125.676 1.59 . . . . 0.0 108.998 -179.603 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 2486 ' ' THR . . . . . . . . . . . . . 88.4 m -129.07 142.84 50.77 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 125.244 1.417 . . . . 0.0 108.449 172.901 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 2487 ' ' TYR . . . . . . . . . . . . . 37.2 p90 -149.36 148.27 29.29 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 113.085 0.772 . . . . 0.0 113.085 174.041 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 2488 ' ' THR . . . . . . . . . . . . . 59.2 m -108.47 118.51 51.93 Favored Pre-proline 0 N--CA 1.473 0.725 0 C-N-CA 124.628 1.171 . . . . 0.0 108.759 168.358 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 2489 ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -82.76 157.34 15.98 Favored 'Trans proline' 0 N--CA 1.457 -0.654 0 C-N-CA 123.719 2.946 . . . . 0.0 111.189 174.108 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 2490 ' ' MET . . . . . . . . . . . . . 28.8 ptm -124.32 5.44 8.42 Favored 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 114.308 1.225 . . . . 0.0 114.308 -174.842 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 2491 ' ' ALA . . . . . . . . . . . . . . . -151.56 148.89 22.91 Favored Pre-proline 0 CA--C 1.546 0.807 0 C-N-CA 125.826 1.651 . . . . 0.0 111.117 178.25 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 2492 ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -74.66 155.33 44.61 Favored 'Trans proline' 0 CA--C 1.536 0.599 0 C-N-CA 123.094 2.529 . . . . 0.0 111.229 173.561 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 2493 ' ' GLY . . . . . . . . . . . . . . . 131.5 -174.37 20.09 Favored Glycine 0 CA--C 1.529 0.935 0 C-N-CA 125.337 1.446 . . . . 0.0 113.662 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 2494 ' ' SER . . . . . . . . . . . . . 11.1 p -86.28 129.81 34.72 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.361 1.064 . . . . 0.0 111.85 174.338 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 2495 ' ' TYR . . . . . . . . . . . . . 60.0 m-85 -107.2 125.48 51.17 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 125.578 1.551 . . . . 0.0 109.279 172.305 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 2496 ' ' LEU . . . . . . . . . . . . . 19.1 tp -94.48 107.0 18.99 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 123.857 0.863 . . . . 0.0 109.546 -178.255 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 2497 ' ' ILE . . . . . . . . . . . . . 48.7 mt -92.66 101.73 12.89 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 C-N-CA 125.631 1.572 . . . . 0.0 107.624 -179.763 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 2498 ' ' SER . . . . . . . . . . . . . 75.8 m -90.36 99.33 12.37 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 124.606 1.162 . . . . 0.0 109.519 176.917 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 2499 ' ' ILE . . . . . . . . . . . . . 23.0 mt -93.47 89.79 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 C-N-CA 124.511 1.125 . . . . 0.0 108.451 -178.133 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 2500 ' ' LYS . . . . . . . . . . . . . 85.1 mttt -99.53 142.52 30.91 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 124.334 1.054 . . . . 0.0 111.722 -178.715 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 2501 ' ' TYR . . . . . . . . . . . . . 72.9 t80 -146.5 138.08 24.58 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 124.738 1.215 . . . . 0.0 111.4 -168.176 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 2502 ' ' GLY . . . . . . . . . . . . . . . 69.03 12.08 64.63 Favored Glycine 0 CA--C 1.534 1.241 0 C-N-CA 124.356 0.979 . . . . 0.0 114.971 -179.45 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 2503 ' ' GLY . . . . . . . . . . . . . . . 138.41 -153.24 22.36 Favored Glycine 0 CA--C 1.539 1.552 0 C-N-CA 125.507 1.527 . . . . 0.0 112.388 -169.421 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 2504 ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -81.75 6.86 5.38 Favored 'Trans proline' 0 CA--C 1.543 0.938 0 C-N-CA 124.354 3.369 . . . . 0.0 114.123 -172.961 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 2505 ' ' TYR . . . . . . . . . . . . . 64.5 m-85 -99.26 136.14 39.64 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.272 1.029 . . . . 0.0 113.18 -172.479 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 2506 ' ' HIS . . . . . . . . . . . . . 93.4 m-70 -64.75 148.2 51.62 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 125.036 1.334 . . . . 0.0 113.305 176.778 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 2507 ' ' ILE . . . . . . . . . . . . . 30.4 pt -73.59 173.27 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 C-N-CA 123.387 0.675 . . . . 0.0 112.523 167.599 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 2508 ' ' GLY . . . . . . . . . . . . . . . -58.97 122.19 29.34 Favored Glycine 0 CA--C 1.534 1.253 0 O-C-N 121.659 -0.651 . . . . 0.0 111.791 172.808 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 2509 ' ' GLY . . . . . . . . . . . . . . . 88.75 -9.99 74.07 Favored Glycine 0 CA--C 1.536 1.362 0 C-N-CA 125.654 1.597 . . . . 0.0 115.226 -178.932 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 2510 ' ' SER . . . . . . . . . . . . . 41.6 t -84.95 147.77 49.06 Favored Pre-proline 0 CA--C 1.549 0.914 0 CA-C-N 119.053 1.426 . . . . 0.0 112.023 179.325 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 2511 ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -79.34 158.7 90.17 Favored 'Cis proline' 0 C--N 1.353 0.801 0 CA-C-N 119.867 0.988 . . . . 0.0 113.456 0.245 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 2512 ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -107.66 137.97 44.72 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 125.471 1.508 . . . . 0.0 110.747 177.847 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 2513 ' ' LYS . . . . . . . . . . . . . 19.1 ptpt -99.5 15.42 26.56 Favored 'General case' 0 N--CA 1.48 1.068 0 N-CA-C 116.289 1.959 . . . . 0.0 116.289 -163.48 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 2514 ' ' ALA . . . . . . . . . . . . . . . -14.89 108.57 0.02 OUTLIER 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 129.388 3.075 . . . . 0.0 116.722 -173.409 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 2515 ' ' LYS . . . . . . . . . . . . . 67.5 mttm -92.24 107.85 19.51 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 124.66 1.184 . . . . 0.0 111.72 -175.26 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 2516 ' ' VAL . . . . . . . . . . . . . 71.3 t -95.74 142.07 14.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 C-N-CA 125.726 1.61 . . . . 0.0 110.493 -177.828 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 2517 ' ' THR . . . . . . . . . . . . . 77.8 p -121.42 179.31 4.47 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 125.28 1.432 . . . . 0.0 111.456 174.321 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 2518 ' ' GLY . . . . . . . . . . . . . . . 99.91 178.78 30.59 Favored Glycine 0 CA--C 1.54 1.635 0 C-N-CA 124.676 1.131 . . . . 0.0 113.635 -178.231 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 2519 ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -72.98 148.4 45.18 Favored 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 123.857 3.038 . . . . 0.0 112.218 -174.46 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 2520 ' ' ARG . . . . . . . . . . . . . 49.4 ttm-85 -77.83 131.91 37.78 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 123.63 0.772 . . . . 0.0 110.281 173.189 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 2521 ' ' LEU . . . . . . . . . . . . . 4.2 mm? -79.85 -16.73 54.83 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.077 0.951 . . . . 0.0 113.279 -176.604 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 2522 ' ' VAL . . . . . . . . . . . . . 14.4 m . . . . . 0 C--O 1.252 1.223 0 C-N-CA 126.675 1.99 . . . . 0.0 113.374 179.838 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.563 0 N-CA-C 111.576 -0.61 . . . . 0.0 111.576 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -158.75 161.87 37.05 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 125.345 1.458 . . . . 0.0 112.313 -178.048 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 2.0 mpt? -74.74 166.38 23.68 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.36 1.464 . . . . 0.0 112.136 176.201 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 2427 ' ' GLY . . . . . . . . . . . . . . . -67.48 160.52 49.35 Favored Glycine 0 CA--C 1.532 1.145 0 C-N-CA 124.844 1.211 . . . . 0.0 113.879 -179.417 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 2428 ' ' ASP . . . . . . . . . . . . . 24.5 m-20 -91.0 133.12 32.6 Favored Pre-proline 0 CA--C 1.549 0.905 0 C-N-CA 124.233 1.013 . . . . 0.0 112.857 -175.205 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 2429 ' ' PRO . . . . . . . . . . . . . 72.5 Cg_exo -55.2 -27.88 58.73 Favored 'Trans proline' 0 C--N 1.352 0.711 0 C-N-CA 124.097 3.198 . . . . 0.0 114.308 171.611 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 2430 ' ' GLY . . . . . . . . . . . . . . . -77.04 -23.13 69.7 Favored Glycine 0 CA--C 1.534 1.254 0 C-N-CA 123.851 0.739 . . . . 0.0 113.819 176.525 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 2431 ' ' LEU . . . . . . . . . . . . . 4.4 mm? -87.42 -31.63 19.96 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.393 1.077 . . . . 0.0 111.612 171.768 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 2432 ' ' VAL . . . . . . . . . . . . . 87.5 t -64.67 130.23 29.55 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 CA-C-N 118.68 0.673 . . . . 0.0 109.901 168.824 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 2433 ' ' SER . . . . . . . . . . . . . 68.0 m -125.59 172.35 9.81 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 125.436 1.494 . . . . 0.0 110.338 174.787 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 2434 ' ' ALA . . . . . . . . . . . . . . . -131.52 143.24 50.24 Favored 'General case' 0 CA--C 1.539 0.53 0 O-C-N 121.205 -0.934 . . . . 0.0 111.29 174.638 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 2435 ' ' TYR . . . . . . . . . . . . . 75.8 m-85 -144.37 147.39 33.37 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 125.234 1.413 . . . . 0.0 112.001 -175.421 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 2436 ' ' GLY . . . . . . . . . . . . . . . 122.33 163.22 11.81 Favored Glycine 0 N--CA 1.473 1.154 0 C-N-CA 125.087 1.327 . . . . 0.0 114.198 175.902 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 2437 ' ' ALA . . . . . . . . . . . . . . . -61.9 -28.64 69.66 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.123 1.369 . . . . 0.0 114.398 -170.445 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 2438 ' ' GLY . . . . . . . . . . . . . . . -64.35 -18.18 62.77 Favored Glycine 0 CA--C 1.533 1.164 0 CA-C-O 118.984 -0.898 . . . . 0.0 114.12 -179.581 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 2439 ' ' LEU . . . . . . . . . . . . . 80.0 mt -76.44 -24.29 53.93 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 118.663 1.232 . . . . 0.0 112.754 171.928 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 2440 ' ' GLU . . . . . . . . . . . . . 37.9 mm-40 -89.05 -27.71 20.64 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.983 1.313 . . . . 0.0 111.792 177.205 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 2441 ' ' GLY . . . . . . . . . . . . . . . 111.93 -138.56 15.05 Favored Glycine 0 CA--C 1.53 1.009 0 C-N-CA 125.943 1.735 . . . . 0.0 112.301 -178.452 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 2442 ' ' GLY . . . . . . . . . . . . . . . 154.32 -148.29 18.62 Favored Glycine 0 N--CA 1.474 1.18 0 C-N-CA 124.019 0.819 . . . . 0.0 113.971 -177.418 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 2443 ' ' VAL . . . . . . . . . . . . . 60.1 t -105.79 139.23 27.64 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 C-N-CA 125.334 1.454 . . . . 0.0 110.032 -178.322 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 2444 ' ' THR . . . . . . . . . . . . . 39.3 p -59.39 144.87 45.55 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.505 1.122 . . . . 0.0 112.675 175.556 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 2445 ' ' GLY . . . . . . . . . . . . . . . 80.0 -18.3 8.03 Favored Glycine 0 CA--C 1.535 1.339 0 C-N-CA 125.033 1.301 . . . . 0.0 114.47 -179.804 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 2446 ' ' ASN . . . . . . . . . . . . . 87.4 m-20 -99.64 144.55 28.54 Favored Pre-proline 0 CA--C 1.545 0.763 0 C-N-CA 125.081 1.353 . . . . 0.0 110.98 176.321 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 2447 ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -73.85 151.26 45.45 Favored 'Trans proline' 0 N--CA 1.457 -0.637 0 C-N-CA 122.816 2.344 . . . . 0.0 111.479 178.281 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 2448 ' ' ALA . . . . . . . . . . . . . . . -135.74 158.7 43.75 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 126.534 1.934 . . . . 0.0 109.492 169.437 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 2449 ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -149.37 155.65 40.82 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 113.913 1.079 . . . . 0.0 113.913 -171.457 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 2450 ' ' PHE . . . . . . . . . . . . . 47.9 p90 -155.03 153.61 31.23 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 126.042 1.737 . . . . 0.0 110.434 178.579 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 2451 ' ' VAL . . . . . . . . . . . . . 12.0 p -107.43 132.4 55.05 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 C-N-CA 124.603 1.161 . . . . 0.0 110.087 175.089 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 2452 ' ' VAL . . . . . . . . . . . . . 34.8 t -86.6 101.57 10.97 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 N-CA-C 106.594 -1.632 . . . . 0.0 106.594 165.684 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 2453 ' ' ASN . . . . . . . . . . . . . 13.2 t-20 -79.57 111.93 16.33 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.23 1.012 . . . . 0.0 111.821 -171.218 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 2454 ' ' THR . . . . . . . . . . . . . 27.9 p -101.16 -13.47 18.13 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 125.335 1.454 . . . . 0.0 113.865 -179.734 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 2455 ' ' SER . . . . . . . . . . . . . 98.1 p -64.39 -24.65 67.71 Favored 'General case' 0 N--CA 1.478 0.957 0 CA-C-N 120.234 1.379 . . . . 0.0 114.213 -174.577 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 2456 ' ' ASN . . . . . . . . . . . . . 49.8 m-80 -77.35 -18.31 57.52 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 124.283 1.033 . . . . 0.0 113.568 171.731 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 2457 ' ' ALA . . . . . . . . . . . . . . . -106.04 -31.3 8.8 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 125.4 1.48 . . . . 0.0 113.827 -176.131 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 2458 ' ' GLY . . . . . . . . . . . . . . . 113.99 -113.85 3.17 Favored Glycine 0 CA--C 1.53 1.008 0 C-N-CA 125.516 1.531 . . . . 0.0 111.491 -174.171 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 2459 ' ' ALA . . . . . . . . . . . . . . . -144.31 158.85 43.52 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 125.17 1.388 . . . . 0.0 111.943 -179.559 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 2460 ' ' GLY . . . . . . . . . . . . . . . 160.28 171.78 26.64 Favored Glycine 0 CA--C 1.531 1.092 0 C-N-CA 125.112 1.339 . . . . 0.0 113.161 -174.098 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 2461 ' ' ALA . . . . . . . . . . . . . . . -75.62 138.2 41.24 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 123.959 0.904 . . . . 0.0 112.241 -178.76 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 2462 ' ' LEU . . . . . . . . . . . . . 50.0 tp -119.84 143.09 48.08 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.462 1.505 . . . . 0.0 110.658 176.734 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 2463 ' ' SER . . . . . . . . . . . . . 12.5 t -128.37 162.71 26.47 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.114 1.365 . . . . 0.0 110.355 160.637 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 2464 ' ' VAL . . . . . . . . . . . . . 7.2 p -162.18 133.06 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 C-N-CA 124.852 1.261 . . . . 0.0 110.353 -178.94 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 2465 ' ' THR . . . . . . . . . . . . . 79.8 m -133.95 138.73 45.66 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 125.236 1.414 . . . . 0.0 109.184 -178.374 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 2466 ' ' ILE . . . . . . . . . . . . . 33.7 mt -119.08 114.94 46.31 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 C-N-CA 124.036 0.934 . . . . 0.0 109.388 177.065 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 2467 ' ' ASP . . . . . . . . . . . . . 33.4 t70 -99.11 165.47 11.71 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 126.01 1.724 . . . . 0.0 110.151 168.501 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 2468 ' ' GLY . . . . . . . . . . . . . . . 168.93 -161.9 35.62 Favored Glycine 0 CA--C 1.536 1.391 0 O-C-N 121.009 -1.057 . . . . 0.0 115.283 178.009 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 2469 ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -67.94 -16.23 45.01 Favored 'Trans proline' 0 CA--C 1.54 0.8 0 C-N-CA 124.297 3.331 . . . . 0.0 113.404 178.808 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 2470 ' ' SER . . . . . . . . . . . . . 32.9 m -151.98 175.09 12.87 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 127.14 2.176 . . . . 0.0 109.31 169.743 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 2471 ' ' LYS . . . . . . . . . . . . . 98.7 mttt -67.74 164.41 19.5 Favored 'General case' 0 CA--C 1.548 0.886 0 O-C-N 121.002 -1.061 . . . . 0.0 111.69 166.484 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 2472 ' ' VAL . . . . . . . . . . . . . 27.2 m -123.08 153.68 28.33 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 C-N-CA 125.168 1.387 . . . . 0.0 111.011 177.057 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 2473 ' ' LYS . . . . . . . . . . . . . 88.3 tttt -91.62 129.17 37.64 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 123.229 0.611 . . . . 0.0 109.387 163.243 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 2474 ' ' MET . . . . . . . . . . . . . 99.0 mtp -121.01 149.55 42.5 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 124.989 1.315 . . . . 0.0 111.895 -177.467 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 2475 ' ' ASP . . . . . . . . . . . . . 38.6 t0 -138.69 83.18 1.95 Allowed 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 126.953 2.101 . . . . 0.0 109.135 174.961 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 2476 ' ' CYS . . . . . . . . . . . . . 24.1 t -77.15 133.5 38.95 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 123.853 0.861 . . . . 0.0 111.126 177.783 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 2477 ' ' GLN . . . . . . . . . . . . . 34.9 mt-30 -138.81 179.93 6.2 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 127.734 2.414 . . . . 0.0 109.357 -169.328 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 2478 ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -143.57 149.18 37.03 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.364 1.066 . . . . 0.0 112.019 179.909 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 2479 ' ' CYS . . . . . . . . . . . . . 20.8 p -156.84 174.14 4.31 Favored Pre-proline 0 CA--C 1.553 1.086 0 C-N-CA 126.108 1.763 . . . . 0.0 110.99 -176.752 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 2480 ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -58.44 -24.72 70.34 Favored 'Trans proline' 0 CA--C 1.539 0.748 0 C-N-CA 123.349 2.7 . . . . 0.0 114.711 177.776 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 2481 ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -79.76 -17.27 53.87 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 124.285 1.034 . . . . 0.0 112.987 178.172 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 2482 ' ' GLY . . . . . . . . . . . . . . . 136.26 -154.5 22.01 Favored Glycine 0 CA--C 1.531 1.056 0 C-N-CA 125.818 1.675 . . . . 0.0 113.372 -178.853 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 2483 ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -85.55 115.23 23.13 Favored 'General case' 0 N--CA 1.468 0.449 0 O-C-N 121.78 -0.835 . . . . 0.0 110.774 175.541 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 2484 ' ' ARG . . . . . . . . . . . . . 35.9 ttt-85 -95.95 121.73 38.0 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 124.401 1.08 . . . . 0.0 110.241 -178.0 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 2485 ' ' VAL . . . . . . . . . . . . . 66.1 t -103.02 125.67 57.39 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 C-N-CA 124.933 1.293 . . . . 0.0 108.392 177.187 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 2486 ' ' THR . . . . . . . . . . . . . 91.8 m -111.69 139.49 47.11 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 167.434 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 2487 ' ' TYR . . . . . . . . . . . . . 14.1 p90 -151.01 154.85 37.84 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 113.361 0.875 . . . . 0.0 113.361 177.022 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 2488 ' ' THR . . . . . . . . . . . . . 98.9 m -118.33 115.49 35.96 Favored Pre-proline 0 N--CA 1.475 0.78 0 C-N-CA 124.717 1.207 . . . . 0.0 109.725 176.996 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 2489 ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -81.3 163.14 19.77 Favored 'Trans proline' 0 C--N 1.351 0.667 0 C-N-CA 123.987 3.125 . . . . 0.0 111.165 169.89 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 2490 ' ' MET . . . . . . . . . . . . . 25.8 ptm -143.05 4.29 1.43 Allowed 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 115.482 1.66 . . . . 0.0 115.482 -170.895 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 2491 ' ' ALA . . . . . . . . . . . . . . . -146.11 148.37 34.99 Favored Pre-proline 0 CA--C 1.546 0.819 0 C-N-CA 125.112 1.365 . . . . 0.0 110.901 174.769 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 2492 ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -72.2 145.37 43.73 Favored 'Trans proline' 0 CA--C 1.536 0.61 0 C-N-CA 122.813 2.342 . . . . 0.0 110.997 177.025 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 2493 ' ' GLY . . . . . . . . . . . . . . . 136.77 -167.03 24.72 Favored Glycine 0 CA--C 1.53 0.971 0 C-N-CA 125.34 1.448 . . . . 0.0 113.44 -177.141 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 2494 ' ' SER . . . . . . . . . . . . . 50.2 m -98.77 120.14 38.7 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.271 1.028 . . . . 0.0 111.298 -179.128 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 2495 ' ' TYR . . . . . . . . . . . . . 73.0 m-85 -93.01 124.96 37.35 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.215 1.006 . . . . 0.0 110.395 170.855 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 2496 ' ' LEU . . . . . . . . . . . . . 22.8 tp -96.65 111.35 23.53 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.423 1.089 . . . . 0.0 109.788 -178.888 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 2497 ' ' ILE . . . . . . . . . . . . . 49.9 mt -98.73 102.1 12.98 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 C-N-CA 126.057 1.743 . . . . 0.0 108.429 -176.663 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 2498 ' ' SER . . . . . . . . . . . . . 73.2 m -92.76 98.34 11.34 Favored 'General case' 0 N--CA 1.468 0.425 0 C-N-CA 124.608 1.163 . . . . 0.0 110.25 178.492 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 2499 ' ' ILE . . . . . . . . . . . . . 28.0 mt -96.05 120.53 45.54 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 C-N-CA 125.834 1.654 . . . . 0.0 109.349 179.65 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 2500 ' ' LYS . . . . . . . . . . . . . 90.5 mttt -134.08 127.78 32.86 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.264 1.026 . . . . 0.0 112.788 -171.137 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 2501 ' ' TYR . . . . . . . . . . . . . 57.5 t80 -128.09 151.56 49.04 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 124.828 1.251 . . . . 0.0 112.621 -171.674 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 2502 ' ' GLY . . . . . . . . . . . . . . . 64.91 20.02 66.17 Favored Glycine 0 CA--C 1.536 1.378 0 C-N-CA 124.241 0.924 . . . . 0.0 113.733 178.297 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 2503 ' ' GLY . . . . . . . . . . . . . . . 126.32 -166.46 19.09 Favored Glycine 0 CA--C 1.542 1.721 0 C-N-CA 125.878 1.704 . . . . 0.0 112.42 -164.785 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 2504 ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -82.11 31.77 0.52 Allowed 'Trans proline' 0 CA--C 1.546 1.113 0 C-N-CA 124.985 3.79 . . . . 0.0 113.522 -173.043 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 2505 ' ' TYR . . . . . . . . . . . . . 75.5 m-85 -113.87 131.47 56.26 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.66 1.184 . . . . 0.0 112.773 -172.933 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 2506 ' ' HIS . . . . . . . . . . . . . 89.5 m-70 -60.54 140.05 57.5 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 124.681 1.192 . . . . 0.0 113.687 -177.072 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 2507 ' ' ILE . . . . . . . . . . . . . 2.2 pp -84.45 160.58 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.199 0 C-N-CA 123.962 0.905 . . . . 0.0 112.442 173.691 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 2508 ' ' GLY . . . . . . . . . . . . . . . 38.67 -110.63 0.14 Allowed Glycine 0 CA--C 1.537 1.435 0 C-N-CA 125.291 1.424 . . . . 0.0 115.607 161.641 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 2509 ' ' GLY . . . . . . . . . . . . . . . -104.75 15.82 48.26 Favored Glycine 0 CA--C 1.538 1.51 0 C-N-CA 126.37 1.938 . . . . 0.0 114.637 175.74 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 2510 ' ' SER . . . . . . . . . . . . . 33.3 t -67.85 146.38 98.32 Favored Pre-proline 0 CA--C 1.551 0.987 0 C-N-CA 125.38 1.472 . . . . 0.0 112.181 179.449 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 2511 ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -79.6 156.19 89.34 Favored 'Cis proline' 0 C--N 1.351 0.687 0 CA-C-N 119.728 0.939 . . . . 0.0 112.915 -0.544 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 2512 ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -106.17 136.14 46.39 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 125.178 1.391 . . . . 0.0 111.07 179.822 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 2513 ' ' LYS . . . . . . . . . . . . . 19.5 ptpt -94.17 11.72 29.11 Favored 'General case' 0 CA--C 1.552 1.024 0 N-CA-C 116.51 2.041 . . . . 0.0 116.51 -164.994 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 2514 ' ' ALA . . . . . . . . . . . . . . . -4.78 99.35 0.01 OUTLIER 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 129.561 3.145 . . . . 0.0 116.474 -179.211 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 2515 ' ' LYS . . . . . . . . . . . . . 52.9 mtpt -89.02 120.0 30.05 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.258 1.023 . . . . 0.0 111.529 -173.332 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 2516 ' ' VAL . . . . . . . . . . . . . 55.0 t -113.14 142.58 25.1 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 125.788 1.635 . . . . 0.0 110.435 -172.484 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 2517 ' ' THR . . . . . . . . . . . . . 40.9 p -127.88 171.88 11.38 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 125.664 1.586 . . . . 0.0 111.458 178.151 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 2518 ' ' GLY . . . . . . . . . . . . . . . 107.31 -173.74 19.08 Favored Glycine 0 CA--C 1.538 1.53 0 C-N-CA 124.919 1.247 . . . . 0.0 113.264 -176.792 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 2519 ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -71.05 156.2 60.32 Favored 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 123.705 2.937 . . . . 0.0 112.209 -176.092 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 2520 ' ' ARG . . . . . . . . . . . . . 39.9 ttm105 -88.13 122.86 32.19 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 123.915 0.886 . . . . 0.0 110.0 171.852 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 2521 ' ' LEU . . . . . . . . . . . . . 4.1 mm? -85.8 -27.39 25.19 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.105 0.962 . . . . 0.0 112.823 -175.665 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 2522 ' ' VAL . . . . . . . . . . . . . 9.9 p . . . . . 0 C--O 1.254 1.292 0 C-N-CA 124.97 1.308 . . . . 0.0 112.625 176.297 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.569 0 N-CA-C 112.009 -0.437 . . . . 0.0 112.009 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -158.82 163.75 36.4 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 125.707 1.603 . . . . 0.0 112.141 -178.489 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 93.3 mmm 79.83 138.41 0.07 Allowed 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 129.042 2.937 . . . . 0.0 113.215 175.394 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 2427 ' ' GLY . . . . . . . . . . . . . . . -86.41 147.18 21.31 Favored Glycine 0 CA--C 1.529 0.951 0 C-N-CA 125.508 1.527 . . . . 0.0 113.099 178.202 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 2428 ' ' ASP . . . . . . . . . . . . . 29.4 m-20 -91.66 136.5 26.47 Favored Pre-proline 0 CA--C 1.547 0.853 0 C-N-CA 124.517 1.127 . . . . 0.0 112.0 -179.087 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 2429 ' ' PRO . . . . . . . . . . . . . 79.6 Cg_exo -54.75 -27.58 53.0 Favored 'Trans proline' 0 C--N 1.353 0.772 0 C-N-CA 123.994 3.129 . . . . 0.0 114.862 175.577 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 2430 ' ' GLY . . . . . . . . . . . . . . . -80.02 -24.54 59.54 Favored Glycine 0 CA--C 1.535 1.285 0 C-N-CA 123.762 0.696 . . . . 0.0 113.969 176.615 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 2431 ' ' LEU . . . . . . . . . . . . . 4.2 mm? -86.22 -32.77 21.0 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.575 1.15 . . . . 0.0 111.315 172.896 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 2432 ' ' VAL . . . . . . . . . . . . . 82.5 t -65.08 136.75 26.18 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 C-N-CA 123.723 0.809 . . . . 0.0 109.723 167.758 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 2433 ' ' SER . . . . . . . . . . . . . 8.4 t -131.88 -168.85 2.1 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.827 1.251 . . . . 0.0 110.823 177.311 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 2434 ' ' ALA . . . . . . . . . . . . . . . -149.91 142.64 24.63 Favored 'General case' 0 CA--C 1.539 0.531 0 O-C-N 121.062 -1.024 . . . . 0.0 111.988 176.395 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 2435 ' ' TYR . . . . . . . . . . . . . 77.4 m-85 -145.79 148.85 33.38 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 125.386 1.474 . . . . 0.0 112.001 -176.416 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 2436 ' ' GLY . . . . . . . . . . . . . . . 123.99 160.42 10.79 Favored Glycine 0 N--CA 1.474 1.2 0 C-N-CA 125.245 1.402 . . . . 0.0 113.974 176.708 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 2437 ' ' ALA . . . . . . . . . . . . . . . -60.93 -30.19 70.06 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.007 1.323 . . . . 0.0 114.167 -171.057 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 2438 ' ' GLY . . . . . . . . . . . . . . . -67.19 -9.81 55.21 Favored Glycine 0 CA--C 1.533 1.169 0 C-N-CA 124.57 1.081 . . . . 0.0 114.514 -179.632 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 2439 ' ' LEU . . . . . . . . . . . . . 88.3 mt -79.41 -26.12 41.95 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 118.973 1.386 . . . . 0.0 112.553 168.397 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 2440 ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -95.94 -36.37 11.09 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.081 1.352 . . . . 0.0 112.236 -173.851 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 2441 ' ' GLY . . . . . . . . . . . . . . . 160.32 -148.96 17.97 Favored Glycine 0 CA--C 1.532 1.134 0 C-N-CA 124.79 1.186 . . . . 0.0 113.146 -176.053 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 2442 ' ' GLY . . . . . . . . . . . . . . . 150.68 178.63 25.72 Favored Glycine 0 CA--C 1.534 1.249 0 C-N-CA 125.412 1.482 . . . . 0.0 112.796 -175.85 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 2443 ' ' VAL . . . . . . . . . . . . . 83.9 t -101.81 134.77 41.33 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 C-N-CA 124.722 1.209 . . . . 0.0 110.097 -179.583 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 2444 ' ' THR . . . . . . . . . . . . . 25.5 p -63.19 140.07 58.84 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.212 1.005 . . . . 0.0 112.325 176.935 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 2445 ' ' GLY . . . . . . . . . . . . . . . 79.58 -11.51 32.19 Favored Glycine 0 CA--C 1.536 1.385 0 C-N-CA 124.705 1.145 . . . . 0.0 114.328 -174.887 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 2446 ' ' ASN . . . . . . . . . . . . . 82.1 m-20 -106.36 152.14 40.48 Favored Pre-proline 0 CA--C 1.548 0.884 0 C-N-CA 125.453 1.501 . . . . 0.0 110.901 173.19 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 2447 ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -73.05 134.28 21.11 Favored 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 122.789 2.326 . . . . 0.0 111.335 175.875 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 2448 ' ' ALA . . . . . . . . . . . . . . . -111.48 156.69 21.3 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 126.232 1.813 . . . . 0.0 109.225 162.049 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 2449 ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -153.37 153.93 33.52 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 113.901 1.074 . . . . 0.0 113.901 -173.389 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 2450 ' ' PHE . . . . . . . . . . . . . 40.2 p90 -158.0 161.02 38.08 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.863 1.665 . . . . 0.0 110.696 177.336 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 2451 ' ' VAL . . . . . . . . . . . . . 14.7 p -113.04 135.07 53.68 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 C-N-CA 124.697 1.199 . . . . 0.0 110.968 175.121 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 2452 ' ' VAL . . . . . . . . . . . . . 25.1 t -84.89 101.76 9.86 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 N-CA-C 106.337 -1.727 . . . . 0.0 106.337 163.315 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 2453 ' ' ASN . . . . . . . . . . . . . 15.8 t-20 -88.66 123.5 33.17 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 123.72 0.808 . . . . 0.0 112.335 -167.006 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 2454 ' ' THR . . . . . . . . . . . . . 69.0 p -109.89 2.03 19.56 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 125.878 1.671 . . . . 0.0 113.745 -174.178 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 2455 ' ' SER . . . . . . . . . . . . . 42.0 m -56.57 -30.93 63.71 Favored 'General case' 0 N--CA 1.479 0.976 0 N-CA-C 114.537 1.31 . . . . 0.0 114.537 -172.887 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 2456 ' ' ASN . . . . . . . . . . . . . 28.0 m120 -88.96 -8.44 54.12 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 124.896 1.278 . . . . 0.0 113.55 177.297 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 2457 ' ' ALA . . . . . . . . . . . . . . . -113.18 -47.64 3.01 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 125.387 1.475 . . . . 0.0 113.755 -170.166 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 2458 ' ' GLY . . . . . . . . . . . . . . . 105.48 -151.29 17.12 Favored Glycine 0 CA--C 1.534 1.277 0 C-N-CA 125.333 1.444 . . . . 0.0 113.144 -174.219 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 2459 ' ' ALA . . . . . . . . . . . . . . . -77.44 156.64 30.97 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.811 1.245 . . . . 0.0 114.023 -174.43 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 2460 ' ' GLY . . . . . . . . . . . . . . . 158.22 172.09 24.93 Favored Glycine 0 CA--C 1.531 1.073 0 C-N-CA 125.246 1.403 . . . . 0.0 113.655 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 2461 ' ' ALA . . . . . . . . . . . . . . . -100.39 148.9 24.2 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.9 1.28 . . . . 0.0 112.84 -176.965 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 2462 ' ' LEU . . . . . . . . . . . . . 16.3 tp -101.97 149.41 24.26 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 125.526 1.531 . . . . 0.0 111.357 176.888 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 2463 ' ' SER . . . . . . . . . . . . . 3.7 t -140.89 40.29 1.82 Allowed 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 125.223 1.409 . . . . 0.0 111.427 179.136 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 2464 ' ' VAL . . . . . . . . . . . . . 14.2 p -65.36 139.23 21.7 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 C-N-CA 125.124 1.37 . . . . 0.0 112.574 -174.928 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 2465 ' ' THR . . . . . . . . . . . . . 93.5 m -135.04 143.38 46.71 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 125.791 1.636 . . . . 0.0 109.706 175.869 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 2466 ' ' ILE . . . . . . . . . . . . . 35.2 mt -121.12 123.97 71.13 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 C-N-CA 124.079 0.951 . . . . 0.0 110.122 175.989 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 2467 ' ' ASP . . . . . . . . . . . . . 34.4 t70 -104.17 162.91 12.78 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 126.809 2.044 . . . . 0.0 110.077 169.048 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 2468 ' ' GLY . . . . . . . . . . . . . . . 168.95 -161.55 35.25 Favored Glycine 0 CA--C 1.536 1.376 0 O-C-N 120.841 -1.162 . . . . 0.0 115.414 178.265 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 2469 ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -71.48 -17.72 30.05 Favored 'Trans proline' 0 CA--C 1.539 0.747 0 C-N-CA 124.006 3.138 . . . . 0.0 113.341 -178.827 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 2470 ' ' SER . . . . . . . . . . . . . 43.3 m -156.79 -168.36 2.65 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 127.213 2.205 . . . . 0.0 109.762 178.775 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 2471 ' ' LYS . . . . . . . . . . . . . 49.0 mmtm -74.12 174.78 8.21 Favored 'General case' 0 CA--C 1.55 0.968 0 O-C-N 120.661 -1.275 . . . . 0.0 112.523 170.32 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 2472 ' ' VAL . . . . . . . . . . . . . 35.4 m -131.06 148.36 33.01 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 C-N-CA 125.448 1.499 . . . . 0.0 109.971 165.848 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 2473 ' ' LYS . . . . . . . . . . . . . 88.5 tttt -94.44 102.89 14.87 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 166.146 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 2474 ' ' MET . . . . . . . . . . . . . 55.4 ttp -117.27 144.56 44.71 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.994 1.317 . . . . 0.0 112.732 -173.193 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 2475 ' ' ASP . . . . . . . . . . . . . 31.7 t70 -127.98 132.97 49.15 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 126.991 2.116 . . . . 0.0 110.057 170.479 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 2476 ' ' CYS . . . . . . . . . . . . . 45.3 t -109.73 138.55 45.93 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 125.138 1.375 . . . . 0.0 111.334 178.291 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 2477 ' ' GLN . . . . . . . . . . . . . 81.6 mt-30 -133.68 128.65 35.46 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.035 1.334 . . . . 0.0 110.392 -175.079 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 2478 ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -81.57 137.01 35.58 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.34 1.056 . . . . 0.0 109.9 173.159 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 2479 ' ' CYS . . . . . . . . . . . . . 29.6 p -156.01 167.24 14.69 Favored Pre-proline 0 CA--C 1.552 1.034 0 C-N-CA 125.024 1.33 . . . . 0.0 111.607 -172.922 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 2480 ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -65.28 -16.81 56.3 Favored 'Trans proline' 0 CA--C 1.543 0.941 0 C-N-CA 122.701 2.267 . . . . 0.0 113.266 174.807 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 2481 ' ' GLU . . . . . . . . . . . . . 19.6 tt0 -80.21 -10.72 59.77 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 124.969 1.308 . . . . 0.0 112.535 173.374 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 2482 ' ' GLY . . . . . . . . . . . . . . . 122.57 -126.35 6.34 Favored Glycine 0 N--CA 1.473 1.115 0 C-N-CA 125.999 1.761 . . . . 0.0 112.102 -177.048 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 2483 ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -115.85 108.84 16.82 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 123.789 0.836 . . . . 0.0 110.572 171.422 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 2484 ' ' ARG . . . . . . . . . . . . . 42.2 ttm-85 -92.59 132.49 36.82 Favored 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 124.007 0.923 . . . . 0.0 109.63 175.8 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 2485 ' ' VAL . . . . . . . . . . . . . 32.6 m -117.65 144.37 25.75 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 C-N-CA 123.845 0.858 . . . . 0.0 110.327 174.97 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 2486 ' ' THR . . . . . . . . . . . . . 88.6 m -124.32 132.75 53.57 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 125.447 1.499 . . . . 0.0 107.49 171.089 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 2487 ' ' TYR . . . . . . . . . . . . . 19.4 p90 -142.46 146.83 35.2 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 113.34 0.867 . . . . 0.0 113.34 178.973 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 2488 ' ' THR . . . . . . . . . . . . . 65.1 m -106.17 116.11 59.98 Favored Pre-proline 0 N--CA 1.471 0.608 0 C-N-CA 124.501 1.12 . . . . 0.0 109.216 172.49 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 2489 ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -79.98 153.8 22.39 Favored 'Trans proline' 0 C--N 1.351 0.681 0 C-N-CA 123.717 2.945 . . . . 0.0 110.665 170.475 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 2490 ' ' MET . . . . . . . . . . . . . 28.5 ptm -117.08 -5.3 11.41 Favored 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 115.055 1.502 . . . . 0.0 115.055 -174.861 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 2491 ' ' ALA . . . . . . . . . . . . . . . -146.5 144.73 21.43 Favored Pre-proline 0 CA--C 1.548 0.898 0 C-N-CA 124.731 1.212 . . . . 0.0 111.447 177.801 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 2492 ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -70.26 156.05 62.91 Favored 'Trans proline' 0 C--N 1.35 0.64 0 C-N-CA 123.571 2.847 . . . . 0.0 111.357 177.88 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 2493 ' ' GLY . . . . . . . . . . . . . . . 126.52 -154.62 19.18 Favored Glycine 0 CA--C 1.528 0.898 0 C-N-CA 124.886 1.231 . . . . 0.0 113.241 -178.929 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 2494 ' ' SER . . . . . . . . . . . . . 74.0 m -104.5 112.94 26.2 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 123.709 0.804 . . . . 0.0 112.206 -176.893 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 2495 ' ' TYR . . . . . . . . . . . . . 69.0 m-85 -88.64 129.6 35.47 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 123.524 0.73 . . . . 0.0 109.89 162.877 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 2496 ' ' LEU . . . . . . . . . . . . . 29.0 tp -101.55 117.69 35.43 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.697 1.199 . . . . 0.0 109.521 179.052 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 2497 ' ' ILE . . . . . . . . . . . . . 61.9 mt -103.46 99.98 9.5 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 C-N-CA 125.574 1.55 . . . . 0.0 108.407 -170.087 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 2498 ' ' SER . . . . . . . . . . . . . 74.6 m -83.32 86.28 7.08 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 125.071 1.348 . . . . 0.0 109.864 176.495 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 2499 ' ' ILE . . . . . . . . . . . . . 37.0 mt -79.19 110.86 15.36 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 C-N-CA 124.124 0.97 . . . . 0.0 109.162 175.876 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 2500 ' ' LYS . . . . . . . . . . . . . 83.7 mttt -121.75 145.46 48.02 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.859 1.264 . . . . 0.0 111.51 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 2501 ' ' TYR . . . . . . . . . . . . . 47.5 t80 -149.31 146.54 27.59 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.563 1.145 . . . . 0.0 112.16 -171.447 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 2502 ' ' GLY . . . . . . . . . . . . . . . 67.19 19.36 70.18 Favored Glycine 0 CA--C 1.536 1.394 0 C-N-CA 124.25 0.928 . . . . 0.0 113.735 177.552 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 2503 ' ' GLY . . . . . . . . . . . . . . . 131.7 -167.32 22.73 Favored Glycine 0 CA--C 1.541 1.699 0 C-N-CA 125.93 1.729 . . . . 0.0 112.364 -166.13 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 2504 ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -81.83 26.77 0.61 Allowed 'Trans proline' 0 CA--C 1.547 1.154 0 C-N-CA 124.921 3.747 . . . . 0.0 113.588 -174.291 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 2505 ' ' TYR . . . . . . . . . . . . . 60.2 m-85 -112.23 134.36 53.82 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 124.638 1.175 . . . . 0.0 113.02 -171.72 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 2506 ' ' HIS . . . . . . . . . . . . . 95.2 m-70 -63.4 142.53 58.36 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 124.842 1.257 . . . . 0.0 113.462 -179.326 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 2507 ' ' ILE . . . . . . . . . . . . . 1.8 pp -83.37 173.43 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.319 0 C-N-CA 123.628 0.771 . . . . 0.0 113.015 174.428 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 2508 ' ' GLY . . . . . . . . . . . . . . . -59.69 113.73 5.57 Favored Glycine 0 CA--C 1.534 1.248 0 O-C-N 121.469 -0.769 . . . . 0.0 112.783 -177.027 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 2509 ' ' GLY . . . . . . . . . . . . . . . 92.66 -5.32 76.79 Favored Glycine 0 CA--C 1.536 1.354 0 C-N-CA 125.615 1.579 . . . . 0.0 114.861 -177.238 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 2510 ' ' SER . . . . . . . . . . . . . 35.0 t -82.22 146.56 54.96 Favored Pre-proline 0 CA--C 1.55 0.969 0 CA-C-N 118.898 1.349 . . . . 0.0 112.271 179.381 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 2511 ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -77.49 156.54 96.09 Favored 'Cis proline' 0 C--N 1.354 0.845 0 CA-C-N 120.02 1.043 . . . . 0.0 113.305 -0.886 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 2512 ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -107.47 134.47 50.45 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 125.32 1.448 . . . . 0.0 111.263 178.682 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 2513 ' ' LYS . . . . . . . . . . . . . 40.4 ttmt -99.47 100.48 11.52 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 123.856 0.862 . . . . 0.0 111.966 -178.15 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 2514 ' ' ALA . . . . . . . . . . . . . . . -82.06 109.35 16.31 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.025 1.33 . . . . 0.0 110.787 177.069 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 2515 ' ' LYS . . . . . . . . . . . . . 30.6 mtmm -91.65 81.2 5.3 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.805 1.642 . . . . 0.0 109.324 -175.954 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 2516 ' ' VAL . . . . . . . . . . . . . 21.0 m -83.49 153.7 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 C-N-CA 124.338 1.055 . . . . 0.0 111.41 -173.226 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 2517 ' ' THR . . . . . . . . . . . . . 77.0 p -132.31 179.46 6.1 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 125.853 1.661 . . . . 0.0 111.118 -175.437 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 2518 ' ' GLY . . . . . . . . . . . . . . . 104.49 -176.15 23.08 Favored Glycine 0 CA--C 1.539 1.576 0 C-N-CA 124.891 1.234 . . . . 0.0 113.309 -176.492 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 2519 ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -74.28 148.59 39.04 Favored 'Trans proline' 0 CA--C 1.537 0.644 0 C-N-CA 123.72 2.946 . . . . 0.0 112.085 -173.92 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 2520 ' ' ARG . . . . . . . . . . . . . 38.3 ttp-105 -89.31 -60.68 1.88 Allowed 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 124.17 0.988 . . . . 0.0 111.883 -179.582 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 2521 ' ' LEU . . . . . . . . . . . . . 40.7 mt 68.7 6.94 5.8 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 127.543 2.337 . . . . 0.0 114.852 175.136 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 2522 ' ' VAL . . . . . . . . . . . . . 31.0 m . . . . . 0 N--CA 1.485 1.321 0 C-N-CA 126.34 1.856 . . . . 0.0 113.057 178.493 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.451 0 N-CA-C 111.237 -0.745 . . . . 0.0 111.237 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -81.24 -176.79 6.16 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 124.831 1.252 . . . . 0.0 112.671 177.907 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 38.0 mmt -72.11 135.23 46.17 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 123.833 0.853 . . . . 0.0 111.306 172.757 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 2427 ' ' GLY . . . . . . . . . . . . . . . -83.27 144.4 22.5 Favored Glycine 0 CA--C 1.53 0.971 0 C-N-CA 125.047 1.308 . . . . 0.0 113.408 -177.012 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 2428 ' ' ASP . . . . . . . . . . . . . 15.3 t70 -100.08 138.87 20.38 Favored Pre-proline 0 CA--C 1.55 0.953 0 C-N-CA 125.314 1.446 . . . . 0.0 111.471 179.448 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 2429 ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -55.49 -26.83 56.11 Favored 'Trans proline' 0 C--N 1.353 0.785 0 C-N-CA 123.782 2.988 . . . . 0.0 115.448 179.85 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 2430 ' ' GLY . . . . . . . . . . . . . . . -81.99 -24.36 55.33 Favored Glycine 0 CA--C 1.533 1.157 0 CA-C-N 119.155 0.889 . . . . 0.0 113.548 176.738 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 2431 ' ' LEU . . . . . . . . . . . . . 4.4 mm? -85.56 -33.75 21.64 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.481 1.112 . . . . 0.0 111.535 172.825 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 2432 ' ' VAL . . . . . . . . . . . . . 87.0 t -66.76 137.2 25.31 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 123.483 0.713 . . . . 0.0 109.539 168.477 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 2433 ' ' SER . . . . . . . . . . . . . 8.3 t -133.39 -170.58 2.51 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 124.85 1.26 . . . . 0.0 110.801 177.773 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 2434 ' ' ALA . . . . . . . . . . . . . . . -152.79 144.39 23.45 Favored 'General case' 0 CA--C 1.537 0.477 0 O-C-N 120.963 -1.086 . . . . 0.0 111.996 176.089 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 2435 ' ' TYR . . . . . . . . . . . . . 74.7 m-85 -147.33 150.2 34.29 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 125.566 1.547 . . . . 0.0 111.825 -174.455 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 2436 ' ' GLY . . . . . . . . . . . . . . . 121.79 162.91 11.77 Favored Glycine 0 N--CA 1.473 1.118 0 C-N-CA 125.288 1.423 . . . . 0.0 113.999 177.135 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 2437 ' ' ALA . . . . . . . . . . . . . . . -60.95 -28.77 69.21 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 125.099 1.36 . . . . 0.0 114.407 -169.677 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 2438 ' ' GLY . . . . . . . . . . . . . . . -66.72 -15.53 64.48 Favored Glycine 0 CA--C 1.532 1.103 0 CA-C-O 118.867 -0.963 . . . . 0.0 114.417 -178.802 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 2439 ' ' LEU . . . . . . . . . . . . . 84.4 mt -76.37 -24.96 54.16 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 118.866 1.333 . . . . 0.0 112.44 169.716 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 2440 ' ' GLU . . . . . . . . . . . . . 43.0 mm-40 -90.89 -31.79 16.27 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.15 1.38 . . . . 0.0 111.896 176.189 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 2441 ' ' GLY . . . . . . . . . . . . . . . 109.22 -133.41 11.63 Favored Glycine 0 CA--C 1.531 1.042 0 C-N-CA 125.921 1.724 . . . . 0.0 112.763 178.928 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 2442 ' ' GLY . . . . . . . . . . . . . . . 135.41 -154.59 21.76 Favored Glycine 0 CA--C 1.533 1.195 0 C-N-CA 124.826 1.203 . . . . 0.0 114.433 -176.998 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 2443 ' ' VAL . . . . . . . . . . . . . 93.0 t -74.37 136.14 25.88 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 C-N-CA 124.284 1.034 . . . . 0.0 111.488 -172.516 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 2444 ' ' THR . . . . . . . . . . . . . 25.1 p -63.37 133.13 53.54 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.445 1.098 . . . . 0.0 111.471 174.908 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 2445 ' ' GLY . . . . . . . . . . . . . . . 85.03 -8.41 70.44 Favored Glycine 0 CA--C 1.536 1.361 0 C-N-CA 124.667 1.127 . . . . 0.0 114.76 -176.511 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 2446 ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -86.01 152.86 56.78 Favored Pre-proline 0 CA--C 1.551 1.018 0 CA-C-N 118.976 1.388 . . . . 0.0 111.796 174.811 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 2447 ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -75.5 97.5 1.1 Allowed 'Trans proline' 0 CA--C 1.538 0.693 0 C-N-CA 123.156 2.571 . . . . 0.0 110.024 173.979 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 2448 ' ' ALA . . . . . . . . . . . . . . . -78.47 143.23 36.85 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.034 0.934 . . . . 0.0 109.481 168.759 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 2449 ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -155.1 148.32 24.89 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 114.33 1.233 . . . . 0.0 114.33 -173.386 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 2450 ' ' PHE . . . . . . . . . . . . . 49.5 p90 -153.93 162.47 41.19 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 126.439 1.895 . . . . 0.0 110.496 -178.91 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 2451 ' ' VAL . . . . . . . . . . . . . 71.5 t -112.68 130.96 65.52 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 C-N-CA 124.821 1.248 . . . . 0.0 109.498 174.953 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 2452 ' ' VAL . . . . . . . . . . . . . 45.5 t -79.52 109.33 14.02 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 161.92 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 2453 ' ' ASN . . . . . . . . . . . . . 12.4 t-20 -88.68 114.5 25.37 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.188 0.995 . . . . 0.0 111.909 -172.372 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 2454 ' ' THR . . . . . . . . . . . . . 70.0 p -107.43 -5.59 17.59 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 125.521 1.528 . . . . 0.0 113.65 -177.91 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 2455 ' ' SER . . . . . . . . . . . . . 13.9 m -57.77 -29.7 65.03 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 124.797 1.239 . . . . 0.0 114.242 -175.033 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 2456 ' ' ASN . . . . . . . . . . . . . 69.0 m-80 -83.16 -10.24 58.75 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 124.688 1.195 . . . . 0.0 113.453 177.097 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 2457 ' ' ALA . . . . . . . . . . . . . . . -115.17 -50.53 2.75 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 125.187 1.395 . . . . 0.0 113.482 -169.459 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 2458 ' ' GLY . . . . . . . . . . . . . . . 121.81 -145.2 16.73 Favored Glycine 0 CA--C 1.533 1.208 0 C-N-CA 125.054 1.312 . . . . 0.0 113.108 -174.083 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 2459 ' ' ALA . . . . . . . . . . . . . . . -96.41 160.22 14.53 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 125.195 1.398 . . . . 0.0 113.113 -175.534 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 2460 ' ' GLY . . . . . . . . . . . . . . . 153.76 164.01 12.33 Favored Glycine 0 CA--C 1.53 1.017 0 C-N-CA 124.261 0.934 . . . . 0.0 114.025 -178.561 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 2461 ' ' ALA . . . . . . . . . . . . . . . -79.7 144.76 33.39 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.37 1.068 . . . . 0.0 112.51 -179.411 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 2462 ' ' LEU . . . . . . . . . . . . . 69.5 tp -115.14 141.38 48.09 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 126.006 1.722 . . . . 0.0 110.526 178.283 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 2463 ' ' SER . . . . . . . . . . . . . 16.4 t -142.11 106.1 4.74 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.532 1.133 . . . . 0.0 109.639 170.959 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 2464 ' ' VAL . . . . . . . . . . . . . 60.5 t -102.39 128.2 55.3 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 C-N-CA 124.083 0.953 . . . . 0.0 109.487 178.881 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 2465 ' ' THR . . . . . . . . . . . . . 98.2 m -116.15 134.22 55.17 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 125.326 1.45 . . . . 0.0 108.636 174.98 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 2466 ' ' ILE . . . . . . . . . . . . . 41.1 mt -122.88 120.3 60.27 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 C-N-CA 123.542 0.737 . . . . 0.0 109.586 177.433 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 2467 ' ' ASP . . . . . . . . . . . . . 32.0 m-20 -107.0 167.69 9.72 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 126.204 1.802 . . . . 0.0 110.168 169.511 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 2468 ' ' GLY . . . . . . . . . . . . . . . 162.78 -153.1 23.56 Favored Glycine 0 CA--C 1.536 1.366 0 CA-C-O 118.854 -0.97 . . . . 0.0 114.481 179.694 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 2469 ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -70.18 -17.54 35.62 Favored 'Trans proline' 0 CA--C 1.54 0.79 0 C-N-CA 123.774 2.983 . . . . 0.0 113.189 180.0 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 2470 ' ' SER . . . . . . . . . . . . . 38.7 m -157.57 -165.17 1.71 Allowed 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 127.546 2.338 . . . . 0.0 109.382 176.383 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 2471 ' ' LYS . . . . . . . . . . . . . 59.3 mtmt -79.13 -175.3 4.53 Favored 'General case' 0 CA--C 1.552 1.042 0 O-C-N 120.802 -1.187 . . . . 0.0 111.79 167.614 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 2472 ' ' VAL . . . . . . . . . . . . . 33.4 m -139.78 151.78 22.32 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 C-N-CA 125.26 1.424 . . . . 0.0 111.09 171.909 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 2473 ' ' LYS . . . . . . . . . . . . . 60.6 mtpt -87.99 86.51 7.14 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 123.836 0.854 . . . . 0.0 110.126 171.706 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 2474 ' ' MET . . . . . . . . . . . . . 58.3 ttm -79.28 143.29 35.38 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 124.277 1.031 . . . . 0.0 112.38 -176.706 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 2475 ' ' ASP . . . . . . . . . . . . . 23.1 t70 -135.56 100.25 4.44 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 126.448 1.899 . . . . 0.0 109.581 165.067 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 2476 ' ' CYS . . . . . . . . . . . . . 44.3 t -95.47 132.3 40.69 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.642 1.177 . . . . 0.0 110.639 175.778 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 2477 ' ' GLN . . . . . . . . . . . . . 86.7 mt-30 -144.99 154.96 43.1 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 125.286 1.434 . . . . 0.0 110.711 -176.511 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 2478 ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -75.95 152.02 37.14 Favored 'General case' 0 CA--C 1.543 0.696 0 O-C-N 121.389 -0.819 . . . . 0.0 112.068 172.464 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 2479 ' ' CYS . . . . . . . . . . . . . 17.3 p -151.39 166.21 15.65 Favored Pre-proline 0 CA--C 1.554 1.106 0 C-N-CA 125.782 1.633 . . . . 0.0 110.774 -179.59 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 2480 ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -66.93 -18.84 52.55 Favored 'Trans proline' 0 CA--C 1.54 0.794 0 C-N-CA 122.327 2.018 . . . . 0.0 113.643 -178.005 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 2481 ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -92.9 -4.0 53.59 Favored 'General case' 0 CA--C 1.553 1.062 0 C-N-CA 125.164 1.386 . . . . 0.0 112.992 175.831 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 2482 ' ' GLY . . . . . . . . . . . . . . . 139.11 -110.85 0.74 Allowed Glycine 0 N--CA 1.471 0.974 0 C-N-CA 125.482 1.515 . . . . 0.0 112.985 179.828 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 2483 ' ' TYR . . . . . . . . . . . . . 95.3 m-85 -130.03 120.08 24.15 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 124.401 1.08 . . . . 0.0 111.317 175.397 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 2484 ' ' ARG . . . . . . . . . . . . . 19.0 ttp-105 -81.05 133.76 35.54 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 123.785 0.834 . . . . 0.0 110.161 171.982 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 2485 ' ' VAL . . . . . . . . . . . . . 89.9 t -115.06 118.07 57.63 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 C-N-CA 125.234 1.414 . . . . 0.0 107.996 168.858 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 2486 ' ' THR . . . . . . . . . . . . . 98.9 m -100.16 146.42 26.85 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 124.872 1.269 . . . . 0.0 108.166 165.405 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 2487 ' ' TYR . . . . . . . . . . . . . 29.2 p90 -153.13 152.0 30.8 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.246 1.018 . . . . 0.0 112.618 171.8 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 2488 ' ' THR . . . . . . . . . . . . . 59.6 m -107.09 113.69 62.14 Favored Pre-proline 0 N--CA 1.473 0.719 0 CA-C-O 117.799 -1.096 . . . . 0.0 109.438 173.918 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 2489 ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -76.01 114.21 3.87 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 123.504 2.803 . . . . 0.0 109.424 172.383 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 2490 ' ' MET . . . . . . . . . . . . . 27.8 ptm -86.42 -7.91 58.06 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 114.661 1.356 . . . . 0.0 114.661 -173.675 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 2491 ' ' ALA . . . . . . . . . . . . . . . -147.04 149.43 35.48 Favored Pre-proline 0 CA--C 1.547 0.855 0 C-N-CA 124.792 1.237 . . . . 0.0 112.146 -179.249 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 2492 ' ' PRO . . . . . . . . . . . . . 78.0 Cg_endo -73.17 155.05 52.21 Favored 'Trans proline' 0 C--N 1.35 0.646 0 C-N-CA 123.627 2.884 . . . . 0.0 111.489 178.243 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 2493 ' ' GLY . . . . . . . . . . . . . . . 131.89 -139.69 11.16 Favored Glycine 0 CA--C 1.529 0.944 0 C-N-CA 125.342 1.449 . . . . 0.0 112.093 -173.635 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 2494 ' ' SER . . . . . . . . . . . . . 65.9 m -133.77 124.99 27.56 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 123.937 0.895 . . . . 0.0 111.465 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 2495 ' ' TYR . . . . . . . . . . . . . 65.6 m-85 -95.53 131.88 41.24 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.845 1.258 . . . . 0.0 111.06 172.759 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 2496 ' ' LEU . . . . . . . . . . . . . 27.8 tp -100.13 114.98 28.76 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 125.297 1.439 . . . . 0.0 109.364 177.881 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 2497 ' ' ILE . . . . . . . . . . . . . 48.2 mt -102.57 102.33 13.42 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 C-N-CA 125.863 1.665 . . . . 0.0 108.667 -173.472 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 2498 ' ' SER . . . . . . . . . . . . . 67.2 m -92.14 109.0 20.35 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 124.888 1.275 . . . . 0.0 109.988 177.413 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 2499 ' ' ILE . . . . . . . . . . . . . 69.1 mt -104.36 104.96 17.64 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 C-N-CA 124.684 1.194 . . . . 0.0 107.926 -176.692 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 2500 ' ' LYS . . . . . . . . . . . . . 84.0 mttt -110.96 137.36 48.68 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.35 1.06 . . . . 0.0 111.244 -179.725 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 2501 ' ' TYR . . . . . . . . . . . . . 51.7 t80 -143.63 137.69 28.48 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 123.915 0.886 . . . . 0.0 111.93 -170.45 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 2502 ' ' GLY . . . . . . . . . . . . . . . 66.54 11.04 55.95 Favored Glycine 0 CA--C 1.537 1.452 0 C-N-CA 124.449 1.023 . . . . 0.0 114.808 177.247 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 2503 ' ' GLY . . . . . . . . . . . . . . . 153.93 -167.53 32.21 Favored Glycine 0 CA--C 1.54 1.625 0 C-N-CA 125.507 1.527 . . . . 0.0 113.31 -170.189 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 2504 ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -82.87 7.88 4.93 Favored 'Trans proline' 0 CA--C 1.543 0.931 0 C-N-CA 124.731 3.621 . . . . 0.0 114.143 -173.43 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 2505 ' ' TYR . . . . . . . . . . . . . 64.4 m-85 -103.24 142.29 34.44 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.648 1.179 . . . . 0.0 113.234 -173.497 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 2506 ' ' HIS . . . . . . . . . . . . . 91.0 m-70 -65.27 147.28 53.72 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 124.278 1.031 . . . . 0.0 112.585 174.891 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 2507 ' ' ILE . . . . . . . . . . . . . 26.9 pt -74.29 169.2 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 O-C-N 121.574 -0.704 . . . . 0.0 112.47 170.524 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 2508 ' ' GLY . . . . . . . . . . . . . . . -57.89 123.88 34.37 Favored Glycine 0 CA--C 1.533 1.18 0 C-N-CA 123.838 0.732 . . . . 0.0 112.179 178.138 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 2509 ' ' GLY . . . . . . . . . . . . . . . 86.92 -10.22 69.02 Favored Glycine 0 CA--C 1.535 1.3 0 C-N-CA 125.535 1.54 . . . . 0.0 114.946 -177.364 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 2510 ' ' SER . . . . . . . . . . . . . 7.2 t -91.65 147.67 35.64 Favored Pre-proline 0 CA--C 1.552 1.045 0 CA-C-N 119.006 1.403 . . . . 0.0 111.538 -179.464 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 2511 ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -73.65 148.0 90.97 Favored 'Cis proline' 0 C--N 1.353 0.814 0 CA-C-N 120.474 1.205 . . . . 0.0 113.546 3.207 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 2512 ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -102.41 131.78 48.85 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 125.262 1.425 . . . . 0.0 110.703 177.764 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 2513 ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.67 106.87 19.03 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 123.934 0.894 . . . . 0.0 111.79 176.149 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 2514 ' ' ALA . . . . . . . . . . . . . . . -92.64 118.55 31.15 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.829 1.652 . . . . 0.0 110.401 177.478 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 2515 ' ' LYS . . . . . . . . . . . . . 48.1 mtpt -94.9 131.51 40.72 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.257 1.023 . . . . 0.0 110.742 -176.733 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 2516 ' ' VAL . . . . . . . . . . . . . 26.9 m -135.43 144.66 33.4 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 C-N-CA 123.832 0.853 . . . . 0.0 112.275 -170.025 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 2517 ' ' THR . . . . . . . . . . . . . 41.3 p -144.76 162.57 36.41 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 125.327 1.451 . . . . 0.0 111.46 -173.177 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 2518 ' ' GLY . . . . . . . . . . . . . . . 117.94 -176.93 16.36 Favored Glycine 0 CA--C 1.539 1.552 0 C-N-CA 125.252 1.406 . . . . 0.0 113.046 -175.039 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 2519 ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -75.41 133.12 15.62 Favored 'Trans proline' 0 C--N 1.349 0.553 0 C-N-CA 123.503 2.802 . . . . 0.0 111.324 -173.72 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 2520 ' ' ARG . . . . . . . . . . . . . 37.7 ttm105 -68.15 -54.11 20.33 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 123.938 0.895 . . . . 0.0 111.699 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 2521 ' ' LEU . . . . . . . . . . . . . 73.1 mt 69.96 -40.57 0.47 Allowed 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 128.966 2.906 . . . . 0.0 114.275 178.809 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 2522 ' ' VAL . . . . . . . . . . . . . 28.4 m . . . . . 0 C--O 1.254 1.311 0 C-N-CA 125.82 1.648 . . . . 0.0 113.772 177.014 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.552 0 N-CA-C 111.476 -0.65 . . . . 0.0 111.476 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -71.99 137.46 47.28 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 124.128 0.971 . . . . 0.0 112.167 179.468 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 25.6 mmt -93.79 138.92 31.45 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.668 1.187 . . . . 0.0 111.507 -179.187 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 2427 ' ' GLY . . . . . . . . . . . . . . . -86.8 153.14 25.53 Favored Glycine 0 CA--C 1.529 0.967 0 C-N-CA 124.967 1.27 . . . . 0.0 112.032 169.658 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 2428 ' ' ASP . . . . . . . . . . . . . 28.5 m-20 -121.46 142.86 36.4 Favored Pre-proline 0 CA--C 1.544 0.714 0 C-N-CA 124.983 1.313 . . . . 0.0 112.098 -177.65 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 2429 ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -64.49 -24.98 63.15 Favored 'Trans proline' 0 CA--C 1.539 0.734 0 C-N-CA 123.196 2.597 . . . . 0.0 112.966 179.12 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 2430 ' ' GLY . . . . . . . . . . . . . . . -73.88 -22.72 77.77 Favored Glycine 0 CA--C 1.535 1.341 0 CA-C-N 118.844 0.747 . . . . 0.0 113.738 174.59 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 2431 ' ' LEU . . . . . . . . . . . . . 4.3 mm? -88.47 -40.96 13.07 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 124.634 1.174 . . . . 0.0 111.201 173.157 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 2432 ' ' VAL . . . . . . . . . . . . . 59.4 t -59.19 137.97 20.91 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 123.936 0.894 . . . . 0.0 111.069 175.038 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 2433 ' ' SER . . . . . . . . . . . . . 8.2 t -127.02 -174.69 3.22 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 125.136 1.374 . . . . 0.0 110.45 171.855 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 2434 ' ' ALA . . . . . . . . . . . . . . . -145.95 146.95 31.23 Favored 'General case' 0 CA--C 1.538 0.487 0 O-C-N 120.91 -1.119 . . . . 0.0 112.123 177.875 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 2435 ' ' TYR . . . . . . . . . . . . . 68.2 m-85 -145.35 150.05 35.89 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 125.411 1.484 . . . . 0.0 111.92 -173.746 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 2436 ' ' GLY . . . . . . . . . . . . . . . 120.63 159.79 10.91 Favored Glycine 0 N--CA 1.474 1.203 0 C-N-CA 125.462 1.506 . . . . 0.0 114.051 177.098 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 2437 ' ' ALA . . . . . . . . . . . . . . . -61.83 -26.98 68.45 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 125.118 1.367 . . . . 0.0 114.446 -171.362 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 2438 ' ' GLY . . . . . . . . . . . . . . . -65.49 -14.48 60.11 Favored Glycine 0 CA--C 1.533 1.183 0 C-N-CA 124.183 0.897 . . . . 0.0 114.217 178.494 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 2439 ' ' LEU . . . . . . . . . . . . . 86.3 mt -78.22 -22.01 49.14 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 118.894 1.347 . . . . 0.0 112.779 169.807 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 2440 ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -98.29 -28.25 13.76 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 125.338 1.455 . . . . 0.0 112.407 -179.268 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 2441 ' ' GLY . . . . . . . . . . . . . . . 105.86 -155.04 16.92 Favored Glycine 0 CA--C 1.533 1.189 0 C-N-CA 125.747 1.641 . . . . 0.0 113.341 179.059 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 2442 ' ' GLY . . . . . . . . . . . . . . . 163.72 -157.06 29.17 Favored Glycine 0 CA--C 1.532 1.102 0 C-N-CA 124.342 0.972 . . . . 0.0 114.071 -175.458 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 2443 ' ' VAL . . . . . . . . . . . . . 61.0 t -87.64 141.33 14.47 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 C-N-CA 124.597 1.159 . . . . 0.0 110.873 -178.192 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 2444 ' ' THR . . . . . . . . . . . . . 26.1 p -62.66 144.3 56.43 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 124.933 1.293 . . . . 0.0 112.666 174.949 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 2445 ' ' GLY . . . . . . . . . . . . . . . 76.33 -9.91 18.59 Favored Glycine 0 CA--C 1.537 1.466 0 C-N-CA 124.605 1.098 . . . . 0.0 114.254 -176.088 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 2446 ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -101.0 142.11 23.97 Favored Pre-proline 0 CA--C 1.553 1.059 0 C-N-CA 126.744 2.018 . . . . 0.0 110.312 175.184 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 2447 ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -76.72 149.32 29.77 Favored 'Trans proline' 0 CA--C 1.536 0.598 0 C-N-CA 123.196 2.597 . . . . 0.0 111.858 178.757 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 2448 ' ' ALA . . . . . . . . . . . . . . . -138.89 141.51 38.56 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 125.648 1.579 . . . . 0.0 109.972 170.834 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 2449 ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -130.21 152.22 49.88 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.23 1.012 . . . . 0.0 113.396 -167.711 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 2450 ' ' PHE . . . . . . . . . . . . . 40.2 p90 -154.3 161.58 41.7 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.972 1.309 . . . . 0.0 111.746 175.445 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 2451 ' ' VAL . . . . . . . . . . . . . 12.3 p -118.26 135.37 58.89 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 C-N-CA 125.273 1.429 . . . . 0.0 110.454 175.35 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 2452 ' ' VAL . . . . . . . . . . . . . 40.9 t -89.19 104.0 14.54 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 N-CA-C 106.751 -1.574 . . . . 0.0 106.751 166.16 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 2453 ' ' ASN . . . . . . . . . . . . . 15.1 t-20 -89.17 117.1 27.9 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 123.955 0.902 . . . . 0.0 112.791 -165.904 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 2454 ' ' THR . . . . . . . . . . . . . 48.5 p -97.63 -2.67 41.01 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 125.809 1.643 . . . . 0.0 114.432 -175.592 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 2455 ' ' SER . . . . . . . . . . . . . 24.4 m -58.0 -27.43 63.5 Favored 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 114.326 1.232 . . . . 0.0 114.326 -176.672 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 2456 ' ' ASN . . . . . . . . . . . . . 81.8 m-20 -76.42 -20.78 56.75 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 124.44 1.096 . . . . 0.0 113.289 175.744 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 2457 ' ' ALA . . . . . . . . . . . . . . . -117.34 -56.49 2.23 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.649 1.18 . . . . 0.0 113.646 -157.151 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 2458 ' ' GLY . . . . . . . . . . . . . . . 113.68 -155.96 15.95 Favored Glycine 0 CA--C 1.534 1.252 0 C-N-CA 124.852 1.215 . . . . 0.0 112.375 -166.893 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 2459 ' ' ALA . . . . . . . . . . . . . . . -85.53 145.52 27.35 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 124.206 1.002 . . . . 0.0 113.681 -173.19 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 2460 ' ' GLY . . . . . . . . . . . . . . . 174.61 160.67 23.1 Favored Glycine 0 CA--C 1.532 1.127 0 C-N-CA 125.357 1.455 . . . . 0.0 113.145 -179.885 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 2461 ' ' ALA . . . . . . . . . . . . . . . -82.2 150.59 27.3 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 124.278 1.031 . . . . 0.0 112.847 -178.388 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 2462 ' ' LEU . . . . . . . . . . . . . 16.9 tp -107.68 147.36 30.83 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.56 1.544 . . . . 0.0 110.976 176.004 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 2463 ' ' SER . . . . . . . . . . . . . 9.5 t -141.06 37.37 1.75 Allowed 'General case' 0 CA--C 1.551 1.005 0 C-N-CA 125.294 1.438 . . . . 0.0 111.563 -179.469 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 2464 ' ' VAL . . . . . . . . . . . . . 12.6 p -61.01 135.73 25.45 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 C-N-CA 125.164 1.386 . . . . 0.0 112.512 -174.888 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 2465 ' ' THR . . . . . . . . . . . . . 95.9 m -136.57 145.24 44.74 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 126.003 1.721 . . . . 0.0 109.727 -179.758 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 2466 ' ' ILE . . . . . . . . . . . . . 30.1 mt -124.89 130.51 73.27 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 124.072 0.949 . . . . 0.0 110.094 176.519 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 2467 ' ' ASP . . . . . . . . . . . . . 33.7 t70 -122.51 128.12 50.4 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 125.949 1.7 . . . . 0.0 109.976 173.919 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 2468 ' ' GLY . . . . . . . . . . . . . . . -155.49 -166.2 15.32 Favored Glycine 0 CA--C 1.537 1.43 0 N-CA-C 115.685 1.034 . . . . 0.0 115.685 -171.174 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 2469 ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -67.72 -16.16 45.83 Favored 'Trans proline' 0 CA--C 1.539 0.765 0 C-N-CA 124.464 3.442 . . . . 0.0 113.267 178.474 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 2470 ' ' SER . . . . . . . . . . . . . 8.1 t -156.63 -168.07 2.58 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 126.491 1.916 . . . . 0.0 109.307 166.346 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 2471 ' ' LYS . . . . . . . . . . . . . 67.7 mttm -74.28 173.66 9.89 Favored 'General case' 0 CA--C 1.55 0.97 0 O-C-N 120.881 -1.137 . . . . 0.0 112.31 169.587 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 2472 ' ' VAL . . . . . . . . . . . . . 33.5 m -127.05 149.18 31.96 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 C-N-CA 125.624 1.57 . . . . 0.0 110.696 174.503 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 2473 ' ' LYS . . . . . . . . . . . . . 59.6 tttp -92.71 97.21 10.64 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 165.685 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 2474 ' ' MET . . . . . . . . . . . . . 48.4 ttp -111.58 142.26 44.12 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 124.874 1.27 . . . . 0.0 112.369 -175.445 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 2475 ' ' ASP . . . . . . . . . . . . . 36.9 t70 -126.05 141.15 52.08 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 126.791 2.037 . . . . 0.0 110.23 170.938 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 2476 ' ' CYS . . . . . . . . . . . . . 63.6 m -123.06 150.82 42.63 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 125.203 1.401 . . . . 0.0 111.989 -173.218 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 2477 ' ' GLN . . . . . . . . . . . . . 3.8 tt0 -151.24 147.14 26.63 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.447 1.099 . . . . 0.0 111.121 179.486 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 2478 ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -90.13 150.06 22.19 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 123.716 0.806 . . . . 0.0 111.083 163.752 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 2479 ' ' CYS . . . . . . . . . . . . . 19.9 p -160.68 172.22 6.14 Favored Pre-proline 0 CA--C 1.554 1.099 0 C-N-CA 125.626 1.571 . . . . 0.0 111.572 -178.384 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 2480 ' ' PRO . . . . . . . . . . . . . 63.6 Cg_exo -58.67 -25.06 73.73 Favored 'Trans proline' 0 CA--C 1.539 0.743 0 C-N-CA 123.454 2.77 . . . . 0.0 114.481 175.362 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 2481 ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -81.72 -8.65 59.72 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 124.814 1.246 . . . . 0.0 113.076 178.162 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 2482 ' ' GLY . . . . . . . . . . . . . . . 120.47 -143.25 16.41 Favored Glycine 0 N--CA 1.471 1.015 0 C-N-CA 126.11 1.814 . . . . 0.0 112.238 -175.263 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 2483 ' ' TYR . . . . . . . . . . . . . 80.1 m-85 -96.23 113.66 25.28 Favored 'General case' 0 N--CA 1.469 0.517 0 O-C-N 121.7 -0.883 . . . . 0.0 110.811 173.381 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 2484 ' ' ARG . . . . . . . . . . . . . 55.6 ttp85 -96.76 142.02 29.28 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 124.62 1.168 . . . . 0.0 110.278 176.85 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 2485 ' ' VAL . . . . . . . . . . . . . 11.3 m -133.97 152.78 35.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 123.806 0.843 . . . . 0.0 111.083 173.962 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 2486 ' ' THR . . . . . . . . . . . . . 40.5 m -131.99 133.86 44.93 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 125.656 1.583 . . . . 0.0 107.66 172.682 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 2487 ' ' TYR . . . . . . . . . . . . . 15.3 p90 -140.5 148.98 41.92 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 113.839 1.051 . . . . 0.0 113.839 176.876 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 2488 ' ' THR . . . . . . . . . . . . . 69.2 m -108.7 115.71 57.11 Favored Pre-proline 0 N--CA 1.469 0.514 0 C-N-CA 124.941 1.297 . . . . 0.0 109.108 172.611 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 2489 ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -80.49 161.26 22.37 Favored 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 123.794 2.996 . . . . 0.0 110.864 169.571 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 2490 ' ' MET . . . . . . . . . . . . . 25.7 ptm -133.4 2.8 3.56 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 114.94 1.459 . . . . 0.0 114.94 -173.703 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 2491 ' ' ALA . . . . . . . . . . . . . . . -143.42 145.55 32.35 Favored Pre-proline 0 CA--C 1.547 0.828 0 C-N-CA 124.644 1.178 . . . . 0.0 111.68 177.764 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 2492 ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -73.23 148.66 44.36 Favored 'Trans proline' 0 CA--C 1.536 0.615 0 C-N-CA 123.126 2.55 . . . . 0.0 111.08 175.851 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 2493 ' ' GLY . . . . . . . . . . . . . . . 135.05 -161.75 24.64 Favored Glycine 0 CA--C 1.53 0.988 0 C-N-CA 125.307 1.432 . . . . 0.0 112.975 -175.54 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 2494 ' ' SER . . . . . . . . . . . . . 49.3 m -105.8 118.04 35.57 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.835 0.854 . . . . 0.0 111.522 179.193 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 2495 ' ' TYR . . . . . . . . . . . . . 78.1 m-85 -88.53 114.44 25.15 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.704 1.202 . . . . 0.0 109.386 167.033 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 2496 ' ' LEU . . . . . . . . . . . . . 27.2 tp -91.0 114.36 26.86 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 125.158 1.383 . . . . 0.0 109.072 179.073 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 2497 ' ' ILE . . . . . . . . . . . . . 44.0 mt -99.88 102.17 13.07 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 C-N-CA 125.534 1.534 . . . . 0.0 108.503 -173.417 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 2498 ' ' SER . . . . . . . . . . . . . 66.5 m -84.87 93.95 8.64 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 124.954 1.302 . . . . 0.0 109.391 174.841 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 2499 ' ' ILE . . . . . . . . . . . . . 48.6 mt -87.38 95.85 5.31 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 C-N-CA 124.402 1.081 . . . . 0.0 108.526 178.884 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 2500 ' ' LYS . . . . . . . . . . . . . 91.2 mttt -98.84 138.89 35.32 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.099 0.959 . . . . 0.0 111.385 177.212 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 2501 ' ' TYR . . . . . . . . . . . . . 64.6 t80 -149.58 148.46 29.37 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.046 1.338 . . . . 0.0 112.228 -172.765 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 2502 ' ' GLY . . . . . . . . . . . . . . . 69.01 26.3 74.8 Favored Glycine 0 CA--C 1.534 1.22 0 C-N-CA 124.065 0.84 . . . . 0.0 112.639 -178.992 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 2503 ' ' GLY . . . . . . . . . . . . . . . 116.19 -164.45 12.28 Favored Glycine 0 CA--C 1.54 1.645 0 C-N-CA 125.877 1.703 . . . . 0.0 112.04 -164.022 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 2504 ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -81.49 33.87 0.54 Allowed 'Trans proline' 0 CA--C 1.548 1.179 0 C-N-CA 124.936 3.757 . . . . 0.0 113.165 -173.991 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 2505 ' ' TYR . . . . . . . . . . . . . 74.9 m-85 -114.8 127.21 55.59 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.815 1.246 . . . . 0.0 112.576 -172.053 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 2506 ' ' HIS . . . . . . . . . . . . . 86.4 m-70 -57.61 138.74 54.97 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 124.802 1.241 . . . . 0.0 113.037 178.326 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 2507 ' ' ILE . . . . . . . . . . . . . 27.1 pt -69.08 166.96 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 O-C-N 121.827 -0.545 . . . . 0.0 112.26 169.689 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 2508 ' ' GLY . . . . . . . . . . . . . . . -59.84 -21.94 56.39 Favored Glycine 0 CA--C 1.539 1.538 0 N-CA-C 116.483 1.353 . . . . 0.0 116.483 -166.688 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 2509 ' ' GLY . . . . . . . . . . . . . . . -106.36 -0.42 37.75 Favored Glycine 0 CA--C 1.536 1.399 0 C-N-CA 125.136 1.351 . . . . 0.0 114.969 174.302 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 2510 ' ' SER . . . . . . . . . . . . . 46.8 t -88.77 148.69 42.16 Favored Pre-proline 0 CA--C 1.549 0.916 0 CA-C-N 118.678 1.239 . . . . 0.0 112.824 -172.488 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 2511 ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -78.39 152.34 90.64 Favored 'Cis proline' 0 C--N 1.353 0.794 0 CA-C-N 119.31 0.789 . . . . 0.0 113.288 -1.669 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 2512 ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -102.29 128.91 48.64 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 125.291 1.437 . . . . 0.0 110.739 179.26 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 2513 ' ' LYS . . . . . . . . . . . . . 57.0 pttt -92.04 100.36 13.02 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 124.097 0.959 . . . . 0.0 112.214 178.644 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 2514 ' ' ALA . . . . . . . . . . . . . . . -88.3 114.59 25.08 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.714 1.206 . . . . 0.0 110.109 175.209 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 2515 ' ' LYS . . . . . . . . . . . . . 66.3 mttm -95.92 119.07 33.76 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 123.867 0.867 . . . . 0.0 111.093 -175.188 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 2516 ' ' VAL . . . . . . . . . . . . . 49.4 t -113.4 140.15 35.09 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 C-N-CA 125.731 1.612 . . . . 0.0 110.408 -169.798 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 2517 ' ' THR . . . . . . . . . . . . . 64.2 p -129.85 173.6 10.51 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 125.82 1.648 . . . . 0.0 111.403 -177.027 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 2518 ' ' GLY . . . . . . . . . . . . . . . 100.5 -171.14 22.81 Favored Glycine 0 CA--C 1.539 1.55 0 C-N-CA 124.705 1.145 . . . . 0.0 113.03 -174.695 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 2519 ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -72.19 157.36 54.04 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 123.719 2.946 . . . . 0.0 112.106 -176.005 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 2520 ' ' ARG . . . . . . . . . . . . . 50.9 ttt85 -87.12 120.12 28.06 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 123.635 0.774 . . . . 0.0 109.665 170.499 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 2521 ' ' LEU . . . . . . . . . . . . . 9.3 mp -85.11 -16.9 39.02 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.571 1.148 . . . . 0.0 112.433 -177.552 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 2522 ' ' VAL . . . . . . . . . . . . . 24.9 t . . . . . 0 C--O 1.253 1.249 0 C-N-CA 126.694 1.997 . . . . 0.0 112.025 179.135 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A 2427 ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.134 0 CA-C-O 121.049 0.249 . . . . 0.0 113.003 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A 2428 ' ' ASP . . . . . . . . . . . . . 13.4 t70 -150.4 135.48 9.91 Favored Pre-proline 0 CA--C 1.55 0.958 0 C-N-CA 124.471 1.108 . . . . 0.0 111.658 -174.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 2429 ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -67.16 -21.18 48.91 Favored 'Trans proline' 0 C--N 1.352 0.717 0 C-N-CA 123.44 2.76 . . . . 0.0 113.946 -175.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 2430 ' ' GLY . . . . . . . . . . . . . . . -80.48 -25.6 56.44 Favored Glycine 0 CA--C 1.532 1.115 0 CA-C-N 119.29 0.95 . . . . 0.0 113.021 174.319 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 2431 ' ' LEU . . . . . . . . . . . . . 4.4 mm? -80.61 -37.55 30.94 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 124.138 0.975 . . . . 0.0 111.058 171.218 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 2432 ' ' VAL . . . . . . . . . . . . . 74.7 t -63.5 137.62 24.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 CA-C-O 121.598 0.713 . . . . 0.0 110.607 170.333 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 2433 ' ' SER . . . . . . . . . . . . . 8.1 t -133.5 -171.4 2.7 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 125.224 1.41 . . . . 0.0 110.103 173.007 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 2434 ' ' ALA . . . . . . . . . . . . . . . -144.59 145.65 31.91 Favored 'General case' 0 CA--C 1.538 0.487 0 O-C-N 121.029 -1.044 . . . . 0.0 111.502 176.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 2435 ' ' TYR . . . . . . . . . . . . . 80.5 m-85 -145.72 154.42 42.05 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 125.454 1.501 . . . . 0.0 111.844 -174.58 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 2436 ' ' GLY . . . . . . . . . . . . . . . 113.64 162.28 14.7 Favored Glycine 0 N--CA 1.473 1.149 0 C-N-CA 125.167 1.365 . . . . 0.0 113.954 176.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 2437 ' ' ALA . . . . . . . . . . . . . . . -60.62 -27.3 67.66 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.322 1.449 . . . . 0.0 114.462 -170.19 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 2438 ' ' GLY . . . . . . . . . . . . . . . -64.83 -18.59 64.4 Favored Glycine 0 CA--C 1.531 1.033 0 CA-C-O 119.025 -0.875 . . . . 0.0 114.33 -179.081 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 2439 ' ' LEU . . . . . . . . . . . . . 87.2 mt -74.33 -24.43 59.19 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 118.576 1.188 . . . . 0.0 112.698 170.703 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 2440 ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -90.07 -28.0 19.31 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.844 1.258 . . . . 0.0 111.691 174.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 2441 ' ' GLY . . . . . . . . . . . . . . . 110.93 -137.1 14.08 Favored Glycine 0 CA--C 1.529 0.931 0 C-N-CA 125.83 1.681 . . . . 0.0 113.428 175.079 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 2442 ' ' GLY . . . . . . . . . . . . . . . 165.34 -136.31 4.13 Favored Glycine 0 N--CA 1.471 1.025 0 C-N-CA 124.032 0.825 . . . . 0.0 113.7 -172.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 2443 ' ' VAL . . . . . . . . . . . . . 73.8 t -130.2 149.3 33.45 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 125.921 1.688 . . . . 0.0 109.302 -178.104 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 2444 ' ' THR . . . . . . . . . . . . . 38.1 p -58.31 136.26 57.33 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.608 0.763 . . . . 0.0 112.005 176.566 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 2445 ' ' GLY . . . . . . . . . . . . . . . 77.67 -10.89 22.0 Favored Glycine 0 CA--C 1.538 1.484 0 C-N-CA 124.905 1.241 . . . . 0.0 114.805 -175.655 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 2446 ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -95.07 141.68 23.57 Favored Pre-proline 0 CA--C 1.553 1.079 0 C-N-CA 125.63 1.572 . . . . 0.0 110.981 177.588 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 2447 ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -74.18 134.74 19.73 Favored 'Trans proline' 0 C--N 1.35 0.649 0 C-N-CA 123.113 2.542 . . . . 0.0 111.437 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 2448 ' ' ALA . . . . . . . . . . . . . . . -116.65 119.98 37.21 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 126.688 1.995 . . . . 0.0 108.919 175.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 2449 ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -122.62 131.7 53.94 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 124.094 0.958 . . . . 0.0 111.94 -168.336 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 2450 ' ' PHE . . . . . . . . . . . . . 15.3 p90 -147.56 166.67 26.62 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 125.283 1.433 . . . . 0.0 111.107 174.307 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 2451 ' ' VAL . . . . . . . . . . . . . 15.0 p -122.42 135.47 62.42 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 C-N-CA 125.045 1.338 . . . . 0.0 110.987 176.796 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 2452 ' ' VAL . . . . . . . . . . . . . 56.9 t -85.08 107.09 15.64 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 N-CA-C 106.825 -1.546 . . . . 0.0 106.825 163.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 2453 ' ' ASN . . . . . . . . . . . . . 17.4 t-20 -92.7 119.77 32.43 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 123.389 0.676 . . . . 0.0 112.49 -168.088 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 2454 ' ' THR . . . . . . . . . . . . . 76.8 p -102.8 -1.17 30.29 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 125.739 1.615 . . . . 0.0 113.906 -178.126 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 2455 ' ' SER . . . . . . . . . . . . . 29.5 m -56.93 -29.63 63.29 Favored 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 114.478 1.288 . . . . 0.0 114.478 -174.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 2456 ' ' ASN . . . . . . . . . . . . . 86.8 m-20 -82.96 -18.42 40.02 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 124.321 1.048 . . . . 0.0 113.396 175.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 2457 ' ' ALA . . . . . . . . . . . . . . . -104.03 -36.03 7.88 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 125.533 1.533 . . . . 0.0 113.626 -172.48 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 2458 ' ' GLY . . . . . . . . . . . . . . . 105.99 -107.17 2.72 Favored Glycine 0 CA--C 1.529 0.958 0 C-N-CA 124.9 1.238 . . . . 0.0 111.167 -172.616 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 2459 ' ' ALA . . . . . . . . . . . . . . . -143.31 156.22 44.66 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.706 1.202 . . . . 0.0 112.905 -176.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 2460 ' ' GLY . . . . . . . . . . . . . . . 164.26 166.81 23.78 Favored Glycine 0 CA--C 1.532 1.136 0 C-N-CA 125.825 1.678 . . . . 0.0 112.772 -174.634 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 2461 ' ' ALA . . . . . . . . . . . . . . . -74.98 144.18 43.27 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 123.921 0.889 . . . . 0.0 112.363 -179.422 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 2462 ' ' LEU . . . . . . . . . . . . . 48.2 tp -124.83 141.73 51.92 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.291 1.436 . . . . 0.0 111.328 179.417 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 2463 ' ' SER . . . . . . . . . . . . . 15.8 t -123.71 160.42 27.27 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 125.005 1.322 . . . . 0.0 110.291 158.11 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 2464 ' ' VAL . . . . . . . . . . . . . 5.8 p -161.68 133.82 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 124.892 1.277 . . . . 0.0 110.634 -176.334 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 2465 ' ' THR . . . . . . . . . . . . . 94.2 m -137.84 138.5 39.2 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 126.048 1.739 . . . . 0.0 109.369 -177.407 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 2466 ' ' ILE . . . . . . . . . . . . . 45.3 mt -119.67 125.3 74.21 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 C-N-CA 124.39 1.076 . . . . 0.0 108.821 176.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 2467 ' ' ASP . . . . . . . . . . . . . 35.7 t70 -137.05 130.5 31.44 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 125.135 1.374 . . . . 0.0 111.296 -174.397 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 2468 ' ' GLY . . . . . . . . . . . . . . . -167.17 -142.43 3.45 Favored Glycine 0 CA--C 1.538 1.506 0 CA-C-O 118.524 -1.153 . . . . 0.0 113.883 -175.111 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 2469 ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo -68.61 -14.36 39.33 Favored 'Trans proline' 0 CA--C 1.539 0.759 0 C-N-CA 123.977 3.118 . . . . 0.0 113.58 -178.465 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 2470 ' ' SER . . . . . . . . . . . . . 7.5 t -157.73 -170.4 3.18 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 125.776 1.63 . . . . 0.0 110.356 170.625 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 2471 ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -77.48 171.39 14.96 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 124.245 1.018 . . . . 0.0 111.824 168.079 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 2472 ' ' VAL . . . . . . . . . . . . . 28.7 m -135.07 151.75 31.4 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 125.376 1.471 . . . . 0.0 110.389 175.097 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 2473 ' ' LYS . . . . . . . . . . . . . 99.7 mttt -93.59 118.51 31.46 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.811 0.845 . . . . 0.0 109.451 170.088 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 2474 ' ' MET . . . . . . . . . . . . . 77.2 mtp -111.13 137.34 48.93 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 125.282 1.433 . . . . 0.0 112.54 -175.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 2475 ' ' ASP . . . . . . . . . . . . . 25.8 t70 -113.59 94.89 5.06 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 126.364 1.866 . . . . 0.0 109.042 162.371 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 2476 ' ' CYS . . . . . . . . . . . . . 47.5 t -91.35 129.43 37.34 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.382 1.073 . . . . 0.0 110.123 173.374 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 2477 ' ' GLN . . . . . . . . . . . . . 70.1 mm-40 -142.33 140.17 32.04 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 124.571 1.148 . . . . 0.0 110.821 -175.527 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 2478 ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -82.22 148.1 28.61 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 123.63 0.772 . . . . 0.0 111.854 173.06 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 2479 ' ' CYS . . . . . . . . . . . . . 31.9 p -161.36 171.7 6.59 Favored Pre-proline 0 CA--C 1.553 1.086 0 C-N-CA 125.639 1.576 . . . . 0.0 111.863 -175.005 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 2480 ' ' PRO . . . . . . . . . . . . . 66.0 Cg_exo -58.42 -24.73 70.24 Favored 'Trans proline' 0 CA--C 1.539 0.772 0 C-N-CA 123.348 2.699 . . . . 0.0 114.341 174.137 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 2481 ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -81.69 -6.51 59.09 Favored 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 124.981 1.312 . . . . 0.0 113.047 177.374 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 2482 ' ' GLY . . . . . . . . . . . . . . . 120.43 -118.04 3.73 Favored Glycine 0 N--CA 1.469 0.883 0 C-N-CA 126.08 1.8 . . . . 0.0 111.987 -176.709 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 2483 ' ' TYR . . . . . . . . . . . . . 93.4 m-85 -124.14 111.78 16.32 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.211 1.004 . . . . 0.0 110.651 173.787 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 2484 ' ' ARG . . . . . . . . . . . . . 13.7 ttp-105 -78.07 139.52 39.08 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 123.871 0.869 . . . . 0.0 109.807 173.571 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 2485 ' ' VAL . . . . . . . . . . . . . 90.7 t -126.96 116.09 43.5 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 C-N-CA 125.202 1.401 . . . . 0.0 108.257 170.719 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 2486 ' ' THR . . . . . . . . . . . . . 87.2 m -103.44 133.61 48.2 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 107.478 -1.304 . . . . 0.0 107.478 164.403 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 2487 ' ' TYR . . . . . . . . . . . . . 27.5 p90 -139.14 155.13 48.09 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 113.166 0.802 . . . . 0.0 113.166 176.4 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 2488 ' ' THR . . . . . . . . . . . . . 93.0 m -120.1 116.97 32.33 Favored Pre-proline 0 N--CA 1.474 0.737 0 C-N-CA 124.205 1.002 . . . . 0.0 109.774 176.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 2489 ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -82.5 158.4 16.83 Favored 'Trans proline' 0 C--N 1.351 0.681 0 C-N-CA 123.97 3.113 . . . . 0.0 111.551 173.402 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 2490 ' ' MET . . . . . . . . . . . . . 25.3 ptm -132.78 7.71 4.09 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 114.612 1.338 . . . . 0.0 114.612 -176.218 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 2491 ' ' ALA . . . . . . . . . . . . . . . -144.83 143.83 22.3 Favored Pre-proline 0 CA--C 1.547 0.838 0 C-N-CA 125.357 1.463 . . . . 0.0 111.224 172.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 2492 ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -76.16 156.86 38.0 Favored 'Trans proline' 0 CA--C 1.536 0.616 0 C-N-CA 123.704 2.936 . . . . 0.0 111.138 175.47 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 2493 ' ' GLY . . . . . . . . . . . . . . . 130.47 -140.37 11.71 Favored Glycine 0 CA--C 1.528 0.89 0 C-N-CA 125.643 1.592 . . . . 0.0 111.181 -171.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 2494 ' ' SER . . . . . . . . . . . . . 54.4 p -140.93 138.59 33.95 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 113.333 0.864 . . . . 0.0 113.333 178.628 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 2495 ' ' TYR . . . . . . . . . . . . . 56.6 m-85 -111.13 131.48 55.06 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 126.215 1.806 . . . . 0.0 110.412 -178.666 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 2496 ' ' LEU . . . . . . . . . . . . . 86.2 mt -86.62 123.2 31.54 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 124.459 1.103 . . . . 0.0 109.33 169.766 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 2497 ' ' ILE . . . . . . . . . . . . . 49.7 mt -100.93 94.45 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 C-N-CA 125.641 1.576 . . . . 0.0 107.939 179.391 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 2498 ' ' SER . . . . . . . . . . . . . 67.1 m -88.71 119.3 29.06 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 125.594 1.557 . . . . 0.0 110.245 -178.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 2499 ' ' ILE . . . . . . . . . . . . . 33.7 mt -127.09 121.4 57.76 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 C-N-CA 125.223 1.409 . . . . 0.0 108.088 -170.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 2500 ' ' LYS . . . . . . . . . . . . . 93.0 mttt -131.8 119.22 20.96 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 123.857 0.863 . . . . 0.0 112.063 -168.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 2501 ' ' TYR . . . . . . . . . . . . . 66.6 t80 -125.87 137.74 53.76 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.796 1.239 . . . . 0.0 112.507 -169.459 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 2502 ' ' GLY . . . . . . . . . . . . . . . 70.06 10.26 64.9 Favored Glycine 0 CA--C 1.537 1.444 0 C-N-CA 124.445 1.022 . . . . 0.0 114.318 -178.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 2503 ' ' GLY . . . . . . . . . . . . . . . 149.94 -176.3 28.66 Favored Glycine 0 CA--C 1.54 1.615 0 C-N-CA 126.094 1.806 . . . . 0.0 112.849 -171.454 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 2504 ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -81.45 34.57 0.55 Allowed 'Trans proline' 0 CA--C 1.546 1.111 0 C-N-CA 125.193 3.929 . . . . 0.0 113.346 -173.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 2505 ' ' TYR . . . . . . . . . . . . . 82.6 m-85 -122.53 135.63 54.69 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 125.026 1.33 . . . . 0.0 112.296 -174.355 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 2506 ' ' HIS . . . . . . . . . . . . . 94.8 m-70 -60.51 140.75 57.17 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 124.254 1.022 . . . . 0.0 113.676 -176.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 2507 ' ' ILE . . . . . . . . . . . . . 1.9 pp -75.98 167.85 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 C-N-CA 123.562 0.745 . . . . 0.0 112.505 172.277 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 2508 ' ' GLY . . . . . . . . . . . . . . . -58.33 112.4 3.93 Favored Glycine 0 CA--C 1.533 1.166 0 C-N-CA 124.003 0.811 . . . . 0.0 112.877 -174.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 2509 ' ' GLY . . . . . . . . . . . . . . . 95.47 -8.94 69.24 Favored Glycine 0 CA--C 1.536 1.37 0 C-N-CA 125.983 1.754 . . . . 0.0 115.004 -178.105 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 2510 ' ' SER . . . . . . . . . . . . . 13.3 t -84.78 145.82 44.94 Favored Pre-proline 0 CA--C 1.552 1.047 0 CA-C-N 119.195 1.498 . . . . 0.0 112.0 179.731 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 2511 ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -75.39 144.25 79.9 Favored 'Cis proline' 0 C--N 1.354 0.83 0 CA-C-N 120.217 1.113 . . . . 0.0 113.026 -0.57 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 2512 ' ' PHE . . . . . . . . . . . . . 94.9 m-85 -96.94 134.1 40.73 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.511 1.124 . . . . 0.0 110.519 175.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 2513 ' ' LYS . . . . . . . . . . . . . 59.6 pttt -89.54 105.56 17.88 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 123.686 0.794 . . . . 0.0 112.358 176.27 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 2514 ' ' ALA . . . . . . . . . . . . . . . -91.88 126.86 37.13 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 125.261 1.424 . . . . 0.0 110.374 174.522 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 2515 ' ' LYS . . . . . . . . . . . . . 30.6 mtpp -101.38 134.44 44.46 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 124.712 1.205 . . . . 0.0 111.123 -175.295 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 2516 ' ' VAL . . . . . . . . . . . . . 84.7 t -132.58 137.01 55.09 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 C-N-CA 124.493 1.117 . . . . 0.0 110.715 -169.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 2517 ' ' THR . . . . . . . . . . . . . 73.4 p -123.65 -177.27 3.68 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 125.741 1.616 . . . . 0.0 110.965 176.219 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 2518 ' ' GLY . . . . . . . . . . . . . . . 98.62 -176.52 29.98 Favored Glycine 0 CA--C 1.54 1.621 0 C-N-CA 124.749 1.166 . . . . 0.0 113.465 -176.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 2519 ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -71.1 151.08 61.11 Favored 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 123.814 3.009 . . . . 0.0 111.885 -176.263 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 2520 ' ' ARG . . . . . . . . . . . . . 21.5 ttt85 . . . . . 0 CA--C 1.539 0.542 0 C-N-CA 123.872 0.869 . . . . 0.0 110.896 176.144 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A 2427 ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.795 0 N-CA-C 112.594 -0.202 . . . . 0.0 112.594 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A 2428 ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -148.9 143.37 17.02 Favored Pre-proline 0 CA--C 1.545 0.765 0 C-N-CA 125.078 1.351 . . . . 0.0 111.643 178.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 2429 ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -65.32 -24.4 57.83 Favored 'Trans proline' 0 C--N 1.351 0.707 0 C-N-CA 123.215 2.61 . . . . 0.0 112.773 177.715 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 2430 ' ' GLY . . . . . . . . . . . . . . . -75.59 -23.28 73.38 Favored Glycine 0 CA--C 1.535 1.317 0 CA-C-N 119.065 0.848 . . . . 0.0 113.805 174.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 2431 ' ' LEU . . . . . . . . . . . . . 4.4 mm? -86.95 -33.16 19.76 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.492 1.117 . . . . 0.0 111.616 173.682 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 2432 ' ' VAL . . . . . . . . . . . . . 53.4 t -70.16 138.31 22.26 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 C-N-CA 124.166 0.987 . . . . 0.0 111.092 172.005 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 2433 ' ' SER . . . . . . . . . . . . . 58.5 m -139.13 146.96 41.28 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 125.705 1.602 . . . . 0.0 109.628 173.549 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 2434 ' ' ALA . . . . . . . . . . . . . . . -98.98 149.36 23.06 Favored 'General case' 0 CA--C 1.54 0.568 0 O-C-N 121.528 -0.733 . . . . 0.0 112.13 176.219 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 2435 ' ' TYR . . . . . . . . . . . . . 89.7 m-85 -142.67 145.18 33.17 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.831 1.652 . . . . 0.0 111.563 -178.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 2436 ' ' GLY . . . . . . . . . . . . . . . 126.93 160.4 10.52 Favored Glycine 0 N--CA 1.474 1.193 0 C-N-CA 125.325 1.44 . . . . 0.0 113.948 178.379 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 2437 ' ' ALA . . . . . . . . . . . . . . . -63.18 -28.83 70.32 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 114.283 1.216 . . . . 0.0 114.283 -171.186 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 2438 ' ' GLY . . . . . . . . . . . . . . . -66.95 -11.08 57.62 Favored Glycine 0 CA--C 1.531 1.093 0 C-N-CA 124.437 1.018 . . . . 0.0 114.501 -178.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 2439 ' ' LEU . . . . . . . . . . . . . 75.6 mt -78.68 -25.22 44.8 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 118.537 1.168 . . . . 0.0 112.594 170.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 2440 ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -94.46 -31.98 13.72 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.897 1.279 . . . . 0.0 112.361 -175.165 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 2441 ' ' GLY . . . . . . . . . . . . . . . 159.22 -155.08 26.15 Favored Glycine 0 CA--C 1.527 0.807 0 C-N-CA 124.45 1.024 . . . . 0.0 113.575 -176.225 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 2442 ' ' GLY . . . . . . . . . . . . . . . 168.01 -171.9 42.54 Favored Glycine 0 CA--C 1.529 0.93 0 C-N-CA 124.636 1.112 . . . . 0.0 113.498 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 2443 ' ' VAL . . . . . . . . . . . . . 95.4 t -117.6 137.55 51.17 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 125.379 1.471 . . . . 0.0 108.996 176.452 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 2444 ' ' THR . . . . . . . . . . . . . 21.5 p -57.99 136.62 57.13 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.18 0.992 . . . . 0.0 112.232 177.308 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 2445 ' ' GLY . . . . . . . . . . . . . . . 79.61 -12.53 27.53 Favored Glycine 0 CA--C 1.534 1.274 0 C-N-CA 124.624 1.107 . . . . 0.0 114.713 -178.644 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 2446 ' ' ASN . . . . . . . . . . . . . 80.5 m-20 -99.43 150.15 36.5 Favored Pre-proline 0 CA--C 1.547 0.843 0 C-N-CA 124.898 1.279 . . . . 0.0 110.825 173.266 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 2447 ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -70.75 142.51 43.76 Favored 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 122.756 2.304 . . . . 0.0 111.01 175.163 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 2448 ' ' ALA . . . . . . . . . . . . . . . -128.35 135.31 49.4 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 126.726 2.011 . . . . 0.0 108.618 171.209 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 2449 ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -142.11 154.04 44.59 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 114.324 1.231 . . . . 0.0 114.324 -163.12 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 2450 ' ' PHE . . . . . . . . . . . . . 54.3 p90 -158.56 155.28 28.04 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 126.118 1.767 . . . . 0.0 111.405 -179.225 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 2451 ' ' VAL . . . . . . . . . . . . . 59.6 t -111.39 129.29 67.0 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 C-N-CA 125.11 1.364 . . . . 0.0 108.914 173.361 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 2452 ' ' VAL . . . . . . . . . . . . . 39.0 t -84.19 101.4 8.71 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 N-CA-C 107.208 -1.405 . . . . 0.0 107.208 166.016 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 2453 ' ' ASN . . . . . . . . . . . . . 19.3 t-20 -83.11 124.74 30.77 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 123.478 0.711 . . . . 0.0 112.472 -169.356 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 2454 ' ' THR . . . . . . . . . . . . . 40.4 p -103.96 -1.25 27.86 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 125.696 1.598 . . . . 0.0 113.881 -179.001 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 2455 ' ' SER . . . . . . . . . . . . . 44.5 m -57.8 -29.13 64.64 Favored 'General case' 0 N--CA 1.48 1.047 0 CA-C-N 120.32 1.418 . . . . 0.0 114.441 -175.445 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 2456 ' ' ASN . . . . . . . . . . . . . 67.3 m-80 -86.86 -11.99 49.18 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 124.688 1.195 . . . . 0.0 113.557 176.152 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 2457 ' ' ALA . . . . . . . . . . . . . . . -112.54 -22.33 10.85 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 126.172 1.789 . . . . 0.0 113.851 -174.073 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 2458 ' ' GLY . . . . . . . . . . . . . . . 91.36 -85.89 1.28 Allowed Glycine 0 CA--C 1.529 0.943 0 C-N-CA 124.986 1.279 . . . . 0.0 111.338 -176.496 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 2459 ' ' ALA . . . . . . . . . . . . . . . -157.84 157.14 32.7 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 124.987 1.315 . . . . 0.0 112.617 -176.466 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 2460 ' ' GLY . . . . . . . . . . . . . . . 165.09 167.34 25.52 Favored Glycine 0 CA--C 1.532 1.126 0 C-N-CA 125.545 1.545 . . . . 0.0 113.008 -176.145 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 2461 ' ' ALA . . . . . . . . . . . . . . . -77.96 145.64 35.94 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.265 1.026 . . . . 0.0 112.572 -178.737 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 2462 ' ' LEU . . . . . . . . . . . . . 29.9 tp -121.21 141.6 50.7 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 125.336 1.455 . . . . 0.0 110.999 178.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 2463 ' ' SER . . . . . . . . . . . . . 29.7 t -102.24 -109.75 0.23 Allowed 'General case' 0 CA--C 1.552 1.02 0 C-N-CA 125.24 1.416 . . . . 0.0 110.014 171.119 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 2464 ' ' VAL . . . . . . . . . . . . . 48.3 t 105.31 123.57 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.247 0 C-N-CA 131.659 3.984 . . . . 0.0 109.702 172.647 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 2465 ' ' THR . . . . . . . . . . . . . 89.9 m -131.95 139.29 48.64 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 125.408 1.483 . . . . 0.0 109.076 174.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 2466 ' ' ILE . . . . . . . . . . . . . 35.8 mt -119.15 117.39 54.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 123.634 0.773 . . . . 0.0 109.649 175.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 2467 ' ' ASP . . . . . . . . . . . . . 34.8 t70 -95.17 162.34 13.74 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 125.776 1.631 . . . . 0.0 110.286 168.638 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 2468 ' ' GLY . . . . . . . . . . . . . . . 168.73 -166.78 39.9 Favored Glycine 0 CA--C 1.536 1.358 0 O-C-N 121.125 -0.985 . . . . 0.0 114.717 178.794 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 2469 ' ' PRO . . . . . . . . . . . . . 76.1 Cg_endo -70.94 -15.86 32.66 Favored 'Trans proline' 0 CA--C 1.541 0.853 0 C-N-CA 123.969 3.113 . . . . 0.0 113.088 177.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 2470 ' ' SER . . . . . . . . . . . . . 37.2 m -153.67 174.52 14.38 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 126.868 2.067 . . . . 0.0 110.343 175.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 2471 ' ' LYS . . . . . . . . . . . . . 67.9 mttm -68.32 167.54 14.3 Favored 'General case' 0 CA--C 1.549 0.918 0 O-C-N 121.252 -0.905 . . . . 0.0 112.181 168.611 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 2472 ' ' VAL . . . . . . . . . . . . . 14.3 m -133.35 144.9 34.84 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 125.468 1.507 . . . . 0.0 111.34 -179.583 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 2473 ' ' LYS . . . . . . . . . . . . . 14.5 mmmm -89.31 71.27 8.18 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.337 1.055 . . . . 0.0 111.588 -179.263 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 2474 ' ' MET . . . . . . . . . . . . . 92.0 mtp -69.77 140.74 53.43 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 124.494 1.118 . . . . 0.0 112.969 -178.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 2475 ' ' ASP . . . . . . . . . . . . . 30.5 t70 -133.4 125.15 28.46 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 126.97 2.108 . . . . 0.0 108.755 163.117 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 2476 ' ' CYS . . . . . . . . . . . . . 42.6 t -122.18 132.75 54.61 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.797 1.239 . . . . 0.0 110.956 -177.706 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 2477 ' ' GLN . . . . . . . . . . . . . 15.9 mm100 -142.02 151.86 42.85 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 125.454 1.502 . . . . 0.0 110.721 -178.622 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 2478 ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -79.88 151.75 30.01 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 123.412 0.685 . . . . 0.0 111.67 169.343 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 2479 ' ' CYS . . . . . . . . . . . . . 19.5 p -156.82 172.15 6.5 Favored Pre-proline 0 CA--C 1.553 1.096 0 C-N-CA 126.083 1.753 . . . . 0.0 111.505 -176.576 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 2480 ' ' PRO . . . . . . . . . . . . . 58.0 Cg_exo -59.02 -26.2 80.71 Favored 'Trans proline' 0 CA--C 1.539 0.75 0 C-N-CA 123.342 2.694 . . . . 0.0 114.584 176.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 2481 ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -88.37 -6.1 57.9 Favored 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 125.382 1.473 . . . . 0.0 113.154 -179.086 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 2482 ' ' GLY . . . . . . . . . . . . . . . 128.24 -132.21 7.26 Favored Glycine 0 N--CA 1.472 1.055 0 C-N-CA 125.335 1.445 . . . . 0.0 112.164 -176.324 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 2483 ' ' TYR . . . . . . . . . . . . . 95.1 m-85 -108.78 117.62 34.67 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 123.809 0.844 . . . . 0.0 110.854 173.551 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 2484 ' ' ARG . . . . . . . . . . . . . 57.5 ttt180 -92.43 130.55 38.07 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 124.117 0.967 . . . . 0.0 110.676 177.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 2485 ' ' VAL . . . . . . . . . . . . . 89.9 t -114.09 132.76 62.18 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 C-N-CA 125.863 1.665 . . . . 0.0 108.47 172.823 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 2486 ' ' THR . . . . . . . . . . . . . 95.4 m -125.6 137.22 53.89 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 125.11 1.364 . . . . 0.0 107.821 169.06 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 2487 ' ' TYR . . . . . . . . . . . . . 21.6 p90 -144.09 152.75 41.37 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 123.72 0.808 . . . . 0.0 112.604 177.415 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 2488 ' ' THR . . . . . . . . . . . . . 84.4 m -113.25 119.71 41.61 Favored Pre-proline 0 N--CA 1.474 0.753 0 CA-C-O 117.892 -1.051 . . . . 0.0 109.466 173.287 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 2489 ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -83.67 154.75 13.66 Favored 'Trans proline' 0 CA--C 1.537 0.634 0 C-N-CA 124.064 3.176 . . . . 0.0 111.209 171.298 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 2490 ' ' MET . . . . . . . . . . . . . 28.0 ptm -119.69 -2.37 10.44 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 114.892 1.441 . . . . 0.0 114.892 -174.211 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 2491 ' ' ALA . . . . . . . . . . . . . . . -147.25 148.23 31.14 Favored Pre-proline 0 CA--C 1.545 0.786 0 C-N-CA 125.687 1.595 . . . . 0.0 110.896 177.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 2492 ' ' PRO . . . . . . . . . . . . . 74.9 Cg_endo -72.18 153.91 56.9 Favored 'Trans proline' 0 CA--C 1.536 0.584 0 C-N-CA 123.043 2.495 . . . . 0.0 111.161 174.546 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 2493 ' ' GLY . . . . . . . . . . . . . . . 135.39 -170.12 23.12 Favored Glycine 0 CA--C 1.529 0.949 0 C-N-CA 125.363 1.459 . . . . 0.0 113.313 -177.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 2494 ' ' SER . . . . . . . . . . . . . 70.3 m -95.54 121.07 36.85 Favored 'General case' 0 N--CA 1.471 0.61 0 O-C-N 121.839 -0.8 . . . . 0.0 111.818 179.303 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 2495 ' ' TYR . . . . . . . . . . . . . 63.5 m-85 -99.07 126.01 44.71 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 125.156 1.382 . . . . 0.0 109.706 171.43 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 2496 ' ' LEU . . . . . . . . . . . . . 26.1 tp -101.2 110.68 22.73 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.359 1.064 . . . . 0.0 109.44 -176.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 2497 ' ' ILE . . . . . . . . . . . . . 39.8 mt -96.56 96.48 5.54 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 C-N-CA 125.688 1.595 . . . . 0.0 108.618 -172.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 2498 ' ' SER . . . . . . . . . . . . . 68.9 m -80.86 83.54 6.58 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 125.409 1.484 . . . . 0.0 110.165 176.795 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 2499 ' ' ILE . . . . . . . . . . . . . 50.5 mt -79.91 114.53 20.9 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 C-N-CA 124.31 1.044 . . . . 0.0 109.227 177.025 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 2500 ' ' LYS . . . . . . . . . . . . . 83.7 mttt -127.52 133.33 49.83 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 125.03 1.332 . . . . 0.0 111.769 -175.165 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 2501 ' ' TYR . . . . . . . . . . . . . 64.4 t80 -141.83 143.09 33.22 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 125.465 1.506 . . . . 0.0 111.805 -170.332 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 2502 ' ' GLY . . . . . . . . . . . . . . . 69.26 11.86 65.01 Favored Glycine 0 CA--C 1.536 1.388 0 C-N-CA 124.443 1.02 . . . . 0.0 114.474 177.729 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 2503 ' ' GLY . . . . . . . . . . . . . . . 145.9 -165.6 28.05 Favored Glycine 0 CA--C 1.54 1.614 0 C-N-CA 125.731 1.634 . . . . 0.0 112.999 -170.487 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 2504 ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -82.28 13.72 2.46 Favored 'Trans proline' 0 CA--C 1.544 0.999 0 C-N-CA 124.762 3.641 . . . . 0.0 113.962 -174.318 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 2505 ' ' TYR . . . . . . . . . . . . . 84.0 m-85 -106.22 142.32 36.1 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.78 1.232 . . . . 0.0 113.452 -173.325 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 2506 ' ' HIS . . . . . . . . . . . . . 97.7 m-70 -65.03 143.89 57.64 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 124.762 1.225 . . . . 0.0 113.046 178.282 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 2507 ' ' ILE . . . . . . . . . . . . . 20.4 pt -73.65 175.6 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 N-CA-C 113.437 0.902 . . . . 0.0 113.437 173.583 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 2508 ' ' GLY . . . . . . . . . . . . . . . -58.95 119.53 18.34 Favored Glycine 0 CA--C 1.534 1.232 0 O-C-N 121.487 -0.758 . . . . 0.0 111.512 172.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 2509 ' ' GLY . . . . . . . . . . . . . . . 87.19 -6.76 82.76 Favored Glycine 0 CA--C 1.536 1.359 0 C-N-CA 125.616 1.579 . . . . 0.0 115.034 -176.733 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 2510 ' ' SER . . . . . . . . . . . . . 43.8 t -89.09 147.67 39.13 Favored Pre-proline 0 CA--C 1.549 0.938 0 CA-C-N 118.914 1.357 . . . . 0.0 112.043 -179.005 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 2511 ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -74.46 146.22 86.16 Favored 'Cis proline' 0 C--N 1.353 0.808 0 CA-C-N 119.671 0.918 . . . . 0.0 112.608 -1.036 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 2512 ' ' PHE . . . . . . . . . . . . . 94.7 m-85 -96.3 126.41 41.49 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.612 1.165 . . . . 0.0 110.797 179.627 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 2513 ' ' LYS . . . . . . . . . . . . . 85.0 tttt -94.5 100.16 12.2 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.025 0.93 . . . . 0.0 111.407 -179.03 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 2514 ' ' ALA . . . . . . . . . . . . . . . -89.02 115.46 26.6 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.355 1.462 . . . . 0.0 110.913 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 2515 ' ' LYS . . . . . . . . . . . . . 48.4 mtpt -94.04 98.64 11.14 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 124.099 0.959 . . . . 0.0 110.529 -174.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 2516 ' ' VAL . . . . . . . . . . . . . 63.7 t -90.96 140.74 15.49 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 125.673 1.589 . . . . 0.0 110.496 -173.39 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 2517 ' ' THR . . . . . . . . . . . . . 72.0 p -124.4 -177.33 3.76 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 125.582 1.553 . . . . 0.0 111.121 177.093 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 2518 ' ' GLY . . . . . . . . . . . . . . . 98.34 178.34 32.81 Favored Glycine 0 CA--C 1.539 1.558 0 C-N-CA 124.752 1.167 . . . . 0.0 113.561 -177.183 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 2519 ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -73.43 141.82 32.24 Favored 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 123.776 2.984 . . . . 0.0 111.932 -173.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 2520 ' ' ARG . . . . . . . . . . . . . 37.6 ttm180 . . . . . 0 CA--C 1.539 0.525 0 C-N-CA 122.959 0.503 . . . . 0.0 110.004 172.733 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A 2427 ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.055 0 CA-C-O 121.335 0.408 . . . . 0.0 113.166 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A 2428 ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -143.52 135.64 13.2 Favored Pre-proline 0 CA--C 1.544 0.738 0 C-N-CA 124.785 1.234 . . . . 0.0 111.204 178.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 2429 ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -67.94 -22.59 41.95 Favored 'Trans proline' 0 CA--C 1.537 0.648 0 C-N-CA 122.964 2.443 . . . . 0.0 113.003 -178.347 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 2430 ' ' GLY . . . . . . . . . . . . . . . -76.72 -23.12 70.64 Favored Glycine 0 CA--C 1.535 1.292 0 CA-C-N 118.864 0.756 . . . . 0.0 113.557 173.399 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 2431 ' ' LEU . . . . . . . . . . . . . 4.3 mm? -87.72 -35.46 17.93 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.514 1.126 . . . . 0.0 111.353 173.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 2432 ' ' VAL . . . . . . . . . . . . . 74.2 t -64.91 139.6 21.13 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 123.389 0.676 . . . . 0.0 110.473 169.639 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 2433 ' ' SER . . . . . . . . . . . . . 8.5 t -131.37 -176.21 3.95 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.942 1.297 . . . . 0.0 110.507 173.162 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 2434 ' ' ALA . . . . . . . . . . . . . . . -141.96 143.19 33.1 Favored 'General case' 0 CA--C 1.538 0.5 0 O-C-N 121.042 -1.036 . . . . 0.0 111.712 177.107 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 2435 ' ' TYR . . . . . . . . . . . . . 79.1 m-85 -143.65 157.5 44.36 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.536 1.534 . . . . 0.0 111.899 -175.111 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 2436 ' ' GLY . . . . . . . . . . . . . . . 108.05 159.75 20.37 Favored Glycine 0 N--CA 1.474 1.17 0 C-N-CA 125.244 1.402 . . . . 0.0 113.694 177.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 2437 ' ' ALA . . . . . . . . . . . . . . . -62.88 -27.42 69.34 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.075 1.35 . . . . 0.0 114.582 -169.294 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 2438 ' ' GLY . . . . . . . . . . . . . . . -66.27 -14.12 61.29 Favored Glycine 0 CA--C 1.532 1.114 0 C-N-CA 123.974 0.797 . . . . 0.0 114.683 -176.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 2439 ' ' LEU . . . . . . . . . . . . . 88.1 mt -72.07 -22.74 61.32 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 118.466 1.133 . . . . 0.0 112.761 170.233 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 2440 ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -94.48 -16.59 23.21 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 125.076 1.35 . . . . 0.0 112.82 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 2441 ' ' GLY . . . . . . . . . . . . . . . 102.92 -138.82 14.15 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 125.559 1.552 . . . . 0.0 112.39 -177.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 2442 ' ' GLY . . . . . . . . . . . . . . . 150.81 -140.72 8.1 Favored Glycine 0 CA--C 1.532 1.125 0 C-N-CA 124.007 0.813 . . . . 0.0 114.088 -177.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 2443 ' ' VAL . . . . . . . . . . . . . 99.2 t -113.08 139.15 39.77 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 C-N-CA 125.601 1.561 . . . . 0.0 110.115 -175.156 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 2444 ' ' THR . . . . . . . . . . . . . 30.1 p -61.72 142.9 56.95 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 124.302 1.041 . . . . 0.0 112.412 176.41 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 2445 ' ' GLY . . . . . . . . . . . . . . . 79.01 -10.61 32.65 Favored Glycine 0 CA--C 1.537 1.412 0 C-N-CA 124.462 1.03 . . . . 0.0 114.558 -177.118 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 2446 ' ' ASN . . . . . . . . . . . . . 79.7 m-20 -101.59 148.39 35.17 Favored Pre-proline 0 CA--C 1.548 0.87 0 C-N-CA 124.94 1.296 . . . . 0.0 111.117 174.159 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 2447 ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -73.75 129.88 14.02 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 123.176 2.584 . . . . 0.0 111.276 178.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 2448 ' ' ALA . . . . . . . . . . . . . . . -101.87 116.34 32.5 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 126.222 1.809 . . . . 0.0 109.031 170.485 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 2449 ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -111.96 132.79 54.55 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.389 1.076 . . . . 0.0 111.66 -172.319 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 2450 ' ' PHE . . . . . . . . . . . . . 37.8 p90 -147.59 168.56 21.68 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.48 1.512 . . . . 0.0 110.882 171.277 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 2451 ' ' VAL . . . . . . . . . . . . . 14.7 p -126.94 136.93 59.4 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 C-N-CA 124.609 1.164 . . . . 0.0 110.508 174.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 2452 ' ' VAL . . . . . . . . . . . . . 22.0 t -89.5 103.8 14.43 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 N-CA-C 106.797 -1.557 . . . . 0.0 106.797 164.669 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 2453 ' ' ASN . . . . . . . . . . . . . 18.6 t-20 -91.29 120.18 31.96 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 123.874 0.87 . . . . 0.0 112.271 -167.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 2454 ' ' THR . . . . . . . . . . . . . 75.1 p -104.24 2.62 31.84 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 125.958 1.703 . . . . 0.0 113.887 -175.397 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 2455 ' ' SER . . . . . . . . . . . . . 45.2 m -56.89 -27.5 60.72 Favored 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 114.782 1.401 . . . . 0.0 114.782 -173.482 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 2456 ' ' ASN . . . . . . . . . . . . . 70.1 m-80 -91.6 -12.22 34.93 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 124.537 1.135 . . . . 0.0 113.644 176.339 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 2457 ' ' ALA . . . . . . . . . . . . . . . -106.6 -33.43 7.66 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 125.575 1.55 . . . . 0.0 113.759 -174.801 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 2458 ' ' GLY . . . . . . . . . . . . . . . 87.28 -152.84 24.76 Favored Glycine 0 CA--C 1.533 1.171 0 C-N-CA 124.779 1.181 . . . . 0.0 112.202 -172.099 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 2459 ' ' ALA . . . . . . . . . . . . . . . -69.22 151.94 45.69 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 123.924 0.89 . . . . 0.0 112.6 178.127 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 2460 ' ' GLY . . . . . . . . . . . . . . . 159.86 157.62 8.72 Favored Glycine 0 CA--C 1.532 1.103 0 C-N-CA 125.302 1.43 . . . . 0.0 113.193 179.4 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 2461 ' ' ALA . . . . . . . . . . . . . . . -85.1 139.88 31.39 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.262 1.025 . . . . 0.0 113.346 -172.659 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 2462 ' ' LEU . . . . . . . . . . . . . 31.6 tp -106.4 146.55 30.34 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.778 1.631 . . . . 0.0 111.023 175.765 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 2463 ' ' SER . . . . . . . . . . . . . 4.0 t -137.62 42.13 2.34 Favored 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 125.885 1.674 . . . . 0.0 110.91 -178.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 2464 ' ' VAL . . . . . . . . . . . . . 11.0 p -63.98 135.34 27.94 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.975 0 C-N-CA 124.982 1.313 . . . . 0.0 112.017 -175.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 2465 ' ' THR . . . . . . . . . . . . . 96.3 m -136.41 145.17 44.98 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 125.925 1.69 . . . . 0.0 109.591 -179.16 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 2466 ' ' ILE . . . . . . . . . . . . . 40.6 mt -121.96 123.42 69.06 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 C-N-CA 123.748 0.819 . . . . 0.0 109.98 173.717 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 2467 ' ' ASP . . . . . . . . . . . . . 36.7 t70 -99.39 155.62 17.44 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 125.836 1.655 . . . . 0.0 110.179 166.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 2468 ' ' GLY . . . . . . . . . . . . . . . 177.17 -169.43 41.7 Favored Glycine 0 CA--C 1.537 1.44 0 O-C-N 121.043 -1.036 . . . . 0.0 115.562 -179.28 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 2469 ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -69.73 -17.49 37.69 Favored 'Trans proline' 0 CA--C 1.54 0.79 0 C-N-CA 124.322 3.348 . . . . 0.0 113.411 179.463 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 2470 ' ' SER . . . . . . . . . . . . . 35.0 m -153.92 176.09 12.58 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 127.165 2.186 . . . . 0.0 109.617 174.228 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 2471 ' ' LYS . . . . . . . . . . . . . 4.0 mppt? -66.84 162.96 20.47 Favored 'General case' 0 CA--C 1.551 0.989 0 O-C-N 121.03 -1.044 . . . . 0.0 111.455 168.432 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 2472 ' ' VAL . . . . . . . . . . . . . 33.0 m -118.84 145.87 24.26 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 C-N-CA 124.928 1.291 . . . . 0.0 110.954 175.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 2473 ' ' LYS . . . . . . . . . . . . . 99.0 mttt -86.04 90.9 8.24 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 123.678 0.791 . . . . 0.0 109.357 171.158 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 2474 ' ' MET . . . . . . . . . . . . . 60.5 ttm -89.9 143.38 26.84 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.546 1.139 . . . . 0.0 112.532 -175.068 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 2475 ' ' ASP . . . . . . . . . . . . . 35.8 t0 -133.94 82.04 1.95 Allowed 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 127.96 2.504 . . . . 0.0 108.559 171.637 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 2476 ' ' CYS . . . . . . . . . . . . . 52.6 t -88.01 134.43 33.74 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.841 1.256 . . . . 0.0 110.666 175.609 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 2477 ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -139.51 140.78 37.29 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.519 1.127 . . . . 0.0 111.394 -175.745 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 2478 ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -82.24 139.61 34.14 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.654 1.181 . . . . 0.0 110.304 172.54 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 2479 ' ' CYS . . . . . . . . . . . . . 30.7 p -158.95 169.23 10.91 Favored Pre-proline 0 CA--C 1.553 1.064 0 C-N-CA 125.293 1.437 . . . . 0.0 111.604 -171.558 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 2480 ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -65.91 -15.66 49.74 Favored 'Trans proline' 0 CA--C 1.543 0.943 0 C-N-CA 122.569 2.179 . . . . 0.0 113.427 173.776 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 2481 ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -77.51 -11.21 59.83 Favored 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 124.69 1.196 . . . . 0.0 112.953 172.133 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 2482 ' ' GLY . . . . . . . . . . . . . . . 117.36 -122.91 5.6 Favored Glycine 0 C--N 1.342 0.911 0 C-N-CA 126.439 1.971 . . . . 0.0 111.48 -172.167 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 2483 ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -117.18 110.4 18.11 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 123.91 0.884 . . . . 0.0 110.209 171.221 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 2484 ' ' ARG . . . . . . . . . . . . . 51.7 ttm-85 -86.37 128.56 34.95 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.741 0.816 . . . . 0.0 109.258 177.289 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 2485 ' ' VAL . . . . . . . . . . . . . 58.4 t -118.98 114.28 44.22 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 C-N-CA 125.331 1.452 . . . . 0.0 108.436 -177.781 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 2486 ' ' THR . . . . . . . . . . . . . 62.8 m -104.58 140.46 37.96 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 165.654 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 2487 ' ' TYR . . . . . . . . . . . . . 23.3 p90 -146.65 144.63 29.63 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 112.538 0.57 . . . . 0.0 112.538 171.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 2488 ' ' THR . . . . . . . . . . . . . 90.5 m -107.11 114.94 60.79 Favored Pre-proline 0 N--CA 1.473 0.685 0 CA-C-O 118.228 -0.892 . . . . 0.0 109.403 173.554 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 2489 ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -81.38 158.31 19.7 Favored 'Trans proline' 0 C--N 1.351 0.69 0 C-N-CA 124.075 3.184 . . . . 0.0 111.218 173.123 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 2490 ' ' MET . . . . . . . . . . . . . 28.9 ptm -128.77 3.31 5.44 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 115.153 1.538 . . . . 0.0 115.153 -171.198 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 2491 ' ' ALA . . . . . . . . . . . . . . . -152.04 150.33 25.51 Favored Pre-proline 0 CA--C 1.548 0.876 0 C-N-CA 125.505 1.522 . . . . 0.0 110.925 175.558 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 2492 ' ' PRO . . . . . . . . . . . . . 99.0 Cg_endo -74.45 151.21 42.16 Favored 'Trans proline' 0 CA--C 1.539 0.738 0 C-N-CA 123.24 2.627 . . . . 0.0 111.375 178.448 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 2493 ' ' GLY . . . . . . . . . . . . . . . 138.39 -173.66 22.39 Favored Glycine 0 CA--C 1.532 1.116 0 C-N-CA 125.55 1.548 . . . . 0.0 113.382 -177.068 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 2494 ' ' SER . . . . . . . . . . . . . 18.1 p -88.69 120.44 30.09 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.304 1.042 . . . . 0.0 111.55 175.085 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 2495 ' ' TYR . . . . . . . . . . . . . 68.8 m-85 -94.51 116.13 28.42 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 124.027 0.931 . . . . 0.0 109.652 168.539 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 2496 ' ' LEU . . . . . . . . . . . . . 22.8 tp -89.94 105.42 17.79 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 124.041 0.936 . . . . 0.0 109.561 -179.081 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 2497 ' ' ILE . . . . . . . . . . . . . 28.1 mt -88.33 103.1 13.39 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 C-N-CA 125.747 1.619 . . . . 0.0 108.335 -179.201 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 2498 ' ' SER . . . . . . . . . . . . . 73.7 m -90.14 95.98 10.46 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 124.819 1.248 . . . . 0.0 109.638 175.442 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 2499 ' ' ILE . . . . . . . . . . . . . 40.1 mt -91.29 92.52 3.94 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 C-N-CA 124.602 1.161 . . . . 0.0 108.566 -178.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 2500 ' ' LYS . . . . . . . . . . . . . 84.1 mttt -103.37 137.02 42.06 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 124.286 1.035 . . . . 0.0 111.721 -179.463 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 2501 ' ' TYR . . . . . . . . . . . . . 60.3 t80 -146.32 144.11 29.58 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.63 1.172 . . . . 0.0 112.357 -171.047 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 2502 ' ' GLY . . . . . . . . . . . . . . . 67.75 18.29 70.15 Favored Glycine 0 CA--C 1.535 1.314 0 C-N-CA 124.252 0.93 . . . . 0.0 113.673 179.209 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 2503 ' ' GLY . . . . . . . . . . . . . . . 134.44 -167.58 23.8 Favored Glycine 0 CA--C 1.54 1.636 0 C-N-CA 126.119 1.819 . . . . 0.0 112.43 -166.366 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 2504 ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -82.19 24.34 0.72 Allowed 'Trans proline' 0 CA--C 1.545 1.072 0 C-N-CA 124.903 3.735 . . . . 0.0 113.653 -173.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 2505 ' ' TYR . . . . . . . . . . . . . 73.9 m-85 -114.15 135.46 54.01 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.684 1.194 . . . . 0.0 113.022 -172.062 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 2506 ' ' HIS . . . . . . . . . . . . . 92.7 m-70 -63.33 142.85 58.23 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 125.359 1.464 . . . . 0.0 113.566 -179.246 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 2507 ' ' ILE . . . . . . . . . . . . . 1.7 pp -76.01 171.93 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 C-N-CA 123.716 0.806 . . . . 0.0 112.898 172.614 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 2508 ' ' GLY . . . . . . . . . . . . . . . -59.8 111.13 3.27 Favored Glycine 0 CA--C 1.534 1.235 0 C-N-CA 123.733 0.682 . . . . 0.0 112.609 -177.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 2509 ' ' GLY . . . . . . . . . . . . . . . 96.26 -8.22 66.97 Favored Glycine 0 CA--C 1.536 1.346 0 C-N-CA 125.835 1.683 . . . . 0.0 114.904 -177.262 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 2510 ' ' SER . . . . . . . . . . . . . 44.3 t -81.98 147.88 59.13 Favored Pre-proline 0 CA--C 1.55 0.962 0 CA-C-N 119.114 1.457 . . . . 0.0 111.841 177.577 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 2511 ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -79.29 155.71 90.42 Favored 'Cis proline' 0 C--N 1.354 0.817 0 CA-C-N 119.794 0.962 . . . . 0.0 113.333 -0.182 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 2512 ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -106.25 130.74 54.05 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.348 1.459 . . . . 0.0 110.466 177.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 2513 ' ' LYS . . . . . . . . . . . . . 19.7 ptpt -86.41 4.89 37.56 Favored 'General case' 0 N--CA 1.479 0.997 0 N-CA-C 116.488 2.032 . . . . 0.0 116.488 -167.664 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 2514 ' ' ALA . . . . . . . . . . . . . . . 3.17 93.19 0.01 OUTLIER 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 129.777 3.231 . . . . 0.0 116.188 -178.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 2515 ' ' LYS . . . . . . . . . . . . . 9.3 mtpm? -84.59 116.51 23.2 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 124.101 0.961 . . . . 0.0 111.364 -174.004 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 2516 ' ' VAL . . . . . . . . . . . . . 52.9 t -108.62 143.48 18.85 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 C-N-CA 125.958 1.703 . . . . 0.0 110.261 -174.5 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 2517 ' ' THR . . . . . . . . . . . . . 77.1 p -132.47 177.94 7.21 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 125.489 1.516 . . . . 0.0 111.438 178.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 2518 ' ' GLY . . . . . . . . . . . . . . . 104.5 -165.73 14.91 Favored Glycine 0 CA--C 1.54 1.643 0 C-N-CA 124.903 1.24 . . . . 0.0 113.424 -177.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 2519 ' ' PRO . . . . . . . . . . . . . 77.3 Cg_endo -70.94 176.53 7.54 Favored 'Trans proline' 0 CA--C 1.538 0.684 0 C-N-CA 124.17 3.247 . . . . 0.0 112.36 -178.302 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 2520 ' ' ARG . . . . . . . . . . . . . 50.9 ptt85 . . . . . 0 N--CA 1.47 0.556 0 C-N-CA 124.774 1.23 . . . . 0.0 111.683 177.769 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A 2427 ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.156 0 CA-C-O 121.312 0.396 . . . . 0.0 113.652 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A 2428 ' ' ASP . . . . . . . . . . . . . 13.8 t70 -106.86 136.52 19.43 Favored Pre-proline 0 CA--C 1.55 0.973 0 C-N-CA 124.958 1.303 . . . . 0.0 112.366 -172.181 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 2429 ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -64.58 -23.99 63.48 Favored 'Trans proline' 0 C--N 1.351 0.693 0 C-N-CA 123.222 2.615 . . . . 0.0 113.855 -178.275 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 2430 ' ' GLY . . . . . . . . . . . . . . . -75.43 -22.44 75.62 Favored Glycine 0 CA--C 1.533 1.209 0 CA-C-N 119.349 0.977 . . . . 0.0 113.345 175.267 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 2431 ' ' LEU . . . . . . . . . . . . . 4.3 mm? -83.96 -37.85 21.74 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.419 1.088 . . . . 0.0 111.197 170.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 2432 ' ' VAL . . . . . . . . . . . . . 69.5 t -61.85 136.8 24.82 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 123.775 0.83 . . . . 0.0 111.166 173.541 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 2433 ' ' SER . . . . . . . . . . . . . 68.5 m -128.72 163.11 25.85 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 125.867 1.667 . . . . 0.0 110.084 172.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 2434 ' ' ALA . . . . . . . . . . . . . . . -124.48 150.38 45.8 Favored 'General case' 0 CA--C 1.538 0.505 0 O-C-N 121.335 -0.853 . . . . 0.0 112.053 174.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 2435 ' ' TYR . . . . . . . . . . . . . 76.4 m-85 -143.24 161.61 37.83 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 126.063 1.745 . . . . 0.0 111.797 -175.183 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 2436 ' ' GLY . . . . . . . . . . . . . . . 106.43 159.75 22.11 Favored Glycine 0 N--CA 1.473 1.116 0 C-N-CA 125.131 1.348 . . . . 0.0 113.851 176.695 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 2437 ' ' ALA . . . . . . . . . . . . . . . -61.82 -28.55 69.55 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.005 1.322 . . . . 0.0 114.428 -169.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 2438 ' ' GLY . . . . . . . . . . . . . . . -66.48 -14.32 62.09 Favored Glycine 0 CA--C 1.532 1.154 0 C-N-CA 124.148 0.88 . . . . 0.0 114.581 -177.501 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 2439 ' ' LEU . . . . . . . . . . . . . 81.5 mt -74.4 -26.99 60.43 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 118.601 1.201 . . . . 0.0 112.338 169.31 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 2440 ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -93.67 -21.26 19.47 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 125.511 1.524 . . . . 0.0 112.255 177.39 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 2441 ' ' GLY . . . . . . . . . . . . . . . 110.65 -136.34 13.52 Favored Glycine 0 N--CA 1.47 0.945 0 C-N-CA 126.004 1.764 . . . . 0.0 113.181 177.234 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 2442 ' ' GLY . . . . . . . . . . . . . . . 156.52 -138.3 5.88 Favored Glycine 0 CA--C 1.53 1.022 0 C-N-CA 123.859 0.742 . . . . 0.0 114.227 -174.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 2443 ' ' VAL . . . . . . . . . . . . . 61.9 t -119.25 141.14 40.61 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 C-N-CA 125.369 1.468 . . . . 0.0 110.474 -173.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 2444 ' ' THR . . . . . . . . . . . . . 19.8 p -54.7 133.84 47.15 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 125.316 1.446 . . . . 0.0 112.29 174.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 2445 ' ' GLY . . . . . . . . . . . . . . . 81.68 -10.02 53.15 Favored Glycine 0 CA--C 1.535 1.314 0 C-N-CA 125.035 1.302 . . . . 0.0 114.844 178.67 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 2446 ' ' ASN . . . . . . . . . . . . . 91.0 m-20 -101.61 150.91 37.7 Favored Pre-proline 0 CA--C 1.548 0.876 0 C-N-CA 125.061 1.344 . . . . 0.0 111.257 175.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 2447 ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -72.68 130.9 16.46 Favored 'Trans proline' 0 C--N 1.35 0.656 0 C-N-CA 122.977 2.451 . . . . 0.0 111.538 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 2448 ' ' ALA . . . . . . . . . . . . . . . -99.82 118.2 35.77 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 126.417 1.887 . . . . 0.0 109.11 170.005 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 2449 ' ' GLU . . . . . . . . . . . . . 45.0 tt0 -115.88 131.8 56.83 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 124.994 1.317 . . . . 0.0 111.356 -169.459 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 2450 ' ' PHE . . . . . . . . . . . . . 40.4 p90 -148.02 165.7 29.96 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.096 1.358 . . . . 0.0 111.742 174.196 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 2451 ' ' VAL . . . . . . . . . . . . . 14.7 p -129.14 133.73 65.29 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 C-N-CA 124.834 1.253 . . . . 0.0 110.631 179.109 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 2452 ' ' VAL . . . . . . . . . . . . . 44.3 t -92.14 104.93 16.1 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 N-CA-C 107.017 -1.475 . . . . 0.0 107.017 169.117 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 2453 ' ' ASN . . . . . . . . . . . . . 19.5 t-20 -90.21 114.5 26.51 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.196 0.998 . . . . 0.0 112.161 -170.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 2454 ' ' THR . . . . . . . . . . . . . 43.7 p -95.88 -1.41 49.42 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 125.569 1.548 . . . . 0.0 113.902 -177.575 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 2455 ' ' SER . . . . . . . . . . . . . 29.8 m -56.76 -28.56 61.39 Favored 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 114.628 1.344 . . . . 0.0 114.628 -175.457 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 2456 ' ' ASN . . . . . . . . . . . . . 85.7 m-20 -79.47 -19.52 49.58 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 124.291 1.036 . . . . 0.0 113.483 175.673 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 2457 ' ' ALA . . . . . . . . . . . . . . . -112.2 -22.36 10.99 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 125.848 1.659 . . . . 0.0 113.902 -170.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 2458 ' ' GLY . . . . . . . . . . . . . . . 99.5 -99.87 2.15 Favored Glycine 0 CA--C 1.529 0.914 0 C-N-CA 125.322 1.439 . . . . 0.0 110.815 -173.32 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 2459 ' ' ALA . . . . . . . . . . . . . . . -153.63 155.4 35.98 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.254 1.422 . . . . 0.0 111.807 179.685 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 2460 ' ' GLY . . . . . . . . . . . . . . . 177.84 169.31 38.65 Favored Glycine 0 CA--C 1.529 0.918 0 C-N-CA 125.233 1.397 . . . . 0.0 112.959 -173.636 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 2461 ' ' ALA . . . . . . . . . . . . . . . -74.84 130.81 40.09 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 123.848 0.859 . . . . 0.0 111.874 -179.336 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 2462 ' ' LEU . . . . . . . . . . . . . 52.1 tp -108.19 138.6 44.19 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.374 1.47 . . . . 0.0 110.548 175.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 2463 ' ' SER . . . . . . . . . . . . . 30.7 t -103.56 -100.9 0.3 Allowed 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 124.806 1.242 . . . . 0.0 110.05 172.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 2464 ' ' VAL . . . . . . . . . . . . . 42.9 t 97.5 124.45 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.218 0 C-N-CA 130.837 3.655 . . . . 0.0 110.155 175.342 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 2465 ' ' THR . . . . . . . . . . . . . 99.8 m -125.01 135.6 52.92 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 125.271 1.428 . . . . 0.0 109.213 173.084 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 2466 ' ' ILE . . . . . . . . . . . . . 49.4 mt -115.93 117.64 56.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 123.998 0.919 . . . . 0.0 109.043 172.467 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 2467 ' ' ASP . . . . . . . . . . . . . 34.8 t70 -105.35 159.03 16.22 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 125.926 1.691 . . . . 0.0 110.255 169.721 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 2468 ' ' GLY . . . . . . . . . . . . . . . 156.44 -163.2 31.93 Favored Glycine 0 CA--C 1.535 1.332 0 O-C-N 121.253 -0.904 . . . . 0.0 114.367 178.718 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 2469 ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -72.47 -3.31 13.19 Favored 'Trans proline' 0 CA--C 1.542 0.923 0 C-N-CA 123.954 3.103 . . . . 0.0 114.622 -176.128 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 2470 ' ' SER . . . . . . . . . . . . . 85.7 p -153.59 154.56 34.46 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 119.751 1.16 . . . . 0.0 112.737 171.314 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 2471 ' ' LYS . . . . . . . . . . . . . 72.6 mmtt -74.52 86.5 2.08 Favored 'General case' 0 CA--C 1.544 0.736 0 O-C-N 120.789 -1.194 . . . . 0.0 110.026 168.765 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 2472 ' ' VAL . . . . . . . . . . . . . 18.4 m -55.7 146.1 5.29 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 C-N-CA 124.93 1.292 . . . . 0.0 113.19 -174.395 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 2473 ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -79.86 121.94 26.03 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 170.461 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 2474 ' ' MET . . . . . . . . . . . . . 26.1 ttt -132.08 142.43 49.52 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 124.556 1.143 . . . . 0.0 112.281 -164.328 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 2475 ' ' ASP . . . . . . . . . . . . . 20.1 m-20 -138.31 158.24 44.67 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 127.053 2.141 . . . . 0.0 110.713 174.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 2476 ' ' CYS . . . . . . . . . . . . . 43.5 t -149.32 148.57 29.69 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 125.207 1.403 . . . . 0.0 110.922 -179.3 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 2477 ' ' GLN . . . . . . . . . . . . . 26.2 tt0 -149.96 134.68 17.63 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.07 1.348 . . . . 0.0 110.347 -177.58 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 2478 ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -84.42 144.27 28.88 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.584 1.153 . . . . 0.0 111.784 172.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 2479 ' ' CYS . . . . . . . . . . . . . 25.5 p -161.0 175.23 3.23 Favored Pre-proline 0 CA--C 1.553 1.092 0 C-N-CA 125.785 1.634 . . . . 0.0 111.69 -173.157 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 2480 ' ' PRO . . . . . . . . . . . . . 77.6 Cg_exo -58.54 -24.03 67.72 Favored 'Trans proline' 0 CA--C 1.539 0.765 0 C-N-CA 123.328 2.685 . . . . 0.0 114.654 175.393 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 2481 ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -82.29 -4.56 57.42 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 124.678 1.191 . . . . 0.0 113.152 177.303 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 2482 ' ' GLY . . . . . . . . . . . . . . . 115.87 -124.62 6.33 Favored Glycine 0 N--CA 1.47 0.938 0 C-N-CA 125.848 1.689 . . . . 0.0 111.76 -175.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 2483 ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -116.77 113.22 22.25 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 124.408 1.083 . . . . 0.0 110.668 173.467 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 2484 ' ' ARG . . . . . . . . . . . . . 14.9 ttm180 -85.08 133.7 34.22 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 123.876 0.87 . . . . 0.0 109.926 173.102 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 2485 ' ' VAL . . . . . . . . . . . . . 90.8 t -121.62 136.25 59.13 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 C-N-CA 126.344 1.857 . . . . 0.0 108.847 179.751 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 2486 ' ' THR . . . . . . . . . . . . . 59.3 m -133.84 135.03 43.47 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.101 0.96 . . . . 0.0 108.913 175.018 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 2487 ' ' TYR . . . . . . . . . . . . . 28.2 p90 -141.99 151.4 42.47 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 112.976 0.732 . . . . 0.0 112.976 176.222 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 2488 ' ' THR . . . . . . . . . . . . . 91.6 m -109.75 107.54 59.17 Favored Pre-proline 0 N--CA 1.471 0.601 0 C-N-CA 124.508 1.123 . . . . 0.0 109.324 177.141 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 2489 ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -76.4 149.95 31.75 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 123.394 2.729 . . . . 0.0 110.131 169.655 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 2490 ' ' MET . . . . . . . . . . . . . 23.3 ptt? -128.74 11.02 6.11 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 114.397 1.258 . . . . 0.0 114.397 -177.58 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 2491 ' ' ALA . . . . . . . . . . . . . . . -141.59 147.64 46.74 Favored Pre-proline 0 CA--C 1.547 0.861 0 C-N-CA 125.269 1.428 . . . . 0.0 111.685 175.11 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 2492 ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -74.36 157.54 45.37 Favored 'Trans proline' 0 CA--C 1.537 0.628 0 C-N-CA 123.154 2.57 . . . . 0.0 111.062 172.7 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 2493 ' ' GLY . . . . . . . . . . . . . . . 130.34 -144.25 15.56 Favored Glycine 0 CA--C 1.528 0.858 0 C-N-CA 125.357 1.456 . . . . 0.0 111.796 -174.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 2494 ' ' SER . . . . . . . . . . . . . 10.5 t -134.91 133.81 40.01 Favored 'General case' 0 N--CA 1.468 0.464 0 O-C-N 121.824 -0.809 . . . . 0.0 111.63 177.602 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 2495 ' ' TYR . . . . . . . . . . . . . 87.8 m-85 -103.15 131.11 50.42 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.526 1.53 . . . . 0.0 110.352 176.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 2496 ' ' LEU . . . . . . . . . . . . . 21.9 tp -96.17 114.47 26.17 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.268 1.027 . . . . 0.0 109.457 178.381 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 2497 ' ' ILE . . . . . . . . . . . . . 36.4 mt -100.49 100.48 10.47 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 C-N-CA 125.459 1.504 . . . . 0.0 108.21 -178.543 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 2498 ' ' SER . . . . . . . . . . . . . 70.0 m -86.42 95.87 9.83 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 124.388 1.075 . . . . 0.0 109.241 174.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 2499 ' ' ILE . . . . . . . . . . . . . 49.9 mt -87.61 96.51 5.8 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 C-N-CA 124.51 1.124 . . . . 0.0 108.724 -178.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 2500 ' ' LYS . . . . . . . . . . . . . 85.6 mttt -104.18 135.74 45.09 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.713 1.205 . . . . 0.0 111.997 -179.207 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 2501 ' ' TYR . . . . . . . . . . . . . 56.5 t80 -151.07 148.76 28.71 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.269 1.428 . . . . 0.0 111.902 -169.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 2502 ' ' GLY . . . . . . . . . . . . . . . 67.21 26.53 73.42 Favored Glycine 0 CA--C 1.535 1.297 0 C-N-CA 123.897 0.76 . . . . 0.0 112.751 -178.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 2503 ' ' GLY . . . . . . . . . . . . . . . 118.16 -164.95 12.75 Favored Glycine 0 CA--C 1.542 1.725 0 C-N-CA 126.011 1.767 . . . . 0.0 112.112 -163.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 2504 ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -81.38 24.35 0.7 Allowed 'Trans proline' 0 CA--C 1.546 1.104 0 C-N-CA 124.933 3.756 . . . . 0.0 113.448 -174.626 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 2505 ' ' TYR . . . . . . . . . . . . . 67.9 m-85 -106.38 131.64 53.35 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.761 1.224 . . . . 0.0 112.764 -171.321 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 2506 ' ' HIS . . . . . . . . . . . . . 88.6 m-70 -59.63 139.27 57.34 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 125.017 1.327 . . . . 0.0 113.092 177.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 2507 ' ' ILE . . . . . . . . . . . . . 21.4 pt -72.6 171.88 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 170.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 2508 ' ' GLY . . . . . . . . . . . . . . . -58.61 119.56 18.12 Favored Glycine 0 CA--C 1.533 1.218 0 O-C-N 121.668 -0.645 . . . . 0.0 111.523 173.215 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 2509 ' ' GLY . . . . . . . . . . . . . . . 91.49 -9.05 78.15 Favored Glycine 0 CA--C 1.537 1.419 0 C-N-CA 125.62 1.581 . . . . 0.0 115.007 -177.012 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 2510 ' ' SER . . . . . . . . . . . . . 38.2 t -83.95 146.61 49.3 Favored Pre-proline 0 CA--C 1.55 0.968 0 CA-C-N 119.187 1.493 . . . . 0.0 112.044 179.311 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 2511 ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -77.41 147.67 85.47 Favored 'Cis proline' 0 C--N 1.354 0.84 0 CA-C-N 119.761 0.951 . . . . 0.0 112.901 -0.168 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 2512 ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -97.93 131.22 44.58 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 125.031 1.333 . . . . 0.0 110.346 178.367 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 2513 ' ' LYS . . . . . 0.435 ' H ' ' HD2' ' A' 2513 ' ' LYS . 0.0 OUTLIER -100.03 112.4 24.69 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.078 0.951 . . . . 0.0 111.719 178.95 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A 2514 ' ' ALA . . . . . . . . . . . . . . . -104.48 105.43 15.54 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 126.232 1.813 . . . . 0.0 110.765 -172.32 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 2515 ' ' LYS . . . . . . . . . . . . . 62.9 mtpt -84.49 125.98 32.87 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.737 1.215 . . . . 0.0 111.13 -175.724 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 2516 ' ' VAL . . . . . . . . . . . . . 70.4 t -123.46 137.53 56.4 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 C-N-CA 125.226 1.41 . . . . 0.0 110.003 -172.268 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 2517 ' ' THR . . . . . . . . . . . . . 66.9 p -127.16 173.31 9.82 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 125.419 1.488 . . . . 0.0 111.18 179.006 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 2518 ' ' GLY . . . . . . . . . . . . . . . 102.01 176.88 27.96 Favored Glycine 0 CA--C 1.539 1.566 0 C-N-CA 124.762 1.172 . . . . 0.0 113.359 -175.731 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 2519 ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -72.47 135.99 25.33 Favored 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 123.691 2.928 . . . . 0.0 112.089 -170.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 2520 ' ' ARG . . . . . . . . . . . . . 48.3 ttm-85 . . . . . 0 CA--C 1.539 0.556 0 C-N-CA 123.971 0.908 . . . . 0.0 110.487 174.37 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A 2427 ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.063 0 CA-C-O 121.77 0.65 . . . . 0.0 114.194 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A 2428 ' ' ASP . . . . . . . . . . . . . 12.6 t70 -160.42 138.56 7.34 Favored Pre-proline 0 CA--C 1.548 0.9 0 C-N-CA 125.702 1.601 . . . . 0.0 110.363 -172.402 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 2429 ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -64.94 -19.5 63.98 Favored 'Trans proline' 0 CA--C 1.54 0.784 0 C-N-CA 123.191 2.594 . . . . 0.0 114.307 -175.172 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 2430 ' ' GLY . . . . . . . . . . . . . . . -80.93 -24.87 57.18 Favored Glycine 0 CA--C 1.534 1.251 0 CA-C-N 119.256 0.934 . . . . 0.0 113.374 173.025 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 2431 ' ' LEU . . . . . . . . . . . . . 4.5 mm? -89.36 -30.4 18.42 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.615 1.166 . . . . 0.0 112.153 174.317 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 2432 ' ' VAL . . . . . . . . . . . . . 66.3 t -67.74 135.23 28.9 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 C-N-CA 123.94 0.896 . . . . 0.0 110.411 172.037 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 2433 ' ' SER . . . . . . . . . . . . . 71.3 m -123.36 -175.33 3.17 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 125.841 1.656 . . . . 0.0 110.896 176.717 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 2434 ' ' ALA . . . . . . . . . . . . . . . -151.14 142.95 23.81 Favored 'General case' 0 CA--C 1.537 0.478 0 O-C-N 120.605 -1.309 . . . . 0.0 111.749 173.224 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 2435 ' ' TYR . . . . . . . . . . . . . 66.4 m-85 -147.99 148.62 30.94 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 125.373 1.469 . . . . 0.0 111.981 -174.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 2436 ' ' GLY . . . . . . . . . . . . . . . 124.48 164.35 11.91 Favored Glycine 0 N--CA 1.474 1.204 0 C-N-CA 125.446 1.498 . . . . 0.0 114.422 174.718 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 2437 ' ' ALA . . . . . . . . . . . . . . . -60.48 -29.2 68.92 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.313 1.445 . . . . 0.0 114.443 -171.177 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 2438 ' ' GLY . . . . . . . . . . . . . . . -63.95 -20.14 64.21 Favored Glycine 0 CA--C 1.532 1.124 0 CA-C-O 118.937 -0.924 . . . . 0.0 113.959 178.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 2439 ' ' LEU . . . . . . . . . . . . . 79.5 mt -75.04 -24.02 58.23 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 118.916 1.358 . . . . 0.0 112.606 170.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 2440 ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -91.08 -30.29 16.83 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 125.131 1.372 . . . . 0.0 112.0 177.808 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 2441 ' ' GLY . . . . . . . . . . . . . . . 109.93 -152.58 17.22 Favored Glycine 0 CA--C 1.534 1.224 0 C-N-CA 126.122 1.82 . . . . 0.0 113.508 178.742 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 2442 ' ' GLY . . . . . . . . . . . . . . . 169.04 -159.37 32.4 Favored Glycine 0 CA--C 1.531 1.072 0 C-N-CA 124.316 0.96 . . . . 0.0 114.001 -174.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 2443 ' ' VAL . . . . . . . . . . . . . 20.7 t -95.77 141.57 15.09 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 C-N-CA 124.461 1.104 . . . . 0.0 110.231 179.185 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 2444 ' ' THR . . . . . . . . . . . . . 31.5 p -58.6 152.19 19.0 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 124.693 1.197 . . . . 0.0 112.88 174.757 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 2445 ' ' GLY . . . . . . . . . . . . . . . 71.73 2.73 52.29 Favored Glycine 0 CA--C 1.536 1.375 0 C-N-CA 124.032 0.825 . . . . 0.0 114.326 179.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 2446 ' ' ASN . . . . . . . . . . . . . 26.0 m-80 -130.72 146.71 63.12 Favored Pre-proline 0 CA--C 1.549 0.928 0 C-N-CA 126.606 1.962 . . . . 0.0 110.284 -178.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 2447 ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -76.55 149.08 30.17 Favored 'Trans proline' 0 C--N 1.349 0.583 0 C-N-CA 123.022 2.481 . . . . 0.0 112.689 -176.179 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 2448 ' ' ALA . . . . . . . . . . . . . . . -133.86 143.08 48.09 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 126.269 1.828 . . . . 0.0 109.525 166.234 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 2449 ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -134.33 149.88 50.9 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 113.78 1.03 . . . . 0.0 113.78 -165.786 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 2450 ' ' PHE . . . . . . . . . . . . . 33.4 p90 -156.11 167.15 31.32 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.814 1.646 . . . . 0.0 111.173 179.672 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 2451 ' ' VAL . . . . . . . . . . . . . 57.4 t -123.14 131.7 72.74 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 C-N-CA 124.74 1.216 . . . . 0.0 109.656 176.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 2452 ' ' VAL . . . . . . . . . . . . . 41.3 t -80.69 104.26 8.87 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 N-CA-C 107.086 -1.45 . . . . 0.0 107.086 163.608 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 2453 ' ' ASN . . . . . . . . . . . . . 13.9 t-20 -78.28 111.2 14.01 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 123.977 0.911 . . . . 0.0 111.86 -172.702 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 2454 ' ' THR . . . . . . . . . . . . . 37.3 p -106.09 -8.04 17.68 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 125.885 1.674 . . . . 0.0 113.811 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 2455 ' ' SER . . . . . . . . . . . . . 88.6 p -65.95 -24.35 66.79 Favored 'General case' 0 N--CA 1.478 0.938 0 CA-C-N 120.173 1.351 . . . . 0.0 113.8 -176.653 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 2456 ' ' ASN . . . . . . . . . . . . . 56.4 m-80 -77.72 -11.6 59.89 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 124.493 1.117 . . . . 0.0 113.57 171.243 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 2457 ' ' ALA . . . . . . . . . . . . . . . -113.5 -57.14 2.32 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 125.11 1.364 . . . . 0.0 113.169 -172.714 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 2458 ' ' GLY . . . . . . . . . . . . . . . 123.34 -159.87 17.93 Favored Glycine 0 CA--C 1.533 1.178 0 C-N-CA 125.522 1.534 . . . . 0.0 112.661 -169.279 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 2459 ' ' ALA . . . . . . . . . . . . . . . -84.13 150.34 25.59 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 124.809 1.244 . . . . 0.0 112.972 -177.625 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 2460 ' ' GLY . . . . . . . . . . . . . . . 164.91 166.92 24.67 Favored Glycine 0 CA--C 1.531 1.089 0 C-N-CA 124.462 1.03 . . . . 0.0 113.862 -178.138 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 2461 ' ' ALA . . . . . . . . . . . . . . . -82.77 135.7 34.9 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.249 1.02 . . . . 0.0 112.709 -175.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 2462 ' ' LEU . . . . . . . . . . . . . 40.9 tp -102.11 143.91 31.34 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.901 1.681 . . . . 0.0 110.585 174.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 2463 ' ' SER . . . . . . . . . . . . . 3.9 t -138.58 41.74 2.18 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 125.206 1.403 . . . . 0.0 111.152 -177.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 2464 ' ' VAL . . . . . . . . . . . . . 9.6 p -65.57 135.21 28.73 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 C-N-CA 124.987 1.315 . . . . 0.0 112.167 -176.723 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 2465 ' ' THR . . . . . . . . . . . . . 95.4 m -135.08 145.74 48.23 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 126.067 1.747 . . . . 0.0 110.102 -178.286 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 2466 ' ' ILE . . . . . . . . . . . . . 50.2 mt -122.58 133.39 68.91 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 C-N-CA 124.5 1.12 . . . . 0.0 110.027 176.053 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 2467 ' ' ASP . . . . . . . . . . . . . 34.7 t70 -139.97 151.69 45.72 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 126.675 1.99 . . . . 0.0 110.409 178.333 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 2468 ' ' GLY . . . . . . . . . . . . . . . 174.52 -144.48 7.48 Favored Glycine 0 CA--C 1.537 1.422 0 CA-C-O 118.495 -1.17 . . . . 0.0 114.567 -177.182 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 2469 ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo -67.99 -15.56 43.66 Favored 'Trans proline' 0 C--N 1.354 0.864 0 C-N-CA 123.83 3.02 . . . . 0.0 113.343 -179.577 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 2470 ' ' SER . . . . . . . . . . . . . 7.6 t -159.07 -161.1 0.91 Allowed 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 126.078 1.751 . . . . 0.0 109.491 170.115 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 2471 ' ' LYS . . . . . . . . . . . . . 98.5 mttt -79.68 -179.61 6.99 Favored 'General case' 0 CA--C 1.55 0.975 0 O-C-N 121.014 -1.054 . . . . 0.0 111.46 164.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 2472 ' ' VAL . . . . . . . . . . . . . 14.3 m -136.37 149.94 27.41 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 125.243 1.417 . . . . 0.0 109.979 170.269 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 2473 ' ' LYS . . . . . . . . . . . . . 25.9 tptp -78.34 107.26 10.83 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 167.77 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 2474 ' ' MET . . . . . . . . . . . . . 22.9 ttt -114.78 140.61 48.77 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 125.191 1.396 . . . . 0.0 112.285 -168.357 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 2475 ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -143.22 157.28 44.63 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 126.618 1.967 . . . . 0.0 110.323 173.359 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 2476 ' ' CYS . . . . . . . . . . . . . 30.9 p -162.15 164.29 28.0 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.043 0.937 . . . . 0.0 113.485 -176.006 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 2477 ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -164.77 173.18 12.08 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.841 1.657 . . . . 0.0 111.59 177.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 2478 ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -80.2 138.83 36.91 Favored 'General case' 0 CA--C 1.544 0.716 0 O-C-N 121.57 -0.706 . . . . 0.0 110.383 164.339 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 2479 ' ' CYS . . . . . . . . . . . . . 59.3 m -132.96 167.14 24.41 Favored Pre-proline 0 CA--C 1.554 1.106 0 C-N-CA 126.824 2.05 . . . . 0.0 110.367 169.52 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 2480 ' ' PRO . . . . . . . . . . . . . 70.2 Cg_exo -57.99 -31.9 93.98 Favored 'Trans proline' 0 C--N 1.353 0.796 0 C-N-CA 123.586 2.858 . . . . 0.0 114.586 177.643 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 2481 ' ' GLU . . . . . . . . . . . . . 20.8 tp10 -77.45 -13.0 60.02 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 125.079 1.352 . . . . 0.0 112.849 177.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 2482 ' ' GLY . . . . . . . . . . . . . . . 129.1 -169.0 20.59 Favored Glycine 0 CA--C 1.53 1.018 0 C-N-CA 126.587 2.041 . . . . 0.0 112.29 -172.618 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 2483 ' ' TYR . . . . . . . . . . . . . 66.8 m-85 -69.78 111.64 5.68 Favored 'General case' 0 CA--C 1.539 0.537 0 O-C-N 121.277 -1.131 . . . . 0.0 111.783 177.808 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 2484 ' ' ARG . . . . . . . . . . . . . 68.5 ttt180 -85.09 138.26 32.53 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 125.366 1.466 . . . . 0.0 110.692 179.319 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 2485 ' ' VAL . . . . . . . . . . . . . 96.4 t -128.59 136.96 58.63 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 C-N-CA 126.333 1.853 . . . . 0.0 108.93 179.261 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 2486 ' ' THR . . . . . . . . . . . . . 85.7 m -133.24 136.58 45.66 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 125.06 1.344 . . . . 0.0 108.303 173.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 2487 ' ' TYR . . . . . . . . . . . . . 31.0 p90 -145.72 148.97 33.58 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 113.489 0.922 . . . . 0.0 113.489 177.628 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 2488 ' ' THR . . . . . . . . . . . . . 23.9 m -109.24 114.31 57.89 Favored Pre-proline 0 N--CA 1.471 0.612 0 C-N-CA 125.308 1.443 . . . . 0.0 108.7 171.304 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 2489 ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -80.07 159.73 23.77 Favored 'Trans proline' 0 N--CA 1.457 -0.628 0 C-N-CA 123.153 2.569 . . . . 0.0 111.203 173.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 2490 ' ' MET . . . . . . . . . . . . . 26.1 ptm -128.79 2.14 5.42 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 114.935 1.458 . . . . 0.0 114.935 -171.406 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 2491 ' ' ALA . . . . . . . . . . . . . . . -145.79 143.46 19.75 Favored Pre-proline 0 CA--C 1.548 0.881 0 C-N-CA 124.74 1.216 . . . . 0.0 111.308 174.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 2492 ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -72.75 155.1 54.19 Favored 'Trans proline' 0 CA--C 1.537 0.641 0 C-N-CA 123.229 2.619 . . . . 0.0 111.106 174.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 2493 ' ' GLY . . . . . . . . . . . . . . . 131.26 -151.52 19.72 Favored Glycine 0 CA--C 1.528 0.875 0 C-N-CA 125.356 1.455 . . . . 0.0 111.992 -173.257 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 2494 ' ' SER . . . . . . . . . . . . . 71.8 m -122.12 127.68 50.41 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 123.647 0.779 . . . . 0.0 112.074 177.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 2495 ' ' TYR . . . . . . . . . . . . . 86.2 m-85 -98.91 134.54 41.62 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.23 1.412 . . . . 0.0 110.676 171.688 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 2496 ' ' LEU . . . . . . . . . . . . . 10.3 mp -92.63 121.57 34.18 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.461 1.104 . . . . 0.0 108.819 168.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 2497 ' ' ILE . . . . . . . . . . . . . 40.5 mt -97.26 101.01 11.72 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.375 0 N-CA-C 107.286 -1.376 . . . . 0.0 107.286 173.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 2498 ' ' SER . . . . . . . . . . . . . 74.7 m -86.98 94.01 9.5 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 125.368 1.467 . . . . 0.0 109.512 179.159 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 2499 ' ' ILE . . . . . . . . . . . . . 26.6 mt -90.46 101.32 12.22 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 C-N-CA 124.909 1.284 . . . . 0.0 108.768 -179.769 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 2500 ' ' LYS . . . . . . . . . . . . . 83.8 mttt -109.52 143.44 39.17 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 124.535 1.134 . . . . 0.0 111.622 178.538 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 2501 ' ' TYR . . . . . . . . . . . . . 53.8 t80 -151.17 141.4 22.28 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.918 0.887 . . . . 0.0 112.698 -171.022 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 2502 ' ' GLY . . . . . . . . . . . . . . . 68.28 15.15 67.47 Favored Glycine 0 CA--C 1.536 1.354 0 C-N-CA 124.262 0.934 . . . . 0.0 114.072 178.381 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 2503 ' ' GLY . . . . . . . . . . . . . . . 142.73 -167.78 26.14 Favored Glycine 0 CA--C 1.54 1.645 0 C-N-CA 125.934 1.73 . . . . 0.0 112.591 -168.419 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 2504 ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -82.37 18.71 1.38 Allowed 'Trans proline' 0 CA--C 1.545 1.026 0 C-N-CA 124.772 3.648 . . . . 0.0 113.833 -174.112 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 2505 ' ' TYR . . . . . . . . . . . . . 73.7 m-85 -110.32 139.36 45.59 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.661 1.185 . . . . 0.0 113.341 -172.494 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 2506 ' ' HIS . . . . . . . . . . . . . 91.1 m-70 -64.23 143.29 58.0 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 125.57 1.548 . . . . 0.0 113.516 179.399 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 2507 ' ' ILE . . . . . . . . . . . . . 1.8 pp -86.37 150.37 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.075 0 C-N-CA 123.882 0.873 . . . . 0.0 111.854 171.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 2508 ' ' GLY . . . . . . . . . . . . . . . 46.23 -114.12 1.3 Allowed Glycine 0 CA--C 1.536 1.38 0 C-N-CA 124.275 0.94 . . . . 0.0 114.531 165.642 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 2509 ' ' GLY . . . . . . . . . . . . . . . -99.67 12.74 61.2 Favored Glycine 0 CA--C 1.537 1.409 0 C-N-CA 126.193 1.854 . . . . 0.0 115.19 178.117 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 2510 ' ' SER . . . . . . . . . . . . . 42.6 t -65.84 146.27 99.0 Favored Pre-proline 0 CA--C 1.552 1.04 0 CA-C-N 119.17 1.485 . . . . 0.0 112.655 179.586 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 2511 ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -75.0 142.15 73.91 Favored 'Cis proline' 0 C--N 1.354 0.852 0 CA-C-N 119.821 0.972 . . . . 0.0 112.868 0.727 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 2512 ' ' PHE . . . . . . . . . . . . . 91.6 m-85 -93.33 127.98 39.16 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.547 1.139 . . . . 0.0 110.858 178.662 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 2513 ' ' LYS . . . . . . . . . . . . . 86.0 tttt -90.24 92.7 9.04 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 124.407 1.083 . . . . 0.0 111.893 -176.768 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 2514 ' ' ALA . . . . . . . . . . . . . . . -79.53 123.84 27.95 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.976 1.31 . . . . 0.0 110.682 174.747 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 2515 ' ' LYS . . . . . . . . . . . . . 26.6 mtmm -101.15 120.87 40.86 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.201 1.401 . . . . 0.0 110.278 -173.558 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 2516 ' ' VAL . . . . . . . . . . . . . 73.0 t -120.42 138.45 50.91 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 124.843 1.257 . . . . 0.0 111.133 -167.692 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 2517 ' ' THR . . . . . . . . . . . . . 68.1 p -128.9 178.53 6.31 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 125.986 1.714 . . . . 0.0 111.088 179.505 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 2518 ' ' GLY . . . . . . . . . . . . . . . 97.67 -176.31 30.96 Favored Glycine 0 CA--C 1.54 1.629 0 C-N-CA 124.545 1.069 . . . . 0.0 113.39 -176.68 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 2519 ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -71.6 148.25 53.04 Favored 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 123.72 2.947 . . . . 0.0 112.167 -174.408 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 2520 ' ' ARG . . . . . . . . . . . . . 35.8 ttp180 . . . . . 0 CA--C 1.539 0.544 0 C-N-CA 123.648 0.779 . . . . 0.0 110.217 173.882 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A 2427 ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.957 0 N-CA-C 111.579 -0.608 . . . . 0.0 111.579 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A 2428 ' ' ASP . . . . . . . . . . . . . 22.2 m-20 -97.33 128.59 34.37 Favored Pre-proline 0 CA--C 1.547 0.853 0 C-N-CA 123.909 0.884 . . . . 0.0 112.726 -175.516 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 2429 ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -66.67 -22.42 50.43 Favored 'Trans proline' 0 C--N 1.352 0.748 0 C-N-CA 122.993 2.462 . . . . 0.0 112.915 177.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 2430 ' ' GLY . . . . . . . . . . . . . . . -75.05 -23.16 75.24 Favored Glycine 0 CA--C 1.535 1.304 0 CA-C-N 119.062 0.847 . . . . 0.0 113.551 173.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 2431 ' ' LEU . . . . . . . . . . . . . 4.2 mm? -86.34 -29.82 22.69 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 124.483 1.113 . . . . 0.0 111.698 171.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 2432 ' ' VAL . . . . . . . . . . . . . 79.1 t -67.94 135.25 28.84 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 C-N-CA 123.51 0.724 . . . . 0.0 110.521 169.723 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 2433 ' ' SER . . . . . . . . . . . . . 57.9 m -140.44 144.66 36.23 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 125.463 1.505 . . . . 0.0 109.439 171.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 2434 ' ' ALA . . . . . . . . . . . . . . . -96.41 148.58 22.64 Favored 'General case' 0 CA--C 1.539 0.553 0 O-C-N 121.572 -0.705 . . . . 0.0 111.794 176.133 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 2435 ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -142.4 142.78 32.45 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.808 1.643 . . . . 0.0 111.468 -178.226 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 2436 ' ' GLY . . . . . . . . . . . . . . . 129.17 159.45 9.91 Favored Glycine 0 N--CA 1.473 1.11 0 C-N-CA 125.438 1.494 . . . . 0.0 113.534 -179.708 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 2437 ' ' ALA . . . . . . . . . . . . . . . -63.56 -26.94 68.92 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 114.259 1.207 . . . . 0.0 114.259 -171.22 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 2438 ' ' GLY . . . . . . . . . . . . . . . -68.19 -11.08 60.81 Favored Glycine 0 CA--C 1.53 0.969 0 C-N-CA 124.001 0.81 . . . . 0.0 114.702 -177.475 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 2439 ' ' LEU . . . . . . . . . . . . . 73.2 mt -78.46 -26.04 46.03 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.724 1.21 . . . . 0.0 112.405 171.607 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 2440 ' ' GLU . . . . . . . . . . . . . 37.5 mm-40 -89.07 -36.61 15.66 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 124.794 1.237 . . . . 0.0 111.853 -178.3 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 2441 ' ' GLY . . . . . . . . . . . . . . . 155.77 -148.39 18.46 Favored Glycine 0 CA--C 1.529 0.926 0 C-N-CA 124.389 0.995 . . . . 0.0 113.813 -176.135 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 2442 ' ' GLY . . . . . . . . . . . . . . . 157.49 -158.39 28.94 Favored Glycine 0 CA--C 1.53 1.012 0 C-N-CA 125.303 1.43 . . . . 0.0 112.924 -176.023 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 2443 ' ' VAL . . . . . . . . . . . . . 81.2 t -129.53 139.61 51.24 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.975 0 C-N-CA 125.321 1.449 . . . . 0.0 109.213 179.086 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 2444 ' ' THR . . . . . . . . . . . . . 33.5 p -60.45 138.06 58.06 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 124.016 0.926 . . . . 0.0 111.978 178.354 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 2445 ' ' GLY . . . . . . . . . . . . . . . 81.3 -10.65 48.23 Favored Glycine 0 CA--C 1.537 1.459 0 C-N-CA 124.75 1.167 . . . . 0.0 114.862 -175.371 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 2446 ' ' ASN . . . . . . . . . . . . . 88.4 m-20 -106.69 149.75 38.8 Favored Pre-proline 0 CA--C 1.548 0.888 0 C-N-CA 125.167 1.387 . . . . 0.0 111.192 174.611 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 2447 ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -73.07 135.83 23.69 Favored 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 122.849 2.366 . . . . 0.0 111.79 -179.485 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 2448 ' ' ALA . . . . . . . . . . . . . . . -109.83 142.17 41.47 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 127.236 2.214 . . . . 0.0 108.772 167.028 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 2449 ' ' GLU . . . . . . . . . . . . . 5.0 tm-20 -147.91 141.24 25.23 Favored 'General case' 0 N--CA 1.471 0.614 0 O-C-N 121.411 -0.806 . . . . 0.0 112.994 -162.598 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 2450 ' ' PHE . . . . . . . . . . . . . 52.9 p90 -156.29 157.44 35.76 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 125.83 1.652 . . . . 0.0 112.458 177.604 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 2451 ' ' VAL . . . . . . . . . . . . . 59.0 t -113.55 133.29 59.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 125.641 1.577 . . . . 0.0 109.443 171.78 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 2452 ' ' VAL . . . . . . . . . . . . . 39.3 t -87.14 105.1 14.78 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 C-N-CA 125.102 1.361 . . . . 0.0 107.819 168.225 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 2453 ' ' ASN . . . . . . . . . . . . . 32.7 t-20 -77.9 117.14 18.96 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 123.612 0.765 . . . . 0.0 110.926 -174.073 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 2454 ' ' THR . . . . . . . . . . . . . 39.5 p -105.1 -9.61 17.69 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 125.088 1.355 . . . . 0.0 113.634 -178.559 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 2455 ' ' SER . . . . . . . . . . . . . 41.2 m -57.94 -29.79 65.44 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.927 1.291 . . . . 0.0 114.234 -175.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 2456 ' ' ASN . . . . . . . . . . . . . 79.4 m-20 -83.79 -16.21 45.52 Favored 'General case' 0 CA--C 1.546 0.809 0 N-CA-C 113.767 1.025 . . . . 0.0 113.767 177.289 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 2457 ' ' ALA . . . . . . . . . . . . . . . -102.45 -41.94 6.14 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 114.458 1.281 . . . . 0.0 114.458 -166.574 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 2458 ' ' GLY . . . . . . . . . . . . . . . 121.64 -133.63 9.56 Favored Glycine 0 N--CA 1.471 1.03 0 C-N-CA 124.653 1.12 . . . . 0.0 112.06 -171.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 2459 ' ' ALA . . . . . . . . . . . . . . . -129.97 120.9 25.55 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.51 1.124 . . . . 0.0 111.944 -175.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 2460 ' ' GLY . . . . . . . . . . . . . . . -165.6 162.71 36.09 Favored Glycine 0 CA--C 1.529 0.963 0 C-N-CA 125.029 1.3 . . . . 0.0 113.029 -177.612 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 2461 ' ' ALA . . . . . . . . . . . . . . . -79.26 145.18 33.69 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.064 0.946 . . . . 0.0 112.484 -179.163 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 2462 ' ' LEU . . . . . . . . . . . . . 13.7 tp -95.26 147.2 23.74 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.178 1.391 . . . . 0.0 110.555 172.812 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 2463 ' ' SER . . . . . . . . . . . . . 9.1 t -137.12 34.58 2.57 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 125.301 1.44 . . . . 0.0 111.506 -178.302 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 2464 ' ' VAL . . . . . . . . . . . . . 10.5 p -59.65 135.17 24.52 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 C-N-CA 125.327 1.451 . . . . 0.0 112.58 -175.621 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 2465 ' ' THR . . . . . . . . . . . . . 96.4 m -134.91 142.9 46.67 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 125.759 1.623 . . . . 0.0 109.389 176.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 2466 ' ' ILE . . . . . . . . . . . . . 36.1 mt -120.27 122.2 67.68 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 C-N-CA 123.773 0.829 . . . . 0.0 109.953 174.05 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 2467 ' ' ASP . . . . . . . . . . . . . 33.0 t70 -104.68 166.8 10.14 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 126.392 1.877 . . . . 0.0 110.12 168.011 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 2468 ' ' GLY . . . . . . . . . . . . . . . 167.48 -160.57 34.24 Favored Glycine 0 CA--C 1.535 1.31 0 O-C-N 120.83 -1.169 . . . . 0.0 114.936 178.752 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 2469 ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -70.04 -16.44 36.39 Favored 'Trans proline' 0 CA--C 1.54 0.819 0 C-N-CA 123.915 3.077 . . . . 0.0 113.246 178.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 2470 ' ' SER . . . . . . . . . . . . . 38.0 m -157.95 -171.8 3.67 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 127.335 2.254 . . . . 0.0 109.819 177.506 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 2471 ' ' LYS . . . . . . . . . . . . . 99.0 mttt -70.74 175.95 4.58 Favored 'General case' 0 CA--C 1.551 0.985 0 O-C-N 120.956 -1.09 . . . . 0.0 112.343 167.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 2472 ' ' VAL . . . . . . . . . . . . . 33.9 m -132.11 148.87 32.09 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.925 0 C-N-CA 125.311 1.444 . . . . 0.0 110.466 169.624 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 2473 ' ' LYS . . . . . . . . . . . . . 62.0 mtpt -87.43 89.17 7.9 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 123.592 0.757 . . . . 0.0 109.52 169.6 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 2474 ' ' MET . . . . . . . . . . . . . 60.0 ttm -83.51 143.0 30.49 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 124.334 1.054 . . . . 0.0 112.071 -177.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 2475 ' ' ASP . . . . . . . . . . . . . 31.7 t70 -139.09 103.87 4.88 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 126.581 1.953 . . . . 0.0 109.221 167.026 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 2476 ' ' CYS . . . . . . . . . . . . . 28.7 p -102.3 155.19 18.39 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 124.954 1.302 . . . . 0.0 112.28 178.143 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 2477 ' ' GLN . . . . . . . . . . . . . 27.4 tt0 -161.59 146.56 13.36 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.26 1.024 . . . . 0.0 111.258 -172.156 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 2478 ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -77.89 122.67 25.79 Favored 'General case' 0 CA--C 1.541 0.615 0 O-C-N 121.478 -0.763 . . . . 0.0 110.609 173.682 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 2479 ' ' CYS . . . . . . . . . . . . . 60.6 m -121.76 166.29 17.12 Favored Pre-proline 0 CA--C 1.553 1.082 0 C-N-CA 126.539 1.936 . . . . 0.0 111.041 179.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 2480 ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -65.32 -26.9 55.82 Favored 'Trans proline' 0 CA--C 1.54 0.797 0 C-N-CA 123.009 2.473 . . . . 0.0 114.567 -174.527 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 2481 ' ' GLU . . . . . . . . . . . . . 82.2 tt0 -82.24 -17.17 46.95 Favored 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 124.143 0.977 . . . . 0.0 112.997 174.46 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 2482 ' ' GLY . . . . . . . . . . . . . . . 140.11 -162.47 26.39 Favored Glycine 0 CA--C 1.528 0.875 0 C-N-CA 125.879 1.705 . . . . 0.0 112.608 -176.306 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 2483 ' ' TYR . . . . . . . . . . . . . 74.0 m-85 -70.36 119.07 13.99 Favored 'General case' 0 CA--C 1.539 0.541 0 O-C-N 121.479 -1.013 . . . . 0.0 111.75 -179.848 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 2484 ' ' ARG . . . . . . . . . . . . . 21.5 ttt180 -95.34 141.83 28.45 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 125.038 1.335 . . . . 0.0 110.725 177.013 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 2485 ' ' VAL . . . . . . . . . . . . . 67.1 t -132.58 122.01 46.43 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 C-N-CA 124.98 1.312 . . . . 0.0 108.943 178.247 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 2486 ' ' THR . . . . . . . . . . . . . 89.9 m -110.07 144.35 38.78 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 124.856 1.262 . . . . 0.0 107.846 165.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 2487 ' ' TYR . . . . . . . . . . . . . 28.7 p90 -148.63 144.24 27.06 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 123.918 0.887 . . . . 0.0 112.185 174.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 2488 ' ' THR . . . . . . . . . . . . . 85.6 m -107.21 117.32 56.53 Favored Pre-proline 0 N--CA 1.476 0.86 0 CA-C-O 117.989 -1.005 . . . . 0.0 109.422 172.233 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 2489 ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -81.68 163.11 18.86 Favored 'Trans proline' 0 C--N 1.351 0.687 0 C-N-CA 124.319 3.346 . . . . 0.0 111.604 174.197 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 2490 ' ' MET . . . . . . . . . . . . . 28.4 ptm -133.85 -3.68 2.87 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 115.603 1.705 . . . . 0.0 115.603 -171.539 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 2491 ' ' ALA . . . . . . . . . . . . . . . -144.78 145.66 28.77 Favored Pre-proline 0 CA--C 1.548 0.871 0 C-N-CA 124.728 1.211 . . . . 0.0 110.937 172.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 2492 ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -71.29 151.98 60.8 Favored 'Trans proline' 0 CA--C 1.535 0.574 0 C-N-CA 123.504 2.803 . . . . 0.0 111.615 -178.715 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 2493 ' ' GLY . . . . . . . . . . . . . . . 129.88 -165.47 22.32 Favored Glycine 0 CA--C 1.53 1.003 0 C-N-CA 125.187 1.375 . . . . 0.0 113.578 -177.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 2494 ' ' SER . . . . . . . . . . . . . 16.7 p -89.96 115.02 26.94 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.835 1.254 . . . . 0.0 112.08 178.823 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 2495 ' ' TYR . . . . . . . . . . . . . 54.6 m-85 -87.74 122.78 31.82 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 123.536 0.735 . . . . 0.0 109.741 163.819 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 2496 ' ' LEU . . . . . . . . . . . . . 21.4 tp -94.34 104.61 16.59 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 124.597 1.159 . . . . 0.0 109.521 -178.467 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 2497 ' ' ILE . . . . . . . . . . . . . 30.2 mt -90.4 98.05 7.84 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 C-N-CA 125.826 1.65 . . . . 0.0 108.23 -177.627 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 2498 ' ' SER . . . . . . . . . . . . . 71.0 m -85.02 80.97 9.1 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 124.675 1.19 . . . . 0.0 109.624 175.783 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 2499 ' ' ILE . . . . . . . . . . . . . 17.9 mt -77.82 114.16 17.99 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 175.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 2500 ' ' LYS . . . . . . . . . . . . . 81.9 mttt -121.76 148.66 44.35 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.528 1.531 . . . . 0.0 111.037 -177.781 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 2501 ' ' TYR . . . . . . . . . . . . . 63.4 t80 -154.91 145.84 22.58 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.119 0.968 . . . . 0.0 112.499 -171.423 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 2502 ' ' GLY . . . . . . . . . . . . . . . 69.04 17.48 71.83 Favored Glycine 0 CA--C 1.536 1.394 0 C-N-CA 124.216 0.913 . . . . 0.0 113.704 178.823 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 2503 ' ' GLY . . . . . . . . . . . . . . . 135.6 -165.05 24.87 Favored Glycine 0 CA--C 1.54 1.643 0 C-N-CA 125.981 1.753 . . . . 0.0 112.528 -167.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 2504 ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -82.26 20.31 1.12 Allowed 'Trans proline' 0 CA--C 1.545 1.06 0 C-N-CA 124.855 3.703 . . . . 0.0 113.638 -174.545 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 2505 ' ' TYR . . . . . . . . . . . . . 80.5 m-85 -109.98 139.96 44.51 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.751 1.22 . . . . 0.0 113.355 -172.644 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 2506 ' ' HIS . . . . . . . . . . . . . 92.5 m-70 -62.57 144.31 56.27 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 125.571 1.548 . . . . 0.0 113.572 -179.61 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 2507 ' ' ILE . . . . . . . . . . . . . 28.0 pt -75.79 174.69 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 C-N-CA 123.633 0.773 . . . . 0.0 112.992 173.123 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 2508 ' ' GLY . . . . . . . . . . . . . . . -58.94 117.91 12.45 Favored Glycine 0 CA--C 1.532 1.152 0 N-CA-C 111.228 -0.749 . . . . 0.0 111.228 171.24 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 2509 ' ' GLY . . . . . . . . . . . . . . . 93.54 -9.77 73.59 Favored Glycine 0 CA--C 1.536 1.388 0 C-N-CA 125.677 1.608 . . . . 0.0 115.168 -178.142 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 2510 ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -78.23 156.09 79.17 Favored Pre-proline 0 N--CA 1.474 0.768 0 CA-C-N 119.647 1.723 . . . . 0.0 113.68 178.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 2511 ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -77.58 152.66 93.51 Favored 'Cis proline' 0 CA--C 1.539 0.768 0 CA-C-N 118.26 0.414 . . . . 0.0 111.435 -9.561 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 2512 ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -98.21 128.8 44.87 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.373 1.069 . . . . 0.0 110.633 179.693 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 2513 ' ' LYS . . . . . . . . . . . . . 24.9 pttm -88.22 7.58 31.29 Favored 'General case' 0 N--CA 1.479 0.995 0 N-CA-C 116.715 2.117 . . . . 0.0 116.715 -165.352 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 2514 ' ' ALA . . . . . . . . . . . . . . . -3.97 97.65 0.01 OUTLIER 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 129.467 3.107 . . . . 0.0 116.462 -175.616 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 2515 ' ' LYS . . . . . . . . . . . . . 62.8 mtpt -89.78 105.24 17.67 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.504 1.122 . . . . 0.0 110.683 -175.104 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 2516 ' ' VAL . . . . . . . . . . . . . 4.0 m -102.36 148.4 7.86 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 C-N-CA 124.315 1.046 . . . . 0.0 111.486 -174.161 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 2517 ' ' THR . . . . . . . . . . . . . 69.1 p -116.66 -169.37 1.62 Allowed 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 125.471 1.508 . . . . 0.0 110.922 179.349 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 2518 ' ' GLY . . . . . . . . . . . . . . . 96.29 -175.7 32.2 Favored Glycine 0 CA--C 1.539 1.575 0 C-N-CA 124.693 1.14 . . . . 0.0 113.331 -176.221 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 2519 ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -70.63 153.39 64.96 Favored 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 123.748 2.966 . . . . 0.0 112.537 -174.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 2520 ' ' ARG . . . . . . . . . . . . . 65.2 ttp85 . . . . . 0 CA--C 1.536 0.419 0 C-N-CA 124.686 1.194 . . . . 0.0 110.053 171.199 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A 2427 ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.111 0 CA-C-O 121.49 0.495 . . . . 0.0 113.787 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A 2428 ' ' ASP . . . . . . . . . . . . . 25.6 m-20 -117.68 137.1 23.94 Favored Pre-proline 0 CA--C 1.546 0.82 0 C-N-CA 125.07 1.348 . . . . 0.0 111.901 -179.595 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 2429 ' ' PRO . . . . . . . . . . . . . 81.1 Cg_exo -54.91 -26.79 50.49 Favored 'Trans proline' 0 C--N 1.353 0.792 0 C-N-CA 124.056 3.171 . . . . 0.0 115.089 174.707 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 2430 ' ' GLY . . . . . . . . . . . . . . . -78.93 -23.1 64.66 Favored Glycine 0 CA--C 1.534 1.225 0 C-N-CA 123.812 0.72 . . . . 0.0 113.786 176.174 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 2431 ' ' LEU . . . . . . . . . . . . . 4.4 mm? -91.04 -32.16 16.01 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.731 1.212 . . . . 0.0 111.89 174.458 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 2432 ' ' VAL . . . . . . . . . . . . . 94.1 t -64.84 134.32 29.5 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 CA-C-N 118.698 0.681 . . . . 0.0 109.76 170.033 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 2433 ' ' SER . . . . . . . . . . . . . 7.9 t -127.28 -167.91 1.81 Allowed 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.93 1.292 . . . . 0.0 111.163 177.545 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 2434 ' ' ALA . . . . . . . . . . . . . . . -153.25 139.37 18.32 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.538 1.135 . . . . 0.0 111.656 177.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 2435 ' ' TYR . . . . . . . . . . . . . 76.8 m-85 -146.54 141.9 27.48 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 125.265 1.426 . . . . 0.0 111.951 -176.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 2436 ' ' GLY . . . . . . . . . . . . . . . 126.0 163.05 11.46 Favored Glycine 0 CA--C 1.534 1.225 0 C-N-CA 125.704 1.621 . . . . 0.0 113.743 179.461 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 2437 ' ' ALA . . . . . . . . . . . . . . . -63.58 -28.39 69.9 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 114.706 1.373 . . . . 0.0 114.706 -168.782 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 2438 ' ' GLY . . . . . . . . . . . . . . . -64.42 -16.6 60.84 Favored Glycine 0 CA--C 1.532 1.095 0 C-N-CA 124.302 0.953 . . . . 0.0 114.502 -177.645 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 2439 ' ' LEU . . . . . . . . . . . . . 95.2 mt -68.73 -29.55 67.99 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 118.575 1.188 . . . . 0.0 112.548 170.159 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 2440 ' ' GLU . . . . . . . . . . . . . 41.7 mm-40 -90.24 -26.92 19.83 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.912 1.285 . . . . 0.0 112.33 178.765 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 2441 ' ' GLY . . . . . . . . . . . . . . . 102.86 -144.42 16.05 Favored Glycine 0 CA--C 1.531 1.087 0 C-N-CA 125.666 1.603 . . . . 0.0 112.881 -178.143 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 2442 ' ' GLY . . . . . . . . . . . . . . . 163.06 -160.26 32.79 Favored Glycine 0 CA--C 1.532 1.124 0 C-N-CA 123.836 0.731 . . . . 0.0 114.872 -176.349 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 2443 ' ' VAL . . . . . . . . . . . . . 83.2 t -83.14 141.49 14.82 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 C-N-CA 124.786 1.235 . . . . 0.0 110.96 -177.533 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 2444 ' ' THR . . . . . . . . . . . . . 18.9 p -56.1 131.41 47.52 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 124.996 1.318 . . . . 0.0 112.228 174.674 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 2445 ' ' GLY . . . . . . . . . . . . . . . 82.88 -10.93 56.05 Favored Glycine 0 CA--C 1.535 1.291 0 C-N-CA 124.993 1.282 . . . . 0.0 114.66 178.667 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 2446 ' ' ASN . . . . . . . . . . . . . 61.1 m-20 -91.99 147.93 35.85 Favored Pre-proline 0 CA--C 1.547 0.833 0 CA-C-N 118.63 1.215 . . . . 0.0 110.727 172.225 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 2447 ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -71.8 143.48 41.55 Favored 'Trans proline' 0 N--CA 1.457 -0.619 0 C-N-CA 122.817 2.345 . . . . 0.0 111.041 177.453 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 2448 ' ' ALA . . . . . . . . . . . . . . . -124.39 143.92 50.34 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 126.698 1.999 . . . . 0.0 109.126 172.495 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 2449 ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -154.41 152.43 30.17 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 113.392 0.886 . . . . 0.0 113.392 -173.462 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 2450 ' ' PHE . . . . . . . . . . . . . 14.0 p90 -161.46 167.14 26.11 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.902 1.681 . . . . 0.0 110.436 177.599 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 2451 ' ' VAL . . . . . . . . . . . . . 59.2 t -112.33 128.69 68.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 124.698 1.199 . . . . 0.0 110.209 177.537 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 2452 ' ' VAL . . . . . . . . . . . . . 48.8 t -77.53 106.11 7.35 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 162.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 2453 ' ' ASN . . . . . . . . . . . . . 16.3 t-20 -83.47 106.31 15.11 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 124.21 1.004 . . . . 0.0 111.732 -170.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 2454 ' ' THR . . . . . . . . . . . . . 40.6 p -97.7 -8.23 29.17 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 125.83 1.652 . . . . 0.0 113.514 177.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 2455 ' ' SER . . . . . . . . . . . . . 12.8 t -58.54 -31.69 68.18 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-N 119.364 0.983 . . . . 0.0 113.45 -176.629 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 2456 ' ' ASN . . . . . . . . . . . . . 57.8 m-80 -76.8 -14.86 59.87 Favored 'General case' 0 CA--C 1.549 0.907 0 N-CA-C 113.942 1.09 . . . . 0.0 113.942 174.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 2457 ' ' ALA . . . . . . . . . . . . . . . -109.0 -39.0 5.43 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 125.344 1.458 . . . . 0.0 113.98 -173.723 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 2458 ' ' GLY . . . . . . . . . . . . . . . 112.67 -148.3 18.42 Favored Glycine 0 CA--C 1.533 1.181 0 C-N-CA 125.379 1.466 . . . . 0.0 112.125 -171.432 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 2459 ' ' ALA . . . . . . . . . . . . . . . -92.36 154.7 18.39 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.21 1.004 . . . . 0.0 112.123 179.417 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 2460 ' ' GLY . . . . . . . . . . . . . . . 166.02 163.71 20.1 Favored Glycine 0 N--CA 1.47 0.924 0 C-N-CA 123.848 0.737 . . . . 0.0 114.3 177.488 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 2461 ' ' ALA . . . . . . . . . . . . . . . -80.04 137.3 36.77 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.349 1.06 . . . . 0.0 112.134 -178.559 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 2462 ' ' LEU . . . . . . . . . . . . . 25.8 tp -110.78 141.76 43.68 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.337 1.455 . . . . 0.0 110.591 176.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 2463 ' ' SER . . . . . . . . . . . . . 4.1 t -130.28 39.0 3.7 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 126.215 1.806 . . . . 0.0 110.653 -177.319 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 2464 ' ' VAL . . . . . . . . . . . . . 11.4 p -65.72 140.98 18.72 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 125.512 1.525 . . . . 0.0 112.058 -176.239 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 2465 ' ' THR . . . . . . . . . . . . . 8.3 t -154.45 167.19 30.88 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 125.137 1.375 . . . . 0.0 111.691 179.704 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 2466 ' ' ILE . . . . . . . . . . . . . 35.2 mt -135.02 131.01 52.56 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 C-N-CA 125.237 1.415 . . . . 0.0 109.936 -176.127 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 2467 ' ' ASP . . . . . . . . . . . . . 36.3 t70 -122.26 136.91 54.98 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 125.811 1.644 . . . . 0.0 110.735 174.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 2468 ' ' GLY . . . . . . . . . . . . . . . 172.94 -162.77 34.34 Favored Glycine 0 CA--C 1.537 1.444 0 CA-C-O 119.062 -0.855 . . . . 0.0 114.121 -177.624 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 2469 ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -72.81 1.2 6.68 Favored 'Trans proline' 0 CA--C 1.544 0.979 0 C-N-CA 123.999 3.133 . . . . 0.0 115.325 -172.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 2470 ' ' SER . . . . . . . . . . . . . 85.0 p -150.55 153.94 36.69 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 120.071 1.305 . . . . 0.0 112.989 167.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 2471 ' ' LYS . . . . . . . . . . . . . 99.1 mttt -75.44 74.45 2.5 Favored 'General case' 0 CA--C 1.545 0.77 0 O-C-N 120.906 -1.121 . . . . 0.0 111.073 175.624 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 2472 ' ' VAL . . . . . . . . . . . . . 18.6 m -54.76 143.14 7.57 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 C-N-CA 124.725 1.21 . . . . 0.0 113.403 -173.422 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 2473 ' ' LYS . . . . . . . . . . . . . 83.8 tttt -83.67 70.8 10.38 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 124.596 1.158 . . . . 0.0 111.129 178.471 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 2474 ' ' MET . . . . . . . . . . . . . 16.6 tmm? -79.78 129.61 34.63 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.185 0.994 . . . . 0.0 111.315 -179.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 2475 ' ' ASP . . . . . . . . . . . . . 35.6 t70 -123.38 126.23 46.43 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 126.209 1.804 . . . . 0.0 110.348 174.261 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 2476 ' ' CYS . . . . . . . . . . . . . 35.9 t -101.92 139.82 37.03 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.066 1.346 . . . . 0.0 111.535 179.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 2477 ' ' GLN . . . . . . . . . . . . . 83.5 mt-30 -141.42 145.25 35.06 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.424 1.49 . . . . 0.0 110.497 -174.092 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 2478 ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -88.11 136.81 32.8 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 123.716 0.806 . . . . 0.0 110.624 174.213 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 2479 ' ' CYS . . . . . . . . . . . . . 14.8 p -146.44 171.53 6.3 Favored Pre-proline 0 CA--C 1.554 1.11 0 C-N-CA 125.617 1.567 . . . . 0.0 111.717 177.69 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 2480 ' ' PRO . . . . . . . . . . . . . 70.5 Cg_exo -58.94 -28.31 87.2 Favored 'Trans proline' 0 CA--C 1.539 0.76 0 C-N-CA 123.468 2.779 . . . . 0.0 114.66 179.331 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 2481 ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -83.79 -14.19 52.01 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 124.62 1.168 . . . . 0.0 113.019 -179.656 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 2482 ' ' GLY . . . . . . . . . . . . . . . 136.09 -143.95 15.57 Favored Glycine 0 N--CA 1.47 0.937 0 C-N-CA 125.83 1.681 . . . . 0.0 112.677 -177.112 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 2483 ' ' TYR . . . . . . . . . . . . . 88.7 m-85 -92.8 108.82 20.28 Favored 'General case' 0 N--CA 1.469 0.506 0 O-C-N 121.678 -0.895 . . . . 0.0 110.911 173.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 2484 ' ' ARG . . . . . . . . . . . . . 12.7 ttp180 -74.44 140.94 45.0 Favored 'General case' 0 N--CA 1.468 0.451 0 O-C-N 121.705 -0.622 . . . . 0.0 109.859 169.217 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 2485 ' ' VAL . . . . . . . . . . . . . 22.5 m -126.18 141.69 45.01 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 C-N-CA 123.669 0.788 . . . . 0.0 110.368 165.583 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 2486 ' ' THR . . . . . . . . . . . . . 88.8 m -132.53 135.84 46.23 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 125.658 1.583 . . . . 0.0 108.443 177.582 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 2487 ' ' TYR . . . . . . . . . . . . . 23.1 p90 -149.84 159.92 43.98 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.792 1.237 . . . . 0.0 112.443 -179.747 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 2488 ' ' THR . . . . . . . . . . . . . 99.4 m -122.27 113.8 30.81 Favored Pre-proline 0 N--CA 1.476 0.871 0 C-N-CA 124.154 0.982 . . . . 0.0 109.59 174.23 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 2489 ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -83.74 134.89 6.56 Favored 'Trans proline' 0 N--CA 1.458 -0.598 0 C-N-CA 123.624 2.883 . . . . 0.0 109.957 169.653 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 2490 ' ' MET . . . . . . . . . . . . . 22.4 ptt? -101.71 -18.05 16.0 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 114.329 1.233 . . . . 0.0 114.329 179.348 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 2491 ' ' ALA . . . . . . . . . . . . . . . -112.98 146.34 34.93 Favored Pre-proline 0 CA--C 1.547 0.835 0 C-N-CA 124.68 1.192 . . . . 0.0 112.346 -175.067 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 2492 ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -72.07 156.67 55.55 Favored 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 122.99 2.46 . . . . 0.0 111.192 172.494 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 2493 ' ' GLY . . . . . . . . . . . . . . . 128.79 -147.83 17.77 Favored Glycine 0 CA--C 1.528 0.894 0 C-N-CA 125.465 1.507 . . . . 0.0 112.239 -175.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 2494 ' ' SER . . . . . . . . . . . . . 63.8 m -129.78 140.55 51.03 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 123.891 0.876 . . . . 0.0 111.973 177.686 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 2495 ' ' TYR . . . . . . . . . . . . . 62.3 m-85 -114.75 127.5 55.77 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 125.993 1.717 . . . . 0.0 109.797 177.245 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 2496 ' ' LEU . . . . . . . . . . . . . 9.9 mp -88.69 117.56 27.75 Favored 'General case' 0 N--CA 1.464 0.242 0 C-N-CA 123.879 0.871 . . . . 0.0 108.963 173.131 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 2497 ' ' ILE . . . . . . . . . . . . . 36.1 mt -93.45 103.95 15.22 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 C-N-CA 125.371 1.468 . . . . 0.0 107.462 176.101 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 2498 ' ' SER . . . . . . . . . . . . . 66.4 m -91.31 101.21 13.91 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 124.816 1.246 . . . . 0.0 109.524 -179.609 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 2499 ' ' ILE . . . . . . . . . . . . . 24.0 mt -97.6 92.01 2.77 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 C-N-CA 125.332 1.453 . . . . 0.0 108.828 -178.05 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 2500 ' ' LYS . . . . . . . . . . . . . 84.2 mttt -102.51 139.68 37.79 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.32 1.048 . . . . 0.0 111.739 178.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 2501 ' ' TYR . . . . . . . . . . . . . 72.8 t80 -145.26 147.45 32.4 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.817 1.247 . . . . 0.0 112.429 -170.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 2502 ' ' GLY . . . . . . . . . . . . . . . 64.83 21.28 67.31 Favored Glycine 0 CA--C 1.535 1.299 0 C-N-CA 124.17 0.89 . . . . 0.0 113.505 177.725 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 2503 ' ' GLY . . . . . . . . . . . . . . . 126.69 -163.49 20.58 Favored Glycine 0 CA--C 1.541 1.686 0 C-N-CA 125.899 1.714 . . . . 0.0 112.173 -163.119 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 2504 ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -83.23 21.49 1.02 Allowed 'Trans proline' 0 CA--C 1.545 1.048 0 C-N-CA 124.776 3.65 . . . . 0.0 113.91 -172.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 2505 ' ' TYR . . . . . . . . . . . . . 80.7 m-85 -105.92 130.5 53.86 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.313 1.045 . . . . 0.0 113.129 -171.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 2506 ' ' HIS . . . . . . . . . . . . . 86.5 m-70 -62.39 140.03 58.55 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 125.369 1.468 . . . . 0.0 113.523 179.705 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 2507 ' ' ILE . . . . . . . . . . . . . 1.8 pp -87.82 150.73 3.68 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.163 0 C-N-CA 123.954 0.902 . . . . 0.0 111.812 172.33 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 2508 ' ' GLY . . . . . . . . . . . . . . . 48.88 -116.8 3.57 Favored Glycine 0 CA--C 1.536 1.377 0 C-N-CA 124.087 0.851 . . . . 0.0 114.074 167.765 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 2509 ' ' GLY . . . . . . . . . . . . . . . -98.59 13.16 62.84 Favored Glycine 0 CA--C 1.536 1.359 0 C-N-CA 126.156 1.836 . . . . 0.0 115.047 177.811 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 2510 ' ' SER . . . . . . . . . . . . . 44.2 t -65.36 145.39 99.08 Favored Pre-proline 0 CA--C 1.553 1.059 0 CA-C-N 119.207 1.503 . . . . 0.0 112.837 -179.004 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 2511 ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -74.7 141.0 70.45 Favored 'Cis proline' 0 C--N 1.355 0.888 0 CA-C-N 119.712 0.933 . . . . 0.0 112.636 0.663 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 2512 ' ' PHE . . . . . . . . . . . . . 87.8 m-85 -94.38 125.43 39.02 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.575 1.15 . . . . 0.0 110.518 178.246 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 2513 ' ' LYS . . . . . . . . . . . . . 25.7 pttm -85.5 105.02 15.8 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 123.545 0.738 . . . . 0.0 112.165 177.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 2514 ' ' ALA . . . . . . . . . . . . . . . -87.94 120.0 28.84 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.239 1.416 . . . . 0.0 109.902 173.433 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 2515 ' ' LYS . . . . . . . . . . . . . 54.0 mtmt -94.41 133.35 38.09 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.383 1.073 . . . . 0.0 110.84 -176.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 2516 ' ' VAL . . . . . . . . . . . . . 87.9 t -131.21 136.94 56.77 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 124.415 1.086 . . . . 0.0 110.743 -170.544 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 2517 ' ' THR . . . . . . . . . . . . . 34.2 p -138.41 156.76 47.28 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 125.265 1.426 . . . . 0.0 111.795 -175.705 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 2518 ' ' GLY . . . . . . . . . . . . . . . 114.73 -176.29 16.7 Favored Glycine 0 CA--C 1.541 1.698 0 C-N-CA 125.584 1.564 . . . . 0.0 113.04 -175.21 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 2519 ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -69.8 149.68 66.97 Favored 'Trans proline' 0 CA--C 1.535 0.562 0 C-N-CA 123.756 2.97 . . . . 0.0 112.246 -174.162 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 2520 ' ' ARG . . . . . . . . . . . . . 37.3 ttm105 . . . . . 0 CA--C 1.545 0.764 0 C-N-CA 123.908 0.883 . . . . 0.0 113.287 178.904 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A 2427 ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.002 0 CA-C-O 121.464 0.48 . . . . 0.0 114.018 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A 2428 ' ' ASP . . . . . . . . . . . . . 21.3 m-20 -132.89 138.71 32.51 Favored Pre-proline 0 CA--C 1.547 0.857 0 C-N-CA 125.381 1.472 . . . . 0.0 111.462 -179.58 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 2429 ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -56.79 -26.32 65.79 Favored 'Trans proline' 0 C--N 1.352 0.756 0 C-N-CA 123.854 3.036 . . . . 0.0 114.568 176.549 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 2430 ' ' GLY . . . . . . . . . . . . . . . -79.12 -23.5 63.38 Favored Glycine 0 CA--C 1.534 1.219 0 C-N-CA 123.737 0.684 . . . . 0.0 113.871 176.66 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 2431 ' ' LEU . . . . . . . . . . . . . 4.3 mm? -86.98 -39.64 15.5 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.519 1.128 . . . . 0.0 111.118 173.261 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 2432 ' ' VAL . . . . . . . . . . . . . 98.7 t -61.41 133.82 27.0 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 123.469 0.708 . . . . 0.0 109.992 172.53 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 2433 ' ' SER . . . . . . . . . . . . . 8.4 t -129.13 -170.09 2.21 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.892 1.277 . . . . 0.0 110.959 178.425 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 2434 ' ' ALA . . . . . . . . . . . . . . . -151.05 143.54 24.29 Favored 'General case' 0 CA--C 1.538 0.496 0 O-C-N 120.956 -1.09 . . . . 0.0 111.889 177.125 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 2435 ' ' TYR . . . . . . . . . . . . . 82.1 m-85 -145.89 143.64 29.7 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 125.242 1.417 . . . . 0.0 111.971 -176.142 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 2436 ' ' GLY . . . . . . . . . . . . . . . 125.71 162.7 11.38 Favored Glycine 0 N--CA 1.475 1.244 0 C-N-CA 125.607 1.575 . . . . 0.0 114.201 176.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 2437 ' ' ALA . . . . . . . . . . . . . . . -62.36 -27.16 68.87 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 125.244 1.418 . . . . 0.0 114.545 -170.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 2438 ' ' GLY . . . . . . . . . . . . . . . -61.87 -22.13 61.9 Favored Glycine 0 CA--C 1.531 1.06 0 C-N-CA 124.022 0.82 . . . . 0.0 113.903 179.326 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 2439 ' ' LEU . . . . . . . . . . . . . 85.5 mt -70.98 -22.8 62.14 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 118.547 1.173 . . . . 0.0 112.97 172.742 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 2440 ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -96.37 -26.44 15.35 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.11 1.364 . . . . 0.0 112.592 -179.796 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 2441 ' ' GLY . . . . . . . . . . . . . . . 101.8 -142.91 15.84 Favored Glycine 0 CA--C 1.532 1.127 0 C-N-CA 125.465 1.507 . . . . 0.0 112.652 -177.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 2442 ' ' GLY . . . . . . . . . . . . . . . 152.36 -152.58 24.26 Favored Glycine 0 CA--C 1.532 1.128 0 C-N-CA 124.205 0.907 . . . . 0.0 114.27 -177.14 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 2443 ' ' VAL . . . . . . . . . . . . . 38.4 t -88.32 141.27 14.53 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 C-N-CA 124.501 1.12 . . . . 0.0 110.333 -179.042 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 2444 ' ' THR . . . . . . . . . . . . . 33.1 p -59.07 152.69 19.49 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 124.361 1.065 . . . . 0.0 112.744 174.385 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 2445 ' ' GLY . . . . . . . . . . . . . . . 70.93 0.72 35.72 Favored Glycine 0 CA--C 1.534 1.224 0 C-N-CA 124.182 0.896 . . . . 0.0 115.133 177.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 2446 ' ' ASN . . . . . . . . . . . . . 14.6 m-80 -116.14 143.35 30.81 Favored Pre-proline 0 CA--C 1.546 0.803 0 C-N-CA 126.043 1.737 . . . . 0.0 110.066 177.095 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 2447 ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -72.99 141.92 33.85 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 122.805 2.337 . . . . 0.0 111.133 178.7 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 2448 ' ' ALA . . . . . . . . . . . . . . . -128.87 137.51 51.5 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.568 1.547 . . . . 0.0 109.403 169.66 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 2449 ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -131.35 151.81 51.18 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.21 1.004 . . . . 0.0 113.402 -166.6 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 2450 ' ' PHE . . . . . . . . . . . . . 27.2 p90 -158.48 163.65 36.93 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 125.915 1.686 . . . . 0.0 110.802 178.18 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 2451 ' ' VAL . . . . . . . . . . . . . 58.2 t -118.36 132.57 67.83 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 124.488 1.115 . . . . 0.0 109.717 175.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 2452 ' ' VAL . . . . . . . . . . . . . 40.3 t -79.19 106.69 10.64 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 162.716 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 2453 ' ' ASN . . . . . . . . . . . . . 15.0 t-20 -84.18 108.38 17.04 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 123.65 0.78 . . . . 0.0 111.7 -172.39 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 2454 ' ' THR . . . . . . . . . . . . . 29.9 p -97.67 -6.87 32.18 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 126.364 1.866 . . . . 0.0 113.644 -179.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 2455 ' ' SER . . . . . . . . . . . . . 14.9 m -58.11 -26.91 63.21 Favored 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 114.229 1.196 . . . . 0.0 114.229 -177.386 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 2456 ' ' ASN . . . . . . . . . . . . . 86.2 m-20 -75.27 -20.17 59.3 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.549 1.139 . . . . 0.0 113.355 175.524 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 2457 ' ' ALA . . . . . . . . . . . . . . . -116.62 -44.48 2.85 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.317 1.447 . . . . 0.0 113.451 -164.518 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 2458 ' ' GLY . . . . . . . . . . . . . . . 100.44 -148.11 18.24 Favored Glycine 0 CA--C 1.533 1.191 0 C-N-CA 124.98 1.276 . . . . 0.0 112.847 -175.135 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 2459 ' ' ALA . . . . . . . . . . . . . . . -73.66 139.26 45.29 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.352 1.061 . . . . 0.0 113.596 -172.553 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 2460 ' ' GLY . . . . . . . . . . . . . . . 168.67 154.79 9.14 Favored Glycine 0 CA--C 1.531 1.041 0 C-N-CA 125.327 1.441 . . . . 0.0 113.167 177.226 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 2461 ' ' ALA . . . . . . . . . . . . . . . -79.85 147.71 31.63 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 124.293 1.037 . . . . 0.0 112.567 -178.289 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 2462 ' ' LEU . . . . . . . . . . . . . 16.6 tp -108.55 143.39 37.64 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.148 1.379 . . . . 0.0 111.131 177.267 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 2463 ' ' SER . . . . . . . . . . . . . 49.4 m -135.0 38.97 2.98 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 125.699 1.6 . . . . 0.0 111.139 -176.514 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 2464 ' ' VAL . . . . . . . . . . . . . 8.5 p -66.03 138.12 23.63 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 C-N-CA 125.453 1.501 . . . . 0.0 112.43 -177.739 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 2465 ' ' THR . . . . . . . . . . . . . 93.1 m -137.87 141.69 40.7 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 125.608 1.563 . . . . 0.0 109.822 175.232 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 2466 ' ' ILE . . . . . . . . . . . . . 56.7 mt -105.61 119.89 55.54 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 123.661 0.784 . . . . 0.0 109.266 170.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 2467 ' ' ASP . . . . . . . . . . . . . 37.4 t70 -108.01 155.68 20.07 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 126.334 1.853 . . . . 0.0 110.603 173.5 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 2468 ' ' GLY . . . . . . . . . . . . . . . 163.56 -160.34 33.06 Favored Glycine 0 CA--C 1.535 1.327 0 CA-C-O 119.136 -0.814 . . . . 0.0 114.044 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 2469 ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -71.04 -14.62 32.16 Favored 'Trans proline' 0 CA--C 1.539 0.766 0 C-N-CA 123.788 2.992 . . . . 0.0 114.003 -177.342 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 2470 ' ' SER . . . . . . . . . . . . . 42.2 m -152.49 159.52 43.33 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 125.257 1.423 . . . . 0.0 111.959 178.573 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 2471 ' ' LYS . . . . . . . . . . . . . 68.3 mttm -76.42 98.07 4.46 Favored 'General case' 0 CA--C 1.544 0.722 0 O-C-N 120.966 -1.084 . . . . 0.0 110.482 172.574 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 2472 ' ' VAL . . . . . . . . . . . . . 16.2 m -60.77 148.38 8.98 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 C-N-CA 123.985 0.914 . . . . 0.0 111.743 179.252 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 2473 ' ' LYS . . . . . . . . . . . . . 88.6 tttt -77.1 109.85 11.28 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 171.015 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 2474 ' ' MET . . . . . . . . . . . . . 25.3 ttt -118.19 142.27 47.63 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.998 1.319 . . . . 0.0 112.434 -166.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 2475 ' ' ASP . . . . . . . . . . . . . 31.0 t70 -128.41 147.03 50.63 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 127.187 2.195 . . . . 0.0 110.16 169.428 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 2476 ' ' CYS . . . . . . . . . . . . . 37.8 t -138.12 140.58 39.99 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.668 1.187 . . . . 0.0 110.244 172.181 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 2477 ' ' GLN . . . . . . . . . . . . . 8.7 pt20 -156.89 163.13 39.51 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.182 1.393 . . . . 0.0 111.17 -172.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 2478 ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -95.13 138.5 32.76 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 123.775 0.83 . . . . 0.0 111.39 -179.365 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 2479 ' ' CYS . . . . . . . . . . . . . 14.0 p -139.18 170.9 9.01 Favored Pre-proline 0 CA--C 1.553 1.071 0 C-N-CA 125.43 1.492 . . . . 0.0 111.168 170.547 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 2480 ' ' PRO . . . . . . . . . . . . . 68.3 Cg_exo -58.43 -26.09 76.3 Favored 'Trans proline' 0 C--N 1.352 0.741 0 C-N-CA 123.508 2.805 . . . . 0.0 114.702 178.415 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 2481 ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -83.09 -11.04 58.37 Favored 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 125.01 1.324 . . . . 0.0 112.862 178.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 2482 ' ' GLY . . . . . . . . . . . . . . . 128.82 -155.49 20.65 Favored Glycine 0 N--CA 1.473 1.125 0 C-N-CA 125.893 1.711 . . . . 0.0 113.402 -178.276 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 2483 ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -76.06 109.29 9.59 Favored 'General case' 0 N--CA 1.47 0.575 0 O-C-N 121.621 -0.929 . . . . 0.0 110.767 175.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 2484 ' ' ARG . . . . . . . . . . . . . 31.5 ttm180 -85.27 131.66 34.38 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 124.892 1.277 . . . . 0.0 110.577 176.242 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 2485 ' ' VAL . . . . . . . . . . . . . 78.7 t -117.93 137.5 51.67 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 C-N-CA 126.062 1.745 . . . . 0.0 108.742 176.397 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 2486 ' ' THR . . . . . . . . . . . . . 85.0 m -131.9 139.0 48.62 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.771 1.229 . . . . 0.0 108.175 171.277 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 2487 ' ' TYR . . . . . . . . . . . . . 30.5 p90 -146.41 149.32 33.5 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 113.38 0.881 . . . . 0.0 113.38 175.61 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 2488 ' ' THR . . . . . . . . . . . . . 62.9 m -112.7 114.21 49.8 Favored Pre-proline 0 N--CA 1.472 0.639 0 C-N-CA 125.17 1.388 . . . . 0.0 108.61 172.411 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 2489 ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -81.06 134.99 9.57 Favored 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 122.851 2.367 . . . . 0.0 110.709 176.004 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 2490 ' ' MET . . . . . . . . . . . . . 17.7 ptm -91.25 -3.72 56.63 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 125.031 1.332 . . . . 0.0 114.192 -177.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 2491 ' ' ALA . . . . . . . . . . . . . . . -151.26 151.08 28.6 Favored Pre-proline 0 CA--C 1.546 0.826 0 C-N-CA 125.429 1.492 . . . . 0.0 112.001 -173.83 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 2492 ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -73.99 165.09 32.92 Favored 'Trans proline' 0 CA--C 1.538 0.685 0 C-N-CA 123.505 2.803 . . . . 0.0 111.727 173.447 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 2493 ' ' GLY . . . . . . . . . . . . . . . 127.09 -158.67 21.07 Favored Glycine 0 CA--C 1.53 0.994 0 C-N-CA 125.539 1.542 . . . . 0.0 112.973 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 2494 ' ' SER . . . . . . . . . . . . . 67.6 m -113.47 128.89 56.6 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.126 0.971 . . . . 0.0 111.262 179.257 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 2495 ' ' TYR . . . . . . . . . . . . . 88.9 m-85 -110.82 132.88 53.83 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.781 1.632 . . . . 0.0 110.531 177.748 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 2496 ' ' LEU . . . . . . . . . . . . . 9.5 mp -96.7 114.74 26.41 Favored 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 124.248 1.019 . . . . 0.0 108.908 173.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 2497 ' ' ILE . . . . . . . . . . . . . 30.6 mt -89.49 92.21 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 N-CA-C 107.306 -1.368 . . . . 0.0 107.306 174.763 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 2498 ' ' SER . . . . . . . . . . . . . 68.0 m -80.92 78.57 7.71 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 126.032 1.733 . . . . 0.0 110.305 -179.311 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 2499 ' ' ILE . . . . . . . . . . . . . 36.1 mt -75.42 107.15 5.83 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 C-N-CA 124.826 1.251 . . . . 0.0 109.204 176.1 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 2500 ' ' LYS . . . . . . . . . . . . . 42.8 mttp -113.02 148.6 34.79 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 124.775 1.23 . . . . 0.0 111.116 175.194 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 2501 ' ' TYR . . . . . . . . . . . . . 67.6 t80 -148.25 145.94 28.43 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.445 1.098 . . . . 0.0 112.281 -172.044 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 2502 ' ' GLY . . . . . . . . . . . . . . . 66.39 14.7 62.48 Favored Glycine 0 CA--C 1.535 1.33 0 C-N-CA 124.556 1.074 . . . . 0.0 114.373 175.162 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 2503 ' ' GLY . . . . . . . . . . . . . . . 138.02 -169.29 24.26 Favored Glycine 0 CA--C 1.54 1.633 0 C-N-CA 125.92 1.724 . . . . 0.0 112.537 -166.154 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 2504 ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -83.76 34.58 0.53 Allowed 'Trans proline' 0 CA--C 1.545 1.068 0 C-N-CA 124.859 3.706 . . . . 0.0 113.143 -171.588 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 2505 ' ' TYR . . . . . . . . . . . . . 92.8 m-85 -125.11 136.27 53.48 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 124.515 1.126 . . . . 0.0 113.053 -174.786 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 2506 ' ' HIS . . . . . . . . . . . . . 92.4 m-70 -63.48 146.09 54.32 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 125.405 1.482 . . . . 0.0 113.455 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 2507 ' ' ILE . . . . . . . . . . . . . 24.2 pt -75.43 173.28 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.192 0 C-N-CA 123.494 0.718 . . . . 0.0 112.684 171.485 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 2508 ' ' GLY . . . . . . . . . . . . . . . -59.29 120.73 24.02 Favored Glycine 0 CA--C 1.534 1.244 0 O-C-N 121.411 -0.806 . . . . 0.0 111.677 175.074 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 2509 ' ' GLY . . . . . . . . . . . . . . . 87.8 -5.77 84.44 Favored Glycine 0 CA--C 1.536 1.371 0 C-N-CA 125.393 1.473 . . . . 0.0 114.995 -177.25 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 2510 ' ' SER . . . . . . . . . . . . . 47.4 t -89.3 145.99 35.18 Favored Pre-proline 0 CA--C 1.551 0.992 0 CA-C-N 119.007 1.404 . . . . 0.0 112.088 -179.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 2511 ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -72.71 143.6 78.12 Favored 'Cis proline' 0 C--N 1.355 0.877 0 CA-C-N 120.042 1.051 . . . . 0.0 112.427 -0.319 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 2512 ' ' PHE . . . . . . . . . . . . . 83.0 m-85 -92.61 122.95 35.54 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.059 0.944 . . . . 0.0 110.718 178.202 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 2513 ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.34 105.08 13.12 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 124.023 0.929 . . . . 0.0 113.462 178.588 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 2514 ' ' ALA . . . . . . . . . . . . . . . -92.84 125.28 37.37 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.07 1.348 . . . . 0.0 110.208 173.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 2515 ' ' LYS . . . . . . . . . . . . . 54.6 mtmt -102.83 123.91 47.37 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.303 1.041 . . . . 0.0 110.637 -178.027 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 2516 ' ' VAL . . . . . . . . . . . . . 92.3 t -122.27 139.06 50.39 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 124.967 1.307 . . . . 0.0 110.523 -168.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 2517 ' ' THR . . . . . . . . . . . . . 38.5 p -132.64 164.66 26.21 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 125.391 1.476 . . . . 0.0 111.75 -177.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 2518 ' ' GLY . . . . . . . . . . . . . . . 108.96 -176.54 19.9 Favored Glycine 0 CA--C 1.54 1.601 0 C-N-CA 124.908 1.242 . . . . 0.0 113.313 -176.373 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 2519 ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -75.12 158.24 41.84 Favored 'Trans proline' 0 CA--C 1.535 0.541 0 C-N-CA 123.819 3.012 . . . . 0.0 112.127 -175.683 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 2520 ' ' ARG . . . . . . . . . . . . . 39.4 ttp180 . . . . . 0 CA--C 1.539 0.526 0 C-N-CA 123.053 0.541 . . . . 0.0 110.058 168.547 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A 2427 ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.107 0 N-CA-C 111.931 -0.467 . . . . 0.0 111.931 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A 2428 ' ' ASP . . . . . . . . . . . . . 13.8 t70 -149.71 136.16 10.63 Favored Pre-proline 0 CA--C 1.55 0.96 0 C-N-CA 123.939 0.896 . . . . 0.0 112.182 -173.658 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 2429 ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -65.79 -20.74 58.7 Favored 'Trans proline' 0 C--N 1.353 0.795 0 C-N-CA 123.58 2.854 . . . . 0.0 114.186 -176.089 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 2430 ' ' GLY . . . . . . . . . . . . . . . -81.69 -26.25 50.89 Favored Glycine 0 CA--C 1.533 1.163 0 CA-C-N 119.261 0.937 . . . . 0.0 113.106 173.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 2431 ' ' LEU . . . . . . . . . . . . . 4.4 mm? -81.7 -34.17 30.77 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.153 0.981 . . . . 0.0 111.383 171.123 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 2432 ' ' VAL . . . . . . . . . . . . . 57.7 t -64.21 138.28 23.34 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 123.516 0.726 . . . . 0.0 110.31 168.462 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 2433 ' ' SER . . . . . . . . . . . . . 8.9 t -131.18 -167.25 1.82 Allowed 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 125.128 1.371 . . . . 0.0 109.897 172.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 2434 ' ' ALA . . . . . . . . . . . . . . . -151.54 145.53 25.22 Favored 'General case' 0 CA--C 1.537 0.477 0 O-C-N 120.794 -1.191 . . . . 0.0 111.643 176.012 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 2435 ' ' TYR . . . . . . . . . . . . . 86.6 m-85 -143.2 149.67 38.3 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.334 1.454 . . . . 0.0 111.892 -177.307 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 2436 ' ' GLY . . . . . . . . . . . . . . . 120.42 160.59 11.2 Favored Glycine 0 N--CA 1.473 1.133 0 C-N-CA 125.534 1.54 . . . . 0.0 113.549 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 2437 ' ' ALA . . . . . . . . . . . . . . . -60.7 -31.74 71.01 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 114.535 1.309 . . . . 0.0 114.535 -168.665 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 2438 ' ' GLY . . . . . . . . . . . . . . . -67.97 -10.43 58.89 Favored Glycine 0 CA--C 1.532 1.132 0 C-N-CA 124.129 0.871 . . . . 0.0 114.891 -176.352 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 2439 ' ' LEU . . . . . . . . . . . . . 75.6 mt -77.75 -27.14 50.31 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 118.702 1.251 . . . . 0.0 112.162 169.208 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 2440 ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -93.19 -34.82 13.44 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 125.121 1.369 . . . . 0.0 111.595 176.493 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 2441 ' ' GLY . . . . . . . . . . . . . . . 138.68 -136.67 8.17 Favored Glycine 0 CA--C 1.531 1.061 0 C-N-CA 125.097 1.332 . . . . 0.0 114.469 176.171 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 2442 ' ' GLY . . . . . . . . . . . . . . . 162.89 -145.06 10.16 Favored Glycine 0 CA--C 1.534 1.246 0 C-N-CA 126.622 2.058 . . . . 0.0 111.148 -167.509 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 2443 ' ' VAL . . . . . . . . . . . . . 8.5 p -141.56 151.99 19.33 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 C-N-CA 124.739 1.216 . . . . 0.0 110.145 176.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 2444 ' ' THR . . . . . . . . . . . . . 22.7 p -53.49 130.27 35.15 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.855 0.862 . . . . 0.0 111.784 178.688 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 2445 ' ' GLY . . . . . . . . . . . . . . . 86.5 -8.37 75.14 Favored Glycine 0 CA--C 1.535 1.32 0 C-N-CA 125.205 1.384 . . . . 0.0 115.363 179.127 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 2446 ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -101.69 146.33 32.04 Favored Pre-proline 0 CA--C 1.551 0.986 0 CA-C-N 119.605 1.703 . . . . 0.0 112.235 177.53 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 2447 ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -75.52 124.53 8.36 Favored 'Trans proline' 0 N--CA 1.457 -0.641 0 C-N-CA 122.727 2.285 . . . . 0.0 110.507 175.781 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 2448 ' ' ALA . . . . . . . . . . . . . . . -107.13 149.03 28.1 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.77 1.628 . . . . 0.0 109.56 168.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 2449 ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -153.88 158.29 40.55 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 113.886 1.069 . . . . 0.0 113.886 -174.671 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 2450 ' ' PHE . . . . . . . . . . . . . 53.0 p90 -160.34 161.11 33.1 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 126.503 1.921 . . . . 0.0 110.838 -177.321 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 2451 ' ' VAL . . . . . . . . . . . . . 58.7 t -114.51 127.56 71.94 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 C-N-CA 124.866 1.266 . . . . 0.0 109.128 174.092 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 2452 ' ' VAL . . . . . . . . . . . . . 42.7 t -79.62 106.27 10.41 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 165.417 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 2453 ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -89.82 117.35 28.59 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 123.995 0.918 . . . . 0.0 111.976 -164.379 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 2454 ' ' THR . . . . . . . . . . . . . 52.5 p -102.19 -1.56 31.08 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 125.857 1.663 . . . . 0.0 113.672 -177.159 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 2455 ' ' SER . . . . . . . . . . . . . 16.9 t -60.94 -33.52 73.29 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-N 119.296 0.953 . . . . 0.0 113.356 -172.667 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 2456 ' ' ASN . . . . . . . . . . . . . 72.6 m-80 -81.96 -13.81 56.94 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 124.196 0.999 . . . . 0.0 113.674 175.684 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 2457 ' ' ALA . . . . . . . . . . . . . . . -102.75 -45.01 5.13 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.97 1.308 . . . . 0.0 113.547 -173.059 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 2458 ' ' GLY . . . . . . . . . . . . . . . 119.96 -113.42 2.45 Favored Glycine 0 CA--C 1.529 0.961 0 C-N-CA 124.93 1.252 . . . . 0.0 111.382 -170.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 2459 ' ' ALA . . . . . . . . . . . . . . . -147.97 155.45 41.56 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.432 1.093 . . . . 0.0 112.798 -176.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 2460 ' ' GLY . . . . . . . . . . . . . . . 164.52 173.29 33.01 Favored Glycine 0 CA--C 1.528 0.87 0 C-N-CA 124.269 0.938 . . . . 0.0 113.774 -176.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 2461 ' ' ALA . . . . . . . . . . . . . . . -73.29 146.2 45.51 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.193 0.997 . . . . 0.0 112.212 178.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 2462 ' ' LEU . . . . . . . . . . . . . 6.0 tt -128.36 147.66 50.64 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 125.742 1.617 . . . . 0.0 110.898 178.672 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 2463 ' ' SER . . . . . . . . . . . . . 14.0 t -132.04 161.21 33.75 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.676 1.191 . . . . 0.0 110.349 161.5 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 2464 ' ' VAL . . . . . . . . . . . . . 7.4 p -161.72 136.96 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.725 0 C-N-CA 124.644 1.178 . . . . 0.0 110.773 -175.056 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 2465 ' ' THR . . . . . . . . . . . . . 63.3 m -141.58 138.49 32.68 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 125.397 1.479 . . . . 0.0 109.711 -175.821 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 2466 ' ' ILE . . . . . . . . . . . . . 37.7 mt -117.41 119.41 61.72 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 124.399 1.08 . . . . 0.0 109.527 175.669 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 2467 ' ' ASP . . . . . . . . . . . . . 34.9 t70 -104.06 161.74 13.75 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 126.164 1.785 . . . . 0.0 110.019 167.527 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 2468 ' ' GLY . . . . . . . . . . . . . . . 172.18 -166.05 38.81 Favored Glycine 0 CA--C 1.536 1.386 0 O-C-N 120.875 -1.141 . . . . 0.0 115.878 179.313 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 2469 ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -70.11 -14.64 35.2 Favored 'Trans proline' 0 CA--C 1.541 0.836 0 C-N-CA 124.544 3.496 . . . . 0.0 113.93 -178.43 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 2470 ' ' SER . . . . . . . . . . . . . 16.8 m -155.79 -177.71 6.76 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 127.306 2.243 . . . . 0.0 109.434 172.746 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 2471 ' ' LYS . . . . . . . . . . . . . 24.8 pttm -66.31 175.42 2.19 Favored 'General case' 0 CA--C 1.549 0.917 0 O-C-N 121.069 -1.019 . . . . 0.0 112.839 169.712 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 2472 ' ' VAL . . . . . . . . . . . . . 27.0 m -132.76 148.39 31.6 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 125.331 1.452 . . . . 0.0 110.138 170.429 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 2473 ' ' LYS . . . . . . . . . . . . . 63.8 tttm -76.13 131.2 39.26 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 107.78 -1.192 . . . . 0.0 107.78 152.417 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 2474 ' ' MET . . . . . . . . . . . . . 27.1 ttt -139.23 139.81 37.56 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.024 0.93 . . . . 0.0 111.489 -172.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 2475 ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -141.7 157.44 45.06 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 126.907 2.083 . . . . 0.0 110.172 -178.103 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 2476 ' ' CYS . . . . . . . . . . . . . 49.7 t -152.43 150.03 29.22 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.191 0.996 . . . . 0.0 111.842 -175.433 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 2477 ' ' GLN . . . . . . . . . . . . . 51.7 tt0 -154.37 133.91 12.77 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 125.457 1.503 . . . . 0.0 110.077 -174.655 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 2478 ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -85.12 142.87 29.2 Favored 'General case' 0 CA--C 1.542 0.66 0 O-C-N 121.641 -0.662 . . . . 0.0 111.414 171.425 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 2479 ' ' CYS . . . . . . . . . . . . . 15.4 p -151.98 173.6 4.33 Favored Pre-proline 0 CA--C 1.553 1.096 0 C-N-CA 125.695 1.598 . . . . 0.0 111.47 -177.518 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 2480 ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -58.36 -27.44 81.39 Favored 'Trans proline' 0 C--N 1.353 0.794 0 C-N-CA 123.563 2.842 . . . . 0.0 114.853 179.288 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 2481 ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -80.37 -19.58 46.04 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 124.374 1.07 . . . . 0.0 112.755 178.234 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 2482 ' ' GLY . . . . . . . . . . . . . . . 134.94 -150.66 20.21 Favored Glycine 0 CA--C 1.529 0.955 0 C-N-CA 126.033 1.778 . . . . 0.0 112.864 -176.55 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 2483 ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -90.85 109.4 20.61 Favored 'General case' 0 CA--C 1.539 0.535 0 O-C-N 121.7 -0.883 . . . . 0.0 110.759 177.308 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 2484 ' ' ARG . . . . . . . . . . . . . 38.9 ttp85 -79.47 134.48 36.53 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 124.445 1.098 . . . . 0.0 110.09 172.355 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 2485 ' ' VAL . . . . . . . . . . . . . 93.4 t -125.51 135.84 62.7 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 126.05 1.74 . . . . 0.0 108.672 178.206 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 2486 ' ' THR . . . . . . . . . . . . . 86.2 m -129.6 140.69 51.12 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 125.653 1.581 . . . . 0.0 108.788 178.171 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 2487 ' ' TYR . . . . . . . . . . . . . 19.6 p90 -150.8 153.26 35.11 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 113.526 0.935 . . . . 0.0 113.526 175.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 2488 ' ' THR . . . . . . . . . . . . . 98.4 m -118.62 115.51 35.4 Favored Pre-proline 0 N--CA 1.474 0.749 0 C-N-CA 124.907 1.283 . . . . 0.0 109.181 175.315 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 2489 ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -82.44 165.15 16.47 Favored 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 124.464 3.443 . . . . 0.0 111.6 175.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 2490 ' ' MET . . . . . . . . . . . . . 24.5 ptm -143.57 5.16 1.39 Allowed 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 115.435 1.643 . . . . 0.0 115.435 -174.367 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 2491 ' ' ALA . . . . . . . . . . . . . . . -143.46 145.98 33.95 Favored Pre-proline 0 CA--C 1.546 0.825 0 C-N-CA 124.675 1.19 . . . . 0.0 110.896 170.184 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 2492 ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -71.65 149.2 54.63 Favored 'Trans proline' 0 CA--C 1.536 0.601 0 C-N-CA 123.063 2.508 . . . . 0.0 111.158 178.189 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 2493 ' ' GLY . . . . . . . . . . . . . . . 131.81 -159.89 23.37 Favored Glycine 0 CA--C 1.53 1.004 0 C-N-CA 125.36 1.457 . . . . 0.0 113.493 -177.354 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 2494 ' ' SER . . . . . . . . . . . . . 23.6 m -98.03 118.65 35.09 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 125.117 1.367 . . . . 0.0 111.523 -177.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 2495 ' ' TYR . . . . . . . . . . . . . 62.3 m-85 -92.64 120.23 32.85 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 123.614 0.766 . . . . 0.0 110.068 167.041 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 2496 ' ' LEU . . . . . . . . . . . . . 22.8 tp -92.94 111.33 22.91 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.626 1.17 . . . . 0.0 109.73 -177.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 2497 ' ' ILE . . . . . . . . . . . . . 32.2 mt -101.85 103.62 15.2 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 C-N-CA 125.922 1.689 . . . . 0.0 108.602 -175.552 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 2498 ' ' SER . . . . . . . . . . . . . 68.4 m -92.0 125.63 36.77 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.274 1.029 . . . . 0.0 109.958 175.503 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 2499 ' ' ILE . . . . . . . . . . . . . 42.2 mt -128.26 123.99 61.31 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.725 0 C-N-CA 124.889 1.276 . . . . 0.0 108.645 -175.389 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 2500 ' ' LYS . . . . . . . . . . . . . 84.5 mttt -127.87 143.49 51.11 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.734 1.214 . . . . 0.0 111.774 -172.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 2501 ' ' TYR . . . . . . . . . . . . . 60.2 t80 -150.02 139.7 21.68 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 123.663 0.785 . . . . 0.0 112.681 -171.196 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 2502 ' ' GLY . . . . . . . . . . . . . . . 68.21 13.73 65.22 Favored Glycine 0 CA--C 1.537 1.419 0 C-N-CA 124.196 0.903 . . . . 0.0 114.162 179.279 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 2503 ' ' GLY . . . . . . . . . . . . . . . 146.46 -172.53 27.0 Favored Glycine 0 CA--C 1.539 1.583 0 C-N-CA 126.087 1.803 . . . . 0.0 112.822 -169.465 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 2504 ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -81.87 22.4 0.85 Allowed 'Trans proline' 0 CA--C 1.545 1.058 0 C-N-CA 124.99 3.794 . . . . 0.0 113.795 -174.52 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 2505 ' ' TYR . . . . . . . . . . . . . 72.8 m-85 -111.59 139.85 46.69 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.935 1.294 . . . . 0.0 112.803 -173.516 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 2506 ' ' HIS . . . . . . . . . . . . . 93.3 m-70 -62.19 144.15 55.84 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 124.447 1.099 . . . . 0.0 113.298 -179.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 2507 ' ' ILE . . . . . . . . . . . . . 26.7 pt -73.59 167.99 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 C-N-CA 123.149 0.58 . . . . 0.0 112.45 171.777 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 2508 ' ' GLY . . . . . . . . . . . . . . . -57.5 120.68 22.42 Favored Glycine 0 CA--C 1.534 1.223 0 C-N-CA 123.651 0.643 . . . . 0.0 111.982 176.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 2509 ' ' GLY . . . . . . . . . . . . . . . 88.58 -8.35 79.36 Favored Glycine 0 CA--C 1.535 1.331 0 C-N-CA 125.599 1.571 . . . . 0.0 115.145 -177.733 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 2510 ' ' SER . . . . . . . . . . . . . 8.4 t -89.33 146.3 35.78 Favored Pre-proline 0 CA--C 1.549 0.939 0 CA-C-N 119.231 1.516 . . . . 0.0 111.897 -179.595 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 2511 ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -75.74 149.78 93.15 Favored 'Cis proline' 0 C--N 1.353 0.786 0 CA-C-N 120.153 1.09 . . . . 0.0 113.424 1.168 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 2512 ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -100.8 131.84 46.49 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 125.386 1.475 . . . . 0.0 110.465 178.266 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 2513 ' ' LYS . . . . . . . . . . . . . 64.5 pttt -87.49 8.75 23.47 Favored 'General case' 0 N--CA 1.479 1.007 0 N-CA-C 116.292 1.96 . . . . 0.0 116.292 -169.084 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 2514 ' ' ALA . . . . . . . . . . . . . . . -7.09 99.45 0.01 OUTLIER 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 129.66 3.184 . . . . 0.0 116.047 -176.783 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 2515 ' ' LYS . . . . . . . . . . . . . 48.6 mtpt -94.86 135.18 36.68 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 124.031 0.932 . . . . 0.0 112.194 -171.27 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 2516 ' ' VAL . . . . . . . . . . . . . 6.0 m -131.82 153.8 39.23 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 C-N-CA 124.224 1.01 . . . . 0.0 111.82 -177.244 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 2517 ' ' THR . . . . . . . . . . . . . 64.0 p -120.64 -171.27 2.15 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.915 1.686 . . . . 0.0 110.106 177.026 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 2518 ' ' GLY . . . . . . . . . . . . . . . 99.1 177.58 31.82 Favored Glycine 0 CA--C 1.539 1.571 0 C-N-CA 124.972 1.272 . . . . 0.0 113.921 178.538 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 2519 ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -70.38 137.4 33.58 Favored 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 123.862 3.042 . . . . 0.0 112.195 -172.152 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 2520 ' ' ARG . . . . . . . . . . . . . 37.8 ttp180 . . . . . 0 CA--C 1.54 0.567 0 C-N-CA 124.127 0.971 . . . . 0.0 110.922 177.085 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A 2427 ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.206 0 CA-C-O 121.488 0.493 . . . . 0.0 113.987 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A 2428 ' ' ASP . . . . . . . . . . . . . 22.8 m-20 -106.0 134.56 19.69 Favored Pre-proline 0 CA--C 1.549 0.929 0 C-N-CA 124.778 1.231 . . . . 0.0 112.834 -176.16 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 2429 ' ' PRO . . . . . . . . . . . . . 77.0 Cg_exo -56.43 -28.9 75.37 Favored 'Trans proline' 0 C--N 1.353 0.794 0 C-N-CA 124.036 3.158 . . . . 0.0 114.45 174.041 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 2430 ' ' GLY . . . . . . . . . . . . . . . -77.15 -22.77 70.26 Favored Glycine 0 CA--C 1.533 1.183 0 C-N-CA 123.751 0.691 . . . . 0.0 113.747 177.074 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 2431 ' ' LEU . . . . . . . . . . . . . 4.2 mm? -86.53 -32.28 20.81 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.453 1.101 . . . . 0.0 111.405 172.642 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 2432 ' ' VAL . . . . . . . . . . . . . 74.6 t -65.07 137.68 24.55 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 CA-C-N 118.58 0.627 . . . . 0.0 110.453 169.243 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 2433 ' ' SER . . . . . . . . . . . . . 8.4 t -130.84 -169.81 2.23 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 125.054 1.342 . . . . 0.0 110.583 174.44 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 2434 ' ' ALA . . . . . . . . . . . . . . . -149.91 141.99 23.98 Favored 'General case' 0 CA--C 1.539 0.548 0 O-C-N 120.903 -1.123 . . . . 0.0 111.473 177.222 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 2435 ' ' TYR . . . . . . . . . . . . . 75.2 m-85 -145.85 151.49 37.98 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 125.511 1.524 . . . . 0.0 111.881 -176.212 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 2436 ' ' GLY . . . . . . . . . . . . . . . 117.23 162.14 12.47 Favored Glycine 0 N--CA 1.474 1.191 0 C-N-CA 125.384 1.469 . . . . 0.0 113.903 177.508 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 2437 ' ' ALA . . . . . . . . . . . . . . . -61.18 -28.7 69.32 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.045 1.338 . . . . 0.0 114.45 -169.687 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 2438 ' ' GLY . . . . . . . . . . . . . . . -65.63 -13.95 59.59 Favored Glycine 0 CA--C 1.533 1.17 0 C-N-CA 124.234 0.921 . . . . 0.0 114.688 -178.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 2439 ' ' LEU . . . . . . . . . . . . . 91.8 mt -75.9 -27.68 57.79 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 118.647 1.224 . . . . 0.0 112.526 169.353 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 2440 ' ' GLU . . . . . . . . . . . . . 43.4 mm-40 -88.02 -31.2 19.44 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.862 1.265 . . . . 0.0 111.519 174.442 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 2441 ' ' GLY . . . . . . . . . . . . . . . 113.83 -146.8 18.63 Favored Glycine 0 CA--C 1.53 1.012 0 C-N-CA 126.086 1.803 . . . . 0.0 113.381 177.013 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 2442 ' ' GLY . . . . . . . . . . . . . . . 170.87 -163.31 36.38 Favored Glycine 0 CA--C 1.53 1.001 0 C-N-CA 124.234 0.921 . . . . 0.0 114.001 -174.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 2443 ' ' VAL . . . . . . . . . . . . . 40.3 t -91.74 146.33 6.41 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 C-N-CA 124.51 1.124 . . . . 0.0 110.245 179.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 2444 ' ' THR . . . . . . . . . . . . . 20.2 p -54.61 142.89 26.42 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 124.898 1.279 . . . . 0.0 112.236 172.221 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 2445 ' ' GLY . . . . . . . . . . . . . . . 72.4 1.0 50.0 Favored Glycine 0 CA--C 1.536 1.361 0 C-N-CA 124.274 0.94 . . . . 0.0 114.685 179.318 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 2446 ' ' ASN . . . . . . . . . . . . . 16.3 m-80 -118.58 149.76 46.85 Favored Pre-proline 0 CA--C 1.549 0.93 0 C-N-CA 126.123 1.769 . . . . 0.0 110.623 179.814 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 2447 ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -74.48 133.1 16.97 Favored 'Trans proline' 0 C--N 1.35 0.648 0 C-N-CA 122.908 2.405 . . . . 0.0 111.99 -174.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 2448 ' ' ALA . . . . . . . . . . . . . . . -105.77 119.92 40.37 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 126.41 1.884 . . . . 0.0 108.645 168.372 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 2449 ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -124.6 135.02 52.77 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.568 1.147 . . . . 0.0 111.821 -169.44 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 2450 ' ' PHE . . . . . . . . . . . . . 15.2 p90 -152.99 170.21 20.98 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.6 1.56 . . . . 0.0 111.183 175.189 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 2451 ' ' VAL . . . . . . . . . . . . . 46.6 t -125.9 132.95 70.11 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 C-N-CA 124.911 1.285 . . . . 0.0 110.106 178.641 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 2452 ' ' VAL . . . . . . . . . . . . . 51.8 t -82.88 107.56 14.78 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 165.035 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 2453 ' ' ASN . . . . . . . . . . . . . 21.1 t-20 -83.3 113.07 20.45 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 123.551 0.74 . . . . 0.0 112.153 -171.741 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 2454 ' ' THR . . . . . . . . . . . . . 30.4 p -99.59 -6.55 27.16 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 126.001 1.72 . . . . 0.0 113.79 179.138 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 2455 ' ' SER . . . . . . . . . . . . . 16.4 m -55.78 -31.41 62.59 Favored 'General case' 0 N--CA 1.478 0.949 0 N-CA-C 114.538 1.31 . . . . 0.0 114.538 -174.26 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 2456 ' ' ASN . . . . . . . . . . . . . 66.3 m-80 -84.46 -15.83 44.7 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 124.49 1.116 . . . . 0.0 113.464 177.558 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 2457 ' ' ALA . . . . . . . . . . . . . . . -106.24 -25.73 11.85 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 125.72 1.608 . . . . 0.0 113.854 -176.386 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 2458 ' ' GLY . . . . . . . . . . . . . . . 104.24 -103.71 2.32 Favored Glycine 0 CA--C 1.529 0.966 0 C-N-CA 125.398 1.475 . . . . 0.0 111.067 -174.243 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 2459 ' ' ALA . . . . . . . . . . . . . . . -151.73 163.29 39.46 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 125.355 1.462 . . . . 0.0 111.768 -179.139 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 2460 ' ' GLY . . . . . . . . . . . . . . . 163.58 171.83 30.31 Favored Glycine 0 CA--C 1.53 1.007 0 C-N-CA 124.774 1.178 . . . . 0.0 113.293 -176.469 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 2461 ' ' ALA . . . . . . . . . . . . . . . -73.08 143.92 47.24 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.104 0.961 . . . . 0.0 112.216 179.473 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 2462 ' ' LEU . . . . . . . . . . . . . 15.7 tp -129.03 139.25 52.14 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.404 1.481 . . . . 0.0 110.662 -178.528 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 2463 ' ' SER . . . . . . . . . . . . . 66.5 m -139.6 52.65 1.72 Allowed 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 125.437 1.495 . . . . 0.0 111.616 -169.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 2464 ' ' VAL . . . . . . . . . . . . . 17.1 t -65.84 137.04 25.67 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.069 0 C-N-CA 124.044 0.938 . . . . 0.0 111.101 -178.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 2465 ' ' THR . . . . . . . . . . . . . 22.7 m -123.24 141.32 52.1 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 124.933 1.293 . . . . 0.0 109.236 170.528 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 2466 ' ' ILE . . . . . . . . . . . . . 52.1 mt -116.13 114.7 46.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 C-N-CA 123.679 0.792 . . . . 0.0 108.981 171.003 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 2467 ' ' ASP . . . . . . . . . . . . . 37.1 t70 -95.29 158.69 15.35 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 125.519 1.527 . . . . 0.0 110.297 168.802 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 2468 ' ' GLY . . . . . . . . . . . . . . . 174.61 -171.3 44.45 Favored Glycine 0 CA--C 1.536 1.36 0 O-C-N 121.271 -0.893 . . . . 0.0 114.789 179.71 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 2469 ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -68.15 -25.95 36.87 Favored 'Trans proline' 0 CA--C 1.538 0.716 0 C-N-CA 123.941 3.094 . . . . 0.0 112.802 178.56 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 2470 ' ' SER . . . . . . . . . . . . . 58.5 m -142.86 174.59 10.52 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 126.058 1.743 . . . . 0.0 110.685 174.177 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 2471 ' ' LYS . . . . . . . . . . . . . 57.1 mtmt -66.71 166.59 12.74 Favored 'General case' 0 CA--C 1.548 0.887 0 O-C-N 121.13 -0.981 . . . . 0.0 112.314 170.025 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 2472 ' ' VAL . . . . . . . . . . . . . 24.7 m -131.39 147.21 32.79 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 125.231 1.412 . . . . 0.0 111.464 -178.687 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 2473 ' ' LYS . . . . . . . . . . . . . 56.8 tttp -83.2 67.64 9.28 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 124.229 1.012 . . . . 0.0 110.931 174.715 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 2474 ' ' MET . . . . . . . . . . . . . 23.3 ttt -75.45 136.33 40.69 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 125.217 1.407 . . . . 0.0 111.979 -174.599 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 2475 ' ' ASP . . . . . . . . . . . . . 36.7 t70 -141.8 129.3 21.35 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 126.429 1.892 . . . . 0.0 110.33 176.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 2476 ' ' CYS . . . . . . . . . . . . . 74.5 m -113.91 148.62 36.47 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.931 1.293 . . . . 0.0 111.55 -176.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 2477 ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -150.3 148.1 28.44 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.269 1.027 . . . . 0.0 111.013 179.485 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 2478 ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -88.94 117.84 28.24 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 123.972 0.909 . . . . 0.0 109.845 173.508 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 2479 ' ' CYS . . . . . . . . . . . . . 87.6 m -122.31 166.36 17.51 Favored Pre-proline 0 CA--C 1.552 1.037 0 C-N-CA 125.601 1.56 . . . . 0.0 111.284 179.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 2480 ' ' PRO . . . . . . . . . . . . . 58.0 Cg_exo -57.88 -30.3 89.14 Favored 'Trans proline' 0 C--N 1.353 0.8 0 C-N-CA 123.534 2.823 . . . . 0.0 114.216 175.394 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 2481 ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -78.44 -7.61 57.58 Favored 'General case' 0 CA--C 1.552 1.02 0 C-N-CA 125.357 1.463 . . . . 0.0 112.991 177.644 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 2482 ' ' GLY . . . . . . . . . . . . . . . 118.66 -163.23 13.16 Favored Glycine 0 CA--C 1.53 1.012 0 C-N-CA 126.313 1.911 . . . . 0.0 112.533 -173.106 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 2483 ' ' TYR . . . . . . . . . . . . . 83.4 m-85 -72.67 107.67 5.26 Favored 'General case' 0 CA--C 1.54 0.571 0 O-C-N 121.564 -0.962 . . . . 0.0 111.31 177.213 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 2484 ' ' ARG . . . . . . . . . . . . . 51.5 ttp85 -79.19 136.89 37.22 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 124.753 1.221 . . . . 0.0 110.231 174.269 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 2485 ' ' VAL . . . . . . . . . . . . . 92.5 t -128.15 125.56 64.6 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 C-N-CA 125.931 1.692 . . . . 0.0 108.48 179.001 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 2486 ' ' THR . . . . . . . . . . . . . 57.9 m -123.99 139.59 53.8 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 124.619 1.168 . . . . 0.0 108.488 172.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 2487 ' ' TYR . . . . . . . . . . . . . 27.3 p90 -147.06 150.51 35.21 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 112.754 0.65 . . . . 0.0 112.754 176.58 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 2488 ' ' THR . . . . . . . . . . . . . 24.7 m -109.79 115.11 55.9 Favored Pre-proline 0 N--CA 1.474 0.736 0 CA-C-O 117.764 -1.112 . . . . 0.0 109.047 174.455 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 2489 ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -81.42 149.06 16.65 Favored 'Trans proline' 0 N--CA 1.459 -0.553 0 C-N-CA 123.515 2.81 . . . . 0.0 110.731 171.237 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 2490 ' ' MET . . . . . . . . . . . . . 27.6 ptm -118.6 6.4 11.66 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 114.411 1.263 . . . . 0.0 114.411 -174.255 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 2491 ' ' ALA . . . . . . . . . . . . . . . -152.57 147.69 19.73 Favored Pre-proline 0 CA--C 1.544 0.74 0 C-N-CA 125.548 1.539 . . . . 0.0 111.41 -179.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 2492 ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -72.86 156.91 52.35 Favored 'Trans proline' 0 CA--C 1.536 0.606 0 C-N-CA 123.379 2.72 . . . . 0.0 111.208 174.557 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 2493 ' ' GLY . . . . . . . . . . . . . . . 134.94 -148.93 19.75 Favored Glycine 0 CA--C 1.527 0.843 0 C-N-CA 125.428 1.489 . . . . 0.0 112.061 -174.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 2494 ' ' SER . . . . . . . . . . . . . 36.8 m -128.6 133.85 48.43 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.694 0.798 . . . . 0.0 111.423 176.57 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 2495 ' ' TYR . . . . . . . . . . . . . 52.3 m-85 -107.18 127.13 53.23 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 126.152 1.781 . . . . 0.0 109.709 179.276 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 2496 ' ' LEU . . . . . . . . . . . . . 26.3 tp -98.75 112.69 24.69 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.411 1.085 . . . . 0.0 109.495 -176.528 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 2497 ' ' ILE . . . . . . . . . . . . . 36.9 mt -96.43 103.29 14.51 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 C-N-CA 125.331 1.452 . . . . 0.0 108.383 -176.191 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 2498 ' ' SER . . . . . . . . . . . . . 74.4 m -96.7 91.16 5.57 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 125.617 1.567 . . . . 0.0 110.247 -177.805 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 2499 ' ' ILE . . . . . . . . . . . . . 59.6 mt -87.62 104.69 14.59 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 C-N-CA 126.363 1.865 . . . . 0.0 109.591 -172.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 2500 ' ' LYS . . . . . . . . . . . . . 30.6 mttp -110.52 138.06 47.41 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.207 1.003 . . . . 0.0 111.589 -176.715 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 2501 ' ' TYR . . . . . . . . . . . . . 76.7 t80 -139.24 148.08 42.59 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.671 1.189 . . . . 0.0 112.452 -174.355 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 2502 ' ' GLY . . . . . . . . . . . . . . . 65.04 20.88 67.36 Favored Glycine 0 CA--C 1.536 1.358 0 C-N-CA 124.143 0.878 . . . . 0.0 113.465 -179.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 2503 ' ' GLY . . . . . . . . . . . . . . . 126.57 -171.31 18.28 Favored Glycine 0 CA--C 1.541 1.66 0 C-N-CA 125.967 1.746 . . . . 0.0 112.238 -163.524 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 2504 ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -84.02 43.55 1.4 Allowed 'Trans proline' 0 CA--C 1.546 1.083 0 C-N-CA 124.898 3.732 . . . . 0.0 112.618 -172.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 2505 ' ' TYR . . . . . . . . . . . . . 78.9 m-85 -127.15 132.01 50.63 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 124.457 1.103 . . . . 0.0 112.81 -175.073 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 2506 ' ' HIS . . . . . . . . . . . . . 79.0 m-70 -60.14 141.71 55.45 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 125.629 1.572 . . . . 0.0 114.46 -173.587 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 2507 ' ' ILE . . . . . . . . . . . . . 1.8 pp -79.26 170.59 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.2 0 C-N-CA 124.028 0.931 . . . . 0.0 112.628 171.725 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 2508 ' ' GLY . . . . . . . . . . . . . . . -60.15 112.1 4.17 Favored Glycine 0 CA--C 1.533 1.216 0 C-N-CA 123.753 0.692 . . . . 0.0 112.628 -176.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 2509 ' ' GLY . . . . . . . . . . . . . . . 95.72 -7.36 67.96 Favored Glycine 0 CA--C 1.536 1.347 0 C-N-CA 125.699 1.618 . . . . 0.0 114.866 -177.476 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 2510 ' ' SER . . . . . . . . . . . . . 45.4 t -79.62 146.97 66.37 Favored Pre-proline 0 CA--C 1.55 0.952 0 CA-C-N 119.16 1.48 . . . . 0.0 111.82 176.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 2511 ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -80.15 157.35 87.41 Favored 'Cis proline' 0 C--N 1.353 0.803 0 CA-C-N 119.834 0.977 . . . . 0.0 113.409 0.668 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 2512 ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -109.96 125.66 53.1 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.18 1.392 . . . . 0.0 111.199 179.75 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 2513 ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.73 101.59 13.83 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 124.449 1.1 . . . . 0.0 112.283 175.167 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 2514 ' ' ALA . . . . . . . . . . . . . . . -88.35 122.87 32.35 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 125.211 1.404 . . . . 0.0 110.28 174.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 2515 ' ' LYS . . . . . . . . . . . . . 27.7 mtpp -97.08 134.95 39.76 Favored 'General case' 0 CA--C 1.542 0.653 0 O-C-N 121.231 -0.918 . . . . 0.0 111.285 -174.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 2516 ' ' VAL . . . . . . . . . . . . . 74.0 t -130.39 138.95 52.57 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.775 0 C-N-CA 124.911 1.285 . . . . 0.0 110.849 -169.07 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 2517 ' ' THR . . . . . . . . . . . . . 54.2 p -134.6 171.07 14.84 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 125.869 1.667 . . . . 0.0 110.892 179.605 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 2518 ' ' GLY . . . . . . . . . . . . . . . 106.37 178.65 23.26 Favored Glycine 0 CA--C 1.539 1.568 0 C-N-CA 124.828 1.204 . . . . 0.0 113.432 -176.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 2519 ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -70.98 136.11 29.04 Favored 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 123.715 2.943 . . . . 0.0 112.129 -171.053 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 2520 ' ' ARG . . . . . . . . . . . . . 50.9 ttp180 . . . . . 0 CA--C 1.539 0.546 0 C-N-CA 124.047 0.939 . . . . 0.0 110.778 176.053 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A 2427 ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.152 0 CA-C-O 121.196 0.331 . . . . 0.0 112.68 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A 2428 ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -144.76 128.22 8.64 Favored Pre-proline 0 CA--C 1.546 0.802 0 C-N-CA 125.65 1.58 . . . . 0.0 109.626 178.001 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 2429 ' ' PRO . . . . . . . . . . . . . 57.3 Cg_exo -56.46 -35.0 96.13 Favored 'Trans proline' 0 C--N 1.353 0.789 0 C-N-CA 123.183 2.588 . . . . 0.0 114.493 -175.378 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 2430 ' ' GLY . . . . . . . . . . . . . . . -73.04 -18.84 79.36 Favored Glycine 0 CA--C 1.534 1.257 0 CA-C-N 118.552 0.615 . . . . 0.0 114.186 179.866 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 2431 ' ' LEU . . . . . . . . . . . . . 4.1 mm? -87.02 -20.29 27.44 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.732 1.213 . . . . 0.0 111.904 173.075 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 2432 ' ' VAL . . . . . . . . . . . . . 60.8 t -80.97 138.31 19.87 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 C-N-CA 124.571 1.148 . . . . 0.0 109.178 172.143 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 2433 ' ' SER . . . . . . . . . . . . . 8.6 t -128.11 -169.86 2.14 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 125.083 1.353 . . . . 0.0 111.001 176.337 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 2434 ' ' ALA . . . . . . . . . . . . . . . -155.45 142.77 19.41 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.692 1.197 . . . . 0.0 111.656 177.303 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 2435 ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -145.24 145.12 31.16 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 125.245 1.418 . . . . 0.0 112.071 -176.433 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 2436 ' ' GLY . . . . . . . . . . . . . . . 129.08 158.48 9.6 Favored Glycine 0 N--CA 1.472 1.077 0 C-N-CA 125.622 1.582 . . . . 0.0 113.395 178.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 2437 ' ' ALA . . . . . . . . . . . . . . . -62.11 -27.79 69.18 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 114.206 1.187 . . . . 0.0 114.206 -170.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 2438 ' ' GLY . . . . . . . . . . . . . . . -65.57 -16.66 63.52 Favored Glycine 0 CA--C 1.531 1.035 0 CA-C-O 118.888 -0.951 . . . . 0.0 114.31 -178.867 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 2439 ' ' LEU . . . . . . . . . . . . . 87.7 mt -73.53 -28.69 62.02 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 118.673 1.237 . . . . 0.0 112.513 171.259 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 2440 ' ' GLU . . . . . . . . . . . . . 41.5 mm-40 -92.25 -33.47 14.64 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.942 1.297 . . . . 0.0 112.167 -177.037 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 2441 ' ' GLY . . . . . . . . . . . . . . . 161.15 -156.38 27.77 Favored Glycine 0 CA--C 1.528 0.894 0 N-CA-C 114.875 0.71 . . . . 0.0 114.875 -176.825 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 2442 ' ' GLY . . . . . . . . . . . . . . . 171.26 -167.14 40.26 Favored Glycine 0 CA--C 1.53 0.992 0 C-N-CA 125.648 1.594 . . . . 0.0 112.298 -178.657 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 2443 ' ' VAL . . . . . . . . . . . . . 98.2 t -125.27 144.83 33.93 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 C-N-CA 124.692 1.197 . . . . 0.0 109.36 175.638 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 2444 ' ' THR . . . . . . . . . . . . . 21.4 p -54.7 127.5 28.48 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 124.95 1.3 . . . . 0.0 111.812 176.42 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 2445 ' ' GLY . . . . . . . . . . . . . . . 79.26 -5.36 59.91 Favored Glycine 0 CA--C 1.536 1.383 0 C-N-CA 124.622 1.106 . . . . 0.0 114.846 -178.399 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 2446 ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -97.66 139.82 21.59 Favored Pre-proline 0 CA--C 1.551 1.019 0 C-N-CA 125.617 1.567 . . . . 0.0 110.953 176.519 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 2447 ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -75.56 122.15 6.78 Favored 'Trans proline' 0 N--CA 1.457 -0.64 0 C-N-CA 122.839 2.36 . . . . 0.0 110.632 176.163 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 2448 ' ' ALA . . . . . . . . . . . . . . . -105.16 156.57 17.97 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.97 1.708 . . . . 0.0 109.883 168.262 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 2449 ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -156.96 159.11 37.75 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 114.035 1.124 . . . . 0.0 114.035 -175.181 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 2450 ' ' PHE . . . . . . . . . . . . . 54.9 p90 -159.49 148.2 17.85 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 126.173 1.789 . . . . 0.0 110.571 178.314 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 2451 ' ' VAL . . . . . . . . . . . . . 11.2 t -102.35 124.22 56.15 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 C-N-CA 124.439 1.095 . . . . 0.0 108.886 174.594 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 2452 ' ' VAL . . . . . . . . . . . . . 43.5 t -75.13 108.81 7.28 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 N-CA-C 106.838 -1.542 . . . . 0.0 106.838 167.303 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 2453 ' ' ASN . . . . . . . . . . . . . 62.7 t-20 -87.55 113.89 23.66 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.136 0.974 . . . . 0.0 110.802 -171.055 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 2454 ' ' THR . . . . . . . . . . . . . 73.1 p -104.92 2.09 29.49 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 126.079 1.752 . . . . 0.0 112.958 -175.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 2455 ' ' SER . . . . . . . . . . . . . 46.9 m -58.42 -30.36 66.82 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 114.518 1.303 . . . . 0.0 114.518 -169.341 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 2456 ' ' ASN . . . . . . . . . . . . . 29.3 m120 -92.89 -11.21 34.05 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 124.663 1.185 . . . . 0.0 113.683 177.251 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 2457 ' ' ALA . . . . . . . . . . . . . . . -101.74 -32.81 10.11 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 125.309 1.444 . . . . 0.0 113.502 -178.427 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 2458 ' ' GLY . . . . . . . . . . . . . . . 85.81 -159.24 32.84 Favored Glycine 0 CA--C 1.533 1.214 0 C-N-CA 124.976 1.274 . . . . 0.0 112.846 -174.77 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 2459 ' ' ALA . . . . . . . . . . . . . . . -60.84 155.48 19.46 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 124.991 1.317 . . . . 0.0 114.016 -177.423 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 2460 ' ' GLY . . . . . . . . . . . . . . . 159.09 -174.62 36.06 Favored Glycine 0 CA--C 1.534 1.228 0 C-N-CA 125.922 1.725 . . . . 0.0 112.904 -176.556 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 2461 ' ' ALA . . . . . . . . . . . . . . . -123.61 143.24 50.35 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.904 1.282 . . . . 0.0 112.198 -177.089 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 2462 ' ' LEU . . . . . . . . . . . . . 24.8 tp -92.69 145.23 24.57 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.588 1.555 . . . . 0.0 111.254 179.093 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 2463 ' ' SER . . . . . . . . . . . . . 4.3 t -138.13 40.07 2.3 Favored 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 125.667 1.587 . . . . 0.0 111.004 -179.794 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 2464 ' ' VAL . . . . . . . . . . . . . 12.6 p -65.2 147.63 12.49 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 C-N-CA 126.008 1.723 . . . . 0.0 112.638 -175.498 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 2465 ' ' THR . . . . . . . . . . . . . 10.8 t -151.9 160.92 43.37 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 125.13 1.372 . . . . 0.0 111.412 172.388 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 2466 ' ' ILE . . . . . . . . . . . . . 55.5 mt -135.11 124.63 42.97 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 124.913 1.285 . . . . 0.0 110.16 -173.853 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 2467 ' ' ASP . . . . . . . . . . . . . 29.9 m-20 -106.36 173.35 6.35 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 126.44 1.896 . . . . 0.0 110.79 169.808 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 2468 ' ' GLY . . . . . . . . . . . . . . . 153.49 -155.02 25.89 Favored Glycine 0 CA--C 1.535 1.331 0 CA-C-O 118.916 -0.935 . . . . 0.0 113.872 179.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 2469 ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -70.21 -10.52 28.39 Favored 'Trans proline' 0 CA--C 1.542 0.883 0 C-N-CA 123.705 2.936 . . . . 0.0 113.756 178.294 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 2470 ' ' SER . . . . . . . . . . . . . 34.0 p -166.77 169.09 13.67 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 125.488 1.515 . . . . 0.0 111.934 -176.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 2471 ' ' LYS . . . . . . . . . . . . . 64.5 mttp -79.73 106.54 11.82 Favored 'General case' 0 CA--C 1.542 0.669 0 O-C-N 121.017 -1.052 . . . . 0.0 110.599 172.547 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 2472 ' ' VAL . . . . . . . . . . . . . 32.9 m -60.84 151.03 6.62 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.15 0 C-N-CA 123.821 0.848 . . . . 0.0 111.838 175.755 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 2473 ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.46 132.92 35.78 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 162.394 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 2474 ' ' MET . . . . . . . . . . . . . 16.3 tmm? -152.1 143.35 23.28 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-N 119.755 1.161 . . . . 0.0 112.975 -170.815 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 2475 ' ' ASP . . . . . . . . . . . . . 36.7 t70 -139.5 146.0 39.45 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 126.947 2.099 . . . . 0.0 110.295 174.214 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 2476 ' ' CYS . . . . . . . . . . . . . 30.0 t -124.35 144.99 49.71 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.515 1.126 . . . . 0.0 111.546 -179.361 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 2477 ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -143.36 169.57 17.42 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.128 1.371 . . . . 0.0 111.87 -179.763 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 2478 ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -77.78 147.21 35.4 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 123.807 0.843 . . . . 0.0 110.711 166.512 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 2479 ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -146.25 168.81 10.77 Favored Pre-proline 0 CA--C 1.552 1.054 0 C-N-CA 127.009 2.123 . . . . 0.0 111.072 178.377 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 2480 ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo -64.56 -29.35 61.33 Favored 'Trans proline' 0 CA--C 1.539 0.765 0 C-N-CA 122.75 2.3 . . . . 0.0 114.47 -173.315 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 2481 ' ' GLU . . . . . . . . . . . . . 5.6 mp0 -88.24 -10.19 50.51 Favored 'General case' 0 CA--C 1.547 0.847 0 N-CA-C 113.765 1.024 . . . . 0.0 113.765 174.216 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 2482 ' ' GLY . . . . . . . . . . . . . . . 151.45 -111.11 0.49 Allowed Glycine 0 N--CA 1.471 1.014 0 CA-C-N 119.794 1.179 . . . . 0.0 113.494 -176.188 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 2483 ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -123.14 123.85 41.73 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.437 1.095 . . . . 0.0 111.714 179.159 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 2484 ' ' ARG . . . . . . . . . . . . . 25.5 ttp180 -91.3 129.52 37.28 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 123.369 0.667 . . . . 0.0 111.108 175.097 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 2485 ' ' VAL . . . . . . . . . . . . . 98.7 t -99.2 132.03 45.35 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.475 0 C-N-CA 125.162 1.385 . . . . 0.0 107.99 168.101 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 2486 ' ' THR . . . . . . . . . . . . . 20.5 m -124.5 126.3 45.64 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 125.415 1.486 . . . . 0.0 107.619 176.132 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 2487 ' ' TYR . . . . . . . . . . . . . 15.8 p90 -143.19 150.13 38.96 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 113.584 0.957 . . . . 0.0 113.584 -176.842 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 2488 ' ' THR . . . . . . . . . . . . . 91.2 m -119.59 115.03 34.05 Favored Pre-proline 0 N--CA 1.468 0.471 0 C-N-CA 125.342 1.457 . . . . 0.0 108.618 176.37 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 2489 ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -79.08 153.3 24.88 Favored 'Trans proline' 0 N--CA 1.456 -0.68 0 C-N-CA 123.339 2.693 . . . . 0.0 110.774 175.084 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 2490 ' ' MET . . . . . . . . . . . . . 24.8 ptm -118.09 -4.87 10.98 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 114.584 1.327 . . . . 0.0 114.584 -174.044 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 2491 ' ' ALA . . . . . . . . . . . . . . . -145.38 152.25 49.54 Favored Pre-proline 0 CA--C 1.548 0.899 0 C-N-CA 125.296 1.439 . . . . 0.0 111.601 177.859 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 2492 ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -72.83 154.85 53.83 Favored 'Trans proline' 0 CA--C 1.537 0.635 0 C-N-CA 123.001 2.467 . . . . 0.0 111.076 173.186 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 2493 ' ' GLY . . . . . . . . . . . . . . . 130.81 -168.37 21.88 Favored Glycine 0 CA--C 1.529 0.964 0 C-N-CA 125.473 1.511 . . . . 0.0 113.508 -178.163 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 2494 ' ' SER . . . . . . . . . . . . . 70.5 m -99.62 116.53 31.96 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 123.923 0.889 . . . . 0.0 111.333 178.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 2495 ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -87.93 150.77 23.27 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.582 1.153 . . . . 0.0 110.53 166.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 2496 ' ' LEU . . . . . . . . . . . . . 32.0 tp -121.99 114.73 21.37 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.803 1.241 . . . . 0.0 109.359 179.583 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 2497 ' ' ILE . . . . . . . . . . . . . 63.4 mt -99.38 108.18 22.01 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 C-N-CA 125.318 1.447 . . . . 0.0 108.415 -172.881 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 2498 ' ' SER . . . . . . . . . . . . . 73.2 m -95.47 101.44 13.16 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 124.507 1.123 . . . . 0.0 109.732 179.358 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 2499 ' ' ILE . . . . . . . . . . . . . 42.8 mt -96.38 105.98 17.79 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 C-N-CA 124.762 1.225 . . . . 0.0 108.729 -178.023 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 2500 ' ' LYS . . . . . . . . . . . . . 85.1 mttt -113.2 142.51 45.71 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.406 1.082 . . . . 0.0 110.912 177.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 2501 ' ' TYR . . . . . . . . . . . . . 43.8 t80 -151.2 139.95 20.79 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.881 0.873 . . . . 0.0 112.258 -174.423 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 2502 ' ' GLY . . . . . . . . . . . . . . . 69.68 12.85 67.91 Favored Glycine 0 CA--C 1.536 1.402 0 C-N-CA 124.308 0.956 . . . . 0.0 114.267 177.862 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 2503 ' ' GLY . . . . . . . . . . . . . . . 150.81 -169.96 30.61 Favored Glycine 0 CA--C 1.539 1.54 0 C-N-CA 125.844 1.687 . . . . 0.0 113.025 -170.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 2504 ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -82.16 14.29 2.28 Favored 'Trans proline' 0 CA--C 1.544 1.011 0 C-N-CA 124.838 3.692 . . . . 0.0 113.918 -174.837 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 2505 ' ' TYR . . . . . . . . . . . . . 68.7 m-85 -108.44 141.64 40.0 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.77 1.228 . . . . 0.0 113.491 -171.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 2506 ' ' HIS . . . . . . . . . . . . . 84.3 m-70 -63.24 141.4 58.78 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 125.114 1.365 . . . . 0.0 112.988 176.246 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 2507 ' ' ILE . . . . . . . . . . . . . 1.6 pp -77.88 172.04 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 C-N-CA 123.612 0.765 . . . . 0.0 112.666 174.823 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 2508 ' ' GLY . . . . . . . . . . . . . . . -59.95 111.29 3.44 Favored Glycine 0 CA--C 1.534 1.264 0 O-C-N 121.531 -0.731 . . . . 0.0 112.582 -176.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 2509 ' ' GLY . . . . . . . . . . . . . . . 96.6 -7.3 65.66 Favored Glycine 0 CA--C 1.536 1.348 0 C-N-CA 125.822 1.677 . . . . 0.0 114.939 -177.19 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 2510 ' ' SER . . . . . . . . . . . . . 47.8 t -82.36 147.55 56.9 Favored Pre-proline 0 CA--C 1.551 0.981 0 CA-C-N 119.098 1.449 . . . . 0.0 112.106 178.123 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 2511 ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -78.41 154.42 92.64 Favored 'Cis proline' 0 C--N 1.353 0.808 0 CA-C-N 119.788 0.96 . . . . 0.0 113.091 -1.108 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 2512 ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -105.71 127.95 53.38 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.32 1.448 . . . . 0.0 110.998 -179.628 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 2513 ' ' LYS . . . . . . . . . . . . . 61.1 pttt -87.06 115.61 24.57 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 123.719 0.808 . . . . 0.0 111.906 175.836 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 2514 ' ' ALA . . . . . . . . . . . . . . . -105.94 114.9 29.32 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.645 1.578 . . . . 0.0 110.522 -179.051 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 2515 ' ' LYS . . . . . . . . . . . . . 54.2 mtpt -94.75 112.94 24.65 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.107 0.963 . . . . 0.0 110.755 -173.282 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 2516 ' ' VAL . . . . . . . . . . . . . 75.6 t -110.67 144.21 19.11 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 125.417 1.487 . . . . 0.0 110.542 -173.22 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 2517 ' ' THR . . . . . . . . . . . . . 66.4 p -133.45 172.53 12.6 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 125.3 1.44 . . . . 0.0 111.232 176.127 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 2518 ' ' GLY . . . . . . . . . . . . . . . 107.35 177.28 22.63 Favored Glycine 0 CA--C 1.541 1.676 0 C-N-CA 125.215 1.388 . . . . 0.0 113.954 -179.733 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 2519 ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -73.74 136.63 23.51 Favored 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 123.972 3.115 . . . . 0.0 112.172 -172.283 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 2520 ' ' ARG . . . . . . . . . . . . . 34.9 ttm180 . . . . . 0 CA--C 1.542 0.664 0 C-N-CA 123.976 0.91 . . . . 0.0 111.286 177.322 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A 2427 ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.821 0 N-CA-C 112.128 -0.389 . . . . 0.0 112.128 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A 2428 ' ' ASP . . . . . . . . . . . . . 12.9 t70 -100.67 129.9 26.62 Favored Pre-proline 0 CA--C 1.552 1.025 0 C-N-CA 124.242 1.017 . . . . 0.0 112.347 -175.572 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 2429 ' ' PRO . . . . . . . . . . . . . 53.8 Cg_exo -58.24 -27.1 79.43 Favored 'Trans proline' 0 C--N 1.354 0.829 0 C-N-CA 123.719 2.946 . . . . 0.0 114.99 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 2430 ' ' GLY . . . . . . . . . . . . . . . -80.05 -23.33 61.66 Favored Glycine 0 CA--C 1.532 1.143 0 CA-C-N 119.154 0.888 . . . . 0.0 113.322 177.674 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 2431 ' ' LEU . . . . . . . . . . . . . 4.3 mm? -82.82 -31.56 28.06 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 124.212 1.005 . . . . 0.0 111.415 170.567 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 2432 ' ' VAL . . . . . . . . . . . . . 81.3 t -69.08 136.57 26.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 123.571 0.748 . . . . 0.0 110.573 169.403 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 2433 ' ' SER . . . . . . . . . . . . . 58.6 m -139.92 144.92 37.36 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 125.174 1.39 . . . . 0.0 109.788 171.817 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 2434 ' ' ALA . . . . . . . . . . . . . . . -94.29 148.48 22.17 Favored 'General case' 0 CA--C 1.541 0.609 0 O-C-N 121.771 -0.581 . . . . 0.0 111.781 175.109 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 2435 ' ' TYR . . . . . . . . . . . . . 93.3 m-85 -142.97 147.73 35.66 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 126.136 1.775 . . . . 0.0 111.453 -178.402 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 2436 ' ' GLY . . . . . . . . . . . . . . . 120.31 161.14 11.4 Favored Glycine 0 N--CA 1.473 1.145 0 C-N-CA 125.151 1.358 . . . . 0.0 113.876 178.374 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 2437 ' ' ALA . . . . . . . . . . . . . . . -62.8 -28.88 70.3 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 114.409 1.263 . . . . 0.0 114.409 -169.682 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 2438 ' ' GLY . . . . . . . . . . . . . . . -66.99 -12.3 59.87 Favored Glycine 0 CA--C 1.532 1.108 0 CA-C-O 119.077 -0.846 . . . . 0.0 114.773 -177.425 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 2439 ' ' LEU . . . . . . . . . . . . . 79.5 mt -76.41 -27.78 56.41 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.54 1.136 . . . . 0.0 112.5 170.265 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 2440 ' ' GLU . . . . . . . . . . . . . 41.5 mm-40 -88.61 -32.51 18.05 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.893 1.277 . . . . 0.0 111.529 176.507 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 2441 ' ' GLY . . . . . . . . . . . . . . . 115.9 -130.55 9.12 Favored Glycine 0 CA--C 1.531 1.05 0 C-N-CA 125.706 1.622 . . . . 0.0 112.503 -179.754 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 2442 ' ' GLY . . . . . . . . . . . . . . . 135.11 -150.0 20.07 Favored Glycine 0 CA--C 1.535 1.311 0 C-N-CA 125.155 1.36 . . . . 0.0 113.701 -174.365 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 2443 ' ' VAL . . . . . . . . . . . . . 90.2 t -89.55 136.26 24.06 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 C-N-CA 124.804 1.242 . . . . 0.0 111.025 -174.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 2444 ' ' THR . . . . . . . . . . . . . 46.3 p -72.24 146.65 47.12 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 124.47 1.108 . . . . 0.0 112.049 176.818 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 2445 ' ' GLY . . . . . . . . . . . . . . . 78.28 -10.73 26.96 Favored Glycine 0 CA--C 1.538 1.5 0 C-N-CA 124.243 0.925 . . . . 0.0 114.193 -172.753 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 2446 ' ' ASN . . . . . . . . . . . . . 77.0 m-20 -102.12 152.54 38.25 Favored Pre-proline 0 CA--C 1.55 0.944 0 C-N-CA 125.469 1.507 . . . . 0.0 111.034 172.474 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 2447 ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -72.07 140.34 34.35 Favored 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 123.075 2.516 . . . . 0.0 111.55 178.25 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 2448 ' ' ALA . . . . . . . . . . . . . . . -121.3 131.14 54.03 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 127.115 2.166 . . . . 0.0 109.089 173.725 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 2449 ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -128.55 141.4 51.38 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.294 1.038 . . . . 0.0 111.806 -166.854 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 2450 ' ' PHE . . . . . . . . . . . . . 37.8 p90 -155.2 161.34 41.22 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.211 1.405 . . . . 0.0 111.998 173.164 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 2451 ' ' VAL . . . . . . . . . . . . . 8.1 p -118.44 139.05 47.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 125.616 1.566 . . . . 0.0 110.417 176.666 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 2452 ' ' VAL . . . . . . . . . . . . . 61.4 t -95.81 101.41 12.37 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 N-CA-C 107.194 -1.41 . . . . 0.0 107.194 168.555 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 2453 ' ' ASN . . . . . . . . . . . . . 22.6 t-20 -83.49 120.29 25.73 Favored 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 -169.601 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 2454 ' ' THR . . . . . . . . . . . . . 35.4 p -99.52 -5.98 28.3 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 125.878 1.671 . . . . 0.0 113.993 -177.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 2455 ' ' SER . . . . . . . . . . . . . 19.9 m -57.39 -32.99 67.38 Favored 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 114.556 1.317 . . . . 0.0 114.556 -172.772 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 2456 ' ' ASN . . . . . . . . . . . . . 28.0 m120 -83.4 -15.9 48.0 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 124.149 0.98 . . . . 0.0 113.601 176.228 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 2457 ' ' ALA . . . . . . . . . . . . . . . -102.49 -42.22 6.03 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.032 1.333 . . . . 0.0 113.505 -173.217 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 2458 ' ' GLY . . . . . . . . . . . . . . . 120.55 -111.4 1.94 Allowed Glycine 0 CA--C 1.53 0.995 0 C-N-CA 125.323 1.439 . . . . 0.0 111.631 -172.246 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 2459 ' ' ALA . . . . . . . . . . . . . . . -148.04 149.92 32.99 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.721 1.208 . . . . 0.0 112.835 -175.808 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 2460 ' ' GLY . . . . . . . . . . . . . . . 171.11 171.09 36.0 Favored Glycine 0 CA--C 1.529 0.906 0 C-N-CA 124.748 1.166 . . . . 0.0 113.152 -176.492 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 2461 ' ' ALA . . . . . . . . . . . . . . . -81.82 142.42 32.58 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.014 0.925 . . . . 0.0 112.454 -179.433 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 2462 ' ' LEU . . . . . . . . . . . . . 16.9 tp -102.02 145.2 29.63 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.154 1.382 . . . . 0.0 110.38 172.559 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 2463 ' ' SER . . . . . . . . . . . . . 5.4 t -138.3 45.09 2.1 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 124.972 1.309 . . . . 0.0 110.625 179.745 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 2464 ' ' VAL . . . . . . . . . . . . . 9.1 p -65.94 134.86 29.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 124.975 1.31 . . . . 0.0 111.855 -177.105 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 2465 ' ' THR . . . . . . . . . . . . . 85.5 m -130.9 144.73 51.68 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 125.992 1.717 . . . . 0.0 109.144 177.617 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 2466 ' ' ILE . . . . . . . . . . . . . 47.7 mt -123.86 120.93 61.01 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 123.617 0.767 . . . . 0.0 109.808 175.764 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 2467 ' ' ASP . . . . . . . . . . . . . 31.2 m-20 -103.06 167.57 9.74 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 125.951 1.7 . . . . 0.0 110.742 169.785 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 2468 ' ' GLY . . . . . . . . . . . . . . . 167.27 -167.06 39.65 Favored Glycine 0 CA--C 1.537 1.41 0 O-C-N 121.387 -0.821 . . . . 0.0 114.534 179.776 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 2469 ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -70.68 -15.74 33.66 Favored 'Trans proline' 0 CA--C 1.54 0.822 0 C-N-CA 124.219 3.279 . . . . 0.0 113.284 178.248 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 2470 ' ' SER . . . . . . . . . . . . . 49.9 m -153.01 179.2 8.9 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 127.081 2.152 . . . . 0.0 110.051 173.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 2471 ' ' LYS . . . . . . . . . . . . . 65.1 pttt -69.4 171.2 9.04 Favored 'General case' 0 CA--C 1.549 0.937 0 O-C-N 121.083 -1.011 . . . . 0.0 112.926 171.269 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 2472 ' ' VAL . . . . . . . . . . . . . 26.7 m -130.9 147.38 33.09 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 125.173 1.389 . . . . 0.0 111.032 175.206 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 2473 ' ' LYS . . . . . . . . . . . . . 51.8 mtmt -88.57 58.73 4.81 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 124.382 1.073 . . . . 0.0 111.688 177.033 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 2474 ' ' MET . . . . . . . . . . . . . 16.0 tmm? -77.53 134.84 38.2 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.31 1.044 . . . . 0.0 112.635 -174.578 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 2475 ' ' ASP . . . . . . . . . . . . . 35.5 t70 -130.56 144.63 51.54 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 126.927 2.091 . . . . 0.0 110.451 172.286 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 2476 ' ' CYS . . . . . . . . . . . . . 48.9 t -127.53 147.63 50.33 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 125.543 1.537 . . . . 0.0 112.583 -173.102 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 2477 ' ' GLN . . . . . . . . . . . . . 23.1 tt0 -151.79 136.96 17.44 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.477 1.111 . . . . 0.0 110.964 170.747 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 2478 ' ' GLU . . . . . . . . . . . . . 4.1 pm0 -75.67 132.41 40.54 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.671 1.188 . . . . 0.0 111.886 172.63 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 2479 ' ' CYS . . . . . . . . . . . . . 80.0 m -133.98 169.37 14.08 Favored Pre-proline 0 CA--C 1.554 1.105 0 C-N-CA 126.157 1.783 . . . . 0.0 110.849 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 2480 ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -57.07 -27.27 73.14 Favored 'Trans proline' 0 CA--C 1.54 0.819 0 C-N-CA 123.569 2.846 . . . . 0.0 113.912 170.073 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 2481 ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -76.46 -3.66 38.37 Favored 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 125.684 1.594 . . . . 0.0 113.093 175.057 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 2482 ' ' GLY . . . . . . . . . . . . . . . 104.39 -170.01 17.97 Favored Glycine 0 CA--C 1.529 0.96 0 C-N-CA 125.949 1.737 . . . . 0.0 112.381 -169.178 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 2483 ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -71.56 116.37 11.83 Favored 'General case' 0 N--CA 1.469 0.488 0 O-C-N 121.493 -1.004 . . . . 0.0 111.116 175.336 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 2484 ' ' ARG . . . . . . . . . . . . . 15.2 ttp-105 -98.8 143.36 29.22 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 123.793 0.837 . . . . 0.0 110.512 174.574 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 2485 ' ' VAL . . . . . . . . . . . . . 35.1 m -132.96 150.03 32.44 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 C-N-CA 124.095 0.958 . . . . 0.0 111.563 174.873 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 2486 ' ' THR . . . . . . . . . . . . . 73.0 m -133.75 135.66 44.08 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 125.332 1.453 . . . . 0.0 108.217 171.8 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 2487 ' ' TYR . . . . . . . . . . . . . 26.4 p90 -141.12 150.98 43.53 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 124.424 1.09 . . . . 0.0 112.5 179.354 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 2488 ' ' THR . . . . . . . . . . . . . 92.2 m -115.49 116.25 41.56 Favored Pre-proline 0 N--CA 1.473 0.676 0 CA-C-O 117.844 -1.074 . . . . 0.0 109.097 173.1 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 2489 ' ' PRO . . . . . . . . . . . . . 77.8 Cg_endo -82.6 135.01 7.78 Favored 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 123.755 2.97 . . . . 0.0 110.382 172.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 2490 ' ' MET . . . . . . . . . . . . . 24.1 ptm -98.12 3.43 49.16 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 114.918 1.451 . . . . 0.0 114.918 -172.421 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 2491 ' ' ALA . . . . . . . . . . . . . . . -153.48 148.64 20.03 Favored Pre-proline 0 CA--C 1.543 0.687 0 C-N-CA 125.146 1.378 . . . . 0.0 111.654 -177.852 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 2492 ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -73.93 153.48 47.48 Favored 'Trans proline' 0 C--N 1.35 0.631 0 C-N-CA 123.522 2.815 . . . . 0.0 111.569 178.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 2493 ' ' GLY . . . . . . . . . . . . . . . 136.85 -150.8 20.71 Favored Glycine 0 CA--C 1.53 1.026 0 C-N-CA 125.297 1.427 . . . . 0.0 113.166 -178.19 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 2494 ' ' SER . . . . . . . . . . . . . 45.3 m -118.31 124.01 46.76 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.625 1.17 . . . . 0.0 110.982 -178.271 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 2495 ' ' TYR . . . . . . . . . . . . . 40.7 m-85 -103.11 125.82 50.0 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 124.803 1.241 . . . . 0.0 110.164 177.477 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 2496 ' ' LEU . . . . . . . . . . . . . 20.1 tp -95.0 106.8 18.81 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.056 0.943 . . . . 0.0 109.467 -178.412 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 2497 ' ' ILE . . . . . . . . . . . . . 51.9 mt -90.89 103.07 14.06 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 C-N-CA 125.837 1.655 . . . . 0.0 107.849 -178.688 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 2498 ' ' SER . . . . . . . . . . . . . 25.5 t -94.61 91.83 6.75 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 126.042 1.737 . . . . 0.0 109.388 -178.402 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 2499 ' ' ILE . . . . . . . . . . . . . 30.1 mt -91.57 90.37 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 C-N-CA 124.521 1.128 . . . . 0.0 109.52 -174.069 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 2500 ' ' LYS . . . . . . . . . . . . . 56.4 mttp -89.99 142.84 27.31 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 123.79 0.836 . . . . 0.0 111.412 174.695 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 2501 ' ' TYR . . . . . . . . . . . . . 85.7 t80 -148.59 147.96 29.59 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 124.756 1.222 . . . . 0.0 112.226 -175.573 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 2502 ' ' GLY . . . . . . . . . . . . . . . 65.29 16.07 62.03 Favored Glycine 0 CA--C 1.535 1.319 0 C-N-CA 124.567 1.08 . . . . 0.0 114.152 175.38 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 2503 ' ' GLY . . . . . . . . . . . . . . . 134.45 -170.84 22.5 Favored Glycine 0 CA--C 1.542 1.749 0 C-N-CA 126.191 1.853 . . . . 0.0 111.904 -161.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 2504 ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -84.11 33.88 0.51 Allowed 'Trans proline' 0 CA--C 1.547 1.127 0 C-N-CA 124.681 3.587 . . . . 0.0 113.202 -172.806 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 2505 ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -124.51 138.51 54.33 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.483 1.113 . . . . 0.0 113.446 -172.77 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 2506 ' ' HIS . . . . . . . . . . . . . 82.6 m-70 -60.28 143.71 52.14 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 125.694 1.598 . . . . 0.0 113.799 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 2507 ' ' ILE . . . . . . . . . . . . . 31.3 pt -75.1 172.31 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 C-N-CA 123.545 0.738 . . . . 0.0 112.73 168.057 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 2508 ' ' GLY . . . . . . . . . . . . . . . -58.63 121.95 28.26 Favored Glycine 0 CA--C 1.533 1.203 0 C-N-CA 123.661 0.648 . . . . 0.0 111.723 172.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 2509 ' ' GLY . . . . . . . . . . . . . . . 88.82 -9.89 74.61 Favored Glycine 0 CA--C 1.536 1.348 0 C-N-CA 125.653 1.597 . . . . 0.0 115.07 -178.003 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 2510 ' ' SER . . . . . . . . . . . . . 40.3 t -83.59 146.31 49.75 Favored Pre-proline 0 CA--C 1.55 0.978 0 CA-C-N 119.193 1.496 . . . . 0.0 111.893 179.158 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 2511 ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -78.81 154.15 91.17 Favored 'Cis proline' 0 C--N 1.353 0.791 0 CA-C-N 119.751 0.947 . . . . 0.0 113.071 0.072 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 2512 ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -103.63 132.24 50.07 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.043 1.337 . . . . 0.0 110.334 177.174 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 2513 ' ' LYS . . . . . . . . . . . . . 64.6 pttt -93.81 15.88 15.48 Favored 'General case' 0 N--CA 1.479 0.982 0 N-CA-C 116.123 1.897 . . . . 0.0 116.123 -165.565 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 2514 ' ' ALA . . . . . . . . . . . . . . . -12.78 104.23 0.02 OUTLIER 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 129.239 3.016 . . . . 0.0 116.205 -174.851 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 2515 ' ' LYS . . . . . . . . . . . . . 50.2 mtmt -93.27 130.18 39.09 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 124.406 1.083 . . . . 0.0 111.015 -176.114 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 2516 ' ' VAL . . . . . . . . . . . . . 25.7 m -134.12 148.37 30.09 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 C-N-CA 124.026 0.93 . . . . 0.0 112.253 -172.042 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 2517 ' ' THR . . . . . . . . . . . . . 45.1 p -139.45 165.84 26.16 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 125.568 1.547 . . . . 0.0 111.08 -175.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 2518 ' ' GLY . . . . . . . . . . . . . . . 119.18 -157.67 15.25 Favored Glycine 0 CA--C 1.539 1.535 0 C-N-CA 124.971 1.272 . . . . 0.0 112.331 -173.62 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 2519 ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -71.7 160.73 47.32 Favored 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 123.486 2.791 . . . . 0.0 112.684 -175.146 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 2520 ' ' ARG . . . . . . . . . . . . . 55.1 ttt85 . . . . . 0 CA--C 1.537 0.469 0 C-N-CA 124.707 1.203 . . . . 0.0 108.941 167.644 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A 2427 ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.081 0 CA-C-O 121.417 0.454 . . . . 0.0 113.148 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A 2428 ' ' ASP . . . . . . . . . . . . . 13.3 t70 -93.01 135.97 25.23 Favored Pre-proline 0 CA--C 1.551 0.984 0 C-N-CA 124.754 1.222 . . . . 0.0 111.625 -178.195 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 2429 ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -67.93 -14.62 41.78 Favored 'Trans proline' 0 CA--C 1.539 0.77 0 C-N-CA 123.575 2.85 . . . . 0.0 114.294 -175.871 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 2430 ' ' GLY . . . . . . . . . . . . . . . -87.54 -27.03 28.38 Favored Glycine 0 CA--C 1.534 1.222 0 C-N-CA 124.392 0.996 . . . . 0.0 113.187 171.475 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 2431 ' ' LEU . . . . . . . . . . . . . 4.3 mm? -78.29 -36.45 46.62 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 118.247 1.023 . . . . 0.0 111.037 170.436 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 2432 ' ' VAL . . . . . . . . . . . . . 72.8 t -64.63 136.86 25.92 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 C-N-CA 123.356 0.662 . . . . 0.0 109.724 166.515 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 2433 ' ' SER . . . . . . . . . . . . . 8.7 t -134.1 -166.68 1.83 Allowed 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.995 1.318 . . . . 0.0 110.1 176.256 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 2434 ' ' ALA . . . . . . . . . . . . . . . -152.12 143.35 23.26 Favored 'General case' 0 CA--C 1.537 0.478 0 O-C-N 121.002 -1.061 . . . . 0.0 111.308 174.188 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 2435 ' ' TYR . . . . . . . . . . . . . 81.4 m-85 -142.38 156.29 45.21 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 125.269 1.428 . . . . 0.0 112.076 -176.712 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 2436 ' ' GLY . . . . . . . . . . . . . . . 116.55 157.27 10.93 Favored Glycine 0 N--CA 1.472 1.06 0 C-N-CA 125.705 1.621 . . . . 0.0 113.266 -179.532 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 2437 ' ' ALA . . . . . . . . . . . . . . . -60.82 -28.46 68.81 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.863 1.265 . . . . 0.0 114.222 -170.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 2438 ' ' GLY . . . . . . . . . . . . . . . -67.68 -9.98 57.04 Favored Glycine 0 CA--C 1.531 1.045 0 CA-C-O 118.894 -0.948 . . . . 0.0 114.957 -178.008 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 2439 ' ' LEU . . . . . . . . . . . . . 79.4 mt -83.33 -24.86 31.92 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 124.747 1.219 . . . . 0.0 112.709 170.048 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 2440 ' ' GLU . . . . . . . . . . . . . 39.5 mm-40 -91.15 -39.23 12.26 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.885 1.274 . . . . 0.0 111.382 -179.34 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 2441 ' ' GLY . . . . . . . . . . . . . . . 164.13 -158.73 31.41 Favored Glycine 0 CA--C 1.528 0.876 0 N-CA-C 115.617 1.007 . . . . 0.0 115.617 -177.834 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 2442 ' ' GLY . . . . . . . . . . . . . . . 175.74 -165.77 36.69 Favored Glycine 0 CA--C 1.531 1.047 0 C-N-CA 125.638 1.589 . . . . 0.0 112.871 179.3 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 2443 ' ' VAL . . . . . . . . . . . . . 86.6 t -129.18 146.4 34.29 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 125.414 1.486 . . . . 0.0 108.672 174.423 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 2444 ' ' THR . . . . . . . . . . . . . 41.6 p -58.34 133.81 56.04 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-O 121.427 0.632 . . . . 0.0 111.661 178.231 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 2445 ' ' GLY . . . . . . . . . . . . . . . 79.14 -6.9 55.33 Favored Glycine 0 CA--C 1.537 1.464 0 C-N-CA 124.734 1.159 . . . . 0.0 115.052 -175.633 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 2446 ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -100.97 142.26 24.27 Favored Pre-proline 0 CA--C 1.553 1.059 0 C-N-CA 125.751 1.62 . . . . 0.0 111.179 177.573 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 2447 ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -74.29 129.52 13.1 Favored 'Trans proline' 0 C--N 1.351 0.68 0 C-N-CA 122.98 2.453 . . . . 0.0 111.34 179.768 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 2448 ' ' ALA . . . . . . . . . . . . . . . -105.57 120.33 41.38 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 126.365 1.866 . . . . 0.0 109.207 172.548 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 2449 ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -119.16 138.49 52.89 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.775 1.23 . . . . 0.0 111.542 -170.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 2450 ' ' PHE . . . . . . . . . . . . . 37.5 p90 -153.34 165.28 36.26 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.311 1.444 . . . . 0.0 111.85 173.272 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 2451 ' ' VAL . . . . . . . . . . . . . 43.0 t -126.85 131.75 70.74 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 C-N-CA 124.897 1.279 . . . . 0.0 109.701 176.172 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 2452 ' ' VAL . . . . . . . . . . . . . 40.0 t -78.6 105.43 7.78 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 N-CA-C 107.318 -1.364 . . . . 0.0 107.318 165.577 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 2453 ' ' ASN . . . . . . . . . . . . . 14.7 t-20 -83.19 115.1 21.78 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 123.804 0.842 . . . . 0.0 112.292 -169.161 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 2454 ' ' THR . . . . . . . . . . . . . 43.9 p -103.96 -9.1 19.14 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 125.687 1.595 . . . . 0.0 113.812 -177.648 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 2455 ' ' SER . . . . . . . . . . . . . 16.3 m -57.29 -29.21 63.69 Favored 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 114.637 1.347 . . . . 0.0 114.637 -172.622 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 2456 ' ' ASN . . . . . . . . . . . . . 68.9 m-80 -85.49 -13.25 49.7 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 124.671 1.188 . . . . 0.0 113.579 177.332 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 2457 ' ' ALA . . . . . . . . . . . . . . . -112.09 -25.6 9.26 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 125.576 1.55 . . . . 0.0 114.162 -174.312 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 2458 ' ' GLY . . . . . . . . . . . . . . . 103.75 -111.89 4.02 Favored Glycine 0 CA--C 1.53 0.987 0 C-N-CA 125.095 1.331 . . . . 0.0 111.844 -177.603 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 2459 ' ' ALA . . . . . . . . . . . . . . . -137.87 160.52 39.07 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.291 1.436 . . . . 0.0 112.201 -176.817 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 2460 ' ' GLY . . . . . . . . . . . . . . . 158.19 174.24 27.64 Favored Glycine 0 CA--C 1.529 0.946 0 C-N-CA 124.427 1.013 . . . . 0.0 113.973 -172.696 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 2461 ' ' ALA . . . . . . . . . . . . . . . -83.03 148.71 27.39 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.48 1.112 . . . . 0.0 112.706 -178.16 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 2462 ' ' LEU . . . . . . . . . . . . . 59.7 tp -129.22 138.85 51.93 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 125.545 1.538 . . . . 0.0 110.588 177.16 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 2463 ' ' SER . . . . . . . . . . . . . 18.2 t -118.26 151.25 38.01 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.478 1.111 . . . . 0.0 109.604 156.559 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 2464 ' ' VAL . . . . . . . . . . . . . 7.5 p -161.77 133.16 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 124.184 0.993 . . . . 0.0 110.819 -178.054 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 2465 ' ' THR . . . . . . . . . . . . . 62.7 m -140.85 142.83 34.51 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 125.578 1.551 . . . . 0.0 109.516 -175.377 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 2466 ' ' ILE . . . . . . . . . . . . . 41.9 mt -114.96 115.94 51.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 124.433 1.093 . . . . 0.0 109.442 177.132 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 2467 ' ' ASP . . . . . . . . . . . . . 35.1 t70 -96.63 161.41 13.9 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 125.929 1.692 . . . . 0.0 110.34 168.657 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 2468 ' ' GLY . . . . . . . . . . . . . . . 166.2 -164.21 37.39 Favored Glycine 0 CA--C 1.536 1.361 0 O-C-N 121.18 -0.95 . . . . 0.0 114.973 178.521 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 2469 ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -70.07 -14.08 34.68 Favored 'Trans proline' 0 CA--C 1.541 0.852 0 C-N-CA 124.202 3.268 . . . . 0.0 114.004 -178.836 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 2470 ' ' SER . . . . . . . . . . . . . 29.1 m -156.87 174.91 14.8 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 126.769 2.027 . . . . 0.0 110.363 175.637 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 2471 ' ' LYS . . . . . . . . . . . . . 58.4 mtmt -68.14 165.82 17.41 Favored 'General case' 0 CA--C 1.549 0.912 0 O-C-N 121.117 -0.989 . . . . 0.0 111.734 166.443 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 2472 ' ' VAL . . . . . . . . . . . . . 19.1 m -135.43 152.26 31.51 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 C-N-CA 124.777 1.231 . . . . 0.0 111.421 -179.442 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 2473 ' ' LYS . . . . . . . . . . . . . 29.2 mtpp -81.18 64.29 5.86 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 124.488 1.115 . . . . 0.0 111.806 179.463 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 2474 ' ' MET . . . . . . . . . . . . . 19.0 ttt -69.43 133.53 47.87 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 125.27 1.428 . . . . 0.0 112.161 -174.518 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 2475 ' ' ASP . . . . . . . . . . . . . 35.1 t70 -139.13 122.94 17.63 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 126.361 1.865 . . . . 0.0 110.109 176.266 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 2476 ' ' CYS . . . . . . . . . . . . . 73.6 m -104.38 140.79 37.41 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.733 1.213 . . . . 0.0 111.182 -179.021 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 2477 ' ' GLN . . . . . . . . . . . . . 81.0 mt-30 -140.83 148.01 39.91 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.127 1.371 . . . . 0.0 110.283 -176.223 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 2478 ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -95.03 118.58 32.08 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 123.686 0.795 . . . . 0.0 109.839 174.74 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 2479 ' ' CYS . . . . . . . . . . . . . 88.8 m -123.21 163.24 35.06 Favored Pre-proline 0 CA--C 1.551 0.992 0 C-N-CA 125.386 1.474 . . . . 0.0 111.587 -179.3 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 2480 ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -57.8 -31.29 91.94 Favored 'Trans proline' 0 C--N 1.353 0.803 0 C-N-CA 123.624 2.883 . . . . 0.0 114.071 174.579 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 2481 ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -77.19 -11.23 59.79 Favored 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 125.329 1.452 . . . . 0.0 112.98 178.216 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 2482 ' ' GLY . . . . . . . . . . . . . . . 125.57 -162.4 19.82 Favored Glycine 0 CA--C 1.53 0.983 0 C-N-CA 126.3 1.905 . . . . 0.0 112.993 -175.688 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 2483 ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -73.27 108.52 6.2 Favored 'General case' 0 CA--C 1.54 0.576 0 O-C-N 121.574 -0.957 . . . . 0.0 111.133 178.345 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 2484 ' ' ARG . . . . . . . . . . . . . 44.5 ttm180 -81.05 140.72 34.96 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 124.756 1.222 . . . . 0.0 110.448 174.561 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 2485 ' ' VAL . . . . . . . . . . . . . 90.4 t -130.72 129.05 63.82 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 C-N-CA 125.608 1.563 . . . . 0.0 108.592 174.499 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 2486 ' ' THR . . . . . . . . . . . . . 48.7 m -122.02 140.24 52.72 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 124.41 1.084 . . . . 0.0 108.351 170.18 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 2487 ' ' TYR . . . . . . . . . . . . . 34.7 p90 -146.22 149.14 33.35 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 123.852 0.861 . . . . 0.0 112.089 176.751 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 2488 ' ' THR . . . . . . . . . . . . . 87.7 m -111.87 115.53 50.78 Favored Pre-proline 0 N--CA 1.473 0.701 0 CA-C-O 117.875 -1.06 . . . . 0.0 108.9 174.161 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 2489 ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -79.61 161.88 24.76 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 123.965 3.11 . . . . 0.0 111.107 174.08 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 2490 ' ' MET . . . . . . . . . . . . . 25.6 ptm -138.32 3.43 2.36 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 114.977 1.473 . . . . 0.0 114.977 -173.071 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 2491 ' ' ALA . . . . . . . . . . . . . . . -143.47 146.23 34.9 Favored Pre-proline 0 CA--C 1.546 0.817 0 C-N-CA 125.179 1.391 . . . . 0.0 110.741 173.058 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 2492 ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -71.92 151.03 56.1 Favored 'Trans proline' 0 CA--C 1.536 0.594 0 C-N-CA 122.852 2.368 . . . . 0.0 111.04 175.51 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 2493 ' ' GLY . . . . . . . . . . . . . . . 135.5 -162.15 24.83 Favored Glycine 0 CA--C 1.529 0.944 0 C-N-CA 125.167 1.365 . . . . 0.0 113.366 -177.159 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 2494 ' ' SER . . . . . . . . . . . . . 42.2 m -101.34 123.46 45.47 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.151 0.98 . . . . 0.0 111.186 178.69 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 2495 ' ' TYR . . . . . . . . . . . . . 79.2 m-85 -96.82 134.34 40.25 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.508 1.123 . . . . 0.0 110.084 168.299 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 2496 ' ' LEU . . . . . . . . . . . . . 23.8 tp -110.4 115.12 29.1 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.724 1.21 . . . . 0.0 109.86 -176.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 2497 ' ' ILE . . . . . . . . . . . . . 45.0 mt -101.72 102.84 14.08 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 C-N-CA 125.683 1.593 . . . . 0.0 108.474 -173.68 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 2498 ' ' SER . . . . . . . . . . . . . 72.3 m -90.71 90.34 7.91 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 124.457 1.103 . . . . 0.0 110.67 -177.814 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 2499 ' ' ILE . . . . . . . . . . . . . 28.3 mt -91.14 118.09 35.71 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 125.035 1.334 . . . . 0.0 109.756 -178.286 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 2500 ' ' LYS . . . . . . . . . . . . . 82.0 mttt -131.71 106.93 8.45 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 124.865 1.266 . . . . 0.0 112.375 -171.733 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 2501 ' ' TYR . . . . . . . . . . . . . 39.3 t80 -109.49 142.89 39.87 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.721 1.208 . . . . 0.0 112.713 -175.183 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 2502 ' ' GLY . . . . . . . . . . . . . . . 70.87 9.55 66.28 Favored Glycine 0 CA--C 1.535 1.307 0 C-N-CA 124.682 1.134 . . . . 0.0 114.756 175.021 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 2503 ' ' GLY . . . . . . . . . . . . . . . 153.28 -171.73 32.19 Favored Glycine 0 CA--C 1.538 1.502 0 C-N-CA 125.802 1.668 . . . . 0.0 113.129 -172.144 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 2504 ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -82.09 19.04 1.3 Allowed 'Trans proline' 0 CA--C 1.546 1.106 0 C-N-CA 124.877 3.718 . . . . 0.0 113.749 -174.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 2505 ' ' TYR . . . . . . . . . . . . . 80.3 m-85 -113.94 143.7 44.28 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.213 1.405 . . . . 0.0 112.751 -175.26 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 2506 ' ' HIS . . . . . . . . . . . . . 97.5 m-70 -63.99 145.14 56.4 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 124.382 1.073 . . . . 0.0 113.632 -178.45 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 2507 ' ' ILE . . . . . . . . . . . . . 29.4 pt -75.06 173.68 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.213 0 C-N-CA 123.56 0.744 . . . . 0.0 112.869 171.373 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 2508 ' ' GLY . . . . . . . . . . . . . . . -58.7 120.5 22.65 Favored Glycine 0 CA--C 1.533 1.206 0 O-C-N 121.486 -0.759 . . . . 0.0 111.704 174.379 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 2509 ' ' GLY . . . . . . . . . . . . . . . 87.0 -8.2 77.36 Favored Glycine 0 CA--C 1.537 1.414 0 C-N-CA 125.52 1.533 . . . . 0.0 115.023 -177.07 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 2510 ' ' SER . . . . . . . . . . . . . 45.8 t -87.64 147.19 40.95 Favored Pre-proline 0 CA--C 1.549 0.937 0 CA-C-N 118.927 1.364 . . . . 0.0 111.826 179.845 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 2511 ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -76.34 151.9 95.47 Favored 'Cis proline' 0 C--N 1.352 0.722 0 CA-C-N 119.711 0.933 . . . . 0.0 112.748 -1.437 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 2512 ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -99.53 132.13 45.07 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 124.705 1.202 . . . . 0.0 111.151 179.851 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 2513 ' ' LYS . . . . . . . . . . . . . 64.9 pttt -96.26 22.85 7.22 Favored 'General case' 0 CA--C 1.552 1.02 0 N-CA-C 115.991 1.849 . . . . 0.0 115.991 -164.38 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 2514 ' ' ALA . . . . . . . . . . . . . . . -28.64 114.74 0.09 Allowed 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 128.118 2.567 . . . . 0.0 115.612 -173.807 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 2515 ' ' LYS . . . . . . . . . . . . . 89.0 mttt -98.17 135.13 40.26 Favored 'General case' 0 N--CA 1.474 0.77 0 O-C-N 121.312 -0.868 . . . . 0.0 112.74 -174.519 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 2516 ' ' VAL . . . . . . . . . . . . . 75.4 t -122.51 139.28 49.88 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 C-N-CA 125.284 1.434 . . . . 0.0 110.609 -170.604 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 2517 ' ' THR . . . . . . . . . . . . . 66.1 p -120.99 178.86 4.56 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 125.783 1.633 . . . . 0.0 111.107 176.331 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 2518 ' ' GLY . . . . . . . . . . . . . . . 100.51 179.55 29.59 Favored Glycine 0 CA--C 1.539 1.585 0 C-N-CA 124.828 1.204 . . . . 0.0 113.263 -175.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 2519 ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -72.53 152.05 53.74 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 123.788 2.992 . . . . 0.0 111.86 -175.449 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 2520 ' ' ARG . . . . . . . . . . . . . 45.8 ttp180 . . . . . 0 CA--C 1.538 0.501 0 C-N-CA 123.384 0.673 . . . . 0.0 110.14 172.476 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A 2427 ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.781 0 N-CA-C 110.132 -1.187 . . . . 0.0 110.132 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A 2428 ' ' ASP . . . . . . . . . . . . . 41.8 m-20 -87.24 142.49 33.54 Favored Pre-proline 0 CA--C 1.548 0.872 0 C-N-CA 123.638 0.775 . . . . 0.0 112.283 -170.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 2429 ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -64.66 -27.12 60.83 Favored 'Trans proline' 0 C--N 1.351 0.69 0 C-N-CA 123.207 2.605 . . . . 0.0 113.216 -176.153 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 2430 ' ' GLY . . . . . . . . . . . . . . . -73.87 -22.24 78.33 Favored Glycine 0 CA--C 1.535 1.295 0 CA-C-N 118.905 0.775 . . . . 0.0 113.652 175.347 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 2431 ' ' LEU . . . . . . . . . . . . . 4.4 mm? -88.67 -28.75 20.39 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 124.622 1.169 . . . . 0.0 111.869 173.108 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 2432 ' ' VAL . . . . . . . . . . . . . 71.1 t -68.79 136.63 25.98 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 123.756 0.823 . . . . 0.0 110.292 169.681 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 2433 ' ' SER . . . . . . . . . . . . . 74.6 m -123.61 -177.86 3.85 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 125.419 1.488 . . . . 0.0 110.261 172.862 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 2434 ' ' ALA . . . . . . . . . . . . . . . -143.77 146.17 32.92 Favored 'General case' 0 CA--C 1.538 0.501 0 O-C-N 120.701 -1.25 . . . . 0.0 111.499 170.541 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 2435 ' ' TYR . . . . . . . . . . . . . 76.2 m-85 -145.06 152.22 39.77 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.441 1.497 . . . . 0.0 111.992 -174.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 2436 ' ' GLY . . . . . . . . . . . . . . . 121.74 158.66 10.41 Favored Glycine 0 N--CA 1.473 1.114 0 C-N-CA 125.492 1.52 . . . . 0.0 113.404 179.184 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 2437 ' ' ALA . . . . . . . . . . . . . . . -61.32 -27.06 68.22 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.79 1.236 . . . . 0.0 114.245 -171.398 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 2438 ' ' GLY . . . . . . . . . . . . . . . -66.79 -14.17 62.55 Favored Glycine 0 CA--C 1.53 0.982 0 CA-C-O 119.067 -0.851 . . . . 0.0 114.492 -179.183 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 2439 ' ' LEU . . . . . . . . . . . . . 67.6 mt -78.82 -23.19 45.24 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 118.442 1.121 . . . . 0.0 112.449 170.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 2440 ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -92.41 -29.28 16.37 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.168 1.387 . . . . 0.0 111.83 176.117 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 2441 ' ' GLY . . . . . . . . . . . . . . . 108.31 -134.66 12.35 Favored Glycine 0 CA--C 1.532 1.114 0 C-N-CA 125.829 1.68 . . . . 0.0 112.525 178.433 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 2442 ' ' GLY . . . . . . . . . . . . . . . 136.78 -153.9 21.92 Favored Glycine 0 CA--C 1.534 1.265 0 C-N-CA 124.884 1.231 . . . . 0.0 114.494 -176.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 2443 ' ' VAL . . . . . . . . . . . . . 87.5 t -79.84 134.65 27.12 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 C-N-CA 124.622 1.169 . . . . 0.0 111.029 -174.83 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 2444 ' ' THR . . . . . . . . . . . . . 39.1 p -68.92 144.06 54.29 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.251 1.021 . . . . 0.0 112.021 176.276 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 2445 ' ' GLY . . . . . . . . . . . . . . . 83.38 -22.28 7.57 Favored Glycine 0 CA--C 1.536 1.359 0 C-N-CA 125.416 1.484 . . . . 0.0 113.903 -174.541 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 2446 ' ' ASN . . . . . . . . . . . . . 80.4 m-20 -87.19 152.96 53.69 Favored Pre-proline 0 CA--C 1.547 0.864 0 C-N-CA 124.749 1.22 . . . . 0.0 110.816 170.851 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 2447 ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -72.04 144.06 41.78 Favored 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 122.942 2.428 . . . . 0.0 111.658 179.387 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 2448 ' ' ALA . . . . . . . . . . . . . . . -119.04 137.98 53.17 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 127.309 2.244 . . . . 0.0 108.847 172.634 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 2449 ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -146.21 138.16 25.01 Favored 'General case' 0 N--CA 1.471 0.589 0 O-C-N 121.517 -0.74 . . . . 0.0 112.585 -163.041 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 2450 ' ' PHE . . . . . . . . . . . . . 50.6 p90 -154.22 159.73 41.49 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 125.52 1.528 . . . . 0.0 112.383 -179.109 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 2451 ' ' VAL . . . . . . . . . . . . . 88.3 t -112.65 132.73 60.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 125.552 1.541 . . . . 0.0 109.349 173.049 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 2452 ' ' VAL . . . . . . . . . . . . . 33.3 t -84.86 103.68 12.27 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 164.638 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 2453 ' ' ASN . . . . . . . . . . . . . 15.5 t-20 -87.06 116.89 25.42 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.2 1.0 . . . . 0.0 112.314 -168.568 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 2454 ' ' THR . . . . . . . . . . . . . 43.3 p -103.2 -4.44 24.37 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 126.214 1.806 . . . . 0.0 114.241 -173.09 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 2455 ' ' SER . . . . . . . . . . . . . 19.6 m -56.0 -34.55 65.9 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 114.961 1.467 . . . . 0.0 114.961 -170.296 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 2456 ' ' ASN . . . . . . . . . . . . . 29.8 m120 -86.94 -10.93 52.08 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 124.329 1.051 . . . . 0.0 113.495 178.061 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 2457 ' ' ALA . . . . . . . . . . . . . . . -103.32 -53.96 2.7 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.206 1.402 . . . . 0.0 112.85 -174.763 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 2458 ' ' GLY . . . . . . . . . . . . . . . 125.63 -121.04 4.05 Favored Glycine 0 CA--C 1.531 1.064 0 C-N-CA 124.967 1.27 . . . . 0.0 112.658 -172.887 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 2459 ' ' ALA . . . . . . . . . . . . . . . -126.65 166.25 17.69 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 125.679 1.592 . . . . 0.0 112.781 -173.326 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 2460 ' ' GLY . . . . . . . . . . . . . . . 146.77 173.06 17.67 Favored Glycine 0 CA--C 1.531 1.047 0 C-N-CA 124.394 0.997 . . . . 0.0 114.054 -177.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 2461 ' ' ALA . . . . . . . . . . . . . . . -82.37 150.92 26.89 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.512 1.125 . . . . 0.0 112.811 -178.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 2462 ' ' LEU . . . . . . . . . . . . . 23.4 tp -109.42 148.27 31.41 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 126.272 1.829 . . . . 0.0 110.678 177.301 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 2463 ' ' SER . . . . . . . . . . . . . 8.4 t -150.03 68.7 1.0 Allowed 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 124.128 0.971 . . . . 0.0 111.449 177.5 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 2464 ' ' VAL . . . . . . . . . . . . . 42.2 t -74.3 139.62 18.96 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.24 0 O-C-N 120.692 -1.255 . . . . 0.0 110.764 178.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 2465 ' ' THR . . . . . . . . . . . . . 16.4 m -125.41 141.34 52.11 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 125.043 1.337 . . . . 0.0 108.929 169.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 2466 ' ' ILE . . . . . . . . . . . . . 26.5 mt -122.14 126.36 74.25 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 123.425 0.69 . . . . 0.0 109.921 171.677 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 2467 ' ' ASP . . . . . . . . . . . . . 35.8 t70 -110.95 148.53 32.29 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 126.044 1.738 . . . . 0.0 110.192 170.176 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 2468 ' ' GLY . . . . . . . . . . . . . . . 170.51 -164.81 38.07 Favored Glycine 0 CA--C 1.536 1.395 0 N-CA-C 114.996 0.758 . . . . 0.0 114.996 -178.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 2469 ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -68.34 -25.02 36.53 Favored 'Trans proline' 0 CA--C 1.54 0.79 0 C-N-CA 124.002 3.135 . . . . 0.0 114.752 -171.712 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 2470 ' ' SER . . . . . . . . . . . . . 17.3 m -159.53 142.54 14.15 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 125.82 1.648 . . . . 0.0 110.566 174.693 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 2471 ' ' LYS . . . . . . . . . . . . . 55.3 mtmt -61.57 122.06 14.31 Favored 'General case' 0 N--CA 1.476 0.862 0 O-C-N 121.074 -1.016 . . . . 0.0 112.9 -172.818 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 2472 ' ' VAL . . . . . . . . . . . . . 21.0 m -77.21 151.6 5.66 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 C-N-CA 124.441 1.096 . . . . 0.0 112.512 -175.598 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 2473 ' ' LYS . . . . . . . . . . . . . 38.3 mtmm -78.63 145.62 34.57 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 123.234 0.614 . . . . 0.0 109.867 160.315 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 2474 ' ' MET . . . . . . . . . . . . . 56.5 ttm -147.94 144.29 27.92 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 124.273 1.029 . . . . 0.0 112.518 -174.804 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 2475 ' ' ASP . . . . . . . . . . . . . 21.5 m-20 -125.81 149.93 48.22 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 126.843 2.057 . . . . 0.0 109.996 162.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 2476 ' ' CYS . . . . . . . . . . . . . 44.7 t -142.98 142.17 31.56 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.89 1.276 . . . . 0.0 110.757 179.075 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 2477 ' ' GLN . . . . . . . . . . . . . 6.0 tp-100 -155.9 146.82 22.21 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.309 1.044 . . . . 0.0 111.017 -175.704 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 2478 ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -78.53 128.63 33.82 Favored 'General case' 0 CA--C 1.541 0.628 0 O-C-N 121.62 -0.675 . . . . 0.0 111.455 174.637 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 2479 ' ' CYS . . . . . . . . . . . . . 95.3 m -124.5 167.09 16.68 Favored Pre-proline 0 CA--C 1.552 1.046 0 C-N-CA 126.152 1.781 . . . . 0.0 110.644 177.148 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 2480 ' ' PRO . . . . . . . . . . . . . 64.3 Cg_exo -57.46 -29.92 86.33 Favored 'Trans proline' 0 C--N 1.353 0.793 0 C-N-CA 123.53 2.82 . . . . 0.0 114.374 175.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 2481 ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -80.53 -6.93 58.94 Favored 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 125.356 1.462 . . . . 0.0 113.099 177.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 2482 ' ' GLY . . . . . . . . . . . . . . . 119.39 -169.39 13.68 Favored Glycine 0 CA--C 1.532 1.095 0 C-N-CA 126.326 1.917 . . . . 0.0 112.408 -172.016 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 2483 ' ' TYR . . . . . . . . . . . . . 63.0 m-85 -69.4 118.69 12.6 Favored 'General case' 0 N--CA 1.47 0.565 0 O-C-N 121.206 -1.173 . . . . 0.0 111.69 177.279 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 2484 ' ' ARG . . . . . . . . . . . . . 58.8 ttt180 -96.19 132.07 42.0 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 125.414 1.486 . . . . 0.0 110.273 178.536 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 2485 ' ' VAL . . . . . . . . . . . . . 67.0 t -123.11 131.98 72.24 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 C-N-CA 125.825 1.65 . . . . 0.0 109.065 -177.372 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 2486 ' ' THR . . . . . . . . . . . . . 50.3 m -124.54 132.96 53.44 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 124.845 1.258 . . . . 0.0 108.126 172.217 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 2487 ' ' TYR . . . . . . . . . . . . . 22.0 p90 -140.45 157.85 44.89 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.194 0.998 . . . . 0.0 112.392 179.162 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 2488 ' ' THR . . . . . . . . . . . . . 91.8 m -113.87 105.2 54.75 Favored Pre-proline 0 N--CA 1.476 0.852 0 CA-C-O 118.107 -0.949 . . . . 0.0 109.818 179.121 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 2489 ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -69.44 128.87 16.96 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 123.022 2.481 . . . . 0.0 109.437 170.344 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 2490 ' ' MET . . . . . . . . . . . . . 27.9 ptm -114.35 -1.47 13.52 Favored 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 114.777 1.399 . . . . 0.0 114.777 -171.33 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 2491 ' ' ALA . . . . . . . . . . . . . . . -147.4 144.82 20.05 Favored Pre-proline 0 CA--C 1.546 0.806 0 C-N-CA 124.902 1.281 . . . . 0.0 110.982 -179.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 2492 ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -72.6 151.43 52.56 Favored 'Trans proline' 0 C--N 1.351 0.688 0 C-N-CA 123.414 2.743 . . . . 0.0 111.392 -176.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 2493 ' ' GLY . . . . . . . . . . . . . . . 133.0 -142.49 14.01 Favored Glycine 0 CA--C 1.529 0.909 0 C-N-CA 124.875 1.226 . . . . 0.0 112.507 -175.386 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 2494 ' ' SER . . . . . . . . . . . . . 39.6 m -123.96 128.5 49.5 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.349 1.059 . . . . 0.0 111.292 -179.576 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 2495 ' ' TYR . . . . . . . . . . . . . 41.7 m-85 -101.04 119.16 38.33 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.775 1.23 . . . . 0.0 110.578 171.602 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 2496 ' ' LEU . . . . . . . . . . . . . 25.3 tp -91.97 110.2 21.55 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.543 1.137 . . . . 0.0 109.512 179.084 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 2497 ' ' ILE . . . . . . . . . . . . . 21.9 mt -97.75 98.99 7.99 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 C-N-CA 125.863 1.665 . . . . 0.0 108.768 -176.299 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 2498 ' ' SER . . . . . . . . . . . . . 69.4 m -86.56 81.92 8.1 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 125.482 1.513 . . . . 0.0 110.133 177.831 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 2499 ' ' ILE . . . . . . . . . . . . . 51.9 mt -76.62 117.71 21.85 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 C-N-CA 124.99 1.316 . . . . 0.0 109.407 177.41 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 2500 ' ' LYS . . . . . . . . . . . . . 2.2 mtmp? -129.01 143.19 50.79 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 125.122 1.369 . . . . 0.0 110.712 -178.627 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 2501 ' ' TYR . . . . . . . . . . . . . 49.5 t80 -152.37 144.46 23.83 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 124.496 1.118 . . . . 0.0 112.321 -171.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 2502 ' ' GLY . . . . . . . . . . . . . . . 67.65 16.24 67.52 Favored Glycine 0 CA--C 1.536 1.384 0 C-N-CA 124.177 0.894 . . . . 0.0 113.728 178.061 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 2503 ' ' GLY . . . . . . . . . . . . . . . 147.04 -174.76 26.73 Favored Glycine 0 CA--C 1.54 1.624 0 C-N-CA 126.216 1.865 . . . . 0.0 112.436 -167.508 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 2504 ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -84.7 12.56 3.02 Favored 'Trans proline' 0 CA--C 1.544 1.006 0 C-N-CA 124.551 3.501 . . . . 0.0 113.904 -173.159 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 2505 ' ' TYR . . . . . . . . . . . . . 58.9 m-85 -110.47 147.58 33.8 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 124.474 1.11 . . . . 0.0 113.849 -171.486 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 2506 ' ' HIS . . . . . . . . . . . . . 92.8 m-70 -63.47 141.14 58.88 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 125.095 1.358 . . . . 0.0 113.497 -175.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 2507 ' ' ILE . . . . . . . . . . . . . 1.7 pp -79.45 175.53 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 N-CA-C 113.281 0.845 . . . . 0.0 113.281 176.449 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 2508 ' ' GLY . . . . . . . . . . . . . . . -60.75 111.14 3.48 Favored Glycine 0 CA--C 1.532 1.155 0 O-C-N 121.237 -0.915 . . . . 0.0 112.652 -178.575 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 2509 ' ' GLY . . . . . . . . . . . . . . . 95.38 -8.72 69.38 Favored Glycine 0 CA--C 1.536 1.353 0 C-N-CA 125.984 1.754 . . . . 0.0 114.7 -176.349 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 2510 ' ' SER . . . . . . . . . . . . . 47.9 t -83.2 147.52 53.87 Favored Pre-proline 0 CA--C 1.549 0.936 0 CA-C-N 118.802 1.301 . . . . 0.0 111.997 179.538 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 2511 ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -78.18 154.76 93.65 Favored 'Cis proline' 0 C--N 1.353 0.781 0 CA-C-N 119.809 0.967 . . . . 0.0 112.98 -1.383 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 2512 ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -104.86 131.67 52.06 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 125.141 1.376 . . . . 0.0 110.728 178.32 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 2513 ' ' LYS . . . . . . . . . . . . . 19.5 ptpt -89.13 8.04 32.02 Favored 'General case' 0 N--CA 1.479 0.983 0 N-CA-C 116.617 2.08 . . . . 0.0 116.617 -166.707 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 2514 ' ' ALA . . . . . . . . . . . . . . . -2.52 96.99 0.01 OUTLIER 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 129.436 3.095 . . . . 0.0 116.316 -177.722 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 2515 ' ' LYS . . . . . . . . . . . . . 44.9 mtpt -90.03 133.18 34.98 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.157 0.983 . . . . 0.0 111.354 -173.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 2516 ' ' VAL . . . . . . . . . . . . . 31.7 m -133.0 149.22 31.53 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 C-N-CA 124.326 1.05 . . . . 0.0 112.426 -168.764 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 2517 ' ' THR . . . . . . . . . . . . . 35.8 p -140.3 164.18 30.79 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 125.611 1.565 . . . . 0.0 111.365 -174.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 2518 ' ' GLY . . . . . . . . . . . . . . . 116.42 -162.19 12.74 Favored Glycine 0 CA--C 1.539 1.538 0 C-N-CA 125.046 1.308 . . . . 0.0 112.441 -174.308 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 2519 ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -72.56 167.23 27.64 Favored 'Trans proline' 0 CA--C 1.536 0.576 0 C-N-CA 123.562 2.842 . . . . 0.0 112.09 -177.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 2520 ' ' ARG . . . . . . . . . . . . . 49.1 ttp180 . . . . . 0 CA--C 1.537 0.457 0 C-N-CA 124.148 0.979 . . . . 0.0 109.189 167.476 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A 2427 ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.961 0 CA-C-O 121.455 0.475 . . . . 0.0 113.832 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A 2428 ' ' ASP . . . . . . . . . . . . . 12.5 t70 -82.89 136.06 44.77 Favored Pre-proline 0 CA--C 1.548 0.896 0 C-N-CA 125.285 1.434 . . . . 0.0 111.211 177.4 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 2429 ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -63.06 -22.08 73.28 Favored 'Trans proline' 0 C--N 1.353 0.771 0 C-N-CA 123.642 2.895 . . . . 0.0 114.244 -174.661 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 2430 ' ' GLY . . . . . . . . . . . . . . . -80.79 -20.2 66.23 Favored Glycine 0 CA--C 1.534 1.232 0 C-N-CA 124.054 0.835 . . . . 0.0 113.691 174.738 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 2431 ' ' LEU . . . . . . . . . . . . . 4.3 mm? -84.49 -28.42 26.77 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.462 1.105 . . . . 0.0 111.999 173.433 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 2432 ' ' VAL . . . . . . . . . . . . . 2.3 t -67.74 143.12 15.65 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 CA-C-N 118.7 0.682 . . . . 0.0 109.491 169.561 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 2433 ' ' SER . . . . . . . . . . . . . 8.1 t -135.86 -172.77 3.19 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.311 1.044 . . . . 0.0 110.569 171.436 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 2434 ' ' ALA . . . . . . . . . . . . . . . -148.93 142.33 25.23 Favored 'General case' 0 CA--C 1.537 0.455 0 O-C-N 120.921 -1.112 . . . . 0.0 111.638 177.232 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 2435 ' ' TYR . . . . . . . . . . . . . 74.7 m-85 -143.67 146.81 33.5 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.229 1.411 . . . . 0.0 112.027 -174.326 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 2436 ' ' GLY . . . . . . . . . . . . . . . 128.35 159.98 10.2 Favored Glycine 0 N--CA 1.473 1.108 0 C-N-CA 125.767 1.651 . . . . 0.0 113.571 179.34 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 2437 ' ' ALA . . . . . . . . . . . . . . . -61.17 -29.6 69.9 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.938 1.295 . . . . 0.0 114.193 -171.27 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 2438 ' ' GLY . . . . . . . . . . . . . . . -65.89 -16.15 63.5 Favored Glycine 0 CA--C 1.53 1.005 0 C-N-CA 124.361 0.981 . . . . 0.0 114.375 -178.082 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 2439 ' ' LEU . . . . . . . . . . . . . 79.0 mt -80.03 -26.87 39.58 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 118.77 1.285 . . . . 0.0 112.594 172.556 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 2440 ' ' GLU . . . . . . . . . . . . . 35.0 mm-40 -87.36 -38.04 16.55 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.72 1.208 . . . . 0.0 111.582 -178.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 2441 ' ' GLY . . . . . . . . . . . . . . . 162.29 -150.43 19.65 Favored Glycine 0 CA--C 1.527 0.8 0 C-N-CA 124.046 0.831 . . . . 0.0 114.173 -175.61 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 2442 ' ' GLY . . . . . . . . . . . . . . . 167.58 -170.29 41.62 Favored Glycine 0 CA--C 1.53 0.999 0 C-N-CA 124.951 1.262 . . . . 0.0 113.616 -179.735 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 2443 ' ' VAL . . . . . . . . . . . . . 97.9 t -120.93 137.02 56.01 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 C-N-CA 125.435 1.494 . . . . 0.0 109.115 176.611 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 2444 ' ' THR . . . . . . . . . . . . . 27.9 p -56.23 128.22 34.6 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.598 1.159 . . . . 0.0 111.837 177.68 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 2445 ' ' GLY . . . . . . . . . . . . . . . 86.26 -10.89 64.73 Favored Glycine 0 CA--C 1.533 1.165 0 C-N-CA 125.28 1.419 . . . . 0.0 114.891 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 2446 ' ' ASN . . . . . . . . . . . . . 86.6 m-20 -104.72 141.72 23.14 Favored Pre-proline 0 CA--C 1.546 0.796 0 C-N-CA 124.693 1.197 . . . . 0.0 110.684 175.338 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 2447 ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -71.63 142.15 39.44 Favored 'Trans proline' 0 N--CA 1.457 -0.641 0 C-N-CA 122.64 2.226 . . . . 0.0 111.118 177.046 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 2448 ' ' ALA . . . . . . . . . . . . . . . -125.51 156.25 39.28 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 126.082 1.753 . . . . 0.0 109.341 167.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 2449 ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -152.52 160.17 43.25 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 114.019 1.118 . . . . 0.0 114.019 -166.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 2450 ' ' PHE . . . . . . . . . . . . . 52.0 p90 -161.75 159.02 26.68 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 126.193 1.797 . . . . 0.0 111.24 -177.425 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 2451 ' ' VAL . . . . . . . . . . . . . 48.2 t -115.98 130.22 71.06 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 C-N-CA 124.847 1.259 . . . . 0.0 109.219 173.151 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 2452 ' ' VAL . . . . . . . . . . . . . 21.4 t -78.95 102.76 5.27 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 N-CA-C 106.795 -1.558 . . . . 0.0 106.795 164.884 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 2453 ' ' ASN . . . . . . . . . . . . . 10.7 t-20 -81.69 114.3 20.27 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.051 0.94 . . . . 0.0 111.856 -169.48 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 2454 ' ' THR . . . . . . . . . . . . . 58.3 p -99.92 -7.25 25.45 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 125.65 1.58 . . . . 0.0 113.856 -176.318 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 2455 ' ' SER . . . . . . . . . . . . . 16.7 m -55.41 -32.92 63.08 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 114.534 1.309 . . . . 0.0 114.534 -174.274 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 2456 ' ' ASN . . . . . . . . . . . . . 92.1 m-20 -85.26 -14.08 47.8 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 124.324 1.049 . . . . 0.0 113.465 177.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 2457 ' ' ALA . . . . . . . . . . . . . . . -105.61 -48.88 3.55 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 125.097 1.359 . . . . 0.0 113.158 -171.491 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 2458 ' ' GLY . . . . . . . . . . . . . . . 117.92 -138.4 13.92 Favored Glycine 0 CA--C 1.532 1.102 0 C-N-CA 125.066 1.317 . . . . 0.0 112.526 -173.464 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 2459 ' ' ALA . . . . . . . . . . . . . . . -97.3 175.86 6.11 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 125.553 1.541 . . . . 0.0 112.575 -179.746 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 2460 ' ' GLY . . . . . . . . . . . . . . . 134.07 162.76 10.08 Favored Glycine 0 CA--C 1.53 0.978 0 C-N-CA 125.21 1.386 . . . . 0.0 113.677 -179.379 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 2461 ' ' ALA . . . . . . . . . . . . . . . -80.49 146.78 31.19 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.273 1.029 . . . . 0.0 112.566 -178.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 2462 ' ' LEU . . . . . . . . . . . . . 14.6 tp -104.14 145.88 29.56 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.765 1.626 . . . . 0.0 110.391 172.363 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 2463 ' ' SER . . . . . . . . . . . . . 22.6 t -124.87 147.6 48.71 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 123.949 0.9 . . . . 0.0 109.335 153.052 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 2464 ' ' VAL . . . . . . . . . . . . . 12.1 p -160.16 139.6 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 O-C-N 121.256 -0.902 . . . . 0.0 111.039 -172.816 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 2465 ' ' THR . . . . . . . . . . . . . 9.5 t -161.5 161.77 30.13 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 125.112 1.365 . . . . 0.0 111.256 -177.727 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 2466 ' ' ILE . . . . . . . . . . . . . 39.7 mt -134.67 121.91 36.94 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 C-N-CA 125.089 1.356 . . . . 0.0 109.934 -173.864 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 2467 ' ' ASP . . . . . . . . . . . . . 36.7 t70 -98.18 156.74 16.54 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.691 1.596 . . . . 0.0 110.234 167.716 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 2468 ' ' GLY . . . . . . . . . . . . . . . 171.93 -165.83 38.65 Favored Glycine 0 CA--C 1.535 1.309 0 O-C-N 120.951 -1.093 . . . . 0.0 115.175 -179.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 2469 ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -69.81 -12.67 33.27 Favored 'Trans proline' 0 CA--C 1.541 0.871 0 C-N-CA 124.116 3.211 . . . . 0.0 113.841 -179.808 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 2470 ' ' SER . . . . . . . . . . . . . 33.3 m -156.16 170.89 21.16 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 126.887 2.075 . . . . 0.0 110.174 173.406 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 2471 ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -67.73 162.0 24.77 Favored 'General case' 0 CA--C 1.548 0.889 0 O-C-N 121.116 -0.99 . . . . 0.0 111.752 167.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 2472 ' ' VAL . . . . . . . . . . . . . 35.8 m -137.79 145.06 29.61 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 C-N-CA 124.785 1.234 . . . . 0.0 111.639 -179.207 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 2473 ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -87.52 90.72 8.48 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.411 1.084 . . . . 0.0 110.867 -179.795 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 2474 ' ' MET . . . . . . . . . . . . . 96.7 mtp -80.93 133.82 35.61 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 124.279 1.032 . . . . 0.0 111.591 178.75 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 2475 ' ' ASP . . . . . . . . . . . . . 21.1 t70 -116.3 118.65 33.35 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 125.865 1.666 . . . . 0.0 109.044 162.892 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 2476 ' ' CYS . . . . . . . . . . . . . 72.4 m -102.81 137.85 40.48 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.397 1.079 . . . . 0.0 110.106 175.053 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 2477 ' ' GLN . . . . . . . . . . . . . 5.4 pt20 -154.12 155.35 35.22 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.499 1.119 . . . . 0.0 110.731 -175.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 2478 ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -97.68 138.07 35.63 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.84 0.856 . . . . 0.0 110.844 -179.425 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 2479 ' ' CYS . . . . . . . . . . . . . 17.0 p -137.02 171.59 8.34 Favored Pre-proline 0 CA--C 1.554 1.107 0 C-N-CA 125.602 1.561 . . . . 0.0 111.479 175.529 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 2480 ' ' PRO . . . . . . . . . . . . . 73.4 Cg_exo -58.6 -27.1 81.6 Favored 'Trans proline' 0 CA--C 1.54 0.791 0 C-N-CA 123.42 2.746 . . . . 0.0 114.572 178.588 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 2481 ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -84.7 -14.29 48.86 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 124.748 1.219 . . . . 0.0 113.135 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 2482 ' ' GLY . . . . . . . . . . . . . . . 139.82 -143.8 14.25 Favored Glycine 0 N--CA 1.471 0.987 0 C-N-CA 125.228 1.394 . . . . 0.0 113.425 178.511 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 2483 ' ' TYR . . . . . . . . . . . . . 66.5 m-85 -91.08 115.83 28.32 Favored 'General case' 0 N--CA 1.467 0.425 0 O-C-N 121.934 -0.745 . . . . 0.0 111.185 175.33 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 2484 ' ' ARG . . . . . . . . . . . . . 43.4 ttt180 -92.01 139.63 30.45 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 125.563 1.545 . . . . 0.0 110.87 178.111 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 2485 ' ' VAL . . . . . . . . . . . . . 65.4 t -126.83 129.59 71.42 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 125.542 1.537 . . . . 0.0 108.855 175.272 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 2486 ' ' THR . . . . . . . . . . . . . 93.8 m -117.6 139.2 51.3 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 125.37 1.468 . . . . 0.0 108.004 169.315 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 2487 ' ' TYR . . . . . . . . . . . . . 19.4 p90 -149.0 150.3 32.6 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 123.692 0.797 . . . . 0.0 112.851 176.656 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 2488 ' ' THR . . . . . . . . . . . . . 99.6 m -110.99 113.71 54.63 Favored Pre-proline 0 N--CA 1.474 0.738 0 C-N-CA 124.37 1.068 . . . . 0.0 109.609 176.712 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 2489 ' ' PRO . . . . . . . . . . . . . 79.3 Cg_endo -77.25 164.31 29.27 Favored 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 123.748 2.965 . . . . 0.0 110.947 169.269 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 2490 ' ' MET . . . . . . . . . . . . . 28.1 ptm -143.85 -3.17 0.89 Allowed 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 115.561 1.689 . . . . 0.0 115.561 -172.3 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 2491 ' ' ALA . . . . . . . . . . . . . . . -140.01 148.02 53.16 Favored Pre-proline 0 CA--C 1.546 0.821 0 C-N-CA 125.167 1.387 . . . . 0.0 110.737 174.139 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 2492 ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -71.34 146.83 51.63 Favored 'Trans proline' 0 CA--C 1.537 0.666 0 C-N-CA 122.856 2.37 . . . . 0.0 110.933 177.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 2493 ' ' GLY . . . . . . . . . . . . . . . 136.39 -167.62 24.4 Favored Glycine 0 CA--C 1.531 1.075 0 C-N-CA 125.214 1.388 . . . . 0.0 113.603 -176.602 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 2494 ' ' SER . . . . . . . . . . . . . 49.4 m -95.22 123.18 38.59 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 124.417 1.087 . . . . 0.0 111.299 179.863 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 2495 ' ' TYR . . . . . . . . . . . . . 73.1 m-85 -97.97 116.95 31.22 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.346 1.058 . . . . 0.0 110.129 170.003 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 2496 ' ' LEU . . . . . . . . . . . . . 23.2 tp -93.16 105.64 17.71 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.943 1.297 . . . . 0.0 109.904 -176.586 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 2497 ' ' ILE . . . . . . . . . . . . . 44.4 mt -93.32 112.37 26.32 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 C-N-CA 126.443 1.897 . . . . 0.0 108.636 -176.545 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 2498 ' ' SER . . . . . . . . . . . . . 75.4 m -96.61 123.87 40.42 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 123.512 0.725 . . . . 0.0 110.002 174.521 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 2499 ' ' ILE . . . . . . . . . . . . . 23.9 mt -124.95 116.23 46.58 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 C-N-CA 125.269 1.427 . . . . 0.0 109.297 -175.785 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 2500 ' ' LYS . . . . . . . . . . . . . 96.0 mttt -127.28 140.77 51.99 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.783 1.233 . . . . 0.0 111.817 -172.821 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 2501 ' ' TYR . . . . . . . . . . . . . 44.4 t80 -146.85 144.47 29.33 Favored 'General case' 0 N--CA 1.474 0.769 0 O-C-N 121.303 -0.873 . . . . 0.0 113.329 -172.331 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 2502 ' ' GLY . . . . . . . . . . . . . . . 69.57 19.46 74.73 Favored Glycine 0 CA--C 1.536 1.345 0 C-N-CA 124.101 0.858 . . . . 0.0 113.207 -179.152 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 2503 ' ' GLY . . . . . . . . . . . . . . . 132.17 -176.04 19.52 Favored Glycine 0 CA--C 1.54 1.637 0 C-N-CA 126.325 1.917 . . . . 0.0 112.293 -166.304 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 2504 ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -82.21 43.97 1.61 Allowed 'Trans proline' 0 CA--C 1.545 1.047 0 C-N-CA 124.959 3.773 . . . . 0.0 112.662 -173.722 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 2505 ' ' TYR . . . . . . . . . . . . . 76.0 m-85 -125.43 131.19 52.95 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.817 1.247 . . . . 0.0 112.475 -174.134 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 2506 ' ' HIS . . . . . . . . . . . . . 88.0 m-70 -59.33 138.07 57.76 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 124.921 1.288 . . . . 0.0 113.536 -177.26 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 2507 ' ' ILE . . . . . . . . . . . . . 2.3 pp -88.97 147.6 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 C-N-CA 123.854 0.862 . . . . 0.0 112.535 175.154 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 2508 ' ' GLY . . . . . . . . . . . . . . . 48.26 -115.32 2.35 Favored Glycine 0 CA--C 1.535 1.323 0 C-N-CA 124.239 0.923 . . . . 0.0 114.031 167.093 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 2509 ' ' GLY . . . . . . . . . . . . . . . -97.05 11.11 65.91 Favored Glycine 0 CA--C 1.537 1.417 0 C-N-CA 126.061 1.791 . . . . 0.0 115.212 177.693 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 2510 ' ' SER . . . . . . . . . . . . . 46.5 t -63.17 144.82 97.28 Favored Pre-proline 0 CA--C 1.55 0.974 0 CA-C-N 119.342 1.571 . . . . 0.0 112.458 178.917 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 2511 ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -79.64 152.34 86.25 Favored 'Cis proline' 0 C--N 1.353 0.779 0 CA-C-N 119.343 0.801 . . . . 0.0 113.349 -0.364 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 2512 ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -103.81 130.46 51.36 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 125.62 1.568 . . . . 0.0 110.782 -179.363 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 2513 ' ' LYS . . . . . . . . . . . . . 7.4 ptpp? -90.57 9.77 28.17 Favored 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 116.833 2.16 . . . . 0.0 116.833 -165.112 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 2514 ' ' ALA . . . . . . . . . . . . . . . -4.0 101.3 0.01 OUTLIER 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 129.404 3.082 . . . . 0.0 116.532 -176.847 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 2515 ' ' LYS . . . . . . . . . . . . . 35.2 mtmm -88.23 119.41 28.6 Favored 'General case' 0 CA--C 1.544 0.715 0 O-C-N 121.293 -0.88 . . . . 0.0 111.778 -173.419 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 2516 ' ' VAL . . . . . . . . . . . . . 54.1 t -111.27 144.08 19.87 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 125.83 1.652 . . . . 0.0 110.605 -173.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 2517 ' ' THR . . . . . . . . . . . . . 53.0 p -131.52 173.44 11.11 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 125.693 1.597 . . . . 0.0 110.949 174.299 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 2518 ' ' GLY . . . . . . . . . . . . . . . 112.88 179.43 19.47 Favored Glycine 0 CA--C 1.54 1.607 0 C-N-CA 125.1 1.333 . . . . 0.0 113.651 -177.863 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 2519 ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -69.68 129.31 17.46 Favored 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 123.896 3.064 . . . . 0.0 111.819 -172.67 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 2520 ' ' ARG . . . . . . . . . . . . . 35.2 ttt-85 . . . . . 0 CA--C 1.538 0.485 0 C-N-CA 123.716 0.806 . . . . 0.0 110.449 177.541 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A 2427 ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.14 0 CA-C-O 121.506 0.503 . . . . 0.0 113.69 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A 2428 ' ' ASP . . . . . . . . . . . . . 22.7 m-20 -94.33 129.69 36.22 Favored Pre-proline 0 CA--C 1.549 0.914 0 C-N-CA 124.496 1.119 . . . . 0.0 112.43 -178.414 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 2429 ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -56.46 -30.3 81.47 Favored 'Trans proline' 0 C--N 1.353 0.775 0 C-N-CA 123.659 2.906 . . . . 0.0 113.916 174.458 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 2430 ' ' GLY . . . . . . . . . . . . . . . -75.41 -21.23 77.88 Favored Glycine 0 CA--C 1.534 1.258 0 CA-C-O 119.379 -0.678 . . . . 0.0 113.92 177.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 2431 ' ' LEU . . . . . . . . . . . . . 4.3 mm? -88.86 -32.01 18.0 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.463 1.105 . . . . 0.0 111.698 173.143 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 2432 ' ' VAL . . . . . . . . . . . . . 95.4 t -68.15 136.22 26.92 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 C-N-CA 123.39 0.676 . . . . 0.0 110.439 170.549 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 2433 ' ' SER . . . . . . . . . . . . . 57.0 m -140.73 144.79 35.76 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 125.27 1.428 . . . . 0.0 109.998 175.544 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 2434 ' ' ALA . . . . . . . . . . . . . . . -100.61 148.19 25.11 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 123.351 0.66 . . . . 0.0 112.134 177.096 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 2435 ' ' TYR . . . . . . . . . . . . . 82.2 m-85 -143.93 146.26 32.84 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 125.852 1.661 . . . . 0.0 111.591 -176.282 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 2436 ' ' GLY . . . . . . . . . . . . . . . 124.89 163.52 11.67 Favored Glycine 0 N--CA 1.475 1.284 0 C-N-CA 125.09 1.328 . . . . 0.0 114.577 175.175 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 2437 ' ' ALA . . . . . . . . . . . . . . . -62.31 -30.62 71.28 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.184 1.394 . . . . 0.0 114.433 -170.064 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 2438 ' ' GLY . . . . . . . . . . . . . . . -66.05 -13.37 59.6 Favored Glycine 0 CA--C 1.532 1.152 0 C-N-CA 124.306 0.955 . . . . 0.0 114.282 -179.501 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 2439 ' ' LEU . . . . . . . . . . . . . 81.6 mt -79.84 -23.91 41.68 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 118.637 1.219 . . . . 0.0 112.801 171.049 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 2440 ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -92.78 -34.96 13.68 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 124.792 1.237 . . . . 0.0 111.985 -175.882 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 2441 ' ' GLY . . . . . . . . . . . . . . . 159.68 -153.22 24.23 Favored Glycine 0 C--N 1.339 0.748 0 C-N-CA 123.806 0.717 . . . . 0.0 114.31 -176.71 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 2442 ' ' GLY . . . . . . . . . . . . . . . 169.85 -168.76 41.63 Favored Glycine 0 CA--C 1.528 0.883 0 C-N-CA 124.802 1.191 . . . . 0.0 113.387 -178.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 2443 ' ' VAL . . . . . . . . . . . . . 38.9 t -128.31 139.11 52.79 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 C-N-CA 124.915 1.286 . . . . 0.0 108.867 174.657 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 2444 ' ' THR . . . . . . . . . . . . . 40.1 p -58.28 141.44 50.92 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.864 0.866 . . . . 0.0 112.706 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 2445 ' ' GLY . . . . . . . . . . . . . . . 78.2 -9.74 31.67 Favored Glycine 0 CA--C 1.535 1.316 0 C-N-CA 124.811 1.196 . . . . 0.0 114.859 -178.505 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 2446 ' ' ASN . . . . . . . . . . . . . 86.1 m-20 -111.59 144.87 31.46 Favored Pre-proline 0 CA--C 1.547 0.862 0 C-N-CA 125.318 1.447 . . . . 0.0 111.289 176.503 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 2447 ' ' PRO . . . . . . . . . . . . . 82.2 Cg_endo -74.71 149.46 38.21 Favored 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 122.893 2.395 . . . . 0.0 111.882 178.681 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 2448 ' ' ALA . . . . . . . . . . . . . . . -136.83 148.59 47.22 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 126.069 1.748 . . . . 0.0 109.654 168.354 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 2449 ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -141.1 157.42 45.32 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 114.164 1.172 . . . . 0.0 114.164 -166.443 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 2450 ' ' PHE . . . . . . . . . . . . . 50.7 p90 -156.59 162.64 39.88 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 126.421 1.888 . . . . 0.0 110.911 178.76 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 2451 ' ' VAL . . . . . . . . . . . . . 8.2 p -122.91 133.9 67.66 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 C-N-CA 124.698 1.199 . . . . 0.0 110.305 175.747 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 2452 ' ' VAL . . . . . . . . . . . . . 45.4 t -90.09 102.45 13.26 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 N-CA-C 106.943 -1.503 . . . . 0.0 106.943 169.64 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 2453 ' ' ASN . . . . . . . . . . . . . 19.6 t-20 -86.35 117.96 25.49 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 112.411 0.523 . . . . 0.0 112.411 -169.528 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 2454 ' ' THR . . . . . . . . . . . . . 53.0 p -97.83 -5.54 34.49 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 125.292 1.437 . . . . 0.0 113.851 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 2455 ' ' SER . . . . . . . . . . . . . 20.5 m -56.51 -28.29 59.49 Favored 'General case' 0 N--CA 1.479 1.006 0 CA-C-N 120.148 1.34 . . . . 0.0 114.54 -175.358 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 2456 ' ' ASN . . . . . . . . . . . . . 64.7 m-80 -83.33 -14.82 52.09 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 124.653 1.181 . . . . 0.0 113.593 176.532 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 2457 ' ' ALA . . . . . . . . . . . . . . . -115.58 -19.69 10.48 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 125.964 1.706 . . . . 0.0 114.271 -173.867 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 2458 ' ' GLY . . . . . . . . . . . . . . . 103.85 -103.13 2.26 Favored Glycine 0 CA--C 1.529 0.929 0 C-N-CA 125.585 1.564 . . . . 0.0 110.923 -172.699 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 2459 ' ' ALA . . . . . . . . . . . . . . . -158.61 163.39 37.01 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 125.898 1.679 . . . . 0.0 111.337 179.755 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 2460 ' ' GLY . . . . . . . . . . . . . . . 167.45 174.97 37.0 Favored Glycine 0 CA--C 1.528 0.9 0 N-CA-C 114.878 0.711 . . . . 0.0 114.878 -175.752 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 2461 ' ' ALA . . . . . . . . . . . . . . . -77.98 128.17 33.47 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.387 1.075 . . . . 0.0 112.434 -176.627 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 2462 ' ' LEU . . . . . . . . . . . . . 25.3 tp -106.64 144.28 33.53 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 125.58 1.552 . . . . 0.0 110.83 177.437 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 2463 ' ' SER . . . . . . . . . . . . . 3.8 t -136.2 40.89 2.65 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 125.843 1.657 . . . . 0.0 110.923 -176.248 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 2464 ' ' VAL . . . . . . . . . . . . . 7.5 p -64.27 133.41 29.86 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 C-N-CA 125.013 1.325 . . . . 0.0 112.107 -176.01 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 2465 ' ' THR . . . . . . . . . . . . . 97.8 m -134.18 142.84 47.57 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 126.027 1.731 . . . . 0.0 109.994 -177.196 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 2466 ' ' ILE . . . . . . . . . . . . . 50.6 mt -118.54 121.67 67.6 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 C-N-CA 124.201 1.0 . . . . 0.0 109.949 175.354 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 2467 ' ' ASP . . . . . . . . . . . . . 36.4 t70 -105.51 159.75 15.7 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 126.269 1.828 . . . . 0.0 110.592 169.314 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 2468 ' ' GLY . . . . . . . . . . . . . . . 172.97 -168.17 41.14 Favored Glycine 0 CA--C 1.535 1.313 0 O-C-N 121.305 -0.872 . . . . 0.0 114.472 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 2469 ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -66.13 -27.17 49.43 Favored 'Trans proline' 0 CA--C 1.54 0.78 0 C-N-CA 123.865 3.043 . . . . 0.0 112.833 177.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 2470 ' ' SER . . . . . . . . . . . . . 70.4 m -143.64 166.1 25.8 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 126.042 1.737 . . . . 0.0 110.184 172.196 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 2471 ' ' LYS . . . . . . . . . . . . . 68.2 mttm -71.65 131.98 43.95 Favored 'General case' 0 CA--C 1.545 0.753 0 O-C-N 120.706 -1.246 . . . . 0.0 110.989 171.9 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 2472 ' ' VAL . . . . . . . . . . . . . 20.5 m -87.47 155.52 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 C-N-CA 123.92 0.888 . . . . 0.0 111.52 177.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 2473 ' ' LYS . . . . . . . . . . . . . 97.5 mttt -80.84 72.35 7.82 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 124.399 1.08 . . . . 0.0 110.843 175.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 2474 ' ' MET . . . . . . . . . . . . . 22.4 ttt -78.97 139.91 38.13 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 125.745 1.618 . . . . 0.0 112.74 -171.588 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 2475 ' ' ASP . . . . . . . . . . . . . 17.6 m-20 -138.99 132.4 30.16 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 126.155 1.782 . . . . 0.0 109.844 167.116 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 2476 ' ' CYS . . . . . . . . . . . . . 48.0 t -118.19 140.67 49.44 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.076 1.35 . . . . 0.0 110.728 176.524 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 2477 ' ' GLN . . . . . . . . . . . . . 42.2 mt-30 -136.4 142.82 43.73 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 125.497 1.519 . . . . 0.0 110.444 -177.071 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 2478 ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -86.37 139.23 31.15 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.08 0.952 . . . . 0.0 110.161 171.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 2479 ' ' CYS . . . . . . . . . . . . . 29.3 p -150.52 169.76 8.75 Favored Pre-proline 0 CA--C 1.552 1.043 0 C-N-CA 125.01 1.324 . . . . 0.0 112.325 -176.866 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 2480 ' ' PRO . . . . . . . . . . . . . 56.3 Cg_exo -58.59 -25.46 74.78 Favored 'Trans proline' 0 CA--C 1.539 0.754 0 C-N-CA 123.356 2.704 . . . . 0.0 114.08 174.436 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 2481 ' ' GLU . . . . . . . . . . . . . 21.6 tt0 -85.23 -2.32 57.91 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 125.242 1.417 . . . . 0.0 113.13 178.37 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 2482 ' ' GLY . . . . . . . . . . . . . . . 121.88 -118.89 3.85 Favored Glycine 0 N--CA 1.47 0.938 0 C-N-CA 125.826 1.679 . . . . 0.0 112.202 -179.394 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 2483 ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -123.88 116.76 23.46 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.083 0.953 . . . . 0.0 110.881 174.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 2484 ' ' ARG . . . . . . . . . . . . . 41.4 ttm-85 -94.25 132.53 38.73 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 124.6 1.16 . . . . 0.0 110.169 179.227 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 2485 ' ' VAL . . . . . . . . . . . . . 86.1 t -119.98 135.36 60.52 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 C-N-CA 125.676 1.59 . . . . 0.0 108.998 -179.603 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 2486 ' ' THR . . . . . . . . . . . . . 88.4 m -129.07 142.84 50.77 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 125.244 1.417 . . . . 0.0 108.449 172.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 2487 ' ' TYR . . . . . . . . . . . . . 37.2 p90 -149.36 148.27 29.29 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 113.085 0.772 . . . . 0.0 113.085 174.041 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 2488 ' ' THR . . . . . . . . . . . . . 59.2 m -108.47 118.51 51.93 Favored Pre-proline 0 N--CA 1.473 0.725 0 C-N-CA 124.628 1.171 . . . . 0.0 108.759 168.358 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 2489 ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -82.76 157.34 15.98 Favored 'Trans proline' 0 N--CA 1.457 -0.654 0 C-N-CA 123.719 2.946 . . . . 0.0 111.189 174.108 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 2490 ' ' MET . . . . . . . . . . . . . 28.8 ptm -124.32 5.44 8.42 Favored 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 114.308 1.225 . . . . 0.0 114.308 -174.842 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 2491 ' ' ALA . . . . . . . . . . . . . . . -151.56 148.89 22.91 Favored Pre-proline 0 CA--C 1.546 0.807 0 C-N-CA 125.826 1.651 . . . . 0.0 111.117 178.25 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 2492 ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -74.66 155.33 44.61 Favored 'Trans proline' 0 CA--C 1.536 0.599 0 C-N-CA 123.094 2.529 . . . . 0.0 111.229 173.561 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 2493 ' ' GLY . . . . . . . . . . . . . . . 131.5 -174.37 20.09 Favored Glycine 0 CA--C 1.529 0.935 0 C-N-CA 125.337 1.446 . . . . 0.0 113.662 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 2494 ' ' SER . . . . . . . . . . . . . 11.1 p -86.28 129.81 34.72 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.361 1.064 . . . . 0.0 111.85 174.338 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 2495 ' ' TYR . . . . . . . . . . . . . 60.0 m-85 -107.2 125.48 51.17 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 125.578 1.551 . . . . 0.0 109.279 172.305 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 2496 ' ' LEU . . . . . . . . . . . . . 19.1 tp -94.48 107.0 18.99 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 123.857 0.863 . . . . 0.0 109.546 -178.255 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 2497 ' ' ILE . . . . . . . . . . . . . 48.7 mt -92.66 101.73 12.89 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 C-N-CA 125.631 1.572 . . . . 0.0 107.624 -179.763 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 2498 ' ' SER . . . . . . . . . . . . . 75.8 m -90.36 99.33 12.37 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 124.606 1.162 . . . . 0.0 109.519 176.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 2499 ' ' ILE . . . . . . . . . . . . . 23.0 mt -93.47 89.79 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 C-N-CA 124.511 1.125 . . . . 0.0 108.451 -178.133 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 2500 ' ' LYS . . . . . . . . . . . . . 85.1 mttt -99.53 142.52 30.91 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 124.334 1.054 . . . . 0.0 111.722 -178.715 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 2501 ' ' TYR . . . . . . . . . . . . . 72.9 t80 -146.5 138.08 24.58 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 124.738 1.215 . . . . 0.0 111.4 -168.176 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 2502 ' ' GLY . . . . . . . . . . . . . . . 69.03 12.08 64.63 Favored Glycine 0 CA--C 1.534 1.241 0 C-N-CA 124.356 0.979 . . . . 0.0 114.971 -179.45 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 2503 ' ' GLY . . . . . . . . . . . . . . . 138.41 -153.24 22.36 Favored Glycine 0 CA--C 1.539 1.552 0 C-N-CA 125.507 1.527 . . . . 0.0 112.388 -169.421 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 2504 ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -81.75 6.86 5.38 Favored 'Trans proline' 0 CA--C 1.543 0.938 0 C-N-CA 124.354 3.369 . . . . 0.0 114.123 -172.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 2505 ' ' TYR . . . . . . . . . . . . . 64.5 m-85 -99.26 136.14 39.64 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.272 1.029 . . . . 0.0 113.18 -172.479 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 2506 ' ' HIS . . . . . . . . . . . . . 93.4 m-70 -64.75 148.2 51.62 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 125.036 1.334 . . . . 0.0 113.305 176.778 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 2507 ' ' ILE . . . . . . . . . . . . . 30.4 pt -73.59 173.27 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 C-N-CA 123.387 0.675 . . . . 0.0 112.523 167.599 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 2508 ' ' GLY . . . . . . . . . . . . . . . -58.97 122.19 29.34 Favored Glycine 0 CA--C 1.534 1.253 0 O-C-N 121.659 -0.651 . . . . 0.0 111.791 172.808 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 2509 ' ' GLY . . . . . . . . . . . . . . . 88.75 -9.99 74.07 Favored Glycine 0 CA--C 1.536 1.362 0 C-N-CA 125.654 1.597 . . . . 0.0 115.226 -178.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 2510 ' ' SER . . . . . . . . . . . . . 41.6 t -84.95 147.77 49.06 Favored Pre-proline 0 CA--C 1.549 0.914 0 CA-C-N 119.053 1.426 . . . . 0.0 112.023 179.325 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 2511 ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -79.34 158.7 90.17 Favored 'Cis proline' 0 C--N 1.353 0.801 0 CA-C-N 119.867 0.988 . . . . 0.0 113.456 0.245 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 2512 ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -107.66 137.97 44.72 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 125.471 1.508 . . . . 0.0 110.747 177.847 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 2513 ' ' LYS . . . . . . . . . . . . . 19.1 ptpt -99.5 15.42 26.56 Favored 'General case' 0 N--CA 1.48 1.068 0 N-CA-C 116.289 1.959 . . . . 0.0 116.289 -163.48 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 2514 ' ' ALA . . . . . . . . . . . . . . . -14.89 108.57 0.02 OUTLIER 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 129.388 3.075 . . . . 0.0 116.722 -173.409 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 2515 ' ' LYS . . . . . . . . . . . . . 67.5 mttm -92.24 107.85 19.51 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 124.66 1.184 . . . . 0.0 111.72 -175.26 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 2516 ' ' VAL . . . . . . . . . . . . . 71.3 t -95.74 142.07 14.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 C-N-CA 125.726 1.61 . . . . 0.0 110.493 -177.828 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 2517 ' ' THR . . . . . . . . . . . . . 77.8 p -121.42 179.31 4.47 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 125.28 1.432 . . . . 0.0 111.456 174.321 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 2518 ' ' GLY . . . . . . . . . . . . . . . 99.91 178.78 30.59 Favored Glycine 0 CA--C 1.54 1.635 0 C-N-CA 124.676 1.131 . . . . 0.0 113.635 -178.231 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 2519 ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -72.98 148.4 45.18 Favored 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 123.857 3.038 . . . . 0.0 112.218 -174.46 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 2520 ' ' ARG . . . . . . . . . . . . . 49.4 ttm-85 . . . . . 0 CA--C 1.539 0.538 0 C-N-CA 123.63 0.772 . . . . 0.0 110.281 173.189 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A 2427 ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.145 0 CA-C-O 121.533 0.518 . . . . 0.0 113.879 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A 2428 ' ' ASP . . . . . . . . . . . . . 24.5 m-20 -91.0 133.12 32.6 Favored Pre-proline 0 CA--C 1.549 0.905 0 C-N-CA 124.233 1.013 . . . . 0.0 112.857 -175.205 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 2429 ' ' PRO . . . . . . . . . . . . . 72.5 Cg_exo -55.2 -27.88 58.73 Favored 'Trans proline' 0 C--N 1.352 0.711 0 C-N-CA 124.097 3.198 . . . . 0.0 114.308 171.611 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 2430 ' ' GLY . . . . . . . . . . . . . . . -77.04 -23.13 69.7 Favored Glycine 0 CA--C 1.534 1.254 0 C-N-CA 123.851 0.739 . . . . 0.0 113.819 176.525 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 2431 ' ' LEU . . . . . . . . . . . . . 4.4 mm? -87.42 -31.63 19.96 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.393 1.077 . . . . 0.0 111.612 171.768 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 2432 ' ' VAL . . . . . . . . . . . . . 87.5 t -64.67 130.23 29.55 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 CA-C-N 118.68 0.673 . . . . 0.0 109.901 168.824 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 2433 ' ' SER . . . . . . . . . . . . . 68.0 m -125.59 172.35 9.81 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 125.436 1.494 . . . . 0.0 110.338 174.787 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 2434 ' ' ALA . . . . . . . . . . . . . . . -131.52 143.24 50.24 Favored 'General case' 0 CA--C 1.539 0.53 0 O-C-N 121.205 -0.934 . . . . 0.0 111.29 174.638 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 2435 ' ' TYR . . . . . . . . . . . . . 75.8 m-85 -144.37 147.39 33.37 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 125.234 1.413 . . . . 0.0 112.001 -175.421 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 2436 ' ' GLY . . . . . . . . . . . . . . . 122.33 163.22 11.81 Favored Glycine 0 N--CA 1.473 1.154 0 C-N-CA 125.087 1.327 . . . . 0.0 114.198 175.902 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 2437 ' ' ALA . . . . . . . . . . . . . . . -61.9 -28.64 69.66 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.123 1.369 . . . . 0.0 114.398 -170.445 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 2438 ' ' GLY . . . . . . . . . . . . . . . -64.35 -18.18 62.77 Favored Glycine 0 CA--C 1.533 1.164 0 CA-C-O 118.984 -0.898 . . . . 0.0 114.12 -179.581 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 2439 ' ' LEU . . . . . . . . . . . . . 80.0 mt -76.44 -24.29 53.93 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 118.663 1.232 . . . . 0.0 112.754 171.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 2440 ' ' GLU . . . . . . . . . . . . . 37.9 mm-40 -89.05 -27.71 20.64 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.983 1.313 . . . . 0.0 111.792 177.205 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 2441 ' ' GLY . . . . . . . . . . . . . . . 111.93 -138.56 15.05 Favored Glycine 0 CA--C 1.53 1.009 0 C-N-CA 125.943 1.735 . . . . 0.0 112.301 -178.452 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 2442 ' ' GLY . . . . . . . . . . . . . . . 154.32 -148.29 18.62 Favored Glycine 0 N--CA 1.474 1.18 0 C-N-CA 124.019 0.819 . . . . 0.0 113.971 -177.418 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 2443 ' ' VAL . . . . . . . . . . . . . 60.1 t -105.79 139.23 27.64 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 C-N-CA 125.334 1.454 . . . . 0.0 110.032 -178.322 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 2444 ' ' THR . . . . . . . . . . . . . 39.3 p -59.39 144.87 45.55 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.505 1.122 . . . . 0.0 112.675 175.556 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 2445 ' ' GLY . . . . . . . . . . . . . . . 80.0 -18.3 8.03 Favored Glycine 0 CA--C 1.535 1.339 0 C-N-CA 125.033 1.301 . . . . 0.0 114.47 -179.804 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 2446 ' ' ASN . . . . . . . . . . . . . 87.4 m-20 -99.64 144.55 28.54 Favored Pre-proline 0 CA--C 1.545 0.763 0 C-N-CA 125.081 1.353 . . . . 0.0 110.98 176.321 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 2447 ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -73.85 151.26 45.45 Favored 'Trans proline' 0 N--CA 1.457 -0.637 0 C-N-CA 122.816 2.344 . . . . 0.0 111.479 178.281 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 2448 ' ' ALA . . . . . . . . . . . . . . . -135.74 158.7 43.75 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 126.534 1.934 . . . . 0.0 109.492 169.437 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 2449 ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -149.37 155.65 40.82 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 113.913 1.079 . . . . 0.0 113.913 -171.457 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 2450 ' ' PHE . . . . . . . . . . . . . 47.9 p90 -155.03 153.61 31.23 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 126.042 1.737 . . . . 0.0 110.434 178.579 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 2451 ' ' VAL . . . . . . . . . . . . . 12.0 p -107.43 132.4 55.05 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 C-N-CA 124.603 1.161 . . . . 0.0 110.087 175.089 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 2452 ' ' VAL . . . . . . . . . . . . . 34.8 t -86.6 101.57 10.97 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 N-CA-C 106.594 -1.632 . . . . 0.0 106.594 165.684 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 2453 ' ' ASN . . . . . . . . . . . . . 13.2 t-20 -79.57 111.93 16.33 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.23 1.012 . . . . 0.0 111.821 -171.218 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 2454 ' ' THR . . . . . . . . . . . . . 27.9 p -101.16 -13.47 18.13 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 125.335 1.454 . . . . 0.0 113.865 -179.734 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 2455 ' ' SER . . . . . . . . . . . . . 98.1 p -64.39 -24.65 67.71 Favored 'General case' 0 N--CA 1.478 0.957 0 CA-C-N 120.234 1.379 . . . . 0.0 114.213 -174.577 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 2456 ' ' ASN . . . . . . . . . . . . . 49.8 m-80 -77.35 -18.31 57.52 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 124.283 1.033 . . . . 0.0 113.568 171.731 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 2457 ' ' ALA . . . . . . . . . . . . . . . -106.04 -31.3 8.8 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 125.4 1.48 . . . . 0.0 113.827 -176.131 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 2458 ' ' GLY . . . . . . . . . . . . . . . 113.99 -113.85 3.17 Favored Glycine 0 CA--C 1.53 1.008 0 C-N-CA 125.516 1.531 . . . . 0.0 111.491 -174.171 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 2459 ' ' ALA . . . . . . . . . . . . . . . -144.31 158.85 43.52 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 125.17 1.388 . . . . 0.0 111.943 -179.559 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 2460 ' ' GLY . . . . . . . . . . . . . . . 160.28 171.78 26.64 Favored Glycine 0 CA--C 1.531 1.092 0 C-N-CA 125.112 1.339 . . . . 0.0 113.161 -174.098 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 2461 ' ' ALA . . . . . . . . . . . . . . . -75.62 138.2 41.24 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 123.959 0.904 . . . . 0.0 112.241 -178.76 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 2462 ' ' LEU . . . . . . . . . . . . . 50.0 tp -119.84 143.09 48.08 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.462 1.505 . . . . 0.0 110.658 176.734 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 2463 ' ' SER . . . . . . . . . . . . . 12.5 t -128.37 162.71 26.47 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.114 1.365 . . . . 0.0 110.355 160.637 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 2464 ' ' VAL . . . . . . . . . . . . . 7.2 p -162.18 133.06 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 C-N-CA 124.852 1.261 . . . . 0.0 110.353 -178.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 2465 ' ' THR . . . . . . . . . . . . . 79.8 m -133.95 138.73 45.66 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 125.236 1.414 . . . . 0.0 109.184 -178.374 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 2466 ' ' ILE . . . . . . . . . . . . . 33.7 mt -119.08 114.94 46.31 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 C-N-CA 124.036 0.934 . . . . 0.0 109.388 177.065 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 2467 ' ' ASP . . . . . . . . . . . . . 33.4 t70 -99.11 165.47 11.71 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 126.01 1.724 . . . . 0.0 110.151 168.501 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 2468 ' ' GLY . . . . . . . . . . . . . . . 168.93 -161.9 35.62 Favored Glycine 0 CA--C 1.536 1.391 0 O-C-N 121.009 -1.057 . . . . 0.0 115.283 178.009 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 2469 ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -67.94 -16.23 45.01 Favored 'Trans proline' 0 CA--C 1.54 0.8 0 C-N-CA 124.297 3.331 . . . . 0.0 113.404 178.808 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 2470 ' ' SER . . . . . . . . . . . . . 32.9 m -151.98 175.09 12.87 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 127.14 2.176 . . . . 0.0 109.31 169.743 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 2471 ' ' LYS . . . . . . . . . . . . . 98.7 mttt -67.74 164.41 19.5 Favored 'General case' 0 CA--C 1.548 0.886 0 O-C-N 121.002 -1.061 . . . . 0.0 111.69 166.484 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 2472 ' ' VAL . . . . . . . . . . . . . 27.2 m -123.08 153.68 28.33 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 C-N-CA 125.168 1.387 . . . . 0.0 111.011 177.057 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 2473 ' ' LYS . . . . . . . . . . . . . 88.3 tttt -91.62 129.17 37.64 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 123.229 0.611 . . . . 0.0 109.387 163.243 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 2474 ' ' MET . . . . . . . . . . . . . 99.0 mtp -121.01 149.55 42.5 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 124.989 1.315 . . . . 0.0 111.895 -177.467 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 2475 ' ' ASP . . . . . . . . . . . . . 38.6 t0 -138.69 83.18 1.95 Allowed 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 126.953 2.101 . . . . 0.0 109.135 174.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 2476 ' ' CYS . . . . . . . . . . . . . 24.1 t -77.15 133.5 38.95 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 123.853 0.861 . . . . 0.0 111.126 177.783 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 2477 ' ' GLN . . . . . . . . . . . . . 34.9 mt-30 -138.81 179.93 6.2 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 127.734 2.414 . . . . 0.0 109.357 -169.328 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 2478 ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -143.57 149.18 37.03 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.364 1.066 . . . . 0.0 112.019 179.909 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 2479 ' ' CYS . . . . . . . . . . . . . 20.8 p -156.84 174.14 4.31 Favored Pre-proline 0 CA--C 1.553 1.086 0 C-N-CA 126.108 1.763 . . . . 0.0 110.99 -176.752 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 2480 ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -58.44 -24.72 70.34 Favored 'Trans proline' 0 CA--C 1.539 0.748 0 C-N-CA 123.349 2.7 . . . . 0.0 114.711 177.776 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 2481 ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -79.76 -17.27 53.87 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 124.285 1.034 . . . . 0.0 112.987 178.172 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 2482 ' ' GLY . . . . . . . . . . . . . . . 136.26 -154.5 22.01 Favored Glycine 0 CA--C 1.531 1.056 0 C-N-CA 125.818 1.675 . . . . 0.0 113.372 -178.853 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 2483 ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -85.55 115.23 23.13 Favored 'General case' 0 N--CA 1.468 0.449 0 O-C-N 121.78 -0.835 . . . . 0.0 110.774 175.541 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 2484 ' ' ARG . . . . . . . . . . . . . 35.9 ttt-85 -95.95 121.73 38.0 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 124.401 1.08 . . . . 0.0 110.241 -178.0 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 2485 ' ' VAL . . . . . . . . . . . . . 66.1 t -103.02 125.67 57.39 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 C-N-CA 124.933 1.293 . . . . 0.0 108.392 177.187 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 2486 ' ' THR . . . . . . . . . . . . . 91.8 m -111.69 139.49 47.11 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 167.434 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 2487 ' ' TYR . . . . . . . . . . . . . 14.1 p90 -151.01 154.85 37.84 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 113.361 0.875 . . . . 0.0 113.361 177.022 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 2488 ' ' THR . . . . . . . . . . . . . 98.9 m -118.33 115.49 35.96 Favored Pre-proline 0 N--CA 1.475 0.78 0 C-N-CA 124.717 1.207 . . . . 0.0 109.725 176.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 2489 ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -81.3 163.14 19.77 Favored 'Trans proline' 0 C--N 1.351 0.667 0 C-N-CA 123.987 3.125 . . . . 0.0 111.165 169.89 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 2490 ' ' MET . . . . . . . . . . . . . 25.8 ptm -143.05 4.29 1.43 Allowed 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 115.482 1.66 . . . . 0.0 115.482 -170.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 2491 ' ' ALA . . . . . . . . . . . . . . . -146.11 148.37 34.99 Favored Pre-proline 0 CA--C 1.546 0.819 0 C-N-CA 125.112 1.365 . . . . 0.0 110.901 174.769 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 2492 ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -72.2 145.37 43.73 Favored 'Trans proline' 0 CA--C 1.536 0.61 0 C-N-CA 122.813 2.342 . . . . 0.0 110.997 177.025 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 2493 ' ' GLY . . . . . . . . . . . . . . . 136.77 -167.03 24.72 Favored Glycine 0 CA--C 1.53 0.971 0 C-N-CA 125.34 1.448 . . . . 0.0 113.44 -177.141 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 2494 ' ' SER . . . . . . . . . . . . . 50.2 m -98.77 120.14 38.7 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.271 1.028 . . . . 0.0 111.298 -179.128 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 2495 ' ' TYR . . . . . . . . . . . . . 73.0 m-85 -93.01 124.96 37.35 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.215 1.006 . . . . 0.0 110.395 170.855 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 2496 ' ' LEU . . . . . . . . . . . . . 22.8 tp -96.65 111.35 23.53 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.423 1.089 . . . . 0.0 109.788 -178.888 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 2497 ' ' ILE . . . . . . . . . . . . . 49.9 mt -98.73 102.1 12.98 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 C-N-CA 126.057 1.743 . . . . 0.0 108.429 -176.663 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 2498 ' ' SER . . . . . . . . . . . . . 73.2 m -92.76 98.34 11.34 Favored 'General case' 0 N--CA 1.468 0.425 0 C-N-CA 124.608 1.163 . . . . 0.0 110.25 178.492 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 2499 ' ' ILE . . . . . . . . . . . . . 28.0 mt -96.05 120.53 45.54 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 C-N-CA 125.834 1.654 . . . . 0.0 109.349 179.65 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 2500 ' ' LYS . . . . . . . . . . . . . 90.5 mttt -134.08 127.78 32.86 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.264 1.026 . . . . 0.0 112.788 -171.137 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 2501 ' ' TYR . . . . . . . . . . . . . 57.5 t80 -128.09 151.56 49.04 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 124.828 1.251 . . . . 0.0 112.621 -171.674 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 2502 ' ' GLY . . . . . . . . . . . . . . . 64.91 20.02 66.17 Favored Glycine 0 CA--C 1.536 1.378 0 C-N-CA 124.241 0.924 . . . . 0.0 113.733 178.297 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 2503 ' ' GLY . . . . . . . . . . . . . . . 126.32 -166.46 19.09 Favored Glycine 0 CA--C 1.542 1.721 0 C-N-CA 125.878 1.704 . . . . 0.0 112.42 -164.785 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 2504 ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -82.11 31.77 0.52 Allowed 'Trans proline' 0 CA--C 1.546 1.113 0 C-N-CA 124.985 3.79 . . . . 0.0 113.522 -173.043 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 2505 ' ' TYR . . . . . . . . . . . . . 75.5 m-85 -113.87 131.47 56.26 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.66 1.184 . . . . 0.0 112.773 -172.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 2506 ' ' HIS . . . . . . . . . . . . . 89.5 m-70 -60.54 140.05 57.5 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 124.681 1.192 . . . . 0.0 113.687 -177.072 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 2507 ' ' ILE . . . . . . . . . . . . . 2.2 pp -84.45 160.58 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.199 0 C-N-CA 123.962 0.905 . . . . 0.0 112.442 173.691 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 2508 ' ' GLY . . . . . . . . . . . . . . . 38.67 -110.63 0.14 Allowed Glycine 0 CA--C 1.537 1.435 0 C-N-CA 125.291 1.424 . . . . 0.0 115.607 161.641 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 2509 ' ' GLY . . . . . . . . . . . . . . . -104.75 15.82 48.26 Favored Glycine 0 CA--C 1.538 1.51 0 C-N-CA 126.37 1.938 . . . . 0.0 114.637 175.74 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 2510 ' ' SER . . . . . . . . . . . . . 33.3 t -67.85 146.38 98.32 Favored Pre-proline 0 CA--C 1.551 0.987 0 C-N-CA 125.38 1.472 . . . . 0.0 112.181 179.449 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 2511 ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -79.6 156.19 89.34 Favored 'Cis proline' 0 C--N 1.351 0.687 0 CA-C-N 119.728 0.939 . . . . 0.0 112.915 -0.544 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 2512 ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -106.17 136.14 46.39 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 125.178 1.391 . . . . 0.0 111.07 179.822 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 2513 ' ' LYS . . . . . . . . . . . . . 19.5 ptpt -94.17 11.72 29.11 Favored 'General case' 0 CA--C 1.552 1.024 0 N-CA-C 116.51 2.041 . . . . 0.0 116.51 -164.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 2514 ' ' ALA . . . . . . . . . . . . . . . -4.78 99.35 0.01 OUTLIER 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 129.561 3.145 . . . . 0.0 116.474 -179.211 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 2515 ' ' LYS . . . . . . . . . . . . . 52.9 mtpt -89.02 120.0 30.05 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.258 1.023 . . . . 0.0 111.529 -173.332 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 2516 ' ' VAL . . . . . . . . . . . . . 55.0 t -113.14 142.58 25.1 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 125.788 1.635 . . . . 0.0 110.435 -172.484 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 2517 ' ' THR . . . . . . . . . . . . . 40.9 p -127.88 171.88 11.38 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 125.664 1.586 . . . . 0.0 111.458 178.151 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 2518 ' ' GLY . . . . . . . . . . . . . . . 107.31 -173.74 19.08 Favored Glycine 0 CA--C 1.538 1.53 0 C-N-CA 124.919 1.247 . . . . 0.0 113.264 -176.792 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 2519 ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -71.05 156.2 60.32 Favored 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 123.705 2.937 . . . . 0.0 112.209 -176.092 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 2520 ' ' ARG . . . . . . . . . . . . . 39.9 ttm105 . . . . . 0 CA--C 1.537 0.479 0 C-N-CA 123.915 0.886 . . . . 0.0 110.0 171.852 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A 2427 ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.951 0 CA-C-O 121.109 0.283 . . . . 0.0 113.099 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A 2428 ' ' ASP . . . . . . . . . . . . . 29.4 m-20 -91.66 136.5 26.47 Favored Pre-proline 0 CA--C 1.547 0.853 0 C-N-CA 124.517 1.127 . . . . 0.0 112.0 -179.087 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 2429 ' ' PRO . . . . . . . . . . . . . 79.6 Cg_exo -54.75 -27.58 53.0 Favored 'Trans proline' 0 C--N 1.353 0.772 0 C-N-CA 123.994 3.129 . . . . 0.0 114.862 175.577 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 2430 ' ' GLY . . . . . . . . . . . . . . . -80.02 -24.54 59.54 Favored Glycine 0 CA--C 1.535 1.285 0 C-N-CA 123.762 0.696 . . . . 0.0 113.969 176.615 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 2431 ' ' LEU . . . . . . . . . . . . . 4.2 mm? -86.22 -32.77 21.0 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.575 1.15 . . . . 0.0 111.315 172.896 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 2432 ' ' VAL . . . . . . . . . . . . . 82.5 t -65.08 136.75 26.18 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 C-N-CA 123.723 0.809 . . . . 0.0 109.723 167.758 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 2433 ' ' SER . . . . . . . . . . . . . 8.4 t -131.88 -168.85 2.1 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.827 1.251 . . . . 0.0 110.823 177.311 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 2434 ' ' ALA . . . . . . . . . . . . . . . -149.91 142.64 24.63 Favored 'General case' 0 CA--C 1.539 0.531 0 O-C-N 121.062 -1.024 . . . . 0.0 111.988 176.395 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 2435 ' ' TYR . . . . . . . . . . . . . 77.4 m-85 -145.79 148.85 33.38 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 125.386 1.474 . . . . 0.0 112.001 -176.416 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 2436 ' ' GLY . . . . . . . . . . . . . . . 123.99 160.42 10.79 Favored Glycine 0 N--CA 1.474 1.2 0 C-N-CA 125.245 1.402 . . . . 0.0 113.974 176.708 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 2437 ' ' ALA . . . . . . . . . . . . . . . -60.93 -30.19 70.06 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.007 1.323 . . . . 0.0 114.167 -171.057 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 2438 ' ' GLY . . . . . . . . . . . . . . . -67.19 -9.81 55.21 Favored Glycine 0 CA--C 1.533 1.169 0 C-N-CA 124.57 1.081 . . . . 0.0 114.514 -179.632 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 2439 ' ' LEU . . . . . . . . . . . . . 88.3 mt -79.41 -26.12 41.95 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 118.973 1.386 . . . . 0.0 112.553 168.397 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 2440 ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -95.94 -36.37 11.09 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.081 1.352 . . . . 0.0 112.236 -173.851 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 2441 ' ' GLY . . . . . . . . . . . . . . . 160.32 -148.96 17.97 Favored Glycine 0 CA--C 1.532 1.134 0 C-N-CA 124.79 1.186 . . . . 0.0 113.146 -176.053 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 2442 ' ' GLY . . . . . . . . . . . . . . . 150.68 178.63 25.72 Favored Glycine 0 CA--C 1.534 1.249 0 C-N-CA 125.412 1.482 . . . . 0.0 112.796 -175.85 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 2443 ' ' VAL . . . . . . . . . . . . . 83.9 t -101.81 134.77 41.33 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 C-N-CA 124.722 1.209 . . . . 0.0 110.097 -179.583 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 2444 ' ' THR . . . . . . . . . . . . . 25.5 p -63.19 140.07 58.84 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.212 1.005 . . . . 0.0 112.325 176.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 2445 ' ' GLY . . . . . . . . . . . . . . . 79.58 -11.51 32.19 Favored Glycine 0 CA--C 1.536 1.385 0 C-N-CA 124.705 1.145 . . . . 0.0 114.328 -174.887 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 2446 ' ' ASN . . . . . . . . . . . . . 82.1 m-20 -106.36 152.14 40.48 Favored Pre-proline 0 CA--C 1.548 0.884 0 C-N-CA 125.453 1.501 . . . . 0.0 110.901 173.19 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 2447 ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -73.05 134.28 21.11 Favored 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 122.789 2.326 . . . . 0.0 111.335 175.875 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 2448 ' ' ALA . . . . . . . . . . . . . . . -111.48 156.69 21.3 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 126.232 1.813 . . . . 0.0 109.225 162.049 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 2449 ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -153.37 153.93 33.52 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 113.901 1.074 . . . . 0.0 113.901 -173.389 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 2450 ' ' PHE . . . . . . . . . . . . . 40.2 p90 -158.0 161.02 38.08 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.863 1.665 . . . . 0.0 110.696 177.336 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 2451 ' ' VAL . . . . . . . . . . . . . 14.7 p -113.04 135.07 53.68 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 C-N-CA 124.697 1.199 . . . . 0.0 110.968 175.121 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 2452 ' ' VAL . . . . . . . . . . . . . 25.1 t -84.89 101.76 9.86 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 N-CA-C 106.337 -1.727 . . . . 0.0 106.337 163.315 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 2453 ' ' ASN . . . . . . . . . . . . . 15.8 t-20 -88.66 123.5 33.17 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 123.72 0.808 . . . . 0.0 112.335 -167.006 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 2454 ' ' THR . . . . . . . . . . . . . 69.0 p -109.89 2.03 19.56 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 125.878 1.671 . . . . 0.0 113.745 -174.178 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 2455 ' ' SER . . . . . . . . . . . . . 42.0 m -56.57 -30.93 63.71 Favored 'General case' 0 N--CA 1.479 0.976 0 N-CA-C 114.537 1.31 . . . . 0.0 114.537 -172.887 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 2456 ' ' ASN . . . . . . . . . . . . . 28.0 m120 -88.96 -8.44 54.12 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 124.896 1.278 . . . . 0.0 113.55 177.297 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 2457 ' ' ALA . . . . . . . . . . . . . . . -113.18 -47.64 3.01 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 125.387 1.475 . . . . 0.0 113.755 -170.166 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 2458 ' ' GLY . . . . . . . . . . . . . . . 105.48 -151.29 17.12 Favored Glycine 0 CA--C 1.534 1.277 0 C-N-CA 125.333 1.444 . . . . 0.0 113.144 -174.219 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 2459 ' ' ALA . . . . . . . . . . . . . . . -77.44 156.64 30.97 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.811 1.245 . . . . 0.0 114.023 -174.43 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 2460 ' ' GLY . . . . . . . . . . . . . . . 158.22 172.09 24.93 Favored Glycine 0 CA--C 1.531 1.073 0 C-N-CA 125.246 1.403 . . . . 0.0 113.655 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 2461 ' ' ALA . . . . . . . . . . . . . . . -100.39 148.9 24.2 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.9 1.28 . . . . 0.0 112.84 -176.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 2462 ' ' LEU . . . . . . . . . . . . . 16.3 tp -101.97 149.41 24.26 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 125.526 1.531 . . . . 0.0 111.357 176.888 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 2463 ' ' SER . . . . . . . . . . . . . 3.7 t -140.89 40.29 1.82 Allowed 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 125.223 1.409 . . . . 0.0 111.427 179.136 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 2464 ' ' VAL . . . . . . . . . . . . . 14.2 p -65.36 139.23 21.7 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 C-N-CA 125.124 1.37 . . . . 0.0 112.574 -174.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 2465 ' ' THR . . . . . . . . . . . . . 93.5 m -135.04 143.38 46.71 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 125.791 1.636 . . . . 0.0 109.706 175.869 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 2466 ' ' ILE . . . . . . . . . . . . . 35.2 mt -121.12 123.97 71.13 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 C-N-CA 124.079 0.951 . . . . 0.0 110.122 175.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 2467 ' ' ASP . . . . . . . . . . . . . 34.4 t70 -104.17 162.91 12.78 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 126.809 2.044 . . . . 0.0 110.077 169.048 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 2468 ' ' GLY . . . . . . . . . . . . . . . 168.95 -161.55 35.25 Favored Glycine 0 CA--C 1.536 1.376 0 O-C-N 120.841 -1.162 . . . . 0.0 115.414 178.265 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 2469 ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -71.48 -17.72 30.05 Favored 'Trans proline' 0 CA--C 1.539 0.747 0 C-N-CA 124.006 3.138 . . . . 0.0 113.341 -178.827 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 2470 ' ' SER . . . . . . . . . . . . . 43.3 m -156.79 -168.36 2.65 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 127.213 2.205 . . . . 0.0 109.762 178.775 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 2471 ' ' LYS . . . . . . . . . . . . . 49.0 mmtm -74.12 174.78 8.21 Favored 'General case' 0 CA--C 1.55 0.968 0 O-C-N 120.661 -1.275 . . . . 0.0 112.523 170.32 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 2472 ' ' VAL . . . . . . . . . . . . . 35.4 m -131.06 148.36 33.01 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 C-N-CA 125.448 1.499 . . . . 0.0 109.971 165.848 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 2473 ' ' LYS . . . . . . . . . . . . . 88.5 tttt -94.44 102.89 14.87 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 166.146 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 2474 ' ' MET . . . . . . . . . . . . . 55.4 ttp -117.27 144.56 44.71 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.994 1.317 . . . . 0.0 112.732 -173.193 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 2475 ' ' ASP . . . . . . . . . . . . . 31.7 t70 -127.98 132.97 49.15 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 126.991 2.116 . . . . 0.0 110.057 170.479 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 2476 ' ' CYS . . . . . . . . . . . . . 45.3 t -109.73 138.55 45.93 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 125.138 1.375 . . . . 0.0 111.334 178.291 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 2477 ' ' GLN . . . . . . . . . . . . . 81.6 mt-30 -133.68 128.65 35.46 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.035 1.334 . . . . 0.0 110.392 -175.079 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 2478 ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -81.57 137.01 35.58 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.34 1.056 . . . . 0.0 109.9 173.159 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 2479 ' ' CYS . . . . . . . . . . . . . 29.6 p -156.01 167.24 14.69 Favored Pre-proline 0 CA--C 1.552 1.034 0 C-N-CA 125.024 1.33 . . . . 0.0 111.607 -172.922 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 2480 ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -65.28 -16.81 56.3 Favored 'Trans proline' 0 CA--C 1.543 0.941 0 C-N-CA 122.701 2.267 . . . . 0.0 113.266 174.807 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 2481 ' ' GLU . . . . . . . . . . . . . 19.6 tt0 -80.21 -10.72 59.77 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 124.969 1.308 . . . . 0.0 112.535 173.374 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 2482 ' ' GLY . . . . . . . . . . . . . . . 122.57 -126.35 6.34 Favored Glycine 0 N--CA 1.473 1.115 0 C-N-CA 125.999 1.761 . . . . 0.0 112.102 -177.048 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 2483 ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -115.85 108.84 16.82 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 123.789 0.836 . . . . 0.0 110.572 171.422 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 2484 ' ' ARG . . . . . . . . . . . . . 42.2 ttm-85 -92.59 132.49 36.82 Favored 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 124.007 0.923 . . . . 0.0 109.63 175.8 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 2485 ' ' VAL . . . . . . . . . . . . . 32.6 m -117.65 144.37 25.75 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 C-N-CA 123.845 0.858 . . . . 0.0 110.327 174.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 2486 ' ' THR . . . . . . . . . . . . . 88.6 m -124.32 132.75 53.57 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 125.447 1.499 . . . . 0.0 107.49 171.089 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 2487 ' ' TYR . . . . . . . . . . . . . 19.4 p90 -142.46 146.83 35.2 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 113.34 0.867 . . . . 0.0 113.34 178.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 2488 ' ' THR . . . . . . . . . . . . . 65.1 m -106.17 116.11 59.98 Favored Pre-proline 0 N--CA 1.471 0.608 0 C-N-CA 124.501 1.12 . . . . 0.0 109.216 172.49 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 2489 ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -79.98 153.8 22.39 Favored 'Trans proline' 0 C--N 1.351 0.681 0 C-N-CA 123.717 2.945 . . . . 0.0 110.665 170.475 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 2490 ' ' MET . . . . . . . . . . . . . 28.5 ptm -117.08 -5.3 11.41 Favored 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 115.055 1.502 . . . . 0.0 115.055 -174.861 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 2491 ' ' ALA . . . . . . . . . . . . . . . -146.5 144.73 21.43 Favored Pre-proline 0 CA--C 1.548 0.898 0 C-N-CA 124.731 1.212 . . . . 0.0 111.447 177.801 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 2492 ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -70.26 156.05 62.91 Favored 'Trans proline' 0 C--N 1.35 0.64 0 C-N-CA 123.571 2.847 . . . . 0.0 111.357 177.88 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 2493 ' ' GLY . . . . . . . . . . . . . . . 126.52 -154.62 19.18 Favored Glycine 0 CA--C 1.528 0.898 0 C-N-CA 124.886 1.231 . . . . 0.0 113.241 -178.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 2494 ' ' SER . . . . . . . . . . . . . 74.0 m -104.5 112.94 26.2 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 123.709 0.804 . . . . 0.0 112.206 -176.893 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 2495 ' ' TYR . . . . . . . . . . . . . 69.0 m-85 -88.64 129.6 35.47 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 123.524 0.73 . . . . 0.0 109.89 162.877 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 2496 ' ' LEU . . . . . . . . . . . . . 29.0 tp -101.55 117.69 35.43 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.697 1.199 . . . . 0.0 109.521 179.052 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 2497 ' ' ILE . . . . . . . . . . . . . 61.9 mt -103.46 99.98 9.5 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 C-N-CA 125.574 1.55 . . . . 0.0 108.407 -170.087 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 2498 ' ' SER . . . . . . . . . . . . . 74.6 m -83.32 86.28 7.08 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 125.071 1.348 . . . . 0.0 109.864 176.495 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 2499 ' ' ILE . . . . . . . . . . . . . 37.0 mt -79.19 110.86 15.36 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 C-N-CA 124.124 0.97 . . . . 0.0 109.162 175.876 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 2500 ' ' LYS . . . . . . . . . . . . . 83.7 mttt -121.75 145.46 48.02 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.859 1.264 . . . . 0.0 111.51 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 2501 ' ' TYR . . . . . . . . . . . . . 47.5 t80 -149.31 146.54 27.59 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.563 1.145 . . . . 0.0 112.16 -171.447 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 2502 ' ' GLY . . . . . . . . . . . . . . . 67.19 19.36 70.18 Favored Glycine 0 CA--C 1.536 1.394 0 C-N-CA 124.25 0.928 . . . . 0.0 113.735 177.552 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 2503 ' ' GLY . . . . . . . . . . . . . . . 131.7 -167.32 22.73 Favored Glycine 0 CA--C 1.541 1.699 0 C-N-CA 125.93 1.729 . . . . 0.0 112.364 -166.13 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 2504 ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -81.83 26.77 0.61 Allowed 'Trans proline' 0 CA--C 1.547 1.154 0 C-N-CA 124.921 3.747 . . . . 0.0 113.588 -174.291 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 2505 ' ' TYR . . . . . . . . . . . . . 60.2 m-85 -112.23 134.36 53.82 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 124.638 1.175 . . . . 0.0 113.02 -171.72 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 2506 ' ' HIS . . . . . . . . . . . . . 95.2 m-70 -63.4 142.53 58.36 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 124.842 1.257 . . . . 0.0 113.462 -179.326 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 2507 ' ' ILE . . . . . . . . . . . . . 1.8 pp -83.37 173.43 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.319 0 C-N-CA 123.628 0.771 . . . . 0.0 113.015 174.428 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 2508 ' ' GLY . . . . . . . . . . . . . . . -59.69 113.73 5.57 Favored Glycine 0 CA--C 1.534 1.248 0 O-C-N 121.469 -0.769 . . . . 0.0 112.783 -177.027 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 2509 ' ' GLY . . . . . . . . . . . . . . . 92.66 -5.32 76.79 Favored Glycine 0 CA--C 1.536 1.354 0 C-N-CA 125.615 1.579 . . . . 0.0 114.861 -177.238 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 2510 ' ' SER . . . . . . . . . . . . . 35.0 t -82.22 146.56 54.96 Favored Pre-proline 0 CA--C 1.55 0.969 0 CA-C-N 118.898 1.349 . . . . 0.0 112.271 179.381 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 2511 ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -77.49 156.54 96.09 Favored 'Cis proline' 0 C--N 1.354 0.845 0 CA-C-N 120.02 1.043 . . . . 0.0 113.305 -0.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 2512 ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -107.47 134.47 50.45 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 125.32 1.448 . . . . 0.0 111.263 178.682 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 2513 ' ' LYS . . . . . . . . . . . . . 40.4 ttmt -99.47 100.48 11.52 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 123.856 0.862 . . . . 0.0 111.966 -178.15 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 2514 ' ' ALA . . . . . . . . . . . . . . . -82.06 109.35 16.31 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.025 1.33 . . . . 0.0 110.787 177.069 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 2515 ' ' LYS . . . . . . . . . . . . . 30.6 mtmm -91.65 81.2 5.3 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.805 1.642 . . . . 0.0 109.324 -175.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 2516 ' ' VAL . . . . . . . . . . . . . 21.0 m -83.49 153.7 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 C-N-CA 124.338 1.055 . . . . 0.0 111.41 -173.226 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 2517 ' ' THR . . . . . . . . . . . . . 77.0 p -132.31 179.46 6.1 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 125.853 1.661 . . . . 0.0 111.118 -175.437 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 2518 ' ' GLY . . . . . . . . . . . . . . . 104.49 -176.15 23.08 Favored Glycine 0 CA--C 1.539 1.576 0 C-N-CA 124.891 1.234 . . . . 0.0 113.309 -176.492 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 2519 ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -74.28 148.59 39.04 Favored 'Trans proline' 0 CA--C 1.537 0.644 0 C-N-CA 123.72 2.946 . . . . 0.0 112.085 -173.92 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 2520 ' ' ARG . . . . . . . . . . . . . 38.3 ttp-105 . . . . . 0 CA--C 1.54 0.596 0 C-N-CA 124.17 0.988 . . . . 0.0 111.883 -179.582 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A 2427 ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.971 0 CA-C-O 121.198 0.332 . . . . 0.0 113.408 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A 2428 ' ' ASP . . . . . . . . . . . . . 15.3 t70 -100.08 138.87 20.38 Favored Pre-proline 0 CA--C 1.55 0.953 0 C-N-CA 125.314 1.446 . . . . 0.0 111.471 179.448 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 2429 ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -55.49 -26.83 56.11 Favored 'Trans proline' 0 C--N 1.353 0.785 0 C-N-CA 123.782 2.988 . . . . 0.0 115.448 179.85 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 2430 ' ' GLY . . . . . . . . . . . . . . . -81.99 -24.36 55.33 Favored Glycine 0 CA--C 1.533 1.157 0 CA-C-N 119.155 0.889 . . . . 0.0 113.548 176.738 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 2431 ' ' LEU . . . . . . . . . . . . . 4.4 mm? -85.56 -33.75 21.64 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.481 1.112 . . . . 0.0 111.535 172.825 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 2432 ' ' VAL . . . . . . . . . . . . . 87.0 t -66.76 137.2 25.31 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 123.483 0.713 . . . . 0.0 109.539 168.477 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 2433 ' ' SER . . . . . . . . . . . . . 8.3 t -133.39 -170.58 2.51 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 124.85 1.26 . . . . 0.0 110.801 177.773 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 2434 ' ' ALA . . . . . . . . . . . . . . . -152.79 144.39 23.45 Favored 'General case' 0 CA--C 1.537 0.477 0 O-C-N 120.963 -1.086 . . . . 0.0 111.996 176.089 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 2435 ' ' TYR . . . . . . . . . . . . . 74.7 m-85 -147.33 150.2 34.29 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 125.566 1.547 . . . . 0.0 111.825 -174.455 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 2436 ' ' GLY . . . . . . . . . . . . . . . 121.79 162.91 11.77 Favored Glycine 0 N--CA 1.473 1.118 0 C-N-CA 125.288 1.423 . . . . 0.0 113.999 177.135 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 2437 ' ' ALA . . . . . . . . . . . . . . . -60.95 -28.77 69.21 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 125.099 1.36 . . . . 0.0 114.407 -169.677 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 2438 ' ' GLY . . . . . . . . . . . . . . . -66.72 -15.53 64.48 Favored Glycine 0 CA--C 1.532 1.103 0 CA-C-O 118.867 -0.963 . . . . 0.0 114.417 -178.802 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 2439 ' ' LEU . . . . . . . . . . . . . 84.4 mt -76.37 -24.96 54.16 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 118.866 1.333 . . . . 0.0 112.44 169.716 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 2440 ' ' GLU . . . . . . . . . . . . . 43.0 mm-40 -90.89 -31.79 16.27 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.15 1.38 . . . . 0.0 111.896 176.189 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 2441 ' ' GLY . . . . . . . . . . . . . . . 109.22 -133.41 11.63 Favored Glycine 0 CA--C 1.531 1.042 0 C-N-CA 125.921 1.724 . . . . 0.0 112.763 178.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 2442 ' ' GLY . . . . . . . . . . . . . . . 135.41 -154.59 21.76 Favored Glycine 0 CA--C 1.533 1.195 0 C-N-CA 124.826 1.203 . . . . 0.0 114.433 -176.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 2443 ' ' VAL . . . . . . . . . . . . . 93.0 t -74.37 136.14 25.88 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 C-N-CA 124.284 1.034 . . . . 0.0 111.488 -172.516 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 2444 ' ' THR . . . . . . . . . . . . . 25.1 p -63.37 133.13 53.54 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.445 1.098 . . . . 0.0 111.471 174.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 2445 ' ' GLY . . . . . . . . . . . . . . . 85.03 -8.41 70.44 Favored Glycine 0 CA--C 1.536 1.361 0 C-N-CA 124.667 1.127 . . . . 0.0 114.76 -176.511 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 2446 ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -86.01 152.86 56.78 Favored Pre-proline 0 CA--C 1.551 1.018 0 CA-C-N 118.976 1.388 . . . . 0.0 111.796 174.811 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 2447 ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -75.5 97.5 1.1 Allowed 'Trans proline' 0 CA--C 1.538 0.693 0 C-N-CA 123.156 2.571 . . . . 0.0 110.024 173.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 2448 ' ' ALA . . . . . . . . . . . . . . . -78.47 143.23 36.85 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.034 0.934 . . . . 0.0 109.481 168.759 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 2449 ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -155.1 148.32 24.89 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 114.33 1.233 . . . . 0.0 114.33 -173.386 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 2450 ' ' PHE . . . . . . . . . . . . . 49.5 p90 -153.93 162.47 41.19 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 126.439 1.895 . . . . 0.0 110.496 -178.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 2451 ' ' VAL . . . . . . . . . . . . . 71.5 t -112.68 130.96 65.52 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 C-N-CA 124.821 1.248 . . . . 0.0 109.498 174.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 2452 ' ' VAL . . . . . . . . . . . . . 45.5 t -79.52 109.33 14.02 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 161.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 2453 ' ' ASN . . . . . . . . . . . . . 12.4 t-20 -88.68 114.5 25.37 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.188 0.995 . . . . 0.0 111.909 -172.372 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 2454 ' ' THR . . . . . . . . . . . . . 70.0 p -107.43 -5.59 17.59 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 125.521 1.528 . . . . 0.0 113.65 -177.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 2455 ' ' SER . . . . . . . . . . . . . 13.9 m -57.77 -29.7 65.03 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 124.797 1.239 . . . . 0.0 114.242 -175.033 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 2456 ' ' ASN . . . . . . . . . . . . . 69.0 m-80 -83.16 -10.24 58.75 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 124.688 1.195 . . . . 0.0 113.453 177.097 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 2457 ' ' ALA . . . . . . . . . . . . . . . -115.17 -50.53 2.75 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 125.187 1.395 . . . . 0.0 113.482 -169.459 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 2458 ' ' GLY . . . . . . . . . . . . . . . 121.81 -145.2 16.73 Favored Glycine 0 CA--C 1.533 1.208 0 C-N-CA 125.054 1.312 . . . . 0.0 113.108 -174.083 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 2459 ' ' ALA . . . . . . . . . . . . . . . -96.41 160.22 14.53 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 125.195 1.398 . . . . 0.0 113.113 -175.534 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 2460 ' ' GLY . . . . . . . . . . . . . . . 153.76 164.01 12.33 Favored Glycine 0 CA--C 1.53 1.017 0 C-N-CA 124.261 0.934 . . . . 0.0 114.025 -178.561 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 2461 ' ' ALA . . . . . . . . . . . . . . . -79.7 144.76 33.39 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.37 1.068 . . . . 0.0 112.51 -179.411 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 2462 ' ' LEU . . . . . . . . . . . . . 69.5 tp -115.14 141.38 48.09 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 126.006 1.722 . . . . 0.0 110.526 178.283 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 2463 ' ' SER . . . . . . . . . . . . . 16.4 t -142.11 106.1 4.74 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.532 1.133 . . . . 0.0 109.639 170.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 2464 ' ' VAL . . . . . . . . . . . . . 60.5 t -102.39 128.2 55.3 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 C-N-CA 124.083 0.953 . . . . 0.0 109.487 178.881 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 2465 ' ' THR . . . . . . . . . . . . . 98.2 m -116.15 134.22 55.17 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 125.326 1.45 . . . . 0.0 108.636 174.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 2466 ' ' ILE . . . . . . . . . . . . . 41.1 mt -122.88 120.3 60.27 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 C-N-CA 123.542 0.737 . . . . 0.0 109.586 177.433 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 2467 ' ' ASP . . . . . . . . . . . . . 32.0 m-20 -107.0 167.69 9.72 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 126.204 1.802 . . . . 0.0 110.168 169.511 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 2468 ' ' GLY . . . . . . . . . . . . . . . 162.78 -153.1 23.56 Favored Glycine 0 CA--C 1.536 1.366 0 CA-C-O 118.854 -0.97 . . . . 0.0 114.481 179.694 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 2469 ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -70.18 -17.54 35.62 Favored 'Trans proline' 0 CA--C 1.54 0.79 0 C-N-CA 123.774 2.983 . . . . 0.0 113.189 180.0 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 2470 ' ' SER . . . . . . . . . . . . . 38.7 m -157.57 -165.17 1.71 Allowed 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 127.546 2.338 . . . . 0.0 109.382 176.383 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 2471 ' ' LYS . . . . . . . . . . . . . 59.3 mtmt -79.13 -175.3 4.53 Favored 'General case' 0 CA--C 1.552 1.042 0 O-C-N 120.802 -1.187 . . . . 0.0 111.79 167.614 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 2472 ' ' VAL . . . . . . . . . . . . . 33.4 m -139.78 151.78 22.32 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 C-N-CA 125.26 1.424 . . . . 0.0 111.09 171.909 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 2473 ' ' LYS . . . . . . . . . . . . . 60.6 mtpt -87.99 86.51 7.14 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 123.836 0.854 . . . . 0.0 110.126 171.706 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 2474 ' ' MET . . . . . . . . . . . . . 58.3 ttm -79.28 143.29 35.38 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 124.277 1.031 . . . . 0.0 112.38 -176.706 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 2475 ' ' ASP . . . . . . . . . . . . . 23.1 t70 -135.56 100.25 4.44 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 126.448 1.899 . . . . 0.0 109.581 165.067 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 2476 ' ' CYS . . . . . . . . . . . . . 44.3 t -95.47 132.3 40.69 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.642 1.177 . . . . 0.0 110.639 175.778 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 2477 ' ' GLN . . . . . . . . . . . . . 86.7 mt-30 -144.99 154.96 43.1 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 125.286 1.434 . . . . 0.0 110.711 -176.511 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 2478 ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -75.95 152.02 37.14 Favored 'General case' 0 CA--C 1.543 0.696 0 O-C-N 121.389 -0.819 . . . . 0.0 112.068 172.464 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 2479 ' ' CYS . . . . . . . . . . . . . 17.3 p -151.39 166.21 15.65 Favored Pre-proline 0 CA--C 1.554 1.106 0 C-N-CA 125.782 1.633 . . . . 0.0 110.774 -179.59 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 2480 ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -66.93 -18.84 52.55 Favored 'Trans proline' 0 CA--C 1.54 0.794 0 C-N-CA 122.327 2.018 . . . . 0.0 113.643 -178.005 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 2481 ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -92.9 -4.0 53.59 Favored 'General case' 0 CA--C 1.553 1.062 0 C-N-CA 125.164 1.386 . . . . 0.0 112.992 175.831 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 2482 ' ' GLY . . . . . . . . . . . . . . . 139.11 -110.85 0.74 Allowed Glycine 0 N--CA 1.471 0.974 0 C-N-CA 125.482 1.515 . . . . 0.0 112.985 179.828 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 2483 ' ' TYR . . . . . . . . . . . . . 95.3 m-85 -130.03 120.08 24.15 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 124.401 1.08 . . . . 0.0 111.317 175.397 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 2484 ' ' ARG . . . . . . . . . . . . . 19.0 ttp-105 -81.05 133.76 35.54 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 123.785 0.834 . . . . 0.0 110.161 171.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 2485 ' ' VAL . . . . . . . . . . . . . 89.9 t -115.06 118.07 57.63 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 C-N-CA 125.234 1.414 . . . . 0.0 107.996 168.858 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 2486 ' ' THR . . . . . . . . . . . . . 98.9 m -100.16 146.42 26.85 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 124.872 1.269 . . . . 0.0 108.166 165.405 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 2487 ' ' TYR . . . . . . . . . . . . . 29.2 p90 -153.13 152.0 30.8 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.246 1.018 . . . . 0.0 112.618 171.8 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 2488 ' ' THR . . . . . . . . . . . . . 59.6 m -107.09 113.69 62.14 Favored Pre-proline 0 N--CA 1.473 0.719 0 CA-C-O 117.799 -1.096 . . . . 0.0 109.438 173.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 2489 ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -76.01 114.21 3.87 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 123.504 2.803 . . . . 0.0 109.424 172.383 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 2490 ' ' MET . . . . . . . . . . . . . 27.8 ptm -86.42 -7.91 58.06 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 114.661 1.356 . . . . 0.0 114.661 -173.675 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 2491 ' ' ALA . . . . . . . . . . . . . . . -147.04 149.43 35.48 Favored Pre-proline 0 CA--C 1.547 0.855 0 C-N-CA 124.792 1.237 . . . . 0.0 112.146 -179.249 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 2492 ' ' PRO . . . . . . . . . . . . . 78.0 Cg_endo -73.17 155.05 52.21 Favored 'Trans proline' 0 C--N 1.35 0.646 0 C-N-CA 123.627 2.884 . . . . 0.0 111.489 178.243 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 2493 ' ' GLY . . . . . . . . . . . . . . . 131.89 -139.69 11.16 Favored Glycine 0 CA--C 1.529 0.944 0 C-N-CA 125.342 1.449 . . . . 0.0 112.093 -173.635 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 2494 ' ' SER . . . . . . . . . . . . . 65.9 m -133.77 124.99 27.56 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 123.937 0.895 . . . . 0.0 111.465 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 2495 ' ' TYR . . . . . . . . . . . . . 65.6 m-85 -95.53 131.88 41.24 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.845 1.258 . . . . 0.0 111.06 172.759 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 2496 ' ' LEU . . . . . . . . . . . . . 27.8 tp -100.13 114.98 28.76 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 125.297 1.439 . . . . 0.0 109.364 177.881 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 2497 ' ' ILE . . . . . . . . . . . . . 48.2 mt -102.57 102.33 13.42 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 C-N-CA 125.863 1.665 . . . . 0.0 108.667 -173.472 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 2498 ' ' SER . . . . . . . . . . . . . 67.2 m -92.14 109.0 20.35 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 124.888 1.275 . . . . 0.0 109.988 177.413 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 2499 ' ' ILE . . . . . . . . . . . . . 69.1 mt -104.36 104.96 17.64 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 C-N-CA 124.684 1.194 . . . . 0.0 107.926 -176.692 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 2500 ' ' LYS . . . . . . . . . . . . . 84.0 mttt -110.96 137.36 48.68 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.35 1.06 . . . . 0.0 111.244 -179.725 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 2501 ' ' TYR . . . . . . . . . . . . . 51.7 t80 -143.63 137.69 28.48 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 123.915 0.886 . . . . 0.0 111.93 -170.45 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 2502 ' ' GLY . . . . . . . . . . . . . . . 66.54 11.04 55.95 Favored Glycine 0 CA--C 1.537 1.452 0 C-N-CA 124.449 1.023 . . . . 0.0 114.808 177.247 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 2503 ' ' GLY . . . . . . . . . . . . . . . 153.93 -167.53 32.21 Favored Glycine 0 CA--C 1.54 1.625 0 C-N-CA 125.507 1.527 . . . . 0.0 113.31 -170.189 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 2504 ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -82.87 7.88 4.93 Favored 'Trans proline' 0 CA--C 1.543 0.931 0 C-N-CA 124.731 3.621 . . . . 0.0 114.143 -173.43 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 2505 ' ' TYR . . . . . . . . . . . . . 64.4 m-85 -103.24 142.29 34.44 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.648 1.179 . . . . 0.0 113.234 -173.497 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 2506 ' ' HIS . . . . . . . . . . . . . 91.0 m-70 -65.27 147.28 53.72 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 124.278 1.031 . . . . 0.0 112.585 174.891 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 2507 ' ' ILE . . . . . . . . . . . . . 26.9 pt -74.29 169.2 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 O-C-N 121.574 -0.704 . . . . 0.0 112.47 170.524 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 2508 ' ' GLY . . . . . . . . . . . . . . . -57.89 123.88 34.37 Favored Glycine 0 CA--C 1.533 1.18 0 C-N-CA 123.838 0.732 . . . . 0.0 112.179 178.138 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 2509 ' ' GLY . . . . . . . . . . . . . . . 86.92 -10.22 69.02 Favored Glycine 0 CA--C 1.535 1.3 0 C-N-CA 125.535 1.54 . . . . 0.0 114.946 -177.364 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 2510 ' ' SER . . . . . . . . . . . . . 7.2 t -91.65 147.67 35.64 Favored Pre-proline 0 CA--C 1.552 1.045 0 CA-C-N 119.006 1.403 . . . . 0.0 111.538 -179.464 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 2511 ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -73.65 148.0 90.97 Favored 'Cis proline' 0 C--N 1.353 0.814 0 CA-C-N 120.474 1.205 . . . . 0.0 113.546 3.207 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 2512 ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -102.41 131.78 48.85 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 125.262 1.425 . . . . 0.0 110.703 177.764 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 2513 ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.67 106.87 19.03 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 123.934 0.894 . . . . 0.0 111.79 176.149 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 2514 ' ' ALA . . . . . . . . . . . . . . . -92.64 118.55 31.15 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.829 1.652 . . . . 0.0 110.401 177.478 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 2515 ' ' LYS . . . . . . . . . . . . . 48.1 mtpt -94.9 131.51 40.72 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.257 1.023 . . . . 0.0 110.742 -176.733 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 2516 ' ' VAL . . . . . . . . . . . . . 26.9 m -135.43 144.66 33.4 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 C-N-CA 123.832 0.853 . . . . 0.0 112.275 -170.025 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 2517 ' ' THR . . . . . . . . . . . . . 41.3 p -144.76 162.57 36.41 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 125.327 1.451 . . . . 0.0 111.46 -173.177 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 2518 ' ' GLY . . . . . . . . . . . . . . . 117.94 -176.93 16.36 Favored Glycine 0 CA--C 1.539 1.552 0 C-N-CA 125.252 1.406 . . . . 0.0 113.046 -175.039 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 2519 ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -75.41 133.12 15.62 Favored 'Trans proline' 0 C--N 1.349 0.553 0 C-N-CA 123.503 2.802 . . . . 0.0 111.324 -173.72 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 2520 ' ' ARG . . . . . . . . . . . . . 37.7 ttm105 . . . . . 0 CA--C 1.54 0.561 0 C-N-CA 123.938 0.895 . . . . 0.0 111.699 -179.984 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A 2427 ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.967 0 N-CA-C 112.032 -0.427 . . . . 0.0 112.032 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A 2428 ' ' ASP . . . . . . . . . . . . . 28.5 m-20 -121.46 142.86 36.4 Favored Pre-proline 0 CA--C 1.544 0.714 0 C-N-CA 124.983 1.313 . . . . 0.0 112.098 -177.65 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 2429 ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -64.49 -24.98 63.15 Favored 'Trans proline' 0 CA--C 1.539 0.734 0 C-N-CA 123.196 2.597 . . . . 0.0 112.966 179.12 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 2430 ' ' GLY . . . . . . . . . . . . . . . -73.88 -22.72 77.77 Favored Glycine 0 CA--C 1.535 1.341 0 CA-C-N 118.844 0.747 . . . . 0.0 113.738 174.59 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 2431 ' ' LEU . . . . . . . . . . . . . 4.3 mm? -88.47 -40.96 13.07 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 124.634 1.174 . . . . 0.0 111.201 173.157 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 2432 ' ' VAL . . . . . . . . . . . . . 59.4 t -59.19 137.97 20.91 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 123.936 0.894 . . . . 0.0 111.069 175.038 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 2433 ' ' SER . . . . . . . . . . . . . 8.2 t -127.02 -174.69 3.22 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 125.136 1.374 . . . . 0.0 110.45 171.855 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 2434 ' ' ALA . . . . . . . . . . . . . . . -145.95 146.95 31.23 Favored 'General case' 0 CA--C 1.538 0.487 0 O-C-N 120.91 -1.119 . . . . 0.0 112.123 177.875 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 2435 ' ' TYR . . . . . . . . . . . . . 68.2 m-85 -145.35 150.05 35.89 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 125.411 1.484 . . . . 0.0 111.92 -173.746 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 2436 ' ' GLY . . . . . . . . . . . . . . . 120.63 159.79 10.91 Favored Glycine 0 N--CA 1.474 1.203 0 C-N-CA 125.462 1.506 . . . . 0.0 114.051 177.098 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 2437 ' ' ALA . . . . . . . . . . . . . . . -61.83 -26.98 68.45 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 125.118 1.367 . . . . 0.0 114.446 -171.362 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 2438 ' ' GLY . . . . . . . . . . . . . . . -65.49 -14.48 60.11 Favored Glycine 0 CA--C 1.533 1.183 0 C-N-CA 124.183 0.897 . . . . 0.0 114.217 178.494 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 2439 ' ' LEU . . . . . . . . . . . . . 86.3 mt -78.22 -22.01 49.14 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 118.894 1.347 . . . . 0.0 112.779 169.807 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 2440 ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -98.29 -28.25 13.76 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 125.338 1.455 . . . . 0.0 112.407 -179.268 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 2441 ' ' GLY . . . . . . . . . . . . . . . 105.86 -155.04 16.92 Favored Glycine 0 CA--C 1.533 1.189 0 C-N-CA 125.747 1.641 . . . . 0.0 113.341 179.059 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 2442 ' ' GLY . . . . . . . . . . . . . . . 163.72 -157.06 29.17 Favored Glycine 0 CA--C 1.532 1.102 0 C-N-CA 124.342 0.972 . . . . 0.0 114.071 -175.458 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 2443 ' ' VAL . . . . . . . . . . . . . 61.0 t -87.64 141.33 14.47 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 C-N-CA 124.597 1.159 . . . . 0.0 110.873 -178.192 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 2444 ' ' THR . . . . . . . . . . . . . 26.1 p -62.66 144.3 56.43 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 124.933 1.293 . . . . 0.0 112.666 174.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 2445 ' ' GLY . . . . . . . . . . . . . . . 76.33 -9.91 18.59 Favored Glycine 0 CA--C 1.537 1.466 0 C-N-CA 124.605 1.098 . . . . 0.0 114.254 -176.088 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 2446 ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -101.0 142.11 23.97 Favored Pre-proline 0 CA--C 1.553 1.059 0 C-N-CA 126.744 2.018 . . . . 0.0 110.312 175.184 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 2447 ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -76.72 149.32 29.77 Favored 'Trans proline' 0 CA--C 1.536 0.598 0 C-N-CA 123.196 2.597 . . . . 0.0 111.858 178.757 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 2448 ' ' ALA . . . . . . . . . . . . . . . -138.89 141.51 38.56 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 125.648 1.579 . . . . 0.0 109.972 170.834 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 2449 ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -130.21 152.22 49.88 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.23 1.012 . . . . 0.0 113.396 -167.711 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 2450 ' ' PHE . . . . . . . . . . . . . 40.2 p90 -154.3 161.58 41.7 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.972 1.309 . . . . 0.0 111.746 175.445 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 2451 ' ' VAL . . . . . . . . . . . . . 12.3 p -118.26 135.37 58.89 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 C-N-CA 125.273 1.429 . . . . 0.0 110.454 175.35 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 2452 ' ' VAL . . . . . . . . . . . . . 40.9 t -89.19 104.0 14.54 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 N-CA-C 106.751 -1.574 . . . . 0.0 106.751 166.16 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 2453 ' ' ASN . . . . . . . . . . . . . 15.1 t-20 -89.17 117.1 27.9 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 123.955 0.902 . . . . 0.0 112.791 -165.904 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 2454 ' ' THR . . . . . . . . . . . . . 48.5 p -97.63 -2.67 41.01 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 125.809 1.643 . . . . 0.0 114.432 -175.592 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 2455 ' ' SER . . . . . . . . . . . . . 24.4 m -58.0 -27.43 63.5 Favored 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 114.326 1.232 . . . . 0.0 114.326 -176.672 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 2456 ' ' ASN . . . . . . . . . . . . . 81.8 m-20 -76.42 -20.78 56.75 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 124.44 1.096 . . . . 0.0 113.289 175.744 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 2457 ' ' ALA . . . . . . . . . . . . . . . -117.34 -56.49 2.23 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.649 1.18 . . . . 0.0 113.646 -157.151 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 2458 ' ' GLY . . . . . . . . . . . . . . . 113.68 -155.96 15.95 Favored Glycine 0 CA--C 1.534 1.252 0 C-N-CA 124.852 1.215 . . . . 0.0 112.375 -166.893 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 2459 ' ' ALA . . . . . . . . . . . . . . . -85.53 145.52 27.35 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 124.206 1.002 . . . . 0.0 113.681 -173.19 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 2460 ' ' GLY . . . . . . . . . . . . . . . 174.61 160.67 23.1 Favored Glycine 0 CA--C 1.532 1.127 0 C-N-CA 125.357 1.455 . . . . 0.0 113.145 -179.885 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 2461 ' ' ALA . . . . . . . . . . . . . . . -82.2 150.59 27.3 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 124.278 1.031 . . . . 0.0 112.847 -178.388 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 2462 ' ' LEU . . . . . . . . . . . . . 16.9 tp -107.68 147.36 30.83 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.56 1.544 . . . . 0.0 110.976 176.004 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 2463 ' ' SER . . . . . . . . . . . . . 9.5 t -141.06 37.37 1.75 Allowed 'General case' 0 CA--C 1.551 1.005 0 C-N-CA 125.294 1.438 . . . . 0.0 111.563 -179.469 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 2464 ' ' VAL . . . . . . . . . . . . . 12.6 p -61.01 135.73 25.45 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 C-N-CA 125.164 1.386 . . . . 0.0 112.512 -174.888 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 2465 ' ' THR . . . . . . . . . . . . . 95.9 m -136.57 145.24 44.74 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 126.003 1.721 . . . . 0.0 109.727 -179.758 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 2466 ' ' ILE . . . . . . . . . . . . . 30.1 mt -124.89 130.51 73.27 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 124.072 0.949 . . . . 0.0 110.094 176.519 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 2467 ' ' ASP . . . . . . . . . . . . . 33.7 t70 -122.51 128.12 50.4 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 125.949 1.7 . . . . 0.0 109.976 173.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 2468 ' ' GLY . . . . . . . . . . . . . . . -155.49 -166.2 15.32 Favored Glycine 0 CA--C 1.537 1.43 0 N-CA-C 115.685 1.034 . . . . 0.0 115.685 -171.174 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 2469 ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -67.72 -16.16 45.83 Favored 'Trans proline' 0 CA--C 1.539 0.765 0 C-N-CA 124.464 3.442 . . . . 0.0 113.267 178.474 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 2470 ' ' SER . . . . . . . . . . . . . 8.1 t -156.63 -168.07 2.58 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 126.491 1.916 . . . . 0.0 109.307 166.346 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 2471 ' ' LYS . . . . . . . . . . . . . 67.7 mttm -74.28 173.66 9.89 Favored 'General case' 0 CA--C 1.55 0.97 0 O-C-N 120.881 -1.137 . . . . 0.0 112.31 169.587 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 2472 ' ' VAL . . . . . . . . . . . . . 33.5 m -127.05 149.18 31.96 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 C-N-CA 125.624 1.57 . . . . 0.0 110.696 174.503 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 2473 ' ' LYS . . . . . . . . . . . . . 59.6 tttp -92.71 97.21 10.64 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 165.685 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 2474 ' ' MET . . . . . . . . . . . . . 48.4 ttp -111.58 142.26 44.12 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 124.874 1.27 . . . . 0.0 112.369 -175.445 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 2475 ' ' ASP . . . . . . . . . . . . . 36.9 t70 -126.05 141.15 52.08 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 126.791 2.037 . . . . 0.0 110.23 170.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 2476 ' ' CYS . . . . . . . . . . . . . 63.6 m -123.06 150.82 42.63 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 125.203 1.401 . . . . 0.0 111.989 -173.218 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 2477 ' ' GLN . . . . . . . . . . . . . 3.8 tt0 -151.24 147.14 26.63 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.447 1.099 . . . . 0.0 111.121 179.486 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 2478 ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -90.13 150.06 22.19 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 123.716 0.806 . . . . 0.0 111.083 163.752 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 2479 ' ' CYS . . . . . . . . . . . . . 19.9 p -160.68 172.22 6.14 Favored Pre-proline 0 CA--C 1.554 1.099 0 C-N-CA 125.626 1.571 . . . . 0.0 111.572 -178.384 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 2480 ' ' PRO . . . . . . . . . . . . . 63.6 Cg_exo -58.67 -25.06 73.73 Favored 'Trans proline' 0 CA--C 1.539 0.743 0 C-N-CA 123.454 2.77 . . . . 0.0 114.481 175.362 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 2481 ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -81.72 -8.65 59.72 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 124.814 1.246 . . . . 0.0 113.076 178.162 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 2482 ' ' GLY . . . . . . . . . . . . . . . 120.47 -143.25 16.41 Favored Glycine 0 N--CA 1.471 1.015 0 C-N-CA 126.11 1.814 . . . . 0.0 112.238 -175.263 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 2483 ' ' TYR . . . . . . . . . . . . . 80.1 m-85 -96.23 113.66 25.28 Favored 'General case' 0 N--CA 1.469 0.517 0 O-C-N 121.7 -0.883 . . . . 0.0 110.811 173.381 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 2484 ' ' ARG . . . . . . . . . . . . . 55.6 ttp85 -96.76 142.02 29.28 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 124.62 1.168 . . . . 0.0 110.278 176.85 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 2485 ' ' VAL . . . . . . . . . . . . . 11.3 m -133.97 152.78 35.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 123.806 0.843 . . . . 0.0 111.083 173.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 2486 ' ' THR . . . . . . . . . . . . . 40.5 m -131.99 133.86 44.93 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 125.656 1.583 . . . . 0.0 107.66 172.682 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 2487 ' ' TYR . . . . . . . . . . . . . 15.3 p90 -140.5 148.98 41.92 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 113.839 1.051 . . . . 0.0 113.839 176.876 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 2488 ' ' THR . . . . . . . . . . . . . 69.2 m -108.7 115.71 57.11 Favored Pre-proline 0 N--CA 1.469 0.514 0 C-N-CA 124.941 1.297 . . . . 0.0 109.108 172.611 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 2489 ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -80.49 161.26 22.37 Favored 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 123.794 2.996 . . . . 0.0 110.864 169.571 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 2490 ' ' MET . . . . . . . . . . . . . 25.7 ptm -133.4 2.8 3.56 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 114.94 1.459 . . . . 0.0 114.94 -173.703 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 2491 ' ' ALA . . . . . . . . . . . . . . . -143.42 145.55 32.35 Favored Pre-proline 0 CA--C 1.547 0.828 0 C-N-CA 124.644 1.178 . . . . 0.0 111.68 177.764 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 2492 ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -73.23 148.66 44.36 Favored 'Trans proline' 0 CA--C 1.536 0.615 0 C-N-CA 123.126 2.55 . . . . 0.0 111.08 175.851 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 2493 ' ' GLY . . . . . . . . . . . . . . . 135.05 -161.75 24.64 Favored Glycine 0 CA--C 1.53 0.988 0 C-N-CA 125.307 1.432 . . . . 0.0 112.975 -175.54 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 2494 ' ' SER . . . . . . . . . . . . . 49.3 m -105.8 118.04 35.57 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.835 0.854 . . . . 0.0 111.522 179.193 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 2495 ' ' TYR . . . . . . . . . . . . . 78.1 m-85 -88.53 114.44 25.15 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.704 1.202 . . . . 0.0 109.386 167.033 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 2496 ' ' LEU . . . . . . . . . . . . . 27.2 tp -91.0 114.36 26.86 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 125.158 1.383 . . . . 0.0 109.072 179.073 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 2497 ' ' ILE . . . . . . . . . . . . . 44.0 mt -99.88 102.17 13.07 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 C-N-CA 125.534 1.534 . . . . 0.0 108.503 -173.417 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 2498 ' ' SER . . . . . . . . . . . . . 66.5 m -84.87 93.95 8.64 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 124.954 1.302 . . . . 0.0 109.391 174.841 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 2499 ' ' ILE . . . . . . . . . . . . . 48.6 mt -87.38 95.85 5.31 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 C-N-CA 124.402 1.081 . . . . 0.0 108.526 178.884 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 2500 ' ' LYS . . . . . . . . . . . . . 91.2 mttt -98.84 138.89 35.32 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.099 0.959 . . . . 0.0 111.385 177.212 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 2501 ' ' TYR . . . . . . . . . . . . . 64.6 t80 -149.58 148.46 29.37 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.046 1.338 . . . . 0.0 112.228 -172.765 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 2502 ' ' GLY . . . . . . . . . . . . . . . 69.01 26.3 74.8 Favored Glycine 0 CA--C 1.534 1.22 0 C-N-CA 124.065 0.84 . . . . 0.0 112.639 -178.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 2503 ' ' GLY . . . . . . . . . . . . . . . 116.19 -164.45 12.28 Favored Glycine 0 CA--C 1.54 1.645 0 C-N-CA 125.877 1.703 . . . . 0.0 112.04 -164.022 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 2504 ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -81.49 33.87 0.54 Allowed 'Trans proline' 0 CA--C 1.548 1.179 0 C-N-CA 124.936 3.757 . . . . 0.0 113.165 -173.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 2505 ' ' TYR . . . . . . . . . . . . . 74.9 m-85 -114.8 127.21 55.59 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.815 1.246 . . . . 0.0 112.576 -172.053 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 2506 ' ' HIS . . . . . . . . . . . . . 86.4 m-70 -57.61 138.74 54.97 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 124.802 1.241 . . . . 0.0 113.037 178.326 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 2507 ' ' ILE . . . . . . . . . . . . . 27.1 pt -69.08 166.96 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 O-C-N 121.827 -0.545 . . . . 0.0 112.26 169.689 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 2508 ' ' GLY . . . . . . . . . . . . . . . -59.84 -21.94 56.39 Favored Glycine 0 CA--C 1.539 1.538 0 N-CA-C 116.483 1.353 . . . . 0.0 116.483 -166.688 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 2509 ' ' GLY . . . . . . . . . . . . . . . -106.36 -0.42 37.75 Favored Glycine 0 CA--C 1.536 1.399 0 C-N-CA 125.136 1.351 . . . . 0.0 114.969 174.302 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 2510 ' ' SER . . . . . . . . . . . . . 46.8 t -88.77 148.69 42.16 Favored Pre-proline 0 CA--C 1.549 0.916 0 CA-C-N 118.678 1.239 . . . . 0.0 112.824 -172.488 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 2511 ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -78.39 152.34 90.64 Favored 'Cis proline' 0 C--N 1.353 0.794 0 CA-C-N 119.31 0.789 . . . . 0.0 113.288 -1.669 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 2512 ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -102.29 128.91 48.64 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 125.291 1.437 . . . . 0.0 110.739 179.26 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 2513 ' ' LYS . . . . . . . . . . . . . 57.0 pttt -92.04 100.36 13.02 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 124.097 0.959 . . . . 0.0 112.214 178.644 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 2514 ' ' ALA . . . . . . . . . . . . . . . -88.3 114.59 25.08 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.714 1.206 . . . . 0.0 110.109 175.209 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 2515 ' ' LYS . . . . . . . . . . . . . 66.3 mttm -95.92 119.07 33.76 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 123.867 0.867 . . . . 0.0 111.093 -175.188 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 2516 ' ' VAL . . . . . . . . . . . . . 49.4 t -113.4 140.15 35.09 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 C-N-CA 125.731 1.612 . . . . 0.0 110.408 -169.798 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 2517 ' ' THR . . . . . . . . . . . . . 64.2 p -129.85 173.6 10.51 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 125.82 1.648 . . . . 0.0 111.403 -177.027 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 2518 ' ' GLY . . . . . . . . . . . . . . . 100.5 -171.14 22.81 Favored Glycine 0 CA--C 1.539 1.55 0 C-N-CA 124.705 1.145 . . . . 0.0 113.03 -174.695 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 2519 ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -72.19 157.36 54.04 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 123.719 2.946 . . . . 0.0 112.106 -176.005 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 2520 ' ' ARG . . . . . . . . . . . . . 50.9 ttt85 . . . . . 0 CA--C 1.538 0.51 0 C-N-CA 123.635 0.774 . . . . 0.0 109.665 170.499 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.537 0 N-CA-C 111.383 -0.687 . . . . 0.0 111.383 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -76.71 -28.15 55.73 Favored 'General case' 0 CA--C 1.545 0.773 0 N-CA-C 113.904 1.076 . . . . 0.0 113.904 -177.66 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 99.4 mmm -83.56 138.18 33.51 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 124.634 1.174 . . . . 0.0 112.04 -179.099 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 2427 ' ' GLY . . . . . . . . . . . . . . . -78.92 167.09 52.45 Favored Glycine 0 CA--C 1.532 1.134 0 C-N-CA 124.592 1.092 . . . . 0.0 113.003 171.638 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 2428 ' ' ASP . . . . . . . . . . . . . 13.4 t70 -150.4 135.48 9.91 Favored Pre-proline 0 CA--C 1.55 0.958 0 C-N-CA 124.471 1.108 . . . . 0.0 111.658 -174.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 2429 ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -67.16 -21.18 48.91 Favored 'Trans proline' 0 C--N 1.352 0.717 0 C-N-CA 123.44 2.76 . . . . 0.0 113.946 -175.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 2430 ' ' GLY . . . . . . . . . . . . . . . -80.48 -25.6 56.44 Favored Glycine 0 CA--C 1.532 1.115 0 CA-C-N 119.29 0.95 . . . . 0.0 113.021 174.319 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 2431 ' ' LEU . . . . . . . . . . . . . 4.4 mm? -80.61 -37.55 30.94 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 124.138 0.975 . . . . 0.0 111.058 171.218 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 2432 ' ' VAL . . . . . . . . . . . . . 74.7 t -63.5 137.62 24.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 CA-C-O 121.598 0.713 . . . . 0.0 110.607 170.333 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 2433 ' ' SER . . . . . . . . . . . . . 8.1 t -133.5 -171.4 2.7 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 125.224 1.41 . . . . 0.0 110.103 173.007 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 2434 ' ' ALA . . . . . . . . . . . . . . . -144.59 145.65 31.91 Favored 'General case' 0 CA--C 1.538 0.487 0 O-C-N 121.029 -1.044 . . . . 0.0 111.502 176.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 2435 ' ' TYR . . . . . . . . . . . . . 80.5 m-85 -145.72 154.42 42.05 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 125.454 1.501 . . . . 0.0 111.844 -174.58 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 2436 ' ' GLY . . . . . . . . . . . . . . . 113.64 162.28 14.7 Favored Glycine 0 N--CA 1.473 1.149 0 C-N-CA 125.167 1.365 . . . . 0.0 113.954 176.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 2437 ' ' ALA . . . . . . . . . . . . . . . -60.62 -27.3 67.66 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.322 1.449 . . . . 0.0 114.462 -170.19 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 2438 ' ' GLY . . . . . . . . . . . . . . . -64.83 -18.59 64.4 Favored Glycine 0 CA--C 1.531 1.033 0 CA-C-O 119.025 -0.875 . . . . 0.0 114.33 -179.081 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 2439 ' ' LEU . . . . . . . . . . . . . 87.2 mt -74.33 -24.43 59.19 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 118.576 1.188 . . . . 0.0 112.698 170.703 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 2440 ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -90.07 -28.0 19.31 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.844 1.258 . . . . 0.0 111.691 174.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 2441 ' ' GLY . . . . . . . . . . . . . . . 110.93 -137.1 14.08 Favored Glycine 0 CA--C 1.529 0.931 0 C-N-CA 125.83 1.681 . . . . 0.0 113.428 175.079 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 2442 ' ' GLY . . . . . . . . . . . . . . . 165.34 -136.31 4.13 Favored Glycine 0 N--CA 1.471 1.025 0 C-N-CA 124.032 0.825 . . . . 0.0 113.7 -172.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 2443 ' ' VAL . . . . . . . . . . . . . 73.8 t -130.2 149.3 33.45 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 125.921 1.688 . . . . 0.0 109.302 -178.104 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 2444 ' ' THR . . . . . . . . . . . . . 38.1 p -58.31 136.26 57.33 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.608 0.763 . . . . 0.0 112.005 176.566 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 2445 ' ' GLY . . . . . . . . . . . . . . . 77.67 -10.89 22.0 Favored Glycine 0 CA--C 1.538 1.484 0 C-N-CA 124.905 1.241 . . . . 0.0 114.805 -175.655 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 2446 ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -95.07 141.68 23.57 Favored Pre-proline 0 CA--C 1.553 1.079 0 C-N-CA 125.63 1.572 . . . . 0.0 110.981 177.588 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 2447 ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -74.18 134.74 19.73 Favored 'Trans proline' 0 C--N 1.35 0.649 0 C-N-CA 123.113 2.542 . . . . 0.0 111.437 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 2448 ' ' ALA . . . . . . . . . . . . . . . -116.65 119.98 37.21 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 126.688 1.995 . . . . 0.0 108.919 175.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 2449 ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -122.62 131.7 53.94 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 124.094 0.958 . . . . 0.0 111.94 -168.336 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 2450 ' ' PHE . . . . . . . . . . . . . 15.3 p90 -147.56 166.67 26.62 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 125.283 1.433 . . . . 0.0 111.107 174.307 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 2451 ' ' VAL . . . . . . . . . . . . . 15.0 p -122.42 135.47 62.42 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 C-N-CA 125.045 1.338 . . . . 0.0 110.987 176.796 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 2452 ' ' VAL . . . . . . . . . . . . . 56.9 t -85.08 107.09 15.64 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 N-CA-C 106.825 -1.546 . . . . 0.0 106.825 163.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 2453 ' ' ASN . . . . . . . . . . . . . 17.4 t-20 -92.7 119.77 32.43 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 123.389 0.676 . . . . 0.0 112.49 -168.088 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 2454 ' ' THR . . . . . . . . . . . . . 76.8 p -102.8 -1.17 30.29 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 125.739 1.615 . . . . 0.0 113.906 -178.126 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 2455 ' ' SER . . . . . . . . . . . . . 29.5 m -56.93 -29.63 63.29 Favored 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 114.478 1.288 . . . . 0.0 114.478 -174.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 2456 ' ' ASN . . . . . . . . . . . . . 86.8 m-20 -82.96 -18.42 40.02 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 124.321 1.048 . . . . 0.0 113.396 175.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 2457 ' ' ALA . . . . . . . . . . . . . . . -104.03 -36.03 7.88 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 125.533 1.533 . . . . 0.0 113.626 -172.48 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 2458 ' ' GLY . . . . . . . . . . . . . . . 105.99 -107.17 2.72 Favored Glycine 0 CA--C 1.529 0.958 0 C-N-CA 124.9 1.238 . . . . 0.0 111.167 -172.616 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 2459 ' ' ALA . . . . . . . . . . . . . . . -143.31 156.22 44.66 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.706 1.202 . . . . 0.0 112.905 -176.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 2460 ' ' GLY . . . . . . . . . . . . . . . 164.26 166.81 23.78 Favored Glycine 0 CA--C 1.532 1.136 0 C-N-CA 125.825 1.678 . . . . 0.0 112.772 -174.634 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 2461 ' ' ALA . . . . . . . . . . . . . . . -74.98 144.18 43.27 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 123.921 0.889 . . . . 0.0 112.363 -179.422 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 2462 ' ' LEU . . . . . . . . . . . . . 48.2 tp -124.83 141.73 51.92 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.291 1.436 . . . . 0.0 111.328 179.417 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 2463 ' ' SER . . . . . . . . . . . . . 15.8 t -123.71 160.42 27.27 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 125.005 1.322 . . . . 0.0 110.291 158.11 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 2464 ' ' VAL . . . . . . . . . . . . . 5.8 p -161.68 133.82 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 124.892 1.277 . . . . 0.0 110.634 -176.334 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 2465 ' ' THR . . . . . . . . . . . . . 94.2 m -137.84 138.5 39.2 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 126.048 1.739 . . . . 0.0 109.369 -177.407 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 2466 ' ' ILE . . . . . . . . . . . . . 45.3 mt -119.67 125.3 74.21 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 C-N-CA 124.39 1.076 . . . . 0.0 108.821 176.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 2467 ' ' ASP . . . . . . . . . . . . . 35.7 t70 -137.05 130.5 31.44 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 125.135 1.374 . . . . 0.0 111.296 -174.397 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 2468 ' ' GLY . . . . . . . . . . . . . . . -167.17 -142.43 3.45 Favored Glycine 0 CA--C 1.538 1.506 0 CA-C-O 118.524 -1.153 . . . . 0.0 113.883 -175.111 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 2469 ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo -68.61 -14.36 39.33 Favored 'Trans proline' 0 CA--C 1.539 0.759 0 C-N-CA 123.977 3.118 . . . . 0.0 113.58 -178.465 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 2470 ' ' SER . . . . . . . . . . . . . 7.5 t -157.73 -170.4 3.18 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 125.776 1.63 . . . . 0.0 110.356 170.625 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 2471 ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -77.48 171.39 14.96 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 124.245 1.018 . . . . 0.0 111.824 168.079 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 2472 ' ' VAL . . . . . . . . . . . . . 28.7 m -135.07 151.75 31.4 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 125.376 1.471 . . . . 0.0 110.389 175.097 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 2473 ' ' LYS . . . . . . . . . . . . . 99.7 mttt -93.59 118.51 31.46 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.811 0.845 . . . . 0.0 109.451 170.088 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 2474 ' ' MET . . . . . . . . . . . . . 77.2 mtp -111.13 137.34 48.93 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 125.282 1.433 . . . . 0.0 112.54 -175.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 2475 ' ' ASP . . . . . . . . . . . . . 25.8 t70 -113.59 94.89 5.06 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 126.364 1.866 . . . . 0.0 109.042 162.371 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 2476 ' ' CYS . . . . . . . . . . . . . 47.5 t -91.35 129.43 37.34 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.382 1.073 . . . . 0.0 110.123 173.374 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 2477 ' ' GLN . . . . . . . . . . . . . 70.1 mm-40 -142.33 140.17 32.04 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 124.571 1.148 . . . . 0.0 110.821 -175.527 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 2478 ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -82.22 148.1 28.61 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 123.63 0.772 . . . . 0.0 111.854 173.06 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 2479 ' ' CYS . . . . . . . . . . . . . 31.9 p -161.36 171.7 6.59 Favored Pre-proline 0 CA--C 1.553 1.086 0 C-N-CA 125.639 1.576 . . . . 0.0 111.863 -175.005 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 2480 ' ' PRO . . . . . . . . . . . . . 66.0 Cg_exo -58.42 -24.73 70.24 Favored 'Trans proline' 0 CA--C 1.539 0.772 0 C-N-CA 123.348 2.699 . . . . 0.0 114.341 174.137 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 2481 ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -81.69 -6.51 59.09 Favored 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 124.981 1.312 . . . . 0.0 113.047 177.374 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 2482 ' ' GLY . . . . . . . . . . . . . . . 120.43 -118.04 3.73 Favored Glycine 0 N--CA 1.469 0.883 0 C-N-CA 126.08 1.8 . . . . 0.0 111.987 -176.709 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 2483 ' ' TYR . . . . . . . . . . . . . 93.4 m-85 -124.14 111.78 16.32 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.211 1.004 . . . . 0.0 110.651 173.787 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 2484 ' ' ARG . . . . . . . . . . . . . 13.7 ttp-105 -78.07 139.52 39.08 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 123.871 0.869 . . . . 0.0 109.807 173.571 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 2485 ' ' VAL . . . . . . . . . . . . . 90.7 t -126.96 116.09 43.5 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 C-N-CA 125.202 1.401 . . . . 0.0 108.257 170.719 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 2486 ' ' THR . . . . . . . . . . . . . 87.2 m -103.44 133.61 48.2 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 107.478 -1.304 . . . . 0.0 107.478 164.403 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 2487 ' ' TYR . . . . . . . . . . . . . 27.5 p90 -139.14 155.13 48.09 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 113.166 0.802 . . . . 0.0 113.166 176.4 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 2488 ' ' THR . . . . . . . . . . . . . 93.0 m -120.1 116.97 32.33 Favored Pre-proline 0 N--CA 1.474 0.737 0 C-N-CA 124.205 1.002 . . . . 0.0 109.774 176.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 2489 ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -82.5 158.4 16.83 Favored 'Trans proline' 0 C--N 1.351 0.681 0 C-N-CA 123.97 3.113 . . . . 0.0 111.551 173.402 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 2490 ' ' MET . . . . . . . . . . . . . 25.3 ptm -132.78 7.71 4.09 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 114.612 1.338 . . . . 0.0 114.612 -176.218 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 2491 ' ' ALA . . . . . . . . . . . . . . . -144.83 143.83 22.3 Favored Pre-proline 0 CA--C 1.547 0.838 0 C-N-CA 125.357 1.463 . . . . 0.0 111.224 172.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 2492 ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -76.16 156.86 38.0 Favored 'Trans proline' 0 CA--C 1.536 0.616 0 C-N-CA 123.704 2.936 . . . . 0.0 111.138 175.47 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 2493 ' ' GLY . . . . . . . . . . . . . . . 130.47 -140.37 11.71 Favored Glycine 0 CA--C 1.528 0.89 0 C-N-CA 125.643 1.592 . . . . 0.0 111.181 -171.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 2494 ' ' SER . . . . . . . . . . . . . 54.4 p -140.93 138.59 33.95 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 113.333 0.864 . . . . 0.0 113.333 178.628 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 2495 ' ' TYR . . . . . . . . . . . . . 56.6 m-85 -111.13 131.48 55.06 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 126.215 1.806 . . . . 0.0 110.412 -178.666 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 2496 ' ' LEU . . . . . . . . . . . . . 86.2 mt -86.62 123.2 31.54 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 124.459 1.103 . . . . 0.0 109.33 169.766 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 2497 ' ' ILE . . . . . . . . . . . . . 49.7 mt -100.93 94.45 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 C-N-CA 125.641 1.576 . . . . 0.0 107.939 179.391 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 2498 ' ' SER . . . . . . . . . . . . . 67.1 m -88.71 119.3 29.06 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 125.594 1.557 . . . . 0.0 110.245 -178.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 2499 ' ' ILE . . . . . . . . . . . . . 33.7 mt -127.09 121.4 57.76 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 C-N-CA 125.223 1.409 . . . . 0.0 108.088 -170.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 2500 ' ' LYS . . . . . . . . . . . . . 93.0 mttt -131.8 119.22 20.96 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 123.857 0.863 . . . . 0.0 112.063 -168.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 2501 ' ' TYR . . . . . . . . . . . . . 66.6 t80 -125.87 137.74 53.76 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.796 1.239 . . . . 0.0 112.507 -169.459 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 2502 ' ' GLY . . . . . . . . . . . . . . . 70.06 10.26 64.9 Favored Glycine 0 CA--C 1.537 1.444 0 C-N-CA 124.445 1.022 . . . . 0.0 114.318 -178.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 2503 ' ' GLY . . . . . . . . . . . . . . . 149.94 -176.3 28.66 Favored Glycine 0 CA--C 1.54 1.615 0 C-N-CA 126.094 1.806 . . . . 0.0 112.849 -171.454 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 2504 ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -81.45 34.57 0.55 Allowed 'Trans proline' 0 CA--C 1.546 1.111 0 C-N-CA 125.193 3.929 . . . . 0.0 113.346 -173.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 2505 ' ' TYR . . . . . . . . . . . . . 82.6 m-85 -122.53 135.63 54.69 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 125.026 1.33 . . . . 0.0 112.296 -174.355 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 2506 ' ' HIS . . . . . . . . . . . . . 94.8 m-70 -60.51 140.75 57.17 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 124.254 1.022 . . . . 0.0 113.676 -176.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 2507 ' ' ILE . . . . . . . . . . . . . 1.9 pp -75.98 167.85 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 C-N-CA 123.562 0.745 . . . . 0.0 112.505 172.277 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 2508 ' ' GLY . . . . . . . . . . . . . . . -58.33 112.4 3.93 Favored Glycine 0 CA--C 1.533 1.166 0 C-N-CA 124.003 0.811 . . . . 0.0 112.877 -174.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 2509 ' ' GLY . . . . . . . . . . . . . . . 95.47 -8.94 69.24 Favored Glycine 0 CA--C 1.536 1.37 0 C-N-CA 125.983 1.754 . . . . 0.0 115.004 -178.105 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 2510 ' ' SER . . . . . . . . . . . . . 13.3 t -84.78 145.82 44.94 Favored Pre-proline 0 CA--C 1.552 1.047 0 CA-C-N 119.195 1.498 . . . . 0.0 112.0 179.731 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 2511 ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -75.39 144.25 79.9 Favored 'Cis proline' 0 C--N 1.354 0.83 0 CA-C-N 120.217 1.113 . . . . 0.0 113.026 -0.57 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 2512 ' ' PHE . . . . . . . . . . . . . 94.9 m-85 -96.94 134.1 40.73 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.511 1.124 . . . . 0.0 110.519 175.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 2513 ' ' LYS . . . . . . . . . . . . . 59.6 pttt -89.54 105.56 17.88 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 123.686 0.794 . . . . 0.0 112.358 176.27 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 2514 ' ' ALA . . . . . . . . . . . . . . . -91.88 126.86 37.13 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 125.261 1.424 . . . . 0.0 110.374 174.522 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 2515 ' ' LYS . . . . . . . . . . . . . 30.6 mtpp -101.38 134.44 44.46 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 124.712 1.205 . . . . 0.0 111.123 -175.295 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 2516 ' ' VAL . . . . . . . . . . . . . 84.7 t -132.58 137.01 55.09 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 C-N-CA 124.493 1.117 . . . . 0.0 110.715 -169.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 2517 ' ' THR . . . . . . . . . . . . . 73.4 p -123.65 -177.27 3.68 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 125.741 1.616 . . . . 0.0 110.965 176.219 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 2518 ' ' GLY . . . . . . . . . . . . . . . 98.62 -176.52 29.98 Favored Glycine 0 CA--C 1.54 1.621 0 C-N-CA 124.749 1.166 . . . . 0.0 113.465 -176.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 2519 ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -71.1 151.08 61.11 Favored 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 123.814 3.009 . . . . 0.0 111.885 -176.263 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 2520 ' ' ARG . . . . . . . . . . . . . 21.5 ttt85 -91.15 129.0 37.19 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 123.872 0.869 . . . . 0.0 110.896 176.144 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 2521 ' ' LEU . . . . . . . . . . . . . 3.9 mm? -92.45 -12.15 32.86 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.374 1.07 . . . . 0.0 113.79 -174.635 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 2522 ' ' VAL . . . . . . . . . . . . . 9.2 p . . . . . 0 N--CA 1.483 1.202 0 C-N-CA 125.028 1.331 . . . . 0.0 113.425 -171.942 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.509 0 N-CA-C 111.447 -0.661 . . . . 0.0 111.447 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -72.86 165.83 24.15 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 124.452 1.101 . . . . 0.0 112.861 177.398 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 97.9 mmm -75.94 -18.17 59.45 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.389 1.076 . . . . 0.0 113.769 179.487 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 2427 ' ' GLY . . . . . . . . . . . . . . . -76.28 128.81 9.61 Favored Glycine 0 CA--C 1.527 0.795 0 C-N-CA 124.437 1.018 . . . . 0.0 112.594 -175.258 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 2428 ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -148.9 143.37 17.02 Favored Pre-proline 0 CA--C 1.545 0.765 0 C-N-CA 125.078 1.351 . . . . 0.0 111.643 178.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 2429 ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -65.32 -24.4 57.83 Favored 'Trans proline' 0 C--N 1.351 0.707 0 C-N-CA 123.215 2.61 . . . . 0.0 112.773 177.715 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 2430 ' ' GLY . . . . . . . . . . . . . . . -75.59 -23.28 73.38 Favored Glycine 0 CA--C 1.535 1.317 0 CA-C-N 119.065 0.848 . . . . 0.0 113.805 174.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 2431 ' ' LEU . . . . . . . . . . . . . 4.4 mm? -86.95 -33.16 19.76 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.492 1.117 . . . . 0.0 111.616 173.682 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 2432 ' ' VAL . . . . . . . . . . . . . 53.4 t -70.16 138.31 22.26 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 C-N-CA 124.166 0.987 . . . . 0.0 111.092 172.005 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 2433 ' ' SER . . . . . . . . . . . . . 58.5 m -139.13 146.96 41.28 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 125.705 1.602 . . . . 0.0 109.628 173.549 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 2434 ' ' ALA . . . . . . . . . . . . . . . -98.98 149.36 23.06 Favored 'General case' 0 CA--C 1.54 0.568 0 O-C-N 121.528 -0.733 . . . . 0.0 112.13 176.219 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 2435 ' ' TYR . . . . . . . . . . . . . 89.7 m-85 -142.67 145.18 33.17 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.831 1.652 . . . . 0.0 111.563 -178.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 2436 ' ' GLY . . . . . . . . . . . . . . . 126.93 160.4 10.52 Favored Glycine 0 N--CA 1.474 1.193 0 C-N-CA 125.325 1.44 . . . . 0.0 113.948 178.379 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 2437 ' ' ALA . . . . . . . . . . . . . . . -63.18 -28.83 70.32 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 114.283 1.216 . . . . 0.0 114.283 -171.186 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 2438 ' ' GLY . . . . . . . . . . . . . . . -66.95 -11.08 57.62 Favored Glycine 0 CA--C 1.531 1.093 0 C-N-CA 124.437 1.018 . . . . 0.0 114.501 -178.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 2439 ' ' LEU . . . . . . . . . . . . . 75.6 mt -78.68 -25.22 44.8 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 118.537 1.168 . . . . 0.0 112.594 170.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 2440 ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -94.46 -31.98 13.72 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.897 1.279 . . . . 0.0 112.361 -175.165 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 2441 ' ' GLY . . . . . . . . . . . . . . . 159.22 -155.08 26.15 Favored Glycine 0 CA--C 1.527 0.807 0 C-N-CA 124.45 1.024 . . . . 0.0 113.575 -176.225 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 2442 ' ' GLY . . . . . . . . . . . . . . . 168.01 -171.9 42.54 Favored Glycine 0 CA--C 1.529 0.93 0 C-N-CA 124.636 1.112 . . . . 0.0 113.498 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 2443 ' ' VAL . . . . . . . . . . . . . 95.4 t -117.6 137.55 51.17 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 125.379 1.471 . . . . 0.0 108.996 176.452 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 2444 ' ' THR . . . . . . . . . . . . . 21.5 p -57.99 136.62 57.13 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.18 0.992 . . . . 0.0 112.232 177.308 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 2445 ' ' GLY . . . . . . . . . . . . . . . 79.61 -12.53 27.53 Favored Glycine 0 CA--C 1.534 1.274 0 C-N-CA 124.624 1.107 . . . . 0.0 114.713 -178.644 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 2446 ' ' ASN . . . . . . . . . . . . . 80.5 m-20 -99.43 150.15 36.5 Favored Pre-proline 0 CA--C 1.547 0.843 0 C-N-CA 124.898 1.279 . . . . 0.0 110.825 173.266 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 2447 ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -70.75 142.51 43.76 Favored 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 122.756 2.304 . . . . 0.0 111.01 175.163 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 2448 ' ' ALA . . . . . . . . . . . . . . . -128.35 135.31 49.4 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 126.726 2.011 . . . . 0.0 108.618 171.209 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 2449 ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -142.11 154.04 44.59 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 114.324 1.231 . . . . 0.0 114.324 -163.12 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 2450 ' ' PHE . . . . . . . . . . . . . 54.3 p90 -158.56 155.28 28.04 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 126.118 1.767 . . . . 0.0 111.405 -179.225 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 2451 ' ' VAL . . . . . . . . . . . . . 59.6 t -111.39 129.29 67.0 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 C-N-CA 125.11 1.364 . . . . 0.0 108.914 173.361 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 2452 ' ' VAL . . . . . . . . . . . . . 39.0 t -84.19 101.4 8.71 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 N-CA-C 107.208 -1.405 . . . . 0.0 107.208 166.016 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 2453 ' ' ASN . . . . . . . . . . . . . 19.3 t-20 -83.11 124.74 30.77 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 123.478 0.711 . . . . 0.0 112.472 -169.356 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 2454 ' ' THR . . . . . . . . . . . . . 40.4 p -103.96 -1.25 27.86 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 125.696 1.598 . . . . 0.0 113.881 -179.001 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 2455 ' ' SER . . . . . . . . . . . . . 44.5 m -57.8 -29.13 64.64 Favored 'General case' 0 N--CA 1.48 1.047 0 CA-C-N 120.32 1.418 . . . . 0.0 114.441 -175.445 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 2456 ' ' ASN . . . . . . . . . . . . . 67.3 m-80 -86.86 -11.99 49.18 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 124.688 1.195 . . . . 0.0 113.557 176.152 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 2457 ' ' ALA . . . . . . . . . . . . . . . -112.54 -22.33 10.85 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 126.172 1.789 . . . . 0.0 113.851 -174.073 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 2458 ' ' GLY . . . . . . . . . . . . . . . 91.36 -85.89 1.28 Allowed Glycine 0 CA--C 1.529 0.943 0 C-N-CA 124.986 1.279 . . . . 0.0 111.338 -176.496 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 2459 ' ' ALA . . . . . . . . . . . . . . . -157.84 157.14 32.7 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 124.987 1.315 . . . . 0.0 112.617 -176.466 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 2460 ' ' GLY . . . . . . . . . . . . . . . 165.09 167.34 25.52 Favored Glycine 0 CA--C 1.532 1.126 0 C-N-CA 125.545 1.545 . . . . 0.0 113.008 -176.145 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 2461 ' ' ALA . . . . . . . . . . . . . . . -77.96 145.64 35.94 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.265 1.026 . . . . 0.0 112.572 -178.737 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 2462 ' ' LEU . . . . . . . . . . . . . 29.9 tp -121.21 141.6 50.7 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 125.336 1.455 . . . . 0.0 110.999 178.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 2463 ' ' SER . . . . . . . . . . . . . 29.7 t -102.24 -109.75 0.23 Allowed 'General case' 0 CA--C 1.552 1.02 0 C-N-CA 125.24 1.416 . . . . 0.0 110.014 171.119 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 2464 ' ' VAL . . . . . . . . . . . . . 48.3 t 105.31 123.57 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.247 0 C-N-CA 131.659 3.984 . . . . 0.0 109.702 172.647 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 2465 ' ' THR . . . . . . . . . . . . . 89.9 m -131.95 139.29 48.64 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 125.408 1.483 . . . . 0.0 109.076 174.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 2466 ' ' ILE . . . . . . . . . . . . . 35.8 mt -119.15 117.39 54.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 123.634 0.773 . . . . 0.0 109.649 175.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 2467 ' ' ASP . . . . . . . . . . . . . 34.8 t70 -95.17 162.34 13.74 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 125.776 1.631 . . . . 0.0 110.286 168.638 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 2468 ' ' GLY . . . . . . . . . . . . . . . 168.73 -166.78 39.9 Favored Glycine 0 CA--C 1.536 1.358 0 O-C-N 121.125 -0.985 . . . . 0.0 114.717 178.794 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 2469 ' ' PRO . . . . . . . . . . . . . 76.1 Cg_endo -70.94 -15.86 32.66 Favored 'Trans proline' 0 CA--C 1.541 0.853 0 C-N-CA 123.969 3.113 . . . . 0.0 113.088 177.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 2470 ' ' SER . . . . . . . . . . . . . 37.2 m -153.67 174.52 14.38 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 126.868 2.067 . . . . 0.0 110.343 175.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 2471 ' ' LYS . . . . . . . . . . . . . 67.9 mttm -68.32 167.54 14.3 Favored 'General case' 0 CA--C 1.549 0.918 0 O-C-N 121.252 -0.905 . . . . 0.0 112.181 168.611 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 2472 ' ' VAL . . . . . . . . . . . . . 14.3 m -133.35 144.9 34.84 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 125.468 1.507 . . . . 0.0 111.34 -179.583 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 2473 ' ' LYS . . . . . . . . . . . . . 14.5 mmmm -89.31 71.27 8.18 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.337 1.055 . . . . 0.0 111.588 -179.263 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 2474 ' ' MET . . . . . . . . . . . . . 92.0 mtp -69.77 140.74 53.43 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 124.494 1.118 . . . . 0.0 112.969 -178.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 2475 ' ' ASP . . . . . . . . . . . . . 30.5 t70 -133.4 125.15 28.46 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 126.97 2.108 . . . . 0.0 108.755 163.117 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 2476 ' ' CYS . . . . . . . . . . . . . 42.6 t -122.18 132.75 54.61 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.797 1.239 . . . . 0.0 110.956 -177.706 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 2477 ' ' GLN . . . . . . . . . . . . . 15.9 mm100 -142.02 151.86 42.85 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 125.454 1.502 . . . . 0.0 110.721 -178.622 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 2478 ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -79.88 151.75 30.01 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 123.412 0.685 . . . . 0.0 111.67 169.343 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 2479 ' ' CYS . . . . . . . . . . . . . 19.5 p -156.82 172.15 6.5 Favored Pre-proline 0 CA--C 1.553 1.096 0 C-N-CA 126.083 1.753 . . . . 0.0 111.505 -176.576 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 2480 ' ' PRO . . . . . . . . . . . . . 58.0 Cg_exo -59.02 -26.2 80.71 Favored 'Trans proline' 0 CA--C 1.539 0.75 0 C-N-CA 123.342 2.694 . . . . 0.0 114.584 176.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 2481 ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -88.37 -6.1 57.9 Favored 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 125.382 1.473 . . . . 0.0 113.154 -179.086 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 2482 ' ' GLY . . . . . . . . . . . . . . . 128.24 -132.21 7.26 Favored Glycine 0 N--CA 1.472 1.055 0 C-N-CA 125.335 1.445 . . . . 0.0 112.164 -176.324 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 2483 ' ' TYR . . . . . . . . . . . . . 95.1 m-85 -108.78 117.62 34.67 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 123.809 0.844 . . . . 0.0 110.854 173.551 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 2484 ' ' ARG . . . . . . . . . . . . . 57.5 ttt180 -92.43 130.55 38.07 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 124.117 0.967 . . . . 0.0 110.676 177.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 2485 ' ' VAL . . . . . . . . . . . . . 89.9 t -114.09 132.76 62.18 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 C-N-CA 125.863 1.665 . . . . 0.0 108.47 172.823 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 2486 ' ' THR . . . . . . . . . . . . . 95.4 m -125.6 137.22 53.89 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 125.11 1.364 . . . . 0.0 107.821 169.06 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 2487 ' ' TYR . . . . . . . . . . . . . 21.6 p90 -144.09 152.75 41.37 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 123.72 0.808 . . . . 0.0 112.604 177.415 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 2488 ' ' THR . . . . . . . . . . . . . 84.4 m -113.25 119.71 41.61 Favored Pre-proline 0 N--CA 1.474 0.753 0 CA-C-O 117.892 -1.051 . . . . 0.0 109.466 173.287 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 2489 ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -83.67 154.75 13.66 Favored 'Trans proline' 0 CA--C 1.537 0.634 0 C-N-CA 124.064 3.176 . . . . 0.0 111.209 171.298 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 2490 ' ' MET . . . . . . . . . . . . . 28.0 ptm -119.69 -2.37 10.44 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 114.892 1.441 . . . . 0.0 114.892 -174.211 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 2491 ' ' ALA . . . . . . . . . . . . . . . -147.25 148.23 31.14 Favored Pre-proline 0 CA--C 1.545 0.786 0 C-N-CA 125.687 1.595 . . . . 0.0 110.896 177.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 2492 ' ' PRO . . . . . . . . . . . . . 74.9 Cg_endo -72.18 153.91 56.9 Favored 'Trans proline' 0 CA--C 1.536 0.584 0 C-N-CA 123.043 2.495 . . . . 0.0 111.161 174.546 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 2493 ' ' GLY . . . . . . . . . . . . . . . 135.39 -170.12 23.12 Favored Glycine 0 CA--C 1.529 0.949 0 C-N-CA 125.363 1.459 . . . . 0.0 113.313 -177.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 2494 ' ' SER . . . . . . . . . . . . . 70.3 m -95.54 121.07 36.85 Favored 'General case' 0 N--CA 1.471 0.61 0 O-C-N 121.839 -0.8 . . . . 0.0 111.818 179.303 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 2495 ' ' TYR . . . . . . . . . . . . . 63.5 m-85 -99.07 126.01 44.71 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 125.156 1.382 . . . . 0.0 109.706 171.43 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 2496 ' ' LEU . . . . . . . . . . . . . 26.1 tp -101.2 110.68 22.73 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.359 1.064 . . . . 0.0 109.44 -176.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 2497 ' ' ILE . . . . . . . . . . . . . 39.8 mt -96.56 96.48 5.54 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 C-N-CA 125.688 1.595 . . . . 0.0 108.618 -172.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 2498 ' ' SER . . . . . . . . . . . . . 68.9 m -80.86 83.54 6.58 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 125.409 1.484 . . . . 0.0 110.165 176.795 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 2499 ' ' ILE . . . . . . . . . . . . . 50.5 mt -79.91 114.53 20.9 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 C-N-CA 124.31 1.044 . . . . 0.0 109.227 177.025 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 2500 ' ' LYS . . . . . . . . . . . . . 83.7 mttt -127.52 133.33 49.83 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 125.03 1.332 . . . . 0.0 111.769 -175.165 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 2501 ' ' TYR . . . . . . . . . . . . . 64.4 t80 -141.83 143.09 33.22 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 125.465 1.506 . . . . 0.0 111.805 -170.332 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 2502 ' ' GLY . . . . . . . . . . . . . . . 69.26 11.86 65.01 Favored Glycine 0 CA--C 1.536 1.388 0 C-N-CA 124.443 1.02 . . . . 0.0 114.474 177.729 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 2503 ' ' GLY . . . . . . . . . . . . . . . 145.9 -165.6 28.05 Favored Glycine 0 CA--C 1.54 1.614 0 C-N-CA 125.731 1.634 . . . . 0.0 112.999 -170.487 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 2504 ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -82.28 13.72 2.46 Favored 'Trans proline' 0 CA--C 1.544 0.999 0 C-N-CA 124.762 3.641 . . . . 0.0 113.962 -174.318 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 2505 ' ' TYR . . . . . . . . . . . . . 84.0 m-85 -106.22 142.32 36.1 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.78 1.232 . . . . 0.0 113.452 -173.325 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 2506 ' ' HIS . . . . . . . . . . . . . 97.7 m-70 -65.03 143.89 57.64 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 124.762 1.225 . . . . 0.0 113.046 178.282 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 2507 ' ' ILE . . . . . . . . . . . . . 20.4 pt -73.65 175.6 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 N-CA-C 113.437 0.902 . . . . 0.0 113.437 173.583 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 2508 ' ' GLY . . . . . . . . . . . . . . . -58.95 119.53 18.34 Favored Glycine 0 CA--C 1.534 1.232 0 O-C-N 121.487 -0.758 . . . . 0.0 111.512 172.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 2509 ' ' GLY . . . . . . . . . . . . . . . 87.19 -6.76 82.76 Favored Glycine 0 CA--C 1.536 1.359 0 C-N-CA 125.616 1.579 . . . . 0.0 115.034 -176.733 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 2510 ' ' SER . . . . . . . . . . . . . 43.8 t -89.09 147.67 39.13 Favored Pre-proline 0 CA--C 1.549 0.938 0 CA-C-N 118.914 1.357 . . . . 0.0 112.043 -179.005 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 2511 ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -74.46 146.22 86.16 Favored 'Cis proline' 0 C--N 1.353 0.808 0 CA-C-N 119.671 0.918 . . . . 0.0 112.608 -1.036 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 2512 ' ' PHE . . . . . . . . . . . . . 94.7 m-85 -96.3 126.41 41.49 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.612 1.165 . . . . 0.0 110.797 179.627 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 2513 ' ' LYS . . . . . . . . . . . . . 85.0 tttt -94.5 100.16 12.2 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.025 0.93 . . . . 0.0 111.407 -179.03 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 2514 ' ' ALA . . . . . . . . . . . . . . . -89.02 115.46 26.6 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.355 1.462 . . . . 0.0 110.913 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 2515 ' ' LYS . . . . . . . . . . . . . 48.4 mtpt -94.04 98.64 11.14 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 124.099 0.959 . . . . 0.0 110.529 -174.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 2516 ' ' VAL . . . . . . . . . . . . . 63.7 t -90.96 140.74 15.49 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 125.673 1.589 . . . . 0.0 110.496 -173.39 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 2517 ' ' THR . . . . . . . . . . . . . 72.0 p -124.4 -177.33 3.76 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 125.582 1.553 . . . . 0.0 111.121 177.093 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 2518 ' ' GLY . . . . . . . . . . . . . . . 98.34 178.34 32.81 Favored Glycine 0 CA--C 1.539 1.558 0 C-N-CA 124.752 1.167 . . . . 0.0 113.561 -177.183 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 2519 ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -73.43 141.82 32.24 Favored 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 123.776 2.984 . . . . 0.0 111.932 -173.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 2520 ' ' ARG . . . . . . . . . . . . . 37.6 ttm180 -68.13 126.46 29.58 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 122.959 0.503 . . . . 0.0 110.004 172.733 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 2521 ' ' LEU . . . . . . . . . . . . . 52.5 mt -83.27 -28.57 29.05 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 123.613 0.765 . . . . 0.0 112.762 -175.624 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 2522 ' ' VAL . . . . . . . . . . . . . 9.1 p . . . . . 0 C--O 1.253 1.249 0 C-N-CA 126.013 1.725 . . . . 0.0 112.625 176.105 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.552 0 N-CA-C 112.092 -0.403 . . . . 0.0 112.092 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -73.89 164.2 26.94 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 124.456 1.102 . . . . 0.0 113.002 178.271 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 98.6 mmm -87.49 -9.27 55.0 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.966 1.306 . . . . 0.0 113.629 175.516 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 2427 ' ' GLY . . . . . . . . . . . . . . . 81.01 161.56 26.62 Favored Glycine 0 CA--C 1.531 1.055 0 C-N-CA 125.332 1.444 . . . . 0.0 113.166 -177.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 2428 ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -143.52 135.64 13.2 Favored Pre-proline 0 CA--C 1.544 0.738 0 C-N-CA 124.785 1.234 . . . . 0.0 111.204 178.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 2429 ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -67.94 -22.59 41.95 Favored 'Trans proline' 0 CA--C 1.537 0.648 0 C-N-CA 122.964 2.443 . . . . 0.0 113.003 -178.347 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 2430 ' ' GLY . . . . . . . . . . . . . . . -76.72 -23.12 70.64 Favored Glycine 0 CA--C 1.535 1.292 0 CA-C-N 118.864 0.756 . . . . 0.0 113.557 173.399 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 2431 ' ' LEU . . . . . . . . . . . . . 4.3 mm? -87.72 -35.46 17.93 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.514 1.126 . . . . 0.0 111.353 173.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 2432 ' ' VAL . . . . . . . . . . . . . 74.2 t -64.91 139.6 21.13 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 123.389 0.676 . . . . 0.0 110.473 169.639 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 2433 ' ' SER . . . . . . . . . . . . . 8.5 t -131.37 -176.21 3.95 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.942 1.297 . . . . 0.0 110.507 173.162 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 2434 ' ' ALA . . . . . . . . . . . . . . . -141.96 143.19 33.1 Favored 'General case' 0 CA--C 1.538 0.5 0 O-C-N 121.042 -1.036 . . . . 0.0 111.712 177.107 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 2435 ' ' TYR . . . . . . . . . . . . . 79.1 m-85 -143.65 157.5 44.36 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.536 1.534 . . . . 0.0 111.899 -175.111 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 2436 ' ' GLY . . . . . . . . . . . . . . . 108.05 159.75 20.37 Favored Glycine 0 N--CA 1.474 1.17 0 C-N-CA 125.244 1.402 . . . . 0.0 113.694 177.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 2437 ' ' ALA . . . . . . . . . . . . . . . -62.88 -27.42 69.34 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.075 1.35 . . . . 0.0 114.582 -169.294 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 2438 ' ' GLY . . . . . . . . . . . . . . . -66.27 -14.12 61.29 Favored Glycine 0 CA--C 1.532 1.114 0 C-N-CA 123.974 0.797 . . . . 0.0 114.683 -176.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 2439 ' ' LEU . . . . . . . . . . . . . 88.1 mt -72.07 -22.74 61.32 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 118.466 1.133 . . . . 0.0 112.761 170.233 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 2440 ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -94.48 -16.59 23.21 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 125.076 1.35 . . . . 0.0 112.82 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 2441 ' ' GLY . . . . . . . . . . . . . . . 102.92 -138.82 14.15 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 125.559 1.552 . . . . 0.0 112.39 -177.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 2442 ' ' GLY . . . . . . . . . . . . . . . 150.81 -140.72 8.1 Favored Glycine 0 CA--C 1.532 1.125 0 C-N-CA 124.007 0.813 . . . . 0.0 114.088 -177.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 2443 ' ' VAL . . . . . . . . . . . . . 99.2 t -113.08 139.15 39.77 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 C-N-CA 125.601 1.561 . . . . 0.0 110.115 -175.156 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 2444 ' ' THR . . . . . . . . . . . . . 30.1 p -61.72 142.9 56.95 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 124.302 1.041 . . . . 0.0 112.412 176.41 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 2445 ' ' GLY . . . . . . . . . . . . . . . 79.01 -10.61 32.65 Favored Glycine 0 CA--C 1.537 1.412 0 C-N-CA 124.462 1.03 . . . . 0.0 114.558 -177.118 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 2446 ' ' ASN . . . . . . . . . . . . . 79.7 m-20 -101.59 148.39 35.17 Favored Pre-proline 0 CA--C 1.548 0.87 0 C-N-CA 124.94 1.296 . . . . 0.0 111.117 174.159 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 2447 ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -73.75 129.88 14.02 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 123.176 2.584 . . . . 0.0 111.276 178.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 2448 ' ' ALA . . . . . . . . . . . . . . . -101.87 116.34 32.5 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 126.222 1.809 . . . . 0.0 109.031 170.485 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 2449 ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -111.96 132.79 54.55 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.389 1.076 . . . . 0.0 111.66 -172.319 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 2450 ' ' PHE . . . . . . . . . . . . . 37.8 p90 -147.59 168.56 21.68 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.48 1.512 . . . . 0.0 110.882 171.277 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 2451 ' ' VAL . . . . . . . . . . . . . 14.7 p -126.94 136.93 59.4 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 C-N-CA 124.609 1.164 . . . . 0.0 110.508 174.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 2452 ' ' VAL . . . . . . . . . . . . . 22.0 t -89.5 103.8 14.43 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 N-CA-C 106.797 -1.557 . . . . 0.0 106.797 164.669 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 2453 ' ' ASN . . . . . . . . . . . . . 18.6 t-20 -91.29 120.18 31.96 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 123.874 0.87 . . . . 0.0 112.271 -167.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 2454 ' ' THR . . . . . . . . . . . . . 75.1 p -104.24 2.62 31.84 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 125.958 1.703 . . . . 0.0 113.887 -175.397 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 2455 ' ' SER . . . . . . . . . . . . . 45.2 m -56.89 -27.5 60.72 Favored 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 114.782 1.401 . . . . 0.0 114.782 -173.482 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 2456 ' ' ASN . . . . . . . . . . . . . 70.1 m-80 -91.6 -12.22 34.93 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 124.537 1.135 . . . . 0.0 113.644 176.339 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 2457 ' ' ALA . . . . . . . . . . . . . . . -106.6 -33.43 7.66 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 125.575 1.55 . . . . 0.0 113.759 -174.801 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 2458 ' ' GLY . . . . . . . . . . . . . . . 87.28 -152.84 24.76 Favored Glycine 0 CA--C 1.533 1.171 0 C-N-CA 124.779 1.181 . . . . 0.0 112.202 -172.099 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 2459 ' ' ALA . . . . . . . . . . . . . . . -69.22 151.94 45.69 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 123.924 0.89 . . . . 0.0 112.6 178.127 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 2460 ' ' GLY . . . . . . . . . . . . . . . 159.86 157.62 8.72 Favored Glycine 0 CA--C 1.532 1.103 0 C-N-CA 125.302 1.43 . . . . 0.0 113.193 179.4 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 2461 ' ' ALA . . . . . . . . . . . . . . . -85.1 139.88 31.39 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.262 1.025 . . . . 0.0 113.346 -172.659 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 2462 ' ' LEU . . . . . . . . . . . . . 31.6 tp -106.4 146.55 30.34 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.778 1.631 . . . . 0.0 111.023 175.765 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 2463 ' ' SER . . . . . . . . . . . . . 4.0 t -137.62 42.13 2.34 Favored 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 125.885 1.674 . . . . 0.0 110.91 -178.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 2464 ' ' VAL . . . . . . . . . . . . . 11.0 p -63.98 135.34 27.94 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.975 0 C-N-CA 124.982 1.313 . . . . 0.0 112.017 -175.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 2465 ' ' THR . . . . . . . . . . . . . 96.3 m -136.41 145.17 44.98 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 125.925 1.69 . . . . 0.0 109.591 -179.16 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 2466 ' ' ILE . . . . . . . . . . . . . 40.6 mt -121.96 123.42 69.06 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 C-N-CA 123.748 0.819 . . . . 0.0 109.98 173.717 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 2467 ' ' ASP . . . . . . . . . . . . . 36.7 t70 -99.39 155.62 17.44 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 125.836 1.655 . . . . 0.0 110.179 166.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 2468 ' ' GLY . . . . . . . . . . . . . . . 177.17 -169.43 41.7 Favored Glycine 0 CA--C 1.537 1.44 0 O-C-N 121.043 -1.036 . . . . 0.0 115.562 -179.28 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 2469 ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -69.73 -17.49 37.69 Favored 'Trans proline' 0 CA--C 1.54 0.79 0 C-N-CA 124.322 3.348 . . . . 0.0 113.411 179.463 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 2470 ' ' SER . . . . . . . . . . . . . 35.0 m -153.92 176.09 12.58 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 127.165 2.186 . . . . 0.0 109.617 174.228 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 2471 ' ' LYS . . . . . . . . . . . . . 4.0 mppt? -66.84 162.96 20.47 Favored 'General case' 0 CA--C 1.551 0.989 0 O-C-N 121.03 -1.044 . . . . 0.0 111.455 168.432 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 2472 ' ' VAL . . . . . . . . . . . . . 33.0 m -118.84 145.87 24.26 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 C-N-CA 124.928 1.291 . . . . 0.0 110.954 175.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 2473 ' ' LYS . . . . . . . . . . . . . 99.0 mttt -86.04 90.9 8.24 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 123.678 0.791 . . . . 0.0 109.357 171.158 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 2474 ' ' MET . . . . . . . . . . . . . 60.5 ttm -89.9 143.38 26.84 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.546 1.139 . . . . 0.0 112.532 -175.068 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 2475 ' ' ASP . . . . . . . . . . . . . 35.8 t0 -133.94 82.04 1.95 Allowed 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 127.96 2.504 . . . . 0.0 108.559 171.637 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 2476 ' ' CYS . . . . . . . . . . . . . 52.6 t -88.01 134.43 33.74 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.841 1.256 . . . . 0.0 110.666 175.609 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 2477 ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -139.51 140.78 37.29 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.519 1.127 . . . . 0.0 111.394 -175.745 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 2478 ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -82.24 139.61 34.14 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.654 1.181 . . . . 0.0 110.304 172.54 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 2479 ' ' CYS . . . . . . . . . . . . . 30.7 p -158.95 169.23 10.91 Favored Pre-proline 0 CA--C 1.553 1.064 0 C-N-CA 125.293 1.437 . . . . 0.0 111.604 -171.558 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 2480 ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -65.91 -15.66 49.74 Favored 'Trans proline' 0 CA--C 1.543 0.943 0 C-N-CA 122.569 2.179 . . . . 0.0 113.427 173.776 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 2481 ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -77.51 -11.21 59.83 Favored 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 124.69 1.196 . . . . 0.0 112.953 172.133 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 2482 ' ' GLY . . . . . . . . . . . . . . . 117.36 -122.91 5.6 Favored Glycine 0 C--N 1.342 0.911 0 C-N-CA 126.439 1.971 . . . . 0.0 111.48 -172.167 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 2483 ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -117.18 110.4 18.11 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 123.91 0.884 . . . . 0.0 110.209 171.221 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 2484 ' ' ARG . . . . . . . . . . . . . 51.7 ttm-85 -86.37 128.56 34.95 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.741 0.816 . . . . 0.0 109.258 177.289 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 2485 ' ' VAL . . . . . . . . . . . . . 58.4 t -118.98 114.28 44.22 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 C-N-CA 125.331 1.452 . . . . 0.0 108.436 -177.781 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 2486 ' ' THR . . . . . . . . . . . . . 62.8 m -104.58 140.46 37.96 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 165.654 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 2487 ' ' TYR . . . . . . . . . . . . . 23.3 p90 -146.65 144.63 29.63 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 112.538 0.57 . . . . 0.0 112.538 171.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 2488 ' ' THR . . . . . . . . . . . . . 90.5 m -107.11 114.94 60.79 Favored Pre-proline 0 N--CA 1.473 0.685 0 CA-C-O 118.228 -0.892 . . . . 0.0 109.403 173.554 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 2489 ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -81.38 158.31 19.7 Favored 'Trans proline' 0 C--N 1.351 0.69 0 C-N-CA 124.075 3.184 . . . . 0.0 111.218 173.123 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 2490 ' ' MET . . . . . . . . . . . . . 28.9 ptm -128.77 3.31 5.44 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 115.153 1.538 . . . . 0.0 115.153 -171.198 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 2491 ' ' ALA . . . . . . . . . . . . . . . -152.04 150.33 25.51 Favored Pre-proline 0 CA--C 1.548 0.876 0 C-N-CA 125.505 1.522 . . . . 0.0 110.925 175.558 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 2492 ' ' PRO . . . . . . . . . . . . . 99.0 Cg_endo -74.45 151.21 42.16 Favored 'Trans proline' 0 CA--C 1.539 0.738 0 C-N-CA 123.24 2.627 . . . . 0.0 111.375 178.448 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 2493 ' ' GLY . . . . . . . . . . . . . . . 138.39 -173.66 22.39 Favored Glycine 0 CA--C 1.532 1.116 0 C-N-CA 125.55 1.548 . . . . 0.0 113.382 -177.068 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 2494 ' ' SER . . . . . . . . . . . . . 18.1 p -88.69 120.44 30.09 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.304 1.042 . . . . 0.0 111.55 175.085 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 2495 ' ' TYR . . . . . . . . . . . . . 68.8 m-85 -94.51 116.13 28.42 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 124.027 0.931 . . . . 0.0 109.652 168.539 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 2496 ' ' LEU . . . . . . . . . . . . . 22.8 tp -89.94 105.42 17.79 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 124.041 0.936 . . . . 0.0 109.561 -179.081 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 2497 ' ' ILE . . . . . . . . . . . . . 28.1 mt -88.33 103.1 13.39 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 C-N-CA 125.747 1.619 . . . . 0.0 108.335 -179.201 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 2498 ' ' SER . . . . . . . . . . . . . 73.7 m -90.14 95.98 10.46 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 124.819 1.248 . . . . 0.0 109.638 175.442 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 2499 ' ' ILE . . . . . . . . . . . . . 40.1 mt -91.29 92.52 3.94 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 C-N-CA 124.602 1.161 . . . . 0.0 108.566 -178.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 2500 ' ' LYS . . . . . . . . . . . . . 84.1 mttt -103.37 137.02 42.06 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 124.286 1.035 . . . . 0.0 111.721 -179.463 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 2501 ' ' TYR . . . . . . . . . . . . . 60.3 t80 -146.32 144.11 29.58 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.63 1.172 . . . . 0.0 112.357 -171.047 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 2502 ' ' GLY . . . . . . . . . . . . . . . 67.75 18.29 70.15 Favored Glycine 0 CA--C 1.535 1.314 0 C-N-CA 124.252 0.93 . . . . 0.0 113.673 179.209 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 2503 ' ' GLY . . . . . . . . . . . . . . . 134.44 -167.58 23.8 Favored Glycine 0 CA--C 1.54 1.636 0 C-N-CA 126.119 1.819 . . . . 0.0 112.43 -166.366 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 2504 ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -82.19 24.34 0.72 Allowed 'Trans proline' 0 CA--C 1.545 1.072 0 C-N-CA 124.903 3.735 . . . . 0.0 113.653 -173.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 2505 ' ' TYR . . . . . . . . . . . . . 73.9 m-85 -114.15 135.46 54.01 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.684 1.194 . . . . 0.0 113.022 -172.062 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 2506 ' ' HIS . . . . . . . . . . . . . 92.7 m-70 -63.33 142.85 58.23 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 125.359 1.464 . . . . 0.0 113.566 -179.246 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 2507 ' ' ILE . . . . . . . . . . . . . 1.7 pp -76.01 171.93 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 C-N-CA 123.716 0.806 . . . . 0.0 112.898 172.614 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 2508 ' ' GLY . . . . . . . . . . . . . . . -59.8 111.13 3.27 Favored Glycine 0 CA--C 1.534 1.235 0 C-N-CA 123.733 0.682 . . . . 0.0 112.609 -177.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 2509 ' ' GLY . . . . . . . . . . . . . . . 96.26 -8.22 66.97 Favored Glycine 0 CA--C 1.536 1.346 0 C-N-CA 125.835 1.683 . . . . 0.0 114.904 -177.262 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 2510 ' ' SER . . . . . . . . . . . . . 44.3 t -81.98 147.88 59.13 Favored Pre-proline 0 CA--C 1.55 0.962 0 CA-C-N 119.114 1.457 . . . . 0.0 111.841 177.577 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 2511 ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -79.29 155.71 90.42 Favored 'Cis proline' 0 C--N 1.354 0.817 0 CA-C-N 119.794 0.962 . . . . 0.0 113.333 -0.182 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 2512 ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -106.25 130.74 54.05 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.348 1.459 . . . . 0.0 110.466 177.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 2513 ' ' LYS . . . . . . . . . . . . . 19.7 ptpt -86.41 4.89 37.56 Favored 'General case' 0 N--CA 1.479 0.997 0 N-CA-C 116.488 2.032 . . . . 0.0 116.488 -167.664 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 2514 ' ' ALA . . . . . . . . . . . . . . . 3.17 93.19 0.01 OUTLIER 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 129.777 3.231 . . . . 0.0 116.188 -178.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 2515 ' ' LYS . . . . . . . . . . . . . 9.3 mtpm? -84.59 116.51 23.2 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 124.101 0.961 . . . . 0.0 111.364 -174.004 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 2516 ' ' VAL . . . . . . . . . . . . . 52.9 t -108.62 143.48 18.85 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 C-N-CA 125.958 1.703 . . . . 0.0 110.261 -174.5 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 2517 ' ' THR . . . . . . . . . . . . . 77.1 p -132.47 177.94 7.21 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 125.489 1.516 . . . . 0.0 111.438 178.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 2518 ' ' GLY . . . . . . . . . . . . . . . 104.5 -165.73 14.91 Favored Glycine 0 CA--C 1.54 1.643 0 C-N-CA 124.903 1.24 . . . . 0.0 113.424 -177.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 2519 ' ' PRO . . . . . . . . . . . . . 77.3 Cg_endo -70.94 176.53 7.54 Favored 'Trans proline' 0 CA--C 1.538 0.684 0 C-N-CA 124.17 3.247 . . . . 0.0 112.36 -178.302 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 2520 ' ' ARG . . . . . . . . . . . . . 50.9 ptt85 -125.99 140.51 52.56 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.774 1.23 . . . . 0.0 111.683 177.769 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 2521 ' ' LEU . . . . . . . . . . . . . 4.2 mm? -85.16 -14.97 45.3 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.683 1.193 . . . . 0.0 112.72 179.551 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 2522 ' ' VAL . . . . . . . . . . . . . 13.0 m . . . . . 0 C--O 1.251 1.149 0 C-N-CA 127.119 2.168 . . . . 0.0 112.62 -178.365 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.497 0 N-CA-C 111.379 -0.689 . . . . 0.0 111.379 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -73.69 160.76 31.09 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 124.373 1.069 . . . . 0.0 113.015 178.757 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 44.2 mtp -131.15 -179.92 5.63 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 125.985 1.714 . . . . 0.0 110.978 175.327 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 2427 ' ' GLY . . . . . . . . . . . . . . . -66.02 154.2 51.4 Favored Glycine 0 CA--C 1.532 1.156 0 C-N-CA 124.51 1.053 . . . . 0.0 113.652 -178.719 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 2428 ' ' ASP . . . . . . . . . . . . . 13.8 t70 -106.86 136.52 19.43 Favored Pre-proline 0 CA--C 1.55 0.973 0 C-N-CA 124.958 1.303 . . . . 0.0 112.366 -172.181 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 2429 ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -64.58 -23.99 63.48 Favored 'Trans proline' 0 C--N 1.351 0.693 0 C-N-CA 123.222 2.615 . . . . 0.0 113.855 -178.275 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 2430 ' ' GLY . . . . . . . . . . . . . . . -75.43 -22.44 75.62 Favored Glycine 0 CA--C 1.533 1.209 0 CA-C-N 119.349 0.977 . . . . 0.0 113.345 175.267 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 2431 ' ' LEU . . . . . . . . . . . . . 4.3 mm? -83.96 -37.85 21.74 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.419 1.088 . . . . 0.0 111.197 170.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 2432 ' ' VAL . . . . . . . . . . . . . 69.5 t -61.85 136.8 24.82 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 123.775 0.83 . . . . 0.0 111.166 173.541 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 2433 ' ' SER . . . . . . . . . . . . . 68.5 m -128.72 163.11 25.85 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 125.867 1.667 . . . . 0.0 110.084 172.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 2434 ' ' ALA . . . . . . . . . . . . . . . -124.48 150.38 45.8 Favored 'General case' 0 CA--C 1.538 0.505 0 O-C-N 121.335 -0.853 . . . . 0.0 112.053 174.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 2435 ' ' TYR . . . . . . . . . . . . . 76.4 m-85 -143.24 161.61 37.83 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 126.063 1.745 . . . . 0.0 111.797 -175.183 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 2436 ' ' GLY . . . . . . . . . . . . . . . 106.43 159.75 22.11 Favored Glycine 0 N--CA 1.473 1.116 0 C-N-CA 125.131 1.348 . . . . 0.0 113.851 176.695 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 2437 ' ' ALA . . . . . . . . . . . . . . . -61.82 -28.55 69.55 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.005 1.322 . . . . 0.0 114.428 -169.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 2438 ' ' GLY . . . . . . . . . . . . . . . -66.48 -14.32 62.09 Favored Glycine 0 CA--C 1.532 1.154 0 C-N-CA 124.148 0.88 . . . . 0.0 114.581 -177.501 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 2439 ' ' LEU . . . . . . . . . . . . . 81.5 mt -74.4 -26.99 60.43 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 118.601 1.201 . . . . 0.0 112.338 169.31 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 2440 ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -93.67 -21.26 19.47 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 125.511 1.524 . . . . 0.0 112.255 177.39 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 2441 ' ' GLY . . . . . . . . . . . . . . . 110.65 -136.34 13.52 Favored Glycine 0 N--CA 1.47 0.945 0 C-N-CA 126.004 1.764 . . . . 0.0 113.181 177.234 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 2442 ' ' GLY . . . . . . . . . . . . . . . 156.52 -138.3 5.88 Favored Glycine 0 CA--C 1.53 1.022 0 C-N-CA 123.859 0.742 . . . . 0.0 114.227 -174.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 2443 ' ' VAL . . . . . . . . . . . . . 61.9 t -119.25 141.14 40.61 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 C-N-CA 125.369 1.468 . . . . 0.0 110.474 -173.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 2444 ' ' THR . . . . . . . . . . . . . 19.8 p -54.7 133.84 47.15 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 125.316 1.446 . . . . 0.0 112.29 174.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 2445 ' ' GLY . . . . . . . . . . . . . . . 81.68 -10.02 53.15 Favored Glycine 0 CA--C 1.535 1.314 0 C-N-CA 125.035 1.302 . . . . 0.0 114.844 178.67 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 2446 ' ' ASN . . . . . . . . . . . . . 91.0 m-20 -101.61 150.91 37.7 Favored Pre-proline 0 CA--C 1.548 0.876 0 C-N-CA 125.061 1.344 . . . . 0.0 111.257 175.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 2447 ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -72.68 130.9 16.46 Favored 'Trans proline' 0 C--N 1.35 0.656 0 C-N-CA 122.977 2.451 . . . . 0.0 111.538 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 2448 ' ' ALA . . . . . . . . . . . . . . . -99.82 118.2 35.77 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 126.417 1.887 . . . . 0.0 109.11 170.005 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 2449 ' ' GLU . . . . . . . . . . . . . 45.0 tt0 -115.88 131.8 56.83 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 124.994 1.317 . . . . 0.0 111.356 -169.459 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 2450 ' ' PHE . . . . . . . . . . . . . 40.4 p90 -148.02 165.7 29.96 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.096 1.358 . . . . 0.0 111.742 174.196 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 2451 ' ' VAL . . . . . . . . . . . . . 14.7 p -129.14 133.73 65.29 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 C-N-CA 124.834 1.253 . . . . 0.0 110.631 179.109 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 2452 ' ' VAL . . . . . . . . . . . . . 44.3 t -92.14 104.93 16.1 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 N-CA-C 107.017 -1.475 . . . . 0.0 107.017 169.117 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 2453 ' ' ASN . . . . . . . . . . . . . 19.5 t-20 -90.21 114.5 26.51 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.196 0.998 . . . . 0.0 112.161 -170.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 2454 ' ' THR . . . . . . . . . . . . . 43.7 p -95.88 -1.41 49.42 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 125.569 1.548 . . . . 0.0 113.902 -177.575 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 2455 ' ' SER . . . . . . . . . . . . . 29.8 m -56.76 -28.56 61.39 Favored 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 114.628 1.344 . . . . 0.0 114.628 -175.457 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 2456 ' ' ASN . . . . . . . . . . . . . 85.7 m-20 -79.47 -19.52 49.58 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 124.291 1.036 . . . . 0.0 113.483 175.673 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 2457 ' ' ALA . . . . . . . . . . . . . . . -112.2 -22.36 10.99 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 125.848 1.659 . . . . 0.0 113.902 -170.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 2458 ' ' GLY . . . . . . . . . . . . . . . 99.5 -99.87 2.15 Favored Glycine 0 CA--C 1.529 0.914 0 C-N-CA 125.322 1.439 . . . . 0.0 110.815 -173.32 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 2459 ' ' ALA . . . . . . . . . . . . . . . -153.63 155.4 35.98 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.254 1.422 . . . . 0.0 111.807 179.685 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 2460 ' ' GLY . . . . . . . . . . . . . . . 177.84 169.31 38.65 Favored Glycine 0 CA--C 1.529 0.918 0 C-N-CA 125.233 1.397 . . . . 0.0 112.959 -173.636 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 2461 ' ' ALA . . . . . . . . . . . . . . . -74.84 130.81 40.09 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 123.848 0.859 . . . . 0.0 111.874 -179.336 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 2462 ' ' LEU . . . . . . . . . . . . . 52.1 tp -108.19 138.6 44.19 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.374 1.47 . . . . 0.0 110.548 175.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 2463 ' ' SER . . . . . . . . . . . . . 30.7 t -103.56 -100.9 0.3 Allowed 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 124.806 1.242 . . . . 0.0 110.05 172.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 2464 ' ' VAL . . . . . . . . . . . . . 42.9 t 97.5 124.45 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.218 0 C-N-CA 130.837 3.655 . . . . 0.0 110.155 175.342 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 2465 ' ' THR . . . . . . . . . . . . . 99.8 m -125.01 135.6 52.92 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 125.271 1.428 . . . . 0.0 109.213 173.084 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 2466 ' ' ILE . . . . . . . . . . . . . 49.4 mt -115.93 117.64 56.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 123.998 0.919 . . . . 0.0 109.043 172.467 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 2467 ' ' ASP . . . . . . . . . . . . . 34.8 t70 -105.35 159.03 16.22 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 125.926 1.691 . . . . 0.0 110.255 169.721 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 2468 ' ' GLY . . . . . . . . . . . . . . . 156.44 -163.2 31.93 Favored Glycine 0 CA--C 1.535 1.332 0 O-C-N 121.253 -0.904 . . . . 0.0 114.367 178.718 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 2469 ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -72.47 -3.31 13.19 Favored 'Trans proline' 0 CA--C 1.542 0.923 0 C-N-CA 123.954 3.103 . . . . 0.0 114.622 -176.128 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 2470 ' ' SER . . . . . . . . . . . . . 85.7 p -153.59 154.56 34.46 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 119.751 1.16 . . . . 0.0 112.737 171.314 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 2471 ' ' LYS . . . . . . . . . . . . . 72.6 mmtt -74.52 86.5 2.08 Favored 'General case' 0 CA--C 1.544 0.736 0 O-C-N 120.789 -1.194 . . . . 0.0 110.026 168.765 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 2472 ' ' VAL . . . . . . . . . . . . . 18.4 m -55.7 146.1 5.29 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 C-N-CA 124.93 1.292 . . . . 0.0 113.19 -174.395 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 2473 ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -79.86 121.94 26.03 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 170.461 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 2474 ' ' MET . . . . . . . . . . . . . 26.1 ttt -132.08 142.43 49.52 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 124.556 1.143 . . . . 0.0 112.281 -164.328 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 2475 ' ' ASP . . . . . . . . . . . . . 20.1 m-20 -138.31 158.24 44.67 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 127.053 2.141 . . . . 0.0 110.713 174.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 2476 ' ' CYS . . . . . . . . . . . . . 43.5 t -149.32 148.57 29.69 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 125.207 1.403 . . . . 0.0 110.922 -179.3 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 2477 ' ' GLN . . . . . . . . . . . . . 26.2 tt0 -149.96 134.68 17.63 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.07 1.348 . . . . 0.0 110.347 -177.58 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 2478 ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -84.42 144.27 28.88 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.584 1.153 . . . . 0.0 111.784 172.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 2479 ' ' CYS . . . . . . . . . . . . . 25.5 p -161.0 175.23 3.23 Favored Pre-proline 0 CA--C 1.553 1.092 0 C-N-CA 125.785 1.634 . . . . 0.0 111.69 -173.157 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 2480 ' ' PRO . . . . . . . . . . . . . 77.6 Cg_exo -58.54 -24.03 67.72 Favored 'Trans proline' 0 CA--C 1.539 0.765 0 C-N-CA 123.328 2.685 . . . . 0.0 114.654 175.393 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 2481 ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -82.29 -4.56 57.42 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 124.678 1.191 . . . . 0.0 113.152 177.303 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 2482 ' ' GLY . . . . . . . . . . . . . . . 115.87 -124.62 6.33 Favored Glycine 0 N--CA 1.47 0.938 0 C-N-CA 125.848 1.689 . . . . 0.0 111.76 -175.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 2483 ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -116.77 113.22 22.25 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 124.408 1.083 . . . . 0.0 110.668 173.467 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 2484 ' ' ARG . . . . . . . . . . . . . 14.9 ttm180 -85.08 133.7 34.22 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 123.876 0.87 . . . . 0.0 109.926 173.102 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 2485 ' ' VAL . . . . . . . . . . . . . 90.8 t -121.62 136.25 59.13 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 C-N-CA 126.344 1.857 . . . . 0.0 108.847 179.751 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 2486 ' ' THR . . . . . . . . . . . . . 59.3 m -133.84 135.03 43.47 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.101 0.96 . . . . 0.0 108.913 175.018 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 2487 ' ' TYR . . . . . . . . . . . . . 28.2 p90 -141.99 151.4 42.47 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 112.976 0.732 . . . . 0.0 112.976 176.222 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 2488 ' ' THR . . . . . . . . . . . . . 91.6 m -109.75 107.54 59.17 Favored Pre-proline 0 N--CA 1.471 0.601 0 C-N-CA 124.508 1.123 . . . . 0.0 109.324 177.141 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 2489 ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -76.4 149.95 31.75 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 123.394 2.729 . . . . 0.0 110.131 169.655 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 2490 ' ' MET . . . . . . . . . . . . . 23.3 ptt? -128.74 11.02 6.11 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 114.397 1.258 . . . . 0.0 114.397 -177.58 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 2491 ' ' ALA . . . . . . . . . . . . . . . -141.59 147.64 46.74 Favored Pre-proline 0 CA--C 1.547 0.861 0 C-N-CA 125.269 1.428 . . . . 0.0 111.685 175.11 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 2492 ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -74.36 157.54 45.37 Favored 'Trans proline' 0 CA--C 1.537 0.628 0 C-N-CA 123.154 2.57 . . . . 0.0 111.062 172.7 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 2493 ' ' GLY . . . . . . . . . . . . . . . 130.34 -144.25 15.56 Favored Glycine 0 CA--C 1.528 0.858 0 C-N-CA 125.357 1.456 . . . . 0.0 111.796 -174.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 2494 ' ' SER . . . . . . . . . . . . . 10.5 t -134.91 133.81 40.01 Favored 'General case' 0 N--CA 1.468 0.464 0 O-C-N 121.824 -0.809 . . . . 0.0 111.63 177.602 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 2495 ' ' TYR . . . . . . . . . . . . . 87.8 m-85 -103.15 131.11 50.42 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.526 1.53 . . . . 0.0 110.352 176.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 2496 ' ' LEU . . . . . . . . . . . . . 21.9 tp -96.17 114.47 26.17 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.268 1.027 . . . . 0.0 109.457 178.381 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 2497 ' ' ILE . . . . . . . . . . . . . 36.4 mt -100.49 100.48 10.47 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 C-N-CA 125.459 1.504 . . . . 0.0 108.21 -178.543 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 2498 ' ' SER . . . . . . . . . . . . . 70.0 m -86.42 95.87 9.83 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 124.388 1.075 . . . . 0.0 109.241 174.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 2499 ' ' ILE . . . . . . . . . . . . . 49.9 mt -87.61 96.51 5.8 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 C-N-CA 124.51 1.124 . . . . 0.0 108.724 -178.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 2500 ' ' LYS . . . . . . . . . . . . . 85.6 mttt -104.18 135.74 45.09 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.713 1.205 . . . . 0.0 111.997 -179.207 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 2501 ' ' TYR . . . . . . . . . . . . . 56.5 t80 -151.07 148.76 28.71 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.269 1.428 . . . . 0.0 111.902 -169.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 2502 ' ' GLY . . . . . . . . . . . . . . . 67.21 26.53 73.42 Favored Glycine 0 CA--C 1.535 1.297 0 C-N-CA 123.897 0.76 . . . . 0.0 112.751 -178.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 2503 ' ' GLY . . . . . . . . . . . . . . . 118.16 -164.95 12.75 Favored Glycine 0 CA--C 1.542 1.725 0 C-N-CA 126.011 1.767 . . . . 0.0 112.112 -163.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 2504 ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -81.38 24.35 0.7 Allowed 'Trans proline' 0 CA--C 1.546 1.104 0 C-N-CA 124.933 3.756 . . . . 0.0 113.448 -174.626 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 2505 ' ' TYR . . . . . . . . . . . . . 67.9 m-85 -106.38 131.64 53.35 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.761 1.224 . . . . 0.0 112.764 -171.321 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 2506 ' ' HIS . . . . . . . . . . . . . 88.6 m-70 -59.63 139.27 57.34 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 125.017 1.327 . . . . 0.0 113.092 177.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 2507 ' ' ILE . . . . . . . . . . . . . 21.4 pt -72.6 171.88 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 170.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 2508 ' ' GLY . . . . . . . . . . . . . . . -58.61 119.56 18.12 Favored Glycine 0 CA--C 1.533 1.218 0 O-C-N 121.668 -0.645 . . . . 0.0 111.523 173.215 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 2509 ' ' GLY . . . . . . . . . . . . . . . 91.49 -9.05 78.15 Favored Glycine 0 CA--C 1.537 1.419 0 C-N-CA 125.62 1.581 . . . . 0.0 115.007 -177.012 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 2510 ' ' SER . . . . . . . . . . . . . 38.2 t -83.95 146.61 49.3 Favored Pre-proline 0 CA--C 1.55 0.968 0 CA-C-N 119.187 1.493 . . . . 0.0 112.044 179.311 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 2511 ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -77.41 147.67 85.47 Favored 'Cis proline' 0 C--N 1.354 0.84 0 CA-C-N 119.761 0.951 . . . . 0.0 112.901 -0.168 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 2512 ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -97.93 131.22 44.58 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 125.031 1.333 . . . . 0.0 110.346 178.367 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 2513 ' ' LYS . . . . . 0.435 ' H ' ' HD2' ' A' 2513 ' ' LYS . 0.0 OUTLIER -100.03 112.4 24.69 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.078 0.951 . . . . 0.0 111.719 178.95 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A 2514 ' ' ALA . . . . . . . . . . . . . . . -104.48 105.43 15.54 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 126.232 1.813 . . . . 0.0 110.765 -172.32 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 2515 ' ' LYS . . . . . . . . . . . . . 62.9 mtpt -84.49 125.98 32.87 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.737 1.215 . . . . 0.0 111.13 -175.724 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 2516 ' ' VAL . . . . . . . . . . . . . 70.4 t -123.46 137.53 56.4 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 C-N-CA 125.226 1.41 . . . . 0.0 110.003 -172.268 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 2517 ' ' THR . . . . . . . . . . . . . 66.9 p -127.16 173.31 9.82 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 125.419 1.488 . . . . 0.0 111.18 179.006 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 2518 ' ' GLY . . . . . . . . . . . . . . . 102.01 176.88 27.96 Favored Glycine 0 CA--C 1.539 1.566 0 C-N-CA 124.762 1.172 . . . . 0.0 113.359 -175.731 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 2519 ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -72.47 135.99 25.33 Favored 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 123.691 2.928 . . . . 0.0 112.089 -170.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 2520 ' ' ARG . . . . . . . . . . . . . 48.3 ttm-85 -67.09 131.5 45.96 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 123.971 0.908 . . . . 0.0 110.487 174.37 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 2521 ' ' LEU . . . . . . . . . . . . . 4.2 mm? -74.94 -29.4 60.93 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.676 0.79 . . . . 0.0 112.162 178.767 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 2522 ' ' VAL . . . . . . . . . . . . . 36.5 t . . . . . 0 C--O 1.253 1.26 0 C-N-CA 126.216 1.806 . . . . 0.0 111.329 176.733 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.551 0 N-CA-C 111.592 -0.603 . . . . 0.0 111.592 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -70.79 156.16 39.88 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 124.325 1.05 . . . . 0.0 112.631 178.019 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 37.7 mmt -83.95 139.51 32.53 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.283 1.033 . . . . 0.0 111.595 176.566 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 2427 ' ' GLY . . . . . . . . . . . . . . . -85.14 -176.59 50.74 Favored Glycine 0 CA--C 1.531 1.063 0 C-N-CA 125.439 1.495 . . . . 0.0 114.194 179.691 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 2428 ' ' ASP . . . . . . . . . . . . . 12.6 t70 -160.42 138.56 7.34 Favored Pre-proline 0 CA--C 1.548 0.9 0 C-N-CA 125.702 1.601 . . . . 0.0 110.363 -172.402 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 2429 ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -64.94 -19.5 63.98 Favored 'Trans proline' 0 CA--C 1.54 0.784 0 C-N-CA 123.191 2.594 . . . . 0.0 114.307 -175.172 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 2430 ' ' GLY . . . . . . . . . . . . . . . -80.93 -24.87 57.18 Favored Glycine 0 CA--C 1.534 1.251 0 CA-C-N 119.256 0.934 . . . . 0.0 113.374 173.025 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 2431 ' ' LEU . . . . . . . . . . . . . 4.5 mm? -89.36 -30.4 18.42 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.615 1.166 . . . . 0.0 112.153 174.317 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 2432 ' ' VAL . . . . . . . . . . . . . 66.3 t -67.74 135.23 28.9 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 C-N-CA 123.94 0.896 . . . . 0.0 110.411 172.037 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 2433 ' ' SER . . . . . . . . . . . . . 71.3 m -123.36 -175.33 3.17 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 125.841 1.656 . . . . 0.0 110.896 176.717 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 2434 ' ' ALA . . . . . . . . . . . . . . . -151.14 142.95 23.81 Favored 'General case' 0 CA--C 1.537 0.478 0 O-C-N 120.605 -1.309 . . . . 0.0 111.749 173.224 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 2435 ' ' TYR . . . . . . . . . . . . . 66.4 m-85 -147.99 148.62 30.94 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 125.373 1.469 . . . . 0.0 111.981 -174.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 2436 ' ' GLY . . . . . . . . . . . . . . . 124.48 164.35 11.91 Favored Glycine 0 N--CA 1.474 1.204 0 C-N-CA 125.446 1.498 . . . . 0.0 114.422 174.718 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 2437 ' ' ALA . . . . . . . . . . . . . . . -60.48 -29.2 68.92 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.313 1.445 . . . . 0.0 114.443 -171.177 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 2438 ' ' GLY . . . . . . . . . . . . . . . -63.95 -20.14 64.21 Favored Glycine 0 CA--C 1.532 1.124 0 CA-C-O 118.937 -0.924 . . . . 0.0 113.959 178.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 2439 ' ' LEU . . . . . . . . . . . . . 79.5 mt -75.04 -24.02 58.23 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 118.916 1.358 . . . . 0.0 112.606 170.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 2440 ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -91.08 -30.29 16.83 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 125.131 1.372 . . . . 0.0 112.0 177.808 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 2441 ' ' GLY . . . . . . . . . . . . . . . 109.93 -152.58 17.22 Favored Glycine 0 CA--C 1.534 1.224 0 C-N-CA 126.122 1.82 . . . . 0.0 113.508 178.742 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 2442 ' ' GLY . . . . . . . . . . . . . . . 169.04 -159.37 32.4 Favored Glycine 0 CA--C 1.531 1.072 0 C-N-CA 124.316 0.96 . . . . 0.0 114.001 -174.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 2443 ' ' VAL . . . . . . . . . . . . . 20.7 t -95.77 141.57 15.09 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 C-N-CA 124.461 1.104 . . . . 0.0 110.231 179.185 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 2444 ' ' THR . . . . . . . . . . . . . 31.5 p -58.6 152.19 19.0 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 124.693 1.197 . . . . 0.0 112.88 174.757 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 2445 ' ' GLY . . . . . . . . . . . . . . . 71.73 2.73 52.29 Favored Glycine 0 CA--C 1.536 1.375 0 C-N-CA 124.032 0.825 . . . . 0.0 114.326 179.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 2446 ' ' ASN . . . . . . . . . . . . . 26.0 m-80 -130.72 146.71 63.12 Favored Pre-proline 0 CA--C 1.549 0.928 0 C-N-CA 126.606 1.962 . . . . 0.0 110.284 -178.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 2447 ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -76.55 149.08 30.17 Favored 'Trans proline' 0 C--N 1.349 0.583 0 C-N-CA 123.022 2.481 . . . . 0.0 112.689 -176.179 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 2448 ' ' ALA . . . . . . . . . . . . . . . -133.86 143.08 48.09 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 126.269 1.828 . . . . 0.0 109.525 166.234 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 2449 ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -134.33 149.88 50.9 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 113.78 1.03 . . . . 0.0 113.78 -165.786 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 2450 ' ' PHE . . . . . . . . . . . . . 33.4 p90 -156.11 167.15 31.32 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.814 1.646 . . . . 0.0 111.173 179.672 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 2451 ' ' VAL . . . . . . . . . . . . . 57.4 t -123.14 131.7 72.74 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 C-N-CA 124.74 1.216 . . . . 0.0 109.656 176.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 2452 ' ' VAL . . . . . . . . . . . . . 41.3 t -80.69 104.26 8.87 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 N-CA-C 107.086 -1.45 . . . . 0.0 107.086 163.608 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 2453 ' ' ASN . . . . . . . . . . . . . 13.9 t-20 -78.28 111.2 14.01 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 123.977 0.911 . . . . 0.0 111.86 -172.702 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 2454 ' ' THR . . . . . . . . . . . . . 37.3 p -106.09 -8.04 17.68 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 125.885 1.674 . . . . 0.0 113.811 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 2455 ' ' SER . . . . . . . . . . . . . 88.6 p -65.95 -24.35 66.79 Favored 'General case' 0 N--CA 1.478 0.938 0 CA-C-N 120.173 1.351 . . . . 0.0 113.8 -176.653 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 2456 ' ' ASN . . . . . . . . . . . . . 56.4 m-80 -77.72 -11.6 59.89 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 124.493 1.117 . . . . 0.0 113.57 171.243 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 2457 ' ' ALA . . . . . . . . . . . . . . . -113.5 -57.14 2.32 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 125.11 1.364 . . . . 0.0 113.169 -172.714 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 2458 ' ' GLY . . . . . . . . . . . . . . . 123.34 -159.87 17.93 Favored Glycine 0 CA--C 1.533 1.178 0 C-N-CA 125.522 1.534 . . . . 0.0 112.661 -169.279 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 2459 ' ' ALA . . . . . . . . . . . . . . . -84.13 150.34 25.59 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 124.809 1.244 . . . . 0.0 112.972 -177.625 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 2460 ' ' GLY . . . . . . . . . . . . . . . 164.91 166.92 24.67 Favored Glycine 0 CA--C 1.531 1.089 0 C-N-CA 124.462 1.03 . . . . 0.0 113.862 -178.138 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 2461 ' ' ALA . . . . . . . . . . . . . . . -82.77 135.7 34.9 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.249 1.02 . . . . 0.0 112.709 -175.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 2462 ' ' LEU . . . . . . . . . . . . . 40.9 tp -102.11 143.91 31.34 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.901 1.681 . . . . 0.0 110.585 174.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 2463 ' ' SER . . . . . . . . . . . . . 3.9 t -138.58 41.74 2.18 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 125.206 1.403 . . . . 0.0 111.152 -177.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 2464 ' ' VAL . . . . . . . . . . . . . 9.6 p -65.57 135.21 28.73 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 C-N-CA 124.987 1.315 . . . . 0.0 112.167 -176.723 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 2465 ' ' THR . . . . . . . . . . . . . 95.4 m -135.08 145.74 48.23 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 126.067 1.747 . . . . 0.0 110.102 -178.286 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 2466 ' ' ILE . . . . . . . . . . . . . 50.2 mt -122.58 133.39 68.91 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 C-N-CA 124.5 1.12 . . . . 0.0 110.027 176.053 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 2467 ' ' ASP . . . . . . . . . . . . . 34.7 t70 -139.97 151.69 45.72 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 126.675 1.99 . . . . 0.0 110.409 178.333 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 2468 ' ' GLY . . . . . . . . . . . . . . . 174.52 -144.48 7.48 Favored Glycine 0 CA--C 1.537 1.422 0 CA-C-O 118.495 -1.17 . . . . 0.0 114.567 -177.182 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 2469 ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo -67.99 -15.56 43.66 Favored 'Trans proline' 0 C--N 1.354 0.864 0 C-N-CA 123.83 3.02 . . . . 0.0 113.343 -179.577 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 2470 ' ' SER . . . . . . . . . . . . . 7.6 t -159.07 -161.1 0.91 Allowed 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 126.078 1.751 . . . . 0.0 109.491 170.115 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 2471 ' ' LYS . . . . . . . . . . . . . 98.5 mttt -79.68 -179.61 6.99 Favored 'General case' 0 CA--C 1.55 0.975 0 O-C-N 121.014 -1.054 . . . . 0.0 111.46 164.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 2472 ' ' VAL . . . . . . . . . . . . . 14.3 m -136.37 149.94 27.41 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 125.243 1.417 . . . . 0.0 109.979 170.269 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 2473 ' ' LYS . . . . . . . . . . . . . 25.9 tptp -78.34 107.26 10.83 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 167.77 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 2474 ' ' MET . . . . . . . . . . . . . 22.9 ttt -114.78 140.61 48.77 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 125.191 1.396 . . . . 0.0 112.285 -168.357 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 2475 ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -143.22 157.28 44.63 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 126.618 1.967 . . . . 0.0 110.323 173.359 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 2476 ' ' CYS . . . . . . . . . . . . . 30.9 p -162.15 164.29 28.0 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.043 0.937 . . . . 0.0 113.485 -176.006 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 2477 ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -164.77 173.18 12.08 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.841 1.657 . . . . 0.0 111.59 177.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 2478 ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -80.2 138.83 36.91 Favored 'General case' 0 CA--C 1.544 0.716 0 O-C-N 121.57 -0.706 . . . . 0.0 110.383 164.339 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 2479 ' ' CYS . . . . . . . . . . . . . 59.3 m -132.96 167.14 24.41 Favored Pre-proline 0 CA--C 1.554 1.106 0 C-N-CA 126.824 2.05 . . . . 0.0 110.367 169.52 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 2480 ' ' PRO . . . . . . . . . . . . . 70.2 Cg_exo -57.99 -31.9 93.98 Favored 'Trans proline' 0 C--N 1.353 0.796 0 C-N-CA 123.586 2.858 . . . . 0.0 114.586 177.643 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 2481 ' ' GLU . . . . . . . . . . . . . 20.8 tp10 -77.45 -13.0 60.02 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 125.079 1.352 . . . . 0.0 112.849 177.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 2482 ' ' GLY . . . . . . . . . . . . . . . 129.1 -169.0 20.59 Favored Glycine 0 CA--C 1.53 1.018 0 C-N-CA 126.587 2.041 . . . . 0.0 112.29 -172.618 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 2483 ' ' TYR . . . . . . . . . . . . . 66.8 m-85 -69.78 111.64 5.68 Favored 'General case' 0 CA--C 1.539 0.537 0 O-C-N 121.277 -1.131 . . . . 0.0 111.783 177.808 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 2484 ' ' ARG . . . . . . . . . . . . . 68.5 ttt180 -85.09 138.26 32.53 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 125.366 1.466 . . . . 0.0 110.692 179.319 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 2485 ' ' VAL . . . . . . . . . . . . . 96.4 t -128.59 136.96 58.63 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 C-N-CA 126.333 1.853 . . . . 0.0 108.93 179.261 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 2486 ' ' THR . . . . . . . . . . . . . 85.7 m -133.24 136.58 45.66 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 125.06 1.344 . . . . 0.0 108.303 173.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 2487 ' ' TYR . . . . . . . . . . . . . 31.0 p90 -145.72 148.97 33.58 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 113.489 0.922 . . . . 0.0 113.489 177.628 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 2488 ' ' THR . . . . . . . . . . . . . 23.9 m -109.24 114.31 57.89 Favored Pre-proline 0 N--CA 1.471 0.612 0 C-N-CA 125.308 1.443 . . . . 0.0 108.7 171.304 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 2489 ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -80.07 159.73 23.77 Favored 'Trans proline' 0 N--CA 1.457 -0.628 0 C-N-CA 123.153 2.569 . . . . 0.0 111.203 173.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 2490 ' ' MET . . . . . . . . . . . . . 26.1 ptm -128.79 2.14 5.42 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 114.935 1.458 . . . . 0.0 114.935 -171.406 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 2491 ' ' ALA . . . . . . . . . . . . . . . -145.79 143.46 19.75 Favored Pre-proline 0 CA--C 1.548 0.881 0 C-N-CA 124.74 1.216 . . . . 0.0 111.308 174.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 2492 ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -72.75 155.1 54.19 Favored 'Trans proline' 0 CA--C 1.537 0.641 0 C-N-CA 123.229 2.619 . . . . 0.0 111.106 174.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 2493 ' ' GLY . . . . . . . . . . . . . . . 131.26 -151.52 19.72 Favored Glycine 0 CA--C 1.528 0.875 0 C-N-CA 125.356 1.455 . . . . 0.0 111.992 -173.257 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 2494 ' ' SER . . . . . . . . . . . . . 71.8 m -122.12 127.68 50.41 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 123.647 0.779 . . . . 0.0 112.074 177.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 2495 ' ' TYR . . . . . . . . . . . . . 86.2 m-85 -98.91 134.54 41.62 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.23 1.412 . . . . 0.0 110.676 171.688 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 2496 ' ' LEU . . . . . . . . . . . . . 10.3 mp -92.63 121.57 34.18 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.461 1.104 . . . . 0.0 108.819 168.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 2497 ' ' ILE . . . . . . . . . . . . . 40.5 mt -97.26 101.01 11.72 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.375 0 N-CA-C 107.286 -1.376 . . . . 0.0 107.286 173.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 2498 ' ' SER . . . . . . . . . . . . . 74.7 m -86.98 94.01 9.5 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 125.368 1.467 . . . . 0.0 109.512 179.159 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 2499 ' ' ILE . . . . . . . . . . . . . 26.6 mt -90.46 101.32 12.22 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 C-N-CA 124.909 1.284 . . . . 0.0 108.768 -179.769 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 2500 ' ' LYS . . . . . . . . . . . . . 83.8 mttt -109.52 143.44 39.17 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 124.535 1.134 . . . . 0.0 111.622 178.538 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 2501 ' ' TYR . . . . . . . . . . . . . 53.8 t80 -151.17 141.4 22.28 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.918 0.887 . . . . 0.0 112.698 -171.022 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 2502 ' ' GLY . . . . . . . . . . . . . . . 68.28 15.15 67.47 Favored Glycine 0 CA--C 1.536 1.354 0 C-N-CA 124.262 0.934 . . . . 0.0 114.072 178.381 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 2503 ' ' GLY . . . . . . . . . . . . . . . 142.73 -167.78 26.14 Favored Glycine 0 CA--C 1.54 1.645 0 C-N-CA 125.934 1.73 . . . . 0.0 112.591 -168.419 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 2504 ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -82.37 18.71 1.38 Allowed 'Trans proline' 0 CA--C 1.545 1.026 0 C-N-CA 124.772 3.648 . . . . 0.0 113.833 -174.112 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 2505 ' ' TYR . . . . . . . . . . . . . 73.7 m-85 -110.32 139.36 45.59 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.661 1.185 . . . . 0.0 113.341 -172.494 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 2506 ' ' HIS . . . . . . . . . . . . . 91.1 m-70 -64.23 143.29 58.0 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 125.57 1.548 . . . . 0.0 113.516 179.399 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 2507 ' ' ILE . . . . . . . . . . . . . 1.8 pp -86.37 150.37 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.075 0 C-N-CA 123.882 0.873 . . . . 0.0 111.854 171.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 2508 ' ' GLY . . . . . . . . . . . . . . . 46.23 -114.12 1.3 Allowed Glycine 0 CA--C 1.536 1.38 0 C-N-CA 124.275 0.94 . . . . 0.0 114.531 165.642 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 2509 ' ' GLY . . . . . . . . . . . . . . . -99.67 12.74 61.2 Favored Glycine 0 CA--C 1.537 1.409 0 C-N-CA 126.193 1.854 . . . . 0.0 115.19 178.117 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 2510 ' ' SER . . . . . . . . . . . . . 42.6 t -65.84 146.27 99.0 Favored Pre-proline 0 CA--C 1.552 1.04 0 CA-C-N 119.17 1.485 . . . . 0.0 112.655 179.586 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 2511 ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -75.0 142.15 73.91 Favored 'Cis proline' 0 C--N 1.354 0.852 0 CA-C-N 119.821 0.972 . . . . 0.0 112.868 0.727 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 2512 ' ' PHE . . . . . . . . . . . . . 91.6 m-85 -93.33 127.98 39.16 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.547 1.139 . . . . 0.0 110.858 178.662 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 2513 ' ' LYS . . . . . . . . . . . . . 86.0 tttt -90.24 92.7 9.04 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 124.407 1.083 . . . . 0.0 111.893 -176.768 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 2514 ' ' ALA . . . . . . . . . . . . . . . -79.53 123.84 27.95 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.976 1.31 . . . . 0.0 110.682 174.747 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 2515 ' ' LYS . . . . . . . . . . . . . 26.6 mtmm -101.15 120.87 40.86 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.201 1.401 . . . . 0.0 110.278 -173.558 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 2516 ' ' VAL . . . . . . . . . . . . . 73.0 t -120.42 138.45 50.91 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 124.843 1.257 . . . . 0.0 111.133 -167.692 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 2517 ' ' THR . . . . . . . . . . . . . 68.1 p -128.9 178.53 6.31 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 125.986 1.714 . . . . 0.0 111.088 179.505 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 2518 ' ' GLY . . . . . . . . . . . . . . . 97.67 -176.31 30.96 Favored Glycine 0 CA--C 1.54 1.629 0 C-N-CA 124.545 1.069 . . . . 0.0 113.39 -176.68 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 2519 ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -71.6 148.25 53.04 Favored 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 123.72 2.947 . . . . 0.0 112.167 -174.408 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 2520 ' ' ARG . . . . . . . . . . . . . 35.8 ttp180 -82.13 128.31 34.01 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 123.648 0.779 . . . . 0.0 110.217 173.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 2521 ' ' LEU . . . . . . . . . . . . . 3.8 mm? -84.76 -23.13 29.35 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.208 1.003 . . . . 0.0 112.25 177.508 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 2522 ' ' VAL . . . . . . . . . . . . . 35.2 t . . . . . 0 C--O 1.253 1.282 0 C-N-CA 126.398 1.879 . . . . 0.0 111.808 179.045 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.578 0 N-CA-C 111.359 -0.697 . . . . 0.0 111.359 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -68.88 160.52 30.53 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 124.269 1.028 . . . . 0.0 112.671 176.768 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 90.0 mtp -138.32 165.83 25.75 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 125.368 1.467 . . . . 0.0 111.997 -179.012 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 2427 ' ' GLY . . . . . . . . . . . . . . . -148.11 145.85 14.82 Favored Glycine 0 CA--C 1.529 0.957 0 C-N-CA 125.666 1.603 . . . . 0.0 111.579 171.618 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 2428 ' ' ASP . . . . . . . . . . . . . 22.2 m-20 -97.33 128.59 34.37 Favored Pre-proline 0 CA--C 1.547 0.853 0 C-N-CA 123.909 0.884 . . . . 0.0 112.726 -175.516 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 2429 ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -66.67 -22.42 50.43 Favored 'Trans proline' 0 C--N 1.352 0.748 0 C-N-CA 122.993 2.462 . . . . 0.0 112.915 177.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 2430 ' ' GLY . . . . . . . . . . . . . . . -75.05 -23.16 75.24 Favored Glycine 0 CA--C 1.535 1.304 0 CA-C-N 119.062 0.847 . . . . 0.0 113.551 173.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 2431 ' ' LEU . . . . . . . . . . . . . 4.2 mm? -86.34 -29.82 22.69 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 124.483 1.113 . . . . 0.0 111.698 171.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 2432 ' ' VAL . . . . . . . . . . . . . 79.1 t -67.94 135.25 28.84 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 C-N-CA 123.51 0.724 . . . . 0.0 110.521 169.723 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 2433 ' ' SER . . . . . . . . . . . . . 57.9 m -140.44 144.66 36.23 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 125.463 1.505 . . . . 0.0 109.439 171.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 2434 ' ' ALA . . . . . . . . . . . . . . . -96.41 148.58 22.64 Favored 'General case' 0 CA--C 1.539 0.553 0 O-C-N 121.572 -0.705 . . . . 0.0 111.794 176.133 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 2435 ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -142.4 142.78 32.45 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.808 1.643 . . . . 0.0 111.468 -178.226 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 2436 ' ' GLY . . . . . . . . . . . . . . . 129.17 159.45 9.91 Favored Glycine 0 N--CA 1.473 1.11 0 C-N-CA 125.438 1.494 . . . . 0.0 113.534 -179.708 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 2437 ' ' ALA . . . . . . . . . . . . . . . -63.56 -26.94 68.92 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 114.259 1.207 . . . . 0.0 114.259 -171.22 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 2438 ' ' GLY . . . . . . . . . . . . . . . -68.19 -11.08 60.81 Favored Glycine 0 CA--C 1.53 0.969 0 C-N-CA 124.001 0.81 . . . . 0.0 114.702 -177.475 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 2439 ' ' LEU . . . . . . . . . . . . . 73.2 mt -78.46 -26.04 46.03 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.724 1.21 . . . . 0.0 112.405 171.607 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 2440 ' ' GLU . . . . . . . . . . . . . 37.5 mm-40 -89.07 -36.61 15.66 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 124.794 1.237 . . . . 0.0 111.853 -178.3 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 2441 ' ' GLY . . . . . . . . . . . . . . . 155.77 -148.39 18.46 Favored Glycine 0 CA--C 1.529 0.926 0 C-N-CA 124.389 0.995 . . . . 0.0 113.813 -176.135 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 2442 ' ' GLY . . . . . . . . . . . . . . . 157.49 -158.39 28.94 Favored Glycine 0 CA--C 1.53 1.012 0 C-N-CA 125.303 1.43 . . . . 0.0 112.924 -176.023 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 2443 ' ' VAL . . . . . . . . . . . . . 81.2 t -129.53 139.61 51.24 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.975 0 C-N-CA 125.321 1.449 . . . . 0.0 109.213 179.086 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 2444 ' ' THR . . . . . . . . . . . . . 33.5 p -60.45 138.06 58.06 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 124.016 0.926 . . . . 0.0 111.978 178.354 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 2445 ' ' GLY . . . . . . . . . . . . . . . 81.3 -10.65 48.23 Favored Glycine 0 CA--C 1.537 1.459 0 C-N-CA 124.75 1.167 . . . . 0.0 114.862 -175.371 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 2446 ' ' ASN . . . . . . . . . . . . . 88.4 m-20 -106.69 149.75 38.8 Favored Pre-proline 0 CA--C 1.548 0.888 0 C-N-CA 125.167 1.387 . . . . 0.0 111.192 174.611 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 2447 ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -73.07 135.83 23.69 Favored 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 122.849 2.366 . . . . 0.0 111.79 -179.485 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 2448 ' ' ALA . . . . . . . . . . . . . . . -109.83 142.17 41.47 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 127.236 2.214 . . . . 0.0 108.772 167.028 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 2449 ' ' GLU . . . . . . . . . . . . . 5.0 tm-20 -147.91 141.24 25.23 Favored 'General case' 0 N--CA 1.471 0.614 0 O-C-N 121.411 -0.806 . . . . 0.0 112.994 -162.598 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 2450 ' ' PHE . . . . . . . . . . . . . 52.9 p90 -156.29 157.44 35.76 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 125.83 1.652 . . . . 0.0 112.458 177.604 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 2451 ' ' VAL . . . . . . . . . . . . . 59.0 t -113.55 133.29 59.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 125.641 1.577 . . . . 0.0 109.443 171.78 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 2452 ' ' VAL . . . . . . . . . . . . . 39.3 t -87.14 105.1 14.78 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 C-N-CA 125.102 1.361 . . . . 0.0 107.819 168.225 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 2453 ' ' ASN . . . . . . . . . . . . . 32.7 t-20 -77.9 117.14 18.96 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 123.612 0.765 . . . . 0.0 110.926 -174.073 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 2454 ' ' THR . . . . . . . . . . . . . 39.5 p -105.1 -9.61 17.69 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 125.088 1.355 . . . . 0.0 113.634 -178.559 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 2455 ' ' SER . . . . . . . . . . . . . 41.2 m -57.94 -29.79 65.44 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.927 1.291 . . . . 0.0 114.234 -175.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 2456 ' ' ASN . . . . . . . . . . . . . 79.4 m-20 -83.79 -16.21 45.52 Favored 'General case' 0 CA--C 1.546 0.809 0 N-CA-C 113.767 1.025 . . . . 0.0 113.767 177.289 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 2457 ' ' ALA . . . . . . . . . . . . . . . -102.45 -41.94 6.14 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 114.458 1.281 . . . . 0.0 114.458 -166.574 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 2458 ' ' GLY . . . . . . . . . . . . . . . 121.64 -133.63 9.56 Favored Glycine 0 N--CA 1.471 1.03 0 C-N-CA 124.653 1.12 . . . . 0.0 112.06 -171.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 2459 ' ' ALA . . . . . . . . . . . . . . . -129.97 120.9 25.55 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.51 1.124 . . . . 0.0 111.944 -175.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 2460 ' ' GLY . . . . . . . . . . . . . . . -165.6 162.71 36.09 Favored Glycine 0 CA--C 1.529 0.963 0 C-N-CA 125.029 1.3 . . . . 0.0 113.029 -177.612 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 2461 ' ' ALA . . . . . . . . . . . . . . . -79.26 145.18 33.69 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.064 0.946 . . . . 0.0 112.484 -179.163 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 2462 ' ' LEU . . . . . . . . . . . . . 13.7 tp -95.26 147.2 23.74 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.178 1.391 . . . . 0.0 110.555 172.812 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 2463 ' ' SER . . . . . . . . . . . . . 9.1 t -137.12 34.58 2.57 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 125.301 1.44 . . . . 0.0 111.506 -178.302 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 2464 ' ' VAL . . . . . . . . . . . . . 10.5 p -59.65 135.17 24.52 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 C-N-CA 125.327 1.451 . . . . 0.0 112.58 -175.621 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 2465 ' ' THR . . . . . . . . . . . . . 96.4 m -134.91 142.9 46.67 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 125.759 1.623 . . . . 0.0 109.389 176.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 2466 ' ' ILE . . . . . . . . . . . . . 36.1 mt -120.27 122.2 67.68 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 C-N-CA 123.773 0.829 . . . . 0.0 109.953 174.05 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 2467 ' ' ASP . . . . . . . . . . . . . 33.0 t70 -104.68 166.8 10.14 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 126.392 1.877 . . . . 0.0 110.12 168.011 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 2468 ' ' GLY . . . . . . . . . . . . . . . 167.48 -160.57 34.24 Favored Glycine 0 CA--C 1.535 1.31 0 O-C-N 120.83 -1.169 . . . . 0.0 114.936 178.752 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 2469 ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -70.04 -16.44 36.39 Favored 'Trans proline' 0 CA--C 1.54 0.819 0 C-N-CA 123.915 3.077 . . . . 0.0 113.246 178.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 2470 ' ' SER . . . . . . . . . . . . . 38.0 m -157.95 -171.8 3.67 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 127.335 2.254 . . . . 0.0 109.819 177.506 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 2471 ' ' LYS . . . . . . . . . . . . . 99.0 mttt -70.74 175.95 4.58 Favored 'General case' 0 CA--C 1.551 0.985 0 O-C-N 120.956 -1.09 . . . . 0.0 112.343 167.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 2472 ' ' VAL . . . . . . . . . . . . . 33.9 m -132.11 148.87 32.09 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.925 0 C-N-CA 125.311 1.444 . . . . 0.0 110.466 169.624 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 2473 ' ' LYS . . . . . . . . . . . . . 62.0 mtpt -87.43 89.17 7.9 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 123.592 0.757 . . . . 0.0 109.52 169.6 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 2474 ' ' MET . . . . . . . . . . . . . 60.0 ttm -83.51 143.0 30.49 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 124.334 1.054 . . . . 0.0 112.071 -177.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 2475 ' ' ASP . . . . . . . . . . . . . 31.7 t70 -139.09 103.87 4.88 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 126.581 1.953 . . . . 0.0 109.221 167.026 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 2476 ' ' CYS . . . . . . . . . . . . . 28.7 p -102.3 155.19 18.39 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 124.954 1.302 . . . . 0.0 112.28 178.143 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 2477 ' ' GLN . . . . . . . . . . . . . 27.4 tt0 -161.59 146.56 13.36 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.26 1.024 . . . . 0.0 111.258 -172.156 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 2478 ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -77.89 122.67 25.79 Favored 'General case' 0 CA--C 1.541 0.615 0 O-C-N 121.478 -0.763 . . . . 0.0 110.609 173.682 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 2479 ' ' CYS . . . . . . . . . . . . . 60.6 m -121.76 166.29 17.12 Favored Pre-proline 0 CA--C 1.553 1.082 0 C-N-CA 126.539 1.936 . . . . 0.0 111.041 179.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 2480 ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -65.32 -26.9 55.82 Favored 'Trans proline' 0 CA--C 1.54 0.797 0 C-N-CA 123.009 2.473 . . . . 0.0 114.567 -174.527 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 2481 ' ' GLU . . . . . . . . . . . . . 82.2 tt0 -82.24 -17.17 46.95 Favored 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 124.143 0.977 . . . . 0.0 112.997 174.46 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 2482 ' ' GLY . . . . . . . . . . . . . . . 140.11 -162.47 26.39 Favored Glycine 0 CA--C 1.528 0.875 0 C-N-CA 125.879 1.705 . . . . 0.0 112.608 -176.306 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 2483 ' ' TYR . . . . . . . . . . . . . 74.0 m-85 -70.36 119.07 13.99 Favored 'General case' 0 CA--C 1.539 0.541 0 O-C-N 121.479 -1.013 . . . . 0.0 111.75 -179.848 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 2484 ' ' ARG . . . . . . . . . . . . . 21.5 ttt180 -95.34 141.83 28.45 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 125.038 1.335 . . . . 0.0 110.725 177.013 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 2485 ' ' VAL . . . . . . . . . . . . . 67.1 t -132.58 122.01 46.43 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 C-N-CA 124.98 1.312 . . . . 0.0 108.943 178.247 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 2486 ' ' THR . . . . . . . . . . . . . 89.9 m -110.07 144.35 38.78 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 124.856 1.262 . . . . 0.0 107.846 165.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 2487 ' ' TYR . . . . . . . . . . . . . 28.7 p90 -148.63 144.24 27.06 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 123.918 0.887 . . . . 0.0 112.185 174.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 2488 ' ' THR . . . . . . . . . . . . . 85.6 m -107.21 117.32 56.53 Favored Pre-proline 0 N--CA 1.476 0.86 0 CA-C-O 117.989 -1.005 . . . . 0.0 109.422 172.233 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 2489 ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -81.68 163.11 18.86 Favored 'Trans proline' 0 C--N 1.351 0.687 0 C-N-CA 124.319 3.346 . . . . 0.0 111.604 174.197 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 2490 ' ' MET . . . . . . . . . . . . . 28.4 ptm -133.85 -3.68 2.87 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 115.603 1.705 . . . . 0.0 115.603 -171.539 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 2491 ' ' ALA . . . . . . . . . . . . . . . -144.78 145.66 28.77 Favored Pre-proline 0 CA--C 1.548 0.871 0 C-N-CA 124.728 1.211 . . . . 0.0 110.937 172.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 2492 ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -71.29 151.98 60.8 Favored 'Trans proline' 0 CA--C 1.535 0.574 0 C-N-CA 123.504 2.803 . . . . 0.0 111.615 -178.715 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 2493 ' ' GLY . . . . . . . . . . . . . . . 129.88 -165.47 22.32 Favored Glycine 0 CA--C 1.53 1.003 0 C-N-CA 125.187 1.375 . . . . 0.0 113.578 -177.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 2494 ' ' SER . . . . . . . . . . . . . 16.7 p -89.96 115.02 26.94 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.835 1.254 . . . . 0.0 112.08 178.823 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 2495 ' ' TYR . . . . . . . . . . . . . 54.6 m-85 -87.74 122.78 31.82 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 123.536 0.735 . . . . 0.0 109.741 163.819 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 2496 ' ' LEU . . . . . . . . . . . . . 21.4 tp -94.34 104.61 16.59 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 124.597 1.159 . . . . 0.0 109.521 -178.467 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 2497 ' ' ILE . . . . . . . . . . . . . 30.2 mt -90.4 98.05 7.84 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 C-N-CA 125.826 1.65 . . . . 0.0 108.23 -177.627 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 2498 ' ' SER . . . . . . . . . . . . . 71.0 m -85.02 80.97 9.1 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 124.675 1.19 . . . . 0.0 109.624 175.783 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 2499 ' ' ILE . . . . . . . . . . . . . 17.9 mt -77.82 114.16 17.99 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 175.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 2500 ' ' LYS . . . . . . . . . . . . . 81.9 mttt -121.76 148.66 44.35 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.528 1.531 . . . . 0.0 111.037 -177.781 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 2501 ' ' TYR . . . . . . . . . . . . . 63.4 t80 -154.91 145.84 22.58 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.119 0.968 . . . . 0.0 112.499 -171.423 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 2502 ' ' GLY . . . . . . . . . . . . . . . 69.04 17.48 71.83 Favored Glycine 0 CA--C 1.536 1.394 0 C-N-CA 124.216 0.913 . . . . 0.0 113.704 178.823 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 2503 ' ' GLY . . . . . . . . . . . . . . . 135.6 -165.05 24.87 Favored Glycine 0 CA--C 1.54 1.643 0 C-N-CA 125.981 1.753 . . . . 0.0 112.528 -167.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 2504 ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -82.26 20.31 1.12 Allowed 'Trans proline' 0 CA--C 1.545 1.06 0 C-N-CA 124.855 3.703 . . . . 0.0 113.638 -174.545 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 2505 ' ' TYR . . . . . . . . . . . . . 80.5 m-85 -109.98 139.96 44.51 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.751 1.22 . . . . 0.0 113.355 -172.644 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 2506 ' ' HIS . . . . . . . . . . . . . 92.5 m-70 -62.57 144.31 56.27 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 125.571 1.548 . . . . 0.0 113.572 -179.61 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 2507 ' ' ILE . . . . . . . . . . . . . 28.0 pt -75.79 174.69 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 C-N-CA 123.633 0.773 . . . . 0.0 112.992 173.123 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 2508 ' ' GLY . . . . . . . . . . . . . . . -58.94 117.91 12.45 Favored Glycine 0 CA--C 1.532 1.152 0 N-CA-C 111.228 -0.749 . . . . 0.0 111.228 171.24 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 2509 ' ' GLY . . . . . . . . . . . . . . . 93.54 -9.77 73.59 Favored Glycine 0 CA--C 1.536 1.388 0 C-N-CA 125.677 1.608 . . . . 0.0 115.168 -178.142 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 2510 ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -78.23 156.09 79.17 Favored Pre-proline 0 N--CA 1.474 0.768 0 CA-C-N 119.647 1.723 . . . . 0.0 113.68 178.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 2511 ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -77.58 152.66 93.51 Favored 'Cis proline' 0 CA--C 1.539 0.768 0 CA-C-N 118.26 0.414 . . . . 0.0 111.435 -9.561 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 2512 ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -98.21 128.8 44.87 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.373 1.069 . . . . 0.0 110.633 179.693 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 2513 ' ' LYS . . . . . . . . . . . . . 24.9 pttm -88.22 7.58 31.29 Favored 'General case' 0 N--CA 1.479 0.995 0 N-CA-C 116.715 2.117 . . . . 0.0 116.715 -165.352 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 2514 ' ' ALA . . . . . . . . . . . . . . . -3.97 97.65 0.01 OUTLIER 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 129.467 3.107 . . . . 0.0 116.462 -175.616 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 2515 ' ' LYS . . . . . . . . . . . . . 62.8 mtpt -89.78 105.24 17.67 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.504 1.122 . . . . 0.0 110.683 -175.104 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 2516 ' ' VAL . . . . . . . . . . . . . 4.0 m -102.36 148.4 7.86 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 C-N-CA 124.315 1.046 . . . . 0.0 111.486 -174.161 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 2517 ' ' THR . . . . . . . . . . . . . 69.1 p -116.66 -169.37 1.62 Allowed 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 125.471 1.508 . . . . 0.0 110.922 179.349 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 2518 ' ' GLY . . . . . . . . . . . . . . . 96.29 -175.7 32.2 Favored Glycine 0 CA--C 1.539 1.575 0 C-N-CA 124.693 1.14 . . . . 0.0 113.331 -176.221 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 2519 ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -70.63 153.39 64.96 Favored 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 123.748 2.966 . . . . 0.0 112.537 -174.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 2520 ' ' ARG . . . . . . . . . . . . . 65.2 ttp85 -94.81 122.93 37.94 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.686 1.194 . . . . 0.0 110.053 171.199 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 2521 ' ' LEU . . . . . . . . . . . . . 4.1 mm? -95.28 -13.35 24.92 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 124.266 1.026 . . . . 0.0 113.7 -175.204 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 2522 ' ' VAL . . . . . . . . . . . . . 14.8 m . . . . . 0 N--CA 1.484 1.264 0 C-N-CA 125.858 1.663 . . . . 0.0 113.66 -174.194 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.545 0 N-CA-C 111.758 -0.537 . . . . 0.0 111.758 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -72.17 -34.47 68.49 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.021 0.929 . . . . 0.0 113.257 -179.588 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 51.1 tpp -73.53 131.47 41.79 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 124.903 1.281 . . . . 0.0 110.99 175.309 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 2427 ' ' GLY . . . . . . . . . . . . . . . -77.76 171.74 55.15 Favored Glycine 0 CA--C 1.532 1.111 0 C-N-CA 124.904 1.24 . . . . 0.0 113.787 179.034 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 2428 ' ' ASP . . . . . . . . . . . . . 25.6 m-20 -117.68 137.1 23.94 Favored Pre-proline 0 CA--C 1.546 0.82 0 C-N-CA 125.07 1.348 . . . . 0.0 111.901 -179.595 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 2429 ' ' PRO . . . . . . . . . . . . . 81.1 Cg_exo -54.91 -26.79 50.49 Favored 'Trans proline' 0 C--N 1.353 0.792 0 C-N-CA 124.056 3.171 . . . . 0.0 115.089 174.707 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 2430 ' ' GLY . . . . . . . . . . . . . . . -78.93 -23.1 64.66 Favored Glycine 0 CA--C 1.534 1.225 0 C-N-CA 123.812 0.72 . . . . 0.0 113.786 176.174 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 2431 ' ' LEU . . . . . . . . . . . . . 4.4 mm? -91.04 -32.16 16.01 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.731 1.212 . . . . 0.0 111.89 174.458 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 2432 ' ' VAL . . . . . . . . . . . . . 94.1 t -64.84 134.32 29.5 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 CA-C-N 118.698 0.681 . . . . 0.0 109.76 170.033 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 2433 ' ' SER . . . . . . . . . . . . . 7.9 t -127.28 -167.91 1.81 Allowed 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.93 1.292 . . . . 0.0 111.163 177.545 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 2434 ' ' ALA . . . . . . . . . . . . . . . -153.25 139.37 18.32 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.538 1.135 . . . . 0.0 111.656 177.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 2435 ' ' TYR . . . . . . . . . . . . . 76.8 m-85 -146.54 141.9 27.48 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 125.265 1.426 . . . . 0.0 111.951 -176.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 2436 ' ' GLY . . . . . . . . . . . . . . . 126.0 163.05 11.46 Favored Glycine 0 CA--C 1.534 1.225 0 C-N-CA 125.704 1.621 . . . . 0.0 113.743 179.461 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 2437 ' ' ALA . . . . . . . . . . . . . . . -63.58 -28.39 69.9 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 114.706 1.373 . . . . 0.0 114.706 -168.782 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 2438 ' ' GLY . . . . . . . . . . . . . . . -64.42 -16.6 60.84 Favored Glycine 0 CA--C 1.532 1.095 0 C-N-CA 124.302 0.953 . . . . 0.0 114.502 -177.645 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 2439 ' ' LEU . . . . . . . . . . . . . 95.2 mt -68.73 -29.55 67.99 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 118.575 1.188 . . . . 0.0 112.548 170.159 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 2440 ' ' GLU . . . . . . . . . . . . . 41.7 mm-40 -90.24 -26.92 19.83 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.912 1.285 . . . . 0.0 112.33 178.765 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 2441 ' ' GLY . . . . . . . . . . . . . . . 102.86 -144.42 16.05 Favored Glycine 0 CA--C 1.531 1.087 0 C-N-CA 125.666 1.603 . . . . 0.0 112.881 -178.143 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 2442 ' ' GLY . . . . . . . . . . . . . . . 163.06 -160.26 32.79 Favored Glycine 0 CA--C 1.532 1.124 0 C-N-CA 123.836 0.731 . . . . 0.0 114.872 -176.349 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 2443 ' ' VAL . . . . . . . . . . . . . 83.2 t -83.14 141.49 14.82 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 C-N-CA 124.786 1.235 . . . . 0.0 110.96 -177.533 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 2444 ' ' THR . . . . . . . . . . . . . 18.9 p -56.1 131.41 47.52 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 124.996 1.318 . . . . 0.0 112.228 174.674 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 2445 ' ' GLY . . . . . . . . . . . . . . . 82.88 -10.93 56.05 Favored Glycine 0 CA--C 1.535 1.291 0 C-N-CA 124.993 1.282 . . . . 0.0 114.66 178.667 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 2446 ' ' ASN . . . . . . . . . . . . . 61.1 m-20 -91.99 147.93 35.85 Favored Pre-proline 0 CA--C 1.547 0.833 0 CA-C-N 118.63 1.215 . . . . 0.0 110.727 172.225 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 2447 ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -71.8 143.48 41.55 Favored 'Trans proline' 0 N--CA 1.457 -0.619 0 C-N-CA 122.817 2.345 . . . . 0.0 111.041 177.453 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 2448 ' ' ALA . . . . . . . . . . . . . . . -124.39 143.92 50.34 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 126.698 1.999 . . . . 0.0 109.126 172.495 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 2449 ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -154.41 152.43 30.17 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 113.392 0.886 . . . . 0.0 113.392 -173.462 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 2450 ' ' PHE . . . . . . . . . . . . . 14.0 p90 -161.46 167.14 26.11 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.902 1.681 . . . . 0.0 110.436 177.599 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 2451 ' ' VAL . . . . . . . . . . . . . 59.2 t -112.33 128.69 68.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 124.698 1.199 . . . . 0.0 110.209 177.537 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 2452 ' ' VAL . . . . . . . . . . . . . 48.8 t -77.53 106.11 7.35 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 162.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 2453 ' ' ASN . . . . . . . . . . . . . 16.3 t-20 -83.47 106.31 15.11 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 124.21 1.004 . . . . 0.0 111.732 -170.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 2454 ' ' THR . . . . . . . . . . . . . 40.6 p -97.7 -8.23 29.17 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 125.83 1.652 . . . . 0.0 113.514 177.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 2455 ' ' SER . . . . . . . . . . . . . 12.8 t -58.54 -31.69 68.18 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-N 119.364 0.983 . . . . 0.0 113.45 -176.629 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 2456 ' ' ASN . . . . . . . . . . . . . 57.8 m-80 -76.8 -14.86 59.87 Favored 'General case' 0 CA--C 1.549 0.907 0 N-CA-C 113.942 1.09 . . . . 0.0 113.942 174.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 2457 ' ' ALA . . . . . . . . . . . . . . . -109.0 -39.0 5.43 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 125.344 1.458 . . . . 0.0 113.98 -173.723 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 2458 ' ' GLY . . . . . . . . . . . . . . . 112.67 -148.3 18.42 Favored Glycine 0 CA--C 1.533 1.181 0 C-N-CA 125.379 1.466 . . . . 0.0 112.125 -171.432 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 2459 ' ' ALA . . . . . . . . . . . . . . . -92.36 154.7 18.39 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.21 1.004 . . . . 0.0 112.123 179.417 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 2460 ' ' GLY . . . . . . . . . . . . . . . 166.02 163.71 20.1 Favored Glycine 0 N--CA 1.47 0.924 0 C-N-CA 123.848 0.737 . . . . 0.0 114.3 177.488 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 2461 ' ' ALA . . . . . . . . . . . . . . . -80.04 137.3 36.77 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.349 1.06 . . . . 0.0 112.134 -178.559 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 2462 ' ' LEU . . . . . . . . . . . . . 25.8 tp -110.78 141.76 43.68 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.337 1.455 . . . . 0.0 110.591 176.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 2463 ' ' SER . . . . . . . . . . . . . 4.1 t -130.28 39.0 3.7 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 126.215 1.806 . . . . 0.0 110.653 -177.319 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 2464 ' ' VAL . . . . . . . . . . . . . 11.4 p -65.72 140.98 18.72 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 125.512 1.525 . . . . 0.0 112.058 -176.239 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 2465 ' ' THR . . . . . . . . . . . . . 8.3 t -154.45 167.19 30.88 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 125.137 1.375 . . . . 0.0 111.691 179.704 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 2466 ' ' ILE . . . . . . . . . . . . . 35.2 mt -135.02 131.01 52.56 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 C-N-CA 125.237 1.415 . . . . 0.0 109.936 -176.127 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 2467 ' ' ASP . . . . . . . . . . . . . 36.3 t70 -122.26 136.91 54.98 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 125.811 1.644 . . . . 0.0 110.735 174.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 2468 ' ' GLY . . . . . . . . . . . . . . . 172.94 -162.77 34.34 Favored Glycine 0 CA--C 1.537 1.444 0 CA-C-O 119.062 -0.855 . . . . 0.0 114.121 -177.624 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 2469 ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -72.81 1.2 6.68 Favored 'Trans proline' 0 CA--C 1.544 0.979 0 C-N-CA 123.999 3.133 . . . . 0.0 115.325 -172.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 2470 ' ' SER . . . . . . . . . . . . . 85.0 p -150.55 153.94 36.69 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 120.071 1.305 . . . . 0.0 112.989 167.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 2471 ' ' LYS . . . . . . . . . . . . . 99.1 mttt -75.44 74.45 2.5 Favored 'General case' 0 CA--C 1.545 0.77 0 O-C-N 120.906 -1.121 . . . . 0.0 111.073 175.624 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 2472 ' ' VAL . . . . . . . . . . . . . 18.6 m -54.76 143.14 7.57 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 C-N-CA 124.725 1.21 . . . . 0.0 113.403 -173.422 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 2473 ' ' LYS . . . . . . . . . . . . . 83.8 tttt -83.67 70.8 10.38 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 124.596 1.158 . . . . 0.0 111.129 178.471 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 2474 ' ' MET . . . . . . . . . . . . . 16.6 tmm? -79.78 129.61 34.63 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.185 0.994 . . . . 0.0 111.315 -179.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 2475 ' ' ASP . . . . . . . . . . . . . 35.6 t70 -123.38 126.23 46.43 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 126.209 1.804 . . . . 0.0 110.348 174.261 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 2476 ' ' CYS . . . . . . . . . . . . . 35.9 t -101.92 139.82 37.03 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.066 1.346 . . . . 0.0 111.535 179.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 2477 ' ' GLN . . . . . . . . . . . . . 83.5 mt-30 -141.42 145.25 35.06 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.424 1.49 . . . . 0.0 110.497 -174.092 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 2478 ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -88.11 136.81 32.8 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 123.716 0.806 . . . . 0.0 110.624 174.213 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 2479 ' ' CYS . . . . . . . . . . . . . 14.8 p -146.44 171.53 6.3 Favored Pre-proline 0 CA--C 1.554 1.11 0 C-N-CA 125.617 1.567 . . . . 0.0 111.717 177.69 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 2480 ' ' PRO . . . . . . . . . . . . . 70.5 Cg_exo -58.94 -28.31 87.2 Favored 'Trans proline' 0 CA--C 1.539 0.76 0 C-N-CA 123.468 2.779 . . . . 0.0 114.66 179.331 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 2481 ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -83.79 -14.19 52.01 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 124.62 1.168 . . . . 0.0 113.019 -179.656 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 2482 ' ' GLY . . . . . . . . . . . . . . . 136.09 -143.95 15.57 Favored Glycine 0 N--CA 1.47 0.937 0 C-N-CA 125.83 1.681 . . . . 0.0 112.677 -177.112 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 2483 ' ' TYR . . . . . . . . . . . . . 88.7 m-85 -92.8 108.82 20.28 Favored 'General case' 0 N--CA 1.469 0.506 0 O-C-N 121.678 -0.895 . . . . 0.0 110.911 173.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 2484 ' ' ARG . . . . . . . . . . . . . 12.7 ttp180 -74.44 140.94 45.0 Favored 'General case' 0 N--CA 1.468 0.451 0 O-C-N 121.705 -0.622 . . . . 0.0 109.859 169.217 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 2485 ' ' VAL . . . . . . . . . . . . . 22.5 m -126.18 141.69 45.01 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 C-N-CA 123.669 0.788 . . . . 0.0 110.368 165.583 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 2486 ' ' THR . . . . . . . . . . . . . 88.8 m -132.53 135.84 46.23 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 125.658 1.583 . . . . 0.0 108.443 177.582 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 2487 ' ' TYR . . . . . . . . . . . . . 23.1 p90 -149.84 159.92 43.98 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.792 1.237 . . . . 0.0 112.443 -179.747 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 2488 ' ' THR . . . . . . . . . . . . . 99.4 m -122.27 113.8 30.81 Favored Pre-proline 0 N--CA 1.476 0.871 0 C-N-CA 124.154 0.982 . . . . 0.0 109.59 174.23 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 2489 ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -83.74 134.89 6.56 Favored 'Trans proline' 0 N--CA 1.458 -0.598 0 C-N-CA 123.624 2.883 . . . . 0.0 109.957 169.653 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 2490 ' ' MET . . . . . . . . . . . . . 22.4 ptt? -101.71 -18.05 16.0 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 114.329 1.233 . . . . 0.0 114.329 179.348 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 2491 ' ' ALA . . . . . . . . . . . . . . . -112.98 146.34 34.93 Favored Pre-proline 0 CA--C 1.547 0.835 0 C-N-CA 124.68 1.192 . . . . 0.0 112.346 -175.067 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 2492 ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -72.07 156.67 55.55 Favored 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 122.99 2.46 . . . . 0.0 111.192 172.494 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 2493 ' ' GLY . . . . . . . . . . . . . . . 128.79 -147.83 17.77 Favored Glycine 0 CA--C 1.528 0.894 0 C-N-CA 125.465 1.507 . . . . 0.0 112.239 -175.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 2494 ' ' SER . . . . . . . . . . . . . 63.8 m -129.78 140.55 51.03 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 123.891 0.876 . . . . 0.0 111.973 177.686 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 2495 ' ' TYR . . . . . . . . . . . . . 62.3 m-85 -114.75 127.5 55.77 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 125.993 1.717 . . . . 0.0 109.797 177.245 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 2496 ' ' LEU . . . . . . . . . . . . . 9.9 mp -88.69 117.56 27.75 Favored 'General case' 0 N--CA 1.464 0.242 0 C-N-CA 123.879 0.871 . . . . 0.0 108.963 173.131 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 2497 ' ' ILE . . . . . . . . . . . . . 36.1 mt -93.45 103.95 15.22 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 C-N-CA 125.371 1.468 . . . . 0.0 107.462 176.101 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 2498 ' ' SER . . . . . . . . . . . . . 66.4 m -91.31 101.21 13.91 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 124.816 1.246 . . . . 0.0 109.524 -179.609 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 2499 ' ' ILE . . . . . . . . . . . . . 24.0 mt -97.6 92.01 2.77 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 C-N-CA 125.332 1.453 . . . . 0.0 108.828 -178.05 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 2500 ' ' LYS . . . . . . . . . . . . . 84.2 mttt -102.51 139.68 37.79 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.32 1.048 . . . . 0.0 111.739 178.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 2501 ' ' TYR . . . . . . . . . . . . . 72.8 t80 -145.26 147.45 32.4 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.817 1.247 . . . . 0.0 112.429 -170.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 2502 ' ' GLY . . . . . . . . . . . . . . . 64.83 21.28 67.31 Favored Glycine 0 CA--C 1.535 1.299 0 C-N-CA 124.17 0.89 . . . . 0.0 113.505 177.725 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 2503 ' ' GLY . . . . . . . . . . . . . . . 126.69 -163.49 20.58 Favored Glycine 0 CA--C 1.541 1.686 0 C-N-CA 125.899 1.714 . . . . 0.0 112.173 -163.119 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 2504 ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -83.23 21.49 1.02 Allowed 'Trans proline' 0 CA--C 1.545 1.048 0 C-N-CA 124.776 3.65 . . . . 0.0 113.91 -172.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 2505 ' ' TYR . . . . . . . . . . . . . 80.7 m-85 -105.92 130.5 53.86 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.313 1.045 . . . . 0.0 113.129 -171.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 2506 ' ' HIS . . . . . . . . . . . . . 86.5 m-70 -62.39 140.03 58.55 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 125.369 1.468 . . . . 0.0 113.523 179.705 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 2507 ' ' ILE . . . . . . . . . . . . . 1.8 pp -87.82 150.73 3.68 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.163 0 C-N-CA 123.954 0.902 . . . . 0.0 111.812 172.33 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 2508 ' ' GLY . . . . . . . . . . . . . . . 48.88 -116.8 3.57 Favored Glycine 0 CA--C 1.536 1.377 0 C-N-CA 124.087 0.851 . . . . 0.0 114.074 167.765 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 2509 ' ' GLY . . . . . . . . . . . . . . . -98.59 13.16 62.84 Favored Glycine 0 CA--C 1.536 1.359 0 C-N-CA 126.156 1.836 . . . . 0.0 115.047 177.811 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 2510 ' ' SER . . . . . . . . . . . . . 44.2 t -65.36 145.39 99.08 Favored Pre-proline 0 CA--C 1.553 1.059 0 CA-C-N 119.207 1.503 . . . . 0.0 112.837 -179.004 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 2511 ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -74.7 141.0 70.45 Favored 'Cis proline' 0 C--N 1.355 0.888 0 CA-C-N 119.712 0.933 . . . . 0.0 112.636 0.663 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 2512 ' ' PHE . . . . . . . . . . . . . 87.8 m-85 -94.38 125.43 39.02 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.575 1.15 . . . . 0.0 110.518 178.246 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 2513 ' ' LYS . . . . . . . . . . . . . 25.7 pttm -85.5 105.02 15.8 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 123.545 0.738 . . . . 0.0 112.165 177.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 2514 ' ' ALA . . . . . . . . . . . . . . . -87.94 120.0 28.84 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.239 1.416 . . . . 0.0 109.902 173.433 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 2515 ' ' LYS . . . . . . . . . . . . . 54.0 mtmt -94.41 133.35 38.09 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.383 1.073 . . . . 0.0 110.84 -176.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 2516 ' ' VAL . . . . . . . . . . . . . 87.9 t -131.21 136.94 56.77 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 124.415 1.086 . . . . 0.0 110.743 -170.544 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 2517 ' ' THR . . . . . . . . . . . . . 34.2 p -138.41 156.76 47.28 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 125.265 1.426 . . . . 0.0 111.795 -175.705 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 2518 ' ' GLY . . . . . . . . . . . . . . . 114.73 -176.29 16.7 Favored Glycine 0 CA--C 1.541 1.698 0 C-N-CA 125.584 1.564 . . . . 0.0 113.04 -175.21 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 2519 ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -69.8 149.68 66.97 Favored 'Trans proline' 0 CA--C 1.535 0.562 0 C-N-CA 123.756 2.97 . . . . 0.0 112.246 -174.162 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 2520 ' ' ARG . . . . . . . . . . . . . 37.3 ttm105 -79.11 -23.03 44.36 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 123.908 0.883 . . . . 0.0 113.287 178.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 2521 ' ' LEU . . . . . . . . . . . . . 3.6 mm? 70.24 -55.28 0.61 Allowed 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 129.374 3.069 . . . . 0.0 112.221 -175.617 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 2522 ' ' VAL . . . . . . . . . . . . . 26.9 m . . . . . 0 C--O 1.252 1.233 0 C-N-CA 125.64 1.576 . . . . 0.0 113.465 176.439 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.554 0 N-CA-C 111.431 -0.668 . . . . 0.0 111.431 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -151.74 155.59 38.57 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 125.656 1.582 . . . . 0.0 111.38 -179.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -88.77 -31.82 18.2 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.763 1.225 . . . . 0.0 111.778 179.647 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 2427 ' ' GLY . . . . . . . . . . . . . . . -82.08 174.43 53.68 Favored Glycine 0 CA--C 1.53 1.002 0 C-N-CA 125.024 1.297 . . . . 0.0 114.018 177.744 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 2428 ' ' ASP . . . . . . . . . . . . . 21.3 m-20 -132.89 138.71 32.51 Favored Pre-proline 0 CA--C 1.547 0.857 0 C-N-CA 125.381 1.472 . . . . 0.0 111.462 -179.58 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 2429 ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -56.79 -26.32 65.79 Favored 'Trans proline' 0 C--N 1.352 0.756 0 C-N-CA 123.854 3.036 . . . . 0.0 114.568 176.549 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 2430 ' ' GLY . . . . . . . . . . . . . . . -79.12 -23.5 63.38 Favored Glycine 0 CA--C 1.534 1.219 0 C-N-CA 123.737 0.684 . . . . 0.0 113.871 176.66 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 2431 ' ' LEU . . . . . . . . . . . . . 4.3 mm? -86.98 -39.64 15.5 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.519 1.128 . . . . 0.0 111.118 173.261 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 2432 ' ' VAL . . . . . . . . . . . . . 98.7 t -61.41 133.82 27.0 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 123.469 0.708 . . . . 0.0 109.992 172.53 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 2433 ' ' SER . . . . . . . . . . . . . 8.4 t -129.13 -170.09 2.21 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.892 1.277 . . . . 0.0 110.959 178.425 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 2434 ' ' ALA . . . . . . . . . . . . . . . -151.05 143.54 24.29 Favored 'General case' 0 CA--C 1.538 0.496 0 O-C-N 120.956 -1.09 . . . . 0.0 111.889 177.125 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 2435 ' ' TYR . . . . . . . . . . . . . 82.1 m-85 -145.89 143.64 29.7 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 125.242 1.417 . . . . 0.0 111.971 -176.142 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 2436 ' ' GLY . . . . . . . . . . . . . . . 125.71 162.7 11.38 Favored Glycine 0 N--CA 1.475 1.244 0 C-N-CA 125.607 1.575 . . . . 0.0 114.201 176.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 2437 ' ' ALA . . . . . . . . . . . . . . . -62.36 -27.16 68.87 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 125.244 1.418 . . . . 0.0 114.545 -170.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 2438 ' ' GLY . . . . . . . . . . . . . . . -61.87 -22.13 61.9 Favored Glycine 0 CA--C 1.531 1.06 0 C-N-CA 124.022 0.82 . . . . 0.0 113.903 179.326 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 2439 ' ' LEU . . . . . . . . . . . . . 85.5 mt -70.98 -22.8 62.14 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 118.547 1.173 . . . . 0.0 112.97 172.742 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 2440 ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -96.37 -26.44 15.35 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.11 1.364 . . . . 0.0 112.592 -179.796 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 2441 ' ' GLY . . . . . . . . . . . . . . . 101.8 -142.91 15.84 Favored Glycine 0 CA--C 1.532 1.127 0 C-N-CA 125.465 1.507 . . . . 0.0 112.652 -177.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 2442 ' ' GLY . . . . . . . . . . . . . . . 152.36 -152.58 24.26 Favored Glycine 0 CA--C 1.532 1.128 0 C-N-CA 124.205 0.907 . . . . 0.0 114.27 -177.14 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 2443 ' ' VAL . . . . . . . . . . . . . 38.4 t -88.32 141.27 14.53 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 C-N-CA 124.501 1.12 . . . . 0.0 110.333 -179.042 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 2444 ' ' THR . . . . . . . . . . . . . 33.1 p -59.07 152.69 19.49 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 124.361 1.065 . . . . 0.0 112.744 174.385 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 2445 ' ' GLY . . . . . . . . . . . . . . . 70.93 0.72 35.72 Favored Glycine 0 CA--C 1.534 1.224 0 C-N-CA 124.182 0.896 . . . . 0.0 115.133 177.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 2446 ' ' ASN . . . . . . . . . . . . . 14.6 m-80 -116.14 143.35 30.81 Favored Pre-proline 0 CA--C 1.546 0.803 0 C-N-CA 126.043 1.737 . . . . 0.0 110.066 177.095 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 2447 ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -72.99 141.92 33.85 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 122.805 2.337 . . . . 0.0 111.133 178.7 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 2448 ' ' ALA . . . . . . . . . . . . . . . -128.87 137.51 51.5 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.568 1.547 . . . . 0.0 109.403 169.66 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 2449 ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -131.35 151.81 51.18 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.21 1.004 . . . . 0.0 113.402 -166.6 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 2450 ' ' PHE . . . . . . . . . . . . . 27.2 p90 -158.48 163.65 36.93 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 125.915 1.686 . . . . 0.0 110.802 178.18 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 2451 ' ' VAL . . . . . . . . . . . . . 58.2 t -118.36 132.57 67.83 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 124.488 1.115 . . . . 0.0 109.717 175.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 2452 ' ' VAL . . . . . . . . . . . . . 40.3 t -79.19 106.69 10.64 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 162.716 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 2453 ' ' ASN . . . . . . . . . . . . . 15.0 t-20 -84.18 108.38 17.04 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 123.65 0.78 . . . . 0.0 111.7 -172.39 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 2454 ' ' THR . . . . . . . . . . . . . 29.9 p -97.67 -6.87 32.18 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 126.364 1.866 . . . . 0.0 113.644 -179.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 2455 ' ' SER . . . . . . . . . . . . . 14.9 m -58.11 -26.91 63.21 Favored 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 114.229 1.196 . . . . 0.0 114.229 -177.386 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 2456 ' ' ASN . . . . . . . . . . . . . 86.2 m-20 -75.27 -20.17 59.3 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.549 1.139 . . . . 0.0 113.355 175.524 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 2457 ' ' ALA . . . . . . . . . . . . . . . -116.62 -44.48 2.85 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.317 1.447 . . . . 0.0 113.451 -164.518 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 2458 ' ' GLY . . . . . . . . . . . . . . . 100.44 -148.11 18.24 Favored Glycine 0 CA--C 1.533 1.191 0 C-N-CA 124.98 1.276 . . . . 0.0 112.847 -175.135 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 2459 ' ' ALA . . . . . . . . . . . . . . . -73.66 139.26 45.29 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.352 1.061 . . . . 0.0 113.596 -172.553 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 2460 ' ' GLY . . . . . . . . . . . . . . . 168.67 154.79 9.14 Favored Glycine 0 CA--C 1.531 1.041 0 C-N-CA 125.327 1.441 . . . . 0.0 113.167 177.226 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 2461 ' ' ALA . . . . . . . . . . . . . . . -79.85 147.71 31.63 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 124.293 1.037 . . . . 0.0 112.567 -178.289 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 2462 ' ' LEU . . . . . . . . . . . . . 16.6 tp -108.55 143.39 37.64 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.148 1.379 . . . . 0.0 111.131 177.267 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 2463 ' ' SER . . . . . . . . . . . . . 49.4 m -135.0 38.97 2.98 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 125.699 1.6 . . . . 0.0 111.139 -176.514 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 2464 ' ' VAL . . . . . . . . . . . . . 8.5 p -66.03 138.12 23.63 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 C-N-CA 125.453 1.501 . . . . 0.0 112.43 -177.739 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 2465 ' ' THR . . . . . . . . . . . . . 93.1 m -137.87 141.69 40.7 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 125.608 1.563 . . . . 0.0 109.822 175.232 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 2466 ' ' ILE . . . . . . . . . . . . . 56.7 mt -105.61 119.89 55.54 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 123.661 0.784 . . . . 0.0 109.266 170.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 2467 ' ' ASP . . . . . . . . . . . . . 37.4 t70 -108.01 155.68 20.07 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 126.334 1.853 . . . . 0.0 110.603 173.5 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 2468 ' ' GLY . . . . . . . . . . . . . . . 163.56 -160.34 33.06 Favored Glycine 0 CA--C 1.535 1.327 0 CA-C-O 119.136 -0.814 . . . . 0.0 114.044 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 2469 ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -71.04 -14.62 32.16 Favored 'Trans proline' 0 CA--C 1.539 0.766 0 C-N-CA 123.788 2.992 . . . . 0.0 114.003 -177.342 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 2470 ' ' SER . . . . . . . . . . . . . 42.2 m -152.49 159.52 43.33 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 125.257 1.423 . . . . 0.0 111.959 178.573 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 2471 ' ' LYS . . . . . . . . . . . . . 68.3 mttm -76.42 98.07 4.46 Favored 'General case' 0 CA--C 1.544 0.722 0 O-C-N 120.966 -1.084 . . . . 0.0 110.482 172.574 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 2472 ' ' VAL . . . . . . . . . . . . . 16.2 m -60.77 148.38 8.98 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 C-N-CA 123.985 0.914 . . . . 0.0 111.743 179.252 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 2473 ' ' LYS . . . . . . . . . . . . . 88.6 tttt -77.1 109.85 11.28 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 171.015 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 2474 ' ' MET . . . . . . . . . . . . . 25.3 ttt -118.19 142.27 47.63 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.998 1.319 . . . . 0.0 112.434 -166.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 2475 ' ' ASP . . . . . . . . . . . . . 31.0 t70 -128.41 147.03 50.63 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 127.187 2.195 . . . . 0.0 110.16 169.428 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 2476 ' ' CYS . . . . . . . . . . . . . 37.8 t -138.12 140.58 39.99 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.668 1.187 . . . . 0.0 110.244 172.181 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 2477 ' ' GLN . . . . . . . . . . . . . 8.7 pt20 -156.89 163.13 39.51 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.182 1.393 . . . . 0.0 111.17 -172.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 2478 ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -95.13 138.5 32.76 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 123.775 0.83 . . . . 0.0 111.39 -179.365 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 2479 ' ' CYS . . . . . . . . . . . . . 14.0 p -139.18 170.9 9.01 Favored Pre-proline 0 CA--C 1.553 1.071 0 C-N-CA 125.43 1.492 . . . . 0.0 111.168 170.547 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 2480 ' ' PRO . . . . . . . . . . . . . 68.3 Cg_exo -58.43 -26.09 76.3 Favored 'Trans proline' 0 C--N 1.352 0.741 0 C-N-CA 123.508 2.805 . . . . 0.0 114.702 178.415 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 2481 ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -83.09 -11.04 58.37 Favored 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 125.01 1.324 . . . . 0.0 112.862 178.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 2482 ' ' GLY . . . . . . . . . . . . . . . 128.82 -155.49 20.65 Favored Glycine 0 N--CA 1.473 1.125 0 C-N-CA 125.893 1.711 . . . . 0.0 113.402 -178.276 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 2483 ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -76.06 109.29 9.59 Favored 'General case' 0 N--CA 1.47 0.575 0 O-C-N 121.621 -0.929 . . . . 0.0 110.767 175.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 2484 ' ' ARG . . . . . . . . . . . . . 31.5 ttm180 -85.27 131.66 34.38 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 124.892 1.277 . . . . 0.0 110.577 176.242 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 2485 ' ' VAL . . . . . . . . . . . . . 78.7 t -117.93 137.5 51.67 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 C-N-CA 126.062 1.745 . . . . 0.0 108.742 176.397 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 2486 ' ' THR . . . . . . . . . . . . . 85.0 m -131.9 139.0 48.62 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.771 1.229 . . . . 0.0 108.175 171.277 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 2487 ' ' TYR . . . . . . . . . . . . . 30.5 p90 -146.41 149.32 33.5 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 113.38 0.881 . . . . 0.0 113.38 175.61 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 2488 ' ' THR . . . . . . . . . . . . . 62.9 m -112.7 114.21 49.8 Favored Pre-proline 0 N--CA 1.472 0.639 0 C-N-CA 125.17 1.388 . . . . 0.0 108.61 172.411 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 2489 ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -81.06 134.99 9.57 Favored 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 122.851 2.367 . . . . 0.0 110.709 176.004 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 2490 ' ' MET . . . . . . . . . . . . . 17.7 ptm -91.25 -3.72 56.63 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 125.031 1.332 . . . . 0.0 114.192 -177.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 2491 ' ' ALA . . . . . . . . . . . . . . . -151.26 151.08 28.6 Favored Pre-proline 0 CA--C 1.546 0.826 0 C-N-CA 125.429 1.492 . . . . 0.0 112.001 -173.83 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 2492 ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -73.99 165.09 32.92 Favored 'Trans proline' 0 CA--C 1.538 0.685 0 C-N-CA 123.505 2.803 . . . . 0.0 111.727 173.447 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 2493 ' ' GLY . . . . . . . . . . . . . . . 127.09 -158.67 21.07 Favored Glycine 0 CA--C 1.53 0.994 0 C-N-CA 125.539 1.542 . . . . 0.0 112.973 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 2494 ' ' SER . . . . . . . . . . . . . 67.6 m -113.47 128.89 56.6 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.126 0.971 . . . . 0.0 111.262 179.257 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 2495 ' ' TYR . . . . . . . . . . . . . 88.9 m-85 -110.82 132.88 53.83 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.781 1.632 . . . . 0.0 110.531 177.748 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 2496 ' ' LEU . . . . . . . . . . . . . 9.5 mp -96.7 114.74 26.41 Favored 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 124.248 1.019 . . . . 0.0 108.908 173.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 2497 ' ' ILE . . . . . . . . . . . . . 30.6 mt -89.49 92.21 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 N-CA-C 107.306 -1.368 . . . . 0.0 107.306 174.763 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 2498 ' ' SER . . . . . . . . . . . . . 68.0 m -80.92 78.57 7.71 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 126.032 1.733 . . . . 0.0 110.305 -179.311 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 2499 ' ' ILE . . . . . . . . . . . . . 36.1 mt -75.42 107.15 5.83 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 C-N-CA 124.826 1.251 . . . . 0.0 109.204 176.1 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 2500 ' ' LYS . . . . . . . . . . . . . 42.8 mttp -113.02 148.6 34.79 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 124.775 1.23 . . . . 0.0 111.116 175.194 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 2501 ' ' TYR . . . . . . . . . . . . . 67.6 t80 -148.25 145.94 28.43 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.445 1.098 . . . . 0.0 112.281 -172.044 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 2502 ' ' GLY . . . . . . . . . . . . . . . 66.39 14.7 62.48 Favored Glycine 0 CA--C 1.535 1.33 0 C-N-CA 124.556 1.074 . . . . 0.0 114.373 175.162 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 2503 ' ' GLY . . . . . . . . . . . . . . . 138.02 -169.29 24.26 Favored Glycine 0 CA--C 1.54 1.633 0 C-N-CA 125.92 1.724 . . . . 0.0 112.537 -166.154 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 2504 ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -83.76 34.58 0.53 Allowed 'Trans proline' 0 CA--C 1.545 1.068 0 C-N-CA 124.859 3.706 . . . . 0.0 113.143 -171.588 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 2505 ' ' TYR . . . . . . . . . . . . . 92.8 m-85 -125.11 136.27 53.48 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 124.515 1.126 . . . . 0.0 113.053 -174.786 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 2506 ' ' HIS . . . . . . . . . . . . . 92.4 m-70 -63.48 146.09 54.32 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 125.405 1.482 . . . . 0.0 113.455 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 2507 ' ' ILE . . . . . . . . . . . . . 24.2 pt -75.43 173.28 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.192 0 C-N-CA 123.494 0.718 . . . . 0.0 112.684 171.485 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 2508 ' ' GLY . . . . . . . . . . . . . . . -59.29 120.73 24.02 Favored Glycine 0 CA--C 1.534 1.244 0 O-C-N 121.411 -0.806 . . . . 0.0 111.677 175.074 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 2509 ' ' GLY . . . . . . . . . . . . . . . 87.8 -5.77 84.44 Favored Glycine 0 CA--C 1.536 1.371 0 C-N-CA 125.393 1.473 . . . . 0.0 114.995 -177.25 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 2510 ' ' SER . . . . . . . . . . . . . 47.4 t -89.3 145.99 35.18 Favored Pre-proline 0 CA--C 1.551 0.992 0 CA-C-N 119.007 1.404 . . . . 0.0 112.088 -179.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 2511 ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -72.71 143.6 78.12 Favored 'Cis proline' 0 C--N 1.355 0.877 0 CA-C-N 120.042 1.051 . . . . 0.0 112.427 -0.319 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 2512 ' ' PHE . . . . . . . . . . . . . 83.0 m-85 -92.61 122.95 35.54 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.059 0.944 . . . . 0.0 110.718 178.202 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 2513 ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.34 105.08 13.12 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 124.023 0.929 . . . . 0.0 113.462 178.588 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 2514 ' ' ALA . . . . . . . . . . . . . . . -92.84 125.28 37.37 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.07 1.348 . . . . 0.0 110.208 173.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 2515 ' ' LYS . . . . . . . . . . . . . 54.6 mtmt -102.83 123.91 47.37 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.303 1.041 . . . . 0.0 110.637 -178.027 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 2516 ' ' VAL . . . . . . . . . . . . . 92.3 t -122.27 139.06 50.39 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 124.967 1.307 . . . . 0.0 110.523 -168.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 2517 ' ' THR . . . . . . . . . . . . . 38.5 p -132.64 164.66 26.21 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 125.391 1.476 . . . . 0.0 111.75 -177.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 2518 ' ' GLY . . . . . . . . . . . . . . . 108.96 -176.54 19.9 Favored Glycine 0 CA--C 1.54 1.601 0 C-N-CA 124.908 1.242 . . . . 0.0 113.313 -176.373 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 2519 ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -75.12 158.24 41.84 Favored 'Trans proline' 0 CA--C 1.535 0.541 0 C-N-CA 123.819 3.012 . . . . 0.0 112.127 -175.683 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 2520 ' ' ARG . . . . . . . . . . . . . 39.4 ttp180 -78.02 132.29 37.73 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 123.053 0.541 . . . . 0.0 110.058 168.547 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 2521 ' ' LEU . . . . . . . . . . . . . 10.3 mp -78.77 -33.76 46.19 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 113.382 0.882 . . . . 0.0 113.382 -174.45 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 2522 ' ' VAL . . . . . . . . . . . . . 59.2 t . . . . . 0 C--O 1.252 1.234 0 C-N-CA 125.386 1.474 . . . . 0.0 111.527 -175.287 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.517 0 N-CA-C 111.759 -0.536 . . . . 0.0 111.759 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -157.3 165.71 35.1 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 125.383 1.473 . . . . 0.0 112.186 -178.419 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 49.1 mtm -86.05 11.96 10.55 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 126.007 1.723 . . . . 0.0 113.362 178.756 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 2427 ' ' GLY . . . . . . . . . . . . . . . -165.2 178.94 40.0 Favored Glycine 0 CA--C 1.532 1.107 0 C-N-CA 127.177 2.322 . . . . 0.0 111.931 175.625 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 2428 ' ' ASP . . . . . . . . . . . . . 13.8 t70 -149.71 136.16 10.63 Favored Pre-proline 0 CA--C 1.55 0.96 0 C-N-CA 123.939 0.896 . . . . 0.0 112.182 -173.658 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 2429 ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -65.79 -20.74 58.7 Favored 'Trans proline' 0 C--N 1.353 0.795 0 C-N-CA 123.58 2.854 . . . . 0.0 114.186 -176.089 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 2430 ' ' GLY . . . . . . . . . . . . . . . -81.69 -26.25 50.89 Favored Glycine 0 CA--C 1.533 1.163 0 CA-C-N 119.261 0.937 . . . . 0.0 113.106 173.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 2431 ' ' LEU . . . . . . . . . . . . . 4.4 mm? -81.7 -34.17 30.77 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.153 0.981 . . . . 0.0 111.383 171.123 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 2432 ' ' VAL . . . . . . . . . . . . . 57.7 t -64.21 138.28 23.34 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 123.516 0.726 . . . . 0.0 110.31 168.462 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 2433 ' ' SER . . . . . . . . . . . . . 8.9 t -131.18 -167.25 1.82 Allowed 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 125.128 1.371 . . . . 0.0 109.897 172.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 2434 ' ' ALA . . . . . . . . . . . . . . . -151.54 145.53 25.22 Favored 'General case' 0 CA--C 1.537 0.477 0 O-C-N 120.794 -1.191 . . . . 0.0 111.643 176.012 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 2435 ' ' TYR . . . . . . . . . . . . . 86.6 m-85 -143.2 149.67 38.3 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.334 1.454 . . . . 0.0 111.892 -177.307 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 2436 ' ' GLY . . . . . . . . . . . . . . . 120.42 160.59 11.2 Favored Glycine 0 N--CA 1.473 1.133 0 C-N-CA 125.534 1.54 . . . . 0.0 113.549 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 2437 ' ' ALA . . . . . . . . . . . . . . . -60.7 -31.74 71.01 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 114.535 1.309 . . . . 0.0 114.535 -168.665 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 2438 ' ' GLY . . . . . . . . . . . . . . . -67.97 -10.43 58.89 Favored Glycine 0 CA--C 1.532 1.132 0 C-N-CA 124.129 0.871 . . . . 0.0 114.891 -176.352 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 2439 ' ' LEU . . . . . . . . . . . . . 75.6 mt -77.75 -27.14 50.31 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 118.702 1.251 . . . . 0.0 112.162 169.208 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 2440 ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -93.19 -34.82 13.44 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 125.121 1.369 . . . . 0.0 111.595 176.493 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 2441 ' ' GLY . . . . . . . . . . . . . . . 138.68 -136.67 8.17 Favored Glycine 0 CA--C 1.531 1.061 0 C-N-CA 125.097 1.332 . . . . 0.0 114.469 176.171 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 2442 ' ' GLY . . . . . . . . . . . . . . . 162.89 -145.06 10.16 Favored Glycine 0 CA--C 1.534 1.246 0 C-N-CA 126.622 2.058 . . . . 0.0 111.148 -167.509 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 2443 ' ' VAL . . . . . . . . . . . . . 8.5 p -141.56 151.99 19.33 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 C-N-CA 124.739 1.216 . . . . 0.0 110.145 176.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 2444 ' ' THR . . . . . . . . . . . . . 22.7 p -53.49 130.27 35.15 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.855 0.862 . . . . 0.0 111.784 178.688 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 2445 ' ' GLY . . . . . . . . . . . . . . . 86.5 -8.37 75.14 Favored Glycine 0 CA--C 1.535 1.32 0 C-N-CA 125.205 1.384 . . . . 0.0 115.363 179.127 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 2446 ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -101.69 146.33 32.04 Favored Pre-proline 0 CA--C 1.551 0.986 0 CA-C-N 119.605 1.703 . . . . 0.0 112.235 177.53 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 2447 ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -75.52 124.53 8.36 Favored 'Trans proline' 0 N--CA 1.457 -0.641 0 C-N-CA 122.727 2.285 . . . . 0.0 110.507 175.781 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 2448 ' ' ALA . . . . . . . . . . . . . . . -107.13 149.03 28.1 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.77 1.628 . . . . 0.0 109.56 168.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 2449 ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -153.88 158.29 40.55 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 113.886 1.069 . . . . 0.0 113.886 -174.671 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 2450 ' ' PHE . . . . . . . . . . . . . 53.0 p90 -160.34 161.11 33.1 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 126.503 1.921 . . . . 0.0 110.838 -177.321 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 2451 ' ' VAL . . . . . . . . . . . . . 58.7 t -114.51 127.56 71.94 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 C-N-CA 124.866 1.266 . . . . 0.0 109.128 174.092 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 2452 ' ' VAL . . . . . . . . . . . . . 42.7 t -79.62 106.27 10.41 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 165.417 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 2453 ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -89.82 117.35 28.59 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 123.995 0.918 . . . . 0.0 111.976 -164.379 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 2454 ' ' THR . . . . . . . . . . . . . 52.5 p -102.19 -1.56 31.08 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 125.857 1.663 . . . . 0.0 113.672 -177.159 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 2455 ' ' SER . . . . . . . . . . . . . 16.9 t -60.94 -33.52 73.29 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-N 119.296 0.953 . . . . 0.0 113.356 -172.667 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 2456 ' ' ASN . . . . . . . . . . . . . 72.6 m-80 -81.96 -13.81 56.94 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 124.196 0.999 . . . . 0.0 113.674 175.684 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 2457 ' ' ALA . . . . . . . . . . . . . . . -102.75 -45.01 5.13 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.97 1.308 . . . . 0.0 113.547 -173.059 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 2458 ' ' GLY . . . . . . . . . . . . . . . 119.96 -113.42 2.45 Favored Glycine 0 CA--C 1.529 0.961 0 C-N-CA 124.93 1.252 . . . . 0.0 111.382 -170.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 2459 ' ' ALA . . . . . . . . . . . . . . . -147.97 155.45 41.56 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.432 1.093 . . . . 0.0 112.798 -176.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 2460 ' ' GLY . . . . . . . . . . . . . . . 164.52 173.29 33.01 Favored Glycine 0 CA--C 1.528 0.87 0 C-N-CA 124.269 0.938 . . . . 0.0 113.774 -176.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 2461 ' ' ALA . . . . . . . . . . . . . . . -73.29 146.2 45.51 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.193 0.997 . . . . 0.0 112.212 178.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 2462 ' ' LEU . . . . . . . . . . . . . 6.0 tt -128.36 147.66 50.64 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 125.742 1.617 . . . . 0.0 110.898 178.672 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 2463 ' ' SER . . . . . . . . . . . . . 14.0 t -132.04 161.21 33.75 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.676 1.191 . . . . 0.0 110.349 161.5 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 2464 ' ' VAL . . . . . . . . . . . . . 7.4 p -161.72 136.96 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.725 0 C-N-CA 124.644 1.178 . . . . 0.0 110.773 -175.056 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 2465 ' ' THR . . . . . . . . . . . . . 63.3 m -141.58 138.49 32.68 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 125.397 1.479 . . . . 0.0 109.711 -175.821 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 2466 ' ' ILE . . . . . . . . . . . . . 37.7 mt -117.41 119.41 61.72 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 124.399 1.08 . . . . 0.0 109.527 175.669 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 2467 ' ' ASP . . . . . . . . . . . . . 34.9 t70 -104.06 161.74 13.75 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 126.164 1.785 . . . . 0.0 110.019 167.527 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 2468 ' ' GLY . . . . . . . . . . . . . . . 172.18 -166.05 38.81 Favored Glycine 0 CA--C 1.536 1.386 0 O-C-N 120.875 -1.141 . . . . 0.0 115.878 179.313 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 2469 ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -70.11 -14.64 35.2 Favored 'Trans proline' 0 CA--C 1.541 0.836 0 C-N-CA 124.544 3.496 . . . . 0.0 113.93 -178.43 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 2470 ' ' SER . . . . . . . . . . . . . 16.8 m -155.79 -177.71 6.76 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 127.306 2.243 . . . . 0.0 109.434 172.746 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 2471 ' ' LYS . . . . . . . . . . . . . 24.8 pttm -66.31 175.42 2.19 Favored 'General case' 0 CA--C 1.549 0.917 0 O-C-N 121.069 -1.019 . . . . 0.0 112.839 169.712 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 2472 ' ' VAL . . . . . . . . . . . . . 27.0 m -132.76 148.39 31.6 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 125.331 1.452 . . . . 0.0 110.138 170.429 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 2473 ' ' LYS . . . . . . . . . . . . . 63.8 tttm -76.13 131.2 39.26 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 107.78 -1.192 . . . . 0.0 107.78 152.417 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 2474 ' ' MET . . . . . . . . . . . . . 27.1 ttt -139.23 139.81 37.56 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.024 0.93 . . . . 0.0 111.489 -172.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 2475 ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -141.7 157.44 45.06 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 126.907 2.083 . . . . 0.0 110.172 -178.103 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 2476 ' ' CYS . . . . . . . . . . . . . 49.7 t -152.43 150.03 29.22 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.191 0.996 . . . . 0.0 111.842 -175.433 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 2477 ' ' GLN . . . . . . . . . . . . . 51.7 tt0 -154.37 133.91 12.77 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 125.457 1.503 . . . . 0.0 110.077 -174.655 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 2478 ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -85.12 142.87 29.2 Favored 'General case' 0 CA--C 1.542 0.66 0 O-C-N 121.641 -0.662 . . . . 0.0 111.414 171.425 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 2479 ' ' CYS . . . . . . . . . . . . . 15.4 p -151.98 173.6 4.33 Favored Pre-proline 0 CA--C 1.553 1.096 0 C-N-CA 125.695 1.598 . . . . 0.0 111.47 -177.518 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 2480 ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -58.36 -27.44 81.39 Favored 'Trans proline' 0 C--N 1.353 0.794 0 C-N-CA 123.563 2.842 . . . . 0.0 114.853 179.288 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 2481 ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -80.37 -19.58 46.04 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 124.374 1.07 . . . . 0.0 112.755 178.234 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 2482 ' ' GLY . . . . . . . . . . . . . . . 134.94 -150.66 20.21 Favored Glycine 0 CA--C 1.529 0.955 0 C-N-CA 126.033 1.778 . . . . 0.0 112.864 -176.55 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 2483 ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -90.85 109.4 20.61 Favored 'General case' 0 CA--C 1.539 0.535 0 O-C-N 121.7 -0.883 . . . . 0.0 110.759 177.308 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 2484 ' ' ARG . . . . . . . . . . . . . 38.9 ttp85 -79.47 134.48 36.53 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 124.445 1.098 . . . . 0.0 110.09 172.355 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 2485 ' ' VAL . . . . . . . . . . . . . 93.4 t -125.51 135.84 62.7 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 126.05 1.74 . . . . 0.0 108.672 178.206 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 2486 ' ' THR . . . . . . . . . . . . . 86.2 m -129.6 140.69 51.12 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 125.653 1.581 . . . . 0.0 108.788 178.171 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 2487 ' ' TYR . . . . . . . . . . . . . 19.6 p90 -150.8 153.26 35.11 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 113.526 0.935 . . . . 0.0 113.526 175.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 2488 ' ' THR . . . . . . . . . . . . . 98.4 m -118.62 115.51 35.4 Favored Pre-proline 0 N--CA 1.474 0.749 0 C-N-CA 124.907 1.283 . . . . 0.0 109.181 175.315 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 2489 ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -82.44 165.15 16.47 Favored 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 124.464 3.443 . . . . 0.0 111.6 175.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 2490 ' ' MET . . . . . . . . . . . . . 24.5 ptm -143.57 5.16 1.39 Allowed 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 115.435 1.643 . . . . 0.0 115.435 -174.367 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 2491 ' ' ALA . . . . . . . . . . . . . . . -143.46 145.98 33.95 Favored Pre-proline 0 CA--C 1.546 0.825 0 C-N-CA 124.675 1.19 . . . . 0.0 110.896 170.184 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 2492 ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -71.65 149.2 54.63 Favored 'Trans proline' 0 CA--C 1.536 0.601 0 C-N-CA 123.063 2.508 . . . . 0.0 111.158 178.189 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 2493 ' ' GLY . . . . . . . . . . . . . . . 131.81 -159.89 23.37 Favored Glycine 0 CA--C 1.53 1.004 0 C-N-CA 125.36 1.457 . . . . 0.0 113.493 -177.354 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 2494 ' ' SER . . . . . . . . . . . . . 23.6 m -98.03 118.65 35.09 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 125.117 1.367 . . . . 0.0 111.523 -177.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 2495 ' ' TYR . . . . . . . . . . . . . 62.3 m-85 -92.64 120.23 32.85 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 123.614 0.766 . . . . 0.0 110.068 167.041 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 2496 ' ' LEU . . . . . . . . . . . . . 22.8 tp -92.94 111.33 22.91 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.626 1.17 . . . . 0.0 109.73 -177.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 2497 ' ' ILE . . . . . . . . . . . . . 32.2 mt -101.85 103.62 15.2 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 C-N-CA 125.922 1.689 . . . . 0.0 108.602 -175.552 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 2498 ' ' SER . . . . . . . . . . . . . 68.4 m -92.0 125.63 36.77 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.274 1.029 . . . . 0.0 109.958 175.503 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 2499 ' ' ILE . . . . . . . . . . . . . 42.2 mt -128.26 123.99 61.31 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.725 0 C-N-CA 124.889 1.276 . . . . 0.0 108.645 -175.389 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 2500 ' ' LYS . . . . . . . . . . . . . 84.5 mttt -127.87 143.49 51.11 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.734 1.214 . . . . 0.0 111.774 -172.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 2501 ' ' TYR . . . . . . . . . . . . . 60.2 t80 -150.02 139.7 21.68 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 123.663 0.785 . . . . 0.0 112.681 -171.196 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 2502 ' ' GLY . . . . . . . . . . . . . . . 68.21 13.73 65.22 Favored Glycine 0 CA--C 1.537 1.419 0 C-N-CA 124.196 0.903 . . . . 0.0 114.162 179.279 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 2503 ' ' GLY . . . . . . . . . . . . . . . 146.46 -172.53 27.0 Favored Glycine 0 CA--C 1.539 1.583 0 C-N-CA 126.087 1.803 . . . . 0.0 112.822 -169.465 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 2504 ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -81.87 22.4 0.85 Allowed 'Trans proline' 0 CA--C 1.545 1.058 0 C-N-CA 124.99 3.794 . . . . 0.0 113.795 -174.52 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 2505 ' ' TYR . . . . . . . . . . . . . 72.8 m-85 -111.59 139.85 46.69 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.935 1.294 . . . . 0.0 112.803 -173.516 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 2506 ' ' HIS . . . . . . . . . . . . . 93.3 m-70 -62.19 144.15 55.84 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 124.447 1.099 . . . . 0.0 113.298 -179.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 2507 ' ' ILE . . . . . . . . . . . . . 26.7 pt -73.59 167.99 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 C-N-CA 123.149 0.58 . . . . 0.0 112.45 171.777 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 2508 ' ' GLY . . . . . . . . . . . . . . . -57.5 120.68 22.42 Favored Glycine 0 CA--C 1.534 1.223 0 C-N-CA 123.651 0.643 . . . . 0.0 111.982 176.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 2509 ' ' GLY . . . . . . . . . . . . . . . 88.58 -8.35 79.36 Favored Glycine 0 CA--C 1.535 1.331 0 C-N-CA 125.599 1.571 . . . . 0.0 115.145 -177.733 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 2510 ' ' SER . . . . . . . . . . . . . 8.4 t -89.33 146.3 35.78 Favored Pre-proline 0 CA--C 1.549 0.939 0 CA-C-N 119.231 1.516 . . . . 0.0 111.897 -179.595 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 2511 ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -75.74 149.78 93.15 Favored 'Cis proline' 0 C--N 1.353 0.786 0 CA-C-N 120.153 1.09 . . . . 0.0 113.424 1.168 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 2512 ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -100.8 131.84 46.49 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 125.386 1.475 . . . . 0.0 110.465 178.266 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 2513 ' ' LYS . . . . . . . . . . . . . 64.5 pttt -87.49 8.75 23.47 Favored 'General case' 0 N--CA 1.479 1.007 0 N-CA-C 116.292 1.96 . . . . 0.0 116.292 -169.084 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 2514 ' ' ALA . . . . . . . . . . . . . . . -7.09 99.45 0.01 OUTLIER 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 129.66 3.184 . . . . 0.0 116.047 -176.783 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 2515 ' ' LYS . . . . . . . . . . . . . 48.6 mtpt -94.86 135.18 36.68 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 124.031 0.932 . . . . 0.0 112.194 -171.27 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 2516 ' ' VAL . . . . . . . . . . . . . 6.0 m -131.82 153.8 39.23 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 C-N-CA 124.224 1.01 . . . . 0.0 111.82 -177.244 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 2517 ' ' THR . . . . . . . . . . . . . 64.0 p -120.64 -171.27 2.15 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.915 1.686 . . . . 0.0 110.106 177.026 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 2518 ' ' GLY . . . . . . . . . . . . . . . 99.1 177.58 31.82 Favored Glycine 0 CA--C 1.539 1.571 0 C-N-CA 124.972 1.272 . . . . 0.0 113.921 178.538 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 2519 ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -70.38 137.4 33.58 Favored 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 123.862 3.042 . . . . 0.0 112.195 -172.152 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 2520 ' ' ARG . . . . . . . . . . . . . 37.8 ttp180 -74.89 131.01 40.4 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.127 0.971 . . . . 0.0 110.922 177.085 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 2521 ' ' LEU . . . . . . . . . . . . . 4.3 mm? -83.36 -34.33 25.64 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.858 0.863 . . . . 0.0 112.764 179.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 2522 ' ' VAL . . . . . . . . . . . . . 35.0 m . . . . . 0 N--CA 1.484 1.24 0 C-N-CA 124.58 1.152 . . . . 0.0 113.996 -177.155 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.565 0 N-CA-C 111.727 -0.549 . . . . 0.0 111.727 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -70.13 149.68 47.32 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.271 1.029 . . . . 0.0 112.452 177.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 2.2 mpt? -74.92 146.77 41.53 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.337 1.055 . . . . 0.0 112.555 -176.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 2427 ' ' GLY . . . . . . . . . . . . . . . -79.0 -178.23 50.62 Favored Glycine 0 CA--C 1.533 1.206 0 C-N-CA 125.14 1.352 . . . . 0.0 113.987 176.841 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 2428 ' ' ASP . . . . . . . . . . . . . 22.8 m-20 -106.0 134.56 19.69 Favored Pre-proline 0 CA--C 1.549 0.929 0 C-N-CA 124.778 1.231 . . . . 0.0 112.834 -176.16 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 2429 ' ' PRO . . . . . . . . . . . . . 77.0 Cg_exo -56.43 -28.9 75.37 Favored 'Trans proline' 0 C--N 1.353 0.794 0 C-N-CA 124.036 3.158 . . . . 0.0 114.45 174.041 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 2430 ' ' GLY . . . . . . . . . . . . . . . -77.15 -22.77 70.26 Favored Glycine 0 CA--C 1.533 1.183 0 C-N-CA 123.751 0.691 . . . . 0.0 113.747 177.074 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 2431 ' ' LEU . . . . . . . . . . . . . 4.2 mm? -86.53 -32.28 20.81 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.453 1.101 . . . . 0.0 111.405 172.642 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 2432 ' ' VAL . . . . . . . . . . . . . 74.6 t -65.07 137.68 24.55 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 CA-C-N 118.58 0.627 . . . . 0.0 110.453 169.243 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 2433 ' ' SER . . . . . . . . . . . . . 8.4 t -130.84 -169.81 2.23 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 125.054 1.342 . . . . 0.0 110.583 174.44 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 2434 ' ' ALA . . . . . . . . . . . . . . . -149.91 141.99 23.98 Favored 'General case' 0 CA--C 1.539 0.548 0 O-C-N 120.903 -1.123 . . . . 0.0 111.473 177.222 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 2435 ' ' TYR . . . . . . . . . . . . . 75.2 m-85 -145.85 151.49 37.98 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 125.511 1.524 . . . . 0.0 111.881 -176.212 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 2436 ' ' GLY . . . . . . . . . . . . . . . 117.23 162.14 12.47 Favored Glycine 0 N--CA 1.474 1.191 0 C-N-CA 125.384 1.469 . . . . 0.0 113.903 177.508 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 2437 ' ' ALA . . . . . . . . . . . . . . . -61.18 -28.7 69.32 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.045 1.338 . . . . 0.0 114.45 -169.687 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 2438 ' ' GLY . . . . . . . . . . . . . . . -65.63 -13.95 59.59 Favored Glycine 0 CA--C 1.533 1.17 0 C-N-CA 124.234 0.921 . . . . 0.0 114.688 -178.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 2439 ' ' LEU . . . . . . . . . . . . . 91.8 mt -75.9 -27.68 57.79 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 118.647 1.224 . . . . 0.0 112.526 169.353 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 2440 ' ' GLU . . . . . . . . . . . . . 43.4 mm-40 -88.02 -31.2 19.44 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.862 1.265 . . . . 0.0 111.519 174.442 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 2441 ' ' GLY . . . . . . . . . . . . . . . 113.83 -146.8 18.63 Favored Glycine 0 CA--C 1.53 1.012 0 C-N-CA 126.086 1.803 . . . . 0.0 113.381 177.013 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 2442 ' ' GLY . . . . . . . . . . . . . . . 170.87 -163.31 36.38 Favored Glycine 0 CA--C 1.53 1.001 0 C-N-CA 124.234 0.921 . . . . 0.0 114.001 -174.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 2443 ' ' VAL . . . . . . . . . . . . . 40.3 t -91.74 146.33 6.41 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 C-N-CA 124.51 1.124 . . . . 0.0 110.245 179.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 2444 ' ' THR . . . . . . . . . . . . . 20.2 p -54.61 142.89 26.42 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 124.898 1.279 . . . . 0.0 112.236 172.221 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 2445 ' ' GLY . . . . . . . . . . . . . . . 72.4 1.0 50.0 Favored Glycine 0 CA--C 1.536 1.361 0 C-N-CA 124.274 0.94 . . . . 0.0 114.685 179.318 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 2446 ' ' ASN . . . . . . . . . . . . . 16.3 m-80 -118.58 149.76 46.85 Favored Pre-proline 0 CA--C 1.549 0.93 0 C-N-CA 126.123 1.769 . . . . 0.0 110.623 179.814 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 2447 ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -74.48 133.1 16.97 Favored 'Trans proline' 0 C--N 1.35 0.648 0 C-N-CA 122.908 2.405 . . . . 0.0 111.99 -174.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 2448 ' ' ALA . . . . . . . . . . . . . . . -105.77 119.92 40.37 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 126.41 1.884 . . . . 0.0 108.645 168.372 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 2449 ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -124.6 135.02 52.77 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.568 1.147 . . . . 0.0 111.821 -169.44 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 2450 ' ' PHE . . . . . . . . . . . . . 15.2 p90 -152.99 170.21 20.98 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.6 1.56 . . . . 0.0 111.183 175.189 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 2451 ' ' VAL . . . . . . . . . . . . . 46.6 t -125.9 132.95 70.11 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 C-N-CA 124.911 1.285 . . . . 0.0 110.106 178.641 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 2452 ' ' VAL . . . . . . . . . . . . . 51.8 t -82.88 107.56 14.78 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 165.035 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 2453 ' ' ASN . . . . . . . . . . . . . 21.1 t-20 -83.3 113.07 20.45 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 123.551 0.74 . . . . 0.0 112.153 -171.741 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 2454 ' ' THR . . . . . . . . . . . . . 30.4 p -99.59 -6.55 27.16 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 126.001 1.72 . . . . 0.0 113.79 179.138 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 2455 ' ' SER . . . . . . . . . . . . . 16.4 m -55.78 -31.41 62.59 Favored 'General case' 0 N--CA 1.478 0.949 0 N-CA-C 114.538 1.31 . . . . 0.0 114.538 -174.26 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 2456 ' ' ASN . . . . . . . . . . . . . 66.3 m-80 -84.46 -15.83 44.7 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 124.49 1.116 . . . . 0.0 113.464 177.558 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 2457 ' ' ALA . . . . . . . . . . . . . . . -106.24 -25.73 11.85 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 125.72 1.608 . . . . 0.0 113.854 -176.386 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 2458 ' ' GLY . . . . . . . . . . . . . . . 104.24 -103.71 2.32 Favored Glycine 0 CA--C 1.529 0.966 0 C-N-CA 125.398 1.475 . . . . 0.0 111.067 -174.243 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 2459 ' ' ALA . . . . . . . . . . . . . . . -151.73 163.29 39.46 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 125.355 1.462 . . . . 0.0 111.768 -179.139 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 2460 ' ' GLY . . . . . . . . . . . . . . . 163.58 171.83 30.31 Favored Glycine 0 CA--C 1.53 1.007 0 C-N-CA 124.774 1.178 . . . . 0.0 113.293 -176.469 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 2461 ' ' ALA . . . . . . . . . . . . . . . -73.08 143.92 47.24 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.104 0.961 . . . . 0.0 112.216 179.473 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 2462 ' ' LEU . . . . . . . . . . . . . 15.7 tp -129.03 139.25 52.14 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.404 1.481 . . . . 0.0 110.662 -178.528 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 2463 ' ' SER . . . . . . . . . . . . . 66.5 m -139.6 52.65 1.72 Allowed 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 125.437 1.495 . . . . 0.0 111.616 -169.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 2464 ' ' VAL . . . . . . . . . . . . . 17.1 t -65.84 137.04 25.67 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.069 0 C-N-CA 124.044 0.938 . . . . 0.0 111.101 -178.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 2465 ' ' THR . . . . . . . . . . . . . 22.7 m -123.24 141.32 52.1 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 124.933 1.293 . . . . 0.0 109.236 170.528 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 2466 ' ' ILE . . . . . . . . . . . . . 52.1 mt -116.13 114.7 46.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 C-N-CA 123.679 0.792 . . . . 0.0 108.981 171.003 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 2467 ' ' ASP . . . . . . . . . . . . . 37.1 t70 -95.29 158.69 15.35 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 125.519 1.527 . . . . 0.0 110.297 168.802 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 2468 ' ' GLY . . . . . . . . . . . . . . . 174.61 -171.3 44.45 Favored Glycine 0 CA--C 1.536 1.36 0 O-C-N 121.271 -0.893 . . . . 0.0 114.789 179.71 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 2469 ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -68.15 -25.95 36.87 Favored 'Trans proline' 0 CA--C 1.538 0.716 0 C-N-CA 123.941 3.094 . . . . 0.0 112.802 178.56 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 2470 ' ' SER . . . . . . . . . . . . . 58.5 m -142.86 174.59 10.52 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 126.058 1.743 . . . . 0.0 110.685 174.177 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 2471 ' ' LYS . . . . . . . . . . . . . 57.1 mtmt -66.71 166.59 12.74 Favored 'General case' 0 CA--C 1.548 0.887 0 O-C-N 121.13 -0.981 . . . . 0.0 112.314 170.025 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 2472 ' ' VAL . . . . . . . . . . . . . 24.7 m -131.39 147.21 32.79 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 125.231 1.412 . . . . 0.0 111.464 -178.687 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 2473 ' ' LYS . . . . . . . . . . . . . 56.8 tttp -83.2 67.64 9.28 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 124.229 1.012 . . . . 0.0 110.931 174.715 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 2474 ' ' MET . . . . . . . . . . . . . 23.3 ttt -75.45 136.33 40.69 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 125.217 1.407 . . . . 0.0 111.979 -174.599 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 2475 ' ' ASP . . . . . . . . . . . . . 36.7 t70 -141.8 129.3 21.35 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 126.429 1.892 . . . . 0.0 110.33 176.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 2476 ' ' CYS . . . . . . . . . . . . . 74.5 m -113.91 148.62 36.47 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.931 1.293 . . . . 0.0 111.55 -176.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 2477 ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -150.3 148.1 28.44 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.269 1.027 . . . . 0.0 111.013 179.485 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 2478 ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -88.94 117.84 28.24 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 123.972 0.909 . . . . 0.0 109.845 173.508 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 2479 ' ' CYS . . . . . . . . . . . . . 87.6 m -122.31 166.36 17.51 Favored Pre-proline 0 CA--C 1.552 1.037 0 C-N-CA 125.601 1.56 . . . . 0.0 111.284 179.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 2480 ' ' PRO . . . . . . . . . . . . . 58.0 Cg_exo -57.88 -30.3 89.14 Favored 'Trans proline' 0 C--N 1.353 0.8 0 C-N-CA 123.534 2.823 . . . . 0.0 114.216 175.394 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 2481 ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -78.44 -7.61 57.58 Favored 'General case' 0 CA--C 1.552 1.02 0 C-N-CA 125.357 1.463 . . . . 0.0 112.991 177.644 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 2482 ' ' GLY . . . . . . . . . . . . . . . 118.66 -163.23 13.16 Favored Glycine 0 CA--C 1.53 1.012 0 C-N-CA 126.313 1.911 . . . . 0.0 112.533 -173.106 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 2483 ' ' TYR . . . . . . . . . . . . . 83.4 m-85 -72.67 107.67 5.26 Favored 'General case' 0 CA--C 1.54 0.571 0 O-C-N 121.564 -0.962 . . . . 0.0 111.31 177.213 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 2484 ' ' ARG . . . . . . . . . . . . . 51.5 ttp85 -79.19 136.89 37.22 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 124.753 1.221 . . . . 0.0 110.231 174.269 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 2485 ' ' VAL . . . . . . . . . . . . . 92.5 t -128.15 125.56 64.6 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 C-N-CA 125.931 1.692 . . . . 0.0 108.48 179.001 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 2486 ' ' THR . . . . . . . . . . . . . 57.9 m -123.99 139.59 53.8 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 124.619 1.168 . . . . 0.0 108.488 172.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 2487 ' ' TYR . . . . . . . . . . . . . 27.3 p90 -147.06 150.51 35.21 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 112.754 0.65 . . . . 0.0 112.754 176.58 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 2488 ' ' THR . . . . . . . . . . . . . 24.7 m -109.79 115.11 55.9 Favored Pre-proline 0 N--CA 1.474 0.736 0 CA-C-O 117.764 -1.112 . . . . 0.0 109.047 174.455 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 2489 ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -81.42 149.06 16.65 Favored 'Trans proline' 0 N--CA 1.459 -0.553 0 C-N-CA 123.515 2.81 . . . . 0.0 110.731 171.237 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 2490 ' ' MET . . . . . . . . . . . . . 27.6 ptm -118.6 6.4 11.66 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 114.411 1.263 . . . . 0.0 114.411 -174.255 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 2491 ' ' ALA . . . . . . . . . . . . . . . -152.57 147.69 19.73 Favored Pre-proline 0 CA--C 1.544 0.74 0 C-N-CA 125.548 1.539 . . . . 0.0 111.41 -179.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 2492 ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -72.86 156.91 52.35 Favored 'Trans proline' 0 CA--C 1.536 0.606 0 C-N-CA 123.379 2.72 . . . . 0.0 111.208 174.557 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 2493 ' ' GLY . . . . . . . . . . . . . . . 134.94 -148.93 19.75 Favored Glycine 0 CA--C 1.527 0.843 0 C-N-CA 125.428 1.489 . . . . 0.0 112.061 -174.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 2494 ' ' SER . . . . . . . . . . . . . 36.8 m -128.6 133.85 48.43 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.694 0.798 . . . . 0.0 111.423 176.57 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 2495 ' ' TYR . . . . . . . . . . . . . 52.3 m-85 -107.18 127.13 53.23 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 126.152 1.781 . . . . 0.0 109.709 179.276 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 2496 ' ' LEU . . . . . . . . . . . . . 26.3 tp -98.75 112.69 24.69 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.411 1.085 . . . . 0.0 109.495 -176.528 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 2497 ' ' ILE . . . . . . . . . . . . . 36.9 mt -96.43 103.29 14.51 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 C-N-CA 125.331 1.452 . . . . 0.0 108.383 -176.191 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 2498 ' ' SER . . . . . . . . . . . . . 74.4 m -96.7 91.16 5.57 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 125.617 1.567 . . . . 0.0 110.247 -177.805 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 2499 ' ' ILE . . . . . . . . . . . . . 59.6 mt -87.62 104.69 14.59 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 C-N-CA 126.363 1.865 . . . . 0.0 109.591 -172.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 2500 ' ' LYS . . . . . . . . . . . . . 30.6 mttp -110.52 138.06 47.41 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.207 1.003 . . . . 0.0 111.589 -176.715 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 2501 ' ' TYR . . . . . . . . . . . . . 76.7 t80 -139.24 148.08 42.59 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.671 1.189 . . . . 0.0 112.452 -174.355 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 2502 ' ' GLY . . . . . . . . . . . . . . . 65.04 20.88 67.36 Favored Glycine 0 CA--C 1.536 1.358 0 C-N-CA 124.143 0.878 . . . . 0.0 113.465 -179.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 2503 ' ' GLY . . . . . . . . . . . . . . . 126.57 -171.31 18.28 Favored Glycine 0 CA--C 1.541 1.66 0 C-N-CA 125.967 1.746 . . . . 0.0 112.238 -163.524 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 2504 ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -84.02 43.55 1.4 Allowed 'Trans proline' 0 CA--C 1.546 1.083 0 C-N-CA 124.898 3.732 . . . . 0.0 112.618 -172.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 2505 ' ' TYR . . . . . . . . . . . . . 78.9 m-85 -127.15 132.01 50.63 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 124.457 1.103 . . . . 0.0 112.81 -175.073 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 2506 ' ' HIS . . . . . . . . . . . . . 79.0 m-70 -60.14 141.71 55.45 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 125.629 1.572 . . . . 0.0 114.46 -173.587 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 2507 ' ' ILE . . . . . . . . . . . . . 1.8 pp -79.26 170.59 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.2 0 C-N-CA 124.028 0.931 . . . . 0.0 112.628 171.725 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 2508 ' ' GLY . . . . . . . . . . . . . . . -60.15 112.1 4.17 Favored Glycine 0 CA--C 1.533 1.216 0 C-N-CA 123.753 0.692 . . . . 0.0 112.628 -176.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 2509 ' ' GLY . . . . . . . . . . . . . . . 95.72 -7.36 67.96 Favored Glycine 0 CA--C 1.536 1.347 0 C-N-CA 125.699 1.618 . . . . 0.0 114.866 -177.476 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 2510 ' ' SER . . . . . . . . . . . . . 45.4 t -79.62 146.97 66.37 Favored Pre-proline 0 CA--C 1.55 0.952 0 CA-C-N 119.16 1.48 . . . . 0.0 111.82 176.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 2511 ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -80.15 157.35 87.41 Favored 'Cis proline' 0 C--N 1.353 0.803 0 CA-C-N 119.834 0.977 . . . . 0.0 113.409 0.668 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 2512 ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -109.96 125.66 53.1 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.18 1.392 . . . . 0.0 111.199 179.75 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 2513 ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.73 101.59 13.83 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 124.449 1.1 . . . . 0.0 112.283 175.167 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 2514 ' ' ALA . . . . . . . . . . . . . . . -88.35 122.87 32.35 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 125.211 1.404 . . . . 0.0 110.28 174.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 2515 ' ' LYS . . . . . . . . . . . . . 27.7 mtpp -97.08 134.95 39.76 Favored 'General case' 0 CA--C 1.542 0.653 0 O-C-N 121.231 -0.918 . . . . 0.0 111.285 -174.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 2516 ' ' VAL . . . . . . . . . . . . . 74.0 t -130.39 138.95 52.57 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.775 0 C-N-CA 124.911 1.285 . . . . 0.0 110.849 -169.07 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 2517 ' ' THR . . . . . . . . . . . . . 54.2 p -134.6 171.07 14.84 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 125.869 1.667 . . . . 0.0 110.892 179.605 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 2518 ' ' GLY . . . . . . . . . . . . . . . 106.37 178.65 23.26 Favored Glycine 0 CA--C 1.539 1.568 0 C-N-CA 124.828 1.204 . . . . 0.0 113.432 -176.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 2519 ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -70.98 136.11 29.04 Favored 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 123.715 2.943 . . . . 0.0 112.129 -171.053 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 2520 ' ' ARG . . . . . . . . . . . . . 50.9 ttp180 -70.9 132.88 45.9 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.047 0.939 . . . . 0.0 110.778 176.053 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 2521 ' ' LEU . . . . . . . . . . . . . 4.2 mm? -78.03 -25.5 47.92 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.856 0.862 . . . . 0.0 112.466 178.282 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 2522 ' ' VAL . . . . . . . . . . . . . 38.9 t . . . . . 0 C--O 1.252 1.206 0 C-N-CA 125.985 1.714 . . . . 0.0 111.512 177.84 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.543 0 N-CA-C 111.41 -0.676 . . . . 0.0 111.41 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -72.34 154.98 40.64 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 124.203 1.001 . . . . 0.0 112.822 178.605 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 16.3 tpt -78.42 -41.99 31.4 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.328 1.051 . . . . 0.0 112.37 177.789 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 2427 ' ' GLY . . . . . . . . . . . . . . . 81.56 147.48 5.88 Favored Glycine 0 CA--C 1.532 1.152 0 C-N-CA 125.123 1.344 . . . . 0.0 112.68 -173.536 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 2428 ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -144.76 128.22 8.64 Favored Pre-proline 0 CA--C 1.546 0.802 0 C-N-CA 125.65 1.58 . . . . 0.0 109.626 178.001 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 2429 ' ' PRO . . . . . . . . . . . . . 57.3 Cg_exo -56.46 -35.0 96.13 Favored 'Trans proline' 0 C--N 1.353 0.789 0 C-N-CA 123.183 2.588 . . . . 0.0 114.493 -175.378 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 2430 ' ' GLY . . . . . . . . . . . . . . . -73.04 -18.84 79.36 Favored Glycine 0 CA--C 1.534 1.257 0 CA-C-N 118.552 0.615 . . . . 0.0 114.186 179.866 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 2431 ' ' LEU . . . . . . . . . . . . . 4.1 mm? -87.02 -20.29 27.44 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.732 1.213 . . . . 0.0 111.904 173.075 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 2432 ' ' VAL . . . . . . . . . . . . . 60.8 t -80.97 138.31 19.87 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 C-N-CA 124.571 1.148 . . . . 0.0 109.178 172.143 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 2433 ' ' SER . . . . . . . . . . . . . 8.6 t -128.11 -169.86 2.14 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 125.083 1.353 . . . . 0.0 111.001 176.337 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 2434 ' ' ALA . . . . . . . . . . . . . . . -155.45 142.77 19.41 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.692 1.197 . . . . 0.0 111.656 177.303 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 2435 ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -145.24 145.12 31.16 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 125.245 1.418 . . . . 0.0 112.071 -176.433 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 2436 ' ' GLY . . . . . . . . . . . . . . . 129.08 158.48 9.6 Favored Glycine 0 N--CA 1.472 1.077 0 C-N-CA 125.622 1.582 . . . . 0.0 113.395 178.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 2437 ' ' ALA . . . . . . . . . . . . . . . -62.11 -27.79 69.18 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 114.206 1.187 . . . . 0.0 114.206 -170.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 2438 ' ' GLY . . . . . . . . . . . . . . . -65.57 -16.66 63.52 Favored Glycine 0 CA--C 1.531 1.035 0 CA-C-O 118.888 -0.951 . . . . 0.0 114.31 -178.867 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 2439 ' ' LEU . . . . . . . . . . . . . 87.7 mt -73.53 -28.69 62.02 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 118.673 1.237 . . . . 0.0 112.513 171.259 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 2440 ' ' GLU . . . . . . . . . . . . . 41.5 mm-40 -92.25 -33.47 14.64 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.942 1.297 . . . . 0.0 112.167 -177.037 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 2441 ' ' GLY . . . . . . . . . . . . . . . 161.15 -156.38 27.77 Favored Glycine 0 CA--C 1.528 0.894 0 N-CA-C 114.875 0.71 . . . . 0.0 114.875 -176.825 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 2442 ' ' GLY . . . . . . . . . . . . . . . 171.26 -167.14 40.26 Favored Glycine 0 CA--C 1.53 0.992 0 C-N-CA 125.648 1.594 . . . . 0.0 112.298 -178.657 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 2443 ' ' VAL . . . . . . . . . . . . . 98.2 t -125.27 144.83 33.93 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 C-N-CA 124.692 1.197 . . . . 0.0 109.36 175.638 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 2444 ' ' THR . . . . . . . . . . . . . 21.4 p -54.7 127.5 28.48 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 124.95 1.3 . . . . 0.0 111.812 176.42 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 2445 ' ' GLY . . . . . . . . . . . . . . . 79.26 -5.36 59.91 Favored Glycine 0 CA--C 1.536 1.383 0 C-N-CA 124.622 1.106 . . . . 0.0 114.846 -178.399 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 2446 ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -97.66 139.82 21.59 Favored Pre-proline 0 CA--C 1.551 1.019 0 C-N-CA 125.617 1.567 . . . . 0.0 110.953 176.519 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 2447 ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -75.56 122.15 6.78 Favored 'Trans proline' 0 N--CA 1.457 -0.64 0 C-N-CA 122.839 2.36 . . . . 0.0 110.632 176.163 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 2448 ' ' ALA . . . . . . . . . . . . . . . -105.16 156.57 17.97 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.97 1.708 . . . . 0.0 109.883 168.262 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 2449 ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -156.96 159.11 37.75 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 114.035 1.124 . . . . 0.0 114.035 -175.181 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 2450 ' ' PHE . . . . . . . . . . . . . 54.9 p90 -159.49 148.2 17.85 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 126.173 1.789 . . . . 0.0 110.571 178.314 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 2451 ' ' VAL . . . . . . . . . . . . . 11.2 t -102.35 124.22 56.15 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 C-N-CA 124.439 1.095 . . . . 0.0 108.886 174.594 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 2452 ' ' VAL . . . . . . . . . . . . . 43.5 t -75.13 108.81 7.28 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 N-CA-C 106.838 -1.542 . . . . 0.0 106.838 167.303 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 2453 ' ' ASN . . . . . . . . . . . . . 62.7 t-20 -87.55 113.89 23.66 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.136 0.974 . . . . 0.0 110.802 -171.055 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 2454 ' ' THR . . . . . . . . . . . . . 73.1 p -104.92 2.09 29.49 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 126.079 1.752 . . . . 0.0 112.958 -175.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 2455 ' ' SER . . . . . . . . . . . . . 46.9 m -58.42 -30.36 66.82 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 114.518 1.303 . . . . 0.0 114.518 -169.341 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 2456 ' ' ASN . . . . . . . . . . . . . 29.3 m120 -92.89 -11.21 34.05 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 124.663 1.185 . . . . 0.0 113.683 177.251 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 2457 ' ' ALA . . . . . . . . . . . . . . . -101.74 -32.81 10.11 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 125.309 1.444 . . . . 0.0 113.502 -178.427 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 2458 ' ' GLY . . . . . . . . . . . . . . . 85.81 -159.24 32.84 Favored Glycine 0 CA--C 1.533 1.214 0 C-N-CA 124.976 1.274 . . . . 0.0 112.846 -174.77 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 2459 ' ' ALA . . . . . . . . . . . . . . . -60.84 155.48 19.46 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 124.991 1.317 . . . . 0.0 114.016 -177.423 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 2460 ' ' GLY . . . . . . . . . . . . . . . 159.09 -174.62 36.06 Favored Glycine 0 CA--C 1.534 1.228 0 C-N-CA 125.922 1.725 . . . . 0.0 112.904 -176.556 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 2461 ' ' ALA . . . . . . . . . . . . . . . -123.61 143.24 50.35 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.904 1.282 . . . . 0.0 112.198 -177.089 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 2462 ' ' LEU . . . . . . . . . . . . . 24.8 tp -92.69 145.23 24.57 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.588 1.555 . . . . 0.0 111.254 179.093 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 2463 ' ' SER . . . . . . . . . . . . . 4.3 t -138.13 40.07 2.3 Favored 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 125.667 1.587 . . . . 0.0 111.004 -179.794 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 2464 ' ' VAL . . . . . . . . . . . . . 12.6 p -65.2 147.63 12.49 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 C-N-CA 126.008 1.723 . . . . 0.0 112.638 -175.498 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 2465 ' ' THR . . . . . . . . . . . . . 10.8 t -151.9 160.92 43.37 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 125.13 1.372 . . . . 0.0 111.412 172.388 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 2466 ' ' ILE . . . . . . . . . . . . . 55.5 mt -135.11 124.63 42.97 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 124.913 1.285 . . . . 0.0 110.16 -173.853 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 2467 ' ' ASP . . . . . . . . . . . . . 29.9 m-20 -106.36 173.35 6.35 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 126.44 1.896 . . . . 0.0 110.79 169.808 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 2468 ' ' GLY . . . . . . . . . . . . . . . 153.49 -155.02 25.89 Favored Glycine 0 CA--C 1.535 1.331 0 CA-C-O 118.916 -0.935 . . . . 0.0 113.872 179.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 2469 ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -70.21 -10.52 28.39 Favored 'Trans proline' 0 CA--C 1.542 0.883 0 C-N-CA 123.705 2.936 . . . . 0.0 113.756 178.294 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 2470 ' ' SER . . . . . . . . . . . . . 34.0 p -166.77 169.09 13.67 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 125.488 1.515 . . . . 0.0 111.934 -176.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 2471 ' ' LYS . . . . . . . . . . . . . 64.5 mttp -79.73 106.54 11.82 Favored 'General case' 0 CA--C 1.542 0.669 0 O-C-N 121.017 -1.052 . . . . 0.0 110.599 172.547 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 2472 ' ' VAL . . . . . . . . . . . . . 32.9 m -60.84 151.03 6.62 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.15 0 C-N-CA 123.821 0.848 . . . . 0.0 111.838 175.755 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 2473 ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.46 132.92 35.78 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 162.394 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 2474 ' ' MET . . . . . . . . . . . . . 16.3 tmm? -152.1 143.35 23.28 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-N 119.755 1.161 . . . . 0.0 112.975 -170.815 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 2475 ' ' ASP . . . . . . . . . . . . . 36.7 t70 -139.5 146.0 39.45 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 126.947 2.099 . . . . 0.0 110.295 174.214 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 2476 ' ' CYS . . . . . . . . . . . . . 30.0 t -124.35 144.99 49.71 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.515 1.126 . . . . 0.0 111.546 -179.361 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 2477 ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -143.36 169.57 17.42 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.128 1.371 . . . . 0.0 111.87 -179.763 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 2478 ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -77.78 147.21 35.4 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 123.807 0.843 . . . . 0.0 110.711 166.512 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 2479 ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -146.25 168.81 10.77 Favored Pre-proline 0 CA--C 1.552 1.054 0 C-N-CA 127.009 2.123 . . . . 0.0 111.072 178.377 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 2480 ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo -64.56 -29.35 61.33 Favored 'Trans proline' 0 CA--C 1.539 0.765 0 C-N-CA 122.75 2.3 . . . . 0.0 114.47 -173.315 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 2481 ' ' GLU . . . . . . . . . . . . . 5.6 mp0 -88.24 -10.19 50.51 Favored 'General case' 0 CA--C 1.547 0.847 0 N-CA-C 113.765 1.024 . . . . 0.0 113.765 174.216 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 2482 ' ' GLY . . . . . . . . . . . . . . . 151.45 -111.11 0.49 Allowed Glycine 0 N--CA 1.471 1.014 0 CA-C-N 119.794 1.179 . . . . 0.0 113.494 -176.188 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 2483 ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -123.14 123.85 41.73 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.437 1.095 . . . . 0.0 111.714 179.159 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 2484 ' ' ARG . . . . . . . . . . . . . 25.5 ttp180 -91.3 129.52 37.28 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 123.369 0.667 . . . . 0.0 111.108 175.097 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 2485 ' ' VAL . . . . . . . . . . . . . 98.7 t -99.2 132.03 45.35 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.475 0 C-N-CA 125.162 1.385 . . . . 0.0 107.99 168.101 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 2486 ' ' THR . . . . . . . . . . . . . 20.5 m -124.5 126.3 45.64 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 125.415 1.486 . . . . 0.0 107.619 176.132 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 2487 ' ' TYR . . . . . . . . . . . . . 15.8 p90 -143.19 150.13 38.96 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 113.584 0.957 . . . . 0.0 113.584 -176.842 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 2488 ' ' THR . . . . . . . . . . . . . 91.2 m -119.59 115.03 34.05 Favored Pre-proline 0 N--CA 1.468 0.471 0 C-N-CA 125.342 1.457 . . . . 0.0 108.618 176.37 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 2489 ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -79.08 153.3 24.88 Favored 'Trans proline' 0 N--CA 1.456 -0.68 0 C-N-CA 123.339 2.693 . . . . 0.0 110.774 175.084 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 2490 ' ' MET . . . . . . . . . . . . . 24.8 ptm -118.09 -4.87 10.98 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 114.584 1.327 . . . . 0.0 114.584 -174.044 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 2491 ' ' ALA . . . . . . . . . . . . . . . -145.38 152.25 49.54 Favored Pre-proline 0 CA--C 1.548 0.899 0 C-N-CA 125.296 1.439 . . . . 0.0 111.601 177.859 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 2492 ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -72.83 154.85 53.83 Favored 'Trans proline' 0 CA--C 1.537 0.635 0 C-N-CA 123.001 2.467 . . . . 0.0 111.076 173.186 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 2493 ' ' GLY . . . . . . . . . . . . . . . 130.81 -168.37 21.88 Favored Glycine 0 CA--C 1.529 0.964 0 C-N-CA 125.473 1.511 . . . . 0.0 113.508 -178.163 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 2494 ' ' SER . . . . . . . . . . . . . 70.5 m -99.62 116.53 31.96 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 123.923 0.889 . . . . 0.0 111.333 178.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 2495 ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -87.93 150.77 23.27 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.582 1.153 . . . . 0.0 110.53 166.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 2496 ' ' LEU . . . . . . . . . . . . . 32.0 tp -121.99 114.73 21.37 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.803 1.241 . . . . 0.0 109.359 179.583 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 2497 ' ' ILE . . . . . . . . . . . . . 63.4 mt -99.38 108.18 22.01 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 C-N-CA 125.318 1.447 . . . . 0.0 108.415 -172.881 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 2498 ' ' SER . . . . . . . . . . . . . 73.2 m -95.47 101.44 13.16 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 124.507 1.123 . . . . 0.0 109.732 179.358 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 2499 ' ' ILE . . . . . . . . . . . . . 42.8 mt -96.38 105.98 17.79 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 C-N-CA 124.762 1.225 . . . . 0.0 108.729 -178.023 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 2500 ' ' LYS . . . . . . . . . . . . . 85.1 mttt -113.2 142.51 45.71 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.406 1.082 . . . . 0.0 110.912 177.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 2501 ' ' TYR . . . . . . . . . . . . . 43.8 t80 -151.2 139.95 20.79 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.881 0.873 . . . . 0.0 112.258 -174.423 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 2502 ' ' GLY . . . . . . . . . . . . . . . 69.68 12.85 67.91 Favored Glycine 0 CA--C 1.536 1.402 0 C-N-CA 124.308 0.956 . . . . 0.0 114.267 177.862 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 2503 ' ' GLY . . . . . . . . . . . . . . . 150.81 -169.96 30.61 Favored Glycine 0 CA--C 1.539 1.54 0 C-N-CA 125.844 1.687 . . . . 0.0 113.025 -170.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 2504 ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -82.16 14.29 2.28 Favored 'Trans proline' 0 CA--C 1.544 1.011 0 C-N-CA 124.838 3.692 . . . . 0.0 113.918 -174.837 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 2505 ' ' TYR . . . . . . . . . . . . . 68.7 m-85 -108.44 141.64 40.0 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.77 1.228 . . . . 0.0 113.491 -171.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 2506 ' ' HIS . . . . . . . . . . . . . 84.3 m-70 -63.24 141.4 58.78 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 125.114 1.365 . . . . 0.0 112.988 176.246 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 2507 ' ' ILE . . . . . . . . . . . . . 1.6 pp -77.88 172.04 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 C-N-CA 123.612 0.765 . . . . 0.0 112.666 174.823 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 2508 ' ' GLY . . . . . . . . . . . . . . . -59.95 111.29 3.44 Favored Glycine 0 CA--C 1.534 1.264 0 O-C-N 121.531 -0.731 . . . . 0.0 112.582 -176.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 2509 ' ' GLY . . . . . . . . . . . . . . . 96.6 -7.3 65.66 Favored Glycine 0 CA--C 1.536 1.348 0 C-N-CA 125.822 1.677 . . . . 0.0 114.939 -177.19 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 2510 ' ' SER . . . . . . . . . . . . . 47.8 t -82.36 147.55 56.9 Favored Pre-proline 0 CA--C 1.551 0.981 0 CA-C-N 119.098 1.449 . . . . 0.0 112.106 178.123 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 2511 ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -78.41 154.42 92.64 Favored 'Cis proline' 0 C--N 1.353 0.808 0 CA-C-N 119.788 0.96 . . . . 0.0 113.091 -1.108 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 2512 ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -105.71 127.95 53.38 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.32 1.448 . . . . 0.0 110.998 -179.628 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 2513 ' ' LYS . . . . . . . . . . . . . 61.1 pttt -87.06 115.61 24.57 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 123.719 0.808 . . . . 0.0 111.906 175.836 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 2514 ' ' ALA . . . . . . . . . . . . . . . -105.94 114.9 29.32 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.645 1.578 . . . . 0.0 110.522 -179.051 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 2515 ' ' LYS . . . . . . . . . . . . . 54.2 mtpt -94.75 112.94 24.65 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.107 0.963 . . . . 0.0 110.755 -173.282 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 2516 ' ' VAL . . . . . . . . . . . . . 75.6 t -110.67 144.21 19.11 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 125.417 1.487 . . . . 0.0 110.542 -173.22 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 2517 ' ' THR . . . . . . . . . . . . . 66.4 p -133.45 172.53 12.6 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 125.3 1.44 . . . . 0.0 111.232 176.127 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 2518 ' ' GLY . . . . . . . . . . . . . . . 107.35 177.28 22.63 Favored Glycine 0 CA--C 1.541 1.676 0 C-N-CA 125.215 1.388 . . . . 0.0 113.954 -179.733 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 2519 ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -73.74 136.63 23.51 Favored 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 123.972 3.115 . . . . 0.0 112.172 -172.283 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 2520 ' ' ARG . . . . . . . . . . . . . 34.9 ttm180 -62.64 135.4 57.36 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 123.976 0.91 . . . . 0.0 111.286 177.322 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 2521 ' ' LEU . . . . . . . . . . . . . 10.3 mp -75.53 -27.87 58.86 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.212 1.005 . . . . 0.0 113.056 -177.289 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 2522 ' ' VAL . . . . . . . . . . . . . 18.4 m . . . . . 0 C--O 1.253 1.269 0 C-N-CA 126.164 1.786 . . . . 0.0 113.498 179.845 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.575 0 N-CA-C 111.22 -0.752 . . . . 0.0 111.22 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -75.41 -15.36 60.46 Favored 'General case' 0 CA--C 1.546 0.81 0 N-CA-C 114.797 1.406 . . . . 0.0 114.797 -174.467 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 97.2 mmm -74.2 -11.78 60.39 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 114.372 1.249 . . . . 0.0 114.372 -177.069 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 2427 ' ' GLY . . . . . . . . . . . . . . . -159.92 126.68 1.67 Allowed Glycine 0 N--CA 1.468 0.821 0 C-N-CA 124.962 1.268 . . . . 0.0 112.128 176.269 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 2428 ' ' ASP . . . . . . . . . . . . . 12.9 t70 -100.67 129.9 26.62 Favored Pre-proline 0 CA--C 1.552 1.025 0 C-N-CA 124.242 1.017 . . . . 0.0 112.347 -175.572 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 2429 ' ' PRO . . . . . . . . . . . . . 53.8 Cg_exo -58.24 -27.1 79.43 Favored 'Trans proline' 0 C--N 1.354 0.829 0 C-N-CA 123.719 2.946 . . . . 0.0 114.99 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 2430 ' ' GLY . . . . . . . . . . . . . . . -80.05 -23.33 61.66 Favored Glycine 0 CA--C 1.532 1.143 0 CA-C-N 119.154 0.888 . . . . 0.0 113.322 177.674 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 2431 ' ' LEU . . . . . . . . . . . . . 4.3 mm? -82.82 -31.56 28.06 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 124.212 1.005 . . . . 0.0 111.415 170.567 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 2432 ' ' VAL . . . . . . . . . . . . . 81.3 t -69.08 136.57 26.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 123.571 0.748 . . . . 0.0 110.573 169.403 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 2433 ' ' SER . . . . . . . . . . . . . 58.6 m -139.92 144.92 37.36 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 125.174 1.39 . . . . 0.0 109.788 171.817 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 2434 ' ' ALA . . . . . . . . . . . . . . . -94.29 148.48 22.17 Favored 'General case' 0 CA--C 1.541 0.609 0 O-C-N 121.771 -0.581 . . . . 0.0 111.781 175.109 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 2435 ' ' TYR . . . . . . . . . . . . . 93.3 m-85 -142.97 147.73 35.66 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 126.136 1.775 . . . . 0.0 111.453 -178.402 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 2436 ' ' GLY . . . . . . . . . . . . . . . 120.31 161.14 11.4 Favored Glycine 0 N--CA 1.473 1.145 0 C-N-CA 125.151 1.358 . . . . 0.0 113.876 178.374 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 2437 ' ' ALA . . . . . . . . . . . . . . . -62.8 -28.88 70.3 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 114.409 1.263 . . . . 0.0 114.409 -169.682 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 2438 ' ' GLY . . . . . . . . . . . . . . . -66.99 -12.3 59.87 Favored Glycine 0 CA--C 1.532 1.108 0 CA-C-O 119.077 -0.846 . . . . 0.0 114.773 -177.425 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 2439 ' ' LEU . . . . . . . . . . . . . 79.5 mt -76.41 -27.78 56.41 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.54 1.136 . . . . 0.0 112.5 170.265 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 2440 ' ' GLU . . . . . . . . . . . . . 41.5 mm-40 -88.61 -32.51 18.05 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.893 1.277 . . . . 0.0 111.529 176.507 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 2441 ' ' GLY . . . . . . . . . . . . . . . 115.9 -130.55 9.12 Favored Glycine 0 CA--C 1.531 1.05 0 C-N-CA 125.706 1.622 . . . . 0.0 112.503 -179.754 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 2442 ' ' GLY . . . . . . . . . . . . . . . 135.11 -150.0 20.07 Favored Glycine 0 CA--C 1.535 1.311 0 C-N-CA 125.155 1.36 . . . . 0.0 113.701 -174.365 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 2443 ' ' VAL . . . . . . . . . . . . . 90.2 t -89.55 136.26 24.06 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 C-N-CA 124.804 1.242 . . . . 0.0 111.025 -174.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 2444 ' ' THR . . . . . . . . . . . . . 46.3 p -72.24 146.65 47.12 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 124.47 1.108 . . . . 0.0 112.049 176.818 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 2445 ' ' GLY . . . . . . . . . . . . . . . 78.28 -10.73 26.96 Favored Glycine 0 CA--C 1.538 1.5 0 C-N-CA 124.243 0.925 . . . . 0.0 114.193 -172.753 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 2446 ' ' ASN . . . . . . . . . . . . . 77.0 m-20 -102.12 152.54 38.25 Favored Pre-proline 0 CA--C 1.55 0.944 0 C-N-CA 125.469 1.507 . . . . 0.0 111.034 172.474 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 2447 ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -72.07 140.34 34.35 Favored 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 123.075 2.516 . . . . 0.0 111.55 178.25 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 2448 ' ' ALA . . . . . . . . . . . . . . . -121.3 131.14 54.03 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 127.115 2.166 . . . . 0.0 109.089 173.725 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 2449 ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -128.55 141.4 51.38 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.294 1.038 . . . . 0.0 111.806 -166.854 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 2450 ' ' PHE . . . . . . . . . . . . . 37.8 p90 -155.2 161.34 41.22 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.211 1.405 . . . . 0.0 111.998 173.164 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 2451 ' ' VAL . . . . . . . . . . . . . 8.1 p -118.44 139.05 47.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 125.616 1.566 . . . . 0.0 110.417 176.666 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 2452 ' ' VAL . . . . . . . . . . . . . 61.4 t -95.81 101.41 12.37 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 N-CA-C 107.194 -1.41 . . . . 0.0 107.194 168.555 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 2453 ' ' ASN . . . . . . . . . . . . . 22.6 t-20 -83.49 120.29 25.73 Favored 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 -169.601 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 2454 ' ' THR . . . . . . . . . . . . . 35.4 p -99.52 -5.98 28.3 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 125.878 1.671 . . . . 0.0 113.993 -177.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 2455 ' ' SER . . . . . . . . . . . . . 19.9 m -57.39 -32.99 67.38 Favored 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 114.556 1.317 . . . . 0.0 114.556 -172.772 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 2456 ' ' ASN . . . . . . . . . . . . . 28.0 m120 -83.4 -15.9 48.0 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 124.149 0.98 . . . . 0.0 113.601 176.228 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 2457 ' ' ALA . . . . . . . . . . . . . . . -102.49 -42.22 6.03 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.032 1.333 . . . . 0.0 113.505 -173.217 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 2458 ' ' GLY . . . . . . . . . . . . . . . 120.55 -111.4 1.94 Allowed Glycine 0 CA--C 1.53 0.995 0 C-N-CA 125.323 1.439 . . . . 0.0 111.631 -172.246 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 2459 ' ' ALA . . . . . . . . . . . . . . . -148.04 149.92 32.99 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.721 1.208 . . . . 0.0 112.835 -175.808 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 2460 ' ' GLY . . . . . . . . . . . . . . . 171.11 171.09 36.0 Favored Glycine 0 CA--C 1.529 0.906 0 C-N-CA 124.748 1.166 . . . . 0.0 113.152 -176.492 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 2461 ' ' ALA . . . . . . . . . . . . . . . -81.82 142.42 32.58 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.014 0.925 . . . . 0.0 112.454 -179.433 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 2462 ' ' LEU . . . . . . . . . . . . . 16.9 tp -102.02 145.2 29.63 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.154 1.382 . . . . 0.0 110.38 172.559 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 2463 ' ' SER . . . . . . . . . . . . . 5.4 t -138.3 45.09 2.1 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 124.972 1.309 . . . . 0.0 110.625 179.745 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 2464 ' ' VAL . . . . . . . . . . . . . 9.1 p -65.94 134.86 29.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 124.975 1.31 . . . . 0.0 111.855 -177.105 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 2465 ' ' THR . . . . . . . . . . . . . 85.5 m -130.9 144.73 51.68 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 125.992 1.717 . . . . 0.0 109.144 177.617 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 2466 ' ' ILE . . . . . . . . . . . . . 47.7 mt -123.86 120.93 61.01 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 123.617 0.767 . . . . 0.0 109.808 175.764 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 2467 ' ' ASP . . . . . . . . . . . . . 31.2 m-20 -103.06 167.57 9.74 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 125.951 1.7 . . . . 0.0 110.742 169.785 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 2468 ' ' GLY . . . . . . . . . . . . . . . 167.27 -167.06 39.65 Favored Glycine 0 CA--C 1.537 1.41 0 O-C-N 121.387 -0.821 . . . . 0.0 114.534 179.776 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 2469 ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -70.68 -15.74 33.66 Favored 'Trans proline' 0 CA--C 1.54 0.822 0 C-N-CA 124.219 3.279 . . . . 0.0 113.284 178.248 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 2470 ' ' SER . . . . . . . . . . . . . 49.9 m -153.01 179.2 8.9 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 127.081 2.152 . . . . 0.0 110.051 173.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 2471 ' ' LYS . . . . . . . . . . . . . 65.1 pttt -69.4 171.2 9.04 Favored 'General case' 0 CA--C 1.549 0.937 0 O-C-N 121.083 -1.011 . . . . 0.0 112.926 171.269 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 2472 ' ' VAL . . . . . . . . . . . . . 26.7 m -130.9 147.38 33.09 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 125.173 1.389 . . . . 0.0 111.032 175.206 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 2473 ' ' LYS . . . . . . . . . . . . . 51.8 mtmt -88.57 58.73 4.81 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 124.382 1.073 . . . . 0.0 111.688 177.033 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 2474 ' ' MET . . . . . . . . . . . . . 16.0 tmm? -77.53 134.84 38.2 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.31 1.044 . . . . 0.0 112.635 -174.578 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 2475 ' ' ASP . . . . . . . . . . . . . 35.5 t70 -130.56 144.63 51.54 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 126.927 2.091 . . . . 0.0 110.451 172.286 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 2476 ' ' CYS . . . . . . . . . . . . . 48.9 t -127.53 147.63 50.33 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 125.543 1.537 . . . . 0.0 112.583 -173.102 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 2477 ' ' GLN . . . . . . . . . . . . . 23.1 tt0 -151.79 136.96 17.44 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.477 1.111 . . . . 0.0 110.964 170.747 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 2478 ' ' GLU . . . . . . . . . . . . . 4.1 pm0 -75.67 132.41 40.54 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.671 1.188 . . . . 0.0 111.886 172.63 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 2479 ' ' CYS . . . . . . . . . . . . . 80.0 m -133.98 169.37 14.08 Favored Pre-proline 0 CA--C 1.554 1.105 0 C-N-CA 126.157 1.783 . . . . 0.0 110.849 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 2480 ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -57.07 -27.27 73.14 Favored 'Trans proline' 0 CA--C 1.54 0.819 0 C-N-CA 123.569 2.846 . . . . 0.0 113.912 170.073 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 2481 ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -76.46 -3.66 38.37 Favored 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 125.684 1.594 . . . . 0.0 113.093 175.057 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 2482 ' ' GLY . . . . . . . . . . . . . . . 104.39 -170.01 17.97 Favored Glycine 0 CA--C 1.529 0.96 0 C-N-CA 125.949 1.737 . . . . 0.0 112.381 -169.178 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 2483 ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -71.56 116.37 11.83 Favored 'General case' 0 N--CA 1.469 0.488 0 O-C-N 121.493 -1.004 . . . . 0.0 111.116 175.336 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 2484 ' ' ARG . . . . . . . . . . . . . 15.2 ttp-105 -98.8 143.36 29.22 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 123.793 0.837 . . . . 0.0 110.512 174.574 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 2485 ' ' VAL . . . . . . . . . . . . . 35.1 m -132.96 150.03 32.44 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 C-N-CA 124.095 0.958 . . . . 0.0 111.563 174.873 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 2486 ' ' THR . . . . . . . . . . . . . 73.0 m -133.75 135.66 44.08 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 125.332 1.453 . . . . 0.0 108.217 171.8 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 2487 ' ' TYR . . . . . . . . . . . . . 26.4 p90 -141.12 150.98 43.53 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 124.424 1.09 . . . . 0.0 112.5 179.354 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 2488 ' ' THR . . . . . . . . . . . . . 92.2 m -115.49 116.25 41.56 Favored Pre-proline 0 N--CA 1.473 0.676 0 CA-C-O 117.844 -1.074 . . . . 0.0 109.097 173.1 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 2489 ' ' PRO . . . . . . . . . . . . . 77.8 Cg_endo -82.6 135.01 7.78 Favored 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 123.755 2.97 . . . . 0.0 110.382 172.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 2490 ' ' MET . . . . . . . . . . . . . 24.1 ptm -98.12 3.43 49.16 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 114.918 1.451 . . . . 0.0 114.918 -172.421 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 2491 ' ' ALA . . . . . . . . . . . . . . . -153.48 148.64 20.03 Favored Pre-proline 0 CA--C 1.543 0.687 0 C-N-CA 125.146 1.378 . . . . 0.0 111.654 -177.852 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 2492 ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -73.93 153.48 47.48 Favored 'Trans proline' 0 C--N 1.35 0.631 0 C-N-CA 123.522 2.815 . . . . 0.0 111.569 178.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 2493 ' ' GLY . . . . . . . . . . . . . . . 136.85 -150.8 20.71 Favored Glycine 0 CA--C 1.53 1.026 0 C-N-CA 125.297 1.427 . . . . 0.0 113.166 -178.19 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 2494 ' ' SER . . . . . . . . . . . . . 45.3 m -118.31 124.01 46.76 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.625 1.17 . . . . 0.0 110.982 -178.271 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 2495 ' ' TYR . . . . . . . . . . . . . 40.7 m-85 -103.11 125.82 50.0 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 124.803 1.241 . . . . 0.0 110.164 177.477 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 2496 ' ' LEU . . . . . . . . . . . . . 20.1 tp -95.0 106.8 18.81 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.056 0.943 . . . . 0.0 109.467 -178.412 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 2497 ' ' ILE . . . . . . . . . . . . . 51.9 mt -90.89 103.07 14.06 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 C-N-CA 125.837 1.655 . . . . 0.0 107.849 -178.688 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 2498 ' ' SER . . . . . . . . . . . . . 25.5 t -94.61 91.83 6.75 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 126.042 1.737 . . . . 0.0 109.388 -178.402 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 2499 ' ' ILE . . . . . . . . . . . . . 30.1 mt -91.57 90.37 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 C-N-CA 124.521 1.128 . . . . 0.0 109.52 -174.069 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 2500 ' ' LYS . . . . . . . . . . . . . 56.4 mttp -89.99 142.84 27.31 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 123.79 0.836 . . . . 0.0 111.412 174.695 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 2501 ' ' TYR . . . . . . . . . . . . . 85.7 t80 -148.59 147.96 29.59 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 124.756 1.222 . . . . 0.0 112.226 -175.573 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 2502 ' ' GLY . . . . . . . . . . . . . . . 65.29 16.07 62.03 Favored Glycine 0 CA--C 1.535 1.319 0 C-N-CA 124.567 1.08 . . . . 0.0 114.152 175.38 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 2503 ' ' GLY . . . . . . . . . . . . . . . 134.45 -170.84 22.5 Favored Glycine 0 CA--C 1.542 1.749 0 C-N-CA 126.191 1.853 . . . . 0.0 111.904 -161.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 2504 ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -84.11 33.88 0.51 Allowed 'Trans proline' 0 CA--C 1.547 1.127 0 C-N-CA 124.681 3.587 . . . . 0.0 113.202 -172.806 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 2505 ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -124.51 138.51 54.33 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.483 1.113 . . . . 0.0 113.446 -172.77 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 2506 ' ' HIS . . . . . . . . . . . . . 82.6 m-70 -60.28 143.71 52.14 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 125.694 1.598 . . . . 0.0 113.799 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 2507 ' ' ILE . . . . . . . . . . . . . 31.3 pt -75.1 172.31 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 C-N-CA 123.545 0.738 . . . . 0.0 112.73 168.057 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 2508 ' ' GLY . . . . . . . . . . . . . . . -58.63 121.95 28.26 Favored Glycine 0 CA--C 1.533 1.203 0 C-N-CA 123.661 0.648 . . . . 0.0 111.723 172.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 2509 ' ' GLY . . . . . . . . . . . . . . . 88.82 -9.89 74.61 Favored Glycine 0 CA--C 1.536 1.348 0 C-N-CA 125.653 1.597 . . . . 0.0 115.07 -178.003 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 2510 ' ' SER . . . . . . . . . . . . . 40.3 t -83.59 146.31 49.75 Favored Pre-proline 0 CA--C 1.55 0.978 0 CA-C-N 119.193 1.496 . . . . 0.0 111.893 179.158 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 2511 ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -78.81 154.15 91.17 Favored 'Cis proline' 0 C--N 1.353 0.791 0 CA-C-N 119.751 0.947 . . . . 0.0 113.071 0.072 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 2512 ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -103.63 132.24 50.07 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.043 1.337 . . . . 0.0 110.334 177.174 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 2513 ' ' LYS . . . . . . . . . . . . . 64.6 pttt -93.81 15.88 15.48 Favored 'General case' 0 N--CA 1.479 0.982 0 N-CA-C 116.123 1.897 . . . . 0.0 116.123 -165.565 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 2514 ' ' ALA . . . . . . . . . . . . . . . -12.78 104.23 0.02 OUTLIER 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 129.239 3.016 . . . . 0.0 116.205 -174.851 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 2515 ' ' LYS . . . . . . . . . . . . . 50.2 mtmt -93.27 130.18 39.09 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 124.406 1.083 . . . . 0.0 111.015 -176.114 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 2516 ' ' VAL . . . . . . . . . . . . . 25.7 m -134.12 148.37 30.09 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 C-N-CA 124.026 0.93 . . . . 0.0 112.253 -172.042 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 2517 ' ' THR . . . . . . . . . . . . . 45.1 p -139.45 165.84 26.16 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 125.568 1.547 . . . . 0.0 111.08 -175.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 2518 ' ' GLY . . . . . . . . . . . . . . . 119.18 -157.67 15.25 Favored Glycine 0 CA--C 1.539 1.535 0 C-N-CA 124.971 1.272 . . . . 0.0 112.331 -173.62 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 2519 ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -71.7 160.73 47.32 Favored 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 123.486 2.791 . . . . 0.0 112.684 -175.146 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 2520 ' ' ARG . . . . . . . . . . . . . 55.1 ttt85 -101.33 117.96 36.01 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.707 1.203 . . . . 0.0 108.941 167.644 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 2521 ' ' LEU . . . . . . . . . . . . . 2.8 mm? -93.17 -7.03 46.46 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 125.264 1.426 . . . . 0.0 112.774 -176.054 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 2522 ' ' VAL . . . . . . . . . . . . . 25.5 t . . . . . 0 C--O 1.254 1.326 0 C-N-CA 126.895 2.078 . . . . 0.0 112.071 176.421 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.513 0 N-CA-C 111.488 -0.645 . . . . 0.0 111.488 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -74.78 168.87 19.02 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 124.593 1.157 . . . . 0.0 113.201 178.867 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 46.4 tpp -150.29 130.69 13.79 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 125.819 1.648 . . . . 0.0 110.079 177.25 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 2427 ' ' GLY . . . . . . . . . . . . . . . -76.55 150.97 39.03 Favored Glycine 0 CA--C 1.531 1.081 0 C-N-CA 124.383 0.992 . . . . 0.0 113.148 -178.738 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 2428 ' ' ASP . . . . . . . . . . . . . 13.3 t70 -93.01 135.97 25.23 Favored Pre-proline 0 CA--C 1.551 0.984 0 C-N-CA 124.754 1.222 . . . . 0.0 111.625 -178.195 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 2429 ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -67.93 -14.62 41.78 Favored 'Trans proline' 0 CA--C 1.539 0.77 0 C-N-CA 123.575 2.85 . . . . 0.0 114.294 -175.871 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 2430 ' ' GLY . . . . . . . . . . . . . . . -87.54 -27.03 28.38 Favored Glycine 0 CA--C 1.534 1.222 0 C-N-CA 124.392 0.996 . . . . 0.0 113.187 171.475 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 2431 ' ' LEU . . . . . . . . . . . . . 4.3 mm? -78.29 -36.45 46.62 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 118.247 1.023 . . . . 0.0 111.037 170.436 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 2432 ' ' VAL . . . . . . . . . . . . . 72.8 t -64.63 136.86 25.92 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 C-N-CA 123.356 0.662 . . . . 0.0 109.724 166.515 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 2433 ' ' SER . . . . . . . . . . . . . 8.7 t -134.1 -166.68 1.83 Allowed 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.995 1.318 . . . . 0.0 110.1 176.256 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 2434 ' ' ALA . . . . . . . . . . . . . . . -152.12 143.35 23.26 Favored 'General case' 0 CA--C 1.537 0.478 0 O-C-N 121.002 -1.061 . . . . 0.0 111.308 174.188 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 2435 ' ' TYR . . . . . . . . . . . . . 81.4 m-85 -142.38 156.29 45.21 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 125.269 1.428 . . . . 0.0 112.076 -176.712 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 2436 ' ' GLY . . . . . . . . . . . . . . . 116.55 157.27 10.93 Favored Glycine 0 N--CA 1.472 1.06 0 C-N-CA 125.705 1.621 . . . . 0.0 113.266 -179.532 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 2437 ' ' ALA . . . . . . . . . . . . . . . -60.82 -28.46 68.81 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.863 1.265 . . . . 0.0 114.222 -170.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 2438 ' ' GLY . . . . . . . . . . . . . . . -67.68 -9.98 57.04 Favored Glycine 0 CA--C 1.531 1.045 0 CA-C-O 118.894 -0.948 . . . . 0.0 114.957 -178.008 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 2439 ' ' LEU . . . . . . . . . . . . . 79.4 mt -83.33 -24.86 31.92 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 124.747 1.219 . . . . 0.0 112.709 170.048 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 2440 ' ' GLU . . . . . . . . . . . . . 39.5 mm-40 -91.15 -39.23 12.26 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.885 1.274 . . . . 0.0 111.382 -179.34 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 2441 ' ' GLY . . . . . . . . . . . . . . . 164.13 -158.73 31.41 Favored Glycine 0 CA--C 1.528 0.876 0 N-CA-C 115.617 1.007 . . . . 0.0 115.617 -177.834 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 2442 ' ' GLY . . . . . . . . . . . . . . . 175.74 -165.77 36.69 Favored Glycine 0 CA--C 1.531 1.047 0 C-N-CA 125.638 1.589 . . . . 0.0 112.871 179.3 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 2443 ' ' VAL . . . . . . . . . . . . . 86.6 t -129.18 146.4 34.29 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 125.414 1.486 . . . . 0.0 108.672 174.423 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 2444 ' ' THR . . . . . . . . . . . . . 41.6 p -58.34 133.81 56.04 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-O 121.427 0.632 . . . . 0.0 111.661 178.231 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 2445 ' ' GLY . . . . . . . . . . . . . . . 79.14 -6.9 55.33 Favored Glycine 0 CA--C 1.537 1.464 0 C-N-CA 124.734 1.159 . . . . 0.0 115.052 -175.633 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 2446 ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -100.97 142.26 24.27 Favored Pre-proline 0 CA--C 1.553 1.059 0 C-N-CA 125.751 1.62 . . . . 0.0 111.179 177.573 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 2447 ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -74.29 129.52 13.1 Favored 'Trans proline' 0 C--N 1.351 0.68 0 C-N-CA 122.98 2.453 . . . . 0.0 111.34 179.768 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 2448 ' ' ALA . . . . . . . . . . . . . . . -105.57 120.33 41.38 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 126.365 1.866 . . . . 0.0 109.207 172.548 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 2449 ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -119.16 138.49 52.89 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.775 1.23 . . . . 0.0 111.542 -170.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 2450 ' ' PHE . . . . . . . . . . . . . 37.5 p90 -153.34 165.28 36.26 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.311 1.444 . . . . 0.0 111.85 173.272 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 2451 ' ' VAL . . . . . . . . . . . . . 43.0 t -126.85 131.75 70.74 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 C-N-CA 124.897 1.279 . . . . 0.0 109.701 176.172 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 2452 ' ' VAL . . . . . . . . . . . . . 40.0 t -78.6 105.43 7.78 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 N-CA-C 107.318 -1.364 . . . . 0.0 107.318 165.577 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 2453 ' ' ASN . . . . . . . . . . . . . 14.7 t-20 -83.19 115.1 21.78 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 123.804 0.842 . . . . 0.0 112.292 -169.161 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 2454 ' ' THR . . . . . . . . . . . . . 43.9 p -103.96 -9.1 19.14 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 125.687 1.595 . . . . 0.0 113.812 -177.648 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 2455 ' ' SER . . . . . . . . . . . . . 16.3 m -57.29 -29.21 63.69 Favored 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 114.637 1.347 . . . . 0.0 114.637 -172.622 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 2456 ' ' ASN . . . . . . . . . . . . . 68.9 m-80 -85.49 -13.25 49.7 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 124.671 1.188 . . . . 0.0 113.579 177.332 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 2457 ' ' ALA . . . . . . . . . . . . . . . -112.09 -25.6 9.26 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 125.576 1.55 . . . . 0.0 114.162 -174.312 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 2458 ' ' GLY . . . . . . . . . . . . . . . 103.75 -111.89 4.02 Favored Glycine 0 CA--C 1.53 0.987 0 C-N-CA 125.095 1.331 . . . . 0.0 111.844 -177.603 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 2459 ' ' ALA . . . . . . . . . . . . . . . -137.87 160.52 39.07 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.291 1.436 . . . . 0.0 112.201 -176.817 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 2460 ' ' GLY . . . . . . . . . . . . . . . 158.19 174.24 27.64 Favored Glycine 0 CA--C 1.529 0.946 0 C-N-CA 124.427 1.013 . . . . 0.0 113.973 -172.696 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 2461 ' ' ALA . . . . . . . . . . . . . . . -83.03 148.71 27.39 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.48 1.112 . . . . 0.0 112.706 -178.16 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 2462 ' ' LEU . . . . . . . . . . . . . 59.7 tp -129.22 138.85 51.93 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 125.545 1.538 . . . . 0.0 110.588 177.16 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 2463 ' ' SER . . . . . . . . . . . . . 18.2 t -118.26 151.25 38.01 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.478 1.111 . . . . 0.0 109.604 156.559 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 2464 ' ' VAL . . . . . . . . . . . . . 7.5 p -161.77 133.16 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 124.184 0.993 . . . . 0.0 110.819 -178.054 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 2465 ' ' THR . . . . . . . . . . . . . 62.7 m -140.85 142.83 34.51 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 125.578 1.551 . . . . 0.0 109.516 -175.377 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 2466 ' ' ILE . . . . . . . . . . . . . 41.9 mt -114.96 115.94 51.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 124.433 1.093 . . . . 0.0 109.442 177.132 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 2467 ' ' ASP . . . . . . . . . . . . . 35.1 t70 -96.63 161.41 13.9 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 125.929 1.692 . . . . 0.0 110.34 168.657 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 2468 ' ' GLY . . . . . . . . . . . . . . . 166.2 -164.21 37.39 Favored Glycine 0 CA--C 1.536 1.361 0 O-C-N 121.18 -0.95 . . . . 0.0 114.973 178.521 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 2469 ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -70.07 -14.08 34.68 Favored 'Trans proline' 0 CA--C 1.541 0.852 0 C-N-CA 124.202 3.268 . . . . 0.0 114.004 -178.836 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 2470 ' ' SER . . . . . . . . . . . . . 29.1 m -156.87 174.91 14.8 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 126.769 2.027 . . . . 0.0 110.363 175.637 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 2471 ' ' LYS . . . . . . . . . . . . . 58.4 mtmt -68.14 165.82 17.41 Favored 'General case' 0 CA--C 1.549 0.912 0 O-C-N 121.117 -0.989 . . . . 0.0 111.734 166.443 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 2472 ' ' VAL . . . . . . . . . . . . . 19.1 m -135.43 152.26 31.51 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 C-N-CA 124.777 1.231 . . . . 0.0 111.421 -179.442 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 2473 ' ' LYS . . . . . . . . . . . . . 29.2 mtpp -81.18 64.29 5.86 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 124.488 1.115 . . . . 0.0 111.806 179.463 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 2474 ' ' MET . . . . . . . . . . . . . 19.0 ttt -69.43 133.53 47.87 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 125.27 1.428 . . . . 0.0 112.161 -174.518 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 2475 ' ' ASP . . . . . . . . . . . . . 35.1 t70 -139.13 122.94 17.63 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 126.361 1.865 . . . . 0.0 110.109 176.266 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 2476 ' ' CYS . . . . . . . . . . . . . 73.6 m -104.38 140.79 37.41 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.733 1.213 . . . . 0.0 111.182 -179.021 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 2477 ' ' GLN . . . . . . . . . . . . . 81.0 mt-30 -140.83 148.01 39.91 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.127 1.371 . . . . 0.0 110.283 -176.223 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 2478 ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -95.03 118.58 32.08 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 123.686 0.795 . . . . 0.0 109.839 174.74 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 2479 ' ' CYS . . . . . . . . . . . . . 88.8 m -123.21 163.24 35.06 Favored Pre-proline 0 CA--C 1.551 0.992 0 C-N-CA 125.386 1.474 . . . . 0.0 111.587 -179.3 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 2480 ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -57.8 -31.29 91.94 Favored 'Trans proline' 0 C--N 1.353 0.803 0 C-N-CA 123.624 2.883 . . . . 0.0 114.071 174.579 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 2481 ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -77.19 -11.23 59.79 Favored 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 125.329 1.452 . . . . 0.0 112.98 178.216 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 2482 ' ' GLY . . . . . . . . . . . . . . . 125.57 -162.4 19.82 Favored Glycine 0 CA--C 1.53 0.983 0 C-N-CA 126.3 1.905 . . . . 0.0 112.993 -175.688 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 2483 ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -73.27 108.52 6.2 Favored 'General case' 0 CA--C 1.54 0.576 0 O-C-N 121.574 -0.957 . . . . 0.0 111.133 178.345 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 2484 ' ' ARG . . . . . . . . . . . . . 44.5 ttm180 -81.05 140.72 34.96 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 124.756 1.222 . . . . 0.0 110.448 174.561 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 2485 ' ' VAL . . . . . . . . . . . . . 90.4 t -130.72 129.05 63.82 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 C-N-CA 125.608 1.563 . . . . 0.0 108.592 174.499 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 2486 ' ' THR . . . . . . . . . . . . . 48.7 m -122.02 140.24 52.72 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 124.41 1.084 . . . . 0.0 108.351 170.18 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 2487 ' ' TYR . . . . . . . . . . . . . 34.7 p90 -146.22 149.14 33.35 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 123.852 0.861 . . . . 0.0 112.089 176.751 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 2488 ' ' THR . . . . . . . . . . . . . 87.7 m -111.87 115.53 50.78 Favored Pre-proline 0 N--CA 1.473 0.701 0 CA-C-O 117.875 -1.06 . . . . 0.0 108.9 174.161 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 2489 ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -79.61 161.88 24.76 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 123.965 3.11 . . . . 0.0 111.107 174.08 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 2490 ' ' MET . . . . . . . . . . . . . 25.6 ptm -138.32 3.43 2.36 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 114.977 1.473 . . . . 0.0 114.977 -173.071 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 2491 ' ' ALA . . . . . . . . . . . . . . . -143.47 146.23 34.9 Favored Pre-proline 0 CA--C 1.546 0.817 0 C-N-CA 125.179 1.391 . . . . 0.0 110.741 173.058 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 2492 ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -71.92 151.03 56.1 Favored 'Trans proline' 0 CA--C 1.536 0.594 0 C-N-CA 122.852 2.368 . . . . 0.0 111.04 175.51 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 2493 ' ' GLY . . . . . . . . . . . . . . . 135.5 -162.15 24.83 Favored Glycine 0 CA--C 1.529 0.944 0 C-N-CA 125.167 1.365 . . . . 0.0 113.366 -177.159 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 2494 ' ' SER . . . . . . . . . . . . . 42.2 m -101.34 123.46 45.47 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.151 0.98 . . . . 0.0 111.186 178.69 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 2495 ' ' TYR . . . . . . . . . . . . . 79.2 m-85 -96.82 134.34 40.25 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.508 1.123 . . . . 0.0 110.084 168.299 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 2496 ' ' LEU . . . . . . . . . . . . . 23.8 tp -110.4 115.12 29.1 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.724 1.21 . . . . 0.0 109.86 -176.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 2497 ' ' ILE . . . . . . . . . . . . . 45.0 mt -101.72 102.84 14.08 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 C-N-CA 125.683 1.593 . . . . 0.0 108.474 -173.68 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 2498 ' ' SER . . . . . . . . . . . . . 72.3 m -90.71 90.34 7.91 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 124.457 1.103 . . . . 0.0 110.67 -177.814 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 2499 ' ' ILE . . . . . . . . . . . . . 28.3 mt -91.14 118.09 35.71 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 125.035 1.334 . . . . 0.0 109.756 -178.286 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 2500 ' ' LYS . . . . . . . . . . . . . 82.0 mttt -131.71 106.93 8.45 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 124.865 1.266 . . . . 0.0 112.375 -171.733 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 2501 ' ' TYR . . . . . . . . . . . . . 39.3 t80 -109.49 142.89 39.87 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.721 1.208 . . . . 0.0 112.713 -175.183 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 2502 ' ' GLY . . . . . . . . . . . . . . . 70.87 9.55 66.28 Favored Glycine 0 CA--C 1.535 1.307 0 C-N-CA 124.682 1.134 . . . . 0.0 114.756 175.021 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 2503 ' ' GLY . . . . . . . . . . . . . . . 153.28 -171.73 32.19 Favored Glycine 0 CA--C 1.538 1.502 0 C-N-CA 125.802 1.668 . . . . 0.0 113.129 -172.144 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 2504 ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -82.09 19.04 1.3 Allowed 'Trans proline' 0 CA--C 1.546 1.106 0 C-N-CA 124.877 3.718 . . . . 0.0 113.749 -174.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 2505 ' ' TYR . . . . . . . . . . . . . 80.3 m-85 -113.94 143.7 44.28 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.213 1.405 . . . . 0.0 112.751 -175.26 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 2506 ' ' HIS . . . . . . . . . . . . . 97.5 m-70 -63.99 145.14 56.4 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 124.382 1.073 . . . . 0.0 113.632 -178.45 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 2507 ' ' ILE . . . . . . . . . . . . . 29.4 pt -75.06 173.68 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.213 0 C-N-CA 123.56 0.744 . . . . 0.0 112.869 171.373 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 2508 ' ' GLY . . . . . . . . . . . . . . . -58.7 120.5 22.65 Favored Glycine 0 CA--C 1.533 1.206 0 O-C-N 121.486 -0.759 . . . . 0.0 111.704 174.379 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 2509 ' ' GLY . . . . . . . . . . . . . . . 87.0 -8.2 77.36 Favored Glycine 0 CA--C 1.537 1.414 0 C-N-CA 125.52 1.533 . . . . 0.0 115.023 -177.07 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 2510 ' ' SER . . . . . . . . . . . . . 45.8 t -87.64 147.19 40.95 Favored Pre-proline 0 CA--C 1.549 0.937 0 CA-C-N 118.927 1.364 . . . . 0.0 111.826 179.845 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 2511 ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -76.34 151.9 95.47 Favored 'Cis proline' 0 C--N 1.352 0.722 0 CA-C-N 119.711 0.933 . . . . 0.0 112.748 -1.437 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 2512 ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -99.53 132.13 45.07 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 124.705 1.202 . . . . 0.0 111.151 179.851 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 2513 ' ' LYS . . . . . . . . . . . . . 64.9 pttt -96.26 22.85 7.22 Favored 'General case' 0 CA--C 1.552 1.02 0 N-CA-C 115.991 1.849 . . . . 0.0 115.991 -164.38 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 2514 ' ' ALA . . . . . . . . . . . . . . . -28.64 114.74 0.09 Allowed 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 128.118 2.567 . . . . 0.0 115.612 -173.807 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 2515 ' ' LYS . . . . . . . . . . . . . 89.0 mttt -98.17 135.13 40.26 Favored 'General case' 0 N--CA 1.474 0.77 0 O-C-N 121.312 -0.868 . . . . 0.0 112.74 -174.519 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 2516 ' ' VAL . . . . . . . . . . . . . 75.4 t -122.51 139.28 49.88 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 C-N-CA 125.284 1.434 . . . . 0.0 110.609 -170.604 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 2517 ' ' THR . . . . . . . . . . . . . 66.1 p -120.99 178.86 4.56 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 125.783 1.633 . . . . 0.0 111.107 176.331 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 2518 ' ' GLY . . . . . . . . . . . . . . . 100.51 179.55 29.59 Favored Glycine 0 CA--C 1.539 1.585 0 C-N-CA 124.828 1.204 . . . . 0.0 113.263 -175.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 2519 ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -72.53 152.05 53.74 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 123.788 2.992 . . . . 0.0 111.86 -175.449 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 2520 ' ' ARG . . . . . . . . . . . . . 45.8 ttp180 -79.15 127.95 32.68 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 123.384 0.673 . . . . 0.0 110.14 172.476 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 2521 ' ' LEU . . . . . . . . . . . . . 4.0 mm? -82.85 -23.26 33.78 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.854 0.862 . . . . 0.0 112.368 178.377 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 2522 ' ' VAL . . . . . . . . . . . . . 43.2 t . . . . . 0 C--O 1.252 1.207 0 C-N-CA 125.884 1.674 . . . . 0.0 111.391 176.493 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.596 0 N-CA-C 111.629 -0.588 . . . . 0.0 111.629 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -78.61 178.68 7.63 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 124.067 0.947 . . . . 0.0 112.45 176.38 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 37.3 mmt -66.46 -16.87 64.44 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.802 0.841 . . . . 0.0 112.702 168.089 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 2427 ' ' GLY . . . . . . . . . . . . . . . -172.2 118.28 0.71 Allowed Glycine 0 CA--C 1.527 0.781 0 C-N-CA 127.116 2.293 . . . . 0.0 110.132 172.874 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 2428 ' ' ASP . . . . . . . . . . . . . 41.8 m-20 -87.24 142.49 33.54 Favored Pre-proline 0 CA--C 1.548 0.872 0 C-N-CA 123.638 0.775 . . . . 0.0 112.283 -170.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 2429 ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -64.66 -27.12 60.83 Favored 'Trans proline' 0 C--N 1.351 0.69 0 C-N-CA 123.207 2.605 . . . . 0.0 113.216 -176.153 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 2430 ' ' GLY . . . . . . . . . . . . . . . -73.87 -22.24 78.33 Favored Glycine 0 CA--C 1.535 1.295 0 CA-C-N 118.905 0.775 . . . . 0.0 113.652 175.347 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 2431 ' ' LEU . . . . . . . . . . . . . 4.4 mm? -88.67 -28.75 20.39 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 124.622 1.169 . . . . 0.0 111.869 173.108 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 2432 ' ' VAL . . . . . . . . . . . . . 71.1 t -68.79 136.63 25.98 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 123.756 0.823 . . . . 0.0 110.292 169.681 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 2433 ' ' SER . . . . . . . . . . . . . 74.6 m -123.61 -177.86 3.85 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 125.419 1.488 . . . . 0.0 110.261 172.862 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 2434 ' ' ALA . . . . . . . . . . . . . . . -143.77 146.17 32.92 Favored 'General case' 0 CA--C 1.538 0.501 0 O-C-N 120.701 -1.25 . . . . 0.0 111.499 170.541 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 2435 ' ' TYR . . . . . . . . . . . . . 76.2 m-85 -145.06 152.22 39.77 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.441 1.497 . . . . 0.0 111.992 -174.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 2436 ' ' GLY . . . . . . . . . . . . . . . 121.74 158.66 10.41 Favored Glycine 0 N--CA 1.473 1.114 0 C-N-CA 125.492 1.52 . . . . 0.0 113.404 179.184 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 2437 ' ' ALA . . . . . . . . . . . . . . . -61.32 -27.06 68.22 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.79 1.236 . . . . 0.0 114.245 -171.398 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 2438 ' ' GLY . . . . . . . . . . . . . . . -66.79 -14.17 62.55 Favored Glycine 0 CA--C 1.53 0.982 0 CA-C-O 119.067 -0.851 . . . . 0.0 114.492 -179.183 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 2439 ' ' LEU . . . . . . . . . . . . . 67.6 mt -78.82 -23.19 45.24 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 118.442 1.121 . . . . 0.0 112.449 170.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 2440 ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -92.41 -29.28 16.37 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.168 1.387 . . . . 0.0 111.83 176.117 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 2441 ' ' GLY . . . . . . . . . . . . . . . 108.31 -134.66 12.35 Favored Glycine 0 CA--C 1.532 1.114 0 C-N-CA 125.829 1.68 . . . . 0.0 112.525 178.433 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 2442 ' ' GLY . . . . . . . . . . . . . . . 136.78 -153.9 21.92 Favored Glycine 0 CA--C 1.534 1.265 0 C-N-CA 124.884 1.231 . . . . 0.0 114.494 -176.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 2443 ' ' VAL . . . . . . . . . . . . . 87.5 t -79.84 134.65 27.12 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 C-N-CA 124.622 1.169 . . . . 0.0 111.029 -174.83 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 2444 ' ' THR . . . . . . . . . . . . . 39.1 p -68.92 144.06 54.29 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.251 1.021 . . . . 0.0 112.021 176.276 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 2445 ' ' GLY . . . . . . . . . . . . . . . 83.38 -22.28 7.57 Favored Glycine 0 CA--C 1.536 1.359 0 C-N-CA 125.416 1.484 . . . . 0.0 113.903 -174.541 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 2446 ' ' ASN . . . . . . . . . . . . . 80.4 m-20 -87.19 152.96 53.69 Favored Pre-proline 0 CA--C 1.547 0.864 0 C-N-CA 124.749 1.22 . . . . 0.0 110.816 170.851 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 2447 ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -72.04 144.06 41.78 Favored 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 122.942 2.428 . . . . 0.0 111.658 179.387 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 2448 ' ' ALA . . . . . . . . . . . . . . . -119.04 137.98 53.17 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 127.309 2.244 . . . . 0.0 108.847 172.634 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 2449 ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -146.21 138.16 25.01 Favored 'General case' 0 N--CA 1.471 0.589 0 O-C-N 121.517 -0.74 . . . . 0.0 112.585 -163.041 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 2450 ' ' PHE . . . . . . . . . . . . . 50.6 p90 -154.22 159.73 41.49 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 125.52 1.528 . . . . 0.0 112.383 -179.109 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 2451 ' ' VAL . . . . . . . . . . . . . 88.3 t -112.65 132.73 60.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 125.552 1.541 . . . . 0.0 109.349 173.049 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 2452 ' ' VAL . . . . . . . . . . . . . 33.3 t -84.86 103.68 12.27 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 164.638 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 2453 ' ' ASN . . . . . . . . . . . . . 15.5 t-20 -87.06 116.89 25.42 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.2 1.0 . . . . 0.0 112.314 -168.568 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 2454 ' ' THR . . . . . . . . . . . . . 43.3 p -103.2 -4.44 24.37 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 126.214 1.806 . . . . 0.0 114.241 -173.09 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 2455 ' ' SER . . . . . . . . . . . . . 19.6 m -56.0 -34.55 65.9 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 114.961 1.467 . . . . 0.0 114.961 -170.296 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 2456 ' ' ASN . . . . . . . . . . . . . 29.8 m120 -86.94 -10.93 52.08 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 124.329 1.051 . . . . 0.0 113.495 178.061 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 2457 ' ' ALA . . . . . . . . . . . . . . . -103.32 -53.96 2.7 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.206 1.402 . . . . 0.0 112.85 -174.763 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 2458 ' ' GLY . . . . . . . . . . . . . . . 125.63 -121.04 4.05 Favored Glycine 0 CA--C 1.531 1.064 0 C-N-CA 124.967 1.27 . . . . 0.0 112.658 -172.887 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 2459 ' ' ALA . . . . . . . . . . . . . . . -126.65 166.25 17.69 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 125.679 1.592 . . . . 0.0 112.781 -173.326 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 2460 ' ' GLY . . . . . . . . . . . . . . . 146.77 173.06 17.67 Favored Glycine 0 CA--C 1.531 1.047 0 C-N-CA 124.394 0.997 . . . . 0.0 114.054 -177.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 2461 ' ' ALA . . . . . . . . . . . . . . . -82.37 150.92 26.89 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.512 1.125 . . . . 0.0 112.811 -178.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 2462 ' ' LEU . . . . . . . . . . . . . 23.4 tp -109.42 148.27 31.41 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 126.272 1.829 . . . . 0.0 110.678 177.301 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 2463 ' ' SER . . . . . . . . . . . . . 8.4 t -150.03 68.7 1.0 Allowed 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 124.128 0.971 . . . . 0.0 111.449 177.5 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 2464 ' ' VAL . . . . . . . . . . . . . 42.2 t -74.3 139.62 18.96 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.24 0 O-C-N 120.692 -1.255 . . . . 0.0 110.764 178.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 2465 ' ' THR . . . . . . . . . . . . . 16.4 m -125.41 141.34 52.11 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 125.043 1.337 . . . . 0.0 108.929 169.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 2466 ' ' ILE . . . . . . . . . . . . . 26.5 mt -122.14 126.36 74.25 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 123.425 0.69 . . . . 0.0 109.921 171.677 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 2467 ' ' ASP . . . . . . . . . . . . . 35.8 t70 -110.95 148.53 32.29 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 126.044 1.738 . . . . 0.0 110.192 170.176 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 2468 ' ' GLY . . . . . . . . . . . . . . . 170.51 -164.81 38.07 Favored Glycine 0 CA--C 1.536 1.395 0 N-CA-C 114.996 0.758 . . . . 0.0 114.996 -178.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 2469 ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -68.34 -25.02 36.53 Favored 'Trans proline' 0 CA--C 1.54 0.79 0 C-N-CA 124.002 3.135 . . . . 0.0 114.752 -171.712 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 2470 ' ' SER . . . . . . . . . . . . . 17.3 m -159.53 142.54 14.15 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 125.82 1.648 . . . . 0.0 110.566 174.693 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 2471 ' ' LYS . . . . . . . . . . . . . 55.3 mtmt -61.57 122.06 14.31 Favored 'General case' 0 N--CA 1.476 0.862 0 O-C-N 121.074 -1.016 . . . . 0.0 112.9 -172.818 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 2472 ' ' VAL . . . . . . . . . . . . . 21.0 m -77.21 151.6 5.66 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 C-N-CA 124.441 1.096 . . . . 0.0 112.512 -175.598 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 2473 ' ' LYS . . . . . . . . . . . . . 38.3 mtmm -78.63 145.62 34.57 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 123.234 0.614 . . . . 0.0 109.867 160.315 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 2474 ' ' MET . . . . . . . . . . . . . 56.5 ttm -147.94 144.29 27.92 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 124.273 1.029 . . . . 0.0 112.518 -174.804 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 2475 ' ' ASP . . . . . . . . . . . . . 21.5 m-20 -125.81 149.93 48.22 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 126.843 2.057 . . . . 0.0 109.996 162.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 2476 ' ' CYS . . . . . . . . . . . . . 44.7 t -142.98 142.17 31.56 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.89 1.276 . . . . 0.0 110.757 179.075 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 2477 ' ' GLN . . . . . . . . . . . . . 6.0 tp-100 -155.9 146.82 22.21 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.309 1.044 . . . . 0.0 111.017 -175.704 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 2478 ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -78.53 128.63 33.82 Favored 'General case' 0 CA--C 1.541 0.628 0 O-C-N 121.62 -0.675 . . . . 0.0 111.455 174.637 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 2479 ' ' CYS . . . . . . . . . . . . . 95.3 m -124.5 167.09 16.68 Favored Pre-proline 0 CA--C 1.552 1.046 0 C-N-CA 126.152 1.781 . . . . 0.0 110.644 177.148 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 2480 ' ' PRO . . . . . . . . . . . . . 64.3 Cg_exo -57.46 -29.92 86.33 Favored 'Trans proline' 0 C--N 1.353 0.793 0 C-N-CA 123.53 2.82 . . . . 0.0 114.374 175.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 2481 ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -80.53 -6.93 58.94 Favored 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 125.356 1.462 . . . . 0.0 113.099 177.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 2482 ' ' GLY . . . . . . . . . . . . . . . 119.39 -169.39 13.68 Favored Glycine 0 CA--C 1.532 1.095 0 C-N-CA 126.326 1.917 . . . . 0.0 112.408 -172.016 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 2483 ' ' TYR . . . . . . . . . . . . . 63.0 m-85 -69.4 118.69 12.6 Favored 'General case' 0 N--CA 1.47 0.565 0 O-C-N 121.206 -1.173 . . . . 0.0 111.69 177.279 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 2484 ' ' ARG . . . . . . . . . . . . . 58.8 ttt180 -96.19 132.07 42.0 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 125.414 1.486 . . . . 0.0 110.273 178.536 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 2485 ' ' VAL . . . . . . . . . . . . . 67.0 t -123.11 131.98 72.24 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 C-N-CA 125.825 1.65 . . . . 0.0 109.065 -177.372 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 2486 ' ' THR . . . . . . . . . . . . . 50.3 m -124.54 132.96 53.44 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 124.845 1.258 . . . . 0.0 108.126 172.217 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 2487 ' ' TYR . . . . . . . . . . . . . 22.0 p90 -140.45 157.85 44.89 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.194 0.998 . . . . 0.0 112.392 179.162 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 2488 ' ' THR . . . . . . . . . . . . . 91.8 m -113.87 105.2 54.75 Favored Pre-proline 0 N--CA 1.476 0.852 0 CA-C-O 118.107 -0.949 . . . . 0.0 109.818 179.121 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 2489 ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -69.44 128.87 16.96 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 123.022 2.481 . . . . 0.0 109.437 170.344 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 2490 ' ' MET . . . . . . . . . . . . . 27.9 ptm -114.35 -1.47 13.52 Favored 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 114.777 1.399 . . . . 0.0 114.777 -171.33 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 2491 ' ' ALA . . . . . . . . . . . . . . . -147.4 144.82 20.05 Favored Pre-proline 0 CA--C 1.546 0.806 0 C-N-CA 124.902 1.281 . . . . 0.0 110.982 -179.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 2492 ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -72.6 151.43 52.56 Favored 'Trans proline' 0 C--N 1.351 0.688 0 C-N-CA 123.414 2.743 . . . . 0.0 111.392 -176.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 2493 ' ' GLY . . . . . . . . . . . . . . . 133.0 -142.49 14.01 Favored Glycine 0 CA--C 1.529 0.909 0 C-N-CA 124.875 1.226 . . . . 0.0 112.507 -175.386 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 2494 ' ' SER . . . . . . . . . . . . . 39.6 m -123.96 128.5 49.5 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.349 1.059 . . . . 0.0 111.292 -179.576 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 2495 ' ' TYR . . . . . . . . . . . . . 41.7 m-85 -101.04 119.16 38.33 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.775 1.23 . . . . 0.0 110.578 171.602 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 2496 ' ' LEU . . . . . . . . . . . . . 25.3 tp -91.97 110.2 21.55 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.543 1.137 . . . . 0.0 109.512 179.084 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 2497 ' ' ILE . . . . . . . . . . . . . 21.9 mt -97.75 98.99 7.99 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 C-N-CA 125.863 1.665 . . . . 0.0 108.768 -176.299 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 2498 ' ' SER . . . . . . . . . . . . . 69.4 m -86.56 81.92 8.1 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 125.482 1.513 . . . . 0.0 110.133 177.831 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 2499 ' ' ILE . . . . . . . . . . . . . 51.9 mt -76.62 117.71 21.85 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 C-N-CA 124.99 1.316 . . . . 0.0 109.407 177.41 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 2500 ' ' LYS . . . . . . . . . . . . . 2.2 mtmp? -129.01 143.19 50.79 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 125.122 1.369 . . . . 0.0 110.712 -178.627 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 2501 ' ' TYR . . . . . . . . . . . . . 49.5 t80 -152.37 144.46 23.83 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 124.496 1.118 . . . . 0.0 112.321 -171.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 2502 ' ' GLY . . . . . . . . . . . . . . . 67.65 16.24 67.52 Favored Glycine 0 CA--C 1.536 1.384 0 C-N-CA 124.177 0.894 . . . . 0.0 113.728 178.061 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 2503 ' ' GLY . . . . . . . . . . . . . . . 147.04 -174.76 26.73 Favored Glycine 0 CA--C 1.54 1.624 0 C-N-CA 126.216 1.865 . . . . 0.0 112.436 -167.508 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 2504 ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -84.7 12.56 3.02 Favored 'Trans proline' 0 CA--C 1.544 1.006 0 C-N-CA 124.551 3.501 . . . . 0.0 113.904 -173.159 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 2505 ' ' TYR . . . . . . . . . . . . . 58.9 m-85 -110.47 147.58 33.8 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 124.474 1.11 . . . . 0.0 113.849 -171.486 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 2506 ' ' HIS . . . . . . . . . . . . . 92.8 m-70 -63.47 141.14 58.88 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 125.095 1.358 . . . . 0.0 113.497 -175.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 2507 ' ' ILE . . . . . . . . . . . . . 1.7 pp -79.45 175.53 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 N-CA-C 113.281 0.845 . . . . 0.0 113.281 176.449 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 2508 ' ' GLY . . . . . . . . . . . . . . . -60.75 111.14 3.48 Favored Glycine 0 CA--C 1.532 1.155 0 O-C-N 121.237 -0.915 . . . . 0.0 112.652 -178.575 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 2509 ' ' GLY . . . . . . . . . . . . . . . 95.38 -8.72 69.38 Favored Glycine 0 CA--C 1.536 1.353 0 C-N-CA 125.984 1.754 . . . . 0.0 114.7 -176.349 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 2510 ' ' SER . . . . . . . . . . . . . 47.9 t -83.2 147.52 53.87 Favored Pre-proline 0 CA--C 1.549 0.936 0 CA-C-N 118.802 1.301 . . . . 0.0 111.997 179.538 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 2511 ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -78.18 154.76 93.65 Favored 'Cis proline' 0 C--N 1.353 0.781 0 CA-C-N 119.809 0.967 . . . . 0.0 112.98 -1.383 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 2512 ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -104.86 131.67 52.06 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 125.141 1.376 . . . . 0.0 110.728 178.32 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 2513 ' ' LYS . . . . . . . . . . . . . 19.5 ptpt -89.13 8.04 32.02 Favored 'General case' 0 N--CA 1.479 0.983 0 N-CA-C 116.617 2.08 . . . . 0.0 116.617 -166.707 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 2514 ' ' ALA . . . . . . . . . . . . . . . -2.52 96.99 0.01 OUTLIER 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 129.436 3.095 . . . . 0.0 116.316 -177.722 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 2515 ' ' LYS . . . . . . . . . . . . . 44.9 mtpt -90.03 133.18 34.98 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.157 0.983 . . . . 0.0 111.354 -173.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 2516 ' ' VAL . . . . . . . . . . . . . 31.7 m -133.0 149.22 31.53 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 C-N-CA 124.326 1.05 . . . . 0.0 112.426 -168.764 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 2517 ' ' THR . . . . . . . . . . . . . 35.8 p -140.3 164.18 30.79 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 125.611 1.565 . . . . 0.0 111.365 -174.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 2518 ' ' GLY . . . . . . . . . . . . . . . 116.42 -162.19 12.74 Favored Glycine 0 CA--C 1.539 1.538 0 C-N-CA 125.046 1.308 . . . . 0.0 112.441 -174.308 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 2519 ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -72.56 167.23 27.64 Favored 'Trans proline' 0 CA--C 1.536 0.576 0 C-N-CA 123.562 2.842 . . . . 0.0 112.09 -177.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 2520 ' ' ARG . . . . . . . . . . . . . 49.1 ttp180 -98.2 121.3 39.96 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.148 0.979 . . . . 0.0 109.189 167.476 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 2521 ' ' LEU . . . . . . . . . . . . . 2.8 mm? -91.28 44.96 1.21 Allowed 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 124.944 1.298 . . . . 0.0 111.794 -173.766 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 2522 ' ' VAL . . . . . . . . . . . . . 7.2 p . . . . . 0 C--O 1.252 1.22 0 C-N-CA 127.683 2.393 . . . . 0.0 111.374 -179.864 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.547 0 N-CA-C 112.065 -0.414 . . . . 0.0 112.065 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -154.41 155.55 35.2 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 125.637 1.575 . . . . 0.0 111.511 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 97.6 mmm -67.05 133.8 50.61 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 124.396 1.078 . . . . 0.0 112.562 -176.776 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 2427 ' ' GLY . . . . . . . . . . . . . . . -92.4 147.23 18.57 Favored Glycine 0 CA--C 1.529 0.961 0 C-N-CA 125.344 1.449 . . . . 0.0 113.832 -179.902 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 2428 ' ' ASP . . . . . . . . . . . . . 12.5 t70 -82.89 136.06 44.77 Favored Pre-proline 0 CA--C 1.548 0.896 0 C-N-CA 125.285 1.434 . . . . 0.0 111.211 177.4 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 2429 ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -63.06 -22.08 73.28 Favored 'Trans proline' 0 C--N 1.353 0.771 0 C-N-CA 123.642 2.895 . . . . 0.0 114.244 -174.661 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 2430 ' ' GLY . . . . . . . . . . . . . . . -80.79 -20.2 66.23 Favored Glycine 0 CA--C 1.534 1.232 0 C-N-CA 124.054 0.835 . . . . 0.0 113.691 174.738 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 2431 ' ' LEU . . . . . . . . . . . . . 4.3 mm? -84.49 -28.42 26.77 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.462 1.105 . . . . 0.0 111.999 173.433 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 2432 ' ' VAL . . . . . . . . . . . . . 2.3 t -67.74 143.12 15.65 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 CA-C-N 118.7 0.682 . . . . 0.0 109.491 169.561 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 2433 ' ' SER . . . . . . . . . . . . . 8.1 t -135.86 -172.77 3.19 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.311 1.044 . . . . 0.0 110.569 171.436 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 2434 ' ' ALA . . . . . . . . . . . . . . . -148.93 142.33 25.23 Favored 'General case' 0 CA--C 1.537 0.455 0 O-C-N 120.921 -1.112 . . . . 0.0 111.638 177.232 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 2435 ' ' TYR . . . . . . . . . . . . . 74.7 m-85 -143.67 146.81 33.5 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.229 1.411 . . . . 0.0 112.027 -174.326 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 2436 ' ' GLY . . . . . . . . . . . . . . . 128.35 159.98 10.2 Favored Glycine 0 N--CA 1.473 1.108 0 C-N-CA 125.767 1.651 . . . . 0.0 113.571 179.34 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 2437 ' ' ALA . . . . . . . . . . . . . . . -61.17 -29.6 69.9 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.938 1.295 . . . . 0.0 114.193 -171.27 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 2438 ' ' GLY . . . . . . . . . . . . . . . -65.89 -16.15 63.5 Favored Glycine 0 CA--C 1.53 1.005 0 C-N-CA 124.361 0.981 . . . . 0.0 114.375 -178.082 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 2439 ' ' LEU . . . . . . . . . . . . . 79.0 mt -80.03 -26.87 39.58 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 118.77 1.285 . . . . 0.0 112.594 172.556 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 2440 ' ' GLU . . . . . . . . . . . . . 35.0 mm-40 -87.36 -38.04 16.55 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.72 1.208 . . . . 0.0 111.582 -178.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 2441 ' ' GLY . . . . . . . . . . . . . . . 162.29 -150.43 19.65 Favored Glycine 0 CA--C 1.527 0.8 0 C-N-CA 124.046 0.831 . . . . 0.0 114.173 -175.61 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 2442 ' ' GLY . . . . . . . . . . . . . . . 167.58 -170.29 41.62 Favored Glycine 0 CA--C 1.53 0.999 0 C-N-CA 124.951 1.262 . . . . 0.0 113.616 -179.735 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 2443 ' ' VAL . . . . . . . . . . . . . 97.9 t -120.93 137.02 56.01 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 C-N-CA 125.435 1.494 . . . . 0.0 109.115 176.611 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 2444 ' ' THR . . . . . . . . . . . . . 27.9 p -56.23 128.22 34.6 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.598 1.159 . . . . 0.0 111.837 177.68 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 2445 ' ' GLY . . . . . . . . . . . . . . . 86.26 -10.89 64.73 Favored Glycine 0 CA--C 1.533 1.165 0 C-N-CA 125.28 1.419 . . . . 0.0 114.891 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 2446 ' ' ASN . . . . . . . . . . . . . 86.6 m-20 -104.72 141.72 23.14 Favored Pre-proline 0 CA--C 1.546 0.796 0 C-N-CA 124.693 1.197 . . . . 0.0 110.684 175.338 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 2447 ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -71.63 142.15 39.44 Favored 'Trans proline' 0 N--CA 1.457 -0.641 0 C-N-CA 122.64 2.226 . . . . 0.0 111.118 177.046 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 2448 ' ' ALA . . . . . . . . . . . . . . . -125.51 156.25 39.28 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 126.082 1.753 . . . . 0.0 109.341 167.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 2449 ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -152.52 160.17 43.25 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 114.019 1.118 . . . . 0.0 114.019 -166.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 2450 ' ' PHE . . . . . . . . . . . . . 52.0 p90 -161.75 159.02 26.68 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 126.193 1.797 . . . . 0.0 111.24 -177.425 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 2451 ' ' VAL . . . . . . . . . . . . . 48.2 t -115.98 130.22 71.06 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 C-N-CA 124.847 1.259 . . . . 0.0 109.219 173.151 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 2452 ' ' VAL . . . . . . . . . . . . . 21.4 t -78.95 102.76 5.27 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 N-CA-C 106.795 -1.558 . . . . 0.0 106.795 164.884 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 2453 ' ' ASN . . . . . . . . . . . . . 10.7 t-20 -81.69 114.3 20.27 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.051 0.94 . . . . 0.0 111.856 -169.48 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 2454 ' ' THR . . . . . . . . . . . . . 58.3 p -99.92 -7.25 25.45 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 125.65 1.58 . . . . 0.0 113.856 -176.318 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 2455 ' ' SER . . . . . . . . . . . . . 16.7 m -55.41 -32.92 63.08 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 114.534 1.309 . . . . 0.0 114.534 -174.274 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 2456 ' ' ASN . . . . . . . . . . . . . 92.1 m-20 -85.26 -14.08 47.8 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 124.324 1.049 . . . . 0.0 113.465 177.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 2457 ' ' ALA . . . . . . . . . . . . . . . -105.61 -48.88 3.55 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 125.097 1.359 . . . . 0.0 113.158 -171.491 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 2458 ' ' GLY . . . . . . . . . . . . . . . 117.92 -138.4 13.92 Favored Glycine 0 CA--C 1.532 1.102 0 C-N-CA 125.066 1.317 . . . . 0.0 112.526 -173.464 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 2459 ' ' ALA . . . . . . . . . . . . . . . -97.3 175.86 6.11 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 125.553 1.541 . . . . 0.0 112.575 -179.746 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 2460 ' ' GLY . . . . . . . . . . . . . . . 134.07 162.76 10.08 Favored Glycine 0 CA--C 1.53 0.978 0 C-N-CA 125.21 1.386 . . . . 0.0 113.677 -179.379 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 2461 ' ' ALA . . . . . . . . . . . . . . . -80.49 146.78 31.19 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.273 1.029 . . . . 0.0 112.566 -178.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 2462 ' ' LEU . . . . . . . . . . . . . 14.6 tp -104.14 145.88 29.56 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.765 1.626 . . . . 0.0 110.391 172.363 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 2463 ' ' SER . . . . . . . . . . . . . 22.6 t -124.87 147.6 48.71 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 123.949 0.9 . . . . 0.0 109.335 153.052 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 2464 ' ' VAL . . . . . . . . . . . . . 12.1 p -160.16 139.6 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 O-C-N 121.256 -0.902 . . . . 0.0 111.039 -172.816 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 2465 ' ' THR . . . . . . . . . . . . . 9.5 t -161.5 161.77 30.13 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 125.112 1.365 . . . . 0.0 111.256 -177.727 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 2466 ' ' ILE . . . . . . . . . . . . . 39.7 mt -134.67 121.91 36.94 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 C-N-CA 125.089 1.356 . . . . 0.0 109.934 -173.864 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 2467 ' ' ASP . . . . . . . . . . . . . 36.7 t70 -98.18 156.74 16.54 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.691 1.596 . . . . 0.0 110.234 167.716 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 2468 ' ' GLY . . . . . . . . . . . . . . . 171.93 -165.83 38.65 Favored Glycine 0 CA--C 1.535 1.309 0 O-C-N 120.951 -1.093 . . . . 0.0 115.175 -179.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 2469 ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -69.81 -12.67 33.27 Favored 'Trans proline' 0 CA--C 1.541 0.871 0 C-N-CA 124.116 3.211 . . . . 0.0 113.841 -179.808 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 2470 ' ' SER . . . . . . . . . . . . . 33.3 m -156.16 170.89 21.16 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 126.887 2.075 . . . . 0.0 110.174 173.406 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 2471 ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -67.73 162.0 24.77 Favored 'General case' 0 CA--C 1.548 0.889 0 O-C-N 121.116 -0.99 . . . . 0.0 111.752 167.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 2472 ' ' VAL . . . . . . . . . . . . . 35.8 m -137.79 145.06 29.61 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 C-N-CA 124.785 1.234 . . . . 0.0 111.639 -179.207 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 2473 ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -87.52 90.72 8.48 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.411 1.084 . . . . 0.0 110.867 -179.795 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 2474 ' ' MET . . . . . . . . . . . . . 96.7 mtp -80.93 133.82 35.61 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 124.279 1.032 . . . . 0.0 111.591 178.75 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 2475 ' ' ASP . . . . . . . . . . . . . 21.1 t70 -116.3 118.65 33.35 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 125.865 1.666 . . . . 0.0 109.044 162.892 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 2476 ' ' CYS . . . . . . . . . . . . . 72.4 m -102.81 137.85 40.48 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.397 1.079 . . . . 0.0 110.106 175.053 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 2477 ' ' GLN . . . . . . . . . . . . . 5.4 pt20 -154.12 155.35 35.22 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.499 1.119 . . . . 0.0 110.731 -175.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 2478 ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -97.68 138.07 35.63 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.84 0.856 . . . . 0.0 110.844 -179.425 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 2479 ' ' CYS . . . . . . . . . . . . . 17.0 p -137.02 171.59 8.34 Favored Pre-proline 0 CA--C 1.554 1.107 0 C-N-CA 125.602 1.561 . . . . 0.0 111.479 175.529 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 2480 ' ' PRO . . . . . . . . . . . . . 73.4 Cg_exo -58.6 -27.1 81.6 Favored 'Trans proline' 0 CA--C 1.54 0.791 0 C-N-CA 123.42 2.746 . . . . 0.0 114.572 178.588 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 2481 ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -84.7 -14.29 48.86 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 124.748 1.219 . . . . 0.0 113.135 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 2482 ' ' GLY . . . . . . . . . . . . . . . 139.82 -143.8 14.25 Favored Glycine 0 N--CA 1.471 0.987 0 C-N-CA 125.228 1.394 . . . . 0.0 113.425 178.511 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 2483 ' ' TYR . . . . . . . . . . . . . 66.5 m-85 -91.08 115.83 28.32 Favored 'General case' 0 N--CA 1.467 0.425 0 O-C-N 121.934 -0.745 . . . . 0.0 111.185 175.33 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 2484 ' ' ARG . . . . . . . . . . . . . 43.4 ttt180 -92.01 139.63 30.45 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 125.563 1.545 . . . . 0.0 110.87 178.111 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 2485 ' ' VAL . . . . . . . . . . . . . 65.4 t -126.83 129.59 71.42 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 125.542 1.537 . . . . 0.0 108.855 175.272 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 2486 ' ' THR . . . . . . . . . . . . . 93.8 m -117.6 139.2 51.3 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 125.37 1.468 . . . . 0.0 108.004 169.315 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 2487 ' ' TYR . . . . . . . . . . . . . 19.4 p90 -149.0 150.3 32.6 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 123.692 0.797 . . . . 0.0 112.851 176.656 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 2488 ' ' THR . . . . . . . . . . . . . 99.6 m -110.99 113.71 54.63 Favored Pre-proline 0 N--CA 1.474 0.738 0 C-N-CA 124.37 1.068 . . . . 0.0 109.609 176.712 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 2489 ' ' PRO . . . . . . . . . . . . . 79.3 Cg_endo -77.25 164.31 29.27 Favored 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 123.748 2.965 . . . . 0.0 110.947 169.269 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 2490 ' ' MET . . . . . . . . . . . . . 28.1 ptm -143.85 -3.17 0.89 Allowed 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 115.561 1.689 . . . . 0.0 115.561 -172.3 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 2491 ' ' ALA . . . . . . . . . . . . . . . -140.01 148.02 53.16 Favored Pre-proline 0 CA--C 1.546 0.821 0 C-N-CA 125.167 1.387 . . . . 0.0 110.737 174.139 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 2492 ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -71.34 146.83 51.63 Favored 'Trans proline' 0 CA--C 1.537 0.666 0 C-N-CA 122.856 2.37 . . . . 0.0 110.933 177.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 2493 ' ' GLY . . . . . . . . . . . . . . . 136.39 -167.62 24.4 Favored Glycine 0 CA--C 1.531 1.075 0 C-N-CA 125.214 1.388 . . . . 0.0 113.603 -176.602 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 2494 ' ' SER . . . . . . . . . . . . . 49.4 m -95.22 123.18 38.59 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 124.417 1.087 . . . . 0.0 111.299 179.863 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 2495 ' ' TYR . . . . . . . . . . . . . 73.1 m-85 -97.97 116.95 31.22 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.346 1.058 . . . . 0.0 110.129 170.003 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 2496 ' ' LEU . . . . . . . . . . . . . 23.2 tp -93.16 105.64 17.71 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.943 1.297 . . . . 0.0 109.904 -176.586 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 2497 ' ' ILE . . . . . . . . . . . . . 44.4 mt -93.32 112.37 26.32 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 C-N-CA 126.443 1.897 . . . . 0.0 108.636 -176.545 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 2498 ' ' SER . . . . . . . . . . . . . 75.4 m -96.61 123.87 40.42 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 123.512 0.725 . . . . 0.0 110.002 174.521 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 2499 ' ' ILE . . . . . . . . . . . . . 23.9 mt -124.95 116.23 46.58 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 C-N-CA 125.269 1.427 . . . . 0.0 109.297 -175.785 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 2500 ' ' LYS . . . . . . . . . . . . . 96.0 mttt -127.28 140.77 51.99 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.783 1.233 . . . . 0.0 111.817 -172.821 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 2501 ' ' TYR . . . . . . . . . . . . . 44.4 t80 -146.85 144.47 29.33 Favored 'General case' 0 N--CA 1.474 0.769 0 O-C-N 121.303 -0.873 . . . . 0.0 113.329 -172.331 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 2502 ' ' GLY . . . . . . . . . . . . . . . 69.57 19.46 74.73 Favored Glycine 0 CA--C 1.536 1.345 0 C-N-CA 124.101 0.858 . . . . 0.0 113.207 -179.152 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 2503 ' ' GLY . . . . . . . . . . . . . . . 132.17 -176.04 19.52 Favored Glycine 0 CA--C 1.54 1.637 0 C-N-CA 126.325 1.917 . . . . 0.0 112.293 -166.304 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 2504 ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -82.21 43.97 1.61 Allowed 'Trans proline' 0 CA--C 1.545 1.047 0 C-N-CA 124.959 3.773 . . . . 0.0 112.662 -173.722 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 2505 ' ' TYR . . . . . . . . . . . . . 76.0 m-85 -125.43 131.19 52.95 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.817 1.247 . . . . 0.0 112.475 -174.134 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 2506 ' ' HIS . . . . . . . . . . . . . 88.0 m-70 -59.33 138.07 57.76 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 124.921 1.288 . . . . 0.0 113.536 -177.26 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 2507 ' ' ILE . . . . . . . . . . . . . 2.3 pp -88.97 147.6 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 C-N-CA 123.854 0.862 . . . . 0.0 112.535 175.154 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 2508 ' ' GLY . . . . . . . . . . . . . . . 48.26 -115.32 2.35 Favored Glycine 0 CA--C 1.535 1.323 0 C-N-CA 124.239 0.923 . . . . 0.0 114.031 167.093 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 2509 ' ' GLY . . . . . . . . . . . . . . . -97.05 11.11 65.91 Favored Glycine 0 CA--C 1.537 1.417 0 C-N-CA 126.061 1.791 . . . . 0.0 115.212 177.693 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 2510 ' ' SER . . . . . . . . . . . . . 46.5 t -63.17 144.82 97.28 Favored Pre-proline 0 CA--C 1.55 0.974 0 CA-C-N 119.342 1.571 . . . . 0.0 112.458 178.917 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 2511 ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -79.64 152.34 86.25 Favored 'Cis proline' 0 C--N 1.353 0.779 0 CA-C-N 119.343 0.801 . . . . 0.0 113.349 -0.364 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 2512 ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -103.81 130.46 51.36 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 125.62 1.568 . . . . 0.0 110.782 -179.363 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 2513 ' ' LYS . . . . . . . . . . . . . 7.4 ptpp? -90.57 9.77 28.17 Favored 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 116.833 2.16 . . . . 0.0 116.833 -165.112 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 2514 ' ' ALA . . . . . . . . . . . . . . . -4.0 101.3 0.01 OUTLIER 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 129.404 3.082 . . . . 0.0 116.532 -176.847 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 2515 ' ' LYS . . . . . . . . . . . . . 35.2 mtmm -88.23 119.41 28.6 Favored 'General case' 0 CA--C 1.544 0.715 0 O-C-N 121.293 -0.88 . . . . 0.0 111.778 -173.419 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 2516 ' ' VAL . . . . . . . . . . . . . 54.1 t -111.27 144.08 19.87 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 125.83 1.652 . . . . 0.0 110.605 -173.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 2517 ' ' THR . . . . . . . . . . . . . 53.0 p -131.52 173.44 11.11 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 125.693 1.597 . . . . 0.0 110.949 174.299 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 2518 ' ' GLY . . . . . . . . . . . . . . . 112.88 179.43 19.47 Favored Glycine 0 CA--C 1.54 1.607 0 C-N-CA 125.1 1.333 . . . . 0.0 113.651 -177.863 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 2519 ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -69.68 129.31 17.46 Favored 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 123.896 3.064 . . . . 0.0 111.819 -172.67 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 2520 ' ' ARG . . . . . . . . . . . . . 35.2 ttt-85 -66.56 124.6 23.25 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 123.716 0.806 . . . . 0.0 110.449 177.541 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 2521 ' ' LEU . . . . . . . . . . . . . 62.9 mt -91.36 25.11 2.69 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 124.969 1.307 . . . . 0.0 112.913 -173.779 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 2522 ' ' VAL . . . . . . . . . . . . . 6.3 p . . . . . 0 C--O 1.253 1.245 0 C-N-CA 127.142 2.177 . . . . 0.0 111.555 -171.111 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.565 0 N-CA-C 111.435 -0.666 . . . . 0.0 111.435 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -81.29 -9.39 59.77 Favored 'General case' 0 CA--C 1.548 0.891 0 N-CA-C 114.669 1.359 . . . . 0.0 114.669 -176.9 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 10.3 tpt -146.96 131.55 17.78 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 125.777 1.631 . . . . 0.0 110.489 -177.113 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 2427 ' ' GLY . . . . . . . . . . . . . . . -81.04 169.21 51.63 Favored Glycine 0 CA--C 1.532 1.14 0 C-N-CA 124.979 1.276 . . . . 0.0 113.69 178.023 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 2428 ' ' ASP . . . . . . . . . . . . . 22.7 m-20 -94.33 129.69 36.22 Favored Pre-proline 0 CA--C 1.549 0.914 0 C-N-CA 124.496 1.119 . . . . 0.0 112.43 -178.414 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 2429 ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -56.46 -30.3 81.47 Favored 'Trans proline' 0 C--N 1.353 0.775 0 C-N-CA 123.659 2.906 . . . . 0.0 113.916 174.458 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 2430 ' ' GLY . . . . . . . . . . . . . . . -75.41 -21.23 77.88 Favored Glycine 0 CA--C 1.534 1.258 0 CA-C-O 119.379 -0.678 . . . . 0.0 113.92 177.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 2431 ' ' LEU . . . . . . . . . . . . . 4.3 mm? -88.86 -32.01 18.0 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.463 1.105 . . . . 0.0 111.698 173.143 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 2432 ' ' VAL . . . . . . . . . . . . . 95.4 t -68.15 136.22 26.92 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 C-N-CA 123.39 0.676 . . . . 0.0 110.439 170.549 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 2433 ' ' SER . . . . . . . . . . . . . 57.0 m -140.73 144.79 35.76 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 125.27 1.428 . . . . 0.0 109.998 175.544 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 2434 ' ' ALA . . . . . . . . . . . . . . . -100.61 148.19 25.11 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 123.351 0.66 . . . . 0.0 112.134 177.096 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 2435 ' ' TYR . . . . . . . . . . . . . 82.2 m-85 -143.93 146.26 32.84 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 125.852 1.661 . . . . 0.0 111.591 -176.282 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 2436 ' ' GLY . . . . . . . . . . . . . . . 124.89 163.52 11.67 Favored Glycine 0 N--CA 1.475 1.284 0 C-N-CA 125.09 1.328 . . . . 0.0 114.577 175.175 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 2437 ' ' ALA . . . . . . . . . . . . . . . -62.31 -30.62 71.28 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.184 1.394 . . . . 0.0 114.433 -170.064 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 2438 ' ' GLY . . . . . . . . . . . . . . . -66.05 -13.37 59.6 Favored Glycine 0 CA--C 1.532 1.152 0 C-N-CA 124.306 0.955 . . . . 0.0 114.282 -179.501 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 2439 ' ' LEU . . . . . . . . . . . . . 81.6 mt -79.84 -23.91 41.68 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 118.637 1.219 . . . . 0.0 112.801 171.049 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 2440 ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -92.78 -34.96 13.68 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 124.792 1.237 . . . . 0.0 111.985 -175.882 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 2441 ' ' GLY . . . . . . . . . . . . . . . 159.68 -153.22 24.23 Favored Glycine 0 C--N 1.339 0.748 0 C-N-CA 123.806 0.717 . . . . 0.0 114.31 -176.71 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 2442 ' ' GLY . . . . . . . . . . . . . . . 169.85 -168.76 41.63 Favored Glycine 0 CA--C 1.528 0.883 0 C-N-CA 124.802 1.191 . . . . 0.0 113.387 -178.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 2443 ' ' VAL . . . . . . . . . . . . . 38.9 t -128.31 139.11 52.79 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 C-N-CA 124.915 1.286 . . . . 0.0 108.867 174.657 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 2444 ' ' THR . . . . . . . . . . . . . 40.1 p -58.28 141.44 50.92 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.864 0.866 . . . . 0.0 112.706 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 2445 ' ' GLY . . . . . . . . . . . . . . . 78.2 -9.74 31.67 Favored Glycine 0 CA--C 1.535 1.316 0 C-N-CA 124.811 1.196 . . . . 0.0 114.859 -178.505 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 2446 ' ' ASN . . . . . . . . . . . . . 86.1 m-20 -111.59 144.87 31.46 Favored Pre-proline 0 CA--C 1.547 0.862 0 C-N-CA 125.318 1.447 . . . . 0.0 111.289 176.503 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 2447 ' ' PRO . . . . . . . . . . . . . 82.2 Cg_endo -74.71 149.46 38.21 Favored 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 122.893 2.395 . . . . 0.0 111.882 178.681 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 2448 ' ' ALA . . . . . . . . . . . . . . . -136.83 148.59 47.22 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 126.069 1.748 . . . . 0.0 109.654 168.354 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 2449 ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -141.1 157.42 45.32 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 114.164 1.172 . . . . 0.0 114.164 -166.443 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 2450 ' ' PHE . . . . . . . . . . . . . 50.7 p90 -156.59 162.64 39.88 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 126.421 1.888 . . . . 0.0 110.911 178.76 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 2451 ' ' VAL . . . . . . . . . . . . . 8.2 p -122.91 133.9 67.66 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 C-N-CA 124.698 1.199 . . . . 0.0 110.305 175.747 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 2452 ' ' VAL . . . . . . . . . . . . . 45.4 t -90.09 102.45 13.26 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 N-CA-C 106.943 -1.503 . . . . 0.0 106.943 169.64 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 2453 ' ' ASN . . . . . . . . . . . . . 19.6 t-20 -86.35 117.96 25.49 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 112.411 0.523 . . . . 0.0 112.411 -169.528 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 2454 ' ' THR . . . . . . . . . . . . . 53.0 p -97.83 -5.54 34.49 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 125.292 1.437 . . . . 0.0 113.851 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 2455 ' ' SER . . . . . . . . . . . . . 20.5 m -56.51 -28.29 59.49 Favored 'General case' 0 N--CA 1.479 1.006 0 CA-C-N 120.148 1.34 . . . . 0.0 114.54 -175.358 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 2456 ' ' ASN . . . . . . . . . . . . . 64.7 m-80 -83.33 -14.82 52.09 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 124.653 1.181 . . . . 0.0 113.593 176.532 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 2457 ' ' ALA . . . . . . . . . . . . . . . -115.58 -19.69 10.48 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 125.964 1.706 . . . . 0.0 114.271 -173.867 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 2458 ' ' GLY . . . . . . . . . . . . . . . 103.85 -103.13 2.26 Favored Glycine 0 CA--C 1.529 0.929 0 C-N-CA 125.585 1.564 . . . . 0.0 110.923 -172.699 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 2459 ' ' ALA . . . . . . . . . . . . . . . -158.61 163.39 37.01 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 125.898 1.679 . . . . 0.0 111.337 179.755 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 2460 ' ' GLY . . . . . . . . . . . . . . . 167.45 174.97 37.0 Favored Glycine 0 CA--C 1.528 0.9 0 N-CA-C 114.878 0.711 . . . . 0.0 114.878 -175.752 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 2461 ' ' ALA . . . . . . . . . . . . . . . -77.98 128.17 33.47 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.387 1.075 . . . . 0.0 112.434 -176.627 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 2462 ' ' LEU . . . . . . . . . . . . . 25.3 tp -106.64 144.28 33.53 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 125.58 1.552 . . . . 0.0 110.83 177.437 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 2463 ' ' SER . . . . . . . . . . . . . 3.8 t -136.2 40.89 2.65 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 125.843 1.657 . . . . 0.0 110.923 -176.248 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 2464 ' ' VAL . . . . . . . . . . . . . 7.5 p -64.27 133.41 29.86 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 C-N-CA 125.013 1.325 . . . . 0.0 112.107 -176.01 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 2465 ' ' THR . . . . . . . . . . . . . 97.8 m -134.18 142.84 47.57 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 126.027 1.731 . . . . 0.0 109.994 -177.196 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 2466 ' ' ILE . . . . . . . . . . . . . 50.6 mt -118.54 121.67 67.6 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 C-N-CA 124.201 1.0 . . . . 0.0 109.949 175.354 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 2467 ' ' ASP . . . . . . . . . . . . . 36.4 t70 -105.51 159.75 15.7 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 126.269 1.828 . . . . 0.0 110.592 169.314 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 2468 ' ' GLY . . . . . . . . . . . . . . . 172.97 -168.17 41.14 Favored Glycine 0 CA--C 1.535 1.313 0 O-C-N 121.305 -0.872 . . . . 0.0 114.472 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 2469 ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -66.13 -27.17 49.43 Favored 'Trans proline' 0 CA--C 1.54 0.78 0 C-N-CA 123.865 3.043 . . . . 0.0 112.833 177.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 2470 ' ' SER . . . . . . . . . . . . . 70.4 m -143.64 166.1 25.8 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 126.042 1.737 . . . . 0.0 110.184 172.196 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 2471 ' ' LYS . . . . . . . . . . . . . 68.2 mttm -71.65 131.98 43.95 Favored 'General case' 0 CA--C 1.545 0.753 0 O-C-N 120.706 -1.246 . . . . 0.0 110.989 171.9 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 2472 ' ' VAL . . . . . . . . . . . . . 20.5 m -87.47 155.52 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 C-N-CA 123.92 0.888 . . . . 0.0 111.52 177.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 2473 ' ' LYS . . . . . . . . . . . . . 97.5 mttt -80.84 72.35 7.82 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 124.399 1.08 . . . . 0.0 110.843 175.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 2474 ' ' MET . . . . . . . . . . . . . 22.4 ttt -78.97 139.91 38.13 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 125.745 1.618 . . . . 0.0 112.74 -171.588 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 2475 ' ' ASP . . . . . . . . . . . . . 17.6 m-20 -138.99 132.4 30.16 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 126.155 1.782 . . . . 0.0 109.844 167.116 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 2476 ' ' CYS . . . . . . . . . . . . . 48.0 t -118.19 140.67 49.44 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.076 1.35 . . . . 0.0 110.728 176.524 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 2477 ' ' GLN . . . . . . . . . . . . . 42.2 mt-30 -136.4 142.82 43.73 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 125.497 1.519 . . . . 0.0 110.444 -177.071 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 2478 ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -86.37 139.23 31.15 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.08 0.952 . . . . 0.0 110.161 171.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 2479 ' ' CYS . . . . . . . . . . . . . 29.3 p -150.52 169.76 8.75 Favored Pre-proline 0 CA--C 1.552 1.043 0 C-N-CA 125.01 1.324 . . . . 0.0 112.325 -176.866 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 2480 ' ' PRO . . . . . . . . . . . . . 56.3 Cg_exo -58.59 -25.46 74.78 Favored 'Trans proline' 0 CA--C 1.539 0.754 0 C-N-CA 123.356 2.704 . . . . 0.0 114.08 174.436 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 2481 ' ' GLU . . . . . . . . . . . . . 21.6 tt0 -85.23 -2.32 57.91 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 125.242 1.417 . . . . 0.0 113.13 178.37 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 2482 ' ' GLY . . . . . . . . . . . . . . . 121.88 -118.89 3.85 Favored Glycine 0 N--CA 1.47 0.938 0 C-N-CA 125.826 1.679 . . . . 0.0 112.202 -179.394 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 2483 ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -123.88 116.76 23.46 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.083 0.953 . . . . 0.0 110.881 174.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 2484 ' ' ARG . . . . . . . . . . . . . 41.4 ttm-85 -94.25 132.53 38.73 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 124.6 1.16 . . . . 0.0 110.169 179.227 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 2485 ' ' VAL . . . . . . . . . . . . . 86.1 t -119.98 135.36 60.52 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 C-N-CA 125.676 1.59 . . . . 0.0 108.998 -179.603 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 2486 ' ' THR . . . . . . . . . . . . . 88.4 m -129.07 142.84 50.77 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 125.244 1.417 . . . . 0.0 108.449 172.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 2487 ' ' TYR . . . . . . . . . . . . . 37.2 p90 -149.36 148.27 29.29 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 113.085 0.772 . . . . 0.0 113.085 174.041 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 2488 ' ' THR . . . . . . . . . . . . . 59.2 m -108.47 118.51 51.93 Favored Pre-proline 0 N--CA 1.473 0.725 0 C-N-CA 124.628 1.171 . . . . 0.0 108.759 168.358 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 2489 ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -82.76 157.34 15.98 Favored 'Trans proline' 0 N--CA 1.457 -0.654 0 C-N-CA 123.719 2.946 . . . . 0.0 111.189 174.108 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 2490 ' ' MET . . . . . . . . . . . . . 28.8 ptm -124.32 5.44 8.42 Favored 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 114.308 1.225 . . . . 0.0 114.308 -174.842 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 2491 ' ' ALA . . . . . . . . . . . . . . . -151.56 148.89 22.91 Favored Pre-proline 0 CA--C 1.546 0.807 0 C-N-CA 125.826 1.651 . . . . 0.0 111.117 178.25 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 2492 ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -74.66 155.33 44.61 Favored 'Trans proline' 0 CA--C 1.536 0.599 0 C-N-CA 123.094 2.529 . . . . 0.0 111.229 173.561 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 2493 ' ' GLY . . . . . . . . . . . . . . . 131.5 -174.37 20.09 Favored Glycine 0 CA--C 1.529 0.935 0 C-N-CA 125.337 1.446 . . . . 0.0 113.662 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 2494 ' ' SER . . . . . . . . . . . . . 11.1 p -86.28 129.81 34.72 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.361 1.064 . . . . 0.0 111.85 174.338 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 2495 ' ' TYR . . . . . . . . . . . . . 60.0 m-85 -107.2 125.48 51.17 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 125.578 1.551 . . . . 0.0 109.279 172.305 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 2496 ' ' LEU . . . . . . . . . . . . . 19.1 tp -94.48 107.0 18.99 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 123.857 0.863 . . . . 0.0 109.546 -178.255 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 2497 ' ' ILE . . . . . . . . . . . . . 48.7 mt -92.66 101.73 12.89 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 C-N-CA 125.631 1.572 . . . . 0.0 107.624 -179.763 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 2498 ' ' SER . . . . . . . . . . . . . 75.8 m -90.36 99.33 12.37 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 124.606 1.162 . . . . 0.0 109.519 176.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 2499 ' ' ILE . . . . . . . . . . . . . 23.0 mt -93.47 89.79 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 C-N-CA 124.511 1.125 . . . . 0.0 108.451 -178.133 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 2500 ' ' LYS . . . . . . . . . . . . . 85.1 mttt -99.53 142.52 30.91 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 124.334 1.054 . . . . 0.0 111.722 -178.715 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 2501 ' ' TYR . . . . . . . . . . . . . 72.9 t80 -146.5 138.08 24.58 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 124.738 1.215 . . . . 0.0 111.4 -168.176 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 2502 ' ' GLY . . . . . . . . . . . . . . . 69.03 12.08 64.63 Favored Glycine 0 CA--C 1.534 1.241 0 C-N-CA 124.356 0.979 . . . . 0.0 114.971 -179.45 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 2503 ' ' GLY . . . . . . . . . . . . . . . 138.41 -153.24 22.36 Favored Glycine 0 CA--C 1.539 1.552 0 C-N-CA 125.507 1.527 . . . . 0.0 112.388 -169.421 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 2504 ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -81.75 6.86 5.38 Favored 'Trans proline' 0 CA--C 1.543 0.938 0 C-N-CA 124.354 3.369 . . . . 0.0 114.123 -172.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 2505 ' ' TYR . . . . . . . . . . . . . 64.5 m-85 -99.26 136.14 39.64 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.272 1.029 . . . . 0.0 113.18 -172.479 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 2506 ' ' HIS . . . . . . . . . . . . . 93.4 m-70 -64.75 148.2 51.62 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 125.036 1.334 . . . . 0.0 113.305 176.778 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 2507 ' ' ILE . . . . . . . . . . . . . 30.4 pt -73.59 173.27 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 C-N-CA 123.387 0.675 . . . . 0.0 112.523 167.599 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 2508 ' ' GLY . . . . . . . . . . . . . . . -58.97 122.19 29.34 Favored Glycine 0 CA--C 1.534 1.253 0 O-C-N 121.659 -0.651 . . . . 0.0 111.791 172.808 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 2509 ' ' GLY . . . . . . . . . . . . . . . 88.75 -9.99 74.07 Favored Glycine 0 CA--C 1.536 1.362 0 C-N-CA 125.654 1.597 . . . . 0.0 115.226 -178.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 2510 ' ' SER . . . . . . . . . . . . . 41.6 t -84.95 147.77 49.06 Favored Pre-proline 0 CA--C 1.549 0.914 0 CA-C-N 119.053 1.426 . . . . 0.0 112.023 179.325 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 2511 ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -79.34 158.7 90.17 Favored 'Cis proline' 0 C--N 1.353 0.801 0 CA-C-N 119.867 0.988 . . . . 0.0 113.456 0.245 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 2512 ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -107.66 137.97 44.72 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 125.471 1.508 . . . . 0.0 110.747 177.847 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 2513 ' ' LYS . . . . . . . . . . . . . 19.1 ptpt -99.5 15.42 26.56 Favored 'General case' 0 N--CA 1.48 1.068 0 N-CA-C 116.289 1.959 . . . . 0.0 116.289 -163.48 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 2514 ' ' ALA . . . . . . . . . . . . . . . -14.89 108.57 0.02 OUTLIER 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 129.388 3.075 . . . . 0.0 116.722 -173.409 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 2515 ' ' LYS . . . . . . . . . . . . . 67.5 mttm -92.24 107.85 19.51 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 124.66 1.184 . . . . 0.0 111.72 -175.26 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 2516 ' ' VAL . . . . . . . . . . . . . 71.3 t -95.74 142.07 14.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 C-N-CA 125.726 1.61 . . . . 0.0 110.493 -177.828 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 2517 ' ' THR . . . . . . . . . . . . . 77.8 p -121.42 179.31 4.47 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 125.28 1.432 . . . . 0.0 111.456 174.321 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 2518 ' ' GLY . . . . . . . . . . . . . . . 99.91 178.78 30.59 Favored Glycine 0 CA--C 1.54 1.635 0 C-N-CA 124.676 1.131 . . . . 0.0 113.635 -178.231 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 2519 ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -72.98 148.4 45.18 Favored 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 123.857 3.038 . . . . 0.0 112.218 -174.46 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 2520 ' ' ARG . . . . . . . . . . . . . 49.4 ttm-85 -77.83 131.91 37.78 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 123.63 0.772 . . . . 0.0 110.281 173.189 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 2521 ' ' LEU . . . . . . . . . . . . . 4.2 mm? -79.85 -16.73 54.83 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.077 0.951 . . . . 0.0 113.279 -176.604 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 2522 ' ' VAL . . . . . . . . . . . . . 14.4 m . . . . . 0 C--O 1.252 1.223 0 C-N-CA 126.675 1.99 . . . . 0.0 113.374 179.838 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.563 0 N-CA-C 111.576 -0.61 . . . . 0.0 111.576 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -158.75 161.87 37.05 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 125.345 1.458 . . . . 0.0 112.313 -178.048 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 2.0 mpt? -74.74 166.38 23.68 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.36 1.464 . . . . 0.0 112.136 176.201 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 2427 ' ' GLY . . . . . . . . . . . . . . . -67.48 160.52 49.35 Favored Glycine 0 CA--C 1.532 1.145 0 C-N-CA 124.844 1.211 . . . . 0.0 113.879 -179.417 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 2428 ' ' ASP . . . . . . . . . . . . . 24.5 m-20 -91.0 133.12 32.6 Favored Pre-proline 0 CA--C 1.549 0.905 0 C-N-CA 124.233 1.013 . . . . 0.0 112.857 -175.205 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 2429 ' ' PRO . . . . . . . . . . . . . 72.5 Cg_exo -55.2 -27.88 58.73 Favored 'Trans proline' 0 C--N 1.352 0.711 0 C-N-CA 124.097 3.198 . . . . 0.0 114.308 171.611 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 2430 ' ' GLY . . . . . . . . . . . . . . . -77.04 -23.13 69.7 Favored Glycine 0 CA--C 1.534 1.254 0 C-N-CA 123.851 0.739 . . . . 0.0 113.819 176.525 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 2431 ' ' LEU . . . . . . . . . . . . . 4.4 mm? -87.42 -31.63 19.96 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.393 1.077 . . . . 0.0 111.612 171.768 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 2432 ' ' VAL . . . . . . . . . . . . . 87.5 t -64.67 130.23 29.55 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 CA-C-N 118.68 0.673 . . . . 0.0 109.901 168.824 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 2433 ' ' SER . . . . . . . . . . . . . 68.0 m -125.59 172.35 9.81 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 125.436 1.494 . . . . 0.0 110.338 174.787 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 2434 ' ' ALA . . . . . . . . . . . . . . . -131.52 143.24 50.24 Favored 'General case' 0 CA--C 1.539 0.53 0 O-C-N 121.205 -0.934 . . . . 0.0 111.29 174.638 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 2435 ' ' TYR . . . . . . . . . . . . . 75.8 m-85 -144.37 147.39 33.37 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 125.234 1.413 . . . . 0.0 112.001 -175.421 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 2436 ' ' GLY . . . . . . . . . . . . . . . 122.33 163.22 11.81 Favored Glycine 0 N--CA 1.473 1.154 0 C-N-CA 125.087 1.327 . . . . 0.0 114.198 175.902 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 2437 ' ' ALA . . . . . . . . . . . . . . . -61.9 -28.64 69.66 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.123 1.369 . . . . 0.0 114.398 -170.445 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 2438 ' ' GLY . . . . . . . . . . . . . . . -64.35 -18.18 62.77 Favored Glycine 0 CA--C 1.533 1.164 0 CA-C-O 118.984 -0.898 . . . . 0.0 114.12 -179.581 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 2439 ' ' LEU . . . . . . . . . . . . . 80.0 mt -76.44 -24.29 53.93 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 118.663 1.232 . . . . 0.0 112.754 171.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 2440 ' ' GLU . . . . . . . . . . . . . 37.9 mm-40 -89.05 -27.71 20.64 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.983 1.313 . . . . 0.0 111.792 177.205 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 2441 ' ' GLY . . . . . . . . . . . . . . . 111.93 -138.56 15.05 Favored Glycine 0 CA--C 1.53 1.009 0 C-N-CA 125.943 1.735 . . . . 0.0 112.301 -178.452 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 2442 ' ' GLY . . . . . . . . . . . . . . . 154.32 -148.29 18.62 Favored Glycine 0 N--CA 1.474 1.18 0 C-N-CA 124.019 0.819 . . . . 0.0 113.971 -177.418 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 2443 ' ' VAL . . . . . . . . . . . . . 60.1 t -105.79 139.23 27.64 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 C-N-CA 125.334 1.454 . . . . 0.0 110.032 -178.322 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 2444 ' ' THR . . . . . . . . . . . . . 39.3 p -59.39 144.87 45.55 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.505 1.122 . . . . 0.0 112.675 175.556 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 2445 ' ' GLY . . . . . . . . . . . . . . . 80.0 -18.3 8.03 Favored Glycine 0 CA--C 1.535 1.339 0 C-N-CA 125.033 1.301 . . . . 0.0 114.47 -179.804 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 2446 ' ' ASN . . . . . . . . . . . . . 87.4 m-20 -99.64 144.55 28.54 Favored Pre-proline 0 CA--C 1.545 0.763 0 C-N-CA 125.081 1.353 . . . . 0.0 110.98 176.321 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 2447 ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -73.85 151.26 45.45 Favored 'Trans proline' 0 N--CA 1.457 -0.637 0 C-N-CA 122.816 2.344 . . . . 0.0 111.479 178.281 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 2448 ' ' ALA . . . . . . . . . . . . . . . -135.74 158.7 43.75 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 126.534 1.934 . . . . 0.0 109.492 169.437 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 2449 ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -149.37 155.65 40.82 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 113.913 1.079 . . . . 0.0 113.913 -171.457 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 2450 ' ' PHE . . . . . . . . . . . . . 47.9 p90 -155.03 153.61 31.23 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 126.042 1.737 . . . . 0.0 110.434 178.579 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 2451 ' ' VAL . . . . . . . . . . . . . 12.0 p -107.43 132.4 55.05 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 C-N-CA 124.603 1.161 . . . . 0.0 110.087 175.089 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 2452 ' ' VAL . . . . . . . . . . . . . 34.8 t -86.6 101.57 10.97 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 N-CA-C 106.594 -1.632 . . . . 0.0 106.594 165.684 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 2453 ' ' ASN . . . . . . . . . . . . . 13.2 t-20 -79.57 111.93 16.33 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.23 1.012 . . . . 0.0 111.821 -171.218 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 2454 ' ' THR . . . . . . . . . . . . . 27.9 p -101.16 -13.47 18.13 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 125.335 1.454 . . . . 0.0 113.865 -179.734 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 2455 ' ' SER . . . . . . . . . . . . . 98.1 p -64.39 -24.65 67.71 Favored 'General case' 0 N--CA 1.478 0.957 0 CA-C-N 120.234 1.379 . . . . 0.0 114.213 -174.577 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 2456 ' ' ASN . . . . . . . . . . . . . 49.8 m-80 -77.35 -18.31 57.52 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 124.283 1.033 . . . . 0.0 113.568 171.731 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 2457 ' ' ALA . . . . . . . . . . . . . . . -106.04 -31.3 8.8 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 125.4 1.48 . . . . 0.0 113.827 -176.131 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 2458 ' ' GLY . . . . . . . . . . . . . . . 113.99 -113.85 3.17 Favored Glycine 0 CA--C 1.53 1.008 0 C-N-CA 125.516 1.531 . . . . 0.0 111.491 -174.171 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 2459 ' ' ALA . . . . . . . . . . . . . . . -144.31 158.85 43.52 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 125.17 1.388 . . . . 0.0 111.943 -179.559 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 2460 ' ' GLY . . . . . . . . . . . . . . . 160.28 171.78 26.64 Favored Glycine 0 CA--C 1.531 1.092 0 C-N-CA 125.112 1.339 . . . . 0.0 113.161 -174.098 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 2461 ' ' ALA . . . . . . . . . . . . . . . -75.62 138.2 41.24 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 123.959 0.904 . . . . 0.0 112.241 -178.76 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 2462 ' ' LEU . . . . . . . . . . . . . 50.0 tp -119.84 143.09 48.08 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.462 1.505 . . . . 0.0 110.658 176.734 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 2463 ' ' SER . . . . . . . . . . . . . 12.5 t -128.37 162.71 26.47 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.114 1.365 . . . . 0.0 110.355 160.637 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 2464 ' ' VAL . . . . . . . . . . . . . 7.2 p -162.18 133.06 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 C-N-CA 124.852 1.261 . . . . 0.0 110.353 -178.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 2465 ' ' THR . . . . . . . . . . . . . 79.8 m -133.95 138.73 45.66 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 125.236 1.414 . . . . 0.0 109.184 -178.374 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 2466 ' ' ILE . . . . . . . . . . . . . 33.7 mt -119.08 114.94 46.31 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 C-N-CA 124.036 0.934 . . . . 0.0 109.388 177.065 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 2467 ' ' ASP . . . . . . . . . . . . . 33.4 t70 -99.11 165.47 11.71 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 126.01 1.724 . . . . 0.0 110.151 168.501 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 2468 ' ' GLY . . . . . . . . . . . . . . . 168.93 -161.9 35.62 Favored Glycine 0 CA--C 1.536 1.391 0 O-C-N 121.009 -1.057 . . . . 0.0 115.283 178.009 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 2469 ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -67.94 -16.23 45.01 Favored 'Trans proline' 0 CA--C 1.54 0.8 0 C-N-CA 124.297 3.331 . . . . 0.0 113.404 178.808 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 2470 ' ' SER . . . . . . . . . . . . . 32.9 m -151.98 175.09 12.87 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 127.14 2.176 . . . . 0.0 109.31 169.743 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 2471 ' ' LYS . . . . . . . . . . . . . 98.7 mttt -67.74 164.41 19.5 Favored 'General case' 0 CA--C 1.548 0.886 0 O-C-N 121.002 -1.061 . . . . 0.0 111.69 166.484 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 2472 ' ' VAL . . . . . . . . . . . . . 27.2 m -123.08 153.68 28.33 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 C-N-CA 125.168 1.387 . . . . 0.0 111.011 177.057 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 2473 ' ' LYS . . . . . . . . . . . . . 88.3 tttt -91.62 129.17 37.64 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 123.229 0.611 . . . . 0.0 109.387 163.243 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 2474 ' ' MET . . . . . . . . . . . . . 99.0 mtp -121.01 149.55 42.5 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 124.989 1.315 . . . . 0.0 111.895 -177.467 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 2475 ' ' ASP . . . . . . . . . . . . . 38.6 t0 -138.69 83.18 1.95 Allowed 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 126.953 2.101 . . . . 0.0 109.135 174.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 2476 ' ' CYS . . . . . . . . . . . . . 24.1 t -77.15 133.5 38.95 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 123.853 0.861 . . . . 0.0 111.126 177.783 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 2477 ' ' GLN . . . . . . . . . . . . . 34.9 mt-30 -138.81 179.93 6.2 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 127.734 2.414 . . . . 0.0 109.357 -169.328 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 2478 ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -143.57 149.18 37.03 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.364 1.066 . . . . 0.0 112.019 179.909 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 2479 ' ' CYS . . . . . . . . . . . . . 20.8 p -156.84 174.14 4.31 Favored Pre-proline 0 CA--C 1.553 1.086 0 C-N-CA 126.108 1.763 . . . . 0.0 110.99 -176.752 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 2480 ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -58.44 -24.72 70.34 Favored 'Trans proline' 0 CA--C 1.539 0.748 0 C-N-CA 123.349 2.7 . . . . 0.0 114.711 177.776 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 2481 ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -79.76 -17.27 53.87 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 124.285 1.034 . . . . 0.0 112.987 178.172 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 2482 ' ' GLY . . . . . . . . . . . . . . . 136.26 -154.5 22.01 Favored Glycine 0 CA--C 1.531 1.056 0 C-N-CA 125.818 1.675 . . . . 0.0 113.372 -178.853 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 2483 ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -85.55 115.23 23.13 Favored 'General case' 0 N--CA 1.468 0.449 0 O-C-N 121.78 -0.835 . . . . 0.0 110.774 175.541 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 2484 ' ' ARG . . . . . . . . . . . . . 35.9 ttt-85 -95.95 121.73 38.0 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 124.401 1.08 . . . . 0.0 110.241 -178.0 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 2485 ' ' VAL . . . . . . . . . . . . . 66.1 t -103.02 125.67 57.39 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 C-N-CA 124.933 1.293 . . . . 0.0 108.392 177.187 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 2486 ' ' THR . . . . . . . . . . . . . 91.8 m -111.69 139.49 47.11 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 167.434 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 2487 ' ' TYR . . . . . . . . . . . . . 14.1 p90 -151.01 154.85 37.84 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 113.361 0.875 . . . . 0.0 113.361 177.022 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 2488 ' ' THR . . . . . . . . . . . . . 98.9 m -118.33 115.49 35.96 Favored Pre-proline 0 N--CA 1.475 0.78 0 C-N-CA 124.717 1.207 . . . . 0.0 109.725 176.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 2489 ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -81.3 163.14 19.77 Favored 'Trans proline' 0 C--N 1.351 0.667 0 C-N-CA 123.987 3.125 . . . . 0.0 111.165 169.89 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 2490 ' ' MET . . . . . . . . . . . . . 25.8 ptm -143.05 4.29 1.43 Allowed 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 115.482 1.66 . . . . 0.0 115.482 -170.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 2491 ' ' ALA . . . . . . . . . . . . . . . -146.11 148.37 34.99 Favored Pre-proline 0 CA--C 1.546 0.819 0 C-N-CA 125.112 1.365 . . . . 0.0 110.901 174.769 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 2492 ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -72.2 145.37 43.73 Favored 'Trans proline' 0 CA--C 1.536 0.61 0 C-N-CA 122.813 2.342 . . . . 0.0 110.997 177.025 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 2493 ' ' GLY . . . . . . . . . . . . . . . 136.77 -167.03 24.72 Favored Glycine 0 CA--C 1.53 0.971 0 C-N-CA 125.34 1.448 . . . . 0.0 113.44 -177.141 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 2494 ' ' SER . . . . . . . . . . . . . 50.2 m -98.77 120.14 38.7 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.271 1.028 . . . . 0.0 111.298 -179.128 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 2495 ' ' TYR . . . . . . . . . . . . . 73.0 m-85 -93.01 124.96 37.35 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.215 1.006 . . . . 0.0 110.395 170.855 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 2496 ' ' LEU . . . . . . . . . . . . . 22.8 tp -96.65 111.35 23.53 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.423 1.089 . . . . 0.0 109.788 -178.888 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 2497 ' ' ILE . . . . . . . . . . . . . 49.9 mt -98.73 102.1 12.98 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 C-N-CA 126.057 1.743 . . . . 0.0 108.429 -176.663 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 2498 ' ' SER . . . . . . . . . . . . . 73.2 m -92.76 98.34 11.34 Favored 'General case' 0 N--CA 1.468 0.425 0 C-N-CA 124.608 1.163 . . . . 0.0 110.25 178.492 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 2499 ' ' ILE . . . . . . . . . . . . . 28.0 mt -96.05 120.53 45.54 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 C-N-CA 125.834 1.654 . . . . 0.0 109.349 179.65 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 2500 ' ' LYS . . . . . . . . . . . . . 90.5 mttt -134.08 127.78 32.86 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.264 1.026 . . . . 0.0 112.788 -171.137 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 2501 ' ' TYR . . . . . . . . . . . . . 57.5 t80 -128.09 151.56 49.04 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 124.828 1.251 . . . . 0.0 112.621 -171.674 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 2502 ' ' GLY . . . . . . . . . . . . . . . 64.91 20.02 66.17 Favored Glycine 0 CA--C 1.536 1.378 0 C-N-CA 124.241 0.924 . . . . 0.0 113.733 178.297 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 2503 ' ' GLY . . . . . . . . . . . . . . . 126.32 -166.46 19.09 Favored Glycine 0 CA--C 1.542 1.721 0 C-N-CA 125.878 1.704 . . . . 0.0 112.42 -164.785 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 2504 ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -82.11 31.77 0.52 Allowed 'Trans proline' 0 CA--C 1.546 1.113 0 C-N-CA 124.985 3.79 . . . . 0.0 113.522 -173.043 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 2505 ' ' TYR . . . . . . . . . . . . . 75.5 m-85 -113.87 131.47 56.26 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.66 1.184 . . . . 0.0 112.773 -172.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 2506 ' ' HIS . . . . . . . . . . . . . 89.5 m-70 -60.54 140.05 57.5 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 124.681 1.192 . . . . 0.0 113.687 -177.072 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 2507 ' ' ILE . . . . . . . . . . . . . 2.2 pp -84.45 160.58 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.199 0 C-N-CA 123.962 0.905 . . . . 0.0 112.442 173.691 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 2508 ' ' GLY . . . . . . . . . . . . . . . 38.67 -110.63 0.14 Allowed Glycine 0 CA--C 1.537 1.435 0 C-N-CA 125.291 1.424 . . . . 0.0 115.607 161.641 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 2509 ' ' GLY . . . . . . . . . . . . . . . -104.75 15.82 48.26 Favored Glycine 0 CA--C 1.538 1.51 0 C-N-CA 126.37 1.938 . . . . 0.0 114.637 175.74 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 2510 ' ' SER . . . . . . . . . . . . . 33.3 t -67.85 146.38 98.32 Favored Pre-proline 0 CA--C 1.551 0.987 0 C-N-CA 125.38 1.472 . . . . 0.0 112.181 179.449 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 2511 ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -79.6 156.19 89.34 Favored 'Cis proline' 0 C--N 1.351 0.687 0 CA-C-N 119.728 0.939 . . . . 0.0 112.915 -0.544 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 2512 ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -106.17 136.14 46.39 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 125.178 1.391 . . . . 0.0 111.07 179.822 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 2513 ' ' LYS . . . . . . . . . . . . . 19.5 ptpt -94.17 11.72 29.11 Favored 'General case' 0 CA--C 1.552 1.024 0 N-CA-C 116.51 2.041 . . . . 0.0 116.51 -164.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 2514 ' ' ALA . . . . . . . . . . . . . . . -4.78 99.35 0.01 OUTLIER 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 129.561 3.145 . . . . 0.0 116.474 -179.211 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 2515 ' ' LYS . . . . . . . . . . . . . 52.9 mtpt -89.02 120.0 30.05 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.258 1.023 . . . . 0.0 111.529 -173.332 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 2516 ' ' VAL . . . . . . . . . . . . . 55.0 t -113.14 142.58 25.1 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 125.788 1.635 . . . . 0.0 110.435 -172.484 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 2517 ' ' THR . . . . . . . . . . . . . 40.9 p -127.88 171.88 11.38 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 125.664 1.586 . . . . 0.0 111.458 178.151 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 2518 ' ' GLY . . . . . . . . . . . . . . . 107.31 -173.74 19.08 Favored Glycine 0 CA--C 1.538 1.53 0 C-N-CA 124.919 1.247 . . . . 0.0 113.264 -176.792 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 2519 ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -71.05 156.2 60.32 Favored 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 123.705 2.937 . . . . 0.0 112.209 -176.092 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 2520 ' ' ARG . . . . . . . . . . . . . 39.9 ttm105 -88.13 122.86 32.19 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 123.915 0.886 . . . . 0.0 110.0 171.852 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 2521 ' ' LEU . . . . . . . . . . . . . 4.1 mm? -85.8 -27.39 25.19 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.105 0.962 . . . . 0.0 112.823 -175.665 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 2522 ' ' VAL . . . . . . . . . . . . . 9.9 p . . . . . 0 C--O 1.254 1.292 0 C-N-CA 124.97 1.308 . . . . 0.0 112.625 176.297 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.569 0 N-CA-C 112.009 -0.437 . . . . 0.0 112.009 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -158.82 163.75 36.4 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 125.707 1.603 . . . . 0.0 112.141 -178.489 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 93.3 mmm 79.83 138.41 0.07 Allowed 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 129.042 2.937 . . . . 0.0 113.215 175.394 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 2427 ' ' GLY . . . . . . . . . . . . . . . -86.41 147.18 21.31 Favored Glycine 0 CA--C 1.529 0.951 0 C-N-CA 125.508 1.527 . . . . 0.0 113.099 178.202 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 2428 ' ' ASP . . . . . . . . . . . . . 29.4 m-20 -91.66 136.5 26.47 Favored Pre-proline 0 CA--C 1.547 0.853 0 C-N-CA 124.517 1.127 . . . . 0.0 112.0 -179.087 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 2429 ' ' PRO . . . . . . . . . . . . . 79.6 Cg_exo -54.75 -27.58 53.0 Favored 'Trans proline' 0 C--N 1.353 0.772 0 C-N-CA 123.994 3.129 . . . . 0.0 114.862 175.577 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 2430 ' ' GLY . . . . . . . . . . . . . . . -80.02 -24.54 59.54 Favored Glycine 0 CA--C 1.535 1.285 0 C-N-CA 123.762 0.696 . . . . 0.0 113.969 176.615 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 2431 ' ' LEU . . . . . . . . . . . . . 4.2 mm? -86.22 -32.77 21.0 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.575 1.15 . . . . 0.0 111.315 172.896 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 2432 ' ' VAL . . . . . . . . . . . . . 82.5 t -65.08 136.75 26.18 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 C-N-CA 123.723 0.809 . . . . 0.0 109.723 167.758 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 2433 ' ' SER . . . . . . . . . . . . . 8.4 t -131.88 -168.85 2.1 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.827 1.251 . . . . 0.0 110.823 177.311 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 2434 ' ' ALA . . . . . . . . . . . . . . . -149.91 142.64 24.63 Favored 'General case' 0 CA--C 1.539 0.531 0 O-C-N 121.062 -1.024 . . . . 0.0 111.988 176.395 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 2435 ' ' TYR . . . . . . . . . . . . . 77.4 m-85 -145.79 148.85 33.38 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 125.386 1.474 . . . . 0.0 112.001 -176.416 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 2436 ' ' GLY . . . . . . . . . . . . . . . 123.99 160.42 10.79 Favored Glycine 0 N--CA 1.474 1.2 0 C-N-CA 125.245 1.402 . . . . 0.0 113.974 176.708 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 2437 ' ' ALA . . . . . . . . . . . . . . . -60.93 -30.19 70.06 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.007 1.323 . . . . 0.0 114.167 -171.057 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 2438 ' ' GLY . . . . . . . . . . . . . . . -67.19 -9.81 55.21 Favored Glycine 0 CA--C 1.533 1.169 0 C-N-CA 124.57 1.081 . . . . 0.0 114.514 -179.632 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 2439 ' ' LEU . . . . . . . . . . . . . 88.3 mt -79.41 -26.12 41.95 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 118.973 1.386 . . . . 0.0 112.553 168.397 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 2440 ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -95.94 -36.37 11.09 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.081 1.352 . . . . 0.0 112.236 -173.851 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 2441 ' ' GLY . . . . . . . . . . . . . . . 160.32 -148.96 17.97 Favored Glycine 0 CA--C 1.532 1.134 0 C-N-CA 124.79 1.186 . . . . 0.0 113.146 -176.053 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 2442 ' ' GLY . . . . . . . . . . . . . . . 150.68 178.63 25.72 Favored Glycine 0 CA--C 1.534 1.249 0 C-N-CA 125.412 1.482 . . . . 0.0 112.796 -175.85 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 2443 ' ' VAL . . . . . . . . . . . . . 83.9 t -101.81 134.77 41.33 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 C-N-CA 124.722 1.209 . . . . 0.0 110.097 -179.583 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 2444 ' ' THR . . . . . . . . . . . . . 25.5 p -63.19 140.07 58.84 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.212 1.005 . . . . 0.0 112.325 176.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 2445 ' ' GLY . . . . . . . . . . . . . . . 79.58 -11.51 32.19 Favored Glycine 0 CA--C 1.536 1.385 0 C-N-CA 124.705 1.145 . . . . 0.0 114.328 -174.887 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 2446 ' ' ASN . . . . . . . . . . . . . 82.1 m-20 -106.36 152.14 40.48 Favored Pre-proline 0 CA--C 1.548 0.884 0 C-N-CA 125.453 1.501 . . . . 0.0 110.901 173.19 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 2447 ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -73.05 134.28 21.11 Favored 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 122.789 2.326 . . . . 0.0 111.335 175.875 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 2448 ' ' ALA . . . . . . . . . . . . . . . -111.48 156.69 21.3 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 126.232 1.813 . . . . 0.0 109.225 162.049 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 2449 ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -153.37 153.93 33.52 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 113.901 1.074 . . . . 0.0 113.901 -173.389 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 2450 ' ' PHE . . . . . . . . . . . . . 40.2 p90 -158.0 161.02 38.08 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.863 1.665 . . . . 0.0 110.696 177.336 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 2451 ' ' VAL . . . . . . . . . . . . . 14.7 p -113.04 135.07 53.68 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 C-N-CA 124.697 1.199 . . . . 0.0 110.968 175.121 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 2452 ' ' VAL . . . . . . . . . . . . . 25.1 t -84.89 101.76 9.86 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 N-CA-C 106.337 -1.727 . . . . 0.0 106.337 163.315 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 2453 ' ' ASN . . . . . . . . . . . . . 15.8 t-20 -88.66 123.5 33.17 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 123.72 0.808 . . . . 0.0 112.335 -167.006 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 2454 ' ' THR . . . . . . . . . . . . . 69.0 p -109.89 2.03 19.56 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 125.878 1.671 . . . . 0.0 113.745 -174.178 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 2455 ' ' SER . . . . . . . . . . . . . 42.0 m -56.57 -30.93 63.71 Favored 'General case' 0 N--CA 1.479 0.976 0 N-CA-C 114.537 1.31 . . . . 0.0 114.537 -172.887 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 2456 ' ' ASN . . . . . . . . . . . . . 28.0 m120 -88.96 -8.44 54.12 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 124.896 1.278 . . . . 0.0 113.55 177.297 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 2457 ' ' ALA . . . . . . . . . . . . . . . -113.18 -47.64 3.01 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 125.387 1.475 . . . . 0.0 113.755 -170.166 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 2458 ' ' GLY . . . . . . . . . . . . . . . 105.48 -151.29 17.12 Favored Glycine 0 CA--C 1.534 1.277 0 C-N-CA 125.333 1.444 . . . . 0.0 113.144 -174.219 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 2459 ' ' ALA . . . . . . . . . . . . . . . -77.44 156.64 30.97 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.811 1.245 . . . . 0.0 114.023 -174.43 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 2460 ' ' GLY . . . . . . . . . . . . . . . 158.22 172.09 24.93 Favored Glycine 0 CA--C 1.531 1.073 0 C-N-CA 125.246 1.403 . . . . 0.0 113.655 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 2461 ' ' ALA . . . . . . . . . . . . . . . -100.39 148.9 24.2 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.9 1.28 . . . . 0.0 112.84 -176.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 2462 ' ' LEU . . . . . . . . . . . . . 16.3 tp -101.97 149.41 24.26 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 125.526 1.531 . . . . 0.0 111.357 176.888 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 2463 ' ' SER . . . . . . . . . . . . . 3.7 t -140.89 40.29 1.82 Allowed 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 125.223 1.409 . . . . 0.0 111.427 179.136 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 2464 ' ' VAL . . . . . . . . . . . . . 14.2 p -65.36 139.23 21.7 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 C-N-CA 125.124 1.37 . . . . 0.0 112.574 -174.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 2465 ' ' THR . . . . . . . . . . . . . 93.5 m -135.04 143.38 46.71 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 125.791 1.636 . . . . 0.0 109.706 175.869 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 2466 ' ' ILE . . . . . . . . . . . . . 35.2 mt -121.12 123.97 71.13 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 C-N-CA 124.079 0.951 . . . . 0.0 110.122 175.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 2467 ' ' ASP . . . . . . . . . . . . . 34.4 t70 -104.17 162.91 12.78 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 126.809 2.044 . . . . 0.0 110.077 169.048 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 2468 ' ' GLY . . . . . . . . . . . . . . . 168.95 -161.55 35.25 Favored Glycine 0 CA--C 1.536 1.376 0 O-C-N 120.841 -1.162 . . . . 0.0 115.414 178.265 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 2469 ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -71.48 -17.72 30.05 Favored 'Trans proline' 0 CA--C 1.539 0.747 0 C-N-CA 124.006 3.138 . . . . 0.0 113.341 -178.827 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 2470 ' ' SER . . . . . . . . . . . . . 43.3 m -156.79 -168.36 2.65 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 127.213 2.205 . . . . 0.0 109.762 178.775 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 2471 ' ' LYS . . . . . . . . . . . . . 49.0 mmtm -74.12 174.78 8.21 Favored 'General case' 0 CA--C 1.55 0.968 0 O-C-N 120.661 -1.275 . . . . 0.0 112.523 170.32 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 2472 ' ' VAL . . . . . . . . . . . . . 35.4 m -131.06 148.36 33.01 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 C-N-CA 125.448 1.499 . . . . 0.0 109.971 165.848 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 2473 ' ' LYS . . . . . . . . . . . . . 88.5 tttt -94.44 102.89 14.87 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 166.146 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 2474 ' ' MET . . . . . . . . . . . . . 55.4 ttp -117.27 144.56 44.71 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.994 1.317 . . . . 0.0 112.732 -173.193 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 2475 ' ' ASP . . . . . . . . . . . . . 31.7 t70 -127.98 132.97 49.15 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 126.991 2.116 . . . . 0.0 110.057 170.479 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 2476 ' ' CYS . . . . . . . . . . . . . 45.3 t -109.73 138.55 45.93 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 125.138 1.375 . . . . 0.0 111.334 178.291 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 2477 ' ' GLN . . . . . . . . . . . . . 81.6 mt-30 -133.68 128.65 35.46 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.035 1.334 . . . . 0.0 110.392 -175.079 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 2478 ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -81.57 137.01 35.58 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.34 1.056 . . . . 0.0 109.9 173.159 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 2479 ' ' CYS . . . . . . . . . . . . . 29.6 p -156.01 167.24 14.69 Favored Pre-proline 0 CA--C 1.552 1.034 0 C-N-CA 125.024 1.33 . . . . 0.0 111.607 -172.922 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 2480 ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -65.28 -16.81 56.3 Favored 'Trans proline' 0 CA--C 1.543 0.941 0 C-N-CA 122.701 2.267 . . . . 0.0 113.266 174.807 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 2481 ' ' GLU . . . . . . . . . . . . . 19.6 tt0 -80.21 -10.72 59.77 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 124.969 1.308 . . . . 0.0 112.535 173.374 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 2482 ' ' GLY . . . . . . . . . . . . . . . 122.57 -126.35 6.34 Favored Glycine 0 N--CA 1.473 1.115 0 C-N-CA 125.999 1.761 . . . . 0.0 112.102 -177.048 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 2483 ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -115.85 108.84 16.82 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 123.789 0.836 . . . . 0.0 110.572 171.422 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 2484 ' ' ARG . . . . . . . . . . . . . 42.2 ttm-85 -92.59 132.49 36.82 Favored 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 124.007 0.923 . . . . 0.0 109.63 175.8 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 2485 ' ' VAL . . . . . . . . . . . . . 32.6 m -117.65 144.37 25.75 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 C-N-CA 123.845 0.858 . . . . 0.0 110.327 174.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 2486 ' ' THR . . . . . . . . . . . . . 88.6 m -124.32 132.75 53.57 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 125.447 1.499 . . . . 0.0 107.49 171.089 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 2487 ' ' TYR . . . . . . . . . . . . . 19.4 p90 -142.46 146.83 35.2 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 113.34 0.867 . . . . 0.0 113.34 178.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 2488 ' ' THR . . . . . . . . . . . . . 65.1 m -106.17 116.11 59.98 Favored Pre-proline 0 N--CA 1.471 0.608 0 C-N-CA 124.501 1.12 . . . . 0.0 109.216 172.49 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 2489 ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -79.98 153.8 22.39 Favored 'Trans proline' 0 C--N 1.351 0.681 0 C-N-CA 123.717 2.945 . . . . 0.0 110.665 170.475 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 2490 ' ' MET . . . . . . . . . . . . . 28.5 ptm -117.08 -5.3 11.41 Favored 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 115.055 1.502 . . . . 0.0 115.055 -174.861 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 2491 ' ' ALA . . . . . . . . . . . . . . . -146.5 144.73 21.43 Favored Pre-proline 0 CA--C 1.548 0.898 0 C-N-CA 124.731 1.212 . . . . 0.0 111.447 177.801 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 2492 ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -70.26 156.05 62.91 Favored 'Trans proline' 0 C--N 1.35 0.64 0 C-N-CA 123.571 2.847 . . . . 0.0 111.357 177.88 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 2493 ' ' GLY . . . . . . . . . . . . . . . 126.52 -154.62 19.18 Favored Glycine 0 CA--C 1.528 0.898 0 C-N-CA 124.886 1.231 . . . . 0.0 113.241 -178.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 2494 ' ' SER . . . . . . . . . . . . . 74.0 m -104.5 112.94 26.2 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 123.709 0.804 . . . . 0.0 112.206 -176.893 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 2495 ' ' TYR . . . . . . . . . . . . . 69.0 m-85 -88.64 129.6 35.47 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 123.524 0.73 . . . . 0.0 109.89 162.877 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 2496 ' ' LEU . . . . . . . . . . . . . 29.0 tp -101.55 117.69 35.43 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.697 1.199 . . . . 0.0 109.521 179.052 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 2497 ' ' ILE . . . . . . . . . . . . . 61.9 mt -103.46 99.98 9.5 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 C-N-CA 125.574 1.55 . . . . 0.0 108.407 -170.087 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 2498 ' ' SER . . . . . . . . . . . . . 74.6 m -83.32 86.28 7.08 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 125.071 1.348 . . . . 0.0 109.864 176.495 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 2499 ' ' ILE . . . . . . . . . . . . . 37.0 mt -79.19 110.86 15.36 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 C-N-CA 124.124 0.97 . . . . 0.0 109.162 175.876 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 2500 ' ' LYS . . . . . . . . . . . . . 83.7 mttt -121.75 145.46 48.02 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.859 1.264 . . . . 0.0 111.51 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 2501 ' ' TYR . . . . . . . . . . . . . 47.5 t80 -149.31 146.54 27.59 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.563 1.145 . . . . 0.0 112.16 -171.447 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 2502 ' ' GLY . . . . . . . . . . . . . . . 67.19 19.36 70.18 Favored Glycine 0 CA--C 1.536 1.394 0 C-N-CA 124.25 0.928 . . . . 0.0 113.735 177.552 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 2503 ' ' GLY . . . . . . . . . . . . . . . 131.7 -167.32 22.73 Favored Glycine 0 CA--C 1.541 1.699 0 C-N-CA 125.93 1.729 . . . . 0.0 112.364 -166.13 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 2504 ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -81.83 26.77 0.61 Allowed 'Trans proline' 0 CA--C 1.547 1.154 0 C-N-CA 124.921 3.747 . . . . 0.0 113.588 -174.291 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 2505 ' ' TYR . . . . . . . . . . . . . 60.2 m-85 -112.23 134.36 53.82 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 124.638 1.175 . . . . 0.0 113.02 -171.72 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 2506 ' ' HIS . . . . . . . . . . . . . 95.2 m-70 -63.4 142.53 58.36 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 124.842 1.257 . . . . 0.0 113.462 -179.326 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 2507 ' ' ILE . . . . . . . . . . . . . 1.8 pp -83.37 173.43 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.319 0 C-N-CA 123.628 0.771 . . . . 0.0 113.015 174.428 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 2508 ' ' GLY . . . . . . . . . . . . . . . -59.69 113.73 5.57 Favored Glycine 0 CA--C 1.534 1.248 0 O-C-N 121.469 -0.769 . . . . 0.0 112.783 -177.027 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 2509 ' ' GLY . . . . . . . . . . . . . . . 92.66 -5.32 76.79 Favored Glycine 0 CA--C 1.536 1.354 0 C-N-CA 125.615 1.579 . . . . 0.0 114.861 -177.238 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 2510 ' ' SER . . . . . . . . . . . . . 35.0 t -82.22 146.56 54.96 Favored Pre-proline 0 CA--C 1.55 0.969 0 CA-C-N 118.898 1.349 . . . . 0.0 112.271 179.381 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 2511 ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -77.49 156.54 96.09 Favored 'Cis proline' 0 C--N 1.354 0.845 0 CA-C-N 120.02 1.043 . . . . 0.0 113.305 -0.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 2512 ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -107.47 134.47 50.45 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 125.32 1.448 . . . . 0.0 111.263 178.682 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 2513 ' ' LYS . . . . . . . . . . . . . 40.4 ttmt -99.47 100.48 11.52 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 123.856 0.862 . . . . 0.0 111.966 -178.15 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 2514 ' ' ALA . . . . . . . . . . . . . . . -82.06 109.35 16.31 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.025 1.33 . . . . 0.0 110.787 177.069 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 2515 ' ' LYS . . . . . . . . . . . . . 30.6 mtmm -91.65 81.2 5.3 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.805 1.642 . . . . 0.0 109.324 -175.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 2516 ' ' VAL . . . . . . . . . . . . . 21.0 m -83.49 153.7 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 C-N-CA 124.338 1.055 . . . . 0.0 111.41 -173.226 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 2517 ' ' THR . . . . . . . . . . . . . 77.0 p -132.31 179.46 6.1 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 125.853 1.661 . . . . 0.0 111.118 -175.437 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 2518 ' ' GLY . . . . . . . . . . . . . . . 104.49 -176.15 23.08 Favored Glycine 0 CA--C 1.539 1.576 0 C-N-CA 124.891 1.234 . . . . 0.0 113.309 -176.492 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 2519 ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -74.28 148.59 39.04 Favored 'Trans proline' 0 CA--C 1.537 0.644 0 C-N-CA 123.72 2.946 . . . . 0.0 112.085 -173.92 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 2520 ' ' ARG . . . . . . . . . . . . . 38.3 ttp-105 -89.31 -60.68 1.88 Allowed 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 124.17 0.988 . . . . 0.0 111.883 -179.582 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 2521 ' ' LEU . . . . . . . . . . . . . 40.7 mt 68.7 6.94 5.8 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 127.543 2.337 . . . . 0.0 114.852 175.136 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 2522 ' ' VAL . . . . . . . . . . . . . 31.0 m . . . . . 0 N--CA 1.485 1.321 0 C-N-CA 126.34 1.856 . . . . 0.0 113.057 178.493 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.451 0 N-CA-C 111.237 -0.745 . . . . 0.0 111.237 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -81.24 -176.79 6.16 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 124.831 1.252 . . . . 0.0 112.671 177.907 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 38.0 mmt -72.11 135.23 46.17 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 123.833 0.853 . . . . 0.0 111.306 172.757 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 2427 ' ' GLY . . . . . . . . . . . . . . . -83.27 144.4 22.5 Favored Glycine 0 CA--C 1.53 0.971 0 C-N-CA 125.047 1.308 . . . . 0.0 113.408 -177.012 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 2428 ' ' ASP . . . . . . . . . . . . . 15.3 t70 -100.08 138.87 20.38 Favored Pre-proline 0 CA--C 1.55 0.953 0 C-N-CA 125.314 1.446 . . . . 0.0 111.471 179.448 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 2429 ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -55.49 -26.83 56.11 Favored 'Trans proline' 0 C--N 1.353 0.785 0 C-N-CA 123.782 2.988 . . . . 0.0 115.448 179.85 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 2430 ' ' GLY . . . . . . . . . . . . . . . -81.99 -24.36 55.33 Favored Glycine 0 CA--C 1.533 1.157 0 CA-C-N 119.155 0.889 . . . . 0.0 113.548 176.738 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 2431 ' ' LEU . . . . . . . . . . . . . 4.4 mm? -85.56 -33.75 21.64 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.481 1.112 . . . . 0.0 111.535 172.825 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 2432 ' ' VAL . . . . . . . . . . . . . 87.0 t -66.76 137.2 25.31 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 123.483 0.713 . . . . 0.0 109.539 168.477 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 2433 ' ' SER . . . . . . . . . . . . . 8.3 t -133.39 -170.58 2.51 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 124.85 1.26 . . . . 0.0 110.801 177.773 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 2434 ' ' ALA . . . . . . . . . . . . . . . -152.79 144.39 23.45 Favored 'General case' 0 CA--C 1.537 0.477 0 O-C-N 120.963 -1.086 . . . . 0.0 111.996 176.089 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 2435 ' ' TYR . . . . . . . . . . . . . 74.7 m-85 -147.33 150.2 34.29 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 125.566 1.547 . . . . 0.0 111.825 -174.455 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 2436 ' ' GLY . . . . . . . . . . . . . . . 121.79 162.91 11.77 Favored Glycine 0 N--CA 1.473 1.118 0 C-N-CA 125.288 1.423 . . . . 0.0 113.999 177.135 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 2437 ' ' ALA . . . . . . . . . . . . . . . -60.95 -28.77 69.21 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 125.099 1.36 . . . . 0.0 114.407 -169.677 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 2438 ' ' GLY . . . . . . . . . . . . . . . -66.72 -15.53 64.48 Favored Glycine 0 CA--C 1.532 1.103 0 CA-C-O 118.867 -0.963 . . . . 0.0 114.417 -178.802 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 2439 ' ' LEU . . . . . . . . . . . . . 84.4 mt -76.37 -24.96 54.16 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 118.866 1.333 . . . . 0.0 112.44 169.716 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 2440 ' ' GLU . . . . . . . . . . . . . 43.0 mm-40 -90.89 -31.79 16.27 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.15 1.38 . . . . 0.0 111.896 176.189 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 2441 ' ' GLY . . . . . . . . . . . . . . . 109.22 -133.41 11.63 Favored Glycine 0 CA--C 1.531 1.042 0 C-N-CA 125.921 1.724 . . . . 0.0 112.763 178.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 2442 ' ' GLY . . . . . . . . . . . . . . . 135.41 -154.59 21.76 Favored Glycine 0 CA--C 1.533 1.195 0 C-N-CA 124.826 1.203 . . . . 0.0 114.433 -176.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 2443 ' ' VAL . . . . . . . . . . . . . 93.0 t -74.37 136.14 25.88 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 C-N-CA 124.284 1.034 . . . . 0.0 111.488 -172.516 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 2444 ' ' THR . . . . . . . . . . . . . 25.1 p -63.37 133.13 53.54 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.445 1.098 . . . . 0.0 111.471 174.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 2445 ' ' GLY . . . . . . . . . . . . . . . 85.03 -8.41 70.44 Favored Glycine 0 CA--C 1.536 1.361 0 C-N-CA 124.667 1.127 . . . . 0.0 114.76 -176.511 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 2446 ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -86.01 152.86 56.78 Favored Pre-proline 0 CA--C 1.551 1.018 0 CA-C-N 118.976 1.388 . . . . 0.0 111.796 174.811 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 2447 ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -75.5 97.5 1.1 Allowed 'Trans proline' 0 CA--C 1.538 0.693 0 C-N-CA 123.156 2.571 . . . . 0.0 110.024 173.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 2448 ' ' ALA . . . . . . . . . . . . . . . -78.47 143.23 36.85 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.034 0.934 . . . . 0.0 109.481 168.759 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 2449 ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -155.1 148.32 24.89 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 114.33 1.233 . . . . 0.0 114.33 -173.386 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 2450 ' ' PHE . . . . . . . . . . . . . 49.5 p90 -153.93 162.47 41.19 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 126.439 1.895 . . . . 0.0 110.496 -178.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 2451 ' ' VAL . . . . . . . . . . . . . 71.5 t -112.68 130.96 65.52 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 C-N-CA 124.821 1.248 . . . . 0.0 109.498 174.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 2452 ' ' VAL . . . . . . . . . . . . . 45.5 t -79.52 109.33 14.02 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 161.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 2453 ' ' ASN . . . . . . . . . . . . . 12.4 t-20 -88.68 114.5 25.37 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.188 0.995 . . . . 0.0 111.909 -172.372 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 2454 ' ' THR . . . . . . . . . . . . . 70.0 p -107.43 -5.59 17.59 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 125.521 1.528 . . . . 0.0 113.65 -177.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 2455 ' ' SER . . . . . . . . . . . . . 13.9 m -57.77 -29.7 65.03 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 124.797 1.239 . . . . 0.0 114.242 -175.033 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 2456 ' ' ASN . . . . . . . . . . . . . 69.0 m-80 -83.16 -10.24 58.75 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 124.688 1.195 . . . . 0.0 113.453 177.097 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 2457 ' ' ALA . . . . . . . . . . . . . . . -115.17 -50.53 2.75 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 125.187 1.395 . . . . 0.0 113.482 -169.459 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 2458 ' ' GLY . . . . . . . . . . . . . . . 121.81 -145.2 16.73 Favored Glycine 0 CA--C 1.533 1.208 0 C-N-CA 125.054 1.312 . . . . 0.0 113.108 -174.083 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 2459 ' ' ALA . . . . . . . . . . . . . . . -96.41 160.22 14.53 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 125.195 1.398 . . . . 0.0 113.113 -175.534 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 2460 ' ' GLY . . . . . . . . . . . . . . . 153.76 164.01 12.33 Favored Glycine 0 CA--C 1.53 1.017 0 C-N-CA 124.261 0.934 . . . . 0.0 114.025 -178.561 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 2461 ' ' ALA . . . . . . . . . . . . . . . -79.7 144.76 33.39 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.37 1.068 . . . . 0.0 112.51 -179.411 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 2462 ' ' LEU . . . . . . . . . . . . . 69.5 tp -115.14 141.38 48.09 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 126.006 1.722 . . . . 0.0 110.526 178.283 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 2463 ' ' SER . . . . . . . . . . . . . 16.4 t -142.11 106.1 4.74 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.532 1.133 . . . . 0.0 109.639 170.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 2464 ' ' VAL . . . . . . . . . . . . . 60.5 t -102.39 128.2 55.3 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 C-N-CA 124.083 0.953 . . . . 0.0 109.487 178.881 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 2465 ' ' THR . . . . . . . . . . . . . 98.2 m -116.15 134.22 55.17 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 125.326 1.45 . . . . 0.0 108.636 174.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 2466 ' ' ILE . . . . . . . . . . . . . 41.1 mt -122.88 120.3 60.27 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 C-N-CA 123.542 0.737 . . . . 0.0 109.586 177.433 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 2467 ' ' ASP . . . . . . . . . . . . . 32.0 m-20 -107.0 167.69 9.72 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 126.204 1.802 . . . . 0.0 110.168 169.511 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 2468 ' ' GLY . . . . . . . . . . . . . . . 162.78 -153.1 23.56 Favored Glycine 0 CA--C 1.536 1.366 0 CA-C-O 118.854 -0.97 . . . . 0.0 114.481 179.694 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 2469 ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -70.18 -17.54 35.62 Favored 'Trans proline' 0 CA--C 1.54 0.79 0 C-N-CA 123.774 2.983 . . . . 0.0 113.189 180.0 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 2470 ' ' SER . . . . . . . . . . . . . 38.7 m -157.57 -165.17 1.71 Allowed 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 127.546 2.338 . . . . 0.0 109.382 176.383 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 2471 ' ' LYS . . . . . . . . . . . . . 59.3 mtmt -79.13 -175.3 4.53 Favored 'General case' 0 CA--C 1.552 1.042 0 O-C-N 120.802 -1.187 . . . . 0.0 111.79 167.614 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 2472 ' ' VAL . . . . . . . . . . . . . 33.4 m -139.78 151.78 22.32 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 C-N-CA 125.26 1.424 . . . . 0.0 111.09 171.909 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 2473 ' ' LYS . . . . . . . . . . . . . 60.6 mtpt -87.99 86.51 7.14 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 123.836 0.854 . . . . 0.0 110.126 171.706 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 2474 ' ' MET . . . . . . . . . . . . . 58.3 ttm -79.28 143.29 35.38 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 124.277 1.031 . . . . 0.0 112.38 -176.706 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 2475 ' ' ASP . . . . . . . . . . . . . 23.1 t70 -135.56 100.25 4.44 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 126.448 1.899 . . . . 0.0 109.581 165.067 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 2476 ' ' CYS . . . . . . . . . . . . . 44.3 t -95.47 132.3 40.69 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.642 1.177 . . . . 0.0 110.639 175.778 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 2477 ' ' GLN . . . . . . . . . . . . . 86.7 mt-30 -144.99 154.96 43.1 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 125.286 1.434 . . . . 0.0 110.711 -176.511 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 2478 ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -75.95 152.02 37.14 Favored 'General case' 0 CA--C 1.543 0.696 0 O-C-N 121.389 -0.819 . . . . 0.0 112.068 172.464 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 2479 ' ' CYS . . . . . . . . . . . . . 17.3 p -151.39 166.21 15.65 Favored Pre-proline 0 CA--C 1.554 1.106 0 C-N-CA 125.782 1.633 . . . . 0.0 110.774 -179.59 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 2480 ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -66.93 -18.84 52.55 Favored 'Trans proline' 0 CA--C 1.54 0.794 0 C-N-CA 122.327 2.018 . . . . 0.0 113.643 -178.005 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 2481 ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -92.9 -4.0 53.59 Favored 'General case' 0 CA--C 1.553 1.062 0 C-N-CA 125.164 1.386 . . . . 0.0 112.992 175.831 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 2482 ' ' GLY . . . . . . . . . . . . . . . 139.11 -110.85 0.74 Allowed Glycine 0 N--CA 1.471 0.974 0 C-N-CA 125.482 1.515 . . . . 0.0 112.985 179.828 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 2483 ' ' TYR . . . . . . . . . . . . . 95.3 m-85 -130.03 120.08 24.15 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 124.401 1.08 . . . . 0.0 111.317 175.397 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 2484 ' ' ARG . . . . . . . . . . . . . 19.0 ttp-105 -81.05 133.76 35.54 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 123.785 0.834 . . . . 0.0 110.161 171.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 2485 ' ' VAL . . . . . . . . . . . . . 89.9 t -115.06 118.07 57.63 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 C-N-CA 125.234 1.414 . . . . 0.0 107.996 168.858 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 2486 ' ' THR . . . . . . . . . . . . . 98.9 m -100.16 146.42 26.85 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 124.872 1.269 . . . . 0.0 108.166 165.405 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 2487 ' ' TYR . . . . . . . . . . . . . 29.2 p90 -153.13 152.0 30.8 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.246 1.018 . . . . 0.0 112.618 171.8 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 2488 ' ' THR . . . . . . . . . . . . . 59.6 m -107.09 113.69 62.14 Favored Pre-proline 0 N--CA 1.473 0.719 0 CA-C-O 117.799 -1.096 . . . . 0.0 109.438 173.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 2489 ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -76.01 114.21 3.87 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 123.504 2.803 . . . . 0.0 109.424 172.383 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 2490 ' ' MET . . . . . . . . . . . . . 27.8 ptm -86.42 -7.91 58.06 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 114.661 1.356 . . . . 0.0 114.661 -173.675 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 2491 ' ' ALA . . . . . . . . . . . . . . . -147.04 149.43 35.48 Favored Pre-proline 0 CA--C 1.547 0.855 0 C-N-CA 124.792 1.237 . . . . 0.0 112.146 -179.249 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 2492 ' ' PRO . . . . . . . . . . . . . 78.0 Cg_endo -73.17 155.05 52.21 Favored 'Trans proline' 0 C--N 1.35 0.646 0 C-N-CA 123.627 2.884 . . . . 0.0 111.489 178.243 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 2493 ' ' GLY . . . . . . . . . . . . . . . 131.89 -139.69 11.16 Favored Glycine 0 CA--C 1.529 0.944 0 C-N-CA 125.342 1.449 . . . . 0.0 112.093 -173.635 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 2494 ' ' SER . . . . . . . . . . . . . 65.9 m -133.77 124.99 27.56 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 123.937 0.895 . . . . 0.0 111.465 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 2495 ' ' TYR . . . . . . . . . . . . . 65.6 m-85 -95.53 131.88 41.24 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.845 1.258 . . . . 0.0 111.06 172.759 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 2496 ' ' LEU . . . . . . . . . . . . . 27.8 tp -100.13 114.98 28.76 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 125.297 1.439 . . . . 0.0 109.364 177.881 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 2497 ' ' ILE . . . . . . . . . . . . . 48.2 mt -102.57 102.33 13.42 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 C-N-CA 125.863 1.665 . . . . 0.0 108.667 -173.472 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 2498 ' ' SER . . . . . . . . . . . . . 67.2 m -92.14 109.0 20.35 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 124.888 1.275 . . . . 0.0 109.988 177.413 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 2499 ' ' ILE . . . . . . . . . . . . . 69.1 mt -104.36 104.96 17.64 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 C-N-CA 124.684 1.194 . . . . 0.0 107.926 -176.692 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 2500 ' ' LYS . . . . . . . . . . . . . 84.0 mttt -110.96 137.36 48.68 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.35 1.06 . . . . 0.0 111.244 -179.725 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 2501 ' ' TYR . . . . . . . . . . . . . 51.7 t80 -143.63 137.69 28.48 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 123.915 0.886 . . . . 0.0 111.93 -170.45 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 2502 ' ' GLY . . . . . . . . . . . . . . . 66.54 11.04 55.95 Favored Glycine 0 CA--C 1.537 1.452 0 C-N-CA 124.449 1.023 . . . . 0.0 114.808 177.247 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 2503 ' ' GLY . . . . . . . . . . . . . . . 153.93 -167.53 32.21 Favored Glycine 0 CA--C 1.54 1.625 0 C-N-CA 125.507 1.527 . . . . 0.0 113.31 -170.189 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 2504 ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -82.87 7.88 4.93 Favored 'Trans proline' 0 CA--C 1.543 0.931 0 C-N-CA 124.731 3.621 . . . . 0.0 114.143 -173.43 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 2505 ' ' TYR . . . . . . . . . . . . . 64.4 m-85 -103.24 142.29 34.44 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.648 1.179 . . . . 0.0 113.234 -173.497 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 2506 ' ' HIS . . . . . . . . . . . . . 91.0 m-70 -65.27 147.28 53.72 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 124.278 1.031 . . . . 0.0 112.585 174.891 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 2507 ' ' ILE . . . . . . . . . . . . . 26.9 pt -74.29 169.2 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 O-C-N 121.574 -0.704 . . . . 0.0 112.47 170.524 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 2508 ' ' GLY . . . . . . . . . . . . . . . -57.89 123.88 34.37 Favored Glycine 0 CA--C 1.533 1.18 0 C-N-CA 123.838 0.732 . . . . 0.0 112.179 178.138 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 2509 ' ' GLY . . . . . . . . . . . . . . . 86.92 -10.22 69.02 Favored Glycine 0 CA--C 1.535 1.3 0 C-N-CA 125.535 1.54 . . . . 0.0 114.946 -177.364 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 2510 ' ' SER . . . . . . . . . . . . . 7.2 t -91.65 147.67 35.64 Favored Pre-proline 0 CA--C 1.552 1.045 0 CA-C-N 119.006 1.403 . . . . 0.0 111.538 -179.464 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 2511 ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -73.65 148.0 90.97 Favored 'Cis proline' 0 C--N 1.353 0.814 0 CA-C-N 120.474 1.205 . . . . 0.0 113.546 3.207 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 2512 ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -102.41 131.78 48.85 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 125.262 1.425 . . . . 0.0 110.703 177.764 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 2513 ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.67 106.87 19.03 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 123.934 0.894 . . . . 0.0 111.79 176.149 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 2514 ' ' ALA . . . . . . . . . . . . . . . -92.64 118.55 31.15 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.829 1.652 . . . . 0.0 110.401 177.478 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 2515 ' ' LYS . . . . . . . . . . . . . 48.1 mtpt -94.9 131.51 40.72 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.257 1.023 . . . . 0.0 110.742 -176.733 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 2516 ' ' VAL . . . . . . . . . . . . . 26.9 m -135.43 144.66 33.4 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 C-N-CA 123.832 0.853 . . . . 0.0 112.275 -170.025 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 2517 ' ' THR . . . . . . . . . . . . . 41.3 p -144.76 162.57 36.41 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 125.327 1.451 . . . . 0.0 111.46 -173.177 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 2518 ' ' GLY . . . . . . . . . . . . . . . 117.94 -176.93 16.36 Favored Glycine 0 CA--C 1.539 1.552 0 C-N-CA 125.252 1.406 . . . . 0.0 113.046 -175.039 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 2519 ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -75.41 133.12 15.62 Favored 'Trans proline' 0 C--N 1.349 0.553 0 C-N-CA 123.503 2.802 . . . . 0.0 111.324 -173.72 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 2520 ' ' ARG . . . . . . . . . . . . . 37.7 ttm105 -68.15 -54.11 20.33 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 123.938 0.895 . . . . 0.0 111.699 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 2521 ' ' LEU . . . . . . . . . . . . . 73.1 mt 69.96 -40.57 0.47 Allowed 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 128.966 2.906 . . . . 0.0 114.275 178.809 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 2522 ' ' VAL . . . . . . . . . . . . . 28.4 m . . . . . 0 C--O 1.254 1.311 0 C-N-CA 125.82 1.648 . . . . 0.0 113.772 177.014 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.552 0 N-CA-C 111.476 -0.65 . . . . 0.0 111.476 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -71.99 137.46 47.28 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 124.128 0.971 . . . . 0.0 112.167 179.468 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 25.6 mmt -93.79 138.92 31.45 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.668 1.187 . . . . 0.0 111.507 -179.187 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 2427 ' ' GLY . . . . . . . . . . . . . . . -86.8 153.14 25.53 Favored Glycine 0 CA--C 1.529 0.967 0 C-N-CA 124.967 1.27 . . . . 0.0 112.032 169.658 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 2428 ' ' ASP . . . . . . . . . . . . . 28.5 m-20 -121.46 142.86 36.4 Favored Pre-proline 0 CA--C 1.544 0.714 0 C-N-CA 124.983 1.313 . . . . 0.0 112.098 -177.65 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 2429 ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -64.49 -24.98 63.15 Favored 'Trans proline' 0 CA--C 1.539 0.734 0 C-N-CA 123.196 2.597 . . . . 0.0 112.966 179.12 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 2430 ' ' GLY . . . . . . . . . . . . . . . -73.88 -22.72 77.77 Favored Glycine 0 CA--C 1.535 1.341 0 CA-C-N 118.844 0.747 . . . . 0.0 113.738 174.59 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 2431 ' ' LEU . . . . . . . . . . . . . 4.3 mm? -88.47 -40.96 13.07 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 124.634 1.174 . . . . 0.0 111.201 173.157 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 2432 ' ' VAL . . . . . . . . . . . . . 59.4 t -59.19 137.97 20.91 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 123.936 0.894 . . . . 0.0 111.069 175.038 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 2433 ' ' SER . . . . . . . . . . . . . 8.2 t -127.02 -174.69 3.22 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 125.136 1.374 . . . . 0.0 110.45 171.855 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 2434 ' ' ALA . . . . . . . . . . . . . . . -145.95 146.95 31.23 Favored 'General case' 0 CA--C 1.538 0.487 0 O-C-N 120.91 -1.119 . . . . 0.0 112.123 177.875 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 2435 ' ' TYR . . . . . . . . . . . . . 68.2 m-85 -145.35 150.05 35.89 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 125.411 1.484 . . . . 0.0 111.92 -173.746 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 2436 ' ' GLY . . . . . . . . . . . . . . . 120.63 159.79 10.91 Favored Glycine 0 N--CA 1.474 1.203 0 C-N-CA 125.462 1.506 . . . . 0.0 114.051 177.098 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 2437 ' ' ALA . . . . . . . . . . . . . . . -61.83 -26.98 68.45 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 125.118 1.367 . . . . 0.0 114.446 -171.362 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 2438 ' ' GLY . . . . . . . . . . . . . . . -65.49 -14.48 60.11 Favored Glycine 0 CA--C 1.533 1.183 0 C-N-CA 124.183 0.897 . . . . 0.0 114.217 178.494 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 2439 ' ' LEU . . . . . . . . . . . . . 86.3 mt -78.22 -22.01 49.14 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 118.894 1.347 . . . . 0.0 112.779 169.807 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 2440 ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -98.29 -28.25 13.76 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 125.338 1.455 . . . . 0.0 112.407 -179.268 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 2441 ' ' GLY . . . . . . . . . . . . . . . 105.86 -155.04 16.92 Favored Glycine 0 CA--C 1.533 1.189 0 C-N-CA 125.747 1.641 . . . . 0.0 113.341 179.059 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 2442 ' ' GLY . . . . . . . . . . . . . . . 163.72 -157.06 29.17 Favored Glycine 0 CA--C 1.532 1.102 0 C-N-CA 124.342 0.972 . . . . 0.0 114.071 -175.458 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 2443 ' ' VAL . . . . . . . . . . . . . 61.0 t -87.64 141.33 14.47 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 C-N-CA 124.597 1.159 . . . . 0.0 110.873 -178.192 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 2444 ' ' THR . . . . . . . . . . . . . 26.1 p -62.66 144.3 56.43 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 124.933 1.293 . . . . 0.0 112.666 174.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 2445 ' ' GLY . . . . . . . . . . . . . . . 76.33 -9.91 18.59 Favored Glycine 0 CA--C 1.537 1.466 0 C-N-CA 124.605 1.098 . . . . 0.0 114.254 -176.088 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 2446 ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -101.0 142.11 23.97 Favored Pre-proline 0 CA--C 1.553 1.059 0 C-N-CA 126.744 2.018 . . . . 0.0 110.312 175.184 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 2447 ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -76.72 149.32 29.77 Favored 'Trans proline' 0 CA--C 1.536 0.598 0 C-N-CA 123.196 2.597 . . . . 0.0 111.858 178.757 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 2448 ' ' ALA . . . . . . . . . . . . . . . -138.89 141.51 38.56 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 125.648 1.579 . . . . 0.0 109.972 170.834 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 2449 ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -130.21 152.22 49.88 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.23 1.012 . . . . 0.0 113.396 -167.711 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 2450 ' ' PHE . . . . . . . . . . . . . 40.2 p90 -154.3 161.58 41.7 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.972 1.309 . . . . 0.0 111.746 175.445 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 2451 ' ' VAL . . . . . . . . . . . . . 12.3 p -118.26 135.37 58.89 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 C-N-CA 125.273 1.429 . . . . 0.0 110.454 175.35 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 2452 ' ' VAL . . . . . . . . . . . . . 40.9 t -89.19 104.0 14.54 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 N-CA-C 106.751 -1.574 . . . . 0.0 106.751 166.16 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 2453 ' ' ASN . . . . . . . . . . . . . 15.1 t-20 -89.17 117.1 27.9 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 123.955 0.902 . . . . 0.0 112.791 -165.904 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 2454 ' ' THR . . . . . . . . . . . . . 48.5 p -97.63 -2.67 41.01 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 125.809 1.643 . . . . 0.0 114.432 -175.592 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 2455 ' ' SER . . . . . . . . . . . . . 24.4 m -58.0 -27.43 63.5 Favored 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 114.326 1.232 . . . . 0.0 114.326 -176.672 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 2456 ' ' ASN . . . . . . . . . . . . . 81.8 m-20 -76.42 -20.78 56.75 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 124.44 1.096 . . . . 0.0 113.289 175.744 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 2457 ' ' ALA . . . . . . . . . . . . . . . -117.34 -56.49 2.23 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.649 1.18 . . . . 0.0 113.646 -157.151 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 2458 ' ' GLY . . . . . . . . . . . . . . . 113.68 -155.96 15.95 Favored Glycine 0 CA--C 1.534 1.252 0 C-N-CA 124.852 1.215 . . . . 0.0 112.375 -166.893 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 2459 ' ' ALA . . . . . . . . . . . . . . . -85.53 145.52 27.35 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 124.206 1.002 . . . . 0.0 113.681 -173.19 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 2460 ' ' GLY . . . . . . . . . . . . . . . 174.61 160.67 23.1 Favored Glycine 0 CA--C 1.532 1.127 0 C-N-CA 125.357 1.455 . . . . 0.0 113.145 -179.885 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 2461 ' ' ALA . . . . . . . . . . . . . . . -82.2 150.59 27.3 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 124.278 1.031 . . . . 0.0 112.847 -178.388 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 2462 ' ' LEU . . . . . . . . . . . . . 16.9 tp -107.68 147.36 30.83 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.56 1.544 . . . . 0.0 110.976 176.004 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 2463 ' ' SER . . . . . . . . . . . . . 9.5 t -141.06 37.37 1.75 Allowed 'General case' 0 CA--C 1.551 1.005 0 C-N-CA 125.294 1.438 . . . . 0.0 111.563 -179.469 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 2464 ' ' VAL . . . . . . . . . . . . . 12.6 p -61.01 135.73 25.45 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 C-N-CA 125.164 1.386 . . . . 0.0 112.512 -174.888 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 2465 ' ' THR . . . . . . . . . . . . . 95.9 m -136.57 145.24 44.74 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 126.003 1.721 . . . . 0.0 109.727 -179.758 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 2466 ' ' ILE . . . . . . . . . . . . . 30.1 mt -124.89 130.51 73.27 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 124.072 0.949 . . . . 0.0 110.094 176.519 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 2467 ' ' ASP . . . . . . . . . . . . . 33.7 t70 -122.51 128.12 50.4 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 125.949 1.7 . . . . 0.0 109.976 173.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 2468 ' ' GLY . . . . . . . . . . . . . . . -155.49 -166.2 15.32 Favored Glycine 0 CA--C 1.537 1.43 0 N-CA-C 115.685 1.034 . . . . 0.0 115.685 -171.174 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 2469 ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -67.72 -16.16 45.83 Favored 'Trans proline' 0 CA--C 1.539 0.765 0 C-N-CA 124.464 3.442 . . . . 0.0 113.267 178.474 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 2470 ' ' SER . . . . . . . . . . . . . 8.1 t -156.63 -168.07 2.58 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 126.491 1.916 . . . . 0.0 109.307 166.346 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 2471 ' ' LYS . . . . . . . . . . . . . 67.7 mttm -74.28 173.66 9.89 Favored 'General case' 0 CA--C 1.55 0.97 0 O-C-N 120.881 -1.137 . . . . 0.0 112.31 169.587 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 2472 ' ' VAL . . . . . . . . . . . . . 33.5 m -127.05 149.18 31.96 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 C-N-CA 125.624 1.57 . . . . 0.0 110.696 174.503 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 2473 ' ' LYS . . . . . . . . . . . . . 59.6 tttp -92.71 97.21 10.64 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 165.685 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 2474 ' ' MET . . . . . . . . . . . . . 48.4 ttp -111.58 142.26 44.12 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 124.874 1.27 . . . . 0.0 112.369 -175.445 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 2475 ' ' ASP . . . . . . . . . . . . . 36.9 t70 -126.05 141.15 52.08 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 126.791 2.037 . . . . 0.0 110.23 170.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 2476 ' ' CYS . . . . . . . . . . . . . 63.6 m -123.06 150.82 42.63 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 125.203 1.401 . . . . 0.0 111.989 -173.218 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 2477 ' ' GLN . . . . . . . . . . . . . 3.8 tt0 -151.24 147.14 26.63 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.447 1.099 . . . . 0.0 111.121 179.486 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 2478 ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -90.13 150.06 22.19 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 123.716 0.806 . . . . 0.0 111.083 163.752 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 2479 ' ' CYS . . . . . . . . . . . . . 19.9 p -160.68 172.22 6.14 Favored Pre-proline 0 CA--C 1.554 1.099 0 C-N-CA 125.626 1.571 . . . . 0.0 111.572 -178.384 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 2480 ' ' PRO . . . . . . . . . . . . . 63.6 Cg_exo -58.67 -25.06 73.73 Favored 'Trans proline' 0 CA--C 1.539 0.743 0 C-N-CA 123.454 2.77 . . . . 0.0 114.481 175.362 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 2481 ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -81.72 -8.65 59.72 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 124.814 1.246 . . . . 0.0 113.076 178.162 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 2482 ' ' GLY . . . . . . . . . . . . . . . 120.47 -143.25 16.41 Favored Glycine 0 N--CA 1.471 1.015 0 C-N-CA 126.11 1.814 . . . . 0.0 112.238 -175.263 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 2483 ' ' TYR . . . . . . . . . . . . . 80.1 m-85 -96.23 113.66 25.28 Favored 'General case' 0 N--CA 1.469 0.517 0 O-C-N 121.7 -0.883 . . . . 0.0 110.811 173.381 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 2484 ' ' ARG . . . . . . . . . . . . . 55.6 ttp85 -96.76 142.02 29.28 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 124.62 1.168 . . . . 0.0 110.278 176.85 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 2485 ' ' VAL . . . . . . . . . . . . . 11.3 m -133.97 152.78 35.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 123.806 0.843 . . . . 0.0 111.083 173.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 2486 ' ' THR . . . . . . . . . . . . . 40.5 m -131.99 133.86 44.93 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 125.656 1.583 . . . . 0.0 107.66 172.682 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 2487 ' ' TYR . . . . . . . . . . . . . 15.3 p90 -140.5 148.98 41.92 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 113.839 1.051 . . . . 0.0 113.839 176.876 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 2488 ' ' THR . . . . . . . . . . . . . 69.2 m -108.7 115.71 57.11 Favored Pre-proline 0 N--CA 1.469 0.514 0 C-N-CA 124.941 1.297 . . . . 0.0 109.108 172.611 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 2489 ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -80.49 161.26 22.37 Favored 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 123.794 2.996 . . . . 0.0 110.864 169.571 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 2490 ' ' MET . . . . . . . . . . . . . 25.7 ptm -133.4 2.8 3.56 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 114.94 1.459 . . . . 0.0 114.94 -173.703 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 2491 ' ' ALA . . . . . . . . . . . . . . . -143.42 145.55 32.35 Favored Pre-proline 0 CA--C 1.547 0.828 0 C-N-CA 124.644 1.178 . . . . 0.0 111.68 177.764 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 2492 ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -73.23 148.66 44.36 Favored 'Trans proline' 0 CA--C 1.536 0.615 0 C-N-CA 123.126 2.55 . . . . 0.0 111.08 175.851 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 2493 ' ' GLY . . . . . . . . . . . . . . . 135.05 -161.75 24.64 Favored Glycine 0 CA--C 1.53 0.988 0 C-N-CA 125.307 1.432 . . . . 0.0 112.975 -175.54 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 2494 ' ' SER . . . . . . . . . . . . . 49.3 m -105.8 118.04 35.57 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.835 0.854 . . . . 0.0 111.522 179.193 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 2495 ' ' TYR . . . . . . . . . . . . . 78.1 m-85 -88.53 114.44 25.15 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.704 1.202 . . . . 0.0 109.386 167.033 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 2496 ' ' LEU . . . . . . . . . . . . . 27.2 tp -91.0 114.36 26.86 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 125.158 1.383 . . . . 0.0 109.072 179.073 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 2497 ' ' ILE . . . . . . . . . . . . . 44.0 mt -99.88 102.17 13.07 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 C-N-CA 125.534 1.534 . . . . 0.0 108.503 -173.417 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 2498 ' ' SER . . . . . . . . . . . . . 66.5 m -84.87 93.95 8.64 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 124.954 1.302 . . . . 0.0 109.391 174.841 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 2499 ' ' ILE . . . . . . . . . . . . . 48.6 mt -87.38 95.85 5.31 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 C-N-CA 124.402 1.081 . . . . 0.0 108.526 178.884 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 2500 ' ' LYS . . . . . . . . . . . . . 91.2 mttt -98.84 138.89 35.32 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.099 0.959 . . . . 0.0 111.385 177.212 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 2501 ' ' TYR . . . . . . . . . . . . . 64.6 t80 -149.58 148.46 29.37 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.046 1.338 . . . . 0.0 112.228 -172.765 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 2502 ' ' GLY . . . . . . . . . . . . . . . 69.01 26.3 74.8 Favored Glycine 0 CA--C 1.534 1.22 0 C-N-CA 124.065 0.84 . . . . 0.0 112.639 -178.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 2503 ' ' GLY . . . . . . . . . . . . . . . 116.19 -164.45 12.28 Favored Glycine 0 CA--C 1.54 1.645 0 C-N-CA 125.877 1.703 . . . . 0.0 112.04 -164.022 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 2504 ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -81.49 33.87 0.54 Allowed 'Trans proline' 0 CA--C 1.548 1.179 0 C-N-CA 124.936 3.757 . . . . 0.0 113.165 -173.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 2505 ' ' TYR . . . . . . . . . . . . . 74.9 m-85 -114.8 127.21 55.59 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.815 1.246 . . . . 0.0 112.576 -172.053 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 2506 ' ' HIS . . . . . . . . . . . . . 86.4 m-70 -57.61 138.74 54.97 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 124.802 1.241 . . . . 0.0 113.037 178.326 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 2507 ' ' ILE . . . . . . . . . . . . . 27.1 pt -69.08 166.96 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 O-C-N 121.827 -0.545 . . . . 0.0 112.26 169.689 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 2508 ' ' GLY . . . . . . . . . . . . . . . -59.84 -21.94 56.39 Favored Glycine 0 CA--C 1.539 1.538 0 N-CA-C 116.483 1.353 . . . . 0.0 116.483 -166.688 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 2509 ' ' GLY . . . . . . . . . . . . . . . -106.36 -0.42 37.75 Favored Glycine 0 CA--C 1.536 1.399 0 C-N-CA 125.136 1.351 . . . . 0.0 114.969 174.302 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 2510 ' ' SER . . . . . . . . . . . . . 46.8 t -88.77 148.69 42.16 Favored Pre-proline 0 CA--C 1.549 0.916 0 CA-C-N 118.678 1.239 . . . . 0.0 112.824 -172.488 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 2511 ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -78.39 152.34 90.64 Favored 'Cis proline' 0 C--N 1.353 0.794 0 CA-C-N 119.31 0.789 . . . . 0.0 113.288 -1.669 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 2512 ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -102.29 128.91 48.64 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 125.291 1.437 . . . . 0.0 110.739 179.26 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 2513 ' ' LYS . . . . . . . . . . . . . 57.0 pttt -92.04 100.36 13.02 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 124.097 0.959 . . . . 0.0 112.214 178.644 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 2514 ' ' ALA . . . . . . . . . . . . . . . -88.3 114.59 25.08 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.714 1.206 . . . . 0.0 110.109 175.209 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 2515 ' ' LYS . . . . . . . . . . . . . 66.3 mttm -95.92 119.07 33.76 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 123.867 0.867 . . . . 0.0 111.093 -175.188 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 2516 ' ' VAL . . . . . . . . . . . . . 49.4 t -113.4 140.15 35.09 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 C-N-CA 125.731 1.612 . . . . 0.0 110.408 -169.798 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 2517 ' ' THR . . . . . . . . . . . . . 64.2 p -129.85 173.6 10.51 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 125.82 1.648 . . . . 0.0 111.403 -177.027 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 2518 ' ' GLY . . . . . . . . . . . . . . . 100.5 -171.14 22.81 Favored Glycine 0 CA--C 1.539 1.55 0 C-N-CA 124.705 1.145 . . . . 0.0 113.03 -174.695 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 2519 ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -72.19 157.36 54.04 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 123.719 2.946 . . . . 0.0 112.106 -176.005 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 2520 ' ' ARG . . . . . . . . . . . . . 50.9 ttt85 -87.12 120.12 28.06 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 123.635 0.774 . . . . 0.0 109.665 170.499 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 2521 ' ' LEU . . . . . . . . . . . . . 9.3 mp -85.11 -16.9 39.02 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.571 1.148 . . . . 0.0 112.433 -177.552 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 2522 ' ' VAL . . . . . . . . . . . . . 24.9 t . . . . . 0 C--O 1.253 1.249 0 C-N-CA 126.694 1.997 . . . . 0.0 112.025 179.135 . . . . . . . . 0 0 . 1 stop_ save_